Citrus Sinensis ID: 042086
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 784 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.897 | 0.673 | 0.432 | 1e-174 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.892 | 0.625 | 0.452 | 1e-163 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.892 | 0.635 | 0.385 | 1e-122 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.895 | 0.562 | 0.359 | 1e-118 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.901 | 0.641 | 0.383 | 1e-116 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.899 | 0.627 | 0.381 | 1e-114 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.889 | 0.610 | 0.358 | 1e-113 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.891 | 0.558 | 0.343 | 1e-111 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.860 | 0.594 | 0.346 | 1e-108 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.887 | 0.687 | 0.342 | 1e-108 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 612 bits (1579), Expect = e-174, Method: Compositional matrix adjust.
Identities = 329/761 (43%), Positives = 465/761 (61%), Gaps = 57/761 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN+ +L TL L NKL G IP + GN+ LA+++LY N L+ SIPP +G ++ + L++S
Sbjct: 283 GNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEIS 342
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
EN+L+G +P + G L+ L L L N LSG IP I N L L L +N +G +P ++
Sbjct: 343 ENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTI 402
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLG-------------------------- 227
L L L +N G +P L + K L+ +
Sbjct: 403 CRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLS 462
Query: 228 ----------------------LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
LS N ++G IP I N+ L L L N+++ GE+P
Sbjct: 463 NNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRIT-GELPES 521
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
I ++ ++ L LNGN+L G +P + LT LEYLDLS+N+ + IP TL NL +L+Y+NL
Sbjct: 522 ISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNL 581
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
S N + P L KL QL LDLS N L+G+I + ++++LE+L+LSHNN SG IP
Sbjct: 582 SRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPS 641
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI---KGFQSCNATFTP 442
F+ M L+ +DVS+N L+GPIP++ F+ P +A +GNK LCG + +G + C+ T +
Sbjct: 642 FKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSK 701
Query: 443 HKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFE 502
+ I+ P++GA+ + + G F R+R E + + LSI +F+
Sbjct: 702 KSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTK-QIEEHTDSESGGETLSIFSFD 760
Query: 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMV---PQP 559
GK+ Y+EI++AT FD KY IG GG G VYKAKL + I+AVKK + + +
Sbjct: 761 GKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQ 819
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
EF+NEI+ LTE+RHR++VK +GFCSH RN+FLVYEY+ERGSL +L ND ++ +W R
Sbjct: 820 EFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKR 879
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
+NV++ VA+ALSYMHHD P IVHRDISS N+LL DYEA++SDFG AK LKPDSSN +
Sbjct: 880 INVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSA 939
Query: 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739
+ GT+GY+APEL Y MKVTEKCDVYSFGVL LEVIKG+HP D +S++SSS + +SL
Sbjct: 940 VAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKS 999
Query: 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
I D RLP P +++E++ I++VA LCL+ P++RP M ++
Sbjct: 1000 ISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 576 bits (1484), Expect = e-163, Method: Compositional matrix adjust.
Identities = 323/714 (45%), Positives = 447/714 (62%), Gaps = 14/714 (1%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN++S+ LDLS+NKL GS+P SFGN T L +YL N LS +IPP + N L L L
Sbjct: 411 GNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILD 470
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N +G P T+ L + L N L G IP + + KSL N+ +G I +
Sbjct: 471 TNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAF 530
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
G +L + N G I S L L +S N+++G IP I N+ L+ L L
Sbjct: 531 GIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLS 590
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
N L GE+P IG L++L+ L LNGNQL G +P L LT LE LDLS+N + IP+T
Sbjct: 591 TNNL-FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQT 649
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
+ LKLH +NLS N+F P L KL QL++LDLS N L+G+IP ++ +++SL+KL+L
Sbjct: 650 FDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDL 708
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI--K 431
SHNN SGLIP+ FEGM L+ +D+S N+L GP+P++ F+ +AL+ N GLC +I +
Sbjct: 709 SHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQ 768
Query: 432 GFQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTF-FILRRREGPSSENRVNCV 490
+ C P K + W I+ P+LG L + + TF + +R+R+ + N +
Sbjct: 769 RLKPCRELKKPKKNGNLVVW--ILVPILGVLVILSICANTFTYCIRKRKLQNGRN-TDPE 825
Query: 491 TNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSL 550
T + + SI + +GK Y++I+ +TN FD + IG GG VY+A L I+AVK+ H
Sbjct: 826 TGENM-SIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDT 883
Query: 551 WPCEM---VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN 607
E+ V + EF+NE+K LTE+RHR++VK +GFCSH R++FL+YEY+E+GSL +L+N
Sbjct: 884 IDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAN 943
Query: 608 DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667
D + WT R+NV++ VA+ALSYMHHD PIVHRDISS N+LL DY A++SDFG A
Sbjct: 944 DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003
Query: 668 KFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS 727
K LK DSSN + + GT+GY+APE YTMKVTEKCDVYSFGVL LE+I G HP D +SS+S
Sbjct: 1004 KLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLS 1063
Query: 728 SSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781
SS +SL I D R+ P +++L+ +VE+A LCL +PESRP M ++
Sbjct: 1064 SSPG-EALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-122, Method: Compositional matrix adjust.
Identities = 282/732 (38%), Positives = 391/732 (53%), Gaps = 32/732 (4%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
G L L LDLS N+LNG+IP L L + L+ N L IPP+IG LD+S
Sbjct: 352 GELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMS 411
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N LSG IP L +L L N LSG+IP + KSL L L NQL+GS+PI L
Sbjct: 412 ANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIEL 471
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
NL NL L L +N L G+I + LG LK L L L+ N+ +G IP IGNL ++G +
Sbjct: 472 FNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNIS 531
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
NQL+ G IP E+G ++ L L+GN+ G + + LG L LE L LS N+L IP +
Sbjct: 532 SNQLT-GHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHS 590
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS-ELDLSLNILEGKIPCEICNMESLEKLN 372
G+L +L L L N + PVEL KL L L++S N L G IP + N++ LE L
Sbjct: 591 FGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILY 650
Query: 373 LSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKG 432
L+ N SG IP+ + L ++S N L G +P++ +FQ GN GLC +
Sbjct: 651 LNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQR- 709
Query: 433 FQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFI---------LRRREGP-- 481
S PH SK W I L+++ + +G+ F+ ++RRE
Sbjct: 710 --SHCQPLVPHSD-SKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFV 766
Query: 482 SSENRVNCVTNQGLLSILTFEGK-ILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGE 540
+ E++ T ++ F K Y+ +V AT F +G G G+VYKA+++ GE
Sbjct: 767 ALEDQ----TKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGE 822
Query: 541 ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGS 600
++AVKK +S F EI TL ++RHR+IVK YGFC H ++ L+YEY+ +GS
Sbjct: 823 VIAVKKLNSRGEGASSDN-SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGS 881
Query: 601 LATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR 660
L L +W R + A L Y+HHDC P IVHRDI S N+LL ++A
Sbjct: 882 LGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAH 941
Query: 661 VSDFGIAKFLKPD-SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
V DFG+AK + S + + + G++GYIAPE YTMKVTEKCD+YSFGV+ LE+I G P
Sbjct: 942 VGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPP 1001
Query: 720 -------RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPE 772
D ++ + S N I E+ D RL T + E+ ++++A C + SP
Sbjct: 1002 VQPLEQGGDLVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPA 1060
Query: 773 SRPPMHTVCQLL 784
SRP M V ++
Sbjct: 1061 SRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-118, Method: Compositional matrix adjust.
Identities = 285/792 (35%), Positives = 409/792 (51%), Gaps = 90/792 (11%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN SL +D+ N G IP S G L L +++L +N L +P +GN L LDL+
Sbjct: 453 GNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLA 512
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI---- 189
+NQLSGSIP + G L L L LY NSL G++P + +L++L ++LS N+L+G+I
Sbjct: 513 DNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLC 572
Query: 190 -------------------PISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230
P+ LGN NL L L +N L G IP LG ++ L L +S+
Sbjct: 573 GSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSS 632
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL 290
N L+G IPL + L + L +N LS G IP +GKLS L L L+ NQ +LP L
Sbjct: 633 NALTGTIPLQLVLCKKLTHIDLNNNFLS-GPIPPWLGKLSQLGELKLSSNQFVESLPTEL 691
Query: 291 GSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS 350
+ T+L L L N L SIP+ +GNL L+ LNL NQF P + KL +L EL LS
Sbjct: 692 FNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLS 751
Query: 351 LNILEGKIPCEICNMESLE-KLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
N L G+IP EI ++ L+ L+LS+NNF+G IPS + L +D+S+N+L G +P S
Sbjct: 752 RNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGS 811
Query: 410 ----------------------RIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQ-- 445
+ F P ++ GN GLCG CN + +KQ
Sbjct: 812 VGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQG 869
Query: 446 ISKRKWFII-VFPLLGALSLSVLAMGTFFILR----RREGPSSENRVNC-----VTNQGL 495
+S R II L A+ L +L + FF R ++ G S + T++ L
Sbjct: 870 LSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPL 929
Query: 496 LSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEM 555
+ I +E+I+ AT+ ++ IG GG G VYKA+L +GE +AVKK LW ++
Sbjct: 930 FRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI--LWKDDL 987
Query: 556 VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN--SFLVYEYLERGSLATILSNDGAIEE 613
+ F E+KTL +RHR +VK G+CS + L+YEY++ GS+ L D + E
Sbjct: 988 MSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLE 1047
Query: 614 -----FNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
+W R+ + +A + Y+HHDC PPIVHRDI S NVLL + EA + DFG+AK
Sbjct: 1048 KKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAK 1107
Query: 669 FLKPDSSNCTE----LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFI- 723
L + T+ ++GYIAPE Y++K TEK DVYS G++ +E++ G P D +
Sbjct: 1108 VLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVF 1167
Query: 724 -----------SSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPE 772
+ + + S R+ ++ L P LP +D ++E+A C SP+
Sbjct: 1168 GAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFE----EDAACQVLEIALQCTKTSPQ 1223
Query: 773 SRPPMHTVCQLL 784
RP C L
Sbjct: 1224 ERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1083), Expect = e-116, Method: Compositional matrix adjust.
Identities = 285/743 (38%), Positives = 404/743 (54%), Gaps = 36/743 (4%)
Query: 62 VISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVI 121
I + LST LK+LS LDLS N L G IP F L L ++ L++NSLS +IPP +
Sbjct: 352 TIPVELST------LKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKL 405
Query: 122 GNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181
G L+ LD+S+N LSG IP L SN+ +L+L N+LSG+IP+ I K+L L L+
Sbjct: 406 GWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLA 465
Query: 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSI 241
N L G P +L N+ + L +N GSIP +GN L L L+ N +G +P I
Sbjct: 466 RNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREI 525
Query: 242 GNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDL 301
G L+ L L + N+L+ GE+P EI L L + N G LP +GSL +LE L L
Sbjct: 526 GMLSQLGTLNISSNKLT-GEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKL 584
Query: 302 STNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS-ELDLSLNILEGKIPC 360
S N L +IP LGNL +L L + N F P EL L L L+LS N L G+IP
Sbjct: 585 SNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPP 644
Query: 361 EICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEAL 420
E+ N+ LE L L++NN SG IPS F + L + SYN L GPIP + + M +
Sbjct: 645 ELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSF 701
Query: 421 QGNKGLCGDIKGFQSCNAT--FTPHKQISK------RKWFIIVFPLLGALSLSVLAMGTF 472
GN+GLCG C T F P + K K I ++G +SL ++A+ +
Sbjct: 702 IGNEGLCG--PPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVY 759
Query: 473 FILRRREGPSSENRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVY 532
+ R +S + + L + ++++V AT+ FD + +G G G+VY
Sbjct: 760 LMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVY 819
Query: 533 KAKLTSGEILAVKKF---HSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589
KA L +G LAVKK H V F EI TL +RHR+IVK +GFC+H ++
Sbjct: 820 KAVLPAGYTLAVKKLASNHEGGNNNNVDN-SFRAEILTLGNIRHRNIVKLHGFCNHQGSN 878
Query: 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649
L+YEY+ +GSL IL + +W+ R + A L+Y+HHDC P I HRDI S
Sbjct: 879 LLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSN 936
Query: 650 NVLLCLDYEARVSDFGIAKFLK-PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGV 708
N+LL +EA V DFG+AK + P S + + + G++GYIAPE YTMKVTEK D+YS+GV
Sbjct: 937 NILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGV 996
Query: 709 LALEVIKGDHP-------RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761
+ LE++ G P D ++ + S +S + +LD RL + + ++++++
Sbjct: 997 VLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALS-SGVLDARLTLEDERIVSHMLTVLK 1055
Query: 762 VAFLCLNESPESRPPMHTVCQLL 784
+A LC + SP +RP M V +L
Sbjct: 1056 IALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1065), Expect = e-114, Method: Compositional matrix adjust.
Identities = 279/732 (38%), Positives = 401/732 (54%), Gaps = 27/732 (3%)
Query: 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135
L++L+ LDLS N L G IP F NLT++ + L+ NSLS IP +G L+ +D SEN
Sbjct: 372 LRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSEN 431
Query: 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
QLSG IPP + SNL +L+L N + G+IP + KSL L + N+L+G P L
Sbjct: 432 QLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCK 491
Query: 196 LSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDN 255
L NL + L +N G +P +G + L L L+ N S +P I L+NL+ + N
Sbjct: 492 LVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSN 551
Query: 256 QLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLG 315
L+ G IP EI L L L+ N G+LP LGSL +LE L LS N+ +IP T+G
Sbjct: 552 SLT-GPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIG 610
Query: 316 NLLKLHYLNLSNNQFRKGFPVELEKLIQLS-ELDLSLNILEGKIPCEICNMESLEKLNLS 374
NL L L + N F P +L L L ++LS N G+IP EI N+ L L+L+
Sbjct: 611 NLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLN 670
Query: 375 HNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQ 434
+N+ SG IP+ FE + L + SYN L G +P+++IFQ + + GNKGLCG +
Sbjct: 671 NNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG--HLR 728
Query: 435 SCNATFT--PH----KQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVN 488
SC+ + + PH K S R+ II+ +S+L + R + V+
Sbjct: 729 SCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVH 788
Query: 489 CVTNQGLLSILTF--EGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKK 546
S + F + + ++I+ AT GF Y +G G G+VYKA + SG+ +AVKK
Sbjct: 789 DKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKK 848
Query: 547 FH----SLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFLVYEYLERGS 600
F EI TL ++RHR+IV+ Y FC H ++ L+YEY+ RGS
Sbjct: 849 LESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGS 908
Query: 601 LATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR 660
L +L + G +W R + A L+Y+HHDC P I+HRDI S N+L+ ++EA
Sbjct: 909 LGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAH 967
Query: 661 VSDFGIAKFLK-PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
V DFG+AK + P S + + + G++GYIAPE YTMKVTEKCD+YSFGV+ LE++ G P
Sbjct: 968 VGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
Query: 720 RDFIS---SISSSSSN--RNISL-NEILDPRLPTPPQNV-QDELISIVEVAFLCLNESPE 772
+ +++ + N R+ SL +EILDP L +V + +I++ ++A LC SP
Sbjct: 1028 VQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPS 1087
Query: 773 SRPPMHTVCQLL 784
RP M V +L
Sbjct: 1088 DRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 289/807 (35%), Positives = 422/807 (52%), Gaps = 110/807 (13%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN L L L +N L+GSIP G LT L ++L++NSL IP IGN L +DLS
Sbjct: 271 GNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLS 330
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N LSGSIP ++G LS L + N SGSIP+ I N SL L L NQ+SG IP L
Sbjct: 331 LNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSEL 390
Query: 194 GNLSNLVV------------------------LHLFENSLFGSIPSILGNLKMLLHLGLS 229
G L+ L + L L NSL G+IPS L L+ L L L
Sbjct: 391 GTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLI 450
Query: 230 TNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRA 289
+N LSG IP IGN ++L+ L L N+++ GEIP IG L +N+L + N+L+G +P
Sbjct: 451 SNSLSGFIPQEIGNCSSLVRLRLGFNRIT-GEIPSGIGSLKKINFLDFSSNRLHGKVPDE 509
Query: 290 LGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSE--- 346
+GS +EL+ +DLS N L S+P + +L L L++S NQF P L +L+ L++
Sbjct: 510 IGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLIL 569
Query: 347 ---------------------LDLSLNILEGKIPCEICNMESLE-KLNLSHNNFSGLIPS 384
LDL N L G+IP E+ ++E+LE LNLS N +G IPS
Sbjct: 570 SKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPS 629
Query: 385 CFEGMHGLSCID-----------------------VSYNELRGPIPNSRIFQYDPMEALQ 421
++ LS +D +SYN G +P++++F+ + L+
Sbjct: 630 KIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLE 689
Query: 422 GNKGLCGDIKGFQSCNATFTP------HKQISKRKWFIIVFPLLGALSLSVLAMGTFFIL 475
GNK LC + SC T+ S+ + + LL L++ ++ +G ++
Sbjct: 690 GNKKLCSSTQ--DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVI 747
Query: 476 RRREGPSSENRVNCVTNQGLLSILTFEG-KILYEEIVRATNGFDVKYCIGIGGQGSVYKA 534
R R +E R + + F+ ++I+R +V IG G G VY+A
Sbjct: 748 RARRNIDNE-RDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNV---IGKGCSGVVYRA 803
Query: 535 KLTSGEILAVKKFHSLWPCEMV----------PQPEFVNEIKTLTELRHRSIVKFYGFCS 584
+ +GE++AVKK LWP MV + F E+KTL +RH++IV+F G C
Sbjct: 804 DVDNGEVIAVKK---LWPA-MVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCW 859
Query: 585 HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHR 644
+ L+Y+Y+ GSL ++L ++ +W +R ++ A L+Y+HHDC PPIVHR
Sbjct: 860 NRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHR 918
Query: 645 DISSKNVLLCLDYEARVSDFGIAKFL-KPDSSNCTELV-GTFGYIAPELVYTMKVTEKCD 702
DI + N+L+ LD+E ++DFG+AK + + D C+ V G++GYIAPE Y+MK+TEK D
Sbjct: 919 DIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSD 978
Query: 703 VYSFGVLALEVIKGDHPRD-----FISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI 757
VYS+GV+ LEV+ G P D I + NR SL E+LD L + + DE++
Sbjct: 979 VYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRG-SL-EVLDSTLRSRTEAEADEMM 1036
Query: 758 SIVEVAFLCLNESPESRPPMHTVCQLL 784
++ A LC+N SP+ RP M V +L
Sbjct: 1037 QVLGTALLCVNSSPDERPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 404 bits (1038), Expect = e-111, Method: Compositional matrix adjust.
Identities = 272/791 (34%), Positives = 404/791 (51%), Gaps = 92/791 (11%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN L +D N+L+G IP S G L +L ++L N L +IP +GN + +DL+
Sbjct: 454 GNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLA 513
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI---- 189
+NQLSGSIP + G L+ L + +Y NSL G++P + NLK+L ++ SSN+ +GSI
Sbjct: 514 DNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLC 573
Query: 190 -------------------PISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230
P+ LG +NL L L +N G IP G + L L +S
Sbjct: 574 GSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISR 633
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL 290
N LSG+IP+ +G L + L +N LS G IP +GKL L L L+ N+ G+LP +
Sbjct: 634 NSLSGIIPVELGLCKKLTHIDLNNNYLS-GVIPTWLGKLPLLGELKLSSNKFVGSLPTEI 692
Query: 291 GSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS 350
SLT + L L N L SIP+ +GNL L+ LNL NQ P + KL +L EL LS
Sbjct: 693 FSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLS 752
Query: 351 LNILEGKIPCEICNMESLEK-LNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
N L G+IP EI ++ L+ L+LS+NNF+G IPS + L +D+S+N+L G +P
Sbjct: 753 RNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQ 812
Query: 410 ----------------------RIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQIS 447
+ F +A GN GLCG CN + +++
Sbjct: 813 IGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCG--SPLSHCNRAGSKNQRSL 870
Query: 448 KRKWFIIVFPL--LGALSLSVLAMGTFF------ILRRREGPSSENRVNCVTNQGLLSIL 499
K +I+ + L A++L VL + FF + R G S+ + + + L S
Sbjct: 871 SPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNG 930
Query: 500 TFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQP 559
+ I +++I+ AT+ + ++ IG GG G VYKA+L +GE +AVKK LW +++
Sbjct: 931 GAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI--LWKDDLMSNK 988
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRN--SFLVYEYLERGSLATIL---SNDGAIEEF 614
F E+KTL +RHR +VK G+CS + + L+YEY+ GS+ L N E
Sbjct: 989 SFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVL 1048
Query: 615 NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674
W R+ + +A + Y+H+DC PPIVHRDI S NVLL + EA + DFG+AK L +
Sbjct: 1049 GWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNY 1108
Query: 675 SNCTE----LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730
TE G++GYIAPE Y++K TEK DVYS G++ +E++ G P + +
Sbjct: 1109 DTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAM------- 1161
Query: 731 SNRNISLNEILDPRLPTPP-QNVQDELIS----------------IVEVAFLCLNESPES 773
+ + ++ L TPP +++LI ++E+A C P+
Sbjct: 1162 FDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQE 1221
Query: 774 RPPMHTVCQLL 784
RP + L
Sbjct: 1222 RPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1009), Expect = e-108, Method: Compositional matrix adjust.
Identities = 270/780 (34%), Positives = 399/780 (51%), Gaps = 105/780 (13%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIP--------------- 118
G +KSL+ +DLS N +G+IP SFGNL+NL + L N+++ SIP
Sbjct: 320 GFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQID 379
Query: 119 ---------PVIGNLKFL------------------------YHLDLSENQLSGSIPPTL 145
P IG LK L LDLS+N L+GS+P L
Sbjct: 380 ANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGL 439
Query: 146 GNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLF 205
L NL L L N++SG IP IGN SL L L +N+++G IP +G L NL L L
Sbjct: 440 FQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLS 499
Query: 206 ENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
EN+L G +P + N + L L LS N L G +PLS+ +L L L + N L+ G+IP
Sbjct: 500 ENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLT-GKIPDS 558
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLH-YLN 324
+G L SLN L+L+ N G +P +LG T L+ LDLS+N + +IPE L ++ L LN
Sbjct: 559 LGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALN 618
Query: 325 LSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPS 384
LS N P + L +LS LD+S N+L G + + +E+L LN+SHN FSG
Sbjct: 619 LSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSA-LSGLENLVSLNISHNRFSGY--- 674
Query: 385 CFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSC----NATF 440
+P+S++F+ ++GN GLC KGF+SC ++
Sbjct: 675 ---------------------LPDSKVFRQLIGAEMEGNNGLCS--KGFRSCFVSNSSQL 711
Query: 441 TPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILT 500
T + + + I LL +++ + +G ++R ++ +N N
Sbjct: 712 TTQRGVHSHR-LRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTP 770
Query: 501 FEG-KILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVP-- 557
F+ E +++ +V IG G G VYKA++ + E++AVKK LWP VP
Sbjct: 771 FQKLNFTVEHVLKCLVEGNV---IGKGCSGIVYKAEMPNREVIAVKK---LWPV-TVPNL 823
Query: 558 ---------QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSND 608
+ F E+KTL +RH++IV+F G C + L+Y+Y+ GSL ++L
Sbjct: 824 NEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHER 883
Query: 609 GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
+ W VR +I A L+Y+HHDC PPIVHRDI + N+L+ D+E + DFG+AK
Sbjct: 884 SGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAK 943
Query: 669 FLKPD--SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRD--FIS 724
+ + + + G++GYIAPE Y+MK+TEK DVYS+GV+ LEV+ G P D
Sbjct: 944 LVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD 1003
Query: 725 SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + I +++D L P++ +E++ + VA LC+N PE RP M V +L
Sbjct: 1004 GLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 392 bits (1008), Expect = e-108, Method: Compositional matrix adjust.
Identities = 260/759 (34%), Positives = 402/759 (52%), Gaps = 63/759 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN+ SL LDL+ KL+G IP G L +L + LY N+ + +IP IG++ L LD S
Sbjct: 233 GNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFS 292
Query: 134 EN------------------------QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSII 169
+N +LSGSIPP + +L+ L VL L+ N+LSG +PS +
Sbjct: 293 DNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDL 352
Query: 170 GNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS 229
G L +L +SSN SG IP +L N NL L LF N+ G IP+ L + L+ + +
Sbjct: 353 GKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQ 412
Query: 230 TNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRA 289
N L+G IP+ G L L L L N+LS G IP +I SL+++ + NQ+ +LP
Sbjct: 413 NNLLNGSIPIGFGKLEKLQRLELAGNRLS-GGIPGDISDSVSLSFIDFSRNQIRSSLPST 471
Query: 290 LGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDL 349
+ S+ L+ ++ N + +P+ + L L+LS+N P + +L L+L
Sbjct: 472 ILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNL 531
Query: 350 SLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
N L G+IP +I M +L L+LS+N+ +G++P L ++VSYN+L GP+P +
Sbjct: 532 RNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPIN 591
Query: 410 RIFQYDPMEALQGNKGLCGDI----KGFQSCNATFTPHKQISKRKWFIIVFPLLGALSLS 465
+ + L+GN GLCG + FQ ++ H + ++ I+ L+G S
Sbjct: 592 GFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSS---HSSLHGKR--IVAGWLIGI--AS 644
Query: 466 VLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFEGKILYEEIVRATNGF---DVKYC 522
VLA+G I+ R + C +G+ + + GF D+ C
Sbjct: 645 VLALGILTIVTRTLYKKWYSNGFCGDETA------SKGEWPWRLMAFHRLGFTASDILAC 698
Query: 523 ------IGIGGQGSVYKAKLT-SGEILAVKK-FHSLWPCEMVPQPEFVNEIKTLTELRHR 574
IG+G G VYKA+++ S +LAVKK + S E +FV E+ L +LRHR
Sbjct: 699 IKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHR 758
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEF--NWTVRMNVIRSVANALSY 632
+IV+ GF + +N +VYE++ G+L + A +W R N+ VA+ L+Y
Sbjct: 759 NIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAY 818
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV 692
+HHDC PP++HRDI S N+LL + +AR++DFG+A+ + + + G++GYIAPE
Sbjct: 819 LHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYG 878
Query: 693 YTMKVTEKCDVYSFGVLALEVIKGDHP--RDFISSISSSSSNR-----NISLNEILDPRL 745
YT+KV EK D+YS+GV+ LE++ G P +F S+ R NISL E LDP +
Sbjct: 879 YTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNV 938
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ VQ+E++ ++++A LC + P+ RP M V +L
Sbjct: 939 GN-CRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISML 976
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 784 | ||||||
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.896 | 0.681 | 0.535 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.900 | 0.708 | 0.515 | 0.0 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.900 | 0.680 | 0.510 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.896 | 0.681 | 0.533 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.899 | 0.679 | 0.506 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.900 | 0.654 | 0.507 | 0.0 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.904 | 0.703 | 0.502 | 0.0 | |
| 297734328 | 2131 | unnamed protein product [Vitis vinifera] | 0.940 | 0.345 | 0.475 | 0.0 | |
| 297813345 | 1019 | hypothetical protein ARALYDRAFT_489780 [ | 0.897 | 0.690 | 0.441 | 1e-175 | |
| 186511602 | 1045 | Leucine-rich repeat-containing protein [ | 0.897 | 0.673 | 0.432 | 1e-172 |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/714 (53%), Positives = 481/714 (67%), Gaps = 11/714 (1%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GNL+SL L++S+N+LNGSIP S GNL NL I+YL N LS+SIPP IG L L L++
Sbjct: 323 GNLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEID 382
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
NQLSG +P + +L ++ N L G IP + N SL L NQL+G+I +
Sbjct: 383 TNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAF 442
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
G NL ++L N +G + G L L ++ N+++G IP G L L L
Sbjct: 443 GVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLS 502
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
N L VGEIP ++G +SSL L+LN N+L GN+P LGSL +L YLDLS N+L SIPE
Sbjct: 503 SNHL-VGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEH 561
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
LGN L L+YLNLSNN+ G PV++ KL LS LDLS N+L G+IP +I ++SLEKLNL
Sbjct: 562 LGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNL 621
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGF 433
SHNN SG+IP FE MHGL +D+SYN+L+G IPNS FQ +E LQGNKGLCG +KG
Sbjct: 622 SHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGL 681
Query: 434 QSC---NATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCV 490
Q C +AT HK + FII+F LLGAL + +G I + R E + V
Sbjct: 682 QPCENRSATKGTHKAV-----FIIIFSLLGALLILSAFIGISLISQGRRNAKME-KAGDV 735
Query: 491 TNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSL 550
+ L SI TF+G+ YE I+ AT FD YCIG GG GSVYKA+L SG I+AVKK H
Sbjct: 736 QTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR- 794
Query: 551 WPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGA 610
+ +M Q +F+NEI+ LTE++HR+IVK GFCSH R+SFLVYEYLERGSL TILS +
Sbjct: 795 FDIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQ 854
Query: 611 IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670
+E W R+N+I+ VA+ALSY+HHDC PPIVHRDISS NVLL YEA VSDFG AKFL
Sbjct: 855 AKEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFL 914
Query: 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730
K DSSN + L GT+GY+APEL YTMKVTEKCDVYSFGVLALEV++G HP D ISS+S+S
Sbjct: 915 KLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASP 974
Query: 731 SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
N+ L ++LDPRLP P + E++S++++A CLN SP+SRP M V Q+L
Sbjct: 975 GKDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/762 (51%), Positives = 491/762 (64%), Gaps = 56/762 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GNLKSL L L +N L+G IP S G+L+ L +++LY N LS IP IGNLK L L+LS
Sbjct: 236 GNLKSLQGLSLYENNLSGPIPASLGDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELS 295
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL-------- 185
ENQL+GSIP +LGNL+NL L L N LSG IP IG L L L + +NQL
Sbjct: 296 ENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGI 355
Query: 186 ----------------SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGN---------- 219
SG IP SL N NL N L G+I ++G+
Sbjct: 356 CQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVS 415
Query: 220 --------------LKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
L L ++ N+++G IP G +L L L N L GEIP +
Sbjct: 416 YNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLDLSSNHL-FGEIPKK 474
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
+G ++SL L+LN NQL GN+P LGSL +L YLDLS N+L SIPE LG+ L L+YLNL
Sbjct: 475 MGSVTSLWKLILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNL 534
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
SNN+ G PV++ KL LS+LDLS N+L G IP +I ++SLE LNLSHNN SG IP
Sbjct: 535 SNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKA 594
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQ 445
FE M GLS +D+SYN+L+GPIPNS+ F+ +EAL+GNKGLCG++K + C +Q
Sbjct: 595 FEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQ 654
Query: 446 ISKRKW---FIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFE 502
K+ FII+FPLLGAL L +G F I RRE + E + V N L SI TF+
Sbjct: 655 PVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAARRER-TPEIKEGEVQND-LFSISTFD 712
Query: 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFV 562
G+ +YEEI++AT FD YCIG GG GSVYKA+L S I+AVKK H EM Q +F+
Sbjct: 713 GRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLHP-SDTEMANQKDFL 771
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
NEI+ LTE++HR+IVK GFCSHPR+ FLVYEYLERGSLATILS + A ++ W R+N+
Sbjct: 772 NEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEA-KKLGWATRVNI 830
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
I+ VA+AL+YMHHDC PPIVHRDISS N+LL YEA +SDFG AK LK DSSN + L G
Sbjct: 831 IKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAG 890
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
TFGY+APEL YTMKVTEK DV+SFGV+ALEVIKG HP D I S+S S NI+L ++LD
Sbjct: 891 TFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLD 950
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
PRLP + E+I+I++ A CL +P+SRP M TV Q+L
Sbjct: 951 PRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQTVSQML 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/762 (51%), Positives = 488/762 (64%), Gaps = 56/762 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GNLKSL L L +N L+G IP S +L+ L +++LY N LS IP IGNLK L L+LS
Sbjct: 278 GNLKSLQELSLYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELS 337
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
ENQL+GSIP +LGNL+NL +L L N LSG IP IG L L L + +NQL GS+P +
Sbjct: 338 ENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGI 397
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLK-------------------------------- 221
+LV + +N L G IP L N +
Sbjct: 398 CQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLS 457
Query: 222 ----------------MLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
L L ++ N+++G IP G NL L L N L VGEIP +
Sbjct: 458 YNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSSNHL-VGEIPKK 516
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
+G L+SL L+LN NQL G++P LGSL+ LEYLDLS N+L SIPE LG+ L LHYLNL
Sbjct: 517 MGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNL 576
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
SNN+ G PV++ KL LS+LDLS N+L G IP +I ++SLE L+LSHNN G IP
Sbjct: 577 SNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKA 636
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQ 445
FE M LS +D+SYN+L+GPIP+S F+ +E L+GNK LCG++KG Q C F +Q
Sbjct: 637 FEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQ 696
Query: 446 ISKRKW---FIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFE 502
K+ FII+FPLLGAL L +G F I RRE + E V N L SI F+
Sbjct: 697 PVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRER-TPEIEEGDVQND-LFSISNFD 754
Query: 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFV 562
G+ +YEEI++AT FD YCIG GG GSVYKA+L S I+AVKK H EM Q +F+
Sbjct: 755 GRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLHP-SDTEMANQKDFL 813
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
NEI+ LTE++HR+IVK GFCSHPR+ FLVYEYLERGSLATILS + A ++ W R+N+
Sbjct: 814 NEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEA-KKLGWATRVNI 872
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
I+ VA+AL+YMHHDC PPIVHRD+SS N+LL YEA +SDFG AK LK DSSN + L G
Sbjct: 873 IKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAG 932
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
TFGY+APEL YTMKVTEK DV+SFGV+ALEVIKG HP D I S+S S NI+L ++LD
Sbjct: 933 TFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLD 992
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
PRLP + E+I+I++ A CL +P+SRP M TV Q+L
Sbjct: 993 PRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQML 1034
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/714 (53%), Positives = 478/714 (66%), Gaps = 11/714 (1%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GNL+SL L++S+N+LNGSIP GNL NL I+YL N LS+SIPP IG L L L++
Sbjct: 323 GNLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEID 382
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
NQLSG +P + +L ++ N L G IP + N SL L NQL+G+I +
Sbjct: 383 TNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAF 442
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
G NL ++L N +G + G L L ++ N+++G IP G L L L
Sbjct: 443 GVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLS 502
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
N L VGEIP ++G +SSL L+LN N+L GN+P LGSL +L YLDLS N+L SIPE
Sbjct: 503 SNHL-VGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEH 561
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
LGN L L+YLNLSNN+ G PV++ KL LS LDLS N+L G+IP +I ++SLEKLNL
Sbjct: 562 LGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNL 621
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGF 433
SHNN SG+IP FE MHGL +D+SYN+L+G IPNS FQ +E LQGNKGLCG +KG
Sbjct: 622 SHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGL 681
Query: 434 QSC---NATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCV 490
Q C +AT HK + FII+F LLGAL + +G I + R E + V
Sbjct: 682 QPCENRSATKGTHKAV-----FIIIFSLLGALLILSAFIGISLISQGRRNAKME-KAGDV 735
Query: 491 TNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSL 550
+ L SI TF+G+ YE I+ AT FD YCIG GG GSVYKA+L SG I+AVKK H
Sbjct: 736 QTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR- 794
Query: 551 WPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGA 610
+ +M Q +FVNEI+ LTE++HR+IVK GFCSH R+SFLVYEYLERGSL TILS +
Sbjct: 795 FDIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQ 854
Query: 611 IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670
+E W R+N+I+ V++ALSY+HHDC PPIVHRDISS NVLL YEA VSDFG AKFL
Sbjct: 855 AKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFL 914
Query: 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730
K DSSN + L GT+GY+APEL YTMKVTEKCDVYSFGVLALEV++G HP D ISS+S S
Sbjct: 915 KLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSP 974
Query: 731 SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
N+ L ++LDPRLP P + E+ S++++A CLN SP+SRP M V Q+L
Sbjct: 975 GKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/762 (50%), Positives = 489/762 (64%), Gaps = 57/762 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GNLKSL L L N L+G IP S +L+ L +++LY N LS IP IGNLK L L+LS
Sbjct: 278 GNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELS 337
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL-------- 185
ENQL+GSIP +LGNL+NL +L L N LSG P IG L L L + +NQL
Sbjct: 338 ENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDTNQLFGSLPEGI 397
Query: 186 ----------------SGSIPISLGNLSNLVVLHLFENSLFGSIPSILG---NLK----- 221
SG IP SL N NL N L G++ ++G NL+
Sbjct: 398 CQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVGDCPNLEFIDLS 457
Query: 222 ----------------MLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
L L ++ N+++G IP G NLI L L N L VGEIP +
Sbjct: 458 YNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNHL-VGEIPKK 516
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
+G L+SL L+LN NQL G++P LGSL+ LEYLDLS N+L SIPE LG+ L LHYLNL
Sbjct: 517 MGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNL 576
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
SNN+ G PV++ KL LS+LDLS N+L G IP +I +ESLE L+LSHNN G IP
Sbjct: 577 SNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLEMLDLSHNNLCGFIPKA 636
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQ 445
FE M LS +D+SYN+L+GPIP+S F+ +E L+GNK LCG++KG Q C F +Q
Sbjct: 637 FEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQ 696
Query: 446 ISKRKW---FIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFE 502
K+ FII+FPLLGAL L +G F I RRE + N LLSI TF+
Sbjct: 697 PVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQNN--LLSISTFD 754
Query: 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFV 562
G+ +YEEI++AT FD YCIG GG GSVYKA+L SG I+AVKK H +M Q +F+
Sbjct: 755 GRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLHP-SDMDMANQKDFL 813
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
N+++ +TE++HR+IV+ GFCS+PR+SFLVYEYLERGSLATILS + A ++ W R+ +
Sbjct: 814 NKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSREEA-KKLGWATRVKI 872
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
I+ VA+ALSYMHHDC PPIVHRDISS N+LL YEA +S+ G AK LK DSSN ++L G
Sbjct: 873 IKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAG 932
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
T GY+APE YTMKVTEK DVYSFGV+ALEVIKG HP D I SIS S +NI L ++LD
Sbjct: 933 TVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSPE-KNIVLKDMLD 991
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
PRLP + E+++I+++A CLN +P+SRP M + Q+L
Sbjct: 992 PRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQML 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/762 (50%), Positives = 482/762 (63%), Gaps = 56/762 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GNL SL + L N L+G IP S G+L+ L +++LY N LS IPP IGNLK L L+LS
Sbjct: 285 GNLTSLQGISLYANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELS 344
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS----- 188
ENQL+GSIP +LGNL+NL +L L N LSG P IG L L L + +N+LSGS
Sbjct: 345 ENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGI 404
Query: 189 -------------------IPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS 229
IP S+ N NL N L G+I ++G+ L ++ LS
Sbjct: 405 CQGGSLVRFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLS 464
Query: 230 TNH------------------------LSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
N ++G IP G NL L L N L VGEIP +
Sbjct: 465 YNRFHGELSHNWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHL-VGEIPKK 523
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
+G L+SL L LN NQL G++P LGSL L +LDLS N+L SI E LG L LHYLNL
Sbjct: 524 MGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNL 583
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
SNN+ P ++ KL LS+LDLS N+L G+IP +I +ESLE LNLSHNN SG IP
Sbjct: 584 SNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKA 643
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQ 445
FE M GLS ID+SYN+L+GPIPNS+ F+ +E L+GNK LCG++KG Q C +Q
Sbjct: 644 FEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQ 703
Query: 446 ISKRKW---FIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFE 502
K+ FIIVFPLLGAL L +G F I R + + E V N L SI TF+
Sbjct: 704 PVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTK-RTPEIEEGDVQND-LFSISTFD 761
Query: 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFV 562
G+ +YEEI++AT FD YCIG GG GSVYKA+L+SG I+AVKK ++ +M Q +F
Sbjct: 762 GRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYA-SDIDMANQRDFF 820
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
NE++ LTE++HR+IVK GFCSHPR+SFLVYEYLERGSLA +LS + A ++ W R+N+
Sbjct: 821 NEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSREEA-KKLGWATRINI 879
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
I+ VA+ALSYMHHDC PPIVHRDISS N+LL YE +SDFG AK LK DSSN + L G
Sbjct: 880 IKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAG 939
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
TFGY+APE YTMKVTEK DVYSFGV+ LEVIKG HP D I S+S S NI L ++LD
Sbjct: 940 TFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIVLEDMLD 999
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
PRLP + E+ISI+ +A CL+ +PESRP M + Q+L
Sbjct: 1000 PRLPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQML 1041
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/762 (50%), Positives = 490/762 (64%), Gaps = 53/762 (6%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
G+LKSL++L L N L+G IP S G LT+L I++LY+N LS +IP +GNL L +L+LS
Sbjct: 249 GDLKSLTSLSLFGNNLSGPIPASLGGLTSLTILHLYQNQLSGTIPKELGNLNSLSNLELS 308
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNL--------------------- 172
EN+L+GSIP +LGNLS L +L L N LSG IP I NL
Sbjct: 309 ENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSKLSLLQLQSNQLTGYLPQNI 368
Query: 173 ---KSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILG----------- 218
K L ++ N+L G IP S+ + +LV LHL N G+I G
Sbjct: 369 CQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFIGNISEDFGVYPYLQFVDIR 428
Query: 219 ----------NLKMLLHLG---LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
M HLG +S N++SG+IP IGN L GL NQL VG IP E
Sbjct: 429 YNKFHGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAARLQGLDFSSNQL-VGRIPKE 487
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
+GKL+SL + L NQL +P GSLT+LE LDLS N+ SIP +GNL+KL+YLNL
Sbjct: 488 LGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFNQSIPGNIGNLVKLNYLNL 547
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
SNNQF + P++L KL+ LS+LDLS N L G+IP E+ M+SLE LNLS NN SG IP
Sbjct: 548 SNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQSLEVLNLSRNNLSGFIPGD 607
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHK- 444
+ MHGLS ID+SYN+L GP+P+++ FQ +EA QGNKGLCG ++G Q C + T
Sbjct: 608 LKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHVQGLQPCKPSSTEQGS 667
Query: 445 --QISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFE 502
+ KR + +I PL GA L + +G F +R + E + ++ +L I +F+
Sbjct: 668 SIKFHKRLFLVISLPLFGAF-LILSFLGVLFFQSKRSKEALEAEKSSQESEEILLITSFD 726
Query: 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFV 562
GK +++EI+ AT+ F+ YCIG GG GSVYKAKL+SG +AVKK H Q EF
Sbjct: 727 GKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKLHQSHDAWKPYQKEFW 786
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
+EI+ LTE++HR+IVKFYGFCS+ SFLVYE +E+GSLATIL ++ A +E W R N+
Sbjct: 787 SEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRDNEAAKELEWFKRANI 846
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
I+ VANALSYMHHDC PPIVHRDISSKN+LL + EARVSDFGIA+ L DSS+ T L G
Sbjct: 847 IKGVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIARILNLDSSHRTALAG 906
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
TFGY+APEL Y++ VTEKCDVYSFGVLALEVI G HP + ISSISSSSS R + L I+D
Sbjct: 907 TFGYMAPELAYSIVVTEKCDVYSFGVLALEVINGKHPGEIISSISSSSSTRKMLLENIVD 966
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P VQ EL++I+ +AF CLN +P+ RP M +C +L
Sbjct: 967 LRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTMEMICHML 1008
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734328|emb|CBI15575.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/790 (47%), Positives = 482/790 (61%), Gaps = 53/790 (6%)
Query: 2 AGKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKR 61
+ +E ALLKWK +L HN S L SWT YP NN TN S + ++SPC W+GI CN A
Sbjct: 31 SNEETQALLKWKATLHNHNHSSLLSWTLYP-NNFTNSSTHLGTEVSPCKWYGISCNHAGS 89
Query: 62 VISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVI 121
VI INL+ GL G IP G LTNL +++L +N L+ SIP I
Sbjct: 90 VIRINLTESGL-----------------GGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEI 132
Query: 122 GNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181
G L LY L L NQL GSIP +LGNLSNLA L+LY N LSG IPS GNLK L L+L
Sbjct: 133 GQLTSLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGPIPSTFGNLKHLTVLYLF 192
Query: 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSI 241
+N LSG IP +GNL +L L L+ N+L G IP L +L L L L N LSG IP I
Sbjct: 193 NNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEI 252
Query: 242 GNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDL 301
GNL +L+ + D G +P I + SL ++ N L ++G LE++DL
Sbjct: 253 GNLKSLLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHL------SVGDCPNLEFIDL 306
Query: 302 STNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCE 361
S N+ + G +L L ++ N P + L LDLS N L G+IP +
Sbjct: 307 SYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNHLVGEIPKK 366
Query: 362 ICNMESLEKLNLSHNNFSGLIP-------SCFEGMHGLSCIDVSYNELRGPIPNSRIFQY 414
+ ++ SL L L+ N SG IP FE M LS +D+SYN+L+GPIP+S F+
Sbjct: 367 MGSLTSLLGLILNDNQLSGSIPPELGSLSKAFEDMPALSYVDISYNQLQGPIPHSNAFRN 426
Query: 415 DPMEALQGNKGLCGDIKGFQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFI 474
+E L+GNK LCG+ S + FII+FPLLGAL L +G F I
Sbjct: 427 ATIEVLKGNKDLCGN-----------------SHKVVFIIIFPLLGALVLLSAFIGIFLI 469
Query: 475 LRRREGPSSENRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKA 534
RRE + N LLSI TF+G+ +YEEI++AT FD YCIG GG GSVYKA
Sbjct: 470 AERRERTPEIEEGDVQNN--LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKA 527
Query: 535 KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594
+L SG I+AVKK H +M Q +F+N+++ +TE++HR+IV+ GFCS+PR+SFLVYE
Sbjct: 528 ELPSGNIVAVKKLHP-SDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYE 586
Query: 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC 654
YLERGSLATILS + A ++ W R+ +I+ VA+ALSYMHHDC PPIVHRDISS N+LL
Sbjct: 587 YLERGSLATILSREEA-KKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLD 645
Query: 655 LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
YEA +S+ G AK LK DSSN ++L GT GY+APE YTMKVTEK DVYSFGV+ALEVI
Sbjct: 646 SQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVI 705
Query: 715 KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
KG HP D I SIS S +NI L ++LDPRLP + E+++I+++A CLN +P+SR
Sbjct: 706 KGRHPGDQILSISVSPE-KNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSR 764
Query: 775 PPMHTVCQLL 784
P M + Q+
Sbjct: 765 PTMEIISQMF 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813345|ref|XP_002874556.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] gi|297320393|gb|EFH50815.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1601), Expect = e-175, Method: Compositional matrix adjust.
Identities = 335/758 (44%), Positives = 465/758 (61%), Gaps = 54/758 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN+ +L TL L NKL G IP + GN+ LAI++LY N LS SIPP +G+++ + L++S
Sbjct: 260 GNMTALDTLSLHTNKLTGPIPSTLGNIKTLAILHLYLNQLSGSIPPELGDMEAMIDLEIS 319
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
EN+L+G +P + G L+ L L L N LSG IP I N L L L +N +G +P ++
Sbjct: 320 ENKLTGPVPDSFGKLTVLEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTI 379
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNH--------------------- 232
L L L +N G +P L N K L+ + NH
Sbjct: 380 CRSGKLENLTLDDNHFEGPVPKSLRNCKSLVRVRFKGNHFSGDISDAFGVYPTLNFIDLS 439
Query: 233 ---------------------------LSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
+SG IP I N+ L L L N+++ GE+P
Sbjct: 440 NNNFHGQLSANWEQSTKLVAFILSNNSISGAIPPEIWNMTQLNQLDLSFNRIT-GELPES 498
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
I ++ ++ L LNGNQL G +P + LT LEYLDLS+N+ G IP TL NL +L+Y+NL
Sbjct: 499 ISNINRISKLQLNGNQLSGKIPSGIRLLTNLEYLDLSSNQFGFEIPATLNNLPRLYYMNL 558
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
S N + P L KL QL LDLS N L+G+I + ++++LE+L+LSHNN SG IP+
Sbjct: 559 SRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFGSLQNLERLDLSHNNLSGQIPTS 618
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQ 445
F+ M L+ IDVS+N L+GPIP++ F+ AL+GN LCGD K + C+ T +
Sbjct: 619 FKDMLALTHIDVSHNNLQGPIPDNAAFRNASPNALEGNNDLCGDNKALKPCSITSSKKSH 678
Query: 446 ISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFEGKI 505
+ I+ P++GA+ + + G F R+R EN + + LSI +F+GK+
Sbjct: 679 KDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEENS-DSESGGETLSIFSFDGKV 737
Query: 506 LYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMV---PQPEFV 562
Y+EI++AT FD KY IG GG G VYKAKL + I+AVKK + + + EF+
Sbjct: 738 RYQEIIKATGEFDSKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSITNPSTKQEFL 796
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
NEI+ LTE+RHR++VK +GFCSH RN+FLVYEY+ERGSL +L ND ++ +W R+NV
Sbjct: 797 NEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINV 856
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
++ VA+ALSYMHHD P IVHRDISS N+LL DYEA++SDFG AK LKPDSSN + + G
Sbjct: 857 VKGVADALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAG 916
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
T+GY+APEL Y MKVTEKCDVYSFGVL LEVIKG+HP D +S++SSS + ++SL I D
Sbjct: 917 TYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDTSLSLKTISD 976
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
RLP P +++E++ I++VA +CL+ P++RP M ++
Sbjct: 977 HRLPEPTPEIKEEVLEILKVALMCLHSDPQARPTMLSI 1014
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1579), Expect = e-172, Method: Compositional matrix adjust.
Identities = 329/761 (43%), Positives = 465/761 (61%), Gaps = 57/761 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN+ +L TL L NKL G IP + GN+ LA+++LY N L+ SIPP +G ++ + L++S
Sbjct: 283 GNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEIS 342
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
EN+L+G +P + G L+ L L L N LSG IP I N L L L +N +G +P ++
Sbjct: 343 ENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTI 402
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLG-------------------------- 227
L L L +N G +P L + K L+ +
Sbjct: 403 CRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLS 462
Query: 228 ----------------------LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
LS N ++G IP I N+ L L L N+++ GE+P
Sbjct: 463 NNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRIT-GELPES 521
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
I ++ ++ L LNGN+L G +P + LT LEYLDLS+N+ + IP TL NL +L+Y+NL
Sbjct: 522 ISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNL 581
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
S N + P L KL QL LDLS N L+G+I + ++++LE+L+LSHNN SG IP
Sbjct: 582 SRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPS 641
Query: 386 FEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI---KGFQSCNATFTP 442
F+ M L+ +DVS+N L+GPIP++ F+ P +A +GNK LCG + +G + C+ T +
Sbjct: 642 FKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSK 701
Query: 443 HKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFE 502
+ I+ P++GA+ + + G F R+R E + + LSI +F+
Sbjct: 702 KSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTK-QIEEHTDSESGGETLSIFSFD 760
Query: 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMV---PQP 559
GK+ Y+EI++AT FD KY IG GG G VYKAKL + I+AVKK + + +
Sbjct: 761 GKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQ 819
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
EF+NEI+ LTE+RHR++VK +GFCSH RN+FLVYEY+ERGSL +L ND ++ +W R
Sbjct: 820 EFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKR 879
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
+NV++ VA+ALSYMHHD P IVHRDISS N+LL DYEA++SDFG AK LKPDSSN +
Sbjct: 880 INVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSA 939
Query: 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739
+ GT+GY+APEL Y MKVTEKCDVYSFGVL LEVIKG+HP D +S++SSS + +SL
Sbjct: 940 VAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKS 999
Query: 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
I D RLP P +++E++ I++VA LCL+ P++RP M ++
Sbjct: 1000 ISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 784 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.897 | 0.673 | 0.416 | 1.4e-144 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.891 | 0.624 | 0.419 | 1.3e-139 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.906 | 0.645 | 0.360 | 2.9e-103 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.896 | 0.638 | 0.355 | 2e-102 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.813 | 0.567 | 0.373 | 1.2e-99 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.896 | 0.561 | 0.331 | 1e-98 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.897 | 0.563 | 0.335 | 1e-98 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.909 | 0.624 | 0.339 | 1.2e-97 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.890 | 0.614 | 0.332 | 2e-97 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.890 | 0.689 | 0.331 | 1.1e-94 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
Identities = 297/713 (41%), Positives = 416/713 (58%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
G ++S+ L++S+NKL G +P SFG LT L ++L N LS IPP I N L L L
Sbjct: 331 GEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLD 390
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N +G +P T+ L L L N G +P + + KSL + N SG I +
Sbjct: 391 TNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAF 450
Query: 194 GNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXXX 253
G L + L N+ G + + S N ++G IP
Sbjct: 451 GVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLS 510
Query: 254 XXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
+++ GE+P I ++ ++ L LNGN+L G +P + LT LEYLDLS+N+ + IP T
Sbjct: 511 SNRIT-GELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPT 569
Query: 314 XXXXXXXXXXXXXXXQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
+ P L KL QL LDLS N L+G+I + ++++LE+L+L
Sbjct: 570 LNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDL 629
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI--- 430
SHNN SG IP F+ M L+ +DVS+N L+GPIP++ F+ P +A +GNK LCG +
Sbjct: 630 SHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTT 689
Query: 431 KGFQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCV 490
+G + C+ T + + I+ P++GA+ + + G F R+R E +
Sbjct: 690 QGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRT-KQIEEHTDSE 748
Query: 491 TNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSL 550
+ LSI +F+GK+ Y+EI++AT FD KY IG GG G VYKAKL + I+AVKK +
Sbjct: 749 SGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNET 807
Query: 551 WPCEMV-P--QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN 607
+ P + EF+NEI+ LTE+RHR++VK +GFCSH RN+FLVYEY+ERGSL +L N
Sbjct: 808 TDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLEN 867
Query: 608 DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667
D ++ +W R+NV++ VA+ALSYMHHD P IVHRDISS N+LL DYEA++SDFG A
Sbjct: 868 DDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTA 927
Query: 668 KFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFXXXXX 727
K LKPDSSN + + GT+GY+APEL Y MKVTEKCDVYSFGVL LEVIKG+HP D
Sbjct: 928 KLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLS 987
Query: 728 XXXXXXXXXXXEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
I D RLP P +++E++ I++VA LCL+ P++RP M ++
Sbjct: 988 SSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1366 (485.9 bits), Expect = 1.3e-139, P = 1.3e-139
Identities = 299/713 (41%), Positives = 416/713 (58%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN++S+ LDLS+NKL GS+P SFGN T L +YL N LS +IPP + N L L L
Sbjct: 411 GNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILD 470
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N +G P T+ L + L N L G IP + + KSL N+ +G I +
Sbjct: 471 TNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAF 530
Query: 194 GNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXXX 253
G +L + N G I S S N+++G IP
Sbjct: 531 GIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLS 590
Query: 254 XXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
L GE+P IG L++L+ L LNGNQL G +P L LT LE LDLS+N + IP+T
Sbjct: 591 TNNL-FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQT 649
Query: 314 XXXXXXXXXXXXXXXQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
+F P L KL QL++LDLS N L+G+IP ++ +++SL+KL+L
Sbjct: 650 FDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDL 708
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI--K 431
SHNN SGLIP+ FEGM L+ +D+S N+L GP+P++ F+ +AL+ N GLC +I +
Sbjct: 709 SHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQ 768
Query: 432 GFQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTF-FILRRREGPSSENRVNCV 490
+ C P K + W ++ P+LG L + + TF + +R+R+ + N +
Sbjct: 769 RLKPCRELKKPKKNGNLVVWILV--PILGVLVILSICANTFTYCIRKRKLQNGRN-TDPE 825
Query: 491 TNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSL 550
T + + SI + +GK Y++I+ +TN FD + IG GG VY+A L I+AVK+ H
Sbjct: 826 TGENM-SIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDT 883
Query: 551 WPCEM---VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN 607
E+ V + EF+NE+K LTE+RHR++VK +GFCSH R++FL+YEY+E+GSL +L+N
Sbjct: 884 IDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAN 943
Query: 608 DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667
D + WT R+NV++ VA+ALSYMHHD PIVHRDISS N+LL DY A++SDFG A
Sbjct: 944 DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003
Query: 668 KFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFXXXXX 727
K LK DSSN + + GT+GY+APE YTMKVTEKCDVYSFGVL LE+I G HP D
Sbjct: 1004 KLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLS 1063
Query: 728 XXXXXXXXXXXEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
I D R+ P +++L+ +VE+A LCL +PESRP M ++
Sbjct: 1064 SSPGEALSLRS-ISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1023 (365.2 bits), Expect = 2.9e-103, P = 2.9e-103
Identities = 270/749 (36%), Positives = 379/749 (50%)
Query: 57 NPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSAS 116
N I + LST LK+LS LDLS N L G IP F L L ++ L++NSLS +
Sbjct: 347 NQLTGTIPVELST------LKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGT 400
Query: 117 IPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLF 176
IPP +G L+ LD+S+N LSG IP L SN+ +L+L N+LSG+IP+ I K+L
Sbjct: 401 IPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLV 460
Query: 177 YLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGV 236
L L+ N L G P +L N+ + L +N GSIP + N +G
Sbjct: 461 QLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGE 520
Query: 237 IPLSXXXXXXXXXXXXXXXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTEL 296
+P +L+ GE+P EI L L + N G LP +GSL +L
Sbjct: 521 LPREIGMLSQLGTLNISSNKLT-GEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQL 579
Query: 297 EYLDLSTNKLGNSIPETXXXXXXXXXXXXXXXQFRKGFPVELEKLIQLS-ELDLSLNILE 355
E L LS N L +IP F P EL L L L+LS N L
Sbjct: 580 ELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLT 639
Query: 356 GKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYD 415
G+IP E+ N+ LE L L++NN SG IPS F + L + SYN L GPIP R
Sbjct: 640 GEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNIS-- 697
Query: 416 PMEALQGNKGLCGDIKGFQSCNAT--FTPHKQISK------RKWFIIVFPLLGALSLSVL 467
M + GN+GLCG C T F P + K K I ++G +SL ++
Sbjct: 698 -MSSFIGNEGLCGP--PLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLI 754
Query: 468 AMGTFFILRRREGPSSENRVNCVTNQGLLSILTFEGK--ILYEEIVRATNGFDVKYCIGI 525
A+ +++RR + + + ++ L I F K ++++V AT+ FD + +G
Sbjct: 755 AL-IVYLMRRPVRTVASSAQDGQPSEMSLDIY-FPPKEGFTFQDLVAATDNFDESFVVGR 812
Query: 526 GGQGSVYKAKLTSGEILAVKKF---HSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
G G+VYKA L +G LAVKK H V F EI TL +RHR+IVK +GF
Sbjct: 813 GACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDN-SFRAEILTLGNIRHRNIVKLHGF 871
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
C+H ++ L+YEY+ +GSL IL + +W+ R + A L+Y+HHDC P I
Sbjct: 872 CNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIF 929
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLK-PDSSNCTELVGTFGYIAPELVYTMKVTEKC 701
HRDI S N+LL +EA V DFG+AK + P S + + + G++GYIAPE YTMKVTEK
Sbjct: 930 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKS 989
Query: 702 DVYSFGVLALEVIKGD---HPRDFXXXXXX---XXXXXXXXXXEILDPRLPTPPQNVQDE 755
D+YS+GV+ LE++ G P D +LD RL + +
Sbjct: 990 DIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSH 1049
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
+++++++A LC + SP +RP M V +L
Sbjct: 1050 MLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 259/729 (35%), Positives = 359/729 (49%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
G L L LDLS N+LNG+IP L L + L+ N L IPP+IG LD+S
Sbjct: 352 GELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMS 411
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N LSG IP L +L L N LSG+IP + KSL L L NQL+GS+PI L
Sbjct: 412 ANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIEL 471
Query: 194 GNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXXX 253
NL NL L L +N L G+I + + N+ +G IP
Sbjct: 472 FNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNIS 531
Query: 254 XXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
QL+ G IP E+G ++ L L+GN+ G + + LG L LE L LS N+L IP +
Sbjct: 532 SNQLT-GHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHS 590
Query: 314 XXXXXXXXXXXXXXXQFRKGFPVELEKLIQLS-ELDLSLNILEGKIPCEICNMESLEKLN 372
+ PVEL KL L L++S N L G IP + N++ LE L
Sbjct: 591 FGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILY 650
Query: 373 LSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKG 432
L+ N SG IP+ + L ++S N L G +P++ +FQ GN GLC +
Sbjct: 651 LNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRS 710
Query: 433 FQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFIL---------RRREGPSS 483
C PH SK W I L+++ + +G+ F++ +RRE P+
Sbjct: 711 H--CQP-LVPHSD-SKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRRE-PAF 765
Query: 484 ENRVNCVTNQGLLSILTFEGK-ILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEIL 542
+ T ++ F K Y+ +V AT F +G G G+VYKA+++ GE++
Sbjct: 766 V-ALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVI 824
Query: 543 AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLA 602
AVKK +S F EI TL ++RHR+IVK YGFC H ++ L+YEY+ +GSL
Sbjct: 825 AVKKLNSRGEGASSDN-SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLG 883
Query: 603 TILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVS 662
L +W R + A L Y+HHDC P IVHRDI S N+LL ++A V
Sbjct: 884 EQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVG 943
Query: 663 DFGIAKFLKPD-SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRD 721
DFG+AK + S + + + G++GYIAPE YTMKVTEKCD+YSFGV+ LE+I G P
Sbjct: 944 DFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQ 1003
Query: 722 FXXXXXXXXXXXXXX------XXEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
E+ D RL T + E+ ++++A C + SP SRP
Sbjct: 1004 PLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRP 1063
Query: 776 PMHTVCQLL 784
M V ++
Sbjct: 1064 TMREVVAMI 1072
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 1.2e-99, P = 1.2e-99
Identities = 247/662 (37%), Positives = 349/662 (52%)
Query: 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135
L++L+ LDLS N L G IP F NLT++ + L+ NSLS IP +G L+ +D SEN
Sbjct: 372 LRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSEN 431
Query: 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
QLSG IPP + SNL +L+L N + G+IP + KSL L + N+L+G P L
Sbjct: 432 QLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCK 491
Query: 196 LSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXXXXX 255
L NL + L +N G +P + N S +P
Sbjct: 492 LVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSN 551
Query: 256 QLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETXX 315
L+ G IP EI L L L+ N G+LP LGSL +LE L LS N+ +IP T
Sbjct: 552 SLT-GPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIG 610
Query: 316 XXXXXXXXXXXXXQFRKGFPVELEKLIQLS-ELDLSLNILEGKIPCEICNMESLEKLNLS 374
F P +L L L ++LS N G+IP EI N+ L L+L+
Sbjct: 611 NLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLN 670
Query: 375 HNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQ 434
+N+ SG IP+ FE + L + SYN L G +P+++IFQ + + GNKGLCG +
Sbjct: 671 NNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG--HLR 728
Query: 435 SCNATFT--PH----KQISKRKW--FIIVFPLLGALSLSVLAMGTFFILRRRE--GPSSE 484
SC+ + + PH K S R+ IIV ++G +SL ++A+ F+ E P
Sbjct: 729 SCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVH 788
Query: 485 NRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAV 544
++ + + + + ++I+ AT GF Y +G G G+VYKA + SG+ +AV
Sbjct: 789 DKEPFFQESDIYFVP--KERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAV 846
Query: 545 KKFHSLWPCEMV----PQPEFVNEIKTLTELRHRSIVKFYGFCSHP-RNS-FLVYEYLER 598
KK S F EI TL ++RHR+IV+ Y FC H NS L+YEY+ R
Sbjct: 847 KKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSR 906
Query: 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE 658
GSL +L + G +W R + A L+Y+HHDC P I+HRDI S N+L+ ++E
Sbjct: 907 GSLGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFE 965
Query: 659 ARVSDFGIAKFLK-PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGD 717
A V DFG+AK + P S + + + G++GYIAPE YTMKVTEKCD+YSFGV+ LE++ G
Sbjct: 966 AHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGK 1025
Query: 718 HP 719
P
Sbjct: 1026 AP 1027
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 245/739 (33%), Positives = 370/739 (50%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN ++ +DL+ N+L+GSIP SFG LT L + +Y NSL ++P + NLK L ++ S
Sbjct: 502 GNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFS 561
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N+ +GSI P G+ S L+ + N G IP +G +L L L NQ +G IP +
Sbjct: 562 SNKFNGSISPLCGSSSYLS-FDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTF 620
Query: 194 GNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXXX 253
G +S L +L + NSL G IP + N+LSGVIP
Sbjct: 621 GKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLS 680
Query: 254 XXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
+ VG +P EI L+++ L L+GN L G++P+ +G+L L L+L N+L +P T
Sbjct: 681 SNKF-VGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPST 739
Query: 314 XXXXXXXXXXXXXXXQFRKGFPVELEKLIQL-SELDLSLNILEGKIPCEICNMESLEKLN 372
PVE+ +L L S LDLS N G+IP I + LE L+
Sbjct: 740 IGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLD 799
Query: 373 LSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKG 432
LSHN G +P M L +++SYN L G + F +A GN GLCG
Sbjct: 800 LSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGS--P 855
Query: 433 FQSCNATFTPHKQISKRKWFIIVFPL--LGALSLSVLAMGTFF-----ILRRREGPSSEN 485
CN + +++ K +I+ + L A++L VL + FF + ++ G +S
Sbjct: 856 LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAF 915
Query: 486 RVNCVTNQG-LLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAV 544
N ++Q L S + I +++I+ AT+ + ++ IG GG G VYKA+L +GE +AV
Sbjct: 916 SSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAV 975
Query: 545 KKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN--SFLVYEYLERGSLA 602
KK LW +++ F E+KTL +RHR +VK G+CS + + L+YEY+ GS+
Sbjct: 976 KKI--LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVW 1033
Query: 603 TIL-SNDGAI--EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659
L +N+ E W R+ + +A + Y+H+DC PPIVHRDI S NVLL + EA
Sbjct: 1034 DWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEA 1093
Query: 660 RVSDFGIAKFLKPDSSNCTE----LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK 715
+ DFG+AK L + TE G++GYIAPE Y++K TEK DVYS G++ +E++
Sbjct: 1094 HLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVT 1153
Query: 716 GDHPRDFXXXXXXXXXX----------XXXXXXEILDPRLPTPPQNVQDELISIVEVAFL 765
G P + +++D L + ++ ++E+A
Sbjct: 1154 GKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQ 1213
Query: 766 CLNESPESRPPMHTVCQLL 784
C P+ RP + L
Sbjct: 1214 CTKSYPQERPSSRQASEYL 1232
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 249/742 (33%), Positives = 368/742 (49%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GN L+ LDL+ N+L+GSIP SFG L L + LY NSL ++P + +L+ L ++LS
Sbjct: 501 GNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLS 560
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N+L+G+I P G+ S L+ + N IP +GN ++L L L NQL+G IP +L
Sbjct: 561 HNRLNGTIHPLCGSSSYLS-FDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTL 619
Query: 194 GNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXXX 253
G + L +L + N+L G+IP + N LSG IP
Sbjct: 620 GKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLS 679
Query: 254 XXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
Q V +P E+ + L L L+GN L G++P+ +G+L L L+L N+ S+P+
Sbjct: 680 SNQF-VESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQA 738
Query: 314 XXXXXXXXXXXXXXXQFRKGFPVELEKLIQL-SELDLSLNILEGKIPCEICNMESLEKLN 372
PVE+ +L L S LDLS N G IP I + LE L+
Sbjct: 739 MGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLD 798
Query: 373 LSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKG 432
LSHN +G +P M L ++VS+N L G + F P ++ GN GLCG
Sbjct: 799 LSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLS 856
Query: 433 FQSCNATFTPHKQISKRKWFII-VFPLLGALSLSVLAMGTFFILR----RREGP-----S 482
+ + + +S R II L A+ L +L + FF R ++ G +
Sbjct: 857 RCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYT 916
Query: 483 SENRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEIL 542
S + + T++ L + I +E+I+ AT+ ++ IG GG G VYKA+L +GE +
Sbjct: 917 SSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETV 976
Query: 543 AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN--SFLVYEYLERGS 600
AVKK LW +++ F E+KTL +RHR +VK G+CS + L+YEY++ GS
Sbjct: 977 AVKKI--LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGS 1034
Query: 601 LATILSNDGAIEE-----FNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655
+ L D + E +W R+ + +A + Y+HHDC PPIVHRDI S NVLL
Sbjct: 1035 IWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDS 1094
Query: 656 DYEARVSDFGIAKFLKPDSSNCTE----LVGTFGYIAPELVYTMKVTEKCDVYSFGVLAL 711
+ EA + DFG+AK L + T+ ++GYIAPE Y++K TEK DVYS G++ +
Sbjct: 1095 NMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLM 1154
Query: 712 EVIKGDHPRDFXXXXXXXXXXXXXXXXEI--------LDPRL-PTPPQNVQDELISIVEV 762
E++ G P D E+ +DP+L P P +D ++E+
Sbjct: 1155 EIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFE-EDAACQVLEI 1213
Query: 763 AFLCLNESPESRPPMHTVCQLL 784
A C SP+ RP C L
Sbjct: 1214 ALQCTKTSPQERPSSRQACDSL 1235
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
Identities = 258/759 (33%), Positives = 389/759 (51%)
Query: 56 CNPAKRV-ISINLSTVGLKGNLKSLSTLD---LSKNKLNGSIPFSFGNLTNLAIMYLYRN 111
C+ K + +S+NL + + ++ LS L+ +S NK +GSIP + N ++L + L +N
Sbjct: 321 CSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKN 380
Query: 112 SLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGN 171
+S IP +G L L NQL GSIPP L + ++L L L NSL+G+IPS +
Sbjct: 381 QISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFM 440
Query: 172 LKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTN 231
L++L L L SN LSG IP +GN S+LV L L N + G IPS S+N
Sbjct: 441 LRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSN 500
Query: 232 HLSGVIPLSXXXXXXXXXXXXXXXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALG 291
L G +P L G +P + LS L L ++ NQ G +P +LG
Sbjct: 501 RLHGKVPDEIGSCSELQMIDLSNNSLE-GSLPNPVSSLSGLQVLDVSANQFSGKIPASLG 559
Query: 292 SLTELEYLDLSTNKLGNSIPETXXXXXXXXXXXXXXXQFRKGFPVELEKLIQLS-ELDLS 350
L L L LS N SIP + + P EL + L L+LS
Sbjct: 560 RLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLS 619
Query: 351 LNILEGKIPCEICNMESLEKLNLSHNNFSG-LIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
N L GKIP +I ++ L L+LSHN G L P + L +++SYN G +P++
Sbjct: 620 SNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP--LANIENLVSLNISYNSFSGYLPDN 677
Query: 410 RIF-QYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQI------SKRKWFIIVFPLLGAL 462
++F Q P + L+GNK LC + SC T+ + S+ + + LL L
Sbjct: 678 KLFRQLSPQD-LEGNKKLCSSTQ--DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITL 734
Query: 463 SLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFEGKILY--EEIVRATNGFDVK 520
++ ++ +G ++R R +E R + + F+ K+ + ++I+R +V
Sbjct: 735 TVVLMILGAVAVIRARRNIDNE-RDSELGETYKWQFTPFQ-KLNFSVDQIIRCLVEPNV- 791
Query: 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVP----------QPEFVNEIKTLTE 570
IG G G VY+A + +GE++AVKK LWP MV + F E+KTL
Sbjct: 792 --IGKGCSGVVYRADVDNGEVIAVKK---LWPA-MVNGGHDEKTKNVRDSFSAEVKTLGT 845
Query: 571 LRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
+RH++IV+F G C + L+Y+Y+ GSL ++L ++ +W +R ++ A L
Sbjct: 846 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGL 904
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL-KPDSSNCTELV-GTFGYIA 688
+Y+HHDC PPIVHRDI + N+L+ LD+E ++DFG+AK + + D C+ V G++GYIA
Sbjct: 905 AYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIA 964
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFXXXXXXXXXX---XXXXXXEILDPRL 745
PE Y+MK+TEK DVYS+GV+ LEV+ G P D E+LD L
Sbjct: 965 PEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTL 1024
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + DE++ ++ A LC+N SP+ RP M V +L
Sbjct: 1025 RSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAML 1063
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
Identities = 244/733 (33%), Positives = 366/733 (49%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
GNL +L L LS N + GSIP N T L + N +S IPP IG LK L ++ L
Sbjct: 344 GNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKEL-NIFLG 402
Query: 134 -ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS 192
+N+L G+IP L NL L L N L+GS+P+ + L++L L L SN +SG IP+
Sbjct: 403 WQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLE 462
Query: 193 LGNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXX 252
+GN ++LV L L N + G IP S N+LSG +PL
Sbjct: 463 IGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNL 522
Query: 253 XXXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE 312
L G +P+ + L+ L L ++ N L G +P +LG L L L LS N IP
Sbjct: 523 SNNTLQ-GYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPS 581
Query: 313 TXXXXXXXXXXXXXXXQFRKGFPVELEKLIQLS-ELDLSLNILEGKIPCEICNMESLEKL 371
+ P EL + L L+LS N L+G IP I + L L
Sbjct: 582 SLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVL 641
Query: 372 NLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIK 431
++SHN SG + S G+ L +++S+N G +P+S++F+ ++GN GLC K
Sbjct: 642 DISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS--K 698
Query: 432 GFQSC----NATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRV 487
GF+SC ++ T + + + I + LL +++ + +G ++R ++ +N
Sbjct: 699 GFRSCFVSNSSQLTTQRGVHSHRLRIAI-GLLISVTAVLAVLGVLAVIRAKQMIRDDNDS 757
Query: 488 NCVTNQGLLSILTFEG-KILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKK 546
N F+ E +++ +V IG G G VYKA++ + E++AVKK
Sbjct: 758 ETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNV---IGKGCSGIVYKAEMPNREVIAVKK 814
Query: 547 FHSLWPCEMVP-----------QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595
LWP VP + F E+KTL +RH++IV+F G C + L+Y+Y
Sbjct: 815 ---LWPVT-VPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDY 870
Query: 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655
+ GSL ++L + W VR +I A L+Y+HHDC PPIVHRDI + N+L+
Sbjct: 871 MSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP 930
Query: 656 DYEARVSDFGIAKFLKPD--SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
D+E + DFG+AK + + + + G++GYIAPE Y+MK+TEK DVYS+GV+ LEV
Sbjct: 931 DFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEV 990
Query: 714 IKGDHPRD--FXXXXXXXXXXXXXXXXEILDPRLPTPPQNVQDELISIVEVAFLCLNESP 771
+ G P D +++D L P++ +E++ + VA LC+N P
Sbjct: 991 LTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIP 1050
Query: 772 ESRPPMHTVCQLL 784
E RP M V +L
Sbjct: 1051 EDRPTMKDVAAML 1063
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 942 (336.7 bits), Expect = 1.1e-94, P = 1.1e-94
Identities = 243/733 (33%), Positives = 375/733 (51%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
G LKSL TL L +N G+IP G++T L ++ N+L+ IP I LK L L+L
Sbjct: 257 GKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLM 316
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N+LSGSIPP + +L+ L VL L+ N+LSG +PS +G L +L +SSN SG IP +L
Sbjct: 317 RNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTL 376
Query: 194 GNLSNLVVLHLFENSLFGSIPSIXXXXXXXXXXXXSTNHLSGVIPLSXXXXXXXXXXXXX 253
N NL L LF N+ G IP+ N L+G IP+
Sbjct: 377 CNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELA 436
Query: 254 XXQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
+LS G IP +I SL+++ + NQ+ +LP + S+ L+ ++ N + +P+
Sbjct: 437 GNRLS-GGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQ 495
Query: 314 XXXXXXXXXXXXXXXQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
P + +L L+L N L G+IP +I M +L L+L
Sbjct: 496 FQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDL 555
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP-NSRIFQYDPMEALQGNKGLCGDI-- 430
S+N+ +G++P L ++VSYN+L GP+P N + +P + L+GN GLCG +
Sbjct: 556 SNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINP-DDLRGNSGLCGGVLP 614
Query: 431 --KGFQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVN 488
FQ AT + H + ++ I+ L+G S VLA+G I+ R +
Sbjct: 615 PCSKFQ--RAT-SSHSSLHGKR--IVAGWLIGIAS--VLALGILTIVTRTLYKKWYSNGF 667
Query: 489 CVTNQGLLSILTFEGKILYEEIVRATNGFDVKYCI------GIGGQGSVYKAKLT-SGEI 541
C S + +++ + T D+ CI G+G G VYKA+++ S +
Sbjct: 668 C--GDETASKGEWPWRLMAFHRLGFTAS-DILACIKESNMIGMGATGIVYKAEMSRSSTV 724
Query: 542 LAVKK-FHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGS 600
LAVKK + S E +FV E+ L +LRHR+IV+ GF + +N +VYE++ G+
Sbjct: 725 LAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGN 784
Query: 601 LATILSNDGAIEEF--NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE 658
L + A +W R N+ VA+ L+Y+HHDC PP++HRDI S N+LL + +
Sbjct: 785 LGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLD 844
Query: 659 ARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDH 718
AR++DFG+A+ + + + G++GYIAPE YT+KV EK D+YS+GV+ LE++ G
Sbjct: 845 ARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRR 904
Query: 719 PRD--FXXXXXXXX-----XXXXXXXXEILDPRLPTPPQNVQDELISIVEVAFLCLNESP 771
P + F E LDP + + VQ+E++ ++++A LC + P
Sbjct: 905 PLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNC-RYVQEEMLLVLQIALLCTTKLP 963
Query: 772 ESRPPMHTVCQLL 784
+ RP M V +L
Sbjct: 964 KDRPSMRDVISML 976
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00017830001 | SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (846 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 784 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-100 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-63 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-62 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 331 bits (849), Expect = e-100
Identities = 242/753 (32%), Positives = 359/753 (47%), Gaps = 79/753 (10%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
G L SL+ LDL N L G IP S GNL NL ++LY+N LS IPP I +L+ L LDLS
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
+N LSG IP + L NL +LHL+ N+ +G IP + +L L L L SN+ SG IP +L
Sbjct: 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
G +NL VL L N+L G IP L + L L L +N L G IP S+G +L + L
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ 412
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQL------------------------YGNLPRA 289
DN S GE+P E KL + +L ++ N L +G LP +
Sbjct: 413 DNSFS-GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471
Query: 290 LGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDL 349
GS LE LDLS N+ ++P LG+L +L L LS N+ P EL +L LDL
Sbjct: 472 FGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDL 530
Query: 350 SLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
S N L G+IP M L +L+LS N SG IP + L +++S+N L G +P++
Sbjct: 531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
Query: 410 RIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQISKRK--WFIIVFPLLGALSLSVL 467
F A+ GN LCG + P K++ K WF I L L L+++
Sbjct: 591 GAFLAINASAVAGNIDLCGGDT-----TSGLPPCKRVRKTPSWWFYITCTLGAFLVLALV 645
Query: 468 AMGTFFILRRREGPSSENRVNCVTNQGLLSILTFEGK----ILYEEIVRATNGFDVKYCI 523
A G FI R RV G + F+ K I +I+ + +V I
Sbjct: 646 AFGFVFIRGRNN--LELKRVE--NEDGTWELQFFDSKVSKSITINDILSSLKEENV---I 698
Query: 524 GIGGQGSVYKAKLTSGEI----LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
G +G+ YK K + + +S+ P +EI + +L+H +IVK
Sbjct: 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSI--------PS--SEIADMGKLQHPNIVKL 748
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
G C + ++L++EY+E +L+ +L N +W R + +A AL ++H C P
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYTMKV 697
+V ++S + +++ E + L CT+ Y+APE T +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-------LSLPGLLCTDTKCFISSAYVAPETRETKDI 855
Query: 698 TEKCDVYSFGVLALEVIKGDHPRDFISSISSS------SSNRNISLNEILDPRLPTPPQN 751
TEK D+Y FG++ +E++ G P D + S + L+ +DP +
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915
Query: 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
Q+E++ ++ +A C P +RP + V + L
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 1e-63
Identities = 169/453 (37%), Positives = 229/453 (50%), Gaps = 54/453 (11%)
Query: 1 MAGKEAYALLKWKTSLQ---KHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCN 57
+ +E LL +K+S+ K+ LS+W N++ C W GI CN
Sbjct: 26 LHAEELELLLSFKSSINDPLKY----LSNW------NSSA---------DVCLWQGITCN 66
Query: 58 PAKRVISINLSTVGLKGNLKS-------LSTLDLSKNKLNGSI----------------- 93
+ RV+SI+LS + G + S + T++LS N+L+G I
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 94 ------PFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGN 147
G++ NL + L N LS IP IG+ L LDL N L G IP +L N
Sbjct: 127 NNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
Query: 148 LSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFEN 207
L++L L L N L G IP +G +KSL +++L N LSG IP +G L++L L L N
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 208 SLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIG 267
+L G IPS LGNLK L +L L N LSG IP SI +L LI L L DN LS GEIP +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS-GEIPELVI 305
Query: 268 KLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSN 327
+L +L L L N G +P AL SL L+ L L +NK IP+ LG L L+LS
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 328 NQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFE 387
N P L L +L L N LEG+IP + SL ++ L N+FSG +PS F
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425
Query: 388 GMHGLSCIDVSYNELRGPIPNSRIFQYDPMEAL 420
+ + +D+S N L+G I NSR + ++ L
Sbjct: 426 KLPLVYFLDISNNNLQGRI-NSRKWDMPSLQML 457
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 5e-62
Identities = 151/387 (39%), Positives = 203/387 (52%), Gaps = 36/387 (9%)
Query: 73 KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132
+G++ +L TLDLS N L+G IP G+ ++L ++ L N L IP + NL L L L
Sbjct: 136 RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS 192
+ NQL G IP LG + +L ++L N+LSG IP IG L SL +L L N L+G IP S
Sbjct: 196 ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255
Query: 193 LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
LGNL NL L L++N L G IP + +L+ L+ L LS N LSG IP + L NL L+L
Sbjct: 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE 312
+ N + G+IP+ + L L L L N+ G +P+ LG L LDLSTN L IPE
Sbjct: 316 FSNNFT-GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 313 TL---GNLLKL---------------------HYLNLSNNQFRKGFPVELEKLIQLSELD 348
L GNL KL + L +N F P E KL + LD
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 349 LSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408
+S N L+G+I +M SL+ L+L+ N F G +P F G L +D+S N+ G +P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPR 493
Query: 409 -----SRIFQYDPMEALQGNKGLCGDI 430
S + Q L NK L G+I
Sbjct: 494 KLGSLSELMQLK----LSENK-LSGEI 515
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPE-FVNEIKTLTELRHR 574
+++ +G G G VY A+ +G+++A+K ++ E + EIK L +L+H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK---KIKKDRERILREIKILKKLKHP 57
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+IV+ Y +LV EY E G L +L G + E R +R + +AL Y+H
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE--DEAR-FYLRQILSALEYLH 114
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
IVHRD+ +N+LL D +++DFG+A+ L P T VGT Y+APE++
Sbjct: 115 SKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLG 170
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP--QNV 752
+ D++S GV+ E++ G P F +I P+ P PP ++
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP--F-----PGDDQLLELFKKIGKPKPPFPPPEWDI 223
Query: 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782
E ++ L + PE R Q
Sbjct: 224 SPEAKDLIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 84/269 (31%), Positives = 125/269 (46%), Gaps = 25/269 (9%)
Query: 522 CIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
+G G G+VYKAK +G+I+AVK Q EI+ L L H +IV+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ-TARREIRILRRLSHPNIVRLI 64
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
+ +LV EY E G L LS G + E + + + L Y+H +
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSE--DEAKK-IALQILRGLEYLHSN---G 118
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE-LVYTMKVTE 699
I+HRD+ +N+LL + +++DFG+AK L SS+ T VGT Y+APE L+
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 700 KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISL-NEILDPRLPTPPQN---VQDE 755
K DV+S GV+ E++ G P F S + + L IL P L +E
Sbjct: 179 KVDVWSLGVILYELLTGKPP--F----SGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
+++ CLN+ P RP T ++L
Sbjct: 233 AKDLIKK---CLNKDPSKRP---TAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 67/223 (30%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G GG G+VY A+ +G+ +A+K ++ + + EI+ L +L H +IVK YG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE--LLREIEILKKLNHPNIVKLYG 58
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
+ +LV EY E GSL +L + + + + ++ + L Y+H + I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 642 VHRDISSKNVLL-CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE-LVYTMKVTE 699
+HRD+ +N+LL + + +++DFG++K L D S +VGT Y+APE L+ +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 700 KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
K D++S GV+ E+ +D I + + S EIL+
Sbjct: 174 KSDIWSLGVILYEL---PELKDLIRKMLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 80/272 (29%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F++ IG GG G VYKA+ +G+ +A+K L E + + +NEI+ L + +H +
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEK--KEKIINEIQILKKCKHPN 58
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH- 634
IVK+YG ++V E+ GSL +L + + V + + L Y+H
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 635 -HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
I+HRDI + N+LL D E ++ DFG++ L D+ +VGT ++APE++
Sbjct: 117 NG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVIN 170
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD-PRLPTPPQNV 752
K D++S G+ A+E+ +G P S + + P L P+
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPP------YSELPPMKALFKIATNGPPGLRN-PEKW 223
Query: 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
DE ++ CL ++PE RP T QLL
Sbjct: 224 SDEFKDFLK---KCLQKNPEKRP---TAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 44/278 (15%)
Query: 522 CIGIGGQGSVYKAK-LTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G GSVY A +GE++AVK E+ EI+ L+ L+H +IV+
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE---ALEREIRILSSLQHPNIVR 63
Query: 579 FYGFC-SHPRNSFLVY-EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-H 635
+YG +N+ ++ EY+ GSL+++L G + E +R R + L+Y+H +
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP--VIR-KYTRQILEGLAYLHSN 120
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK--PDSSNCTELVGTFGYIAPELVY 693
IVHRDI N+L+ D +++DFG AK L + GT ++APE++
Sbjct: 121 G----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHP-------RDFISSISSSSSNRNISLNEILDPRLP 746
+ D++S G +E+ G P + I SS I
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI----------- 225
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P+++ +E + CL P+ RP T +LL
Sbjct: 226 --PEHLSEEAKDFLR---KCLRRDPKKRP---TADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 79/276 (28%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 517 FDVKYCIGIGGQGSVYKA--KLTSGEILAVKKFHSLWPCEMVPQPEF----VNEIKTLTE 570
+ +G G G VYK K T G+I A+KK H + EF + E+KTL
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPT-GKIYALKKIH------VDGDEEFRKQLLRELKTLRS 55
Query: 571 LRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
+VK YG +V EY++ GSLA +L G I E V + R + L
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGL 112
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
Y+H I+HRDI N+L+ E +++DFGI+K L+ C VGT Y++PE
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL--DPRLPTP 748
+ + D++S G+ LE G P L + + P P
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP------FLPPGQPSFFELMQAICDGPPPSLP 224
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ E + CL + P+ RP + +LL
Sbjct: 225 AEEFSPEFRDFIS---ACLQKDPKKRP---SAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 35/274 (12%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G G VYK KL +AVK EF+ E + + +L H ++V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREARIMRKLDHPNVV 64
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
K G C+ ++V EY+E G L + L + + + ++ +A + Y+
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV-GTFGYIAPELVYTMK 696
+HRD++++N L+ + ++SDFG+++ L D ++APE + K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 697 VTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEIL-----DPRLPTPPQ 750
T K DV+SFGVL E+ G+ P +S E+L RLP P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYP------------GMSNEEVLEYLKNGYRLP-QPP 226
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
N EL ++ C E PE RP + ++L
Sbjct: 227 NCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 74/278 (26%), Positives = 119/278 (42%), Gaps = 42/278 (15%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G G VYK L +AVK EF+ E + + +L H +IV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLDHPNIV 64
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
K G C+ +V EY+ G L L + +E + + ++ +A + Y+
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK- 122
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELV 692
+HRD++++N L+ + ++SDFG+++ L D + G + APE +
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG----GKLPIRWMAPESL 176
Query: 693 YTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILD-----PRLP 746
K T K DV+SFGVL E+ G+ P +S E+L+ RLP
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYP------------GMSNAEVLEYLKKGYRLP 224
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P N EL ++ C E PE RP + ++L
Sbjct: 225 -KPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 46/274 (16%)
Query: 529 GSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIVKFYGF 582
G VYK L + +AVK +L + EF+ E + +L H +IV+ G
Sbjct: 13 GEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGV 69
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HDCFPPI 641
C+ ++V EY+ G L L G ++M +A + Y+ +
Sbjct: 70 CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM--ALQIAKGMEYLESKNF---- 123
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELVYTMK 696
VHRD++++N L+ + ++SDFG+++ + D G + APE + K
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPESLKDGK 180
Query: 697 VTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILD-----PRLPTPPQ 750
T K DV+SFGVL E+ G+ P +S E+L+ RLP P+
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYP------------GMSNEEVLELLEDGYRLP-RPE 227
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
N DEL ++ C PE RP + + L
Sbjct: 228 NCPDELYELML---QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 51/286 (17%)
Query: 523 IGIGGQGSVYKAKLTSGE----ILAVKK---FHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G G VYK KL + +AVK S + +F+ E + + +L H +
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-----EERKDFLKEARVMKKLGHPN 57
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSN------DGAIEEFNWTVRMNVIRSVANA 629
+V+ G C+ +LV EY+E G L L + ++ +A
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-- 687
+ Y+ VHRD++++N L+ D ++SDFG+++ + D T G +
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPI 171
Query: 688 ---APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP 743
APE + T K DV+SFGVL E+ G P +S E+L+
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP------------YPGLSNEEVLEY 219
Query: 744 -----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P+ DEL ++ C PE RP + + L
Sbjct: 220 LRKGYRLP-KPEYCPDELYELML---SCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 79/265 (29%), Positives = 123/265 (46%), Gaps = 41/265 (15%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPE--FVNEIKTLTELRHRSIVKF 579
IG G G VYKA +G+ +A+KK + Q + +NEI + + +H +IV +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKK------MRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 580 YGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMN------VIRSVANALS 631
Y S+ ++V EY++ GSL I I + VRMN V R V L
Sbjct: 81 YD--SYLVGDELWVVMEYMDGGSLTDI------ITQNF--VRMNEPQIAYVCREVLQGLE 130
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
Y+H ++HRDI S N+LL D +++DFG A L + S +VGT ++APE+
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKGDHPR-DFISSISSSSSNRNISLNEILDPRLPTPPQ 750
+ K D++S G++ +E+ +G+ P + I+ I P L P+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE----PPLRALFLITTKGI--PPLKN-PE 240
Query: 751 NVQDELISIVEVAFLCLNESPESRP 775
E + CL + PE RP
Sbjct: 241 KWSPEFKDFLN---KCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 27/264 (10%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKKF--HSLWPCEMVPQPEFVNEIKTLTELRH 573
+ + IG G G VYK L +G+ +A+K+ + + + EI L L+H
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKH 58
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+IVK+ G + +++ EY E GSL I+ G F ++ + V L+Y+
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYL 115
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H ++HRDI + N+L D +++DFG+A L S + +VGT ++APE++
Sbjct: 116 HEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
+ D++S G +E++ G+ P ++ ++ +L I+ P P+ +
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--------ALFRIVQDDHPPLPEGIS 224
Query: 754 DELISIVEVAFL--CLNESPESRP 775
EL FL C + P RP
Sbjct: 225 PELKD-----FLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 37/279 (13%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELRH 573
+++ IG G G VY + + G++ +K+ ++ E + + +NE+K L +L H
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE---REDALNEVKILKKLNH 58
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGA----IEEF---NWTVRMNVIRSV 626
+I+K+Y +V EY + G L+ + E +W V++
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------ 112
Query: 627 ANALSYMH--HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
AL Y+H I+HRDI +N+ L + ++ DFGI+K L +VGT
Sbjct: 113 CLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744
Y++PEL K D++S G + E+ HP F N +IL +
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F------EGENLLELALKILKGQ 219
Query: 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783
P P EL ++V L + PE RP + + Q
Sbjct: 220 YPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 43/285 (15%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFH----SLWPCEMVPQPEFVNEIKTLTEL 571
++V IG G G+V K + + G+IL K+ + + + V+E+ L EL
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL-----VSEVNILREL 56
Query: 572 RHRSIVKFYGFCSHPRNS--FLVYEYLERGSLATILSN----DGAIEE-FNWTVRMNVIR 624
+H +IV++Y N ++V EY E G LA ++ IEE F W ++
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILT 112
Query: 625 SVANALSYMHH--DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
+ AL H+ D ++HRD+ N+ L + ++ DFG+AK L DSS VG
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP---RDFISSISSSSSNRNISLNE 739
T Y++PE + M EK D++S G L E+ P R+ + S +
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS-----------K 221
Query: 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
I + + P EL +++ LN P+ RP + +LL
Sbjct: 222 IKEGKFRRIPYRYSSELNEVIK---SMLNVDPDKRP---STEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-26
Identities = 76/190 (40%), Positives = 99/190 (52%), Gaps = 11/190 (5%)
Query: 56 CNPAKRVISINLSTVGLKGNLKSLST-------LDLSKNKLNGSIPFSFGNLTNLAIMYL 108
C +RV L G L S T LD+S N L G I ++ +L ++ L
Sbjct: 403 CRSLRRV---RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459
Query: 109 YRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSI 168
RN +P G+ K L +LDLS NQ SG++P LG+LS L L L N LSG IP
Sbjct: 460 ARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518
Query: 169 IGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGL 228
+ + K L L LS NQLSG IP S + L L L +N L G IP LGN++ L+ + +
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578
Query: 229 STNHLSGVIP 238
S NHL G +P
Sbjct: 579 SHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 78/257 (30%), Positives = 127/257 (49%), Gaps = 24/257 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH---RSIVK 578
IG G G+VY+ K + +G ++A+K + P + V + E+ L++LR +I K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS--DIQREVALLSQLRQSQPPNITK 66
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
+YG +++ EY E GS+ T L G I E +V +IR V AL Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISV---IIREVLVALKYIHKV-- 120
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
++HRDI + N+L+ ++ DFG+A L +SS + VGT ++APE++ K
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 699 E-KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI 757
+ K D++S G+ E+ G+ P S + R + L I + P N +L+
Sbjct: 180 DTKADIWSLGITIYEMATGNPP------YSDVDAFRAMML--IPKSKPPRLEDNGYSKLL 231
Query: 758 SIVEVAFLCLNESPESR 774
E CL+E P+ R
Sbjct: 232 R--EFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 19/276 (6%)
Query: 516 GFDVKYCIGIGGQGSVYKAKLTSGEILAVKKF-HSLWPCEMVPQPEFVNEIKTLTELRHR 574
+ + +G G G VY A+ +++A+K L + F+ EI+ L L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVE-RFLREIQILASLNHP 57
Query: 575 S-IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
IVK Y F + +LV EY++ GSL +L G + + + ++ + +AL Y+
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 634 HHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKFLKPDSSN------CTELVGTFGY 686
H I+HRDI +N+LL D ++ DFG+AK L S + VGT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 687 IAPELVYTM---KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743
+APE++ + + D++S G+ E++ G P + + S++S I L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 744 RL-PTPPQNVQDELISIVEVAFLCLNESPESRPPMH 778
P P N + + ++ L + P++R
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 79/257 (30%), Positives = 125/257 (48%), Gaps = 31/257 (12%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCE--------MVPQPEFVNEIKTLTELRH 573
IG G GSVY +SGE++AVK+ M+ EI L EL+H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQH 65
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+IV++ G + + EY+ GS+A +L+N GA EE T+ N +R + L+Y+
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYL 122
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT------ELVGTFGYI 687
H+ I+HRDI N+L+ ++SDFGI+K L+ +S + L G+ ++
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 688 APELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747
APE+V T K D++S G L +E++ G HP + ++ +I + P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP--------FPDCTQLQAIFKIGENASPE 231
Query: 748 PPQNVQDELISIVEVAF 764
P N+ E I +E F
Sbjct: 232 IPSNISSEAIDFLEKTF 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
IG G G VY A L +GE++AVK + P + E +E+K L L+H ++VK+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI---KEIADEMKVLELLKHPNLVKY 64
Query: 580 YGFCSHPRNSFLVY-EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN----ALSYMH 634
YG H R ++ EY G+L +L + G I + +VIR L+Y+H
Sbjct: 65 YGVEVH-REKVYIFMEYCSGGTLEELLEH-GRILD------EHVIRVYTLQLLEGLAYLH 116
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE----LVGTFGYIAPE 690
IVHRDI N+ L + ++ DFG A LK +++ E L GT Y+APE
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 691 LVYTMKVTEK---CDVYSFGVLALEVIKGDHP 719
++ K D++S G + LE+ G P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 62/203 (30%), Positives = 110/203 (54%), Gaps = 21/203 (10%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTELRHRSIVKFY 580
IG G G+VY A + +G+ +A+K+ + + P+ E + NEI + E +H +IV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN----LQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 581 GFCSHPRNSFLVYEYLERGSLATILS----NDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
++V EYL GSL +++ ++G I V R AL ++H +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALEFLHSN 134
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
++HRDI S N+LL +D +++DFG + P+ S + +VGT ++APE+V
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 697 VTEKCDVYSFGVLALEVIKGDHP 719
K D++S G++A+E+++G+ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 47/277 (16%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF---VNEIKTLTELR 572
+++ IG G G VYKA+ + +GE++A+K ++ P +F EI L E R
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI------KLEPGDDFEIIQQEISMLKECR 58
Query: 573 HRSIVKFYGFCSHPRNSFL--VYEYLERGSLATILS-NDGAIEEFNWTVRMNVIRSVANA 629
H +IV ++G S+ R L V EY GSL I G + E V R
Sbjct: 59 HPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE---LQIAYVCRETLKG 113
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
L+Y+H +HRDI N+LL D + +++DFG++ L + +GT ++AP
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 690 ELV---YTMKVTEKCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNISLNEI 740
E+ KCD+++ G+ A+E+ + HP + IS S+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-------- 222
Query: 741 LDPRLPTPPQNVQDELISIVEVAFL--CLNESPESRP 775
PP+ E S V F+ CL + P+ RP
Sbjct: 223 -------PPKLKDKEKWSPVFHDFIKKCLTKDPKKRP 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
+F+ E K + +L H ++V+ YG C+ R F+V EY+ G L L W +
Sbjct: 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD 104
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
M V A+ Y+ + F +HRD++++N L+ D +VSDFG+A+++ D ++
Sbjct: 105 M--CSDVCEAMEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159
Query: 680 LVGT---FGYIAPELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNI 735
GT + PE+ + + K DV+SFGVL EV +G P + S+S ++
Sbjct: 160 --GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE---RFSNSEVVESV 214
Query: 736 SLNEILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
S L P+L + + + C +E PE RP
Sbjct: 215 SAGYRLYRPKLAPTE---------VYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 77/260 (29%), Positives = 120/260 (46%), Gaps = 30/260 (11%)
Query: 522 CIGIGGQGSVYKA-KLTSGEILAVKKF---HSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
CIG G G VYKA + +++A+K + E + Q EI+ L++ R I
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-----EIQFLSQCRSPYIT 62
Query: 578 KFYGFCSHPRNSFL--VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
K+YG S + S L + EY GS +L G ++E ++R V L Y+H
Sbjct: 63 KYYG--SFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAF---ILREVLLGLEYLHE 116
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
+ +HRDI + N+LL + + +++DFG++ L S VGT ++APE++
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
EK D++S G+ A+E+ KG+ P S + I N P L
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPL---SDLHPMRVLFLIPKNNP--PSL--EGNKFSKP 226
Query: 756 LISIVEVAFLCLNESPESRP 775
V LCLN+ P+ RP
Sbjct: 227 FKDFVS---LCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVKKF-HSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G V + +GE +AVK HS E + +F EI+ L L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHENI 68
Query: 577 VKFYGFC--SHPRNSFLVYEYLERGSLATIL----SNDGAIEEFNWTVRMNVIRSVANAL 630
VK+ G C R+ L+ EYL GSL L ++ + + +
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGM 122
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS----SNCTELVGTFGY 686
Y+ +HRD++++N+L+ + ++SDFG+AK L D F Y
Sbjct: 123 DYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 687 IAPELVYTMKVTEKCDVYSFGVLALEVIK-GDH----PRDFISSISSSSSNRNIS-LNEI 740
APE + T K + DV+SFGV E+ GD P +F+ I + ++ L E+
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 741 LDP--RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781
L RLP PP + DE+ +++ LC P+ RP +
Sbjct: 239 LKEGERLPRPP-SCPDEVYDLMK---LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 37/278 (13%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F++ IG G G V+K + + A+K+ L + E ++E + L +L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 576 IVKFYGFCSHPRNSFL-------VYEYLERGSLATILSNDGA---IEEFNWTVRMNVIRS 625
I+++Y SFL V EY E G L +L E+ W + ++
Sbjct: 61 IIRYY-------ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL- 112
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG 685
L+++H I+HRDI S N+ L ++ D G+AK L +++ +VGT
Sbjct: 113 ---GLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY 166
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745
Y++PEL EK DV++ GV+ E G HP D ++N+ + +I+
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVF 218
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783
P Q +L +++ CL + RP + +
Sbjct: 219 PPVSQMYSQQLAQLID---QCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 6e-22
Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 21/203 (10%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTELRHRSIVKFY 580
IG G G+VY A + +G+ +A+++ + + P+ E + NEI + E ++ +IV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 581 GFCSHPRNSFLVYEYLERGSLATILS----NDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
++V EYL GSL +++ ++G I V R AL ++H +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALEFLHSN 135
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
++HRDI S N+LL +D +++DFG + P+ S + +VGT ++APE+V
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 697 VTEKCDVYSFGVLALEVIKGDHP 719
K D++S G++A+E+I+G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 26/265 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKF----HSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G S Y+A+ + +G ++AVK+ ++ E V + EI+ + L H I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHPHII 66
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+ G + L E++ GS++ +LS GA +E V +N + LSY+H +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN- 122
Query: 638 FPPIVHRDISSKNVLL-CLDYEARVSDFGIAKFLKPDSSNCTE----LVGTFGYIAPELV 692
I+HRD+ N+L+ R++DFG A L + E L+GT ++APE++
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 693 YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP-PQN 751
+ CDV+S G + +E+ P + + SN + +I P++
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWN-----AEKHSNHLALIFKIASATTAPSIPEH 235
Query: 752 VQDELISIVEVAFLCLNESPESRPP 776
+ L +V CL PE RPP
Sbjct: 236 LSPGL---RDVTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFH-SLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
IG+G VY A L + E +A+K+ + E E++ +++ H ++VK+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPNVVKYY 65
Query: 581 GFCSHPRNSFLVYEYLERGSLATILS---NDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+LV YL GSL I+ G ++E + V++ V L Y+H +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA---IIATVLKEVLKGLEYLHSN- 121
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE-----LVGTFGYIAPELV 692
+HRDI + N+LL D +++DFG++ L D + T VGT ++APE++
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLA-DGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 693 YTMK-VTEKCDVYSFGVLALEVIKGDHP 719
+ K D++SFG+ A+E+ G P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 2e-21
Identities = 63/199 (31%), Positives = 111/199 (55%), Gaps = 13/199 (6%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTELRHRSIVKFY 580
IG G G+V+ A + +G+ +A+K+ + + P+ E + NEI + EL++ +IV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
F+V EYL GSL +++ + ++E V R AL ++H +
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVT-ETCMDEAQIAA---VCRECLQALEFLHAN---Q 135
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
++HRDI S NVLL +D +++DFG + P+ S + +VGT ++APE+V K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 701 CDVYSFGVLALEVIKGDHP 719
D++S G++A+E+++G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 518 DVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+ IG G G V G+ +AVK + F+ E +T LRH ++V
Sbjct: 9 KLGATIGKGEFGDVMLGDY-RGQKVAVKCLK----DDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDG--AIEEFNWTVRMNVIRSVANALSYMHH 635
+ G ++V EY+ +GSL L + G I ++ V + Y+
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ---QLGFALDVCEGMEYLEE 120
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVY 693
F VHRD++++NVL+ D A+VSDFG+AK ++ + G + APE +
Sbjct: 121 KNF---VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALR 172
Query: 694 TMKVTEKCDVYSFGVLALEV 713
K + K DV+SFG+L E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 67/261 (25%), Positives = 121/261 (46%), Gaps = 34/261 (13%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V+ K + +A+K + E +F+ E K + +L H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
C+ + ++V E++E G L L + + + +++ + V + Y+ + F +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF---I 122
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG------YIAPELVYTMK 696
HRD++++N L+ +VSDFG+ +++ D E + G + PE+ K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 697 VTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISL-NEILDPRLPTPPQNVQD 754
+ K DV+SFGVL EV +G P S+ IS + P+L +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMP---FEKKSNYEVVEMISRGFRLYRPKLAS------- 227
Query: 755 ELISIVEVAFLCLNESPESRP 775
+++ EV + C +E PE RP
Sbjct: 228 --MTVYEVMYSCWHEKPEGRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V K + +GEI+A+KKF E V + + E+K L +LRH +IV
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKK-TALREVKVLRQLRHENIVNLKE 67
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----VANALSYMH-HD 636
+LV+EY+ER T+L +E + + +RS + A++Y H H+
Sbjct: 68 AFRRKGRLYLVFEYVER----TLLE---LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK-PDSSNCTELVGTFGYIAPE-LVYT 694
I+HRDI +N+L+ ++ DFG A+ L+ +S T+ V T Y APE LV
Sbjct: 121 ----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 695 MKVTEKCDVYSFGVLALEVIKG 716
+ DV++ G + E++ G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-21
Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 21/203 (10%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTELRHRSIVKFY 580
IG G G+VY A + +G+ +A+K+ + + P+ E + NEI + E ++ +IV +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 581 GFCSHPRNSFLVYEYLERGSLATILS----NDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
++V EYL GSL +++ ++G I V R AL ++H +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALDFLHSN 134
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
++HRDI S N+LL +D +++DFG + P+ S + +VGT ++APE+V
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 697 VTEKCDVYSFGVLALEVIKGDHP 719
K D++S G++A+E+++G+ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 48/277 (17%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVN--------------EIKT 567
IG G G VY A +T+GE++AVK+ +P EI+T
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVE-------LPATIAGRHDSRQKDMVKALRSEIET 61
Query: 568 LTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA 627
L +L H +IV++ GF + + EY+ GS+ + L G EE + V
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE---QLVRFFTEQVL 118
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP--DSSNCTELVGTFG 685
L+Y+H I+HRD+ + N+L+ D ++SDFGI+K D+ + G+
Sbjct: 119 EGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 686 YIAPELVYTMK--VTEKCDVYSFGVLALEVIKGDHP---RDFISSISSSSSNRNISLNEI 740
++APE++++ + K D++S G + LE+ G P + I+++ + R+
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS------ 229
Query: 741 LDPRLPTPPQNVQDELISIVEVAFL--CLNESPESRP 775
P PP +S V + FL C +P++RP
Sbjct: 230 ---APPIPPDVSM--NLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 27/268 (10%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
IG G G VYK L +AVK S P ++ + +F+ E + L + H +IVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
C + ++V E + GSL T L ++M A + Y+ +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM--SLDAAAGMEYLESKN---CI 115
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELVYTMKV 697
HRD++++N L+ + ++SDFG++ + + + I APE + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 698 TEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756
T + DV+S+G+L E GD P +S+ + I R+P PQ +E+
Sbjct: 173 TSESDVWSYGILLWETFSLGDTP---YPGMSNQQTRERIESGY----RMP-APQLCPEEI 224
Query: 757 ISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ C PE+RP + L
Sbjct: 225 YRLML---QCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 80/275 (29%), Positives = 130/275 (47%), Gaps = 35/275 (12%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
FD+ +G G GSVYKA +G+++A+K P E Q E + EI L +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQ-EIIKEISILKQCDSPY 59
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATI--LSNDGAIEEFNWTVRMNVIRSVANALSYM 633
IVK+YG + ++V EY GS++ I ++N EE + + L Y+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI----LYQTLKGLEYL 115
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H +HRDI + N+LL + +A+++DFG++ L + ++GT ++APE++
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP----P 749
+ K D++S G+ A+E+ +G P I + R I + P P P P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM------RAI----FMIPNKPPPTLSDP 222
Query: 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ E V+ CL + PE RP + QLL
Sbjct: 223 EKWSPEFNDFVK---KCLVKDPEERP---SAIQLL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
EF+ E K + +L H +V+ YG C+ R ++V EY+ G L L G + F +
Sbjct: 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQL 102
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
+ + + V ++Y+ F +HRD++++N L+ +VSDFG+++++ D T
Sbjct: 103 LEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--TS 157
Query: 680 LVGT---FGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNI 735
VG+ + PE++ K + K DV++FGVL EV G P + +N
Sbjct: 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-------NNSET 210
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
RL P + + + + C +E E RP
Sbjct: 211 VEKVSQGLRLYRPHLASE----KVYAIMYSCWHEKAEERP 246
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 41/270 (15%)
Query: 523 IGIGGQGSVYKAKLTS-GEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
I G G V+ AK S G+I A+K K + V Q + E L++ + +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQ--VLTERDILSQAQSPYVVKL 58
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
Y +N +LV EYL G LA++L N G+++E V I + AL Y+H +
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE---DVARIYIAEIVLALEYLHSN--- 112
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKF--------LKPDSSNCTELVGTFGYIAPEL 691
I+HRD+ N+L+ + +++DFG++K L D +VGT YIAPE+
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKG------DHPRDFISSISSSSSNRNISLNEILDPRL 745
+ ++ D +S G + E + G + P + NI +I P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ---------NILNGKIEWPED 223
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRP 775
D LIS + L PE R
Sbjct: 224 VEVSDEAID-LISKL------LVPDPEKRL 246
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 66/268 (24%), Positives = 124/268 (46%), Gaps = 37/268 (13%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V++ + +A+K S +++ Q +F E++ L LRH+ ++ +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANALSYMHHDCFPP 640
CS +++ E +E+GSL L + E V +++ VA ++Y+
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD--SSNCTELVGTFGYIAPELVYTMKVT 698
+HRD++++N+L+ D +V+DFG+A+ +K D S+ ++ + + APE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 699 EKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQNV 752
K DV+SFG+L E+ G P ++ +E+ D R+P P +
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYP------------GMNNHEVYDQITAGYRMPCPAKCP 230
Query: 753 QDELISIVEVAFLCLNESPESRPPMHTV 780
Q I ++ C PE RP +
Sbjct: 231 Q----EIYKIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 39/277 (14%)
Query: 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTL 568
EI R + + K +G G G V+ +AVK +L P M P+ F+ E + +
Sbjct: 2 EIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVK---TLKPGTMSPE-AFLQEAQIM 55
Query: 569 TELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVA 627
+LRH +V+ Y CS ++V EY+ +GSL L + G V M +A
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA--QIA 113
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---F 684
++Y+ + +HRD++++N+L+ + +++DFG+A+ ++ D E G
Sbjct: 114 EGMAYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE--GAKFPI 168
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP 743
+ APE + T K DV+SFG+L E++ G P +NR E+L+
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP-------YPGMTNR-----EVLEQ 216
Query: 744 -----RLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
R+P PP N +EL ++ C ++ PE RP
Sbjct: 217 VERGYRMPRPP-NCPEELYDLML---QCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 35/240 (14%)
Query: 523 IGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
IG G G V + +L +A+K + + + +F+ E + + H +I++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ--RLDFLTEASIMGQFDHPNIIR 69
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
G + R ++ EY+E GSL L NDG +F + ++R +A+ + Y+
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG--YIAPELVYTM 695
+ VHRD++++N+L+ + +VSDFG+++ L+ + T G + APE +
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 696 KVTEKCDVYSFGVLALEVIK-GDHP------RDFISSISSSSSNRNISLNEILDPRLPTP 748
K T DV+SFG++ EV+ G+ P +D I ++ RLP P
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------------GYRLPPP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 68/244 (27%), Positives = 121/244 (49%), Gaps = 38/244 (15%)
Query: 523 IGIGGQGSVYKAKLT---SGEI-LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
IG G G V + +L EI +A+K S + + + +F++E + + H +I+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPNIIH 69
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILS-NDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
G + R ++ E++E G+L + L NDG +F + ++R +A + Y+
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELV 692
+ VHRD++++N+L+ + +VSDFG+++FL+ D+S+ T G I APE +
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 693 YTMKVTEKCDVYSFGVLALEVIK-GDHP------RDFISSISSSSSNRNISLNEILDPRL 745
K T DV+S+G++ EV+ G+ P +D I++I D RL
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------DYRL 230
Query: 746 PTPP 749
P P
Sbjct: 231 PPPM 234
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 69/258 (26%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
IG G G V+ +A+K + + +F+ E + + +L H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
C+ LV+E++E G L+ L +F+ + + V ++Y+ +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNV---I 122
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPD---SSNCTELVGTFGYIAPELVYTMKVTE 699
HRD++++N L+ + +VSDFG+ +F+ D SS T+ + +PE+ K +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSS 180
Query: 700 KCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLN-EILDPRLPTPPQNVQDELI 757
K DV+SFGVL EV +G P + + S+S I+ + PRL +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYE---NRSNSEVVETINAGFRLYKPRLASQ--------- 228
Query: 758 SIVEVAFLCLNESPESRP 775
S+ E+ C E PE RP
Sbjct: 229 SVYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 42/266 (15%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELRHRSIVK 578
IG G G V A ++G +AVKK ++ Q NE+ + + +H +IV+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 579 FYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMN------VIRSVANAL 630
Y S+ ++V E+LE G+L I+++ RMN V +V AL
Sbjct: 81 MYS--SYLVGDELWVVMEFLEGGALTDIVTH----------TRMNEEQIATVCLAVLKAL 128
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
S++H ++HRDI S ++LL D ++SDFG + + LVGT ++APE
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 185
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750
++ + + D++S G++ +E++ G+ P + + + I N P
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPP---YFNEPPLQAMKRIRDNL---PPKLKNLH 239
Query: 751 NVQDELISIVEVAFLCLNESPESRPP 776
V L S ++ L P R
Sbjct: 240 KVSPRLRSFLD---RMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 67/238 (28%), Positives = 97/238 (40%), Gaps = 26/238 (10%)
Query: 516 GFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQP--------EFVNEIK 566
F++ IG G G V + + ++ A+K M Q +NE +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK--------YMNKQKCVEKGSVRNVLNERR 52
Query: 567 TLTELRHRSIVKF-YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS 625
L EL H +V Y F N +LV + L G L LS E V+ I
Sbjct: 53 ILQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSEE--QVKF-WICE 108
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG 685
+ AL Y+H I+HRDI N+LL ++DF IA + PD+ T GT G
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPG 164
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743
Y+APE++ + D +S GV A E ++G P S ++L P
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP 222
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 4e-19
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 522 CIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
+G G G VYKA+ +GEI+A+KK E +P + EI L EL+H +IVK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-STALREISLLKELKHPNIVKLL 64
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVA----NALSYMHH 635
R +LV+EY + L L G + N+I+S+ L+Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP-------NLIKSIMYQLLRGLAYCHS 116
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV--- 692
I+HRD+ +N+L+ D +++DFG+A+ T V T Y APE++
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 693 --YTMKVTEKCDVYSFGVLALEVIKG 716
Y+ V D++S G + E+I G
Sbjct: 174 KHYSTAV----DIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 19/192 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKK----FHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
IG G G VYKA+ +GEI+A+KK F S + + EIK L EL H +I+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-----LREIKLLKELNHPNII 61
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HD 636
K H + +LV+E+++ L ++ ++ + + + L++ H H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
HRD+ +N+L+ + +++DFG+A+ T V T Y APEL+ K
Sbjct: 119 IL----HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 697 V-TEKCDVYSFG 707
+ D++S G
Sbjct: 175 GYSTPVDIWSVG 186
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 21/228 (9%)
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
NE+ + + +H+++V+ Y +++ E+L+ G+L I+S EE TV
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV---- 122
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
SV AL Y+H ++HRDI S ++LL LD ++SDFG + D LVG
Sbjct: 123 CESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP-------------RDFISSISSS 729
T ++APE++ + D++S G++ +E++ G+ P RD +
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 239
Query: 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPM 777
+ + L + L+ L PQ + +++ FL PE P+
Sbjct: 240 AHKISPVLRDFLERMLTREPQE-RATAQELLDHPFLLQTGLPECLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 7e-19
Identities = 70/257 (27%), Positives = 109/257 (42%), Gaps = 27/257 (10%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKTLTELRHRSIVK- 578
+G G G V K +G++ A+K + + V E L+ + H IVK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL--TERNILSRINHPFIVKL 58
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HDC 637
Y F + +LV EY G L + LS +G E R + AL Y+H
Sbjct: 59 HYAFQT-EEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARF-YAAEIVLALEYLHSLG- 113
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKV 697
I++RD+ +N+LL D +++DFG+AK L + S GT Y+APE++
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 698 TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI 757
+ D +S GVL E++ G P F + +R +IL L P + E
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP--F------YAEDRKEIYEKILKDPLRFPE-FLSPEAR 221
Query: 758 SIVEVAFLCLNESPESR 774
++ L + P R
Sbjct: 222 DLISG---LLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 70/270 (25%), Positives = 103/270 (38%), Gaps = 46/270 (17%)
Query: 523 IGIGGQGSV----YKAKLTSGEILAVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIV 577
+G G GSV Y K +AVK + EF+ E + +L H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+ G C LV E G L L I + + VA ++Y+
Sbjct: 60 RLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLESKH 115
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG---TFGYIAPELVYT 694
F VHRD++++NVLL ++A++SDFG+++ L S + APE +
Sbjct: 116 F---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 695 MKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-----PRLPTP 748
K + K DV+S+GV E G P + E++ RLP P
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPY------------GEMKGAEVIAMLESGERLPRP 220
Query: 749 ---PQNVQDELISIVEVAFLCLNESPESRP 775
PQ + + C PE RP
Sbjct: 221 EECPQEIYS-------IMLSCWKYRPEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 69/265 (26%), Positives = 113/265 (42%), Gaps = 22/265 (8%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V K +G+I+AVK Q + + E+ L + IV FYG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 582 FCSHPRNSFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
+ + + EY++ GSL IL G I E + + +V L+Y+H
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPER---ILGKIAVAVLKGLTYLHEKH--K 121
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
I+HRD+ N+L+ + ++ DFG++ L + VGT Y+APE + + K
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVK 179
Query: 701 CDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD---PRLPTPPQNVQDELI 757
D++S G+ +E+ G P + L I++ PRLP+ +
Sbjct: 180 SDIWSLGLSLIELATGRFP---YPPENDPPDGIFELLQYIVNEPPPRLPS--GKFSPDFQ 234
Query: 758 SIVEVAFLCLNESPESRPPMHTVCQ 782
V LCL + P RP + +
Sbjct: 235 DFVN---LCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 70/271 (25%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQ-PEFVNEIKTLTELRHRSIVKFY 580
IG G G V++ L G +L P Q +F++E + + H +I++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 581 GFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
G + + + ++ EY+E G+L L +DG EF+ + ++R +A + Y+ +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMNY- 128
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG---TFGYIAPELVYTMK 696
VHRD++++N+L+ + E +VSDFG+++ L+ D G + APE + K
Sbjct: 129 --VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 697 VTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNI--SLNEILDPRLPTPPQNVQ 753
T DV+SFG++ EV+ G+ P SN + ++N+ RLP P
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERP-------YWDMSNHEVMKAINDGF--RLPAP----M 233
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784
D ++ ++ C + RP + LL
Sbjct: 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 48/288 (16%)
Query: 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL 571
T F++ IG G G VYKA+ +G+++A+K + E + E E L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DE---EEEIKEEYNILRKY 59
Query: 572 -RHRSIVKFYG--FCSHPRNS----FLVYEYLERGSLA----TILSNDGAIEEFNWTVRM 620
H +I FYG +P + +LV E GS+ + ++E W
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EWIAY- 117
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
++R L+Y+H + ++HRDI +N+LL + E ++ DFG++ L
Sbjct: 118 -ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 681 VGTFGYIAPELVYTMKVTE-----KCDVYSFGVLALEVIKGD------HPRDFISSISSS 729
+GT ++APE++ + + + DV+S G+ A+E+ G HP + I +
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233
Query: 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPM 777
P L P+N + + CL ++ E RP M
Sbjct: 234 PP-----------PTL-KSPENWSKKFNDFISE---CLIKNYEQRPFM 266
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 31/208 (14%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELRHRSIVK 578
IG G G V A + +SG+++AVKK ++ Q NE+ + + +H ++V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 579 FYGFCSHPRNSFLV-------YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
Y NS+LV E+LE G+L I+++ EE V + V++ ALS
Sbjct: 82 MY-------NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK----ALS 130
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
+H ++HRDI S ++LL D ++SDFG + + LVGT ++APEL
Sbjct: 131 VLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKGDHP 719
+ + + D++S G++ +E++ G+ P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 31/280 (11%)
Query: 514 TNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQP---EFVNEIKTLT 569
F ++ IG G VYKA L G ++A+KK EM+ + + EI L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF---EMMDAKARQDCLKEIDLLK 57
Query: 570 ELRHRSIVKFYGFCSHPRNSFL--VYEYLERGSLATILSN----DGAIEEFN-WTVRMNV 622
+L H +++K+ S N+ L V E + G L+ ++ + I E W + +
Sbjct: 58 QLDHPNVIKYLA--SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
+AL +MH I+HRDI NV + ++ D G+ +F ++ LVG
Sbjct: 116 ----CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
T Y++PE ++ K D++S G L E+ P + ++ S + I +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEKCDY-- 225
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
P P + +EL +V C+N PE RP + V Q
Sbjct: 226 --PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 77/278 (27%), Positives = 117/278 (42%), Gaps = 48/278 (17%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKF----HSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G GSVY+ L G+ AVK+ E V Q E EI L++L+H +IV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE--QEIALLSKLQHPNIV 65
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
++ G N ++ E + GSLA +L G+ E V R + L Y+H
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR- 121
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV----- 692
VHRDI N+L+ + +++DFG+AK + + S G+ ++APE++
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 693 YTMKVTEKCDVYSFGVLALEVIKGDHPRD------FISSISSSSSNRNISLNEILDPRLP 746
Y + D++S G LE+ G P + I S LP
Sbjct: 179 YGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-------------KELP 221
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P ++ DE + CL P RP T +LL
Sbjct: 222 PIPDHLSDEAKDFI---LKCLQRDPSLRP---TAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 79/274 (28%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 523 IGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G GSV + +GE++AVKK L +F EI+ L L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKK---LQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 578 KFYGFCSHP--RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
K+ G C RN LV EYL GSL L E + + + + Y+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGS 126
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG-----YIAPE 690
+ VHRD++++N+L+ + ++ DFG+ K L D V G + APE
Sbjct: 127 KRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK--VREPGESPIFWYAPE 181
Query: 691 LVYTMKVTEKCDVYSFGVLALEV-----IKGDHPRDFISSISSSSSNRNIS--LNEILDP 743
+ K + DV+SFGV+ E+ P +F+ + + + I L E+L
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 744 --RLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
RLP PP E+ +I++ C N P RP
Sbjct: 242 NGRLPAPP-GCPAEIYAIMK---ECWNNDPSQRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 19/259 (7%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G GSV K K + +G ++A K H + + + + E++ + E R IV FYG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQILRELQIMHECRSPYIVSFYG 70
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM---HHDCF 638
+ N + E+++ GSL I G I + + +V L+Y+ H
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPV---EILGKIAVAVVEGLTYLYNVHR--- 124
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
I+HRDI N+L+ + ++ DFG++ L +S VGT Y++PE + K T
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGGKYT 180
Query: 699 EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758
K DV+S G+ +E+ G P F S+I + + + ++L + PP +
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 759 IVEVAF--LCLNESPESRP 775
F CL + P RP
Sbjct: 240 EDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 24/256 (9%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V+ +AVK +L P M P+ F+ E + + +LRH +V+ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVK---TLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAV 69
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
S ++V EY+ +GSL L DG +++ VA ++Y+ + +
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 124
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYTMKVTEK 700
HRD+ S N+L+ +++DFG+A+ ++ D+ F + APE + T K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 701 CDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISI 759
DV+SFG+L E++ KG P +NR + R+P P QD IS+
Sbjct: 184 SDVWSFGILLTELVTKGRVP-------YPGMNNREVLEQVERGYRMPCP----QDCPISL 232
Query: 760 VEVAFLCLNESPESRP 775
E+ C + PE RP
Sbjct: 233 HELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 42/214 (19%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPE-----FVNEIKTLTELRHRSI 576
IG G G VYKA+ +GE++A+KK M + E + EIK L +LRH +I
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI------RMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 577 VKFYGFC-SHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMNV--IRSVA----N 628
V+ S + S ++V+EY++ L +L + V+ I+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLE 111
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS-NCTELVGTFGYI 687
L Y+H + I+HRDI N+L+ D +++DFG+A+ +S + T V T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 688 APELV-----YTMKVTEKCDVYSFGVLALEVIKG 716
PEL+ Y +V D++S G + E+ G
Sbjct: 169 PPELLLGATRYGPEV----DMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMV--PQPEFV-NEIKTLTELR 572
F+ +G G G V + SG+ A+K ++V Q E V NE + L +R
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQSIR 59
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVAN 628
H +V YG N +LV EY+ G L + L G E V R V
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-------PVARFYAAQVVL 112
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
AL Y+H IV+RD+ +N+LL D +++DFG AK +K L GT Y+A
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLCGTPEYLA 166
Query: 689 PELV----YTMKVTEKCDVYSFGVLALEVIKGDHP 719
PE++ Y V D ++ G+L E++ G P
Sbjct: 167 PEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 44/279 (15%)
Query: 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTL 568
EI R + +VK +G G G V+ +A+K +L P M P+ F+ E + +
Sbjct: 2 EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEA-FLQEAQVM 55
Query: 569 TELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM----NVIR 624
+LRH +V+ Y S ++V EY+ +GSL L E +R+ ++
Sbjct: 56 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAA 109
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
+A+ ++Y+ + VHRD+ + N+L+ + +V+DFG+A+ ++ D+ F
Sbjct: 110 QIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKF 165
Query: 685 --GYIAPELVYTMKVTEKCDVYSFGVLALEV-IKGDHPRDFISSISSSSSNRNISLNEIL 741
+ APE + T K DV+SFG+L E+ KG P NR E+L
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNR-----EVL 213
Query: 742 DP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
D R+P PP+ + S+ ++ C + PE RP
Sbjct: 214 DQVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 564 EIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
EI L++ + K+YG +++ EYL GS +L G +EF ++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIA---TML 107
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT 683
+ + L Y+H + +HRDI + NVLL + +++DFG+A L VGT
Sbjct: 108 KEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 684 FGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743
++APE++ K D++S G+ A+E+ KG+ P +S+ + L P
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----------NSDMHPMRVLFLIP 214
Query: 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
+ PP + E CLN+ P RP
Sbjct: 215 KNN-PPTLTGEFSKPFKEFIDACLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 9/197 (4%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V K K +G+I+A+KKF +MV + EI+ L +LRH ++V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQLRHENLVNLIE 67
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
+ +LV+E+++ L + ++E VR + + + + H I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDES--RVR-KYLFQILRGIEFCHSH---NI 121
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL-VYTMKVTEK 700
+HRDI +N+L+ ++ DFG A+ L T+ V T Y APEL V K
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 701 CDVYSFGVLALEVIKGD 717
D+++ G L E++ G+
Sbjct: 182 VDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 35/266 (13%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V++ + +AVK L P M P+ +F+ E + + +LRH +++ Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT---LKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAV 69
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
C+ ++V E ++ GSL L +++ VA+ ++Y+ + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQNY---I 125
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELVYTMKVTE 699
HRD++++NVL+ + +V+DFG+A+ +K D E G + APE + +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSI 183
Query: 700 KCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQNVQ 753
K DV+SFG+L E++ G P +N E+L R+P PP
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP-------YPGMTNA-----EVLQQVDQGYRMPCPP-GCP 230
Query: 754 DELISIVEVAFLCLNESPESRPPMHT 779
EL I+ C E P+ RP T
Sbjct: 231 KELYDIM---LDCWKEDPDDRPTFET 253
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G GSV K +L + ++ K + P + Q + + E++ + IVK+YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL-QKQILRELEINKSCKSPYIVKYYGA 67
Query: 583 CSHPRNSFL--VYEYLERGSLATI----LSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
+S + EY E GSL +I G I E V + SV LSY+H
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE---KVLGKIAESVLKGLSYLHSR 124
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
I+HRDI N+LL + ++ DFG++ L +S GT Y+APE +
Sbjct: 125 ---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQGKP 179
Query: 697 VTEKCDVYSFGVLALEVIKGDHP 719
+ DV+S G+ LEV + P
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELRHRSIVK 578
IG G G V A + +G+ +AVKK ++ Q NE+ + + H ++V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
Y ++V E+LE G+L I+++ EE TV ++V+R ALSY+H+
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQ-- 137
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
++HRDI S ++LL D ++SDFG + + LVGT ++APE++ +
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 699 EKCDVYSFGVLALEVIKGDHP 719
+ D++S G++ +E+I G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 71/253 (28%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
IG G G V+K + + K L E + + EI L++ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 70
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
+++ EYL GS +L G ++E T ++R + L Y+H + +
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLE-PGPLDE---TQIATILREILKGLDYLHSE---KKI 123
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCD 702
HRDI + NVLL E +++DFG+A L VGT ++APE++ K D
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 703 VYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEV 762
++S G+ A+E+ KG+ P + + L I PT N L VE
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNNPPTLEGNYSKPLKEFVEA 235
Query: 763 AFLCLNESPESRP 775
CLN+ P RP
Sbjct: 236 ---CLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 523 IGIGGQGSVYKAKLTSG------EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G V+ + E++AVK + +F E + LT +H +I
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--TASNDARKDFEREAELLTNFQHENI 70
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATIL-----------SNDGAIEEFNWTVRMNVIRS 625
VKFYG C+ +V+EY+E G L L S D + E + + +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT-- 683
+A+ + Y+ F VHRD++++N L+ D ++ DFG+++ + +++ + G
Sbjct: 131 IASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHTM 185
Query: 684 --FGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
++ PE + K T + DV+SFGV+ E+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 51/193 (26%), Positives = 98/193 (50%), Gaps = 15/193 (7%)
Query: 526 GGQ-GSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFC 583
GGQ G VY+ +AVK + + EF+ E + E++H ++V+ G C
Sbjct: 16 GGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 584 SHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVH 643
+ +++ E++ G+L L +E N V + + +++A+ Y+ F +H
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNF---IH 127
Query: 644 RDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELVYTMKVTEK 700
RD++++N L+ ++ +V+DFG+++ + D+ T G + APE + K + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 701 CDVYSFGVLALEV 713
DV++FGVL E+
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 68/264 (25%), Positives = 122/264 (46%), Gaps = 28/264 (10%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVN---EIKTLTELRHRSIVKF 579
+G G G+VY G+++AVK+ + + E+ E+ L L+H +IV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
G C + E++ GS+++IL+ G + E V + + + ++Y+H++C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE---PVFCKYTKQILDGVAYLHNNC-- 122
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE------LVGTFGYIAPELVY 693
+VHRDI NV+L + ++ DFG A+ L + T + GT ++APE++
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
K D++S G E+ G P ++S+ ++ I + L PRLP
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLP------- 231
Query: 754 DELISIVEVAFL--CLNESPESRP 775
+ S + F+ CL RP
Sbjct: 232 -DSFSAAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G V+KAK +GE +A+KK +P + + EIK L +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQACQHPYVVKLLD 66
Query: 582 FCSHPRNSFLVYEYLERGSLATILSN------DGAIEEFNWTVRMNVIRSVANALSYMHH 635
H LV EY+ L+ +L + + ++ + +R + ++YMH
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSY--------MRMLLKGVAYMHA 117
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC-TELVGTFGYIAPELVY- 693
+ I+HRD+ N+L+ D +++DFG+A+ + + V T Y APEL+Y
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 694 TMKVTEKCDVYSFGVLALEVIKG 716
K D+++ G + E++ G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 71/271 (26%), Positives = 131/271 (48%), Gaps = 42/271 (15%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
IG G G+V + + T G+ +AVK C++ Q F+ E +T+L H+++V+ G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIK----CDVTAQA-FLEETAVMTKLHHKNLVRLLGV 67
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
H ++V E + +G+L L G A+ ++ ++ VA + Y+ +
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KL 121
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKC 701
VHRD++++N+L+ D A+VSDFG+A+ + + ++L + APE + K + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKL--PVKWTAPEALKHKKFSSKS 178
Query: 702 DVYSFGVLALEVI---KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQNVQ 753
DV+S+GVL EV + +P+ +SL E+ + R+ PP+
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPK--------------MSLKEVKECVEKGYRM-EPPEGCP 223
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ ++ C P+ RP H + + L
Sbjct: 224 ADVYVLMTS---CWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 71/259 (27%), Positives = 128/259 (49%), Gaps = 28/259 (10%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G+VY A+ + E++A+KK + + E++ L +LRH + +++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 582 FCSHPRNSFLVYEYLERGSLATILS-NDGAIEEFNWTVRMNVIRSVA-NALSYMHHDCFP 639
++LV EY GS + IL + ++E V + I A L+Y+H
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVHKKPLQE----VEIAAICHGALQGLAYLHSHE-- 135
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM---K 696
+HRDI + N+LL +++DFG A + P +S VGT ++APE++ M +
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEGQ 190
Query: 697 VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756
K DV+S G+ +E+ + P + ++++ S+ +I+ N+ P L + + D
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND--SPTLSSNDWS--DYF 243
Query: 757 ISIVEVAFLCLNESPESRP 775
+ V+ CL + P+ RP
Sbjct: 244 RNFVD---SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 32/271 (11%)
Query: 523 IGIGGQGSVYKAKLTSGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G V+ +L + AVK P ++ + +F+ E + L + H +IV+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
C+ + ++V E ++ G T L +G + ++M + + A + Y+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM--VENAAAGMEYLESKH---C 115
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELVYTMK 696
+HRD++++N L+ ++SDFG++ + + G I APE + +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 697 VTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP--RLPTPPQNVQ 753
+ + DV+SFG+L E G P +S N E ++ RLP P+
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLS---------NQQTREAIEQGVRLP-CPELCP 222
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784
D + ++E C P RP TV Q L
Sbjct: 223 DAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTL 568
EI R + DVK +G G G V+ +A+K +L P M+P+ F+ E + +
Sbjct: 2 EIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIK---TLKPGTMMPEA-FLQEAQIM 55
Query: 569 TELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVA 627
+LRH +V Y S ++V E++ +GSL L DG + V M +A
Sbjct: 56 KKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA--QIA 112
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--G 685
+ ++Y+ + +HRD+ + N+L+ + +++DFG+A+ ++ D+ F
Sbjct: 113 DGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIK 168
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPR 744
+ APE + T K DV+SFG+L E++ KG P NR + R
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGMVNREVLEQVERGYR 221
Query: 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+P PQ + S+ E+ LC + P+ RP + L
Sbjct: 222 MPC-PQGCPE---SLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF----VNEIKTLTELRHRSIV 577
IG G G V+K + +G+I+A+KKF E P + EI+ L +L+H ++V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-----VESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HD 636
R LV+EY + L + N + E + +I A+++ H H+
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE---HLIKKIIWQTLQAVNFCHKHN 120
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL-VYTM 695
C +HRD+ +N+L+ + ++ DFG A+ L + T+ V T Y APEL V
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 696 KVTEKCDVYSFGVLALEVIKG 716
+ DV++ G + E++ G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G VY+A+ TSGEI+A+KK + +P + EI L LRH +IV+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRHPNIVELKE 73
Query: 582 FC--SHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
H + FLV EY E+ LA++L N F+ + ++ + L Y+H +
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT--PFSESQVKCLMLQLLRGLQYLHENF-- 128
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKV-T 698
I+HRD+ N+LL +++DFG+A+ + T V T Y APEL+ T
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 699 EKCDVYSFGVLALEVIKG 716
D+++ G + E++
Sbjct: 188 TAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 73/269 (27%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 523 IGIGGQGSVYKAKLTSG--EILAVKKFHSLWPCEMVPQPE-------FVNEIKTLTE-LR 572
+G G G VYK + + +LA+K+ + P + E V+E+ + E LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN-----DGAIEEFNWTVRMNVIRSVA 627
H +IV++Y ++V + +E L ++ EE W N+ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFVQMV 123
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
AL Y+H + IVHRD++ N++L D + ++DFG+AK K S T +VGT Y
Sbjct: 124 LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYS 180
Query: 688 APELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISL-NEILDPRLP 746
PE+V EK DV++FG + ++ P S +SL +I++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---------FYSTNMLSLATKIVEAVYE 231
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRP 775
P+ + E ++ V + CL E+RP
Sbjct: 232 PLPEGMYSEDVTDVITS--CLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 45/282 (15%)
Query: 516 GFDVKYCIGIGGQGSVYKAK-LTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELR 572
F V +G G GSVYK K L+ + A+K+ S+ E + + VNEI+ L +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE---REDAVNEIRILASVN 57
Query: 573 HRSIVKFYGFCSHPRNSFL-------VYEYLERGSLATILSNDGAI-----EEFNWTVRM 620
H +I+ + + +FL V EY G L+ +S E+ W + +
Sbjct: 58 HPNIISY-------KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
++R L +H I+HRD+ S N+LL + ++ D GI+K LK + +
Sbjct: 111 QLLR----GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-- 161
Query: 681 VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740
+GT Y+APE+ + K D++S G L E+ P F + + +
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP--FEARSMQDLRYK------V 213
Query: 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ P P +L + + L P+ RP +
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 21/254 (8%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G VYK + E++A+K L E + + EI L++ I ++YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
+++ EYL GS +L G +EE T ++R + L Y+H +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPGPLEE---TYIATILREILKGLDYLHSE---RK 122
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKC 701
+HRDI + NVLL + +++DFG+A L VGT ++APE++ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 702 DVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761
D++S G+ A+E+ KG+ P + + L P+ +PP E
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVL----------FLIPK-NSPPTLEGQYSKPFKE 231
Query: 762 VAFLCLNESPESRP 775
CLN+ P RP
Sbjct: 232 FVEACLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEI---KTLTELRHRSIVK 578
IG G G+VYKA+ L +G +A+KK E +P + EI K L H +IV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL-STLREIALLKQLESFEHPNIVR 65
Query: 579 FYGFCSHPRNS-----FLVYEYLERGSLATILSN--DGAIEEFNWTVRMNVIRSVANALS 631
C PR LV+E++++ LAT LS + T++ +++R + +
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP--ETIK-DLMRQLLRGVD 121
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
++H IVHRD+ +N+L+ D + +++DFG+A+ + + T +V T Y APE+
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEV 177
Query: 692 VYTMKVTEKCDVYSFG 707
+ D++S G
Sbjct: 178 LLQSSYATPVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 87/298 (29%), Positives = 136/298 (45%), Gaps = 51/298 (17%)
Query: 507 YEEIVRATNGFDVKYCIGIGGQGS---VYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVN 563
YE + R + +V IG G G+ VYKAK LA K E + +++
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--DYMV 58
Query: 564 EIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVRMNV 622
EI+ L H IVK G +++ E+ G++ A +L D + E V +
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---I 115
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI-AKFLKP----DSSNC 677
R + AL Y+H I+HRD+ + NVLL LD + +++DFG+ AK +K DS
Sbjct: 116 CRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--- 169
Query: 678 TELVGTFGYIAPELVY--TMKVTE---KCDVYSFGVLALEV--IKGDH----PRDFISSI 726
+GT ++APE+V TMK T K D++S G+ +E+ I+ H P + I
Sbjct: 170 --FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227
Query: 727 SSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ S +P + P E ++ A L++ PE+RP + QLL
Sbjct: 228 AKS------------EPPTLSQPSKWSMEFRDFLKTA---LDKHPETRP---SAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-16
Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 21/255 (8%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V+ + +AVK +L P M Q F+ E + L+H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAV 69
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
+ +++ EY+ +GSL L +D + ++ +A ++Y+ + +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKNY---I 125
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG-TFGYIAPELVYTMKVTEKC 701
HRD+ + NVL+ +++DFG+A+ ++ + E + APE + T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 702 DVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIV 760
DV+SFG+L E++ G P SN ++ R+P +N DEL I+
Sbjct: 186 DVWSFGILLYEIVTYGKIP-------YPGMSNSDVMSALQRGYRMPR-MENCPDELYDIM 237
Query: 761 EVAFLCLNESPESRP 775
+ C E E RP
Sbjct: 238 K---TCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 47/272 (17%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELRHRSIVKF 579
+G G G VYKA+ + A K ++ + E F+ EI L+E +H +IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI-----IQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 580 YGFCSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
Y + +++ E+ + G+L + +L + + E V R + AL+++H
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY---VCRQMLEALNFLHSH-- 122
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY--TMK 696
++HRD+ + N+LL LD + +++DFG++ K +GT ++APE+V T K
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 697 VTE---KCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNISLNEILDPRLPT 747
K D++S G+ +E+ + + +P + I S P L
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-----------PTLDQ 230
Query: 748 P---PQNVQDELISIVEVAFLCLNESPESRPP 776
P + D L S CL + P+ RP
Sbjct: 231 PSKWSSSFNDFLKS-------CLVKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 58/236 (24%), Positives = 108/236 (45%), Gaps = 34/236 (14%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTV 618
+F++E + + H +I+ G + + +V EY+E GSL L +DG +F
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQ 107
Query: 619 RMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678
+ ++R +A+ + Y+ + VHRD++++N+L+ + +VSDFG+++ L+ D
Sbjct: 108 LVGMLRGIASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164
Query: 679 ELVG---TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHP------RDFISSISS 728
G + APE + K T DV+S+G++ EV+ G+ P +D I +I
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224
Query: 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P D ++ ++ C + RP + +L
Sbjct: 225 GY-------------RLPAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-15
Identities = 86/244 (35%), Positives = 124/244 (50%), Gaps = 13/244 (5%)
Query: 144 TLGNLSNLAVLHLYGNSL--SGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVV 201
+LS L L L S S + NL L L L+ N+L +I L L+NL
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTS 120
Query: 202 LHLFENSLFGSIPSILGNLKM-LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260
L L N++ IP ++G LK L L LS N + +P + NL NL L L N LS
Sbjct: 121 LDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-- 176
Query: 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKL 320
++P + LS+LN L L+GN++ +LP + L+ LE LDLS N + + +L NL L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSI-IELLSSLSNLKNL 234
Query: 321 HYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380
L LSNN+ + P + L L LDLS N + I + ++ +L +L+LS N+ S
Sbjct: 235 SGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSN 291
Query: 381 LIPS 384
+P
Sbjct: 292 ALPL 295
|
Length = 394 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 68/262 (25%), Positives = 116/262 (44%), Gaps = 27/262 (10%)
Query: 523 IGIGGQGSVYKAKLTS--GEIL--AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G G V + + ++ G+++ AVK S ++ +F+ E + L H ++++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 579 FYGFC-SHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
YG +HP +V E GSL L A+ F + + +AN + Y+
Sbjct: 61 LYGVVLTHP--LMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT---ELVGTFGYIAPELVYT 694
F +HRD++++N+LL D + ++ DFG+ + L + + L F + APE + T
Sbjct: 118 F---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 695 MKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
+ DV+ FGV E+ G+ P + +S S + I RL P Q
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP---WAGLSGSQILKKIDKEG---ERLERPEACPQ 228
Query: 754 DELISIVEVAFLCLNESPESRP 775
D I V C +P RP
Sbjct: 229 D----IYNVMLQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 34/228 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTEL- 571
F IG G +V AK + + A+K K + + E + LT L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI---KEKKVKYVKIEKEVLTRLN 59
Query: 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
H I+K Y N + V EY G L + G+++ T + AL
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTR--FYAAEILLALE 116
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--------------- 676
Y+H I+HRD+ +N+LL D +++DFG AK L P+SS
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 677 -----CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
VGT Y++PEL+ + D+++ G + +++ G P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 12/156 (7%)
Query: 561 FVNEIKTLTELRHRSIVKFYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVR 619
F+ E +T+LRH ++V+ G + ++V EY+ +GSL L + G
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCL 104
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
+ V A+ Y+ + F VHRD++++NVL+ D A+VSDFG+ K ++ T+
Sbjct: 105 LKFSLDVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ 156
Query: 680 LVGTF--GYIAPELVYTMKVTEKCDVYSFGVLALEV 713
G + APE + K + K DV+SFG+L E+
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 42/266 (15%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKF-------HSLWPCEMVPQPEFVNEIKTLTELRHR 574
IG G G+VY A + E++AVKK + W + + E+K L +L+H
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-------DIIKEVKFLQQLKHP 81
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILS-NDGAIEEFNWTVRMNVIRSVANALSYM 633
+ +++ G ++LV EY GS + +L + ++E + L+Y+
Sbjct: 82 NTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYL 137
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H ++HRDI + N+LL + +++DFG A P +S VGT ++APE++
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVIL 190
Query: 694 TMKVTE---KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750
M + K DV+S G+ +E+ + P + ++++ S+ +I+ N+ PT
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDS-----PTLQS 242
Query: 751 NV-QDELISIVEVAFLCLNESPESRP 775
N D V+ CL + P+ RP
Sbjct: 243 NEWTDSFRGFVD---YCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 25/267 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F ++ IG G VY+A L G +A+KK + + + + EI L +L H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSV-------AN 628
++K+Y +V E + G L+ + I+ F R+ ++V +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRM------IKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
AL +MH ++HRDI NV + ++ D G+ +F ++ LVGT Y++
Sbjct: 118 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748
PE ++ K D++S G L E+ P + ++ S + I + P P P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDY--P--PLP 229
Query: 749 PQNVQDELISIVEVAFLCLNESPESRP 775
+ +EL +V +C+N PE RP
Sbjct: 230 SDHYSEELRQLVN---MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVK----KFHSLWPCEMVPQPEFVNEIKTLTEL 571
+ V +G G GSVY A+ +GE++A+K KF+S C + E+K+L +L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL------REVKSLRKL 54
Query: 572 -RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANA 629
H +IVK + V+EY+E + G E +R ++I +
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSES--VIR-SIIYQILQG 111
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
L+++H F HRD+ +N+L+ +++DFG+A+ ++ T+ V T Y AP
Sbjct: 112 LAHIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAP 167
Query: 690 ELV-----YTMKVTEKCDVYSFGVLALEV 713
E++ Y+ V D+++ G + E+
Sbjct: 168 EILLRSTSYSSPV----DIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-15
Identities = 46/140 (32%), Positives = 67/140 (47%), Gaps = 41/140 (29%)
Query: 48 PCA-----WFGIQC----NPAKRVIS-INLSTVGLKG-------NLKSLSTLDLSKNKLN 90
PC W G C K I + L GL+G L+ L +++LS N +
Sbjct: 396 PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIR 455
Query: 91 GSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSN 150
G+IP S G++T+L + LDLS N +GSIP +LG L++
Sbjct: 456 GNIPPSLGSITSLEV------------------------LDLSYNSFNGSIPESLGQLTS 491
Query: 151 LAVLHLYGNSLSGSIPSIIG 170
L +L+L GNSLSG +P+ +G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
NEI L+ L+H +I+ +Y + EY G+L + + F + +
Sbjct: 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWY 106
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
+ + +A+SY+H I+HRDI + N+ L ++ DFGI+K L + S +VG
Sbjct: 107 LFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVG 163
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVI------KGDHPRDFISSISSSSSNRNIS 736
T Y++PEL +K K D+++ G + E++ +P + + I +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN------ 217
Query: 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
P ELIS+V L + PE RP
Sbjct: 218 -------YTPVVSVYSS-ELISLVHS---LLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-15
Identities = 44/100 (44%), Positives = 61/100 (61%), Gaps = 2/100 (2%)
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
F+ L L L G IP + L +L ++L GNS+ G+IP +G++ SL L LS N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLH 225
+GSIP SLG L++L +L+L NSL G +P+ LG LLH
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR--LLH 516
|
Length = 623 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-15
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 21/192 (10%)
Query: 538 SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY--GFCSHPRNSFLVYEY 595
+G +A+K + P E + F E L H +IV G P F V+EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEY 60
Query: 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC- 654
+ +L +L+ DGA+ T R+ + V +AL+ H+ IVHRD+ +N+++
Sbjct: 61 VPGRTLREVLAADGALPAGE-TGRL--MLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 655 --LDYEARVSDFGIAKFLKPDSSNC--------TELVGTFGYIAPELVYTMKVTEKCDVY 704
+ A+V DFGI L P + TE++GT Y APE + VT D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 705 SFGVLALEVIKG 716
++G++ LE + G
Sbjct: 174 AWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-14
Identities = 38/82 (46%), Positives = 54/82 (65%)
Query: 113 LSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNL 172
L IP I L+ L ++LS N + G+IPP+LG++++L VL L NS +GSIP +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 173 KSLFYLHLSSNQLSGSIPISLG 194
SL L+L+ N LSG +P +LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 67/259 (25%), Positives = 127/259 (49%), Gaps = 28/259 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G+VY A+ + + E++A+KK + + E++ L +LRH + +++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 582 FCSHPRNSFLVYEYLERGSLATILS-NDGAIEEFNWTVRMNVIRSVANALSYMH-HDCFP 639
++LV EY GS + +L + ++E V L+Y+H H+
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSHN--- 135
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
++HRD+ + N+LL ++ DFG A + P + VGT ++APE++ M +
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190
Query: 700 ---KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756
K DV+S G+ +E+ + P + ++++ S+ +I+ NE P L + + +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPALQS--GHWSEYF 243
Query: 757 ISIVEVAFLCLNESPESRP 775
+ V+ CL + P+ RP
Sbjct: 244 RNFVDS---CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
E + E + +L + IV+ G C + LV E E G L L + + E N T
Sbjct: 42 ELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-- 98
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
++ V+ + Y+ F VHRD++++NVLL + A++SDFG++K L D N +
Sbjct: 99 -ELVHQVSMGMKYLEETNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYK 153
Query: 680 LVGT----FGYIAPELVYTMKVTEKCDVYSFGVLALE 712
+ APE + K + K DV+SFGVL E
Sbjct: 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 70/274 (25%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKT----LTEL 571
F + +G GG G V+ A K +GEI+A+K+ ++ + V + T LT
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK----SLLFKLNEVRHVLTERDILTTT 58
Query: 572 RHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE----FNWTVRMNVIRSV 626
+ +VK Y F +L EY+ G T+L+N G + E F + M
Sbjct: 59 KSEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDA 116
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFG 685
+ L Y+H D P +N L+ +++DFG++K + +S +VG+
Sbjct: 117 LHELGYIHRDLKP---------ENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPD 163
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN---RNI-SLNEIL 741
Y+APE++ D +S G + E + G P S S+ N N+ E L
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP------FSGSTPNETWENLKYWKETL 217
Query: 742 D-PRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
P P N+ DE ++ +N+ P R
Sbjct: 218 QRPVYDDPRFNLSDEAWDLITK---LIND-PSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 522 CIGIGGQGSVYKA-KLTSGEILAVKKFH----SLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G VY + +G LAVK+ S + V E EI+ L L+H I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALE--CEIQLLKNLQHERI 66
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
V++YG + EY+ GS+ L GA+ E TV R + + Y+H +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE---TVTRKYTRQILEGVEYLHSN 123
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT---ELVGTFGYIAPELVY 693
IVHRDI N+L ++ DFG +K L+ S+ T + GT +++PE++
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHP 719
K DV+S G +E++ P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 84/225 (37%), Positives = 117/225 (52%), Gaps = 9/225 (4%)
Query: 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ 136
+L LDLS NK+ S+P NL NL + L N LS +P ++ NL L +LDLS N+
Sbjct: 140 SNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197
Query: 137 LSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNL 196
+S +PP + LS L L L NS+ + S + NLK+L L LS+N+L +P S+GNL
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 197 SNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256
SNL L L N + S S LG+L L L LS N LS +PL L L L +
Sbjct: 255 SNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL--ELLLNLL 310
Query: 257 LSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDL 301
L++ + +++ + N ++ NG L SL L LD
Sbjct: 311 LTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFV---NEIKTLTELRHRSIVK 578
+G G G VYKA L +GE+ AVK ++ P +F EI + E +H +IV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII------KLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
++G ++ EY GSL I G + E V R L+Y+H
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYLHSKG- 126
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK-- 696
+HRDI N+LL + + +++DFG+A + + +GT ++APE+ K
Sbjct: 127 --KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 697 -VTEKCDVYSFGVLALEV 713
+ CD+++ G+ A+E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 48/233 (20%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSND----GAIEEFN 615
E ++E + + H +V+ G C + L+ + + G L + N G+ N
Sbjct: 55 EILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLN 113
Query: 616 WTVRMNVIRSVANALSY--MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673
W V+ +A +SY +VHRD++++NVL+ +++DFG+AK L D
Sbjct: 114 WCVQ------IAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
Query: 674 SSNCTELVGTFG-----YIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSIS 727
E G ++A E + T K DV+S+GV E++ G P +
Sbjct: 163 EK---EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE------ 213
Query: 728 SSSSNRNISLNEILD-----PRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
I EI D RLP PP D + +V+ C ESRP
Sbjct: 214 ------GIPAVEIPDLLEKGERLPQPPICTIDVYMVLVK----CWMIDAESRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 8/198 (4%)
Query: 523 IGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G+GG G V K+ S A+K E Q +E + L E H IVK Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
+ +++ EY G L TIL + G +E +T R I V A Y+H+ I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARF-YIACVVLAFEYLHNR---GI 114
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKC 701
++RD+ +N+LL + ++ DFG AK LK T GT Y+APE++
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSV 173
Query: 702 DVYSFGVLALEVIKGDHP 719
D +S G+L E++ G P
Sbjct: 174 DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI----- 576
I G GSVY A K ++G+ A+K ++ + + + + + R+I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK---------VLKKSDMIAKNQVTNVKAERAIMMIQG 54
Query: 577 -----VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
K Y +LV EYL G A+++ G + E +W I V +
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWA--KQYIAEVVLGVE 111
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK--FLKPDSSNCTELVGTFGYIAP 689
+H I+HRDI +N+L+ +++DFG+++ VGT Y+AP
Sbjct: 112 DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAP 162
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
E + + + D +S G + E + G P
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-14
Identities = 40/89 (44%), Positives = 54/89 (60%)
Query: 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSI 213
L L L G IP+ I L+ L ++LS N + G+IP SLG++++L VL L NS GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 214 PSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
P LG L L L L+ N LSG +P ++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 38/266 (14%)
Query: 538 SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFLVYEY 595
+GE++AVK C + EI L L H +IVK+ G CS + L+ EY
Sbjct: 32 TGEMVAVKTLKR--ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89
Query: 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655
+ GSL L + N + + + ++Y+H + +HRD++++NVLL
Sbjct: 90 VPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLLDN 142
Query: 656 DYEARVSDFGIAKFL---------KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSF 706
D ++ DFG+AK + + D + F Y A E + K + DV+SF
Sbjct: 143 DRLVKIGDFGLAKAVPEGHEYYRVREDGDS-----PVFWY-AVECLKENKFSYASDVWSF 196
Query: 707 GVLALEVI-----KGDHPRDFISSISSSSSNRN-ISLNEILD--PRLPTPPQNVQDELIS 758
GV E++ K P+ F I + L E+L+ RLP P+N E+
Sbjct: 197 GVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYI 255
Query: 759 IVEVAFLCLNESPESRPPMHTVCQLL 784
+++ C + RP ++ +L
Sbjct: 256 LMKN---CWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTELRHRS 575
+ +G G G V+ + E K ++ + Q + V NE + L E+ H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
I++ + R +++ EY+ G L + L N G F+ + + + AL Y+H
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHS 119
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
IV+RD+ +N+LL + +++DFG AK L L GT Y+APE++ +
Sbjct: 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLCGTPEYLAPEVIQSK 173
Query: 696 KVTEKCDVYSFGVLALEVIKGDHP 719
+ D ++ G+L E++ G P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 67/258 (25%), Positives = 125/258 (48%), Gaps = 26/258 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G+VY A+ + + E++A+KK + + E+K L ++H + +++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 582 FCSHPRNSFLVYEYLERGSLATILS-NDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
++LV EY GS + +L + ++E + L+Y+H
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH---N 145
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE- 699
++HRDI + N+LL + +++DFG A P +S VGT ++APE++ M +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQY 201
Query: 700 --KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI 757
K DV+S G+ +E+ + P + ++++ S+ +I+ NE P L + D
Sbjct: 202 DGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPTLQS--NEWSDYFR 254
Query: 758 SIVEVAFLCLNESPESRP 775
+ V+ CL + P+ RP
Sbjct: 255 NFVDS---CLQKIPQDRP 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 519 VKYCIGIGGQGSVYKAKLTS------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR 572
+K+ +G G G V+ A+ + ++AVK +L + +F E + LT L+
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEASESARQDFQREAELLTVLQ 65
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSL----------ATIL--SNDGAIEEFNWTVRM 620
H+ IV+FYG C+ R +V+EY+ G L A IL D A + +
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
+ +A+ + Y+ F VHRD++++N L+ ++ DFG+++ + S++ +
Sbjct: 126 AIASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRV 180
Query: 681 VG----TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHP 719
G ++ PE + K T + D++SFGV+ E+ G P
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 63/254 (24%), Positives = 117/254 (46%), Gaps = 20/254 (7%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V+ +A+K SL M P+ F+ E + +L+H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK---SLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAV 69
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
+ +++ EY+E GSL L I+ +++ +A ++++ + +
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG-TFGYIAPELVYTMKVTEKC 701
HRD+ + N+L+ +++DFG+A+ ++ + E + APE + T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 702 DVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761
DV+SFG+L E++ + R +++ +N+ R+P P N +EL E
Sbjct: 185 DVWSFGILLTEIVT--YGRIPYPGMTNPEVIQNLERGY----RMPR-PDNCPEEL---YE 234
Query: 762 VAFLCLNESPESRP 775
+ LC E PE RP
Sbjct: 235 LMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 61/269 (22%), Positives = 123/269 (45%), Gaps = 24/269 (8%)
Query: 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTL 568
EI R + + K +G G G V+ A +AVK ++ P M + F+ E +
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVEA-FLAEANVM 55
Query: 569 TELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVA 627
L+H +VK + + +++ E++ +GSL L S++G+ + + + +A
Sbjct: 56 KTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA--QIA 112
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG-TFGY 686
++++ + +HRD+ + N+L+ +++DFG+A+ ++ + E +
Sbjct: 113 EGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 687 IAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746
APE + T K DV+SFG+L +E++ + R +S+ R + + PR
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVIRALERGYRM-PRPE 226
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRP 775
P+ + + ++ C PE RP
Sbjct: 227 NCPEELYNIMMR-------CWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELRHRSI 576
+G G VYKA+ +G I+A+KK + E + +N EIK L EL+H +I
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKK---IKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-- 634
+ H N LV+E++E L ++ + +++ + A+ SYM
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKD------------KSIVLTPADIKSYMLMT 111
Query: 635 -------HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
H + I+HRD+ N+L+ D +++DFG+A+ + T V T Y
Sbjct: 112 LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169
Query: 688 APELVY-TMKVTEKCDVYSFGVLALEVI 714
APEL++ D++S G + E++
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 70/286 (24%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 523 IGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G G V+ A+ T ++L K +L + + +F E + LT L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDG-------------AIEEFNWTVRMNVIR 624
KFYG C +V+EY++ G L L G A E + +++
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG-- 682
+A+ + Y+ F VHRD++++N L+ + ++ DFG+++ + S++ + G
Sbjct: 131 QIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGHT 185
Query: 683 --TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNE 739
++ PE + K T + DV+SFGV+ E+ G P +S++ I+
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNTEVIECITQGR 242
Query: 740 ILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+L+ PR+ P+ V D ++ C P+ R + + ++L
Sbjct: 243 VLERPRV--CPKEVYDIMLG-------CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 512 RATNGFDVKYCIGIGGQGSVYKA--KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLT 569
R + FD+ IG G G VYKA K T GE++A+KK E P + EIK L
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLDNEKEGFPITA-IREIKILR 61
Query: 570 ELRHRSIVKFY----------GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
+L HR+IV F +LV+EY++ L +L + + F+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHI 118
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN-CT 678
+ ++ + L+Y H F +HRDI N+LL + +++DFG+A+ + S T
Sbjct: 119 KSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 679 ELVGTFGYIAPELVY-TMKVTEKCDVYSFG 707
V T Y PEL+ + DV+S G
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCG 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV---NEIKTLTELR 572
F++ IG G G VYKA+ + +GE+ A+K ++ P +F EI + + +
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI------KLEPGEDFAVVQQEIIMMKDCK 64
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSY 632
H +IV ++G ++ E+ GSL I G + E V R L Y
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYY 121
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV 692
+H +HRDI N+LL + +++DFG++ + + +GT ++APE+
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 693 YTMK---VTEKCDVYSFGVLALEVIKGDHP 719
+ + CD+++ G+ A+E+ + P
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHR 574
F++ +G G G VYK + + +G++ A+K + + E EI L + HR
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTGDEEEEIKQEINMLKKYSHHR 63
Query: 575 SIVKFYG--FCSHPRNS----FLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVA 627
+I +YG +P +LV E+ GS+ ++ N G + W + R +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREIL 121
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
LS++H ++HRDI +NVLL + E ++ DFG++ L +GT ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 688 APELVYTMKVTE-----KCDVYSFGVLALEVIKGDHP 719
APE++ + + K D++S G+ A+E+ +G P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G VYKA+ +GE++A+KK E VP + EI L EL H +IVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHPNIVKLLD 66
Query: 582 FCSHPRNSFLVYEYLERG--SLATILSNDGAIEEFNWTVRMNVIRS----VANALSYMH- 634
+LV+E+L + G + + +I+S + L++ H
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSG--------IPLPLIKSYLFQLLQGLAFCHS 118
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVY 693
H ++HRD+ +N+L+ + +++DFG+A+ F P + E+V T Y APE++
Sbjct: 119 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 173
Query: 694 TMKV-TEKCDVYSFGVLALEVI 714
K + D++S G + E++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 16/161 (9%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLAT-ILSNDGAIEE---FN 615
E + + + L H IV+ G C LV + GSL + + +++ N
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLN 113
Query: 616 WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675
W V+ +A + Y+ +VHR+++++N+LL D +++DFG+A L PD
Sbjct: 114 WCVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 676 NC--TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
+E ++A E + + T + DV+S+GV E++
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 36/244 (14%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL----------ATILSNDG 609
+F E + LT L+H IVKFYG C +V+EY++ G L A +++
Sbjct: 53 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112
Query: 610 AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669
E + +++ + +A + Y+ F VHRD++++N L+ + ++ DFG+++
Sbjct: 113 RPAELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRD 169
Query: 670 LKPDSSNCTELVG----TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFIS 724
+ S++ + G ++ PE + K T + DV+S GV+ E+ G P
Sbjct: 170 VY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP---WY 224
Query: 725 SISSSSSNRNISLNEILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPP---MHTV 780
+S++ I+ +L PR T P+ V D ++ C P R +H++
Sbjct: 225 QLSNNEVIECITQGRVLQRPR--TCPKEVYDLMLG-------CWQREPHMRLNIKEIHSL 275
Query: 781 CQLL 784
Q L
Sbjct: 276 LQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-13
Identities = 39/75 (52%), Positives = 48/75 (64%)
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
DNQ G IP +I KL L + L+GN + GN+P +LGS+T LE LDLS N SIPE+
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 314 LGNLLKLHYLNLSNN 328
LG L L LNL+ N
Sbjct: 486 LGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 39/281 (13%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHR 574
F++ +G G G VYK + + +G++ A+K + + E EI L + HR
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTEDEEEEIKLEINMLKKYSHHR 73
Query: 575 SIVKFYGF------CSHPRNSFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVA 627
+I +YG H +LV E+ GS+ ++ N G + +W + R +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREIL 131
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
L+++H ++HRDI +NVLL + E ++ DFG++ L +GT ++
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188
Query: 688 APELVYTMKVTE-----KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
APE++ + + + D++S G+ A+E+ +G P + R + L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP------LCDMHPMRAL----FLI 238
Query: 743 PRLPTP---PQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
PR P P + + I +E CL ++ SRP +
Sbjct: 239 PRNPPPKLKSKKWSKKFIDFIEG---CLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 564 EIKTLTELRHRSIVKFYGFC--SHPRNSFLVY-EYLERGSLATILSNDGAIEEFNWTVRM 620
EI+ L L+H IV++YG C + ++ EY+ GS+ L GA+ E +V
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTR 109
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP---DSSNC 677
R + +SY+H + IVHRDI N+L ++ DFG +K L+ +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 678 TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
+ GT +++PE++ K DV+S G +E++ P
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 35/265 (13%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQP--EFVNEIKTLTELRHRSIVKF 579
+G G G+VYK + GE + + + P+ EF++E + + H +V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 580 YGFCSHPRNSFLVYEYLERGSLATIL----SNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
G C P LV + + G L + N G+ NW V+ +A + Y+
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVY 693
+VHRD++++NVL+ +++DFG+A+ L+ D G ++A E ++
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 694 TMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP--RLPTPPQ 750
K T + DV+S+GV E++ G P D I + R I ++L+ RLP PP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIP--DLLEKGERLPQPPI 235
Query: 751 NVQDELISIVEVAFLCLNESPESRP 775
D + +V+ C +SRP
Sbjct: 236 CTIDVYMVMVK----CWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 71/277 (25%), Positives = 113/277 (40%), Gaps = 47/277 (16%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G+VYK +G + A+K + E + + EI+ L ++ H ++VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYG--NHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
H ++ E+++ GSL D E+F +V R + + ++Y+H I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIAD---EQF----LADVARQILSGIAYLHRR---HI 189
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-----MK 696
VHRDI N+L+ +++DFG+++ L C VGT Y++PE + T
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 697 VTEKCDVYSFGVLALEVIKGDHP------RDFIS---SISSSSSNRNISLNEILDPRLPT 747
D++S GV LE G P D+ S +I S P
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--------------PE 295
Query: 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P E + CL P R + QLL
Sbjct: 296 APATASREFRHFIS---CCLQREPAKRW---SAMQLL 326
|
Length = 353 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 32/244 (13%)
Query: 558 QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNW 616
Q F+ E++ EL H ++++ G C LV E+ G L L SN G + +
Sbjct: 39 QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQ 98
Query: 617 T-VRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675
V + VA+ L ++H F +H D++ +N L D ++ D+G+A P+
Sbjct: 99 KDVLQRMACEVASGLLWLHQADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155
Query: 676 NCTE--LVGTFGYIAPELV-------YTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISS 725
T+ ++APELV T+K +++S GV E+ D P
Sbjct: 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP------ 209
Query: 726 ISSSSSNRNISLNEIL---DPRLPTP--PQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
S+ + L +++ D +LP P D +++ +L PE+RP V
Sbjct: 210 -YPDLSDEQV-LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL----DPETRPTAEEV 263
Query: 781 CQLL 784
+LL
Sbjct: 264 HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-13
Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 1/92 (1%)
Query: 202 LHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGE 261
L L L G IP+ + L+ L + LS N + G IP S+G++ +L L L N + G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN-GS 481
Query: 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSL 293
IP +G+L+SL L LNGN L G +P ALG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 26/259 (10%)
Query: 538 SGEILAVKKFHSLWPCEMVPQ-PEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF--LVYE 594
+GE +AVK SL P + EI+ L L H +IVK+ G C+ + L+ E
Sbjct: 32 TGEQVAVK---SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88
Query: 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC 654
+L GSL L + + N ++ + + Y+ + VHRD++++NVL+
Sbjct: 89 FLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 143
Query: 655 LDYEARVSDFGIAKFLKPDSSNCT---ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLAL 711
+++ ++ DFG+ K ++ D T +L + APE + K DV+SFGV
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203
Query: 712 EVI-----KGDHPRDFISSISSSSSNRNIS-LNEILD--PRLPTPPQNVQDELISIVEVA 763
E++ + F+ I + ++ L +L+ RLP PP N +E+ ++
Sbjct: 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-NCPEEVYQLMRK- 261
Query: 764 FLCLNESPESRPPMHTVCQ 782
C P R + +
Sbjct: 262 --CWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 564 EIKTLTELRHRSIVKFYGFCSHPRNS--------FLVYEYLERGSLATILSND-GAIEEF 614
E + L++L+H +IV + R S ++V + E G L L G +
Sbjct: 49 EAQLLSQLKHPNIVAY-------RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE 101
Query: 615 NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674
N V V +A AL Y+H I+HRD+ ++NV L +V D GIA+ L+
Sbjct: 102 NQVVEWFV--QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156
Query: 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRN 734
+ L+GT Y++PEL K DV++ G E+ H + ++ + N
Sbjct: 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH--------AFNAKDMN 208
Query: 735 ISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
+ I++ +LP P++ EL ++ L++ PE RP + ++
Sbjct: 209 SLVYRIIEGKLPPMPKDYSPELGELIATM---LSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 58/293 (19%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVP--QPEFVNEIKTLTELRHRSIVKF 579
+G G G V K SG I+A K H E+ P + + + E+K L E IV F
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIH----LEIKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 580 YG-FCSHPRNSFLVYEYLERGSLATILSNDGAI-EEFNWTVRMNVIRSVANALSYMH--H 635
YG F S S + E+++ GSL +L G I E + + V+R L+Y+ H
Sbjct: 65 YGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILGKISIAVLR----GLTYLREKH 119
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
I+HRD+ N+L+ E ++ DFG++ L +N VGT Y++PE +
Sbjct: 120 K----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGT 173
Query: 696 KVTEKCDVYSFGVLALEVIKGDHP-------------RDFISSISSSSSNRNISLN---- 738
T + D++S G+ +E+ G +P +S + S+R +S +
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233
Query: 739 -------EILD-------PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPM 777
E+LD P+LP+ DE V+ CL ++P+ R +
Sbjct: 234 PRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDK---CLKKNPKERADL 281
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIVKFY 580
IG G G V A T +GE +A+KK + ++ E V + EIK L LRH IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 581 GFCSHP-----RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
P ++ ++V+E +E I +ND E + ++R AL Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR----ALKYIHT 121
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC---TELVGTFGYIAPELV 692
+ HRD+ KN+L D + ++ DFG+A+ D+ T+ V T Y APEL
Sbjct: 122 ---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 693 --YTMKVTEKCDVYSFGVLALEVIKG 716
+ K T D++S G + EV+ G
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F ++ IG G VY+A L + +A+KK + + + V EI L +L H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSV-------AN 628
++K+ +V E + G L+ + I+ F R+ R+V +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQM------IKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
A+ +MH ++HRDI NV + ++ D G+ +F ++ LVGT Y++
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748
PE ++ K D++S G L E+ P + ++ S + I + P P P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKIEQCDY--P--PLP 229
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783
++ ++L +V +C+ P+ RP + V Q+
Sbjct: 230 TEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G VYKA+ +LA K E + +++ EI L H +IVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKLLDA 70
Query: 583 CSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
+ N +++ E+ G++ A +L + + E V V + AL+Y+H + I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV---VCKQTLEALNYLHEN---KI 124
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE-- 699
+HRD+ + N+L LD + +++DFG++ +GT ++APE+V +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 700 ---KCDVYSFGVLALEVIKGDHP 719
K DV+S G+ +E+ + + P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 523 IGIGGQGSVYKA--KLTSGEI-LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G G V K K+ +I +A+K + E + E + E + + +L + IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN--ENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
G C LV E G L LS G +E + + ++ V+ + Y+ F
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF- 116
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG-----YIAPELVYT 694
VHRD++++NVLL + A++SDFG++K L D S + G + APE +
Sbjct: 117 --VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINF 172
Query: 695 MKVTEKCDVYSFGVLALE 712
K + + DV+S+G+ E
Sbjct: 173 RKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G V+KA+ + +I+A+KK E P + EIK L L+H ++V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 78
Query: 582 FCSHPRNS--------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
C +LV+E+ E LA +LSN +F + V++ + N L Y+
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYI 135
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL---KPDSSNC-TELVGTFGYIAP 689
H I+HRD+ + N+L+ D +++DFG+A+ K N T V T Y P
Sbjct: 136 H---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 690 EL 691
EL
Sbjct: 193 EL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH 573
N F+V +G G G V K + + EI+A+KKF E V + + E+K L L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETT-LRELKMLRTLKQ 59
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVANALSY 632
+IV+ +LV+EY+E+ L + +G E VR + I + A+ +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE---KVR-SYIYQLIKAIHW 115
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS-SNCTELVGTFGYIAPEL 691
H + IVHRDI +N+L+ + ++ DFG A+ L S +N TE V T Y +PEL
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKG 716
+ + D++S G + E+ G
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 34/262 (12%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVP--QPEFVNEIKTLTELRHRSIVKF 579
+G G G+VYKA L + ILAVK + P ++ Q + ++E++ L + I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVK----VIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 580 YG-FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
YG F R S + E+++ GSL I E V + +V L+Y+
Sbjct: 65 YGAFFVENRIS-ICTEFMDGGSLDVY----RKIPE---HVLGRIAVAVVKGLTYLWS--- 113
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
I+HRD+ N+L+ + ++ DFG++ L +S VGT Y+APE + +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYG 171
Query: 699 EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD---PRLPTPPQNVQDE 755
DV+S G+ +E+ G P I S + L I+D P LP
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP-------VG 223
Query: 756 LISIVEVAFL--CLNESPESRP 775
S V F+ C+ + P+ RP
Sbjct: 224 QFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+++ IG G G +Y AK S V K L + + E+ L +++H +I
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAI-----EEFNWTVRMNVIRSVANALS 631
V F+ F+V EY + G L ++ + + +W V+ ++ L
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLK 115
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
++H I+HRDI S+N+ L + A++ DFGIA+ L VGT Y++PE
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
+ K D++S G + E+ HP
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-12
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 323 LNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLI 382
L L N R P ++ KL L ++LS N + G IP + ++ SLE L+LS+N+F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 383 PSCFEGMHGLSCIDVSYNELRGPIPNS---RIFQYDPMEALQGNKGLCGDIKGFQSCNAT 439
P + L ++++ N L G +P + R+ N GLCG I G ++C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN-FTDNAGLCG-IPGLRACG-- 538
Query: 440 FTPHKQISKRKWFIIVFPLLGALSLSVLAMGTFFILRRRE 479
PH + + I +++ L + +RR+
Sbjct: 539 --PHLSVGAK----IGIAFGVSVAFLFLVICAMCWWKRRQ 572
|
Length = 623 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 523 IGIGGQGSVYKAKLTSGEI-LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G VY A+ S ++ +A+K+ + P E EI + L+HR+IV++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72
Query: 582 FCSHPRNSFLVY-EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
S F ++ E + GSL+ +L + + N + + + L Y+H +
Sbjct: 73 SDSE-NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128
Query: 641 IVHRDISSKNVLLCLDYEA--RVSDFGIAKFLKPDSSNCTE-LVGTFGYIAPELV----- 692
IVHRDI NVL+ Y ++SDFG +K L + CTE GT Y+APE++
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 693 -YTMKVTEKCDVYSFGVLALEVIKGDHP 719
Y D++S G +E+ G P
Sbjct: 187 GY----GAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
+F+ E+K L+ L +I + G C+ ++ EY+E G L L +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ---KHVAETSGLA 121
Query: 620 MNVIRSVANALSYM------------HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667
N + L YM + VHRD++++N L+ +Y +++DFG++
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 668 KFLKPDSSNCTELVGT----FGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
+ L SS+ + G ++A E V K T K DV++FGV E+
Sbjct: 178 RNLY--SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 34/265 (12%)
Query: 527 GQGSVYKAKL----TSGEILAVKKFHSLWPCEMVPQP--EFVNEIKTLTELRHRSIVKFY 580
G+GS KA L G+ +K+ + +M P+ E E+ L+ ++H +IV++
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINI---SKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAI-----EEFNWTVRMNVIRSVANALSYMHH 635
N ++V +Y E G L ++ + + +W V++ + AL ++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
I+HRDI S+N+ L D ++ DFGIA+ L +GT Y++PE+
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
K D+++ G + E+ H + + + +N+ L I P D
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE-------AGNMKNLVLKIIRGSYPPVSSHYSYD- 228
Query: 756 LISIVEVAFLCLNESPESRPPMHTV 780
L ++V F +P RP ++++
Sbjct: 229 LRNLVSQLF---KRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G G VY +G LAVK+ F P EI+ L L H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 580 YGFCSHP--RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
YG P R + E++ GS+ L + GA+ E V R + +SY+H +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE---NVTRKYTRQILEGVSYLHSNM 126
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP---DSSNCTELVGTFGYIAPELVYT 694
IVHRDI N+L ++ DFG +K L+ + + GT +++PE++
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHP 719
K D++S G +E++ P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G+V+KAK + EI+A+K+ E VP EI L EL+H++IV+ Y
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVRLYD 66
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN----ALSYMH-HD 636
+ LV+EY ++ S +G I+ +++S L++ H H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDID-------PEIVKSFMFQLLKGLAFCHSHN 119
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVYTM 695
++HRD+ +N+L+ + E +++DFG+A+ F P E+V T Y P++++
Sbjct: 120 ----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 174
Query: 696 KV-TEKCDVYSFGVLALEVIKGDHP 719
K+ + D++S G + E+ P
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 70/296 (23%)
Query: 523 IGIGGQGSVYKAKL---------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH 573
+G G G VYK +L TS I +K+ E Q EF E + +++L+H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-----EPKVQQEFRQEAELMSDLQH 67
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATIL------------SNDGAIEEFNWTVRM- 620
+IV G C+ + + +++EYL G L L S D ++
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 621 NVIRSVANALSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678
++ +A + Y+ HH VHRD++++N L+ ++SDFG+++ + S++
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADYY 180
Query: 679 ELVGT----FGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHP------RDFISSIS 727
+ ++ PE + K T + D++SFGV+ E+ G P ++ I I
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240
Query: 728 SSSSNRNISLNEILDPRLPTP---PQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
S R + LP P P V +I C NE P RP +
Sbjct: 241 S----RQL---------LPCPEDCPARVYALMIE-------CWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 563 NEIKTLTELRHRSIVKF-YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMN 621
E L E+ H IVK Y F + +L+ ++L G L T LS + E + V+
Sbjct: 47 MERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKF- 102
Query: 622 VIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV 681
+ +A AL ++H I++RD+ +N+LL + +++DFG++K
Sbjct: 103 YLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159
Query: 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741
GT Y+APE+V T+ D +SFGVL E++ G P +R ++ IL
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP--------FQGKDRKETMTMIL 211
Query: 742 DPRLPTPPQNVQDELISIVEVAF 764
+L PQ + E S++ F
Sbjct: 212 KAKLGM-PQFLSPEAQSLLRALF 233
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 37/271 (13%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS----IV 577
+G G GSVYK +G +A+K+ + + +F I L ++ H++ IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-----ELDESKFNQIIMEL-DILHKAVSPYIV 62
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANA----LSYM 633
FYG ++ EY++ GSL + + A E + +V+R + A L ++
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATE----GIPEDVLRRITYAVVKGLKFL 118
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
+ I+HRD+ NVL+ + + ++ DFG++ L + +G Y+APE +
Sbjct: 119 KEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIK 174
Query: 694 TMKVTE------KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747
+ + + DV+S G+ LE+ G +P + +N L+ I+D PT
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVDGDPPT 229
Query: 748 PPQNVQDELISIVEVAFLCLNESPESRPPMH 778
P D+ V CLN+ P RP
Sbjct: 230 LPSGYSDDAQDFVA---KCLNKIPNRRPTYA 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 80/294 (27%), Positives = 120/294 (40%), Gaps = 53/294 (18%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTE 570
+ F+V IG G G V+ + +G++ A+K L +M+ + + E L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV---LRKSDMIKRNQIAHVRAERDILAD 57
Query: 571 LRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANA 629
IVK +Y F + +LV EY+ G L +L E T R + V A
Sbjct: 58 ADSPWIVKLYYSF-QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE--TARFYIAELVL-A 113
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-----------------FLKP 672
L +H F +HRDI N+L+ D +++DFG+ K L
Sbjct: 114 LDSVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 673 DSSN------------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPR 720
D+ VGT YIAPE++ +CD +S GV+ E++ G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP- 229
Query: 721 DFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
F S + N+ I+ E L R P P V E I ++ LC PE R
Sbjct: 230 -FYSDTLQETYNKIINWKESL--RFP-PDPPVSPEAIDLIC-RLLC---DPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 42/242 (17%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-------------- 605
+ ++E L ++ H ++K YG CS L+ EY + GSL + L
Sbjct: 49 DLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108
Query: 606 SNDGAIEEFNWTVR---MNVIRSVANALSY-MHHDCFPPIVHRDISSKNVLLCLDYEARV 661
N + N R M + S A +S M + +VHRD++++NVL+ + ++
Sbjct: 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKI 168
Query: 662 SDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDH 718
SDFG+++ + + S G ++A E ++ T + DV+SFGVL E++ G +
Sbjct: 169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 719 PRDFISSISSSSSNRNISLNEILDPRLPT-----PPQNVQDELISIVEVAFLCLNESPES 773
P I+ E L L T P+N +E+ +++ C + P+
Sbjct: 229 PYPGIAP-------------ERLFNLLKTGYRMERPENCSEEMYNLM---LTCWKQEPDK 272
Query: 774 RP 775
RP
Sbjct: 273 RP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 508 EEIVRATNGFDVKYCIGIGGQGSVYK-AKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIK 566
E + T+ +++ IG G G VYK G + AVK + + + E+ N ++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY-NILQ 73
Query: 567 TLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILS--NDGAIEEF---------- 614
+L H ++VKFYG F + L G L +L N G++ E
Sbjct: 74 SLPN--HPNVVKFYGM-------FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 615 -NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673
+ + ++ L ++H++ I+HRD+ N+LL + ++ DFG++ L
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 674 SSNCTELVGTFGYIAPELV-----YTMKVTEKCDVYSFGVLALEVIKGDHP 719
VGT ++APE++ Y +CDV+S G+ A+E+ GD P
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 28/256 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF--VNEIKTLTELRHRSIVKF 579
IG+G G+VYKA+ SG +A+K + +P V +K L H +IV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 580 YGFCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
C+ R LV+E++++ L T L T++ +++R L ++H
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDFLH 125
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
+C IVHRD+ +N+L+ + +++DFG+A+ + T +V T Y APE++
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQ 181
Query: 695 MKVTEKCDVYSFGVLALEVIK------GDHPRDFISSI-------SSSSSNRNISL-NEI 740
D++S G + E+ + G+ D + I R+++L
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241
Query: 741 LDPRLPTPPQNVQDEL 756
PR P P Q+V E+
Sbjct: 242 FSPRGPRPVQSVVPEI 257
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 523 IGIGGQGSVYKAKL-----TSGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G V+ AK GE L VK E + Q EF E+ +L H+++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENL-QSEFRRELDMFRKLSHKNV 70
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATIL----SNDGAIEEFNWTV--RMNVIRSVANAL 630
V+ G C +++ EY + G L L S D ++ + ++ + +A +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG---YI 687
++ + F VHRD++++N L+ E +VS ++K +S +L ++
Sbjct: 131 DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWL 185
Query: 688 APELVYTMKVTEKCDVYSFGVLALEV 713
APE V + K DV+SFGVL EV
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 74/211 (35%), Positives = 110/211 (52%), Gaps = 11/211 (5%)
Query: 195 NLSNLVVLHLFENSLFGS--IPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+LS L+ L L S S L NL L L L+ N L I + L NL L L
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDL 123
Query: 253 YDNQLSVGEIPIEIGKL-SSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311
+N ++ +IP IG L S+L L L+ N++ +LP L +L L+ LDLS N L + +P
Sbjct: 124 DNNNIT--DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDL-SDLP 179
Query: 312 ETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKL 371
+ L NL L+ L+LS N+ P E+E L L ELDLS N + ++ + N+++L L
Sbjct: 180 KLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGL 237
Query: 372 NLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
LS+N +P + L +D+S N++
Sbjct: 238 ELSNNKLE-DLPESIGNLSNLETLDLSNNQI 267
|
Length = 394 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 38/296 (12%)
Query: 505 ILYEEIVRATNGFDVKYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVN 563
I+++ ++ +++ IG G G V+K +G AVK + + + E+ N
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY-N 66
Query: 564 EIKTLTELRHRSIVKFYG--FCSHPRNS---FLVYEYLERGSLATILSNDGAI---EEFN 615
+K L++ H ++VKFYG + +N +LV E GS+ ++ G + E
Sbjct: 67 ILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVK--GFLKRGERME 122
Query: 616 WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675
+ ++ L ++H + +HRD+ N+LL + ++ DFG++ L
Sbjct: 123 EPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 676 NCTELVGTFGYIAPELVYTMK-----VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730
VGT ++APE++ + +CDV+S G+ A+E+ GD P + +
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--- 236
Query: 731 SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFL--CLNESPESRPPMHTVCQLL 784
+L +I PR P PP Q EL S F+ CL + E RP TV LL
Sbjct: 237 -----ALFKI--PRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRP---TVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELR 572
F++ IG G G V K+ +G++ A+K + W EM+ + E F E L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK-W--EMLKRAETACFREERDVLVNGD 59
Query: 573 HRSIVKF-YGFCSHPRNSFLVYEYLERGSLATILSN--DGAIEE---FNWTVRMNVIRSV 626
R I Y F N +LV +Y G L T+LS D E+ F + I SV
Sbjct: 60 RRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL-VGTFG 685
+ L Y VHRDI NVLL + R++DFG L D + + + VGT
Sbjct: 119 -HQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 686 YIAPELVYTM-----KVTEKCDVYSFGVLALEVIKGDHP 719
YI+PE++ M + +CD +S GV E++ G+ P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 526 GGQGSVYKAK-LTSGEILAVK--KFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIV--KF 579
G G VY+A+ +GEI+A+K K E P + EI L +L+H +IV K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEK----EKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
S+ ++V EY+E L +++ + F + ++ + + ++++H +
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW-- 126
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY-TMKVT 698
I+HRD+ + N+LL ++ DFG+A+ T+LV T Y APEL+ + +
Sbjct: 127 -ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 699 EKCDVYSFGVLALEVIKGD 717
D++S G + E++
Sbjct: 186 TAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVN----EIKTLTELRHRSIV 577
+G G G VY +G LAVK+ + + VN EI+ L LRH IV
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE--VNALECEIQLLKNLRHDRIV 67
Query: 578 KFYGFCSHP--RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
++YG P + + EY+ GS+ L GA+ E V R + +SY+H
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE---NVTRRYTRQILQGVSYLHS 124
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP---DSSNCTELVGTFGYIAPELV 692
+ IVHRDI N+L ++ DFG +K ++ + + GT +++PE++
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 693 YTMKVTEKCDVYSFGVLALEVIKGDHP 719
K DV+S +E++ P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/261 (23%), Positives = 120/261 (45%), Gaps = 32/261 (12%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V+K L +AVK P E+ + +F++E + L + H +IVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL--KIKFLSEARILKQYDHPNIVKLIGV 60
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HDCFPPI 641
C+ + ++V E + G + L + V+ + A ++Y+ +C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKNC---- 114
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPD-----SSNCTELVGTFGYIAPELVYTMK 696
+HRD++++N L+ + ++SDFG+++ + D SS ++ + APE + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQI--PIKWTAPEALNYGR 170
Query: 697 VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP--RLPTPPQNVQD 754
+ + DV+S+G+L E F + N E ++ R+ + PQ D
Sbjct: 171 YSSESDVWSYGILLWET--------FSLGVCPYPGMTNQQAREQVEKGYRM-SCPQKCPD 221
Query: 755 ELISIVEVAFLCLNESPESRP 775
++ +++ C + PE+RP
Sbjct: 222 DVYKVMQ---RCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVP--QPEFVNEIKTLTELRHRSIVKF 579
+G G G V K + SG I+A K H E+ P + + + E++ L E IV F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH----LEIKPAIRNQIIRELQVLHECNSPYIVGF 68
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAI-EEFNWTVRMNVIRSVANALSYMHHDCF 638
YG + E+++ GSL +L I EE V + V+R +A L H
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA-YLREKHQ--- 124
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
I+HRD+ N+L+ E ++ DFG++ L +N VGT Y++PE + +
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYS 180
Query: 699 EKCDVYSFGVLALEVIKGDHP 719
+ D++S G+ +E+ G +P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 69/263 (26%), Positives = 114/263 (43%), Gaps = 34/263 (12%)
Query: 523 IGIGGQGSVYK-AKLTSGEILAVKKFHSLWPCEMVP--QPEFVNEIKTLTELRHRSIVKF 579
+G G G V+K + SG I+A K H E+ P + + + E++ L E IV F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIH----LEIKPAIRNQIIRELQVLHECNSPYIVGF 68
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
YG + E+++ GSL +L G I E + V +V L+Y+
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREK--H 123
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
I+HRD+ N+L+ E ++ DFG++ L +N VGT Y++PE + +
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSV 181
Query: 700 KCDVYSFGVLALEVIKGDHP-----RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754
+ D++S G+ +E+ G +P + + + + +E PR P PP
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE-TSPR-PRPPGRPLS 239
Query: 755 ELISIVEVAFLCLNESPESRPPM 777
P+SRPPM
Sbjct: 240 SY-------------GPDSRPPM 249
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G VYKA+ + E +A+KK E VP + EI L E++H +IV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVRLQD 68
Query: 582 FCSHPRNSFLVYEYLE------RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
+ +LV+EYL+ S N I+ + + ++R +A Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY----QILRGIA----YCHS 120
Query: 636 DCFPPIVHRDISSKNVLLCLDYEA-RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV-- 692
++HRD+ +N+L+ A +++DFG+A+ T V T Y APE++
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 693 ---YTMKVTEKCDVYSFGVLALEVI 714
Y+ V D++S G + E++
Sbjct: 178 SRHYSTPV----DIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 67/267 (25%), Positives = 120/267 (44%), Gaps = 43/267 (16%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G+G G V A+ +G+ +A+KK + ++ + + E+K L LRH +I+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76
Query: 582 -FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
F S + + V E L L +L++ ++F ++R L Y+H
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILR----GLKYVHS---AG 128
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTE 699
+VHRD+ N+L+ + + ++ DFG+A + T V T Y APE++ T K
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 700 KCDVYSFGVLALEVIKG-------DH--------------PRDFISSISSSSSNRNISLN 738
+ D++S G + E+++G DH P D I++I S ++ R +
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV--- 242
Query: 739 EILDPRLPTPP----QNVQDELISIVE 761
+ L R P P +N I ++E
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLE 269
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 516 GFDVKYCIGIGGQGSVYKAKL---TSGEILAVKKFH-SLWPCEMVPQPEFVNEIKTLTEL 571
++++ CIG G G VYKAK G+ A+KKF + Q EI L EL
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLREL 59
Query: 572 RHRSIVKFYG-FCSHPRNS-FLVYEYLERGSLATI----LSNDGAIEEFNWTVRMNVIRS 625
+H ++V F H S +L+++Y E I + +I V+ +++
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPS--MVK-SLLWQ 116
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR----VSDFGIAKF----LKPDSSNC 677
+ N + Y+H + ++HRD+ N+L+ + R + D G+A+ LKP ++
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-LADL 172
Query: 678 TELVGTFGYIAPELV-----YTMKVTEKCDVYSFG-----VLALEVI-KGD 717
+V T Y APEL+ YT + D+++ G +L LE I KG
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELRH 573
F++ IG G G V KL + + + K + W EM+ + E F E L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDN 60
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN--DGAIEEFNWTVRMNVIRSVANALS 631
+ I + N +LV +Y G L T+LS D E+ ++ ++ +++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG-IAKFLKPDSSNCTELVGTFGYIAPE 690
+H+ VHRDI N+L+ ++ R++DFG K ++ + + VGT YI+PE
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 691 LVYTM-----KVTEKCDVYSFGVLALEVIKGDHP 719
++ M K +CD +S GV E++ G+ P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-11
Identities = 42/112 (37%), Positives = 57/112 (50%), Gaps = 4/112 (3%)
Query: 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGN 285
LGL L G IP I L +L + L N + G IP +G ++SL L L+ N G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIR-GNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 286 LPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLH--YLNLSNNQFRKGFP 335
+P +LG LT L L+L+ N L +P LG L LH N ++N G P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 44/140 (31%), Positives = 63/140 (45%), Gaps = 8/140 (5%)
Query: 582 FCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
FC+ F V EYL G L + + G +E I L ++H
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIIC---GLQFLHKK--- 115
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
I++RD+ NVLL D +++DFG+ K + GT YIAPE++ K E
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 700 KCDVYSFGVLALEVIKGDHP 719
D +SFGVL E++ G P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 43/248 (17%)
Query: 520 KYCIGIGGQGSVYKAKLTS--GEILAVKKFHSLWPCEMVPQPE----FVNEIKTLTELRH 573
CIG G G VY+ S E +AV ++ C+ P F+ E + + H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAV----AVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS--VANALS 631
IVK G + ++V E G L + L +++ + ++ S ++ AL+
Sbjct: 67 PHIVKLIGVITEN-PVWIVMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALA 121
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAP 689
Y+ F VHRDI+++NVL+ ++ DFG++++L+ D S G ++AP
Sbjct: 122 YLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAP 177
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVIK-GDHP------RDFISSISSSSSNRNISLNEILD 742
E + + T DV+ FGV E++ G P D I I +
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE------------ 225
Query: 743 PRLPTPPQ 750
RLP PP
Sbjct: 226 -RLPMPPN 232
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 73/267 (27%), Positives = 115/267 (43%), Gaps = 36/267 (13%)
Query: 523 IGIGGQGSVYKAKLTSGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
IG G G VY L + AVK + + E V Q F+ E + + H +++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--FLKEGIIMKDFSHPNVLS 60
Query: 579 FYGFCSHPRNSFLV-YEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANALSYMHH 635
G C S LV Y++ G L + + E N TV+ + VA + Y+
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK------FLKPDSSNCTELVGTFGYIAP 689
F VHRD++++N +L + +V+DFG+A+ + + +L ++A
Sbjct: 117 KKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMAL 171
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748
E + T K T K DV+SFGVL E++ +G P + S + +L R
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT--------VYLLQGRRLLQ 223
Query: 749 PQNVQDELISIVEVAFLCLNESPESRP 775
P+ D L EV C + PE RP
Sbjct: 224 PEYCPDPL---YEVMLSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 32/241 (13%)
Query: 558 QPEFVNEIKTLTELRHRSIVKFYGFC--SHPRNSFLVYEYLERGSLATILSNDGAIEEFN 615
+ +F+ E +++ H++IV+ G PR F++ E + G L + L + E
Sbjct: 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERP 110
Query: 616 WTVRM----NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV---SDFGIAK 668
++ M R VA Y+ + F +HRDI+++N LL RV +DFG+A+
Sbjct: 111 SSLTMKDLLFCARDVAKGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
Query: 669 FLKPDS----SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFI 723
+ S L ++ PE T K DV+SFGVL E+ G P
Sbjct: 168 DIYRASYYRKGGRAML--PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP---- 221
Query: 724 SSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783
+N+ + RL PP+ + + C +PE RP T+ +
Sbjct: 222 ---YPGRTNQEVMEFVTGGGRL-DPPKGCPG---PVYRIMTDCWQHTPEDRPNFATILER 274
Query: 784 L 784
+
Sbjct: 275 I 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/226 (23%), Positives = 100/226 (44%), Gaps = 24/226 (10%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
EF+NE + E +V+ G S + + ++ E + RG L + L + E N
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 620 MNVIR-------SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672
++ +A+ ++Y++ + F VHRD++++N ++ D+ ++ DFG+ + +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 673 DSSNCTELVGTFG--YIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSS 729
G +++PE + T DV+SFGV+ E+ + P
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQG 224
Query: 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
SN + L +++ L P N D L E+ +C +P+ RP
Sbjct: 225 MSNEQV-LRFVMEGGLLDKPDNCPDMLF---ELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 507 YEEIVRATNG-------FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQP 559
YE+IVR +DV IG G G V + S + + K S + EM+ +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF--EMIKRS 85
Query: 560 E---FVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNW 616
+ F E + +V+ + + ++V EY+ G L ++SN E++
Sbjct: 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK 145
Query: 617 TVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS- 675
V+ ++ +A+ M ++HRD+ N+LL +++DFG +K D +
Sbjct: 146 FYTAEVVLAL-DAIHSMG------LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETG 196
Query: 676 --NCTELVGTFGYIAPELVYTMK----VTEKCDVYSFGVLALEVIKGDHP 719
C VGT YI+PE++ + +CD +S GV E++ GD P
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F++ +G G G V AK +GE A+K +M E L EL H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 576 IVKFY-GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
IV F R FL+ E++ G L T L G F V + A Y+H
Sbjct: 80 IVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLH 135
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
I++RD+ +N+LL +V+DFG AK + PD + L GT Y+APE++ +
Sbjct: 136 SK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT--FTLCGTPEYLAPEVIQS 189
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHP 719
+ D ++ GVL E I G P
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 568 LTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL-ATILSNDGAI--EE--FNWTVRMNV 622
L +++H +IV F + ++V EY + G L I G + E+ W V+M +
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL-KPDSSNCTELV 681
+ ++H ++HRDI SKN+ L + + ++ DFG A+ L P + CT V
Sbjct: 112 ------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YV 161
Query: 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741
GT Y+ PE+ M K D++S G + E+ HP ++S +N+ L
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP-------FQANSWKNLILKVCQ 214
Query: 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
P P EL S+++ F +P SRP T+
Sbjct: 215 GSYKPLPSH-YSYELRSLIKQMF---KRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 38/280 (13%)
Query: 523 IGIGGQGSVYKAKLT------SGEI-LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G G VY+ T SG I +AVK + + EF+ E ++ H +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ--EKKEFLKEAHLMSNFNHPN 60
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEF-----NWTVRMNVIRSVANAL 630
IVK G C +++ E +E G L + L D +E F +++ VA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCL-DYEAR----VSDFGIAKFLKPDSSNCTELVGTFG 685
Y+ F +HRD++++N L+ Y+A + DFG+A+ + E G
Sbjct: 120 VYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 686 --YIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD 742
++APE + K T + DV+SFGVL E++ G P + +N+ + L +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP-------YPALNNQEV-LQHVTA 228
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
P+N D++ ++ C + P RP Q
Sbjct: 229 GGRLQKPENCPDKIYQLMT---NCWAQDPSERPTFD-RIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 562 VNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVR 619
++E+K ++ L H +IV G C+ ++ EY G L L + +
Sbjct: 86 MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
+ VA ++++ +HRD++++NVLL ++ DFG+A+ + D SN
Sbjct: 146 FSY--QVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVV 199
Query: 680 LVGTF---GYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNI 735
++APE ++ T + DV+S+G+L E+ G +P + S
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------- 252
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
I + P++ E+ I++ C + P RP + QL+
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDIMKT---CWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELRH 573
F++ IG G G V K+ E + K + W EM+ + E F E L
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETACFREERNVLVNGDC 60
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN--DGAIEEFNWTVRMNVIRSVANALS 631
+ I + +LV +Y G L T+LS D E+ R + V A+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYIAEMVL-AIH 116
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG-IAKFLKPDSSNCTELVGTFGYIAPE 690
+H + VHRDI NVLL ++ R++DFG K + + + VGT YI+PE
Sbjct: 117 SIHQLHY---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 691 LVYTM-----KVTEKCDVYSFGVLALEVIKGDHP 719
++ M K +CD +S GV E++ G+ P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 47/283 (16%)
Query: 518 DVKY--CIGIGGQGSVYKAKLTSGEI---LAVKKFHSLWPCEMVPQPEFVNEIKTLTEL- 571
D+K+ IG G G V KA++ + A+K+ +F E++ L +L
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLG 65
Query: 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSL------ATILSNDGAIEEFNWTVR------ 619
H +I+ G C H +L EY G+L + +L D A N T
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 620 -MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678
++ VA + Y+ F +HRD++++N+L+ +Y A+++DFG+++
Sbjct: 126 LLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQEV 176
Query: 679 ELVGTFG-----YIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSN 732
+ T G ++A E + T DV+S+GVL E++ G P ++ +
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELY 233
Query: 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
+ L+ P N DE+ ++ C E P RP
Sbjct: 234 EKLPQGYRLE-----KPLNCDDEVYDLMR---QCWREKPYERP 268
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
NE + L L H +I+++Y + +V EY G+LA + + ++
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHF 106
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA-RVSDFGIAKFLKPDSSNCTELV 681
+ AL ++H I+HRD+ ++N+LL ++ DFGI+K L S T +V
Sbjct: 107 FVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VV 162
Query: 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
GT YI+PEL +K D+++ G + E+
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 53/229 (23%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 518 DVKYC--IGIGGQGSVYKAK---LTSGE---ILAVKKFHSLWPCEMVPQPEFVNEIKTLT 569
+++Y IG G G V++A+ L E ++AVK +M Q +F E +
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMA 63
Query: 570 ELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-------------------SNDGA 610
E H +IVK G C+ + L++EY+ G L L
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 611 IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI---- 666
+ T ++ + + VA ++Y+ F VHRD++++N L+ + +++DFG+
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 667 --AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
A + K ++ + ++ PE ++ + T + DV+++GV+ E+
Sbjct: 181 YSADYYKASENDAIPI----RWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649
F V E+L G L + + G + + T I L ++H I++RD+
Sbjct: 72 FFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC---GLQFLHSK---GIIYRDLKLD 125
Query: 650 NVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVL 709
NV+L D +++DFG+ K + + GT YIAPE++ +K T D +SFGVL
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVL 185
Query: 710 ALEVIKGDHP 719
E++ G P
Sbjct: 186 LYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 57/279 (20%)
Query: 527 GQGS---VYK---AKLTSGEI---LAVKKFHSLWPCE-MVPQPEFVNEIKTLTELRHRSI 576
GQGS VY+ + GE +A+K ++ M + EF+NE + E +
Sbjct: 15 GQGSFGMVYEGLAKGVVKGEPETRVAIK---TVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATIL----SND---------GAIEEFNWTVRMNVI 623
V+ G S + + +V E + +G L + L +
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE---- 127
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK------FLKPDSSNC 677
+A+ ++Y+ F VHRD++++N ++ D ++ DFG+ + + +
Sbjct: 128 --IADGMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 678 TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNIS 736
+ ++APE + T K DV+SFGV+ E+ + P SN +
Sbjct: 183 LPV----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP-------YQGLSNEEV- 230
Query: 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
L ++D P+N D+L+ ++ +C +P+ RP
Sbjct: 231 LKFVIDGGHLDLPENCPDKLLELMR---MCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 74/258 (28%), Positives = 114/258 (44%), Gaps = 45/258 (17%)
Query: 515 NGFDVKYCIGIG--GQGSVYKAKLTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKT--- 567
FDVK +G G G+ V + K T G+I A+K L E V E +I +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 568 ---LTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVI 623
+ +L+ Y F N +LV EY G L ++L+ + +E ++
Sbjct: 60 SPWIPQLQ-------YAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE-------DMA 104
Query: 624 R----SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS-NCT 678
+ + A+ +H + VHRDI +NVL+ +++DFG A L + N
Sbjct: 105 QFYLAELVLAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161
Query: 679 ELVGTFGYIAPELVYTMKVTEK------CDVYSFGVLALEVIKGDHPRDFISSISSSSSN 732
VGT YIAPE++ TM K CD +S GV+A E+I G P F S+ + N
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP--FHEGTSAKTYN 219
Query: 733 RNISLNEILDPRLPTPPQ 750
++ L + P P+
Sbjct: 220 NIMNFQRFL--KFPEDPK 235
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V+ A+L + + A+K ++V + V T+ E R S+ +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKK----DVVLMDDDVE--CTMVEKRVLSLAWEHP 56
Query: 582 FCSH-------PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
F +H N F V EYL G L + + + +F+ + L ++H
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVY 693
IV+RD+ N+LL D +++DFG+ K + D+ CT GT YIAPE++
Sbjct: 114 SK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILL 169
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHP 719
K D +SFGVL E++ G P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 58/251 (23%), Positives = 103/251 (41%), Gaps = 52/251 (20%)
Query: 560 EFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTV 618
+ V+E++ + + +H++I+ G C+ ++V EY G+L L E+
Sbjct: 61 DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120
Query: 619 RMNVIR-------------SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665
VA + ++ +HRD++++NVL+ D+ +++DFG
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 666 IAKFLKPDSSNCTELVGT------FGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDH 718
+A+ D + T ++APE ++ T + DV+SFGVL E+ G
Sbjct: 178 LAR----DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 719 PRDFISSISSSSSNRNISLNEILD-----PRLPTPPQNVQDELISIVEVAFLCLNESPES 773
P I + E+ R+ PQN EL ++ C +E P
Sbjct: 234 PYP------------GIPVEELFKLLKEGYRM-EKPQNCTQELYHLMRD---CWHEVPSQ 277
Query: 774 RPPMHTVCQLL 784
RP T QL+
Sbjct: 278 RP---TFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 43/269 (15%)
Query: 523 IGIGGQGSVY---KAKLTSGEILAVKK---FHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G+VY K + E L V K L P E V + E + L++L H +I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPAI 64
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM----NVIRSVANAL-- 630
VKF+ ++ EY E L D +EE T + V L
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDL------DCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 631 -SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
YMH I+HRD+ +KN+ L + ++ DFG+++ L T GT Y++P
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVIKGDHP---RDFISSISSSSSNRNISLNEILDPRLP 746
E + K D++S G + E+ H ++F+S + I++ P
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR-----------IVEGPTP 223
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRP 775
+ P+ +L SI++ LN+ P RP
Sbjct: 224 SLPETYSRQLNSIMQSM---LNKDPSLRP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 66/290 (22%), Positives = 125/290 (43%), Gaps = 51/290 (17%)
Query: 518 DVKY--CIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLT 569
D+K+ IG G G V +A + + I +K+F S +F E++ L
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-----ENDHRDFAGELEVLC 57
Query: 570 EL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSL------ATILSNDGAIEEFNWTVRM-- 620
+L H +I+ G C + ++ EY G+L + +L D A + + T
Sbjct: 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 621 --NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678
+++ ++ + M + +HRD++++NVL+ + ++++DFG++ + +
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS---RGEEVYVK 174
Query: 679 ELVGTFG--YIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNI 735
+ +G ++A E + T K DV+SFGVL E++ G P ++
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------- 226
Query: 736 SLNEILDPRLPT-----PPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
L +LP P+N DE + E+ C + P RPP +
Sbjct: 227 -----LYEKLPQGYRMEKPRNCDDE---VYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWT-- 617
+F+ EIK ++ L++ +I++ G C ++ EY+E G L LS F
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 618 ----VRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673
N++ S M + VHRD++++N L+ Y +++DFG+++ L
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY-- 180
Query: 674 SSNCTELVG----TFGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
S + + G ++A E + K T DV++FGV E+
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
F +++L H+ +VK YG C N +V EY++ G L L + +W +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--K 103
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC---LDYE----ARVSDFGIAKFLKP 672
++V + +A+AL Y+ +VH ++ KN+L+ L+ ++SD GI +
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
Query: 673 DSSNCTELVGTFGYIAPELVY--TMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSS 729
E V +IAPE + +T D +SFG LE+ G+ P +S++SSS
Sbjct: 161 RE----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP---LSTLSSS 213
Query: 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
R RLP P LI+ C P RP +
Sbjct: 214 EKERFYQDQH----RLPMPDCAELANLIN------QCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 3e-09
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKK----FHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
IG G G V A +G +A+KK F L + + + EIK L LRH +I+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI-----LREIKLLRHLRHENII 62
Query: 578 KFYGFCSHP-RNSF----LVYEYLERGSLATILSNDGAIEE-----FNWTVRM-NVIRSV 626
P F +V E +E L ++ + + + F + ++R
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYF-----LYQILR-- 114
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC---TELVGT 683
L Y+H ++HRD+ N+L+ + + ++ DFG+A+ + PD TE V T
Sbjct: 115 --GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 684 FGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKG 716
Y APEL+ + + T+ D++S G + E++
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G VYKA+ +GEI+A+KK E VP + EI L EL H +IV+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65
Query: 582 FCSHPRNSFLVYEYLERG------SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH- 634
+LV+E+L+ S + I+ + + + ++Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY--------QLLQGIAYCHS 117
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELV- 692
H ++HRD+ +N+L+ + +++DFG+A+ F P + E+V T Y APE++
Sbjct: 118 HR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 172
Query: 693 ----YTMKVTEKCDVYSFGVLALEVI 714
Y+ V D++S G + E++
Sbjct: 173 GSRQYSTPV----DIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 13/145 (8%)
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPE 690
+HH ++HRDI S N+LLC + ++ DFG +K S+ GT Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750
+ ++K D++S GVL E++ P D N +++ L R P
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------GENMEEVMHKTLAGRYDPLPP 267
Query: 751 NVQDELISIVEVAFLCLNESPESRP 775
++ E+ IV L+ P+ RP
Sbjct: 268 SISPEMQEIVT---ALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G +VYK + T+GEI+A+K+ H L E P + EI + EL+H +IV+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTA-IREISLMKELKHENIVRLHD 65
Query: 582 FCSHPRNSFLVYEYLERG--SLATILSNDGAIEEFNWTVRMNVIRSVANAL----SYMHH 635
LV+EY+++ GA++ N ++S L ++ H
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD-------PNTVKSFTYQLLKGIAFCHE 118
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVYT 694
+ ++HRD+ +N+L+ E +++DFG+A+ F P ++ E+V T Y AP+++
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 695 MKV-TEKCDVYSFGVLALEVIKG 716
+ + D++S G + E+I G
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPE---FVNEIKTLT 569
FDV IG G G V + +S ++ A+K KF EM+ + + F E +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF------EMIKRSDSAFFWEERDIMA 98
Query: 570 ELRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
IV+ Y F + ++V EY+ G L ++SN E+ W V
Sbjct: 99 HANSEWIVQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARFY--TAEVVL 153
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS---NCTELVGTFG 685
AL +H F +HRD+ N+LL +++DFG +K D++ C VGT
Sbjct: 154 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRCDTAVGTPD 208
Query: 686 YIAPELVYTMKVT----EKCDVYSFGVLALEVIKGDHP 719
YI+PE++ + +CD +S GV E++ GD P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G GG G V ++ +G++ A KK + + +NE + L ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS--- 64
Query: 582 FCSHPRNSFLVYEYLERGSLATILS--NDGAIE---------EFNWTVRMNVIRSVANAL 630
L Y Y + +L +L+ N G ++ F + + L
Sbjct: 65 ---------LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
+H + IV+RD+ +N+LL R+SD G+A + P+ VGT GY+APE
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPE 171
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
+V + T D ++ G L E+I G P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 38/240 (15%)
Query: 560 EFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSL------ATILSNDGAIE 612
+F E++ L +L H +I+ G C H +L EY G+L + +L D A
Sbjct: 41 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100
Query: 613 EFNWTVRM----NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
N T ++ A+ M + +HRD++++N+L+ +Y A+++DFG++
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS- 159
Query: 669 FLKPDSSNCTELVGTFG--YIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISS 725
+ + +G ++A E + T DV+S+GVL E++ G P ++
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217
Query: 726 ISSSSSNRNISLNEILDPRLPT-----PPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
L +LP P N DE + ++ C E P RP +
Sbjct: 218 AE-------------LYEKLPQGYRLEKPLNCDDE---VYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 27/172 (15%)
Query: 609 GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
G+ + NW V+ +A +SY+ +VHRD++++NVL+ +++DFG+A+
Sbjct: 107 GSQDLLNWCVQ------IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
Query: 669 FLKPDSSNCTELVGT--FGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISS 725
L D + G ++A E + + T + DV+S+GV E++ G P D I +
Sbjct: 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
Query: 726 ISSSSSNRNISLNEILDP--RLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
R I ++L+ RLP PP D + +V+ C E RP
Sbjct: 218 -------REIP--DLLEKGERLPQPPICTIDVYMIMVK----CWMIDSECRP 256
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G GSV A +GE +A+KK + E+ + + E+ L ++H +++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81
Query: 582 -FCSHP-----RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
F S ++ +LV Y+ + L I+ + + ++ + ++ + L Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS 135
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT- 694
I+HRD+ N+ + D E ++ DFG+A+ + T V T Y APE++
Sbjct: 136 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILNW 189
Query: 695 MKVTEKCDVYSFGVLALEVIKG 716
M + D++S G + E++ G
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 48/186 (25%), Positives = 90/186 (48%), Gaps = 11/186 (5%)
Query: 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649
F V EY+ G L + + E + ++ AL+Y+H I++RD+
Sbjct: 72 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYS---AEISLALNYLHER---GIIYRDLKLD 125
Query: 650 NVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGV 708
NVLL + +++D+G+ K L+P + + GT YIAPE++ D ++ GV
Sbjct: 126 NVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 709 LALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLN 768
L E++ G P D + S + N L +++ + P+++ + S+++ +F LN
Sbjct: 185 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK-SF--LN 241
Query: 769 ESPESR 774
+ P+ R
Sbjct: 242 KDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 614 FNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673
NW V+ +A ++Y+ +VHRD++++NVL+ +++DFG+AK L D
Sbjct: 112 LNWCVQ------IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
Query: 674 SSNCTELVGT--FGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFI--SSISS 728
G ++A E + T + DV+S+GV E++ G P D I S ISS
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 222
Query: 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
RLP PP D + +V+ C +SRP
Sbjct: 223 ILEK---------GERLPQPPICTIDVYMIMVK----CWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 13/146 (8%)
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
FY F R ++V EY+ G L ++SN E++ V+ AL +H F
Sbjct: 109 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL----ALDAIHSMGF 163
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIA-KFLKPDSSNCTELVGTFGYIAPELVYTMK- 696
+HRD+ N+LL +++DFG K K C VGT YI+PE++ +
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 697 ---VTEKCDVYSFGVLALEVIKGDHP 719
+CD +S GV E++ GD P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 41/175 (23%), Positives = 85/175 (48%), Gaps = 29/175 (16%)
Query: 560 EFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIE-EFNWT 617
+ V+E++ + + +H++I+ G C+ +++ EY +G+L L E+++
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 618 VR------------MNVIRSVANALSYM-HHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664
+ ++ VA + Y+ C +HRD++++NVL+ + +++DF
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADF 181
Query: 665 GIAKFLKPDSSNCTELVGT------FGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
G+A+ D +N T ++APE ++ T + DV+SFGVL E+
Sbjct: 182 GLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 38/231 (16%)
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLV---YEYLERGSLATILSNDGAIEEFNWTVR 619
NEI L L H +I+K N++++ Y++ L + + + E F+W R
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYD----EAFDWKDR 263
Query: 620 ------MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA-KFLKP 672
+++ + A+ Y+H ++HRDI +N+ L D + + DFG A F K
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN 732
+ VGT +PE++ E D++S G++ L+++ D I
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD-----FCPIGDGGGK 375
Query: 733 RNISLNEIL------DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPM 777
L +I+ D P PP + D + S ++ + S PP+
Sbjct: 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSA------EIDHAGHSVPPL 420
|
Length = 501 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 39/139 (28%), Positives = 53/139 (38%), Gaps = 19/139 (13%)
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
IV+RD+ +NVLL R+SD G+A L GT GY+APE++
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 701 CDVYSFGVLALEVIKGDHP-RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD----E 755
D ++ G E+I G P R + E L R D E
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVE----------KEELKRRTLEMAVEYPDKFSPE 224
Query: 756 LISIVEVAFLCLNESPESR 774
+ E A L + PE R
Sbjct: 225 AKDLCE-ALLQ--KDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G VYK + +G+I+A+KK E VP + EI L EL+H +IV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
+L++E+L L L + + + + + + + + + H +
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELV-----YTM 695
+HRD+ +N+L+ +++DFG+A+ F P E+V T Y APE++ Y+
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYST 181
Query: 696 KVTEKCDVYSFGVLALEVI 714
V D++S G + E+
Sbjct: 182 PV----DIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 57/195 (29%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 562 VNEIKTLTELRHRSIVKF-YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM 620
V E + L RH + Y F +H R F V EY G L LS + E
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTEERARFYG 101
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
I S AL Y+H +V+RDI +N++L D +++DFG+ K D +
Sbjct: 102 AEIVS---ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155
Query: 681 VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG-------DHPRDFISSISSSSSNR 733
GT Y+APE++ D + GV+ E++ G DH R F
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----------E 205
Query: 734 NISLNEILDPRLPTP 748
I + EI PR +P
Sbjct: 206 LILMEEIRFPRTLSP 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 522 CIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK-- 578
IG G G V A T SG+ +A+KK + + + E+K L +H +I+
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIR 70
Query: 579 --FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVANALSY 632
+ ++ ++V + +E L I+ +D + E IR + L Y
Sbjct: 71 DILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTE-------EHIRYFLYQLLRGLKY 122
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL--KPD--SSNCTELVGTFGYIA 688
+H ++HRD+ N+L+ D E R+ DFG+A+ L P TE V T Y A
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 689 PELVYTM-KVTEKCDVYSFGVLALEVI 714
PEL+ ++ + T D++S G + E++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 48/223 (21%)
Query: 523 IGIGGQGSVYKA--KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
IG GG G VY A + S + A+KK + + F+ E K +L H IV Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRV-ALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 581 GFCSHPRNSFLVYEYLERGSLATIL---------SNDGAIEEFNWTVRMNVIRSVANALS 631
CS + Y+E +L ++L S + A + SV LS
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT-----------SVGAFLS 117
Query: 632 YMHHDCFP-------PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD----------- 673
H C ++HRD+ N+LL L E + D+G A F K +
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 674 ----SSNCT---ELVGTFGYIAPELVYTMKVTEKCDVYSFGVL 709
S+ T ++VGT Y+APE + + +E D+Y+ GV+
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 39/162 (24%), Positives = 79/162 (48%), Gaps = 28/162 (17%)
Query: 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL----------SNDGAI---EEFNWTV 618
+H++I+ G C+ +++ EY +G+L L + D E+ ++
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 619 RMNVIRSVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK------FLK 671
++ VA + Y+ C +HRD++++NVL+ D +++DFG+A+ + K
Sbjct: 136 LVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
S+ + ++APE ++ T + DV+SFG+L E+
Sbjct: 192 KTSNGRLPV----KWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 38/219 (17%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF----VNEIKTLTEL 571
+ IG G G V A +G +A+KK P E F + EIK L
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS---PFE---HQTFCQRTLREIKILRRF 60
Query: 572 RHRSIVKFY------GFCSHPRNSFLVYEYLERGSLATI----LSNDGAIEEFNWTVRMN 621
+H +I+ F S + ++V E +E I LSND I+ F
Sbjct: 61 KHENIIGILDIIRPPSFESF-NDVYIVQELMETDLYKLIKTQHLSND-HIQYF------- 111
Query: 622 VIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN---CT 678
+ + L Y+H ++HRD+ N+LL + + ++ DFG+A+ P+ + T
Sbjct: 112 -LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 679 ELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKG 716
E V T Y APE++ K T+ D++S G + E++
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 23/155 (14%)
Query: 582 FCSHPRNSFL--VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
FCS L V EY+E G AT+L N GA+ RM +V AL Y+H+
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD--MARMYFAETVL-ALEYLHN---Y 120
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKF-LKPDSSNCTE--------------LVGTF 684
IVHRD+ N+L+ +++DFG++K L ++N E + GT
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
YIAPE++ + D ++ G++ E + G P
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 64/295 (21%), Positives = 102/295 (34%), Gaps = 57/295 (19%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
C + K K + ++AVKK +L C EI T +L+H +I+ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYV- 65
Query: 582 FCSHPRNSFL-------VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
SF+ V + GS L E +++ V NAL Y+H
Sbjct: 66 ------TSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA-------KFLKPDSSNCTELVGTFGYI 687
F +HR + + ++LL D + +S + K + V ++
Sbjct: 119 SKGF---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 688 APELVYT--MKVTEKCDVYSFGVLALEVIKG-----DHPRDF---------------ISS 725
+PE++ EK D+YS G+ A E+ G D P S+
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKST 235
Query: 726 ISSSSSNRNISLNEILDPRLPTPPQNVQDELIS-----IVEVAFLCLNESPESRP 775
+ + S + P + S VE LCL PESRP
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE---LCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 23/195 (11%)
Query: 529 GSVYKAKLTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF-YGFCSH 585
G Y K+ E++ K H+L E + L RH + Y F +H
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTL------------TENRVLQNSRHPFLTALKYSFQTH 67
Query: 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS-VANALSYMHHDCFPPIVHR 644
R F V EY G L LS + E R + + +AL Y+H + +V+R
Sbjct: 68 DRLCF-VMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE--KNVVYR 120
Query: 645 DISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVY 704
D+ +N++L D +++DFG+ K D + GT Y+APE++ D +
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 705 SFGVLALEVIKGDHP 719
GV+ E++ G P
Sbjct: 181 GLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 502 EGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEI--LAVKKFHSLWPCEMVPQP 559
+ K+ YE+ F+ +G G G V A + + +A+K+F +++ Q
Sbjct: 24 KNKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK---SKIIKQK 73
Query: 560 EF---VNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNW 616
+ +E K L + H V YG +LV E++ G T L + + F
Sbjct: 74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN---KRFPN 130
Query: 617 TVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN 676
V + Y+ IV+RD+ +N+LL D +++DFG AK + +
Sbjct: 131 DVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TR 184
Query: 677 CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
L GT YIAPE++ + + D ++ G+ E++ G P
Sbjct: 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-08
Identities = 30/85 (35%), Positives = 47/85 (55%)
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF 334
L L+ L G +P + L L+ ++LS N + +IP +LG++ L L+LS N F
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 335 PVELEKLIQLSELDLSLNILEGKIP 359
P L +L L L+L+ N L G++P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILS-----NDGAIEEF 614
+F+ EIK ++ L+ +I++ C ++ EY+E G L LS +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 615 NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674
+I S M + VHRD++++N L+ +Y +++DFG+++ L S
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY--S 182
Query: 675 SNCTELVG----TFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
+ + G +++ E + K T DV++FGV E++
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G GG G V ++ +G++ A K+ + + +NE + L ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN--- 64
Query: 582 FCSHPRNSFLVYEYLERGSLATILS--NDGAIEEFNWTV------RMNVIRSVANALSYM 633
L Y Y + +L +L+ N G ++ + + + A L +
Sbjct: 65 ---------LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
V+RD+ +N+LL R+SD G+A + P+ + VGT GY+APE++
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAPEVLN 174
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHP 719
+ T D + G L E+I+G P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 65/276 (23%), Positives = 122/276 (44%), Gaps = 52/276 (18%)
Query: 529 GSVYKAKL---TSGE---ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
G VYK L GE +A+K E + EF +E + L+H +IV G
Sbjct: 19 GKVYKGHLFGTAPGEQTQAVAIKTLKD--KAEGPLREEFKHEAMMRSRLQHPNIVCLLGV 76
Query: 583 CSHPRNSFLVYEYLERGSLATIL------SNDGAIEEFNWTVR--------MNVIRSVAN 628
+ + +++ Y L L S+ G+ ++ + TV+ ++++ +A
Sbjct: 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD-DKTVKSTLEPADFVHIVTQIAA 135
Query: 629 ALSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT--- 683
+ ++ HH +VH+D++++NVL+ ++SD G+ F + +++ +L+G
Sbjct: 136 GMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGL--FREVYAADYYKLMGNSLL 188
Query: 684 -FGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
+++PE + K + D++S+GV+ EV F + N + E++
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV--------FSYGLQPYCGYSNQDVIEMIR 240
Query: 743 PR--LPTPPQNVQDELISIVEVAFL-CLNESPESRP 775
R LP P D+ + V L C NE P RP
Sbjct: 241 NRQVLPCP-----DDCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 9/132 (6%)
Query: 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKN 650
L+ +Y+ G L T L E VR+ I + AL ++H I++RDI +N
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESE--VRV-YIAEIVLALDHLHQ---LGIIYRDIKLEN 135
Query: 651 VLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVYTMKV--TEKCDVYSFG 707
+LL + ++DFG++K FL + GT Y+APE++ + D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 708 VLALEVIKGDHP 719
VL E++ G P
Sbjct: 196 VLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 44/175 (25%), Positives = 84/175 (48%), Gaps = 29/175 (16%)
Query: 560 EFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL----------SND 608
+ V+E++ + + +H++I+ G C+ +++ EY +G+L L S D
Sbjct: 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 609 GAI---EEFNWTVRMNVIRSVANALSYM-HHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664
E+ + ++ VA + Y+ C +HRD++++NVL+ D +++DF
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADF 178
Query: 665 GIAKFLKPDSSNCTELVGT------FGYIAPELVYTMKVTEKCDVYSFGVLALEV 713
G+A+ D N T ++APE ++ T + DV+SFGVL E+
Sbjct: 179 GLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 31/262 (11%)
Query: 528 QGSVYKAKLTSGEIL--AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFC-- 583
Q S+YK + E++ KKFH + NEIK L + +I+K YGF
Sbjct: 33 QNSIYKGIFNNKEVIIRTFKKFHKGHKVLI---DITENEIKNLRRIDSNNILKIYGFIID 89
Query: 584 ---SHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
PR S L+ EY RG L +L + ++ ++ ++++ L ++ P
Sbjct: 90 IVDDLPRLS-LILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKP 145
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM--KVT 698
+++++S + L+ +Y+ ++ G+ K L V Y + +++ + + T
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK---NVNFMVYFSYKMLNDIFSEYT 200
Query: 699 EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758
K D+YS GV+ E+ G P + + ++ ++ +N+ +LP + E+
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENL----TTKEIYDLIINKNNSLKLPL---DCPLEIKC 253
Query: 759 IVEVAFLCLNESPESRPPMHTV 780
IVE C + RP + +
Sbjct: 254 IVEA---CTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 523 IGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKT----LTELRHR 574
+G GG G V++ + +G+I A+K L +V + K L ++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMK---VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 575 SIVKF-YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
IV Y F + + +L+ EYL G L L +G E + ++ AL ++
Sbjct: 61 FIVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFME---DTACFYLSEISLALEHL 116
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H I++RD+ +N+LL +++DFG+ K + + GT Y+APE++
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749
+ D +S G L +++ G P ++ NR ++++IL +L PP
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPP--------FTAENRKKTIDKILKGKLNLPP 221
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 26/208 (12%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFV----NEIKTL-TELRHRSI 576
+G G G V A+L + E+ AVK +++ Q + V E + L +H +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKK----DVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVANALSY 632
+ + F V EY+ G L + G +E R + L +
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE-------PRARFYAAEIVLGLQF 111
Query: 633 MH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
+H I++RD+ NVLL + +++DFG+ K + GT YIAPE+
Sbjct: 112 LHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKGDHP 719
+ D ++ GVL E++ G P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 71/279 (25%), Positives = 108/279 (38%), Gaps = 62/279 (22%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-----HRS- 575
IG G G VYK + +G ++AVK+ E + L +L H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--------ENKRILMDLDVVLKSHDCP 74
Query: 576 -IVKFYGFCSHPRNSFLVYEYLERGSLATILSN-----DGAIEEFNWTVRMNVIRSVANA 629
IVK YG+ + F+ E + +T L G I E + + ++ A
Sbjct: 75 YIVKCYGYFITDSDVFICMELM-----STCLDKLLKRIQGPIPED---ILGKMTVAIVKA 126
Query: 630 LSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
L Y+ H ++HRD+ N+LL ++ DFGI+ L DS T G Y+
Sbjct: 127 LHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGCAAYM 181
Query: 688 APELVYTMKVTEK----CDVYSFGVLALEVIKGDHP-----RDFISSISSSSSNRNISLN 738
APE + K DV+S G+ +E+ G P +F L
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------------EVLT 229
Query: 739 EILDPRLPTPP--QNVQDELISIVEVAFLCLNESPESRP 775
+IL P+ P + + S V+ LCL + RP
Sbjct: 230 KILQEEPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 8/136 (5%)
Query: 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649
FLV EY+ G L + + E + R + AL+++H I++RD+
Sbjct: 72 FLVIEYVNGGDLMFHMQRQRKLPEEH--ARFYAAE-ICIALNFLHER---GIIYRDLKLD 125
Query: 650 NVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGV 708
NVLL D +++D+G+ K L P + T GT YIAPE++ + D ++ GV
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGV 184
Query: 709 LALEVIKGDHPRDFIS 724
L E++ G P D I+
Sbjct: 185 LMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 60/242 (24%), Positives = 94/242 (38%), Gaps = 52/242 (21%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVN-EIKTLTELRHRSIVKFY 580
IGIG G V K+ + + A+K M Q V E L E + +VK Y
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKA-DVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
N + V +Y+ G + ++L G EE + I + A+ +H F
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE---DLARFYIAELTCAIESVHKMGF-- 122
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGI---------AKFLKP----------------DSS 675
+HRDI N+L+ D +++DFG+ +K+ + +
Sbjct: 123 -IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 676 NCT------------------ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGD 717
C LVGT YIAPE++ T+ CD +S GV+ E++ G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 718 HP 719
P
Sbjct: 242 PP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 1/79 (1%)
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
IV+RD+ +N+LL R+SD G+A + P+ VGT GY+APE++ K T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 701 CDVYSFGVLALEVIKGDHP 719
D + G L E+I+G P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 56/271 (20%), Positives = 115/271 (42%), Gaps = 45/271 (16%)
Query: 528 QGSVYKAKLTSGEILAVKKFHSLWPCEMVPQ--PEFVNEIKTLTELRHRSIVKFYGFCSH 585
+G +Y + +++A+K + PQ EF E + EL H +IV G +
Sbjct: 23 KGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78
Query: 586 PRNSFLVYEYLERGSLATIL------SNDGAIEEFNWTVR--------MNVIRSVANALS 631
+ +++EYL +G L L S+ G + + TV+ +++ +A +
Sbjct: 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK------FLKPDSSNCTELVGTFG 685
Y+ F VH+D++++N+L+ ++SD G+++ + + + +
Sbjct: 139 YLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI----R 191
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745
++ PE + K + D++SFGV+ E+ F + N + E++ R
Sbjct: 192 WMPPEAIMYGKFSSDSDIWSFGVVLWEI--------FSFGLQPYYGFSNQEVIEMVRKRQ 243
Query: 746 PTP-PQNVQDELISIVEVAFLCLNESPESRP 775
P ++ + S++ C E P RP
Sbjct: 244 LLPCSEDCPPRMYSLMTE---CWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 30/200 (15%)
Query: 527 GQGSVYKAKLTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF-YGFC 583
G Y K+ E++ K H+L E + L RH + Y F
Sbjct: 18 ASGKYYAMKILKKEVIIAKDEVAHTL------------TESRVLKNTRHPFLTSLKYSFQ 65
Query: 584 SHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVANALSYMHHDCFP 639
+ R F V EY+ G L LS + E + R + +AL Y+H
Sbjct: 66 TKDRLCF-VMEYVNGGELFFHLSRERVFSE-------DRTRFYGAEIVSALDYLHSG--- 114
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
IV+RD+ +N++L D +++DFG+ K D++ GT Y+APE++
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 700 KCDVYSFGVLALEVIKGDHP 719
D + GV+ E++ G P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 63/255 (24%), Positives = 112/255 (43%), Gaps = 40/255 (15%)
Query: 523 IGIGGQGSVYKAKLTS---GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVK 578
+G G G V A+ E +A+KK +++ +++ + + E+K L R H++I
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAK-RALRELKLLRHFRGHKNITC 66
Query: 579 FYGF---CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
Y N +YE L L I+ + + + ++ + I + L Y+H
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF---QSFIYQILCGLKYIHS 123
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD----SSNCTELVGTFGYIAPEL 691
++HRD+ N+L+ D E ++ DFG+A+ + + TE V T Y APE+
Sbjct: 124 ---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 692 VYTMK-VTEKCDVYSFGVLALE------VIKGDHPRDFISSISSSSSNRNISLNEILDPR 744
+ + + T+ DV+S G + E V KG +D++ LN+IL
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKG---KDYVD-----------QLNQILQ-V 225
Query: 745 LPTPPQNVQDELISI 759
L TP + + S
Sbjct: 226 LGTPDEETLSRIGSP 240
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 64/277 (23%), Positives = 119/277 (42%), Gaps = 38/277 (13%)
Query: 523 IGIGGQGSVYKAKLTSGE-ILAVK-KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
+G G GSV + +L + IL V K + C +F++E + E H ++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 581 GFC--SHPRNSF----LVYEYLERGSLATIL--SNDGAIEEFNWT-VRMNVIRSVANALS 631
G C + + ++ +++ G L + L S G ++ T + + + +A+ +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAP 689
Y+ F +HRD++++N +L + V+DFG++K + + +IA
Sbjct: 127 YLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 690 ELVYTMKVTEKCDVYSFGVLALEV-IKGDHPRDFISSISSSSSNRNISLNEILD-----P 743
E + T K DV+SFGV E+ +G P + + +EI D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------------SEIYDYLRQGN 231
Query: 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
RL PP D L + + C +P+ RP T+
Sbjct: 232 RLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILS-----------NDGAIEEFNWTVR- 619
+H++I+ G C+ +++ EY +G+L L N + E + +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 620 -MNVIRSVANALSYM-HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC 677
++ VA + Y+ C +HRD++++NVL+ D +++DFG+A+ +
Sbjct: 142 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 678 TELVGTF--GYIAPELVYTMKVTEKCDVYSFGVLALEV 713
G ++APE ++ T + DV+SFGVL E+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 61/245 (24%), Positives = 97/245 (39%), Gaps = 54/245 (22%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+GIG G V A K+ + + A+K E L E + +VK Y
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
N + V +Y+ G + ++L +E F + I + A+ +H F
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMGF--- 122
Query: 642 VHRDISSKNVLLCLDYEARVSDFGI---------AKF-----------LKP-----DSSN 676
+HRDI N+L+ LD +++DFG+ +K+ ++P D SN
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 677 CT----------------------ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
C LVGT YIAPE++ T+ CD +S GV+ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 715 KGDHP 719
G P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 27/156 (17%)
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSY 632
+ + +K Y + + L+ +Y++ G L +L +G + E V+ +IR + AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA--EVK-KIIRQLVEALND 124
Query: 633 MH-HDCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSNCTELVGTFGYIAP 689
+H H+ I+H DI +NV L + R+ D+G+ K + S C + GT Y +P
Sbjct: 125 LHKHN----IIHNDIKLENV-LYDRAKDRIYLCDYGLCKIIGTPS--CYD--GTLDYFSP 175
Query: 690 ELVYTMKVT-EKCDVYSF-----GVLALEVIKGDHP 719
E K+ D SF GVL E++ G HP
Sbjct: 176 E-----KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 32/80 (40%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 641 IVHRDISSKNVLLCLDY-EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
IV+RD+ +N+LL DY R+SD G+A + P+ VGT GY+APE+V + T
Sbjct: 123 IVYRDLKPENILLD-DYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 700 KCDVYSFGVLALEVIKGDHP 719
D + G L E+I+G P
Sbjct: 181 SPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 40/173 (23%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN------------ 607
+F+ E+K L+ L+ +I++ G C ++ EY+E G L LS+
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 608 ----DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663
+ +++ ++V +A+ + Y+ F VHRD++++N L+ + +++D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVGENLTIKIAD 181
Query: 664 FGIAKFLKPDSSNCTE--LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
FG+++ L + V ++A E + K T DV++FGV E++
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 21/188 (11%)
Query: 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM-HHDCFPPIVHRDISSKNV 651
Y+ + +LS+DG+ E ++ VA + ++ +C VHRD++++NV
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNV 268
Query: 652 LLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF---GYIAPELVYTMKVTEKCDVYSFGV 708
LL ++ DFG+A+ + D SN TF ++APE ++ T DV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 709 LALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCL 767
L E+ G P + I S+ I R+ P Q+ + ++ C
Sbjct: 328 LLWEIFSLGGTP--YPGMIVDSTFYNKIKSGY----RMAKPDHATQE----VYDIMVKCW 377
Query: 768 NESPESRP 775
N PE RP
Sbjct: 378 NSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649
+ V EY+ G L + G +E + +A L ++H I++RD+
Sbjct: 77 YFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFFLHSK---GIIYRDLKLD 130
Query: 650 NVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGV 708
NV+L + +++DFG+ K + + T GT YIAPE++ + D ++FGV
Sbjct: 131 NVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 709 LALEVIKGDHPRD 721
L E++ G P D
Sbjct: 190 LLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 523 IGIGGQGSVYKAK--LTSGEILAVKKFHSLWPCEMVPQPEF--VNEIKTLTELRHRSIVK 578
IG G G V+KA+ G +A+K+ E +P V ++ L H ++V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 579 FYGFCSHPRNS-----FLVYEYLERGSLATILS---NDGAIEEFNWTVRMNVIRSVANAL 630
+ C+ R LV+E++++ L T L G E T++ +++ + L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE---TIK-DMMFQLLRGL 123
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
++H +VHRD+ +N+L+ + +++DFG+A+ + T +V T Y APE
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAPE 179
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIK 715
++ D++S G + E+ +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 40/224 (17%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFH-SLWPCEMVPQPEFVN----------EIKTLTE 570
+G G G V KA T +G+I+A+KK ++ + V E+K + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 571 LRHRSIVKFYG-FCSHPRNSF--LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA 627
++H +I+ + F LV + + L ++ + E + I +
Sbjct: 77 IKHENIMGLVDVYVE---GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA-KFLKPDSS----------- 675
N L H + +HRD+S N+ + +++DFG+A ++ P S
Sbjct: 133 NVL----HKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 676 --NCTELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVIKG 716
T V T Y APEL+ K D++S G + E++ G
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 61/272 (22%), Positives = 102/272 (37%), Gaps = 72/272 (26%)
Query: 509 EIVRATNGFDVKY----CIGIGGQGSVYKAKLT-SGEILAVKK----FHSLWPCEMVPQP 559
E+ + +Y +G G G V A T +G +A+KK F S
Sbjct: 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS---------A 55
Query: 560 EFVN----EIKTLTELRHRSIVKFYG-FC-SHPRNSF----LVYEYLERGSLATI----- 604
E++ L + H +++ F + F LV + L I
Sbjct: 56 IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQK 114
Query: 605 LSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664
LS+D ++ ++ + L Y+H I+HRD+ N+ + D E ++ DF
Sbjct: 115 LSDD--------HIQF-LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF 162
Query: 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKG------- 716
G+A + T V T Y APE++ M + D++S G + E++ G
Sbjct: 163 GLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
Query: 717 DH--------------PRDFISSISSSSSNRN 734
DH + + ISS S+ RN
Sbjct: 220 DHIDQLKRIMNLVGTPDEELLQKISSESA-RN 250
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 73/274 (26%), Positives = 110/274 (40%), Gaps = 58/274 (21%)
Query: 517 FDVKYCIGIGGQGSV-YKAKLTSGEILAVKKFHSLWPCEMVPQPEFVN---EIKTLTELR 572
F+ IG G G V K +G I A+K L +M+ + + + E L E
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMK---ILRKADMLEKEQVAHIRAERDILVEAD 59
Query: 573 HRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAI--EEFNWTVRMNVIRSVANA 629
+VK FY F RN +L+ E+L G + T+L + E + + V+ A
Sbjct: 60 GAWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-----A 113
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK--------------PDS- 674
+ +H F +HRDI N+LL ++SDFG+ LK P S
Sbjct: 114 IDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 675 ----------------SNCTEL----VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
N +L VGT YIAPE+ + CD +S GV+ E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 715 KGDHPRDFISSISSSSSNRNISLNEIL--DPRLP 746
G P F S + + ++ E L P +P
Sbjct: 231 IGYPP--FCSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 47/251 (18%)
Query: 558 QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN------DGAI 611
Q EF+ + L+H +I++ G C LV+EY E G L + LS + +
Sbjct: 39 QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL 98
Query: 612 EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA---- 667
RM +A +++MH F +H D++ +N L D +V D+GI
Sbjct: 99 LLLQ---RMAC--EIAAGVTHMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150
Query: 668 --KFLKPDSSNCTELVGTFGYIAPELV-------YTMKVTEKCDVYSFGVLALEVIKGDH 718
+++ + C L ++APELV T + T+ +V++ GV E+
Sbjct: 151 KEDYIETEDDKCVPL----RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF---- 202
Query: 719 PRDFISSISSSSSNRNISLNEIL---DPRLPTP--PQNVQDELISIVEVAFLCLNESPES 773
+ + S S+R + LN ++ +L P + +++ +L SPE
Sbjct: 203 --ENAAQPYSHLSDREV-LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWL----SPEK 255
Query: 774 RPPMHTVCQLL 784
R V +LL
Sbjct: 256 RATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 52/238 (21%), Positives = 104/238 (43%), Gaps = 30/238 (12%)
Query: 560 EFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNW--- 616
EF+NE + +V+ G S + + +V E + G L + L + E N
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 617 --TVR--MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672
T++ + + +A+ ++Y++ F VHRD++++N ++ D+ ++ DFG+ + +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 673 DSSNCTELVGTF--GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730
G ++APE + T D++SFGV+ E I+S++
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE----------ITSLAEQP 221
Query: 731 ----SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
SN + L ++D P N + + ++ +C +P+ RP + LL
Sbjct: 222 YQGLSNEQV-LKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-------HR 574
+G G G V A+L SG + AVK +++ Q + V T+TE R H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKK----DVILQDDDVE--CTMTEKRILSLARNHP 56
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+ + Y P F V E++ G L + +E I S AL ++H
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITS---ALMFLH 113
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
I++RD+ NVLL + +++DFG+ K + + GT YIAPE++
Sbjct: 114 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHP 719
M D ++ GVL E++ G P
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 568 LTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA 627
++++ H + +G C + +V E++E G L L + W ++ V + +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVS-DFGIAKFLKPDSSNCT-------E 679
+ALSY+ +VH ++ +KN+LL AR+ G + F+K + E
Sbjct: 128 SALSYLEDK---NLVHGNVCAKNILL-----ARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 680 LVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEV-IKGDHPRDFISSISSSSSNRNISL 737
V +IAPE V ++ D +SFG LE+ G+ P + + S R
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---LKERTPSEKERFYEK 236
Query: 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
RLP P LIS CL P RP T+
Sbjct: 237 KH----RLPEPSCKELATLIS------QCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/248 (23%), Positives = 101/248 (40%), Gaps = 60/248 (24%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVN---EIKTLTELRHRSIVK 578
+GIG G V A K+ + + A+K +L +++ + + + E L E + +V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMK---TLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
Y N + V +Y+ G + ++L G E + I + A+ +H F
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE---DLARFYIAELTCAVESVHKMGF 122
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGI---------AKFLKP----------------D 673
+HRDI N+L+ D +++DFG+ +K+ + D
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 674 SSNCT----------------------ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLAL 711
+NC LVGT YIAPE++ T+ CD +S GV+
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 712 EVIKGDHP 719
E++ G P
Sbjct: 240 EMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 27/200 (13%)
Query: 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM-HHDCFPPIVHRDISSKN 650
+ ER T+++ A+ ++ + VAN + ++ +C VHRD++++N
Sbjct: 217 LPSAPERTRRDTLINESPAL---SYMDLVGFSYQVANGMEFLASKNC----VHRDLAARN 269
Query: 651 VLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF---GYIAPELVYTMKVTEKCDVYSFG 707
VL+C ++ DFG+A+ + D SN TF ++APE ++ T DV+SFG
Sbjct: 270 VLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFG 328
Query: 708 VLALEVIK---GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAF 764
+L E+ +P ++ ++ R + + P + DE+ I++
Sbjct: 329 ILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK---------PAHASDEIYEIMQ--- 376
Query: 765 LCLNESPESRPPMHTVCQLL 784
C E E RP + L+
Sbjct: 377 KCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 24/66 (36%), Positives = 33/66 (50%)
Query: 344 LSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ L L L G IP +I + L+ +NLS N+ G IP + L +D+SYN
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 404 GPIPNS 409
G IP S
Sbjct: 480 GSIPES 485
|
Length = 623 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRS 575
F++ +G G G V+ + SG L+ +++ + V + KT R R
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSG-----KLYAMKVLKKATIVQKAKTTEHTRTERQ 56
Query: 576 IVKF-----------YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR 624
+++ Y F + + L+ +Y+ G L T LS +E +
Sbjct: 57 VLEHIRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKEQEVQI---YSG 112
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGT 683
+ AL ++H I++RDI +N+LL + ++DFG++K F + + GT
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 684 FGYIAPELVYTMKV--TEKCDVYSFGVLALEVIKGDHP 719
Y+AP++V + D +S GVL E++ G P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 61/231 (26%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKK-FHSLWPCEMVPQPEFVN---------EI 565
+++ +G G G V+KA + E++A+KK F + F N EI
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-----------FRNATDAQRTFREI 57
Query: 566 KTLTELR-HRSIVKFYGFCSHP----RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM 620
L EL H +IVK ++ +LV+EY+E T L +R
Sbjct: 58 MFLQELGDHPNIVKLLNV--IKAENDKDIYLVFEYME-----TDLHA---------VIRA 101
Query: 621 NVIRSV---------ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671
N++ V AL Y+H ++HRD+ N+LL D +++DFG+A+ L
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
Query: 672 PDSSNC-----TELVGTFGYIAPE-LVYTMKVTEKCDVYSFGVLALEVIKG 716
N T+ V T Y APE L+ + + T+ D++S G + E++ G
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HDCFPPIVHR 644
+ +LV +Y+ G L L +G E I + AL ++H +D IV+R
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF---YIAELVLALEHLHKYD----IVYR 120
Query: 645 DISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK-VTEKCDV 703
D+ +N+LL + DFG++K D+ GT Y+APE++ K T+ D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 704 YSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744
+S GVL E+ G P + + RNI+ ++ P+
Sbjct: 181 WSLGVLVFEMCCGWSP---FYAEDTQQMYRNIAFGKVRFPK 218
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G +VYK +G+++A+K + E VP + E L L+H +IV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTA-IREASLLKGLKHANIVLLHD 70
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
V+EY+ ++ + G + +N VR+ + + + L+Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN--VRLFMFQ-LLRGLAYIHGQ---HI 124
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE-LVYTMKVTEK 700
+HRD+ +N+L+ E +++DFG+A+ S + V T Y P+ L+ +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 701 CDVYSFGVLALEVIKG 716
D++ G + +E+++G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 626 VANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
V AL ++H H +++RD+ N+LL + +++DFG+ K + T GT
Sbjct: 105 VTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
YIAPE++ ++ D ++ GVL E++ G P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G +VYK K +G+++A+K L E P + E L L+H +IV +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTA-IREASLLKGLKHANIVLLHD 70
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
LV+EY+ + + G + N V++ + + + LSY+H I
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPEN--VKLFLFQ-LLRGLSYIHQRY---I 124
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKC 701
+HRD+ +N+L+ E +++DFG+A+ S + V T Y P+++ C
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 702 -DVYSFGVLALEVIKG 716
D++ G + +E+I+G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 70/278 (25%), Positives = 101/278 (36%), Gaps = 71/278 (25%)
Query: 515 NGFDVKYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVP--QPEFVN-EIKTLTE 570
+ F+ IG G G V K +G I A+KK L EM+ Q V E L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKK---LRKSEMLEKEQVAHVRAERDILAE 57
Query: 571 LRHRSIVKFYGFCSHPRNSFLVYEYLERGSLAT------ILSNDGA---IEEFNWTVRMN 621
+ +VK Y +L+ EYL G + T + + I E T+
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE---TIL-- 112
Query: 622 VIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN----- 676
I S+ + L Y +HRDI N+LL ++SDFG+ LK
Sbjct: 113 AIDSI-HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 677 -------------CTEL--------------------VGTFGYIAPELVYTMKVTEKCDV 703
+ VGT YIAPE+ ++CD
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 704 YSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741
+S GV+ E++ G P F S + + I+ E L
Sbjct: 223 WSLGVIMYEMLVGYPP--FCSDNPQETYRKIINWKETL 258
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 61/290 (21%)
Query: 523 IGIGGQGSV-YKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV---- 577
+G G G+V +G +A+KK + + E+ + + E++ L ++H +++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLD 81
Query: 578 ---------KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMN-VIRSVA 627
+F+ F +LV ++ L ++ ++ E+ R+ ++ +
Sbjct: 82 VFTPDLSLDRFHDF-------YLVMPFMGT-DLGKLMKHEKLSED-----RIQFLVYQML 128
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
L Y+H I+HRD+ N+ + D E ++ DFG+A + S T V T Y
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYR 182
Query: 688 APELVYT-MKVTEKCDVYSFGVLALEVIKG-------DH--------------PRDFISS 725
APE++ M T+ D++S G + E++ G DH ++F+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242
Query: 726 ISSSSSNRNI-SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
+ S + + L + N ++++E L L+ ESR
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE-KMLVLD--AESR 289
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 29/79 (36%), Positives = 42/79 (53%)
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
I++RD+ +NVLL D R+SD G+A LK S GT G++APEL+ +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 701 CDVYSFGVLALEVIKGDHP 719
D ++ GV E+I P
Sbjct: 178 VDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 561 FVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM 620
F +++L H+ +V YG C S +V EY++ GSL T L + + +W ++
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA--------RVSDFGIAKFLKP 672
V + +A AL ++ + H ++ +KNVLL + + ++SD GI+ + P
Sbjct: 104 EVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160
Query: 673 DSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKG-DHPRDFISSISSSS 730
L+ ++ PE + + ++ D +SFG E+ G D P +S+
Sbjct: 161 KEI----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP------LSALD 210
Query: 731 SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
S + + E +LP P EL +++ C++ P+ RP
Sbjct: 211 SQKKLQFYEDRH-QLPAPKWT---ELANLINQ---CMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 39/147 (26%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYI 687
AL+++H I++RD+ NVLL + +++D+G+ K ++P + T GT YI
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 688 APELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747
APE++ D ++ GVL E++ G P D + + N L +++ +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR 223
Query: 748 PPQNVQDELISIVEVAFLCLNESPESR 774
P+++ + S+++ F LN+ P+ R
Sbjct: 224 IPRSLSVKASSVLK-GF--LNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 518 DVKY----CIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR 572
D KY IG G G V AK + E +A+KK + + + + EIK L L
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD 62
Query: 573 HRSIVKFYGFCSHP-RNSF----LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA 627
H +++ P R +F +VYE ++ I S+ ++ ++R
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR--- 119
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
L Y+H ++HRD+ N+LL + + ++ DFG+A+ TE V T Y
Sbjct: 120 -GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 688 APELVYTM-KVTEKCDVYSFGVLALEVI 714
APEL+ + T DV+S G + E++
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 10/136 (7%)
Query: 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRD 645
P +LV ++ G L L +G F+ + + AL +H +++RD
Sbjct: 65 PEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHK---FNVIYRD 118
Query: 646 ISSKNVLLCLDYEARVS--DFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDV 703
+ +N+LL DY+ ++ DFG+ K D GT Y+APEL+ T+ D
Sbjct: 119 LKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 704 YSFGVLALEVIKGDHP 719
++ GVL E++ G P
Sbjct: 177 WTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
IV+RD+ +NVLL R+SD G+A L D T+ GT GY+APE++ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 701 CDVYSFGVLALEVIKGDHP-RDFISSISSSSSNRNISLNEI 740
D ++ G E++ G P +D ++ R +E+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 9e-07
Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 33/234 (14%)
Query: 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHR 574
N ++V IG G G V+ K + K S + + + V E+ + EL+H+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 575 SIVKFYGFCSHPRNS--FLVYEYLERGSLATILSND----GAIEEFNWTVRMNVIRSVAN 628
+IV++ + N +++ E+ + G L+ + G IEE +++ R + +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH---AIVDITRQLLH 129
Query: 629 ALSYMHHDCFPP----IVHRDISSKNVLLCLDYE-----------------ARVSDFGIA 667
AL+Y H+ P ++HRD+ +N+ L A++ DFG++
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 668 KFLKPDSSNCTELVGTFGYIAPELVY--TMKVTEKCDVYSFGVLALEVIKGDHP 719
K + +S VGT Y +PEL+ T +K D+++ G + E+ G P
Sbjct: 190 KNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 39/226 (17%)
Query: 517 FDVKYC-IGIGGQGSVYKAKLTSG---EILAVKKFH----SLWPCEMVPQPEFVNEIKTL 568
F+ + C +G G G VYKAK G A+K+ S+ C EI L
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR---------EIALL 52
Query: 569 TELRHRSIVKFYG-FCSHP-RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM------ 620
EL+H +++ F SH R +L+++Y E L I+ A + V++
Sbjct: 53 RELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 111
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR----VSDFGIAKF----LKP 672
+++ + + + Y+H + ++HRD+ N+L+ + R ++D G A+ LKP
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 673 DSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGD 717
++ +V TF Y APEL+ + T+ D+++ G + E++ +
Sbjct: 169 -LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 15/105 (14%)
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
S+ AL Y+H ++HRD+ NVL+ + + ++ DFGI+ +L DS T G
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCK 167
Query: 685 GYIAPELV--------YTMKVTEKCDVYSFGVLALEVIKGDHPRD 721
Y+APE + Y + K DV+S G+ +E+ G P D
Sbjct: 168 PYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 6/132 (4%)
Query: 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649
+ V EY+ G L + G +E + ++ L ++H I++RD+
Sbjct: 77 YFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFFLHRR---GIIYRDLKLD 130
Query: 650 NVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVL 709
NV+L + +++DFG+ K D GT YIAPE++ + D +++GVL
Sbjct: 131 NVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190
Query: 710 ALEVIKGDHPRD 721
E++ G P D
Sbjct: 191 LYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 36/132 (27%), Positives = 61/132 (46%), Gaps = 6/132 (4%)
Query: 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649
+ V EY+ G L + G +E + +A L ++H I++RD+
Sbjct: 77 YFVMEYVNGGDLMYQIQQVGRFKEPHAVF---YAAEIAIGLFFLHSK---GIIYRDLKLD 130
Query: 650 NVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVL 709
NV+L + +++DFG+ K D GT YIAPE++ + D ++FGVL
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190
Query: 710 ALEVIKGDHPRD 721
E++ G P +
Sbjct: 191 LYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 562 VNEIKTLTELRHRSIVKF-YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM 620
+ E + L RH + Y F +H R F V EY G L LS + E
Sbjct: 43 LTESRVLQNTRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSEDRARFYG 101
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
I S AL Y+H +V+RD+ +N++L D +++DFG+ K D +
Sbjct: 102 AEIVS---ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155
Query: 681 VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
GT Y+APE++ D + GV+ E++ G P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 561 FVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM 620
F + ++ H+ IV YG C + +V E++E G L + + W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC---LDYEA----RVSDFGIAKFLKPD 673
V + +A+ALSY+ +VH ++ +KN+LL +D E ++SD GI +
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 674 SSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEV 713
E V +IAPE V K + D +SFG E+
Sbjct: 166 Q----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 67/241 (27%), Positives = 90/241 (37%), Gaps = 34/241 (14%)
Query: 196 LSNLVVLHLFENSLFGS----IPSILGNLKMLLHLGLSTNHLS------GVIPLSIGNLN 245
L L VL L N+L + S L L L LS N + +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 246 NLIGLYLYDNQLSVGEIPI--EIGKLSSLNYLVLNGNQLYGN----LPRALGSLTE-LEY 298
L L L DN L + + + SSL L LN N L L + L L LE
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 299 LDLSTNKLGNSIPETLGNLL----KLHYLNLSNNQFR-KGFPV---ELEKLIQLSELDLS 350
L L N+L + E L L L LNL+NN G L+ L LDL+
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 351 LNILE---GKIPCE-ICNMESLEKLNLSHNNFSG-----LIPSCFEGMHGLSCIDVSYNE 401
N L E + +++SLE LNL NN + L + L + +S N+
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261
Query: 402 L 402
+
Sbjct: 262 I 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 44/205 (21%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G GSV + +L+ + +K K L EF++E + + H +++K
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 580 YGFC--SHPRNSF----LVYEYLERGSLAT-ILSNDGAIEEFNWTVRMNV--IRSVANAL 630
G C + ++ +++ G L + +L + ++ + + +A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIA 688
Y+ + F +HRD++++N +L D V+DFG++K + + +IA
Sbjct: 127 EYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 689 PELVYTMKVTEKCDVYSFGVLALEV 713
E + T K DV++FGV E+
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 27/153 (17%)
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAK--FLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
+HRD++++N+LL + ++ DFG+A+ + PD + ++APE ++ T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 700 KCDVYSFGVLALEVIK-GDHP-------RDFISSISSSSSNRNISLNEILDPRLPTPPQN 751
+ DV+SFGVL E+ G P +F + + R P+
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--------------PEY 300
Query: 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
E+ SI+ C + +PE RP + ++L
Sbjct: 301 ATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 523 IGIGGQGSVYK--AKLTSGEILAVKKFH----SLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G +V+K +KLT ++A+K+ PC + E+ L L+H +I
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAI------REVSLLKNLKHANI 65
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
V + R LV+EYL+ L L N G + + V++ + + + LSY H
Sbjct: 66 VTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMH-NVKIFMFQ-LLRGLSYCHKR 122
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE-LVYTM 695
I+HRD+ +N+L+ E +++DFG+A+ + + V T Y P+ L+ +
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 696 KVTEKCDVYSFGVLALEVIKG 716
+ + D++ G + E+ G
Sbjct: 180 EYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G +V+K + E L K L E P + E+ L +L+H +IV +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHDI 72
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
++ LV+EYL++ L + + G I + V++ + + L+Y H ++
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH-NVKI-FLYQILRGLAYCHRR---KVL 126
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE-LVYTMKVTEKC 701
HRD+ +N+L+ E +++DFG+A+ + + V T Y P+ L+ + + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 702 DVYSFGVLALEVIKG 716
D++ G + E+ G
Sbjct: 187 DMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 69/287 (24%), Positives = 108/287 (37%), Gaps = 73/287 (25%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR--HRS---- 575
IG G G+V K SG I+AVK+ S V + E + + L +L RS
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRS-----TVDEKE---QKRLLMDLDVVMRSSDCP 63
Query: 576 -IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMN------------V 622
IVKFYG + ++ E + D ++++F V +
Sbjct: 64 YIVKFYGALFREGDCWICMELM-----------DISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
+ AL+Y+ + I+HRD+ N+LL + ++ DFGI+ L DS T G
Sbjct: 113 AVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAG 169
Query: 683 TFGYIAPELVYTMKVTE---KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739
Y+APE + + DV+S G+ EV G P N
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP--------------KWNS 215
Query: 740 ILD----------PRL-PTPPQNVQDELISIVEVAFLCLNESPESRP 775
+ D P L + + ++ + LCL + RP
Sbjct: 216 VFDQLTQVVKGDPPILSNSEEREFSPSFVNFIN---LCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 31/269 (11%)
Query: 523 IGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G GSV +A+L S + +AVK + + EF+ E + E H +++K
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVIK 65
Query: 579 FYGFCSHPRNS------FLVYEYLERGSLATIL--SNDGAIEEFNWTVRMNVIRSVANAL 630
G R ++ +++ G L T L S G E F ++ ++R + +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQT-LVRFMIDIA 123
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS---SNCTELVGTFGYI 687
S M + +HRD++++N +L + V+DFG++K + C + ++
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVKWL 182
Query: 688 APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPRLP 746
A E + T DV++FGV E++ +G P + N I I RL
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-------ENSEIYNYLIKGNRLK 235
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRP 775
PP ++D + E+ C + P+ RP
Sbjct: 236 QPPDCLED----VYELMCQCWSPEPKCRP 260
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 13/146 (8%)
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAK--FLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
+HRD++++N+LL + ++ DFG+A+ + PD ++APE ++ T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 700 KCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758
+ DV+SFGVL E+ G P + I+ R + P TP
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGV-QINEEFCQRLKDGTRMRAPENATP---------E 305
Query: 759 IVEVAFLCLNESPESRPPMHTVCQLL 784
I + C P+ RP + ++L
Sbjct: 306 IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 76/271 (28%), Positives = 98/271 (36%), Gaps = 40/271 (14%)
Query: 148 LSNLAVLHLYGNSLSGS----IPSIIGNLKSLFYLHLSSNQLSGSIPI------SLGNLS 197
L L VL L GN+L + S + SL L LS N+ L
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 198 NLVVLHLFENSLFGSIPSILGNL---KMLLHLGLSTNHLSGVI-PLSIGNLN----NLIG 249
L L L +N+L +L +L L L L+ N L L L L
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 250 LYLYDNQLSVG------EIPIEIGKLSSLNYLVLNGNQLYG--NLPRALGSLTELEYLDL 301
L L N+L + L LN L NG G L L + LE LDL
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELN-LANNGIGDAGIRALAEGLKANCNLEVLDL 200
Query: 302 STNKL----GNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL-----EKLIQLSELDLSLN 352
+ N L +++ ETL +L L LNL +N L I L L LS N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260
Query: 353 ILE---GKIPCEIC-NMESLEKLNLSHNNFS 379
+ K E+ ESL +L+L N F
Sbjct: 261 DITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G +VYK + + L K L E P + E+ L +L+H +IV +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHDI 72
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
++ LV+EYL++ L L + G + V++ + + + L+Y H ++
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH-NVKLFLFQ-LLRGLNYCHRR---KVL 126
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE-LVYTMKVTEKC 701
HRD+ +N+L+ E +++DFG+A+ + + V T Y P+ L+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 702 DVYSFGVLALEVIKG 716
D++ G + E+ G
Sbjct: 187 DMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 24/74 (32%), Positives = 44/74 (59%), Gaps = 2/74 (2%)
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAK--FLKPDSSNCTELVGTFGYIAPELVYTMKVTE 699
+HRD++++N+LL + ++ DFG+A+ + PD + ++APE ++ T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 700 KCDVYSFGVLALEV 713
+ DV+SFGVL E+
Sbjct: 261 QSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 523 IGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G QG V A T G +AVKK + + + + E+ L + H++I+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 87
Query: 582 FCSHPRNS-------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+ P+ S +LV E ++ +L ++ + E ++ ++ + + ++H
Sbjct: 88 VFT-PQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 140
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELV 692
I+HRD+ N+++ D ++ DFG+A+ +N T V T Y APE++
Sbjct: 141 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVI 194
Query: 693 YTMKVTEKCDVYSFGVLALEVIKG 716
M E D++S G + E++KG
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 523 IGIGGQGSV---YKAKLTSGEILAVKK----FHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G GSV Y +L + +AVKK F SL + E++ L ++H +
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSL-----IHARRTYRELRLLKHMKHEN 75
Query: 576 IVKFYGFCSHPRNSFLVYE--YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
++ + P S + YL + L+N ++ + +I + L Y+
Sbjct: 76 VIGLLDVFT-PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H I+HRD+ NV + D E R+ DFG+A + T V T Y APE++
Sbjct: 135 HS---AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIML 188
Query: 694 T-MKVTEKCDVYSFGVLALEVIKG 716
M + D++S G + E++KG
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 561 FVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVR 619
F+ E TL + H +IV+ G + +V EY+ G+L + L ++G +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL--- 109
Query: 620 MNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC-- 677
M ++ +A+ + Y+ + VH+ +++ VL+ D ++S F L+ D S
Sbjct: 110 MGMLPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIY 163
Query: 678 TELVG--TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHP------RDFISSISS 728
T + G + APE + + DV+SFG++ EV+ G+ P +D I ++
Sbjct: 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED 223
Query: 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
RLP P+N + L ++ C + RP
Sbjct: 224 GF-------------RLP-APRNCPNLLHQLM---LDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 60/255 (23%), Positives = 110/255 (43%), Gaps = 24/255 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSG----EILAVKKFHSLWPCEMVPQPEFVNEIKT---LT 569
F++ +G G G V+ + +G ++ A+K L +V + + V +T +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMK---VLQKAALVQKAKTVEHTRTERNVL 58
Query: 570 ELRHRS---IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSV 626
E +S + Y F + + L+ +Y+ G + T L E VR +
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSED--EVRFYS-GEI 114
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFG 685
AL ++H IV+RDI +N+LL + ++DFG++K FL + GT
Sbjct: 115 ILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 686 YIAPELVYTMKVTEKC-DVYSFGVLALEVIKGDHPRDFISSISSSS--SNRNISLNEILD 742
Y+APE++ K D +S G+L E++ G P ++ S S R + +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP 231
Query: 743 PRLPTPPQNVQDELI 757
+ Q++ +L+
Sbjct: 232 SFIGPEAQDLLHKLL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 15/121 (12%)
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA---KFLKPDSSNCTELVGTFGY 686
L +MH+ +V+RD+ N+LL R+SD G+A KP +S VGT GY
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 161
Query: 687 IAPE-LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745
+APE L + D +S G + ++++G P + +R + + L
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMAVEL 218
Query: 746 P 746
P
Sbjct: 219 P 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 523 IGIGGQGSVYKAKLTSGEILA---VKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
IG G G V ++ SG A VK+ + Q +F+ E + L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRV--SASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEF--NWTVRMNVIRSVANALSYMHHDC 637
G C+ LV E+ G L L + E + T + +A L ++H +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAK-------FLKPDSSNCTELVGTFGYIAPE 690
F +H D++ +N LL D ++ D+G++ ++ PD +L +IAPE
Sbjct: 121 F---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD-----QLWVPLRWIAPE 172
Query: 691 LV-------YTMKVTEKCDVYSFGVLALEVIK-GDHP 719
LV + T++ +V+S GV E+ + G P
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 72/277 (25%), Positives = 110/277 (39%), Gaps = 64/277 (23%)
Query: 517 FDVKYCIGIGGQGSV-YKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKT----LTEL 571
F+ IG G G V K +G + A+K L +M+ + E V I+ L E
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMK---ILRKADML-EKEQVGHIRAERDILVEA 58
Query: 572 RHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAI--EEFNWTVRMNVIRSVAN 628
+VK FY F N +L+ E+L G + T+L + EE + + V+
Sbjct: 59 DSLWVVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL----- 112
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL-------- 680
A+ +H F +HRDI N+LL ++SDFG+ LK ++ TE
Sbjct: 113 AIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSL 167
Query: 681 -----------------------------VGTFGYIAPELVYTMKVTEKCDVYSFGVLAL 711
VGT YIAPE+ + CD +S GV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 712 EVIKGDHPRDFISSISSSSSNRNISLNEIL--DPRLP 746
E++ G P F S + + ++ E L P +P
Sbjct: 228 EMLIGYPP--FCSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G GSV A T +G +AVKK + ++ E++ L ++H +++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 582 FCSHPRNSFLVYE--YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
+ P S + YL + L+N ++ +I + L Y+H
Sbjct: 84 VFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 139
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVT 698
I+HRD+ N+ + D E ++ DFG+A+ T V T Y APE++ M
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEIMLNWMHYN 196
Query: 699 EKCDVYSFGVLALEVIKG 716
+ D++S G + E++ G
Sbjct: 197 QTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 65/289 (22%), Positives = 95/289 (32%), Gaps = 55/289 (19%)
Query: 77 KSLSTLDLSKNKLNGSIPF------SFGNLTNLAIMYLYRNSLSASIPPVIGNL---KFL 127
SL L LS N+ L + L N+L V+ +L L
Sbjct: 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110
Query: 128 YHLDLSENQLSGSIPPTLG-----NLSNLAVLHLYGNSLSG----SIPSIIGNLKSLFYL 178
L L+ N L L L L L N L G ++ + + L L
Sbjct: 111 QELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170
Query: 179 HLSSNQLSGSIPISLG----NLSNLVVLHLFENSL----FGSIPSILGNLKMLLHLGLST 230
+L++N + + +L NL VL L N L ++ L +LK L L L
Sbjct: 171 NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGD 230
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL----YGNL 286
N+L+ G + L SL L L+ N + +L
Sbjct: 231 NNLTDA------------GAAALASALLSP--------NISLLTLSLSCNDITDDGAKDL 270
Query: 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLL-----KLHYLNLSNNQF 330
L L LDL NK G + L L +L L + ++ F
Sbjct: 271 AEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G G V+ A + + +AVKK L + V + EIK + L H +IVK
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKI-VLTDPQSVKHA--LREIKIIRRLDHDNIVKV 67
Query: 580 Y---GFCSHPRNS-----------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS 625
Y G ++V EY+E LA +L EE ++R
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLR- 125
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKFLKPDSSN---CTELV 681
L Y+H ++HRD+ NV + D ++ DFG+A+ + P S+ +E +
Sbjct: 126 ---GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 682 GTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKG 716
T Y +P L+ + T+ D+++ G + E++ G
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 23/151 (15%)
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS-----NCTELVGTFGYIAPELVYTMK 696
+HRD++++NVLL A++ DFG+A+ + DS+ N V ++APE ++
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290
Query: 697 VTEKCDVYSFGVLALEVI---KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
T + DV+S+G+L E+ K +P ++S R ++ P
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR---------PDFAP 341
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784
E+ SI++ +C N P RP + QL+
Sbjct: 342 PEIYSIMK---MCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA---KFLKPDSSNCTELVGTFG 685
L +MH+ +V+RD+ N+LL R+SD G+A KP +S VGT G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 160
Query: 686 YIAPELVYTMKVTE-KCDVYSFGVLALEVIKGDHP 719
Y+APE++ + D +S G + ++++G P
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 34/169 (20%)
Query: 562 VNEIKTLTELRHRSIVKFYGFCSH--------PRNSFLVYEYL---ERGSLATILSNDGA 610
E L + H SI++ G ++ PR +Y YL ++ IL+
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA---- 186
Query: 611 IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670
+ RSV A+ Y+H + I+HRDI ++N+ + + + DFG A F
Sbjct: 187 -----------IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF- 231
Query: 671 KPDSSNCTELVGTFGYIA---PELVYTMKVTEKCDVYSFGVLALEVIKG 716
P N + G G IA PEL+ D++S G++ E+
Sbjct: 232 -PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK------FLKPDSSNCTELVG 682
AL +H ++HRD+ S N+ L ++ DFG +K L SS C G
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC----G 233
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
T Y+APEL + ++K D++S GV+ E++ P S R I + ++L
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP-------FKGPSQREI-MQQVLY 285
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ P V + ++++ L+++P RP T QLL
Sbjct: 286 GKYDPFPCPVSSGMKALLDP---LLSKNPALRP---TTQQLL 321
|
Length = 478 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK----FLKPDSSNCTELVGTF 684
L Y+H + IV+RD+ N+LL + +++DFG+ K F S+ C GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC----GTP 165
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
++APE++ T D + GVL E++ G+ P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 25/95 (26%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 622 VIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF--LKPDSSNCTE 679
+ + + L Y+H I+HRD+ ++N+ + + + D G A+F + P
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--- 215
Query: 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
L GT APE++ K K D++S G++ E++
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 27/60 (45%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 127 LYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L LDLS N+L+ IP L NL VL L GN+L+ P L SL L LS N L
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 523 IGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE-LRHRSIVKFY 580
IG G G V AK S G AVK + Q + E L + L+H +V +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS-VANALSYMHHDCFP 639
+ V +Y+ G L L + E R + VA+A+ Y+H
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE----PRARFYAAEVASAIGYLHS---L 115
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
I++RD+ +N+LL ++DFG+ K ++P+ + T GT Y+APE++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYD 174
Query: 699 EKCDVYSFGVLALEVIKGDHP 719
D + G + E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 35/239 (14%)
Query: 561 FVNEIKTLTELRHRSIVKFYGFCSH-PRNSFLVYEYLERGSLATILSNDGAIEEFNWT-- 617
+ E L L H++I+ C F++Y Y+ G+L L E N
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 618 -----VRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672
V M + +A +SY+H ++H+DI+++N ++ + + +++D +++ L P
Sbjct: 115 STQQLVHMAI--QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 673 DSSNCTELVGT-----FGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSI 726
+C +G ++A E + + + DV+SFGVL E++ G P I
Sbjct: 170 MDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226
Query: 727 SSSSSNRNISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + D RL P N DEL +++ + PE RP + Q L
Sbjct: 227 EMA--------AYLKDGYRLAQPI-NCPDELFAVMACCWALD---PEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
I+HRD+ N+++ D ++ DFG+A+ S T V T Y APE++ M E
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197
Query: 701 CDVYSFGVLALEVIKG 716
D++S G + E+I+G
Sbjct: 198 VDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-05
Identities = 22/60 (36%), Positives = 28/60 (46%)
Query: 271 SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF 330
+L L L+ N+L A L L+ LDLS N L + PE L L L+LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 31/185 (16%)
Query: 564 EIKTLTELRHRSIVKF---YGFCS-----HPRNSFLVYEYLERGS---LATILSNDGAIE 612
EI L + HR+I+ Y + S P+ ++ Y++R L ++ I+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT----IQ 191
Query: 613 EFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK- 671
R + AL+Y+H I+HRD+ ++N+ L A + DFG A L
Sbjct: 192 -----------RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 672 -PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730
PD+ C GT +PEL+ K D++S G++ E+ + SSSS
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297
Query: 731 SNRNI 735
R+I
Sbjct: 298 QLRSI 302
|
Length = 392 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 22/151 (14%)
Query: 527 GQGS---VYKA--KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
G+GS VYK KLT G+++A+K+ L E P + E L +L+H +IV +
Sbjct: 14 GEGSYATVYKGRSKLT-GQLVALKEI-RLEHEEGAPFTA-IREASLLKDLKHANIVTLHD 70
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVANALSYMHHDC 637
+ LV+EYL+ L + + G + M+ +R + L+Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGG------LSMHNVRLFLFQLLRGLAYCHQR- 122
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
++HRD+ +N+L+ E +++DFG+A+
Sbjct: 123 --RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 31/125 (24%), Positives = 65/125 (52%), Gaps = 15/125 (12%)
Query: 595 YLERGSLATILSNDGA---IEEFNWTVRMNVIRSVANALSYM-HHDCFPPIVHRDISSKN 650
Y+++ + IL D E+ ++ VA +S++ +C +HRD++++N
Sbjct: 194 YIDQDVTSEILEEDELALDTEDL-----LSFSYQVAKGMSFLASKNC----IHRDLAARN 244
Query: 651 VLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYTMKVTEKCDVYSFGV 708
+LL ++ DFG+A+ ++ DS+ + ++APE ++ T + DV+S+G+
Sbjct: 245 ILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 304
Query: 709 LALEV 713
L E+
Sbjct: 305 LLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 15/130 (11%)
Query: 590 FLVYEYLERGSLATILSNDGAIEE---FNWTVRMNVIRSVANALSYMHHDCFPPIVHRDI 646
FLV ++ E G L + +S I E W M V AL +H + IV RD+
Sbjct: 61 FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALDALHRE---GIVCRDL 111
Query: 647 SSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSF 706
+ N+LL +++ F ++ + + S E V Y APE+ + TE CD +S
Sbjct: 112 NPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM-YCAPEVGGISEETEACDWWSL 168
Query: 707 GVLALEVIKG 716
G + E++ G
Sbjct: 169 GAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 13/93 (13%)
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS-NCTELVGTFGYIA 688
L Y+H I+HRDI N+L+ + ++ DFG+A+ +PD S + T+ V T Y A
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 689 PELV-----YTMKVTEKCDVYSFGVLALEVIKG 716
PE++ YT V D++S G + E++
Sbjct: 173 PEILMGSRHYTSAV----DIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 21/60 (35%), Positives = 30/60 (50%)
Query: 343 QLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
L LDLS N L + +L+ L+LS NN + + P F G+ L +D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
+A+AL Y+H IV+RD+ +N+LL ++DFG+ K S T G
Sbjct: 102 AAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
T Y+APE++ D + G + E++ G P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 45/180 (25%), Positives = 65/180 (36%), Gaps = 24/180 (13%)
Query: 599 GSLATILSNDGAI--EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656
SLA IL G EE W V AL +HR S N+LL D
Sbjct: 1 VSLADILEVRGRPLNEEEIWAV----CLQCLGALRE---------LHRQAKSGNILLTWD 47
Query: 657 YEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG 716
+ G F P+ S APE++ TEK D+YS G+ E +
Sbjct: 48 --GLLKLDGSVAFKTPEQSRPDPYFM-----APEVIQGQSYTEKADIYSLGITLYEALDY 100
Query: 717 DHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP 776
+ P + +S+ ++ DPR + + V S + LC + P+ R
Sbjct: 101 ELPYNEERELSAILEIL-LNGMPADDPRDRSNLEGV-SAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 65/264 (24%), Positives = 107/264 (40%), Gaps = 24/264 (9%)
Query: 143 PTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVL 202
P L +NL L L S +PS I L L L +S + +P + NL +L L
Sbjct: 651 PDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRL 709
Query: 203 HLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEI 262
+L S S P I N+ L + + L NL+ LI + +L
Sbjct: 710 NLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLE--NLDELILCEMKSEKLWERVQ 767
Query: 263 PIE--IGKLS-SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK 319
P+ + LS SL L L+ LP ++ +L +LE+L++ ++P + NL
Sbjct: 768 PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLES 826
Query: 320 LHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFS 379
L L+LS + FP D+S NI + + +E++ FS
Sbjct: 827 LESLDLSGCSRLRTFP------------DISTNISDLNLS-----RTGIEEVPWWIEKFS 869
Query: 380 GLIPSCFEGMHGLSCIDVSYNELR 403
L G + L + ++ ++L+
Sbjct: 870 NLSFLDMNGCNNLQRVSLNISKLK 893
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGTF 684
+A+AL Y+H IV+RD+ +N+LL ++DFG+ K ++ + + T GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTP 160
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
Y+APE+++ D + G + E++ G P
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
I+HRD+ N+++ D ++ DFG+A+ +V + Y APE++ M E
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKEN 205
Query: 701 CDVYSFGVLALEVIKG 716
D++S G + E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS-IVKFY 580
IG G G VYKA+ +G+++A+KK E +P P + EI L L IV+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-PTALREISLLQMLSESIYIVRLL 67
Query: 581 GFCSHPRNS-----FLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVANALSYMH 634
+ +LV+EYL+ + SN G + + + +++ H
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEA-RVSDFGIAK-FLKPDSSNCTELVGTFGYIAPE-L 691
++HRD+ +N+L+ +++D G+ + F P S E+V T Y APE L
Sbjct: 128 KH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEVL 183
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKG 716
+ + + D++S G + E+ +
Sbjct: 184 LGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 72/294 (24%), Positives = 110/294 (37%), Gaps = 66/294 (22%)
Query: 523 IGIGGQGSV-YKAKLTSGEILAVKKFHSLWPCEMVPQPEFVN---EIKTLTELRHRSIVK 578
IG G G V K +G+I A+K +L EM + + + E L E +V
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
Y + +L+ E+L G L T+L + F+ V + A+ +H F
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLGF 122
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGI----------AKFLKP---------------- 672
+HRDI N+L+ ++SDFG+ A + K
Sbjct: 123 ---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 673 --DSSNCT-------------------ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLAL 711
DS N T VGT YIAPE+ ++CD +S G +
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 712 EVIKGDHPRDFISSISSSSSNRNISLNEIL----DPRLPTPPQNVQDELISIVE 761
E + G P F S S + + I+ E L D L +++ LI+ E
Sbjct: 240 ECLIGWPP--FCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAE 291
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
I+HRD+ N+++ D ++ DFG+A+ S T V T Y APE++ M E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 701 CDVYSFGVLALEVIK 715
D++S G + E+++
Sbjct: 199 VDIWSVGCIMGEMVR 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG 685
+A+AL Y+H I++RD+ +N+LL ++DFG+ K S + GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
Y+APE++ D + G + E++ G P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 4e-04
Identities = 15/53 (28%), Positives = 22/53 (41%), Gaps = 14/53 (26%)
Query: 5 EAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCN 57
+ ALL +K+SL LSSW + PC+W G+ C+
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSD--------------PCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 40/221 (18%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G VYKA ++ +G ++A+KK + P EIK L +L+H ++V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74
Query: 582 -FCSHPRNS-------FLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALS 631
P S ++V Y++ L+ +L N T + + ++
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGIN 129
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA--------KFLKPDSSNC---TEL 680
Y+H + I+HRDI + N+L+ +++DFG+A T L
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 681 VGTFGYIAPELV-----YTMKVTEKCDVYSFGVLALEVIKG 716
V T Y PEL+ YT V D++ G + E+
Sbjct: 187 VVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
I G G VY K + ++ AVK K + MV Q E L + IV
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ--VQAERDALALSKSPFIVHL 69
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV--IRSVANALSYMHHDC 637
Y N +LV EYL G + ++L G +E M V I VA AL Y+H
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYISEVALALDYLHRH- 123
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
I+HRD+ N+L+ + +++DFG++K
Sbjct: 124 --GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 64/268 (23%), Positives = 99/268 (36%), Gaps = 68/268 (25%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVK---KFHSLWPCEMVPQPEFVN---EIKTLTELRHRS 575
+G G G V+ +L +G++ A+K K EM+ + + E + L L H
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKK------EMIKRNKVKRVLTEQEILATLDHPF 62
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILS--NDGAIEEFNWTVRMNVIR----SVANA 629
+ Y LV +Y G L +L + E V R V A
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE-------EVARFYAAEVLLA 115
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK--------------------- 668
L Y+H IV+RD+ +N+LL +SDF ++K
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 669 --------FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPR 720
F + S VGT YIAPE++ D ++ G+L E++ G P
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP- 231
Query: 721 DFISSISSSSSNRNISLNEIL--DPRLP 746
F SNR+ + + IL + P
Sbjct: 232 -F------KGSNRDETFSNILKKEVTFP 252
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 622 VIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE-- 679
V R + +A+ Y+H + I+HRDI ++NVL+ + + DFG A F + S
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALE 712
+ GT APE++ T D++S G++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
+L +LDLS N+L +F L NL ++ L N+L++ P L L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 150 NLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSL 209
NL L L N L+ L +L L LS N L+ P + L +L L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 21/57 (36%), Positives = 24/57 (42%)
Query: 296 LEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352
L+ LDLS N+L L L L+LS N P L L LDLS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 523 IGIGGQGSVYKAKLTSGEIL---AVKKFHSLWPCEMVPQPEFVNEI---------KTLTE 570
IG GG G VY+ + S + AV K +L +V + N I K +
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 571 LRHRSIVKFYGFCSHPRNSFLVYEY--LERGSLAT--ILSNDGAIEEFNWTVRMNVIRSV 626
+ H I K+YG S R + Y + LE+ T I I+ N + N+++ +
Sbjct: 80 IDHLGIPKYYGCGSFKRCR-MYYRFILLEKLVENTKEIFKR---IKCKNKKLIKNIMKDM 135
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670
L Y+H I H DI +N+++ + + D+GIA
Sbjct: 136 LTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 784 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.34 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.31 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.21 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.66 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-93 Score=868.70 Aligned_cols=737 Identities=34% Similarity=0.560 Sum_probs=478.2
Q ss_pred chHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCcccceeEEcCCCCeEEEEeCCCcccC-------
Q 042086 2 AGKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVISINLSTVGLKG------- 74 (784)
Q Consensus 2 ~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~------- 74 (784)
+++|+.||++||+++. +|.+.+++|+. ..+||.|.||+|+..++|+.+++...++.+
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~~w~~---------------~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~ 90 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLSNWNS---------------SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIF 90 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCCCCCC---------------CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHh
Confidence 4689999999999995 67778899953 257999999999987899999988654321
Q ss_pred CCCcccEEeCCCCccc-----------------------------------------------ccCCCCcCCCCCCCEEE
Q 042086 75 NLKSLSTLDLSKNKLN-----------------------------------------------GSIPFSFGNLTNLAIMY 107 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~-----------------------------------------------~~~~~~~~~l~~L~~L~ 107 (784)
.+++|+.|+|++|+++ +.+|..++++++|++|+
T Consensus 91 ~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 170 (968)
T PLN00113 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170 (968)
T ss_pred CCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence 2333333333333333 33444445555555555
Q ss_pred ccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCC
Q 042086 108 LYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG 187 (784)
Q Consensus 108 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 187 (784)
|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++.+++|++|+|++|.+++.+|..++++++|++|+|++|.+++
T Consensus 171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 250 (968)
T PLN00113 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250 (968)
T ss_pred CccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCC--------
Q 042086 188 SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSV-------- 259 (784)
Q Consensus 188 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-------- 259 (784)
.+|..++++++|+.|+|++|.+.+.+|..+.++++|+.|++++|.+++.+|..+.++++|+.|++++|.++.
T Consensus 251 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 330 (968)
T PLN00113 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330 (968)
T ss_pred ccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhc
Confidence 555555555555555555555555555555555555555555555554445444444455555544444430
Q ss_pred ---------------CCcccccccccccceEeccCccccCCCCccc------------------------cCCCc-----
Q 042086 260 ---------------GEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL------------------------GSLTE----- 295 (784)
Q Consensus 260 ---------------~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l------------------------~~l~~----- 295 (784)
+.+|..+..+++|+.|++++|++++.+|..+ ..+++
T Consensus 331 l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~ 410 (968)
T PLN00113 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410 (968)
T ss_pred CCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEE
Confidence 2344444444555555555554433222211 11112
Q ss_pred ------------------------------------------------------------------cceeecccCccCCC
Q 042086 296 ------------------------------------------------------------------LEYLDLSTNKLGNS 309 (784)
Q Consensus 296 ------------------------------------------------------------------L~~L~Ls~n~l~~~ 309 (784)
|+.|++++|++++.
T Consensus 411 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~ 490 (968)
T PLN00113 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGA 490 (968)
T ss_pred CcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCc
Confidence 22222333333333
Q ss_pred CcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCc
Q 042086 310 IPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGM 389 (784)
Q Consensus 310 ~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 389 (784)
+|..+.++++|+.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 491 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 570 (968)
T PLN00113 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570 (968)
T ss_pred cChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcC
Confidence 34444445555666666666666666677777777777788888877788888888888888888888888888888888
Q ss_pred ccceEEEcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCCC--CCCCCCCCCCCcccccccceeeeehhHHHHHHHHHH
Q 042086 390 HGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIK--GFQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVL 467 (784)
Q Consensus 390 ~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~--~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 467 (784)
++|+.|++++|++.|.+|....|..+....+.+|+++|+... ..+.|... ... ..+.+++.+++++++++++
T Consensus 571 ~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~-~~~~~~~~~~~~~~~~~~~ 644 (968)
T PLN00113 571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKT-PSWWFYITCTLGAFLVLAL 644 (968)
T ss_pred cccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----ccc-ceeeeehhHHHHHHHHHHH
Confidence 888888888888888888887787788888999999998643 23445311 112 2233344444444433333
Q ss_pred HHhhhchhhhccCCCCCcccccccCCCcceee----eccccccHHHHHHHhcCCCCceeEecccceEEEEEEE-cCCCEE
Q 042086 468 AMGTFFILRRREGPSSENRVNCVTNQGLLSIL----TFEGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKL-TSGEIL 542 (784)
Q Consensus 468 ~~~~~~~~rrr~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~v 542 (784)
++++++++|+|++... ...... .+..... .......++++ ...|+..+.||+|+||.||+|+. .+++.|
T Consensus 645 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~v 718 (968)
T PLN00113 645 VAFGFVFIRGRNNLEL-KRVENE--DGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQF 718 (968)
T ss_pred HHHHHHHHHhhhcccc-cccccc--cccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEE
Confidence 3333333333322111 111100 0000000 01112233333 34678888999999999999987 478999
Q ss_pred EEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHH
Q 042086 543 AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622 (784)
Q Consensus 543 avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i 622 (784)
|||++..... ....|++++++++|||||+++|++.+++..++||||+++|+|.++++ .++|..+.++
T Consensus 719 avK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i 785 (968)
T PLN00113 719 VVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKI 785 (968)
T ss_pred EEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHH
Confidence 9998864321 12356889999999999999999999999999999999999999995 3789999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchh
Q 042086 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCD 702 (784)
Q Consensus 623 ~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD 702 (784)
+.|+|+|++|||+.+.++|+||||||+||+++.++.+++. ||.+...... ....++++|+|||++.+..++.++|
T Consensus 786 ~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sD 860 (968)
T PLN00113 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSD 860 (968)
T ss_pred HHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccc
Confidence 9999999999997666699999999999999999888876 6655433221 2336789999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCcccccccc------ccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 042086 703 VYSFGVLALEVIKGDHPRDFISSISSS------SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP 776 (784)
Q Consensus 703 vwslGv~l~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 776 (784)
||||||++|||+||+.||+........ ..........++|+.+........++..++.+++.+||+.||++|||
T Consensus 861 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt 940 (968)
T PLN00113 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940 (968)
T ss_pred hhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcC
Confidence 999999999999999998632211000 00111223345566554433344566778999999999999999999
Q ss_pred HHHHHHhC
Q 042086 777 MHTVCQLL 784 (784)
Q Consensus 777 ~~~vl~~L 784 (784)
|+||++.|
T Consensus 941 ~~evl~~L 948 (968)
T PLN00113 941 ANDVLKTL 948 (968)
T ss_pred HHHHHHHH
Confidence 99999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=434.49 Aligned_cols=279 Identities=39% Similarity=0.665 Sum_probs=237.0
Q ss_pred cccccHHHHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEe
Q 042086 502 EGKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581 (784)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 581 (784)
...++++++..+|++|...+.||+|+||.||+|...+|+.||||++....... ..+|.+|+.++.+++|||+|+++|
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence 44578999999999999999999999999999999999999999877643221 456999999999999999999999
Q ss_pred EEecCC-ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceE
Q 042086 582 FCSHPR-NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR 660 (784)
Q Consensus 582 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 660 (784)
||.+.+ ..++|||||++|+|.++++..... .++|..|++||.++|+||+|||+.+.|+||||||||+|||+|+++++|
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999988 499999999999999999876543 789999999999999999999999988999999999999999999999
Q ss_pred EeccccccccCCCCCccccc-ccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccc------cc-cccc
Q 042086 661 VSDFGIAKFLKPDSSNCTEL-VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI------SS-SSSN 732 (784)
Q Consensus 661 l~DfG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~------~~-~~~~ 732 (784)
|+|||+|+............ .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+..... .+ ....
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999997654312222222 8999999999999999999999999999999999999987743211 11 1122
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+++|+++........++...+.+++.+|++.+|++||+|.||+++|
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 3337889999998642111126788899999999999999999999998865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=377.56 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=212.8
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-ceEEEEe
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR-NSFLVYE 594 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 594 (784)
++..+.||+|..|+|||++++ +++.+|+|.+... .+..-.+++.+|++++++.+||+||++||.|.++. ...|+||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 445678999999999999976 7999999999543 23345678999999999999999999999999988 4999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
||++|+|+++++..+ .+++....+|+.+|++||.|||+.. +||||||||+|||++..|+|||||||.+..+...
T Consensus 159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999998654 5788999999999999999999732 9999999999999999999999999999877543
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
....++||..|||||.+.+..|+.++||||||++++|+.+|+.||.... ........-+..|++...+..+.. .
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~ppP~lP~~--~ 306 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEPPPRLPEG--E 306 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCCCCCCCcc--c
Confidence 5678899999999999999999999999999999999999999986431 112223334455666555544443 3
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+.++.+++..|+++||.+||+++|+++
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 4557889999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=394.47 Aligned_cols=253 Identities=29% Similarity=0.531 Sum_probs=207.8
Q ss_pred CCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-ceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR-NSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 594 (784)
.+.+.+.+|+|+||+||+|.++....||||++......... .++|.+|+.+|.+++|||||+++|+|.++. ..++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34455669999999999999985555999999875433333 679999999999999999999999999877 7999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEeCCCCCCeeecCCC-ceEEeccccccccCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP-IVHRDISSKNVLLCLDY-EARVSDFGIAKFLKP 672 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~ 672 (784)
||++|+|.++++.. ....+++..+.+++.+||+||+|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999874 235799999999999999999999999 7 99999999999999997 999999999987664
Q ss_pred CCCcccccccccccccccccc--cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVY--TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD-PRLPTPP 749 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~ 749 (784)
.....+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.......... ..+.. .+...+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~-------~v~~~~~Rp~~p- 268 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS-------AVVVGGLRPPIP- 268 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhcCCCCCCC-
Confidence 434445578999999999999 6699999999999999999999999998654321111 01111 122222
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+ ...+..++.+||+.||++||++.+++..|
T Consensus 269 ~~~---~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 269 KEC---PPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred ccC---CHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 222 23577888899999999999999998764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=375.52 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=216.9
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCC----ChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMV----PQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++....... ......+|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567889999999999999999755 8999999999875443322 2334679999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEecc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVSDF 664 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Df 664 (784)
..||||||++||+|.+++-.++. +.....+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999977654 44467788999999999999999 99999999999999766 77999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCC--cC-cchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMK--VT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
|+|+... ........+|||.|.|||++.+.. +. .++|+||+||+||-+++|.+||.... .......++.
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~-------~~~sl~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY-------TDPSLKEQIL 395 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc-------CCccHHHHHh
Confidence 9999876 445567889999999999997554 33 37899999999999999999997321 1222334566
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+....+..+.+...+..++|.+||..||++|||++|+++
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 67777777778888889999999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=390.95 Aligned_cols=249 Identities=28% Similarity=0.491 Sum_probs=207.2
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
..+++.+.||+|.||+||.|.++....||+|.++.. .-..++|.+|+++|++++|++||+++|+|..++..+||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 345667889999999999999998889999999874 2345789999999999999999999999999889999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
||+.|+|.++|+... ...+.....+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+....+.
T Consensus 282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999998732 34678899999999999999999999 99999999999999999999999999999665544
Q ss_pred Cccc-ccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-CCCCCCCCCC
Q 042086 675 SNCT-ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEIL-DPRLPTPPQN 751 (784)
Q Consensus 675 ~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~~~ 751 (784)
+... ...-+..|.|||.+...+++.|||||||||+||||+| |+.||..+...+ .+..+- ..|++.|. .
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~GyRlp~P~-~ 428 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERGYRLPRPE-G 428 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhccCcCCCCC-C
Confidence 4322 2234568999999999999999999999999999999 899986433211 111111 13566654 4
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+++ ++.+++..||+.+|++|||++.+...
T Consensus 429 CP~---~vY~lM~~CW~~~P~~RPtF~~L~~~ 457 (468)
T KOG0197|consen 429 CPD---EVYELMKSCWHEDPEDRPTFETLREV 457 (468)
T ss_pred CCH---HHHHHHHHHhhCCcccCCCHHHHHHH
Confidence 555 47789999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=389.14 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=218.8
Q ss_pred cCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
..|...+.||+|||+.+|+++. .+|+.||+|++.+.........+...+|+++.+.++|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 789999999998876666777889999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|+|++++|..+++.. ..+++.+++.++.||+.|+.|||+. +|+|||||..|+|++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999854 3688899999999999999999999 9999999999999999999999999999999888
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.......+|||-|+|||++.....+..+||||+||++|-|++|++||+... .++....+.......|.
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~Ik~~~Y~~P~---- 239 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNKIKLNEYSMPS---- 239 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHHHHhcCccccc----
Confidence 788889999999999999998889999999999999999999999998321 11222222222222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.-+.+..+||.++|+.||.+|||+++|+.
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22335778999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=356.75 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=210.1
Q ss_pred cCCCCceeEecccceEEEEEE-EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEe-EEecCC-ceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG-FCSHPR-NSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~l 591 (784)
..|++.++||+|.||+|||+. ..+|..||.|.++ ..-.+....++...|+.++++++|||||++++ .+.++. ..+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 357888999999999999997 5589999999988 33344556778999999999999999999999 444444 4889
Q ss_pred EEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 592 VYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPP-IVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
||||+..|+|.+.++... ....+++..+++++.|+++||..+|+...++ |+||||||.||+++.+|.|||+|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999997533 2346899999999999999999999954422 78999999999999999999999999999
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
+..........+|||.||+||.+.+..|+.||||||+||++|||..-++||..-... .-..+|-+...+..+
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~--------~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL--------SLCKKIEQGDYPPLP 249 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH--------HHHHHHHcCCCCCCc
Confidence 988777788899999999999999999999999999999999999999999743211 112233333333222
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTV 780 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~v 780 (784)
..-.+..+.++|..|+..||+.||+.-.+
T Consensus 250 --~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 250 --DEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred --HHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 13456789999999999999999984433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.29 Aligned_cols=200 Identities=29% Similarity=0.514 Sum_probs=180.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|.+.+.||+|.||+||+|+.+ ++..||||.+.+..- .....+-+..|+++++.++|||||.+++++..++..++|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 467888899999999999999976 689999999876432 223456688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC------CceEEecccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD------YEARVSDFGI 666 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~DfG~ 666 (784)
||||.+|+|.+|++..+ .+++...+.++.|+|.|+++||++ +||||||||.|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999999875 578899999999999999999999 99999999999999865 4589999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRD 721 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~ 721 (784)
|+.+.+ .......+|+|-|||||++...+|+.|+|+||.|+++||+++|+.||+
T Consensus 162 AR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 162 ARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 998874 344567899999999999999999999999999999999999999997
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=391.76 Aligned_cols=255 Identities=25% Similarity=0.451 Sum_probs=210.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.......+.||+|+||+||+|+.. +...||||.++... +....++|.+|+++++.++|||||+++|+|.+++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 345566788999999999999743 45689999998742 3335789999999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC
Q 042086 588 NSFLVYEYLERGSLATILSNDGA-----------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 656 (784)
.++||+|||..|||.+||+..++ ..+++..+.+.||.|||.|++||-++ .+|||||.++|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999964321 22478889999999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCC-CCCccc-ccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 042086 657 YEARVSDFGIAKFLKP-DSSNCT-ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNR 733 (784)
Q Consensus 657 ~~~kl~DfG~a~~~~~-~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~ 733 (784)
..|||+|||+++.+-. +.+... ...-+.+|||||.+..++||++||||||||+|||+++ |+.||.... .
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--------n 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--------N 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--------h
Confidence 9999999999986433 222222 3445789999999999999999999999999999998 999986332 2
Q ss_pred ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 734 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
++.+.-+-+.++-..++.++. ++++|+..||+..|++||+++||-..|
T Consensus 712 ~EVIe~i~~g~lL~~Pe~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSCPENCPT---EVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred HHHHHHHHcCCcccCCCCCCH---HHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 233333444455455555555 588899999999999999999997654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=356.57 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=213.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||+||.++.+ +++.+|+|++++....+....+...+|..++.+++||.||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457999999999999999999855 7999999999887766666678899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||+.||.|..+|++.+ .|++..+.-++.+|+.||.|||++ +|||||+||+|||+|++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 578898999999999999999999 999999999999999999999999999997666
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
........+||+.|||||++.+..++.++|.||+|+++|||++|.+||... ........+...+...++...
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~~~~p~~l 249 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKLPLPPGYL 249 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcCCCCCccC
Confidence 666667789999999999999999999999999999999999999999732 222333444445544444433
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC
Q 042086 753 QDELISIVEVAFLCLNESPESRP 775 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RP 775 (784)
.. +..+++.+.+..||++|.
T Consensus 250 s~---~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 SE---EARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CH---HHHHHHHHHhccCHHHhc
Confidence 33 466788899999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.51 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=207.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|+....+|+|+||+|||++.+ +|+.||||++.+.... ..-.+-..+|++++++++|||+|.++++|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 45777889999999999999976 6999999999775432 333566789999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++. ++.+-+..... .++.....+++.|+++|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.+...
T Consensus 81 E~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99998 55555654432 467788999999999999999999 9999999999999999999999999999999877
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccc---------ccc---ccccc
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN---------RNI---SLNEI 740 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~---------~~~---~~~~~ 740 (784)
...++..+.|..|.|||.+.+ .+|.+.+||||.||++.||++|.+-|...+++..-... +.. ....+
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 778889999999999999987 67999999999999999999999987644432211000 000 00011
Q ss_pred cCC-CCCCCC------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 LDP-RLPTPP------QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 ~d~-~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.. +++.+. ...+....-++++++.|++.||++|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 110 111111 112233446889999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.53 Aligned_cols=268 Identities=25% Similarity=0.453 Sum_probs=218.5
Q ss_pred eeeccccccHHHHHHHhc---------CCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHH
Q 042086 498 ILTFEGKILYEEIVRATN---------GFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNE 564 (784)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~---------~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E 564 (784)
...+-+..+||+...+.. ..++.++||.|.||.||+|+++ ....||||.++... .+.++.+|+.|
T Consensus 603 ~k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~E 680 (996)
T KOG0196|consen 603 TKTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSE 680 (996)
T ss_pred ceeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhh
Confidence 344444556665544433 3457889999999999999876 24579999998743 55678899999
Q ss_pred HHHHhccCCCceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEe
Q 042086 565 IKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHR 644 (784)
Q Consensus 565 ~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 644 (784)
+.||.+++||||+++.|+.......+||+|||++|+|+.||+.+. ++|++.+...+..+||.|+.||.+. ++|||
T Consensus 681 AsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHR 755 (996)
T KOG0196|consen 681 ASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHR 755 (996)
T ss_pred hhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhh
Confidence 999999999999999999999999999999999999999998775 4699999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCceEEeccccccccCCCCCc-ccccc--cccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCC
Q 042086 645 DISSKNVLLCLDYEARVSDFGIAKFLKPDSSN-CTELV--GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPR 720 (784)
Q Consensus 645 Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~ 720 (784)
||.++|||++.+-.+|++|||+++.+.++... .+... -+.+|.|||.+..+++|.+||||||||++||.++ |+.||
T Consensus 756 DLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 756 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 99999999999999999999999988655432 22222 3468999999999999999999999999999986 99996
Q ss_pred Ccccccccccccccccccccc-CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 721 DFISSISSSSSNRNISLNEIL-DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
=.+. .+..++.+. +.|++.+.+ ....+.+|++.||++|-.+||++.+|+..|
T Consensus 836 WdmS--------NQdVIkaIe~gyRLPpPmD----CP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 836 WDMS--------NQDVIKAIEQGYRLPPPMD----CPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred cccc--------hHHHHHHHHhccCCCCCCC----CcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 3211 111222222 346666543 334688999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.21 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=216.1
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
+..++|.+++.||.|.|++|++|+.. +++.||||++.+.....+...+....|-.+|..+ .||.|++++-.|+++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34568999999999999999999865 7999999998776555555667788999999999 899999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
|+|+||+++|+|.++++..+ .|++...+.++.+|+.||+|||++ |||||||||+|||+|.|+++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999998875 488899999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc-------------ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 042086 670 LKPDSSN-------------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNIS 736 (784)
Q Consensus 670 ~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 736 (784)
+.+.... ...++||-.|.+||++.....++.+|+|+|||++|+|+.|++||.... ....
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--------eyli 295 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--------EYLI 295 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--------HHHH
Confidence 7643211 145899999999999999999999999999999999999999997432 2233
Q ss_pred cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 737 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+++|++-....++... ..+.+|+.+.|..||.+|+|.++|-+.
T Consensus 296 FqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 4455554444443322 346788999999999999999998653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=318.92 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=209.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.+|...+.+|+|.||.||+|++. +|+.||||+++.....+.. .....+|++.++.++|+||+.++++|.+.+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 36778889999999999999865 8999999999876443332 346789999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|||+. +|+..++.... .++...++.++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+.+.
T Consensus 81 Efm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eeccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 99988 99999986543 678899999999999999999999 9999999999999999999999999999999877
Q ss_pred CCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------ccccccccccccC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS----------SSNRNISLNEILD 742 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~~d 742 (784)
.......+-|..|.|||.+.+.+ |+..+|+||.||++.||+-|.+-|....+++.- ....+..+..+-|
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 77666668899999999998754 899999999999999999987766543332110 0111111111111
Q ss_pred C---C-CCCCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 743 P---R-LPTPP--QNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 743 ~---~-~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
. + .+.++ ...+.......+++..++..||.+|+|++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 0 11110 1223444567899999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=338.76 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=207.7
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||.|..++||+|+. ..++.||||++.-+...+ ..+++.+|+..|+.++||||++++..|..+...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 46799999999999999999984 478999999998754332 368899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|.||.+|++.+.++..-. ..+++..+..|..++++||.|||++ |.||||||+.|||++.+|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999976433 3588899999999999999999999 999999999999999999999999998876654
Q ss_pred CCCcc----ccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 673 DSSNC----TELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 673 ~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
..... ...+||+.|||||+++. ..|+.|+||||||++..|+.+|..||..+..... +..-+....+
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--------Ll~tLqn~pp 250 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--------LLLTLQNDPP 250 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--------HHHHhcCCCC
Confidence 43332 44589999999999653 4589999999999999999999999985543210 0000011110
Q ss_pred ------CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 ------TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+........+.+++..|+.+||++|||++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111223447889999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.20 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=199.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC--ceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR--NSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 591 (784)
..+...+.||+|.||.||++... +|+..|||.+..... ...+.+.+|+.+|++++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 35777889999999999999876 499999998765411 12567899999999999999999999854444 6889
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CCceEEecccccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKFL 670 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~ 670 (784)
.|||+++|+|.+++...+. .+++..+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999999988764 588999999999999999999999 9999999999999999 799999999999876
Q ss_pred CCC---CCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcc-ccccccccccccccccccCCCC
Q 042086 671 KPD---SSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFI-SSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 671 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
... ........||+.|||||++..+ ....++||||+||++.||+||+.||... ... ............
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~-------~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA-------EALLLIGREDSL 241 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH-------HHHHHHhccCCC
Confidence 631 1223457899999999999953 3445999999999999999999998742 100 000111111112
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+..+... +.+..+++.+|+..||++|||++++++.
T Consensus 242 P~ip~~l---s~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 242 PEIPDSL---SDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCCccc---CHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 2222223 3357788999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=343.81 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=206.1
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSF 590 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 590 (784)
.+.|+.++.||+|.||.||+|+. .+|+.||+|+++..... ........+||.+|++++||||+++.+...+. ...|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34577778999999999999985 48999999999765432 23345678999999999999999999998776 6899
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
||+|||++ ||.-++...+- .|+..+++.++.|++.||+|+|++ +|.|||||.+|||||.+|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999999 99998876543 688999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCc-ccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------------cccc--c
Q 042086 671 KPDSSN-CTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------------SSNR--N 734 (784)
Q Consensus 671 ~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------------~~~~--~ 734 (784)
...... .+..+.|..|.|||.+.+. .|+.++|+||.|||+.||++|++.|..-..++.. ..+. .
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 765543 6778899999999999865 5999999999999999999999998643332111 0000 0
Q ss_pred cccccccCCCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 ISLNEILDPRLPTPP---QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 ~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
-.....+.+..+... +.........++|+..+|..||++|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011111111111000 001112335778999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.99 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=206.9
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
++++...+++.+.+.||+|.||+||+|++.. .||||++........ ..++|+.|+.++++-+|.||+-+.|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4555566677889999999999999999862 589999987655433 6789999999999999999999999999877
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
. .||+.||+|-+|+.+++... .+|+..+.+.|+.|||+|+.|||.+ +|||||||..|||+.++++|||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 6 99999999999999998654 4788899999999999999999999 9999999999999999999999999999
Q ss_pred cccCC--CCCccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042086 668 KFLKP--DSSNCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742 (784)
Q Consensus 668 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d 742 (784)
..-.. .........|..-|||||+++. .+|++.+||||||+|+|||+||..||. ...- .........-..-
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~---dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR---DQIIFMVGRGYLM 611 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh---hheEEEecccccC
Confidence 75332 1222334567888999999963 468999999999999999999999987 2211 0000000001111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 743 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+++..... ....++.+|+..||..+|++||.+.+|+..
T Consensus 612 pd~s~~~s---~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 612 PDLSKIRS---NCPKAMKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred ccchhhhc---cCHHHHHHHHHHHHhcCcccCccHHHHHHH
Confidence 12222222 334467788999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.48 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=209.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCC-C-CCChhhHHHHHHHHhccC-CCceeeEEeEEecCCc
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPC-E-MVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRN 588 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 588 (784)
..+.|.+++.||+|.||.|+.|... +++.||+|++...... . ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999754 7899999977664221 1 123456778999999998 9999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEeccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIA 667 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a 667 (784)
.++||||+.+|+|.+++...+ ++.+..+.+++.|++.|++|||++ +|+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999998744 466689999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCCcccccccccccccccccccCC-cC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTMK-VT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
.............+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ......+.....
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRKIRKGEF 240 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHHHhcCCc
Confidence 98753445567889999999999999877 86 579999999999999999999985221 111112333333
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+.... ..++..++.+|+..||.+|+|+.++++
T Consensus 241 ~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 3322211 456889999999999999999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=380.60 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=208.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc--CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
....+..+.||+|+||.||.|... +|. .||||.+.+. .+.....+|.+|+.+|+.++|||||+++|++-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445677889999999999999865 343 4899988764 34556789999999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEec
Q 042086 588 NSFLVYEYLERGSLATILSNDGA----IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
..+|++|||++|+|..||++... ...+.....+.++.+||+|+.||+++ ++|||||.++|+|+++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999986521 23678888999999999999999999 999999999999999999999999
Q ss_pred cccccccC-CCCCccccc-ccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042086 664 FGIAKFLK-PDSSNCTEL-VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 664 fG~a~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
||+|+.+- .+.+..... .-...|||||.+..+.++.|+|||||||++||++| |..||......+ ....-.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHH
Confidence 99999543 333333322 33468999999999999999999999999999998 899986433211 111122
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
-..|+..+ .++++ .+.+++..||+.+|++||++.++++++
T Consensus 919 ~ggRL~~P-~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 919 EGGRLDPP-SYCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred hCCccCCC-CCCCh---HHHHHHHHHccCChhhCccHHHHHhhh
Confidence 23456554 45555 477999999999999999999998753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.64 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=207.0
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+.....+++.||+|.||.|..+....+..||||+++... ......+|.+|+++|.+++|||||.++|+|..++.+++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 345677899999999999999999988999999999854 334468999999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+|||++|+|.+|+..+.... ..-....+|+.|||.|++||.+. ++|||||.++|+|++.++++||+|||+++-+-.
T Consensus 614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999998764322 34455678999999999999998 999999999999999999999999999985432
Q ss_pred -CCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh--CCCCCCccccccccccccccccccccCC-CC--
Q 042086 673 -DSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK--GDHPRDFISSISSSSSNRNISLNEILDP-RL-- 745 (784)
Q Consensus 673 -~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~-- 745 (784)
+.+. ....+-+.+|||||.+.-++++++||||+||+++||+++ .+.||+....-+.. +...++++. ..
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-----en~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-----ENAGEFFRDQGRQV 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-----HhhhhhcCCCCcce
Confidence 2222 234556789999999999999999999999999999885 78898754432110 011111111 11
Q ss_pred -CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 -PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+..+ ..++++++.+||+.|-++||+++++...|
T Consensus 765 ~l~~P~~c---p~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 765 VLSRPPAC---PQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred eccCCCcC---cHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 1111222 33678999999999999999999987643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=356.97 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=203.5
Q ss_pred cCCCCceeEecccceEEEEEEEcC--C--CE-EEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTS--G--EI-LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
++..+.+.||+|+||.||+|+++. + .. ||||..+...........+|..|+++|+.++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345556899999999999998652 2 23 899998864444566788999999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|||+|+||+|.++|+..+. .++..++.+++.++|+||+|||++ ++|||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999987654 688999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc-c-CCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEI-L-DPRLP 746 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~-d~~~~ 746 (784)
-...........-+..|+|||.+....|++++|||||||++||+++ |..||...... .....+ . ..+.+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRMP 383 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccCC
Confidence 4311111112235678999999999999999999999999999998 88898744321 111122 1 11222
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+ ...+. .+..++..||..||++||+|.++.+.|
T Consensus 384 ~~-~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 384 IP-SKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred CC-CCCHH---HHHHHHHHhccCChhhccCHHHHHHHH
Confidence 22 23333 466778899999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.04 Aligned_cols=248 Identities=27% Similarity=0.372 Sum_probs=210.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+... ...+.+.+.+|++++++++|||||.++++|+...+.++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 46888899999999999999866 789999999877533 2334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+.| +|..++...+ .++++.+..++.+++.||.|||+. +|.|||+||.||+++..+.+|+||||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99988 9999998765 477899999999999999999999 9999999999999999999999999999998877
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
....+...|||.|||||...+.+|+..+|.||+||++||+++|++||--.. + ..-.+.|.......+ .
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-i-------~~Lv~~I~~d~v~~p-~--- 221 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-I-------TQLVKSILKDPVKPP-S--- 221 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-H-------HHHHHHHhcCCCCCc-c---
Confidence 777788899999999999999999999999999999999999999984211 0 011112222222222 2
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+..++...+.+||.+|-|-.+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 44556888999999999999999888764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.64 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=209.8
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
...|+..+.||+|+.|.||.|+. .+++.||||++..... ...+-+.+|+.+|+..+|+|||.+++.|...+..++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 44677788999999999999975 4789999999876422 2355688999999999999999999999888999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||||++|+|.+.+... .+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999999998654 478899999999999999999999 999999999999999999999999999998887
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
....-...+|||+|||||++....|.+|.||||||++++||+-|++||-....+...+.. ...-.+++. ..
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-----a~ng~P~lk----~~ 492 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNGTPKLK----NP 492 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-----hhcCCCCcC----Cc
Confidence 766667789999999999999999999999999999999999999998643322211110 001112222 22
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+..+.+++.+||+.||++||++.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 233456888999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.79 Aligned_cols=239 Identities=25% Similarity=0.345 Sum_probs=207.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+.......+.+...+|..+++.+.||.++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888999999999999999976 68999999998876666667788899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++||.|.+++++.+ +|+...++-++.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999998765 588899999999999999999999 9999999999999999999999999999987533
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.-..+|||.|+|||.+.+..+..++|-|||||++|||+.|.+||-.... .....+|+..++..|....
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~fP~~fs- 265 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVKFPSYFS- 265 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcccCCcccC-
Confidence 5678999999999999999999999999999999999999999863222 2233455555555443322
Q ss_pred HHHHHHHHHHHhcccCCCCCC
Q 042086 754 DELISIVEVAFLCLNESPESR 774 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~R 774 (784)
..+.+|+...+++|-.+|
T Consensus 266 ---~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 ---SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---HHHHHHHHHHHhhhhHhh
Confidence 246788888899998888
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=352.30 Aligned_cols=256 Identities=22% Similarity=0.397 Sum_probs=199.5
Q ss_pred hcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 46799999999999999999974 245789999986532 222346789999999999 899999999998764
Q ss_pred -CceEEEEecccCCCHHHHHhcCCC-------------------------------------------------------
Q 042086 587 -RNSFLVYEYLERGSLATILSNDGA------------------------------------------------------- 610 (784)
Q Consensus 587 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 610 (784)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 457899999999999999964321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC--ccccccccc
Q 042086 611 ----IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTF 684 (784)
Q Consensus 611 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~ 684 (784)
...+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 12477888999999999999999998 999999999999999999999999999986543221 122334567
Q ss_pred ccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHH
Q 042086 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVA 763 (784)
Q Consensus 685 ~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li 763 (784)
.|+|||++.+..++.++|||||||++|||++ |..||....... .....+.+......+.. ....+.+++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~---~~~~l~~li 310 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGTRMRAPEN---ATPEIYRIM 310 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCCCCCCCCC---CCHHHHHHH
Confidence 8999999999999999999999999999997 999987432110 00011111111111111 223578999
Q ss_pred HhcccCCCCCCCCHHHHHHhC
Q 042086 764 FLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 764 ~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+||+.||++|||+.|+++.|
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 311 LACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred HHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=402.34 Aligned_cols=307 Identities=42% Similarity=0.598 Sum_probs=215.3
Q ss_pred CCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccce
Q 042086 98 GNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY 177 (784)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 177 (784)
..+++|++|+|++|++++.+|. +.+++|++|+|++|.+.+.+|..++.+++|++|+|++|.+.+.+|..+.++++|++
T Consensus 115 ~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 192 (968)
T PLN00113 115 TTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192 (968)
T ss_pred ccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCe
Confidence 4788999999999988877775 45777888888888877777777777888888888888777777777777777888
Q ss_pred eeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCC
Q 042086 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL 257 (784)
Q Consensus 178 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 257 (784)
|+|++|.+.+.+|..++++++|+.|+|++|++++.+|..++++++|++|++++|.+++..|..++++++|+.|++++|++
T Consensus 193 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 272 (968)
T PLN00113 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272 (968)
T ss_pred eeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCee
Confidence 88877777777777777777777777777777777777777777777777777777777777777777777777777776
Q ss_pred CCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchh
Q 042086 258 SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE 337 (784)
Q Consensus 258 ~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~ 337 (784)
. +.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..
T Consensus 273 ~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 351 (968)
T PLN00113 273 S-GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351 (968)
T ss_pred e-ccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChH
Confidence 5 455666667777777777777777666766666777777777777776666666666666666666666666666666
Q ss_pred hhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 338 LEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 338 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
++.+++|+.|++++|++.+.+|..++.+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|
T Consensus 352 l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p 421 (968)
T PLN00113 352 LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421 (968)
T ss_pred HhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECC
Confidence 6666666666666666665555555555555555555555444444444444444444444444444333
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.30 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=201.9
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|+..+.||+|+||.||+|... +|+.||+|.+.............+.+|+.+++.++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999864 799999999875433223334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 9999999988864332 3578899999999999999999999 9999999999999999999999999999876432
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .+.....+....... ...
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~----~~~ 227 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKEDQEEY----SEK 227 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcccccC----Ccc
Confidence 223445789999999999999999999999999999999999999974221100 000000111111111 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
....+.+++.+||+.||++||+ ++++++
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2346788999999999999997 788765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.83 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=208.1
Q ss_pred HhcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCC-ce
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPR-NS 589 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~ 589 (784)
..++|.+++.||.|.||.||+|+. .+|..||||+++..... .+.--=.+|++.++++. |||||++.+++.+.+ ..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 346799999999999999999985 47999999998764321 11222468999999998 999999999998887 89
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|||||+. +|++.++.+ ...|++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 999999977 999999877 35799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccc----cc-c
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSN----RN-I 735 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~----~~-~ 735 (784)
+.. ....+..+.|..|.|||++. ...|+.+.|+||+|||++|+.+-++-|-.....+.- .+. .+ .
T Consensus 160 v~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 160 VRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 764 34567889999999999985 677999999999999999999988877654432110 000 00 1
Q ss_pred ccccccCCCCCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 736 SLNEILDPRLPTPPQ-----NVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 736 ~~~~~~d~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+...+.-+++.... ..+....+..+++.+|+..||++|||+++.++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111222222222211 112244578899999999999999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.91 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=212.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
-++|++++.||+|.||.||.|+.+ ++-.||+|++.+..........++.+|+++-+.++||||+++|+||.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357999999999999999999865 7889999999776554445567899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||...|.+...|+... ..+++......++.|+|.|+.|+|.+ +|+||||||+|+|++.++..|++|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999998543 34677888889999999999999999 99999999999999999999999999997543
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
...-...+||..|.|||+..+...+..+|+|++|++.||++.|.+||+... ..+..+++...++..+ .
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k~~~~~p-~-- 243 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRKVDLKFP-S-- 243 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHHccccCC-c--
Confidence 344467899999999999999999999999999999999999999998432 2222223332233222 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......++|.+|+..+|.+|.+..||++
T Consensus 244 -~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 244 -TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 22335788999999999999999999986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.48 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=211.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
...|+..+.||+|.||.||+|.+. +++.||+|++.-.. .....++++.|+.++..++++||.++|+.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 345777899999999999999865 79999999997653 334577899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+.+|++.+.++.... +++..+.-|+.++..|+.|||++ +.+|||||+.||++..+|.+|++|||.+..+..
T Consensus 90 Mey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999999999976543 35566777889999999999999 999999999999999999999999999998876
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.......++|||.|||||++....|+.|+|+||||++.+||.+|.+|+..... .+..-++....++ ...
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------mrvlflIpk~~PP--~L~ 232 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------MRVLFLIPKSAPP--RLD 232 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------ceEEEeccCCCCC--ccc
Confidence 66666788999999999999988999999999999999999999999864433 1122222222222 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
......+.+++..|+.+||+.||++.++++.
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2555678899999999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=346.76 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=210.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+-|++++.||.|+-|.|..|+.. +|+.+|||++.+...........+.+|+-+|+-+.||||+++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 46888999999999999999864 89999999998775555556778999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|-|.+++-..+. +...++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 99999999999987664 67789999999999999999999 999999999999999999999999999986443
Q ss_pred CCcccccccccccccccccccCCcCc-chhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTE-KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
+.--...+|+|.|.|||++++.+|+- ++||||.|||||.|+||+.||+.-.- ..-+.++-...+.-+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G~f~MP---- 232 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRGVFEMP---- 232 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCcccCC----
Confidence 33345679999999999999999874 79999999999999999999983111 111112222222221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.....++++|+.+|+..||++|-|++||.+.
T Consensus 233 s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1233468899999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=339.72 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=205.1
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||.||.|+-+ +|..+|+|++++..-....+.+....|-.+|...++|.||++|-.|++.+.+|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3568999999999999999999865 799999999998766666677889999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||++||++..+|...+ .+++..+..++.+.+-|++.+|+. |+|||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998765 477789999999999999999999 99999999999999999999999999985221
Q ss_pred C-----------------------CCC-----c-------------------ccccccccccccccccccCCcCcchhHH
Q 042086 672 P-----------------------DSS-----N-------------------CTELVGTFGYIAPELVYTMKVTEKCDVY 704 (784)
Q Consensus 672 ~-----------------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvw 704 (784)
. +.. . ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 0 0124799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCccccccccccccccccccccCCC--CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 042086 705 SFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR--LPTPPQNVQDELISIVEVAFLCLNESPESRPP 776 (784)
Q Consensus 705 slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 776 (784)
|+|||+|||+.|.+||.... ..+....++..+ +..+.+ .+...+..+||.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~t--------p~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSET--------PQETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999996322 222233343333 333322 1223567899999999 9999985
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.33 Aligned_cols=237 Identities=30% Similarity=0.518 Sum_probs=197.1
Q ss_pred ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCC
Q 042086 520 KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERG 599 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 599 (784)
.+-||+|+.|.||.|++. ++.||||+++... ..+++-|++++||||+++.|+|...-.+|||||||..|
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 456999999999999997 7899999876531 25788999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccc
Q 042086 600 SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679 (784)
Q Consensus 600 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 679 (784)
-|...|+.... +.......+..+||.|+.|||.+ .|||||||.-||||+.+..|||+|||.++....- ...-.
T Consensus 198 qL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS 270 (904)
T KOG4721|consen 198 QLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS 270 (904)
T ss_pred cHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence 99999987653 55577888999999999999999 9999999999999999999999999999876543 45567
Q ss_pred cccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHH
Q 042086 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISI 759 (784)
Q Consensus 680 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l 759 (784)
++||..|||||++...+.++|+||||||||||||+||..||..+.... ..++.....+. ++- +..+++ .+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVGsNsL~--Lpv-PstcP~---Gf 340 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVGSNSLH--LPV-PSTCPD---GF 340 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEeccCCccc--ccC-cccCch---HH
Confidence 899999999999999999999999999999999999999987544321 11111222221 222 233444 45
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 760 VEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 760 ~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.-|++.||+..|..||++.+++..|
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHH
Confidence 5688899999999999999998754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.21 Aligned_cols=244 Identities=21% Similarity=0.247 Sum_probs=198.9
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERG 599 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 599 (784)
+.||+|+||.||+|+.. +|+.||+|++.............+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 78999999987543223334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccc
Q 042086 600 SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679 (784)
Q Consensus 600 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 679 (784)
+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 9999987643 578899999999999999999999 9999999999999999999999999999764433333455
Q ss_pred cccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHH
Q 042086 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISI 759 (784)
Q Consensus 680 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l 759 (784)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+ . ....++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p-~---~~~~~~ 222 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFP-R---TLSPEA 222 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCC-C---CCCHHH
Confidence 6799999999999999999999999999999999999999863211 111111111122111 1 123357
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 760 VEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 760 ~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
.+++.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 8899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.39 Aligned_cols=243 Identities=21% Similarity=0.344 Sum_probs=195.1
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec----CCceEEEEecc
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH----PRNSFLVYEYL 596 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 596 (784)
..||+|++|.||+|.. +|+.||||.+...........+.|.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 589999999876533222224678899999999999999999999876 34678999999
Q ss_pred cCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc
Q 042086 597 ERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN 676 (784)
Q Consensus 597 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 676 (784)
++|+|.++++..+ .+++....+++.+++.|++|||+.. +++||||||+||++++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999997643 5788999999999999999999732 78899999999999999999999999998654321
Q ss_pred cccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCCCC
Q 042086 677 CTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD--PRLPTPPQNV 752 (784)
Q Consensus 677 ~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~ 752 (784)
....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||+...... ....+.. .+...+.
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~--- 245 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--------IYDLIINKNNSLKLPL--- 245 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcCCCCCCCC---
Confidence 23467899999999976 678999999999999999999999997432110 0111111 1111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++.+||+.||++|||++|+++.|
T Consensus 246 -~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 246 -DCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred -cCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 2234688999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.92 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=202.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999876 78999999986532222234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997653 478888999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~--- 220 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAGKLEFPRH--- 220 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCcCCCcc---
Confidence 23457899999999999888999999999999999999999998642211 1111222222222111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
....+.+++.+|++.||++||+ ++|+++
T Consensus 221 -~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 221 -LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1235778999999999999995 888775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=344.94 Aligned_cols=247 Identities=26% Similarity=0.308 Sum_probs=203.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999876 68999999987543323344567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997653 467788889999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+...+...+. ..
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~p~-~~- 238 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGRLKFPN-WF- 238 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCCcCCCC-CC-
Confidence 23457899999999999998999999999999999999999998632211 111122222222211 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
...+.+++.+||+.||++||+ ++++++
T Consensus 239 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 --DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 235778999999999999997 677764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.27 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=216.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc-eEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN-SFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 592 (784)
+.|..++.+|+|+||.++.++.+ +++.|++|.+......+ ..++....|+.++++++|||||.+.+.|.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 57889999999999999999866 67899999997764433 345578899999999999999999999998888 8999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|+|++||++.+.+.... ...|++..+.+++.|++.|+.|||++ +|+|||||+.|||++.++.|||+|||+|+.+.+
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998665 34688899999999999999999988 999999999999999999999999999999988
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
+.......+||+.||+||.+.+.+|..|+|+||+||++|||.+-+++|+..+ ...-..++........+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~~~~Plp--- 227 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRGLYSPLP--- 227 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhccCCCCC---
Confidence 7767788999999999999999999999999999999999999999997322 12222233333322222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
..+..++..++..|+..+|+.||++.+++..
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2445578889999999999999999999863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=342.46 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=196.4
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||+|+||.||+|+.. +++.||+|++.............+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 6889999998754322333456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccc
Q 042086 602 ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV 681 (784)
Q Consensus 602 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 681 (784)
.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 99997643 478899999999999999999999 999999999999999999999999999986544334445567
Q ss_pred cccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHH
Q 042086 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761 (784)
Q Consensus 682 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~ 761 (784)
||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+ . .....+.+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~-~---~~~~~~~~ 222 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEPLRFP-D---GFDRDAKD 222 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCCCC-C---cCCHHHHH
Confidence 99999999999999999999999999999999999999863221 111111222222211 1 12235778
Q ss_pred HHHhcccCCCCCCCC---HHHHHH
Q 042086 762 VAFLCLNESPESRPP---MHTVCQ 782 (784)
Q Consensus 762 li~~cl~~dP~~RPs---~~~vl~ 782 (784)
++.+||+.||++||+ +.++++
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHc
Confidence 999999999999985 566653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.34 Aligned_cols=262 Identities=21% Similarity=0.355 Sum_probs=198.7
Q ss_pred hcCCCCceeEecccceEEEEEEEcC-----------------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS-----------------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 576 (784)
.++|++.+.||+|+||.||+|.+++ +..||+|.+.... ......+|.+|++++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 3578999999999999999997532 3479999887532 22235679999999999999999
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHHHHhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDG----------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 640 (784)
+++++++.+.+..++||||+++|+|.+++.... ....+++..+.+++.|++.||+|||+. +
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999999999999999999999999986432 113478889999999999999999999 9
Q ss_pred eEEeCCCCCCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh--C
Q 042086 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK--G 716 (784)
Q Consensus 641 ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt--g 716 (784)
|+||||||+||+++.++.+||+|||+++.+...... .....++..|+|||.+.+..++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999999865433211 223345788999999988889999999999999999997 5
Q ss_pred CCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 717 DHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 717 ~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..||...........................+ . .....+.+++.+||+.||++|||+.+|.+.|
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRP-P---PCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCC-C---CCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 56765332111000000000000000000111 1 1223688999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=341.80 Aligned_cols=244 Identities=23% Similarity=0.246 Sum_probs=198.3
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERG 599 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 599 (784)
+.||+|+||.||+++.. +|+.||+|++.............+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 78999999987643323334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccc
Q 042086 600 SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679 (784)
Q Consensus 600 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 679 (784)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++............
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9999887543 578899999999999999999999 9999999999999999999999999998764333333445
Q ss_pred cccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHH
Q 042086 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISI 759 (784)
Q Consensus 680 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l 759 (784)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+. . ...++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~~p~-~---~~~~~ 222 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEIRFPR-T---LSPEA 222 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCCC-C---CCHHH
Confidence 67999999999999989999999999999999999999998632211 111111111221111 1 22357
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 760 VEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 760 ~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
.+++.+|++.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 7899999999999998 8888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.85 Aligned_cols=250 Identities=24% Similarity=0.452 Sum_probs=202.3
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||.||+|+.+++..+|+|.+... ....++|..|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG----AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC----CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 458889999999999999999988889999987643 2235689999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.++++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999999997543 2578999999999999999999999 99999999999999999999999999998654322
Q ss_pred Cc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 675 SN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 675 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.. .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ....+........+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~~- 225 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--------VVEMISRGFRLYRPKL- 225 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCCCCCCC-
Confidence 21 122345668999999988889999999999999999999 899986432111 1111111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+.+++.+||+.+|++||+++++++.|
T Consensus 226 --~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 --ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=324.71 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=210.2
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++....+....-.+.+|+++|+.++||||+.+|++|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35688889999999999999985 68999999999987666655556789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||..+|.|++|+.+.+ .+++.++.+++.||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++-++..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998765 478899999999999999999999 999999999999999999999999999988753
Q ss_pred CCCcccccccccccccccccccCCcC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
...-..++|+|-|.+||.+.+.+|. +.+|.||+||+||.++.|..||+..+. .....++-......+ +.
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~GaYrEP-~~ 275 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGAYREP-ET 275 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhcccccCC-CC
Confidence 3445778999999999999999986 579999999999999999999984322 111222222222221 11
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ....-||+.|+..+|++|.|+.||..
T Consensus 276 P----SdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 276 P----SDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred C----chHHHHHHHHHhcCcccchhHHHHhh
Confidence 1 12446889999999999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.70 Aligned_cols=244 Identities=22% Similarity=0.248 Sum_probs=199.0
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERG 599 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 599 (784)
+.||+|+||.||+++.. +++.||+|++.............+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 78999999987643333444567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccc
Q 042086 600 SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679 (784)
Q Consensus 600 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 679 (784)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9999886543 578899999999999999999999 9999999999999999999999999998864433333445
Q ss_pred cccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHH
Q 042086 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISI 759 (784)
Q Consensus 680 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l 759 (784)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......+. ....++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~~~~~~p~----~~~~~~ 222 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEDIKFPR----TLSADA 222 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhccCCccCCC----CCCHHH
Confidence 67999999999999889999999999999999999999998632211 111111111111111 122357
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 760 VEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 760 ~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
.+++.+|++.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 7899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.79 Aligned_cols=312 Identities=25% Similarity=0.389 Sum_probs=217.0
Q ss_pred eeeehhHHHHHHHHHHHHhhhchhhhccCCCCCcccccccCCCcceeeeccccccHHHHHHHhcCCCCceeEecccceEE
Q 042086 452 FIIVFPLLGALSLSVLAMGTFFILRRREGPSSENRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSV 531 (784)
Q Consensus 452 ~~~~~~~~~~~~l~~~~~~~~~~~rrr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V 531 (784)
++++++..++.+++++++.+|+.+|+++..+.......... ...+...... .......++.++||+|.||.|
T Consensus 155 ~~al~~~~~v~~l~~lvi~~~~~~r~~k~~~~~~e~~~~p~-------~d~~~~~ssp-l~~l~pl~l~eli~~Grfg~V 226 (534)
T KOG3653|consen 155 IYALIPLLLVSLLAALVILAFLGYRQRKNAREEIEPVLIPL-------EDSGPAPSSP-LLELDPLQLLELIGRGRFGCV 226 (534)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCcccC-------CCCCCCCCcc-cccCCchhhHHHhhcCcccee
Confidence 33444444455666666777777777776554221111000 0000000000 011345566788999999999
Q ss_pred EEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc--CCCceeeEEeEEecCC----ceEEEEecccCCCHHHHH
Q 042086 532 YKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL--RHRSIVKFYGFCSHPR----NSFLVYEYLERGSLATIL 605 (784)
Q Consensus 532 y~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l 605 (784)
|||.+. ++.||||++... ..+.|++|-++++.. +|+||++++++-.... .+++|+||.+.|+|.+||
T Consensus 227 ~KaqL~-~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL 299 (534)
T KOG3653|consen 227 WKAQLD-NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL 299 (534)
T ss_pred ehhhcc-CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH
Confidence 999997 599999998653 467899998888865 8999999999876555 789999999999999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc--c
Q 042086 606 SNDGAIEEFNWTVRMNVIRSVANALSYMHHDC------FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--C 677 (784)
Q Consensus 606 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~ 677 (784)
+.+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||..|+++.|+|||+|..+.+.... .
T Consensus 300 ~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~ 375 (534)
T KOG3653|consen 300 KAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDT 375 (534)
T ss_pred Hhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcch
Confidence 875 5899999999999999999999763 478999999999999999999999999999988754332 3
Q ss_pred cccccccccccccccccCC-cC-----cchhHHHHHHHHHHHHhCCCCCCc--cc----ccc---ccccccccccccccC
Q 042086 678 TELVGTFGYIAPELVYTMK-VT-----EKCDVYSFGVLALEVIKGDHPRDF--IS----SIS---SSSSNRNISLNEILD 742 (784)
Q Consensus 678 ~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwslGv~l~elltg~~p~~~--~~----~~~---~~~~~~~~~~~~~~d 742 (784)
...+||.+|||||++.+.. +. .+.||||+|.|+|||++...-++. .. .++ ...+..+....-++.
T Consensus 376 ~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~ 455 (534)
T KOG3653|consen 376 HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR 455 (534)
T ss_pred hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh
Confidence 3468999999999997653 22 368999999999999985433210 00 000 000101111111111
Q ss_pred ----CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 743 ----PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 743 ----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
|.++...... ..+..+.+.+..||..||+.|.|+.=|-++
T Consensus 456 kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 456 KKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred hccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 2222211112 345568889999999999999998766554
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.80 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=204.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999976 68999999987643323334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 477888999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD-PRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~ 752 (784)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .....+. +....+ .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~---~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK--YWKETLQRPVYDDP---R 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH--hccccccCCCCCcc---c
Confidence 2345678999999999999899999999999999999999999997432211000000 0000010 111000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.....++.+++.+|+..+|++||+++++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1223467889999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=311.29 Aligned_cols=261 Identities=24% Similarity=0.292 Sum_probs=204.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe--cCCceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS--HPRNSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 591 (784)
++|+..+.|++|.||.||+|+++ +++.||+|+++.......-+. ...+|+.++.+.+|||||.+-.+.. +-+..||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 45788899999999999999976 789999999987653333323 4679999999999999999999875 3467999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||||+. +|.+.++..+ .+|...+.+-++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999998 9999998765 4788899999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccccc--ccc--
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRNI--SLN-- 738 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~~--~~~-- 738 (784)
......+..+-|..|.|||.+.+.+ |+++.|+||+|||+.|++++++-|.....+..- .+.... ...
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 8777788889999999999998764 899999999999999999998877543322100 000000 000
Q ss_pred ccc-CCCCCCCC-CC----CHH--HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EIL-DPRLPTPP-QN----VQD--ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~-d~~~~~~~-~~----~~~--~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+ .-..+..+ .. ... ....-.+|+...+..||++|-|++|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000 00010000 00 000 1234567888999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=325.42 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=203.8
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCC-----------CCCCChhhHHHHHHHHhccCCCceeeEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWP-----------CEMVPQPEFVNEIKTLTELRHRSIVKFY 580 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~l~ 580 (784)
.-++|++.+.||+|.||.|-+|+.. +++.||||++.+..- ......+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999865 799999999865321 1112345789999999999999999999
Q ss_pred eEEecC--CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc
Q 042086 581 GFCSHP--RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE 658 (784)
Q Consensus 581 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 658 (784)
++..++ +..|||+|||..|.+... .....+++..++++|+.+++.||+|||.+ +||||||||+|+|++++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 999765 578999999999877542 12222389999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCC-----CCcccccccccccccccccccCC----cCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 042086 659 ARVSDFGIAKFLKPD-----SSNCTELVGTFGYIAPELVYTMK----VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS 729 (784)
Q Consensus 659 ~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~ 729 (784)
|||+|||.+...... .......+|||.|+|||...++. ...+.||||+||+||-++.|+.||-.-
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~------ 322 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD------ 322 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc------
Confidence 999999999876322 12234478999999999987633 235789999999999999999998621
Q ss_pred ccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+|++..+..+.. ++....+.+||.++|.+||++|.+..+|..
T Consensus 323 --~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 323 --FELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --hHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 2223344566666555432 245567889999999999999999998864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.38 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=202.6
Q ss_pred hcCCCCceeEecccceEEEEEEEcC--CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS--GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|..+. +..||+|.+...........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3569999999999999999998653 46899999865433333445678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997654 478889999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+ ..
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p-~~ 250 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGIIYFP-KF 250 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCCCC-CC
Confidence 32 23457899999999999888999999999999999999999999643221 11112222222211 11
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
. ...+.+++.+|++.||++|+ +++++++
T Consensus 251 ~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 251 L---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred C---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 2 23467899999999999995 8998875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.94 Aligned_cols=249 Identities=23% Similarity=0.255 Sum_probs=197.5
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||+|+||+||++... +++.||+|.+...........+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 7899999998654322222345678899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccccc
Q 042086 602 ATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680 (784)
Q Consensus 602 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 680 (784)
.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 98875422 234688999999999999999999999 99999999999999999999999999998765444444456
Q ss_pred ccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHH
Q 042086 681 VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIV 760 (784)
Q Consensus 681 ~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~ 760 (784)
.|++.|+|||++.+..++.++|||||||++|||++|+.||....... ........+....... .......+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILNDSVTY----PDKFSPASK 229 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcccCCCC----cccCCHHHH
Confidence 78999999999999999999999999999999999999986322110 0000111111111111 112334678
Q ss_pred HHHHhcccCCCCCCC-----CHHHHHH
Q 042086 761 EVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 761 ~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
+++.+|++.||++|| +++++++
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 899999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.29 Aligned_cols=260 Identities=20% Similarity=0.270 Sum_probs=199.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46899999999999999999876 78999999986532 1223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ +|.+++...+. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99985 99998865432 467888999999999999999999 9999999999999999999999999999865443
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------------ccc----cccc
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------------SSN----RNIS 736 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------------~~~----~~~~ 736 (784)
........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||......... ... ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 333445678999999999875 56889999999999999999999998632211000 000 0000
Q ss_pred cccccCCCCCCCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 LNEILDPRLPTPP--QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ~~~~~d~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.....+ ........+..+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001111100000 000111235779999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.58 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=217.8
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+-|++.+.||+|.|++|-.|+. -+|..||||++.+..-.+ .....+..|++.|+.++|||||++|++...+...|+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34588889999999999999974 489999999998875433 3456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEeccccccccC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~~~~ 671 (784)
+|.-++|+|.+|+.++.. .+.+....+++.||++|+.|+|+. ++|||||||+||.+-+. |.|||.|||++-.+.
T Consensus 96 LELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999976643 688899999999999999999999 99999999999988655 889999999998887
Q ss_pred CCCCcccccccccccccccccccCCcC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
+. ..-...+|+..|.|||.+.+..|+ +++||||+||+||.+++|+.||+.+ ...+.+..|+|.+...+
T Consensus 171 PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA--------NDSETLTmImDCKYtvP-- 239 (864)
T KOG4717|consen 171 PG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA--------NDSETLTMIMDCKYTVP-- 239 (864)
T ss_pred Cc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc--------cchhhhhhhhcccccCc--
Confidence 54 345678999999999999999987 5799999999999999999999843 44556677888887654
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....++.+||..|+..||++|.+.++|+.
T Consensus 240 --shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 240 --SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 355668999999999999999999999874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.32 Aligned_cols=255 Identities=23% Similarity=0.394 Sum_probs=200.4
Q ss_pred hcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.++|++.+.||+|+||.||+|.. .++..||||+++.... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45799999999999999999963 2467899999875422 22356789999999999 899999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCC--------------------------------------------------------
Q 042086 587 RNSFLVYEYLERGSLATILSNDGA-------------------------------------------------------- 610 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 610 (784)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 611 ----------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 611 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
...+++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12478889999999999999999998 99999999999999999999999999998664332
Q ss_pred Cc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC-CCCCC
Q 042086 675 SN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRL-PTPPQ 750 (784)
Q Consensus 675 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~ 750 (784)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+.+.... ...+.
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--------KFYKMIKEGYRMLSPE 340 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--------HHHHHHHhCccCCCCC
Confidence 21 122335668999999999999999999999999999998 888886432110 0001111110 01111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.. ..++.+++..||+.||++||+++||++.|
T Consensus 341 ~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 341 CA---PSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred CC---CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 11 23688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=330.65 Aligned_cols=249 Identities=32% Similarity=0.514 Sum_probs=192.4
Q ss_pred CceeEecccceEEEEEEEc-----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 519 VKYCIGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.+.||.|.||.||+|.+. .+..|+||.+... ......++|.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 4678999999999999876 3678999999552 12223678999999999999999999999999888899999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++... ...+++..+.+|+.||++||+|||++ +++||||+++||+++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999998762 24689999999999999999999999 9999999999999999999999999999876322
Q ss_pred CCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 SSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
... .........|+|||.+....++.++||||||+++||+++ |+.||...... .....+.+......+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 228 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--------EIIEKLKQGQRLPIPD 228 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--------HHHHHHHTTEETTSBT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccccceecc
Confidence 211 223456778999999999999999999999999999999 78887643211 1111111111111112
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.. ...+.+++..||+.||++|||++++++.|
T Consensus 229 ~~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 NC---PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TS---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ch---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22 23577899999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.50 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=199.5
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 6899999999764333333456788999999988 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99999886543 588899999999999999999999 999999999999999999999999999975433333445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-cccccccccCCCCCCCCCCCHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN-RNISLNEILDPRLPTPPQNVQDELI 757 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~ 757 (784)
...||+.|+|||++.+..++.++|+|||||++|||++|+.||+........... .......+.......+ .. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~---~~~ 230 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-RS---LSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC-CC---CCH
Confidence 567999999999999999999999999999999999999999743221100000 0011111222222222 11 223
Q ss_pred HHHHHHHhcccCCCCCCCC------HHHHHH
Q 042086 758 SIVEVAFLCLNESPESRPP------MHTVCQ 782 (784)
Q Consensus 758 ~l~~li~~cl~~dP~~RPs------~~~vl~ 782 (784)
++.+++.+|++.||++||+ ++++++
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 5778999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=300.98 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=207.1
Q ss_pred hcCCCCceeEecccceEEEEEE-EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----R 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 587 (784)
.++|++.+.+|+|||+-||.++ ..+++.||+|++.... .++.+...+|++..++++||||++++++...+ .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4689999999999999999998 5678999999987642 34577899999999999999999999987433 3
Q ss_pred ceEEEEecccCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAI-EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
..|++++|...|+|.+.+...... ..+++.+.++|+.+|++||++||+.. ++++||||||.||++++++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 489999999999999999764433 36899999999999999999999973 3699999999999999999999999999
Q ss_pred ccccCCCCCc---------ccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 042086 667 AKFLKPDSSN---------CTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRN 734 (784)
Q Consensus 667 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~ 734 (784)
++...-.-.. ......|..|.|||.+. +...++++|||||||++|+|+.|..||+.+.. ...+.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl--- 251 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL--- 251 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE---
Confidence 9865432111 12234688999999995 45578899999999999999999999986543 11111
Q ss_pred cccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 735 ISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 735 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.-.+..+.+..+.+. ..++.+.+++..|+++||.+||++.+++..
T Consensus 252 --aLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 --ALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred --EEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 112333333333222 256688999999999999999999999875
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.60 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=197.8
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 6889999998765333333456688899988877 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 99999886543 578899999999999999999999 999999999999999999999999999976443333345
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccc-ccccccCCCCCCCCCCCHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI-SLNEILDPRLPTPPQNVQDELI 757 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~ 757 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.............. ....+.......+ . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-~---~~~~ 230 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-R---SLSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC-C---CCCH
Confidence 567999999999999999999999999999999999999999643221110000000 0111122222211 1 1233
Q ss_pred HHHHHHHhcccCCCCCCCC------HHHHHH
Q 042086 758 SIVEVAFLCLNESPESRPP------MHTVCQ 782 (784)
Q Consensus 758 ~l~~li~~cl~~dP~~RPs------~~~vl~ 782 (784)
++.+++.+|++.||++||+ +.++++
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 5778999999999999998 467654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.23 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=208.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
.++|.+.++||+|.||+|+++..+ +++.+|||++++...-...+.+..+.|.+++... +||.++.++..|++.++.+.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999977 6889999999998777777788899999999877 59999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+.||++..+.+ ...|++..+.-++..|+.||.|||++ +||+||||.+|||+|.+|.+||+|||+++.-.
T Consensus 447 vmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999444333 24688899999999999999999999 99999999999999999999999999999755
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
......+.++|||.|||||++.+..|+.++|-|||||++|||+.|+.||..- ..++-...|+......|
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--------dEee~FdsI~~d~~~yP--- 588 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--------DEEEVFDSIVNDEVRYP--- 588 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHhcCCCCCC---
Confidence 4455678899999999999999999999999999999999999999999732 22333333333333222
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~ 777 (784)
.-.+.+...++++.+.++|++|.-+
T Consensus 589 -~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 -RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CcccHHHHHHHHHHhccCcccccCC
Confidence 2334467788899999999999866
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.43 Aligned_cols=252 Identities=19% Similarity=0.322 Sum_probs=199.9
Q ss_pred cCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||.||+|.++ .+..||+|.++... .....+.|.+|+.+++.++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 56899999999999999999753 46789999987642 2223467999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999997643 3688999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCC
Q 042086 671 KPDSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 671 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
...... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ....+.+......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 229 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGFRLPA 229 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCCC
Confidence 222111 112234678999999999999999999999999999875 999986432211 0111111111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+. .....+.+++..||+.+|++||+++++.+.|
T Consensus 230 ~~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 230 PR---NCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred CC---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 11 2233578899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.95 Aligned_cols=247 Identities=22% Similarity=0.302 Sum_probs=197.3
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHH---hccCCCceeeEEeEEecCCceEEE
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTL---TELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
|++.+.||+|+||.||+|... +++.||||++...........+.+..|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999865 6899999998754322233455677776655 566899999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|..+++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988864 2588999999999999999999999 999999999999999999999999999876443
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......+ ..
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~p-~~- 223 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDEVRYP-RF- 223 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCC-CC-
Confidence 333445567999999999999989999999999999999999999998632211 11111222222111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
....+.+++.+|++.||++|| ++.++++
T Consensus 224 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 224 --LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 123577899999999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.40 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=206.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||||.+.............+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999865 78999999886543333344567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||+++|+|.+++..... ...++...+..++.|++.|++|||++ +++||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864221 23578888999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... .......+.....+ +...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~--~~~~ 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCDYP--PLPT 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCCCC--CCCh
Confidence 433334456888999999998888899999999999999999999998522110 00000011010111 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+.+++.+||+.+|++||++.+|++.+
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 23345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.49 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=202.1
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|++.+.||+|+||+||++... +++.||+|++.............+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999865 789999999865432222234567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 999999999886533 23588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......|++.|+|||.+.+..++.++||||+||++||+++|+.||....... ........+...... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~---~~~~ 227 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKEDQEE---YSEK 227 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhhcccc---cCcc
Confidence 22234578999999999998889999999999999999999999997422100 000011111111111 1122
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
....+.+++.+|++.||++|| +++++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 344678899999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.62 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=205.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +++.||+|++.............+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999876 79999999987643333344667899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 3578899999999999999999998 9999999999999999999999999999876543
Q ss_pred C-----------------------------CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccc
Q 042086 674 S-----------------------------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFIS 724 (784)
Q Consensus 674 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~ 724 (784)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 12334578999999999999999999999999999999999999987432
Q ss_pred cccccccccccccccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHh
Q 042086 725 SISSSSSNRNISLNEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESRPP-MHTVCQL 783 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~~vl~~ 783 (784)
... ....+.. .....+... .....+.+++.+|+. ||++||+ ++++++.
T Consensus 235 ~~~--------~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE--------TYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH--------HHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 1111111 111111111 123457789999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.23 Aligned_cols=244 Identities=22% Similarity=0.251 Sum_probs=197.8
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERG 599 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 599 (784)
+.||+|+||.||+++.. +|+.||+|++.............+..|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 78999999987643333334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 600 SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 600 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9999886543 57889999999999999999997 6 999999999999999999999999999876443333344
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... +.....+.......+ .. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~~~~~p-~~---~~~~ 222 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFP-RT---LSPE 222 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcCCCCCC-CC---CCHH
Confidence 56799999999999998999999999999999999999999863221 111111111121111 11 1235
Q ss_pred HHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 759 IVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 759 l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
+.+++.+|++.||++|+ ++.++++
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 77899999999999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.61 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=199.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 467999999999999999999976 789999999875422 22344678999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||++ ++|.+++.... ..++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99996 58888886543 3577888999999999999999999 999999999999999999999999999976543
Q ss_pred CCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------cccccc-----cc
Q 042086 673 DSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---------SSNRNI-----SL 737 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---------~~~~~~-----~~ 737 (784)
.........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......... ...... ..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 3333445678999999999865 45788999999999999999999999753221000 000000 00
Q ss_pred ccccCCCCCC-CCCCCH------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 738 NEILDPRLPT-PPQNVQ------DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 738 ~~~~d~~~~~-~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+... .+.... .....+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 000000 01235778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.55 Aligned_cols=250 Identities=24% Similarity=0.444 Sum_probs=202.3
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||+||+|+..++..+|+|.+... ....++|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG----SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC----cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 358889999999999999999887778999987653 2235679999999999999999999999998889999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++..... .+++..++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999999976433 588999999999999999999999 99999999999999999999999999998654332
Q ss_pred Cc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 675 SN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 675 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.. .....++..|+|||...+..++.++|||||||++|||++ |+.||....... ....+........+..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~- 225 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRLYRPHL- 225 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCCCCCCC-
Confidence 21 122345678999999998889999999999999999998 999986432210 0111111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+.+++.+||+.||++||++.++++.|
T Consensus 226 --~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 226 --ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred --CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 234688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=336.39 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=197.2
Q ss_pred eeEecccceEEEEEEE----cCCCEEEEEEcCCCCC-CCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 521 YCIGIGGQGSVYKAKL----TSGEILAVKKFHSLWP-CEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
+.||+|+||.||+++. .+++.||+|.+..... ........+..|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3588999999865321 1122345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++|+|.+++...+ .+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999997654 467788888999999999999999 999999999999999999999999999976543333
Q ss_pred cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHH
Q 042086 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 755 (784)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~~~~~~~----~ 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLNLPPY----L 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----C
Confidence 34456799999999999988899999999999999999999999964221 11122222333222221 1
Q ss_pred HHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 756 LISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 756 ~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
...+.+++.+|++.||++|| +++++++
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 23577899999999999999 7888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.22 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=175.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999876 68899999887532 122346799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999997643 4788899999999999999999852 699999999999999999999999999986543
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2 22345789999999999998999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=334.98 Aligned_cols=244 Identities=22% Similarity=0.281 Sum_probs=197.0
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC-CceeeEEeEEecCCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH-RSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 593 (784)
+|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999876 578999999876433233345678899999999976 56888999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999987543 478889999999999999999999 9999999999999999999999999998754333
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~~~~~---- 222 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNVSYPK---- 222 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCC----
Confidence 33344567999999999999999999999999999999999999999632211 111112222221111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 042086 754 DELISIVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~ 777 (784)
....++.+++.+|++.||++|++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 123357789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=335.76 Aligned_cols=239 Identities=24% Similarity=0.324 Sum_probs=194.0
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.+ +++.||+|++...........+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 6899999998754322333456778899988876 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99999987643 478899999999999999999999 999999999999999999999999999886543333445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......+ .. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~-~~---~~~~ 222 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVVYP-TW---LSQD 222 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCCCCC-CC---CCHH
Confidence 567999999999999889999999999999999999999999743211 11111222222111 11 2235
Q ss_pred HHHHHHhcccCCCCCCCCH
Q 042086 759 IVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~ 777 (784)
+.+++.+|++.||++||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 7789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.67 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=200.1
Q ss_pred HhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH 585 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 585 (784)
..++|++.+.||+|+||.||+|+.. ++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 3457999999999999999998742 345899999875422 12346788999999999 89999999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcCCC-------------------------------------------------------
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGA------------------------------------------------------- 610 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 610 (784)
.+..++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999854210
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc--
Q 042086 611 ------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN-- 676 (784)
Q Consensus 611 ------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 676 (784)
...+++..+.+++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12478888999999999999999998 9999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC-CCCCCCHH
Q 042086 677 CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLP-TPPQNVQD 754 (784)
Q Consensus 677 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~ 754 (784)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .....+..... ..+..
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~~~~~~~~~~~--- 339 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRGYQMSRPDF--- 339 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHHcccCccCCCC---
Confidence 112335668999999998899999999999999999997 999986432110 01111111110 00111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...++.+++.+||+.||++|||+.+|++.|
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 123678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=332.82 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=211.6
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
++++-...+.....+||.|.||.||.|.++ ..-.||||.+++. .-..++|+.|+.+|+.++|||+|+++|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 455555667888899999999999999987 4668999998873 33578999999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
-..|||+|||.+|+|.+||++... .+++.-..+.++.||+.|++||..+ ++|||||.++|.|+.++..||++|||+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 999999999999999999987543 4566677889999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccc-cccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 042086 667 AKFLKPDSSNCTE-LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 667 a~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
+++|..+.+.... ..-.+.|.|||.+....++.|+|||+|||+|||+.| |..||..++..+...... .+.+
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------kgyR 484 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------KGYR 484 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------cccc
Confidence 9999876554322 223568999999999999999999999999999998 888986554322111000 1123
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+..+ +.+++ ++++|++.||+.+|.+||++.|+-+.
T Consensus 485 M~~P-eGCPp---kVYeLMraCW~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 485 MDGP-EGCPP---KVYELMRACWNWSPSDRPSFAEIHQA 519 (1157)
T ss_pred ccCC-CCCCH---HHHHHHHHHhcCCcccCccHHHHHHH
Confidence 4343 33444 57889999999999999999998654
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=333.43 Aligned_cols=243 Identities=25% Similarity=0.324 Sum_probs=193.5
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|.++..........+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 6889999998764332333445666777777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99999987643 478888999999999999999999 999999999999999999999999999986544344445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... +.. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~-~~~---~~~~ 222 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDRPHF-PRW---ISKE 222 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCC-CCC---CCHH
Confidence 567999999999999989999999999999999999999998643211 1111111111111 111 2235
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHH
Q 042086 759 IVEVAFLCLNESPESRPPMH-TVC 781 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~-~vl 781 (784)
+.+++.+||+.||++||++. ++.
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 67899999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.81 Aligned_cols=251 Identities=22% Similarity=0.411 Sum_probs=203.3
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 3578999999999999999999888889999987652 223578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999997543 23578889999999999999999998 9999999999999999999999999999876533
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
... .....++..|+|||++....++.++|||||||++|||++ |+.||....... ....+... +.+.. .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-~ 227 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGYRMPRM-E 227 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCCCC-C
Confidence 221 123345678999999998889999999999999999998 999985321110 00001000 11111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....++.+++.+|++.+|++||+++++.+.|
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 1233578899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=334.58 Aligned_cols=244 Identities=21% Similarity=0.292 Sum_probs=198.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+..|..++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999876 6789999998764332333445677888888877 5899999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999987543 478899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........||+.|+|||++.+..++.++|||||||++|||+||+.||+.... ......+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~p~---- 222 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK---- 222 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC----
Confidence 3344556799999999999999999999999999999999999999974321 1111122222222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 042086 754 DELISIVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~ 777 (784)
....++.+++.+|++.||++|++.
T Consensus 223 ~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHHhcCCC
Confidence 123457889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.63 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=199.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +++.||||++.............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999876 68999999987532222234456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997643 478899999999999999999999 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh
Q 042086 674 SS--------------------------------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK 715 (784)
Q Consensus 674 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt 715 (784)
.. .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0112468999999999998899999999999999999999
Q ss_pred CCCCCCccccccccccccccccccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 042086 716 GDHPRDFISSISSSSSNRNISLNEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESRPP---MHTVCQ 782 (784)
Q Consensus 716 g~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~vl~ 782 (784)
|..||....... ....+.. ..+..+... .....+.+++.+|+. +|.+|++ ++++++
T Consensus 235 G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE--------TYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH--------HHHHHHcCCCccCCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999996432211 0111111 111111110 112356788888886 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.30 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=202.3
Q ss_pred cCCCCceeEecccceEEEEEEEcC------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTS------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+|.+|+..++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 368889999999999999998642 2579999886532 22234678999999999999999999999998889
Q ss_pred eEEEEecccCCCHHHHHhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 589 SFLVYEYLERGSLATILSNDGAI-------------EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
.+++|||+++|+|.+++...... ..+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 99999999999999999754221 3578889999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042086 656 DYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSN 732 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~ 732 (784)
++.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999986543221 1233456788999999998889999999999999999998 99998632210
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+........+ .....++.+++.+||+.||++||+++||++.|
T Consensus 234 --~~~~~i~~~~~~~~~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 234 --EVIEMIRSRQLLPCP---EDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred --HHHHHHHcCCcCCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111111111111111 22345688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=335.57 Aligned_cols=244 Identities=22% Similarity=0.288 Sum_probs=197.5
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 5889999998764332333456678899998866 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99999887543 478889999999999999999999 999999999999999999999999999986544444445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+..... .....+.......+ .. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~~~~p-~~---~~~~ 222 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDDVLYP-VW---LSKE 222 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCC-CC---CCHH
Confidence 567999999999999889999999999999999999999999743211 11112222222111 11 1235
Q ss_pred HHHHHHhcccCCCCCCC-------CHHHHHH
Q 042086 759 IVEVAFLCLNESPESRP-------PMHTVCQ 782 (784)
Q Consensus 759 l~~li~~cl~~dP~~RP-------s~~~vl~ 782 (784)
+.+++.+|++.||++|| +++++++
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 77899999999999999 7787764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=306.13 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=207.3
Q ss_pred HhcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
.++.|++.+.||+|+|+.||++.. .+|+.+|+|++..... +....+++.+|+++-+.++|||||++.+.+.+....++
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 356788889999999999999864 5899999998865433 23367889999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~ 668 (784)
|+|+|.|++|..-+-.+ ..+++..+..++.||+.++.|+|.+ +|||||+||+|+++... .-+||+|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999996655432 3467778889999999999999999 99999999999999543 358999999999
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
.+. +.......+|||+|||||++...+|+..+|||+.||+||-++.|..||-.... ..-...++......+
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQIKAGAYDYP 232 (355)
T ss_pred EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHHHhccccCCC
Confidence 887 55667788999999999999999999999999999999999999999853211 111122222222222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+...+....+..+|+++|+..||.+|-|+.|.++
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2233444556788999999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=340.94 Aligned_cols=202 Identities=27% Similarity=0.343 Sum_probs=175.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +++.||+|++.............+..|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46899999999999999999865 68999999987543222334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997643 578899999999999999999999 9999999999999999999999999998765321
Q ss_pred CC-----------------------------------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCC
Q 042086 674 SS-----------------------------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDH 718 (784)
Q Consensus 674 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~ 718 (784)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123579999999999999999999999999999999999999
Q ss_pred CCCc
Q 042086 719 PRDF 722 (784)
Q Consensus 719 p~~~ 722 (784)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.03 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=193.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 34667789999999999999865 78999999986532 2223467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+.. ..++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.+...
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999986532 245567788999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
........||..|+|||++.. ...+.++|||||||++|||++|+.||........ ......+......
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~-- 294 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-----ASLMCAICMSQPP-- 294 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhccCCC--
Confidence 433455679999999998743 2234689999999999999999999862211000 0000000000111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
........++.+++.+||+.||++||++.|+++.
T Consensus 295 -~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 -EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111233468899999999999999999999863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.63 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=202.0
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+..|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999875 689999999865322223334568899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998653 367788888999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-cccccccccccccccccccC----CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC--
Q 042086 672 PDSS-NCTELVGTFGYIAPELVYTM----KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR-- 744 (784)
Q Consensus 672 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~-- 744 (784)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.+..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~ 265 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKNS 265 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCc
Confidence 3322 23456799999999998653 3788999999999999999999998642211 1112222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPES--RPPMHTVCQ 782 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~vl~ 782 (784)
+..+. ......++.+++.+|++.+|++ ||+++|+++
T Consensus 266 ~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11111 1122346788999999999998 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.02 Aligned_cols=261 Identities=25% Similarity=0.310 Sum_probs=200.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 46899999999999999999976 688999999875432 2234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999997776554332 3578889999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cc---------cccc
Q 042086 674 SS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SN---------RNIS 736 (784)
Q Consensus 674 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~---------~~~~ 736 (784)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .. ....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 22 2234578999999999998889999999999999999999999996432111000 00 0000
Q ss_pred cccccCCCCCCCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 LNEILDPRLPTPPQ----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ~~~~~d~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+....... ........+.+++.+|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 00112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=324.81 Aligned_cols=253 Identities=25% Similarity=0.470 Sum_probs=207.2
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
...+|++.+.||.|+||.||+|...+++.+++|.+.... .....++..|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 455789999999999999999998889999999987642 22356789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 999999999999976432 4578999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
.........++..|+|||.+....++.++||||||+++|+|++ |+.||...... .....+... +.+.+ .
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~-~ 227 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMPCP-A 227 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCCCC-C
Confidence 3333334456778999999988889999999999999999998 89998643211 011111111 11111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++.+|++.||++|||++++++.|
T Consensus 228 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 228 ---KCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred ---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 2234578999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.93 Aligned_cols=251 Identities=24% Similarity=0.444 Sum_probs=203.4
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...++|.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45789999999999999999998888899999987532 23567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999997643 24688999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
... ......+..|+|||++.+..++.++||||||+++||+++ |+.||....... ....+... ..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-- 226 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQGYRMPCP-- 226 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCC--
Confidence 211 111223457999999998899999999999999999999 999986322110 00011000 11111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+.+++.+|++.+|++||+++++++.|
T Consensus 227 --~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 227 --PGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred --CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 12234688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=342.70 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=196.1
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|++++.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999865 689999999876433233345678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999997643 477888889999999999999999 99999999999999999999999999976432100
Q ss_pred C-----------------------------------------------cccccccccccccccccccCCcCcchhHHHHH
Q 042086 675 S-----------------------------------------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFG 707 (784)
Q Consensus 675 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 707 (784)
. .....+||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 01234799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCCCCHHHHHHHHHHHHh--cccCCCCCCCCHHHHHH
Q 042086 708 VLALEVIKGDHPRDFISSISSSSSNRNISLNEILD--PRLPTPPQNVQDELISIVEVAFL--CLNESPESRPPMHTVCQ 782 (784)
Q Consensus 708 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~~vl~ 782 (784)
|++|||++|+.||...... .....+++ .....+.. .....++.+++.+ |+..+|..||+++++++
T Consensus 236 ~il~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPT--------ETQLKVINWENTLHIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCHH--------HHHHHHHccccccCCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999999642211 00111111 11111110 0112346677766 55667777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.98 Aligned_cols=256 Identities=21% Similarity=0.387 Sum_probs=201.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+|.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4567999999999999999999753 35689999886532 112345789999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 587 RNSFLVYEYLERGSLATILSNDGA-------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
...++||||+++|+|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 999999999999999999965321 12467888999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNIS 736 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 736 (784)
+|+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||..... +..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQV 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 99999998765432221 112345778999999998889999999999999999999 7888863221 111
Q ss_pred cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+........+... ...+.+++.+|++.||++|||+.|+++.|
T Consensus 231 ~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 231 LRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred HHHHHcCCcCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 1111111211112222 23578899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.43 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=206.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||||.+...........+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999864 89999999876543333334568899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||+++++|.++++... ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986422 234688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........++..|+|||.+.+..++.++|+||||+++|||++|..||...... .......+.....+. ...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~~~ 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPP--LPS 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCCCCC--CCc
Confidence 433334557889999999999888999999999999999999999998532110 000011111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+.+++.+||+.||++||||.+|++.+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 12344688999999999999999999887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.66 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=197.7
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 5889999998764322333456778899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99999887643 588899999999999999999999 999999999999999999999999999976433333344
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+ . .....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~~~~~~-~---~~~~~ 222 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDEVRYP-R---WLSKE 222 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCCC-C---cCCHH
Confidence 567899999999999999999999999999999999999999643211 11111111111111 1 12235
Q ss_pred HHHHHHhcccCCCCCCCCH-----HHHHH
Q 042086 759 IVEVAFLCLNESPESRPPM-----HTVCQ 782 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~-----~~vl~ 782 (784)
+.+++.+||+.||++||++ .++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 7889999999999999999 88764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.47 Aligned_cols=254 Identities=25% Similarity=0.466 Sum_probs=203.6
Q ss_pred cCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.|.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 46888999999999999999764 35789999986532 12235689999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 589 SFLVYEYLERGSLATILSNDGA-----------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
.++||||+++|+|.++++..+. ...+++..+..++.|++.|++|||++ +++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 9999999999999999975432 24578899999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 042086 658 EARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRN 734 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 734 (784)
.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------- 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------- 231 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence 999999999976533221 1223345788999999999999999999999999999998 99998632211
Q ss_pred cccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 735 ISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 735 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+........+. .....+.+++.+||+.||++||++.||++.|
T Consensus 232 ~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 232 EVIECITQGRLLQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 1111111122222122 2234688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=308.57 Aligned_cols=264 Identities=21% Similarity=0.287 Sum_probs=204.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCc-eeeEEeEEecCC-----
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS-IVKFYGFCSHPR----- 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 587 (784)
..|+..+.||+|.||+||+|+.+ +|+.||+|+++-.... +.......+|+.++++++|+| ||.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34666778999999999999865 7999999999865433 224456789999999999999 999999998766
Q ss_pred -ceEEEEecccCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 588 -NSFLVYEYLERGSLATILSNDGAI-EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 588 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
..++|+||++. +|.+++...... ..++...++.++.|+++|++|||++ +|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78899999987 999999865532 3455578999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cc--ccc
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SS--NRN 734 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~--~~~ 734 (784)
+|+.+.-+....+..++|..|.|||++.+. .|++..|+||+||+++||+++++-|........- .+ ..+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999876555556777899999999999876 6899999999999999999998887643332100 00 001
Q ss_pred cccccccCCC--CCCC---CCCCH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 735 ISLNEILDPR--LPTP---PQNVQ---DELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 735 ~~~~~~~d~~--~~~~---~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
......-+.+ .+.. ..... .......+++.+|++.+|.+|.|++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111111 1111 00001 111257789999999999999999998763
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.81 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=200.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3568999999999999999999876 688999999865332233345568899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999653 367788899999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-cccccccccccccccccccCC----cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC--
Q 042086 672 PDSS-NCTELVGTFGYIAPELVYTMK----VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR-- 744 (784)
Q Consensus 672 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~-- 744 (784)
.... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ......+.+..
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~ 265 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKNS 265 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcc
Confidence 3322 234567999999999987543 77899999999999999999999963221 11112222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHh
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPES--RPPMHTVCQL 783 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~vl~~ 783 (784)
+..+. .......+.+++..|+..+|++ ||++.|+++.
T Consensus 266 ~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111 1122345677888889865544 8899998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.43 Aligned_cols=253 Identities=26% Similarity=0.325 Sum_probs=201.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999875 78999999987643323334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997652 3588899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccccccccccc------cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC-CC
Q 042086 674 SSN-CTELVGTFGYIAPELVY------TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP-RL 745 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~ 745 (784)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+... +.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~ 227 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQRF 227 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCCc
Confidence 322 23357899999999986 4567789999999999999999999996322110 01111111 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+. .......+.+++..|++ +|++||+++++++
T Consensus 228 ~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000 11123357788899997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.63 Aligned_cols=249 Identities=27% Similarity=0.465 Sum_probs=200.8
Q ss_pred CCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
+|++.+.||+|+||.||+|+.+++..+|+|.+... ....++|.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG----AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC----CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 57888999999999999999887889999988643 22356789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999975433 578999999999999999999999 999999999999999999999999999986543221
Q ss_pred c-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 676 N-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 676 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
. .....++..|+|||.+.+..++.++||||||+++||+++ |+.||+......... ...... +...+ .
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----~~~~~~--~~~~~-~--- 224 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-----SVSAGY--RLYRP-K--- 224 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-----HHHcCC--cCCCC-C---
Confidence 1 112233457999999998899999999999999999999 899986432211000 000101 11111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....++.+++.+||+.+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1234688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=347.62 Aligned_cols=250 Identities=20% Similarity=0.238 Sum_probs=200.4
Q ss_pred CCCCceeEecccceEEEEEEEc-C-CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-S-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.|.+.+.||+|+||.||+|... + ++.||+|.+... .......+.+|+.+++.++|||||++++++..++..++||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4899999999999999999754 4 678888876432 2223456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 594 EYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||+++|+|.++++.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999988643 2233578889999999999999999999 999999999999999999999999999987653
Q ss_pred CCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 673 DSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 673 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
... ......||++|+|||++.+..++.++|||||||++|||++|+.||..... ......+........+.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~~~ 293 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPFPC 293 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCc
Confidence 322 23445799999999999999999999999999999999999999863221 11111111111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ....+.+++.+||+.||++||++.+++.
T Consensus 294 ~---~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 P---VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred c---CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 2235788999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.31 Aligned_cols=261 Identities=20% Similarity=0.305 Sum_probs=195.7
Q ss_pred cCCCCceeEecccceEEEEEEEc--CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc---CCCceeeEEeEEe-----
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT--SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL---RHRSIVKFYGFCS----- 584 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----- 584 (784)
.+|++.+.||+|+||.||+|+.. +++.||+|.++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 36899999999999999999863 4788999988754322 22234567788777765 6999999999985
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
.....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 2456899999997 599999875432 3578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------c-cccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------S-SNRNIS 736 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~-~~~~~~ 736 (784)
|+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......... . ......
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 999876433 2334567899999999998888999999999999999999999998743221100 0 000000
Q ss_pred c------ccccCCCCCCCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 L------NEILDPRLPTPP-QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ~------~~~~d~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ...+......+. ...++....+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000111110000 000112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.12 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=219.6
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 590 (784)
....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.........+.+.+|+.+|+++. |||||.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457899999999999999999977 59999999998765544445678999999999997 999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC----CceEEecccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD----YEARVSDFGI 666 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~ 666 (784)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+. ||+|||+||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 288899999999999999999998 99999999999999644 4799999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
+..... .......+||++|+|||++....++..+||||+||++|.|++|..||..... .....++....+.
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~--------~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE--------FEIFLAILRGDFD 256 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh--------hHHHHHHHcCCCC
Confidence 998876 5667888999999999999999999999999999999999999999974321 1222244445544
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.....+.+++..++..||.+|+|+.++++
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 444555666778889999999999999999999986
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.30 Aligned_cols=252 Identities=24% Similarity=0.420 Sum_probs=201.8
Q ss_pred cCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||+||+|... +...||+|.+.... ......+|.+|+.+++.++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 56899999999999999999874 24579999886532 2234567999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++.+
T Consensus 82 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999997643 2688999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 042086 671 KPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 671 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
...... .....+++.|+|||.+.+..++.++||||||+++||+++ |..||...... .....+.+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRLP 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence 522221 122334678999999998899999999999999999998 99998532211 0011111111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+. .....+.+++.+|++.+|++||++.+|++.|
T Consensus 229 ~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 229 PPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111 2234678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=319.72 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=202.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE---PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC---ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 347999999999999999999864 7899999998643 222345688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||+++++|.++++..+ .+++..+..++.|++.|++|||+. +|+|||++|+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999987543 478889999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.........+++.|+|||.+. ...++.++|||||||++|||++|+.||.......... .........+...
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~--- 232 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLK--- 232 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---eeecCCCCCCCCc---
Confidence 333334457889999999884 3447789999999999999999999985322111000 0000000011111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
........+.+++.+||+.+|++||+++++++.|
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 -DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112334688999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=343.51 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=196.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46899999999999999999865 78999999986532222334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999997543 477888899999999999999999 9999999999999999999999999999643211
Q ss_pred CC-----------------------------------------------cccccccccccccccccccCCcCcchhHHHH
Q 042086 674 SS-----------------------------------------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSF 706 (784)
Q Consensus 674 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl 706 (784)
.. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHH
Q 042086 707 GVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESR---PPMHTVC 781 (784)
Q Consensus 707 Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~~vl 781 (784)
||++|||++|+.||....... ....+.. ..+..+ . ......++.+++.+|+. +|.+| +++.|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p-~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE--------TYRKIINWRETLYFP-D-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCC-C-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999999996322110 0111111 111111 1 01123357788999997 67665 5999987
Q ss_pred H
Q 042086 782 Q 782 (784)
Q Consensus 782 ~ 782 (784)
+
T Consensus 304 ~ 304 (377)
T cd05629 304 S 304 (377)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.86 Aligned_cols=252 Identities=26% Similarity=0.452 Sum_probs=205.1
Q ss_pred HhcCCCCceeEecccceEEEEEEEcC---CC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTS---GE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
..+.....++||.|.||.||+|.+.+ |. .||||.-+.. .+....+.|..|+.+|+.++|||||+++|+|.+ .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 34456677899999999999998542 33 5777876553 344557899999999999999999999999976 5
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..+||||.++.|.|..|++.+.. .++......++.||+.||+|||+. ++|||||.++|||+....-||++|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 78999999999999999987654 577788889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc-cccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CC
Q 042086 668 KFLKPDSSNC-TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PR 744 (784)
Q Consensus 668 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~ 744 (784)
+.+..+.+.. +...-+..|||||.+.-++++.+||||.|||.+||++. |..||....... .+..+.+ .|
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGeR 610 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGER 610 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCCC
Confidence 9987655442 33344668999999999999999999999999999986 999997543211 1112222 35
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
++.++.+ +. .++.++.+||..+|.+||++.++...|
T Consensus 611 lP~P~nC-Pp---~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 611 LPCPPNC-PP---ALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred CCCCCCC-Ch---HHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 5555443 33 467899999999999999999987653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.58 Aligned_cols=250 Identities=24% Similarity=0.417 Sum_probs=201.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.+|++.+.||+|++|.||+|... +++.||+|.+... ....+++.+|+++++.++||||+++++++...+..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 45888899999999999999865 5889999987642 223567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++..... ..+++..++.++.|+++|++|||+. +++||||||+||++++++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999975432 3578899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcc-cccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 674 SSNC-TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 674 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
.... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ....+... +... +.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~ 228 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKGYRMER-PE 228 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCCCC-CC
Confidence 2211 12234568999999998999999999999999999998 999986322110 00001000 1111 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....++.+++.+|++.||++||++.++++.|
T Consensus 229 ---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 229 ---GCPPKVYELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred ---CCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 1234688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.33 Aligned_cols=240 Identities=23% Similarity=0.283 Sum_probs=191.4
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHH-HHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIK-TLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||+||+|+.. +|+.||+|++...........+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999876 78999999986542222223345556655 46788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 99999987643 477888999999999999999999 999999999999999999999999999976443333445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......++. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~----~~~~ 222 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKPLRLKPN----ISVS 222 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----CCHH
Confidence 56799999999999999999999999999999999999999863221 11111122222221111 2345
Q ss_pred HHHHHHhcccCCCCCCCCHH
Q 042086 759 IVEVAFLCLNESPESRPPMH 778 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~ 778 (784)
+.+++.+|++.||++||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 78899999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=343.45 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=196.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999865 689999999865432223345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++...+ .++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999997653 467788889999999999999999 99999999999999999999999999975331000
Q ss_pred -------------------------------------------CcccccccccccccccccccCCcCcchhHHHHHHHHH
Q 042086 675 -------------------------------------------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLAL 711 (784)
Q Consensus 675 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ 711 (784)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0012347999999999999999999999999999999
Q ss_pred HHHhCCCCCCccccccccccccccccccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC---CHHHHHH
Q 042086 712 EVIKGDHPRDFISSISSSSSNRNISLNEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESRP---PMHTVCQ 782 (784)
Q Consensus 712 elltg~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~~vl~ 782 (784)
||++|+.||........ ...+.. .....+. .......+.+++.+|+ .+|++|+ ++.++++
T Consensus 236 ell~G~~Pf~~~~~~~~--------~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAET--------QLKVINWETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHH--------HHHHhccCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999974332110 001111 1111110 0112234566777765 5999999 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.76 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=193.1
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|.++..........+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 5789999998764322223345677788888764 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 99999997543 478889999999999999999999 999999999999999999999999999875433333344
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... +.. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~-~~~---~~~~ 222 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDNPCY-PRW---LTRE 222 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC-Ccc---CCHH
Confidence 567899999999999989999999999999999999999998632211 0001111111111 111 2235
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHH
Q 042086 759 IVEVAFLCLNESPESRPPMH-TVC 781 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~-~vl 781 (784)
+.+++.+|++.||++||++. ++.
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHH
Confidence 77899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.26 Aligned_cols=243 Identities=23% Similarity=0.286 Sum_probs=193.4
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +|+.||+|.++..........+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 6899999998754322223345677788888754 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 99999987643 478888999999999999999999 999999999999999999999999999875433333445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... +.. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~~~~-~~~---~~~~ 222 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHY-PRW---ITKE 222 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC-CCC---CCHH
Confidence 567999999999999999999999999999999999999998632211 0011111111111 111 2235
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHH
Q 042086 759 IVEVAFLCLNESPESRPPMH-TVC 781 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~-~vl 781 (784)
+.+++.+|++.||++||++. ++.
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 77899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.50 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=208.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|... +|+.||+|.++..........+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999877 89999999887543333444678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||+++|+|.+++..... ...+++..+..++.+++.|++|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865322 23578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .......+........+ .
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~--~ 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEKCDYPPLP--A 230 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhhhcCCCCCCC--h
Confidence 433344557889999999999888999999999999999999999998532110 00000011111111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+.+++.+||+.+|++|||+.+|++.|
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 13344688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.80 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=195.1
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----Cce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----RNS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 589 (784)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+++++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4888999999999999999865 789999999875322 122345788999999999999999999988543 247
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999996 59999887543 478899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC---ccccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------c-------
Q 042086 670 LKPDSS---NCTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------S------- 730 (784)
Q Consensus 670 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~------- 730 (784)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 532221 1234578999999999865 67889999999999999999999998643211000 0
Q ss_pred -cccccccccc---cCCCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 731 -SNRNISLNEI---LDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 731 -~~~~~~~~~~---~d~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+. +....+.+ ....+.....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000 00000000 0000112235778999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.27 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=206.4
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+++.+|+++++.++||||+++++++.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4778899999999999999875 689999998864322 23346789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.++++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++..+....
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999997642 24678899999999999999999998 99999999999999999999999999998776544
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......+++.|+|||+..+..++.++|+|||||++|||++|+.||...... .....+.....+..+. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~ 224 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIRGVFPPVSQ---M 224 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCcc---c
Confidence 4444557889999999999988999999999999999999999998643211 1111111111111111 2
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 33468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.12 Aligned_cols=247 Identities=22% Similarity=0.265 Sum_probs=194.1
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||+|+||.||+++.+ +|+.||+|.+...........+.+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 6999999998653322222344567799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccc
Q 042086 602 ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV 681 (784)
Q Consensus 602 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 681 (784)
.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 998865432 3478899999999999999999998 9999999999999999999999999999876532 2233457
Q ss_pred cccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHH
Q 042086 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761 (784)
Q Consensus 682 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~ 761 (784)
|++.|+|||++.+..++.++||||+||++|||++|+.||....... ................... ....++.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLEDEVKFEHQ---NFTEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhccccccccc---cCCHHHHH
Confidence 8999999999998889999999999999999999999986322100 0001111111112111111 12335789
Q ss_pred HHHhcccCCCCCCCCHHHHH
Q 042086 762 VAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 762 li~~cl~~dP~~RPs~~~vl 781 (784)
++.+||+.||++||++.|++
T Consensus 229 li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHhccCHhhCCCCccch
Confidence 99999999999999996654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.11 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=201.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEec
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSH 585 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 585 (784)
..++|.+.+.||+|+||.||+|... .+..||||++.... .....+.|.+|+++++++. ||||+++++++.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3568999999999999999999753 23479999987532 2233567999999999996 9999999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcCCC-------------------------------------------------------
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGA------------------------------------------------------- 610 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 610 (784)
....++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999864210
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCee
Q 042086 611 --------------------------------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVL 652 (784)
Q Consensus 611 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil 652 (784)
...+++..+.+++.|+++|++|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 12477888899999999999999998 9999999999999
Q ss_pred ecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccc
Q 042086 653 LCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSS 729 (784)
Q Consensus 653 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~ 729 (784)
++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-- 347 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-- 347 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence 99999999999999986543222 1223456788999999999899999999999999999997 999986422110
Q ss_pred ccccccccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 730 SSNRNISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 730 ~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+... +...+ ......+.+++.+||+.||++||++.+|.++|
T Consensus 348 -----~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 348 -----TFYNKIKSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred -----HHHHHHhcCCCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 000001111 11111 12234688999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.71 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=174.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 468999999999999999999876 68899999876532 122346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++..+ .+++.....++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999997643 4778888999999999999999742 799999999999999999999999999976532
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 22345689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=316.67 Aligned_cols=250 Identities=22% Similarity=0.437 Sum_probs=201.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.+.|++.+.||+|+||.||+|..++++.||+|.+... ....++|.+|+.++++++||||+++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG----SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC----CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 4678999999999999999999888999999998753 234578999999999999999999999874 46789999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999875432 4688899999999999999999998 9999999999999999999999999999876532
Q ss_pred CC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 674 SS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 674 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
.. ......++..|+|||++....++.++||||||+++||+++ |+.||....... ....+.+. +... +.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~ 226 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------VIQNLERGYRMPR-PD 226 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHHcCCCCCC-CC
Confidence 22 1223345678999999988889999999999999999999 999986322110 00000000 1111 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....++.+++.+|++.+|++||+++++.+.|
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 1223688999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=346.85 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=202.8
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC---
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR--- 587 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 587 (784)
...++|++.+.||+|+||+||+|+.. +|+.||||.+..... .......+.+|+..+..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34578999999999999999999864 799999999865422 2233457889999999999999999988775432
Q ss_pred -----ceEEEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 588 -----NSFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 588 -----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999997532 234688899999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCC--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 662 SDFGIAKFLKPDS--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 662 ~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 9999998764321 223446799999999999999999999999999999999999999863221 011111
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+........+.. ...++.+++.+||+.||++||++.++++
T Consensus 257 ~~~~~~~~~~~~---~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 TLAGRYDPLPPS---ISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HhcCCCCCCCCC---CCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 111111111111 2335788999999999999999999975
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.75 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=197.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 593 (784)
.|+..+.||+|+||.||+|+.. +|+.||+|++...........+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3778899999999999999865 68999999987543323334567888999998885 578889999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987543 488899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~p~---- 222 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPK---- 222 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc----
Confidence 3334456789999999999988899999999999999999999999874321 1111122222222111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 042086 754 DELISIVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~ 777 (784)
....++.+++.+|++.||++|++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHhhCCCC
Confidence 122357789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.83 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=206.7
Q ss_pred hcCCCCceeEecccceEEEEEEEcCC-CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEe-EEec-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSG-EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYG-FCSH----- 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~----- 585 (784)
..++++.+.|.+|||+.||.|....+ ..||+|++-.. ++...+...+|+.+|+.++ |||||.+++ ....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34678889999999999999998765 99999998654 5556788999999999995 999999999 3321
Q ss_pred -CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 586 -PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 586 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
.-.+++.||||++|.|-+++..+... .|++.++++|+.++++|+++||.. .|+|||||||.+|||++.++..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 13568999999999999999765433 489999999999999999999985 668999999999999999999999999
Q ss_pred ccccccCCCCCccc---------cccccccccccccc---ccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccc
Q 042086 665 GIAKFLKPDSSNCT---------ELVGTFGYIAPELV---YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN 732 (784)
Q Consensus 665 G~a~~~~~~~~~~~---------~~~gt~~y~aPE~~---~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~ 732 (784)
|.|.-......... ...-|+.|.|||++ .+...++|+|||+|||+||-|.....||+...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------- 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------- 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence 99874322111111 12458999999997 46778999999999999999999999998432
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...|++.....++. +.+...+.+||..||++||++||++-+|++.+
T Consensus 263 ----~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 263 ----KLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ----ceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 23566666655543 46677899999999999999999999998753
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.43 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=194.3
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999865 688999999875422223345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999997643 467788899999999999999999 99999999999999999999999999975321100
Q ss_pred -----------------------------------------------CcccccccccccccccccccCCcCcchhHHHHH
Q 042086 675 -----------------------------------------------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFG 707 (784)
Q Consensus 675 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 707 (784)
.......||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 042086 708 VLALEVIKGDHPRDFISSISSSSSNRNISLNEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESRPP---MHTVCQ 782 (784)
Q Consensus 708 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~vl~ 782 (784)
|++|||++|+.||....... ....+.. .....+.. .....++.+++.+++ .+|++|++ ++++++
T Consensus 236 vil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE--------TQMKVINWQTSLHIPPQ--AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH--------HHHHHHccCCCcCCCCc--ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999996432111 0111111 11111110 111234556666665 59999997 877764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.25 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=197.9
Q ss_pred CCCCceeEecccceEEEEEEE----cCCCEEEEEEcCCCCCC-CCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKL----TSGEILAVKKFHSLWPC-EMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
+|++.+.||+|+||.||+++. .+++.||+|++.+.... .....+.+..|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999975 36899999998653211 222345688999999999 599999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 478899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC-CcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 670 LKPDS-SNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 670 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
+.... .......||+.|+|||.+.+.. ++.++|||||||++|||+||+.||........ .......+.......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~ 230 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKCDPPF 230 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcCCCCC
Confidence 54332 2233467999999999998654 78899999999999999999999963221100 000011111111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
+ . .....+.+++.+|++.||++|| +++++++
T Consensus 231 ~-~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 231 P-S---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C-C---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 1 1233577899999999999999 7778764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=352.99 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=199.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +|+.||+|++...........++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999876 68999999987643333333567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 594 EYLERGSLATILSNDG--------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
||+++|+|.+++.... .....++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 112456778889999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC------------------CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 042086 666 IAKFLKPDS------------------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS 727 (784)
Q Consensus 666 ~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~ 727 (784)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998662111 01123468999999999999999999999999999999999999986422100
Q ss_pred ccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 042086 728 SSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP-MHTVCQ 782 (784)
Q Consensus 728 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~~vl~ 782 (784)
. .....+.++....+ ..+....+.+++.+|++.||++||+ ++++.+
T Consensus 239 i------~~~~~i~~P~~~~p---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 I------SYRDVILSPIEVAP---YREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred h------hhhhhccChhhccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 00001111111111 1122345778999999999999975 444443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.81 Aligned_cols=254 Identities=24% Similarity=0.440 Sum_probs=201.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.++|.+.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357889999999999999999742 3566899988653 2223567999999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 588 NSFLVYEYLERGSLATILSNDGA----------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
..++||||+++++|.+++...+. ...+++..+..++.|++.||+|||++ +++||||||+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999999975431 23589999999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 042086 658 EARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRN 734 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 734 (784)
.+||+|||+++.+...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------- 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------- 229 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 9999999999865432211 223345778999999998889999999999999999998 89998633211
Q ss_pred cccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 735 ISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 735 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+........+.. ...++.+++.+||+.||.+|||+++|.+.|
T Consensus 230 ~~~~~i~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 230 EVIECITQGRVLQRPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred HHHHHHHcCCcCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 01111111111111111 223588999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=321.17 Aligned_cols=253 Identities=21% Similarity=0.379 Sum_probs=199.4
Q ss_pred cCCCCceeEecccceEEEEEEE-----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+|++.+.||+|+||.||+|.. .+++.|++|.+.... ......+|.+|+.++++++||||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4688889999999999999974 256889999987532 122346789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 590 FLVYEYLERGSLATILSNDGA--------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
++||||+++|+|.+++..... ...+++.....++.|++.|++|||++ +|+||||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999853221 12478888999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042086 656 DYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSN 732 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~ 732 (784)
++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999986543221 1233345678999999988889999999999999999998 98898532110
Q ss_pred cccccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 733 RNISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 733 ~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+.+.. .....+... ...+.+++.+|++.||++||++.+|.+.|
T Consensus 234 ---~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 234 ---EVIEMVRKRQLLPCSEDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred ---HHHHHHHcCCcCCCCCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 00111111 111111112 23577899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=333.77 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=196.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|... +++.||+|... .+.+.+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 357999999999999999999875 78999999643 23578999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+|++. ++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99985 68998886543 478899999999999999999999 999999999999999999999999999975432
Q ss_pred C-CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------------------c
Q 042086 673 D-SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--------------------S 731 (784)
Q Consensus 673 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--------------------~ 731 (784)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 2 222345679999999999999899999999999999999999998864221110000 0
Q ss_pred -cccccccccc----C--CCCCC-CC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 732 -NRNISLNEIL----D--PRLPT-PP--QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 732 -~~~~~~~~~~----d--~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.. . ...+. .+ ........++.+++.+|++.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0 00000 00 011123446889999999999999999999985
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=326.66 Aligned_cols=249 Identities=24% Similarity=0.432 Sum_probs=197.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+|++.+.||+|+||.||+|++. +++ .||+|.+.... .....++|..|+.+++.++||||++++|++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46999999999999999999854 343 48999986432 223356799999999999999999999999764 57
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|+||+++|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 79999999999999997643 3578889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcc--cccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--CC
Q 042086 670 LKPDSSNC--TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD--PR 744 (784)
Q Consensus 670 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d--~~ 744 (784)
+....... ....++..|+|||.+.+..++.++|||||||++||+++ |+.||+...... ...++. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGER 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHhCCCC
Confidence 65433221 22234678999999999999999999999999999998 999986432110 011111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.++. ....+.+++.+||..||++||++.++++.|
T Consensus 230 ~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l 265 (316)
T cd05108 230 LPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEF 265 (316)
T ss_pred CCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 222211 123578899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.88 Aligned_cols=250 Identities=25% Similarity=0.449 Sum_probs=201.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.|.+|+.++++++|+|++++++++. ....++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT----MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC----CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 35689999999999999999998888899999987532 23567999999999999999999999885 45678999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++++.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++..+...
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 80 EYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999975432 3578999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
... .....++..|+|||...+.+++.++|+||||+++||+++ |..||....... ....+... ..+.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~--- 224 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------VLEQVERGYRMPC--- 224 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCC---
Confidence 221 122345668999999988889999999999999999999 889986322110 01111111 1111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+....+.+++.+|+..+|++|||+.++.+.|
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 225 -PQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred -CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 112334688999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=322.13 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=201.5
Q ss_pred cCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 45888899999999999999742 3567889987643 22234679999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 589 SFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
.++||||+++++|.+++...+. ...+++..++.++.|++.|++|||++ +|+||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 9999999999999999975431 23588999999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042086 656 DYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSN 732 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~ 732 (784)
++.++|+|||++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 233 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----- 233 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999999976543221 1233456788999999999899999999999999999999 999986432110
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+. .....+.+++.+||+.||++||++++|++.|
T Consensus 234 ---~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 234 ---VIECITQGRVLERPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred ---HHHHHhCCCCCCCCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 011111111111111 1234688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.38 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=190.4
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHH-HHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIK-TLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 68999999986543222223445666654 57888999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .++...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99999886543 467788889999999999999998 999999999999999999999999999876433333345
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+. .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~ 222 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHKPLQLPG----GKTVA 222 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcCCCCCCC----CCCHH
Confidence 56789999999999988899999999999999999999999863221 1111122222222221 22335
Q ss_pred HHHHHHhcccCCCCCCCCHH
Q 042086 759 IVEVAFLCLNESPESRPPMH 778 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~ 778 (784)
+.+++.+|++.||++||+..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 78899999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=315.81 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=204.0
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|+||.||++... +++.||+|.+.... .....+.+..|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788999999999999999866 68999999886432 22345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++..... ..++......++.|++.|+.|||++ +|+|+||||+||++++++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999999998864322 3578888999999999999999999 99999999999999999999999999998765444
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......+++.|+|||++.+..++.++|+||||+++|+|++|+.||+..... .....+........+. .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~ 223 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVCQGSYKPLPS---H 223 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHhcCCCCCCCc---c
Confidence 4344567889999999999888999999999999999999999998632210 0001111111111111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+.+++.+||+.||++||++.++++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 23357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.41 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=195.0
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 6789999999764333333456688999999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++...+ .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99999886543 588899999999999999999999 999999999999999999999999999976433333445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+......... ........+.......+ .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~p-~~---~~~~ 229 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIRIP-RF---LSVK 229 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCCCC-CC---CCHH
Confidence 5679999999999999999999999999999999999999996432211000 00011111122222211 11 2235
Q ss_pred HHHHHHhcccCCCCCCCCH
Q 042086 759 IVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~ 777 (784)
+.+++.+|++.||++||++
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 7789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=335.57 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=203.6
Q ss_pred CCCCceeEecccceEEEEEEE-cCC----CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKL-TSG----EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
..+..++||+|+||+||||.+ ..| -+||+|++.... .....+++.+|+..|.+++|||+++++|+|.... ..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 345678999999999999964 344 368888876642 3345678999999999999999999999998755 88
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
||++||+.|+|.+|++.+.. .+.....+.+..|||+||.|||.+ ++|||||.++||||..-..+|+.|||+|+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 99999999999999987543 566788899999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCccccc--ccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 042086 671 KPDSSNCTEL--VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 671 ~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
..+....... .-.+.|||-|.+....++.++|||||||++||++| |..|++.+..-+ ..-.--...|+..
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geRLsq 921 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGERLSQ 921 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhccccCCC
Confidence 7766554433 33568999999999999999999999999999998 999988544311 1100111235666
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
++....+ +..++.+||..|++.||+++++.+.
T Consensus 922 PpiCtiD----Vy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 922 PPICTID----VYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred CCCccHH----HHHHHHHHhccCcccCccHHHHHHH
Confidence 6655544 6778889999999999999998764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.36 Aligned_cols=241 Identities=22% Similarity=0.258 Sum_probs=190.2
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHH-HHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIK-TLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||+||+|+.. +++.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 67889999986532222222344555544 56788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+.......++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 99999997643 466788888999999999999999 999999999999999999999999999986543334445
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........+ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~----~~~~~ 222 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPLQLKP----NITNS 222 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCcCCCC----CCCHH
Confidence 667999999999999999999999999999999999999998632211 111111111221111 22335
Q ss_pred HHHHHHhcccCCCCCCCCHHH
Q 042086 759 IVEVAFLCLNESPESRPPMHT 779 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~~ 779 (784)
+.+++.+|++.||++||++.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCC
Confidence 778999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=310.99 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=192.7
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--C---ce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--R---NS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~---~~ 589 (784)
.|...+++|.|.||.||+|... +++.||||+...... .-.+|+.+|+.++|||||++.-+|... . ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 5677899999999999999866 579999999866432 223799999999999999999988542 2 34
Q ss_pred EEEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEeccccc
Q 042086 590 FLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIA 667 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a 667 (784)
.+|||||+. +|.+.++... ....++...++-++.||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 589999998 9999997421 123466667788999999999999998 99999999999999987 89999999999
Q ss_pred cccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------------ccccc
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------------SSNRN 734 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------------~~~~~ 734 (784)
+.+...... .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|...+....- +....
T Consensus 174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 998766555 455679999999999875 5899999999999999999999988643321100 00000
Q ss_pred ccc--ccccCCCCCCCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 ISL--NEILDPRLPTPPQ---NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 ~~~--~~~~d~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... .+...+.+...+- .......+..+++.+++..+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 000 0111122211110 11122346789999999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.20 Aligned_cols=240 Identities=23% Similarity=0.286 Sum_probs=191.4
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHH-HHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIK-TLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|+.. +|+.||+|++............++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 78999999986543222233455666655 46778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99999887543 578899999999999999999999 999999999999999999999999999876433333345
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........+. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~~~~~~~~----~~~~ 222 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHKPLVLRPG----ASLT 222 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcCCccCCCC----CCHH
Confidence 567999999999999999999999999999999999999998632211 1111122222222211 2335
Q ss_pred HHHHHHhcccCCCCCCCCHH
Q 042086 759 IVEVAFLCLNESPESRPPMH 778 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~ 778 (784)
+.+++.+|++.||++||++.
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHhccCHHhcCCCC
Confidence 77899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=319.33 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=199.9
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC----
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP---- 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---- 586 (784)
+++.|++.+.||+|+||.||+|... +++.||+|.+... .....++..|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 5677889999999999999999865 6889999998653 23456789999999998 799999999998653
Q ss_pred --CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 587 --RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 587 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 45789999999999999987543 23578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
|++..............|++.|+|||++. ...++.++|||||||++|||++|+.||+.......... ...
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-----~~~ 230 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPR 230 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-----Hhc
Confidence 99987654434445567899999999986 34578899999999999999999999864322110000 000
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....... . ......+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~--~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRLK--S---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCC--C---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0001111 0 112336789999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.86 Aligned_cols=251 Identities=22% Similarity=0.385 Sum_probs=200.5
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|...+...||+|++... ....++|.+|+.+++.++||||+++++++.+ ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC----ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 3569999999999999999999877778999998753 2235679999999999999999999998754 5679999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++.+...
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999997532 23578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
... .....++..|+|||+..+..++.++||||||+++||++| |+.||...... .....+...... ..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~---~~ 224 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRM---PC 224 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCCC---CC
Confidence 322 123346678999999988889999999999999999999 88888632210 000111111000 01
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+....+.+++.+|++.||++||++.++++.|
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 123345688999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.59 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=194.3
Q ss_pred eeEecccceEEEEEEE----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecc
Q 042086 521 YCIGIGGQGSVYKAKL----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
+.||+|+||.||+++. .+|+.||+|++..... .......+..|++++++++||||+++++++.+++..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999975 3689999999875322 1223456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc
Q 042086 597 ERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN 676 (784)
Q Consensus 597 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 676 (784)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999999986543 478899999999999999999999 9999999999999999999999999999876544334
Q ss_pred ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHH
Q 042086 677 CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756 (784)
Q Consensus 677 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 756 (784)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......+. . ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~~~~p~-~---~~ 222 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAKLGMPQ-F---LS 222 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCCCCCCC-C---CC
Confidence 45567899999999999888899999999999999999999998743211 111112222222111 1 22
Q ss_pred HHHHHHHHhcccCCCCCCCCHHH
Q 042086 757 ISIVEVAFLCLNESPESRPPMHT 779 (784)
Q Consensus 757 ~~l~~li~~cl~~dP~~RPs~~~ 779 (784)
..+.+++.+||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 35778999999999999999543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.84 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=198.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec-
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH- 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 585 (784)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 457999999999999999999632 357899999875321 22345678899999999 89999999998865
Q ss_pred CCceEEEEecccCCCHHHHHhcCCC-------------------------------------------------------
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGA------------------------------------------------------- 610 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 610 (784)
+...++++||+++|+|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4567899999999999999864221
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc--ccccccccc
Q 042086 611 ---IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFG 685 (784)
Q Consensus 611 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~ 685 (784)
...+++..+.+++.||+.|++|||++ +|+||||||+||++++++.+||+|||+++.+...... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12578999999999999999999999 9999999999999999999999999999876432221 223455678
Q ss_pred cccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCCCCCHHHHHHHHHHH
Q 042086 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPR-LPTPPQNVQDELISIVEVA 763 (784)
Q Consensus 686 y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~~l~~li 763 (784)
|+|||++.+..++.++|||||||++|||++ |+.||....... .....+... ....+. ....++.+++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~l~ 309 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--------EFCRRLKEGTRMRAPE---YATPEIYSIM 309 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--------HHHHHHhccCCCCCCc---cCCHHHHHHH
Confidence 999999999999999999999999999998 999986322110 000111100 001111 1234688999
Q ss_pred HhcccCCCCCCCCHHHHHHhC
Q 042086 764 FLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 764 ~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+||+.+|++||++.|+++.|
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l 330 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEIL 330 (337)
T ss_pred HHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.65 Aligned_cols=256 Identities=21% Similarity=0.378 Sum_probs=200.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......++.+|+..++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4578999999999999999999653 25589999876432 122345688999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 587 RNSFLVYEYLERGSLATILSNDGA-------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
+..++||||+++|+|.++++..+. ....++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 23456778889999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNIS 736 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 736 (784)
+|+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... +..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999999865432221 122345678999999998889999999999999999998 7888853221 111
Q ss_pred cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+.+......+.. ....+.+++.+|++.||++|||+.++++.|
T Consensus 231 ~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 231 LKFVMDGGYLDQPDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred HHHHHcCCCCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111222211111111 124688999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.40 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=203.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..+|++.+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 357899999999999999999864 78999999886532 22356788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.++++.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999998642 467889999999999999999999 999999999999999999999999999887654
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........+++.|+|||.+.+..++.++|||||||++|||++|+.||........ ........... ....
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~--~~~~ 239 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTPE--LQNP 239 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-------HHHHhcCCCCC--CCCc
Confidence 43333445788999999999988889999999999999999999999864322100 00000111100 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.+++.+||..||++||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 223346788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=335.23 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=200.6
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
++....++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445678999999999999999999876 68899999986532222233456889999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||+++|+|.++++.. .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999998653 367788889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-cccccccccccccccccccC----CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042086 668 KFLKPDSS-NCTELVGTFGYIAPELVYTM----KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742 (784)
Q Consensus 668 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d 742 (784)
........ ......||+.|+|||++... .++.++|||||||++|||++|+.||...... .....+..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~ 261 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMN 261 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHc
Confidence 87653322 23456799999999998654 3788999999999999999999999732211 11111211
Q ss_pred CC--CCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHh
Q 042086 743 PR--LPTPPQNVQDELISIVEVAFLCLNESPES--RPPMHTVCQL 783 (784)
Q Consensus 743 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~vl~~ 783 (784)
.. +..+ ........+.+++..|+..+|.+ ||++.++++.
T Consensus 262 ~~~~~~~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNSLTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCcccCC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11 1111 11123345778889999844433 7799988763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.47 Aligned_cols=249 Identities=23% Similarity=0.418 Sum_probs=199.8
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|+++++.++|||++++++++. .+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 5688999999999999999998877789999876532 23567899999999999999999999885 456889999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999997543 23578999999999999999999998 99999999999999999999999999998764332
Q ss_pred Cc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCCC
Q 042086 675 SN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQN 751 (784)
Q Consensus 675 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~ 751 (784)
.. .....++..|+|||...+..++.++||||||+++|||+| |+.||....... ....+... ....
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~---- 224 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERGYRMPC---- 224 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC----
Confidence 21 123345678999999998889999999999999999999 899986322110 00111111 1111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.......+.+++.+||+.||++||++++|++.|
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 112344688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.45 Aligned_cols=246 Identities=23% Similarity=0.396 Sum_probs=194.5
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERG 599 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 599 (784)
+.||+|+||.||+|... +++.||+|.+.... .......|.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999875 78999999876432 2223467999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc--
Q 042086 600 SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC-- 677 (784)
Q Consensus 600 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-- 677 (784)
+|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999997543 3578899999999999999999999 99999999999999999999999999987654321111
Q ss_pred cccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCCHHHH
Q 042086 678 TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756 (784)
Q Consensus 678 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 756 (784)
.....+..|+|||.+.+..++.++|||||||++||+++ |..||+...... ....+....... ......
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---------~~~~~~~~~~~~--~~~~~~ 222 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------TREAIEQGVRLP--CPELCP 222 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------HHHHHHcCCCCC--CcccCC
Confidence 11123457999999998889999999999999999998 888886332110 001111110000 111223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 757 ISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 757 ~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+.+++.+|++.+|++|||+++|.+.|
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 4688899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.39 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=205.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|... +++.|++|.+.... ..+++.+|++++++++||||+++++++.+....+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 367899999999999999999976 48999999986531 167899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999986543 3678999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........++..|+|||++.+..++.++||||||+++|||++|+.||.......... . +...........
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------~-~~~~~~~~~~~~ 222 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------M-IPNKPPPTLSDP 222 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------h-hccCCCCCCCch
Confidence 4333344568889999999998889999999999999999999999987432211000 0 000000000111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.+++.+|++.||++|||+.||++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 122346889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=310.13 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-----C
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-----P 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 586 (784)
....|...+.||+|+||.|+.|..+ +|+.||||++..... .....++..+|+++++.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~-~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE-NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh-chHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3456666889999999999999876 799999999875433 23346678899999999999999999999854 3
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
...|+|+|+|+. +|.+.++... .++......++.|+++|+.|+|+. +|+|||+||+|++++.+...||+|||+
T Consensus 99 ~DvYiV~elMet-DL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 568999999965 9999998754 377799999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC--CCcccccccccccccccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc
Q 042086 667 AKFLKPD--SSNCTELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNIS 736 (784)
Q Consensus 667 a~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~ 736 (784)
|+..... ....+..+.|..|.|||.+. ...|+.+.||||.||++.||++|++-|.+.+.+..- ....+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987642 33346778899999999985 567999999999999999999999988654332100 1111111
Q ss_pred cccc--------cCCCCCCCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 LNEI--------LDPRLPTPPQ----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ~~~~--------~d~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+..+ +..-...+.. ..+.......+|+.+|+..||++|+|++|.++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111 1101111100 11122235778999999999999999999886
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=320.43 Aligned_cols=253 Identities=20% Similarity=0.330 Sum_probs=199.4
Q ss_pred CCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.|++.+.||+|+||.||+|... +++.||+|++.... .....+.|..|+.+++.++||||+++++++.+....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4677889999999999999864 35789999987532 112245688999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC
Q 042086 590 FLVYEYLERGSLATILSNDG-------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 656 (784)
++++||+++++|.+++.... ....+++..+.+++.|++.|++|+|++ +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999985321 123478888999999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 042086 657 YEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNR 733 (784)
Q Consensus 657 ~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~ 733 (784)
+.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 99999999998865432211 123345778999999988889999999999999999998 8888763221
Q ss_pred ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 734 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+.+......+... ...+.+++..||+.+|++||++++|++.|
T Consensus 233 ~~~~~~i~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 233 QDVIEMIRNRQVLPCPDDC---PAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHHHHHHHcCCcCCCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 1111122222222212222 33578899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=320.14 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=199.5
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|+..+.||+|+||+||+|... +++.||+|.+...........+.+.+|+++++.++|+||+++.+++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677789999999999999865 7899999998654332233345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++++|.+++...+. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-E 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-C
Confidence 999999998865432 3589999999999999999999998 9999999999999999999999999999765432 2
Q ss_pred cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHH
Q 042086 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 755 (784)
......|+..|+|||.+.+..++.++|+|||||++||+++|+.||........ .+.....+........ ...
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~~~----~~~ 228 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEVYS----AKF 228 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccccccC----ccC
Confidence 22345789999999999988899999999999999999999999863221100 0000011111111111 122
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 756 LISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 756 ~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
...+.+++..|++.||++||+ +.++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 335778999999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.81 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=197.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|+.++..++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 68999999987543333344567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999997643 478889999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCC
Q 042086 674 SS-----------------------------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDH 718 (784)
Q Consensus 674 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~ 718 (784)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 0123479999999999999999999999999999999999999
Q ss_pred CCCccccccccccccccccccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 042086 719 PRDFISSISSSSSNRNISLNEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESRPP---MHTVCQ 782 (784)
Q Consensus 719 p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~vl~ 782 (784)
||....... ....+.. .....++.. ....++.+++.+++ .||++|++ ++++++
T Consensus 235 Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQE--------TYRKVMNWKETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHH--------HHHHHHcCCCceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 996432111 1111111 111111110 11234667777766 49999985 667654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.21 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=198.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|.+.+.||+|+||.||+|+.+ +++.||+|.+..... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 56899999999999999999876 688999999875432 223456789999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ +|.+++...+ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99986 8988886543 2478888999999999999999999 9999999999999999999999999999865443
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc------cccc
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNI------SLNE 739 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~------~~~~ 739 (784)
........+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.......... ..... ...+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 333344567899999999865 457889999999999999999999986432110000 00000 0000
Q ss_pred ccCCCCCCCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPP-----QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+...+... ........++.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 000112335779999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.73 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=200.8
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|+..+.||+|+||.||++... +++.||+|.+...........+.+..|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999865 789999999875433222234567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++...+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998865332 3578899999999999999999998 99999999999999999999999999997654322
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .......+.+......+. .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~---~ 227 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEVQEEYSE---K 227 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhhhhhhcCc---c
Confidence 2234578999999999999899999999999999999999999997422110 000011111110001111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
....+.+++..||+.||++||| ++|+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2335778999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.31 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=199.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.++|++.+.||+|++|.||+|... .+..||+|.+.... .......|..|+.+++.++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 467999999999999999999875 35788999876432 1223457999999999999999999999999888
Q ss_pred ceEEEEecccCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC---ceE
Q 042086 588 NSFLVYEYLERGSLATILSNDGA----IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY---EAR 660 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~k 660 (784)
..++||||+++++|.++++.... ...+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 99999999999999999975432 23589999999999999999999999 999999999999998764 599
Q ss_pred EeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccc
Q 042086 661 VSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISL 737 (784)
Q Consensus 661 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 737 (784)
|+|||+++.+...... ......+..|+|||++.+..++.++|||||||++|||++ |+.||+..... . .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~-~ 230 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------E-V 230 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------H-H
Confidence 9999999876332211 112233568999999998999999999999999999997 99998632211 0 0
Q ss_pred ccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.+. .+...+ . .....+.+++.+|++.+|++||++.+|++.|
T Consensus 231 ~~~~~~~~~~~~~-~---~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 231 MEFVTGGGRLDPP-K---GCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred HHHHHcCCcCCCC-C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 11111 111111 1 1234678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.33 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=202.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 357889999999999999999864 24689999976432 1223457889999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceE
Q 042086 588 NSFLVYEYLERGSLATILSNDGA-------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR 660 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 660 (784)
..++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 99999999999999999965322 22478889999999999999999998 999999999999999999999
Q ss_pred EeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccc
Q 042086 661 VSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISL 737 (784)
Q Consensus 661 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 737 (784)
|+|||+++.+..... ......++..|+|||.+.+..++.++|||||||++||+++ |..||...... ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVL 231 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHH
Confidence 999999986543321 1223456788999999988889999999999999999998 99998632211 111
Q ss_pred ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+.+......+... ...+.+++.+||+.+|++|||+.++++.|
T Consensus 232 ~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 232 KFVIDGGHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred HHHhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 111111111111222 34688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.27 Aligned_cols=251 Identities=24% Similarity=0.491 Sum_probs=203.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|..++++.||||.+... ....+++.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG----TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC----ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4679999999999999999999888889999998753 234678999999999999999999999999889999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++..... ..+++..+..++.+++.|++|||++ +++|+||||+||++++++.+|++|||.+..+...
T Consensus 81 e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999976432 3588999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||...... .....+... +...+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~- 227 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPRPP- 227 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCC-
Confidence 211 122234568999999998889999999999999999999 99998532210 011111110 111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....++.+++.+|++.+|++||+++++.+.|
T Consensus 228 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 228 ---NCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred ---CCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 1134688999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=302.16 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=198.0
Q ss_pred HHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc--CCCceeeEEeEEecC--
Q 042086 511 VRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL--RHRSIVKFYGFCSHP-- 586 (784)
Q Consensus 511 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-- 586 (784)
.....+..+.+.||+|.||+||+|+++ |+.||||++... +++.+.+|.++++.+ +|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 345667889999999999999999998 889999998653 355688888888765 999999999886433
Q ss_pred --CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEEeCCCCCCeeecCCCce
Q 042086 587 --RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD-----CFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 587 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
.+.++|++|.+.|||.|||... .++....++++..+|.||++||.. .+|.|.|||||+.|||+..++..
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 2578999999999999999863 578889999999999999999964 46899999999999999999999
Q ss_pred EEeccccccccCCCCCc----ccccccccccccccccccCC----cC--cchhHHHHHHHHHHHHhC----------CCC
Q 042086 660 RVSDFGIAKFLKPDSSN----CTELVGTFGYIAPELVYTMK----VT--EKCDVYSFGVLALEVIKG----------DHP 719 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~--~~sDvwslGv~l~elltg----------~~p 719 (784)
.|+|+|+|......... ....+||.+|||||++...- +. ..+||||||.|+||+... +.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999999877654322 34578999999999985432 22 369999999999999962 456
Q ss_pred CCcccccccc-ccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 720 RDFISSISSS-SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 720 ~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
|...-...++ +..++..-.+-+.|.++... ...+.+..+.++++.||..+|..|-|+--+-+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 5432221111 11111111111222222222 23466788999999999999999998766544
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.38 Aligned_cols=249 Identities=27% Similarity=0.469 Sum_probs=200.8
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.+|++.+.||+|+||.||+|...+++.+|+|.+... .....+|.+|++++++++|||++++++++......++|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG----AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC----CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 468888999999999999998877889999988653 2235679999999999999999999999999899999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999999987543 2578899999999999999999998 99999999999999999999999999988654322
Q ss_pred Cc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCCC
Q 042086 675 SN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQN 751 (784)
Q Consensus 675 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~ 751 (784)
.. .....++.+|+|||.+.+..++.++||||||+++||+++ |+.||+...... ....+... +... +..
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~~ 225 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--------VVETINAGFRLYK-PRL 225 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHhCCCCCCC-CCC
Confidence 11 122335678999999998889999999999999999998 999986322110 00000000 1100 111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+.+++.+||+.+|++|||+.++++.|
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=326.34 Aligned_cols=329 Identities=28% Similarity=0.252 Sum_probs=223.4
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
..+.|||++|++....+..|.++++|++++|.+|.++ .+|...+...+|+.|+|.+|.|+..-.+.+..++.|++||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3456777777777666666677777777777777766 555555555556666666666665555555555656666666
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCC------
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTN------ 231 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n------ 231 (784)
.|.|+......|..-.++++|+|++|.|+..-...|.++.+|..|.|++|+|+...+..|.++++|+.|+|..|
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 66555444444444455555555555555444455555555555555555555444455555555555555555
Q ss_pred ------------------ccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCC
Q 042086 232 ------------------HLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSL 293 (784)
Q Consensus 232 ------------------~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l 293 (784)
.|.......|-.+.++++|+|..|++.... ..++.++++|+.|+|++|.|..+.++.+...
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn-~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN-EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh-cccccccchhhhhccchhhhheeecchhhhc
Confidence 444444455666666677777777765222 2356777888888888888887777788888
Q ss_pred CccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccc---ccccccccccE
Q 042086 294 TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP---CEICNMESLEK 370 (784)
Q Consensus 294 ~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~ 370 (784)
++|+.|+|++|+|+...+..|..+.+|+.|+|++|.+...-...|..+++|+.|||++|.++..+. ..|.++++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 888888888888887777788888888888888888887777778888888888888888877554 34567888888
Q ss_pred EecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 371 LNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 371 L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
|.|.+|++.......|..+.+|++|||.+|.+...-|+
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~n 434 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPN 434 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeeccc
Confidence 88888888877778888888888888888888765554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.90 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=210.2
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCC-----ChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMV-----PQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
..-+.|.-.+.+|+|..++|.++..+ +|+.+|+|++......... -.++-..|+.+++++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34557888899999999999998754 7899999988654332211 124456799999998 7999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
.+...++|+|.|+.|.|.|++.+.- .+++....+|+.|+..|++|||.. .|||||+||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999997643 477889999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccc------CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYT------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
|+|+.+.+ ...-...+|||+|.|||.+.. ..|+..+|.|+.||++|.++.|.+||=.-. ....+.
T Consensus 168 GFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR 238 (411)
T KOG0599|consen 168 GFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLR 238 (411)
T ss_pred ceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHH
Confidence 99998865 345578899999999999853 347788999999999999999999973211 111222
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.++..........+.+.+....+||.+|++.||.+|-|++|+++
T Consensus 239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 34444554444556677778889999999999999999999885
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.30 Aligned_cols=262 Identities=21% Similarity=0.255 Sum_probs=199.8
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4788899999999999999875 689999999865322 22234678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|++ ++|.+++........+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 58999887654445688999999999999999999999 99999999999999999999999999998664433
Q ss_pred CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc---ccccccC-
Q 042086 675 SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNI---SLNEILD- 742 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~---~~~~~~d- 742 (784)
.......+++.|+|||.+.+. .++.++|||||||++|||+||+.||.......... ..... ......+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 333444678899999988654 46889999999999999999999986322110000 00000 0000000
Q ss_pred -CCCCCCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 -PRLPTPP-----QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 -~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+... ........++.+++.+|++.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 000112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.58 Aligned_cols=246 Identities=24% Similarity=0.409 Sum_probs=201.5
Q ss_pred CCCceeEecccceEEEEEEEc--CCC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT--SGE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+..+.||+|.||+|++|.++ +|+ .||||.++..... ....+|.+|+.+|.+++|||++++||+.-+ ....||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445678999999999999876 343 6899999875432 256899999999999999999999999987 678899
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+|.++.|+|.+.|+. .....|-......++.|||.|+.||.++ +.||||+.++|+++-....|||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 3445678888899999999999999999 999999999999999999999999999998876
Q ss_pred CCCccc---ccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--CCCC
Q 042086 673 DSSNCT---ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD--PRLP 746 (784)
Q Consensus 673 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~ 746 (784)
....+. ...-.+.|+|||.+....|+.+||||+|||++|||+| |+.||-...... +-+.+| ++++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---------IL~~iD~~erLp 335 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---------ILKNIDAGERLP 335 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---------HHHhccccccCC
Confidence 554432 1233568999999999999999999999999999998 788876433211 111222 2444
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+ ..+ .+.++++++.||..+|++|||+..+.+
T Consensus 336 RP-k~c---sedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 RP-KYC---SEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CC-CCC---hHHHHHHHHHhccCCccccccHHHHHH
Confidence 44 333 346889999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.68 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=211.4
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
-|++++.||+|.||.||||..+ +|+.+|+|.+... ...+++..|+.+|++.+.|+||++||.|......++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3677889999999999999866 7999999998653 247899999999999999999999999988899999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
||-.|+..+.++.+. ..+++.++..+....++||+|||.. .-||||||+.|||++.+|.+||+|||.|..+...-
T Consensus 109 YCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999999997654 3788899999999999999999998 77999999999999999999999999998766544
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.....+.|||-|||||++..-.|+.++|+||+|++..||.-|++||..+.... .--++....+.-.....+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEeccCCCCCCCCChHh
Confidence 44566789999999999999999999999999999999999999987554321 111222222222233455
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+.++-+++++|+-+.|++|.|+.++++.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 67789999999999999999999988763
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.36 Aligned_cols=246 Identities=23% Similarity=0.386 Sum_probs=195.9
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCC
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGS 600 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 600 (784)
+.||+|+||.||+|...+++.||+|.++.... ......|.+|+++++.++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999988899999999875421 1224568899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc-cc
Q 042086 601 LATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC-TE 679 (784)
Q Consensus 601 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~ 679 (784)
|.+++.... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999986543 3578899999999999999999998 99999999999999999999999999997644322211 12
Q ss_pred cccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 680 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
..+++.|+|||++.+..++.++||||||+++||+++ |..||.......... ..... .+...+ . .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-----~~~~~--~~~~~~-~---~~~~~ 222 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----QVEKG--YRMSCP-Q---KCPDD 222 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-----HHHcC--CCCCCC-C---CCCHH
Confidence 234567999999998889999999999999999998 999986332111000 00000 011111 1 12346
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 759 IVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.+++.+|++.+|++||++.|+++.|
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHh
Confidence 88999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.26 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=202.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC--CCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE--MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
+.|++.+.||+|++|.||+|... +++.||+|.+....... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46899999999999999999864 68999999886543221 1234578899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|+||+++++|.+++...+ .+++..+.+++.|++.|++|||+. +|+||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987653 477888999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcc---cccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC-CCCC
Q 042086 672 PDSSNC---TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP-RLPT 747 (784)
Q Consensus 672 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~ 747 (784)
...... ....++..|+|||.+.+..++.++||||+|+++||+++|+.||........ ....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--------IFKIATQPTNPQ 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--------HHHHhccCCCCC
Confidence 322111 234678899999999998899999999999999999999999863222110 0001111 1111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+ ......+.+++.+||..+|++|||+.++++.
T Consensus 228 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LP---SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CC---ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 1223457889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.98 Aligned_cols=253 Identities=24% Similarity=0.449 Sum_probs=199.9
Q ss_pred cCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.+|...+.||+|+||.||++... ++..+|+|.+... .....+.|.+|+++++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 46788899999999999999642 4668899987653 22335679999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC
Q 042086 589 SFLVYEYLERGSLATILSNDGA------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 656 (784)
.++|+||+++|+|.+++...+. ...+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 9999999999999999975432 13578899999999999999999998 99999999999999999
Q ss_pred CceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 042086 657 YEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNR 733 (784)
Q Consensus 657 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~ 733 (784)
+.+||+|||++..+..... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------ 232 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------ 232 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------
Confidence 9999999999976543221 1122345678999999998899999999999999999998 899985322111
Q ss_pred ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 734 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+... ...+.+++.+||+.||++||++++|.+.|
T Consensus 233 --~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 233 --AIECITQGRELERPRTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred --HHHHHHcCccCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 01111111111111111 23577899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.80 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=206.3
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|+..+.||.|+||.||.++.. +++.+++|.+..... +....+++.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 4888999999999999999855 689999998765322 22345678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999997643 24578899999999999999999998 99999999999999999999999999998765544
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......+++.|+|||...+..++.++||||||+++|||++|+.||+..... .....+......... ..
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~ 224 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQGNYTPVV---SV 224 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCCc---cc
Confidence 3445567899999999998888899999999999999999999998632211 111111222221111 22
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...++.+++.+||+.+|++||+++++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 23467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.52 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=201.8
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
...++|++.+.||+|+||.||+|... +...+|+|.+.... ......++.+|+.++.++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34567899999999999999999764 24689999887532 222345688999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSND-------------GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
..+..++||||+++|+|.++++.. .....+++..+++++.|++.|++|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999999643 1234688999999999999999999998 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++.+...... .....++..|+|||.+.+..++.++|||||||++||+++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 9999999999999999876543221 122335678999999988889999999999999999997 989876322110
Q ss_pred cccccccccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+... ....+ . .....+.+++.+|+..||++|||+.|+++.|
T Consensus 243 -------~~~~~~~~~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 243 -------LFKLLKEGYRMEKP-Q---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred -------HHHHHHcCCcCCCC-C---CCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 00001111 11111 1 1233578899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.14 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=197.4
Q ss_pred CCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc----
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN---- 588 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 588 (784)
|++.+.||+|+||.||+|... .+..||+|+++.... .....+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 577899999999999999864 247899999875321 22234678999999999999999999999865544
Q ss_pred --eEEEEecccCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEec
Q 042086 589 --SFLVYEYLERGSLATILSNDG---AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 589 --~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
.++|+||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 789999999999999985432 224688999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042086 664 FGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 664 fG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
||+++.+...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYL 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence 9999876543221 112234678999999988889999999999999999999 88988643211 111111
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+......+. ....++.+++.+|++.||++|||+.|+++.|
T Consensus 229 ~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 229 RHGNRLKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred HcCCCCCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111111111 2234688999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.06 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=194.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
++|++.+.||+|+||+||+|.+. +++ .+++|.+.... ......++..|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 46888999999999999999864 454 47777764321 12234578888889999999999999998864 457
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++++||+++|+|.+++.... ..+++..+..++.||+.|++|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 78999999999999997543 3588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 042086 670 LKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RL 745 (784)
Q Consensus 670 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~ 745 (784)
...... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ..+++.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---------VPDLLEKGER 229 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCCc
Confidence 643322 2234456778999999998899999999999999999998 999986432110 0111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+... ...+.+++.+||..||++|||+.|+++.|
T Consensus 230 ~~~~~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 230 LAQPQIC---TIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred CCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1111111 23467889999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.91 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=200.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcC-----------------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS-----------------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 576 (784)
..+|++.+.||+|+||.||+|...+ +..||+|.+..... ....+++.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 4578999999999999999997542 34689998875422 2345678999999999999999
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGA--------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISS 648 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 648 (784)
+++++++...+..++|+||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 9999999998999999999999999999976431 12588999999999999999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh--CCCCCCccc
Q 042086 649 KNVLLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK--GDHPRDFIS 724 (784)
Q Consensus 649 ~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt--g~~p~~~~~ 724 (784)
+||+++.++.++|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999986543221 1223456778999999988889999999999999999998 677775322
Q ss_pred cccccccccccccccccC-CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 725 SISSSSSNRNISLNEILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..... ........ ...............++.+++.+|++.||++|||+.+|++.|
T Consensus 239 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 239 DQQVI-----ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred hHHHH-----HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 11000 00000000 000000000111224688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.00 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=196.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||.||+|... ++. .+++|.++... .....+.|.+|+.+++++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57899999999999999999875 333 47888776421 112346789999999999 7999999999999989999
Q ss_pred EEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 591 LVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
+|+||+++|+|.++++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 99999999999999975321 13478899999999999999999998 999999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042086 658 EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNIS 736 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 736 (784)
.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 157 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~ 227 (297)
T cd05089 157 ASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------L 227 (297)
T ss_pred eEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence 9999999998643211 11111233557999999998889999999999999999997 999986432110 0
Q ss_pred cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+........+.. ....+.+++.+|++.+|.+||+++++++.|
T Consensus 228 ~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 228 YEKLPQGYRMEKPRN---CDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred HHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 011111111111111 223578999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.24 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=211.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|++.+.||+|.-|+||+++.+ ++..+|+|++.+..........+.+.|-+||+.++||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 35777889999999999999987 46899999998865555555667888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC-
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP- 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~- 672 (784)
|||+||+|....+.+. ...|++..++.++.+|+-||+|||.. |||.|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999887654 36799999999999999999999999 999999999999999999999999998753210
Q ss_pred --------------------------------C-C----------------------CcccccccccccccccccccCCc
Q 042086 673 --------------------------------D-S----------------------SNCTELVGTFGYIAPELVYTMKV 697 (784)
Q Consensus 673 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 697 (784)
. . .....++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 00123578999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-
Q 042086 698 TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP- 776 (784)
Q Consensus 698 ~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 776 (784)
+.++|-|+|||++|||+.|+.||.. ...++.+..++-..+..+.. +..+..+.+||++.|.+||.+|--
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG--------~~~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKG--------SNNKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCC--------CCchhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhcc
Confidence 9999999999999999999999973 34455555666555444322 255667899999999999999987
Q ss_pred ---HHHHHH
Q 042086 777 ---MHTVCQ 782 (784)
Q Consensus 777 ---~~~vl~ 782 (784)
+.||-+
T Consensus 383 ~rGA~eIK~ 391 (459)
T KOG0610|consen 383 KRGAAEIKR 391 (459)
T ss_pred ccchHHhhc
Confidence 666543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.53 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=191.9
Q ss_pred eEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 522 CIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
.||+|+||.||+|.++ ++..+|+|++..... .....+++..|+.+++.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 5899999999999653 578999998864321 22235679999999999999999999998864 567899999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc--
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN-- 676 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 676 (784)
|+|.+++.... .+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++..+......
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999997543 578899999999999999999998 9999999999999999999999999999876543221
Q ss_pred -ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 677 -CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 677 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.....+++.|+|||.+....++.++|+|||||++|||++ |+.||........ ...+........+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------~~~i~~~~~~~~~~~--- 222 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV--------TQMIESGERMECPQR--- 222 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHCCCCCCCCCC---
Confidence 122234578999999988888999999999999999998 9999874322110 001111111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...++.+++.+||+.||++||++++|++.|
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 223578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.05 Aligned_cols=251 Identities=25% Similarity=0.472 Sum_probs=199.8
Q ss_pred cCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||.||+|+.. .+..+|+|.+.... .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46888999999999999999864 23479999886532 2223568999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..+
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999997643 3578899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcc---cccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 042086 671 KPDSSNC---TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RL 745 (784)
Q Consensus 671 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~ 745 (784)
....... ....++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ....+.+. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYRL 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCcC
Confidence 5432211 11223567999999998889999999999999999886 999986432110 01111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.+ . .....+.+++.+|++.+|++||+|.++++.|
T Consensus 229 ~~~-~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 229 PAP-M---DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred CCC-C---CCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 111 1 1233578899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.61 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=196.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||.||+|..+ ++. .+++|.+.... .....+.|.+|+.++.++ +||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 357899999999999999999865 454 45777765421 222346788999999999 899999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC
Q 042086 590 FLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 656 (784)
++|+||+++|+|.++++..+. ...+++..++.++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999975431 13578899999999999999999998 99999999999999999
Q ss_pred CceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 042086 657 YEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNI 735 (784)
Q Consensus 657 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 735 (784)
+.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------- 231 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------- 231 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence 99999999998643211 11112234667999999988889999999999999999998 999986322110
Q ss_pred ccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 736 SLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 736 ~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+... +...+ . .....+.+++.+|++.+|++||+++++++.|
T Consensus 232 ~~~~~~~~~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 232 LYEKLPQGYRLEKP-L---NCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HHHHHhcCCcCCCC-C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00011111 11111 1 1223578899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.38 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=204.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... .......+.+|+.+++.++||||+++++++.++...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36888899999999999999876 68999999986532 2334567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++.+...
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999998753 578899999999999999999998 9999999999999999999999999999887654
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........+++.|+|||.+.+..++.++|||||||++|||+||+.||+...... ....+.....+.....
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~-- 221 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKNNPPSLEGN-- 221 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhcCCCCCccc--
Confidence 344455678889999999998889999999999999999999999986432110 0001111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++.+|+..||++|||++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02346788999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.08 Aligned_cols=255 Identities=23% Similarity=0.429 Sum_probs=201.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .....++|.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 457899999999999999999863 46889999987532 1223467999999999999999999999999989
Q ss_pred ceEEEEecccCCCHHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 042086 588 NSFLVYEYLERGSLATILSNDG-------------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISS 648 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 648 (784)
..++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9999999999999999996421 112478888999999999999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 042086 649 KNVLLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISS 725 (784)
Q Consensus 649 ~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~ 725 (784)
+||+++.++.++|+|||++..+..... .......++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543221 1122344678999999998899999999999999999997 8888753221
Q ss_pred ccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 726 ISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 726 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+.+......+.. ...++.+++.+|++.||++|||+.|+++.|
T Consensus 239 --------~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 239 --------EEVIYYVRDGNVLSCPDN---CPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred --------HHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 111111222222111111 234688899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.10 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=203.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 357999999999999999999864 79999999886532 22356788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999998643 467888999999999999999999 999999999999999999999999999987655
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........+++.|+|||.+.+..++.++|+|||||++|++++|+.||........ ........... ....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~~~~~~~~~~~--~~~~ 238 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGTPE--LQNP 238 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------eeeeccCCCCC--CCCc
Confidence 44444455788999999999988899999999999999999999999863221110 00000001100 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.+++.+||+.+|++||+++++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.83 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=199.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+.... ......++..|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357999999999999999999753 23579999987532 222356788999999999 7999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
..+..++||||+++|+|.+++..... ...+++..+.+++.|++.||+|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999975432 13588999999999999999999998 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||.++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-- 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence 9999999999999999865432211 112234568999999998889999999999999999998 88887532210
Q ss_pred cccccccccccccCCC-CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPR-LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ..+.+... ....+. ....++.+++.+|++.+|++|||+.+|++.|
T Consensus 250 ------~-~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 250 ------E-LFKLLKEGHRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred ------H-HHHHHHcCCCCCCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 0 00011111 111111 2234678899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.05 Aligned_cols=262 Identities=21% Similarity=0.348 Sum_probs=198.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcC---------------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceee
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS---------------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 578 (784)
.++|++.+.||+|+||.||+++... ...||+|.++... .....+.|.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 3579999999999999999987532 2358999987532 1223457999999999999999999
Q ss_pred EEeEEecCCceEEEEecccCCCHHHHHhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCC
Q 042086 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGA---------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649 (784)
Q Consensus 579 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~ 649 (784)
+++++...+..++||||+++++|.+++..... ...+++..+.+++.|+++|++|||+. +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 99999999999999999999999999864321 12468889999999999999999999 9999999999
Q ss_pred CeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh--CCCCCCcccc
Q 042086 650 NVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK--GDHPRDFISS 725 (784)
Q Consensus 650 Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt--g~~p~~~~~~ 725 (784)
||++++++.+||+|||++......... .....+++.|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999999765432211 122345678999999998889999999999999999998 5667753221
Q ss_pred ccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 726 ISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 726 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
........+ .............+. .....+.+++.+|++.||++||++++|++.|
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 239 EQVIENTGE-FFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHH-hhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 100000000 000000000000011 1123688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.22 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=195.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+++.. +++.||+|++.+.........+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999865 68999999987532223334566889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997532 2578888999999999999999999 9999999999999999999999999999766543
Q ss_pred CCc-cccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD--PRL 745 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~ 745 (784)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ...+.. ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--------~~~i~~~~~~~ 227 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YGKIMNHKEHF 227 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--------HHHHHcCCCcc
Confidence 322 233568999999999863 4577899999999999999999999863221110 001111 011
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCC--CCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPE--SRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~~vl~ 782 (784)
..+. ........+.+++.+|+..+++ .||+++++++
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 228 QFPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred cCCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 1111 1111233566777777755443 3889999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.63 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=203.0
Q ss_pred HHHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 507 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
++.+..+.++|++.+.||+|+||.||+|... +++.+|+|.+... .....++.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3455567889999999999999999999865 6889999987542 12245788999999999 7999999999874
Q ss_pred -----cCCceEEEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc
Q 042086 585 -----HPRNSFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE 658 (784)
Q Consensus 585 -----~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 658 (784)
.++..++||||+++++|.++++... ....+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 3456899999999999999886421 224578888999999999999999998 9999999999999999999
Q ss_pred eEEeccccccccCCCCCccccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 042086 659 ARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR 733 (784)
Q Consensus 659 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 733 (784)
+||+|||++..+...........|++.|+|||++.. ..++.++||||+||++|||++|+.||..........
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--- 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--- 239 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh---
Confidence 999999999876544333345578999999999853 447889999999999999999999986432211000
Q ss_pred ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 734 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.......+....+ . .....+.+++.+||+.||++|||+.|+++.
T Consensus 240 --~~~~~~~~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 --KIPRNPPPTLHQP-E---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hccccCCCcccCC-C---CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000000111111 1 112358889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.25 Aligned_cols=254 Identities=21% Similarity=0.338 Sum_probs=201.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcC-----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-CC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS-----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-PR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 587 (784)
.++|++.+.||+|+||.||+|...+ +..|++|.+.... .....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4678999999999999999998765 7889999876432 23345678999999999999999999998765 56
Q ss_pred ceEEEEecccCCCHHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEe
Q 042086 588 NSFLVYEYLERGSLATILSNDGAI-----EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVS 662 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 662 (784)
..++++||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999754322 4688999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 042086 663 DFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 663 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
|||+++.+...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||........ ...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~~ 231 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM--------AAY 231 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH--------HHH
Confidence 99999866443221 122345678999999998889999999999999999999 9999864322110 000
Q ss_pred ccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 740 ILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 740 ~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.+. +.... . .....+.+++.+||+.||++|||+.++++.|
T Consensus 232 ~~~~~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 232 LKDGYRLAQP-I---NCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred HHcCCCCCCC-C---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 0011 11111 1 1223578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.91 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=198.5
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
.+++.+.....||+|+||.||+|+.. +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556667789999999999999865 67889999876532 223567899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CCceEEeccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKF 669 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~ 669 (784)
+|+||+++++|.+++.........++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999997542211226788889999999999999998 9999999999999986 67899999999987
Q ss_pred cCCCCCcccccccccccccccccccCC--cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMK--VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
............+++.|+|||++.... ++.++||||||+++|++++|+.||........ ...........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~ 232 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA------AMFKVGMFKIHPE 232 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh------hHhhhhhhccCCC
Confidence 654333334456889999999986543 78899999999999999999999863221100 0000000001111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+. ....++.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 IPE---SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCc---ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 111 22345788999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=310.75 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=204.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||.|+||+||+|... ++..+++|++...... ...+.+.+|+++++.++|+||+++++.+..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 46899999999999999999865 6889999998653222 24678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++++.......+++.....++.|++.|++|||+. +|+||||+|+||++++++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999997644334688899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc----ccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---CCC
Q 042086 674 SSN----CTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD---PRL 745 (784)
Q Consensus 674 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d---~~~ 745 (784)
... .....++..|+|||++... .++.++|+|||||++|||++|+.||....... ...+... +..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 227 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQNDPPSL 227 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcCCCCCc
Confidence 322 1334688999999998876 78899999999999999999999986432211 0011111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... .........+.+++.+|++.||++||++.++++
T Consensus 228 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETG-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCc-cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 110 001133456889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=313.32 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=198.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|... +++.||+|.+.... .....++|.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36888999999999999999864 78999999886532 2223467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999997652 357788889999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ........+.++.....+ ..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~ 223 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVLP--VG 223 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCCCCCC--CC
Confidence 2344578999999999998889999999999999999999999986432211000 000001111111111110 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....++.+++.+|++.||++||+++|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 123357899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.23 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=197.8
Q ss_pred CCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
+|++.+.||+|+||.||+|... ....+++|.+..... ....+++.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4778899999999999999753 235788888765321 12346789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 042086 590 FLVYEYLERGSLATILSNDG---------------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISS 648 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 648 (784)
++|+||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999999986421 113578899999999999999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 042086 649 KNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISS 725 (784)
Q Consensus 649 ~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~ 725 (784)
+||++++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999865432221 122345678999999988889999999999999999998 9999863221
Q ss_pred ccccccccccccccccCCCCC-CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 726 ISSSSSNRNISLNEILDPRLP-TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 726 ~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ...+.+..... ..+. .....+.+++.+|++.+|++||+++++++.|
T Consensus 236 ~---------~~~~~~~~~~~~~~~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 236 E---------RLFNLLKTGYRMERPE---NCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred H---------HHHHHHhCCCCCCCCC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 1 00111111111 0111 1234688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.02 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=202.6
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-CCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-PRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 593 (784)
+|++.+.||+|++|.||++... +++.||+|++..... .....+.+..|++++++++|+|++++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4889999999999999999865 678999999865322 22235678899999999999999999998864 44678999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++.... ...+++.++..++.+++.|++|||+. +|+||||||+||+++.++.++|+|||++..+...
T Consensus 80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999997532 23578999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........+++.|+|||.+.+..++.++||||||++++|+++|+.||+..... .....+.....+..+ .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~---~ 224 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIEGKLPPMP---K 224 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCCCCCc---c
Confidence 33344557889999999999999999999999999999999999998632211 001111111121111 2
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.....+.+++.+|++.||++||++.++++.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.89 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=202.8
Q ss_pred cCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.+|++.+.||.|++|.||+|.. .+++.|++|.+... .....+.+.+|+.+++.++|||++++++++...+..++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc---cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4689999999999999999986 47899999988653 2234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999988643 478899999999999999999999 9999999999999999999999999998876544
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... .......+....+ .
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----~~~~~~~~~~~~~-~--- 239 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGTPELQNP-E--- 239 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcCCcccCCc-c---
Confidence 433344578899999999998889999999999999999999999987433211000 0000000111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++.+||..||++||++.++++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 22335778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.00 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=199.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 46888899999999999999865 68999999886532 223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++...+ .+++.....++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999987544 578899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
........|++.|+|||.+. ...++.++|||||||++|||++|+.||.......... .........+....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~--- 233 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQPPKLKD--- 233 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hhhccCCCCCcccc---
Confidence 33344567899999999974 4457889999999999999999999975322110000 00000000011110
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.+++.+|++.+|++||+++++++
T Consensus 234 -~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 -KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0112235788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.54 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=200.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
.++|++.+.||+|+||.||+|+.. ++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 457889999999999999999741 34579999886532 223356799999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
.....++||||+++|+|.+++..... ...+++..+..++.|+++|++|||++ +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999975421 23578889999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++.+...... .....+++.|+|||.+.+..++.++||||||+++||+++ |..||.......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 9999999999999999876533221 122345678999999998889999999999999999998 788875322110
Q ss_pred cccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+. .....+.+++.+||+.+|++|||+.|+++.|
T Consensus 248 -------~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 248 -------LFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred -------HHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 000111111011111 2234678899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=312.41 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=193.9
Q ss_pred CCCceeEecccceEEEEEEEcC-CC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------C
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTS-GE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------R 587 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 587 (784)
|.+.+.||+|+||.||+|+..+ ++ .||+|.+..... .....+.|..|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4567899999999999998764 33 689998765321 223356789999999999999999999987432 2
Q ss_pred ceEEEEecccCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 588 NSFLVYEYLERGSLATILSNDG---AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
..++|+||+++|+|.+++.... ....+++.....++.|++.|++|||++ +|+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 4689999999999999874321 223578999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc
Q 042086 665 GIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 665 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
|+++.+...... .....+++.|+|||...+..++.++||||||+++||+++ |+.||....... ....+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--------IYDYLR 228 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHH
Confidence 999876543221 122345678999999999899999999999999999999 888986422110 001111
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 742 d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.......+. .....+.+++.+||+.||++|||+.++++.|
T Consensus 229 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 229 QGNRLKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred cCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111111111 1223578999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.18 Aligned_cols=255 Identities=22% Similarity=0.379 Sum_probs=201.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.++|.+.+.||+|+||.||+|... ++..||+|.++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 457999999999999999999742 356899998875321 22346789999999999 799999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
+..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||++ +|+|+||||+||+++.++.++++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999975332 3478999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 042086 667 AKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 667 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
++........ .....++..|+|||.+.+..++.++|||||||++||+++ |..||....... ...+.++.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~~~~ 259 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKLIKE 259 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHHHHc
Confidence 9865433211 122345678999999999899999999999999999998 999986332110 01111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..... .......++.+++.+|++.+|++|||+.|+++.|
T Consensus 260 ~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 260 GYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred CCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 11110 0011234688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=311.16 Aligned_cols=251 Identities=26% Similarity=0.494 Sum_probs=199.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CC---CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SG---EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
+.|+..+.||+|+||.||+|+.. ++ ..+++|.+.... .....+++..|+++++.++|||++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 46888999999999999999875 33 379999886532 1223567899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999997543 3688899999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCcc---cccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 042086 671 KPDSSNC---TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RL 745 (784)
Q Consensus 671 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~ 745 (784)
....... .....++.|+|||++....++.++|||||||++||+++ |+.||...... .....+... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCC
Confidence 4322211 11223457999999988889999999999999999998 99998532211 111111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.. .+...++.+++.+|++.+|++||++.+|++.|
T Consensus 230 ~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 230 PAP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111 12234678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=324.77 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=196.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC----
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR---- 587 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 587 (784)
..++|++.+.||+|+||.||+|+.. +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4578999999999999999999875 689999999865422 2233567889999999999999999999986443
Q ss_pred --ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 588 --NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 588 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999976 67666642 367788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cc-------
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SS------- 731 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~------- 731 (784)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..
T Consensus 169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred CccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 99765332 2234457899999999999999999999999999999999999999643211000 00
Q ss_pred ---------------ccccccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 732 ---------------NRNISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 732 ---------------~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.... ..+............+.+++.+|++.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000 000000000111345789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=308.31 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=190.1
Q ss_pred EecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCC
Q 042086 523 IGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERG 599 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 599 (784)
||+|+||.||+|... ++..||+|.+.... .....++|.+|+.++++++||||+++++++.. ...++||||+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 899999999999764 45679999886542 22334679999999999999999999998864 5789999999999
Q ss_pred CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc--
Q 042086 600 SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC-- 677 (784)
Q Consensus 600 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-- 677 (784)
+|.+++.... ..+++..+.+++.|++.|++|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999987533 3588899999999999999999998 99999999999999999999999999998654332211
Q ss_pred -cccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCCCCHH
Q 042086 678 -TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQNVQD 754 (784)
Q Consensus 678 -~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~ 754 (784)
....+++.|+|||.+....++.++|||||||++||+++ |+.||........ ...+... +...+ . .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~-~---~ 222 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--------MSFIEQGKRLDCP-A---E 222 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--------HHHHHCCCCCCCC-C---C
Confidence 11223568999999988889999999999999999996 9999864322110 0000010 11111 1 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...++.+++.+||..||++||++.+|.+.|
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 234677899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.03 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=198.2
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|++.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 677888999999999999876 5788899987543 222356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999999876432 3588999999999999999999999 999999999999999999999999999976544333
Q ss_pred cccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 676 NCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
......+++.|+|||++. ...++.++|||||||++|||++|+.||........... ......+....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~-- 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK-----IAKSEPPTLAQP-- 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH-----HhhcCCCCCCCc--
Confidence 334557899999999984 34577899999999999999999999864322110000 000001111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.....++.+++.+||+.||++||++.++++.
T Consensus 232 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 --SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123468899999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=308.13 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=201.3
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 357889999999999999999876 88999999876422 4678999999999999999999999999889999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999976432 3588999999999999999999999 9999999999999999999999999999876322
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
. .....+..|+|||++.+..++.++||||||+++||+++ |..||.......... .... +.+...+ .
T Consensus 156 ~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----~~~~--~~~~~~~-~-- 222 (256)
T cd05039 156 Q---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----HVEK--GYRMEAP-E-- 222 (256)
T ss_pred c---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHhc--CCCCCCc-c--
Confidence 1 12344668999999998889999999999999999997 999986332110000 0000 0011111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++.+|+..+|++|||+.++++.|
T Consensus 223 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 223 -GCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred -CCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 1234688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=316.47 Aligned_cols=261 Identities=21% Similarity=0.372 Sum_probs=198.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-----------------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-----------------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 576 (784)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... .....++|.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 356999999999999999998532 24468999887532 22234679999999999999999
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGA--------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISS 648 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 648 (784)
+++++++...+..++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +|+||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 9999999999999999999999999999975432 12477888999999999999999999 999999999
Q ss_pred CCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh--CCCCCCccc
Q 042086 649 KNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK--GDHPRDFIS 724 (784)
Q Consensus 649 ~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt--g~~p~~~~~ 724 (784)
+||+++.++.++|+|||+++.+...... .....+++.|+|||....+.++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999865432211 122334678999999888889999999999999999998 778875332
Q ss_pred cccccccccccccccc-cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 725 SISSSSSNRNISLNEI-LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
........ ....... .....+.+ .. ....+.+++..||+.||++||++.+|++.|
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~-~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 239 DEQVIENT-GEFFRDQGRQVYLPKP-AL---CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred hHHHHHHH-HHHHhhccccccCCCC-CC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 11100000 0000000 00011111 11 124688999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.88 Aligned_cols=243 Identities=24% Similarity=0.263 Sum_probs=189.2
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc---CCCceeeEEeEEecCCceEEEEecccC
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL---RHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
||+|+||+||+|+.. +++.||+|++.............+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 6899999998653222222334556677777655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.+++...+ .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99999987543 478899999999999999999999 999999999999999999999999999976443333345
Q ss_pred ccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHH
Q 042086 679 ELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI 757 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 757 (784)
...||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.......+... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~---~~~ 223 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFGKVRFPKNV---LSD 223 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcCCCCCCCcc---CCH
Confidence 56799999999998765 4789999999999999999999998632211 11111111111111111 123
Q ss_pred HHHHHHHhcccCCCCCCC----CHHHHHH
Q 042086 758 SIVEVAFLCLNESPESRP----PMHTVCQ 782 (784)
Q Consensus 758 ~l~~li~~cl~~dP~~RP----s~~~vl~ 782 (784)
.+.+++.+||+.||++|| ++.++++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 567899999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.21 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=200.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||.||+|+.. +++.|++|.+... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 356889999999999999999876 5899999998653 222356788999999999999999999999988999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|..++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999998876433 2578899999999999999999998 999999999999999999999999999876544
Q ss_pred CCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
.........+++.|+|||++. ...++.++|||||||++|||++|+.||....... ....+.....+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 234 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEPPT 234 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--------HHHHHhcCCCcc
Confidence 333334556889999999985 3446789999999999999999999986432110 001111111100
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ........++.+++.+||+.||++||++.++++
T Consensus 235 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 L-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 011122346788999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.25 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=200.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEec
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSH 585 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 585 (784)
..++|.+.+.||+|+||.||+|++. .++.||+|++.... .....+.+.+|++++.++. ||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3456888999999999999999853 34689999997532 1223457899999999997 9999999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcCCC-------------------------------------------------------
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGA------------------------------------------------------- 610 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 610 (784)
.+..++|+||+++|+|.++++..+.
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999964321
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCC
Q 042086 611 ----------------------------------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKN 650 (784)
Q Consensus 611 ----------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 650 (784)
...+++.....++.|++.|++|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 12367778889999999999999998 99999999999
Q ss_pred eeecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 042086 651 VLLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSIS 727 (784)
Q Consensus 651 ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~ 727 (784)
|++++++.+||+|||+++....... ......+++.|+|||.+....++.++|||||||++|||++ |+.||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986532221 1223456788999999998889999999999999999998 889986432111
Q ss_pred ccccccccccccccCC--CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 728 SSSSNRNISLNEILDP--RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 728 ~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+.+.. +...+ . ....++.+++.+||+.+|++||+++||++.|
T Consensus 350 --------~~~~~~~~~~~~~~p-~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 350 --------QFYNAIKRGYRMAKP-A---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred --------HHHHHHHcCCCCCCC-C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 00011111 11111 1 1234688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=308.99 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=204.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||.|+||.||+|... +++.+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 57899999999999999999875 67899999987542 224678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++.... ..++...+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999999987542 3578899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccC---CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTM---KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
........++..|+|||.+... .++.++||||||+++|||++|+.||.......... ............ .
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~----~ 227 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISKSNFPPPKL----K 227 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhccCCCccc----c
Confidence 3333455788899999999776 78899999999999999999999986432111000 000000000011 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......++.+++.+||..+|++|||+++|++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12233457889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.30 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=198.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+++.. +++.||+|.+.+.........+.+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999876 68899999986532222333456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997632 2578888999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-cccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--CC
Q 042086 674 SSN-CTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP--RL 745 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~--~~ 745 (784)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+... +.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~ 227 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEERF 227 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCcc
Confidence 322 233569999999999875 45788999999999999999999998632211 011111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPES--RPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~vl~ 782 (784)
+.+ ....+...++.+++.+|+..++++ |++++++++
T Consensus 228 ~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 111 111223346778888988866544 468888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.17 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=201.5
Q ss_pred eeEecccceEEEEEEEcC----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecc
Q 042086 521 YCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
+.||+|+||.||+|.... +..|++|.+....... ..+++.+|+++++.++|+||+++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 468999999999998763 8899999987643222 4678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 597 ERGSLATILSNDGA------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 597 ~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
++++|.+++..... ...+++..+..++.|++.|++|||++ +|+||||+|+||+++.++.+||+|||.+..+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999986521 24689999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCC--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCC
Q 042086 671 KPDS--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLP 746 (784)
Q Consensus 671 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~ 746 (784)
.... .......+++.|+|||.+....++.++||||+|+++|||++ |..||+...... ....+.+. +..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 227 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--------VLEYLRKGYRLP 227 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence 5432 22334567889999999988889999999999999999999 699987442211 01111111 111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+ . ....++.+++.+|++.+|++|||+.|+++.|
T Consensus 228 ~~-~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 228 KP-E---YCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CC-c---cCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 1 2234688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.52 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=196.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--CC
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PR 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 587 (784)
..|++.+.||+|+||.||+|..+ +++.||+|.+... .....+.|.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 47889999999999999999742 5889999998653 22235678999999999999999999998754 34
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 6789999999999999997543 3578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc---cccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--ccccc-----ccc
Q 042086 668 KFLKPDSSNC---TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--SSNRN-----ISL 737 (784)
Q Consensus 668 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--~~~~~-----~~~ 737 (784)
..+....... ....++..|+|||.+.+..++.++|||||||++|||++|..|+......... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8765432211 1122345699999999888999999999999999999987775422111000 00000 000
Q ss_pred ccccCCCCC-CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEILDPRLP-TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~d~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.+..... ..+. .....+.+++.+||..+|++|||++||++.|
T Consensus 236 ~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 236 IELLKNNGRLPAPP---GCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHHhcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 011111111 1111 1233688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=316.26 Aligned_cols=260 Identities=19% Similarity=0.251 Sum_probs=198.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.+ +++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 56899999999999999999876 688999999865321 223456789999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++ ++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9997 49999887543 2578889999999999999999999 9999999999999999999999999999865443
Q ss_pred CCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccccccccc----
Q 042086 674 SSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNISLNEIL---- 741 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~---- 741 (784)
........+++.|+|||.+.+. .++.++|||||||++|||+||+.||......... ..........+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 3333445678999999998654 4788999999999999999999998643210000 000000000000
Q ss_pred --CCCCCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 --DPRLPTPPQ-----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 --d~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.... ........+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 00112335778999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.65 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=203.9
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|+||.||++... +|+.||+|.+..... .....+++.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 4888999999999999999865 789999999865322 22235678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999999875332 2468889999999999999999998 99999999999999999999999999998765443
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......|++.|+|||+..+..++.++|+|||||+++++++|+.||..... .....++.....+..+ ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~ 224 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGSYPPVS---SH 224 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCCCCCCc---cc
Confidence 333445688899999999988899999999999999999999999863211 0111111111111111 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+.+++.+||+.+|++||++.+|++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 23468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.60 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=196.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.++|++.+.||+|+||+||+|+.. +++ .||+|.+.... .....+++.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 357889999999999999999853 454 48999886532 22235678899999999999999999999975 45
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++++||+++|+|.++++... ..+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 679999999999999997543 3588899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 042086 669 FLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-- 743 (784)
Q Consensus 669 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-- 743 (784)
.+...... .....+++.|+|||...+..++.++|||||||++||+++ |..||+...... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~ 228 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKGE 228 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCC
Confidence 76533222 122234678999999998889999999999999999998 899986322110 0001111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+.+ . .....+.+++.+||+.||++||++.++++.|
T Consensus 229 ~~~~~-~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 229 RLPQP-P---ICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred cCCCC-c---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11111 1 1233578899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.25 Aligned_cols=250 Identities=29% Similarity=0.439 Sum_probs=200.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC------CChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM------VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
+|.+.+.||+|++|.||+|... +++.||+|.+........ ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999865 688999998865432221 112468899999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++|+||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997653 477888999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042086 669 FLKPDSS------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742 (784)
Q Consensus 669 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d 742 (784)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--------AIFKIGE 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------HHHHHhc
Confidence 7653211 1123457889999999998889999999999999999999999997432211 0011111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+..+ ......+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 NASPEIP---SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCcCC---cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111 122346788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.87 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=196.2
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe-cCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS-HPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 593 (784)
.+|++.+.||+|+||.||+|..+ |+.||+|.+... ...+.|.+|+.++++++|+|++++++++. ..+..++|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 46889999999999999999876 788999987542 23567999999999999999999999764 456789999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++.... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999976442 3578899999999999999999998 9999999999999999999999999998865432
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||........... ......+.. +.
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~---~~-- 222 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDA---PD-- 222 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhcCCCCCC---CC--
Confidence 2 22344678999999998889999999999999999998 9999863221100000 000000011 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++.+|++.+|++|||+.++++.|
T Consensus 223 -~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 223 -GCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 1233678899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.21 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=196.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+++.+ +++.||+|++.+...........+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46899999999999999999876 57889999986532222333456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997633 2578888999999999999999999 9999999999999999999999999999765433
Q ss_pred CC-cccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--CC
Q 042086 674 SS-NCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP--RL 745 (784)
Q Consensus 674 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~--~~ 745 (784)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+... +.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKERF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCccc
Confidence 22 223457999999999986 3457889999999999999999999996432111 11111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPES--RPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~vl~ 782 (784)
..+ .........+.+++.+|+..+|++ |++++|+++
T Consensus 228 ~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 228 QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 111 111122345777888888655544 789998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.75 Aligned_cols=251 Identities=22% Similarity=0.419 Sum_probs=201.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|...++..+|+|.+... ....+.|.+|+++++.++|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 4679999999999999999999888888999987652 2235689999999999999999999999887 7789999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999997643 24578889999999999999999998 9999999999999999999999999999865432
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
... .....++..|+|||++....++.++|+|||||++|++++ |+.||........ ...... +......
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-----~~~~~~--~~~~~~~--- 225 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----IRALER--GYRMPRP--- 225 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHhC--CCCCCCc---
Confidence 221 222345678999999998889999999999999999999 8999863221100 000000 0011111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....++.+++.+|++.+|++||++.++.+.|
T Consensus 226 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 226 -ENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred -ccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 12234688999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.68 Aligned_cols=254 Identities=30% Similarity=0.469 Sum_probs=200.8
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|++++.||+|+||+||+++.. +++.||+|.+........ ......+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 677899999999999999977 567899999977432211 122345599999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++++|.+++... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||.+..+.....
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp ETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999832 3578899999999999999999999 999999999999999999999999999986544444
Q ss_pred cccccccccccccccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 676 NCTELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
......+++.|+|||.+. +..++.++||||+|+++|+|++|..||.......... ...+...............
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 228 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE-----IIEKILKRPLPSSSQQSRE 228 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH-----HHHHHHHTHHHHHTTSHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh-----hhhhcccccccccccccch
Confidence 556678899999999998 8889999999999999999999999987541110000 0000000000000000001
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...++.+++.+||+.||++||++.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1257899999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.01 Aligned_cols=247 Identities=25% Similarity=0.413 Sum_probs=196.8
Q ss_pred eeEecccceEEEEEEEcC--C--CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecc
Q 042086 521 YCIGIGGQGSVYKAKLTS--G--EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...++|.+|+.++++++||||+++++++.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998643 3 36999998764332 346789999999999999999999999988 8899999999
Q ss_pred cCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc
Q 042086 597 ERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN 676 (784)
Q Consensus 597 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 676 (784)
++|+|.+++..... ..+++.....++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++..+......
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999976543 4689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 677 ---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 677 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||+........... .. .......+ .
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~-~~~~~~~~-~-- 224 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-----DK-EGERLERP-E-- 224 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----Hh-cCCcCCCC-c--
Confidence 122456788999999998889999999999999999998 99998633221100000 00 00111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++.+|++.+|++||++.++++.|
T Consensus 225 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 225 -ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred -cCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 2234688899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.25 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=200.3
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++......++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4666788999999999999865 68899999876432 12235678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++.. ..+++..+..++.|+++|++|||++ +++|+||+|+||++++++.++++|||++..+....
T Consensus 83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999999998864 2578889999999999999999998 99999999999999999999999999998765433
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......++..|+|||++.+..++.++|||||||++|||++|+.|+....... ....+.....+ .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~---~~~~~ 224 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPP---TLEGQ 224 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCC---CCCcc
Confidence 33344567889999999998889999999999999999999999986322110 00011111111 11112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 3446889999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.59 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=203.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
..|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35778889999999999999875 68899999886532 1223567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++... .+++.....++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999998643 467788899999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........++..|+|||++.+..++.++|||||||++|||++|+.||........ . ..+... .++....
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~-~~~~~~--~~~~~~~ 223 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------L-FLIPKN--NPPTLTG 223 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------h-hhhhcC--CCCCCch
Confidence 3334445678899999999988899999999999999999999999863221100 0 000000 1112223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 45567889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=317.60 Aligned_cols=255 Identities=21% Similarity=0.375 Sum_probs=198.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
.++|.+.+.||+|+||.||+|+.. ....||+|.+.... .....+++..|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 457889999999999999999742 34579999877532 122356788999999999 6999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+.+..++||||+++|+|.+++..... ...+++..+.+++.|++.|++|||++ +|+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 98999999999999999999975321 23588999999999999999999998 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++.+...... .....+++.|+|||.+.+..++.++|||||||++||+++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999876432221 112234467999999998889999999999999999999 888886332110
Q ss_pred cccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+.. ...++.+++.+|++.+|++|||+.++++.|
T Consensus 245 -------~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 245 -------LFKLLREGHRMDKPSN---CTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred -------HHHHHHcCCCCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000111111111111 223577899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=310.65 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=200.4
Q ss_pred CCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCC---CCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCE---MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+|++.+.||+|+||.||+|...+++.+|+|.+....... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999886532211 11235688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||+++++|.+++...+ .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 467888999999999999999998 999999999999999999999999999876532
Q ss_pred CC------CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 673 DS------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 673 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
.. .......++..|+|||++.+..++.++|||||||++||+++|+.||.......... ...... ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~~~---~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YIGAHR---GLMP 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---Hhhhcc---CCCC
Confidence 11 11234568889999999998889999999999999999999999986432211000 000000 0011
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+. ....++.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPD---SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 22345788999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.63 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=196.5
Q ss_pred CCCceeEecccceEEEEEEE-----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--Cce
Q 042086 517 FDVKYCIGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNS 589 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 589 (784)
|++.+.||+|+||+||++.. .+++.||+|.+.... .....+.|.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48889999999999988653 367899999987532 112356788999999999999999999988653 457
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++... .+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 8999999999999999653 488999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----c-cccccccccc
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-----S-SNRNISLNEI 740 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-----~-~~~~~~~~~~ 740 (784)
+...... .....++..|+|||.+....++.++||||||+++|||+||..|+......... . ........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6533221 11223456799999998888999999999999999999999997642211000 0 0000111111
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.....+ .......++.+++..||+.||++|||+++|++.|
T Consensus 237 ~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 237 LERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 11111110 0112234688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.40 Aligned_cols=260 Identities=24% Similarity=0.325 Sum_probs=194.1
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc---CCCceeeEEeEEec-----C
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL---RHRSIVKFYGFCSH-----P 586 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 586 (784)
+|++.+.||+|+||+||+|+.. +++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4888999999999999999876 68999999887542221 2234566777777665 69999999998854 2
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
...++||||+++ +|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 457899999985 89998875432 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccccccc-
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRNISL- 737 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~~~~- 737 (784)
++..... .......+++.|+|||.+.+..++.++||||+||++|||++|++||......... ........
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 155 ARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 9876432 2234456889999999999888999999999999999999999998532211000 00000000
Q ss_pred -----ccccCCCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 738 -----NEILDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 738 -----~~~~d~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+..... ....++...++.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000 0011122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.25 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=192.2
Q ss_pred eeEecccceEEEEEEEc--C--CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecc
Q 042086 521 YCIGIGGQGSVYKAKLT--S--GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
+.||+|+||.||+|... + +..||+|.+...... ...+++.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999753 2 378999998764322 24567999999999999999999999876 45689999999
Q ss_pred cCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc
Q 042086 597 ERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN 676 (784)
Q Consensus 597 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 676 (784)
++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.+......
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999997654 578899999999999999999998 9999999999999999999999999999876543322
Q ss_pred cc---ccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCCC
Q 042086 677 CT---ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQN 751 (784)
Q Consensus 677 ~~---~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~ 751 (784)
.. ...++..|+|||.+.+..++.++|||||||++||+++ |+.||+....... ...+... ....+ .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~-~- 221 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--------IAMLESGERLPRP-E- 221 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH--------HHHHHcCCcCCCC-C-
Confidence 11 1223467999999998899999999999999999998 9999864322110 0000000 11111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++.+|+..+|++||++.++++.|
T Consensus 222 --~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 222 --ECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 1234678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.69 Aligned_cols=259 Identities=21% Similarity=0.309 Sum_probs=196.3
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----ce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR-----NS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 589 (784)
+|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999864 799999999865321 2223467889999999999999999999998766 78
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|+||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999997 48888876543 578899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC-CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------cccc-----
Q 042086 670 LKPDS-SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--------SNRN----- 734 (784)
Q Consensus 670 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--------~~~~----- 734 (784)
..... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||+......... ...+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 54332 222344678999999998774 47889999999999999999999996432210000 0000
Q ss_pred -cccccccCCCCCCCC------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 -ISLNEILDPRLPTPP------QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 -~~~~~~~d~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+......++ ....+...++.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000000000 000112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=309.95 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=188.5
Q ss_pred eeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEeccc
Q 042086 521 YCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
+.||+|+||.||+|... ++..+|+|.+..... ......|.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 35899999999999764 346799998865432 2234578999999999999999999999999899999999999
Q ss_pred CCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 598 RGSLATILSNDGA--IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 598 ~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+|+|.++++.... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999975332 22456778889999999999999999 999999999999999999999999999975433221
Q ss_pred c--ccccccccccccccccccC-------CcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042086 676 N--CTELVGTFGYIAPELVYTM-------KVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 676 ~--~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
. .....+++.|+|||++... .++.++|+||||+++|||++ |+.||...................+.++..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 1 2234567889999998632 35789999999999999996 999986432111000000000001111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ......+.+++..|+ .+|++|||++||++.|
T Consensus 236 ~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 236 K------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred C------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1 112234677888998 5899999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.93 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=201.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.|..|++++++++||||+++++++..+...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 456889999999999999999875 6899999998643 222356789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++...+ ..+++..+..++.|++.|+.|||+. +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999987543 2588899999999999999999999 999999999999999999999999999876554
Q ss_pred CCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
.........+++.|+|||.+. ...++.++|+||||+++|||++|+.||....... ....+.....+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 227 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEPPT 227 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCCCC
Confidence 443444567899999999974 3456779999999999999999999986432111 001111111000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ........++.+++.+||+.+|++||++.++++
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 L-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred c-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0 001122346788999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=312.32 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=203.3
Q ss_pred cHHHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEE
Q 042086 506 LYEEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFC 583 (784)
Q Consensus 506 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 583 (784)
++.++..+.+.|++.+.||+|+||.||+|+.. +++.||+|.+... .....++..|+.+++++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 44555667789999999999999999999875 6899999987542 22346788999999998 799999999998
Q ss_pred ec------CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 584 SH------PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 584 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
.. .+..+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 53 4578999999999999999875432 3467888899999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccc
Q 042086 658 EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN 732 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~ 732 (784)
.++|+|||++..............|++.|+|||.+. ...++.++|||||||++|||++|+.||.......
T Consensus 159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----- 233 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----- 233 (282)
T ss_pred CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----
Confidence 999999999886543333344567899999999985 3457889999999999999999999986322111
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+....... .........+.+++.+||+.||++||++.|+++
T Consensus 234 ---~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 ---ALFLIPRNPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hhhhHhhCCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000111111111 011123446889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.88 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=200.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||++... ++..||+|.+.... ......++.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36899999999999999999865 68889999876532 1223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++++.. ..+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++..+...
T Consensus 79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999999765 35788899999999999999999732 8999999999999999999999999998765332
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----cc---ccccc---------
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-----SS---NRNIS--------- 736 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-----~~---~~~~~--------- 736 (784)
......+++.|+|||.+.+..++.++|+|||||++|||++|+.||......... .. .....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 223457889999999998888999999999999999999999998532211000 00 00000
Q ss_pred -----------cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 737 -----------LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 737 -----------~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...+.....+..+ ......++.+++.+|++.||++|||+.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000 01123468899999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.72 Aligned_cols=251 Identities=27% Similarity=0.511 Sum_probs=198.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CC---CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SG---EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
..|++.+.||+|+||.||+|... ++ ..||+|.+.... .....++|..|+.+++.++||||+++++++.++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35788999999999999999865 33 369999986532 2223568999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.++++... ..+++..+..++.|++.|++|||++ +++||||||+||+++.++.+|++|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999997543 3588999999999999999999998 9999999999999999999999999998865
Q ss_pred CCCCCcc--c-ccc--cccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-CC
Q 042086 671 KPDSSNC--T-ELV--GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEIL-DP 743 (784)
Q Consensus 671 ~~~~~~~--~-~~~--gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-d~ 743 (784)
....... . ... .+..|+|||.+.+..++.++|||||||++||+++ |..||....... ....+. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~~~~i~~~~ 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQDY 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCC
Confidence 4322211 1 111 2457999999998899999999999999999986 999986322110 000110 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.+.+. +....+.+++.+||+.+|++||++++|++.|
T Consensus 229 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 229 RLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred cCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 122211 2234578899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.22 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=204.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 592 (784)
...|++.+.||+||.+.||++...+.+.||+|++..... +....+-|..|+..|.++ .|.+||++++|-..++..|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 456889999999999999999998899999998765432 334567899999999999 599999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||-+- +|..+|+..... ...| .++.+..|++.|+.++|.+ ||||.||||.|+++- +|.+||+|||+|..+..
T Consensus 439 mE~Gd~-DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecccc-cHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 998755 999999876542 2334 6778999999999999999 999999999999995 68999999999998877
Q ss_pred CCCcc--cccccccccccccccccCC-----------cCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 673 DSSNC--TELVGTFGYIAPELVYTMK-----------VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 673 ~~~~~--~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
+.... ...+||+.||+||.+.... ...+|||||+||+||+|+.|+.||..+.. ....+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl~a 584 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKLHA 584 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHHHh
Confidence 65543 3468999999999985332 45789999999999999999999974432 3344556
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.|+.-..+....++ ..+++++++.||..||++|||..++++
T Consensus 585 I~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 666632111111111 113889999999999999999999986
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.60 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=203.6
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|.-.+.||.|.||.||-|++. +.+.||||++.-....+.+.-.++..|++.++.++|||++.+.|+|-.+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455577999999999999865 7899999998765545555567899999999999999999999999988999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
|-| +-.|++.-... ++....+..|..+.++||+|||+. +.||||||+.|||+++.|.|||+|||.|..+.+.
T Consensus 108 ClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred Hhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 965 88887765433 577788999999999999999999 9999999999999999999999999999887653
Q ss_pred cccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 676 NCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
..++|||.|||||++. .+.|+.|+||||+|++-.|+.-.++|...+.....-+.. ...-.|.++ .
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-----AQNesPtLq-----s 247 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNESPTLQ-----S 247 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-----HhcCCCCCC-----C
Confidence 5679999999999985 678999999999999999999999997654433211100 000111222 2
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+.+..+..++..|+++-|.+|||..++++
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 466778899999999999999999999875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=323.00 Aligned_cols=259 Identities=19% Similarity=0.262 Sum_probs=196.8
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP----- 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 586 (784)
..++|++.+.||+|+||.||+|... .++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4578999999999999999999865 689999999875422 222346788999999999999999999988543
Q ss_pred -CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 587 -RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 587 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999976 77776643 477888899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------cc-----
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--------SN----- 732 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--------~~----- 732 (784)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99865432 22344578999999999999899999999999999999999999986432110000 00
Q ss_pred -cccccccccC----------------CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 -RNISLNEILD----------------PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 -~~~~~~~~~d----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........++ ...+............+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000000 0000000011112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.14 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=201.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|++|.||+|+.+ +++.||+|++..... .....+.+.+|+.+++.++|||++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 46889999999999999999876 689999998865422 1223456889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|..+..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988888775432 478999999999999999999998 9999999999999999999999999999877554
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccc---------ccc
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNR---------NIS 736 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~---------~~~ 736 (784)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ... ...
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 433344567889999999876 457889999999999999999999986432211000 000 000
Q ss_pred cccccCCCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 737 LNEILDPRLPTPP---QNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 737 ~~~~~d~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
......+...... .........+.+++.+||+.||++||++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 0001123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.80 Aligned_cols=257 Identities=21% Similarity=0.251 Sum_probs=189.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------ 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 586 (784)
..+|++.+.||+|+||.||+|... +++.||||++... .....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999875 6899999987542 22345799999999999999999987432
Q ss_pred --CceEEEEecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEe
Q 042086 587 --RNSFLVYEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVS 662 (784)
Q Consensus 587 --~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~ 662 (784)
...++||||+++ ++.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 246689999986 787776532 1224688899999999999999999999 999999999999998665 79999
Q ss_pred ccccccccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc
Q 042086 663 DFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRN 734 (784)
Q Consensus 663 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~ 734 (784)
|||+|+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||......... .....
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999998765332 22345789999999998754 6899999999999999999999998643211000 00000
Q ss_pred ccccc----ccCCCCCCCC-CC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 ISLNE----ILDPRLPTPP-QN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 ~~~~~----~~d~~~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..... ..+...+... .. ......++.+++.+||+.||++|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 0000000000 00 0011236889999999999999999999985
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.77 Aligned_cols=239 Identities=22% Similarity=0.365 Sum_probs=186.6
Q ss_pred eeEecccceEEEEEEEcC-------------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 521 YCIGIGGQGSVYKAKLTS-------------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
+.||+|+||.||+|+..+ ...|++|.+... .......|..|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999997532 235888887653 2223457889999999999999999999999988
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc-------eE
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE-------AR 660 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------~k 660 (784)
..++||||+++|+|..++.... ..+++..+.+++.||++|++|||++ +|+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999999886543 3578899999999999999999999 9999999999999987654 89
Q ss_pred EeccccccccCCCCCcccccccccccccccccc-cCCcCcchhHHHHHHHHHHHH-hCCCCCCccccccccccccccccc
Q 042086 661 VSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 661 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+....... ..
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~ 219 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---------KE 219 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------HH
Confidence 9999998755322 2345788999999886 466888999999999999998 5888875321110 00
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
........... ....++.+++.+||+.||++||++.++++.|
T Consensus 220 ~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 01111111111 1123578999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=313.90 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=201.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36888999999999999999876 78999999886431 2223467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++++.......+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999876433346899999999999999999999632 8999999999999999999999999999765432
Q ss_pred CCcccccccccccccccccccCC------cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMK------VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
......+++.|+|||.+.+.. ++.++|+|||||++|||++|+.||....... .......+.+.....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~ 229 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQLSAIVDGDPPT 229 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHHHHHHhhcCCCC
Confidence 223346788999999986543 4789999999999999999999986321100 001111122222111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ..+....+.+++.+|++.+|++||+++++++
T Consensus 230 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 230 L---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C---CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 1224456788999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.10 Aligned_cols=194 Identities=23% Similarity=0.378 Sum_probs=160.4
Q ss_pred ceeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--CCceEEEEe
Q 042086 520 KYCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PRNSFLVYE 594 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 594 (784)
.+.||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 467999999999999864 56889999886431 23467899999999999999999999854 456789999
Q ss_pred cccCCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee----cCCCceEEecc
Q 042086 595 YLERGSLATILSNDG------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL----CLDYEARVSDF 664 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Df 664 (784)
|+.+ +|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9865 8888875321 122578889999999999999999999 99999999999999 45678999999
Q ss_pred ccccccCCCCC---cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 665 GIAKFLKPDSS---NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 665 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
|+++.+..... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99987653322 22345789999999999764 578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.41 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=202.3
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH 585 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 585 (784)
+++..+.++|++.+.||+|+||.||+|... +++.+|+|.+... ....+++.+|+.+++++ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344556788999999999999999999875 7899999988642 22346788999999999 89999999999865
Q ss_pred C-----CceEEEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 586 P-----RNSFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 586 ~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
. +..++|+||+++|+|.++++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 35799999999999999886422 223678899999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCcccccccccccccccccccCC-----cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK-----VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRN 734 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~ 734 (784)
||+|||++..............++..|+|||.+.... ++.++|||||||++|||++|+.||..........
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~---- 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF---- 243 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH----
Confidence 9999999987654433334457889999999986432 6789999999999999999999986432211000
Q ss_pred cccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 ISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 244 -~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 -KIPRNPPPTLLH----PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHhcCCCCCCCc----ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000000011111 1122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.88 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=203.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|++|.||++... +++.||+|.+...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999876 68999999987543333344567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++...+ .++...+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999997653 578899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ......+.......+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--- 220 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKVRFPSF--- 220 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCccCCcc---
Confidence 3345688999999999888889999999999999999999999863321 11111222222222211
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
....+.+++.+||..||++|| +++|+++
T Consensus 221 -~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 -FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 134577899999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.34 Aligned_cols=259 Identities=18% Similarity=0.251 Sum_probs=192.4
Q ss_pred CceeEecc--cceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 519 VKYCIGIG--GQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 519 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
+.+.||+| +|++||+++.+ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 78999999865 7899999998654221 12245677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999865422 3478899999999999999999999 999999999999999999999999987554321111
Q ss_pred -------ccccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc------
Q 042086 676 -------NCTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI------ 740 (784)
Q Consensus 676 -------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 740 (784)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||+...................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 1122346778999999976 4588999999999999999999999964321100000000000000
Q ss_pred -------------cCC----------CCCC-----CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 -------------LDP----------RLPT-----PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 -------------~d~----------~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+. .... ...........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0000 00011122346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=313.34 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=203.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|... +|+.||+|++.... .....+.+.+|+++++.++||||+++++++......++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 46888899999999999999865 68899999876532 2234578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++...+ .+++..+..++.+++.|+.|||+.. +++||||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999999987643 5788999999999999999999732 8999999999999999999999999998754322
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccc---ccccccccccCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSS---NRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~d~~~~~~~~ 750 (784)
......|+..|+|||++.+..++.++|+|||||++||+++|+.||+.......... ........++....+..+
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP- 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC-
Confidence 12345789999999999888899999999999999999999999974322100000 000011112211111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
..+...++.+++.+|++.||++|||++|+++.
T Consensus 235 -~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 235 -SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11234468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.00 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=186.2
Q ss_pred eEecccceEEEEEEEcC---CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 522 CIGIGGQGSVYKAKLTS---GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
.||+|+||+||+|...+ ...+++|.+.... .......|.+|+..++.++||||+++++++.+.+..++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999997543 4578888765432 222345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC-
Q 042086 599 GSLATILSNDGA--IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS- 675 (784)
Q Consensus 599 gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 675 (784)
|+|.+++..... ....++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 22356778889999999999999999 999999999999999999999999999875433221
Q ss_pred -ccccccccccccccccccc-------CCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 042086 676 -NCTELVGTFGYIAPELVYT-------MKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 676 -~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||......... ... .. ..+..++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~-~~-~~~~~~~ 231 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL---KQV-VR-EQDIKLP 231 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---HHH-hh-ccCccCC
Confidence 1223345678999998743 356789999999999999999 78887633211000 000 00 0001111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+ .........+.+++..|+ .||++|||+++|++.|
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11 111122335667888888 5999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=320.85 Aligned_cols=255 Identities=21% Similarity=0.377 Sum_probs=196.6
Q ss_pred hcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 45799999999999999999973 357899999987532 122345788999999999 689999999988654
Q ss_pred -CceEEEEecccCCCHHHHHhcCCC-------------------------------------------------------
Q 042086 587 -RNSFLVYEYLERGSLATILSNDGA------------------------------------------------------- 610 (784)
Q Consensus 587 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 610 (784)
...++||||+++|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999864211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc--ccc
Q 042086 611 ---------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTE 679 (784)
Q Consensus 611 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~ 679 (784)
...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999999 9999999999999999999999999999865432221 122
Q ss_pred cccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCCCCHHHHH
Q 042086 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQNVQDELI 757 (784)
Q Consensus 680 ~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~ 757 (784)
..+++.|+|||.+.+..++.++||||||+++||+++ |..||....... .....+... +...+ ... ..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~-~~~---~~ 309 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRAP-DYT---TP 309 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------HHHHHHhccCCCCCC-CCC---CH
Confidence 345678999999998889999999999999999997 999986432110 000001011 11111 111 23
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 758 SIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 758 ~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
++.+++..||+.||++|||+.||++.|
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 578899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.60 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=204.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|++|.||+|... +++.||+|.+...........+.+..|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999876 58999999987653332234567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987532 24688899999999999999999998 9999999999999999999999999998755322
Q ss_pred CC-----------------------------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccc
Q 042086 674 SS-----------------------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFIS 724 (784)
Q Consensus 674 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~ 724 (784)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 1123467889999999998889999999999999999999999986332
Q ss_pred cccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 042086 725 SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP----MHTVCQ 782 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~~vl~ 782 (784)
. ......+.+.....+.. ......+.+++.+|++.||++||+ ++++++
T Consensus 237 ~--------~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R--------DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h--------HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11122222222222111 113456889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.78 Aligned_cols=192 Identities=24% Similarity=0.314 Sum_probs=167.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..+|.+.+.||+|+||.||+|... +++.||||... ...+.+|++++++++|+|||++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 447999999999999999999876 58899999532 23467899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||++. ++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99995 69999886543 2689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCC
Q 042086 673 DSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPR 720 (784)
Q Consensus 673 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~ 720 (784)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 2221 22456999999999999999999999999999999999987664
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.24 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=188.3
Q ss_pred eeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe-cCCceEEEEec
Q 042086 521 YCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS-HPRNSFLVYEY 595 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 595 (784)
+.||+|+||.||+|... ++..||+|.+.... .....+.+..|+.+++.++||||+++++++. .++..++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999853 24579999875421 2223567889999999999999999999875 45568899999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.+.....
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999975432 456778889999999999999998 999999999999999999999999999986543211
Q ss_pred ----cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 676 ----NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG-DHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 676 ----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
......++..|+|||.+.+..++.++|||||||++|||++| ..||....... ....+........+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 225 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--------ITVYLLQGRRLLQPE 225 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcCCCCCCCC
Confidence 11233456789999999888899999999999999999995 55554321110 011111111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.. ...+.+++.+||+.+|++||++.+|++.|
T Consensus 226 ~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 226 YC---PDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred cC---CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 12 23578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.17 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=199.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
..+|++.+.||+|+||.||+|+.. .+..||+|.+.... .....+++.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 346899999999999999999742 12368999876431 222356899999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDG-------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
..+..++++||+++|+|.+++.... ....+++..+.+++.|++.|++|||++ +|+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999997532 123578899999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 9999999999999999866432221 122234567999999999999999999999999999998 888875322110
Q ss_pred cccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+. ....++.+++.+|++.+|++||++.|+++.|
T Consensus 245 -------~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 245 -------LFKLLKEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred -------HHHHHHcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 011111111111111 2233688999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.41 Aligned_cols=259 Identities=19% Similarity=0.272 Sum_probs=197.0
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP----- 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 586 (784)
..++|++.+.||+|+||.||+|... .++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3578999999999999999999865 688999999875422 223356788999999999999999999987543
Q ss_pred -CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 587 -RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 587 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 78777743 367788999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------c-c-----
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------S-N----- 732 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~-~----- 732 (784)
+++..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.......... . .
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99865432 22344578999999999999999999999999999999999999996432110000 0 0
Q ss_pred ----------------cccccccccCCC-CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 ----------------RNISLNEILDPR-LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 ----------------~~~~~~~~~d~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+..... .+............+.+++.+|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00000001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.74 Aligned_cols=244 Identities=27% Similarity=0.429 Sum_probs=195.8
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCC
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGS 600 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 600 (784)
+.||+|+||.||+|...+++.|++|.+...... ...+.|.+|++++++++||||+++++++.+....++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999999877999999988754321 235679999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc--c
Q 042086 601 LATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC--T 678 (784)
Q Consensus 601 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--~ 678 (784)
|.+++.... ..+++..+..++.+++.|++|||++ +++||||+|+||+++.++.+||+|||++.......... .
T Consensus 79 l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999997543 2578889999999999999999999 99999999999999999999999999998654222111 1
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--CCCCCCCCCHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP--RLPTPPQNVQDE 755 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~ 755 (784)
...++..|+|||.+.+..++.++|+|||||++||++| |..||....... ..+.+.. +... +. ..
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---------~~~~~~~~~~~~~-~~---~~ 220 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---------TRERIESGYRMPA-PQ---LC 220 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---------HHHHHhcCCCCCC-Cc---cC
Confidence 1233567999999988889999999999999999999 888875332110 0011111 1111 11 22
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 756 ~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..++.+++.+|++.+|++|||+.|+++.|
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 34688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.19 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=198.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|+||.||+|+.. +|+.||+|.+..... .......+.+|+.++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4788899999999999999875 789999999865322 22234568889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++ +|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 9975 8888876533 3588999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccccc---cccccccC
Q 042086 675 SNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRN---ISLNEILD 742 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~---~~~~~~~d 742 (784)
.......+++.|+|||.+.+.. ++.++|||||||++|||+||+.|+......... ..... .......+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 3344456788999999987654 688999999999999999999986422111000 00000 00000000
Q ss_pred C-CCCCCC------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 743 P-RLPTPP------QNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 743 ~-~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
. ...... ...+....++.+++.+|++.||++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 000000 0011223467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.55 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=200.4
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCC--CCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPC--EMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+|++.+.||+|++|.||+|... +++.||+|.+...... .......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999875 6899999998764322 112245677899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997654 3588999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cc--c---cccccc
Q 042086 673 DSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SS--N---RNISLN 738 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~--~---~~~~~~ 738 (784)
.........+++.|+|||.+.+ ..++.++|||||||++|||++|..||......... .. . ......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 4333444566888999999865 45788999999999999999998777532211000 00 0 000000
Q ss_pred cccCCCCCCC---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 739 EILDPRLPTP---PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 739 ~~~d~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.......... ..........+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 00011224568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.60 Aligned_cols=328 Identities=28% Similarity=0.260 Sum_probs=288.2
Q ss_pred cEEeCCCCcccccCCCCcCC-C-CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 80 STLDLSKNKLNGSIPFSFGN-L-TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 80 ~~L~L~~n~i~~~~~~~~~~-l-~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
..||.+++++....-..+.. + +.-+.|+|++|+++.+-+..|.++++|+++++.+|.++ .+|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 34555555554322122211 1 34567999999999999999999999999999999999 888777777889999999
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (784)
+|.|+..-.+.++.++.|+.||||.|.|+...-.+|..-.++++|+|++|+|+......|.++.+|..|.|++|+|+...
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 99999888889999999999999999999666667877789999999999999999999999999999999999999888
Q ss_pred CCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccccccc
Q 042086 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNL 317 (784)
Q Consensus 238 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l 317 (784)
+..|.+++.|+.|+|..|+|...+ -..|..+++|+.|.|..|.+...-..+|..+.++++|+|+.|+++..-..++.++
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive-~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgL 292 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVE-GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGL 292 (873)
T ss_pred HHHhhhcchhhhhhccccceeeeh-hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccccc
Confidence 889999999999999999997332 2368889999999999999998888899999999999999999998878889999
Q ss_pred ccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEc
Q 042086 318 LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDV 397 (784)
Q Consensus 318 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 397 (784)
++|+.|+||+|.|..+-++.++-.++|++|+||+|+|+...+..|..+.+|+.|+|++|+++..-...|..+.+|+.|||
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence 99999999999999999999999999999999999999888889999999999999999999888888999999999999
Q ss_pred CCCCCcccCCCC
Q 042086 398 SYNELRGPIPNS 409 (784)
Q Consensus 398 ~~N~l~~~~p~~ 409 (784)
++|.+...|.+.
T Consensus 373 r~N~ls~~IEDa 384 (873)
T KOG4194|consen 373 RSNELSWCIEDA 384 (873)
T ss_pred cCCeEEEEEecc
Confidence 999998877663
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.88 Aligned_cols=248 Identities=27% Similarity=0.414 Sum_probs=198.8
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|.....||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 444467999999999999865 6899999987542 222356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++++|.+++... .+++..+..++.||+.|++|||++ +|+||||||+||+++.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999988542 478899999999999999999999 999999999999999999999999999986654433
Q ss_pred cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHH
Q 042086 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 755 (784)
......+++.|+|||.+.+..++.++||||||+++||+++|+.||......... ......+.+.... ....
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~ 244 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-----RRIRDNLPPRVKD----SHKV 244 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcCCCcccc----cccc
Confidence 334567899999999998888999999999999999999999998632221100 0011111111111 1122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 756 LISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 756 ~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...+.+++.+|+..||++|||++++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3357789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.54 Aligned_cols=253 Identities=28% Similarity=0.403 Sum_probs=202.4
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--CCceEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PRNSFLV 592 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 592 (784)
+|++.+.||.|+||.||+|... +++.||+|.+..... .....+.+..|+++++.++||||+++++++.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 4788899999999999999865 788999998865322 22335678899999999999999999998754 4567899
Q ss_pred EecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 593 YEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMH-----HDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
|||+++++|.+++.... ....+++..++.++.|++.|++||| +. +++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 99999999999996532 2346889999999999999999999 66 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
+..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||+..... .....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 228 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIKEGKFR 228 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHhcCCCC
Confidence 987765443344567899999999999888999999999999999999999998743210 001111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
..+ ......+.+++.+|++.+|++||++++|++.
T Consensus 229 ~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RIP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCc---cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 1233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.40 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=201.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCC---
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPR--- 587 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--- 587 (784)
++++|++.+.||+|++|.||+|..+ +++.+++|.+.... ...++|.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4678999999999999999999875 67899999886532 2356899999999999 7999999999996544
Q ss_pred ---ceEEEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEec
Q 042086 588 ---NSFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 588 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
..++||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999986532 224688899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
||++..............+++.|+|||++.. ..++.++|||||||++|++++|+.||....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~ 228 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALF 228 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHH
Confidence 9999876544333445668899999998753 346778999999999999999999986322110 011
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
++....... ..........+.+++.+|+..||++|||+.++++
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 KIPRNPPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HhhccCCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111100 0111223456889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=314.21 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=198.7
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|+....||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 444557999999999999875 78999999986532 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++..+.....
T Consensus 100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 999999998754 2478899999999999999999999 999999999999999999999999999976654443
Q ss_pred cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHH
Q 042086 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 755 (784)
......+++.|+|||++.+..++.++|||||||++|||++|+.||........... ......+.... ....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~----~~~~ 243 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-----LRDSPPPKLKN----AHKI 243 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HhccCCCCccc----cCCC
Confidence 34456789999999999988899999999999999999999999864322110000 00000000111 1112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 756 LISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 756 ~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+|++.+|++||+++++++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 235778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.35 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=197.9
Q ss_pred CCCCceeEecccceEEEEEEE-----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--Cc
Q 042086 516 GFDVKYCIGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RN 588 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 588 (784)
-|++.+.||+|+||.||+++. .+++.||+|.++... .....+++.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 478889999999999999974 358899999987542 223356799999999999999999999998765 56
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 889999999999999986543 2578999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc---ccccccc---ccc
Q 042086 669 FLKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---SSNRNIS---LNE 739 (784)
Q Consensus 669 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---~~~~~~~---~~~ 739 (784)
.+...... .....++..|+|||.+.+..++.++|||||||++||+++++.|+......... ....+.. ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76533221 12345667899999998888999999999999999999987764321110000 0000000 000
Q ss_pred cc-CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 740 IL-DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 740 ~~-d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+ +......+. .....+.+++.+|++.+|++|||++++++.|
T Consensus 238 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 238 VLEEGKRLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred HHHcCccCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 00 111111111 2334688999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.09 Aligned_cols=261 Identities=19% Similarity=0.230 Sum_probs=197.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+++|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999865 689999999865421 22334678999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||+. +++.+++.... ..+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred Eeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99996 68877775432 2467788889999999999999999 999999999999999999999999999986544
Q ss_pred CCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccc----------
Q 042086 673 DSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNR---------- 733 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~---------- 733 (784)
.........+++.|+|||.+.+. .++.++|||||||++|||++|+.||+........ ....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 33333445678999999998754 4788999999999999999999999743321000 0000
Q ss_pred ccccccccCCCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 NISLNEILDPRLPTPP---QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 ~~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+......+... .........+.+++.+|++.||++|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 000011345778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.30 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=197.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+|++.+.||+|+||.||+|..+ +|+ .||+|.+..... .....++.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 56889999999999999999864 333 589998765421 2234678899999999999999999999987 788
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|+||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999976433 488999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccc--ccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 042086 670 LKPDSSNCT--ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 670 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
......... ...++..|+|||.+....++.++|+||||+++||+++ |+.||+...... ....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~ 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGERL 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhCCCCC
Confidence 654332211 1223568999999988889999999999999999998 999987432110 00111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+.. ....+.+++.+||..||++||++.++++.|
T Consensus 231 ~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 231 PQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 11111 123577899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.85 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=201.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|..+ +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46889999999999999999976 68999999986643322 23567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++..... .+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999988775432 478999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc------cccccccccc------
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS------SNRNISLNEI------ 740 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~------~~~~~~~~~~------ 740 (784)
........++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... ..........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 443445568899999999875 346789999999999999999999985322110000 0000000000
Q ss_pred c----CCCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 L----DPRLPTPP---QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 ~----d~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+ .+...... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00000000 001122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.12 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=200.4
Q ss_pred CCCCceeEecccceEEEEEEEcC--CCEEEEEEcCCCCCC-------CCCChhhHHHHHHHHhc-cCCCceeeEEeEEec
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLTS--GEILAVKKFHSLWPC-------EMVPQPEFVNEIKTLTE-LRHRSIVKFYGFCSH 585 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 585 (784)
+|++.+.||+|+||.||+|.... ++.+|+|.+...... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998764 788999987543211 12233557788888875 699999999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 586 PRNSFLVYEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
.+..++||||+++++|.+++... .....+++..+++++.|++.|+.|||+.. +++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988532 12246888999999999999999999631 8999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
|.+....... ......++..|+|||.+.+..++.++||||||+++||+++|+.||....... ....+.+..
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--------~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--------LATKIVEAV 229 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------HHHHHhhcc
Confidence 9998765433 3345678899999999998889999999999999999999999986322110 011111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...... ......+.+++.+||+.||++||++.||.+++
T Consensus 230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 111111 11234688899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.18 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=190.2
Q ss_pred eeEecccceEEEEEEEc-CCC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEecc
Q 042086 521 YCIGIGGQGSVYKAKLT-SGE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
+.||+|+||.||+|+.. ++. .+++|.+.... .....+.+.+|+.+++++ +||||+++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 35899999999999875 344 46888876432 122346788999999999 8999999999999999999999999
Q ss_pred cCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEec
Q 042086 597 ERGSLATILSNDG-------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 597 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
++|+|.++++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999997532 123478899999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD 742 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d 742 (784)
||++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... ....+..
T Consensus 156 fgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~ 226 (270)
T cd05047 156 FGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQ 226 (270)
T ss_pred CCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHhC
Confidence 9998632211 11112233567999999988889999999999999999997 999986322110 0001100
Q ss_pred C-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 743 P-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 743 ~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. +...+ . .....+.+++.+|++.||.+|||+.++++.|
T Consensus 227 ~~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 227 GYRLEKP-L---NCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred CCCCCCC-C---cCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 0 11111 1 1223578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=305.89 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=200.3
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC---CCceeeEEeEEecCCceEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR---HRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 591 (784)
.|+..+.||+|+||.||+|... +++.||+|.+.... .....+++.+|+.+++.++ |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4778889999999999999864 78999999886532 2234567889999999996 9999999999999899999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++++|.++++.. .+++.....++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||++..+.
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999998653 578899999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
..........|+..|+|||.+.++ .++.++|||||||++|+|++|+.||+........ ..+.....+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 224 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--------MLIPKSKPPRLED 224 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--------hccccCCCCCCCc
Confidence 554444555789999999998754 4688999999999999999999998643221100 0000001111101
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....++.+++.+|++.||++||++.++++
T Consensus 225 --~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 --NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 113446889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.62 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=196.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||++... +++.|++|.+...........+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999876 67899999887543222233567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997653 478889999999999999999998 9999999999999999999999999998642110
Q ss_pred C---------------CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 674 S---------------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 674 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
. .......++..|+|||.+....++.++|+|||||++||+++|+.||..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~~ 226 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFG 226 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 0 001123578899999999888899999999999999999999999852211 11111
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
.........+.. .......+.+++.+||+.||++||++.++.
T Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 268 (305)
T cd05609 227 QVISDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAF 268 (305)
T ss_pred HHHhcccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHH
Confidence 111111111110 011233578999999999999999854433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.87 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=186.0
Q ss_pred eEecccceEEEEEEEcCC---CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 522 CIGIGGQGSVYKAKLTSG---EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
.||+|+||.||+|+..++ ..+++|.+.... .....+.|.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999975433 356667665432 122356899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC--C
Q 042086 599 GSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS--S 675 (784)
Q Consensus 599 gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--~ 675 (784)
|+|.++++.... ....++.....++.||++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999976432 23456677889999999999999998 99999999999999999999999999986432211 1
Q ss_pred ccccccccccccccccccc-------CCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 042086 676 NCTELVGTFGYIAPELVYT-------MKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
......++..|+|||++.. ..++.++|||||||++|||++ |..||.....................++.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 2234567889999998753 245779999999999999997 56677532211100000001111122222221
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++..|| .+|++||++++|++.|
T Consensus 237 ------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 237 ------PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 12235677888999 6799999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=308.17 Aligned_cols=258 Identities=27% Similarity=0.332 Sum_probs=200.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 591 (784)
++|+..+.||.|++|.||+|... +++.+|+|.+..... .....++.+|++++++++||||+++++++.+. +..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 46888999999999999999975 689999998875321 23356799999999999999999999998653 46899
Q ss_pred EEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 592 VYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
||||+++++|.+++.... ....+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999999875421 223578889999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---CCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD---PRLPT 747 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d---~~~~~ 747 (784)
.... .....++..|+|||.+.+..++.++||||+||++|||++|+.||+....... ........+.+ +.+..
T Consensus 156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 156 VNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLSYIVNMPNPELKD 230 (287)
T ss_pred cccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHHHHhcCCchhhcc
Confidence 4322 1234578899999999988999999999999999999999999874422000 00000111111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+.........+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111223456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=303.18 Aligned_cols=237 Identities=26% Similarity=0.426 Sum_probs=187.8
Q ss_pred eeEecccceEEEEEEEcCCC-----------EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 521 YCIGIGGQGSVYKAKLTSGE-----------ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
+.||+|+||.||+|...+.. .|++|.+.... .....|.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999876432 57777765432 126789999999999999999999999988 778
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-------ceEEe
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-------EARVS 662 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~ 662 (784)
++|+||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999999976542 578899999999999999999998 999999999999999887 79999
Q ss_pred ccccccccCCCCCcccccccccccccccccccC--CcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 042086 663 DFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM--KVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 663 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
|||++..... .....++..|+|||++.+. .++.++|||||||++||+++ |..|+........ .... .
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-----~~~~-~ 220 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-----ERFY-Q 220 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-----HHHH-h
Confidence 9999986543 2234567789999999876 78899999999999999999 5777653321100 0000 0
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 740 ~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+ . ...+.+++.+||..+|++|||+.+|++.|
T Consensus 221 -~~~~~~~~-~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -DQHRLPMP-D-----CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -cCCCCCCC-C-----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00111111 1 14688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=343.05 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=198.4
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--CCc
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PRN 588 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 588 (784)
...++|++.+.||+|+||+||+|+.. +++.||+|.+..... .......|..|+.+++.++|||||+++++|.+ ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34578999999999999999999876 678899998865322 22335678999999999999999999998854 356
Q ss_pred eEEEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEEeCCCCCCeeecCC-------
Q 042086 589 SFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCF----PPIVHRDISSKNVLLCLD------- 656 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dlk~~Nill~~~------- 656 (784)
+++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997532 22468999999999999999999998521 259999999999999642
Q ss_pred ----------CceEEeccccccccCCCCCccccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCccc
Q 042086 657 ----------YEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFIS 724 (784)
Q Consensus 657 ----------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~ 724 (784)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998764322 2344578999999999854 458899999999999999999999996432
Q ss_pred cccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 725 SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... ..... +......+.. .....+.+||..||+.+|++||++.+++.
T Consensus 248 ~~~-------qli~~-lk~~p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS-------QLISE-LKRGPDLPIK---GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH-------HHHHH-HhcCCCCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 00011 1111111111 12346889999999999999999999874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=304.42 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=201.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|+||.||+|... +++.|++|.+...... ....+.+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 4888999999999999999865 7899999998764322 2346789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++.... .+++..+..++.++++|++|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999997643 367788999999999999999999 99999999999999999999999999998765433
Q ss_pred Cccc----ccccccccccccccccCC---cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 675 SNCT----ELVGTFGYIAPELVYTMK---VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 675 ~~~~----~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
.... ...+++.|+|||++.+.. .+.++||||||+++||+++|+.||+......... ........+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~ 229 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FHVGAGHKPPIPD 229 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HHHhcCCCCCCCc
Confidence 3222 356788999999998766 8889999999999999999999996432100000 0000001111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.+++.+|++.+|++||++.+++.
T Consensus 230 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 ----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1112345778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.32 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=197.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57899999999999999999876 689999999875422 122345778999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ +|.+++..... .+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99985 99998875432 578899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccccccc------c
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRNISL------N 738 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~~~~------~ 738 (784)
........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......... ........ .
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 222233456889999999875 45788999999999999999999998643310000 00000000 0
Q ss_pred cccCCCCCCC--C---CC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EILDPRLPTP--P---QN--VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~d~~~~~~--~---~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......... . .. .......+.+++.+|++.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 0 00 0011146778999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=301.76 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=201.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|+..+.||+|++|.||++... +++.+|+|.+..... .....+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 4888999999999999999865 788999999865422 23346789999999999999999999999998899999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEeccccccccCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKPD 673 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~~~~~~ 673 (784)
|+++++|.+++.... ...+++..+.+++.++++|++|||++ +|+||||+|+||+++.+ +.+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999997543 23478899999999999999999999 99999999999999865 46899999999876533
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+..... .....+........+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--- 223 (256)
T cd08220 156 S-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMSGTFAPISD--- 223 (256)
T ss_pred c-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHhcCCCCCCC---
Confidence 2 223456888999999999888899999999999999999999998643211 0111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12335788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=307.98 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=203.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 57999999999999999999864 6889999987543 2234567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999998653 467888999999999999999999 9999999999999999999999999998876554
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........+++.|+|||.+....++.++|||||||++||+++|+.||.......... .....+.... ....
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~~--~~~~ 239 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPEL--QNPE 239 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehhcCCCCCC--CCcc
Confidence 444445578889999999988889999999999999999999999996432211000 0000111111 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.....+.+++.+||..+|++||++.+++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 233468889999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=303.11 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=194.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC--CCChhhHHHHHHHHhccCCCceeeEEeEEec--CCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE--MVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 589 (784)
..|+..+.||+|+||.||+|... +++.|++|++....... ....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999865 68999999886532211 1223568899999999999999999999865 3567
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++++||+++++|.+++...+ .+++.....++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997643 477888999999999999999998 999999999999999999999999999986
Q ss_pred cCCCC---CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 670 LKPDS---SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 670 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
..... .......++..|+|||.+.+..++.++|||||||++||+++|+.||........ ..........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~ 228 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-------IFKIATQPTNP 228 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-------HHHHhcCCCCC
Confidence 54321 112334578899999999988899999999999999999999999864322110 00000001111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++ +||..+|++||+++||++
T Consensus 229 ---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 ---QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111223455566 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.03 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=202.8
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|+||.||+|..+ +|..||+|.+..... .....+.+.+|+.+++.++|+||+++++++.+....++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4788899999999999999876 688999999865321 22345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEeccccccccCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKFLKPD 673 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~~ 673 (784)
|+++++|.+++..... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999875432 3578999999999999999999998 999999999999999885 4699999999876544
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........|++.|+|||...+..++.++||||||+++||+++|+.||...... ....+.......... +
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---~ 224 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--------QLVLKICQGYFAPIS---P 224 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhcccCCCCC---C
Confidence 33334456889999999998888999999999999999999999998632211 011111111111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.....+.+++.+|++.+|++|||+.|+++.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 223368889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.55 Aligned_cols=238 Identities=22% Similarity=0.358 Sum_probs=184.6
Q ss_pred eEecccceEEEEEEEcC-------------------------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce
Q 042086 522 CIGIGGQGSVYKAKLTS-------------------------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 576 (784)
.||+|+||.||+|.... ...|++|.+.... .....+|.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 58999999999997421 2358888876431 1234578899999999999999
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 656 (784)
+++++++.+....++||||+++|+|..++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999999986533 3578899999999999999999998 99999999999999764
Q ss_pred C-------ceEEeccccccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHH-hCCCCCCcccccc
Q 042086 657 Y-------EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVI-KGDHPRDFISSIS 727 (784)
Q Consensus 657 ~-------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~ell-tg~~p~~~~~~~~ 727 (784)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3 3799999988654322 22356788999998865 56889999999999999995 6999986322110
Q ss_pred ccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 728 SSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 728 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...........+... ...+.+++.+||+.+|++|||+++|++.|
T Consensus 230 ---------~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 ---------KERFYEKKHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ---------HHHHHHhccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 001111111111111 12578899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.59 Aligned_cols=192 Identities=21% Similarity=0.307 Sum_probs=165.8
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
...+|++.+.||+|+||.||+|+.. +++.||+|.... .....|+.++++++||||+++++++.+....++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3467999999999999999999876 578899997432 133579999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|+||+. ++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999995 58999886543 3688999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPR 720 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~ 720 (784)
.. .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22 2234567899999999999999999999999999999999865553
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=302.56 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=207.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|++|.||+|... +++.|++|++...... ...+++.+|+.++.+++|+|++++++++...+..++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 36888999999999999999876 5999999998764221 34678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999765 357889999999999999999999 8 999999999999999999999999999987765
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........++..|+|||.+.+..++.++|+||||+++||+++|+.||...... ........+...........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~- 226 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAICDGPPPSLPAE- 226 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHhcCCCCCCCcc-
Confidence 444444567889999999999888999999999999999999999998644310 00111111222111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++..|++.+|++||++.++++
T Consensus 227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 227 -EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 03446889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=301.62 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=200.0
Q ss_pred CCCceeEecccceEEEEEEEcC-----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTS-----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
+++.+.||+|+||.||+++..+ +..||+|.+..... ....+.+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 4567899999999999998763 48899999865421 1146789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
+|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++....
T Consensus 79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999999975432 1288999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccc-ccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 672 PDSSNCT-ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 672 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
....... ...+++.|+|||.+.+..++.++||||+|++++||++ |+.||+...... ....+........+
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~ 226 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--------VLEYLKKGYRLPKP 226 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCC
Confidence 4322211 2336789999999988889999999999999999998 788876322110 00111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ....++.+++.+|+..||++|||+.|+++.|
T Consensus 227 ~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 E---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 1334688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.94 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=196.7
Q ss_pred cCCCCceeEecccceEEEEEEEcC----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|.+.+.||+|+||.||+|...+ ...|++|....... ....+.|.+|+.+++.++||||+++++++.+ ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 468889999999999999998643 34789998765321 2235679999999999999999999999875 5578
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999997643 2578999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCC
Q 042086 671 KPDSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRLPT 747 (784)
Q Consensus 671 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~ 747 (784)
...... .....++..|+|||.+....++.++||||||+++||+++ |..||....... ....+.. .+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~~~ 229 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGERLPM 229 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCcCCC
Confidence 443211 222334568999999988889999999999999999996 999986432111 0001111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+ ... ...+.+++.+|+..+|++|||+.++++.|
T Consensus 230 ~-~~~---~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 230 P-PNC---PPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred C-CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 122 23688899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.96 Aligned_cols=244 Identities=27% Similarity=0.460 Sum_probs=195.5
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||.||+|.. +++.||+|.+... ...+.+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4588999999999999999975 5788999988642 2346799999999999999999999998764 4789999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999976432 3578899999999999999999998 9999999999999999999999999998764322
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC-CCCCCCC
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRL-PTPPQNV 752 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~ 752 (784)
......+..|+|||.+.+..++.++|+|||||++|||++ |+.||........ .+.+.... ..++.
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~-- 220 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---------KECVEKGYRMEPPE-- 220 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---------HHHHhCCCCCCCCC--
Confidence 122334578999999988889999999999999999997 9999863321100 00011111 11111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+++.+||+.+|++||+++++++.|
T Consensus 221 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 221 -GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred -cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2234678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.54 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=170.1
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-C-----CceeeEEeEEecCCc
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-H-----RSIVKFYGFCSHPRN 588 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~ 588 (784)
+|.+.+.||+|.||.|.+|.+. +++.||||+++.. ..-..+-..|+.+|..++ | -|+|++++||...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7899999999999999999865 7999999999873 223556778999999996 4 399999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC--CceEEecccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD--YEARVSDFGI 666 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfG~ 666 (784)
.|||+|.+.. +|+++++.+.. ..++...++.++.||+.||..||+. +|||+||||+|||+.+- ..+||+|||.
T Consensus 263 lciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999977 99999987654 4589999999999999999999999 99999999999999754 4799999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPR 720 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~ 720 (784)
|+...... ....-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|
T Consensus 338 Sc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 338 SCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred ccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 99754332 2566788999999999999999999999999999999997655
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.51 Aligned_cols=259 Identities=19% Similarity=0.202 Sum_probs=191.4
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC------CceeeEEeE
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH------RSIVKFYGF 582 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~ 582 (784)
+....++|++.+.||+|+||+||+|... +++.||||+++... ....++..|+.+++.++| +++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3345678999999999999999999865 68899999986421 123456677777777654 458999999
Q ss_pred EecC-CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCC---
Q 042086 583 CSHP-RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDY--- 657 (784)
Q Consensus 583 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~--- 657 (784)
+... ...++|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 8764 4678999987 679999887643 58889999999999999999997 5 999999999999998765
Q ss_pred -------------ceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccc
Q 042086 658 -------------EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFIS 724 (784)
Q Consensus 658 -------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~ 724 (784)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432 22345689999999999999999999999999999999999999997433
Q ss_pred cccccc-------ccc--------ccccccccCCCC--C-C-C-----------CCCCHHHHHHHHHHHHhcccCCCCCC
Q 042086 725 SISSSS-------SNR--------NISLNEILDPRL--P-T-P-----------PQNVQDELISIVEVAFLCLNESPESR 774 (784)
Q Consensus 725 ~~~~~~-------~~~--------~~~~~~~~d~~~--~-~-~-----------~~~~~~~~~~l~~li~~cl~~dP~~R 774 (784)
...... ... .....++++... . . . ..........+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 211000 000 000000000000 0 0 0 00000112357799999999999999
Q ss_pred CCHHHHHH
Q 042086 775 PPMHTVCQ 782 (784)
Q Consensus 775 Ps~~~vl~ 782 (784)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.54 Aligned_cols=239 Identities=23% Similarity=0.398 Sum_probs=187.2
Q ss_pred eeEecccceEEEEEEEcC--------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 521 YCIGIGGQGSVYKAKLTS--------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+.||+|+||.||+|.... ...|++|.+... .....+++..|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999997642 234788876542 122346788999999999999999999999998899999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc--------eEEecc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE--------ARVSDF 664 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~Df 664 (784)
|||+++|+|.++++..+. .+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999976543 578899999999999999999999 9999999999999987765 699999
Q ss_pred ccccccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCC-CCCCccccccccccccccccccccC
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGD-HPRDFISSISSSSSNRNISLNEILD 742 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~d 742 (784)
|++...... ....+++.|+|||.+.+. .++.++|||||||++||+++|. .|+....... ......
T Consensus 153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------~~~~~~ 219 (258)
T cd05078 153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------KLQFYE 219 (258)
T ss_pred ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------HHHHHH
Confidence 998755322 234678899999999864 5788999999999999999985 5654322110 001111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 743 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+...+. ....++.+++.+||+.||++|||++++++.|
T Consensus 220 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 DRHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ccccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1111111 1123578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.60 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=196.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC--CCChhhHHHHHHHHhccCCCceeeEEeEEecC--Cce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE--MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 589 (784)
++|++.+.||+|+||.||+|... +++.||+|.+....... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46899999999999999999875 68999999875432111 12245788899999999999999999998763 467
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++++|.+++.... .+++....+++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 467788899999999999999999 999999999999999999999999999986
Q ss_pred cCCCC---CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 670 LKPDS---SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 670 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
..... .......++..|+|||.+.+..++.++|||||||++||+++|+.||........ .......+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~ 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-------IFKIATQPTNP 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-------HHHHhcCCCCC
Confidence 54211 112334688899999999888899999999999999999999999863321110 00000111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.........+.+++.+|+. +|++||+++||++.
T Consensus 229 ---~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 ---VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1112334467788889985 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=304.79 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=198.7
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCC-------ChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMV-------PQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
+|.+.+.||+|+||.||+|... +|+.||+|.+......... ..+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778889999999999999865 6899999987542211111 1246788999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++|+||+++|+|.++++..+ .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 578889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC--cccccccccccccccccccCC--cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042086 668 KFLKPDSS--NCTELVGTFGYIAPELVYTMK--VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 668 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
........ ......++..|+|||.+.... ++.++||||||+++||+++|+.||............... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK------RS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc------cc
Confidence 86543211 123346788999999987654 788999999999999999999998632221100000000 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+.....+....+.+++.+|++.||++||++++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111112234568889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.63 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=200.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+-|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+..+++++||||+++++++..++..++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 34778899999999999999865 78999999875432 1223567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++..+...
T Consensus 82 e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 82 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999999998642 478899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........++..|+|||.+.+..++.++|+|||||++|++++|..||....... ....+.....+ ....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~---~~~~ 223 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNNPP---TLEG 223 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCCCC---CCCc
Confidence 333344567889999999988888999999999999999999999986322110 00001001111 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....++.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 23346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=301.61 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=200.6
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCC--CCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPC--EMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+|+..+.||+|++|.||+|... +++.|++|.+...... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999876 7999999988653221 122346799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997643 478899999999999999999999 999999999999999999999999999887543
Q ss_pred CCCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD-PRLPTPPQ 750 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~ 750 (784)
.. ......+++.|+|||.+.... ++.++|+||||+++|++++|+.||......... ..+.. ...+..+.
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--------~~~~~~~~~~~~~~ 225 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--------FKIGRSKELPPIPD 225 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--------HHHHhcccCCCcCC
Confidence 32 234556889999999987766 889999999999999999999998643211100 00000 11111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++.+||+.+|++||++.++++
T Consensus 226 ---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 ---HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 12345778999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=309.36 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=197.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
..|+..+.||+|+||.||+|... +++.||+|.+...........+++.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888999999999999999875 68999999886543222333457889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++ |++.+++.... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 58877775433 2578899999999999999999998 9999999999999999999999999998765432
Q ss_pred CCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||........ ...+.....+. .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~--~ 234 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPT--L 234 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--------HHHHhcCCCCC--C
Confidence 2346788999999874 45688899999999999999999999864322110 00000001111 0
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+.+++.+||+.||++||++.+|+.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11223456889999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.23 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=203.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|+..+.||+|++|.||+|... +++.||+|.+..... ....+++.+|++++++++||||+++++++...+..++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 35788899999999999999876 689999998876422 234567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||+++++|.+++.... ..++.....+++.|++.|++|||+ . +++||||||+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999999997643 467888999999999999999999 7 999999999999999999999999999876543
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
... ....++..|+|||.+.+..++.++||||||+++|++++|+.||......... .......+.....+..+.
T Consensus 154 ~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-- 226 (265)
T cd06605 154 SLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNEPPPRLPS-- 226 (265)
T ss_pred HHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HHHHHHHHhcCCCCCCCh--
Confidence 222 1267888999999999989999999999999999999999998643210000 000111111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.+++.+||..||++|||+.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 113456889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=321.39 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=195.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
..+|++.+.||+|+||.||++... .++.||+|.+... ..+.+|+++++.++||||+++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999753 4678999987542 24568999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+|||++. ++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999986 5899988433 3588999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------------cccc
Q 042086 671 KPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---------------SSNR 733 (784)
Q Consensus 671 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---------------~~~~ 733 (784)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 543222 23467999999999999999999999999999999999999998532211000 0000
Q ss_pred cc------ccccc---cCCCCCCCCCCC--HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 NI------SLNEI---LDPRLPTPPQNV--QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 ~~------~~~~~---~d~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.. ..... ..+....+ ... ......+.+++.+|+..||++|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIP-PVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccchhHHHHHHhhcccccCCcccc-chhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000 00000000 000 011235778999999999999999999986
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.86 Aligned_cols=194 Identities=23% Similarity=0.383 Sum_probs=159.8
Q ss_pred ceeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--CCceEEEEe
Q 042086 520 KYCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PRNSFLVYE 594 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 594 (784)
...||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 357999999999999865 45789999886531 23467899999999999999999999853 456789999
Q ss_pred cccCCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee----cCCCceEEecc
Q 042086 595 YLERGSLATILSNDG------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL----CLDYEARVSDF 664 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Df 664 (784)
|+++ +|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 8888775321 123578889999999999999999999 99999999999999 45678999999
Q ss_pred ccccccCCCCC---cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 665 GIAKFLKPDSS---NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 665 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
|+++....... ......+|+.|+|||.+.+. .++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987654322 12345789999999998764 578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=303.97 Aligned_cols=255 Identities=23% Similarity=0.393 Sum_probs=200.2
Q ss_pred cCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+.... .....+++.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 46888999999999999999854 35679999876431 11134679999999999999999999999999899
Q ss_pred eEEEEecccCCCHHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEe
Q 042086 589 SFLVYEYLERGSLATILSNDGAI------EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVS 662 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 662 (784)
.++||||+++|+|.++++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999755421 2589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCC-CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042086 663 DFGIAKFLKPDS-SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 663 DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
|||++....... .......+++.|+|||.+.+..++.++||||||+++|++++ |..||....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHHH
Confidence 999987543221 22234456788999999988888999999999999999998 788885322111 00111
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......... .......+.+++.+|++.+|++||++.|+++.|
T Consensus 232 ~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 232 QAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred HcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 111111100 011223688899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=313.92 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=196.9
Q ss_pred eEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCC
Q 042086 522 CIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGS 600 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 600 (784)
++|+|.||+||.|++. +...+|||.+.+.. ....+-+..|+..-+.++|.|||+++|.+.+.+..-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999976 46678999886542 2235568899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-CCCceEEeccccccccCCCCCccc
Q 042086 601 LATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC-LDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 601 L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|.+.++.. ++. .-++.+.-.+..||++||.|||++ .|||||||-+|||++ ..|.+||+|||.++++..-..-..
T Consensus 659 LSsLLrskWGPl-KDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 659 LSSLLRSKWGPL-KDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHHHHhccCCC-ccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 99999743 322 126677888999999999999999 999999999999996 458999999999988765555556
Q ss_pred ccccccccccccccccCC--cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC-CCCCCCCCHHH
Q 042086 679 ELVGTFGYIAPELVYTMK--VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR-LPTPPQNVQDE 755 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~-~~~~~~~~~~~ 755 (784)
.+.||..|||||++..++ |..++|||||||++.||.||++||-....... .++.-. ....|.-..+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----------AMFkVGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----------AMFKVGMYKVHPPIPEEL 804 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----------hhhhhcceecCCCCcHHH
Confidence 788999999999997554 88899999999999999999999864332111 111101 11111222355
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 756 LISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 756 ~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+...+|.+|+.+||.+||+++++++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 667889999999999999999999875
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=305.96 Aligned_cols=247 Identities=24% Similarity=0.275 Sum_probs=194.7
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||+|+||+||++... +|+.||+|.+.............+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 6899999998754322233355678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccc
Q 042086 602 ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV 681 (784)
Q Consensus 602 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 681 (784)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence 999976543 3578899999999999999999999 999999999999999999999999999986543 22233456
Q ss_pred cccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHH
Q 042086 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761 (784)
Q Consensus 682 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~ 761 (784)
++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .............. ........+.+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLEMAVE----YPDKFSPEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhcccccccc----CCccCCHHHHH
Confidence 78899999999888899999999999999999999999864322100 00000011111111 11122346788
Q ss_pred HHHhcccCCCCCCC-----CHHHHHH
Q 042086 762 VAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 762 li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
++.+||+.||++|| ++.++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.89 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=199.1
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|+..+.||+|++|.||+|... +++.|++|++... .....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3555679999999999999864 7899999987542 22235568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++.. ..+++..+..++.|++.|++|||++ +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999876 2478899999999999999999999 99999999999999999999999999987655433
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......|++.|+|||...+..++.++|||||||++|||++|+.||.......... .......+.... ...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~----~~~ 240 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-----RIRDNLPPKLKN----LHK 240 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-----HHHhcCCCCCcc----ccc
Confidence 33344568999999999988889999999999999999999999986322111000 000000111111 111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=304.50 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=193.9
Q ss_pred eeEecccceEEEEEEEcC-------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 521 YCIGIGGQGSVYKAKLTS-------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......++.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 358999999999998642 3579999876532 2234668999999999999999999999999989999999
Q ss_pred ecccCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-----ceEEecc
Q 042086 594 EYLERGSLATILSNDG----AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-----EARVSDF 664 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~Df 664 (784)
||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999997532 123478899999999999999999998 999999999999999887 8999999
Q ss_pred ccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc
Q 042086 665 GIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 665 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
|++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||........ ...+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--------~~~~~ 227 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--------LQHVT 227 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--------HHHHh
Confidence 99976543221 1122345678999999999999999999999999999998 9999863221110 00010
Q ss_pred C-CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 742 D-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 742 d-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. .+... +. .....+.+++.+||..+|++||++++|++.|
T Consensus 228 ~~~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 228 AGGRLQK-PE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred cCCccCC-cc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 1 11111 11 2234678999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=307.24 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=197.9
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|+..+.||.|++|.||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4788999999999999999875 689999998865432 22234578999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+. ++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 589998865432 4688999999999999999999998 99999999999999999999999999998665443
Q ss_pred CcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc---ccccccC-
Q 042086 675 SNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNI---SLNEILD- 742 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~---~~~~~~d- 742 (784)
.......+++.|+|||.+.+.. ++.++|||||||++|||+||+.||......... ...... ....+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 3334456788999999887654 578999999999999999999998532211000 000000 0000000
Q ss_pred -CCCCCC-CCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 -PRLPTP-PQN----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 -~~~~~~-~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.. ... ......++.+++.+|++.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 000 0011235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=305.94 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=198.6
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|++.+.||.|++|.||+|... +|+.||+|++..... .....+.+.+|+++++.++|||++++++++.+++..++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 677899999999999999875 799999999875422 222345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
++ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++..+.....
T Consensus 80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 95 599999875442 3588999999999999999999998 999999999999999999999999999986654333
Q ss_pred cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc---ccc-----
Q 042086 676 NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNIS---LNE----- 739 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~---~~~----- 739 (784)
......+++.|+|||++.+. .++.++||||||+++|||++|+.||......... ....... ...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 33444668899999988664 4688999999999999999999998643221000 0000000 000
Q ss_pred --ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 --ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 --~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...................+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000011122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.38 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=195.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.++|+..+.||+|+||.||+|... +|+ .||+|.+.... ......++.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 356888899999999999999864 444 57888876532 122234788999999999999999999998754 4
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 679999999999999987543 2578889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 042086 669 FLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD--P 743 (784)
Q Consensus 669 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d--~ 743 (784)
.+...... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ..+++. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~ 228 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---------IPDLLEKGE 228 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHCCC
Confidence 76533221 223345678999999998889999999999999999997 899986322110 001111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.+.+. .....+.+++..||..+|++||+++++++.|
T Consensus 229 ~~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l 265 (303)
T cd05110 229 RLPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265 (303)
T ss_pred CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111111 1223578899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.05 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=201.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--CC
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PR 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 587 (784)
..|++.+.||+|+||.||+|+.. +++.||||.+...... ...++|.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46788899999999999999853 4789999998764221 236789999999999999999999999877 55
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 78999999999999999976542 588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcc---cccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--c-c---ccccccc
Q 042086 668 KFLKPDSSNC---TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--S-S---NRNISLN 738 (784)
Q Consensus 668 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--~-~---~~~~~~~ 738 (784)
.......... ....++..|+|||...+..++.++||||||+++|||++|+.|+......... . . .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8765332211 1223456799999998888999999999999999999999997532211000 0 0 0000011
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.+......+ .......++.+++.+||+.+|++|||+.||+++|
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 237 ELLKEGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred HHHHcCCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 1111111110 0111224688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.54 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=195.0
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC----
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP---- 586 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 586 (784)
...++|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 45678999999999999999999864 788999999865321 122345678999999999999999999987533
Q ss_pred --CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 587 --RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 587 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
...++++|++ +++|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 6799988754 2588899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNIS 736 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~ 736 (784)
|+++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... .......
T Consensus 163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999875432 234578999999999876 56888999999999999999999998642211000 0000000
Q ss_pred cccc-------cCCCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 LNEI-------LDPRLPTPPQN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ~~~~-------~d~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+ ....++..+.. .......+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000000000 0001124678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=283.52 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=198.0
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.+.+..||.|..|.||+++.+ +|...|||.+.... ..+..+++...++++..- ++|.||+.+|||......++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455667999999999999876 68999999988743 334456777777777655 5999999999999989999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|.|.. .++.+++.... .+++...-++...++.||.||.+++ +|+|||+||+|||+|+.|++|+||||++-++.+.
T Consensus 171 elMs~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 99865 66666655432 4677777788999999999999875 9999999999999999999999999999887643
Q ss_pred CCccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
...+..+|-+.|||||.+.. ..|+.++||||||+.++|+.||+.||..-.. ..+.+..+++...+..+.
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-------dFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-------DFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-------cHHHHHHHHhcCCCCCCc
Confidence 33456688899999999963 4688899999999999999999999874221 222333444433322221
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
. ...+..+.+++..|+++|+.+||...++++.
T Consensus 318 ~-~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 H-MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c-cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 1145578899999999999999999998863
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.39 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=200.5
Q ss_pred CCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCC---ChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMV---PQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
+|+..+.||+|++|.||+|.. .+++.||+|.+......... ..+.+..|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 47899999998654321111 24678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEecccccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKFL 670 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~ 670 (784)
|+||+++++|.+++...+ .+++..+..++.|++.|++|||++ +++|+||+|+||+++.++ .+||+|||.+..+
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997643 578899999999999999999999 999999999999998776 5999999999876
Q ss_pred CCCCCc----ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 671 KPDSSN----CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 671 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
...... .....++..|+|||.+.+..++.++||||+|+++|++++|+.||........ .....+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~--~ 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKIASA--T 227 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHHhcc--C
Confidence 543211 2234678899999999888899999999999999999999999863221100 0000000000 0
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+.........+.+++.+|+..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111112233456888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.16 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=201.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|++|.||+|... +++.||+|.++.... .....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36889999999999999999876 688999998875432 2334568999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++++.+..+.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999987777665443 2478899999999999999999999 9999999999999999999999999999876654
Q ss_pred CC-cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------cccccccc--cc
Q 042086 674 SS-NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS----------SSNRNISL--NE 739 (784)
Q Consensus 674 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~----------~~~~~~~~--~~ 739 (784)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||......... ........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 33 33456778899999999888 7889999999999999999999998632211000 00000000 00
Q ss_pred ccCC-CCCCCCC-------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDP-RLPTPPQ-------NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~-~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.... ..+.... .......++.+++++||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 0000000 00011456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=305.33 Aligned_cols=252 Identities=29% Similarity=0.444 Sum_probs=205.2
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
.++.|+..+.||+|++|.||+|..+ +++.|++|.+..... ..+.+.+|+++++.++|+|++++++++...+..++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567888899999999999999877 789999999875322 46678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999998654 3688999999999999999999998 99999999999999999999999999987655
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
..........+++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+........ ..
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~-~~ 238 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--------LFLITTKGIPPL-KN 238 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhcCCCCC-cc
Confidence 433333344578899999999888899999999999999999999999864322110 000111111110 01
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112346888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.36 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=204.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||.|+||.||+|+.. +++.||+|.+...........+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999876 689999999876543333456789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 3578899999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCCCCCH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD-PRLPTPPQNVQ 753 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~ 753 (784)
......++..|+|||.+.+..++.++|+||||+++|++++|+.||....... ......... .....+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~---- 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQETADVLYPA---- 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhccccccCcc----
Confidence 2344568889999999988889999999999999999999999987432110 000001111 1111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH--HHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPM--HTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~--~~vl~ 782 (784)
.....+.+++.+||+.||++||++ +|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 123468899999999999999999 88764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.07 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=200.7
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||.|++|.||+|+.. +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788999999999999999976 689999999875422 2234677899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++ +|.+++........+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 8999887655445689999999999999999999998 99999999999999999999999999998664433
Q ss_pred CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc-----cccc
Q 042086 675 SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNISL-----NEIL 741 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~~-----~~~~ 741 (784)
.......+++.|+|||.+.+. .++.++|||||||++||+++|+.||.......... ....... ....
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 333445678899999998654 46889999999999999999999986432110000 0000000 0000
Q ss_pred CCCCCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 DPRLPTPPQ-----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 d~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.... ..+.....+.+++.+|++.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011110000 00112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.78 Aligned_cols=261 Identities=24% Similarity=0.323 Sum_probs=200.4
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|++|.||+|... +|+.||+|++...... ....+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4888999999999999999875 7899999998764321 2335679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+ +++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 999999987543 3588999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-cccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------c--ccccc------c
Q 042086 675 S-NCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------S--SNRNI------S 736 (784)
Q Consensus 675 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~--~~~~~------~ 736 (784)
. ......++..|+|||.+.+.. ++.++||||+|+++|||++|.+||......... . ..... .
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1 233456889999999987544 688999999999999999998877532211000 0 00000 0
Q ss_pred cccccCCCCCC--CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 737 LNEILDPRLPT--PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 737 ~~~~~d~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...+..+.... ..+...+....+.+++.+|++.||++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 000011223578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.54 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=194.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHH-HhccCCCceeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKT-LTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
++|++.+.||+|+||.||+|+.. +|+.||+|.+..... .....++..|+.. ++..+||||+++++++..++..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 36889999999999999999876 699999999865421 1223456666665 5666899999999999999999999
Q ss_pred EecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||++ |+|.+++... .....+++..+..++.|++.|++|||+++ +++||||||+||+++.++.+||+|||++..+.
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99997 5898887642 22346899999999999999999999853 89999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccc----CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYT----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
.. .......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||+..... .......+......
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 227 (283)
T cd06617 156 DS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVEEPSPQ 227 (283)
T ss_pred cc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHhcCCCC
Confidence 32 22233567889999998864 44688999999999999999999998632110 01111111111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+. .....++.+++.+||..+|++||+++++++
T Consensus 228 ~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCc--cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 100 112346889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.12 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=192.5
Q ss_pred CCceeEecccceEEEEEEEc-CCCEEEEEEcCC-CCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc--eEEEE
Q 042086 518 DVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHS-LWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN--SFLVY 593 (784)
Q Consensus 518 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 593 (784)
+..+.||+|+|-+||||.+. +|..||=-.++. .........++|..|+.+|+.++||||+++|+++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45578999999999999875 577777221111 111233345889999999999999999999999987655 67899
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~~~~~ 672 (784)
|.|..|+|..|.++.+ ..+....+.++.||++||.|||++ .|+|||||||-+||||+.+ |.|||+|.|+|..+..
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999998765 477789999999999999999997 6799999999999999866 8999999999998764
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
. +.....|||.|||||++. ..|++.+||||||+.++||+|+..||..=... ....+++.-...+......
T Consensus 199 s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 199 S--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred c--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHHHhhcc
Confidence 3 334589999999999987 67999999999999999999999998521100 0001111111111110001
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. -.++.++|.+|+.. .++|||+.|+++
T Consensus 269 ~--dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 K--DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred C--CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 12577899999999 899999999985
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.03 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=198.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 591 (784)
++|++.+.||+|+||.||+|... +++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46888999999999999999876 6899999998654222 22234677899999999999999999998776 88999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|+||+++ +|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..+.
T Consensus 84 v~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999975 99998875432 588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------------------
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------------------- 730 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------------------- 730 (784)
..........+++.|+|||.+.+.. ++.++|+||||+++|||++|+.||..........
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 5433344456788999999987544 6889999999999999999999986432110000
Q ss_pred -cccccccccccCCCCCCCCCCCHH--HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 731 -SNRNISLNEILDPRLPTPPQNVQD--ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 731 -~~~~~~~~~~~d~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..............+. ...+. ....+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLR---KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhh---ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000000000 00111 2345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.30 Aligned_cols=263 Identities=19% Similarity=0.252 Sum_probs=197.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCc----
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRN---- 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~---- 588 (784)
++|++.+.||+|+||.||+|... +++.||+|.+...... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46889999999999999999875 6899999987654322 223457889999999994 6999999999977655
Q ss_pred -eEEEEecccCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CCceEEecc
Q 042086 589 -SFLVYEYLERGSLATILSNDGA--IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDF 664 (784)
Q Consensus 589 -~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Df 664 (784)
.++||||+++ +|.+++..... ...+++..+..++.||+.||+|||+. +|+||||+|+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999986 89988865332 24689999999999999999999999 9999999999999998 889999999
Q ss_pred ccccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNIS 736 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~ 736 (784)
|++..+...........+++.|+|||.+.+ ..++.++||||||+++|||++|..||.......... ......
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 999866443333344467889999998865 457889999999999999999999986432211000 000000
Q ss_pred ccccc-------CCCCC--CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 LNEIL-------DPRLP--TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ~~~~~-------d~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..... .+... ......+....++.+++.+|++.||++||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000 000001123446889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.29 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=194.2
Q ss_pred CCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
|++.+.||+|+||.||+|... +++.||+|.+..... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999753 468999999865432 2223567899999999999999999999886432
Q ss_pred -ceEEEEecccCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEec
Q 042086 588 -NSFLVYEYLERGSLATILSNDG---AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 588 -~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
..++++||+++|+|.+++.... ....+++.....++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 2478899999999998875321 223578889999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042086 664 FGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 664 fG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
||+++....... ......+++.|++||.+....++.++|||||||++|||++ |+.||...... .....+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--------~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--------EIYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------HHHHHH
Confidence 999986643221 1123345678999999998889999999999999999999 88887632211 000111
Q ss_pred cCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 741 LDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 741 ~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
... ....+ ......+.+++.+|++.+|++||++.++++.|
T Consensus 229 ~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 229 IKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred HcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111 11111 12234688999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.56 Aligned_cols=243 Identities=28% Similarity=0.375 Sum_probs=197.7
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||.|++|.||+|+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 5899999998765433334457899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccc
Q 042086 602 ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV 681 (784)
Q Consensus 602 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 681 (784)
.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99997643 478889999999999999999998 99999999999999999999999999998765432 223456
Q ss_pred cccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCCCCHHHHHHH
Q 042086 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD--PRLPTPPQNVQDELISI 759 (784)
Q Consensus 682 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l 759 (784)
+++.|+|||.+....++.++|+||+|+++||+++|+.||...... .......+.+ .....+ ... ..++
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~-~~~---~~~~ 223 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGNGKLEFP-NYI---DKAA 223 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccCCCCCCC-ccc---CHHH
Confidence 788999999998888999999999999999999999998643210 0111112221 111111 111 3468
Q ss_pred HHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 760 VEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 760 ~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
.+++.+||+.+|++||+ ++|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 89999999999999999 788775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.00 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=202.5
Q ss_pred cCCCCceeEecccceEEEEEEEcCC-CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSG-EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+-|.++..||.|+||.||+|..++. -..|-|.+.. .+.+..++|.-|+++++..+||+||++++.|...+.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 3466677899999999999987754 4445565543 24556789999999999999999999999999899999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|||.||-.+..+-.-+. .+...++.-++.|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999999887765443 678899999999999999999999 9999999999999999999999999998765544
Q ss_pred CCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
......+.|||+|||||+.+ ..+|+.++||||||++|.||..+.+|........ . -..+..--.|.+..
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---V--llKiaKSePPTLlq- 257 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---V--LLKIAKSEPPTLLQ- 257 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---H--HHHHhhcCCCcccC-
Confidence 44556789999999999975 4578999999999999999999999965332210 0 00111111122222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.+++.+|+.+||..||++.++++
T Consensus 258 ---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2356678899999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.14 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=196.7
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|+..+.||+|+||.||+|+.. ++..||+|.+...........+++.+|+++++.++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999865 689999999865433333344678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++ ++.+.+.... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 8888775433 3588999999999999999999999 9999999999999999999999999998754432
Q ss_pred Ccccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 675 SNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
....+++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+........ .
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~--~ 245 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPTL--Q 245 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhccCCCC--C
Confidence 3346788999999974 456888999999999999999999997532211 00011111111111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.......+.+++.+|++.+|++||++.++++.
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 11233468889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.06 Aligned_cols=245 Identities=21% Similarity=0.238 Sum_probs=187.5
Q ss_pred eEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhc---cCCCceeeEEeEEecCCceEEEEeccc
Q 042086 522 CIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE---LRHRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
.||+|+||.||++... +++.||+|.+.............+.+|..+++. .+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 689999998876433222223344555544443 479999999999999899999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc
Q 042086 598 RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC 677 (784)
Q Consensus 598 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 677 (784)
+|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++...... ..
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence 999999987543 588999999999999999999999 9999999999999999999999999998755432 22
Q ss_pred ccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHH
Q 042086 678 TELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756 (784)
Q Consensus 678 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 756 (784)
....|++.|+|||.+.+ ..++.++||||+||++|||++|..||.....-. ......... . ..........
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~-~--~~~~~~~~~~ 223 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEIDRMTL-T--VNVELPDSFS 223 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------HHHHHHHhh-c--CCcCCccccC
Confidence 33568999999999864 557899999999999999999999986322110 000001000 0 0001111233
Q ss_pred HHHHHHHHhcccCCCCCCC-----CHHHHHHh
Q 042086 757 ISIVEVAFLCLNESPESRP-----PMHTVCQL 783 (784)
Q Consensus 757 ~~l~~li~~cl~~dP~~RP-----s~~~vl~~ 783 (784)
.++.+++.+|++.||++|| +++++++.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 4678899999999999999 69998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=293.92 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=203.7
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
.|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3778899999999999999976 789999999876422 346789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999999987643 3688999999999999999999998 99999999999999999999999999998765443
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
. .....++..|+|||.+.+..++.++||||||+++|++++|+.||........... ......+..... ..
T Consensus 153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~----~~ 222 (253)
T cd05122 153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-----IATNGPPGLRNP----EK 222 (253)
T ss_pred c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-----HHhcCCCCcCcc----cc
Confidence 2 3455788999999999888889999999999999999999999874321110000 000000111111 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 13468899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.08 Aligned_cols=262 Identities=22% Similarity=0.300 Sum_probs=196.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46899999999999999999876 789999999865422 1223467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CCceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~ 672 (784)
||++ ++|.+++..... ..+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9996 488888765432 2357788889999999999999999 9999999999999985 46799999999986544
Q ss_pred CCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc------cc
Q 042086 673 DSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNIS------LN 738 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~------~~ 738 (784)
.........+++.|+|||.+.+. .++.++||||+||++|+|+||+.||......... ....... ..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 33333445678899999998664 5788999999999999999999998632211000 0000000 00
Q ss_pred ccc--CCCCCCCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EIL--DPRLPTPP--QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~--d~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... .+...... ...+....++.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000000 001112345788999999999999999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=329.34 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=195.6
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC----
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP---- 586 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 586 (784)
+-..+|+..+.||+||||.|||++.+ ||+.||||++.... +......+.+|++.+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 44567888899999999999999987 99999999997643 233456788999999999999999997542100
Q ss_pred --------------------------------------------------------------------------------
Q 042086 587 -------------------------------------------------------------------------------- 586 (784)
Q Consensus 587 -------------------------------------------------------------------------------- 586 (784)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 042086 587 -----------------------------------RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631 (784)
Q Consensus 587 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 631 (784)
...||-||||+..++.++++.+.... .....++++.+|+.|++
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 11478899999977777776543211 35678899999999999
Q ss_pred HHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC------------------CCCCcccccccccccccccccc
Q 042086 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK------------------PDSSNCTELVGTFGYIAPELVY 693 (784)
Q Consensus 632 ~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~ 693 (784)
|+|++ |||||||||.||++++++.|||+|||+|.... ......+..+||.-|+|||.+.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 99999999999999999999999999998621 0112345678999999999997
Q ss_pred cC---CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCC
Q 042086 694 TM---KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNES 770 (784)
Q Consensus 694 ~~---~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~d 770 (784)
+. +|+.|+|+||+|||++||+ .||.. ...+-..+..+-++.++.++....+....=.++|++++++|
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~T-------sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGT-------SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHh---ccCCc-------hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence 54 4999999999999999999 45542 11122233334445555543333444444568999999999
Q ss_pred CCCCCCHHHHHH
Q 042086 771 PESRPPMHTVCQ 782 (784)
Q Consensus 771 P~~RPs~~~vl~ 782 (784)
|.+|||+.|++.
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999985
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.77 Aligned_cols=243 Identities=23% Similarity=0.277 Sum_probs=186.4
Q ss_pred eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHH-hccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 521 YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTL-TELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.||+|+||.||+|... +++.||+|.+.............+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 6899999998654222222233455565544 445899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
++|.++++..+ .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++..... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999997643 477888999999999999999998 999999999999999999999999999875432 23
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...+++.|+|||.+.+..++.++||||||+++||+++|..||....... ....+.......+..........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--------VFDNILSRRINWPEEVKEFCSPE 223 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcccCCCCcccccCCHH
Confidence 4467889999999988888999999999999999999999986322110 00011111111111111122346
Q ss_pred HHHHHHhcccCCCCCCCCHHHHH
Q 042086 759 IVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~~vl 781 (784)
+.+++.+||+.+|++||++.++.
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~ 246 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQ 246 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHH
Confidence 88999999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.33 Aligned_cols=263 Identities=21% Similarity=0.316 Sum_probs=197.0
Q ss_pred CCCCceeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSF 590 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 590 (784)
+|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999865 4799999998764322233346788999999999999999999999887 7899
Q ss_pred EEEecccCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC----CCceEEecc
Q 042086 591 LVYEYLERGSLATILSNDGA--IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL----DYEARVSDF 664 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Df 664 (784)
+||||+++ ++.+++..... ...++...+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 77777653322 23578899999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCCC---cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-ccccc----
Q 042086 665 GIAKFLKPDSS---NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-SNRNI---- 735 (784)
Q Consensus 665 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-~~~~~---- 735 (784)
|++..+..... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 22345678899999988764 57889999999999999999999986432211000 00000
Q ss_pred --------------------cccccc-CCCCCCCC-CCCH-------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 --------------------SLNEIL-DPRLPTPP-QNVQ-------DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 --------------------~~~~~~-d~~~~~~~-~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...... ........ .... .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00000000 0000 22346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=293.08 Aligned_cols=249 Identities=25% Similarity=0.438 Sum_probs=204.0
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|++|.||+|... +++.|++|.+...... ....+.+.+|++++++++|||++++++++.++...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4788899999999999999865 6889999998765321 2345679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998765 3588999999999999999999999 99999999999999999999999999998876544
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......++..|+|||...+..++.++||||+|+++|++++|+.||......... ...........+..
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~--- 222 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--------FRIVQDDHPPLPEG--- 222 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--------HHHhccCCCCCCCC---
Confidence 4344567889999999998877889999999999999999999998643221100 00111111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.+++.+|+..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2336778999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.79 Aligned_cols=250 Identities=25% Similarity=0.285 Sum_probs=204.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..+.|..-++||+|+||.||-++.+ +|+.||.|++.+..........-...|-.|+.++..+.||.+--.|++.+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456888899999999999999865 799999998866544333445567889999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|+..|.||+|.-+|.+.+. ..|++..+..++.+|+.||++||.. +||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999987765 5789999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC-CCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP-TPPQ 750 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~ 750 (784)
.... ....+||.+|||||++...+|+...|-||+||++|||+.|+.||..... ....+-+|.+.. .+.+
T Consensus 339 ~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke---------Kvk~eEvdrr~~~~~~e 408 (591)
T KOG0986|consen 339 EGKP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE---------KVKREEVDRRTLEDPEE 408 (591)
T ss_pred CCCc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh---------hhhHHHHHHHHhcchhh
Confidence 5443 4556999999999999999999999999999999999999999963221 111112222221 1112
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPP 776 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs 776 (784)
.....+.+..++....+++||++|.-
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhcc
Confidence 22333445667777889999999973
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.86 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=196.1
Q ss_pred ceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 520 KYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
...||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++|+|++++++++...+..++||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 357999999999999875 7899999987542 222456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
++|.+++... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++...........
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9999987542 478889999999999999999999 999999999999999999999999999876654333334
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHH
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELIS 758 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 758 (784)
...+++.|+|||.+.+..++.++|+||+|+++|||++|+.||......... ........+..... ......
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~ 245 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----KMIRDNLPPKLKNL----HKVSPS 245 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhhCCcccCCc----ccCCHH
Confidence 457889999999998888899999999999999999999998632211100 00011111111111 112335
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 042086 759 IVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 759 l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.+++.+||+.||.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=301.77 Aligned_cols=262 Identities=27% Similarity=0.314 Sum_probs=197.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSF 590 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 590 (784)
.++|++.+.||+|+||.||+|... +|+.||+|.++..... ......+.+|+.++++++|+||+++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 467999999999999999999875 6999999998654322 12233567899999999999999999998754 4689
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++ +|.+++.... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 8988886543 3688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc---ccc
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNIS---LNE 739 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~---~~~ 739 (784)
...........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.......... ...... ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 544333344456788999999875 457889999999999999999999986332211000 000000 000
Q ss_pred ccC-C--CCC-CCCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILD-P--RLP-TPPQNV----QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d-~--~~~-~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.-. . ... .+.... ......+.+++.+|++.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0 000 000000 112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.13 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=205.0
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFLV 592 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 592 (784)
+|+..+.||+|++|.||+|... +++.|++|.+...... ....+.+.+|+.++++++||||+++++.+.+. +..++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999876 7899999998764321 23467899999999999999999999999888 889999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999997654 688999999999999999999998 999999999999999999999999999987765
Q ss_pred CCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCC
Q 042086 673 DSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD-PRLPTPP 749 (784)
Q Consensus 673 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~ 749 (784)
... ......++..|+|||.+.+...+.++||||||+++|++++|..||....... .....+.. ......+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-------AALYKIGSSGEPPEIP 226 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHhccccCCCcCCC
Confidence 432 1345678889999999988889999999999999999999999987443110 00011111 1111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. .....+.+++.+|++.||++||++.++++
T Consensus 227 ~---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 E---HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred c---ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1 22446889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=292.71 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=206.0
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|+||.||++... +++.|++|++..... .....+++.+|+++++.++|||++++++.+...+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4788899999999999999876 689999999876432 22346678999999999999999999999999899999999
Q ss_pred cccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 595 YLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|+++++|.+++.... ....+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999997642 124689999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
........+++.|+|||......++.++||||+|+++++|++|+.||+..... ..............+.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--- 225 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPIPS--- 225 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCCCC---
Confidence 33344557889999999998888999999999999999999999998643211 0111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++.+||..+|++|||+.++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22335788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.35 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=195.4
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||+|+||.||+++.. +|+.|++|.+...........+.+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999977 5999999998765333334567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC------
Q 042086 602 ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS------ 675 (784)
Q Consensus 602 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~------ 675 (784)
.++++..+ .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997644 578899999999999999999998 999999999999999999999999999876543311
Q ss_pred --cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 676 --NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 676 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
......++..|+|||.......+.++||||||+++||+++|+.||...... .....+.......+ ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-~~~- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGKIEWP-EDV- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCcCCC-ccc-
Confidence 223456788999999998888899999999999999999999998632211 11111111111111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH---HHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPM---HTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~---~~vl~ 782 (784)
.....+.+++.+|++.+|++|||+ .++++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 113467899999999999999999 55543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.63 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=206.8
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
....|.+...||+|.|+.|..|+.. ++..||+|.+++.... ....+.+.+|+++|..++|||||+++.+...+...|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3567899999999999999999865 7999999999886443 3334558999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+.+|.+.+++..++... ...+..++.|+.+|++|||++ .|||||||++||+++.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr~~---e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMK---EKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhcccch---hhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999998877533 367788999999999999999 99999999999999999999999999999887
Q ss_pred CCCCcccccccccccccccccccCCcC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
. .......+|++.|.|||++.+..+. +++|+||+|+++|-++.|..||+.-... .....++..++..+.
T Consensus 207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------~Lr~rvl~gk~rIp~- 276 (596)
T KOG0586|consen 207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------ELRPRVLRGKYRIPF- 276 (596)
T ss_pred c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------cccchheeeeecccc-
Confidence 3 3445678999999999999988875 6899999999999999999999842221 111122222222221
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
-...++-+++.+++-.+|.+|++++++.+
T Consensus 277 ---~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 277 ---YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ---eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11224667888999999999999999875
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.31 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=193.5
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 593 (784)
+|+..+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4566778999999999999875 6899999998753221 33567899999999995 999999999999888999999
Q ss_pred ecccCCCHHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 594 EYLERGSLATILSN--DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 594 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||+.. ++.++... ......+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99865 66554321 111246888999999999999999999742 89999999999999999999999999997654
Q ss_pred CCCCcccccccccccccccccccC---CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---CCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTM---KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD---PRL 745 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d---~~~ 745 (784)
... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....... ....++.. +.+
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~ 231 (288)
T cd06616 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-------DQLTQVVKGDPPIL 231 (288)
T ss_pred cCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-------HHHhhhcCCCCCcC
Confidence 322 22334678899999999766 68899999999999999999999986432100 00111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.. ........++.+++.+|++.||++|||+++|++
T Consensus 232 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 232 SN--SEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CC--cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111223446889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.41 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=204.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 592 (784)
++|.+.+.||+|++|.||+|... +++.||+|++...........+.+..|++++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999876 79999999987643333334567899999999998 99999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997653 588999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC--------------------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccc
Q 042086 673 DSS--------------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN 732 (784)
Q Consensus 673 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~ 732 (784)
... ......++..|+|||......++.++|+||||++++++++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------ 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence 321 122345788999999998888999999999999999999999998743311
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPM----HTVCQ 782 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~~vl~ 782 (784)
.....+.+.....+. .....+.+++.+|++.+|++||++ +++++
T Consensus 229 --~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 --LTFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111121221111 113357889999999999999999 88875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=298.51 Aligned_cols=259 Identities=19% Similarity=0.237 Sum_probs=183.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcC----CCEEEEEEcCCCCCCCCCC--------hhhHHHHHHHHhccCCCceeeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVP--------QPEFVNEIKTLTELRHRSIVKFYG 581 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~ 581 (784)
.++|++.+.||+|+||.||+|...+ +..+|+|............ ......+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998764 4566666543221100000 011223344556678999999999
Q ss_pred EEecCC----ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 582 FCSHPR----NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 582 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
++.... ..++++|++.. ++.+.++... ..++..+..++.|++.|++|||+. +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 765443 34678887754 6777665432 346778889999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 042086 658 EARVSDFGIAKFLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~ 730 (784)
.++|+|||+|+.+..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221 1123468999999999999999999999999999999999999997542211000
Q ss_pred -cccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 731 -SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 731 -~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.........+....... ... ...+.+++..|+..+|++||+++++.+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKI--KNA---NKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhhcc--CCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00000011111111111 111 24578899999999999999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.92 Aligned_cols=259 Identities=21% Similarity=0.296 Sum_probs=196.9
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP----- 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 586 (784)
..++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4578999999999999999999865 789999999864322 222345678899999999999999999998543
Q ss_pred -CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 587 -RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 587 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 356999999965 888887542 67788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------c--------
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------S-------- 730 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~-------- 730 (784)
+++...... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......... .
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 998764322 223456788999999999999999999999999999999999998633210000 0
Q ss_pred --------------cccccccccccCCCCC-CCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 731 --------------SNRNISLNEILDPRLP-TPP-QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 731 --------------~~~~~~~~~~~d~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+....... ... .........+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000011100000 000 001122446789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=294.68 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=203.5
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|++.+.||+|++|.||+++.. +++.+++|.+...... .....++.+|+++++.++|+||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4788899999999999999765 7889999998754322 2335678899999999999999999999999899999999
Q ss_pred cccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 595 YLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999865321 24578899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
......+++.|+|||.+.+..++.++|+||||+++||+++|+.||+...... ....+.....+..+ .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---~ 223 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKYPPIP---P 223 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCCCCc---h
Confidence 2233567889999999999889999999999999999999999986432110 00111111111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 33456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.57 Aligned_cols=248 Identities=20% Similarity=0.279 Sum_probs=191.4
Q ss_pred HHHHHhcCCCCceeE--ecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 509 EIVRATNGFDVKYCI--GIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 509 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
+.....+.|++.+.+ |+|+||.||++..+ +++.+|+|.+...... . .|+.....+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~--~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------A--IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------h--hhHHHHHHhhcCCCEEEEEEEEe
Confidence 344455677777776 99999999999865 7889999987653211 1 122222222 7999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEec
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSD 663 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~D 663 (784)
.++..++||||+++|+|.+++.... .+++..+..++.|+++|++|||+. +++||||||+||+++.++ .++|+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999997653 688999999999999999999999 999999999999999998 999999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
||++...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .. ..........
T Consensus 154 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~-~~~~~~~~~~ 225 (267)
T PHA03390 154 YGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LD-LESLLKRQQK 225 (267)
T ss_pred CccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hh-HHHHHHhhcc
Confidence 9998865432 23467899999999998889999999999999999999999987322110 00 0000111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPP-MHTVCQ 782 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~~vl~ 782 (784)
... ........+.+++.+|++.+|++||+ ++++++
T Consensus 226 ~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111 11233446889999999999999996 699875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=326.23 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=204.2
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc----C----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeE
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT----S----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGF 582 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 582 (784)
...++.++.+.+|+|.||.||+|... . ...||||.++..... .+.+.+..|+++|+.+ +||||+.++|+
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 33455567779999999999999743 1 457999998875432 5678899999999999 69999999999
Q ss_pred EecCCceEEEEecccCCCHHHHHhcCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCC
Q 042086 583 CSHPRNSFLVYEYLERGSLATILSNDG-----------AI--EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSK 649 (784)
Q Consensus 583 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~ 649 (784)
|...+..++|+||++.|+|.++++... .. ..++......++.|||.|++||++. ++||||+.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999998655 01 1378889999999999999999999 9999999999
Q ss_pred CeeecCCCceEEeccccccccCCCCCcc-cccc--cccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 042086 650 NVLLCLDYEARVSDFGIAKFLKPDSSNC-TELV--GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISS 725 (784)
Q Consensus 650 Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~ 725 (784)
|||++.+..+||+|||+|+......... .... -...|||||.+....|+.|||||||||++||++| |..||..+..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999755433322 2222 2457999999999999999999999999999998 8889864211
Q ss_pred ccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 726 ISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 726 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ......+.+......|..+.+ ++.++++.||+.+|++||++.++++.+
T Consensus 528 ~-------~~l~~~l~~G~r~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 528 T-------EELLEFLKEGNRMEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred H-------HHHHHHHhcCCCCCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 0 001111222222222334434 577899999999999999999998753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.24 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=199.3
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------Cce
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------RNS 589 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 589 (784)
+...+.||+|+||.||+|+.+ +|+.||||.++... .....+...+|++++++++|||||+++++-.+. +..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 455678999999999999955 89999999998754 445678889999999999999999999986543 356
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec--CCCc--eEEeccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC--LDYE--ARVSDFG 665 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~--~kl~DfG 665 (784)
.+|||||.+|||...+........++..+.+.+...++.||.|||++ +||||||||.||++- ++|. -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999998877777899999999999999999999999 999999999999994 4443 6999999
Q ss_pred cccccCCCCCcccccccccccccccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------------
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------------- 729 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------------- 729 (784)
.|+.+.++ ......+||..|.+||.+. .+.|+..+|.|||||++|+.+||..||.........
T Consensus 170 ~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 170 AARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99988754 4678899999999999998 488888999999999999999999999743332110
Q ss_pred --ccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 042086 730 --SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775 (784)
Q Consensus 730 --~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 775 (784)
....++...-.+...++.+....+.....+......++..+|++|.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0000000000111223333333344445566667778888888887
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.43 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=198.2
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceEEEE
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFLVY 593 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 593 (784)
|++.+.||+|++|.||+|... +++.+|+|++.... ......+.+.+|+.+++.++|||++++++++.+. +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 677899999999999999876 58999999998653 2233356788999999999999999999999887 7899999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ +|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99975 8999886543 3688899999999999999999998 9999999999999999999999999999876543
Q ss_pred CC-ccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------ccccccccccc-
Q 042086 674 SS-NCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS----------SSNRNISLNEI- 740 (784)
Q Consensus 674 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~- 740 (784)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+........ .........++
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 1233456788999998765 45788999999999999999999998643221000 00000000000
Q ss_pred ----cCCCCCCCC---CCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 741 ----LDPRLPTPP---QNVQD-ELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 741 ----~d~~~~~~~---~~~~~-~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
..+...... +.... ....+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 00001 14568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=293.95 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=196.3
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc---CCCceeeEEeEEecCCc----
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL---RHRSIVKFYGFCSHPRN---- 588 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~---- 588 (784)
|++.+.||+|+||.||+|+.+ +++.||+|++...... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678899999999999999987 5899999998754332 22234567788777666 59999999999987776
Q ss_pred -eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 589 -SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 589 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
.+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 89998875432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------c-cccccc--
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------S-NRNISL-- 737 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~-~~~~~~-- 737 (784)
..+.... ......++..|+|||.+.+..++.++|+|||||++|||++|+.||+......... . ......
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 8764332 2233457889999999999889999999999999999999999986432110000 0 000000
Q ss_pred ----ccccCCCCCC-CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 738 ----NEILDPRLPT-PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 738 ----~~~~d~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......... ......+....+.+++.+||+.||++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 01111233456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.42 Aligned_cols=256 Identities=19% Similarity=0.252 Sum_probs=192.8
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecC--CceEEE
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHP--RNSFLV 592 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 592 (784)
|++.+.||+|+||.||+|... +++.||+|.++.... ........+|+.++.++. |||++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 677899999999999999865 789999999875422 112334567899999885 99999999999887 889999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+||++ |++.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 99997 48888886543 3588999999999999999999999 9999999999999999 9999999999987643
Q ss_pred CCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc-----ccccc
Q 042086 673 DSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRN-----ISLNE 739 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~-----~~~~~ 739 (784)
... .....+++.|+|||.+.. ..++.++|||||||++|||++|+.||......... ..... .....
T Consensus 152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 152 KPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 322 234567889999997654 55788999999999999999999999643221100 00000 00000
Q ss_pred ccCCCCCCCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPP-----QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+...+... ........++.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 001123457899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=299.35 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=195.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|++|.||+|... +++.||||.+..... .....++..|+.++.+. +||||+++++++.+....++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 357899999999999999999987 489999999875321 22345677788777666 59999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+.+ ++.++..... ..+++..+..++.|++.|++|||+.. +|+||||+|+||+++.++.+||+|||++..+.
T Consensus 92 v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999855 7877765533 26888999999999999999999731 89999999999999999999999999998764
Q ss_pred CCCCcccccccccccccccccccCC----cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMK----VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
.... .....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||...... ......+++...+.
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 238 (296)
T cd06618 167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPPS 238 (296)
T ss_pred CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCCC
Confidence 3222 23345788999999987554 788999999999999999999998632110 01111112111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+. ......++.+++.+||+.||++||++.++++.
T Consensus 239 ~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 LPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 01123468899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.91 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=201.3
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|++.+.||+|++|.||+|... +++.+++|.+...... ......+..|+.++++++|+||+++++++.+++..++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567889999999999999875 7899999998764322 22356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++ ++.+++.... ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 976 8988887643 3688899999999999999999999 999999999999999999999999999987765443
Q ss_pred cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccccccccC-----
Q 042086 676 NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNISLNEILD----- 742 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~d----- 742 (784)
......++..|+|||.+.+. .++.++|+||+|+++|+++||+.||......... ............+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 33445678899999998876 6889999999999999999999998643321100 0000000000000
Q ss_pred ------CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 ------PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 ------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...............++.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000111233557889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.45 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=195.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+...........+++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999875 68899999886432222233457889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+. |++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 58888775433 2478899999999999999999998 9999999999999999999999999998865432
Q ss_pred CCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||........ ...+.....+..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~-- 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPAL-- 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--------HHHHhhcCCCCc--
Confidence 3346788999999974 35678899999999999999999999753221110 000111111110
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
........+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 111234468899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.90 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=201.9
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+-+++....||.|.||.||.|.. .+|...|+|-+...... ....+...+|++++..++|||+|++||+-.+.+..+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34567778899999999999984 57999999988654333 44567788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
||||++|+|.+.+...+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999875543 34466677889999999999999 999999999999999999999999999998876
Q ss_pred CCCc----ccccccccccccccccccCC---cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 673 DSSN----CTELVGTFGYIAPELVYTMK---VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 673 ~~~~----~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
.... .....||+.|||||++.+.. ...+.||||+|||+.||+||+.||...+. ....+..+--...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC
Confidence 5322 23568999999999997654 34579999999999999999999864321 1111112222233
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+..|+. .+.+=.+++..|+..||++|.++.|+++.
T Consensus 1460 Pq~P~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 PQIPER---LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCchh---hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 333333 33445678889999999999999998863
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.74 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=197.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCC--CCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--Cce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWP--CEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 589 (784)
..|++.+.||+|+||.||+|... +++.||+|.+..... ........+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46899999999999999999865 689999998753221 1222345788999999999999999999998664 457
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|+||+++++|.+++...+ .+++....+++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 367888999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 670 LKPD---SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 670 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
.... ........++..|+|||.+.+..++.++|+|||||++||+++|+.||....... ...++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~- 226 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------AIFKIATQPT- 226 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--------HHHHHHcCCC-
Confidence 5421 111234568899999999998888999999999999999999999986322110 1111111100
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+........++.+++.+|+. +|.+||+..++++.
T Consensus 227 -~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 -KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011112233468889999999 57999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.51 Aligned_cols=244 Identities=22% Similarity=0.239 Sum_probs=187.2
Q ss_pred eEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHH---HhccCCCceeeEEeEEecCCceEEEEeccc
Q 042086 522 CIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKT---LTELRHRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
.||+|+||.||+|+.. +++.||+|.+.............+..|..+ ++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 689999999876432222222234445443 444579999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc
Q 042086 598 RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC 677 (784)
Q Consensus 598 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 677 (784)
+|+|.+++...+ .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++..+.... .
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 999999886543 588999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred cccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHH
Q 042086 678 TELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756 (784)
Q Consensus 678 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 756 (784)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........ ..............+ ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~s 223 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVELP----DSFS 223 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHHhhccCCCCC----CcCC
Confidence 344689999999998754 588999999999999999999999864321100 000000000111111 1123
Q ss_pred HHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 757 ISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 757 ~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
.++.+++.+|+..+|++|| ++.++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 4688899999999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=322.05 Aligned_cols=266 Identities=18% Similarity=0.215 Sum_probs=186.6
Q ss_pred HhcCCCCceeEecccceEEEEEEEc--CCCEEEEEEc--------------CCCCCCCCCChhhHHHHHHHHhccCCCce
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT--SGEILAVKKF--------------HSLWPCEMVPQPEFVNEIKTLTELRHRSI 576 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~--------------~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 576 (784)
..++|++.+.||+|+||+||++..+ ++..++.|.+ .+...........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998754 2222222211 11101111234568899999999999999
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGA--IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC 654 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 654 (784)
+++++++.+.+..++|+|++.+ +|.+++..... ...........++.|++.||+|||++ +||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999854 78887753321 12234556778999999999999999 999999999999999
Q ss_pred CCCceEEeccccccccCCCCC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCC-CCcccccccc---
Q 042086 655 LDYEARVSDFGIAKFLKPDSS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP-RDFISSISSS--- 729 (784)
Q Consensus 655 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p-~~~~~~~~~~--- 729 (784)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987654322 22346799999999999999999999999999999999998754 3211110000
Q ss_pred ------ccccc------cccccccCC-CCCCCCCCCHH------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 ------SSNRN------ISLNEILDP-RLPTPPQNVQD------ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 ------~~~~~------~~~~~~~d~-~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+ ....+.++. .....+..... ....+.+++.+|++.||++|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 000000000 00000000001 1124667889999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=305.93 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=196.7
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC--Cc
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP--RN 588 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~ 588 (784)
..++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3567899999999999999999876 688999998865322 222345678899999999 999999999998653 36
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 7999999974 999988653 577888999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC-----ccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc-
Q 042086 669 FLKPDSS-----NCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRN- 734 (784)
Q Consensus 669 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~- 734 (784)
.+..... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6644321 2234568899999998765 45788999999999999999999998643211100 00000
Q ss_pred -------cccccccC----CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 -------ISLNEILD----PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 -------~~~~~~~d----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+++ ...............++.+++.+|++.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00000010 0110001111112446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=295.63 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=198.0
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC---
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR--- 587 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 587 (784)
...++|++.+.||+|+||.||+|..+ +|+.||+|.++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45678999999999999999999976 689999999875432 1223456789999999999999999999987654
Q ss_pred -------ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceE
Q 042086 588 -------NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR 660 (784)
Q Consensus 588 -------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 660 (784)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 787777654 23688999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCC-ccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cc
Q 042086 661 VSDFGIAKFLKPDSS-NCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SS 731 (784)
Q Consensus 661 l~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~ 731 (784)
|+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||+........ ..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999987654332 2233456788999998865 45788999999999999999999998643221100 00
Q ss_pred ccccccccc--------cCCCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 732 NRNISLNEI--------LDPRLPTPP---QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 732 ~~~~~~~~~--------~d~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+ .++...... .........+.+++..||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 000000000 000011346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=305.35 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=195.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----R 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 587 (784)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... .......+..|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 468999999999999999999865 78999999986422 122345688999999999999999999987544 3
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++|+||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 47899999975 888887542 588899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc
Q 042086 668 KFLKPDSSN---CTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNIS 736 (784)
Q Consensus 668 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~ 736 (784)
......... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 865432221 233567899999998754 45788999999999999999999998532210000 0000000
Q ss_pred cccccCCC-------CCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 737 LNEILDPR-------LPTPPQ-----NVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 737 ~~~~~d~~-------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...+.+.. .+.... ..+....++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111100 000000 001123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=297.30 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=193.8
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|...+.||+|+||+||+|+.. +++.|++|.+...........+.+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999865 6899999998654332333345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+. |++.+++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 58888876433 3578899999999999999999999 999999999999999999999999999864322
Q ss_pred cccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 676 NCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.....|+..|+|||.+. ...++.++|||||||++|||++|..||......... ..+.....+.. ..
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~--------~~~~~~~~~~~--~~ 242 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------YHIAQNDSPTL--QS 242 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH--------HHHHhcCCCCC--Cc
Confidence 23456888999999984 456888999999999999999999998643221100 00000011110 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.+++.+|++.+|++||++.++++
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122235788999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=295.80 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=193.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
.++|++.+.||+|+||.||+|... +++.||||.+...... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 357999999999999999999875 6899999988653221 122345678999999999999999999986654
Q ss_pred ---ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 588 ---NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 588 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
..++||||+.+ +|.+++.... ..+++..+..++.|++.|++|||++ +++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 8888886543 3578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc----ccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------
Q 042086 665 GIAKFLKPDSSN----CTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---------- 729 (784)
Q Consensus 665 G~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---------- 729 (784)
|++..+...... .....++..|+|||.+.+.. ++.++||||||+++|||++|..||.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999876432221 22345788899999887654 688999999999999999999998643211000
Q ss_pred --ccccccccccccCC-CCCCCCC-CCH------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 --SSNRNISLNEILDP-RLPTPPQ-NVQ------DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 --~~~~~~~~~~~~d~-~~~~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+..+. ..+.... ... .....+.+++.+|++.||++|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000000 0000000 000 01235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=277.55 Aligned_cols=262 Identities=21% Similarity=0.336 Sum_probs=204.6
Q ss_pred HHHHHHHhcCCCCceeEecccceEEEEEE-EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 507 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
+++....++ +.||+|+++.|-.+. ..+|..||||++.+. ....+.+..+|++++... .|+||++++++|+
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 455544443 579999999999986 678999999999875 455678899999999999 6999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC---ceEE
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY---EARV 661 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl 661 (784)
++...|+|||.|.||+|.++++++. .|++.++.+++.+|+.||.+||.+ ||.|||+||+|||..+.. -+||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999998765 478899999999999999999999 999999999999997654 4799
Q ss_pred eccccccccCCCCC-------cccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccc--c
Q 042086 662 SDFGIAKFLKPDSS-------NCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI--S 727 (784)
Q Consensus 662 ~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~--~ 727 (784)
|||.++.-+..... .-...+|+-.|||||+.. ...|+.+.|.||+|||+|-|+.|.+||...=.- .
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 99998875432211 123457888999999873 335888999999999999999999999642211 0
Q ss_pred cc--c---cccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 728 SS--S---SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 728 ~~--~---~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+. + .-.+.-+..|-+.....|...+...+.+..+++...+..||.+|.++.++++
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 0 0011111223333444444445555677888999999999999999988875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.27 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=197.6
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC--CCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE--MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
+|.+.+.||+|+||.||+++.. .+..+++|.++...... .....++..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4888899999999999999865 34556666655432221 22234577899999999999999999999988899999
Q ss_pred EecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
+||+++++|.+++.... ....+++..++.++.|++.|+.|||+. +++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886422 234689999999999999999999998 9999999999999975 569999999998765
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
..........+++.|+|||...+..++.++|+||||+++|++++|..||...... .....+.....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~--- 225 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVEGPTPSL--- 225 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCC---
Confidence 4444444556888999999998888899999999999999999999998632211 01111111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......++.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1233456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.22 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=195.5
Q ss_pred CCCCceeEecccceEEEEEEE----cCCCEEEEEEcCCCCCC-CCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKL----TSGEILAVKKFHSLWPC-EMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
.|++.+.||+|+||.||+|+. .+|+.||+|.+...... .....+.+.+|+++++.+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 36899999998653221 122346788999999999 699999999999998899
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999997643 477888889999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC-cccccccccccccccccccC--CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 670 LKPDSS-NCTELVGTFGYIAPELVYTM--KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 670 ~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
...... ......|+..|+|||.+... .++.++||||||+++|+|++|+.||....... ........+.....+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~~~ 230 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSEPP 230 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhhccCCC
Confidence 643321 12345688999999998753 46789999999999999999999986321100 001111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
.+ . .....+.+++.+|++.||++|| +.+++++
T Consensus 231 ~~-~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YP-Q---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CC-c---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11 1 1233577899999999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.72 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=198.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----R 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 587 (784)
.++|.+.+.||+|+||+||+|+.. +++.||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 457999999999999999999865 789999999875432 222345678899999999999999999988644 3
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++|+||+. ++|.+++...+ .+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999996 68999887543 588899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc----
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNI---- 735 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~---- 735 (784)
..............++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 876543333344567889999998864 46888999999999999999999998642210000 000000
Q ss_pred ----ccccccCC--CCCCC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 736 ----SLNEILDP--RLPTP--PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 736 ----~~~~~~d~--~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.....+.. ..... ....+....++.+++.+|++.||++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 00000 00011223467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.25 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=190.0
Q ss_pred eEecc--cceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 522 CIGIG--GQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 522 ~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
.||+| +||+||+|+.. +|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 99999999875 7999999998653221 12346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc-
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC- 677 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~- 677 (784)
|++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999876432 3578889999999999999999998 99999999999999999999999998664432211111
Q ss_pred ------cccccccccccccccccC--CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------ccccc---------
Q 042086 678 ------TELVGTFGYIAPELVYTM--KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------SSNRN--------- 734 (784)
Q Consensus 678 ------~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------~~~~~--------- 734 (784)
....++..|+|||++.+. .++.++|||||||++|||++|+.||......... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 112345679999999764 4788999999999999999999998643210000 00000
Q ss_pred -----------------ccc-----ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 -----------------ISL-----NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 -----------------~~~-----~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... ..+.+..... .........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT--PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccc--hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 0000001111 112234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=292.34 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=196.5
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEEEEe
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 594 (784)
|++.+.||+|++|+||+|... +++.|++|++...... .......+|+..+++++ |||++++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 677899999999999999976 5889999998654221 22334567999999998 9999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+ +|+|.+++.... ...+++..+..++.|++.++.|||++ +++|+||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 789999887654 23578999999999999999999999 99999999999999999999999999998764322
Q ss_pred Ccccccccccccccccccc-cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccc-----cccccccc
Q 042086 675 SNCTELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSN-----RNISLNEI 740 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~-----~~~~~~~~ 740 (784)
......++..|+|||.+. ...++.++|+||||++++||++|+.||......... ... ........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223456788999999885 445788999999999999999999998533211000 000 00000001
Q ss_pred cCCCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 741 LDPRLPTPPQN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 741 ~d~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
++...+..... .......+.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11111110000 01113468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.12 Aligned_cols=259 Identities=21% Similarity=0.258 Sum_probs=191.1
Q ss_pred CceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 519 VKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
+.+.+|.|+++.||++.. +++.||+|++.... ......+.+..|+++++.++||||+++++++.+.+..+++|||+++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 344455555555555544 69999999987642 2233567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC---
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS--- 675 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--- 675 (784)
|+|.+++..... ..+++.....++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+..+.....
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999975432 3578888999999999999999999 999999999999999999999999998875543221
Q ss_pred ----cccccccccccccccccccC--CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------c----------ccc
Q 042086 676 ----NCTELVGTFGYIAPELVYTM--KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------S----------SNR 733 (784)
Q Consensus 676 ----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------~----------~~~ 733 (784)
......++..|+|||.+... .++.++|||||||++|||++|+.||......... . ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 12234567789999998763 4788999999999999999999999743211000 0 000
Q ss_pred cccccc----ccCCCC--CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 734 NISLNE----ILDPRL--PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 734 ~~~~~~----~~d~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...... ..++.. ............++.+++.+||+.||++|||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000000 01111122334578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.25 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=202.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
-++|+..++||+|.||.|..++.+ +|+.||+|++++...........-..|-++++..+||.+..+--.|+..++.|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467899999999999999999866 7999999999987666555566678899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||..||.|.-++.... .+++.....+-..|+.||.|||++ +||.||+|.+|.|+|.||++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999998886543 477788888899999999999999 999999999999999999999999999986555
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.......++|||.|+|||++....|..++|-|.+||++|||++|+.||-.- ..+.-+.-++-..+..+.. .
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--------dh~kLFeLIl~ed~kFPr~-l 391 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--------DHEKLFELILMEDLKFPRT-L 391 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--------chhHHHHHHHhhhccCCcc-C
Confidence 556677899999999999999999999999999999999999999998521 1122222223333333222 2
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC
Q 042086 753 QDELISIVEVAFLCLNESPESRP 775 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RP 775 (784)
.. +...|+...+.+||++|.
T Consensus 392 s~---eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 SP---EAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CH---HHHHHHHHHhhcChHhhc
Confidence 22 344566788999999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=276.44 Aligned_cols=204 Identities=23% Similarity=0.364 Sum_probs=172.1
Q ss_pred HhcCCCCceeEecccceEEEEEEEc---C--CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-C
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT---S--GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-P 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 586 (784)
...+|+....||+|.||.||+|.-+ + .+.+|+|+++.....+..+ ....+|+..++.++||||+.+..++-. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3457999999999999999999533 2 2379999998876655443 356799999999999999999998866 7
Q ss_pred CceEEEEecccCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC----CceE
Q 042086 587 RNSFLVYEYLERGSLATILSNDG--AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD----YEAR 660 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~k 660 (784)
...++++||.+. +|...++.+. ....++....+.|+.||+.|+.|||++ -|+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 889999999998 9999886433 234678889999999999999999999 89999999999999888 8999
Q ss_pred EeccccccccCCCCCc---ccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCC
Q 042086 661 VSDFGIAKFLKPDSSN---CTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRD 721 (784)
Q Consensus 661 l~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~ 721 (784)
|+|||+|+.+...-.. ...++-|..|.|||.+.+.+ ||++.|||+.||++.||+|-++-|.
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999999988654322 34567899999999998765 8999999999999999999766554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.83 Aligned_cols=362 Identities=27% Similarity=0.356 Sum_probs=245.2
Q ss_pred eEEEEeCCCcccC--------CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEcc
Q 042086 62 VISINLSTVGLKG--------NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133 (784)
Q Consensus 62 v~~l~l~~~~~~~--------~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 133 (784)
|..+|+++..+.| .++.++-|.|.+.++. .+|+.+++|.+|++|.+++|++. .+...++.|+.|+.+++.
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence 4445555544443 4566777777777765 56777778888888888888776 455667777777777777
Q ss_pred CCccCCC-CCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCc
Q 042086 134 ENQLSGS-IPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGS 212 (784)
Q Consensus 134 ~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 212 (784)
+|++... +|..+..|..|..||||+|++. ..|..+.+.+++-.|+||+|+|.......|-+++.|-.|+|++|++. .
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~ 164 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-M 164 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-h
Confidence 7777643 5677777777777888888777 57777777777777788888777333334567777777777777775 5
Q ss_pred cchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccC
Q 042086 213 IPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGS 292 (784)
Q Consensus 213 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~ 292 (784)
+|.....+..|++|+|++|.+....-..+..|++|+.|++++.+-+...+|..+..+.+|..++++.|.+. .+|+.+-.
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~ 243 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYK 243 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhh
Confidence 56667777777777777777764444455556677777777776666667777777777777777777776 66777777
Q ss_pred CCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccc-cccccccccccccEE
Q 042086 293 LTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG-KIPCEICNMESLEKL 371 (784)
Q Consensus 293 l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L 371 (784)
+++|+.|+||+|+|+ .+....+...+|++|+||.|+++. +|.++.++++|+.|.+.+|+++- -+|..++.+.+|+.+
T Consensus 244 l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf 321 (1255)
T KOG0444|consen 244 LRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF 321 (1255)
T ss_pred hhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence 777777777777776 344444555667777777777765 66777777777777777776653 366667777777777
Q ss_pred ecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCCCCCCCCCCC
Q 042086 372 NLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGNKGLCGDIKG 432 (784)
Q Consensus 372 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~~~ 432 (784)
..++|++. .+|+.+..+..|+.|.|+.|+|-. +|.. ..........+..||.+-.+|++
T Consensus 322 ~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 322 HAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred Hhhccccc-cCchhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCccCCCCc
Confidence 77666665 556777777777777777776665 4432 23344455566666666666544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=286.96 Aligned_cols=242 Identities=26% Similarity=0.341 Sum_probs=198.3
Q ss_pred EecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||+|+||.||++... +++.+|+|.+...........+.+..|+++++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 5899999998765433333566899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccc
Q 042086 602 ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV 681 (784)
Q Consensus 602 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 681 (784)
.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997653 478899999999999999999998 999999999999999999999999999987654433345567
Q ss_pred cccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHH
Q 042086 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761 (784)
Q Consensus 682 gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~ 761 (784)
++..|+|||...+...+.++|+||||+++||+++|+.||+.... ......+.......+ ... ...+.+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~-~~~---~~~l~~ 222 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFP-EFL---SPEARD 222 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCC-CCC---CHHHHH
Confidence 88899999999888889999999999999999999999863321 111111222222221 111 235778
Q ss_pred HHHhcccCCCCCCCCH---HHHHH
Q 042086 762 VAFLCLNESPESRPPM---HTVCQ 782 (784)
Q Consensus 762 li~~cl~~dP~~RPs~---~~vl~ 782 (784)
++.+|+..||++||++ +++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHh
Confidence 9999999999999999 67654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.80 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=196.4
Q ss_pred CCCCceeEecccceEEEEEEE----cCCCEEEEEEcCCCCCC-CCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKL----TSGEILAVKKFHSLWPC-EMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
+|++.+.||+|++|.||+++. .+++.||||.+...... .....+.+..|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 378889999999999999974 35789999988653221 122345788999999999 699999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999986543 478888999999999999999998 999999999999999999999999999887
Q ss_pred cCCCCCc-ccccccccccccccccccCC--cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 670 LKPDSSN-CTELVGTFGYIAPELVYTMK--VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 670 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
....... .....+++.|+|||...+.. .+.++||||||+++|||++|+.||....... ........+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~ 230 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHHHccCCC
Confidence 5443221 23346889999999987665 6789999999999999999999985321110 000001111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+ .. ....+.+++.+|++.||++|||+.++.+.
T Consensus 231 ~~-~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 231 FP-KT---MSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred CC-cc---cCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 11 11 22357789999999999999998877554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.52 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=197.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec----CCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH----PRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 588 (784)
.++|++.+.||+|++|.||+|... +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 468999999999999999999865 699999999875432 22335677889999999999999999998753 346
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++|+||+. |+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 799999996 59999886543 478899999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCc----cccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccc----
Q 042086 669 FLKPDSSN----CTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSN---- 732 (784)
Q Consensus 669 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~---- 732 (784)
........ .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432211 234578889999999865 45788999999999999999999999643211000 000
Q ss_pred ----cccccccccC---CCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 ----RNISLNEILD---PRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 ----~~~~~~~~~d---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.++ .....+ ....+....++.+++.+|++.||++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000 000000 0001123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.07 Aligned_cols=262 Identities=22% Similarity=0.282 Sum_probs=193.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
.++|++.+.||+|+||.||+|... +++.||+|++......+ .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 468999999999999999999865 68999999886543221 22346789999999999999999999875433
Q ss_pred ---ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 588 ---NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 588 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
..++|+||+.+ ++.+.+.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999976 7877776432 3688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-----------ccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc---
Q 042086 665 GIAKFLKPDSSN-----------CTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--- 729 (784)
Q Consensus 665 G~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--- 729 (784)
|+++........ .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865432211 1234567889999988654 5788999999999999999999998643221100
Q ss_pred ----cccc------cccccc----ccCCCCCCCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 ----SSNR------NISLNE----ILDPRLPTPP-QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 ----~~~~------~~~~~~----~~d~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.... ...... ......+... .........+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 000000 0000000000 000111246889999999999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=298.70 Aligned_cols=261 Identities=20% Similarity=0.245 Sum_probs=193.2
Q ss_pred cCCC-CceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCC-----------ChhhHHHHHHHHhccCCCceeeEEe
Q 042086 515 NGFD-VKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMV-----------PQPEFVNEIKTLTELRHRSIVKFYG 581 (784)
Q Consensus 515 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 581 (784)
++|. +.+.||+|+||+||+|... +++.||+|.+......... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4577999999999999865 7899999988653221100 1125789999999999999999999
Q ss_pred EEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 582 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
++...+..++||||++ |+|.+++.... .+++.....++.|++.|++|||+. +|+||||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 59999986533 478899999999999999999998 9999999999999999999999
Q ss_pred eccccccccCC--------------CCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 042086 662 SDFGIAKFLKP--------------DSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSI 726 (784)
Q Consensus 662 ~DfG~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~ 726 (784)
+|||++..... .........+++.|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986541 11112233567889999998764 4688999999999999999999998643221
Q ss_pred ccc-------ccccccccccc-----cCCCCCCCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 727 SSS-------SSNRNISLNEI-----LDPRLPTPPQ----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 727 ~~~-------~~~~~~~~~~~-----~d~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... ........... ..+.....+. .......++.+++.+|++.+|++||+++|++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 000 00000000000 0000000000 00112346789999999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.95 Aligned_cols=260 Identities=22% Similarity=0.344 Sum_probs=200.3
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----ce
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR-----NS 589 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 589 (784)
+|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4888999999999999999976 589999999876432 2334567999999999999999999999997765 78
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++ +|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 999999985 8999887543 688899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC---CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccc------
Q 042086 670 LKPDS---SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSN------ 732 (784)
Q Consensus 670 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~------ 732 (784)
..... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65443 123445678899999999887 7889999999999999999999998643211000 000
Q ss_pred --cccccccccCCCCCCC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 733 --RNISLNEILDPRLPTP----PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 733 --~~~~~~~~~d~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
......+.+....... ....+.....+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000000000 00011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=290.57 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=199.8
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ......+.+..|+.+++.++|+|++++++++.+.+..++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 566788999999999999876 59999999987653 1223356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+++ +|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CDM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 984 9999997653 3588999999999999999999999 999999999999999999999999999987654433
Q ss_pred cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------ccccccccccc--cC
Q 042086 676 NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS----------SSNRNISLNEI--LD 742 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~--~d 742 (784)
......++..|+|||.+.+. .++.++|||||||++||+++|+.||......... ..........+ .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 33444567889999998766 7889999999999999999999998642211000 00000000000 01
Q ss_pred CCCCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 PRLPTPPQ-----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 ~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.... ..+.....+.+++.+|+..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 11111000 01112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=278.73 Aligned_cols=259 Identities=19% Similarity=0.315 Sum_probs=207.0
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEe
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 581 (784)
.++.....+++....+-+|.||.||.|.++ +.+.|.||.++.. .+.-+...+..|.-++..+.|||+..+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 344555667888888999999999999554 3556778877543 23334567889999999999999999999
Q ss_pred EEec-CCceEEEEecccCCCHHHHHh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 582 FCSH-PRNSFLVYEYLERGSLATILS-----NDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 582 ~~~~-~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
++.+ ....+++|.++.-|+|..|+. .......+.-.+...++.|++.|++|||++ +|||.||.++|.++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 9854 567889999999999999997 333334566677888999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCCcccc--cccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042086 656 DYEARVSDFGIAKFLKPDSSNCTE--LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSN 732 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~ 732 (784)
.-.+||+|-.+++.+.+.++++-. ...+..||+||.+....|+.++|||||||++|||+| |+.|+-.++..+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----- 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----- 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----
Confidence 999999999999988777666432 334678999999999999999999999999999998 999976444322
Q ss_pred cccccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 733 RNISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 733 ~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...-+.|. |+..| .++++ ++..++.-||..+|++||++++++.-
T Consensus 507 ---m~~ylkdGyRlaQP-~NCPD---eLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 507 ---MEHYLKDGYRLAQP-FNCPD---ELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred ---HHHHHhccceecCC-CCCcH---HHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 22223343 44444 45666 47788999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=271.73 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=203.2
Q ss_pred hcCCCCc-eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec----C
Q 042086 514 TNGFDVK-YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH----P 586 (784)
Q Consensus 514 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~ 586 (784)
+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++.. .....+|++.--.. .|||||.++++|.. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3444443 57999999999999765 899999998864 23456788775555 79999999999843 4
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEec
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVSD 663 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~D 663 (784)
.+..+|||.|+||.|.+.++.++. ..|++.++.+|+.||+.|+.|||+. +|.||||||+|+|.+.. ..+||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 577899999999999999987664 4689999999999999999999999 99999999999999754 5689999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
||+|+.-.. .......+-||.|.|||++-..+|+...|+||+||++|-|++|.+||-...... ...+....|...
T Consensus 208 fGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~g 282 (400)
T KOG0604|consen 208 FGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTG 282 (400)
T ss_pred cccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhcc
Confidence 999986543 233455678999999999999999999999999999999999999985333221 112222334444
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.+.+.+.++...++|+..+..+|.+|.|+.++++
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 555555667778888999999999999999999999875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=295.35 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=196.4
Q ss_pred HHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-CCc
Q 042086 511 VRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-PRN 588 (784)
Q Consensus 511 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 588 (784)
...+++|++.+.||.|+||.||+|... +++.||+|++..... .....+.+..|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 346788999999999999999999865 799999998865322 22235678899999999999999999999865 457
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++|+||+ +++|.++++.. .+++.....++.|++.|++|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 55999888642 467788889999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccccccc
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNISLNEI 740 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~ 740 (784)
..... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||......... ....+.....+
T Consensus 157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 64322 233467889999998866 56889999999999999999999998642210000 00000000000
Q ss_pred cCC-------CCC----CC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 LDP-------RLP----TP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 ~d~-------~~~----~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+. ... .+ .+..+.....+.+++.+|++.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000 00 0001112346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=320.55 Aligned_cols=148 Identities=28% Similarity=0.394 Sum_probs=132.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|++.............+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999876 78999999987643333333467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
||+++++|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 477888999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.22 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=192.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
.++|.+.+.||+|+||.||+|... +|+.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 468999999999999999999865 7899999998754322 223456889999999999999999999986542
Q ss_pred -ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 588 -NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 588 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
..++|+||+.. +|.++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999975 7877652 2478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cc------
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SN------ 732 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~------ 732 (784)
++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9865322 234567889999999876 458889999999999999999999996432110000 00
Q ss_pred --cccccccccCCCCCCCCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 --RNISLNEILDPRLPTPPQN----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 --~~~~~~~~~d~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...............+... .+.....+.+++.+|++.||++||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000000000000 0112235779999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=277.76 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=195.2
Q ss_pred ceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEeccc
Q 042086 520 KYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
...||.|+||+|+|-..+ +|+..|||+++.... ..+.+++..|.+...+- ++||||++||.+..++..+|-||.|+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 356999999999999765 799999999987643 34567888888865544 79999999999988899999999996
Q ss_pred CCCHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 598 RGSLATILSND--GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 598 ~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
- +++.+.+.- -...++++...-+|+...++||.||.... .|||||+||+|||++..|.+||||||++-.+.. +.
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-Si 222 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-SI 222 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-HH
Confidence 6 777765421 11235777777788888899999998864 899999999999999999999999999876543 33
Q ss_pred ccccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 676 NCTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
..+..+|-..|||||.+.. ..|+.+|||||+|++|||+.||..|+..+.... .+...-..-|+..........
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-----eql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-----EQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-----HHHHHHHcCCCCeecCccccc
Confidence 3455678889999999963 348999999999999999999999987543321 111111112222222223344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+....+.++|..|+.+|-..||+++++.+
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 56678999999999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.66 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=197.0
Q ss_pred HHHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec
Q 042086 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH 585 (784)
Q Consensus 507 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 585 (784)
..++...+++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456667899999999999999999999864 789999999875322 22234678899999999999999999998854
Q ss_pred C------CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 586 P------RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 586 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
. ...+++++++ +++|.++++.. .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3467888876 77999887642 478899999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cc
Q 042086 660 RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SS 731 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~ 731 (784)
||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876432 2234567889999999866 46788999999999999999999998532211000 00
Q ss_pred ccccccccccC----------CCCCCC-C-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 732 NRNISLNEILD----------PRLPTP-P-QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 732 ~~~~~~~~~~d----------~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+.+ +..+.. . .........+.+++.+|++.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00000000000 000000 0 000011335789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.03 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=194.7
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC---
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR--- 587 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 587 (784)
...++|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34678999999999999999999855 799999999865321 2223456889999999999999999999986543
Q ss_pred ---ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 588 ---NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 588 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 6799988764 2578899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc------ccccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS------SNRNISL 737 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~------~~~~~~~ 737 (784)
|++...... .....+++.|+|||.+.+ ..++.++|+|||||++|++++|+.||.......... .......
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999865432 233467889999999876 457889999999999999999999986332110000 0000000
Q ss_pred ccccC--------CCCCCCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 738 NEILD--------PRLPTPP-----QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 738 ~~~~d--------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+.+. ..++... .........+.+++.+|++.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000000 000112235789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=315.80 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=207.6
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
++....++|+++++||+|+||.|..++.+ ++++||.|++.+..-.......-|..|-++|..-+.+-|+.+.-.|++++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34445678999999999999999999976 78999999998743333344567999999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
+.|+|||||+||+|..++...+ .++...++.++..|+-||..+|+. |+|||||||+|||+|..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999998764 578888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-cccccccccccccccccc----c-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042086 668 KFLKPDSS-NCTELVGTFGYIAPELVY----T-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 668 ~~~~~~~~-~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
-.+..++. .....+|||.|++||++. + +.|.+.+|-||+||++|||+.|..||-- +.+ -+....|+
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dsl-------veTY~KIm 294 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSL-------VETYGKIM 294 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHH-------HHHHHHHh
Confidence 98886544 356678999999999985 3 6788999999999999999999999842 111 11122333
Q ss_pred CC--CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHH
Q 042086 742 DP--RLPTPPQNVQDELISIVEVAFLCLNESPESRPP---MHTVC 781 (784)
Q Consensus 742 d~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~vl 781 (784)
+. .+..| ...+.+.+..+||.+.+. +|+.|.. ++++-
T Consensus 295 ~hk~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 295 NHKESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred chhhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 33 23332 122355567778877666 7888887 66654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.24 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=191.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------ 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 586 (784)
..+|++.+.||.|+||.||+|... +|+.||+|.+.... ....+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 367999999999999999999875 68999999886542 23456788999999999999999999876543
Q ss_pred --------CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CC
Q 042086 587 --------RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DY 657 (784)
Q Consensus 587 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~ 657 (784)
...++|+||++ ++|.+++... .+++..+..++.||+.|++|||+. +|+||||||+||+++. ++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 4998888542 478899999999999999999999 9999999999999974 56
Q ss_pred ceEEeccccccccCCCCC---ccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc----
Q 042086 658 EARVSDFGIAKFLKPDSS---NCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---- 729 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---- 729 (784)
.+|++|||.+........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 789999999986543211 1123457889999998754 45788999999999999999999999643221100
Q ss_pred ---ccccccccccc--------c-CCCCCCC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 ---SSNRNISLNEI--------L-DPRLPTP--PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 ---~~~~~~~~~~~--------~-d~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........... . +...... ....+....++.+++.+|++.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000 0 0000000 0000112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=296.41 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=211.1
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe---
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS--- 584 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 584 (784)
....++.|++.+.||.|.+|.||+++. ++++.+|+|+..... ...+++..|.+|++.. .|||++.++|+|.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 334567899999999999999999985 479999999987743 3466788999999988 7999999999984
Q ss_pred --cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEe
Q 042086 585 --HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVS 662 (784)
Q Consensus 585 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 662 (784)
.++..++|||||.+|+..|+++... ...+.|..+..|+..+++|+.+||.+ .++|||||-.|||++.++.||++
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 3578999999999999999998766 46789999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 042086 663 DFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISL 737 (784)
Q Consensus 663 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 737 (784)
|||.+..+...........|||.|||||++.. ..|+.++|+||+|++..||--|.+|+-.+.... .+
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------aL 237 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------AL 237 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------hh
Confidence 99999988776666777899999999999963 347779999999999999999999975433211 00
Q ss_pred ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 738 ~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.. +....+...........++-++|..|+.+|-++||++.++++
T Consensus 238 F~-IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FL-IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cc-CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 01 111111111223455678999999999999999999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=291.57 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=191.0
Q ss_pred CCCCceeEecccceEEEEEEEc-C--CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec----CC
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-S--GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH----PR 587 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 587 (784)
+|++.+.||+|+||.||+++.. + +..||+|++..... .....+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4788899999999999999865 4 78999998865322 122345788999999999 59999999987532 24
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++++||+. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5788889886 59999886543 578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----ccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc
Q 042086 668 KFLKPDSS----NCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNI 735 (784)
Q Consensus 668 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~ 735 (784)
........ ......|++.|+|||.+.+ ..++.++|+||+||++|++++|+.||......... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86543221 1233568899999998765 46789999999999999999999998643211000 000000
Q ss_pred ccccccCC----------CCC--CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 SLNEILDP----------RLP--TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 ~~~~~~d~----------~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+..+ ..+ ............+.+++.+|++.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 000 000000111346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.94 Aligned_cols=258 Identities=19% Similarity=0.287 Sum_probs=195.2
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc---
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN--- 588 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 588 (784)
..++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4678999999999999999999876 688999998865322 12234567889999999999999999998865554
Q ss_pred ---eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 589 ---SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 589 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699998864 3588899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc-
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNIS- 736 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~- 736 (784)
++...... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||.......... ......
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 99865432 234467889999999865 357889999999999999999999986322110000 000000
Q ss_pred -------cccccCCCC-CCCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 -------LNEILDPRL-PTPPQ---NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 -------~~~~~d~~~-~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.... ..... .......++.+++.+|++.||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 00000 00012346889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=276.21 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=204.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
..+|.+..+||+|+||.|-+|..+ +.+.+|||++++.........+--..|-++++.. +-|.++++...|+..++.|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346899999999999999999766 5678999999887654444455556777788776 57899999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+.||+|.-++++-+. +.+..+..+|.+||-||-+||++ +||.||||..|||+|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999987654 55688889999999999999999 99999999999999999999999999998655
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
-+......++|||.|+|||.+...+|...+|-|||||+||||+.|++||+.. ..++-...+.+.....+.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--------DE~elF~aI~ehnvsyPK-- 571 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--------DEDELFQAIMEHNVSYPK-- 571 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHHccCcCcc--
Confidence 5566677899999999999999999999999999999999999999999843 233444555555554332
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC
Q 042086 752 VQDELISIVEVAFLCLNESPESRP 775 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RP 775 (784)
..+.+...++...+.+.|.+|.
T Consensus 572 --slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 572 --SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --cccHHHHHHHHHHhhcCCcccc
Confidence 2344566788888999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=284.60 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=201.9
Q ss_pred ceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 520 KYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
.+.||+|.||+||-|+.+ +|+.||||++.+... .....+.+.+|+.+++.++||.||.+--.|+.++..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF-p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF-PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccC-CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 478999999999999865 899999999987644 334467899999999999999999999999999999999999966
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEeccccccccCCCCC
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~~~~~~~~ 675 (784)
+..+.+-... .++++....+.++.||+.||.|||.+ +|+|+|+||+|||+... -.+||||||+|+.+.+. .
T Consensus 648 -DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s 721 (888)
T KOG4236|consen 648 -DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S 721 (888)
T ss_pred -hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence 6666553322 24688888888999999999999999 99999999999999754 36999999999998743 3
Q ss_pred cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHH
Q 042086 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 755 (784)
.....+|||.|+|||++..+.|...-|+||.||++|--+.|..||..-+++. .++-+..+..+++.+.+.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn----------dQIQNAaFMyPp~PW~ei 791 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN----------DQIQNAAFMYPPNPWSEI 791 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh----------HHhhccccccCCCchhhc
Confidence 3467899999999999999999999999999999999999999997322221 122233344445556677
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 756 LISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 756 ~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
.....++|...++..-.+|-|.+.-+
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 77888999999999999998877654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-34 Score=302.05 Aligned_cols=321 Identities=33% Similarity=0.434 Sum_probs=288.2
Q ss_pred CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCccc-ccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCc
Q 042086 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLS-ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLA 152 (784)
Q Consensus 74 ~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 152 (784)
+.+..|++|.+++|++. .+-..+..|+.|+.+.+..|++. .-+|+.+..+..|+.||||+|+++ +.|..+....++-
T Consensus 52 ~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~i 129 (1255)
T KOG0444|consen 52 SRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSI 129 (1255)
T ss_pred HHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcE
Confidence 46778999999999988 45567889999999999999985 358888999999999999999999 8899999999999
Q ss_pred EEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCc
Q 042086 153 VLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNH 232 (784)
Q Consensus 153 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 232 (784)
.|+||+|+|..+....|.+++.|-.||||+|.+. .+|+.+..+..|++|.|++|.+...--..+..+++|+.|.+++.+
T Consensus 130 VLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~Tq 208 (1255)
T KOG0444|consen 130 VLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQ 208 (1255)
T ss_pred EEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccccc
Confidence 9999999999555566789999999999999999 788889999999999999999865544556667788899999876
Q ss_pred cc-cccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCc
Q 042086 233 LS-GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311 (784)
Q Consensus 233 l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~ 311 (784)
-+ .-+|.++.++.+|..++++.|.+. .+|..+.++++|+.|+|++|+|+ .+........+|++|+||.|+++ .+|
T Consensus 209 RTl~N~Ptsld~l~NL~dvDlS~N~Lp--~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP 284 (1255)
T KOG0444|consen 209 RTLDNIPTSLDDLHNLRDVDLSENNLP--IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLP 284 (1255)
T ss_pred chhhcCCCchhhhhhhhhccccccCCC--cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cch
Confidence 54 467999999999999999999997 88999999999999999999998 55666777789999999999999 899
Q ss_pred ccccccccceEEeccccccc-CCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcc
Q 042086 312 ETLGNLLKLHYLNLSNNQFR-KGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMH 390 (784)
Q Consensus 312 ~~l~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 390 (784)
..+.++++|+.|.+.+|+++ ..+|..++++.+|+.+..++|.+. ..|+.++.+..|+.|.|++|++.. +|+.+.-++
T Consensus 285 ~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~ 362 (1255)
T KOG0444|consen 285 DAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLP 362 (1255)
T ss_pred HHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceee-chhhhhhcC
Confidence 99999999999999999986 358999999999999999999999 999999999999999999999984 599999999
Q ss_pred cceEEEcCCCCCc
Q 042086 391 GLSCIDVSYNELR 403 (784)
Q Consensus 391 ~L~~l~l~~N~l~ 403 (784)
.|+.|||..|+=-
T Consensus 363 ~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 363 DLKVLDLRENPNL 375 (1255)
T ss_pred CcceeeccCCcCc
Confidence 9999999999543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=271.99 Aligned_cols=219 Identities=21% Similarity=0.187 Sum_probs=175.6
Q ss_pred ccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCHHHH
Q 042086 526 GGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATI 604 (784)
Q Consensus 526 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 604 (784)
|.+|.||++++. +++.||+|.+.... .+..|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999875 78999999987531 234455555566799999999999999999999999999999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccccccccc
Q 042086 605 LSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684 (784)
Q Consensus 605 l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 684 (784)
+.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+..+... .....++.
T Consensus 76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~ 146 (237)
T cd05576 76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN 146 (237)
T ss_pred HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence 87543 478899999999999999999998 9999999999999999999999999988765432 22345577
Q ss_pred ccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHH
Q 042086 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAF 764 (784)
Q Consensus 685 ~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~ 764 (784)
.|+|||...+..++.++||||+|+++|||++|+.|++..... ........++ . .....+.+++.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~---~---~~~~~~~~li~ 210 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIP---E---WVSEEARSLLQ 210 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCc---c---cCCHHHHHHHH
Confidence 899999998888899999999999999999999887522110 0000000111 1 12235788999
Q ss_pred hcccCCCCCCCCH
Q 042086 765 LCLNESPESRPPM 777 (784)
Q Consensus 765 ~cl~~dP~~RPs~ 777 (784)
+|++.||++||++
T Consensus 211 ~~l~~dp~~R~~~ 223 (237)
T cd05576 211 QLLQFNPTERLGA 223 (237)
T ss_pred HHccCCHHHhcCC
Confidence 9999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=287.95 Aligned_cols=239 Identities=23% Similarity=0.318 Sum_probs=192.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
++.|.+...+|.|+|+.|-.+... +++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++...++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 457888888999999999998755 7889999998764 22344677666666 79999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee-cCCCceEEecccccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL-CLDYEARVSDFGIAKFL 670 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfG~a~~~ 670 (784)
|||.+.+|-+.+.+.... .+. ..+.+|+.+|+.|+.|||++ ||||||+||+|||+ +.+++++|+|||.++..
T Consensus 394 v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999998888776543 223 66778999999999999998 99999999999999 68899999999999977
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
..+ ....+-|..|.|||+.....+++++|+||||++||+|++|+.||..... ... +..++..+..
T Consensus 467 ~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-------~~e-----i~~~i~~~~~ 531 (612)
T KOG0603|consen 467 ERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-------GIE-----IHTRIQMPKF 531 (612)
T ss_pred chh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-------hHH-----HHHhhcCCcc
Confidence 654 3344668899999999999999999999999999999999999863221 111 1112211111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ...+....+|+..||+.||.+||+|+++..
T Consensus 532 s-~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 S-ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred c-cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1 234456788999999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=275.49 Aligned_cols=257 Identities=28% Similarity=0.373 Sum_probs=197.8
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCCh----hhHHHHHHHHhccCCCceeeEEeEEe-cCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQ----PEFVNEIKTLTELRHRSIVKFYGFCS-HPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 587 (784)
-++|-+..+||+|||+.||||.+ ...+.||||+-+....+..+.. +...+|.++-+.++||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34577788999999999999975 4678899998766555544333 33678999999999999999999996 456
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEecc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSDF 664 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 664 (784)
..|-|+||++|.+|+-+|+.+. .+++.++..|+.||+.||.||.+. .++|||-||||.|||+-. -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7889999999999999998765 467799999999999999999875 579999999999999953 478999999
Q ss_pred ccccccCCCCCc-------cccccccccccccccccc----CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 042086 665 GIAKFLKPDSSN-------CTELVGTFGYIAPELVYT----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR 733 (784)
Q Consensus 665 G~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 733 (784)
|+++.|..+.+. .+..+||..|++||.+.- .+.+.|+||||.||++|+.+.|+.||..-..-.. ...
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHh
Confidence 999999876544 245679999999998853 3467899999999999999999999974221100 000
Q ss_pred ccccccccCCC-CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 734 NISLNEILDPR-LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 734 ~~~~~~~~d~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
+ ..++..+ ...++ .+....+...+|++|++..-++|....++.
T Consensus 696 e---NTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 E---NTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h---hchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0 1122211 11111 123344677899999999988888777664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=235.68 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=196.8
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|+..+.||+|.||+||||+.. +++.||+|+++-....+.. .....+|+-+++.++|+|||++++....+...-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4666788999999999999865 6899999999876554443 4567899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
||.. +|..+...-. +.++.+....++.|+++|+.++|++ ++.|||+||.|.+++.+|+.|++|||+++.+.-.-
T Consensus 82 ~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9976 9999887543 3678888999999999999999999 99999999999999999999999999999876555
Q ss_pred CcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCC-CCcccccc--------cc--ccccccccccccC
Q 042086 675 SNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHP-RDFISSIS--------SS--SSNRNISLNEILD 742 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p-~~~~~~~~--------~~--~~~~~~~~~~~~d 742 (784)
.-.+..+-|..|.+|.++.+.+ |++..|+||-||++.|+.....| |...+... -. ....+..+...-|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 4456667899999999998876 78899999999999999975444 43211100 00 0111112222222
Q ss_pred CCC-CCCCC--CCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 PRL-PTPPQ--NVQ----DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 ~~~-~~~~~--~~~----~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... +..+. ... .-...=.+++++.+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 211 11110 011 11112245666778889999999998876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=260.20 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=206.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
.+.|++.++||+|.|+.|..++.+ +.+.||+|++++....+.+..+=.+.|-.+..+- +||.+|.+..+|+.+...+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999865 6889999999887665555666677788887766 79999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|.||+++|+|.-+++... .++++.+..+...|.-||.|||++ |||.||+|..||++|..|++|+.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999987776543 578899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc-ccCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE-ILDPRLPTPPQ 750 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~~ 750 (784)
.+....+.++|||.|+|||.+.+..|...+|-|++||+++||+.|+.||+....... ....+..+.+ ++...+..+.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~-d~ntedylfqvilekqiripr- 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-DMNTEDYLFQVILEKQIRIPR- 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-ccchhHHHHHHHhhhcccccc-
Confidence 566677889999999999999999999999999999999999999999996553221 1122222222 3333333322
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRP 775 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RP 775 (784)
..+.+...+++.-+++||++|.
T Consensus 481 ---slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhc
Confidence 1223455677788999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.90 Aligned_cols=239 Identities=28% Similarity=0.430 Sum_probs=192.1
Q ss_pred cceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCHHHHH
Q 042086 527 GQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL 605 (784)
Q Consensus 527 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 605 (784)
+||.||+|... +++.+|+|++....... ..+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999987 58999999987643221 1678999999999999999999999999989999999999999999998
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccccccc
Q 042086 606 SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG 685 (784)
Q Consensus 606 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 685 (784)
..... +++..+..++.+++++++|||+. +++|+||+|+||+++.++.++++|||.+....... ......+++.
T Consensus 79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred HhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 76432 78899999999999999999999 99999999999999999999999999998765432 3345567889
Q ss_pred cccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHh
Q 042086 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFL 765 (784)
Q Consensus 686 y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~ 765 (784)
|+|||......++.++||||||++++++++|..||+..... .............. .........++.+++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPF-PPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCC-ccccccCCHHHHHHHHH
Confidence 99999999888899999999999999999999998642111 00011111111111 01100033468889999
Q ss_pred cccCCCCCCCCHHHHHH
Q 042086 766 CLNESPESRPPMHTVCQ 782 (784)
Q Consensus 766 cl~~dP~~RPs~~~vl~ 782 (784)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=258.59 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=191.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--------
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-------- 585 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 585 (784)
..|.....||+|.||.||+|+.+ +|+.||+|++.-......- .....+|++++..++|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf-pitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC-cHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45666778999999999999865 6888999876443222222 3456799999999999999999998843
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
....|+||++|+. +|.-.+.... -+++..++.+++.++..||.|+|.. .|+|||+||.|||++.++.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 2347999999988 9999887553 3688899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC----CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccc---------cc--
Q 042086 666 IAKFLKPDS----SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSIS---------SS-- 729 (784)
Q Consensus 666 ~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~---------~~-- 729 (784)
+++.+.... ...+..+-|..|.+||.+.+. .++++.|+|.-||++.||+||.+-++.-.... .+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 997664322 224556779999999999865 48899999999999999999988765321100 00
Q ss_pred -cccc---ccccccccC-CCCCCC-CCCCHHHHH------HHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 -SSNR---NISLNEILD-PRLPTP-PQNVQDELI------SIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 -~~~~---~~~~~~~~d-~~~~~~-~~~~~~~~~------~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.... .-.+.+-+. +.++.. ....++... +..+++..++..||.+|+++++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0000 000001110 001000 000111111 4678888999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=267.43 Aligned_cols=257 Identities=19% Similarity=0.269 Sum_probs=199.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-C-C----ceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-H-R----SIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~ 586 (784)
.++|.+...+|+|.||.|-++.+. .+..||||+++..... .++.+-|+++++++. + | -+|.+.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY----reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY----REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH----hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 678999999999999999999865 5789999998864332 456778999999993 2 2 478888999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-----------
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL----------- 655 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----------- 655 (784)
++.+||+|.+ |-++.+++..++. ..++..++..++.|+++++++||+. +++|-||||+||++.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 9999999988 4499999987654 4689999999999999999999999 9999999999999941
Q ss_pred ---------CCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 042086 656 ---------DYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI 726 (784)
Q Consensus 656 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~ 726 (784)
+..+||+|||.|++-.+. .+..+.|..|.|||++.+-.++.++||||+||||+|+.||..-|..-+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 345899999999875433 26678899999999999999999999999999999999999877532211
Q ss_pred c---cc---------cccccc--------------------ccccccCCCC--CCCCCCCHHHHHHHHHHHHhcccCCCC
Q 042086 727 S---SS---------SSNRNI--------------------SLNEILDPRL--PTPPQNVQDELISIVEVAFLCLNESPE 772 (784)
Q Consensus 727 ~---~~---------~~~~~~--------------------~~~~~~d~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~ 772 (784)
+ -. ...... ....+.++-. .........+..++.+|+.+|+..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 1 00 000000 0001111000 000112234556799999999999999
Q ss_pred CCCCHHHHHH
Q 042086 773 SRPPMHTVCQ 782 (784)
Q Consensus 773 ~RPs~~~vl~ 782 (784)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=276.48 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=201.6
Q ss_pred cCCCCceeEecccceEEEEEEEcCCC-EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGE-ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.+++.+..||-|+||.|=.++.++.+ .+|+|++++....+..+.+.+..|-.+|...+.|.||++|..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667778999999999999877443 48899888766666677788999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|-|-||.|...++..+. |+..+...++..+.+|++|||++ +||.|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999988765 66688888999999999999999 9999999999999999999999999999998755
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.. .-.++|||.|.|||.+..+..+.++|.||+|+++||+++|.+||...+...-......+ +..+ .++ .
T Consensus 574 ~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id~i---~~P------r 642 (732)
T KOG0614|consen 574 RK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-IDKI---EFP------R 642 (732)
T ss_pred Cc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hhhh---hcc------c
Confidence 43 35689999999999999999999999999999999999999999854432211100000 0000 111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC
Q 042086 754 DELISIVEVAFLCLNESPESRPP 776 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs 776 (784)
.......+++++.+..+|.+|.-
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhc
Confidence 22335668888999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=293.88 Aligned_cols=259 Identities=19% Similarity=0.220 Sum_probs=168.6
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-C----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeE-----
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-S----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF----- 582 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~----- 582 (784)
..++|++.+.||+|+||.||+|+.. + +..||+|++.... ..+.+..| .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4578999999999999999999875 4 7899999875421 11111111 1111122222222211
Q ss_pred -EecCCceEEEEecccCCCHHHHHhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEe
Q 042086 583 -CSHPRNSFLVYEYLERGSLATILSNDGAI-----------------EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHR 644 (784)
Q Consensus 583 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 644 (784)
.......++|+||+++++|.++++..... .......+..++.|++.||+|||++ +|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 23556789999999999999998753210 0112234567999999999999998 99999
Q ss_pred CCCCCCeeecC-CCceEEeccccccccCCCC-CcccccccccccccccccccC----------------------CcCcc
Q 042086 645 DISSKNVLLCL-DYEARVSDFGIAKFLKPDS-SNCTELVGTFGYIAPELVYTM----------------------KVTEK 700 (784)
Q Consensus 645 Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 700 (784)
||||+|||++. ++.+||+|||+|+.+.... .......+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 5789999999998664332 223456789999999976322 23446
Q ss_pred hhHHHHHHHHHHHHhCCCCCCcccc-----ccccccccccccccccCCCCCCC----CCCCHHHHHHHHHHHHhcccCCC
Q 042086 701 CDVYSFGVLALEVIKGDHPRDFISS-----ISSSSSNRNISLNEILDPRLPTP----PQNVQDELISIVEVAFLCLNESP 771 (784)
Q Consensus 701 sDvwslGv~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~d~~~~~~----~~~~~~~~~~l~~li~~cl~~dP 771 (784)
+|||||||++|||+++..|++.... +..... ..........++.... .+..........+|+.+|++.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDY-DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCC-cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 7999999999999998777542100 000000 0000011111111000 00000011234589999999999
Q ss_pred CCCCCHHHHHH
Q 042086 772 ESRPPMHTVCQ 782 (784)
Q Consensus 772 ~~RPs~~~vl~ 782 (784)
++|||++++++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.44 Aligned_cols=200 Identities=26% Similarity=0.382 Sum_probs=173.7
Q ss_pred CCCCceeEecccceEEEEEE-EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
-|..++.||-|+||+|.+++ .++...||.|.+++.......+....+.|-+||..-+.+-||++|-.|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47778899999999999996 45678899999887655555566778899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC--
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP-- 672 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~-- 672 (784)
|++||++.++|-..+ -|.+..+..++.+++.|+++.|.. |+|||||||+|||||.||++||.|||++.-++-
T Consensus 710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999987654 467788888999999999999999 999999999999999999999999999863321
Q ss_pred -------CCCc---------------------------------ccccccccccccccccccCCcCcchhHHHHHHHHHH
Q 042086 673 -------DSSN---------------------------------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALE 712 (784)
Q Consensus 673 -------~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~e 712 (784)
.+.. ....+||+.|+|||++....++.-+|-||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0000 012479999999999999999999999999999999
Q ss_pred HHhCCCCCC
Q 042086 713 VIKGDHPRD 721 (784)
Q Consensus 713 lltg~~p~~ 721 (784)
|+.|+.||-
T Consensus 864 m~~g~~pf~ 872 (1034)
T KOG0608|consen 864 MLVGQPPFL 872 (1034)
T ss_pred HhhCCCCcc
Confidence 999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=280.80 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=181.4
Q ss_pred hcCCCCceeEecccceEEEEEEE-----------------cCCCEEEEEEcCCCCCCC-----------CCChhhHHHHH
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-----------------TSGEILAVKKFHSLWPCE-----------MVPQPEFVNEI 565 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~ 565 (784)
.++|++.++||+|+||+||+|.. ..++.||||++....... ....+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 245789999986432110 01123345577
Q ss_pred HHHhccCCCce-----eeEEeEEec--------CCceEEEEecccCCCHHHHHhcCCC---------------------C
Q 042086 566 KTLTELRHRSI-----VKFYGFCSH--------PRNSFLVYEYLERGSLATILSNDGA---------------------I 611 (784)
Q Consensus 566 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~ 611 (784)
.++.+++|.++ +++++||.. .+..++||||+++|+|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 88888876654 677787743 3567999999999999999874211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc-cccccccccccccc
Q 042086 612 EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN-CTELVGTFGYIAPE 690 (784)
Q Consensus 612 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE 690 (784)
..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..+...... .....+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2356788899999999999999998 9999999999999999999999999999765432211 12233478999999
Q ss_pred ccccCCc----------------------CcchhHHHHHHHHHHHHhCCC-CCCccccccccccccccccc---cccCCC
Q 042086 691 LVYTMKV----------------------TEKCDVYSFGVLALEVIKGDH-PRDFISSISSSSSNRNISLN---EILDPR 744 (784)
Q Consensus 691 ~~~~~~~----------------------~~~sDvwslGv~l~elltg~~-p~~~~~~~~~~~~~~~~~~~---~~~d~~ 744 (784)
.+..... ..+.||||+||++|||++|.. |+.................. .+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8754321 124799999999999999875 66532221110000000000 000001
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHHh
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESP---ESRPPMHTVCQL 783 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~~vl~~ 783 (784)
... ...........+++.+++..+| .+|+|++|+++.
T Consensus 461 ~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 100 1111223457788889999766 689999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-33 Score=281.04 Aligned_cols=231 Identities=35% Similarity=0.485 Sum_probs=154.6
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
+|..+++|++++|+++ .+|.+++.+..++.|+.++|+++ ++|++++.+.+|+.|++++|.+. ++|+.++.+..|..|
T Consensus 66 nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl 142 (565)
T KOG0472|consen 66 NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDL 142 (565)
T ss_pred cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhh
Confidence 6777888888888887 66778888888888888888887 77888888888888888888887 667777777778888
Q ss_pred eecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccc
Q 042086 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 155 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (784)
+..+|+++ ..|+.+.++.+|..|++.+|++....|..+. ++.|++|+...|-+. .+|..++++.+|..|+|..|+|.
T Consensus 143 ~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 143 DATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR 219 (565)
T ss_pred hccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc
Confidence 88887777 5666777777777777777777643333333 666666666666654 55566666666666666666666
Q ss_pred cccCCCCcCCCCcceEEecCCCCCCCCccccc-ccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccc
Q 042086 235 GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313 (784)
Q Consensus 235 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l-~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 313 (784)
..| .|.++..|++|+++.|+++ .+|++. .++++|..|||.+|+++ ..|+.++-+.+|.+||+|+|.++ ..|..
T Consensus 220 -~lP-ef~gcs~L~Elh~g~N~i~--~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~s 293 (565)
T KOG0472|consen 220 -FLP-EFPGCSLLKELHVGENQIE--MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYS 293 (565)
T ss_pred -cCC-CCCccHHHHHHHhcccHHH--hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcc
Confidence 444 5556666666666666554 444443 25555555555555555 45555555555555555555555 23444
Q ss_pred cccc
Q 042086 314 LGNL 317 (784)
Q Consensus 314 l~~l 317 (784)
++++
T Consensus 294 Lgnl 297 (565)
T KOG0472|consen 294 LGNL 297 (565)
T ss_pred cccc
Confidence 4444
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=238.81 Aligned_cols=206 Identities=24% Similarity=0.343 Sum_probs=168.7
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
...+....+..||+|++|.|-+.++. +|+..|+|.+..... ....++..+|+++..+- .+|.+|.+||.+......
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34455566778999999999998854 899999999976542 33456778888876655 799999999999999999
Q ss_pred EEEEecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 590 FLVYEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
++-||.|+- +|+.+.++- ......++...-+|+..+.+||.|||++. .+||||+||+|||++.+|.+|+||||.+-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999976 888876532 11235777888899999999999999985 89999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccc----CCcCcchhHHHHHHHHHHHHhCCCCCCcc
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYT----MKVTEKCDVYSFGVLALEVIKGDHPRDFI 723 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGv~l~elltg~~p~~~~ 723 (784)
.+.. +-..+...|-..|||||.+.. ..|+.||||||+|+.+.||.+++.||+..
T Consensus 198 ~L~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 7653 223344567788999999853 35889999999999999999999998743
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=282.38 Aligned_cols=243 Identities=26% Similarity=0.397 Sum_probs=187.1
Q ss_pred CCCceeEecccceE-EEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEEe
Q 042086 517 FDVKYCIGIGGQGS-VYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 517 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 594 (784)
|.-.+.+|.|..|+ ||+|... |+.||||++-.. ..+-..+|+..++.- +|||||++|+.-+++...||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 34456789998776 5999986 889999988653 234567999999988 69999999999999999999999
Q ss_pred cccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---C--CceEEecccccc
Q 042086 595 YLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---D--YEARVSDFGIAK 668 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~DfG~a~ 668 (784)
.|.- +|.+++...+. .....-...+.+..|++.|+++||+. +||||||||.||||+. + ..++|+|||+++
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9966 99999987411 11111134567889999999999998 9999999999999976 3 468999999999
Q ss_pred ccCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCCC
Q 042086 669 FLKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG-DHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 669 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
.+..+... .....||.||+|||++...+-+.++|+||+||++|+.++| .+||+.....+ . .|+...
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-------~---NIl~~~ 729 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-------A---NILTGN 729 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-------h---hhhcCc
Confidence 88765443 3456799999999999998888899999999999999995 99997432211 1 111111
Q ss_pred CC-CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 745 LP-TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 745 ~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.. .......+. +..+||.+|++.||..||++.+|+.
T Consensus 730 ~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 YTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 000111122 6779999999999999999999985
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-32 Score=272.60 Aligned_cols=91 Identities=34% Similarity=0.589 Sum_probs=54.7
Q ss_pred CcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccccc------------------------cccc
Q 042086 310 IPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCE------------------------ICNM 365 (784)
Q Consensus 310 ~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------------------~~~l 365 (784)
+|..+..+++|+.|+|++|.+.. +|..++.+..|+.||+|.|++. .+|.. +.+|
T Consensus 427 v~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm 504 (565)
T KOG0472|consen 427 VPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNM 504 (565)
T ss_pred chHHHHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhh
Confidence 33444555666677777776665 6666666666777777766654 44433 5555
Q ss_pred ccccEEecCCCccCCCCcccccCcccceEEEcCCCCCc
Q 042086 366 ESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403 (784)
Q Consensus 366 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 403 (784)
.+|..|||.+|.+. .+|..++++++|++|+++||++.
T Consensus 505 ~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 505 RNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 56666666666655 34555566666666666666555
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=253.59 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=194.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-----C---CceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-----H---RSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~ 584 (784)
.++|.+.++||-|+|++||++.+. +.+.||+|+.+... .-.+....|+++|++++ | ..||+++++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 368999999999999999999875 67899999988743 33567789999999983 2 48999999996
Q ss_pred c----CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC----
Q 042086 585 H----PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---- 656 (784)
Q Consensus 585 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---- 656 (784)
. +.+++||+|++ |.+|..++..... ..++...+++|+.||+.||.|||.+| +|||-||||+|||+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccch
Confidence 5 45789999998 5599999986654 45788999999999999999999998 99999999999999500
Q ss_pred --------------------------------------------------------------------------------
Q 042086 657 -------------------------------------------------------------------------------- 656 (784)
Q Consensus 657 -------------------------------------------------------------------------------- 656 (784)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 042086 657 -------------------------------------------------------------------------------- 656 (784)
Q Consensus 657 -------------------------------------------------------------------------------- 656 (784)
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence
Q ss_pred --CceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----
Q 042086 657 --YEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS----- 729 (784)
Q Consensus 657 --~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~----- 729 (784)
-.+||+|||-|+.+. .+++....|..|.|||++.+..|++.+|+||++|++|||+||..-|+.-+.-...
T Consensus 389 ~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred cceeEEEeeccchhhhh---hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 014566666655432 2334445678899999999999999999999999999999999888642221100
Q ss_pred ------------------------ccccccccccccCCCC-------CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 042086 730 ------------------------SSNRNISLNEILDPRL-------PTPPQNVQDELISIVEVAFLCLNESPESRPPMH 778 (784)
Q Consensus 730 ------------------------~~~~~~~~~~~~d~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 778 (784)
-..+.+.+..|-.-+. ....+-..+...++.+++.-||+.+|++|||+.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 0001111111110000 011123356677899999999999999999999
Q ss_pred HHHH
Q 042086 779 TVCQ 782 (784)
Q Consensus 779 ~vl~ 782 (784)
+.++
T Consensus 546 ~cl~ 549 (590)
T KOG1290|consen 546 QCLK 549 (590)
T ss_pred HHhc
Confidence 9875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=234.57 Aligned_cols=253 Identities=19% Similarity=0.300 Sum_probs=193.1
Q ss_pred hcCCCCceeEecccceEEEEEE-EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCC--ce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPR--NS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 589 (784)
.++|++.+.+|+|.+++||.|. ..+.+.++||++++. ..+.+.+|+++++.+. ||||++++++..++. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3578899999999999999997 557889999998764 3678999999999996 999999999997754 56
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEecccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAK 668 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~ 668 (784)
.+|+||+.+.+...... .++...+..++.+++.||.|+|+. ||.|||+||.||++|.. ...+|+|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 89999999988877653 355567888999999999999999 99999999999999866 569999999999
Q ss_pred ccCCCCCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc------------------
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------------------ 729 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------------------ 729 (784)
++.+... ....+.+..|..||.+..-+ |+..-|+|||||++..|+..+.||..-..-...
T Consensus 182 FYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 182 FYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 9876543 35567788899999987654 778899999999999999999998532211000
Q ss_pred --ccccccccccccCCCCCC------CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 --SSNRNISLNEILDPRLPT------PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 --~~~~~~~~~~~~d~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..........++...... ..++..-...+..+++.+.+..|-++|||++|.++
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000001111111110000 00111111246778889999999999999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-31 Score=248.35 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=190.2
Q ss_pred CCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----CceEE
Q 042086 518 DVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----RNSFL 591 (784)
Q Consensus 518 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 591 (784)
+-.+.||.|+||+||.+.+. +|+.||.|++.... .+...-+.+.+|++++..++|.|++..+++.+-. ...|+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44578999999999999865 89999999886532 2334467889999999999999999998887543 24678
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
++|.|.. +|...+-..+ .++-..++-+..||++||.|||+. +|.||||||.|.+++.+...||||||+|+.-+
T Consensus 135 ~TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 8999876 8888776543 466688888999999999999999 99999999999999999999999999999755
Q ss_pred CCC-CcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccc---------------ccccccc
Q 042086 672 PDS-SNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSIS---------------SSSSNRN 734 (784)
Q Consensus 672 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~---------------~~~~~~~ 734 (784)
.+. .+.+..+-|..|.|||.+++.+ |+.+.||||.||++.|++..+.-|+-...++ .....-+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 432 3345567789999999999765 8999999999999999998777665322211 0011111
Q ss_pred cccccccCCCCCCCC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 ISLNEILDPRLPTPP-------QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 ~~~~~~~d~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+....++......+. ....+...+...+...++..||++|.+..+.+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 111222221111110 011122234556777889999999999887764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=238.38 Aligned_cols=212 Identities=32% Similarity=0.556 Sum_probs=185.1
Q ss_pred EecccceEEEEEEEcC-CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCH
Q 042086 523 IGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSL 601 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 601 (784)
||+|.+|.||++...+ ++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999999764 8999999987642211 346899999999999999999999999998999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CCceEEeccccccccCCCCCccccc
Q 042086 602 ATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKFLKPDSSNCTEL 680 (784)
Q Consensus 602 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~ 680 (784)
.+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 99987542 3578899999999999999999999 9999999999999999 8999999999998765443223445
Q ss_pred ccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHH
Q 042086 681 VGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISI 759 (784)
Q Consensus 681 ~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l 759 (784)
.+...|++||..... ..+.++|+|++|++++++ ..+
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~ 190 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL 190 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence 678899999999877 788899999999999999 357
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 760 VEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 760 ~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+++..|++.+|++||++.++++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 7899999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=261.23 Aligned_cols=199 Identities=23% Similarity=0.297 Sum_probs=171.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC-----CChhhHHHHHHHHhccC---CCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM-----VPQPEFVNEIKTLTELR---HRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 584 (784)
...|...+.+|.|+||.|+.|.++ +...|+||.+.+...-.. ...-..-.|+.+|..++ |+||+|++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999876 567899999876543211 11223668999999997 999999999999
Q ss_pred cCCceEEEEeccc-CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEec
Q 042086 585 HPRNSFLVYEYLE-RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 585 ~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
+++.+|++||... +.+|.+++.... .+++..+..|+.||+.|+++||+. +|||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 9999999999754 459999997654 577799999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCc-chhHHHHHHHHHHHHhCCCCC
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE-KCDVYSFGVLALEVIKGDHPR 720 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslGv~l~elltg~~p~ 720 (784)
||.|.+.. .+....++||.+|.|||++.+.+|-- .-|+|++|++||.++....||
T Consensus 714 fgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 714 FGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99998765 34567789999999999999998865 589999999999999999996
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=234.73 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=188.8
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeE-EecCCce
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGF-CSHPRNS 589 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~ 589 (784)
..+.|++.+.+|+|.||.+-+++.+ +.+.+++|.++.. ....++|.+|..---.+ .|.||+.-|+. |+..+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3567999999999999999999977 6788999988763 33478999998877777 58999988875 5777888
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-C-CCceEEeccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC-L-DYEARVSDFGIA 667 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~-~~~~kl~DfG~a 667 (784)
+.++||++.|+|.+-+... .+.+....+++.|++.|+.|||++ ++||||||.+|||+- . ...+||||||..
T Consensus 98 vF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 8999999999999877653 355677889999999999999999 999999999999993 3 357999999998
Q ss_pred cccCCCCCcccccccccccccccccccC-----CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTM-----KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d 742 (784)
+.... .......+..|.|||..... ...+.+|+|.||+++|.++||+.||+-...... ...+......-..
T Consensus 171 ~k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 171 RKVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQWLKRKN 246 (378)
T ss_pred cccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHHHhcccC
Confidence 76432 22333445679999987432 356789999999999999999999983322211 1111111122222
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 743 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
++.+ .........++++.++-+.++|++|-...++.
T Consensus 247 ~~~P---~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 247 PALP---KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ccCc---hhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 2333 33334455678888899999999995555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=237.26 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=192.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------C
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------R 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 587 (784)
.+|.-.+.+|.|.- .|..|.+. .+++||+|+....... ....+...+|...+..+.|+|+++++.+|.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 45667778899988 66666544 7899999988766433 34456778999999999999999999998432 3
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..|+|||+|.. +|.+.+.. +++-.....+..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|
T Consensus 95 e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 57999999976 99988873 355577889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------------------
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------------------ 729 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------------------ 729 (784)
+.-..+ -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.....+...
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 865443 3456778899999999999888999999999999999999998776422111000
Q ss_pred -----c--cccc----ccccccc-CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 -----S--SNRN----ISLNEIL-DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 -----~--~~~~----~~~~~~~-d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. .... ....+.+ |...+...+...-......+++.+||-.||++|-+++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 0000 0111111 11111111111122335778899999999999999999986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=258.59 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=202.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|+...++|+|.+|.|||+++. +++..|+|+++-.-. ...+-.+.|+-+++..+|||||.++|.+-..+..++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 457899999999999999999865 799999999876532 3455677899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+.+|+|++..+..+ .+++.++..+.....+|++|||+. +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999999887665 466678888899999999999999 889999999999999999999999999987766
Q ss_pred CCCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.-.....+.||++|||||+.. .+.|...+|||+.|+...|+---++|-......... ....+..+++.-...+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l----~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL----FLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH----HHhhccCCCCCcccCC
Confidence 555566789999999999974 445888999999999999999888884432221110 0011111221111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
-.....+-++++.|+.++|++||+++.+++
T Consensus 241 ---~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 ---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 123445778999999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=231.01 Aligned_cols=198 Identities=34% Similarity=0.556 Sum_probs=172.3
Q ss_pred CCCceeEecccceEEEEEEEcC-CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
|++.+.||+|++|.||+|...+ ++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5678899999999999999874 899999998764322 2467899999999999999999999999988999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC-
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS- 674 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 674 (784)
+++++|.+++..... .+++.....++.++++++.+||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999999976432 178899999999999999999999 99999999999999999999999999998765432
Q ss_pred Cccccccccccccccccc-ccCCcCcchhHHHHHHHHHHHHhCCCCCC
Q 042086 675 SNCTELVGTFGYIAPELV-YTMKVTEKCDVYSFGVLALEVIKGDHPRD 721 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~elltg~~p~~ 721 (784)
.......++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 122345678889999998 66678889999999999999999999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=244.20 Aligned_cols=263 Identities=19% Similarity=0.227 Sum_probs=204.6
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC------CceeeEEeE
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH------RSIVKFYGF 582 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~ 582 (784)
-+....+|.+....|+|-|++|.+|.+. -|..||||++.... ...+.=+.|+++|+++.. -|.++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3445678999999999999999999876 58899999998743 335667799999999952 388999999
Q ss_pred EecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEE
Q 042086 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARV 661 (784)
Q Consensus 583 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl 661 (784)
|.+..++|||+|-+.- +|.+.|+..+..-.+...++..++.|+.-||..|... +|+|.||||.|||+++.. .+||
T Consensus 503 F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 9999999999998755 9999999888777889999999999999999999988 999999999999999874 5799
Q ss_pred eccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccc----------------
Q 042086 662 SDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISS---------------- 725 (784)
Q Consensus 662 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~---------------- 725 (784)
||||.|...... ..+.+..+.-|.|||++.+-+|+...|+||.||.|||+.||+.-|.....
T Consensus 579 CDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 579 CDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred ccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 999999876543 23444556779999999999999999999999999999999876632100
Q ss_pred ------------cccc---------ccc--cccccccccCC------CC---CCCCCCCHHHHHHHHHHHHhcccCCCCC
Q 042086 726 ------------ISSS---------SSN--RNISLNEILDP------RL---PTPPQNVQDELISIVEVAFLCLNESPES 773 (784)
Q Consensus 726 ------------~~~~---------~~~--~~~~~~~~~d~------~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~ 773 (784)
+... ... ........+.| .+ +..+.........+.+|+..|+..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0000 000 00000111111 01 1122334455678899999999999999
Q ss_pred CCCHHHHHH
Q 042086 774 RPPMHTVCQ 782 (784)
Q Consensus 774 RPs~~~vl~ 782 (784)
|-|..+.++
T Consensus 737 Rit~nqAL~ 745 (752)
T KOG0670|consen 737 RITVNQALK 745 (752)
T ss_pred cCCHHHHhc
Confidence 999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=227.78 Aligned_cols=200 Identities=26% Similarity=0.369 Sum_probs=167.1
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEE
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFC 583 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 583 (784)
.+....+.|..+++||.|.|++||++.+. ..+.||+|.+.... ....+.+|+++|..+ .+.||+++.+++
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhh
Confidence 34455678999999999999999999743 46889999987642 345689999999999 699999999999
Q ss_pred ecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEe
Q 042086 584 SHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVS 662 (784)
Q Consensus 584 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~ 662 (784)
...+...+|+||++.....++... ++...+..++..+..||+++|++ |||||||||+|++.+.. +.-.|+
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence 999999999999999999998864 55688889999999999999999 99999999999999855 677899
Q ss_pred ccccccccCCCC--------------C--------------------c----------ccccccccccccccccccC-Cc
Q 042086 663 DFGIAKFLKPDS--------------S--------------------N----------CTELVGTFGYIAPELVYTM-KV 697 (784)
Q Consensus 663 DfG~a~~~~~~~--------------~--------------------~----------~~~~~gt~~y~aPE~~~~~-~~ 697 (784)
|||+|....... . . ....+||+||.|||++... ..
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997221000 0 0 0124699999999998754 46
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 698 TEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 698 ~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
++++||||-||+++-+++++.||-.
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred CCccceeeccceeehhhcccccccc
Confidence 8899999999999999999999853
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-27 Score=258.20 Aligned_cols=208 Identities=30% Similarity=0.365 Sum_probs=143.4
Q ss_pred hhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccc-c--
Q 042086 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL-G-- 291 (784)
Q Consensus 215 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l-~-- 291 (784)
+++..+.+|+.|+..+|+++ .+|..+..+++|+.|.+.+|+++ .+|.....+++|++|+|..|+|. ..|+.+ .
T Consensus 258 ~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~--yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~ 333 (1081)
T KOG0618|consen 258 EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE--YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVL 333 (1081)
T ss_pred HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh--hCCCcccccceeeeeeehhcccc-ccchHHHhhh
Confidence 44444444444444444443 33444444444444444444444 45555666777888888888776 333211 0
Q ss_pred -----------------------CCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeec
Q 042086 292 -----------------------SLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELD 348 (784)
Q Consensus 292 -----------------------~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 348 (784)
..+.|+.|.+.+|.+++..-..+.++++|+.|+|++|++.......+.++..|++|+
T Consensus 334 ~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~ 413 (1081)
T KOG0618|consen 334 NASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELN 413 (1081)
T ss_pred hHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHh
Confidence 123466777788888777777788888999999999999886677788999999999
Q ss_pred cCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcc-cCCCCCCCcCCCcccccCCCCCC
Q 042086 349 LSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRG-PIPNSRIFQYDPMEALQGNKGLC 427 (784)
Q Consensus 349 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~p~~~~~~~~~~~~~~~n~~~c 427 (784)
||+|+++ .+|..+.++..|++|...+|++... | .+.+++.|+.+|+|.|+|+. .+|..-.+..+....+.||.++-
T Consensus 414 LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 414 LSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-P-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred cccchhh-hhhHHHHhhhhhHHHhhcCCceeec-h-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 9999999 7888889999999999999998855 4 78889999999999999884 34443333455555777887644
Q ss_pred CC
Q 042086 428 GD 429 (784)
Q Consensus 428 ~~ 429 (784)
-+
T Consensus 491 ~d 492 (1081)
T KOG0618|consen 491 FD 492 (1081)
T ss_pred cc
Confidence 33
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=267.93 Aligned_cols=194 Identities=19% Similarity=0.197 Sum_probs=139.5
Q ss_pred ccCC-CceeeEEeEE-------ecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 042086 570 ELRH-RSIVKFYGFC-------SHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641 (784)
Q Consensus 570 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 641 (784)
.++| +||+++++++ .+.+..+.++||+ +++|.+++.... ..+++..++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888887 2334667888988 559999997532 3588999999999999999999999 99
Q ss_pred EEeCCCCCCeeecC-------------------CCceEEeccccccccCCCC----------------Cccccccccccc
Q 042086 642 VHRDISSKNVLLCL-------------------DYEARVSDFGIAKFLKPDS----------------SNCTELVGTFGY 686 (784)
Q Consensus 642 vH~Dlk~~Nill~~-------------------~~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~~y 686 (784)
+||||||+|||++. ++.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456677777765421100 001123578899
Q ss_pred ccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhc
Q 042086 687 IAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLC 766 (784)
Q Consensus 687 ~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~c 766 (784)
||||++.+..++.++|||||||++|||++|..|+........ ........+.. .........++.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS------SLRHRVLPPQI-------LLNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH------HHHHhhcChhh-------hhcCHHHHHHHHHh
Confidence 999999999999999999999999999999888652211000 00000111110 11122355788899
Q ss_pred ccCCCCCCCCHHHHHH
Q 042086 767 LNESPESRPPMHTVCQ 782 (784)
Q Consensus 767 l~~dP~~RPs~~~vl~ 782 (784)
|+++|.+||+|.|+++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999986
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=252.43 Aligned_cols=222 Identities=30% Similarity=0.374 Sum_probs=190.1
Q ss_pred cccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEe
Q 042086 173 KSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252 (784)
Q Consensus 173 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 252 (784)
.+|+++++++|+++ .+|++++.+.+|+.+...+|+++ .+|..+..+++|+.|.+..|.+. -+|....++++|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 36888888888888 56689999999999999999995 77788888899999999999998 67777888999999999
Q ss_pred cCCCCCCCCccccc--------------------------ccccccceEeccCccccCCCCccccCCCccceeecccCcc
Q 042086 253 YDNQLSVGEIPIEI--------------------------GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL 306 (784)
Q Consensus 253 ~~n~l~~~~~~~~l--------------------------~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l 306 (784)
..|+|. .+|..+ ..++.|+.|++.+|.+++..-..+.+.++|+.|+|++|++
T Consensus 318 ~~N~L~--~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL 395 (1081)
T KOG0618|consen 318 QSNNLP--SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL 395 (1081)
T ss_pred hhcccc--ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence 999886 333311 1235788999999999987777889999999999999999
Q ss_pred CCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccc
Q 042086 307 GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCF 386 (784)
Q Consensus 307 ~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 386 (784)
.......+.++..|+.|+||+|+++. +|..+.+++.|+.|...+|++. .+| ++..+++|+.+|+|.|+++...-...
T Consensus 396 ~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~ 472 (1081)
T KOG0618|consen 396 NSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEA 472 (1081)
T ss_pred ccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhh
Confidence 85555568999999999999999998 8899999999999999999999 888 89999999999999999986654444
Q ss_pred cCcccceEEEcCCCCC
Q 042086 387 EGMHGLSCIDVSYNEL 402 (784)
Q Consensus 387 ~~l~~L~~l~l~~N~l 402 (784)
...++|++|||+||..
T Consensus 473 ~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 473 LPSPNLKYLDLSGNTR 488 (1081)
T ss_pred CCCcccceeeccCCcc
Confidence 4458999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=209.98 Aligned_cols=163 Identities=25% Similarity=0.304 Sum_probs=122.4
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
|+|.++++..+ ..+++..++.++.|+++||+|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997643 3589999999999999999999998 5 999999999999999 99998764322
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHH-
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI- 757 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~- 757 (784)
..|++.|+|||++.+..++.++|||||||++|||+||+.||.......... ....... .+..+...........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL---EILLNGM-PADDPRDRSNLESVSAA 138 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH---HHHHHHh-ccCCccccccHHHHHhh
Confidence 257899999999999999999999999999999999999986432211000 0000000 0000000001112222
Q ss_pred -HHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 758 -SIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 758 -~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
++.+++.+||+.||++||++.++++.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHH
Confidence 58999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=256.38 Aligned_cols=316 Identities=24% Similarity=0.259 Sum_probs=196.4
Q ss_pred cCCCCcccEEeCCCCc------ccccCCCCcCCCC-CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCc
Q 042086 73 KGNLKSLSTLDLSKNK------LNGSIPFSFGNLT-NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTL 145 (784)
Q Consensus 73 ~~~l~~l~~L~L~~n~------i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 145 (784)
+..+.+|+.|.+..+. +...+|..|..++ +|+.|.+.++.+. .+|..| .+.+|++|+|++|++. .++..+
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~ 630 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGV 630 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccc
Confidence 3457778888776543 3445677776664 5888888877765 566665 4677888888888776 566677
Q ss_pred cCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccce
Q 042086 146 GNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLH 225 (784)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 225 (784)
..+++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.
T Consensus 631 ~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~ 708 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYR 708 (1153)
T ss_pred ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCE
Confidence 778888888887765444555 36677788888888776555777777778888888887765444555544 6777888
Q ss_pred eccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCcccc-------CCCCccccCCCccce
Q 042086 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLY-------GNLPRALGSLTELEY 298 (784)
Q Consensus 226 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~-------~~~~~~l~~l~~L~~ 298 (784)
|++++|......|.. .++|++|++++|.+. .+|..+ .+++|++|++.++... ...+......++|+.
T Consensus 709 L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~--~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 709 LNLSGCSRLKSFPDI---STNISWLDLDETAIE--EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred EeCCCCCCccccccc---cCCcCeeecCCCccc--cccccc-cccccccccccccchhhccccccccchhhhhccccchh
Confidence 888777655455542 356777777777765 455433 3556666666553321 111111222356666
Q ss_pred eecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCcc
Q 042086 299 LDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNF 378 (784)
Q Consensus 299 L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 378 (784)
|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|+|++|.....+|.. ..+|+.|+|++|.+
T Consensus 783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i 858 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGI 858 (1153)
T ss_pred eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCC
Confidence 6666666555666666666666666666654333345444 4566666666665444444432 24566666666666
Q ss_pred CCCCcccccCcccceEEEcCC-CCCcc
Q 042086 379 SGLIPSCFEGMHGLSCIDVSY-NELRG 404 (784)
Q Consensus 379 ~~~~p~~~~~l~~L~~l~l~~-N~l~~ 404 (784)
+ .+|..+..+++|+.|++++ |++.+
T Consensus 859 ~-~iP~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 859 E-EVPWWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred c-cChHHHhcCCCCCEEECCCCCCcCc
Confidence 5 3455666666666666666 34443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=255.71 Aligned_cols=310 Identities=25% Similarity=0.286 Sum_probs=255.3
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
..|+.|++.++.+. .+|..| ...+|++|+|.+|++. .++..+..+++|+.|+|++|.....+| .++.+++|++|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEe
Confidence 46999999999876 678777 5799999999999997 678888999999999999987655777 4888999999999
Q ss_pred cCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccc
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV 236 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 236 (784)
++|.....+|..+.++++|+.|++++|..-..+|..+ ++++|+.|++++|.....+|.. .++|++|++++|.+. .
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~ 739 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-E 739 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-c
Confidence 9998777899999999999999999986555777766 7899999999999766566643 457899999999987 4
Q ss_pred cCCCCcCCCCcceEEecCCCCCC-----CCc-ccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCC
Q 042086 237 IPLSIGNLNNLIGLYLYDNQLSV-----GEI-PIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310 (784)
Q Consensus 237 ~~~~l~~l~~L~~L~L~~n~l~~-----~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 310 (784)
+|..+ .+++|++|.+.++.... ..+ +......++|+.|++++|...+.+|..++++++|+.|++++|...+.+
T Consensus 740 lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~L 818 (1153)
T PLN03210 740 FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETL 818 (1153)
T ss_pred ccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCee
Confidence 56554 57889999887744210 011 111233578999999999888889999999999999999998655577
Q ss_pred cccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcc
Q 042086 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMH 390 (784)
Q Consensus 311 ~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 390 (784)
|..+ ++++|+.|++++|..-..+|.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++|+-...+|..+..++
T Consensus 819 P~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~ 893 (1153)
T PLN03210 819 PTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLK 893 (1153)
T ss_pred CCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCccccccc
Confidence 7766 7899999999998665545543 368999999999998 7899999999999999999765556788889999
Q ss_pred cceEEEcCCCC
Q 042086 391 GLSCIDVSYNE 401 (784)
Q Consensus 391 ~L~~l~l~~N~ 401 (784)
+|+.++++++.
T Consensus 894 ~L~~L~l~~C~ 904 (1153)
T PLN03210 894 HLETVDFSDCG 904 (1153)
T ss_pred CCCeeecCCCc
Confidence 99999999873
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=241.28 Aligned_cols=260 Identities=27% Similarity=0.368 Sum_probs=134.6
Q ss_pred ccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecC
Q 042086 79 LSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYG 158 (784)
Q Consensus 79 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 158 (784)
-..|+|++|+++ .+|..+. ++|+.|++.+|+|+. +|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 456777777777 4666554 367777777777763 4432 466777777777776 33432 35666777777
Q ss_pred CCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccC
Q 042086 159 NSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP 238 (784)
Q Consensus 159 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 238 (784)
|.++ .+|..+ ++|+.|+|++|+++ .+|.. +++|+.|+|++|+|++. |... .+|+.|++++|.+++ +|
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTS-LP 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccccC-CCCc---ccccccccccCcccc-cc
Confidence 7666 334322 45666667777666 33432 35566666666666532 2211 245556666666653 33
Q ss_pred CCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccc
Q 042086 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL 318 (784)
Q Consensus 239 ~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~ 318 (784)
.. ..+|+.|+|++|+|+ .+|.. .++|+.|++++|++++ +|.. ..+|+.|+|++|+|
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls--~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~L------------ 394 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLA--SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRL------------ 394 (788)
T ss_pred cc---ccccceEecCCCccC--CCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcc------------
Confidence 21 124555555555554 23321 1244445555555542 3321 12344445555444
Q ss_pred cceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcC
Q 042086 319 KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 398 (784)
++ +|.. .++|+.|++++|+++ .+|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|+
T Consensus 395 ------------t~-LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 395 ------------TS-LPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ------------cC-CCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 43 2221 134455555555554 23322 123445555555555 335555555555555555
Q ss_pred CCCCcccCC
Q 042086 399 YNELRGPIP 407 (784)
Q Consensus 399 ~N~l~~~~p 407 (784)
+|+|+|.+|
T Consensus 454 ~N~Ls~~~~ 462 (788)
T PRK15387 454 GNPLSERTL 462 (788)
T ss_pred CCCCCchHH
Confidence 555555444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=238.06 Aligned_cols=257 Identities=30% Similarity=0.381 Sum_probs=164.9
Q ss_pred CCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccc
Q 042086 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206 (784)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 206 (784)
-..|+|++|.++ .+|+.+. ++|+.|++++|+++. +|.. .++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 445566666555 4454443 356666666666652 3432 355666666666666 33432 24566666666
Q ss_pred cccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCC
Q 042086 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286 (784)
Q Consensus 207 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 286 (784)
|.+.. +|..+ ++|+.|++++|+++. +|. ..++|+.|+|++|+++ .+|.. ..+|+.|++++|++++ +
T Consensus 272 N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~--~Lp~l---p~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 272 NPLTH-LPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLA--SLPAL---PSELCKLWAYNNQLTS-L 337 (788)
T ss_pred Cchhh-hhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccc--cCCCC---cccccccccccCcccc-c
Confidence 66652 23222 456667777777763 343 2356777777777776 34431 2357778888888874 4
Q ss_pred CccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccc
Q 042086 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNME 366 (784)
Q Consensus 287 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 366 (784)
|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|+. +|.. ..+|+.|+|++|+|+ .+|.. .+
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s 402 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL---PS 402 (788)
T ss_pred ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCc---cc
Confidence 532 2578899999999984 5543 2478888999999986 5543 357999999999999 46643 36
Q ss_pred cccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCCCCCCC
Q 042086 367 SLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGNKGLCG 428 (784)
Q Consensus 367 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~ 428 (784)
+|+.|++++|+|++ +|.. ..+|+.|++++|+++ .+|.. ..+.......+.+|+....
T Consensus 403 ~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCch
Confidence 89999999999996 4654 346889999999998 47753 2234444556777765433
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-26 Score=225.64 Aligned_cols=293 Identities=25% Similarity=0.259 Sum_probs=216.2
Q ss_pred CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecC-CCcccccCCccccccccceeec
Q 042086 102 NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYG-NSLSGSIPSIIGNLKSLFYLHL 180 (784)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L 180 (784)
.-++++|..|+|+.+.|.+|+.+++|+.||||+|.|+.+-|++|.++++|..|.+.+ |+|+......|.++.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456777777777777777888888888888888888888888888888887776666 7888666677888888888888
Q ss_pred cccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCC
Q 042086 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260 (784)
Q Consensus 181 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 260 (784)
.-|++.-.....|..+++|..|.+.+|.+..+-...|..+.+++.+.+..|.+- ...+++.+... +..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~~-~a~------ 215 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLADD-LAM------ 215 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhhH-Hhh------
Confidence 888888777777888888888888888877555557777778888877777643 11222222211 111
Q ss_pred CcccccccccccceEeccCccccCCCCccccCC-CccceeecccCccCCCCcc-cccccccceEEecccccccCCCchhh
Q 042086 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSL-TELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVEL 338 (784)
Q Consensus 261 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l-~~L~~L~Ls~n~l~~~~~~-~l~~l~~L~~L~ls~N~l~~~~~~~~ 338 (784)
.|..++...-..-..+.++++...-+..|... ..+..--.+.+...+.-|. .|..+++|+.|+|++|+|+++-+.+|
T Consensus 216 -~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF 294 (498)
T KOG4237|consen 216 -NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF 294 (498)
T ss_pred -chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence 12233334444445566666654444444322 2232222333334444443 58899999999999999999999999
Q ss_pred hcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 339 EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 339 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
.++..+++|.|..|++...-...|.++..|+.|+|.+|+|+...|..|..+.+|..|+|-.|+|.|.+-
T Consensus 295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR 363 (498)
T ss_pred cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence 999999999999999997777888999999999999999999999999999999999999999998665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=204.40 Aligned_cols=248 Identities=20% Similarity=0.359 Sum_probs=182.9
Q ss_pred CCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecc
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
..+..+|.+...|+.|+|+++ |..+++|++.... ....-.++|..|.-.++-+.||||++++|.|..+....++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~-~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVRE-VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc-Ccchhhhhhhhhh-cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 445667899999999999998 4445566665432 23334568999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEe-CCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 597 ERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHR-DISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 597 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~-Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
+.|+|+..+++... -..+-.++.+++.++|+|++|||+.. +++-| -+.+..|++|++.+++|+ .+-+++..
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsf---- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF---- 341 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeee----
Confidence 99999999987543 24566788899999999999999963 55544 789999999999888764 11122111
Q ss_pred cccccccccccccccccccCCcC---cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 676 NCTELVGTFGYIAPELVYTMKVT---EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
......-+|.||+||.+...+.+ .++|+|||++++||+.|...||......+-. .+. ....-+...++.
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---mki---aleglrv~ippg-- 413 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---MKI---ALEGLRVHIPPG-- 413 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---hhh---hhccccccCCCC--
Confidence 11233457899999999876644 4789999999999999999999754432211 111 111112222222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+.+++.-|+++||.+||.++.|+-.|
T Consensus 414 --is~hm~klm~icmnedpgkrpkfdmivpil 443 (448)
T KOG0195|consen 414 --ISRHMNKLMNICMNEDPGKRPKFDMIVPIL 443 (448)
T ss_pred --ccHHHHHHHHHHhcCCCCcCCCcceehhhH
Confidence 233567788899999999999999887543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=218.36 Aligned_cols=167 Identities=22% Similarity=0.209 Sum_probs=130.1
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc--CCCEEEEEEcCCCCC--CCCCChhhHHHHHHHHhccCCCceee-EEeEEecC
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT--SGEILAVKKFHSLWP--CEMVPQPEFVNEIKTLTELRHRSIVK-FYGFCSHP 586 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~ 586 (784)
...++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.|.+|++++++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999865 578889998753211 11123556999999999999999985 4432
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC-CCCCeeecCCCceEEeccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDI-SSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfG 665 (784)
+..++||||+++++|... ... . ...++.++++||+|||+. +|+|||| ||+||+++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~---~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH---G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc---c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999732 111 1 146788999999999999 9999999 9999999999999999999
Q ss_pred cccccCCCCCc--------ccccccccccccccccccC
Q 042086 666 IAKFLKPDSSN--------CTELVGTFGYIAPELVYTM 695 (784)
Q Consensus 666 ~a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 695 (784)
+|+.+...... .....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99977543311 1345678889999998643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-26 Score=225.68 Aligned_cols=267 Identities=24% Similarity=0.281 Sum_probs=209.8
Q ss_pred EEEeCCCcccC---CC-CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccC-CccC
Q 042086 64 SINLSTVGLKG---NL-KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE-NQLS 138 (784)
Q Consensus 64 ~l~l~~~~~~~---~l-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-n~l~ 138 (784)
.++.++.|+.. +| ...++++|..|+|+..-|.+|+.+++|+.|+|++|.|+.+-|++|.++++|..|-+-+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 34555555543 33 3578999999999999999999999999999999999999999999999988877666 9999
Q ss_pred CCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccC--------
Q 042086 139 GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLF-------- 210 (784)
Q Consensus 139 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------- 210 (784)
......|++|..|+.|.+.-|++.-.....|..+++|..|.+-+|.+....-..|..+.+++.+.+..|.+.
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchh
Confidence 777789999999999999999999888889999999999999999999444448999999999999988831
Q ss_pred ----CccchhhhcccccceeccC-------------------------CCccccccC-CCCcCCCCcceEEecCCCCCCC
Q 042086 211 ----GSIPSILGNLKMLLHLGLS-------------------------TNHLSGVIP-LSIGNLNNLIGLYLYDNQLSVG 260 (784)
Q Consensus 211 ----~~~~~~l~~l~~L~~L~L~-------------------------~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~ 260 (784)
...|..+++........+. .+...+..| ..|..+++|+.|+|++|+++.
T Consensus 210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~- 288 (498)
T KOG4237|consen 210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR- 288 (498)
T ss_pred hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch-
Confidence 1122223332222222222 222222333 347788889999999998873
Q ss_pred CcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEeccccccc
Q 042086 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR 331 (784)
Q Consensus 261 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~ 331 (784)
.-+.+|..+..+++|+|..|++.......|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|.+.
T Consensus 289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 33557888888899999999888666778888888899999999998888888888888888888877774
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=209.70 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=186.8
Q ss_pred CCCCceeEecccceEEEEEEEcCC--CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC----CceeeEEeEE-ecCCc
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLTSG--EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH----RSIVKFYGFC-SHPRN 588 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~ 588 (784)
+|.+.+.||+|+||.||++...+. ..+|+|........ ....+..|+.++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~---~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS---KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC---CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 799999999999999999997653 57888886653211 12268889999988863 6899999999 57778
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-----CceEEec
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-----YEARVSD 663 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~D 663 (784)
.++||+.+ |-+|.++..... ...++..+..+|+.|++.+|+++|+. |++||||||.|+.+... ..+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 89999977 669999876555 46799999999999999999999999 99999999999999865 4689999
Q ss_pred ccccc--ccCCCCC--------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 042086 664 FGIAK--FLKPDSS--------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR 733 (784)
Q Consensus 664 fG~a~--~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 733 (784)
||+++ .+..... ......||..|+++....+...+.+.|+||++.++.|++.|..||.............
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99999 3322211 1234569999999999999999999999999999999999999986443211100000
Q ss_pred ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 734 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.......... .....+. ++.++...+-..+..++|....+.+.
T Consensus 251 ~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTDR----FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhcccc----ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0000000000 1112223 34444445555788999988877653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-20 Score=203.11 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=196.5
Q ss_pred CCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCC-ceeeEEeEEecCCceEEEEec
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHR-SIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 595 (784)
|.+.+.||.|+||.||++... ..+++|.+.............|.+|+.+++.+.|+ +++++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999887 88899998775443323467899999999999988 799999999777778999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEeccccccccCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKFLKPDS 674 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~ 674 (784)
+.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543112467788999999999999999999 999999999999999988 79999999998665433
Q ss_pred C------ccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 675 S------NCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 675 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
. ......|+..|+|||.+.+ .......|+||+|++++++++|..||.......... ...........+..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHH-HHHHHHHhcCCccc
Confidence 2 2356789999999999987 578889999999999999999999976433200000 00000000000000
Q ss_pred CCCCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 746 PTPPQN--VQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 746 ~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
...... .......+.+++..|+..+|..|.++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 000000 011234677889999999999999988765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-22 Score=227.34 Aligned_cols=246 Identities=29% Similarity=0.414 Sum_probs=134.5
Q ss_pred CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeecc
Q 042086 102 NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181 (784)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 181 (784)
+.+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+++ .+|..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4556666666665 3444432 35666666666666 3444433 36666666666666 3444332 356666666
Q ss_pred ccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCC
Q 042086 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGE 261 (784)
Q Consensus 182 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 261 (784)
+|.+. .+|..+. ++|+.|+|++|+++. +|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|+++ .
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt--~ 318 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT--A 318 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc--c
Confidence 66666 4454443 356666666666652 343332 356666666666653 333222 35566666666655 3
Q ss_pred cccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcc
Q 042086 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKL 341 (784)
Q Consensus 262 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l 341 (784)
+|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+++ .+|..+. ++|+.|+|++|+++. +|..+.
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~-- 387 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP-- 387 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--
Confidence 343322 456666666666653 444442 56666666666665 3454443 466666666666664 444443
Q ss_pred cccCeeccCCccccccccccc----cccccccEEecCCCccC
Q 042086 342 IQLSELDLSLNILEGKIPCEI----CNMESLEKLNLSHNNFS 379 (784)
Q Consensus 342 ~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~ 379 (784)
..|+.|++++|++. .+|..+ ..++.+..|+|.+|+++
T Consensus 388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 25666666666666 344333 23355666666666665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-22 Score=226.71 Aligned_cols=265 Identities=26% Similarity=0.403 Sum_probs=209.2
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
.+.++|+|++++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+++ .+|..+. ++|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 357899999999984 566553 58999999999999 5676554 58999999999998 5676554 58999999
Q ss_pred cCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccc
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV 236 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 236 (784)
++|++. .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|++|+++. +|..+. ++|+.|++++|+++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence 999998 6676664 58999999999999 5777664 589999999999985 444332 479999999999995
Q ss_pred cCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccc
Q 042086 237 IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGN 316 (784)
Q Consensus 237 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~ 316 (784)
+|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+++ .+|..+ .++|+.|+|++|+|+ .+|..+.
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt--~LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~- 387 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALT--SLPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENLP- 387 (754)
T ss_pred CCcccc--ccceeccccCCccc--cCChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCC-CCCHhHH-
Confidence 454443 68999999999997 5776554 79999999999998 567655 368999999999999 5676665
Q ss_pred cccceEEecccccccCCCchhh----hcccccCeeccCCccccccccccccccccccEEecCCCccCC
Q 042086 317 LLKLHYLNLSNNQFRKGFPVEL----EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380 (784)
Q Consensus 317 l~~L~~L~ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 380 (784)
.+|+.|++++|++++ +|..+ ..++.+..|++.+|.++. ..+.+|+.| ++.+.+.|
T Consensus 388 -~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 388 -AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred -HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 379999999999986 55544 445889999999999883 344555555 44455544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=181.72 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=188.1
Q ss_pred HhcCCCCceeEecccceEEEEEE-EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 590 (784)
..+.|.+++.||+|+||.+|.|. ..+|..||||.-... ..-.++..|.++.+.++ ...|..+..|..+...-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 35789999999999999999997 568999999986543 22346889999999996 467888888888888999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEeccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVSDFGIA 667 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a 667 (784)
+|||.. |-+|.+.+.-.. ..++..+.+-.+-|++.-++|+|.+ ++|||||||+|+|+.-+ ..+.++|||+|
T Consensus 88 lVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 999988 559999886433 2578889999999999999999999 99999999999999754 46899999999
Q ss_pred cccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042086 668 KFLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 668 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
+.+.+... ......||.+|.+--...+...+.+-|+=|+|.++.++-.|..||+.+..... ......+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEkI 236 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEKI 236 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHHH
Confidence 98764322 23456899999998888888888899999999999999999999986543211 1111122
Q ss_pred cCCCCCCCCC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 042086 741 LDPRLPTPPQ-NVQDELISIVEVAFLCLNESPESRPPMHTV 780 (784)
Q Consensus 741 ~d~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~~v 780 (784)
...++..+.+ .+...+.++.-.+.-|-..--++-|...-+
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 2222222211 111222345555556666666666665443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=223.28 Aligned_cols=254 Identities=19% Similarity=0.255 Sum_probs=186.3
Q ss_pred CCceeEecccceEEEEEEEc-CCCEEEEEEcCCC--CCCCC-CChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 518 DVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSL--WPCEM-VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 518 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
...+.+|.|++|.|+..... .....+.|.+... ..... .....+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988877543 4444555544311 00011 11112566777788889999998888887776666669
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ +|..++...+ .+....+..++.|+.+|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999997653 466678888999999999999999 9999999999999999999999999999876543
Q ss_pred CC----cccccccccccccccccccCCcCcc-hhHHHHHHHHHHHHhCCCCCCccccccccc-cccccccccccCCCCCC
Q 042086 674 SS----NCTELVGTFGYIAPELVYTMKVTEK-CDVYSFGVLALEVIKGDHPRDFISSISSSS-SNRNISLNEILDPRLPT 747 (784)
Q Consensus 674 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~d~~~~~ 747 (784)
.. .....+|+..|+|||.+.+..|+++ .||||.|+++..|.+|+.||.......... .........+ ...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~----~~~ 549 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI----FEG 549 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc----ccC
Confidence 22 2456789999999999999999875 899999999999999999997554322110 0000000000 011
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.....+.......++.++++.||.+|-|+++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11122333456778899999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=192.39 Aligned_cols=236 Identities=19% Similarity=0.204 Sum_probs=155.2
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC----------CCceeeEEeEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR----------HRSIVKFYGFCS 584 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~ 584 (784)
.+..++.||.|+++.||.+.+. +++.+|||++...........+++++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3556788999999999999987 69999999986655444455677888876665532 223444444332
Q ss_pred cC------------C-----ceEEEEecccCCCHHHHHhc---C-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 042086 585 HP------------R-----NSFLVYEYLERGSLATILSN---D-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVH 643 (784)
Q Consensus 585 ~~------------~-----~~~lv~e~~~~gsL~~~l~~---~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 643 (784)
.. . ..+++|+-+.. ||.+++.. . .....+....+..+..|+++.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 23678887755 89888642 1 1122344566778889999999999999 9999
Q ss_pred eCCCCCCeeecCCCceEEeccccccccCCCCCcccccccccccccccccccC--------CcCcchhHHHHHHHHHHHHh
Q 042086 644 RDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM--------KVTEKCDVYSFGVLALEVIK 715 (784)
Q Consensus 644 ~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwslGv~l~ellt 715 (784)
+||+|+|++++.+|.++|+||+....... .......+..|.|||..... .++.+.|.|++|+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999998876432 11213445789999987542 47889999999999999999
Q ss_pred CCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCC
Q 042086 716 GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774 (784)
Q Consensus 716 g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 774 (784)
|..||+.......... .+ ..+.+....+..||..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~------------~f----~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------------DF----SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------------GG----TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------------cc----hhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999985432111100 11 1222556678899999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=189.50 Aligned_cols=174 Identities=12% Similarity=0.098 Sum_probs=136.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhh------HHHHHHHHhccCCCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPE------FVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
..++|+..+.+|.|+||.||.+.. +++.+|+|.+++.........+. +.+|+..+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999766 57789999998754433322222 68999999999999999999986533
Q ss_pred --------CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc
Q 042086 587 --------RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE 658 (784)
Q Consensus 587 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 658 (784)
...++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999988732 222 2456899999999999 999999999999999988
Q ss_pred eEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHH
Q 042086 659 ARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714 (784)
Q Consensus 659 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ell 714 (784)
++++|||.......+... ..+.....+..++|+|+||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755322111 11334445667999999999987765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=183.23 Aligned_cols=200 Identities=22% Similarity=0.334 Sum_probs=170.6
Q ss_pred cCCCCceeEecccceEEEEEE-EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 592 (784)
-.|+++++||+|.||+++.|+ +-+++.||||.-... ....++..|.+..+.+ ..++|...|-|..++.+-.+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 369999999999999999998 447999999975432 2345788899999888 589999999888888888999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-----CceEEeccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-----YEARVSDFGIA 667 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DfG~a 667 (784)
+|.+ |-+|+|++.-.+. .|+..++..+|.|++.-++|+|++ ..|.|||||+|+||..- ..+.++|||+|
T Consensus 103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9988 5599998875543 689999999999999999999999 99999999999999744 35899999999
Q ss_pred cccCCCCCc-------ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 042086 668 KFLKPDSSN-------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISS 725 (784)
Q Consensus 668 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~ 725 (784)
+.+.+.... .....||-+||+--...+++.+.+-|.=|+|=++.+.+.|..||+....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 988654332 2346799999999999999999999999999999999999999986543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=217.64 Aligned_cols=244 Identities=21% Similarity=0.222 Sum_probs=182.4
Q ss_pred CCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHH--HhccCCCceeeEEeEEecCCceEEEE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKT--LTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++...+.+|++.|=.|.+|+.++|. |+||++-+.. .....+.|.++++- ...++|||.+++.-+-...+..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~--p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQD--PTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccC--CCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6788899999999999999999887 8889886543 22234445444433 44558999999988877778889999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc--cC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF--LK 671 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~--~~ 671 (784)
+|..+ +|+|.+..+. -+...+.+.|+.|++.|+..+|.. +|+|||||.+|||++.-.-+.|+||..-+- +.
T Consensus 101 qyvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 99977 9999997653 366678889999999999999999 999999999999999999999999975532 22
Q ss_pred CCCCc-ccccccc----cccccccccccC----------C-cCcchhHHHHHHHHHHHHh-CCCCCCccccccccc---c
Q 042086 672 PDSSN-CTELVGT----FGYIAPELVYTM----------K-VTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSS---S 731 (784)
Q Consensus 672 ~~~~~-~~~~~gt----~~y~aPE~~~~~----------~-~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~---~ 731 (784)
.+... .+.+..| ..|+|||.+... . .+++-||||.||++.|+++ |++||+..+.+.... .
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD 253 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence 22221 2222333 369999998541 1 5678899999999999998 788898655443221 1
Q ss_pred ccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 732 NRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 732 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
..+.-+.+|-|. .+..++..|++.||++|-++++.++.
T Consensus 254 ~~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 111112222111 46688999999999999999999863
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=181.31 Aligned_cols=142 Identities=20% Similarity=0.203 Sum_probs=109.4
Q ss_pred ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCC------hhh-----------------HHHHHHHHhccCCCce
Q 042086 520 KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVP------QPE-----------------FVNEIKTLTELRHRSI 576 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~------~~~-----------------~~~E~~~l~~l~h~ni 576 (784)
...||+|+||.||+|...+|+.||||+++......... ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998899999999997643211110 112 2349999999988877
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEeCCCCCCeeecC
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM-HHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk~~Nill~~ 655 (784)
.....+.. ...++||||++++++....... ..++.....+++.|++.+++|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 54444332 2348999999998776543222 2577888999999999999999 677 999999999999998
Q ss_pred CCceEEecccccccc
Q 042086 656 DYEARVSDFGIAKFL 670 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~ 670 (784)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-22 Score=210.66 Aligned_cols=278 Identities=26% Similarity=0.222 Sum_probs=141.9
Q ss_pred EEEccCCccc-ccCCCCCCCCCCCCEEEccCCccCCC----CCcCccCCCcCcEEeecCCCccc------ccCCcccccc
Q 042086 105 IMYLYRNSLS-ASIPPVIGNLKFLYHLDLSENQLSGS----IPPTLGNLSNLAVLHLYGNSLSG------SIPSIIGNLK 173 (784)
Q Consensus 105 ~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~------~~~~~l~~l~ 173 (784)
.|+|.++.++ ...+..+..+.+|++|++++|.+++. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566666665 33444455566677777777766432 33444555666666666665541 1223344455
Q ss_pred ccceeeccccccCCCccccccCccC---CceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCC-CCcce
Q 042086 174 SLFYLHLSSNQLSGSIPISLGNLSN---LVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNL-NNLIG 249 (784)
Q Consensus 174 ~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~ 249 (784)
+|++|++++|.+.+..+..+..+.+ |++|++++|+++.... ..+...+..+ ++|++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 5555555555555433333333333 5555555555432111 0111122233 44444
Q ss_pred EEecCCCCCCC---CcccccccccccceEeccCccccCC----CCccccCCCccceeecccCccCCCC----cccccccc
Q 042086 250 LYLYDNQLSVG---EIPIEIGKLSSLNYLVLNGNQLYGN----LPRALGSLTELEYLDLSTNKLGNSI----PETLGNLL 318 (784)
Q Consensus 250 L~L~~n~l~~~---~~~~~l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----~~~l~~l~ 318 (784)
|++++|.++.. .++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++.. +..+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 44444444311 1222334445566666666655532 2223334456666666666665322 22344556
Q ss_pred cceEEecccccccCCCchhhhc-----ccccCeeccCCccccc----cccccccccccccEEecCCCccCCC----Cccc
Q 042086 319 KLHYLNLSNNQFRKGFPVELEK-----LIQLSELDLSLNILEG----KIPCEICNMESLEKLNLSHNNFSGL----IPSC 385 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~ 385 (784)
+|++|++++|.+++.....+.. .++|++|++++|.++. .+...+..+++|+.|++++|.+... ....
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 6667777666666432222222 2567777777776652 2334445556777777777777755 3333
Q ss_pred ccCc-ccceEEEcCCCCC
Q 042086 386 FEGM-HGLSCIDVSYNEL 402 (784)
Q Consensus 386 ~~~l-~~L~~l~l~~N~l 402 (784)
+... +.|+.+++.+|+|
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 3334 5677777777654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=174.34 Aligned_cols=143 Identities=21% Similarity=0.221 Sum_probs=112.2
Q ss_pred ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCC------------------C-----hhhHHHHHHHHhccCCCce
Q 042086 520 KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMV------------------P-----QPEFVNEIKTLTELRHRSI 576 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------~-----~~~~~~E~~~l~~l~h~ni 576 (784)
.+.||+|++|.||+|...+|+.||||+++........ . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998765321000 0 1124578999999999988
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeec
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLATI-LSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLC 654 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~ 654 (784)
.....+... ..++||||++++++... +.. ..++.....+++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 655555433 24899999998855433 332 245677888999999999999999 8 999999999999999
Q ss_pred CCCceEEeccccccccCC
Q 042086 655 LDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 655 ~~~~~kl~DfG~a~~~~~ 672 (784)
++.++|+|||++..+..
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.6e-22 Score=210.43 Aligned_cols=277 Identities=26% Similarity=0.266 Sum_probs=178.8
Q ss_pred EEeCCCCccc-ccCCCCcCCCCCCCEEEccCCcccc----cCCCCCCCCCCCCEEEccCCccCC------CCCcCccCCC
Q 042086 81 TLDLSKNKLN-GSIPFSFGNLTNLAIMYLYRNSLSA----SIPPVIGNLKFLYHLDLSENQLSG------SIPPTLGNLS 149 (784)
Q Consensus 81 ~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~------~~p~~l~~l~ 149 (784)
.|+|.++.++ ......|..+.+|++|++++|.++. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788889888 4455667788889999999999854 356677888999999999998873 2345677789
Q ss_pred cCcEEeecCCCcccccCCccccccc---cceeeccccccCCC----ccccccCc-cCCceeeccccccCCc----cchhh
Q 042086 150 NLAVLHLYGNSLSGSIPSIIGNLKS---LFYLHLSSNQLSGS----IPISLGNL-SNLVVLHLFENSLFGS----IPSIL 217 (784)
Q Consensus 150 ~L~~L~L~~n~l~~~~~~~l~~l~~---L~~L~L~~n~l~~~----~~~~~~~l-~~L~~L~L~~n~l~~~----~~~~l 217 (784)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|.+++. +...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998666666666655 99999999998842 33345566 8889999999988743 33445
Q ss_pred hcccccceeccCCCccccc----cCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCC
Q 042086 218 GNLKMLLHLGLSTNHLSGV----IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSL 293 (784)
Q Consensus 218 ~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l 293 (784)
..+++|++|++++|.+++. ++..+..+++|+.|++++|.++.... +.++..+..+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~---------------------~~l~~~~~~~ 220 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA---------------------SALAETLASL 220 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH---------------------HHHHHHhccc
Confidence 5666788888888877632 12223333455555555555431100 0112233445
Q ss_pred CccceeecccCccCCCCcccccc-----cccceEEecccccccC----CCchhhhcccccCeeccCCcccccc----ccc
Q 042086 294 TELEYLDLSTNKLGNSIPETLGN-----LLKLHYLNLSNNQFRK----GFPVELEKLIQLSELDLSLNILEGK----IPC 360 (784)
Q Consensus 294 ~~L~~L~Ls~n~l~~~~~~~l~~-----l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~ 360 (784)
++|++|++++|.+++.....+.. .++|++|++++|.++. .+...+..+++|+.+++++|.++.. ...
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 55666666665555422222221 2566666666666652 2233445556677777777776644 333
Q ss_pred ccccc-ccccEEecCCCcc
Q 042086 361 EICNM-ESLEKLNLSHNNF 378 (784)
Q Consensus 361 ~~~~l-~~L~~L~L~~N~l 378 (784)
.+... +.|+.|++.+|++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 301 SLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhhcCCchhhcccCCCCC
Confidence 33333 5677777777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=169.66 Aligned_cols=186 Identities=12% Similarity=0.049 Sum_probs=138.7
Q ss_pred CCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCC-ChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEEEEe
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMV-PQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 594 (784)
+.+...|++|+||+||.+.. .+.+++.+.+......... ....|.+|+++|+++. |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34568899999999997766 5778887776653222111 1225889999999995 5889999886 34699999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC-CCCCeeecCCCceEEeccccccccCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDI-SSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|++|.+|.+.... ....++.|+++++.++|+. ||+|||| ||+||+++.++.++|+|||+|......
T Consensus 79 yI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 79 YLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred eecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999998764321 1134678999999999999 9999999 799999999999999999999865433
Q ss_pred CCc----c---------cccccccccccccccccC-CcC-cchhHHHHHHHHHHHHhCCCCC
Q 042086 674 SSN----C---------TELVGTFGYIAPELVYTM-KVT-EKCDVYSFGVLALEVIKGDHPR 720 (784)
Q Consensus 674 ~~~----~---------~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslGv~l~elltg~~p~ 720 (784)
... . .-...++.|++|+...-- +.+ .+.+-++-|.-+|+++|+..|+
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 221 0 011246777777654322 233 5678889999999999999884
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-19 Score=190.99 Aligned_cols=207 Identities=26% Similarity=0.478 Sum_probs=155.5
Q ss_pred HhccCCCceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EEeCC
Q 042086 568 LTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI-VHRDI 646 (784)
Q Consensus 568 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dl 646 (784)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.|.+.... -.++|.....++.+|+.|++|+|+. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 456799999999999999999999999999999999998643 3688999999999999999999998 55 89999
Q ss_pred CCCCeeecCCCceEEeccccccccCCC--CCcccccccccccccccccccCC-------cCcchhHHHHHHHHHHHHhCC
Q 042086 647 SSKNVLLCLDYEARVSDFGIAKFLKPD--SSNCTELVGTFGYIAPELVYTMK-------VTEKCDVYSFGVLALEVIKGD 717 (784)
Q Consensus 647 k~~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslGv~l~elltg~ 717 (784)
+++|.++|....+|++|||+....... ........-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999999876421 11112222345699999987531 456799999999999999999
Q ss_pred CCCCccccccccccccccccccccC-CCCCCCCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 718 HPRDFISSISSSSSNRNISLNEILD-PRLPTPPQN--VQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 718 ~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.||+........ .+....+.+ ..-+..|.. ..+...++..++..||..+|++||++++|-..
T Consensus 156 ~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 156 GPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred CccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 999753322110 111111111 111111111 11233368899999999999999999988643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-20 Score=165.93 Aligned_cols=161 Identities=33% Similarity=0.546 Sum_probs=114.5
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
++++++.|.||+|+++ ..|..+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.+|.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4566777777887777 45667777777777777777776 66777777777777777777776 677777777777777
Q ss_pred eecCCCcc-cccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcc
Q 042086 155 HLYGNSLS-GSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233 (784)
Q Consensus 155 ~L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 233 (784)
||++|++. ..+|..|..+..|+.|.|++|.++ .+|..++.+++|+.|.+..|.+- .+|..++.++.|++|.+++|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 77777776 346667777777777777777777 66667777777777777777664 5566677777777777777777
Q ss_pred ccccCCCC
Q 042086 234 SGVIPLSI 241 (784)
Q Consensus 234 ~~~~~~~l 241 (784)
+ .+|..+
T Consensus 186 ~-vlppel 192 (264)
T KOG0617|consen 186 T-VLPPEL 192 (264)
T ss_pred e-ecChhh
Confidence 6 344333
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=193.91 Aligned_cols=226 Identities=25% Similarity=0.313 Sum_probs=177.7
Q ss_pred EecccceEEEEEE----EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEEEEeccc
Q 042086 523 IGIGGQGSVYKAK----LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 523 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
+|+|.||.|+.++ .+.|..+|.|...+......... ....|..++..++ ||.+|++.-.++.+...+++.+|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6899999999874 34578889988766543322222 5667888999996 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcc
Q 042086 598 RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC 677 (784)
Q Consensus 598 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 677 (784)
+|.+...+.... .++......+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998886554 355666777888999999999999 9999999999999999999999999999875433222
Q ss_pred cccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHH
Q 042086 678 TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI 757 (784)
Q Consensus 678 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 757 (784)
+||..|||||++. ....++|-||||++.+||+||..||.. .....+....+. ...+...
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~----~p~~l~~ 212 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELE----MPRELSA 212 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccC----CchhhhH
Confidence 8999999999998 456789999999999999999999873 111122222222 2234445
Q ss_pred HHHHHHHhcccCCCCCCCCH
Q 042086 758 SIVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 758 ~l~~li~~cl~~dP~~RPs~ 777 (784)
...+++..+...+|..|--.
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHhhCHHHHhcc
Confidence 67778888888899888744
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-18 Score=197.33 Aligned_cols=199 Identities=23% Similarity=0.250 Sum_probs=163.4
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC---CCceeeEEeEEec
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR---HRSIVKFYGFCSH 585 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 585 (784)
+++...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....++.- --.+++.+++ -+-|..+...+.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHcc
Confidence 455567789999999999999999999888999999998876665432 2234445555 2334444444455
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-------CCc
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-------DYE 658 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~ 658 (784)
.+.-++|+||.+.|+|.+++... +..+|...+.++.|+++.+++||.. +||||||||+|.|+.. ...
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CCcceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 67788999999999999999743 4578899999999999999999999 9999999999999952 345
Q ss_pred eEEeccccccccC--CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 042086 659 ARVSDFGIAKFLK--PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719 (784)
Q Consensus 659 ~kl~DfG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p 719 (784)
++|+|||.+..|. ++.......++|-++-++|+..++.++...|-|.++.+++-|+.|+.-
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 8999999998664 345567788999999999999999999999999999999999999754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.7e-20 Score=162.07 Aligned_cols=163 Identities=35% Similarity=0.511 Sum_probs=81.0
Q ss_pred CCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceec
Q 042086 148 LSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLG 227 (784)
Q Consensus 148 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 227 (784)
+.+.+.|.||+|+++ .+|+.++.+.+|+.|++++|+|+ .+|..++.+++|+.|++
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnv----------------------- 86 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNV----------------------- 86 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheec-----------------------
Confidence 344444444444444 34444444444444444444444 33444444444444444
Q ss_pred cCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccC
Q 042086 228 LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLG 307 (784)
Q Consensus 228 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 307 (784)
+-|++. ..|..|+.++.|+.|+|.+|.++...+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+-
T Consensus 87 -gmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 87 -GMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred -chhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence 444443 344444444444444444444443445555555555666666666555 55555555555555555555554
Q ss_pred CCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccc
Q 042086 308 NSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICN 364 (784)
Q Consensus 308 ~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 364 (784)
. +|..++.+..|++|++.+|+++ .+|.++++
T Consensus 164 -~------------------------lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 164 -S------------------------LPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred -h------------------------CcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 3 4455555555555555555555 45544443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.7e-17 Score=161.16 Aligned_cols=137 Identities=16% Similarity=0.233 Sum_probs=104.7
Q ss_pred CCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-----CCCceeeEEeEEecCC---ce
Q 042086 518 DVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-----RHRSIVKFYGFCSHPR---NS 589 (784)
Q Consensus 518 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~ 589 (784)
.-.+.||+|+||.||. .-.++.. +||++.... ....+++.+|+.+++.+ +||||++++|++.++. ..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3457899999999996 2224444 688876532 22456899999999999 5799999999998763 33
Q ss_pred E-EEEec--ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEEeCCCCCCeeecCC----CceEE
Q 042086 590 F-LVYEY--LERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL-SYMHHDCFPPIVHRDISSKNVLLCLD----YEARV 661 (784)
Q Consensus 590 ~-lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl 661 (784)
+ +|+|| +++|+|.++++.. .+++. ..++.+++.++ +|||++ +|+||||||+||+++.. +.++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 3 78999 6679999999653 24444 35577888777 999999 99999999999999743 47999
Q ss_pred ec-ccccc
Q 042086 662 SD-FGIAK 668 (784)
Q Consensus 662 ~D-fG~a~ 668 (784)
+| ||...
T Consensus 151 iDg~G~~~ 158 (210)
T PRK10345 151 CDNIGEST 158 (210)
T ss_pred EECCCCcc
Confidence 99 45433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=163.86 Aligned_cols=190 Identities=23% Similarity=0.354 Sum_probs=132.2
Q ss_pred CCCceeeEEeEEec---------------------------CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHH
Q 042086 572 RHRSIVKFYGFCSH---------------------------PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR 624 (784)
Q Consensus 572 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 624 (784)
+|||||++.++|.+ +...|+||..++. +|.+++.... .+.-.+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 59999999987632 2346899988866 9999997543 33445667889
Q ss_pred HHHHHHHHHhhCCCCCeEEeCCCCCCeee--cCCC--ceEEeccccccccCCC------CCccccccccccccccccccc
Q 042086 625 SVANALSYMHHDCFPPIVHRDISSKNVLL--CLDY--EARVSDFGIAKFLKPD------SSNCTELVGTFGYIAPELVYT 694 (784)
Q Consensus 625 ~i~~~l~~LH~~~~~~ivH~Dlk~~Nill--~~~~--~~kl~DfG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~ 694 (784)
|+++|+.|||.+ ||.|||+|++|||+ |+|+ ...|+|||.+-.-+.. ........|.-.-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 3443 4689999987432211 111233456778999999864
Q ss_pred CC------cCcchhHHHHHHHHHHHHhCCCCCCcccc--ccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhc
Q 042086 695 MK------VTEKCDVYSFGVLALEVIKGDHPRDFISS--ISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLC 766 (784)
Q Consensus 695 ~~------~~~~sDvwslGv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~c 766 (784)
.+ .-.|+|.|+.|.+.||+++...||-.-.. ++... .-...++.-++..+. .+.+++...
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---------Yqe~qLPalp~~vpp---~~rqlV~~l 493 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---------YQESQLPALPSRVPP---VARQLVFDL 493 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---------hhhhhCCCCcccCCh---HHHHHHHHH
Confidence 33 12489999999999999999999842111 11000 011123332333333 466788889
Q ss_pred ccCCCCCCCCHHHHH
Q 042086 767 LNESPESRPPMHTVC 781 (784)
Q Consensus 767 l~~dP~~RPs~~~vl 781 (784)
++.||.+||+..-..
T Consensus 494 L~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAA 508 (598)
T ss_pred hcCCccccCCccHHH
Confidence 999999999976443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.4e-17 Score=163.26 Aligned_cols=145 Identities=21% Similarity=0.211 Sum_probs=111.4
Q ss_pred CCCCceeEecccceEEEEEE--EcCCCEEEEEEcCCCCCCCC-----------------C----ChhhHHHHHHHHhccC
Q 042086 516 GFDVKYCIGIGGQGSVYKAK--LTSGEILAVKKFHSLWPCEM-----------------V----PQPEFVNEIKTLTELR 572 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~ 572 (784)
-|++.+.||+|++|.||+|. ..+|+.||+|+++....... . ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 56899999999875421100 0 0123568999999997
Q ss_pred CC--ceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEeCCCCC
Q 042086 573 HR--SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP-IVHRDISSK 649 (784)
Q Consensus 573 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~ 649 (784)
+. .+.+++++ ...++||||+++++|........ .+.......++.|++.++++||+. + |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 53 34445543 23589999999988876543222 244456678999999999999999 8 999999999
Q ss_pred CeeecCCCceEEeccccccccC
Q 042086 650 NVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 650 Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=159.00 Aligned_cols=147 Identities=18% Similarity=0.171 Sum_probs=113.6
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCC-------------------CChhhHHHHHHHHh
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEM-------------------VPQPEFVNEIKTLT 569 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~ 569 (784)
++......|.+.+.||+|+||.||+|...+|+.||||++........ .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445888899999999999999988899999998764321100 01123678899999
Q ss_pred ccCCC--ceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCC
Q 042086 570 ELRHR--SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDIS 647 (784)
Q Consensus 570 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 647 (784)
.+.|+ .+.+.++. ...++||||+++++|.+.... ....+++.+++.++.++|+. +|+|||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 98777 44444442 456899999999999775421 23457889999999999998 99999999
Q ss_pred CCCeeecCCCceEEeccccccccC
Q 042086 648 SKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 648 ~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|+||++++++.++|+|||.+....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=159.14 Aligned_cols=137 Identities=20% Similarity=0.341 Sum_probs=114.6
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCC-----CChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEM-----VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
+.||+|++|.||+|+. .|..|++|+......... .....+.+|+.++..+.|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577899998654322111 1124578899999999999998888888777888999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
+++++|.+++.... + .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 1 6788999999999999999 999999999999999 78999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-17 Score=175.38 Aligned_cols=173 Identities=25% Similarity=0.438 Sum_probs=135.0
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
+.+|.|+++...+|.+|+.........++.....++.|++.|++| + +.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877666788899999999999999999 5 8899999999999999999999999999
Q ss_pred cccCCCC------CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042086 668 KFLKPDS------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 668 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
..+.... ...+...||..||+||.+.+..|+.|+|+||+|++|+|++. =..+++.. ..+.++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------ATLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hhhhhh
Confidence 8776544 12345689999999999999999999999999999999997 33333322 222233
Q ss_pred cCCCCCC-CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 741 LDPRLPT-PPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 741 ~d~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
-|..++. .....+++ ..++..++...|.+||++.++.
T Consensus 473 r~g~ip~~~~~d~p~e----~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEE----YTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hcCCCChHHhhcCcHH----HHHHHHhcCCCcccCchHHHHh
Confidence 3333331 11112222 3577788999999999665543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=155.96 Aligned_cols=134 Identities=21% Similarity=0.357 Sum_probs=108.6
Q ss_pred eEecccceEEEEEEEcCCCEEEEEEcCCCCCCCC-----CChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecc
Q 042086 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEM-----VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
.||+|+||.||+|.. +|+.|++|.......... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 478899998654321111 11356778999999999888766666666667789999999
Q ss_pred cCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 597 ERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 597 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
++++|.+++..... .++.++++++.++|+. +++|||++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998754210 7889999999999999 999999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-17 Score=182.74 Aligned_cols=208 Identities=23% Similarity=0.304 Sum_probs=143.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..+|+.++.|..|++|.||..+++ +.+.+|.| +.+.. -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~--------lilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN--------LILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc--------hhhhc--cccccCCccee---------------
Confidence 457999999999999999999887 46778874 33211 11111 23333344433
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|+-...++..+. ++. +.+.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+++....
T Consensus 136 ------gDc~tllk~~g~---lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGP---LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------chhhhhcccCCC---Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 566666665443 222 237899999999 999999999999999999999999999874321
Q ss_pred CCC---------------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 042086 673 DSS---------------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISL 737 (784)
Q Consensus 673 ~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 737 (784)
... .....+|||.|+|||++....|...+|-|++|+++||.+-|+.||+.-. .++-+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--------peelf 267 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELF 267 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--------HHHHH
Confidence 100 1234689999999999999999999999999999999999999987321 11112
Q ss_pred ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 042086 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP 776 (784)
Q Consensus 738 ~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 776 (784)
..++......+ +.......+..+++...++++|..|--
T Consensus 268 g~visd~i~wp-E~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 268 GQVISDDIEWP-EEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhhhhhcccc-ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 22222222111 112222335778888999999999863
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=178.24 Aligned_cols=141 Identities=20% Similarity=0.307 Sum_probs=113.6
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEE-cCCCCCCC----CCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKK-FHSLWPCE----MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
...|...+.||+|+||+||+|.+.+.. +++|+ ..+..... ....+.+.+|+++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567899999999999999876444 34443 22211111 0123568899999999999999998888887778
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999875 3467899999999999999 99999999999999 67899999999998
Q ss_pred cc
Q 042086 669 FL 670 (784)
Q Consensus 669 ~~ 670 (784)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-15 Score=175.61 Aligned_cols=152 Identities=34% Similarity=0.525 Sum_probs=123.5
Q ss_pred hHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCc-----ccceeEEcCCCCeEEEEeCCCcccCCCC
Q 042086 3 GKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPC-----AWFGIQCNPAKRVISINLSTVGLKGNLK 77 (784)
Q Consensus 3 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C-----~w~gv~C~~~~~v~~l~l~~~~~~~~l~ 77 (784)
.+|..||++||+++..+. . .+|.+ ||| .|.||+|+..... ...
T Consensus 371 ~~~~~aL~~~k~~~~~~~-~--~~W~g-----------------~~C~p~~~~w~Gv~C~~~~~~------------~~~ 418 (623)
T PLN03150 371 LEEVSALQTLKSSLGLPL-R--FGWNG-----------------DPCVPQQHPWSGADCQFDSTK------------GKW 418 (623)
T ss_pred chHHHHHHHHHHhcCCcc-c--CCCCC-----------------CCCCCcccccccceeeccCCC------------Cce
Confidence 468999999999986332 2 47964 344 7999999632110 011
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
.++.|+|++|+++|.+|..+..+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|+.++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCCccccc-cccceeeccccccC
Q 042086 158 GNSLSGSIPSIIGNL-KSLFYLHLSSNQLS 186 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l-~~L~~L~L~~n~l~ 186 (784)
+|++++.+|..+..+ .++..+++.+|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999887654 46677888877644
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.4e-15 Score=140.44 Aligned_cols=135 Identities=18% Similarity=0.158 Sum_probs=114.2
Q ss_pred CceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC--CceeeEEeEEecCCceEEEEecc
Q 042086 519 VKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH--RSIVKFYGFCSHPRNSFLVYEYL 596 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~ 596 (784)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.+++.++| ..+.+++++...++..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999999865 7899998765321 4678999999999976 58999999988888899999999
Q ss_pred cCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 597 ERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 597 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
+++.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.++++|||.+..
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98766543 4456678899999999999986444799999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-15 Score=146.22 Aligned_cols=139 Identities=20% Similarity=0.199 Sum_probs=99.3
Q ss_pred ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhh---------------------HHHHHHHHhccCCC--ce
Q 042086 520 KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPE---------------------FVNEIKTLTELRHR--SI 576 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--ni 576 (784)
.+.||+|+||.||+|...+++.||||++............. ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999887543211111111 13566666666443 24
Q ss_pred eeEEeEEecCCceEEEEecccCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeec
Q 042086 577 VKFYGFCSHPRNSFLVYEYLERGSLAT-ILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLC 654 (784)
Q Consensus 577 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~ 654 (784)
.+++++ ...++||||++++++.. .+..... . .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~----~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL----L-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhh----c-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 24589999999954321 1111100 0 4567899999999999999 7 999999999999999
Q ss_pred CCCceEEeccccccccC
Q 042086 655 LDYEARVSDFGIAKFLK 671 (784)
Q Consensus 655 ~~~~~kl~DfG~a~~~~ 671 (784)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=145.15 Aligned_cols=139 Identities=14% Similarity=0.221 Sum_probs=107.3
Q ss_pred ceeEe-cccceEEEEEEEcCCCEEEEEEcCCCC----------CCCCCChhhHHHHHHHHhccCCCce--eeEEeEEecC
Q 042086 520 KYCIG-IGGQGSVYKAKLTSGEILAVKKFHSLW----------PCEMVPQPEFVNEIKTLTELRHRSI--VKFYGFCSHP 586 (784)
Q Consensus 520 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 586 (784)
...|| .|+.|+||++... +..++||.+.... ..+......+.+|+.++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999886 7788998875321 1112334578899999999998875 6777765432
Q ss_pred C----ceEEEEecccC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 587 R----NSFLVYEYLER-GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 587 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
. ..++|+|++++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6999988642 23332 356899999999999 9999999999999999999999
Q ss_pred ecccccccc
Q 042086 662 SDFGIAKFL 670 (784)
Q Consensus 662 ~DfG~a~~~ 670 (784)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.6e-16 Score=173.47 Aligned_cols=254 Identities=21% Similarity=0.259 Sum_probs=185.3
Q ss_pred cCCCCceeEecccceEEEEEEEc--CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT--SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 591 (784)
..|.+.+.||+|.|+.|-..... ....+|+|.+.... ......+....|..+-..+. |+|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 46778888999999999988754 34566666665432 22333445556777777775 9999999999999999999
Q ss_pred EEecccCCCHHHHH-hcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEeCCCCCCeeecCCC-ceEEecccccc
Q 042086 592 VYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMH-HDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~ 668 (784)
++||..++++.+.+ +... ...+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999998887 4332 12333556678999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC-CC--Cccccccc-ccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042086 669 FLKP-DS--SNCTELVG-TFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 669 ~~~~-~~--~~~~~~~g-t~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
.+.. .. ......+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++....-... .......
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------~~~~~~~ 246 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------YSSWKSN 246 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------ceeeccc
Confidence 7765 22 22345577 99999999998854 456799999999999999999999865432211 1111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
+-...............++..+++..+|..|.+.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 10000001111222455677788989999999988764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.7e-14 Score=161.97 Aligned_cols=118 Identities=31% Similarity=0.515 Sum_probs=101.6
Q ss_pred cceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcC
Q 042086 319 KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 398 (784)
.++.|+|++|.+++.+|..+..+++|+.|+|++|.+.|.+|..++.+++|+.|+|++|+++|.+|+.+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccCCCCCC--CcCCCcccccCCCCCCCCCCCCCCCC
Q 042086 399 YNELRGPIPNSRI--FQYDPMEALQGNKGLCGDIKGFQSCN 437 (784)
Q Consensus 399 ~N~l~~~~p~~~~--~~~~~~~~~~~n~~~c~~~~~~~~c~ 437 (784)
+|+++|.+|.... ........+.+|+++|+.+ ....|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCc
Confidence 9999999997421 1223345678999999965 345675
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.7e-13 Score=135.07 Aligned_cols=200 Identities=22% Similarity=0.338 Sum_probs=138.6
Q ss_pred HHHhccCCCceeeEEeEEecCC-----ceEEEEecccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 042086 566 KTLTELRHRSIVKFYGFCSHPR-----NSFLVYEYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFP 639 (784)
Q Consensus 566 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 639 (784)
.-+-.+.|-|||++..|+.+.. ...+++|||..|++.++|++... ...+....-.+++.||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3444567999999999986533 46789999999999999986433 2345666677899999999999998 578
Q ss_pred CeEEeCCCCCCeeecCCCceEEeccccccccCCC-----CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHH
Q 042086 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD-----SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714 (784)
Q Consensus 640 ~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ell 714 (784)
+|+|+++.-+-|++..+|-+|++--.-. ..... ......-.+-++|.|||+=.....+.++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999997531111 00000 00112234568999999988778888999999999999999
Q ss_pred hCCCC-CCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 715 KGDHP-RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 715 tg~~p-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.|..- .+... ....++.....+- .. ++.. =..++..|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS-----~~~~ee~ia~~i~----~l-en~l-----qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSES-----KVEVEENIANVII----GL-ENGL-----QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcc-----eeehhhhhhhhee----ec-cCcc-----ccCcCcccccCCCCCCcchhhhhc
Confidence 87653 11111 1111222211111 10 1111 124677899999999999998864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-12 Score=143.98 Aligned_cols=148 Identities=20% Similarity=0.257 Sum_probs=104.4
Q ss_pred CCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCC-----------------------C--------------h
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMV-----------------------P--------------Q 558 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~--------------~ 558 (784)
.|+ .+.||+|++|.||+|+.++|+.||||+.++....... . .
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 3679999999999999999999999998764211000 0 0
Q ss_pred hhHHHHHHHHhccC-----CCceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHH
Q 042086 559 PEFVNEIKTLTELR-----HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN-ALSY 632 (784)
Q Consensus 559 ~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~ 632 (784)
-+|..|+..+.+++ +++|.-..-|.......++||||++|++|.++...... .. .+.+++..+++ .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHH
Confidence 13556666666552 34443222233334567999999999999887653211 11 23456666665 4678
Q ss_pred HhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 633 LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
+|.. |++|+|++|.||++++++.++++|||++..+.+
T Consensus 273 l~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 273 VLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8988 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-13 Score=148.40 Aligned_cols=199 Identities=39% Similarity=0.550 Sum_probs=105.5
Q ss_pred EEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCcccccc-ccceeeccccccCCCccccccCccCCceeecccc
Q 042086 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLK-SLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFEN 207 (784)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 207 (784)
.|+++.|.+... +..+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 455555554311 223333455555555555555 3444444442 5566666666555 44444555555666666655
Q ss_pred ccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCC
Q 042086 208 SLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP 287 (784)
Q Consensus 208 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 287 (784)
+++ .++...+..++|+.|++++|+++ .+|........|++|.+++|.+. ..+..+..+.++..|.+.+|++. ..+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~--~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce--ecchhhhhcccccccccCCceee-ecc
Confidence 554 33333335555666666666655 33333333444555555555322 33444555566666666666665 234
Q ss_pred ccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchh
Q 042086 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE 337 (784)
Q Consensus 288 ~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~ 337 (784)
..++.+++++.|++++|.++.. +. ++.+.+|+.|++++|.+....+..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhh
Confidence 5566666666666666666633 22 666666666666666666544433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.4e-13 Score=148.33 Aligned_cols=262 Identities=37% Similarity=0.433 Sum_probs=162.6
Q ss_pred EEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCC-cCcEEeecCCCcccccCCccccccccceeecccc
Q 042086 105 IMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLS-NLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183 (784)
Q Consensus 105 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 183 (784)
.|++..|.+.. .+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 56777776642 2233455577777788777777 5566666664 7888888888777 45566777788888888888
Q ss_pred ccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcc
Q 042086 184 QLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIP 263 (784)
Q Consensus 184 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 263 (784)
++. .+|...+.+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+..+.++..+.+.+|++. .++
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~--~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE--DLP 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee--ecc
Confidence 877 55555556777888888888876 44554455556788888888544 34556777777777778888775 335
Q ss_pred cccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccc
Q 042086 264 IEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQ 343 (784)
Q Consensus 264 ~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 343 (784)
..+..++++++|++++|+++. ++. +..+.+++.|++++|.+....|...........+ .. +.+.. .+........
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~~-~~-~~~~~-~~~~~~~~~~ 323 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLELL-LN-LLLTL-KALELKLNSI 323 (394)
T ss_pred chhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhhccchhHHhh-hh-hhhhc-cccccccccc
Confidence 567777788888888888874 333 7778888888888888876555443322111111 11 21111 1122222233
Q ss_pred cCeeccCCccccccccccccccccccEEecCCCccCC
Q 042086 344 LSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380 (784)
Q Consensus 344 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 380 (784)
+....+..+... ..+..+.....+..++...+....
T Consensus 324 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 359 (394)
T COG4886 324 LLNNNILSNGET-SSPEALSILESLNNLWTLDNALDE 359 (394)
T ss_pred cccccccccccc-ccchhhcccccccCceeccccccc
Confidence 333344444444 444455555555666655555443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-14 Score=150.48 Aligned_cols=175 Identities=35% Similarity=0.521 Sum_probs=95.6
Q ss_pred cccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceE
Q 042086 171 NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250 (784)
Q Consensus 171 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 250 (784)
.+.--...||+.|++. .+|..+..+..|+.|.|+.|.|. .+|..+.++..|++|+|+.|+++ .+|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3445566777888877 67777777777777777777775 66677777777777777777776 4555444443 4444
Q ss_pred EecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccc
Q 042086 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF 330 (784)
Q Consensus 251 ~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l 330 (784)
.+++|+++ .+|..++.+.+|..|+.+.|.+. .+|..++.+.+|+.|.+..|.+. .+|+++..| .|..||+|.|++
T Consensus 149 i~sNNkl~--~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT--SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEecCccc--cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 55555444 34444444444444444444444 33444444444444444444444 233333322 344444444444
Q ss_pred cCCCchhhhcccccCeeccCCcccc
Q 042086 331 RKGFPVELEKLIQLSELDLSLNILE 355 (784)
Q Consensus 331 ~~~~~~~~~~l~~L~~L~Ls~N~l~ 355 (784)
+. +|-.|.+|..|++|-|.+|.+.
T Consensus 224 s~-iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 224 SY-LPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred ee-cchhhhhhhhheeeeeccCCCC
Confidence 43 4444444444444444444444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.2e-14 Score=148.80 Aligned_cols=198 Identities=32% Similarity=0.410 Sum_probs=154.9
Q ss_pred EEccCCccCCCCCcCc-cCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccc
Q 042086 130 LDLSENQLSGSIPPTL-GNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENS 208 (784)
Q Consensus 130 L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 208 (784)
|.|++-+++...-.+. -.+.--...||+.|++. .+|..+..+-.|+.|.|..|.+. .+|..+.++..|+.|+|+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 5566666653221222 23455566788888888 78888888888888889888888 788888888899999999988
Q ss_pred cCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCc
Q 042086 209 LFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR 288 (784)
Q Consensus 209 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~ 288 (784)
++ ..|..+..++ |+.|-+++|+++ .+|..++.+.+|..|+.+.|++. .+|..++.+.+|+.|.+..|++. .+|.
T Consensus 133 lS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~--slpsql~~l~slr~l~vrRn~l~-~lp~ 206 (722)
T KOG0532|consen 133 LS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ--SLPSQLGYLTSLRDLNVRRNHLE-DLPE 206 (722)
T ss_pred hh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh--hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence 87 5566666655 888888888888 67888888888888898888886 78888888888999999888887 5677
Q ss_pred cccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhh
Q 042086 289 ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL 338 (784)
Q Consensus 289 ~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 338 (784)
.+..+ .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.+.. .|..+
T Consensus 207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqI 253 (722)
T KOG0532|consen 207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQI 253 (722)
T ss_pred HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHH
Confidence 77744 5888899999988 788888899999999999998886 44444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.1e-14 Score=143.05 Aligned_cols=254 Identities=24% Similarity=0.263 Sum_probs=120.0
Q ss_pred CCCCCCCEEEccCCcccc----cCCCCCCCCCCCCEEEccCC---ccCCCCCcCccCCCcCcEEeecCCCcccccCCccc
Q 042086 98 GNLTNLAIMYLYRNSLSA----SIPPVIGNLKFLYHLDLSEN---QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIG 170 (784)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n---~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~ 170 (784)
..+..++.|+|++|.+.. .+...+.+.++|+..++|+= ++...+|+.+.. +..++.
T Consensus 27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~-----------------l~~aL~ 89 (382)
T KOG1909|consen 27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKM-----------------LSKALL 89 (382)
T ss_pred cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHH-----------------HHHHHh
Confidence 344555566666665532 23445556667777777652 233334443321 112233
Q ss_pred cccccceeeccccccCCCcccc----ccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCC
Q 042086 171 NLKSLFYLHLSSNQLSGSIPIS----LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN 246 (784)
Q Consensus 171 ~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 246 (784)
..++|++||||+|-+....+.. +.++..|++|.|.+|++.......++. .|..|. .|+. .+.-+.
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~ 158 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPK 158 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcc
Confidence 3345555555555554332222 234566666666666664222222211 121111 1110 111233
Q ss_pred cceEEecCCCCCCCC---cccccccccccceEeccCccccCC----CCccccCCCccceeecccCccCCC----Cccccc
Q 042086 247 LIGLYLYDNQLSVGE---IPIEIGKLSSLNYLVLNGNQLYGN----LPRALGSLTELEYLDLSTNKLGNS----IPETLG 315 (784)
Q Consensus 247 L~~L~L~~n~l~~~~---~~~~l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~----~~~~l~ 315 (784)
|+.+...+|++..+. +...|...+.|+.+.++.|.|... +...|..+++|+.|||.+|-++.. +.+.++
T Consensus 159 Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~ 238 (382)
T KOG1909|consen 159 LRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALS 238 (382)
T ss_pred eEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhc
Confidence 444444444443211 112233344555555555554311 112344555555555555555432 223344
Q ss_pred ccccceEEecccccccCCCchhh-----hcccccCeeccCCcccccc----ccccccccccccEEecCCCccC
Q 042086 316 NLLKLHYLNLSNNQFRKGFPVEL-----EKLIQLSELDLSLNILEGK----IPCEICNMESLEKLNLSHNNFS 379 (784)
Q Consensus 316 ~l~~L~~L~ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 379 (784)
.+++|+.|++++|.++..-..++ ...++|+.|.|.+|.++.. +...+...+.|+.|+|++|++.
T Consensus 239 s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 239 SWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 55566666666666554332222 2256677777777766542 2234445678888888888884
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-12 Score=139.85 Aligned_cols=249 Identities=23% Similarity=0.259 Sum_probs=180.0
Q ss_pred cCCCCceeEec--ccceEEEEEEE--c-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGI--GGQGSVYKAKL--T-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 588 (784)
..|.+...+|. |.+|.||.+.. . ++..+|+|+-+..... ......=.+|+...+.+ .|++.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccccchhhcccccCccccccccCcccccCCc
Confidence 35677788999 99999999986 3 6889999975432221 11122334677777777 49999998888999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEec
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN----ALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSD 663 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~D 663 (784)
.++-+|++. .+|.++.+.... -++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++|
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 999999886 599888875443 2444566677777777 99999999 99999999999999999 8899999
Q ss_pred cccccccCCCCCcccc-----cccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 664 FGIAKFLKPDSSNCTE-----LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
||+...+....-.... ..|...|++||...+ .++..+|+|++|.+..+..+|..+...-.... +....
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~~r 339 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQLR 339 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccccc
Confidence 9999988765422222 256778999998755 46789999999999999999877643210000 00000
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. .. .+.+.+.....++...+..+++.+|-.|++.+.+..
T Consensus 340 ~----~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 Q----GY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c----cc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 00 111222233345556888999999999999888764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-13 Score=140.64 Aligned_cols=209 Identities=28% Similarity=0.251 Sum_probs=126.2
Q ss_pred CCCCCCCEEEccCCccCCCCC--cCccCCCcCcEEeecCCCcccc--cCCccccccccceeeccccccCCCcccc-ccCc
Q 042086 122 GNLKFLYHLDLSENQLSGSIP--PTLGNLSNLAVLHLYGNSLSGS--IPSIIGNLKSLFYLHLSSNQLSGSIPIS-LGNL 196 (784)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~~~~-~~~l 196 (784)
+++++|++..|.++.+. ..+ .....+++++.|||+.|-+... +......+++|+.|+|+.|.+..-.... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46778888888888776 333 3566788889999998877733 2344567888999999988876322211 2246
Q ss_pred cCCceeeccccccCCc-cchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceE
Q 042086 197 SNLVVLHLFENSLFGS-IPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYL 275 (784)
Q Consensus 197 ~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L 275 (784)
+.|+.|.|+.|+++.. +...+..+|+|+.|+|..|...........-++.|++|+|++|++-....-...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 7888888888888622 334456778888888888863333334445566777777777776533222345566667777
Q ss_pred eccCccccCCC-Ccc-----ccCCCccceeecccCccCC-CCcccccccccceEEeccccccc
Q 042086 276 VLNGNQLYGNL-PRA-----LGSLTELEYLDLSTNKLGN-SIPETLGNLLKLHYLNLSNNQFR 331 (784)
Q Consensus 276 ~l~~n~l~~~~-~~~-----l~~l~~L~~L~Ls~n~l~~-~~~~~l~~l~~L~~L~ls~N~l~ 331 (784)
+++.|.+...- |+. ...+++|++|+++.|++.. .....+..+++|+.|.+..|.++
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 76666665321 211 2334555555555555531 01112333344444444444444
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3e-13 Score=138.35 Aligned_cols=215 Identities=26% Similarity=0.234 Sum_probs=129.2
Q ss_pred ccccccceeeccccccCCCcc--ccccCccCCceeeccccccCCc--cchhhhcccccceeccCCCccccccCCC-CcCC
Q 042086 170 GNLKSLFYLHLSSNQLSGSIP--ISLGNLSNLVVLHLFENSLFGS--IPSILGNLKMLLHLGLSTNHLSGVIPLS-IGNL 244 (784)
Q Consensus 170 ~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~~~~-l~~l 244 (784)
.++.+|++..|.+..+. ..+ .....|++++.|+|++|-+... +......+++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 35666777777777665 222 2445677777777777776532 2345667888888888888876322221 1256
Q ss_pred CCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCC-cccccccccceEE
Q 042086 245 NNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI-PETLGNLLKLHYL 323 (784)
Q Consensus 245 ~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-~~~l~~l~~L~~L 323 (784)
+.|+.|.|+.|.++...+...+..+|+|+.|+|..|.....-......+..|+.|||++|++-... ....+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 778888888888886666656677788888888888533333344455677888888888775321 1345667777777
Q ss_pred ecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCc-ccccCcccceEEEcCCCCC
Q 042086 324 NLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIP-SCFEGMHGLSCIDVSYNEL 402 (784)
Q Consensus 324 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l 402 (784)
+++.|.+..+-.... ..-+....+++|++|+++.|++..... ..+..+.+|+.|....|.+
T Consensus 277 nls~tgi~si~~~d~------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDV------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred hccccCcchhcCCCc------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccc
Confidence 777777665221111 000011234556666666666542211 3344455666666666666
Q ss_pred c
Q 042086 403 R 403 (784)
Q Consensus 403 ~ 403 (784)
.
T Consensus 339 n 339 (505)
T KOG3207|consen 339 N 339 (505)
T ss_pred c
Confidence 5
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.5e-13 Score=129.12 Aligned_cols=135 Identities=25% Similarity=0.288 Sum_probs=101.7
Q ss_pred ccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhccccc
Q 042086 265 EIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQL 344 (784)
Q Consensus 265 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 344 (784)
....+..|++|+|++|.|+ .+.+++.-+|.++.|++|+|.+... ..+..+++|+.||||+|.++. +..+-.++.+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCE
Confidence 4455667888888888887 5566777778888888888888733 347778888888888888876 44555667788
Q ss_pred CeeccCCccccccccccccccccccEEecCCCccCCCCc-ccccCcccceEEEcCCCCCccc
Q 042086 345 SELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIP-SCFEGMHGLSCIDVSYNELRGP 405 (784)
Q Consensus 345 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~ 405 (784)
+.|.|++|.+.. -..+..+-+|.+||+++|+|..... ..+++++-|+++.|.+|++.+.
T Consensus 355 KtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 355 KTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 888888887762 2256677788888888888876544 6688899999999999998873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=118.21 Aligned_cols=131 Identities=20% Similarity=0.151 Sum_probs=97.1
Q ss_pred ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCcee-eEEeEEecCCceEEEEecccC
Q 042086 520 KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV-KFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 598 (784)
++.++.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.+++ +++++. ....++||||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 467899999999999876 77899998765321 234578899999998655544 444443 2345899999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC--FPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
.++.+. . .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~----~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE----D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc----c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 877543 0 011245678999999999982 12359999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.6e-13 Score=128.62 Aligned_cols=225 Identities=23% Similarity=0.224 Sum_probs=139.0
Q ss_pred CCcCcEEeecCCC--------cccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhc
Q 042086 148 LSNLAVLHLYGNS--------LSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGN 219 (784)
Q Consensus 148 l~~L~~L~L~~n~--------l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 219 (784)
..+|+.|.++... +...+|-.+.-+++|..+.+|.+.-. .+......-|.|+.+.+.+.-++.. +.+-.
T Consensus 181 ~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~--~~l~p 257 (490)
T KOG1259|consen 181 CTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDV--PSLLP 257 (490)
T ss_pred hhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccccc--ccccc
Confidence 4566666665531 11222333334455666666655433 1222222225566665554443211 11111
Q ss_pred ccccceeccCC-CccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccce
Q 042086 220 LKMLLHLGLST-NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY 298 (784)
Q Consensus 220 l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 298 (784)
...+..+.-+. .-.+|..-.....++.|++++|++|.|+ .+..+..-.|.++.|++++|.+... ..+..+++|+.
T Consensus 258 e~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~--~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~ 333 (490)
T KOG1259|consen 258 ETILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT--QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQL 333 (490)
T ss_pred hhhhcCccCCCCCccCCceEEecchHhhhhhccccccchh--hhhhhhhhccceeEEeccccceeee--hhhhhcccceE
Confidence 12222111111 1122333334455677888999999887 6666777778889999999988733 23778888999
Q ss_pred eecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccc-ccccccccccccEEecCCCc
Q 042086 299 LDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK-IPCEICNMESLEKLNLSHNN 377 (784)
Q Consensus 299 L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~ 377 (784)
||||+|.++ .+..+-.++-++++|.|+.|.|.. -..++++-+|..||+++|+|... --..++++|.|+.|.|.+|+
T Consensus 334 LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 334 LDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred eecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 999998887 455566677788888999888864 34577788888889999988752 22577888889999999998
Q ss_pred cCCCC
Q 042086 378 FSGLI 382 (784)
Q Consensus 378 l~~~~ 382 (784)
+.+.+
T Consensus 411 l~~~v 415 (490)
T KOG1259|consen 411 LAGSV 415 (490)
T ss_pred ccccc
Confidence 88663
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-11 Score=131.15 Aligned_cols=166 Identities=19% Similarity=0.246 Sum_probs=126.8
Q ss_pred EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCC
Q 042086 536 LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFN 615 (784)
Q Consensus 536 ~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~ 615 (784)
..++.+|.|+....... ...+...+-++.++.++||||+++++.++..+..|+|+|.+. .|..++++.+
T Consensus 34 k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------ 102 (690)
T ss_pred eccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------
Confidence 44788888887765322 334567788999999999999999999999999999999874 5777776543
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccccccccccccccccC
Q 042086 616 WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695 (784)
Q Consensus 616 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 695 (784)
.......+.||+.||.+||+.| +++|+++.-..|+++..|+.||++|.++..............--..|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 3556677899999999999776 89999999999999999999999999887654332211222222346666654332
Q ss_pred CcCcchhHHHHHHHHHHHHhC
Q 042086 696 KVTEKCDVYSFGVLALEVIKG 716 (784)
Q Consensus 696 ~~~~~sDvwslGv~l~elltg 716 (784)
. -..|.|.||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 246999999999999998
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.8e-13 Score=132.34 Aligned_cols=245 Identities=24% Similarity=0.259 Sum_probs=161.7
Q ss_pred CCCcCcEEeecCCCcccc----cCCccccccccceeeccccccC---CCccc-------cccCccCCceeeccccccCCc
Q 042086 147 NLSNLAVLHLYGNSLSGS----IPSIIGNLKSLFYLHLSSNQLS---GSIPI-------SLGNLSNLVVLHLFENSLFGS 212 (784)
Q Consensus 147 ~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~---~~~~~-------~~~~l~~L~~L~L~~n~l~~~ 212 (784)
.+..++.|+|++|.+... +...+.+.++|+..++++=--. ..+|+ .+-.+++|++|+||+|-+...
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 344555555555555421 2334445556666666543211 12232 234456788888888877544
Q ss_pred cch----hhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCC--
Q 042086 213 IPS----ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL-- 286 (784)
Q Consensus 213 ~~~----~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~-- 286 (784)
.+. .+..+..|+.|+|.||.+.-..-..++. .|.+|. .| ...++-+.|+++...+|++....
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~--------kk~~~~~~Lrv~i~~rNrlen~ga~ 175 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN--------KKAASKPKLRVFICGRNRLENGGAT 175 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH--------hccCCCcceEEEEeeccccccccHH
Confidence 333 3455667777777777765221111111 122221 11 12345578999999999997432
Q ss_pred --CccccCCCccceeecccCccCCCCc----ccccccccceEEecccccccC----CCchhhhcccccCeeccCCccccc
Q 042086 287 --PRALGSLTELEYLDLSTNKLGNSIP----ETLGNLLKLHYLNLSNNQFRK----GFPVELEKLIQLSELDLSLNILEG 356 (784)
Q Consensus 287 --~~~l~~l~~L~~L~Ls~n~l~~~~~----~~l~~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~ 356 (784)
...|...+.|+.+.++.|.|..... ..|..+++|+.|||.+|-++. .+...+..+++|+.|++++|.+..
T Consensus 176 ~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~ 255 (382)
T KOG1909|consen 176 ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN 255 (382)
T ss_pred HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence 2356677999999999999864322 357789999999999999985 345667889999999999999987
Q ss_pred ccccccc-----ccccccEEecCCCccCCC----CcccccCcccceEEEcCCCCCc
Q 042086 357 KIPCEIC-----NMESLEKLNLSHNNFSGL----IPSCFEGMHGLSCIDVSYNELR 403 (784)
Q Consensus 357 ~~~~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~ 403 (784)
.-..+|. ..|+|+.|.+.+|.++.. +...+...+.|..|+|++|++.
T Consensus 256 ~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 256 EGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 6554443 468999999999999854 2344566899999999999994
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-11 Score=134.49 Aligned_cols=148 Identities=17% Similarity=0.208 Sum_probs=96.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcC-CCEEEEEEcCCCCCC---------------------C--CCC------------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS-GEILAVKKFHSLWPC---------------------E--MVP------------ 557 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------~--~~~------------ 557 (784)
...|+. +.||+|++|.||+|+.++ |+.||||++++.... . ...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999999987 999999999764210 0 000
Q ss_pred --hhhHHHHHHHHhccC----CCceeeEEeEEe-cCCceEEEEecccCCCHHHH--HhcCCC-CCCCCHHHHHHHHHHHH
Q 042086 558 --QPEFVNEIKTLTELR----HRSIVKFYGFCS-HPRNSFLVYEYLERGSLATI--LSNDGA-IEEFNWTVRMNVIRSVA 627 (784)
Q Consensus 558 --~~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~--l~~~~~-~~~l~~~~~~~i~~~i~ 627 (784)
+-+|.+|+..+.+++ +...+.+-.++. .....++||||++|+.+.++ +...+. ...+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 012455555554442 333333333332 24567899999999999874 222221 011212222222333
Q ss_pred HHHHHHhhCCCCCeEEeCCCCCCeeecCCC----ceEEeccccccccCC
Q 042086 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDY----EARVSDFGIAKFLKP 672 (784)
Q Consensus 628 ~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~a~~~~~ 672 (784)
+... |++|+|+||.||+++.++ .++++|||++..+.+
T Consensus 276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3345 999999999999999988 999999999987754
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.9e-12 Score=141.09 Aligned_cols=249 Identities=31% Similarity=0.328 Sum_probs=152.0
Q ss_pred CCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccce
Q 042086 98 GNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY 177 (784)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 177 (784)
..+..++.+.+..|.+.. +-..+..+++|+.|++.+|+|... ...+..+++|++|+|++|.|+.. ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 345556666666666653 334456666777777777777633 22356667777777777777644 33455566777
Q ss_pred eeccccccCCCccccccCccCCceeeccccccCCccc-hhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCC
Q 042086 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256 (784)
Q Consensus 178 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 256 (784)
|++++|.|.. ...+..+++|+.+++++|++....+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 7777777762 2334446777777777777754433 2 46666777777777777522 233444455555667776
Q ss_pred CCCCCcccccccccc--cceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccC--
Q 042086 257 LSVGEIPIEIGKLSS--LNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRK-- 332 (784)
Q Consensus 257 l~~~~~~~~l~~l~~--L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~-- 332 (784)
++... .+..+.. |+.+++++|.+. ..+..+..++++..|++.+|++... ..+...+.+..+..+.|++..
T Consensus 220 i~~~~---~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 293 (414)
T KOG0531|consen 220 ISKLE---GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSE 293 (414)
T ss_pred ceecc---CcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchh
Confidence 65211 2222233 778888888876 3335566777888888888887643 334555667777777777653
Q ss_pred -CCchh-hhcccccCeeccCCcccccccccc
Q 042086 333 -GFPVE-LEKLIQLSELDLSLNILEGKIPCE 361 (784)
Q Consensus 333 -~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~ 361 (784)
..... ....+.++.+.+..|.+....+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 294 AISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred hhhccccccccccccccccccCccccccccc
Confidence 12222 556678888888888777655433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.4e-12 Score=141.69 Aligned_cols=249 Identities=31% Similarity=0.286 Sum_probs=182.8
Q ss_pred CCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCce
Q 042086 122 GNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVV 201 (784)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 201 (784)
..+..++.+++..|.+.. +-..+..+.+|+.|++..|+|.. +...+..+++|++|+|++|.|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhh
Confidence 456777888888888884 44557888999999999999984 3333778899999999999998542 4566777999
Q ss_pred eeccccccCCccchhhhcccccceeccCCCccccccC-CCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCc
Q 042086 202 LHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP-LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN 280 (784)
Q Consensus 202 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n 280 (784)
|++.+|.|... ..+..+++|+.+++++|++...-+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i---~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI---EGLDLLKKLVLLSLLDN 218 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc---cchHHHHHHHHhhcccc
Confidence 99999998633 345568889999999999985544 2 57788999999999988622 24555566666688888
Q ss_pred cccCCCCccccCCC--ccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccc-
Q 042086 281 QLYGNLPRALGSLT--ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK- 357 (784)
Q Consensus 281 ~l~~~~~~~l~~l~--~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~- 357 (784)
.++...+ +..+. .|+.+++++|.+. ..+..+..+.++..|++++|++... ..+.....+..+.+..|.+...
T Consensus 219 ~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 293 (414)
T KOG0531|consen 219 KISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSE 293 (414)
T ss_pred cceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchh
Confidence 8874432 22233 3889999999987 4446777888899999999988762 3355667778888888877632
Q ss_pred --cccc-ccccccccEEecCCCccCCCCccc
Q 042086 358 --IPCE-ICNMESLEKLNLSHNNFSGLIPSC 385 (784)
Q Consensus 358 --~~~~-~~~l~~L~~L~L~~N~l~~~~p~~ 385 (784)
.... ....+.++.+++.+|.+....+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 294 AISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred hhhccccccccccccccccccCccccccccc
Confidence 2222 456788899999999888765543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-11 Score=143.63 Aligned_cols=289 Identities=27% Similarity=0.293 Sum_probs=176.7
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCc--ccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNS--LSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
..+++..+-+|.+.- ++... .+++|+.|-+.+|. +....+..|..++.|+.|||++|.=.+.+|..++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~-~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEH-IAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhh-ccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 456677777776652 22222 33478888888886 554555567888999999999887777889999999999999
Q ss_pred eecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeecccccc--CCccchhhhcccccceeccCCCc
Q 042086 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTNH 232 (784)
Q Consensus 155 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l--~~~~~~~l~~l~~L~~L~L~~n~ 232 (784)
+|+++.++ .+|..+.+++.|.+||+..+.....+|.....|++|++|.+..-.. +...-..+.++.+|+.|......
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s 679 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISS 679 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecch
Confidence 99999888 7888889999999999988876656677777788999988866542 22223334455555555543322
Q ss_pred cccccCCCCcCCCCcc----eEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccC------CCccceeecc
Q 042086 233 LSGVIPLSIGNLNNLI----GLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGS------LTELEYLDLS 302 (784)
Q Consensus 233 l~~~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~------l~~L~~L~Ls 302 (784)
. .+-..+..++.|. .+.+.++.. ...+..+..+.+|+.|.+.++.+.......... ++++..+...
T Consensus 680 ~--~~~e~l~~~~~L~~~~~~l~~~~~~~--~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~ 755 (889)
T KOG4658|consen 680 V--LLLEDLLGMTRLRSLLQSLSIEGCSK--RTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSIL 755 (889)
T ss_pred h--HhHhhhhhhHHHHHHhHhhhhccccc--ceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhh
Confidence 2 1112223333333 333322222 244556777778888888888776433222221 2223333333
Q ss_pred cCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccc-ccccccccccccEEec
Q 042086 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK-IPCEICNMESLEKLNL 373 (784)
Q Consensus 303 ~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L 373 (784)
++... ..+.+.--.++|+.|.+..+.....+++....+..+..+-+..+.+.+. .-...+.++++..+.+
T Consensus 756 ~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 756 NCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred ccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 32221 2233333456788888887777666666666666677666666666654 3344444444444433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.6e-10 Score=107.98 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=98.8
Q ss_pred eeEecccceEEEEEEEcC-------CCEEEEEEcCCCCC----------CC---------CCChhhHH----HHHHHHhc
Q 042086 521 YCIGIGGQGSVYKAKLTS-------GEILAVKKFHSLWP----------CE---------MVPQPEFV----NEIKTLTE 570 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------~~---------~~~~~~~~----~E~~~l~~ 570 (784)
..||.|--+.||.|...+ +..+|||+.+.... .+ ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 57999998743211 00 11122333 79999998
Q ss_pred cCC--CceeeEEeEEecCCceEEEEecccCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEeCC
Q 042086 571 LRH--RSIVKFYGFCSHPRNSFLVYEYLERGSLAT-ILSNDGAIEEFNWTVRMNVIRSVANALSYM-HHDCFPPIVHRDI 646 (784)
Q Consensus 571 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dl 646 (784)
+.. -++.+++++ ...++||||+.++.+.. .++.. .++......+..+++.++.++ |.. +|||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666664 45789999997754422 22221 233345667789999999999 777 9999999
Q ss_pred CCCCeeecCCCceEEeccccccccC
Q 042086 647 SSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 647 k~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
+++||+++ ++.+.++|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 5689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.5e-10 Score=103.64 Aligned_cols=132 Identities=23% Similarity=0.347 Sum_probs=101.5
Q ss_pred eEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCC------hhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVP------QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 522 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
.+++|+-+.+|.+.+. |..+++|.= ..+.+.-.. .+.-.+|++++++.+--.|...+-|..+++...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~R-i~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKER-IPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEee-cCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5789999999999775 444555532 222222211 23467899999999777777777788888999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|-.|.+.+... +..++..+-.-+.-||.. +|+|||+.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 134556677777889999 999999999999998654 99999999975
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.1e-11 Score=113.66 Aligned_cols=125 Identities=32% Similarity=0.292 Sum_probs=36.2
Q ss_pred CCCCCCEEEccCCcccccCCCCCC-CCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCcc-ccccccc
Q 042086 99 NLTNLAIMYLYRNSLSASIPPVIG-NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSII-GNLKSLF 176 (784)
Q Consensus 99 ~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~ 176 (784)
+..++++|+|.+|.|+.+ +.++ .+.+|+.|+|++|.|+.. +.+..+++|++|++++|+|+. +.+.+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 333455555555555422 2333 355566666666666532 245556666666666666663 22222 2456666
Q ss_pred eeeccccccCCC-ccccccCccCCceeeccccccCCcc---chhhhcccccceecc
Q 042086 177 YLHLSSNQLSGS-IPISLGNLSNLVVLHLFENSLFGSI---PSILGNLKMLLHLGL 228 (784)
Q Consensus 177 ~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~---~~~l~~l~~L~~L~L 228 (784)
+|+|++|+|... .-..++.+++|++|+|.+|.++... ...+..+|+|+.||-
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 666666666532 1123455666666666666664221 234566677776664
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.4e-11 Score=114.40 Aligned_cols=83 Identities=35% Similarity=0.394 Sum_probs=18.1
Q ss_pred CCcCcEEeecCCCcccccCCccc-cccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhccccccee
Q 042086 148 LSNLAVLHLYGNSLSGSIPSIIG-NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHL 226 (784)
Q Consensus 148 l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 226 (784)
..+++.|+|.+|.|+. + +.++ .+.+|+.|+|++|.|+. +. .+..+++|+.|++++|+|+...+.....+++|+.|
T Consensus 18 ~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred cccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 3455666666666653 2 2233 35556666666666652 22 34555566666666666553322222345555555
Q ss_pred ccCCCccc
Q 042086 227 GLSTNHLS 234 (784)
Q Consensus 227 ~L~~n~l~ 234 (784)
+|++|+|.
T Consensus 94 ~L~~N~I~ 101 (175)
T PF14580_consen 94 YLSNNKIS 101 (175)
T ss_dssp E-TTS---
T ss_pred ECcCCcCC
Confidence 55555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.8e-11 Score=128.07 Aligned_cols=246 Identities=20% Similarity=0.199 Sum_probs=173.9
Q ss_pred HhcCCCCceeEecccceEEEEEEEc--CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT--SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
...+|..+..||.|.|+.|++...+ ++..|++|.......... +...-..|+.+...+ .|.+++..+..+..-+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3567889999999999999998644 688999998766543322 222334666666666 589999888888777788
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEecccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAK 668 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~ 668 (784)
++--||+++++........ ..++...++++..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 8999999999887766322 2355577888999999999999998 99999999999999886 788999999987
Q ss_pred ccCCCCCccccccccccc-ccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGY-IAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
.+... ......++..| .+|+......+..+.|+||||.-+.+.++|..--+.... ...+.....+.
T Consensus 416 ~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------~~~i~~~~~p~ 482 (524)
T KOG0601|consen 416 RLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------SLTIRSGDTPN 482 (524)
T ss_pred cccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------ceeeecccccC
Confidence 53211 11112223334 355666677788899999999999999998664221110 01111122222
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+ .....+..+.+.+..+|+..||.+.+...
T Consensus 483 ~~----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 483 LP----GLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred CC----chHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 11 11245667777889999999998877643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.8e-11 Score=136.79 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=170.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.+.+.+.+-+|.++.++-++-. .|...+.|.............+....+-.+.-..++|-++...-.+......++|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 456777778899999999988643 3433333332221100111122222333333334567777666555566778999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
++|..+++|...++..+. .+.......+..+.++.+|||+. .+.|+|++|.|.+...++..++.|||......-
T Consensus 883 ~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999987663 23344455666788999999997 789999999999999999999999984432210
Q ss_pred ------C---------------C----------CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCC
Q 042086 673 ------D---------------S----------SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRD 721 (784)
Q Consensus 673 ------~---------------~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~ 721 (784)
. . .......+|+.|.|||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 00123568999999999999999999999999999999999999987
Q ss_pred ccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 042086 722 FISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMH 778 (784)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 778 (784)
... .+..+..+.....+. +....+......+++...+..+|.+|-.+.
T Consensus 1037 a~t--------pq~~f~ni~~~~~~~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AET--------PQQIFENILNRDIPW-PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccc--------hhhhhhccccCCCCC-CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 322 222223333333332 233344455677888888899999998765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.5e-10 Score=110.99 Aligned_cols=143 Identities=22% Similarity=0.260 Sum_probs=109.4
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC--CceeeEEeEEecC---CceEEEEec
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH--RSIVKFYGFCSHP---RNSFLVYEY 595 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~ 595 (784)
+.++.|..+.||++...+|+.+++|........ ....++..|+++++.+.+ ..+.+++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 578999999999998877789999987653221 235578999999999965 3457777777654 256899999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC-------------------------------------- 637 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 637 (784)
++++++.+.+.. ..++...+..++.++++++.+||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888765431 23566677778888888888888521
Q ss_pred ---------------CCCeEEeCCCCCCeeecC--CCceEEeccccccc
Q 042086 638 ---------------FPPIVHRDISSKNVLLCL--DYEARVSDFGIAKF 669 (784)
Q Consensus 638 ---------------~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~ 669 (784)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.6e-11 Score=139.41 Aligned_cols=202 Identities=30% Similarity=0.350 Sum_probs=119.8
Q ss_pred CCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCc--cCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccce
Q 042086 100 LTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ--LSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY 177 (784)
Q Consensus 100 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 177 (784)
....+.+.+.+|.+. .++... .+++|+.|-+..|. +.....+.|..++.|++|||++|.=-+.+|..++++-+|++
T Consensus 522 ~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 356677777777765 233332 33468888888875 55444455777888888888887666678888888888888
Q ss_pred eeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcc--ccccCCCCcCCCCcceEEecCC
Q 042086 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL--SGVIPLSIGNLNNLIGLYLYDN 255 (784)
Q Consensus 178 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l--~~~~~~~l~~l~~L~~L~L~~n 255 (784)
|+|++..+. .+|..+.++..|.+|++..+.-...++.....+++|++|.+..-.. +...-..+..+.+|+.+.....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 888888887 7788888888888888877776555566677778888877755432 2222223334444444444222
Q ss_pred CCCCCCcccccccccccc----eEeccCccccCCCCccccCCCccceeecccCccCC
Q 042086 256 QLSVGEIPIEIGKLSSLN----YLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN 308 (784)
Q Consensus 256 ~l~~~~~~~~l~~l~~L~----~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~ 308 (784)
.. .+...+..++.|. .+.+.++... ..+..+..+.+|+.|.+.++.+..
T Consensus 679 s~---~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 679 SV---LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred hh---HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 21 1111122222222 2222222222 334455566666666666666653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-09 Score=99.52 Aligned_cols=146 Identities=16% Similarity=0.232 Sum_probs=107.9
Q ss_pred CceeEecccceEEEEEEEcCCCEEEEEEc-CCCCCCCC----CChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 519 VKYCIGIGGQGSVYKAKLTSGEILAVKKF-HSLWPCEM----VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
....+-+|+-+.|+++.+. |+..+||.- .+...... -..++.+.|++.+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999987 777777642 22211111 12346788999999987666666666777777788999
Q ss_pred ecccC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc---eEEeccccccc
Q 042086 594 EYLER-GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE---ARVSDFGIAKF 669 (784)
Q Consensus 594 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~a~~ 669 (784)
||+++ -++.+++...-..+. ........+..|-+.+.-||.+ +||||||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 478888865433222 2223357788888999999999 9999999999999976653 58999999865
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-08 Score=103.87 Aligned_cols=254 Identities=18% Similarity=0.240 Sum_probs=158.7
Q ss_pred CCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeE----E---ecCCce
Q 042086 518 DVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGF----C---SHPRNS 589 (784)
Q Consensus 518 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~---~~~~~~ 589 (784)
...+.||+|+-+.+|..-.- +. -+-|+++..-. . .-...+.+|... .||-+-.-+.+ . ..+...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Ppp-----a-~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPP-----A-AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCc-----h-HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45678999999999975322 11 23466665311 1 112334445444 67754331221 1 112235
Q ss_pred EEEEecccCC-CHHHHHh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 590 FLVYEYLERG-SLATILS---NDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 590 ~lv~e~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
-+.|..+++. -+..++. ........+|....+++..+|.+.+.||.. |.+-||+.++|+|+++++.|.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 5777777664 2333332 334456789999999999999999999999 99999999999999999999999865
Q ss_pred cccccCCCCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhC-CCCCCcccccccccccccccccc
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKG-DHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
.-... .........+|...|.+||.-. +...+..+|-|.+||++++++.| ++||..+..........+..+..
T Consensus 163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 33322 2333345668899999999864 44456789999999999999986 99998766544332222211111
Q ss_pred -----ccCCC--CCCCCCCCH--HHHHHHHHHHHhcccCC--CCCCCCHHHHHHh
Q 042086 740 -----ILDPR--LPTPPQNVQ--DELISIVEVAFLCLNES--PESRPPMHTVCQL 783 (784)
Q Consensus 740 -----~~d~~--~~~~~~~~~--~~~~~l~~li~~cl~~d--P~~RPs~~~vl~~ 783 (784)
.-+.+ ...++...+ --...+..+..+|+... |.-|||++..+..
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 11111 111111111 11224566777888753 5689999887754
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.6e-10 Score=78.01 Aligned_cols=42 Identities=36% Similarity=0.797 Sum_probs=30.9
Q ss_pred hHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCcccceeEEc
Q 042086 3 GKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCN 57 (784)
Q Consensus 3 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C~w~gv~C~ 57 (784)
..|++|||+||+++..+|.+.+++|+... +.+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-------------~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-------------DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT---------------S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC-------------CCCCeeeccEEeC
Confidence 57999999999999988889999997421 2589999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.3e-08 Score=99.36 Aligned_cols=144 Identities=21% Similarity=0.181 Sum_probs=101.2
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCC----C----CCChhhHHHHHHHHhccCCCce--eeEEeEEec-----
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPC----E----MVPQPEFVNEIKTLTELRHRSI--VKFYGFCSH----- 585 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~----~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~----- 585 (784)
+.+-.-....|+++.. +|+.|.||......-. . ..+...+.+|...+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455667655 5788999976432200 0 1122358899999988853333 344556543
Q ss_pred CCceEEEEecccCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-------CC
Q 042086 586 PRNSFLVYEYLERG-SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-------DY 657 (784)
Q Consensus 586 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-------~~ 657 (784)
....++|+|++++- +|.+++..... ...+...+..++.+++..+.-||.. ||+|+|++++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 89998854221 2344566778999999999999999 9999999999999975 46
Q ss_pred ceEEeccccccc
Q 042086 658 EARVSDFGIAKF 669 (784)
Q Consensus 658 ~~kl~DfG~a~~ 669 (784)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.1e-09 Score=81.54 Aligned_cols=57 Identities=44% Similarity=0.603 Sum_probs=21.3
Q ss_pred CCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeecccc
Q 042086 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183 (784)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 183 (784)
|++|++++|+++...+..|.++++|++|++++|.++...+..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333333333333222233333333333333333333333333333333333333333
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.1e-08 Score=96.21 Aligned_cols=129 Identities=23% Similarity=0.298 Sum_probs=82.9
Q ss_pred EEEEEEEcCCCEEEEEEcCCCCC----------CCCC-------------ChhhHHHHHHHHhccCCC--ceeeEEeEEe
Q 042086 530 SVYKAKLTSGEILAVKKFHSLWP----------CEMV-------------PQPEFVNEIKTLTELRHR--SIVKFYGFCS 584 (784)
Q Consensus 530 ~Vy~~~~~~~~~vavK~~~~~~~----------~~~~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 584 (784)
.||.|...+|..+|||..+.... .... ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999999999999998754211 0000 112367899999999765 456666553
Q ss_pred cCCceEEEEeccc--CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 585 HPRNSFLVYEYLE--RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSY-MHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 585 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
..++||||++ +..+..+.... ++......++.+++..+.. +|.. ||+|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3579999999 54454433221 1123345677788886665 4677 99999999999999987 9999
Q ss_pred eccccccccC
Q 042086 662 SDFGIAKFLK 671 (784)
Q Consensus 662 ~DfG~a~~~~ 671 (784)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.4e-09 Score=81.38 Aligned_cols=60 Identities=40% Similarity=0.486 Sum_probs=34.2
Q ss_pred CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCc
Q 042086 102 NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSL 161 (784)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 161 (784)
+|++|++++|+|+...+..|.++++|++|++++|.++...|..|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555556666666666655555555555666666666665543
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-07 Score=99.65 Aligned_cols=170 Identities=20% Similarity=0.269 Sum_probs=129.2
Q ss_pred cceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec----CCceEEEEecccC-CC
Q 042086 527 GQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH----PRNSFLVYEYLER-GS 600 (784)
Q Consensus 527 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gs 600 (784)
-..+.||+... ||..|++|+++....+... .-..-+++++++.|+|||++.+++.. +...++||+|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 44678999754 8999999999775544332 22355789999999999999998862 3467899999987 47
Q ss_pred HHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 601 LATILSNDG------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 601 L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
|.+..-... .....++...+.++.|++.||.++|+. |...+-+.+++|+++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 877652211 112457788999999999999999999 99999999999999999899999888777
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p 719 (784)
.+..+.. |-+.+ ..+-|.=.||.+++.+.||..-
T Consensus 442 vl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 6554331 11111 2357899999999999999543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-09 Score=105.73 Aligned_cols=177 Identities=26% Similarity=0.227 Sum_probs=91.5
Q ss_pred cCCceeeccccccC--CccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccce
Q 042086 197 SNLVVLHLFENSLF--GSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY 274 (784)
Q Consensus 197 ~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~ 274 (784)
+.++.|+|.+|.|+ ..+...+.++|.|+.|+|+.|++...+...-..+.+|+.|.|.+..+.+......+..+|.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 44455555555553 1223344556666666666666653332211345566666666666665555555566666666
Q ss_pred EeccCccccCCC--Cc----------cccCCCccceeecccCccCCCCcccccccccceEEecccccccCCC-chhhhcc
Q 042086 275 LVLNGNQLYGNL--PR----------ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF-PVELEKL 341 (784)
Q Consensus 275 L~l~~n~l~~~~--~~----------~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~-~~~~~~l 341 (784)
|+++.|.+.... .+ .+..++.+..+.++-|++... ++++..+-+..|++.... .+....+
T Consensus 151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~ 223 (418)
T KOG2982|consen 151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPF 223 (418)
T ss_pred hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCC
Confidence 666666332110 01 122223333334444444322 346666777777665422 2334555
Q ss_pred cccCeeccCCcccccccc-ccccccccccEEecCCCccCC
Q 042086 342 IQLSELDLSLNILEGKIP-CEICNMESLEKLNLSHNNFSG 380 (784)
Q Consensus 342 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 380 (784)
+.+.-|+|+.|+|..... +++..+++|..|.+++|++..
T Consensus 224 p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 224 PSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred CcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 666667777776664222 345566666666666666553
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.5e-08 Score=94.18 Aligned_cols=138 Identities=22% Similarity=0.214 Sum_probs=97.0
Q ss_pred CCCceeEecccceEEEEEEEcCCCEEEEEEcCCCC----------C---------CCCCChhhHHHHHHHHhccCCC--c
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLW----------P---------CEMVPQPEFVNEIKTLTELRHR--S 575 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~---------~~~~~~~~~~~E~~~l~~l~h~--n 575 (784)
..+++.||-|--+.||.|...+|.++|||.=+... . +-..+.....+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678899999999999999999999999421110 0 0112234577899999998654 6
Q ss_pred eeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 576 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
|.+.+++ +..++|||++++--|...- ++......++..|++-+.-.-.. ||||||+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 6676654 4568999999996554421 11222333444455444444455 9999999999999999
Q ss_pred CCceEEeccccccc
Q 042086 656 DYEARVSDFGIAKF 669 (784)
Q Consensus 656 ~~~~kl~DfG~a~~ 669 (784)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-09 Score=104.33 Aligned_cols=38 Identities=24% Similarity=0.350 Sum_probs=15.8
Q ss_pred CccceeecccCccCCC-CcccccccccceEEeccccccc
Q 042086 294 TELEYLDLSTNKLGNS-IPETLGNLLKLHYLNLSNNQFR 331 (784)
Q Consensus 294 ~~L~~L~Ls~n~l~~~-~~~~l~~l~~L~~L~ls~N~l~ 331 (784)
+.+-.|+|+.|+|..- --+.+..+++|..|.+++|++.
T Consensus 224 p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 224 PSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred CcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 3344444444444321 1123444444444444444443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=9.8e-10 Score=119.21 Aligned_cols=127 Identities=31% Similarity=0.296 Sum_probs=72.2
Q ss_pred CcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEec
Q 042086 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325 (784)
Q Consensus 246 ~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~l 325 (784)
.|...+.++|.+. .+...+.-++.|+.|+|++|+++.. +.+..+++|++|||++|.+. .+|..=..-.+|..|.+
T Consensus 165 ~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhheeeee
Confidence 4555555666654 3444555566666666666666643 25666666666666666665 23321111123666666
Q ss_pred ccccccCCCchhhhcccccCeeccCCcccccccc-ccccccccccEEecCCCccC
Q 042086 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP-CEICNMESLEKLNLSHNNFS 379 (784)
Q Consensus 326 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 379 (784)
++|.++. -..+.++.+|+.||+|+|-|.+.-. ..++.+..|+.|+|.||.+.
T Consensus 240 rnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 6666654 2345666666667777766654221 23445566666667666665
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.9e-07 Score=85.71 Aligned_cols=141 Identities=20% Similarity=0.214 Sum_probs=103.4
Q ss_pred EecccceEEEEEEEcCCCEEEEEEcCCCCCCC---CCChhhHHHHHHHHhccCCC--ceeeEEeEEe---cC--CceEEE
Q 042086 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCE---MVPQPEFVNEIKTLTELRHR--SIVKFYGFCS---HP--RNSFLV 592 (784)
Q Consensus 523 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~---~~--~~~~lv 592 (784)
-|+||-+-|+..... |+.+-+|....-...+ ......|.+|...+..+..- .+.++. ++. .+ -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888889997765 4478889764211111 33677899999999998532 244444 332 11 235799
Q ss_pred EecccC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc--eEEeccccccc
Q 042086 593 YEYLER-GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfG~a~~ 669 (784)
+|-+++ -+|.+++.... ..+.+...+..++.+++++++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997763 49999886532 23556677889999999999999999 9999999999999986666 99999987654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-09 Score=117.52 Aligned_cols=180 Identities=28% Similarity=0.242 Sum_probs=127.8
Q ss_pred chhhhcccccceeccCCCccccccCCCCcCC-CCcceEEecCCCCCCCCccc-------ccc---cccccceEeccCccc
Q 042086 214 PSILGNLKMLLHLGLSTNHLSGVIPLSIGNL-NNLIGLYLYDNQLSVGEIPI-------EIG---KLSSLNYLVLNGNQL 282 (784)
Q Consensus 214 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~~~-------~l~---~l~~L~~L~l~~n~l 282 (784)
|-.+..+.+|+.|.|.++.+.. ...+..+ ..|++|... |.+. .+.. .+. .+..|...+.++|.+
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~--Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L 176 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLD--ALRHVFASCGGDISNSPVWNKLATASFSYNRL 176 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHH--HHHHHHHHhccccccchhhhhHhhhhcchhhH
Confidence 4456777889999999988863 1112222 234444332 2211 1100 111 123688888999999
Q ss_pred cCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccc
Q 042086 283 YGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362 (784)
Q Consensus 283 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 362 (784)
. .+..++.-++.|++|+|++|+++.. +.+..+++|++|||++|.++.+.--..... .|+.|.|++|.++.. ..+
T Consensus 177 ~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrnN~l~tL--~gi 250 (1096)
T KOG1859|consen 177 V-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRNNALTTL--RGI 250 (1096)
T ss_pred H-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeecccHHHhh--hhH
Confidence 8 6677888889999999999999854 378889999999999999987433333333 399999999998832 356
Q ss_pred cccccccEEecCCCccCCCCc-ccccCcccceEEEcCCCCCcc
Q 042086 363 CNMESLEKLNLSHNNFSGLIP-SCFEGMHGLSCIDVSYNELRG 404 (784)
Q Consensus 363 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~ 404 (784)
.++.+|+.||+++|-|.+.-. ..+..+..|+.|+|.||++.+
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 788999999999999886533 345668889999999999987
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.5e-08 Score=111.02 Aligned_cols=150 Identities=20% Similarity=0.313 Sum_probs=100.8
Q ss_pred HHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC-ccc--------ccccccccccccccc
Q 042086 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS-NCT--------ELVGTFGYIAPELVY 693 (784)
Q Consensus 623 ~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~--------~~~gt~~y~aPE~~~ 693 (784)
+.+++.|+.|+|... ++||++|.|++|.++.++.+||+.|+++....+... .+. -..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999874 899999999999999999999999999876544211 111 112345799999999
Q ss_pred cCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCC
Q 042086 694 TMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPE 772 (784)
Q Consensus 694 ~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 772 (784)
+...+.++|+||+||++|-+.. |+.-+..-.........+ ...+..........+ .++.+=+.+.+..++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----~~~~~~~~~~s~~~p---~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----NLLNAGAFGYSNNLP---SELRESLKKLLNGDSA 254 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----cccccccccccccCc---HHHHHHHHHHhcCCcc
Confidence 9888999999999999999995 444333211111000000 011111111112222 3466667788999999
Q ss_pred CCCCHHHHHH
Q 042086 773 SRPPMHTVCQ 782 (784)
Q Consensus 773 ~RPs~~~vl~ 782 (784)
.||++.++..
T Consensus 255 ~rp~~~~l~~ 264 (700)
T KOG2137|consen 255 VRPTLDLLLS 264 (700)
T ss_pred cCcchhhhhc
Confidence 9998887654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.8e-07 Score=87.87 Aligned_cols=108 Identities=20% Similarity=0.304 Sum_probs=84.7
Q ss_pred ChhhHHHHHHHHhccCCC--ceeeEEeEEecCC----ceEEEEecccCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 042086 557 PQPEFVNEIKTLTELRHR--SIVKFYGFCSHPR----NSFLVYEYLERG-SLATILSNDGAIEEFNWTVRMNVIRSVANA 629 (784)
Q Consensus 557 ~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 629 (784)
....+.+|...+..+... .+.+++++..... ..++|+|++++. +|.+++..... .+......++.++++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence 345688898888887533 3456666665422 347999999884 89999875332 3446677899999999
Q ss_pred HHHHhhCCCCCeEEeCCCCCCeeecCCC---ceEEecccccccc
Q 042086 630 LSYMHHDCFPPIVHRDISSKNVLLCLDY---EARVSDFGIAKFL 670 (784)
Q Consensus 630 l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG~a~~~ 670 (784)
++-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 784 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-28 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-27 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-08 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 4e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 1h6u_A | 308 | Internalin H: Crystal Structure Of Fused N-Terminal | 5e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 7e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 9e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 1e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1H6U|A Chain A, Internalin H: Crystal Structure Of Fused N-Terminal Domains Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 784 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-115 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-104 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-98 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-81 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-92 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-37 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-86 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-80 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-78 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-75 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-69 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-77 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-27 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-72 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-70 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-69 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-34 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-33 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-63 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-62 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-61 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-54 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-51 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-50 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-62 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-62 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-60 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-59 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-59 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-27 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-17 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-62 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-61 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-60 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-54 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-51 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-57 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-56 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-55 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-54 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-31 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-53 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-50 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-49 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-48 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-47 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-45 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-54 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-51 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-50 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-29 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-51 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-51 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-51 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-51 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-45 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-16 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-51 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-41 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-34 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-50 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-50 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-43 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-33 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-28 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-06 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-06 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-50 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-42 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 7e-39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-35 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-49 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-48 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-47 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-41 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-39 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-09 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-46 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-43 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-25 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-45 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 8e-42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-38 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-37 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-12 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-45 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-45 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-43 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-41 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-40 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-38 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-37 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-37 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-19 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 8e-45 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-44 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-44 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-43 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-23 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-44 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-44 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-40 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-40 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-40 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-20 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-44 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-44 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-44 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 8e-44 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-39 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-36 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-43 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-42 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-42 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-39 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-36 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-12 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-40 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-38 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-38 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-33 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-38 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-37 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-16 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-12 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-38 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-36 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-30 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-37 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-32 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-29 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-25 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-15 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 9e-37 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-36 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-35 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-34 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-36 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-36 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-34 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-33 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-32 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 5e-20 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-35 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-35 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-35 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-31 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 8e-13 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 7e-35 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-34 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-33 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-31 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-34 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 5e-34 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-33 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-33 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-32 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-31 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-33 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-28 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-20 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-33 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-33 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-32 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-29 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-29 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-23 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-32 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-32 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-32 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-31 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-31 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 8e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-30 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-30 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-30 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-06 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-29 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-28 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-26 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-26 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-24 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-29 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 9e-29 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-28 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-28 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-27 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-25 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-17 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-28 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-28 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-28 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-27 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-27 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-27 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-27 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 9e-27 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-25 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-26 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-09 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-26 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-26 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-24 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-07 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-26 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-26 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-26 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-26 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-26 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-26 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-25 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-25 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-25 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-25 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-25 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-25 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-25 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-25 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 7e-25 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-25 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-25 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 9e-25 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-24 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-24 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-24 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-24 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-24 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-24 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-24 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-24 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-24 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-24 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-24 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-23 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-23 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-22 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-07 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-24 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-24 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-24 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 8e-24 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-23 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-23 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-23 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-23 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 9e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-10 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-22 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-22 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-22 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-22 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-22 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-22 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-22 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-22 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-22 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-22 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-21 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-21 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-21 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-20 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-20 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-17 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-20 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-20 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-19 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-19 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-19 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-19 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-08 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-19 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-19 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-19 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-15 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 9e-19 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-18 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-18 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-17 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 7e-15 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 4e-10 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-18 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-18 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-17 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-17 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-17 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-17 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-17 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-17 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-16 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 6e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-04 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 5e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 9e-16 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-15 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-15 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-15 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-15 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-15 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-15 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-08 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-15 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 9e-15 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 9e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-14 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-14 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-14 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-14 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-14 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-14 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-14 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-14 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-14 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-14 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 6e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-14 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 8e-14 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-13 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-13 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-13 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 5e-13 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-13 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-13 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-12 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 9e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 8e-13 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-08 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-13 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 9e-13 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-07 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-12 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-12 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 9e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-09 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-10 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-10 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-10 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 6e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 6e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-09 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 6e-09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-07 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 8e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-04 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 5e-07 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 5e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 5e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 6e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-08 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-07 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 9e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 7e-05 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-07 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-07 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-07 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 3e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-07 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-06 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-06 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-06 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-06 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 1e-05 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 3e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 364 bits (938), Expect = e-115
Identities = 118/381 (30%), Positives = 176/381 (46%), Gaps = 8/381 (2%)
Query: 73 KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132
+ +L L L N G IP + N + L ++L N LS +IP +G+L L L L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS 192
N L G IP L + L L L N L+G IPS + N +L ++ LS+N+L+G IP
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 193 LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+G L NL +L L NS G+IP+ LG+ + L+ L L+TN +G IP ++ + +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----I 565
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVL--NGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
N ++ G+ + I N + G L L+ ++++ G
Sbjct: 566 AANFIA-GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEK 370
T N + +L++S N P E+ + L L+L N + G IP E+ ++ L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 371 LNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGD- 429
L+LS N G IP + L+ ID+S N L GPIP F+ P N GLCG
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744
Query: 430 IKGFQSCNATFTPHKQISKRK 450
+ NA H Q S
Sbjct: 745 LPRCDPSNADGYAHHQRSHHH 765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-104
Identities = 116/343 (33%), Positives = 156/343 (45%), Gaps = 14/343 (4%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSF---GNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLD 131
L SL LDLS N ++G+ + L + + N +S + + L LD
Sbjct: 149 KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLD 206
Query: 132 LSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
+S N S IP LG+ S L L + GN LSG I L L++SSNQ G IP
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265
Query: 192 SLGNLSNLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
L +L L L EN G IP + G L L LS NH G +P G+ + L L
Sbjct: 266 L--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323
Query: 251 YLYDNQLSVGEIPIE-IGKLSSLNYLVLNGNQLYGNLPRALGSLT-ELEYLDLSTNKLGN 308
L N S GE+P++ + K+ L L L+ N+ G LP +L +L+ L LDLS+N
Sbjct: 324 ALSSNNFS-GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 309 SIPETLGNLLK--LHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNME 366
I L K L L L NN F P L +L L LS N L G IP + ++
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 367 SLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
L L L N G IP + L + + +N+L G IP+
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = 5e-98
Identities = 122/342 (35%), Positives = 162/342 (47%), Gaps = 12/342 (3%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
LKSL L L++NK G IP G L + L N ++PP G+ L L LS
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLK-SLFYLHLSSNQLSGSIPI 191
N SG +P TL + L VL L N SG +P + NL SL L LSSN SG I
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 192 SLGN--LSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIG 249
+L + L L+L N G IP L N L+ L LS N+LSG IP S+G+L+ L
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNS 309
L L+ N L GEIP E+ + +L L+L+ N L G +P L + T L ++ LS N+L
Sbjct: 447 LKLWLNMLE-GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 310 IPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLE 369
IP+ +G L L L LSNN F P EL L LDL+ N+ G IP +
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ---- 561
Query: 370 KLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN--ELRGPIPNS 409
++ N +G + + N E +G
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-81
Identities = 99/416 (23%), Positives = 161/416 (38%), Gaps = 92/416 (22%)
Query: 4 KEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVI 63
+E + L+ +K L +++LL W ++ N PC + G+ C +V
Sbjct: 12 REIHQLISFKDVL--PDKNLLPDW-----SSNKN----------PCTFDGVTCRD-DKVT 53
Query: 64 SINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGN 123
SI+LS+ L ++ S +LT L ++L + ++ S+
Sbjct: 54 SIDLSSKPLNVGF--------------SAVSSSLLSLTGLESLFLSNSHINGSVSG-FKC 98
Query: 124 LKFLYHLDLSENQLSGSIPP--TLGNLSNLAVLHLYGNSLSGSIP-SIIGNLKSLFYLHL 180
L LDLS N LSG + +LG+ S L L++ N+L S L SL L L
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 181 SSNQLSGSIPISL---GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237
S+N +SG+ + L L + N + G + + L L +S+N+ S I
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216
Query: 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELE 297
P +G+ + L L + N+LS G+ I + L L ++ NQ G +P L L+
Sbjct: 217 P-FLGDCSALQHLDISGNKLS-GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQ 272
Query: 298 YLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK 357
YL L+ NK IP+ L
Sbjct: 273 YLSLAENKFTGEIPDFLSGACD-------------------------------------- 294
Query: 358 IPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQ 413
+L L+LS N+F G +P F L + +S N G +P + +
Sbjct: 295 ---------TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 6e-92
Identities = 100/385 (25%), Positives = 155/385 (40%), Gaps = 83/385 (21%)
Query: 5 EAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVIS 64
+ ALL+ K L N + LSSW W G+ C+
Sbjct: 7 DKQALLQIKKDL--GNPTTLSSWL-------PTTDC------CNRTWLGVLCDT------ 45
Query: 65 INLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNL 124
++ LDLS L P IP + NL
Sbjct: 46 --------DTQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANL 75
Query: 125 KFLYHLDLS-ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183
+L L + N L G IPP + L+ L L++ ++SG+IP + +K+L L S N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 184 QLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLL-HLGLSTNHLSGVIPLSIG 242
LSG++P S+ +L NLV + N + G+IP G+ L + +S N L+G IP +
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195
Query: 243 NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302
NL NL + L N L G+ + G + + L N L +L + +G L LDL
Sbjct: 196 NL-NLAFVDLSRNMLE-GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252
Query: 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362
N++ ++P+ L L LH LN+S N L G+IP +
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNN------------------------LCGEIP-QG 287
Query: 363 CNMESLEKLNLSHNNF--SGLIPSC 385
N++ + ++N +P+C
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 45/185 (24%), Positives = 70/185 (37%), Gaps = 27/185 (14%)
Query: 228 LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS-VGEIPIEIGKLSSLNYLVL-NGNQLYGN 285
GV+ + + L L L IP + L LN+L + N L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 286 LPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS 345
+P A+ LT+L YL ++ + +IP+ L + L L+ S N
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA---------------- 136
Query: 346 ELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLS-CIDVSYNELRG 404
L G +P I ++ +L + N SG IP + L + +S N L G
Sbjct: 137 --------LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 405 PIPNS 409
IP +
Sbjct: 189 KIPPT 193
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 3e-86
Identities = 91/289 (31%), Positives = 147/289 (50%), Gaps = 15/289 (5%)
Query: 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIK 566
E+ A++ F K +G GG G VYK +L G ++AVK+ + + +F E++
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR-LKEERTQGG-ELQFQTEVE 79
Query: 567 TLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRS 625
++ HR++++ GFC P LVY Y+ GS+A+ L + +W R +
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC-TELVGTF 684
A L+Y+H C P I+HRD+ + N+LL ++EA V DFG+AK + ++ T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN---------RNI 735
G+IAPE + T K +EK DV+ +GV+ LE+I G D + +
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
L ++D L +E+ +++VA LC SP RP M V ++L
Sbjct: 260 KLEALVDVDLQGNY--KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 8e-80
Identities = 69/369 (18%), Positives = 128/369 (34%), Gaps = 41/369 (11%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSA--------SIPPVIGNLK 125
NLK L+ +++ +P L + ++ + N + +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 126 FLYHLDLSENQL-SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQ 184
+ + + N L + + +L + L +L N L G +P+ G+ L L+L+ NQ
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQ 364
Query: 185 LSGSIPISLGNLSNLVVLHLFENSLFGSIPSIL--GNLKMLLHLGLSTNHLSGV------ 236
++ G + L N L IP+I ++ ++ + S N + V
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 237 -IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL-------YGNLPR 288
+ + N+ + L +NQ+S S L+ + L GN L +
Sbjct: 424 PLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 289 ALGSLTELEYLDLSTNKLGNSIPETL--GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSE 346
+ L +DL NKL + + L L ++LS N F FP + L
Sbjct: 483 NFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKG 540
Query: 347 L------DLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
D N + P I SL +L + N+ + +S +D+ N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP---NISVLDIKDN 597
Query: 401 ELRGPIPNS 409
+
Sbjct: 598 PNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 4e-78
Identities = 58/367 (15%), Positives = 115/367 (31%), Gaps = 39/367 (10%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L L + + N + NLK L +++
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVY 257
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSL--------SGSIPSIIGNLKSLFYLHLSSNQL 185
+P L L + ++++ N + + + +++ N L
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 186 -SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNL 244
+ + SL + L +L N L G +P+ G+ L L L+ N ++ + G
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 245 NNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYG-------NLPRALGSLTELE 297
+ L N+L + +S ++ + + N++ L +
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 298 YLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR-------KGFPVELEKLIQLSELDLS 350
++LS N++ E L +NL N K + L+ +DL
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 351 LNILEGKIPCEI--CNMESLEKLNLSHNNFSGLIPSCFEGMHGL------SCIDVSYNEL 402
N L + + + L ++LS+N+FS P+ L + D N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 403 RGPIPNS 409
P
Sbjct: 555 LREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 9e-75
Identities = 64/445 (14%), Positives = 126/445 (28%), Gaps = 55/445 (12%)
Query: 8 ALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAW------------FGIQ 55
L K +L W N N S W G+
Sbjct: 20 IKLSRTAEYIKDYLALKEIW---DALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVS 76
Query: 56 CNPAKRVISINLSTVGLKG-------NLKSLSTLDLSKNKLNG----SIPFSFGNLTNLA 104
N RV ++L G G L L L L + P +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 105 IMYLYRNSLSASIPPVIGNLKF--LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLS 162
R + F L ++ + SI + + N+++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 163 GSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKM 222
+ + L L ++ ++ N + + NLK
Sbjct: 197 -FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKD 250
Query: 223 LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL-------SVGEIPIEIGKLSSLNYL 275
L + + +P + L + + + N+ + + + +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 276 VLNGNQL-YGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF 334
+ N L + +L + +L L+ N+L G+ +KL LNL+ NQ
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQL-EGKLPAFGSEIKLASLNLAYNQI-TEI 368
Query: 335 PVEL-EKLIQLSELDLSLNILEGKIP--CEICNMESLEKLNLSHNNFSGLIPSCFEGMHG 391
P Q+ L + N L+ IP + ++ + ++ S+N + F+ +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 392 LSC-------IDVSYNELRGPIPNS 409
I++S N++
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKEL 452
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 7e-69
Identities = 54/335 (16%), Positives = 106/335 (31%), Gaps = 30/335 (8%)
Query: 74 GNLKSLSTLDLSKNKL-NGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132
+ + + + N L + S + L ++ N L P G+ L L+L
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE-GKLPAFGSEIKLASLNL 360
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSI--IGNLKSLFYLHLSSNQLSG--- 187
+ NQ++ G + L N L IP+I ++ + + S N++
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 188 ----SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV------- 236
+ + N+ ++L N + + L + L N L+ +
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 237 IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTEL 296
+ N L + L N+L+ L L + L+ N P + + L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTL 538
Query: 297 EYLDLSTNKLGN------SIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS 350
+ + + PE + L L + +N R ++ +S LD+
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIK 595
Query: 351 LNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
N +C L ++ I C
Sbjct: 596 DNPNISIDLSYVCPYIEAGMYMLFYDKTQD-IRGC 629
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-47
Identities = 46/260 (17%), Positives = 84/260 (32%), Gaps = 27/260 (10%)
Query: 71 GLKGNLKSLSTLDLSKNKLNG-SIPFSFGNLTNLAIMYLYRNSLS-------ASIPPVIG 122
G + + L + NKL F +++ ++ + N + + P
Sbjct: 371 NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSG-------SIPSIIGNLKSL 175
+ ++LS NQ+S S L+ ++L GN L+ N L
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 176 FYLHLSSNQLSGSIP-ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST---- 230
+ L N+L+ L LV + L NS P+ N L G+
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDA 549
Query: 231 --NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR 288
N P I +L L + N + ++ +I +++ L + N
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIR--KVNEKI--TPNISVLDIKDNPNISIDLS 605
Query: 289 ALGSLTELEYLDLSTNKLGN 308
+ E L +K +
Sbjct: 606 YVCPYIEAGMYMLFYDKTQD 625
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 1e-77
Identities = 88/362 (24%), Positives = 140/362 (38%), Gaps = 17/362 (4%)
Query: 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135
+++ L+L+ N+L +F + L + + N++S P + L L L+L N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
+LS T +NL LHL NS+ + K+L L LS N LS + +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 196 LSNLVVLHLFENSLFGSIPSILGNLKM--LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
L NL L L N + L L L LS+N + P + L GL+L
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 254 DNQLSVGEIPIEIG---KLSSLNYLVLNGNQLYGNLPRALGSL--TELEYLDLSTNKLGN 308
+ QL + ++ +S+ L L+ +QL L T L LDLS N L
Sbjct: 204 NVQLG-PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262
Query: 309 SIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNI---------LEGKIP 359
++ L +L Y L N + F L L + L+L + L
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322
Query: 360 CEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEA 419
++ LE LN+ N+ G+ + F G+ L + +S + + F
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
Query: 420 LQ 421
L
Sbjct: 383 LH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-69
Identities = 88/364 (24%), Positives = 129/364 (35%), Gaps = 24/364 (6%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRN---------SLSASIPPVIGNL 124
L L L N + S L N+ + L R+ SL L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328
Query: 125 KFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIG----NLKSLFYLHL 180
K L HL++ +N + G L NL L L + S + L L+L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLSGVIPL 239
+ N++S + L +L VL L N + + L+ + + LS N +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
Query: 240 SIGNLNNLIGLYLYDNQLS-VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY 298
S + +L L L L V P L +L L L+ N + L L +LE
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508
Query: 299 LDLSTNKL--------GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS 350
LDL N L L L LH LNL +N F + + L +L +DL
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568
Query: 351 LNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFE-GMHGLSCIDVSYNELRGPIPNS 409
LN L N SL+ LNL N + + F L+ +D+ +N +
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628
Query: 410 RIFQ 413
F
Sbjct: 629 AWFV 632
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-66
Identities = 80/322 (24%), Positives = 129/322 (40%), Gaps = 9/322 (2%)
Query: 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS 160
+ + L+ +P + + L+L+ NQL S L L + N+
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 161 LSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNL 220
+S P + L L L+L N+LS + +NL LHL NS+ +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 221 KMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS-VGEIPIEIGKLSSLNYLVLNG 279
K L+ L LS N LS + L NL L L +N++ + ++I SSL L L+
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 280 NQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLG---NLLKLHYLNLSNNQFRKGFPV 336
NQ+ P ++ L L L+ +LG S+ E L + L+LSN+Q
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 337 ELE--KLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSC 394
K L+ LDLS N L + LE L +NN L G+ +
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 395 IDVSYNELRGPIPNSRIFQYDP 416
+++ + + I + + + D
Sbjct: 301 LNLKRSFTKQSISLASLPKIDD 322
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-27
Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 9/182 (4%)
Query: 63 ISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLS-------- 114
+ S+ L++L+ LDLS N + L L I+ L N+L+
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525
Query: 115 ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKS 174
+ L L+ L+L N +L L ++ L N+L+ S+ N S
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS 585
Query: 175 LFYLHLSSNQLSGSIPISLG-NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233
L L+L N ++ G NL L + N + SI + + + L
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPEL 645
Query: 234 SG 235
S
Sbjct: 646 SS 647
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 4e-72
Identities = 95/295 (32%), Positives = 134/295 (45%), Gaps = 32/295 (10%)
Query: 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQ--PEFVNE 564
++ ATN FD K+ IG G G VYK L G +A+K+ Q EF E
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-----ESSQGIEEFETE 85
Query: 565 IKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILS-NDGAIEEFNWTVRMNVI 623
I+TL+ RH +V GFC L+Y+Y+E G+L L +D +W R+ +
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC---TEL 680
A L Y+H I+HRD+ S N+LL ++ +++DFGI+K + T +
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLSTVV 201
Query: 681 VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI----- 735
GT GYI PE ++TEK DVYSFGV+ EV+ S N+
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ----SLPREMVNLAEWAV 257
Query: 736 ------SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
L +I+DP L + + L + A CL S E RP M V L
Sbjct: 258 ESHNNGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-70
Identities = 85/302 (28%), Positives = 142/302 (47%), Gaps = 41/302 (13%)
Query: 507 YEEIVRATNGFDVKYC------IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQ-- 558
+ E+ TN FD + +G GG G VYK + + +AVKK ++ +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT-TEELK 74
Query: 559 PEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTV 618
+F EIK + + +H ++V+ GF S + LVY Y+ GSL LS +W +
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 619 RMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC- 677
R + + AN ++++H + +HRDI S N+LL + A++SDFG+A+ +
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTV 190
Query: 678 --TELVGTFGYIAPELVY-TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRN 734
+ +VGT Y+APE ++T K D+YSFGV+ LE+I G D +
Sbjct: 191 MTSRIVGTTAYMAPE--ALRGEITPKSDIYSFGVVLLEIITGLPAVDE------HREPQL 242
Query: 735 I------------SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ ++ + +D ++ + ++ VA CL+E RP + V Q
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 783 LL 784
LL
Sbjct: 300 LL 301
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 4e-69
Identities = 65/385 (16%), Positives = 123/385 (31%), Gaps = 44/385 (11%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLS---------ASIPPVIGNL 124
NLK L+ ++L +P +L L + + N +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 125 KFLYHLDLSENQLSG-SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183
+ + N L +L + L +L N + + + G L L L N
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYN 605
Query: 184 QLSGSIPISLG-NLSNLVVLHLFENSLFGSIPSI--LGNLKMLLHLGLSTNHLSGVIP-- 238
Q+ IP + L N L IP+I ++ ++ + S N +
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 239 ---LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL-------YGNLPR 288
+ N + L N++ S ++ ++L+ N +
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 289 ALGSLTELEYLDLSTNKLGNSIPETL--GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSE 346
+ L +DL NKL S+ + L L +++S N F FP + QL
Sbjct: 723 NYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKA 780
Query: 347 LDLSLNI------LEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
+ + + P I SL +L + N+ + + L +D++ N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE---KLTPQLYILDIADN 837
Query: 401 EL-RGPIPNSRIFQYDPMEALQGNK 424
+ + + M L +K
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 1e-62
Identities = 67/375 (17%), Positives = 124/375 (33%), Gaps = 43/375 (11%)
Query: 67 LSTVGLKGNLKSLSTLDLSKNKLNG------SIPFSFGNLTNLAIMYLYRNSLSASIPPV 120
++ +K S + L ++ I + LT L I+Y + + V
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 121 IGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180
+ + + + NL +L + LY +P + +L L L++
Sbjct: 468 -----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522
Query: 181 SSNQLSG---------SIPISLGNLSNLVVLHLFENSLFGSIPSI-LGNLKMLLHLGLST 230
+ N+ + + + ++ N+L S L + L L
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGK-LSSLNYLVLNGNQLYGNLPRA 289
N + + + G L L L NQ+ EIP + + L + N+L +P
Sbjct: 583 NKVR-HLE-AFGTNVKLTDLKLDYNQIE--EIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 290 --LGSLTELEYLDLSTNKLGNSIPETLG-----NLLKLHYLNLSNNQFRKGFPVELEKLI 342
S+ + +D S NK+G+ + + LS N+ +K
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 343 QLSELDLSLNILE-------GKIPCEICNMESLEKLNLSHNNFSGLIPS-CFEGMHGLSC 394
+S + LS N++ N L ++L N + L + LS
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSN 757
Query: 395 IDVSYNELRGPIPNS 409
+DVSYN P
Sbjct: 758 MDVSYNCFSS-FPTQ 771
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-52
Identities = 52/345 (15%), Positives = 100/345 (28%), Gaps = 26/345 (7%)
Query: 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGS 140
+ + N + + L +P IG L L L + + S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 141 IPPTLGNLSNLAVLHLYGNSLSGSIPSIIG----NLKSLFYLHLSSNQLSGSIPISLGNL 196
+ + + + L L + N+ PI +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 197 SNLVVLHLFENS-LFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDN 255
+L + + I + L L + + + + N Y+N
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482
Query: 256 QLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL--------- 306
+ L L + L LP L L EL+ L+++ N+
Sbjct: 483 ------EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 307 GNSIPETLGNLLKLHYLNLSNNQFRKGFPVE--LEKLIQLSELDLSLNILEGKIPCEICN 364
+ + K+ + N + FP L+K+++L LD N + +
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGT 593
Query: 365 MESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
L L L +N + + + S+N+L+ IPN
Sbjct: 594 NVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-34
Identities = 41/356 (11%), Positives = 97/356 (27%), Gaps = 55/356 (15%)
Query: 107 YLYRNSLSASIPPVIGNLKFLYHLDLSENQLSG------SIPPTLGNLSNLAVLHLYGNS 160
Y S +++ + +N+L+ + T + + L +
Sbjct: 222 TTYSQSGIKRSELETQSVR-GESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEA 280
Query: 161 LSGSIPSIIGNLKSLFYLH------LSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP 214
L G + + + L N + L L G +P
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340
Query: 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY 274
+G L L L T+ + L +++ + + + LN
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400
Query: 275 LVLNGNQLYGN----------------------------LPRALGSLTELEYLDLSTNKL 306
L + + N + +A+ LT+L+ + + +
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF 460
Query: 307 GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNME 366
Y N + L L++++L ++P + ++
Sbjct: 461 TYDNIAVDWEDANSDYAKQYEN-----EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515
Query: 367 SLEKLNLSHNNFSGL---------IPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQ 413
L+ LN++ N + + + + YN L ++ + +
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-33
Identities = 37/230 (16%), Positives = 74/230 (32%), Gaps = 33/230 (14%)
Query: 63 ISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSA------- 115
N+S + ST+ LS N++ F + ++ + L N +++
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 116 SIPPVIGNLKFLYHLDLSENQLSGSIPPTL--GNLSNLAVLHLYGNSLSGSIPSIIGNLK 173
N L +DL N+L+ S+ L L+ + + N S S P+ N
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSS 776
Query: 174 SLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233
L + N + P+ + L+ L + +N +
Sbjct: 777 QLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818
Query: 234 SGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY-LVLNGNQL 282
+ + L L + DN ++ + + Y L+ + Q
Sbjct: 819 RK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-63
Identities = 83/366 (22%), Positives = 132/366 (36%), Gaps = 38/366 (10%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
S LDLS N L +SF + L ++ L R + +L L L L+ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL-SGSIPISLGNL 196
LS+L L +L+ IG+LK+L L+++ N + S +P NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 197 SNLVVLHLFENSLFGSIPSILGNLKML----LHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+NL L L N + + L L + L L LS N ++ + P + + L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL 207
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVL------NGNQLYGNLPRALGSLTELEYLDLSTNKL 306
+N S+ + I L+ L L N L AL L L + L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 307 ---GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS------------- 350
+ I + L + +L + + + L+L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 351 ------LNILEGKIPCEICNMESLEKLNLSHN--NFSGLIPSCFEGMHGLSCIDVSYNEL 402
+G ++ SLE L+LS N +F G G L +D+S+N +
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 403 RGPIPN 408
N
Sbjct: 386 ITMSSN 391
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 6e-62
Identities = 83/387 (21%), Positives = 133/387 (34%), Gaps = 29/387 (7%)
Query: 43 KIKISPCAWFGIQCNPAKRVISINLSTVGLKG------NLKSLSTLDLSKNKLNGSIP-F 95
KI+ C + +S++LS + L L L N + ++
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
Query: 96 SFGNLTNLAIMYLYRNSLSASI---PPVIGNLKFLYHLDLSENQLS------GSIPPTLG 146
L L + L L+ L +L + E +L+ I
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 147 NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206
L+N++ L ++ +L L + + + L +L L
Sbjct: 280 CLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
Query: 207 NSLFGSIPSILGNLKMLLHLGLSTNHLS--GVIPLSIGNLNNLIGLYLYDNQLSVGEIPI 264
+ F +L L L LS N LS G S +L L L N + +
Sbjct: 338 GNAFS-----EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI--TMSS 390
Query: 265 EIGKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYL 323
L L +L + L SL L YLD+S + L L L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 324 NLSNNQFRKGF-PVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLI 382
++ N F++ F P +L L+ LDLS LE P ++ SL+ LN+SHNNF L
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 383 PSCFEGMHGLSCIDVSYNELRGPIPNS 409
++ ++ L +D S N +
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-61
Identities = 78/371 (21%), Positives = 130/371 (35%), Gaps = 39/371 (10%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
+ L LDLS+ ++ ++ +L++L+ + L N + + L L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSL-SGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS 192
E L+ +G+L L L++ N + S +P NL +L +L LSSN++
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 193 LGNLSNL----VVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG-VIPLSIGNLNNL 247
L L + + L L N + P ++ L L L N S V+ I L L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 248 IGLYLYDNQLS--VGEIPIEIGKLSSLNYLVLNGNQL------YGNLPRALGSLTELEYL 299
L + + L L L + +L ++ LT +
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 300 DLSTNKLGNSIPETLGNLLKLHYLNLSNNQF-------------------RKGFPVELEK 340
L + + +L L N +F + G
Sbjct: 288 SLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345
Query: 341 LIQLSELDLSLNIL--EGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398
L L LDLS N L +G SL+ L+LS N + + F G+ L +D
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQ 404
Query: 399 YNELRGPIPNS 409
++ L+ S
Sbjct: 405 HSNLKQMSEFS 415
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-54
Identities = 75/363 (20%), Positives = 128/363 (35%), Gaps = 14/363 (3%)
Query: 33 NNATNVSFYSKIKISPCAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGS 92
N N+ + K + I+ + + L L ++S+ L +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 93 IPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLA 152
FS+ + L + +LK L G + +L +L
Sbjct: 298 KDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLE 350
Query: 153 VLHLYGNSLS--GSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLF 210
L L N LS G SL YL LS N + + + L L L ++L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 211 GSIP-SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKL 269
S+ +L+ L++L +S H L++L L + N +P +L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 270 SSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQ 329
+L +L L+ QL P A SL+ L+ L++S N + L L L+ S N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 330 FRKGFPVELEKLI-QLSELDLSLNILEGKIPCE--ICNMESLEKLNLSHNNFSGLIPSCF 386
EL+ L+ L+L+ N + + ++ +L + PS
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 387 EGM 389
+GM
Sbjct: 590 QGM 592
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-51
Identities = 64/309 (20%), Positives = 105/309 (33%), Gaps = 21/309 (6%)
Query: 116 SIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSL 175
IP + +LDLS N L + + L VL L + +L L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 176 FYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG 235
L L+ N + + LS+L L E +L +G+LK L L ++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 236 V-IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY----LVLNGNQLYGNLPRAL 290
+P NL NL L L N++ ++ L + L L+ N + P A
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 291 GSLTELEYLDLSTNKL-GNSIPETLGNLLKLHYLNLSNNQFRKGFPVE------LEKLIQ 343
+ L L L N N + + L L L +FR +E LE L
Sbjct: 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 344 LSELDLSLNILE---GKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
L+ + L L+ I + ++ +L + F G +++
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNC 314
Query: 401 ELRGPIPNS 409
+
Sbjct: 315 KFGQFPTLK 323
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-50
Identities = 61/293 (20%), Positives = 98/293 (33%), Gaps = 18/293 (6%)
Query: 131 DLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIP 190
E IP L + L L N L + L L LS ++
Sbjct: 13 QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 191 ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
+ +LS+L L L N + L L L +L+ + IG+L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY----LDLSTNKL 306
+ N + ++P L++L +L L+ N++ L L ++ LDLS N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 307 GNSIPETLGNLLKLHYLNLSNNQFRKGFP-VELEKLIQLSELDLSLNILEGKIPCE---I 362
P ++LH L L NN ++ L L L L + E
Sbjct: 190 NFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 363 CNMESLEKLNLSHNNFSGL------IPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+E L L + + L I F + +S + + S
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-63
Identities = 69/344 (20%), Positives = 124/344 (36%), Gaps = 10/344 (2%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L +L+ LDL++ ++ +F + L + L N L + K L HL
Sbjct: 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
+ +S L N L L+L N +S + L L +N + +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 194 GNLSNL--VVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGN--LNNLIG 249
+L + L+L N + I + + L VI + N + +L
Sbjct: 174 SSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 250 LYLYDNQLS-VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN 308
D + E S+ + L + + + L+ LDL+ L +
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-S 291
Query: 309 SIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKI-PCEICNMES 367
+P L L L L LS N+F + L+ L + N ++ + N+E+
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 368 LEKLNLSHNN--FSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
L +L+LSH++ S + L +++SYNE +
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-62
Identities = 78/345 (22%), Positives = 125/345 (36%), Gaps = 12/345 (3%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
+ L TL L+ N L + L ++ + +S+ + N K L L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSL--FYLHLSSNQLSGSIPI 191
N +S P L VL N++ + +L+ L+L+ N ++ I
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEP 196
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKM--LLHLGLSTNHLSGVIPLSIGNL--NNL 247
+ + L+ I L N + L + P L ++
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 248 IGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLG 307
+ L + S L L L L LP L L+ L+ L LS NK
Sbjct: 257 ESINLQKHYFF-NISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFE 314
Query: 308 NSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELDLSLNILEGKIPC--EICN 364
N + N L +L++ N R LE L L ELDLS + +E C ++ N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 365 MESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ L+ LNLS+N L F+ L +D+++ L+ S
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-62
Identities = 72/344 (20%), Positives = 116/344 (33%), Gaps = 8/344 (2%)
Query: 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135
S L+ S N L +F L NL + L R + + L L L+ N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
L L L L +S + N K+L L+L SN +S
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 196 LSNLVVLHLFENSLFGSIPSILGNLKML--LHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
L VL N++ + +L+ L L L+ N ++G I + L
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 254 DNQLSVGEIP-IEIGKLSSLNYLVLNGNQLYGNLPRALGSLTE--LEYLDLSTNKLGNSI 310
Q + ++ + SL P L E +E ++L + N
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEK 370
T L L+L+ P L L L +L LS N E N SL
Sbjct: 271 SNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 371 LNLSHNNFSGLIPS-CFEGMHGLSCIDVSYNELRGPIPNSRIFQ 413
L++ N + + C E + L +D+S++++ + +
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 6e-60
Identities = 66/333 (19%), Positives = 107/333 (32%), Gaps = 8/333 (2%)
Query: 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGS 140
T + LN IP + + + N L L L LDL+ Q+
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 141 IPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLV 200
T + L L L N L + + K+L +L +S I L N L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 201 VLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260
L+L N + + L L N + + + +L L L N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALG--SLTELEYLDLSTNKLGNSIPETLGNL- 317
I + L G Q + + L ++ L + P L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 318 -LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHN 376
+ + +NL + F L ELDL+ L ++P + + +L+KL LS N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 377 NFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
F L L+ + + N R +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-59
Identities = 76/336 (22%), Positives = 119/336 (35%), Gaps = 10/336 (2%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLY--RNSLSASIPPVIGNLKFLYHLDL 132
++SL P F L +++ + ++ L LDL
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI-PI 191
+ LS +P L LS L L L N N SL +L + N +
Sbjct: 286 TATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
Query: 192 SLGNLSNLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIG 249
L NL NL L L + + L NL L L LS N + + L
Sbjct: 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNS 309
L L +L V + L L L L+ + L + + L L++L+L N
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 310 I---PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNME 366
+L L +L L LS L ++ +DLS N L + +++
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
Query: 367 SLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
+ LNL+ N+ S ++PS + I++ N L
Sbjct: 525 GIY-LNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-59
Identities = 73/310 (23%), Positives = 122/310 (39%), Gaps = 10/310 (3%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
S+ +++L K+ +F + L + L LS +P + L L L LS N+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQL--SGSIPISLG 194
+ N +L L + GN+ + + + NL++L L LS + + S + L
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSI-GNLNNLIGLYLY 253
NLS+L L+L N L L L+ L S NL+ L L L
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGN---LPRALGSLTELEYLDLSTNKLGNSI 310
+ L L +L +L L GN +L +L LE L LS L +
Sbjct: 434 HSLLD-ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEK 370
+L +++++LS+N+ L L + L+L+ N + +P + +
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRT 551
Query: 371 LNLSHNNFSG 380
+NL N
Sbjct: 552 INLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-55
Identities = 72/348 (20%), Positives = 124/348 (35%), Gaps = 14/348 (4%)
Query: 74 GNLKSLS--TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKF--LYH 129
+L+ + +L+L+ N + I + + I + N L+
Sbjct: 174 SSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 130 LDLSENQLSGSIPPTLGNLSNLAV--LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG 187
+ P L ++V ++L + + L L L++ LS
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS- 291
Query: 188 SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI-PLSIGNLNN 246
+P L LS L L L N N L HL + N + + NL N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 247 LIGLYLYDNQLS-VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
L L L + + +++ LS L L L+ N+ A +LE LDL+ +
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 306 LGNSIPET-LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCE--- 361
L ++ NL L LNLS++ + L L L+L N +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 362 ICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ + LE L LS + S + F + ++ +D+S+N L +
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 50/188 (26%), Positives = 73/188 (38%), Gaps = 8/188 (4%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASI---PPVIGNLKFLYHL 130
NL L L+LS + L+ S F L L + L N + L L L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 131 DLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIP 190
LS LS +L + + L N L+ S + +LK + YL+L+SN +S +P
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540
Query: 191 ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
L LS ++L +N L + N+ L + L N L G+
Sbjct: 541 SLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGV 596
Query: 251 YLYDNQLS 258
L D LS
Sbjct: 597 RLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-17
Identities = 34/146 (23%), Positives = 60/146 (41%), Gaps = 5/146 (3%)
Query: 64 SINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGN 123
N+ L L L LS L+ +F +L + + L N L++S + +
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 124 LKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183
LK +Y L+L+ N +S +P L LS ++L N L + N+ L + +
Sbjct: 523 LKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT----CSNIYFLEWYKENMQ 577
Query: 184 QLSGSIPISLGNLSNLVVLHLFENSL 209
+L + N L + L + +L
Sbjct: 578 KLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-62
Identities = 69/308 (22%), Positives = 122/308 (39%), Gaps = 40/308 (12%)
Query: 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIK 566
E + + + G G V+KA+L E +AVK F + E+
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW----QNEYEVY 70
Query: 567 TLTELRHRSIVKFYGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
+L ++H +I++F G + +L+ + E+GSL+ L +W ++
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHI 126
Query: 623 IRSVANALSYMHHDCF-------PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675
++A L+Y+H D P I HRDI SKNVLL + A ++DFG+A + S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 676 --NCTELVGTFGYIAPE-----LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFIS---- 724
+ VGT Y+APE + + + D+Y+ G++ E+ D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 725 --------SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP 776
S + + +++ P L Q + + E C + E+R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA-GMAMLCETIEECWDHDAEARLS 305
Query: 777 MHTVCQLL 784
V + +
Sbjct: 306 AGCVGERI 313
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 7e-61
Identities = 87/338 (25%), Positives = 162/338 (47%), Gaps = 24/338 (7%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
+++ V + L+S++ L ++ K+ SI LTNL + L N ++ P + NL
Sbjct: 33 SVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLV 88
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L +L + N+++ L NL+NL L+L +++S P + NL ++ L+L +N
Sbjct: 89 KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN 144
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
+ L N++ L L + E+ + P + NL L L L+ N + + PL +L
Sbjct: 145 LSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPL--ASLT 199
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
+L Y NQ++ + ++ LN L + N++ +L L +L++L +L++ TN+
Sbjct: 200 SLHYFTAYVNQITD---ITPVANMTRLNSLKIGNNKI-TDLS-PLANLSQLTWLEIGTNQ 254
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
+ S + +L KL LN+ +NQ L L QL+ L L+ N L + I +
Sbjct: 255 I--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 366 ESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+L L LS N+ + + P + + D + ++
Sbjct: 311 TNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-60
Identities = 84/333 (25%), Positives = 147/333 (44%), Gaps = 24/333 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+L L K + + L ++ + + ++ SI I L L +L+L+
Sbjct: 20 DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNG 75
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
NQ++ P L NL L L++ N ++ S + NL +L L+L+ + +S P L
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LA 129
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
NL+ + L+L N S S L N+ L +L ++ + + V P I NL +L L L
Sbjct: 130 NLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
NQ+ + L+SL+Y NQ+ P + ++T L L + NK+ + P L
Sbjct: 187 NQIED---ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--L 239
Query: 315 GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374
NL +L +L + NQ ++ L +L L++ N + + N+ L L L+
Sbjct: 240 ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLN 295
Query: 375 HNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407
+N G+ L+ + +S N + P
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 80/331 (24%), Positives = 149/331 (45%), Gaps = 26/331 (7%)
Query: 79 LSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLS 138
+TL +N P + +L L + S++ + L+ + L ++ +++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 139 GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSN 198
SI + L+NL L+L GN ++ P + NL L L++ +N++ + +L NL+N
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 199 LVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258
L L+L E+++ P L NL + L L NH + + N+ L L + ++++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 259 VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL 318
I L+ L L LN NQ+ L SLT L Y N++ + P + N+
Sbjct: 169 D---VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 319 KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNF 378
+L+ L + NN+ P L L QL+ L++ N + I + ++ L+ LN+ N
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQI 277
Query: 379 SGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
S + + L+ + ++ N+L
Sbjct: 278 SDISV--LNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 6e-51
Identities = 75/259 (28%), Positives = 121/259 (46%), Gaps = 18/259 (6%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
NL +L L L+++ ++ P NLT + + L N S + N+ L +L ++
Sbjct: 107 QNLTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVT 163
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
E+++ P + NL++L L L N + P + +L SL Y NQ++ P +
Sbjct: 164 ESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--V 217
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
N++ L L + N + P L NL L L + TN +S + + +L L L +
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAV--KDLTKLKMLNVG 273
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
NQ+S +I + LS LN L LN NQL +G LT L L LS N + + P
Sbjct: 274 SNQIS--DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-- 328
Query: 314 LGNLLKLHYLNLSNNQFRK 332
L +L K+ + +N +K
Sbjct: 329 LASLSKMDSADFANQVIKK 347
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-57
Identities = 74/281 (26%), Positives = 131/281 (46%), Gaps = 28/281 (9%)
Query: 505 ILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNE 564
I Y+EI +V+ +G G G V KAK + +A+K+ S + F+ E
Sbjct: 5 IDYKEI-------EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERK-----AFIVE 51
Query: 565 IKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR 624
++ L+ + H +IVK YG C +P LV EY E GSL +L + + M+
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE-ARVSDFGIAKFLKPDSSNCTELVGT 683
+ ++Y+H ++HRD+ N+LL ++ DFG A ++ ++ T G+
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGS 166
Query: 684 FGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743
++APE+ +EKCDV+S+G++ EVI P D I + + +
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA------VHNG 220
Query: 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P +N+ + S++ C ++ P RP M + +++
Sbjct: 221 TRPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-56
Identities = 86/314 (27%), Positives = 144/314 (45%), Gaps = 29/314 (9%)
Query: 476 RRREGPSSEN---RVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKYCIGIGGQGSVY 532
P S+ + QG + + I + ++ ++K IG G G+V+
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMD--IPWCDL-------NIKEKIGAGSFGTVH 54
Query: 533 KAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592
+A+ G +AVK EF+ E+ + LRH +IV F G + P N +V
Sbjct: 55 RAEW-HGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112
Query: 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVL 652
EYL RGSL +L GA E+ + R+++ VA ++Y+H+ PPIVHR++ S N+L
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLL 171
Query: 653 LCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALE 712
+ Y +V DFG+++ + GT ++APE++ EK DVYSFGV+ E
Sbjct: 172 VDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
Query: 713 VIKGDHPRDFISS--ISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNES 770
+ P ++ + ++ + P+N+ ++ +I+E C
Sbjct: 232 LATLQQPWGNLNPAQVVAAVGFKCKR---------LEIPRNLNPQVAAIIE---GCWTNE 279
Query: 771 PESRPPMHTVCQLL 784
P RP T+ LL
Sbjct: 280 PWKRPSFATIMDLL 293
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-55
Identities = 98/334 (29%), Positives = 149/334 (44%), Gaps = 28/334 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L +L+ ++ S N+L P NLT L + + N ++ P + NL L L L
Sbjct: 65 EYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
NQ++ P L NL+NL L L N++S S + L SL L NQ++ P L
Sbjct: 121 NNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--L 173
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
NL+ L L + N + S S+L L L L + N +S + PL G L NL L L
Sbjct: 174 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLN 229
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
NQL +I + L++L L L NQ+ P L LT+L L L N++ N P
Sbjct: 230 GNQLK--DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 282
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
L L L L L+ NQ + L L+ L L N + P + ++ L++L
Sbjct: 283 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407
+N S + + ++ + +N++ P
Sbjct: 339 YNNKVSDVSS--LANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-54
Identities = 96/336 (28%), Positives = 147/336 (43%), Gaps = 28/336 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
NL L + ++ N++ P NLTNL + L+ N ++ I P + NL L L+LS
Sbjct: 87 KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT-DIDP-LKNLTNLNRLELS 142
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N +S L L++L L GN ++ P + NL +L L +SSN++S L
Sbjct: 143 SNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVL 195
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
L+NL L N + P LG L L L L+ N L + L+ +L NL L L
Sbjct: 196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLA--SLTNLTDLDLA 251
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
+NQ+S + L+ L L L NQ+ P L LT L L+L+ N+L + P
Sbjct: 252 NNQISN---LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-- 304
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
+ NL L YL L N + L +L L N + + N+ ++ L+
Sbjct: 305 ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSA 360
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
HN S L P + ++ + ++ N
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-53
Identities = 97/336 (28%), Positives = 146/336 (43%), Gaps = 26/336 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
NL +L+ L L N++ P NLTNL + L N++S I + L L L
Sbjct: 109 ANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTIS-DISA-LSGLTSLQQLSFG 164
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
NQ++ P L NL+ L L + N +S S++ L +L L ++NQ+S P L
Sbjct: 165 -NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--L 217
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
G L+NL L L N L L +L L L L+ N +S + PLS L L L L
Sbjct: 218 GILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLG 273
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
NQ+S I + L++L L LN NQL P + +L L YL L N + + P
Sbjct: 274 ANQIS--NIS-PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-- 326
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
+ +L KL L NN+ L L ++ L N + P + N+ + +L L
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ ++ + + + + L P S
Sbjct: 383 NDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-53
Identities = 92/333 (27%), Positives = 148/333 (44%), Gaps = 28/333 (8%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L L K + ++ + +L + + R + SI + L L ++ S
Sbjct: 22 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 77
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
NQL+ P L NL+ L + + N ++ P + NL +L L L +NQ++ P L
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LK 131
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
NL+NL L L N++ S S L L L L N ++ + PL NL L L +
Sbjct: 132 NLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDLKPL--ANLTTLERLDISS 186
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
N++S + KL++L L+ NQ+ P LG LT L+ L L+ N+L TL
Sbjct: 187 NKVS---DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTL 239
Query: 315 GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374
+L L L+L+NNQ L L +L+EL L N + P + + +L L L+
Sbjct: 240 ASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 295
Query: 375 HNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407
N + P + L+ + + +N + P
Sbjct: 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-49
Identities = 82/330 (24%), Positives = 145/330 (43%), Gaps = 27/330 (8%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
L + ++++ I F+ L L + +++ ++ +L + L +
Sbjct: 2 PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLS 197
+ L+NL ++ N L+ P + NL L + +++NQ++ P L NL+
Sbjct: 59 --KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 198 NLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL 257
NL L LF N + P L NL L L LS+N +S + LS L +L L +
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS--GLTSLQQLSFGNQVT 168
Query: 258 SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNL 317
+ L++L L ++ N++ L LT LE L + N++ + P LG L
Sbjct: 169 D----LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 318 LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNN 377
L L+L+ NQ + L L L++LDL+ N + P + + L +L L N
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276
Query: 378 FSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407
S + P G+ L+ ++++ N+L P
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-49
Identities = 87/310 (28%), Positives = 134/310 (43%), Gaps = 22/310 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
NL +L LD+S NK+ S LTNL + N +S I P +G L L L L+
Sbjct: 174 ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQIS-DITP-LGILTNLDELSLN 229
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
NQL TL +L+NL L L N +S P + L L L L +NQ+S P++
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA- 284
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
L+ L L L EN L P + NLK L +L L N++S + P+S +L L L+ Y
Sbjct: 285 -GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFY 339
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
+N++S + L+++N+L NQ+ P L +LT + L L+ N+
Sbjct: 340 NNKVS---DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
N+ + + P + +E D++ N+ +
Sbjct: 395 KANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGK 451
Query: 374 SHNNFSGLIP 383
FSG +
Sbjct: 452 GTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-31
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
L +G +L +L+ LDL+ N+++ P S LT L + L N +S +I P + L
Sbjct: 232 QLKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQIS-NISP-LAGLT 287
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L +L+L+ENQL P + NL NL L LY N++S P + +L L L +N++
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
S SL NL+N+ L N + P L NL + LGL+ + N++
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL 282
+ L P I S + N
Sbjct: 400 IPNTVKNVTGALI---APATISDGGSYTEPDITWNLP 433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 9/168 (5%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
NLK+L+ L L N ++ P S +LT L ++ Y N +S + NL + L
Sbjct: 306 SNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVS--DVSSLANLTNINWLSAG 361
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
NQ+S P L NL+ + L L + + + + N+ + + L P ++
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATI 417
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSI 241
+ + + N + + +G T SG + +
Sbjct: 418 SDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 9e-55
Identities = 73/345 (21%), Positives = 127/345 (36%), Gaps = 21/345 (6%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
S +DLS N L +SF N + L + L R + L L +L L+ N +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG-SIPISLGNL 196
P + L++L L L+ IG L +L L+++ N + +P NL
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 197 SNLVVLHLFENSLFGSIPSILGNLKML----LHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+NLV + L N + + L L+ L L +S N + I L L L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTL 211
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL------PRALGSLTEL--EYLDLSTN 304
N S + + L+ L+ L + P + L ++ + L+
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
Query: 305 KLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICN 364
+ L + ++L+ + + ++ K + L + L+ P +
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIK--YLEDVPKHFKWQSLSIIRCQLKQ-FPTL--D 326
Query: 365 MESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ L+ L L+ N S I + LS +D+S N L S
Sbjct: 327 LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCS 369
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-53
Identities = 80/348 (22%), Positives = 121/348 (34%), Gaps = 22/348 (6%)
Query: 75 NLKSLSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRN------SLSASIPPVIGNLKFL 127
L L L N + +I NL L + L +L P ++ L +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 128 Y--HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L+ L+N++ + L G S+ + + + L + QL
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF-KWQSLSIIRCQL 319
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
+L L L L N SI L L +L LS N LS S +L
Sbjct: 320 KQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 246 --NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLS 302
+L L L N + + L L +L + L A SL +L YLD+S
Sbjct: 375 TNSLRHLDLSFNGAII--MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELDLSLNILEGKIPCE 361
L L+ L ++ N F+ L+ LDLS LE
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 362 ICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ L+ LN+SHNN L S + ++ LS +D S+N +
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-50
Identities = 65/340 (19%), Positives = 108/340 (31%), Gaps = 19/340 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS------FGNLTNLAIMYLY--RNSLSASIPPVIGNLKF 126
NL L L + L ++ I + + L
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286
Query: 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLS 186
+ + L+ + + L + L P+ +L L L L+ N+ S
Sbjct: 287 VSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS 341
Query: 187 GSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKM--LLHLGLSTNHLSGVIPLSIGNL 244
I L +L L L N+L S +L L HL LS N ++ + L
Sbjct: 342 --ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398
Query: 245 NNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
L L + L L L YL ++ + LT L L ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 305 KL-GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEIC 363
N++ N L +L+LS Q + + L +L L++S N L
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 364 NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ SL L+ S N L+ +++ N +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-49
Identities = 77/351 (21%), Positives = 126/351 (35%), Gaps = 24/351 (6%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L LS L L+ N + P SF LT+L + L++ IG L L L+++
Sbjct: 77 HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA 136
Query: 134 ENQLSG-SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLK----SLFYLHLSSNQLSGS 188
N + +P NL+NL + L N + + + L+ L +S N +
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-F 195
Query: 189 IPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSI------ 241
I L L L N +I L NL L L L I
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 242 GNLNNLIGLYLYDNQLSVGEI-PIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300
L ++ + ++ L++++ + L G + + + + L
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLS 313
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPC 360
+ +L P +L L L L+ N+ + L LS LDLS N L C
Sbjct: 314 IIRCQL-KQFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 361 --EICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
SL L+LS N ++ + F G+ L +D ++ L+ S
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS 418
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-48
Identities = 63/344 (18%), Positives = 116/344 (33%), Gaps = 26/344 (7%)
Query: 81 TLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSG 139
T KL+ +P + N+ L N L N L LDLS ++
Sbjct: 15 TYQCMDQKLS-KVPDDIPSSTKNI---DLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 140 SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL 199
L +L+ L L GN + P L SL L +L+ +G L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 200 VVLHLFENSLFG-SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL----IGLYLYD 254
L++ N + +P+ NL L+H+ LS N++ + + L + L +
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNKLGNSI--- 310
N + I + + L+ L L GN N+ + L +L L L + +
Sbjct: 191 NPID--FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 311 ---PETLGNLLKLHY--LNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
P + L + L+ V+ L +S + L+ ++ ++
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKH 306
Query: 366 ESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ L++ + L + ++ N+
Sbjct: 307 FKWQSLSIIRCQLKQFP---TLDLPFLKSLTLTMNKGSISFKKV 347
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-47
Identities = 65/312 (20%), Positives = 111/312 (35%), Gaps = 17/312 (5%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L ++S + L+ + + + R L P +L FL L L+
Sbjct: 282 HCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLT 336
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLK--SLFYLHLSSNQLSGSIPI 191
N+ S I L +L+ L L N+LS S +L SL +L LS N +
Sbjct: 337 MNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSA 393
Query: 192 SLGNLSNLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
+ L L L ++L S +L+ LL+L +S + L +L L
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
+ N + ++L +L L+ QL +L L+ L++S N L
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513
Query: 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESL-E 369
L L L+ S N+ + L+ +L+ N + C IC + +
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN----SVAC-ICEHQKFLQ 568
Query: 370 KLNLSHNNFSGL 381
+ +
Sbjct: 569 WVKEQKQFLVNV 580
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-45
Identities = 63/302 (20%), Positives = 109/302 (36%), Gaps = 18/302 (5%)
Query: 115 ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKS 174
S+ P I + + + +LS +P + S+ + L N L N
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 175 LFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234
L +L LS ++ + L +L L L N + P L L +L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 235 GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT 294
+ IG L L L + N + ++P L++L ++ L+ N + L L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 295 EL----EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF-RKGFPVELEKLIQLSELDL 349
E LD+S N + + I + +KLH L L N L+ L L L
Sbjct: 178 ENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 350 SLNILEGKIPCEICNMESLEKL--------NLSHNNFSGLIPSCFEGMHGLSCIDVSYNE 401
L + + EI +E L L++ N F + +S + ++
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 402 LR 403
++
Sbjct: 297 IK 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 55/338 (16%), Positives = 106/338 (31%), Gaps = 30/338 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
+ L + R + N +
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRT 64
Query: 134 ENQLSGSIPPTLGNLS--NLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
L + L + + L L L P L L ++ + + L +P
Sbjct: 65 GRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD 121
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
++ + L L L N L ++P+ + +L L L + +P + +
Sbjct: 122 TMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLAST------- 173
Query: 252 LYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311
+ E L +L L L + +LP ++ +L L+ L + + L +++
Sbjct: 174 ---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALG 222
Query: 312 ETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS-LNILEGKIPCEICNMESLEK 370
+ +L KL L+L + +P L L L + L +P +I + LEK
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK 281
Query: 371 LNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408
L+L +PS + I V + +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 53/255 (20%), Positives = 90/255 (35%), Gaps = 17/255 (6%)
Query: 73 KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132
L+L L P L++L M + L +P + L L L
Sbjct: 77 DATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTL 134
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGN---------LKSLFYLHLSSN 183
+ N L ++P ++ +L+ L L + +P + + L +L L L
Sbjct: 135 ARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 184 QLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGN 243
+ S+P S+ NL NL L + + L ++ + +L L L L P G
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 244 LNNLIGLYLYD-NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302
L L L D + L +P++I +L+ L L L G LP + L + +
Sbjct: 252 RAPLKRLILKDCSNLL--TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 303 TNKLGNSIPETLGNL 317
+
Sbjct: 310 PHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-50
Identities = 60/322 (18%), Positives = 108/322 (33%), Gaps = 30/322 (9%)
Query: 91 GSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSN 150
GS + + +Y ++ V+ + Y+ D + + N +N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 151 LAVLHLYGNSLSGSIPSIIGNLKS--LFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENS 208
+ G +L + ++ + L L S L P LS+L + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 209 LFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD-NQLSVGEIPIEIG 267
L +P + L L L+ N L +P SI +LN L L + +L+ E+P +
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT--ELPEPLA 171
Query: 268 KLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSN 327
L L+ L L + S+P ++ NL L L + N
Sbjct: 172 STD---------------ASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRN 215
Query: 328 NQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFE 387
+ + L +L ELDL P L++L L + +P
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274
Query: 388 GMHGLSCIDVSYNELRGPIPNS 409
+ L +D+ +P+
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 7e-47
Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 19/233 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L L + + L +P + L + L RN L ++P I +L L L +
Sbjct: 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158
Query: 134 ENQLSGSIPPTLGN---------LSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQ 184
+P L + L NL L L + S+P+ I NL++L L + ++
Sbjct: 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 185 LSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS-TNHLSGVIPLSIGN 243
LS ++ ++ +L L L L + + P I G L L L ++L +PL I
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHR 275
Query: 244 LNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN---QLYGNLPRALGSL 293
L L L L ++ +P I +L + +++ + QL + P A +
Sbjct: 276 LTQLEKLDLRGCV-NLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 36/155 (23%), Positives = 57/155 (36%), Gaps = 2/155 (1%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
+ G L +L +L L + S+P S NL NL + + + LS ++ P I +L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L LDL + PP G + L L L S ++P I L L L L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNL 220
+P + L ++ + +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 28/274 (10%)
Query: 523 IGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQP----EFVNEIKTLTELRHRSIV 577
IG GG G V+K +L ++A+K EF E+ ++ L H +IV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
K YG +P +V E++ G L L + W+V++ ++ +A + YM +
Sbjct: 87 KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 638 FPPIVHRDISSKNVLL-----CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV 692
PPIVHRD+ S N+ L A+V+DFG+++ + + L+G F ++APE +
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQWMAPETI 198
Query: 693 YT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750
TEK D YSF ++ ++ G+ P D S N R PT P+
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----R-PTIPE 253
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ L +++E LC + P+ RP + + L
Sbjct: 254 DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 37/291 (12%)
Query: 505 ILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQP-EFVN 563
I + E+ ++ IGIGG G VY+A G+ +AVK ++
Sbjct: 4 IDFAEL-------TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 564 EIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
E K L+H +I+ G C N LV E+ G L +LS + + +N
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWA 111
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR--------VSDFGIAKFLKPDSS 675
+A ++Y+H + PI+HRD+ S N+L+ E ++DFG+A+ +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISS--ISSSSSNR 733
G + ++APE++ ++ DV+S+GVL E++ G+ P I ++ +
Sbjct: 172 --MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
Query: 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ LP P + ++E C N P SRP + L
Sbjct: 230 KL--------ALPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 56/290 (19%), Positives = 108/290 (37%), Gaps = 15/290 (5%)
Query: 92 SIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNL 151
+I N I + +SL ++ + + + LDLS N LS L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 152 AVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFG 211
+L+L N L + +L +L L L++N + L ++ LH N++
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 212 SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS 271
+ + ++ L+ N ++ + L G + + L L N++ +
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 272 LNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR 331
L +L L N +Y ++ +L+ LDLS+NKL + + + +++L NN+
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 332 KGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGL 381
L L DL N ++ ++ L
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKL 275
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-51
Identities = 59/303 (19%), Positives = 106/303 (34%), Gaps = 17/303 (5%)
Query: 72 LKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLD 131
+K N ++ + L ++ + N+ + L N LS + L L+
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 132 LSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
LS N L L +LS L L L N + + S+ LH ++N +S +
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR---V 114
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV-IPLSIGNLNNLIGL 250
S ++L N + G + +L L N + V + + L L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
L N + ++ ++ + L L L+ N+L + S + ++ L NKL I
Sbjct: 175 NLQYNFIY--DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL-VLI 229
Query: 311 PETLGNLLKLHYLNLSNNQFRKG-FPVELEKLIQLSELDLSLNILEGKIPCEICNMESLE 369
+ L L + +L N F G K ++ + E C + +L
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 370 KLN 372
Sbjct: 290 HYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 53/265 (20%), Positives = 99/265 (37%), Gaps = 16/265 (6%)
Query: 140 SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL 199
+I N + + + +SL ++ S+ + ++ L LS N LS L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 200 VVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSV 259
+L+L N L + +L L L L+ N++ + ++ L+ +N +S
Sbjct: 61 ELLNLSSNVL-YETLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 260 GEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN-SIPETLGNLL 318
+ + + L N++ G + ++YLDL N++ + E +
Sbjct: 114 ----VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 319 KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNF 378
L +LNL N +L LDLS N L + E + + ++L +N
Sbjct: 170 TLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 379 SGLIPSCFEGMHGLSCIDVSYNELR 403
I L D+ N
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 25/170 (14%), Positives = 52/170 (30%), Gaps = 12/170 (7%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
++ L + +L L+L N + + L + L N L+ + P +
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLS-GSIPSIIGNLKSLFYLHLSSNQ 184
+ + L N+L I L NL L GN G++ + + + + +
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 185 LSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234
+ + L + +P + L +H
Sbjct: 274 ---KLTGQNEEECTVPTLGHYGAYCCEDLP----APFADRLIALGHHHHH 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-51
Identities = 73/343 (21%), Positives = 123/343 (35%), Gaps = 23/343 (6%)
Query: 63 ISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVI- 121
+ ++ L + + + + + + ++ L + I
Sbjct: 31 QTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAF 89
Query: 122 GNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180
+ L + N + +PP N+ L VL L N LS I N L L +
Sbjct: 90 AYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148
Query: 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLS 240
S+N L + ++L L L N L + L + L H +S N LS +
Sbjct: 149 SNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLLS-----T 200
Query: 241 IGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300
+ + L N ++V + L L L N L + L + L +D
Sbjct: 201 LAIPIAVEELDASHNSINV----VRGPVNVELTILKLQHNNL-TDTA-WLLNYPGLVEVD 254
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPC 360
LS N+L + + +L L +SNN+ + + + L LDLS N L +
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 312
Query: 361 EICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ LE L L HN+ L S H L + +S+N+
Sbjct: 313 NQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-41
Identities = 65/314 (20%), Positives = 116/314 (36%), Gaps = 19/314 (6%)
Query: 92 SIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPP-TLGNLSN 150
I + +++ + L + + + +P L +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 151 LAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLF 210
+ +L+L + ++ L++ N + P N+ L VL L N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 211 GSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLS 270
I N L L +S N+L + + +L L L N+L+ +++ +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH----VDLSLIP 186
Query: 271 SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF 330
SL + ++ N L L +E LD S N + N + ++L L L +N
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQHNNL 238
Query: 331 RKGFPVELEKLIQLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGM 389
L L E+DLS N LE KI M+ LE+L +S+N + + +
Sbjct: 239 TD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 294
Query: 390 HGLSCIDVSYNELR 403
L +D+S+N L
Sbjct: 295 PTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 57/295 (19%), Positives = 113/295 (38%), Gaps = 16/295 (5%)
Query: 110 RNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSII 169
R I + Y + + L+N ++ +++ +++
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 170 GNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS 229
+ + + L+L+ Q+ + + L++ N++ P + N+ +L L L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 230 TNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPR 288
N LS + N L L + +N L I + +SL L L+ N+L ++
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE--RIEDDTFQATTSLQNLQLSSNRL-THVD- 181
Query: 289 ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELD 348
L + L + ++S N L TL + + L+ S+N V ++L+ L
Sbjct: 182 -LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV---VRGPVNVELTILK 232
Query: 349 LSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L N L + N L +++LS+N ++ F M L + +S N L
Sbjct: 233 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 61/256 (23%), Positives = 95/256 (37%), Gaps = 20/256 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
N L+TL +S N L +F T+L + L N L+ + + L+H ++S
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVS 194
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N LS TL + L NS++ + L L L N L+ L
Sbjct: 195 YNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTA-WL 244
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
N LV + L N L + ++ L L +S N L + L + L L L
Sbjct: 245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL-GNSIPE 312
N L + + L L L+ N + L L + L+ L LS N NS+
Sbjct: 304 HNHLL--HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNSLRA 358
Query: 313 TLGNLLKLHYLNLSNN 328
N+ + + +
Sbjct: 359 LFRNVARPAVDDADQH 374
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-50
Identities = 63/365 (17%), Positives = 126/365 (34%), Gaps = 43/365 (11%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
+ ++ LDLS N L+ T L ++ L N L + +L L LDL+
Sbjct: 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLN 88
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N + L ++ LH N++S + + ++L++N+++ +
Sbjct: 89 NNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDE 140
Query: 194 GNLSNLVVLHLFENSLFG-SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
G S + L L N + + + + L HL L N + V L L L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV--VFAKLKTLDL 198
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL-GNSIP 311
N+L+ + E + + ++ L N+L + +AL LE+ DL N ++
Sbjct: 199 SSNKLA--FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 312 ETLGNLLKLHYL----------------------NLSNNQFRKGFPVELEKLIQLSELDL 349
+ ++ + + ++LI L +
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEH 315
Query: 350 SLNILEG----KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGP 405
+L +G ++ CE N +++ + +I ++ L
Sbjct: 316 ALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQ 375
Query: 406 IPNSR 410
+ N R
Sbjct: 376 VSNGR 380
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-50
Identities = 59/312 (18%), Positives = 112/312 (35%), Gaps = 15/312 (4%)
Query: 92 SIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNL 151
+I N I + +SL ++ + + + LDLS N LS L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 152 AVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFG 211
+L+L N L ++ + +L +L L L++N + L ++ LH N++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 212 SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS 271
S K ++ L+ N ++ + L G + + L L N++ +
Sbjct: 114 VSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 272 LNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR 331
L +L L N +Y ++ +L+ LDLS+NKL + + + +++L NN+
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 332 KGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHG 391
L L DL N ++ ++ L E
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 392 LSCIDVSYNELR 403
+
Sbjct: 286 PTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-49
Identities = 58/334 (17%), Positives = 111/334 (33%), Gaps = 17/334 (5%)
Query: 72 LKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLD 131
+K N ++ + L ++ + N+ + L N LS + L L+
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 132 LSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
LS N L L +LS L L L N + + S+ LH ++N +S +
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR---V 114
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV-IPLSIGNLNNLIGL 250
S ++L N + G + +L L N + V + + L L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
L N + ++ ++ + L L L+ N+L + S + ++ L NKL I
Sbjct: 175 NLQYNFIY--DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL-VLI 229
Query: 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEK 370
+ L L + +L N F G + ++ ++
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 371 LNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRG 404
+ L + + L + + +G
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-43
Identities = 54/350 (15%), Positives = 108/350 (30%), Gaps = 20/350 (5%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
L +L +L TLDL+ N + ++ ++ N++S + +
Sbjct: 69 VLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQ 120
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSG-SIPSIIGNLKSLFYLHLSSNQ 184
++ L+ N+++ G S + L L N + + + + +L +L+L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 185 LSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNL 244
+ + + + L L L N L + + + + L N L +I ++
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 245 NNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQ-LYGNLPRALGSLTELEYLDLST 303
NL L N G + K + + + L G T Y
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 304 NKLGNSIPETLGNL--LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCE 361
L + L L + L+ ++ + E E + E+D I
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQV 355
Query: 362 ICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCI---DVSYNELRGPIPN 408
++ L + + L V EL+
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 38/313 (12%), Positives = 88/313 (28%), Gaps = 19/313 (6%)
Query: 74 GNLKSLSTLDLSKNKLNG-SIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132
G + LDL N+++ + + L + L N + + + L LDL
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDL 198
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLS-GSIPI 191
S N+L+ + P + + + + L N L I + ++L + L N G++
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
+ + + ++ + L + LI L
Sbjct: 257 FFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE---DLPAPFADRLIALK 311
Query: 252 LYDNQL------SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
++ L + E + + Q + + L+
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN-ILEGKIPCEICN 364
L + +L + E+ L L + E + +
Sbjct: 372 LDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQ 430
Query: 365 MESLEKLNLSHNN 377
++ ++ +
Sbjct: 431 NNAIRDWDMYQHK 443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 34/296 (11%), Positives = 77/296 (26%), Gaps = 16/296 (5%)
Query: 67 LSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKF 126
++ L + +L L+L N + + L + L N L+ + P +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLS-GSIPSIIGNLKSLFYLHLSSNQL 185
+ + L N+L I L NL L GN G++ + + ++ +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTV 272
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG----VIPLSI 241
+ + + H L L + G +
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332
Query: 242 GNLNNLIGLYLYDNQLSVGEIPIEIGK-LSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300
N + Q + ++ + L L + + EL+
Sbjct: 333 ENQARQREIDALKEQYR--TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFR-KGFPVELEKLIQLSELDLSLNILE 355
+ L L ++ + + + + D+ +
Sbjct: 391 QQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 18/214 (8%), Positives = 46/214 (21%), Gaps = 7/214 (3%)
Query: 64 SINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGN 123
++ T + + L L S S +
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 124 LKF----LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH 179
+ +D + Q I L +L + + L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 180 LSSNQLSGSIPISLGNLSNLVVL-HLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP 238
+ + + S L +L + + + + + + + +
Sbjct: 391 QQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQL-A 448
Query: 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSL 272
L L G + + + + +L
Sbjct: 449 EENARLKKLNGEADLALASANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 10/67 (14%), Positives = 28/67 (41%)
Query: 341 LIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
+ ++ + L+ + + ++++L+LS N S + + L +++S N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 401 ELRGPIP 407
L +
Sbjct: 69 VLYETLD 75
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 9e-50
Identities = 73/327 (22%), Positives = 133/327 (40%), Gaps = 48/327 (14%)
Query: 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135
+ L++ ++ L ++P ++ + + N+L+ S+P + L+ L++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSGN 91
Query: 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
QL+ S+P L L++ L P++ L L + NQL+ S+P+
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLPVLPPG 142
Query: 196 LSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDN 255
L L + +N L S+P++ L L N L+ +P+ L L + DN
Sbjct: 143 LQE---LSVSDNQL-ASLPALPSELC---KLWAYNNQLT-SLPMLPSGLQE---LSVSDN 191
Query: 256 QLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLG 315
QL+ +P +L L N+L +LP L E L +S N+L S+P
Sbjct: 192 QLA--SLPTLPSELYKLWAY---NNRLT-SLPALPSGLKE---LIVSGNRL-TSLPVLPS 241
Query: 316 NLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSH 375
L L +S N+ P+ L L + N L ++P + ++ S +NL
Sbjct: 242 E---LKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 376 NNFSGLIPSCFEGMHGLSCIDVSYNEL 402
N S + + ++ +
Sbjct: 294 NPLSERT---LQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-42
Identities = 73/316 (23%), Positives = 123/316 (38%), Gaps = 43/316 (13%)
Query: 72 LKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLD 131
L L TL++S N+L S+P L L+I L P + L L
Sbjct: 76 LPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLC---KLW 127
Query: 132 LSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
+ NQL+ S+P L L + N L+ S+P++ L L +NQL+ S+P+
Sbjct: 128 IFGNQLT-SLPVLPPGLQE---LSVSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPM 178
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
L L + +N L S+P++ L L N L+ +P L L
Sbjct: 179 LPS---GLQELSVSDNQL-ASLPTLPSELY---KLWAYNNRLT-SLPALPSGLKE---LI 227
Query: 252 LYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311
+ N+L+ +P+ +L L ++GN+L +LP L L + N+L +P
Sbjct: 228 VSGNRLT--SLPVLPSELKELM---VSGNRL-TSLPMLPSGLLS---LSVYRNQL-TRLP 277
Query: 312 ETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELD----LSLNILEGKIPCEICNMES 367
E+L +L +NL N + ++ + I + + ++ P E +
Sbjct: 278 ESLIHLSSETTVNLEGNPLSE-RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL 336
Query: 368 LEKLNLSHNNFSGLIP 383
L P
Sbjct: 337 AAADWLVPAREGEPAP 352
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-39
Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 39/304 (12%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L LS L P L L +++ N L+ S+P + L+ L +S
Sbjct: 101 PGLLELSIFSNPLTHL----PALPSGLCKL---WIFGNQLT-SLPVLPPGLQ---ELSVS 149
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
+NQL+ S+P L L Y N L+ S+P + L+ L +S NQL+ S+P
Sbjct: 150 DNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLP 200
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
L L + N L S+P++ LK L +S N L+ +P+ L L +
Sbjct: 201 SELYKLWAYN---NRL-TSLPALPSGLK---ELIVSGNRLTS-LPVLPSELKE---LMVS 249
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
N+L+ +P+ L SL+ + NQL LP +L L+ ++L N L +
Sbjct: 250 GNRLT--SLPMLPSGLLSLS---VYRNQL-TRLPESLIHLSSETTVNLEGNPL-SERTLQ 302
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
+ + + L + ++ + E +
Sbjct: 303 ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE-GEPAPADRWHMFGQ 361
Query: 374 SHNN 377
N
Sbjct: 362 EDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 66/287 (22%), Positives = 105/287 (36%), Gaps = 32/287 (11%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
+ L L L + N+L S+P L L + N L+ S+P + L
Sbjct: 110 SNPLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALPSELC 164
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L NQL+ S+P L L + N L+ S+P++ L L +N+L
Sbjct: 165 ---KLWAYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSELYK---LWAYNNRL 213
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
+ S+P L L + N L S+P + LK L +S N L+ +P+ L
Sbjct: 214 T-SLPALPSGLK---ELIVSGNRL-TSLPVLPSELK---ELMVSGNRLTS-LPMLPSGLL 264
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
+ L +Y NQL+ +P + LSS + L GN L +AL +T +
Sbjct: 265 S---LSVYRNQLT--RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352
+ LH + + E + N
Sbjct: 320 FDMAGASAPRETRALH--LAAADWLVPAREGEPAPADRWHMFGQEDN 364
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 70/320 (21%), Positives = 116/320 (36%), Gaps = 53/320 (16%)
Query: 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNE-- 564
E + + IG G G+VYK L +AVK F + F+NE
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINEKN 57
Query: 565 IKTLTELRHRSIVKFYGFCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVR 619
I + + H +I +F LV EY GSL LS +W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSS 113
Query: 620 MNVIRSVANALSYMHHD------CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL--- 670
+ SV L+Y+H + P I HRD++S+NVL+ D +SDFG++ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 671 -----KPDSSNCTELVGTFGYIAPE-------LVYTMKVTEKCDVYSFGVLALEVIKGDH 718
+ + VGT Y+APE L ++ D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 719 PR--------------DFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAF 764
+ + + + + E P+ P + + S+ E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 765 LCLNESPESRPPMHTVCQLL 784
C ++ E+R + +
Sbjct: 294 DCWDQDAEARLTAQXAEERM 313
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 50/269 (18%), Positives = 106/269 (39%), Gaps = 28/269 (10%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+ G ++K + G + VK + +F E L H +++ G
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR-DFNEECPRLRIFSHPNVLPVLGA 75
Query: 583 CSHP--RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
C P + L+ ++ GSL +L ++G + + + +A ++++H P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV---YTMKV 697
I ++S++V++ D AR+S + + + ++APE +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTN 188
Query: 698 TEKCDVYSFGVLALEVIKGDHPRDFISS--ISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
D++SF VL E++ + P +S+ I + + R PP +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL--------RPTIPP-GISPH 239
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ +++ +C+NE P RP + +L
Sbjct: 240 VSKLMK---ICMNEDPAKRPKFDMIVPIL 265
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-47
Identities = 73/343 (21%), Positives = 122/343 (35%), Gaps = 23/343 (6%)
Query: 63 ISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVI- 121
+ ++ L + + + + + + ++ L + I
Sbjct: 37 QTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAF 95
Query: 122 GNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180
+ L + N + +PP N+ L VL L N LS I N L L +
Sbjct: 96 AYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154
Query: 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLS 240
S+N L + ++L L L N L + L + L H +S N LS +
Sbjct: 155 SNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLLS-----T 206
Query: 241 IGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300
+ + L N ++V + L L L N L L + L +D
Sbjct: 207 LAIPIAVEELDASHNSINV----VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVD 260
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPC 360
LS N+L + + +L L +SNN+ + + + L LDLS N L +
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 318
Query: 361 EICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ LE L L HN+ L S H L + +S+N+
Sbjct: 319 NQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-41
Identities = 81/357 (22%), Positives = 127/357 (35%), Gaps = 31/357 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVI-GNLKFLYHLDL 132
++ L + N + P F N+ L ++ L RN LS S+P I N L L +
Sbjct: 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 154
Query: 133 SENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
S N L I T ++L L L N L+ + + + SLF+ ++S N LS
Sbjct: 155 SNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS----- 205
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
+L + L NS+ + L L L N+L+ L N L+ +
Sbjct: 206 TLAIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQHNNLTDTAWLL--NYPGLVEVD 260
Query: 252 LYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
L N+L +I K+ L L ++ N+L L + L+ LDLS N L +
Sbjct: 261 LSYNELE--KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHL-LHV 316
Query: 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEK 370
+L L L +N ++L L L LS N C
Sbjct: 317 ERNQPQFDRLENLYLDHNSIVT---LKLSTHHTLKNLTLSHN----DWDC-NSLRALFRN 368
Query: 371 LNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLC 427
+ + + + C S I +E +Q +G C
Sbjct: 369 VARPAVDDADQHCKIDYQLEHGLCCKESDKPYL-DRLLQYIALTSVVEKVQRAQGRC 424
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-39
Identities = 66/327 (20%), Positives = 119/327 (36%), Gaps = 24/327 (7%)
Query: 84 LSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLY-----HLDLSENQLS 138
N + + Y + V + + + + +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 139 GSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLS 197
+P L + + +L+L + ++ L++ N + P N+
Sbjct: 65 -KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 198 NLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256
L VL L N L S+P I N L L +S N+L + + +L L L N+
Sbjct: 124 LLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 257 LSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGN 316
L+ +++ + SL + ++ N L L +E LD S N + N +
Sbjct: 183 LTH----VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI-NVVRG--PV 230
Query: 317 LLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHN 376
++L L L +N L L E+DLS N LE + M+ LE+L +S+N
Sbjct: 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 288
Query: 377 NFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ + + L +D+S+N L
Sbjct: 289 RLVA-LNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 25/137 (18%), Positives = 49/137 (35%), Gaps = 11/137 (8%)
Query: 277 LNGNQLYGNLPRALGS-------LTELEYLDLSTNKLGNSIPETL--GNLLKLHYLNLSN 327
+ G Q Y PR + + D+ + + L + N
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 328 NQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCF 386
+ RK L+ Q+ L+L+ +E +I +++KL + N L P F
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 119
Query: 387 EGMHGLSCIDVSYNELR 403
+ + L+ + + N+L
Sbjct: 120 QNVPLLTVLVLERNDLS 136
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 32/277 (11%)
Query: 523 IGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G K +GE++ +K+ E + F+ E+K + L H +++KF G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQR-TFLKEVKVMRCLEHPNVLKFIG 74
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
+ + EY++ G+L I+ + ++ W+ R++ + +A+ ++Y+H I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFL--------------KPDSSNCTELVGTFGYI 687
+HRD++S N L+ + V+DFG+A+ + KPD +VG ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 688 APELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747
APE++ EK DV+SFG++ E+I + + LN
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LPRTMDFGLNVRGFLDRY- 243
Query: 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P N I C + PE RP + L
Sbjct: 244 CPPNCPPSFFPI---TVRCCDLDPEKRPSFVKLEHWL 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 52/299 (17%), Positives = 109/299 (36%), Gaps = 50/299 (16%)
Query: 505 ILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNE 564
I +E++ ++ IG G G VY + GE+ A++ E + F E
Sbjct: 30 IPFEQL-------EIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLK-AFKRE 79
Query: 565 IKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR 624
+ + RH ++V F G C P + ++ + +L +++ + + + +
Sbjct: 80 VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQ 137
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-----FLKPDSSNCTE 679
+ + Y+H I+H+D+ SKNV + + ++DFG+
Sbjct: 138 EIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 680 LVGTFGYIAPELVYTMKV---------TEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730
G ++APE++ + ++ DV++ G + E+ + P F
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--F-------- 243
Query: 731 SNRNISLNEIL-----DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ I+ + + E+ I+ C E RP + +L
Sbjct: 244 --KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDML 297
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-45
Identities = 65/336 (19%), Positives = 124/336 (36%), Gaps = 14/336 (4%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSA-SIPPVIGNLKFLYHLDLS 133
+L SL LDLS N L+ FG L++L + L N + + NL L L +
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS 192
+ I L++L L + SL + +++ + +L L ++ + + I
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 193 LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
LS++ L L + +L S L ++ + S + S L L+ L
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE 312
+++ + L+ L + + + L + + L + L +
Sbjct: 252 ELSEVE-----FDDCTLNGLGDFNPSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLST 304
Query: 313 TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCE---ICNMESLE 369
L K+ + + N++ + L L LDLS N++ + SL+
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 370 KLNLSHNNFSGL--IPSCFEGMHGLSCIDVSYNELR 403
L LS N+ + + L+ +D+S N
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-43
Identities = 81/355 (22%), Positives = 144/355 (40%), Gaps = 26/355 (7%)
Query: 73 KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132
G ++ +LDLS NK+ NL ++ L + ++ +L L HLDL
Sbjct: 22 SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81
Query: 133 SENQLSGSIPP-TLGNLSNLAVLHLYGNSLSG-SIPSIIGNLKSLFYLHLSSNQLSGSIP 190
S+N LS S+ G LS+L L+L GN + S+ NL +L L + + + I
Sbjct: 82 SDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 191 -ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIG 249
I L++L L + SL L +++ + HL L + + ++ + L+++
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 250 LYLYDNQLSVGEIPIEIGK--LSSLNYLVLNGNQLYGN-------LPRALGSLTELEYLD 300
L L D L+ + S + L G+ L L R + L+E+E+ D
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 301 LSTNKLGNSIPETLG--------NLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352
+ N LG+ P + + L++ L ++ + + +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 353 ILEGKIPCEIC-NMESLEKLNLSHNNFSGLI---PSCFEGMHGLSCIDVSYNELR 403
+ +PC +++SLE L+LS N +C L + +S N LR
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 71/365 (19%), Positives = 136/365 (37%), Gaps = 42/365 (11%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L SL+ L++ L S ++ ++ + L+ + + + L + +L+L +
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 135 NQLSG---SIPPTLGNLSNLAVLHLYGNSLS----GSIPSIIGNLKSLFYLHLSSNQLSG 187
L+ S P S + L G+ L+ + ++ + L + L+G
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 188 SIPISLG-----------NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV 236
+ + LH+ + LF + ++ L+ + + + + + V
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 237 IPLSIGNLNNLIGLYLYDNQLS--VGEIPIEIGKLSSLNYLVLNGNQLY--GNLPRALGS 292
+L +L L L +N + + G SL LVL+ N L L +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 293 LTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR---KGFPVELEKLI------- 342
L L LD+S N + +P++ K+ +LNLS+ R P LE L
Sbjct: 386 LKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD 444
Query: 343 -------QLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCI 395
+L EL +S N L+ +P + L + +S N + F+ + L I
Sbjct: 445 SFSLFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKI 502
Query: 396 DVSYN 400
+ N
Sbjct: 503 WLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-34
Identities = 60/316 (18%), Positives = 114/316 (36%), Gaps = 24/316 (7%)
Query: 108 LYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS 167
S + SIP + + LDLS N+++ L +NL VL L + ++
Sbjct: 12 GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68
Query: 168 IIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFG-SIPSILGNLKMLLHL 226
+L SL +L LS N LS G LS+L L+L N + S+ NL L L
Sbjct: 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128
Query: 227 GLS-TNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGN 285
+ S + + L +L L + L + + + +++L L+ ++
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ-SQSLKSIRDIHHLTLHLSESAFL 187
Query: 286 LPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRK----------GFP 335
L L+ + YL+L L L + +
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 336 VELEKLIQLSELDLSLNILEGKIPCEICNME--------SLEKLNLSHNNFSGLIPSCFE 387
+ +L ++ D +LN L P E + ++ +L++ + + +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 388 GMHGLSCIDVSYNELR 403
+ + I V +++
Sbjct: 308 LLEKVKRITVENSKVF 323
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 57/346 (16%), Positives = 116/346 (33%), Gaps = 46/346 (13%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
+++ + L L ++ + L+++ + L +L+ + + +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228
Query: 134 ENQLSG----------SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLK--------SL 175
+ S + + LS + N L PS + ++
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 176 FYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG 235
LH+ L + L + + + + +F S +LK L L LS N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 236 VI---PLSIGNLNNLIGLYLYDNQL-SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALG 291
G +L L L N L S+ + + L +L L ++ N +P +
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQ 407
Query: 292 SLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKL---------- 341
++ +L+LS+ + + L L++SNN F + L +L
Sbjct: 408 WPEKMRFLNLSSTGI-RVVKT--CIPQTLEVLDVSNNNLDS-FSLFLPRLQELYISRNKL 463
Query: 342 ---------IQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNF 378
L + +S N L+ + SL+K+ L N +
Sbjct: 464 KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 47/249 (18%), Positives = 81/249 (32%), Gaps = 40/249 (16%)
Query: 63 ISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP--- 119
+ + L+ + + + +K+ +L +L + L N +
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 120 VIGNLKFLYHLDLSENQLS--GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY 177
G L L LS+N L L L NL L + N+ +P + + +
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237
L+LSS + + L VL + N+L S L L+
Sbjct: 415 LNLSSTGIRV---VKTCIPQTLEVLDVSNNNL-DSFSLFLPRLQE--------------- 455
Query: 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELE 297
LY+ N+L +P + L + ++ NQL LT L+
Sbjct: 456 ------------LYISRNKLK--TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500
Query: 298 YLDLSTNKL 306
+ L TN
Sbjct: 501 KIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 28/96 (29%), Positives = 42/96 (43%), Gaps = 8/96 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
++L LD+S N L+ S L L Y+ RN L ++P L + +S
Sbjct: 428 CIPQTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNKLK-TLPD-ASLFPVLLVMKIS 481
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSI 168
NQL S+P L++L + L+ N S P I
Sbjct: 482 RNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-45
Identities = 78/354 (22%), Positives = 127/354 (35%), Gaps = 27/354 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
L + L LS N + SF L L ++ L +I NL L LDL
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSI--PSIIGNLKSLFYLHLSSNQLSG-SI 189
+++ + P L +L L LY LS ++ NLK+L L LS NQ+ +
Sbjct: 82 SSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 190 PISLGNLSNLVVLHLFENSLFGSIPSILGNLKM--LLHLGLSTNHLSGVIPLSIGNLNN- 246
S G L++L + N +F L L+ L L+ N L + + G N
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 247 -----LIGLYLYDNQLSV-----------GEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL 290
L L + N +V + + + +
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260
Query: 291 GSL--TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELD 348
L + + +LDLS + + L L LNL+ N+ K L L L+
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLN 320
Query: 349 LSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
LS N+L + + ++L N+ + + F+ + L +D+ N L
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-42
Identities = 78/336 (23%), Positives = 140/336 (41%), Gaps = 19/336 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP--VIGNLKFLYHLDL 132
NL +L LDL +K+ P +F L +L + LY LS ++ NLK L LDL
Sbjct: 71 NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130
Query: 133 SENQLSG-SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNL--KSLFYLHLSSNQLSGSI 189
S+NQ+ + P+ G L++L + N + + L K+L + L++N L +
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRV 190
Query: 190 PISLGNLSN-LVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLI 248
+ G N + L + GN + G +N +S S+ ++++
Sbjct: 191 SVDWGKCMNPFRNMVLEILDV-------SGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 249 GLYLYDNQL-SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLG 307
G + + + SS+ +L L+ ++ R +L +L+ L+L+ NK+
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
Query: 308 NSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMES 367
E L L LNLS N + + L +++ +DL N + +E
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363
Query: 368 LEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L+ L+L N + + + I +S N+L
Sbjct: 364 LQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-41
Identities = 80/373 (21%), Positives = 143/373 (38%), Gaps = 25/373 (6%)
Query: 65 INLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNL 124
+ L + + GN ++ N ++ S FS ++ +++ L
Sbjct: 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263
Query: 125 KFLY--HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182
HLDLS + L +L VL+L N ++ L +L L+LS
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
N L + L + + L +N + L+ L L L N L+ +I
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIH 378
Query: 243 NLNNLIGLYLYDNQLSVGEIPIEIGKLS-SLNYLVLNGNQLYGNLPRA-LGSLTELEYLD 300
+ ++ ++L N+L + K++ + N + L+ N+L L + L+ L
Sbjct: 379 FIPSIPDIFLSGNKLV------TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILI 432
Query: 301 LSTNKLGN-SIPETLGNLLKLHYLNLSNNQFRKGFPVELEK-----LIQLSELDLSLNIL 354
L+ N+ + S +T L L L N + + EL L L L L+ N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 355 EGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQY 414
P ++ +L L+L+ N + L + L +D+S N+L PN +F
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN--LEILDISRNQLL--APNPDVFVS 548
Query: 415 DPMEALQGNKGLC 427
+ + NK +C
Sbjct: 549 LSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-38
Identities = 70/351 (19%), Positives = 114/351 (32%), Gaps = 29/351 (8%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
L +P L + L N + L+ L L+L
Sbjct: 5 DGRIAFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 138 SGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI--PISLG 194
+I NL NL +L L + + P L LF L L LS ++
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
Query: 195 NLSNLVVLHLFENSLFG-SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNL--NNLIGLY 251
NL L L L +N + + G L L + S+N + V + L L
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180
Query: 252 LYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL-----------------PRALGSLT 294
L N L ++ +VL + GN +L
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
Query: 295 ELEYLDLSTNKLGNSIPETLGNL--LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352
+ + + + T L + +L+LS+ E L L L+L+ N
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 353 ILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ +++L+ LNLS+N L S F G+ ++ ID+ N +
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-37
Identities = 80/363 (22%), Positives = 132/363 (36%), Gaps = 39/363 (10%)
Query: 74 GNLKSLSTLDLSKNKLNG-SIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKF--LYHL 130
NLK+L+ LDLSKN++ + SFG L +L + N + + L+ L
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
Query: 131 DLSENQLSGSIPPTLGNLSN------LAVLHLYGNSLSGSIPSIIGN------------L 172
L+ N L + G N L +L + GN + I N
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239
Query: 173 KSLFYLHLSSNQLSGSIPISLGNL--SNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230
+ + + + L S++ L L +F + LK L L L+
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRA 289
N ++ + + L+NL L L N L E+ L + Y+ L N + +
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLG--ELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 290 LGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKL-IQLSELD 348
L +L+ LDL N L T+ + + + LS N+ L K+ + + +
Sbjct: 358 FKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-----TLPKINLTANLIH 407
Query: 349 LSLNILEG-KIPCEICNMESLEKLNLSHNNFSGLIPSC-FEGMHGLSCIDVSYNELRGPI 406
LS N LE I + + L+ L L+ N FS L + + N L+
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 407 PNS 409
Sbjct: 468 ETE 470
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 6e-19
Identities = 39/174 (22%), Positives = 58/174 (33%), Gaps = 9/174 (5%)
Query: 243 NLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNL-PRALGSLTELEYLD 300
LN L L N + + L L L L + A +L L LD
Sbjct: 22 VLNTTERLLLSFNYIR--TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF--PVELEKLIQLSELDLSLN-ILEGK 357
L ++K+ P+ L L L L L L+ LDLS N I
Sbjct: 80 LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 358 IPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHG--LSCIDVSYNELRGPIPNS 409
+ + SL+ ++ S N + E + G LS ++ N L +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 26/118 (22%), Positives = 40/118 (33%), Gaps = 5/118 (4%)
Query: 297 EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356
L +P+ L L LS N R L QL L+L
Sbjct: 7 RIAFYRFCNL-TQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 357 KIPCEIC-NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQ 413
I E N+ +L L+L + L P F+G+ L + + + L + F+
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 67/294 (22%), Positives = 122/294 (41%), Gaps = 42/294 (14%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNE--IKTLTELRHRSIVKF 579
C+G G G V++ GE +AVK F S + + E + LRH +I+ F
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGF 67
Query: 580 YGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
R+S +L+ Y E GSL L + + ++ S+A+ L+++H
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHI 123
Query: 636 DCF-----PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS----NCTELVGTFGY 686
+ F P I HRD+ SKN+L+ + + ++D G+A ++ VGT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 687 IAPEL------VYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS---SSSSNRNISL 737
+APE+ V ++ D+++FG++ EV + + + S
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 738 NEILDP------RLPTPPQNVQDE-LISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ R P + D L S+ ++ C ++P +R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-45
Identities = 85/360 (23%), Positives = 132/360 (36%), Gaps = 38/360 (10%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
S LDLS N L +SF + L ++ L R + +L L L L+ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL-SGSIPISLGNL 196
LS+L L +L+ IG+LK+L L+++ N + S +P NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 197 SNLVVLHLFENSLFGSIPSILGNLKML----LHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+NL L L N + + L L + L L LS N ++ I L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVL------NGNQLYGNLPRALGSLTELEYLDLSTNKL 306
+N S+ + I L+ L L N L AL L L + L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 307 ---GNSIPETLGNLLKLHYLNLSNNQFRK----GFPVELEKL---------------IQL 344
+ I + L + +L + + + + L L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 345 SELDLSLNILEGKIPCEICNMESLEKLNLSHN--NFSGLIPSCFEGMHGLSCIDVSYNEL 402
L + N G E+ ++ SLE L+LS N +F G G L +D+S+N +
Sbjct: 328 KRLTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-43
Identities = 80/365 (21%), Positives = 135/365 (36%), Gaps = 40/365 (10%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+L LSTL L+ N + +F L++L + +L++ IG+LK L L+++
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 135 NQL-SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSL----FYLHLSSNQLSGSI 189
N + S +P NL+NL L L N + + + L + L LS N ++ I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 190 PISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGL------STNHLSGVIPLSIG 242
L L L N ++ + L L L + +L ++
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 243 NLNNLIGLYLYDNQL--SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL---------- 290
L NL L + +I L++++ L + +
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELV 312
Query: 291 ---------GSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKG--FPVELE 339
L L+ L ++NK GN+ E +L L +L+LS N
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 340 KLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIP-SCFEGMHGLSCIDVS 398
L LDLS N + + +E LE L+ H+N + S F + L +D+S
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 399 YNELR 403
+ R
Sbjct: 430 HTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 4e-42
Identities = 81/354 (22%), Positives = 126/354 (35%), Gaps = 28/354 (7%)
Query: 74 GNLKSLSTLDLSKNKLN-GSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFL----Y 128
G+LK+L L+++ N + +P F NLTNL + L N + + + L +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSG 187
LDLS N ++ I P L L L N S ++ I L L L +
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 188 SIPIS------LGNLSNLVVLHLFENSL---FGSIPSILGNLKMLLHLGLSTNHLSGVIP 238
+ L L NL + L I + L + L + + V
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY 298
S L L + + KL SL L N+ GN + L LE+
Sbjct: 300 FS--YNFGWQHLELVNCKFG----QFPTLKLKSLKRLTFTSNKG-GNAF-SEVDLPSLEF 351
Query: 299 LDLSTNKLG--NSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356
LDLS N L ++ L YL+LS N L QL LD + L+
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 357 KIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ ++ +L L++SH + F G+ L + ++ N +
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 83/369 (22%), Positives = 135/369 (36%), Gaps = 46/369 (12%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIM----YLYRNSLSASIPPVIGNLKFLYH 129
NL +L LDLS NK+ L + ++ L N ++ I P L+
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHK 204
Query: 130 LDLSENQLSGSIPPT-LGNLSNLAVLHLYG------NSLSGSIPSIIGNLKSLFYLHLSS 182
L L N S ++ T + L+ L V L +L S + L +L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 183 NQLSGS---IPISLGNLSNLVVLHLFENSL---------------------FGSIPSILG 218
L I L+N+ L ++ FG P++
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL-- 322
Query: 219 NLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEI-PIEIGKLSSLNYLVL 277
LK L L ++N +L +L L L N LS +SL YL L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 278 NGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE--TLGNLLKLHYLNLSNNQFRKGFP 335
+ N + + L +LE+LD + L + E +L L YL++S+ R F
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 336 VELEKLIQLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSC 394
L L L ++ N + +I + +L L+LS L P+ F + L
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 395 IDVSYNELR 403
++++ N+L+
Sbjct: 499 LNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-40
Identities = 77/378 (20%), Positives = 127/378 (33%), Gaps = 29/378 (7%)
Query: 43 KIKISPCAWFGIQCNPAKRVISINLSTVGLKG------NLKSLSTLDLSKNKLNGSIP-F 95
KI+ C + +S++LS + L L L N + ++
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
Query: 96 SFGNLTNLAIMYLYR------NSLSASIPPVIGNLKFLYHLDLSENQLSGS---IPPTLG 146
L L + L +L + L L + L I
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 147 NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206
L+N++ L ++ + N +L L + + + L +L L
Sbjct: 280 CLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
Query: 207 NSLFGSIPSILGNLKMLLHLGLSTNHLS--GVIPLSIGNLNNLIGLYLYDNQLSVGEIPI 264
+ F + +L L L LS N LS G S +L L L N + +
Sbjct: 338 GNAFSEV-----DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI--TMSS 390
Query: 265 EIGKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYL 323
L L +L + L SL L YLD+S + L L L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 324 NLSNNQFRKGFPVE-LEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLI 382
++ N F++ F + +L L+ LDLS LE P ++ SL+ LN++ N +
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 383 PSCFEGMHGLSCIDVSYN 400
F+ + L I + N
Sbjct: 511 DGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-38
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 15/271 (5%)
Query: 65 INLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSF-GNLTNLAIMYLYRNSLSASIPPVIGN 123
+ L L ++S+ L + FS+ +L ++
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LK 323
Query: 124 LKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLS--GSIPSIIGNLKSLFYLHLS 181
LK L L + N+ + + +L +L L L N LS G SL YL LS
Sbjct: 324 LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP--SILGNLKMLLHLGLSTNHLSGVIPL 239
N + ++ + L L L ++L + S+ +L+ L++L +S H
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 240 SIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYL 299
L++L L + N +P +L +L +L L+ QL P A SL+ L+ L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 300 DLSTNKLGNSIPETLGNLLKLHYLNLSNNQF 330
++++N+L + L L + L N +
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-37
Identities = 66/373 (17%), Positives = 115/373 (30%), Gaps = 53/373 (14%)
Query: 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGS 140
T + IP + + + L N L + L LDLS ++
Sbjct: 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 141 IPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLV 200
+LS+L+ L L GN + L SL L L+ +G+L L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 201 VLHLFENSL-FGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL----IGLYLYDN 255
L++ N + +P NL L HL LS+N + + + L+ + + L L N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 256 QLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNKL-------- 306
++ I K L+ L L N N+ + + L LE L +
Sbjct: 188 PMN--FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 307 -------------------------GNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEK 340
+ I + L + +L + +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG 305
Query: 341 LIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
L ++ ++SL++L + N + L +D+S N
Sbjct: 306 WQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRN 357
Query: 401 ELRGPIPNSRIFQ 413
L S+
Sbjct: 358 GLSFKGCCSQSDF 370
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-37
Identities = 66/317 (20%), Positives = 102/317 (32%), Gaps = 20/317 (6%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS------FGNLTNLAIMYLYRNSLSAS---IPPVIGNLK 125
L L L + L NL I L I + L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
+ L + + N L L P++ LKSL L +SN+
Sbjct: 283 NVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNKG 337
Query: 186 SGSIPISLGNLSNLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGN 243
+ S +L +L L L N L G L +L LS N + + +
Sbjct: 338 GNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 244 LNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLST 303
L L L + L L +L YL ++ L+ LE L ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 304 NKLGNSI-PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362
N + P+ L L +L+LS Q + P L L L+++ N L+
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 363 CNMESLEKLNLSHNNFS 379
+ SL+K+ L N +
Sbjct: 515 DRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 50/200 (25%), Positives = 78/200 (39%), Gaps = 7/200 (3%)
Query: 64 SINLSTVGLKGNLKSLSTLDLSKNKLN--GSIPFSFGNLTNLAIMYLYRNSLSASIPPVI 121
S + +L SL LDLS+N L+ G S T+L + L N + ++
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 122 GNLKFLYHLDLSENQLSGSIPP--TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH 179
L+ L HLD + L + +L NL L + + I L SL L
Sbjct: 393 LGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 180 LSSNQLSGSI-PISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP 238
++ N + P L NL L L + L P+ +L L L +++N L V
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511
Query: 239 LSIGNLNNLIGLYLYDNQLS 258
L +L ++L+ N
Sbjct: 512 GIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 38/145 (26%), Positives = 56/145 (38%), Gaps = 2/145 (1%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L+ L LD + L FS F +L NL + + + + L L L ++
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS 192
N + P L NL L L L P+ +L SL L+++SNQL
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 193 LGNLSNLVVLHLFENSLFGSIPSIL 217
L++L + L N S P I
Sbjct: 514 FDRLTSLQKIWLHTNPWDCSCPRID 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 1/126 (0%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNL 124
+S + +L++L LD+S + F L++L ++ + NS + P + L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 125 KFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQ 184
+ L LDLS+ QL P +LS+L VL++ N L I L SL + L +N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529
Query: 185 LSGSIP 190
S P
Sbjct: 530 WDCSCP 535
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-45
Identities = 69/294 (23%), Positives = 114/294 (38%), Gaps = 42/294 (14%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNE--IKTLTELRHRSIVKF 579
IG G G V+ K GE +AVK F + E + E I +RH +I+ F
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFT--TEEA----SWFRETEIYQTVLMRHENILGF 96
Query: 580 YGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
S +L+ +Y E GSL L + + + + S + L ++H
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 636 DCF-----PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN----CTELVGTFGY 686
+ F P I HRD+ SKN+L+ + ++D G+A D++ VGT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 687 IAPEL------VYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI---SSSSSNRNISL 737
+ PE+ + D+YSFG++ EV + + + S
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 738 NEILDP------RLPTPPQNVQDE-LISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ + R P + DE L + ++ C +P SR V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 69/267 (25%), Positives = 117/267 (43%), Gaps = 20/267 (7%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
IG G G+VYK K G++ AVK + P Q F NE+ L + RH +I+ F G+
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVNILLFMGY 88
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
+ P +V ++ E SL L +F +++ R A + Y+H I+
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLK--PDSSNCTELVGTFGYIAPELV---YTMKV 697
HRD+ S N+ L D ++ DFG+A S +L G+ ++APE++ +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 698 TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELI 757
+ + DVY+FG++ E++ G P I++ L P L N +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG---RGSLSPDLSKVRSNCPKRMK 259
Query: 758 SIVEVAFLCLNESPESRPPMHTVCQLL 784
++ CL + + RP + +
Sbjct: 260 RLMA---ECLKKKRDERPSFPRILAEI 283
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-44
Identities = 76/331 (22%), Positives = 131/331 (39%), Gaps = 14/331 (4%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
+ + + ++P T ++ L +N + + L L+L+EN +
Sbjct: 12 QDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 138 SGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISLGN 195
S ++ P NL NL L L N L IP + L +L L +S N++ + +
Sbjct: 69 S-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 196 LSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
L NL L + +N L I L L L L +L+ + ++ +L+ LI L L
Sbjct: 127 LYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 255 NQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE- 312
++ I +L L L ++ + L L ++ L ++P
Sbjct: 186 LNIN--AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYL 242
Query: 313 TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLN 372
+ +L+ L +LNLS N L +L++L E+ L L P + L LN
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302
Query: 373 LSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+S N + L S F + L + + N L
Sbjct: 303 VSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-43
Identities = 83/316 (26%), Positives = 123/316 (38%), Gaps = 17/316 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
+ L L+L++N ++ P +F NL NL + L N L IP V L L LD+S
Sbjct: 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDIS 112
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI 191
EN++ + +L NL L + N L I L SL L L L+ SIP
Sbjct: 113 ENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPT 169
Query: 192 -SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
+L +L L+VL L ++ L L L +S + + NL L
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 251 YLYDNQLSVGEIPIE-IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNS 309
+ L+ +P + L L +L L+ N + L L L+ + L +L
Sbjct: 230 SITHCNLT--AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287
Query: 310 IPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLE 369
P L L LN+S NQ + L L L N L C+ C + +
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA----CD-CRLLWV- 341
Query: 370 KLNLSHNNFSGLIPSC 385
NF+ P+C
Sbjct: 342 FRRRWRLNFNRQQPTC 357
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 45/233 (19%), Positives = 85/233 (36%), Gaps = 30/233 (12%)
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237
+ + ++P + + +L L +N + + L L L+ N +S V
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTEL 296
P + NL NL L L N+L IP+ + LS+L L ++ N++ L L L
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLK--LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130
Query: 297 EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356
+ L++ N L L L L L L+ +
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN--------------LTSIPTEA----- 171
Query: 357 KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ ++ L L L H N + + F+ ++ L +++S+ + +
Sbjct: 172 -----LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-44
Identities = 82/356 (23%), Positives = 136/356 (38%), Gaps = 62/356 (17%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIM-------------YLYRNSLSASIPPV 120
N+KS + + ++ + P G +A+ L LS S+P +
Sbjct: 31 ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL 89
Query: 121 IGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180
+L+ L S N L+ +P +L +L V + +LS P L YL +
Sbjct: 90 PPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGV 138
Query: 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLS 240
S+NQL +P L N S L ++ + NSL +P + +L+ + N L +P
Sbjct: 139 SNNQLE-KLP-ELQNSSFLKIIDVDNNSL-KKLPDLPPSLE---FIAAGNNQLE-ELP-E 190
Query: 241 IGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300
+ NL L +Y +N L ++P L S+ N L L +L L +
Sbjct: 191 LQNLPFLTAIYADNNSLK--KLPDLPLSLESIV---AGNNIL--EELPELQNLPFLTTIY 243
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP- 359
N L ++P+ +L LN+ +N P + L L + + L P
Sbjct: 244 ADNNLL-KTLPDLPPSL---EALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPN 298
Query: 360 -----------CEICN-MESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+C+ SLE+LN+S+N L L + S+N L
Sbjct: 299 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL----PALPPRLERLIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-44
Identities = 76/356 (21%), Positives = 127/356 (35%), Gaps = 63/356 (17%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNL---------- 124
+ L + L +P N+ + Y + + PP G
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 125 ---KFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181
+ + L+L+ LS S+P +L + L NSL+ +P + +LKSL + +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 182 SNQLSGSIPI---------------SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHL 226
LS P+ L N S L ++ + NSL +P + +L+ +
Sbjct: 123 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL-KKLPDLPPSLE---FI 178
Query: 227 GLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286
N L +P + NL L +Y +N L ++P L S+ N L
Sbjct: 179 AAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK--KLPDLPLSLESIV---AGNNIL--EE 229
Query: 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSE 346
L +L L + N L ++P+ + L LN+ +N P + L L
Sbjct: 230 LPELQNLPFLTTIYADNNLL-KTLPDLPPS---LEALNVRDNYLTD-LPELPQSLTFLDV 284
Query: 347 LDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
+ + L P +L LN S N L L ++VS N+L
Sbjct: 285 SENIFSGLSELPP-------NLYYLNASSNEIRSLCDL----PPSLEELNVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-41
Identities = 81/338 (23%), Positives = 133/338 (39%), Gaps = 48/338 (14%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
N + L L L +S N+L +P N + L I+ + NSL +P + +L+
Sbjct: 120 NNNLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLE 176
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
+ NQL P L NL L ++ NSL +P + +L+S+ +N L
Sbjct: 177 ---FIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNIL 227
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
+P L NL L ++ N L ++P + +L+ L + N+L+ +P +L
Sbjct: 228 E-ELP-ELQNLPFLTTIYADNNLL-KTLPDLPPSLE---ALNVRDNYLTD-LPELPQSLT 280
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
L + LS +L YL + N++ +L SL EL ++S NK
Sbjct: 281 FLDVSENIFSGLS--------ELPPNLYYLNASSNEI-RSLCDLPPSLEEL---NVSNNK 328
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
L +P L L S N + P + L +L + N L + P ++
Sbjct: 329 L-IELPALPPRL---ERLIASFNHLAE-VPELPQNL---KQLHVEYNPLR-EFPDIPESV 379
Query: 366 ESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
E L + + E L + V N LR
Sbjct: 380 EDLRMNSH--------LAEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 74/323 (22%), Positives = 129/323 (39%), Gaps = 46/323 (14%)
Query: 99 NLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV----- 153
+ T L + ++L+ +P N+K + ++ + PP G +AV
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 154 --------LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLF 205
L L LS S+P + +L+S L S N L+ +P +L +L+V +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 206 ENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
+L P L +LG+S N L +P + N + L + + +N L ++P
Sbjct: 123 LKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK--KLPDL 171
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNL 325
L + NQL LP L +L L + N L +P+ + L +
Sbjct: 172 PPSLEFIA---AGNNQL-EELP-ELQNLPFLTAIYADNNSL-KKLPDLPLS---LESIVA 222
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC 385
NN + EL+ L L+ + N+L+ +P + LE LN+ N + L P
Sbjct: 223 GNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLTDL-PEL 275
Query: 386 FEGMHGLSCIDVSYNELRGPIPN 408
+ + L + ++ L PN
Sbjct: 276 PQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-40
Identities = 69/321 (21%), Positives = 116/321 (36%), Gaps = 48/321 (14%)
Query: 72 LKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLD 131
L SL + N+L +P NL L +Y NSL +P + +L+ +
Sbjct: 168 LPDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIV 221
Query: 132 LSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
N L P L NL L ++ N L ++P + +L++L ++ N L+ +P
Sbjct: 222 AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPE 274
Query: 192 SLGNLSNLVVLHLFENSLFGSIPS-------------ILGNLKMLLHLGLSTNHLSGVIP 238
+L+ L V + L P+ + L L +S N L +P
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP 333
Query: 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY 298
L L N L+ E+P L L+ + N L P S+ +L
Sbjct: 334 ALPPRLERL---IASFNHLA--EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 384
Query: 299 LDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKI 358
+ L +PE NL L++ N R+ FP E + +L ++ +
Sbjct: 385 N----SHL-AEVPELPQNL---KQLHVETNPLRE-FPDIPE---SVEDLRMNSERVVDPY 432
Query: 359 PCEICNMESLEKLNLSHNNFS 379
+ LE H++
Sbjct: 433 EFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-40
Identities = 74/345 (21%), Positives = 117/345 (33%), Gaps = 58/345 (16%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
N L +D+ N L +P +L + N L P + NL FL +
Sbjct: 150 QNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLEE--LPELQNLPFLTAIYAD 203
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N L +P +L ++ N L +P + NL L ++ +N L ++P
Sbjct: 204 NNSLK-KLPDLPLSLESI---VAGNNILE-ELPEL-QNLPFLTTIYADNNLLK-TLPDLP 256
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
+L L V + L P + +L L + LS + P NL L
Sbjct: 257 PSLEALNVRDNYLTDL----PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNAS 305
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
N++ + L LN ++ N+L LP L L S N L +PE
Sbjct: 306 SNEIR--SLCDLPPSLEELN---VSNNKLI-ELPALPPRLERL---IASFNHL-AEVPEL 355
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS----------------ELDLSLNILEGK 357
NL L++ N R+ FP E + L +L + N L +
Sbjct: 356 PQNL---KQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-E 410
Query: 358 IPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
P ES+E L ++ E L ++
Sbjct: 411 FPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-33
Identities = 59/265 (22%), Positives = 96/265 (36%), Gaps = 37/265 (13%)
Query: 141 IPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLV 200
I P + + L + ++L+ +P N+KS + + ++ + P G +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 201 VLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260
V L + + L L+ LS +P +L + L N L+
Sbjct: 62 VSRLRDCL-----------DRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-- 104
Query: 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKL 320
E+P L SL N L P LEYL +S N+L +PE L N L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQL-EKLPE-LQNSSFL 155
Query: 321 HYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380
+++ NN +K P L + N LE ++P E+ N+ L + +N+
Sbjct: 156 KIIDVDNNSLKK-LPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK 209
Query: 381 LIPSCFEGMHGLSCIDVSYNELRGP 405
L L I N L
Sbjct: 210 LPDLP----LSLESIVAGNNILEEL 230
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 41/209 (19%), Positives = 74/209 (35%), Gaps = 37/209 (17%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
+ L +SL+ LD+S+N + + NL L N + S+ + +L+
Sbjct: 266 DNYLTDLPELPQSLTFLDVSENIFS-GLSELPPNLYYL---NASSNEIR-SLCDLPPSLE 320
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L++S N+L +P L L N L+ +P + NLK L H+ N L
Sbjct: 321 ---ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQNLKQL---HVEYNPL 369
Query: 186 SGSIPISLGNL----------------SNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS 229
P ++ NL LH+ N L P I +++ L ++
Sbjct: 370 R-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL-REFPDIPESVE---DLRMN 424
Query: 230 TNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258
+ + + + L +
Sbjct: 425 SERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 42/294 (14%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNE--IKTLTELRHRSIVKF 579
IG G G V++ K GE +AVK F S + + E I LRH +I+ F
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGF 101
Query: 580 YGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
+ + +LV +Y E GSL L+ + + S A+ L+++H
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 157
Query: 636 DCF-----PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS----NCTELVGTFGY 686
+ P I HRD+ SKN+L+ + ++D G+A + VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 687 IAPEL------VYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS---SSSSNRNISL 737
+APE+ + + ++ D+Y+ G++ E+ + + S+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 738 NEILDP------RLPTPPQNVQDELIS-IVEVAFLCLNESPESRPPMHTVCQLL 784
E+ R P + E + + ++ C + +R + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 29/313 (9%)
Query: 78 SLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSEN 135
L + S L +P + L L N ++ I NLK L+ L L N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALL---DLQNNKIT-EIKDGDFKNLKNLHTLILINN 86
Query: 136 QLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
++S I P L L L+L N L +P K+L L + N+++
Sbjct: 87 KIS-KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFN 142
Query: 195 NLSNLVVLHLFENSLFGSI--PSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
L+ ++V+ L N L S +K L ++ ++ +++ + G +L L+L
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI---PQGLPPSLTELHL 199
Query: 253 YDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311
N+++ ++ L++L L L+ N + +L + L L L+ NKL +P
Sbjct: 200 DGNKIT--KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVP 256
Query: 312 ETLGNLLKLHYLNLSNNQFRK------GFPVELEKLIQLSELDLSLN-ILEGKIPCEI-C 363
L + + + L NN P K S + L N + +I
Sbjct: 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 364 NMESLEKLNLSHN 376
+ + L +
Sbjct: 317 CVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 22/266 (8%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
NLK+L TL L NK++ P +F L L +YL +N L +P K L L + E
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHE 130
Query: 135 NQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSI--PSIIGNLKSLFYLHLSSNQLSGSIPI 191
N+++ + L+ + V+ L N L S +K L Y+ ++ ++ I
Sbjct: 131 NEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---I 186
Query: 192 SLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
G +L LHL N + + + L L L LGLS N +S V S+ N +L L
Sbjct: 187 PQGLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYG------NLPRALGSLTELEYLDLSTN 304
+L +N+L ++P + + + L+ N + P + L +N
Sbjct: 246 HLNNNKLV--KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 305 KLGNSI--PETLGNLLKLHYLNLSNN 328
+ P T + + L N
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 69/285 (24%), Positives = 113/285 (39%), Gaps = 17/285 (5%)
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L + S+ L +P L + A+L L N ++ NLK+L L L +N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
S P + L L L+L +N L +P K L L + N ++ V LN
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPE--KMPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 246 NLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
+I + L N L I + L+Y+ + + +P+ G L L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGN 202
Query: 305 KLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICN 364
K+ +L L L L LS N L L EL L+ N L K+P + +
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
Query: 365 MESLEKLNLSHNNFSGLIPSCF------EGMHGLSCIDVSYNELR 403
+ ++ + L +NN S + + F S + + N ++
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 18/241 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
L L L LSKN+L L L ++ N ++ + V L + ++L
Sbjct: 98 PLVKLERLYLSKNQLKELPEKMPKTLQEL---RVHENEIT-KVRKSVFNGLNQMIVVELG 153
Query: 134 ENQL-SGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
N L S I + L+ + + +++ +IP G SL LHL N+++
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAA 210
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
SL L+NL L L NS+ L N L L L+ N L +P + + + +Y
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 252 LYDNQLS-----VGEIPIEIGKLSSLNYLVLNGNQL-YGNLPR-ALGSLTELEYLDLSTN 304
L++N +S P K +S + + L N + Y + + + L
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
Query: 305 K 305
K
Sbjct: 330 K 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 37/143 (25%), Positives = 66/143 (46%), Gaps = 6/143 (4%)
Query: 271 SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF 330
L + + L +P+ L + LDL NK+ NL LH L L NN+
Sbjct: 32 HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 331 RKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMH 390
K P L++L L LS N L+ ++P ++ ++L++L + N + + S F G++
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 391 GLSCIDVSYNELRGPIPNSRIFQ 413
+ +++ N L+ + FQ
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQ 168
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 28/270 (10%)
Query: 522 CIGIGGQGSVYKAK-LTSGEILAVKKFH-SLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
IG G +VYK + +A + + F E + L L+H +IV+F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR--FKEEAEMLKGLQHPNIVRF 90
Query: 580 YGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
Y LV E + G+L T L ++ V + R + L ++H
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI---KVLRSWCRQILKGLQFLH- 146
Query: 636 DCFPPIVHRDISSKNVLL-CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
PPI+HRD+ N+ + ++ D G+A + +S ++GT ++APE +Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPE-MYE 203
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754
K E DVY+FG+ LE+ ++P S + I + + +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 755 ELISIVEVAFLCLNESPESRPPMHTVCQLL 784
E+ I+E C+ ++ + R ++ LL
Sbjct: 258 EVKEIIE---GCIRQNKDERY---SIKDLL 281
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-38
Identities = 59/340 (17%), Positives = 125/340 (36%), Gaps = 37/340 (10%)
Query: 63 ISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIG 122
+ + + L +L++LD + + + LT L + N+++ ++ +
Sbjct: 28 FEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LS 82
Query: 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182
L +L N+L+ ++ + L+ L L+ N L+ + + L YL+ +
Sbjct: 83 QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCAR 136
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
N L+ I + + + L L N + + L L S N ++ L +
Sbjct: 137 NTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVS 188
Query: 243 NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302
L L N ++ +++ + L +L + N+L + + LT+L Y D S
Sbjct: 189 QNKLLNRLNCDTNNITK----LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCS 241
Query: 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362
N L + + L KL L+ + ++L QL ++ ++
Sbjct: 242 VNPL-TELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL--DV 293
Query: 363 CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
+ L L+ + L L + ++ EL
Sbjct: 294 THNTQLYLLDCQAAGITELD---LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-38
Identities = 61/329 (18%), Positives = 120/329 (36%), Gaps = 38/329 (11%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L L+ L + N + ++ S TNL + N L+ ++ + L L +L+
Sbjct: 61 EKLTGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N+L+ + + L L+ N+L+ I + + L L N+ + ++
Sbjct: 115 TNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT- 167
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
+ L L N + + + K+L L TN+++ L + L L
Sbjct: 168 -PQTQLTTLDCSFNKI-TELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCS 220
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
N+L+ I++ L+ L Y + N L L + +L++L L L I
Sbjct: 221 SNKLTE----IDVTPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDL-LEID-- 270
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
L + +L Y + K +++ QL LD + ++ + L L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIK--ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYL 325
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
++ + L L + +
Sbjct: 326 NNTELTEL---DVSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-37
Identities = 57/311 (18%), Positives = 104/311 (33%), Gaps = 34/311 (10%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L L+ L+ NKL L + RN+L+ I + + L LD
Sbjct: 103 TPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCH 156
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N+ + + L L N ++ + + K L L+ +N ++ + L
Sbjct: 157 LNKKITK--LDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK---LDL 208
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
L L N L I + L L + S N L+ L + L+ L L+
Sbjct: 209 NQNIQLTFLDCSSNKL-TEID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCI 262
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
L I++ + L Y G + L + T+L LD + +
Sbjct: 263 QTDLLE----IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI-TELD-- 313
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNL 373
L KL YL L+N + + +++ +L L ++ + + +L
Sbjct: 314 LSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFE 368
Query: 374 SHNNFSGLIPS 384
+ +
Sbjct: 369 AEGQTITMPKE 379
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-36
Identities = 61/328 (18%), Positives = 118/328 (35%), Gaps = 37/328 (11%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
N S + S L L + + +S++ + I L L L +
Sbjct: 19 NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTS 73
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
N ++ ++ L +NL L N L+ ++ + L L YL+ +N+L+ + +
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
L L+ N+L I + + L L N + ++ L L
Sbjct: 125 QNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSF 179
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
N+++ +++ + LN L + N + L L +L +LD S+NKL I +
Sbjct: 180 NKITE----LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-TEID--V 229
Query: 315 GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374
L +L Y + S N + +++ L +L+ L L +I + + L
Sbjct: 230 TPLTQLTYFDCSVNPLTE---LDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAE 283
Query: 375 HNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
+ L +D +
Sbjct: 284 GCRK--IKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-33
Identities = 54/312 (17%), Positives = 106/312 (33%), Gaps = 38/312 (12%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L+ L+ ++N L + T L + + N + + L LD S
Sbjct: 124 SQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCS 178
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
N+++ + + L L+ N+++ + + L +L SSN+L+ I +
Sbjct: 179 FNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDV 229
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
L+ L N L + + L L L L + + + LI
Sbjct: 230 TPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAE 283
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
+ +++ + L L + L L +L YL L+ +L +
Sbjct: 284 GCRKI---KELDVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTEL-TELD-- 334
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESL----- 368
+ + KL L+ N + F + K+ L+ + +P E SL
Sbjct: 335 VSHNTKLKSLSCVNAHI-QDFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVS 391
Query: 369 -EKLNLSHNNFS 379
+ L+ N +
Sbjct: 392 PDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 57/273 (20%), Positives = 95/273 (34%), Gaps = 43/273 (15%)
Query: 149 SNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS---------------- 192
N A + + L +L L ++ ++ I
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT 77
Query: 193 ---LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIG 249
L +NL L N L ++ + L L +L TN L+ L + L
Sbjct: 78 TLDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTY 131
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNS 309
L N L+ I++ + L L + N+ L + T+L LD S NK+
Sbjct: 132 LNCARNTLTE----IDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI-TE 184
Query: 310 IPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLE 369
+ + L+ LN N K ++L + IQL+ LD S N L +I + + L
Sbjct: 185 LD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 370 KLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
+ S N + L S L+ + +L
Sbjct: 237 YFDCSVNPLTELDVSTLS---KLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 38/243 (15%), Positives = 79/243 (32%), Gaps = 21/243 (8%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L L+ D S N L + S L+ L ++ + L I + + L +
Sbjct: 230 TPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAE 283
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
+ + + + + L +L ++ + + L YL+L++ +L+ + +S
Sbjct: 284 GCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS- 336
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
+ + L L + S+ G + L + + +P N+L + +
Sbjct: 337 -HNTKLKSLSCVNAHI-QDFSSV-GKIPALNNNFEAEGQTI-TMPKETLTNNSLT-IAVS 391
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313
+ L P+ I Y + NL + Y S N T
Sbjct: 392 PDLLDQFGNPMNIEPGDGGVYDQATNTITWENLS---TDNPAVTYTFTSENGAIVGTVTT 448
Query: 314 LGN 316
Sbjct: 449 PFE 451
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-38
Identities = 60/303 (19%), Positives = 113/303 (37%), Gaps = 36/303 (11%)
Query: 73 KGNLKSLSTLDLSKNKLNG---SIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYH 129
N SLS + N ++G ++ A+ RN + + + +
Sbjct: 7 INNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSE 63
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
L L+ LS S+P L + VL + N+L S+P + +L+ YL N+LS ++
Sbjct: 64 LQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TL 115
Query: 190 PISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIG 249
P +L +L + N L +P + L+ ++ N L+ ++P +L L
Sbjct: 116 PELPASLKHL---DVDNNQL-TMLPELPALLE---YINADNNQLT-MLPELPTSLEVL-- 165
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELE----YLDLSTNK 305
+ +NQL+ +P L +L+ ++ N L +LP E + N+
Sbjct: 166 -SVRNNQLT--FLPELPESLEALD---VSTNLL-ESLPAVPVRNHHSEETEIFFRCRENR 218
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
+ IPE + +L + L +N L + + +
Sbjct: 219 I-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
Query: 366 ESL 368
L
Sbjct: 278 RPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-37
Identities = 67/335 (20%), Positives = 137/335 (40%), Gaps = 39/335 (11%)
Query: 31 PVNNATNVS---FYSKIKISPCAWFGIQCNPAKRVIS----INLSTVGLKGNLKSLSTLD 83
P+NN ++S FY+ I + +F K+ + ++ + + S L
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ 65
Query: 84 LSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPP 143
L++ L+ S+P + + ++ + +N+L S+P + +L+ +LD +N+LS ++P
Sbjct: 66 LNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TLPE 117
Query: 144 TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLH 203
+L + L + N L+ +P + L+ Y++ +NQL+ +P +L VL
Sbjct: 118 LPASLKH---LDVDNNQLT-MLPELPALLE---YINADNNQLT-MLPELPTSLE---VLS 166
Query: 204 LFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL----IGLYLYDNQLSV 259
+ N L +P + +L+ L +STN L +P ++ I +N+++
Sbjct: 167 VRNNQL-TFLPELPESLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT- 220
Query: 260 GEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK 319
IP I L ++L N L + +L T S + N L
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLH 277
Query: 320 LHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNIL 354
+ F + ++ ++ E + N
Sbjct: 278 RPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTF 312
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 5e-16
Identities = 45/289 (15%), Positives = 80/289 (27%), Gaps = 47/289 (16%)
Query: 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFL----YHLD 131
SL L + N+L +P +L L + N L S+P V
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 132 LSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
EN+++ IP + +L + L N LS I + + H S S
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
N + + + S + + N S + + + +
Sbjct: 273 Q--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLD-RLSDTVSARNTS 329
Query: 252 LYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311
+ Q++ L L+ L + +
Sbjct: 330 GFREQVA-----------------------------AWLEKLSASAELRQQSFAVAADAT 360
Query: 312 ETLGNLLKLHYLNLSNNQF-----RKGFPVELEKLIQLSELDLSLNILE 355
E+ + + L + NL F + L+ L L ILE
Sbjct: 361 ESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGREMFRLEILE 409
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 34/169 (20%), Positives = 52/169 (30%), Gaps = 40/169 (23%)
Query: 237 IPLSIGNLNNLIGLYLYDNQLSV--GEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT 294
I L I N +L Y N +S + K N N+ L L +
Sbjct: 3 IMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 295 ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNIL 354
+ L L+ L +S+P+ L + L ++ N
Sbjct: 60 QFSELQLNRLNL-SSLPDNLPPQIT--VLEITQNALIS---------------------- 94
Query: 355 EGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+P + LE L+ N S L P + L DV N+L
Sbjct: 95 ---LPELPAS---LEYLDACDNRLSTL-PELPASLKHL---DVDNNQLT 133
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 63/260 (24%), Positives = 96/260 (36%), Gaps = 33/260 (12%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSAS--IPPVIGNLKFLYHLDLSEN 135
S + L+L NKL F LT L + L N LS L +LDLS N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIP--SIIGNLKSLFYLHLSSNQLSGSIPISL 193
+ ++ L L L ++L + S+ +L++L YL +S +
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 194 GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
LS+L VL + NS + I L+ L L LS L + P + +L++L L +
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE 312
N + L L+ LD S N + S +
Sbjct: 207 SHNNFF--SLD-----------------------TFPYKCLNSLQVLDYSLNHIMTSKKQ 241
Query: 313 TLGNLLK-LHYLNLSNNQFR 331
L + L +LNL+ N F
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 73/258 (28%), Positives = 105/258 (40%), Gaps = 14/258 (5%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
+ + L+ S+P + S+ L L N L + L L L LSSN LS
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-F 66
Query: 189 IPISLG---NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSI-GNL 244
++L L L N + ++ S L+ L HL ++L + S+ +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 245 NNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLS 302
NLI L + V I LSSL L + GN N L L +LDLS
Sbjct: 126 RNLIYLDISHTHTRV--AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362
+L P +L L LN+S+N F + L L LD SLN + E+
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243
Query: 363 CNM-ESLEKLNLSHNNFS 379
+ SL LNL+ N+F+
Sbjct: 244 QHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 11/231 (4%)
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS--G 235
+ +S L+ S+P + S+ L L N L + L L L LS+N LS G
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR-ALGSLT 294
S +L L L N + + L L +L + L SL
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI--TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 295 ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELDLSLNI 353
L YLD+S + L L L ++ N F++ F + +L L+ LDLS
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 354 LEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
LE ++ ++ SL+ LN+SHNNF L ++ ++ L +D S N +
Sbjct: 187 LE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 8/189 (4%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP--VIGNLKFLYHLDL 132
SL LDLS N + ++ +F L L + ++L + V +L+ L +LD+
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDI 133
Query: 133 SENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIP 190
S LS+L VL + GNS + I L++L +L LS QL P
Sbjct: 134 SHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192
Query: 191 ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNL-NNLIG 249
+ +LS+L VL++ N+ F L L L S NH+ + + ++L
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 252
Query: 250 LYLYDNQLS 258
L L N +
Sbjct: 253 LNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 6/148 (4%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNL 124
+S + +L++L LD+S + F L++L ++ + NS + P + L
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174
Query: 125 KFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183
+ L LDLS+ QL + P +LS+L VL++ N+ L SL L S N
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 184 QLSGSIPISL--GNLSNLVVLHLFENSL 209
+ + S+L L+L +N
Sbjct: 234 HIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 37/161 (22%), Positives = 60/161 (37%), Gaps = 8/161 (4%)
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNS 309
+ L+ +P I SS L L N+L LT+L L LS+N L
Sbjct: 12 IRCNSKGLT--SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 310 --IPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI-CNME 366
++ L YL+LS N L QL LD + L+ + ++
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 367 SLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407
+L L++SH + F G+ L + ++ N +
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-37
Identities = 83/357 (23%), Positives = 140/357 (39%), Gaps = 34/357 (9%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
++ +DLS N + SF L +L + + + + I L L L L NQ
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 137 LSGSIPP-TLGNLSNLAVLHLYGNSLSGSI--PSIIGNLKSLFYLHLSSNQLSGSIPISL 193
+ L+NL VL L +L G++ + L SL L L N + P S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 194 -GNLSNLVVLHLFENSLFGSIPSILGNL--KMLLHLGLSTNHLSGVIPLSIG-------- 242
N+ VL L N + L N K L LS+ L + +G
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 243 NLNNLIGLYLYDNQL--SVGEIPIEIGKLSSLNYLVLNGNQLYG------------NLPR 288
++ L L N S+ + + + + L+L+ + G N
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 289 ALGSLTELEYLDLSTNKLGNSIPETL-GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSEL 347
+ ++ DLS +K+ ++ +++ + L L L+ N+ K L L +L
Sbjct: 270 KGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 348 DLSLNILEGKIPCEIC-NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+LS N L G I + N++ LE L+LS+N+ L F G+ L + + N+L+
Sbjct: 329 NLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 71/357 (19%), Positives = 124/357 (34%), Gaps = 34/357 (9%)
Query: 75 NLKSLSTLDLSKNKLNGSIPF-SFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
L+ L L + + I +F L++L I+ L N + L L L L
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTL 110
Query: 133 SENQL-SGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSII-GNLKSLFYLHLSSNQLSGSI 189
++ L + L++L +L L N++ P+ N++ L L+ N++
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
Query: 190 PISLGNL--SNLVVLHLFENSLF--------GSIPSILGNLKMLLHLGLSTNHLSGVIP- 238
L N + +L L +L + L LS N +
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 239 --LSIGNLNNLIGLYLYDNQLSVGEIPIEIGK-----------LSSLNYLVLNGNQLYGN 285
+ L L ++ K S + L+ ++++
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFAL 290
Query: 286 LPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQL 344
L T+LE L L+ N++ N I + L L LNLS N E L +L
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349
Query: 345 SELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
LDLS N + + + + +L++L L N + F+ + L I + N
Sbjct: 350 EVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-35
Identities = 76/337 (22%), Positives = 117/337 (34%), Gaps = 39/337 (11%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSL-SASIPP-VIGNLKFLYHLD 131
L SL L L N+ + F L NL ++ L + +L A + L L L
Sbjct: 77 GLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135
Query: 132 LSENQLSGSIPP--TLGNLSNLAVLHLYGNSLSGSIPSIIGNL--KSLFYLHLSSNQLSG 187
L +N + I P N+ VL L N + + N K L LSS L
Sbjct: 136 LRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
Query: 188 SIPISLG--------NLSNLVVLHLFENSLFGSIPSILGNLKMLLHL------------- 226
LG +++ L L N S+ + +
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 227 GLSTNHLSGVIPLSIGNL--NNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLY 283
+ + L + + L +++ + + + L L L N++
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF--ALLKSVFSHFTDLEQLTLAQNEIN 312
Query: 284 GNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL-EKLI 342
A LT L L+LS N LG+ NL KL L+LS N + + L
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLP 371
Query: 343 QLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNF 378
L EL L N L+ +P I + SL+K+ L N +
Sbjct: 372 NLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-32
Identities = 69/334 (20%), Positives = 124/334 (37%), Gaps = 34/334 (10%)
Query: 101 TNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYG 158
++ + L NS++ + L+ L L + + I T LS+L +L L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 159 NSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSI--PISLGNLSNLVVLHLFENSLFGSIP- 214
N + + L +L L L+ L G++ L++L +L L +N++ P
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNL--NNLIGLYLYDNQLS----VGEIPIEIG- 267
S N++ L L+ N + + + N + L L L + G
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 268 --KLSSLNYLVLNGNQLYGNLPRA---LGSLTELEYL----------DLSTNKLGNSIPE 312
K +S+ L L+GN ++ + + T+++ L +
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 313 TLGNLL--KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEIC-NMESLE 369
T L + +LS ++ L +L L+ N + KI + L
Sbjct: 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLL 326
Query: 370 KLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
KLNLS N + FE + L +D+SYN +R
Sbjct: 327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 56/286 (19%), Positives = 97/286 (33%), Gaps = 33/286 (11%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPPVIGNL--KFLYHLD 131
L SL L L N + P S F N+ ++ L N + + + N K L
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 132 LSENQL--------SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH---- 179
LS L +++ L L GN S+ + + +
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 180 ---------LSSNQLSGSIPISLGNL--SNLVVLHLFENSLFGSIPS-ILGNLKMLLHLG 227
+ L S + L ++ +F ++ + + L L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 228 LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNL 286
L+ N ++ + + L +L+ L L N L I + L L L L+ N +
Sbjct: 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLG--SIDSRMFENLDKLEVLDLSYNHIRALG 363
Query: 287 PRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFR 331
++ L L+ L L TN+L S+P+ L L + L N +
Sbjct: 364 DQSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 51/292 (17%), Positives = 97/292 (33%), Gaps = 36/292 (12%)
Query: 140 SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI-SLGNLSN 198
+P ++ + L NS++ + L+ L +L + I + LS+
Sbjct: 27 ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 199 LVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHL-SGVIPLSI-GNLNNLIGLYLYDN 255
L++L L N + + L L L L+ +L V+ + L +L L L DN
Sbjct: 81 LIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 256 QLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT--ELEYLDLSTNKL------- 306
+ + + + L L N++ L + L LS+ L
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 307 -GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSEL-DLSLNILEGKIPCEICN 364
G + L+LS N F++ I +++ L L+
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 365 --------------MESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
++ +LS + L+ S F L + ++ NE+
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI 311
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 41/223 (18%), Positives = 76/223 (34%), Gaps = 17/223 (7%)
Query: 212 SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS 271
+P + ++ ++ LS N ++ + S L +L L + + LSS
Sbjct: 24 QVPELPAHVN---YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 272 LNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI--PETLGNLLKLHYLNLSNNQ 329
L L L+ NQ A L LE L L+ L ++ L L L L +N
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 330 FRKGFPVEL-EKLIQLSELDLSLNILE----------GKIPCEICNMESLEKLNLSHNNF 378
+K P + + LDL+ N ++ + + S+ +++
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 379 SGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQ 421
++ +D+S N + R F +Q
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQ 242
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 12/167 (7%)
Query: 72 LKGNLKSLSTLDLSKNKLNGSIPFSFGNL--TNLAIMYLYRNSLSASIPPVI-GNLKFLY 128
L + F+F L + + L ++ + ++ + + L
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLE 302
Query: 129 HLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLS 186
L L++N+++ I L++L L+L N L SI S + NL L L LS N +
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
Query: 187 GSIPI-SLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTN 231
++ S L NL L L N L S+P I L L + L TN
Sbjct: 361 -ALGDQSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 405
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 61/300 (20%), Positives = 122/300 (40%), Gaps = 50/300 (16%)
Query: 512 RATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQP--EFVNEIKTL 568
R F+ C+G GG G V++AK A+K+ + + E+K L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKAL 57
Query: 569 TELRHRSIVKFYGFCSHPRNS------------FLVYEYLERGSLATILSNDGAIEEFNW 616
+L H IV+++ + ++ + + +L ++ IEE
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 617 TVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK----- 671
+V +++ +A A+ ++H ++HRD+ N+ +D +V DFG+ +
Sbjct: 118 SVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 672 -------PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFIS 724
P + T VGT Y++PE ++ + K D++S G++ E++ +P F
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--F-- 227
Query: 725 SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
S+ R +L ++ + + P +V+ L+ SP RP ++
Sbjct: 228 ---STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERP---EAINII 278
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 66/310 (21%), Positives = 107/310 (34%), Gaps = 43/310 (13%)
Query: 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSEN 135
+ LDL N ++ F L +L + L N +S I L+ L L +S+N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN 112
Query: 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
L IPP L S+L L ++ N + + L+++ + + N L + G
Sbjct: 113 HLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGA 168
Query: 196 LSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDN 255
L L +L +S L+G+ L L+L N
Sbjct: 169 FDGL----------------------KLNYLRISEAKLTGIPK---DLPETLNELHLDHN 203
Query: 256 QLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
++ I +E + S L L L NQ+ +L L L L L NKL + +P L
Sbjct: 204 KIQ--AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGL 260
Query: 315 GNLLKLHYLNLSNNQFRK------GFPVELEKLIQLSELDLSLNILEGKI--PCEICNME 366
+L L + L N K K + + L N + P +
Sbjct: 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 367 SLEKLNLSHN 376
+ +
Sbjct: 321 DRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 61/267 (22%), Positives = 100/267 (37%), Gaps = 23/267 (8%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L+ L L L NK++ +F L L +Y+ +N L IPP L L + +
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHD 132
Query: 135 NQLSGSIPP-TLGNLSNLAVLHLYGNSL-SGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS 192
N++ +P L N+ + + GN L + + L YL +S +L+G I
Sbjct: 133 NRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG---IP 188
Query: 193 LGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
L LHL N + +I L L LGL N + + S+ L L L+
Sbjct: 189 KDLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 252 LYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP-------RALGSLTELEYLDLSTN 304
L +N+LS +P + L L + L+ N + + + L N
Sbjct: 248 LDNNKLS--RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNN 304
Query: 305 KLGNSI--PETLGNLLKLHYLNLSNNQ 329
+ P T + + N +
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 16/294 (5%)
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L + S+ L ++P + + +L L N +S L+ L+ L L +N++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
S + L L L++ +N L IP L+ L + N + V L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHL-VEIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
N+ + + N L LNYL ++ +L +P+ L L L NK
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPK--DLPETLNELHLDHNK 204
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
+ E L KL+ L L +NQ R L L L EL L N L ++P + ++
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263
Query: 366 ESLEKLNLSHNNFSGLIPSCFEGMHG------LSCIDVSYNELRGPIPNSRIFQ 413
+ L+ + L NN + + + F + + I + N + F+
Sbjct: 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 80/280 (28%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELRH 573
++V Y IG G G K + + G+IL K+ + S+ E + V+E+ L EL+H
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKH 64
Query: 574 RSIVKFYGFCSHPRNSFL--VYEYLERGSLATILSNDGAI-----EEFNWTVRMNVIRSV 626
+IV++Y N+ L V EY E G LA++++ EEF V+ +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQL 120
Query: 627 ANALSYMH--HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
AL H D ++HRD+ NV L ++ DFG+A+ L D+S VGT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744
Y++PE + M EK D++S G L E+ P F ++ ++ +I + +
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F------TAFSQKELAGKIREGK 232
Query: 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P DEL I+ LN RP +V ++L
Sbjct: 233 FRRIPYRYSDELNEIIT---RMLNLKDYHRP---SVEEIL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 60/267 (22%), Positives = 109/267 (40%), Gaps = 18/267 (6%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
++ +LDLS N++ NL + L N ++ +I +L L HLDLS N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 137 LSGSIPP-TLGNLSNLAVLHLYGNSLSGSIP--SIIGNLKSLFYLHLSSNQLSGSIPI-S 192
LS ++ LS+L L+L GN ++ S+ +L L L + + I
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 193 LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
L+ L L + + L P L +++ + HL L ++ + + +++ L L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 253 YDNQLSVGEIP-IEIG------KLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
D L + G K + + + L+ + + L ++ L L+ S N+
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288
Query: 306 LGNSIPE-TLGNLLKLHYLNLSNNQFR 331
L S+P+ L L + L N +
Sbjct: 289 L-KSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 65/290 (22%), Positives = 106/290 (36%), Gaps = 25/290 (8%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
S LN SIP G + + L N ++ I + L L L+ N
Sbjct: 32 RNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNG 87
Query: 137 LSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL- 193
++ +I + +L +L L L N LS ++ S L SL +L+L N SL
Sbjct: 88 IN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLF 145
Query: 194 GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+L+ L +L + F I L L L + + L P S+ ++ N+ L L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 253 YDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGN--------LPRALGSLTELEYLDLST 303
+ Q + + SS+ L L L +L + ++
Sbjct: 206 HMKQHIL--LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 304 NKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELDLSLN 352
L + + L + L L S NQ K P ++L L ++ L N
Sbjct: 264 ESL-FQVMKLLNQISGLLELEFSRNQL-KSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 26/280 (9%)
Query: 115 ASIPPVIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNL 172
SIP + + + LDLS N+++ I L NL L L N ++ +I +L
Sbjct: 44 NSIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSL 99
Query: 173 KSLFYLHLSSNQLSGSIPISL-GNLSNLVVLHLFENSLFGSIP--SILGNLKMLLHLGLS 229
SL +L LS N LS ++ S LS+L L+L N ++ S+ +L L L +
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQILRVG 157
Query: 230 TNHLSGVIPLSI-GNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLP 287
I L L L + + L + + ++++L+L+ Q L
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQ--SYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 288 RALGSLTELEYLDLSTNKLG----NSIPE----TLGNLLKLHYLNLSNNQFRKGFPVELE 339
+ + +E L+L L + + +L + +++ + L
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLN 274
Query: 340 KLIQLSELDLSLNILEGKIPCEIC-NMESLEKLNLSHNNF 378
++ L EL+ S N L+ +P I + SL+K+ L N +
Sbjct: 275 QISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-32
Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 21/285 (7%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
S L+ SIP G + L L N ++ S + +L L L+SN ++ +
Sbjct: 35 ICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-T 90
Query: 189 IPI-SLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSI-GNLN 245
I S +L +L L L N L ++ S L L L L N + S+ +L
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149
Query: 246 NLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
L L + + + +I + L+ L L ++ + L P++L S+ + +L L
Sbjct: 150 KLQILRVGNMD-TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 305 KLGNSIPE----TLGNL--LKLHYLNLSNNQFRKGFPVE---LEKLIQLSELDLSLNILE 355
+ + E ++ L+L +L F + E L K + ++ L
Sbjct: 209 QH-ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 356 GKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
++ + + L +L S N + F+ + L I + N
Sbjct: 268 -QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 26/237 (10%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP--VIGNLKFLYHLD 131
+L SL LDLS N L ++ S F L++L + L N ++ + +L L L
Sbjct: 98 SLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILR 155
Query: 132 LSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIP 190
+ I L+ L L + + L P + +++++ +L L Q +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 191 ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
I + S++ L L + L + LS S+ +
Sbjct: 216 IFVDVTSSVECLELRDTDL----------------DTFHFSELSTGETNSLIKKFTFRNV 259
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNKL 306
+ D L ++ + ++S L L + NQL ++P LT L+ + L TN
Sbjct: 260 KITDESLF--QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 17/208 (8%)
Query: 210 FGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIG- 267
SIPS + +K L LS N ++ + + NL L L N ++ IE
Sbjct: 43 LNSIPSGLTEAVK---SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT----IEEDS 95
Query: 268 --KLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE--TLGNLLKLHYL 323
L SL +L L+ N L L+ L +L+L N ++ E +L KL L
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQIL 154
Query: 324 NLSNNQFRKGFPVE-LEKLIQLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNFSGL 381
+ N + L L EL++ + L+ + +++++ L L L
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILL 213
Query: 382 IPSCFEGMHGLSCIDVSYNELRGPIPNS 409
+ + + C+++ +L +
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSE 241
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 67/275 (24%), Positives = 103/275 (37%), Gaps = 39/275 (14%)
Query: 520 KYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF-VNEIKTLTELRHRSIV 577
+ +G G G V++ K +G AVKK V F V E+ L IV
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPRIV 113
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
YG + E LE GSL ++ G + E + + L Y+H
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR 170
Query: 638 FPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKPDSSNCTE-----LVGTFGYIAPEL 691
I+H D+ + NVLL D A + DFG A L+PD + + GT ++APE+
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751
V K D++S + L ++ G HP + I+ P PP
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEP--PPIREIPPS- 281
Query: 752 VQDELISIVEVAFL--CLNESPESRPPMHTVCQLL 784
+ + + L + P R + +L
Sbjct: 282 -----CAPLTAQAIQEGLRKEPVHRA---SAMELR 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 30/276 (10%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTEL 571
+ IG G G K G +K+ + E + E E+ L +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE---REESRREVAVLANM 80
Query: 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAI---EEFNWTVRMNVIRSVAN 628
+H +IV++ + ++V +Y E G L ++ + E+ + +
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFVQICL 136
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
AL ++H I+HRDI S+N+ L D ++ DFGIA+ L +GT Y++
Sbjct: 137 ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748
PE+ K D+++ G + E+ H F + + + +I+ P
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA--F------EAGSMKNLVLKIISGSFPPV 245
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ +L S+V +P RP +V +L
Sbjct: 246 SLHYSYDLRSLVS---QLFKRNPRDRP---SVNSIL 275
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 56/295 (18%), Positives = 110/295 (37%), Gaps = 58/295 (19%)
Query: 512 RATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQP--EFVNEIKTL 568
R F IG GG G V+KAK G+ +K+ V + E+K L
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---------VKYNNEKAEREVKAL 58
Query: 569 TELRHRSIVKFYGF----------------CSHPRNSFLVYEYLERGSLATILSNDGAI- 611
+L H +IV + G S + F+ E+ ++G+L +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 612 --EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669
+ + + + Y+H +++RD+ N+ L + ++ DFG+
Sbjct: 119 LDKVLAL----ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS 729
LK D GT Y++PE + + ++ D+Y+ G++ E++ S
Sbjct: 172 LKNDGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF--- 227
Query: 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ D + + ++++ L++ PE RP ++L
Sbjct: 228 -------FTDLRDGIISD---IFDKKEKTLLQ---KLLSKKPEDRP---NTSEIL 266
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 19/261 (7%)
Query: 78 SLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSEN 135
S + ++ L+ +P N L L N++ I +L L L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPSNTRYL---NLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 136 QLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI-S 192
+ I L++L L L+ N L+ IPS L L L L +N + SIP +
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 193 LGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
+ +L+ L L E I L L +L L ++ + L+ L L L
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLT--PLVGLEELE 224
Query: 252 LYDNQLSVGEIPIE-IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
+ N EI LSSL L + +Q+ A L L L+L+ N L +
Sbjct: 225 MSGNHFP--EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282
Query: 311 PETLGNLLKLHYLNLSNNQFR 331
+ L L L+L +N +
Sbjct: 283 HDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 54/213 (25%), Positives = 82/213 (38%), Gaps = 12/213 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
+L L L L +N + +F L +L + L+ N L+ IP L L L L
Sbjct: 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLR 155
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYG-NSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
N + SIP + +L L L L L +L YL+L + +P
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP- 212
Query: 192 SLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
+L L L L + N I L L L + + +S + + L +L+ L
Sbjct: 213 NLTPLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271
Query: 251 YLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQL 282
L N LS +P ++ L L L L+ N
Sbjct: 272 NLAHNNLS--SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 28/98 (28%), Positives = 43/98 (43%), Gaps = 4/98 (4%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNL 124
N+ + L L L++S N P SF L++L +++ + +S I L
Sbjct: 207 NIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGL 265
Query: 125 KFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSL 161
L L+L+ N LS S+P L L LHL+ N
Sbjct: 266 ASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 45/280 (16%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF---VNEIKTLTELR 572
+ IG G G+VY A + +G+ +A+++ + QP+ +NEI + E +
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQ------MNLQQQPKKELIINEILVMRENK 75
Query: 573 HRSIVKFYGFCSHPRNSFL--VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
+ +IV + S+ L V EYL GSL +++ E V R AL
Sbjct: 76 NPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV----CRECLQAL 129
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
++H + ++HRDI S N+LL +D +++DFG + P+ S + +VGT ++APE
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNISLNEILDPR 744
+V K D++S G++A+E+I+G+ +P + I+++ + P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-----------PE 235
Query: 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
L P+ + + CL E R + +LL
Sbjct: 236 LQN-PEKLSAIFRDFLN---RCLEMDVEKRG---SAKELL 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 19/261 (7%)
Query: 78 SLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSEN 135
S + + L +P N L L+ N + I +L+ L L LS N
Sbjct: 44 QFSKVICVRKNLR-EVPDGISTNTRLL---NLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 136 QLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL 193
+ +I L+NL L L+ N L+ +IP+ L L L L +N + SIP
Sbjct: 99 HIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYA 155
Query: 194 -GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
+ +L L L E I L L +L L+ +L + L+ L L L
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLT--PLIKLDELD 213
Query: 252 LYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
L N LS I L L L + +Q+ A +L L ++L+ N L
Sbjct: 214 LSGNHLSA--IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271
Query: 311 PETLGNLLKLHYLNLSNNQFR 331
+ L L ++L +N +
Sbjct: 272 HDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-33
Identities = 67/256 (26%), Positives = 112/256 (43%), Gaps = 13/256 (5%)
Query: 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLS 186
+ L +P + +N +L+L+ N + + +L+ L L LS N +
Sbjct: 45 FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 187 GSIPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
+ L+NL L LF+N L +IP+ L L L L N + + + +
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIP 160
Query: 246 NLIGLYLYD-NQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLST 303
+L L L + +LS I LS+L YL L L +P L L +L+ LDLS
Sbjct: 161 SLRRLDLGELKRLS--YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216
Query: 304 NKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEIC 363
N L P + L+ L L + +Q + + L L E++L+ N L +P ++
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLF 275
Query: 364 -NMESLEKLNLSHNNF 378
+ LE+++L HN +
Sbjct: 276 TPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 12/213 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
+L+ L L LS+N + +F L NL + L+ N L+ +IP L L L L
Sbjct: 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYG-NSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI 191
N + SIP + +L L L LS L +L YL+L+ L IP
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP- 201
Query: 192 SLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
+L L L L L N L +I L L L + + + + + NL +L+ +
Sbjct: 202 NLTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 251 YLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQL 282
L N L+ +P ++ L L + L+ N
Sbjct: 261 NLAHNNLT--LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 7/161 (4%)
Query: 245 NNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
N + L E+P I ++ L L+ NQ+ + L LE L LS N
Sbjct: 43 NQFSKVICVRKNLR--EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 305 KLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI-C 363
+ L L+ L L +N+ L +L EL L N +E IP
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 364 NMESLEKLNLSHNN-FSGLIPSCFEGMHGLSCIDVSYNELR 403
+ SL +L+L S + FEG+ L ++++ LR
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 4/98 (4%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNL 124
NL + L L LDLS N L+ P SF L +L +++ ++ + I NL
Sbjct: 196 NLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNL 254
Query: 125 KFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSL 161
+ L ++L+ N L+ +P L +L +HL+ N
Sbjct: 255 QSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 24/274 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F ++ IG G VY+A L G +A+KK + + + + EI L +L H +
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAI-----EEFNWTVRMNVIRSVANAL 630
++K+Y +V E + G L+ ++ + E W + +AL
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSAL 149
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
+MH ++HRDI NV + ++ D G+ +F ++ LVGT Y++PE
Sbjct: 150 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750
++ K D++S G L E+ P F + ++ P P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP--F---YGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ +EL +V +C+N PE RP V +
Sbjct: 262 HYSEELRQLVN---MCINPDPEKRP---DVTYVY 289
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 45/280 (16%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF---VNEIKTLTELR 572
D IG G G V A+ SG +AVK ++ Q NE+ + + +
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKM------MDLRKQQRRELLFNEVVIMRDYQ 100
Query: 573 HRSIVKFYGFCSHPRNSFL--VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
H ++V+ Y S+ L + E+L+ G+L I+S + E V +V AL
Sbjct: 101 HFNVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIAT---VCEAVLQAL 154
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
+Y+H ++HRDI S ++LL LD ++SDFG + D LVGT ++APE
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNISLNEILDPR 744
++ + D++S G++ +E++ G+ P + + S P+
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-----------PK 260
Query: 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
L V L +E L P+ R T +LL
Sbjct: 261 LKN-SHKVSPVLRDFLE---RMLVRDPQERA---TAQELL 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 43/279 (15%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPE-FVNEIKTLTELRHR 574
FDV +G G GSVYKA +G+I+A+K+ + + + EI + +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ------VPVESDLQEIIKEISIMQQCDSP 84
Query: 575 SIVKFYGFCSHPRNSFL--VYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALS 631
+VK+YG S+ +N+ L V EY GS++ I+ + + E +++S L
Sbjct: 85 HVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---ILQSTLKGLE 139
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
Y+H +HRDI + N+LL + A+++DFG+A L + ++GT ++APE+
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNISLNEILDPRL 745
+ + D++S G+ A+E+ +G HP I I ++ P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-----------PTF 245
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P+ D V+ CL +SPE R T QLL
Sbjct: 246 -RKPELWSDNFTDFVK---QCLVKSPEQRA---TATQLL 277
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 67/281 (23%), Positives = 106/281 (37%), Gaps = 17/281 (6%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
+ L ++P + + + L+GN +S + ++L L L SN L+
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 189 IPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247
+ L+ L L L +N+ S+ L L L L L + P L L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 248 IGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL 306
LYL DN L +P + L +L +L L+GN++ RA L L+ L L N++
Sbjct: 132 QYLYLQDNALQ--ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 307 GNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
+ +L +L L L N L L L L L+ N C+ C
Sbjct: 190 -AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV----CD-CRA 243
Query: 366 ESLEKLNLSHNNFSGLIPSCF--EGMHGLSCIDVSYNELRG 404
L L S C + + G ++ N+L+G
Sbjct: 244 RPL-WAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
+ + L N+++ SF NL I++L+ N L+ I L L LDLS+N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNA 91
Query: 137 LSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI-SL 193
S+ P T L L LHL L + + L +L YL+L N L ++P +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 194 GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+L NL L L N + S+P L L L L N ++ V P + +L L+ LYL
Sbjct: 150 RDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 253 YDNQLSVGEIPIEI-GKLSSLNYLVLNGNQL 282
+ N LS +P E L +L YL LN N
Sbjct: 209 FANNLS--ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 15/230 (6%)
Query: 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGS 140
T + L ++P ++L+ N +S + L L L N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-R 70
Query: 141 IPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI-SLGNLS 197
I L+ L L L N+ S+ L L LHL L + L+
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA 129
Query: 198 NLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256
L L+L +N+L ++P +L L HL L N +S V + L++L L L+ N+
Sbjct: 130 ALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 257 LSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTN 304
++ + L L L L N L LP AL L L+YL L+ N
Sbjct: 189 VA--HVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 7/187 (3%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
++L+ L L N L +F L L + L N+ S+ P L L+ L L
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI 191
L + P L+ L L+L N+L ++P +L +L +L L N++S
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 192 SLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
+ L +L L L +N + + +L L+ L L N+LS + ++ L L L
Sbjct: 172 AFRGLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 251 YLYDNQL 257
L DN
Sbjct: 231 RLNDNPW 237
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 62/255 (24%), Positives = 121/255 (47%), Gaps = 19/255 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L + + K+ + ++ + +L + + + ++ +I + L L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
NQ++ + P L NL+ + L L GN L ++ +I L+S+ L L+S Q++ P++
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLK-NVSAI-AGLQSIKTLDLTSTQITDVTPLA-- 126
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
LSNL VL+L N + +I L L L +L + +S + PL+ NL+ L L D
Sbjct: 127 GLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADD 182
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
N++S +I + L +L + L NQ+ ++ L + + L + L+ + N
Sbjct: 183 NKIS--DIS-PLASLPNLIEVHLKNNQI-SDVS-PLANTSNLFIVTLTNQTITNQPVFYN 237
Query: 315 GNLLKLHYLNLSNNQ 329
NL+ + + +
Sbjct: 238 NNLVVPNVVKGPSGA 252
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 21/265 (7%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
N++ + +L ++TL + +I L NL + L N ++ + P + NL
Sbjct: 30 NVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT-DLAP-LKNLT 85
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
+ L+LS N L ++ + L ++ L L ++ P + L +L L+L NQ+
Sbjct: 86 KITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI 141
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
+ +I L L+NL L + + S + L NL L L N +S + PL+ +L
Sbjct: 142 T-NIS-PLAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKISDISPLA--SLP 195
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
NLI ++L +NQ+S + S+L + L + + L ++
Sbjct: 196 NLIEVHLKNNQISDVS---PLANTSNLFIVTLTNQTITNQ---PVFYNNNLVVPNVVKGP 249
Query: 306 LGNSI-PETLGNLLKLHYLNLSNNQ 329
G I P T+ + NL+ N
Sbjct: 250 SGAPIAPATISDNGTYASPNLTWNL 274
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/239 (23%), Positives = 106/239 (44%), Gaps = 19/239 (7%)
Query: 145 LGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHL 204
L+N + ++++ ++ +L + L ++ +I + L+NL+ L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70
Query: 205 FENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPI 264
+N + + + L NL + L LS N L V ++ L ++ L L Q++ ++
Sbjct: 71 KDNQI--TDLAPLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQIT--DVT- 123
Query: 265 EIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLN 324
+ LS+L L L+ NQ+ N+ L LT L+YL + ++ + P L NL KL L
Sbjct: 124 PLAGLSNLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 325 LSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIP 383
+N+ P L L L E+ L N + P + N +L + L++ +
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 55/241 (22%), Positives = 99/241 (41%), Gaps = 21/241 (8%)
Query: 164 SIPSIIG--NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLK 221
+I I L + + + ++ ++ + +L + L F + +I + L
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV-TTI-EGVQYLN 63
Query: 222 MLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQ 281
L+ L L N ++ + PL NL + L L N L + I L S+ L L Q
Sbjct: 64 NLIGLELKDNQITDLAPLK--NLTKITELELSGNPLK--NVS-AIAGLQSIKTLDLTSTQ 118
Query: 282 LYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKL 341
+ P L L+ L+ L L N++ N P L L L YL++ N Q P L L
Sbjct: 119 ITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANL 172
Query: 342 IQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNE 401
+L+ L N + I + ++ +L +++L +N S + P L + ++
Sbjct: 173 SKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQT 228
Query: 402 L 402
+
Sbjct: 229 I 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 20/221 (9%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
NL ++ L+LS N L + L ++ + L ++ + P + L L L L
Sbjct: 82 KNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLD 137
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
NQ++ +I P L L+NL L + +S P + NL L L N++S I L
Sbjct: 138 LNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PL 191
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
+L NL+ +HL N + S S L N L + L+ ++ NL +
Sbjct: 192 ASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGP 249
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT 294
PI +S + L NL + +++
Sbjct: 250 SGA------PIAPATIS--DNGTYASPNLTWNLTSFINNVS 282
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 51/287 (17%), Positives = 98/287 (34%), Gaps = 39/287 (13%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ +G GG V + L G A+K+ E + E E H +
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPN 87
Query: 576 IVKFYGFCSHPRNS----FLVYEYLERGSLATIL----SNDGAIEEFNWTVRMNVIRSVA 627
I++ +C R + +L+ + +RG+L + + E + + ++ +
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED--QI-LWLLLGIC 144
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL------- 680
L +H HRD+ N+LL + + + D G +
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 681 --VGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735
T Y APEL + E+ DV+S G + ++ G+ P + S
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALA 259
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
N++ P+ P + L++ + P RP + +
Sbjct: 260 VQNQLSIPQSPRHSSALWQ-LLNS------MMTVDPHQRPHIPLLLS 299
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-33
Identities = 69/362 (19%), Positives = 134/362 (37%), Gaps = 22/362 (6%)
Query: 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ 136
+ + L++S+N ++ +L+ L I+ + N + V + L +LDLS N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 137 LSGSIPPTLGNLSNLAVLHLYGNSL-SGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
L I NL L L N+ + I GN+ L +L LS+ L S + + +
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 196 LSNL-VVLHLFENSLFGSIPSILGNLKML-LHLGLSTNHLSGVIP------LSIGNLNNL 247
L+ V+L L E P L + LH+ TN I ++ L+N+
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 248 IGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSL---TELEYLDLSTN 304
+ + I ++ L+ L LN + N + L T + Y +S
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 305 KLG-----NSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP 359
KL + +L L + ++ F E ++ + +++
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317
Query: 360 CEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEA 419
+ L+ S+N + + + L + + N+L+ + + M++
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT--TQMKS 375
Query: 420 LQ 421
LQ
Sbjct: 376 LQ 377
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 67/352 (19%), Positives = 120/352 (34%), Gaps = 28/352 (7%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFS--FGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLD 131
+L LDLS N + ++P FGN++ L + L L S I +L L
Sbjct: 87 HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145
Query: 132 LSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSII-----GNLKSLFYLHLSSNQLS 186
+ P L + L+ + I + +L ++
Sbjct: 146 VLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 187 GSIPISLGNLSNLVVLHLFENSLFG-------SIPSILGNLKM--LLHLGLSTNHLSGVI 237
L L+ L N S IL + + + +S L G +
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263
Query: 238 PLSIGNL--NNLIGLYLYDNQLSVGEIPIEIG--KLSSLNYLVLNGNQLYGNLPRALGSL 293
+ +L L ++ V P S++N + +
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI 323
Query: 294 TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE--LEKLIQLSELDLSL 351
+ +LD S N L +++ E G+L +L L L NQ ++ + ++ L +LD+S
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ 383
Query: 352 NILEGKIPCEIC-NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
N + C +SL LN+S N + I C + +D+ N++
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-29
Identities = 67/372 (18%), Positives = 123/372 (33%), Gaps = 50/372 (13%)
Query: 74 GNLKSLSTLDLSKNKL----------------------NGSIPFSFGNLTNLAIMYLYRN 111
GN+ L L LS L L + L+
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171
Query: 112 SLSASIPPVIGNLKFLYHLDLSENQLSG-----------SIPPTLGNLSNLAVLHLYGNS 160
+ I ++ +L + + SI L L+ L L
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
Query: 161 LSGSIPSIIGNL---KSLFYLHLSSNQLSG-----SIPISLGNLSNLVVLHLFENSLFGS 212
+ + I L +++Y +S+ +L G S +L L + + +
Sbjct: 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291
Query: 213 IPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSS 271
I + + + V L ++ + L +N L+ + E G L+
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT--DTVFENCGHLTE 349
Query: 272 LNYLVLNGNQL--YGNLPRALGSLTELEYLDLSTNKLGNSIP-ETLGNLLKLHYLNLSNN 328
L L+L NQL + + L+ LD+S N + L LN+S+N
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
Query: 329 QFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEG 388
L ++ LDL N ++ IP ++ +E+L++LN++ N + F+
Sbjct: 410 ILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR 466
Query: 389 MHGLSCIDVSYN 400
+ L I + N
Sbjct: 467 LTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 65/339 (19%), Positives = 131/339 (38%), Gaps = 29/339 (8%)
Query: 65 INLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLS---------- 114
+ T G K + + L + + F + ++++ + LS
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 115 ----ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNL---SNLAVLHLYGNSLSGSIPS 167
SI + L +L L+ + + + + L + + + L G +
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 168 IIG-----NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKM 222
+LK+L + S+ SN+ + + + +
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325
Query: 223 LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL-SVGEIPIEIGKLSSLNYLVLNGNQ 281
LHL S N L+ + + G+L L L L NQL + +I ++ SL L ++ N
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 282 LYGNLPR-ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEK 340
+ + + L L++S+N L ++I L ++ L+L +N+ + P ++ K
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVK 442
Query: 341 LIQLSELDLSLNILEGKIPCEIC-NMESLEKLNLSHNNF 378
L L EL+++ N L+ +P I + SL+K+ L N +
Sbjct: 443 LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 57/317 (17%), Positives = 109/317 (34%), Gaps = 17/317 (5%)
Query: 26 SWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLS 85
F + S ++ I+C S LS + LS L L+
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
Query: 86 KNKLNGSIPFSFGNL---TNLAIMYLYRNSL-----SASIPPVIGNLKFLYHLDLSENQL 137
+ + L T + + L +LK L + +
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLS 197
SN+ + + + + +L S+N L+ ++ + G+L+
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT 348
Query: 198 NLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTNHLSGVIPLSI-GNLNNLIGLYLYD 254
L L L N L I + +K L L +S N +S +L+ L +
Sbjct: 349 ELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-T 313
N L+ I + L L+ N++ ++P+ + L L+ L++++N+L S+P+
Sbjct: 409 NILTDT---IFRCLPPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQL-KSVPDGI 463
Query: 314 LGNLLKLHYLNLSNNQF 330
L L + L N +
Sbjct: 464 FDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 65/316 (20%), Positives = 120/316 (37%), Gaps = 29/316 (9%)
Query: 108 LYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS 167
+N L +P + + L++S+N +S + +LS L +L + N + S
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 168 IIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP--SILGNLKMLLH 225
+ + L YL LS N+L IS NL L L N+ ++P GN+ L
Sbjct: 64 VFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKF 119
Query: 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKL--SSLNYLVLNGNQLY 283
LGLST HL L I +LN L + E P + SL+ + + +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 284 GNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK-----------LHYLNLSNNQFRK 332
L ++ ++ LE ++ N L L K L+ + + N F +
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 333 GFPVELEKLIQLSELDLSLNILEGKIPCEI-----CNMESLEKLNLSHNNFSGLIPSCFE 387
+L + +S L+G++ ++++L + + F +E
Sbjct: 240 IL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 388 GMHGLSCIDVSYNELR 403
++ + + + R
Sbjct: 298 IFSNMNIKNFTVSGTR 313
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 61/263 (23%), Positives = 118/263 (44%), Gaps = 29/263 (11%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV----NEIKTLTELRHRSIV 577
+G GG +VY A+ +A+K + E + E+ ++L H++IV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFI----PPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+LV EY+E +L+ + + G + + +N + + + + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL---SVDTAINFTNQILDGIKHAHDM- 130
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE---LVGTFGYIAPELVYT 694
IVHRDI +N+L+ + ++ DFGIAK L ++ T+ ++GT Y +PE
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754
E D+YS G++ E++ G+ P + +++S I++ I D +P +V+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDS-VPNVTTDVRK 238
Query: 755 EL-ISIVEVAFLCLNESPESRPP 776
++ S+ V + +R
Sbjct: 239 DIPQSLSNVILRATEKDKANRYK 261
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 40/277 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F IG G G V+K + +++A+K L E + + EI L++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIE-DIQQEITVLSQCDSPY 81
Query: 576 IVKFYGFCSHPRNSFL--VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+ K+YG S+ +++ L + EYL GS +L G ++E ++R + L Y+
Sbjct: 82 VTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIAT---ILREILKGLDYL 135
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H + +HRDI + NVLL E +++DFG+A L VGT ++APE++
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 694 TMKVTEKCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNISLNEILDPRLPT 747
K D++S G+ A+E+ +G+ HP + I ++ P L
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-----------PTLE- 240
Query: 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
N L VE CLN+ P RP T +LL
Sbjct: 241 --GNYSKPLKEFVE---ACLNKEPSFRP---TAKELL 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 63/276 (22%), Positives = 105/276 (38%), Gaps = 40/276 (14%)
Query: 522 CIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
+G G G VY + L++ +A+K+ EI L+H++IV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLH--EEIALHKHLKHKNIVQYL 85
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
G S + E + GSL+ +L + + N + + L Y+H +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 641 IVHRDISSKNVLL-CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKV-- 697
IVHRDI NVL+ ++SDFG +K L + GT Y+APE++
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 698 TEKCDVYSFGVLALEVIKGDHPRDFISS-------ISSSSSNRNISLNEILDPRLPTPPQ 750
+ D++S G +E+ G P + + + P +P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH----------PEIP---- 248
Query: 751 NVQDELISIVEVAFL--CLNESPESRPPMHTVCQLL 784
E +S AF+ C P+ R LL
Sbjct: 249 ----ESMSAEAKAFILKCFEPDPDKRA---CANDLL 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 44/282 (15%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRS--IV 577
IG GG V++ +I A+K + + NEI L +L+ S I+
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 91
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HD 636
+ Y + + ++V E L + L +I+ W + + +++ A+ +H H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERK-SYWKNMLEAVHTIHQHG 147
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC--TELVGTFGYIAPELV-- 692
IVH D+ N L+ D ++ DFGIA ++PD+++ VGT Y+ PE +
Sbjct: 148 ----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 693 ---------YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743
K++ K DV+S G + + G P F N+ L+ I+DP
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDP 255
Query: 744 RLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P + +L +++ CL P+ R ++ +LL
Sbjct: 256 NHEIEFPDIPEKDLQDVLK---CCLKRDPKQRI---SIPELL 291
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 34/272 (12%)
Query: 523 IGIGGQGSVYKAKLTSGEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIVKFY 580
IG G G V+ +L + L AVK +F+ E + L + H +IV+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
G C+ + ++V E ++ G T L +G + ++ A + Y+ C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY--IAPELVYTMKVT 698
+HRD++++N L+ ++SDFG+++ + + APE + + +
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 699 EKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQNV 752
+ DV+SFG+L E G P N+S + + RLP P+
Sbjct: 294 SESDVWSFGILLWETFSLGASPYP------------NLSNQQTREFVEKGGRLP-CPELC 340
Query: 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
D + ++E C P RP T+ Q L
Sbjct: 341 PDAVFRLME---QCWAYEPGQRPSFSTIYQEL 369
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 75/297 (25%), Positives = 133/297 (44%), Gaps = 49/297 (16%)
Query: 507 YEEIVRATN---GFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPE-- 560
YE + R + +++ +G G G VYKAK +G + A K E + E
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV------IETKSEEELE 61
Query: 561 -FVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTV 618
++ EI+ L H IVK G H +++ E+ G++ I+ D + E V
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 619 RMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678
V R + AL+++H I+HRD+ + NVL+ L+ + R++DFG++
Sbjct: 122 ---VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175
Query: 679 ELVGTFGYIAPELVYTMKVTE-----KCDVYSFGVLALEVIKGD------HPRDFISSIS 727
+GT ++APE+V + + K D++S G+ +E+ + + +P + I+
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235
Query: 728 SSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
S P L T P E ++ + L+++PE+RP + QLL
Sbjct: 236 KSDP-----------PTLLT-PSKWSVEFRDFLK---IALDKNPETRP---SAAQLL 274
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 44/282 (15%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRS--IV 577
IG GG V++ +I A+K + + NEI L +L+ S I+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 72
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HD 636
+ Y + + ++V E L + L +I+ W + + +++ A+ +H H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERK-SYWKNMLEAVHTIHQHG 128
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC--TELVGTFGYIAPELV-- 692
IVH D+ N L+ D ++ DFGIA ++PD+++ VGT Y+ PE +
Sbjct: 129 ----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 693 ---------YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743
K++ K DV+S G + + G P F N+ L+ I+DP
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDP 236
Query: 744 RLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P + +L +++ CL P+ R ++ +LL
Sbjct: 237 NHEIEFPDIPEKDLQDVLK---CCLKRDPKQRI---SIPELL 272
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 65/265 (24%), Positives = 107/265 (40%), Gaps = 14/265 (5%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F+ +G G G V+K SG ++A K H L + + + + E++ L E
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAI-RNQIIRELQVLHECNSPY 92
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
IV FYG + E+++ GSL +L G I E + V +V L+Y+
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLRE 149
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
I+HRD+ N+L+ E ++ DFG++ L S VGT Y++PE +
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGT 205
Query: 696 KVTEKCDVYSFGVLALEVIKGDHP----RDFISSISSSSSNRNISLNEILDPRLPTPPQN 751
+ + D++S G+ +E+ G +P + + PR P P N
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 752 VQDELISIVEVAFLCLNESPESRPP 776
F L+ PP
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPP 290
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 70/307 (22%), Positives = 114/307 (37%), Gaps = 61/307 (19%)
Query: 512 RATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE 570
R + F+ +G G G V KA+ A+KK ++E+ L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLAS 58
Query: 571 LRHRSIVKFYGFCSHPRNS-------------FLVYEYLERGSLATILSNDGAI--EEFN 615
L H+ +V++Y RN F+ EY E G+L ++ ++ +
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 616 WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD-- 673
W + R + ALSY+H I+HRD+ N+ + ++ DFG+AK +
Sbjct: 119 W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 674 ------------SSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPR 720
S N T +GT Y+A E++ EK D+YS G++ E+I
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST- 230
Query: 721 DFISSISSSSSNRNISLNEILDPRLPTPPQ---NVQDELISIVEVAFLCLNESPESRPPM 777
R L ++ + PP N I+ L ++ P RP
Sbjct: 231 ---------GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRP-- 276
Query: 778 HTVCQLL 784
LL
Sbjct: 277 -GARTLL 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-31
Identities = 60/283 (21%), Positives = 109/283 (38%), Gaps = 42/283 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRS 575
F K +G G +G++ + +AVK+ E + E++ L E H +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP----ECFSFAD--REVQLLRESDEHPN 79
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLA-TILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+++++ + ++ E +L + D A + +++ + L+++H
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 635 HDCFPPIVHRDISSKNVLLCLDYE-----ARVSDFGIAKFLKPDSSNCTEL---VGTFGY 686
IVHRD+ N+L+ + A +SDFG+ K L + + GT G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 687 IAPELV---YTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILD 742
IAPE++ T D++S G + VI +G HP S NI L
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG-----KSLQRQANI-LLGACS 246
Query: 743 PRLPTPPQNVQDE---LISIVEVAFLCLNESPESRPPMHTVCQ 782
P ++ LI + P+ RP V +
Sbjct: 247 LDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHVLK 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRS--IV 577
IG GG V++ +I A+K + + NEI L +L+ S I+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 119
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HD 636
+ Y + + ++V E L + L +I+ W + + +++ A+ +H H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERK-SYWKNMLEAVHTIHQHG 175
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE--LVGTFGYIAPELV-- 692
IVH D+ N L+ +D ++ DFGIA ++PD+++ + VG Y+ PE +
Sbjct: 176 ----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 693 ---------YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743
K++ K DV+S G + + G P F N+ L+ I+DP
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDP 283
Query: 744 RLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P + +L +++ CL P+ R ++ +LL
Sbjct: 284 NHEIEFPDIPEKDLQDVLK---CCLKRDPKQRI---SIPELL 319
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 65/278 (23%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F IG G G+VY A+ + + E++A+KK + + E++ L +LRH +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
+++ G ++LV EY + + + ++E V L+Y+H
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 172
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
++HRD+ + N+LL ++ DFG A + P +S VGT ++APE++ M
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 225
Query: 696 KVTE---KCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNISLNEILDPRLP 746
+ K DV+S G+ +E+ + + + I+ + S P L
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------PALQ 274
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + + + V+ CL + P+ RP T LL
Sbjct: 275 SG--HWSEYFRNFVD---SCLQKIPQDRP---TSEVLL 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV----NEIKTLTELRHRSIV 577
+G GG V+ A+ L +AVK + ++ P F E + L H +IV
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRA----DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 578 KFY--GFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
Y G P ++V EY++ +L I+ +G + + VI AL++
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQALNFS 132
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE---LVGTFGYIAPE 690
H + I+HRD+ N+++ +V DFGIA+ + ++ T+ ++GT Y++PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
V + DVYS G + EV+ G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 24/207 (11%)
Query: 523 IGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFV----NEIKTLTELRHRSIV 577
+G GG G VY+A+ T I+A+K + P F E +T L+ +V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSE----TLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANALSYMHH 635
+ F ++ + LA +L G + + ++R + +AL H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPL-----APPRAVAIVRQIGSALDAAHA 152
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE---LVGTFGYIAPELV 692
HRD+ +N+L+ D A + DFGIA T+ VGT Y+APE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERF 207
Query: 693 YTMKVTEKCDVYSFGVLALEVIKGDHP 719
T + D+Y+ + E + G P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 50/289 (17%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHR 574
F++ +G G G VYK + + +G++ A+K + E EI L + HR
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLKKYSHHR 81
Query: 575 SIVKFYG--FCSHPRNS----FLVYEYLERGSLATILSN--DGAIEEFNWTVRMNVIRSV 626
+I +YG +P +LV E+ GS+ ++ N ++E + R +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---ICREI 138
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY 686
LS++H ++HRDI +NVLL + E ++ DFG++ L +GT +
Sbjct: 139 LRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195
Query: 687 IAPELVYTMKVTE-----KCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNI 735
+APE++ + + K D++S G+ A+E+ +G HP + I + +
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA---- 251
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
PRL + + S +E CL ++ RP QL+
Sbjct: 252 -------PRL--KSKKWSKKFQSFIE---SCLVKNHSQRP---ATEQLM 285
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 21/256 (8%)
Query: 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182
+L + ++ T L+++ + + + S+ I L ++ L L+
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
N+L+ I L NL NL L L EN + + S L +LK L L L N +S + L
Sbjct: 75 NKLT-DIK-PLTNLKNLGWLFLDENKI-KDLSS-LKDLKKLKSLSLEHNGISDINGLV-- 128
Query: 243 NLNNLIGLYLYDNQLSVGEIPIE-IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDL 301
+L L LYL +N+++ I + +L+ L+ L L NQ+ ++ L LT+L+ L L
Sbjct: 129 HLPQLESLYLGNNKITD----ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 182
Query: 302 STNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCE 361
S N + S L L L L L + + L+ + + + L P
Sbjct: 183 SKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEI 238
Query: 362 ICNMESLEKLNLSHNN 377
I + EK N+ +
Sbjct: 239 ISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 60/254 (23%), Positives = 104/254 (40%), Gaps = 19/254 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+L K + ++ + L ++ + + + S+ I L + L L+
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
N+L+ I P L NL NL L L N + + S + +LK L L L N +S I L
Sbjct: 75 NKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLV 128
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
+L L L+L N + + ++L L L L L N +S ++PL+ L L LYL
Sbjct: 129 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSK 184
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
N +S ++ + L +L+ L L + +L + + L PE +
Sbjct: 185 NHIS--DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEII 239
Query: 315 GNLLKLHYLNLSNN 328
+ N+ +
Sbjct: 240 SDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 2e-26
Identities = 58/304 (19%), Positives = 110/304 (36%), Gaps = 43/304 (14%)
Query: 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLS 186
+ + I P + +L S++ ++ L S+ + +++ +
Sbjct: 1 MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 187 GSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN 246
S+ + L N+ L L+ N L+ + PL+ NL N
Sbjct: 57 -----SVQGIQYLP------------------NVT---KLFLNGNKLTDIKPLT--NLKN 88
Query: 247 LIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL 306
L L+L +N++ ++ + L L L L N + ++ L L +LE L L NK+
Sbjct: 89 LGWLFLDENKIK--DLS-SLKDLKKLKSLSLEHNGI-SDIN-GLVHLPQLESLYLGNNKI 143
Query: 307 GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNME 366
+ L L KL L+L +NQ P L L +L L LS N + + + ++
Sbjct: 144 --TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLK 197
Query: 367 SLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGL 426
+L+ L L + + + + + L P S Y+
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEF 257
Query: 427 CGDI 430
++
Sbjct: 258 TNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 27/119 (22%), Positives = 44/119 (36%), Gaps = 6/119 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L L TL L N+++ I LT L +YL +N +S + + LK L L+L
Sbjct: 151 RLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 206
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL 193
+ NL + SL P II + ++ + + +S
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
S LDLS N L +SF + L ++ L R + +I +L L L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 137 LSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPIS-- 192
+ S+ LS+L L +L+ S+ + IG+LK+L L+++ N + S +
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144
Query: 193 LGNLSNLVVLHLFENSLFGSIP----SILGNLKML-LHLGLSTNHLSGVIPLSIGNLNNL 247
NL+NL L L N + SI +L + +L L L LS N ++ + P + + L
Sbjct: 145 FSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RL 202
Query: 248 IGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGN 280
L L NQL +P I +L+SL + L+ N
Sbjct: 203 KELALDTNQLKS--VPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 11/219 (5%)
Query: 140 SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL-GNLSN 198
IP L + L L N L + L L LS ++ +I +LS+
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 199 LVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL 257
L L L N + S+ L L L +L+ + IG+L L L + N +
Sbjct: 78 LSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 258 SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY----LDLSTNKLGNSIPET 313
++P L++L +L L+ N++ L L ++ LDLS N + N I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPG 195
Query: 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352
++L L L NQ + ++L L ++ L N
Sbjct: 196 AFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 17/214 (7%)
Query: 101 TNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYG 158
+ + L N L + + L LDLS ++ +I +LS+L+ L L G
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 159 NSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIP-ISLGNLSNLVVLHLFENSLFGSIPS- 215
N + S+ L SL L L+ S+ +G+L L L++ N + S
Sbjct: 86 NPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI-QSFKLP 142
Query: 216 -ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL----IGLYLYDNQLSVGEIPIEIGKLS 270
NL L HL LS+N + + + L+ + + L L N ++ I K
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN--FIQPGAFKEI 200
Query: 271 SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
L L L+ NQL LT L+ + L TN
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 60/247 (24%), Positives = 92/247 (37%), Gaps = 30/247 (12%)
Query: 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS- 215
+ IP + S L LS N L S + L VL L + +I
Sbjct: 15 MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDG 70
Query: 216 ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNY 274
+L L L L+ N + + + L++L L + L+ + G L +L
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA--SLENFPIGHLKTLKE 128
Query: 275 LVLNGNQL-YGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKG 333
L + N + LP +LT LE+LDLS+NK+ + L L ++ LNL
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL-------- 180
Query: 334 FPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLS 393
LDLSLN + I L++L L N + F+ + L
Sbjct: 181 ------------SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQ 227
Query: 394 CIDVSYN 400
I + N
Sbjct: 228 KIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 16/167 (9%)
Query: 75 NLKSLSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
+L LSTL L+ N + S+ +F L++L + +L+ S+ IG+LK L L++
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNV 131
Query: 133 SENQLSGSIPP--TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSL----FYLHLSSNQL 185
+ N + S NL+NL L L N + SI + L + L LS N +
Sbjct: 132 AHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTN 231
+ I L L L N L S+P I L L + L TN
Sbjct: 190 N-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 14/163 (8%)
Query: 250 LYLYDNQLSVGEIPIEIG---KLSSLNYLVLNGNQLYGNLP-RALGSLTELEYLDLSTNK 305
L L N L + L L L+ ++ + A SL+ L L L+ N
Sbjct: 33 LDLSFNPLRH----LGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN-ILEGKIPCEICN 364
+ + L L L + L L EL+++ N I K+P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 365 MESLEKLNLSHNNFSGLIPSCFEGMHGLSCI----DVSYNELR 403
+ +LE L+LS N + + +H + + D+S N +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 25/111 (22%), Positives = 48/111 (43%), Gaps = 2/111 (1%)
Query: 294 TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNI 353
+ LDLS N L + + + +L L+LS + + + L LS L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 354 LEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
++ + + SL+KL N + L + L ++V++N ++
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 75/390 (19%), Positives = 139/390 (35%), Gaps = 35/390 (8%)
Query: 39 SFYSKIKISPCAWFGIQ--CNPAKRV--ISINLSTVGLKGNLKSLSTLDLSKNKLNGSIP 94
SF+ ++ V + NL+ V K L LS+N ++
Sbjct: 11 SFHFVCALALIVGSMTPFSNELESMVDYSNRNLTHV-PKDLPPRTKALSLSQNSISELRM 69
Query: 95 FSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV 153
L+ L ++ L N + S+ V + L +LD+S N+L +I +++L
Sbjct: 70 PDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRH 125
Query: 154 LHLYGNSLSGSIP--SIIGNLKSLFYLHLSSNQLSGSIPISLGNLS-NLVVLHLFENSLF 210
L L N +P GNL L +L LS+ + + + +L + ++L L +
Sbjct: 126 LDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184
Query: 211 GSIPSILGNLKM-LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL------SVGEIP 263
G L +LHL N L V ++N L L L + +L +
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVN--MSVNALGHLQLSNIKLNDENCQRLMTFL 242
Query: 264 IEIGKLSSLNYLVLNGNQLYGNLPRALGSL---TELEYLDLSTNKLGNSIPETLGN---- 316
E+ + +L + L + L +EYL++ + I
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET 302
Query: 317 -LLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEIC--NMESLEKLNL 373
L L ++ N F +++ LS++ + +C + S LN
Sbjct: 303 ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS--DTPFIHMVCPPSPSSFTFLNF 360
Query: 374 SHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ N F+ + + L + + N L+
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 69/348 (19%), Positives = 114/348 (32%), Gaps = 26/348 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L L L LS N++ S+ F F +L + + N L +I + L HLDLS
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLS 129
Query: 134 ENQLSGSIPPT--LGNLSNLAVLHLYGNSL-SGSIPSIIGNLKSLFYLHLSSNQLSGSIP 190
N +P GNL+ L L L + + S L L S + G
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 191 ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNL------ 244
SL N VLHL + + ++ L HL LS L+ +
Sbjct: 189 ESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247
Query: 245 -NNLIGLYLYDNQLSVGEIP--IEIGKLSSLNYLVLNGNQLYGNLPRALG-----SLTEL 296
L+ + L + + + + YL + + + R +L L
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307
Query: 297 EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356
+ S +++ LS + V + L+ + N+
Sbjct: 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD 367
Query: 357 KIPCEICNMESLEKLNLSHNNFSGL--IPSCFEGMHGLSCIDVSYNEL 402
+ ++ L+ L L N + + M L +DVS N L
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 55/328 (16%), Positives = 106/328 (32%), Gaps = 36/328 (10%)
Query: 64 SINLSTVGLKGNLKSLSTLDLSKNKLN-----GSIPFSFGNLTNLAIMYLYRNSLSASIP 118
+L +V + ++ +L L LS KLN + F ++ + + +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 119 PVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYL 178
+ +F + + + L + LKSL
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYN--------------LTITERIDREEFTYSETALKSLMIE 310
Query: 179 HLSSNQLSGSIPISLGNLSNLVVLHLFEN---SLFGSIPSILGNLKMLLHLGLSTNHLSG 235
H+ + S + + + L + + P + L + N +
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT---FLNFTQNVFTD 367
Query: 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL----YGNLPRALG 291
+ L L L L N L +++ L L R
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLK--NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425
Query: 292 SLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSL 351
+ L+LS+N L S+ L K+ L+L NN+ P ++ L L EL+++
Sbjct: 426 WAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVAS 482
Query: 352 NILEGKIPCEIC-NMESLEKLNLSHNNF 378
N L+ +P + + SL+ + L N +
Sbjct: 483 NQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-24
Identities = 61/326 (18%), Positives = 119/326 (36%), Gaps = 16/326 (4%)
Query: 15 SLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVISINLSTVGLKG 74
SLQ N ++L F+P + + S + I+ N + + +G
Sbjct: 190 SLQIPNTTVLH-LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248
Query: 75 NLKSLSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRNSLSASIPPVIGN-----LKFLY 128
TL + S+ F F + + +Y +++ I LK L
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
+ S + + + L + + S +L+ + N + S
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368
Query: 189 IPISLGNLSNLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTNHL-SGVIPLSIGNLN 245
+ L L L L N L F + + N+ L L +S N L S +
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
+++ L L N L+ + + L L+ N++ ++P+ + L L+ L++++N+
Sbjct: 429 SILVLNLSSNMLTGS---VFRCLPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQ 484
Query: 306 LGNSIPE-TLGNLLKLHYLNLSNNQF 330
L S+P+ L L Y+ L +N +
Sbjct: 485 L-KSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 62/371 (16%), Positives = 124/371 (33%), Gaps = 50/371 (13%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLY--RNSLSASIPPVIGNLKFLY-HL 130
GNL L+ L LS K + +L+ + L + + HL
Sbjct: 143 GNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 131 DLSENQLSGSIPPTLGN---------------------------LSNLAVLHLYGNSLSG 163
N L N +L++ +
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 164 SIPSIIGNLKSLF-----YLHLSSNQLSGSIP-----ISLGNLSNLVVLHLFENSLFGSI 213
+ + + + YL++ + ++ I S L +L++ H+ S
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321
Query: 214 PSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLN 273
++ + LS + + + + ++ L N + + L L
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD-SVFQGCSTLKRLQ 380
Query: 274 YLVLNGNQLYGNLPRA---LGSLTELEYLDLSTNKLGNSIPETLGNLL-KLHYLNLSNNQ 329
L+L N L N + +++ LE LD+S N L + + + LNLS+N
Sbjct: 381 TLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439
Query: 330 FRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGM 389
L ++ LDL N + IP ++ ++++L++LN++ N + F+ +
Sbjct: 440 LTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496
Query: 390 HGLSCIDVSYN 400
L I + N
Sbjct: 497 TSLQYIWLHDN 507
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 58/270 (21%), Positives = 98/270 (36%), Gaps = 57/270 (21%)
Query: 522 CIGIGGQGSVYKAK--LTSGEILAVKKFHSLWPCEMVPQ--PEFV----NEIKTLTELRH 573
CI GG G +Y A +G + +K +V E E + L E+ H
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLK--------GLVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 574 RSIVKFYGFCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
SIV+ + F H ++V EY+ SL + E + + +
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA-----IAYLLEILP 193
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
ALSY+H +V+ D+ +N++L + + ++ D G + L GT G+ A
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQA 245
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHPR--DFISSISSSSSNRNISLNEILDPRLP 746
PE+V T T D+Y+ G + R ++ + DP L
Sbjct: 246 PEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------------DPVLK 292
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRPP 776
T ++ A ++ P R
Sbjct: 293 TYD-----SYGRLLRRA---IDPDPRQRFT 314
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 40/239 (16%), Positives = 94/239 (39%), Gaps = 31/239 (12%)
Query: 558 QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWT 617
+I+ + ++ V S ++ + + +L ++ ++E+
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 618 VRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS-- 675
V +++ +A A+ ++H ++HRD+ N+ +D +V DFG+ + D
Sbjct: 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 676 ----------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISS 725
T VGT Y++PE ++ + K D++S G++ E++ +
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSF----- 273
Query: 726 ISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
S+ R + ++ + + P + +V+ L+ SP RP ++
Sbjct: 274 --STQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERP---EATDII 324
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 54/316 (17%), Positives = 105/316 (33%), Gaps = 58/316 (18%)
Query: 517 FDVKYCIGIGGQ--GSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH 573
+++ IG G + +V A+ +GE + V++ +L C E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNH 85
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN--DGAIEEFNWTVRMNVIRSVANALS 631
+IV + ++V ++ GS ++ + E +++ V AL
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE---LAIAYILQGVLKALD 142
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL-------KPDSSNCTELVGTF 684
Y+HH VHR + + ++L+ +D + +S + + V
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 685 GYIAPELVYTMKV--TEKCDVYSFGVLALEVIKGD------HP----------------- 719
+++PE++ K D+YS G+ A E+ G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 720 ---------RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAF--LCLN 768
S ++S + P P + S F CL
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 769 ESPESRPPMHTVCQLL 784
+P++RP + LL
Sbjct: 320 RNPDARP---SASTLL 332
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 10/201 (4%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
++ + L+ ++PP L + +LHL N L + + L L+L +L+
Sbjct: 14 EVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-K 69
Query: 189 IPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLI 248
+ + G L L L L N L S+P + L L L +S N L+ + ++ L L
Sbjct: 70 LQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 249 GLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLG 307
LYL N+L +P + L L L N L L L L+ L L N L
Sbjct: 128 ELYLKGNELKT--LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL- 184
Query: 308 NSIPETLGNLLKLHYLNLSNN 328
+IP+ L + L N
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+ S ++ K L ++P + I++L N L + L L+L
Sbjct: 8 KVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL- 193
+L + G L L L L N L S+P + L +L L +S N+L+ S+P+
Sbjct: 65 AEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 194 GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
L L L+L N L ++P +L L L L+ N+L+ + + L NL L L
Sbjct: 121 RGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 253 YDNQLSVGEIPIEIGKLSSLNYLVLNGN 280
+N L IP L + L+GN
Sbjct: 180 QENSLYT--IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 14/209 (6%)
Query: 171 NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230
+ S ++ L+ ++P L + +LHL EN L+ + L L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR-A 289
L+ + + G L L L L NQL +P+ L +L L ++ N+L +LP A
Sbjct: 65 AELT-KLQVD-GTLPVLGTLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRL-TSLPLGA 119
Query: 290 LGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVEL-EKLIQLSEL 347
L L EL+ L L N+L ++P L KL L+L+NN + P L L L L
Sbjct: 120 LRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTL 177
Query: 348 DLSLNILEGKIPCEICNMESLEKLNLSHN 376
L N L IP L L N
Sbjct: 178 LLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 67 LSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLK 125
L+ + + G L L TLDLS N+L S+P L L ++ + N L+ S+P + L
Sbjct: 67 LTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 126 FLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSN 183
L L L N+L ++PP L L L L N+L+ +P+ ++ L++L L L N
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 184 QLSGSIPISLGNLSNLVVLHLFEN 207
L +IP L L N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 35/211 (16%)
Query: 195 NLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
+++ + ++ + +L ++P + + L LS N L ++ L L L
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDLPKDTT---ILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE- 312
+L+ ++ ++ G L L L L+ NQL +LP +L L LD+S N+L S+P
Sbjct: 64 RAELT--KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRL-TSLPLG 118
Query: 313 TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLN 372
L L +L L L N+ + L +L LEKL+
Sbjct: 119 ALRGLGELQELYLKGNELK----------------TLPPGLLTP--------TPKLEKLS 154
Query: 373 LSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L++NN + L G+ L + + N L
Sbjct: 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY 185
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 58/298 (19%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
++++ IG G V A E +A+K+ +L C+ E + EI+ +++ H +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMD-ELLKEIQAMSQCHHPN 74
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATIL--------SNDGAIEEFNWTVRMNVIRSVA 627
IV +Y +LV + L GS+ I+ G ++E + ++R V
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE---STIATILREVL 131
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL-----VG 682
L Y+H + +HRD+ + N+LL D +++DFG++ FL VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 683 TFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGD------HPRDFISSISSSSSNRNI 735
T ++APE++ ++ K D++SFG+ A+E+ G P + +
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP---- 244
Query: 736 SLNEILDPRLPTPPQNVQD---------ELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P L T Q+ + ++IS LCL + PE RP T +LL
Sbjct: 245 -------PSLETGVQDKEMLKKYGKSFRKMIS------LCLQKDPEKRP---TAAELL 286
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 34/293 (11%), Positives = 67/293 (22%), Gaps = 43/293 (14%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+ +G + V+ + + E A+K F L S +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 582 FC------------SHPR--------------NSFLVYEYLERGSLATILSNDGAIEEFN 615
S P N L+ L + S + F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 616 ----WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671
+ + + + +VH + N+ + D + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---W 242
Query: 672 PDSSNCTELVGTFGYIAPELVY--TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS 729
+ Y E + T T + + G+ V P ++
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
S R D + D + +++ LN R +
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/276 (22%), Positives = 96/276 (34%), Gaps = 39/276 (14%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQ--PEFVNEIKTLTEL-R 572
F +G G G V+K G + AVK+ S P+ + E+ + ++ +
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP---FRGPKDRARKLAEVGSHEKVGQ 115
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALS 631
H V+ +L E SL GA + E V +R AL+
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEA--QVW-GYLRDTLLALA 171
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
++H +VH D+ N+ L ++ DFG+ L + + G Y+APEL
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGDPRYMAPEL 227
Query: 692 V---YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748
+ Y DV+S G+ LEV L P
Sbjct: 228 LQGSY----GTAADVFSLGLTILEVACNMEL-------PHGGEGWQQLRQGYLPPEF--- 273
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ EL S++ + L P+ R T LL
Sbjct: 274 TAGLSSELRSVLV---MMLEPDPKLRA---TAEALL 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 62/299 (20%), Positives = 117/299 (39%), Gaps = 53/299 (17%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQ--PEFVNEIKTLTEL-RH 573
+ +G G G+V G +AVK+ M+ + EIK LTE H
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKR--------MLIDFCDIALMEIKLLTESDDH 68
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM----NVIRSVANA 629
+++++Y + R ++ E +L ++ + +E + +++R +A+
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLC-------------LDYEARVSDFGIAKFLKPD--- 673
++++H I+HRD+ +N+L+ + +SDFG+ K L
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 674 -SSNCTELVGTFGYIAPEL-------VYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFIS 724
+N GT G+ APEL ++T D++S G + ++ KG HP
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--- 241
Query: 725 SISSSSSNRNISLNEI-LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
S NI LD +++ E ++ ++ P RP V +
Sbjct: 242 --DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLR 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 30/271 (11%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTL-TELRHRSIVKFY 580
+G G G V+K + +G ++AVK+ + + ++ + IV+ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEE-NKRILMDLDVVLKSHDCPYIVQCF 90
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
G + F+ E + + G I E + + ++ AL Y+
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALYYLKEK--HG 145
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTE- 699
++HRD+ N+LL + ++ DFGI+ L D G Y+APE + T+
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 700 ----KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ-- 753
+ DV+S G+ +E+ G P + L ++L P P ++
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFE-------VLTKVLQEEPPLLPGHMGFS 257
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ S V+ CL + RP +LL
Sbjct: 258 GDFQSFVK---DCLTKDHRKRP---KYNKLL 282
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 63/267 (23%), Positives = 103/267 (38%), Gaps = 31/267 (11%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G GG ++ + E+ A K K L + EI L H+ +V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREK--MSMEISIHRSLAHQHVVG 79
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
F+GF F+V E R SL + A+ E R +R + Y+H +
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQYLHRNR- 135
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
++HRD+ N+ L D E ++ DFG+A ++ D L GT YIAPE++ +
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 699 EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP---QNVQDE 755
+ DV+S G + ++ G P + +S + I P
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKKNEYSIPKHINPVAAS- 244
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQ 782
LI L P +RP ++ +
Sbjct: 245 LIQ------KMLQTDPTARPTINELLN 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 65/266 (24%), Positives = 105/266 (39%), Gaps = 29/266 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G GG ++ + E+ A K K L + EI L H+ +V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPK-SLLLKPHQREK--MSMEISIHRSLAHQHVVG 105
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
F+GF F+V E R SL + A+ E R +R + Y+H +
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQYLHRNR- 161
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
++HRD+ N+ L D E ++ DFG+A ++ D L GT YIAPE++ +
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 699 EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN--RNISLNEILDPRLPTPPQNVQDEL 756
+ DV+S G + ++ G P + +S I NE P L
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE-----TSCLKETYLRIKKNEYSIP--KHINPVAAS-L 271
Query: 757 ISIVEVAFLCLNESPESRPPMHTVCQ 782
I L + P +RP ++ +
Sbjct: 272 IQ----KMLQTD--PTARPTINELLN 291
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKTLTELRH 573
F++ +G G G+VY A+ S ILA+K L + Q E++ + LRH
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHLRH 68
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+I++ YG+ +L+ EY G++ L +E I +ANALSY
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTA-TYITELANALSYC 125
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H ++HRDI +N+LL E +++DFG + P S L GT Y+ PE++
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD-LCGTLDYLPPEMIE 180
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHP 719
EK D++S GVL E + G P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 56/293 (19%), Positives = 104/293 (35%), Gaps = 52/293 (17%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTEL-R 572
F IG G GSV+K K G I A+K+ + + + E+ L +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREVYAHAVLGQ 69
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE-FNWTVRMNVIRSVANALS 631
H +V+++ + + + EY GSLA +S + I F +++ V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLD-------------------YEARVSDFGIAKFLKP 672
Y+H +VH DI N+ + ++ D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 673 DSSNCTELVGTFGYIAPELV-YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSS 731
S+ G ++A E++ K D+++ + + +
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----- 237
Query: 732 NRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+EI RLP PQ + E +++ + ++ PE RP + L+
Sbjct: 238 ------HEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRP---SAMALV 278
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 58/274 (21%), Positives = 120/274 (43%), Gaps = 38/274 (13%)
Query: 522 CIGIGGQGSVYKAKLTSGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
+G G G VY+ + AVK +L M + EF+ E + E++H ++V+
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 282
Query: 581 GFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
G C+ +++ E++ G+L L + + M +++A+ Y+ F
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQISSAMEYLEKKNF- 339
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD---SSNCTELVGTFGYIAPELVYTMK 696
+HR+++++N L+ ++ +V+DFG+++ + D + + + APE + K
Sbjct: 340 --IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNK 395
Query: 697 VTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQ 750
+ K DV++FGVL E+ G P I L+++ + R+ P+
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP------------YPGIDLSQVYELLEKDYRME-RPE 442
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+++ ++ C +P RP + Q
Sbjct: 443 GCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 473
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 19/254 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+L K + ++ + L ++ + + + S+ I L + L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
N+L+ I P L NL NL L L N + + S + +LK L L L N +S I L
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLV 131
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
+L L L+L N + + ++L L L L L N +S ++PL+ L L LYL
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSK 187
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
N +S + L +L+ L L + +L + + L PE +
Sbjct: 188 NHISDLR---ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEII 242
Query: 315 GNLLKLHYLNLSNN 328
+ N+ +
Sbjct: 243 SDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 19/263 (7%)
Query: 95 FSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154
FS L + S++ ++ L + + + + + S+ + L N+ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP 214
L GN L+ I + NLK+L +L L N++ + SL +L L L L N + I
Sbjct: 74 FLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI-SDIN 128
Query: 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY 274
L +L L L L N ++ + LS L L L L DNQ+S +I + L+ L
Sbjct: 129 G-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS--DIV-PLAGLTKLQN 182
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF 334
L L+ N + + RAL L L+ L+L + + N NL+ + + ++
Sbjct: 183 LYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT-- 238
Query: 335 PVELEKLIQLSELDLSLNILEGK 357
P + + ++ ++ E
Sbjct: 239 PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 21/241 (8%)
Query: 171 NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSI--LGNLKMLLHLGL 228
+L ++ ++ + L+++ + + I S+ + L + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD----IKSVQGIQYLPNVTKLFL 75
Query: 229 STNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR 288
+ N L+ + PL+ NL NL L+L +N++ + L L L L N + ++
Sbjct: 76 NGNKLTDIKPLA--NLKNLGWLFLDENKVKDLS---SLKDLKKLKSLSLEHNGI-SDIN- 128
Query: 289 ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELD 348
L L +LE L L NK+ + L L KL L+L +NQ P L L +L L
Sbjct: 129 GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 349 LSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408
LS N + + + +++L+ L L + + + + + L P
Sbjct: 185 LSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 242
Query: 409 S 409
S
Sbjct: 243 S 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 15/186 (8%)
Query: 217 LGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLV 276
+ L ++ + + LN++ + ++ + + I L ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK--SVQ-GIQYLPNVTKLF 74
Query: 277 LNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPV 336
LNGN+L ++ L +L L +L L NK+ + +L +L KL L+L +N
Sbjct: 75 LNGNKL-TDIK-PLANLKNLGWLFLDENKV-KDL-SSLKDLKKLKSLSLEHNGISDING- 129
Query: 337 ELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCID 396
L L QL L L N + I + + L+ L+L N S + G+ L +
Sbjct: 130 -LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLY 184
Query: 397 VSYNEL 402
+S N +
Sbjct: 185 LSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 36/136 (26%), Positives = 51/136 (37%), Gaps = 7/136 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+L L +L L NK+ S LT L + L N +S I P + L L +L LS+
Sbjct: 132 HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSK 187
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS-L 193
N +S + L L NL VL L+ + NL + + L IS
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD 245
Query: 194 GNLSNLVVLHLFENSL 209
G+ V
Sbjct: 246 GDYEKPNVKWHLPEFT 261
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/300 (21%), Positives = 105/300 (35%), Gaps = 24/300 (8%)
Query: 49 CAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYL 108
C + + + + + + V L G +SL L + F+ + +L++ L
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFT-DIIKSLSLKRL 73
Query: 109 YRNSLSASIPPVIGNLKF-----LYHLDLSENQLSGSIPPTLGNLS--NLAVLHLYGNSL 161
+ + G L+ L L L +++G+ PP L + +L +L+L S
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 162 SGSIPSI----IGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSI---- 213
+ + L L ++ + L L L +N G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 214 ---PSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLS 270
P L++L SGV L GL L N L S
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 271 SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF 330
LN L L+ L +P+ L + +L LDLS N+L + P L ++ L+L N F
Sbjct: 254 QLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRL-DRNPSPDE-LPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 53/313 (16%), Positives = 98/313 (31%), Gaps = 48/313 (15%)
Query: 111 NSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIG 170
N L A+ + G + L +L + + + +L++ L + + G
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVD-TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG 87
Query: 171 NLK-----SLFYLHLSSNQLSGSIPISLGNLS--NLVVLHLFENSL--FGSIPSILGNLK 221
L+ L L L + +++G+ P L + +L +L+L S + + L
Sbjct: 88 ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL 147
Query: 222 M--LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI---GKLSSLNYLV 276
L L ++ H + L L L DN I K +L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 277 LNGNQ---LYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL-KLHYLNLSNNQFRK 332
L G + +L+ LDLS N L ++ + +L+ LNLS ++
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267
Query: 333 GFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGL 392
L L+LS+N + + +
Sbjct: 268 VPK---------------------------GLPAKLSVLDLSYNRLDRN--PSPDELPQV 298
Query: 393 SCIDVSYNELRGP 405
+ + N
Sbjct: 299 GNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 31/185 (16%), Positives = 56/185 (30%), Gaps = 25/185 (13%)
Query: 242 GNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR---ALGSLTELEY 298
G +L L + + +I K SL L + ++ + + ++ L+
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99
Query: 299 LDLSTNKLGNSIPETLGNL--LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356
L L ++ + P L L+ LNL N + L +L Q
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW-ATRDAWLAELQQWL----------- 147
Query: 357 KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDP 416
L+ L+++ + LS +D+S N G
Sbjct: 148 --------KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
Query: 417 MEALQ 421
LQ
Sbjct: 200 FPTLQ 204
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/218 (22%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ + +G G +V++ + +G++ A+K F+++ + P + E + L +L H++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKN 68
Query: 576 IVKFYGF--CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
IVK + + R+ L+ E+ GSL T+L + + V+R V ++++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEAR----VSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
+ IVHR+I N++ + + + ++DFG A+ L+ D L GT Y+ P
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHP 184
Query: 690 ELV--------YTMKVTEKCDVYSFGVLALEVIKGDHP 719
++ + K D++S GV G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 31/184 (16%), Positives = 63/184 (34%), Gaps = 10/184 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
K+ L ++ + + +L + L +++ + I + L ++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
+ P + LSNL L + G ++ + L SL L +S + SI +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
L + + L N I L L L L + + + + + L LY +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFS 190
Query: 255 NQLS 258
+
Sbjct: 191 QTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 35/191 (18%), Positives = 72/191 (37%), Gaps = 11/191 (5%)
Query: 191 ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
I + L ++S + L ++ L+ +++ + + +N+ L
Sbjct: 17 IPDSTFKAYLNGLLGQSST---ANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDL 71
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
+ + + I LS+L L + G + + L LT L LD+S + +SI
Sbjct: 72 TINNIHATNYN---PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEK 370
+ L K++ ++LS N L+ L +L L++ + + I + L +
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185
Query: 371 LNLSHNNFSGL 381
L G
Sbjct: 186 LYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 30/184 (16%), Positives = 67/184 (36%), Gaps = 11/184 (5%)
Query: 219 NLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLN 278
K L+ L + + ++ +N+L + L + ++ I ++ L +N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLT---GIEYAHNIKDLTIN 74
Query: 279 GNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL 338
N + L+ LE L + + + L L L L++S++ ++
Sbjct: 75 NIHA-TNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 339 EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398
L +++ +DLS N I + + L+ LN+ + E L+ +
Sbjct: 133 NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 399 YNEL 402
+
Sbjct: 190 SQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 25/114 (21%), Positives = 44/114 (38%), Gaps = 3/114 (2%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
L +L L + + + LT+L ++ + ++ SI I L + +DLS
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144
Query: 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG 187
N I P L L L L++ + + I + L L+ S + G
Sbjct: 145 YNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 23/146 (15%), Positives = 49/146 (33%), Gaps = 5/146 (3%)
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314
L + + I S+ + + L Y+ L+ + + +
Sbjct: 6 TGLKASQDNVNI-PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--I 62
Query: 315 GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374
+ L ++N P + L L L + + + + SL L++S
Sbjct: 63 EYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 375 HNNFSGLIPSCFEGMHGLSCIDVSYN 400
H+ I + + ++ ID+SYN
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 18/118 (15%), Positives = 40/118 (33%), Gaps = 7/118 (5%)
Query: 292 SLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSL 351
+ L + T + L Y+ L+N +E + +L ++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 352 NILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
P I + +LE+L + + + G+ L+ +D+S++ I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 12/191 (6%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G VY+A+ + +G +A+K +++ MV + NE+K +L+H SI++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILEL 76
Query: 580 YGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
Y + +LV E G + L + E R + + + + Y+H
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE--NEAR-HFMHQIITGMLYLHSHG- 132
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT 698
I+HRD++ N+LL + +++DFG+A LK L GT YI+PE+
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 699 EKCDVYSFGVL 709
+ DV+S G +
Sbjct: 191 LESDVWSLGCM 201
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 38/276 (13%)
Query: 523 IGIGGQGSVYKAKLTS---GEIL-AVKKFHSLWPCEMVPQ-PEFVNEIKTLTELRHRSIV 577
IG G G V +L ++ A+K +L Q +F++E + + H +I+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+ G + R + +V EY+E GSL T L +F + ++R V + Y+
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI---APELVYT 694
+ VHRD++++NVL+ + +VSDFG+++ L+ D G I APE +
Sbjct: 172 Y---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 695 MKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTP 748
+ DV+SFGV+ EV+ G+ P N++ +++ RLP
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERPYW------------NMTNRDVISSVEEGYRLP-A 275
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P L ++ C ++ RP + +L
Sbjct: 276 PMGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVL 308
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 59/288 (20%), Positives = 102/288 (35%), Gaps = 46/288 (15%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKK--FHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVK 578
+ GG VY+A+ + SG A+K+ + + + E+ + +L H +IV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-----IQEVCFMKKLSGHPNIVQ 90
Query: 579 FYGFCSHPRNS-------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
F S + FL+ L +G L L + + + + A+
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL----------- 680
+MH PPI+HRD+ +N+LL ++ DFG A +
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 681 -VGTFGYIAPELVYTMK---VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNIS 736
T Y PE++ + EK D+++ G + + HP + + I
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-------DGAKLRIV 262
Query: 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ P T LI L +PE R + V L
Sbjct: 263 NGKYSIPPHDTQYTVFHS-LIRA------MLQVNPEERLSIAEVVHQL 303
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 69/273 (25%), Positives = 118/273 (43%), Gaps = 38/273 (13%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V+ +A+K +L P M P+ F+ E + + +LRH +V+ Y
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 582 FCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
S ++V EY+ +GSL L G V M +A+ ++Y+ +
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAYVERMNY-- 301
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD---SSNCTELVGTFGYIAPELVYTMKV 697
VHRD+ + N+L+ + +V+DFG+A+ ++ + + + + APE +
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRF 358
Query: 698 TEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQN 751
T K DV+SFG+L E+ KG P + E+LD R+P P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMP-CPPE 405
Query: 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ L ++ C + PE RP + L
Sbjct: 406 CPESLHDLM---CQCWRKEPEERPTFEYLQAFL 435
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
IG G G V+ + + +A+K ++ M + +F+ E + + +L H +V+ YG
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIK---TIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
C LV E++E G L+ L F + + V ++Y+ C +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACV---I 126
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY--IAPELVYTMKVTEK 700
HRD++++N L+ + +VSDFG+ +F+ D + F +PE+ + + K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 701 CDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQNVQD 754
DV+SFGVL EV +G P + N S +E+++ RL P+
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYE------------NRSNSEVVEDISTGFRLY-KPRLAST 232
Query: 755 ELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ I+ C E PE RP + + L
Sbjct: 233 HVYQIMN---HCWRERPEDRPAFSRLLRQL 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V + + A+K + + E+ L L H +I+K Y
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKII-RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALSYMHHDCFP 639
F RN +LV E + G L D I + +I+ V + ++Y+H
Sbjct: 104 FFEDKRNYYLVMECYKGGELF-----DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 640 PIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
IVHRD+ +N+LL D ++ DFG++ + E +GT YIAPE V K
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPE-VLRKK 213
Query: 697 VTEKCDVYSFGVLALEVIKGDHP 719
EKCDV+S GV+ ++ G P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPP 236
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 26/204 (12%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---------KFHSLWPCEMVPQPEFV-NEIKTLTEL 571
+G G G V K A+K +S + E + NEI L L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANA 629
H +I+K + + +LV E+ E G L + I + N+++ + +
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELF-----EQIINRHKFDECDAANIMKQILSG 158
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGY 686
+ Y+H IVHRDI +N+LL ++ DFG++ F D + +GT Y
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYY 214
Query: 687 IAPELVYTMKVTEKCDVYSFGVLA 710
IAPE V K EKCDV+S GV+
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 66/281 (23%), Positives = 106/281 (37%), Gaps = 45/281 (16%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIK-----TLTELRHRSI 576
IG G GSV K SG+I+AVK+ + ++ + I
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIR------STVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSN-----DGAIEEFNWTVRMNVIRSVANALS 631
V+FYG + ++ E + S D I E + + + AL+
Sbjct: 84 VQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPE---EILGKITLATVKALN 139
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
++ + I+HRDI N+LL ++ DFGI+ L DS T G Y+APE
Sbjct: 140 HLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPER 196
Query: 692 VYTMKV----TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD---PR 744
+ + DV+S G+ E+ G P +S+ L +++ P+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDPPQ 249
Query: 745 LPTPPQNV-QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
L + I+ V LCL + RP +LL
Sbjct: 250 LSNSEEREFSPSFINFVN---LCLTKDESKRP---KYKELL 284
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V K +AVK + M EF E +T+ +L H +VKFYG
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642
CS ++V EY+ G L L + G + + + + V ++++ F +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQF---I 126
Query: 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY--IAPELVYTMKVTEK 700
HRD++++N L+ D +VSDFG+ +++ D + + F APE+ + K + K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 701 CDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQNVQD 754
DV++FG+L EV G P D + +E++ RL P D
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYD------------LYTNSEVVLKVSQGHRLY-RPHLASD 232
Query: 755 ELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ I+ C +E PE RP + +
Sbjct: 233 TIYQIMY---SCWHELPEKRPTFQQLLSSI 259
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 31/281 (11%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G GSV + +GE++AVKK L +F EI+ L L+H +IV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 578 KFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
K+ G C L+ EYL GSL L E + + + + Y+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT 132
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELV 692
+ +HRD++++N+L+ + ++ DFG+ K L D + APE +
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 693 YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR----NISLNEILDP----- 743
K + DV+SFGV+ E+ + + + +++
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P DE+ I+ C N + RP + +
Sbjct: 250 RLPRPD-GCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 286
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 69/273 (25%), Positives = 118/273 (43%), Gaps = 38/273 (13%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V+ +A+K +L P M P+ F+ E + + +LRH +V+ Y
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 329
Query: 582 FCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
S ++V EY+ +GSL L G V M +A+ ++Y+ +
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAYVERMNY-- 384
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD---SSNCTELVGTFGYIAPELVYTMKV 697
VHRD+ + N+L+ + +V+DFG+A+ ++ + + + + APE +
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRF 441
Query: 698 TEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQN 751
T K DV+SFG+L E+ KG P + E+LD R+P P
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMP-CPPE 488
Query: 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ L ++ C + PE RP + L
Sbjct: 489 CPESLHDLM---CQCWRKEPEERPTFEYLQAFL 518
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 44/281 (15%), Positives = 84/281 (29%), Gaps = 43/281 (15%)
Query: 517 FDVKYCIGIGGQGSVYKAK------LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE 570
V + +G G VY+A + + +K P E ++ L
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY---IGTQLMERLKP 123
Query: 571 LRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE--FNWTVRMNVIRSVAN 628
+KFY S LV E G+L ++ E + ++ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEA-----------RVSDFGIAKFLK--PDSS 675
+ +H I+H DI N +L + + D G + +K P +
Sbjct: 184 MIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735
T T G+ E++ + D + ++ G + + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-------VKNEGGEC 293
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPP 776
+ RLP ++ + E + LN P
Sbjct: 294 KPEGLF-RRLP------HLDMWN--EFFHVMLNIPDCHHLP 325
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 58/283 (20%), Positives = 119/283 (42%), Gaps = 25/283 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ + +G G +V++ + +G++ A+K F+++ + P + E + L +L H++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKN 68
Query: 576 IVKFYGF--CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
IVK + + R+ L+ E+ GSL T+L + + V+R V ++++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEAR----VSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
+ IVHR+I N++ + + + ++DFG A+ L+ D L GT Y+ P
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHP 184
Query: 690 ELV--------YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741
++ + K D++S GV G P F N+ + + +I+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPF-EGPRRNKEV-MYKII 240
Query: 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ VQ ++ + SR + +L
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 16/193 (8%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V K +G+ AVK + + + E++ L +L H +I+K Y
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALSYMHHDCFP 639
F +LV E G L D I ++ +IR V + ++YMH +
Sbjct: 94 FFEDKGYFYLVGEVYTGGELF-----DEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 640 PIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
IVHRD+ +N+LL D R+ DFG++ + + +GT YIAPE V
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAPE-VLHGT 203
Query: 697 VTEKCDVYSFGVL 709
EKCDV+S GV+
Sbjct: 204 YDEKCDVWSTGVI 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/275 (21%), Positives = 111/275 (40%), Gaps = 37/275 (13%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIK-TLTELRHRSIVKFY 580
+G G G V K + SG+I+AVK+ + Q + ++ ++ + V FY
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 581 GFCSHPRNSFLVYEYLERGSLATIL----SNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
G + ++ E ++ SL I E + + S+ AL ++H
Sbjct: 73 GALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE---DILGKIAVSIVKALEHLHSK 128
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
++HRD+ NVL+ + ++ DFGI+ +L D G Y+APE +
Sbjct: 129 L--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERINPEL 185
Query: 697 V----TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD---PRLPTPP 749
+ K D++S G+ +E+ P D + L ++++ P+L P
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-------QLKQVVEEPSPQL--PA 236
Query: 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
E + CL ++ + RP T +L+
Sbjct: 237 DKFSAEFVDFTS---QCLKKNSKERP---TYPELM 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 31/281 (11%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G GSV + +GE++AVK L +F EI+ L L+H +IV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 578 KFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
K+ G C L+ EYL GSL L E + + + + Y+
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT 163
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELV 692
+ +HRD++++N+L+ + ++ DFG+ K L D + APE +
Sbjct: 164 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 693 YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR----NISLNEILDP----- 743
K + DV+SFGV+ E+ + + + +++
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
Query: 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P DE+ I+ C N + RP + +
Sbjct: 281 RLPRPD-GCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 317
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V K K + + AVK + + + E++ L +L H +I+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALSYMHHDCFP 639
+ ++V E G L D I+ ++ +I+ V + ++YMH
Sbjct: 89 ILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 640 PIVHRDISSKNVLL---CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
IVHRD+ +N+LL D + ++ DFG++ + ++ + +GT YIAPE V
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE-VLRGT 198
Query: 697 VTEKCDVYSFGV 708
EKCDV+S GV
Sbjct: 199 YDEKCDVWSAGV 210
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 71/282 (25%), Positives = 115/282 (40%), Gaps = 34/282 (12%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G GSV + +G ++AVK+ L Q +F EI+ L L IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ---LQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 578 KFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
K+ G P LV EYL G L L A + + + + + Y+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 145
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APE 690
VHRD++++N+L+ + +++DFG+AK L D +V G APE
Sbjct: 146 RRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--YYVVREPGQSPIFWYAPE 200
Query: 691 LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNR--NISLNEILDP---- 743
+ + + DV+SFGV+ E+ D + +L+ +L+
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 744 -RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P E+ +++ LC SP+ RP + L
Sbjct: 261 QRLP-APPACPAEVHELMK---LCWAPSPQDRPSFSALGPQL 298
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V+ A +AVK ++ P M + F+ E + L+H +VK +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA 250
Query: 582 FCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
+ +++ E++ +GSL L S++G+ + + +A ++++ +
Sbjct: 251 VVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQRNY-- 305
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI---APELVYTMKV 697
+HRD+ + N+L+ +++DFG+A+ ++ + T G I APE +
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSF 362
Query: 698 TEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQN 751
T K DV+SFG+L +E++ G P +S E++ R+P P+N
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP------------YPGMSNPEVIRALERGYRMP-RPEN 409
Query: 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+EL +I+ C PE RP + +L
Sbjct: 410 CPEELYNIM---MRCWKNRPEERPTFEYIQSVL 439
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPE--FVNEIKTLTELRHRSIVKF 579
+G GG G V + +GE +A+K+ E+ P+ + EI+ + +L H ++V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 580 Y------GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+ L EY E G L L+ ++ +++AL Y+
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 634 HHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
H + I+HRD+ +N++L ++ D G AK L CTE VGT Y+APE
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPE 193
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
L+ K T D +SFG LA E I G P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 40/277 (14%)
Query: 523 IGIGGQGSVYKAKL---TSGEIL-AVKKFHSLWPCEMVPQ-PEFVNEIKTLTELRHRSIV 577
+G G G V +L + EI A+K +L Q +F+ E + + H +I+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
+ G + + +V EY+E GSL + L +D +F + ++R +A+ + Y+
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDM 166
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI---APELVY 693
+ VHRD++++N+L+ + +VSDFG+ + L+ D G I +PE +
Sbjct: 167 GY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 694 TMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPT 747
K T DV+S+G++ EV+ G+ P +S +++ RLP
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYW------------EMSNQDVIKAVDEGYRLP- 270
Query: 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
PP + L ++ C + +RP + +L
Sbjct: 271 PPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 37/284 (13%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G G V + +GE +AVK K S + EI+ L L H +
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIA-DLKKEIEILRNLYHEN 84
Query: 576 IVKFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
IVK+ G C+ + L+ E+L GSL L + + N ++ + + Y+
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYL 142
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----A 688
+ VHRD++++NVL+ +++ ++ DFG+ K ++ D T V A
Sbjct: 143 GSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFWYA 197
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSN--RNISLNEILDP-- 743
PE + K DV+SFGV E++ D ++ +++ +++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 744 ---RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P N DE+ ++ C P +R + +
Sbjct: 258 EGKRLP-CPPNCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGF 297
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 69/276 (25%), Positives = 109/276 (39%), Gaps = 40/276 (14%)
Query: 523 IGIGGQGSVYKAKLTSGEIL---AVKKFHSLWPCEMVPQP--EFVNEIKTLTELRHRSIV 577
+G G G+V K +++ AVK L P E + E + +L + IV
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+ G C LV E E G L L + + ++ V+ + Y+
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN 137
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELVYT 694
F VHRD++++NVLL + A++SDFG++K L+ D + + APE +
Sbjct: 138 F---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 695 MKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTP 748
K + K DV+SFGVL E G P + +E+ R+
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYR------------GMKGSEVTAMLEKGERMG-C 241
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P E+ ++ LC E+RP V L
Sbjct: 242 PAGCPREMYDLM---NLCWTYDVENRPGFAAVELRL 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELR 572
F K +G G G V+ + +SG +K K S P E + EI+ L L
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI-----EAEIEVLKSLD 78
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVRMNVIRSVANALS 631
H +I+K + N ++V E E G L I+S + + +++ + NAL+
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 632 YMH-HDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
Y H +VH+D+ +N+L ++ DFG+A+ K D T GT Y+
Sbjct: 139 YFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGTALYM 193
Query: 688 APELVYTMKVTEKCDVYSFGV 708
APE V+ VT KCD++S GV
Sbjct: 194 APE-VFKRDVTFKCDIWSAGV 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 45/280 (16%)
Query: 523 IGIGGQGSVYKAKLTSGEIL-----AVKKFHSLWPCEMVPQ-PEFVNEIKTLTELRHRSI 576
IG G G VYK L + A+K +L Q +F+ E + + H +I
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIK---TLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
++ G S + ++ EY+E G+L L DG EF+ + ++R +A + Y+ +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN 165
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APE 690
+ VHRD++++N+L+ + +VSDFG+++ L+ D G G I APE
Sbjct: 166 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG--GKIPIRWTAPE 220
Query: 691 LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----R 744
+ K T DV+SFG++ EV+ G+ P +S +E++ R
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYW------------ELSNHEVMKAINDGFR 268
Query: 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
LP P + + ++ C + RP + +L
Sbjct: 269 LP-TPMDCPSAIYQLMM---QCWQQERARRPKFADIVSIL 304
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 56/281 (19%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
+G G G V K +A+K + M EF+ E K + L H +V+ YG
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 583 CSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
C+ R F++ EY+ G L L F + + + V A+ Y+ F
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQF--- 141
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI------------AP 689
+HRD++++N L+ +VSDFG+++++ D Y P
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-----------YTSSVGSKFPVRWSPP 190
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP----- 743
E++ K + K D+++FGVL E+ G P + + +E +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE------------RFTNSETAEHIAQGL 238
Query: 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RL P +++ +I+ C +E + RP + +
Sbjct: 239 RLY-RPHLASEKVYTIMY---SCWHEKADERPTFKILLSNI 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/274 (22%), Positives = 121/274 (44%), Gaps = 40/274 (14%)
Query: 523 IGIGGQGSVYKAKLTSGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G VY+ + AVK +L M + EF+ E + E++H ++V+ G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
C+ +++ E++ G+L L +E + V + + +++A+ Y+ F
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELVYTMK 696
+HRD++++N L+ ++ +V+DFG+++ + D T APE + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNK 188
Query: 697 VTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQ 750
+ K DV++FGVL E+ G P I L+++ + R+ P+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYP------------GIDLSQVYELLEKDYRME-RPE 235
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+++ ++ C +P RP + Q
Sbjct: 236 GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF 266
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 34/293 (11%), Positives = 76/293 (25%), Gaps = 62/293 (21%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLW-------------------------PCEMV 556
+G + +A +GE V + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 557 PQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFLVYEYLER------GSLATILSND 608
F+ + + + + +++ + F +Y ++ L + S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 609 GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
++ R+ + V L+ +HH +VH + +++L ++ F
Sbjct: 206 KSLVH---HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 669 FL-KPDSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDF 722
S A ++ +T D ++ G+ + D P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--N 317
Query: 723 ISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
+ I PQ V+ L+ L E R
Sbjct: 318 ------TDDAALGGSEWIF-RSCKNIPQPVRA-LLE------GFLRYPKEDRL 356
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/278 (24%), Positives = 110/278 (39%), Gaps = 36/278 (12%)
Query: 519 VKYCIGIGGQGSVYKAKLT--SGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G GSV + +I A+K + + E + E + + +L +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTE-EMMREAQIMHQLDNPY 71
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
IV+ G C LV E G L L EE + ++ V+ + Y+
Sbjct: 72 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE 128
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELV 692
F VHRD++++NVLL + A++SDFG++K L D S T + APE +
Sbjct: 129 KNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 693 YTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLP 746
K + + DV+S+GV E + G P + E++ R+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYK------------KMKGPEVMAFIEQGKRME 233
Query: 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P EL +++ C E RP TV Q +
Sbjct: 234 -CPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRM 267
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 50/279 (17%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKTLTELRH 573
FD+ +G G G+VY A+ + I+A+K L + Q EI+ + LRH
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLRH 73
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+I++ Y + + +L+ E+ RG L L G +E + +A+AL Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE--QRSA-TFMEELADALHYC 130
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H ++HRDI +N+L+ E +++DFG + P T + GT Y+ PE++
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYLPPEMIE 185
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHP----------------------------RDFISS 725
EK D++ GVL E + G P +D IS
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245
Query: 726 ISSSSSNRNISLNEILD---------PRLPTPPQNVQDE 755
+ + + L +++ LP Q+ Q +
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 38/273 (13%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V+ +AVK SL M P F+ E + +L+H+ +V+ Y
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVK---SLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYA 75
Query: 582 FCS-HPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
+ P +++ EY+E GSL L + G N + M +A ++++ +
Sbjct: 76 VVTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDM--AAQIAEGMAFIEERNY- 130
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY--IAPELVYTMKV 697
+HRD+ + N+L+ +++DFG+A+ ++ D+ F APE +
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 698 TEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQN 751
T K DV+SFG+L E++ G P ++ E++ R+ P N
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYP------------GMTNPEVIQNLERGYRMV-RPDN 234
Query: 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+EL ++ LC E PE RP + +L
Sbjct: 235 CPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 47/199 (23%), Positives = 81/199 (40%), Gaps = 16/199 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTELRHR 574
+D+ +G G G V++ +G A K E V EI+T++ LRH
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFV----MTPHESDKETVRKEIQTMSVLRHP 214
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
++V + ++YE++ G L + + E + +R V L +M
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE---DEAVEYMRQVCKGLCHM 271
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
H + VH D+ +N++ + DFG+ L P + GT + APE+
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEV 327
Query: 692 VYTMKVTEKCDVYSFGVLA 710
V D++S GVL+
Sbjct: 328 AEGKPVGYYTDMWSVGVLS 346
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 12/195 (6%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
IG G V + +G+ AVK + + E L+H IV+
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 580 YGFCSHPRNSFLVYEYLERGSLA-TILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HDC 637
S ++V+E+++ L I+ A ++ V + +R + AL Y H ++
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 638 FPPIVHRDISSKNVLLCLDYEA---RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
I+HRD+ VLL + ++ FG+A L VGT ++APE+V
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
Query: 695 MKVTEKCDVYSFGVL 709
+ DV+ GV+
Sbjct: 208 EPYGKPVDVWGCGVI 222
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 43/205 (20%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELR 572
+D+ +G G V K + ++G A K K S V + E E+ L ++
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANAL 630
H +++ + + + L+ E + G L D ++ + + + I+ + + +
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGV 128
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEA-----RVSDFGIAKFLKPDSSNCTELVGTFG 685
+Y+H I H D+ +N ++ LD ++ DFG+A ++ + GT
Sbjct: 129 NYLHTKK---IAHFDLKPEN-IMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPE 183
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLA 710
++APE+V + + D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 22/202 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTELRHR 574
+D+ +G G G V++ +G + K V NEI + +L H
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFI----NTPYPLDKYTVKNEISIMNQLHHP 108
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVR--MNVIRSVANALS 631
++ + L+ E+L G L I + E++ + +N +R L
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-----EDYKMSEAEVINYMRQACEGLK 163
Query: 632 YMH-HDCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSNCTELVGTFGYIA 688
+MH H IVH DI +N++ + V DFG+A L PD T + A
Sbjct: 164 HMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAA 218
Query: 689 PELVYTMKVTEKCDVYSFGVLA 710
PE+V V D+++ GVL
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 41/215 (19%), Positives = 86/215 (40%), Gaps = 39/215 (18%)
Query: 514 TNGFDVKYCIG--IG-GQ-GSVYKAK-LTSGEILAVKKF--HSLWPCEMVPQPEFVNEIK 566
F +Y + +G G V + + +G+ A L + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD---HQKLEREAR 62
Query: 567 TLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM------ 620
L+H +IV+ + S + +L+++ + G L F V
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL------------FEDIVAREYYSEA 110
Query: 621 ---NVIRSVANALSYMH-HDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPD 673
+ I+ + A+ + H +VHR++ +N+LL +++DFG+A ++ +
Sbjct: 111 DASHCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGV 708
GT GY++PE++ + D+++ GV
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 64/209 (30%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 79 LSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
+++D S KL +IP + + L L N LS S+P L L L L++N+
Sbjct: 18 KNSVDCSSKKLT-AIPSNIPADTKKL---DLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK 72
Query: 137 LSGSIPPTL-GNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL- 193
L ++P + L NL L + N L ++P + L +L L L NQL S+P +
Sbjct: 73 LQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF 129
Query: 194 GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
+L+ L L L N L S+P + L L L L N L V + L L L L
Sbjct: 130 DSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188
Query: 253 YDNQLSVGEIPIEI-GKLSSLNYLVLNGN 280
+NQL +P L L L L N
Sbjct: 189 DNNQLK--RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 131 DLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIP 190
D S +L+ +IP ++ L L N LS L L L+L+ N+L ++P
Sbjct: 22 DCSSKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP 77
Query: 191 ISL-GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSI-GNLNNL 247
+ L NL L + +N L ++P + L L L L N L +P + +L L
Sbjct: 78 AGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKL 135
Query: 248 IGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL 306
L L N+L +P + KL+SL L L NQL A LTEL+ L L N+L
Sbjct: 136 TYLSLGYNELQ--SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193
Query: 307 GNSIPETLGNLLKLHYLNLSNN 328
+L KL L L N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 60/183 (32%), Positives = 86/183 (46%), Gaps = 10/183 (5%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
LDL NKL+ +F LT L ++YL N L ++P + LK L L +++N+
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 137 LSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL- 193
L ++P L NLA L L N L S+P + +L L YL L N+L S+P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 194 GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252
L++L L L+ N L +P L L L L N L V + +L L L L
Sbjct: 154 DKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 253 YDN 255
+N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 63/180 (35%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 130 LDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSG 187
LDL N+LS S+P L+ L +L+L N L ++P+ I LK+L L ++ N+L
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 188 SIPISL-GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
++PI + L NL L L N L S+P + +L L +L L N L + L
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157
Query: 246 NLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
+L L LY+NQL +P KL+ L L L+ NQL A SL +L+ L L N
Sbjct: 158 SLKELRLYNNQLKR--VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 54/162 (33%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
L L L L+ NKL ++P F L NL +++ N L ++P V L L L L
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRL 116
Query: 133 SENQLSGSIPPTL-GNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIP 190
NQL S+PP + +L+ L L L N L S+P + L SL L L +NQL +P
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVP 173
Query: 191 ISL-GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTN 231
L+ L L L N L +L+ L L L N
Sbjct: 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 212 SIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKL 269
+IPS I + K L L +N LS + + L L LYL DN+L +P I +L
Sbjct: 30 AIPSNIPADTK---KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ--TLPAGIFKEL 84
Query: 270 SSLNYLVLNGNQLYGNLP-RALGSLTELEYLDLSTNKLGNSIPETL-GNLLKLHYLNLSN 327
+L L + N+L LP L L L L N+L S+P + +L KL YL+L
Sbjct: 85 KNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGY 142
Query: 328 NQFRKGFPVEL-EKLIQLSELDLSLNILEGKIPCEIC-NMESLEKLNLSHNNFSGLIPSC 385
N+ + P + +KL L EL L N L+ ++P + L+ L L +N +
Sbjct: 143 NEL-QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 386 FEGMHGLSCIDVSYN 400
F+ + L + + N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 250 LYLYDNQLSVGEIPIEIG---KLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNK 305
L L N+LS + +L+ L L LN N+L LP L LE L ++ NK
Sbjct: 42 LDLQSNKLSS----LPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNK 96
Query: 306 LGNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEIC- 363
L ++P L+ L L L NQ + P + L +L+ L L N L+ +P +
Sbjct: 97 L-QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 364 NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ SL++L L +N + F+ + L + + N+L+
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 41/133 (30%), Positives = 55/133 (41%), Gaps = 18/133 (13%)
Query: 66 NLSTVGLKGN------------LKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNS 112
NL T+ + N L +L+ L L +N+L S+P F +LT L + L N
Sbjct: 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 113 LSASIPP-VIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIG 170
L S+P V L L L L NQL +P L+ L L L N L
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202
Query: 171 NLKSLFYLHLSSN 183
+L+ L L L N
Sbjct: 203 SLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 31/112 (27%), Positives = 57/112 (50%), Gaps = 4/112 (3%)
Query: 294 TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL-EKLIQLSELDLSLN 352
+ + LDL +NKL + + L KL L L++N+ + P + ++L L L ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 353 ILEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L+ +P + + +L +L L N L P F+ + L+ + + YNEL+
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 65/284 (22%), Positives = 108/284 (38%), Gaps = 39/284 (13%)
Query: 523 IGIGGQGSVYKAKLT-----SGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G G V +GE++AVK K + + EI L L H
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRS-GWKQEIDILRTLYHEH 94
Query: 576 IVKFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
I+K+ G C + LV EY+ GSL L + + + ++Y+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYL 150
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----A 688
H + +HRD++++NVLL D ++ DFG+AK + V G A
Sbjct: 151 HAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVREDGDSPVFWYA 205
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSN--RNISLNEILDP-- 743
PE + K DV+SFGV E++ D + + +++ + +
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 744 ---RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RLP P E+ +++ C RP + +L
Sbjct: 266 RGERLPRPD-KCPAEVYHLMK---NCWETEASFRPTFENLIPIL 305
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/276 (22%), Positives = 101/276 (36%), Gaps = 36/276 (13%)
Query: 523 IGIGGQGSVYKAKLTSGEIL----AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G G V + + + AVK + +F+ E+ + L HR++++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
YG P +V E GSL L F VA + Y+ F
Sbjct: 86 LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELVYTM 695
+HRD++++N+LL ++ DFG+ + L + + F + APE + T
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 696 KVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP------RLPTP 748
+ D + FGV E+ G P ++ ++IL RLP P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWI------------GLNGSQILHKIDKEGERLPRP 247
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
D I V C PE RP + L
Sbjct: 248 E----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 58/267 (21%), Positives = 102/267 (38%), Gaps = 39/267 (14%)
Query: 523 IGIGGQGSVYKAKLT----SGEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSI 576
+G G G+VYK +I A+K L E ++E + + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
+ G C L+ + + G L + + +N +A ++Y+
Sbjct: 80 CRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYT 694
VHRD++++NVL+ +++DFG+AK L + G ++A E +
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 695 MKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTP 748
T + DV+S+GV E++ G P D I +EI RLP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYD------------GIPASEISSILEKGERLP-Q 240
Query: 749 PQNVQDELISIVEVAFLCLNESPESRP 775
P ++ I+ C +SRP
Sbjct: 241 PPICTIDVYMIM---RKCWMIDADSRP 264
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 43/200 (21%), Positives = 86/200 (43%), Gaps = 23/200 (11%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G V K + ++G A K K + V + + E+ L E++H +++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANALSYMH-H 635
+ + + L+ E + G L D E+ + T ++ + N + Y+H
Sbjct: 79 LHEVYENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 636 DCFPPIVHRDISSKNVLLCLDYEA-----RVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
I H D+ +N ++ LD ++ DFG+A + + + GT ++APE
Sbjct: 134 Q----IAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPE 187
Query: 691 LVYTMKVTEKCDVYSFGVLA 710
+V + + D++S GV+
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 41/216 (18%)
Query: 512 RATNGFDVKYCIG--IG-GQ-GSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV-NEI 565
T + +G G V+ K +G++ A+K + + NEI
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK----SPAFRDSSLENEI 57
Query: 566 KTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM----- 620
L +++H +IV + +LV + + G L F+ +
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL------------FDRILERGVYTE 105
Query: 621 ----NVIRSVANALSYMH-HDCFPPIVHRDISSKNVLLCL---DYEARVSDFGIAKFLKP 672
VI+ V +A+ Y+H + IVHRD+ +N+L + + ++DFG++K +
Sbjct: 106 KDASLVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
Query: 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGV 708
+ GT GY+APE++ ++ D +S GV
Sbjct: 162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 38/275 (13%)
Query: 523 IGIGGQGSVYKAKLT--SGEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIVK 578
+G G GSV + +I A+K L E + E + + +L + IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
G C LV E G L L EE + ++ V+ + Y+ F
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT---FGYIAPELVYTM 695
VHR+++++NVLL + A++SDFG++K L D S T + APE +
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 696 KVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPP 749
K + + DV+S+GV E + G P + E++ R+ P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYK------------KMKGPEVMAFIEQGKRME-CP 561
Query: 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
EL +++ C E RP TV Q +
Sbjct: 562 PECPPELYALM---SDCWIYKWEDRPDFLTVEQRM 593
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V K K + + AVK + + + E++ L +L H +I+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALSYMHHDCFP 639
+ ++V E G L D I+ ++ +I+ V + ++YMH
Sbjct: 89 ILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 640 PIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK 696
IVHRD+ +N+LL D + ++ DFG++ + ++ + +GT YIAPE V
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE-VLRGT 198
Query: 697 VTEKCDVYSFGV 708
EKCDV+S GV
Sbjct: 199 YDEKCDVWSAGV 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 21/199 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G V K + +G+ A K K V + E E+ L E+RH +I+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANALSYMHHD 636
+ + + L+ E + G L D E+ + T ++ + + + Y+H
Sbjct: 73 LHDIFENKTDVVLILELVSGGELF-----DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 637 CFPPIVHRDISSKNVLLCLDYEA-----RVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
I H D+ +N ++ LD ++ DFGIA ++ + + GT ++APE+
Sbjct: 128 R---IAHFDLKPEN-IMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEI 182
Query: 692 VYTMKVTEKCDVYSFGVLA 710
V + + D++S GV+
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 21/195 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V++ +S + K + Q EI L RHR+I+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV----KVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 582 FCSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVR--MNVIRSVANALSYMH-HDC 637
+++E++ + I + F R ++ + V AL ++H H+
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINT-----SAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 638 FPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
I H DI +N++ + + +FG A+ LKP N L Y APE+
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHD 178
Query: 696 KVTEKCDVYSFGVLA 710
V+ D++S G L
Sbjct: 179 VVSTATDMWSLGTLV 193
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 43/199 (21%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G V K + ++G A K K S V + E E+ L ++ H +I+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANALSYMHHD 636
+ + + L+ E + G L D ++ + + + I+ + + ++Y+H
Sbjct: 80 LHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 637 CFPPIVHRDISSKNVLLCLDYEA-----RVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
I H D+ +N ++ LD ++ DFG+A ++ + GT ++APE+
Sbjct: 135 K---IAHFDLKPEN-IMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEI 189
Query: 692 VYTMKVTEKCDVYSFGVLA 710
V + + D++S GV+
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 54/291 (18%), Positives = 102/291 (35%), Gaps = 65/291 (22%)
Query: 523 IGIGGQGSVYKAKLTSGEIL--------AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHR 574
+G G ++K +K L F +++L H+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLK---VLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+V YG C + LV E+++ GSL T L + W + + + +A A+ ++
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFLE 130
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEAR--------VSDFGIAKFLKPDSSNCTELVGTFGY 686
+ +H ++ +KN+LL + + + +SD GI+ + P
Sbjct: 131 ENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------IL 177
Query: 687 ------IAPE-LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLN 738
+ PE + + D +SFG E+ GD P +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS------------ALDSQ 225
Query: 739 EILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
L +LP P EL +++ C++ P+ RP + + L
Sbjct: 226 RKLQFYEDRHQLPAPK---AAELANLIN---NCMDYEPDHRPSFRAIIRDL 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V+K + +G LA K + M + E NEI + +L H ++++ Y
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 582 FCSHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVR--MNVIRSVANALSYMHHDCF 638
+ LV EY++ G L I+ E +N T + ++ + + +MH
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIID-----ESYNLTELDTILFMKQICEGIRHMHQM-- 206
Query: 639 PPIVHRDISSKNVLLCLDYEA---RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
I+H D+ +N +LC++ +A ++ DFG+A+ KP GT ++APE+V
Sbjct: 207 -YILHLDLKPEN-ILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYD 263
Query: 696 KVTEKCDVYSFGVLA 710
V+ D++S GV+A
Sbjct: 264 FVSFPTDMWSVGVIA 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 40/272 (14%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G V G +AVK F+ E +T+LRH ++V+ G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 582 FCSHPRNSF-LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
+ +V EY+ +GSL L + G + V A+ Y+ + F
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF-- 310
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY--IAPELVYTMKVT 698
VHRD++++NVL+ D A+VSDFG+ K G APE + K +
Sbjct: 311 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFS 364
Query: 699 EKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPPQNV 752
K DV+SFG+L E+ G P I L +++ ++ P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP------------YPRIPLKDVVPRVEKGYKMD-APDGC 411
Query: 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ ++ C + +RP + + L
Sbjct: 412 PPAVYDVM---KNCWHLDAATRPTFLQLREQL 440
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 40/209 (19%)
Query: 523 IGIGGQGSVYKA--KLTSGEILAVK-----KFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G G V A + T + +A++ KF E P EI+ L +L H
Sbjct: 143 LGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM---------NVIRSV 626
I+K F + ++V E +E G L F+ V +
Sbjct: 202 IIKIKNFFDAE-DYYIVLELMEGGEL------------FDKVVGNKRLKEATCKLYFYQM 248
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA---RVSDFGIAKFLKPDSSNCTELVGT 683
A+ Y+H + I+HRD+ +NVLL E +++DFG +K L S L GT
Sbjct: 249 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGT 304
Query: 684 FGYIAPELVYTMKV---TEKCDVYSFGVL 709
Y+APE++ ++ D +S GV+
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 58/208 (27%), Positives = 84/208 (40%), Gaps = 40/208 (19%)
Query: 523 IGIGGQGSVYKA--KLTSGEILAVK-----KFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G G V A + T + +A+K KF E P EI+ L +L H
Sbjct: 18 LGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM---------NVIRSV 626
I+K F + ++V E +E G L F+ V +
Sbjct: 77 IIKIKNFFDAE-DYYIVLELMEGGEL------------FDKVVGNKRLKEATCKLYFYQM 123
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA---RVSDFGIAKFLKPDSSNCTELVGT 683
A+ Y+H + I+HRD+ +NVLL E +++DFG +K L S L GT
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGT 179
Query: 684 FGYIAPE-LVYTMKV--TEKCDVYSFGV 708
Y+APE LV D +S GV
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 46/258 (17%), Positives = 85/258 (32%), Gaps = 37/258 (14%)
Query: 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSE- 134
++ L KL +F +L + + +N + I V NL L+ + + +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 135 NQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSII-GNLKSLFYLHLSSNQLSGSIPI- 191
N L I P NL NL L + + +P + + L + N +I
Sbjct: 90 NNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
S LS + L L+ N + + +
Sbjct: 148 SFVGLSFE-----------------------SVILWLNKNGIQEIHNSAFNGTQLDELNL 184
Query: 252 LYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310
+N L E+P ++ S L ++ +++ L +L +L K +
Sbjct: 185 SDNNNLE--ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KL 239
Query: 311 PETLGNLLKLHYLNLSNN 328
P TL L+ L +L+
Sbjct: 240 P-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 43/251 (17%), Positives = 79/251 (31%), Gaps = 12/251 (4%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
E++++ IP L N L L L + +S N + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 190 PIS-LGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247
NL L + + + + I NL L +L +S + + + +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130
Query: 248 IGLYLYDNQLSVGEIPIEI--GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
+ L + DN +++ I G L LN N + A E N
Sbjct: 131 VLLDIQDN-INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN 189
Query: 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
L + L++S + LE L +L K+P + +
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKL 245
Query: 366 ESLEKLNLSHN 376
+L + +L++
Sbjct: 246 VALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 43/212 (20%), Positives = 81/212 (38%), Gaps = 13/212 (6%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
L +++S+N + I F NL L + + + + I P NL L +L +
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111
Query: 133 SENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIP--SIIGNLKSLFYLHLSSNQLSGSI 189
S + +P + +L + N +I S +G L L+ N + I
Sbjct: 112 SNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EI 169
Query: 190 PISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLI 248
S N + L L+L +N+ +P+ + + L +S + + + NL L
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 229
Query: 249 GLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN 280
Y+ + ++P + KL +L L
Sbjct: 230 ARSTYNLK----KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 44/231 (19%), Positives = 77/231 (33%), Gaps = 14/231 (6%)
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGV 236
++++ IP L N + L L I L + +S N + V
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 237 IPLSI-GNLNNLIGLYLYD-NQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSL 293
I + NL L + + N L I E L +L YL+++ +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLL--YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 294 TELEYLDLSTNKLGNSIPETL--GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSL 351
+ LD+ N ++I G + L L+ N ++ QL EL+LS
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSD 186
Query: 352 NILEGKIPCEIC-NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNE 401
N ++P ++ L++S L E + L +
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 17/201 (8%)
Query: 212 SIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIG--- 267
IPS + N L L + + +L + + N + IE
Sbjct: 23 EIPSDLPRNAI---ELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL---EVIEADVFS 76
Query: 268 KLSSLNYL-VLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNL 325
L L+ + + N L P A +L L+YL +S + +P+ + L+ L++
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDI 135
Query: 326 SNNQFRKGFPVE-LEKL-IQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNN-FSGLI 382
+N L + L L+ N ++ +I N L++LNLS NN L
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 383 PSCFEGMHGLSCIDVSYNELR 403
F G G +D+S +
Sbjct: 195 NDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 10/138 (7%)
Query: 71 GLKGNLKSLSTLDLSKNKLNGSIP-FSFGNLT-NLAIMYLYRNSLSASIPPVIGNLKFLY 128
K + LD+ N +I SF L+ I++L +N + +
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDE 181
Query: 129 HLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLS 186
N L +P S +L + + S+PS + NLK L + +
Sbjct: 182 LNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK-- 237
Query: 187 GSIPISLGNLSNLVVLHL 204
+P +L L L+ L
Sbjct: 238 -KLP-TLEKLVALMEASL 253
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 66/275 (24%), Positives = 111/275 (40%), Gaps = 48/275 (17%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582
IG G G V G +AVK F+ E +T+LRH ++V+ G
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 583 CSHPRNS-FLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
+ ++V EY+ +GSL L S ++ + ++ V A+ Y+ + F
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDVCEAMEYLEGNNF-- 138
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELVYTM 695
VHRD++++NVL+ D A+VSDFG+ K G + APE +
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKWTAPEALREK 189
Query: 696 KVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPP 749
K + K DV+SFG+L E+ G P I L +++ ++ P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYP------------RIPLKDVVPRVEKGYKMD-AP 236
Query: 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ +++ C + RP + + L
Sbjct: 237 DGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQL 268
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 21/193 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G V A + A K + + F EI+ + L H +I++ Y
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAK---KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALSYMH-HDCF 638
+ +LV E G L + + + + +++ V +A++Y H +
Sbjct: 74 TFEDNTDIYLVMELCTGGELF-----ERVVHKRVFRESDAARIMKDVLSAVAYCHKLN-- 126
Query: 639 PPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
+ HRD+ +N L D ++ DFG+A KP VGT Y++P+ V
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQ-VLEG 182
Query: 696 KVTEKCDVYSFGV 708
+CD +S GV
Sbjct: 183 LYGPECDEWSAGV 195
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 31/199 (15%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVK-----KFHSLWPCEMVPQPEFVNEIKTLTELR-HRS 575
+G G K S + AVK + EI L H +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----------KEITALKLCEGHPN 67
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALSYM 633
IVK + ++FLV E L G L + ++ +++ ++R + +A+S+M
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELF-----ERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 634 HHDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
H +VHRD+ +N+L + E ++ DFG A+ PD+ T Y APE
Sbjct: 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 691 LVYTMKVTEKCDVYSFGVL 709
L+ E CD++S GV+
Sbjct: 180 LLNQNGYDESCDLWSLGVI 198
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 39/267 (14%)
Query: 523 IGIGGQGSVYKAKLT----SGEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSI 576
+G G G+VYK +I A+K L E ++E + + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
+ G C L+ + + G L + + +N +A ++Y+
Sbjct: 80 CRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYT 694
VHRD++++NVL+ +++DFG+AK L + G ++A E +
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 695 MKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTP 748
T + DV+S+GV E++ G P D I +EI RLP P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYD------------GIPASEISSILEKGERLPQP 241
Query: 749 PQNVQDELISIVEVAFLCLNESPESRP 775
P I + + C +SRP
Sbjct: 242 P----ICTIDVYMIMVKCWMIDADSRP 264
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 45/225 (20%)
Query: 512 RATNGFDVKY----CIGIGGQGSVYKA--KLTSGEILAVK-----KFHSLWPCEMVPQPE 560
+T+GF Y +G G V + K T + AVK S E+ E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 561 FV-NEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTV 618
E+ L ++ H +I++ FLV++ +++G L F++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL------------FDYLT 116
Query: 619 RM---------NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669
++R++ + +H IVHRD+ +N+LL D +++DFG +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 670 LKPDSSNCTELVGTFGYIAPELVYTMKV------TEKCDVYSFGV 708
L P E+ GT Y+APE++ ++ D++S GV
Sbjct: 174 LDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 34/199 (17%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G VY+ K + + A+K ++V EI L L H +I+K
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV-----RTEIGVLLRLSHPNIIKLKE 115
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM---------NVIRSVANALSY 632
P LV E + G L F+ V + ++ + A++Y
Sbjct: 116 IFETPTEISLVLELVTGGEL------------FDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 633 MHHDCFPPIVHRDISSKNVLLCL---DYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
+H + IVHRD+ +N+L D +++DFG++K ++ + GT GY AP
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAP 219
Query: 690 ELVYTMKVTEKCDVYSFGV 708
E++ + D++S G+
Sbjct: 220 EILRGCAYGPEVDMWSVGI 238
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 512 RATNGFDVKY----CIGIGGQGSVYKA--KLTSGEILAVK-----KFHSLWPCEMVPQPE 560
A F KY IG G V + + T G AVK +
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 561 FVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR 619
E L ++ H I+ FLV++ + +G L F++
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL------------FDYLTE 193
Query: 620 M---------NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670
+++RS+ A+S++H + IVHRD+ +N+LL + + R+SDFG + L
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 671 KPDSSNCTELVGTFGYIAPE-LVYTMKVTEK-----CDVYSFGV 708
+P EL GT GY+APE L +M T D+++ GV
Sbjct: 251 EPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 38/303 (12%), Positives = 79/303 (26%), Gaps = 71/303 (23%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR--------- 572
+G + +A +GE V + + E+ L LR
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 573 ----------------HRSIVKFYGFCSHP--RNSFLVYEYLER------GSLATILSND 608
+ +++ + F +Y ++ L + S
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 609 GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668
++ R+ + V L+ +HH +VH + +++L ++ F
Sbjct: 201 KSLVH---HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 669 FLKPDSSNCTELVGTFGYIAPELVYTM-----------KVTEKCDVYSFGVLALEVIKGD 717
+ + G+ PEL +T D ++ G++ + D
Sbjct: 255 RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 718 HPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPM 777
P + I P V+ L+ L E R
Sbjct: 311 LP--I------TKDAALGGSEWIFRSCKNIPQP-VRA-LLE------GFLRYPKEDRLLP 354
Query: 778 HTV 780
Sbjct: 355 LQA 357
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 45/219 (20%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 508 EEIVRATNGFDVKYCIG--IG-GQ-GSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFV 562
E ++ A+ F Y + +G G V + T+G A K ++ +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLE 76
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM-- 620
E + +L+H +IV+ + +LV++ + G L F V
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL------------FEDIVAREF 124
Query: 621 -------NVIRSVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEA---RVSDFGIAKF 669
+ I+ + +++Y H + IVHR++ +N+LL + +++DFG+A
Sbjct: 125 YSEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGV 708
+ + GT GY++PE++ ++ D+++ GV
Sbjct: 181 VNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 51/236 (21%), Positives = 82/236 (34%), Gaps = 51/236 (21%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKF--HSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
IG G G V A + I A+K + + E++ + +L H +I +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM------------------- 620
Y + LV E G L L+ + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 621 ------------------NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV- 661
N++R + +AL Y+H+ I HRDI +N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 662 -SDFGIAKFLKP----DSSNCTELVGTFGYIAPELVYTM--KVTEKCDVYSFGVLA 710
DFG++K + T GT ++APE++ T KCD +S GVL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 41/276 (14%)
Query: 523 IGIGGQGSVYKAKLTSGEIL----AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIV 577
+G G G VY+ T+ + AVK + + +F++E + L H IV
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 578 KFYGFCS-HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
K G P +++ E G L L + + + A++Y+
Sbjct: 77 KLIGIIEEEPT--WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI 132
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYT 694
VHRDI+ +N+L+ ++ DFG++++++ D V +++PE +
Sbjct: 133 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINF 188
Query: 695 MKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTP 748
+ T DV+ F V E++ G P + +++ RLP
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFF------------WLENKDVIGVLEKGDRLP-K 235
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P L +++ C + P RP + L
Sbjct: 236 PDLCPPVLYTLMT---RCWDYDPSDRPRFTELVCSL 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 41/267 (15%)
Query: 523 IGIGGQGSVYKAKLTSGEIL----AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIV 577
IG G G V++ S E A+K + C +F+ E T+ + H IV
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 578 KFYGFCS-HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
K G + +P +++ E G L + L + + ++ AL+Y+
Sbjct: 80 KLIGVITENPV--WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK 135
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYT 694
F VHRDI+++NVL+ + ++ DFG++++++ DS+ G ++APE +
Sbjct: 136 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 191
Query: 695 MKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTP 748
+ T DV+ FGV E++ G P + N+++ RLP
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQ------------GVKNNDVIGRIENGERLP-M 238
Query: 749 PQNVQDELISIVEVAFLCLNESPESRP 775
P N L S++ C P RP
Sbjct: 239 PPNCPPTLYSLMT---KCWAYDPSRRP 262
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 37/266 (13%)
Query: 523 IGIGGQGSVYKAKLT----SGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G G+V+K S +I +K Q + + + L H IV
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIED-KSGRQSFQ-AVTDHMLAIGSLDHAHIV 78
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+ G C LV +YL GSL + + +N +A + Y+
Sbjct: 79 RLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVYTM 695
VHR+++++NVLL + +V+DFG+A L PD ++A E ++
Sbjct: 136 M---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 696 KVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPTPP 749
K T + DV+S+GV E++ G P + L E+ D RL P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYA------------GLRLAEVPDLLEKGERLA-QP 239
Query: 750 QNVQDELISIVEVAFLCLNESPESRP 775
Q ++ ++ C RP
Sbjct: 240 QICTIDVYMVM---VKCWMIDENIRP 262
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 41/200 (20%), Positives = 82/200 (41%), Gaps = 32/200 (16%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G V + T+G A K + + E + +L+H +IV+ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM---------NVIRSVANALSY 632
+LV++ + G L F V + I+ + +++Y
Sbjct: 73 SIQEESFHYLVFDLVTGGEL------------FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 633 MH-HDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
H + IVHR++ +N+LL +++DFG+A + + GT GY++
Sbjct: 121 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLS 175
Query: 689 PELVYTMKVTEKCDVYSFGV 708
PE++ ++ D+++ GV
Sbjct: 176 PEVLKKDPYSKPVDIWACGV 195
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 52/273 (19%), Positives = 101/273 (36%), Gaps = 32/273 (11%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVK----------KFHSLWPCEMVPQPEFV----NEIKTL 568
+ G + + + A+K + + + + NE++ +
Sbjct: 39 LNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 569 TELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE-----FNWTVRMNVI 623
T++++ + G ++ +++YEY+E S+ +++ V +I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT 683
+SV N+ SY+H+ I HRD+ N+L+ + ++SDFG ++++ D GT
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDKKIKG-SRGT 213
Query: 684 FGYIAPELVYTMKVT--EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741
+ ++ PE K D++S G+ + P F IS NI I
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKISLVELFNNIRTKNIE 271
Query: 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
P S FL S E
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFL----SNEDI 300
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 49/236 (20%), Positives = 91/236 (38%), Gaps = 20/236 (8%)
Query: 95 FSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154
F L N L + S++ + L + + + + + S+ + +NL L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP 214
HL N +S + + +L L L ++ N+L ++ + L L L N L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNEL--RDT 121
Query: 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY 274
L +LK L L + N L ++ L L+ L L L+ N+++ + +L +N+
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTG---GLTRLKKVNW 176
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI-PETLGNLLKLHYLNLSNNQ 329
+ L G + N P + EL + + G I P + N +
Sbjct: 177 IDLTGQKCV-NEP--VKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 48/237 (20%), Positives = 92/237 (38%), Gaps = 18/237 (7%)
Query: 121 IGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180
L +L + ++ + LS + + +++ S+ + +L LHL
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAGM-QFFTNLKELHL 70
Query: 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLS 240
S NQ+S + L +L+ L L + N L + + + L L L N L L
Sbjct: 71 SHNQIS-DLS-PLKDLTKLEELSVNRNRL--KNLNGIPSAC-LSRLFLDNNELRDTDSLI 125
Query: 241 IGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300
+L NL L + +N+L I +G LS L L L+GN++ L L ++ ++D
Sbjct: 126 --HLKNLEILSIRNNKLK--SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWID 178
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK 357
L+ K N + L + + + ++ P + + + +
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 19/217 (8%)
Query: 167 SIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHL 226
L + +L ++ + LS + + +++ + + L L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68
Query: 227 GLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286
LS N +S + PL +L L L + N+L + + L+ L L+ N+L
Sbjct: 69 HLSHNQISDLSPLK--DLTKLEELSVNRNRLKN----LNGIPSACLSRLFLDNNELRD-- 120
Query: 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSE 346
+L L LE L + NKL SI LG L KL L+L N+ L +L +++
Sbjct: 121 TDSLIHLKNLEILSIRNNKL-KSI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNW 176
Query: 347 LDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIP 383
+DL+ + + L N + I
Sbjct: 177 IDLTGQKCVNE---PVKYQPELYITNTVKDPDGRWIS 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 37/188 (19%), Positives = 72/188 (38%), Gaps = 16/188 (8%)
Query: 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY 274
L + L ++ ++ L+ + ++ + + ++L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLA---GMQFFTNLKE 67
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF 334
L L+ NQ+ +L L LT+LE L ++ N+L ++ L L L NN+ R
Sbjct: 68 LHLSHNQI-SDLS-PLKDLTKLEELSVNRNRL-KNLNG--IPSACLSRLFLDNNELRDTD 122
Query: 335 PVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSC 394
L L L L + N L+ I + + LE L+L N + + ++
Sbjct: 123 S--LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNW 176
Query: 395 IDVSYNEL 402
ID++ +
Sbjct: 177 IDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 35/176 (19%), Positives = 72/176 (40%), Gaps = 16/176 (9%)
Query: 228 LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP 287
++ V P L N + L ++ ++ +LS + + + + +L
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVT--DLV-SQKELSGVQNFNGDNSNI-QSLA 57
Query: 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSEL 347
+ T L+ L LS N++ S L +L KL L+++ N+ + + LS L
Sbjct: 58 -GMQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRL 111
Query: 348 DLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L N L + ++++LE L++ +N + + L +D+ NE+
Sbjct: 112 FLDNNELR-DTD-SLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 32/135 (23%), Positives = 55/135 (40%), Gaps = 9/135 (6%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+L L L +++N+L L+ L +L N L + +LK L L +
Sbjct: 83 DLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELR-DTDS-LIHLKNLEILSIRN 137
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
N+L SI LG LS L VL L+GN ++ + + LK + ++ L+ +
Sbjct: 138 NKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQP 193
Query: 195 NLSNLVVLHLFENSL 209
L + +
Sbjct: 194 ELYITNTVKDPDGRW 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 29/256 (11%), Positives = 59/256 (23%), Gaps = 41/256 (16%)
Query: 522 CIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY 580
G ++A +A+ E ++ L+ + + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP 640
+V E++ GSL + + +R ++S+A A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG---AIR--AMQSLAAAADAAHRA---G 149
Query: 641 IVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK 700
+ V VS G + + +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD-------ANPQ 182
Query: 701 CDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIV 760
D+ G ++ P S + + P +D I
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLA-----PAERDTAGQPIEPADIDRDIPFQIS 237
Query: 761 EVAFLCLNESPESRPP 776
VA + R
Sbjct: 238 AVAARSVQGDGGIRSA 253
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 48/237 (20%), Positives = 89/237 (37%), Gaps = 20/237 (8%)
Query: 55 QCNPAKRVI--SINLSTVGLKGNLKSLSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRN 111
+C+ + ++ + S TL L + L +IP +F NL N++ +Y+ +
Sbjct: 9 ECHQEEDFRVTCKDIQRI--PSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65
Query: 112 SLSASIPP-VIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIP--S 167
+ NL + H+++ + I P L L L L ++ L P +
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124
Query: 168 IIGNLKSLFYLHLSSNQLSGSIPI-SLGNLSN-LVVLHLFENSLFGSIPSILGNLKMLLH 225
+ + F L ++ N SIP+ + L N + L L+ N S+ N L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDA 183
Query: 226 LGLSTNHLSGVIPLSI--GNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN 280
+ L+ N VI G + L + ++ +P + L L L+
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT--ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 45/249 (18%), Positives = 87/249 (34%), Gaps = 33/249 (13%)
Query: 149 SNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI-SLGNLSNLVVLHLFEN 207
+ + IPS+ + + L L L +IP + NL N+ +++ +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLPPSTQ---TLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65
Query: 208 SLFGSIPS-ILGNLKMLLHLGLS-TNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE 265
+ S NL + H+ + T +L+ + P ++ L L L +++ L + +
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTK 125
Query: 266 IGKLSSLNYLVLNGNQLYGNLP-RALGSLT-ELEYLDLSTNKLGNSIPETLGNLLKLHYL 323
+ L + N ++P A L E L L N S+ N KL +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAV 184
Query: 324 NLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIP 383
L+ N+ L+ +D + G L++S + + L
Sbjct: 185 YLNKNK-------------YLTVIDK--DAFGG-------VYSGPSLLDVSQTSVTALPS 222
Query: 384 SCFEGMHGL 392
E + L
Sbjct: 223 KGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 10/187 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
NL ++S + +S + + SF NL+ + + + I P + L L L +
Sbjct: 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112
Query: 133 SENQLSGSIPPT--LGNLSNLAVLHLYGNSLSGSIP--SIIGNLKSLFYLHLSSNQLSGS 188
L P + + +L + N SIP + G L L +N + S
Sbjct: 113 FNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-S 170
Query: 189 IPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLH-LGLSTNHLSGVIPLSIGNLNN 246
+ N + L ++L +N I G + L +S ++ + + +L
Sbjct: 171 VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKE 230
Query: 247 LIGLYLY 253
LI +
Sbjct: 231 LIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 34/194 (17%), Positives = 68/194 (35%), Gaps = 34/194 (17%)
Query: 212 SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS 271
IPS+ + + L L HL + + NL N+ +Y+ + L
Sbjct: 25 RIPSLPPSTQ---TLKLIETHLRTIPSHAFSNLPNISRIYVSID-----------VTLQQ 70
Query: 272 LNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP-ETLGNLLKLHYLNLSNNQF 330
L + +L+++ ++++ + I + L L L +L + N
Sbjct: 71 LE-------------SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117
Query: 331 RKGFP--VELEKLIQLSELDLSLNILEGKIPCEICN--MESLEKLNLSHNNFSGLIPSCF 386
+ FP ++ L+++ N IP L L +N F+ + F
Sbjct: 118 KM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF 176
Query: 387 EGMHGLSCIDVSYN 400
G L + ++ N
Sbjct: 177 NGTK-LDAVYLNKN 189
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 1e-20
Identities = 51/187 (27%), Positives = 77/187 (41%), Gaps = 32/187 (17%)
Query: 78 SLSTLDLSKNKLNGSIP--FSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSE 134
+ LDLS N L + ++ LTNL + L N L+ I + L +LDLS
Sbjct: 40 YTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 135 NQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPIS 192
N L ++ +L L VL LY N + + ++ L L+LS NQ+S P
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFP-- 152
Query: 193 LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL--IGL 250
+ L ++ L L+ L LS+N L + + L GL
Sbjct: 153 ---------VELIKD---------GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 251 YLYDNQL 257
YL++N L
Sbjct: 195 YLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 16/183 (8%)
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS--ILGNLKMLLHLGLSTNHLSG 235
L S QL ++P SL S +L L N+L + + L L L LS NHL+
Sbjct: 23 LSCSKQQLP-NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF 78
Query: 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPR-ALGSL 293
+ + + NL L L N L + + L +L L+L N + + R A +
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLHT--LDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDM 135
Query: 294 TELEYLDLSTNKLGNSIPE----TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDL 349
+L+ L LS N++ + P L KL L+LS+N+ +K +L+KL + L
Sbjct: 136 AQLQKLYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 350 SLN 352
L+
Sbjct: 195 YLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 226 LGLSTNHLSGVIP-LSIGNLNNLIGLYLYDNQLSVGEIPIEIG---KLSSLNYLVLNGNQ 281
L LS N+LS + + L NL L L N L+ I + +L YL L+ N
Sbjct: 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF----ISSEAFVPVPNLRYLDLSSNH 99
Query: 282 LYGNLPR-ALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVE-- 337
L L L LE L L N + + ++ +L L LS NQ + FPVE
Sbjct: 100 L-HTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQISR-FPVELI 156
Query: 338 --LEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS-HNN 377
KL +L LDLS N L+ ++ + + K L HNN
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 41/144 (28%), Positives = 60/144 (41%), Gaps = 13/144 (9%)
Query: 75 NLKSLSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
L +L +L LS N LN I +F + NL + L N L ++ + +L+ L L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 133 SENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIP----SIIGNLKSLFYLHLSSNQLSG 187
N + + +++ L L+L N +S P L L L LSSN+L
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 188 SIPISLGNLSNLVV--LHLFENSL 209
L L V L+L N L
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 46/230 (20%), Positives = 86/230 (37%), Gaps = 43/230 (18%)
Query: 500 TFEGKILYEEIVRATNGFDVKY----CIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCE 554
T + +++ R + F Y IG+G + + AVK
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----- 57
Query: 555 MVPQPEFVNEIKTL-TELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE 613
+ + EI+ L +H +I+ + ++V E ++ G L
Sbjct: 58 --SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL------------ 103
Query: 614 FNWTVRM---------NVIRSVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEA---- 659
+ +R V+ ++ + Y+H +VHRD+ N+L +
Sbjct: 104 LDKILRQKFFSEREASAVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESI 159
Query: 660 RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVL 709
R+ DFG AK L+ ++ T ++APE++ CD++S GVL
Sbjct: 160 RICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-20
Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 43/277 (15%)
Query: 523 IGIGGQGSVYKAKLTS---GEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRSIV 577
IG G G V++ S + A+K + C +F+ E T+ + H IV
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 578 KFYGFCS-HPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
K G + +P +++ E G L + L + + ++ AL+Y+
Sbjct: 455 KLIGVITENPV--WIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLES 509
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPELVY 693
F VHRDI+++NVL+ + ++ DFG++++++ DS+ G ++APE +
Sbjct: 510 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565
Query: 694 TMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP-----RLPT 747
+ T DV+ FGV E++ G P + N+++ RLP
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQ------------GVKNNDVIGRIENGERLP- 612
Query: 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P N L S++ C P RP + L
Sbjct: 613 MPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 646
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 36/276 (13%)
Query: 523 IGIGGQGSVYKAKLTSGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
IG G G VY L + AVK + + ++ +F+ E + + H +++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 579 FYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVR--MNVIRSVANALSYMHH 635
G C S +V Y++ G L + N+ N TV+ + VA + ++
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS 210
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APE 690
F VHRD++++N +L + +V+DFG+A+ + + T + A E
Sbjct: 211 KKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALE 266
Query: 691 LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILD-PRLPTP 748
+ T K T K DV+SFGVL E++ +G P + + +I +L RL
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDI-TVYLLQGRRLL-Q 317
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P+ D L ++ C + E RP + +
Sbjct: 318 PEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 350
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 44/207 (21%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFY 580
+G G V L + + AVK + + E++ L + + HR++++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 581 GFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALSYMHHDCF 638
F +LV+E + GS+ + ++ V++ VA+AL ++H
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSIL-----SHIHKRRHFNELEASVVVQDVASALDFLH---N 129
Query: 639 PPIVHRDISSKNVLLCLDYEA----RVSDFGIAKFLKPDSSNC-------TELVGTFGYI 687
I HRD+ +N +LC ++ DF + +K + G+ Y+
Sbjct: 130 KGIAHRDLKPEN-ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 688 APELVYTMKVT-----EKCDVYSFGVL 709
APE+V ++CD++S GV+
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 57/293 (19%)
Query: 523 IGIGGQGSVYKAKL-----TSGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G V+ A+ T ++L AVK +L + + +F E + LT L+H I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----------- 625
VKFYG C +V+EY++ G L L G + +
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 626 --VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT 683
+A+ + Y+ F VHRD++++N L+ + ++ DFG+++ + S++ VG
Sbjct: 140 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR-VGG 193
Query: 684 FGYI-----APE-LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNIS 736
+ PE ++Y K T + DV+SFGV+ E+ G P +S
Sbjct: 194 HTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPW------------FQLS 240
Query: 737 LNEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
E+++ L P+ E+ ++ C P+ R + + ++L
Sbjct: 241 NTEVIECITQGRVLE-RPRVCPKEVYDVML---GCWQREPQQRLNIKEIYKIL 289
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 2e-19
Identities = 46/252 (18%), Positives = 81/252 (32%), Gaps = 11/252 (4%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
+QL + S+ + + LF LS + +
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-V 363
Query: 189 IPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLI 248
+ L + L L +I ++ L LL+ + + S + +
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY-- 421
Query: 249 GLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN 308
+ E + + + + L L L + L L + +LDLS N+L
Sbjct: 422 --LDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL-R 476
Query: 309 SIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG-KIPCEICNMES 367
++P L L L L S+N + L +L EL L N L+ + +
Sbjct: 477 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 368 LEKLNLSHNNFS 379
L LNL N+
Sbjct: 535 LVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 1e-18
Identities = 56/343 (16%), Positives = 108/343 (31%), Gaps = 24/343 (6%)
Query: 15 SLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWF--------GIQCNPAKRVISIN 66
S ++R LL + V +VS + + + +S+
Sbjct: 227 SAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVE 286
Query: 67 LSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLT----NLAIMYLYRNSLSASIPPVIG 122
T + + DL LN +P + + +
Sbjct: 287 WRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSA 346
Query: 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182
+ L+ +LS + + + L + L L +II +++L L
Sbjct: 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL---LTIILLMRALDPLLYEK 402
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
L + + L + + + L L+ L+ + L
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHL--E 460
Query: 243 NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302
L + L L N+L +P + L L L + N L N+ + +L L+ L L
Sbjct: 461 QLLLVTHLDLSHNRLR--ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLC 516
Query: 303 TNKLGN-SIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQL 344
N+L + + L + +L LNL N + E+L ++
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 35/230 (15%), Positives = 72/230 (31%), Gaps = 20/230 (8%)
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237
++QL + S+ + + L LS + V+
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364
Query: 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELE 297
+ + L L + + I + +L+ L+ L + +L ++
Sbjct: 365 QSELESCKELQELEPENKWCLL----TIILLMRALDPLLYEKETL-----QYFSTLKAVD 415
Query: 298 YLDLSTNKLGNSI-----PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352
+ + S + L+L++ LE+L+ ++ LDLS N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHN 473
Query: 353 ILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
L +P + + LE L S N + + L + + N L
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 24/166 (14%), Positives = 50/166 (30%), Gaps = 8/166 (4%)
Query: 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELE 297
L L + + + E+ L L + + +L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST--VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 298 YLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK 357
Y + + + + + +L + + V + + L L+ L
Sbjct: 400 YEKETLQYFSTL--KAVDPMRAAYLDDLRSKFLLE-NSVLKMEYADVRVLHLAHKDLT-- 454
Query: 358 IPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ C + + + L+LSHN +P + L + S N L
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 71/291 (24%), Positives = 116/291 (39%), Gaps = 54/291 (18%)
Query: 523 IGIGGQGSVYKAKLT-----SGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G V+ A+ ++L AVK +L + +F E + LT L+H+ I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEASESARQDFQREAELLTMLQHQHI 105
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATIL------------SNDGAIEEFNWTVRMNVIR 624
V+F+G C+ R +V+EY+ G L L D A + V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
VA + Y+ F VHRD++++N L+ ++ DFG+++ + VG
Sbjct: 166 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR 219
Query: 685 GYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLN 738
+ PE + K T + DV+SFGV+ E+ G P +S
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW------------YQLSNT 267
Query: 739 EILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
E +D L P+ E+ +I+ C P+ R + V L
Sbjct: 268 EAIDCITQGRELE-RPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARL 314
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 43/204 (21%), Positives = 87/204 (42%), Gaps = 33/204 (16%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHR-SIV 577
+G G V + ++G+ A K K C E ++EI L + ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA----EILHEIAVLELAKSCPRVI 92
Query: 578 KFYGFCSHPRNSFLVYEYLERGSL--------ATILSNDGAIEEFNWTVRMNVIRSVANA 629
+ + L+ EY G + A ++S + I +I+ +
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR---------LIKQILEG 143
Query: 630 LSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY 686
+ Y+H + IVH D+ +N+LL + ++ DFG+++ + E++GT Y
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEY 199
Query: 687 IAPELVYTMKVTEKCDVYSFGVLA 710
+APE++ +T D+++ G++A
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 82/410 (20%), Positives = 138/410 (33%), Gaps = 70/410 (17%)
Query: 63 ISINLSTVGLKGN-------------LKSLSTLDLSKNKLN----GSIPFSFGNLTNLAI 105
+S+++ ++ ++ L+ + L L I + LA
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 106 MYLYRNSLSASIPPVIGN-LKF----LYHLDLSENQLS----GSIPPTLGNLSNLAVLHL 156
+ L N L + L+ + L L L+ G + TL L L LHL
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 157 YGNSLSGS-IPSIIGNLKS----LFYLHLSSNQLS--GSIPIS--LGNLSNLVVLHLFEN 207
N L + + + L L L L LS P++ L + L + N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 208 SL----FGSIPSILGNLK-MLLHLGLSTNHLS--GVIPLS--IGNLNNLIGLYLYDNQLS 258
+ + L + L L L + ++ L + + +L L L N+L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 259 VGEI----PIEIGKLSSLNYLVLNGNQL----YGNLPRALGSLTELEYLDLSTNKLGNSI 310
+ P + S L L + + G+L R L + L+ L L+ N+LG+
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300
Query: 311 PETLGNLLK-----LHYLNLSNNQFRKGFPVELEKLIQ----LSELDLSLNILEGKIPCE 361
L L L L + + F ++ L EL +S N LE E
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 360
Query: 362 IC-----NMESLEKLNLSHNNFS----GLIPSCFEGMHGLSCIDVSYNEL 402
+C L L L+ + S + + H L +D+S N L
Sbjct: 361 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 69/347 (19%), Positives = 103/347 (29%), Gaps = 80/347 (23%)
Query: 71 GLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHL 130
GL L L L L S + LA V+ L
Sbjct: 136 GLLDPQCRLEKLQLEYCSL------SAASCEPLA--------------SVLRAKPDFKEL 175
Query: 131 DLSENQLSGS----IPPTLG-NLSNLAVLHLYGNSLS----GSIPSIIGNLKSLFYLHLS 181
+S N ++ + + L + L L L ++ + I+ + SL L L
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 235
Query: 182 SNQL--SGSIPISLGNL---SNLVVLHLFENSL----FGSIPSILGNLKMLLHLGLSTNH 232
SN+L G + G L S L L ++E + G + +L + L L L+ N
Sbjct: 236 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295
Query: 233 L--SGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL----YGNL 286
L G L L L L + +
Sbjct: 296 LGDEGARLLCETLLEP----------------------GCQLESLWVKSCSFTAACCSHF 333
Query: 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLK-----LHYLNLSNNQFR----KGFPVE 337
L L L +S N+L ++ L L L L L++
Sbjct: 334 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393
Query: 338 LEKLIQLSELDLSLNILEGKIPCEIC-----NMESLEKLNLSHNNFS 379
L L ELDLS N L ++ LE+L L +S
Sbjct: 394 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 62/313 (19%), Positives = 107/313 (34%), Gaps = 65/313 (20%)
Query: 71 GLKGNLKSLSTLDLSKNKLNGS--------IPFSFGNLTNLAIMYLYRNSLSA----SIP 118
L+ L +S N +N + + S L L L +++ +
Sbjct: 165 VLRAK-PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL---KLESCGVTSDNCRDLC 220
Query: 119 PVIGNLKFLYHLDLSENQLSGS-----IPPTLGNLSNLAVLHLYGNSLS----GSIPSII 169
++ + L L L N+L P L S L L ++ ++ G + ++
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280
Query: 170 GNLKSLFYLHLSSNQL--SGSIPISLG---NLSNLVVLHLFENSL----FGSIPSILGNL 220
+SL L L+ N+L G+ + L L + S S+L
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 221 KMLLHLGLSTNHL--SGVIPLSIG---NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYL 275
+ LL L +S N L +GV L G + L L+L D +
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV------------------ 382
Query: 276 VLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK-----LHYLNLSNNQF 330
+ +L L + L LDLS N LG++ L ++ L L L + +
Sbjct: 383 ---SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
Query: 331 RKGFPVELEKLIQ 343
+ L+ L +
Sbjct: 440 SEEMEDRLQALEK 452
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 64/274 (23%), Positives = 111/274 (40%), Gaps = 32/274 (11%)
Query: 523 IGIGGQGSVYKAKLTSGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
IG G G VY L + AVK + + ++ +F+ E + + H +++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 579 FYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
G C S +V Y++ G L + N+ + VA + Y+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-----APELV 692
F VHRD++++N +L + +V+DFG+A+ + T + A E +
Sbjct: 149 F---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH-NKTGAKLPVKWMALESL 204
Query: 693 YTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILD-PRLPTPPQ 750
T K T K DV+SFGVL E++ +G P + + +I +L RL P+
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDI-TVYLLQGRRLL-QPE 255
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
D L ++ C + E RP + +
Sbjct: 256 YCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 58/287 (20%), Positives = 116/287 (40%), Gaps = 50/287 (17%)
Query: 523 IGIGGQGSVYKAKLTS-----GEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRS 575
+G G G VY+ E A+K ++ + + EF+NE + E
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVR-------MNVIRSVAN 628
+V+ G S + + ++ E + RG L + L + N + + + +A+
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI- 687
++Y++ + F VHRD++++N ++ D+ ++ DFG+ + + G G +
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLP 203
Query: 688 ----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILD 742
+PE + T DV+SFGV+ E+ + P + +S ++L
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------------QGLSNEQVLR 251
Query: 743 P-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
L P N D L ++ +C +P+ RP + +
Sbjct: 252 FVMEGGLLD-KPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSI 294
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/283 (21%), Positives = 105/283 (37%), Gaps = 40/283 (14%)
Query: 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGE----ILAVKKFHSLWPCEMVPQPEFVNE 564
I IG G G VY + A+K + + F+ E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVE-AFLRE 72
Query: 565 IKTLTELRHRSIVKFYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
+ L H +++ G P ++ Y+ G L + + ++
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFG 130
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT 683
VA + Y+ F VHRD++++N +L + +V+DFG+A+ + D +
Sbjct: 131 LQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHR 186
Query: 684 FGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISL 737
+ A E + T + T K DV+SFGVL E++ +G P R+I
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY------------RHIDP 234
Query: 738 NEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRP 775
++ RLP P+ D L +++ C P RP
Sbjct: 235 FDLTHFLAQGRRLP-QPEYCPDSLYQVMQ---QCWEADPAVRP 273
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 48/286 (16%)
Query: 523 IGIGGQGSVYKAKLT-----SGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G VY+ +++ + AVK + + + +F+ E +++ H++I
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNI 136
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATIL--SNDGAIEEFNWTVR--MNVIRSVANALSY 632
V+ G F++ E + G L + L + + + + ++V R +A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARV---SDFGIAKFLKPDSSNCTELVGTFGYI-- 687
+ + F +HRDI+++N LL RV DFG+A+ + + G +
Sbjct: 197 LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAMLPV 250
Query: 688 ---APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP 743
PE T K D +SFGVL E+ G P + S E+L+
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------------PSKSNQEVLEF 298
Query: 744 -----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
R+ PP+N + I+ C PE RP + + +
Sbjct: 299 VTSGGRMD-PPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 340
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 523 IGIGGQGSVYKAKLTSGE------ILAVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRS 575
+G G G VY+ +++ +AVK +L +F+ E +++ H++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI----RSVANALS 631
IV+ G F++ E + G L + L ++ M + R +A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARV---SDFGIAKFLKPDSSNCTELVGTFGYI- 687
Y+ + F +HRDI+++N LL RV DFG+A+ + ++ G +
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYR-KGGCAMLP 208
Query: 688 ----APE-LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEIL 741
PE + T K D +SFGVL E+ G P S SN+ + L +
Sbjct: 209 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQEV-LEFVT 259
Query: 742 D-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
R+ PP+N + I+ C PE RP + + +
Sbjct: 260 SGGRMD-PPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 299
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 63/261 (24%), Positives = 94/261 (36%), Gaps = 73/261 (27%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
+L K + + L ++ + + + + I L + +L L N+L
Sbjct: 20 ETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL 75
Query: 138 SGSIPPTLG---NLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL 193
+ L+NL L L GN L S+P+ + L +L L L NQL S+P
Sbjct: 76 H-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLP--- 125
Query: 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253
GV L NL L L
Sbjct: 126 ----------------------------------------DGV----FDKLTNLTYLNLA 141
Query: 254 DNQLSVGEIPIEIG---KLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNKLGNS 309
NQL + G KL++L L L+ NQL +LP LT+L+ L L N+L S
Sbjct: 142 HNQLQS----LPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQL-KS 195
Query: 310 IPE-TLGNLLKLHYLNLSNNQ 329
+P+ L L Y+ L +N
Sbjct: 196 VPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 11/180 (6%)
Query: 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSI 213
+L S++ + L S+ + +++ + I L N+ L L N L I
Sbjct: 24 ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKL-HDI 78
Query: 214 PSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSL 272
L L L +L L+ N L + L NL L L +NQL +P + KL++L
Sbjct: 79 S-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ--SLPDGVFDKLTNL 135
Query: 273 NYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFR 331
YL L NQL LT L LDLS N+L S+PE L +L L L NQ +
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 12/200 (6%)
Query: 14 TSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVISIN-LSTVGL 72
+S+ + T +N+ + + S N + N L +
Sbjct: 22 IKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLHDISA 80
Query: 73 KGNLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHL 130
L +L+ L L+ N+L S+P F LTNL + L N L S+P V L L +L
Sbjct: 81 LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYL 138
Query: 131 DLSENQLSGSIPPTL-GNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGS 188
+L+ NQL S+P + L+NL L L N L S+P + L L L L NQL S
Sbjct: 139 NLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-S 195
Query: 189 IPI-SLGNLSNLVVLHLFEN 207
+P L++L + L +N
Sbjct: 196 VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL-SVGEIPIEIGKLSSLNYLVLNGNQLYG 284
L ++ + + LN++ + ++ + SV I L ++ YL L GN+L
Sbjct: 24 ANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ----YLPNVRYLALGGNKL-- 75
Query: 285 NLPRALG---SLTELEYLDLSTNKLGNSIPETL-GNLLKLHYLNLSNNQFRKGFPVELEK 340
+ LT L YL L+ N+L S+P + L L L L NQ + +K
Sbjct: 76 ---HDISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDK 131
Query: 341 LIQLSELDLSLNILEGKIPCEIC-NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSY 399
L L+ L+L+ N L+ +P + + +L +L+LS+N L F+ + L + +
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ 190
Query: 400 NELR 403
N+L+
Sbjct: 191 NQLK 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 50/135 (37%), Positives = 63/135 (46%), Gaps = 20/135 (14%)
Query: 66 NLSTVGLKGN------------LKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNS 112
NL+ + L GN L +L L L +N+L S+P F LTNL + L N
Sbjct: 86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ 144
Query: 113 LSASIPP-VIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPS-II 169
L S+P V L L LDLS NQL S+P L+ L L LY N L S+P +
Sbjct: 145 LQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVF 201
Query: 170 GNLKSLFYLHLSSNQ 184
L SL Y+ L N
Sbjct: 202 DRLTSLQYIWLHDNP 216
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 60/285 (21%), Positives = 111/285 (38%), Gaps = 46/285 (16%)
Query: 523 IGIGGQGSVYKAKLTSGEIL----AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G GSV + L + AVK + + EF++E + + H ++++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE-EFLSEAACMKDFSHPNVIR 100
Query: 579 FYGFCS-----HPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVR--MNVIRSVANAL 630
G C ++ +++ G L T L + + ++ + + +A +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI--- 687
Y+ + F +HRD++++N +L D V+DFG++K + G +
Sbjct: 161 EYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAKMPVK 214
Query: 688 --APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP- 743
A E + T K DV++FGV E+ +G P + +E+ D
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY------------PGVQNHEMYDYL 262
Query: 744 ----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RL P++ DEL I+ C P RP + L
Sbjct: 263 LHGHRLK-QPEDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 25/195 (12%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G G V K + +G I+A+KKF +MV + EIK L +LRH ++V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNLLE 91
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA----NALSYMHHDC 637
C + +LV+E+++ ++ L E F + V++ N + + H
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDL------ELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL-----V 692
I+HRDI +N+L+ ++ DFG A+ L + V T Y APEL
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 693 YTMKVTEKCDVYSFG 707
Y V DV++ G
Sbjct: 202 YGKAV----DVWAIG 212
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 30/130 (23%), Positives = 54/130 (41%), Gaps = 6/130 (4%)
Query: 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSG 139
+ L +N + P +F L + L N +S + P L+ L L L N+++
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 140 SIPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISLGNLS 197
+P L +L +L L N ++ + +L +L L L N+L + L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 198 NLVVLHLFEN 207
+ +HL +N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 5/129 (3%)
Query: 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYG 284
+ L N + + P + L + L +NQ+S E+ + L SLN LVL GN++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS--ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 285 NLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQ 343
L L+ L L+ NK+ N + +L L+ L+L +N+ + L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 344 LSELDLSLN 352
+ + L+ N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 6/112 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPF-SFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
K L +DLS N+++ + +F L +L + LY N ++ +P + L L L L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111
Query: 133 SENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183
+ N+++ + +L NL +L LY N L L+++ +HL+ N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 101 TNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYG 158
+ + L +N++ IPP K L +DLS NQ+S + P L +L L LYG
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 159 NSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI-SLGNLSNLVVLHLFENSLFGSIPSI 216
N ++ +P + L SL L L++N+++ + + + +L NL +L L++N L
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 217 LGNLKMLLHLGLSTN 231
L+ + + L+ N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 9/144 (6%)
Query: 140 SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPI-SLGNLSN 198
IP L + + L N++ P K L + LS+NQ+S + + L +
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 199 LVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL 257
L L L+ N + +P + L L L L+ N ++ + + +L+NL L LYDN+L
Sbjct: 82 LNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 258 SVGEIPIEI-GKLSSLNYLVLNGN 280
I L ++ + L N
Sbjct: 141 Q--TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 28/129 (21%), Positives = 52/129 (40%), Gaps = 6/129 (4%)
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKG 333
+ L N + P A +L +DLS N++ + + L L+ L L N+
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKI-TE 94
Query: 334 FPVEL-EKLIQLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHG 391
P L E L L L L+ N + + + ++ +L L+L N + F +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 392 LSCIDVSYN 400
+ + ++ N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 32/129 (24%), Positives = 58/129 (44%), Gaps = 6/129 (4%)
Query: 294 TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNI 353
+ + L N + P KL ++LSNNQ + P + L L+ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 354 LEGKIPCEI-CNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIF 412
+ ++P + + SL+ L L+ N + L F+ +H L+ + + N+L+ I
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT-IAKG--- 146
Query: 413 QYDPMEALQ 421
+ P+ A+Q
Sbjct: 147 TFSPLRAIQ 155
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 27/201 (13%)
Query: 520 KYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIV 577
K +G+G G V + +G+ A+K + P+ E+ + IV
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASGGPHIV 85
Query: 578 KFYGFC---SHPRNSF-LVYEYLERGSLATILSNDGAIEEFNWTVRM--NVIRSVANALS 631
H + ++ E +E G L S + +T R ++R + A+
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 632 YMHHDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
++H I HRD+ +N+L D +++DFG AK ++ T Y+A
Sbjct: 143 FLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVA 197
Query: 689 PELVYTMKVTEKCDVYSFGVL 709
PE++ K + CD++S GV+
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVI 218
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 46/198 (23%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 523 IGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTEL-RHRSIVKF 579
+G+G G V + + E A+K M+ E++ + IV+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRASQCPHIVRI 120
Query: 580 YGFC----SHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+ + +V E L+ G L + I + F +++S+ A+ Y+H
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH 178
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEA---RVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
I HRD+ +N+L +++DFG AK +S T T Y+APE+
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEV 234
Query: 692 VYTMKVTEKCDVYSFGVL 709
+ K + CD++S GV+
Sbjct: 235 LGPEKYDKSCDMWSLGVI 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 59/286 (20%), Positives = 109/286 (38%), Gaps = 47/286 (16%)
Query: 523 IGIGGQGSVYKAKLTSGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G GSV +A+L + +AVK + + EF+ E + E H + K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKEFDHPHVAK 89
Query: 579 FYGFCS------HPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVR--MNVIRSVANA 629
G ++ +++ G L L ++ FN ++ + + +A
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI-- 687
+ Y+ F +HRD++++N +L D V+DFG+++ + G +
Sbjct: 150 MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPV 203
Query: 688 ---APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDP 743
A E + T DV++FGV E++ +G P I EI +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY------------AGIENAEIYNY 251
Query: 744 -----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
RL P +E+ ++ C + P+ RP + L
Sbjct: 252 LIGGNRLK-QPPECMEEVYDLMY---QCWSADPKQRPSFTCLRMEL 293
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 20/176 (11%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G V+K + +G+I+A+KKF ++ + + EI+ L +L+H ++V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-LREIRMLKQLKHPNLVNLLE 69
Query: 582 FCSHPRNSFLVYEYLERGSLATILSND--GAIEEFNWTVRMNVIRS----VANALSYMHH 635
R LV+EY + ++ + V ++++S A+++ H
Sbjct: 70 VFRRKRRLHLVFEYCDH---------TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
+HRD+ +N+L+ ++ DFG A+ L S + V T Y +PEL
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 69/295 (23%), Positives = 112/295 (37%), Gaps = 65/295 (22%)
Query: 523 IGIGGQGSVYKAKLTSGEIL---AVKKFHSLWPCEMVPQP-EFVNEIKTLTEL-RHRSIV 577
IG G G V KA++ + A+K + +F E++ L +L H +I+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS------------ 625
G C H +L EY G+L L +E N S
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 626 -VANALSY---MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELV 681
VA + Y +HRD++++N+L+ +Y A+++DFG+++
Sbjct: 150 DVARGMDYLSQKQ------FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV--K 197
Query: 682 GTFGYI-----APE-LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRN 734
T G + A E L Y+ T DV+S+GVL E++ G P
Sbjct: 198 KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYC------------G 244
Query: 735 ISLNEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ E+ + RL P N DE+ ++ C E P RP + L
Sbjct: 245 MTCAELYEKLPQGYRLE-KPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSL 295
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 36/274 (13%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELR 572
F++ IG G V K+ +G++ A+K + +M+ + E F E L
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKI---MNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 573 HRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
R I + + F +LV EY G L T+LS G R + + A+
Sbjct: 120 RRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RF-YLAEIVMAID 176
Query: 632 YMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFLKPDSSNCTE-LVGTFGYI 687
+H VHRDI N+LL D R++DFG L+ D + + VGT Y+
Sbjct: 177 SVHRLG----YVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 688 APELVYTMKVTEK-------CDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740
+PE++ + CD ++ GV A E+ G P F + S++ + I ++
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP--FYAD-STAETYGKI-VHYK 286
Query: 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
LP + V +E ++ LC PE+R
Sbjct: 287 EHLSLPLVDEGVPEEARDFIQ-RLLC---PPETR 316
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 38/213 (17%)
Query: 519 VKYCIGIGGQGSVYKAK---LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G G VYKAK + A+K+ + EI L EL+H +
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG----TGIS-MSACREIALLRELKHPN 79
Query: 576 IVKFYG-FCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMN--VIRSVA---- 627
++ F SH +L+++Y E L I+ A + V++ +++S+
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR----VSDFGIAKF----LKPDSSNCTE 679
+ + Y+H + ++HRD+ N+L+ + R ++D G A+ LKP +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 680 LVGTFGYIAPEL-----VYTMKVTEKCDVYSFG 707
+V TF Y APEL YT + D+++ G
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAI----DIWAIG 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 60/296 (20%), Positives = 109/296 (36%), Gaps = 62/296 (20%)
Query: 523 IGIGGQGSVYKAKLTSGE------ILAVKKFHSLWPCEMVPQ-PEFVNEIKTLTELRHRS 575
+G G VYK L +A+K +L P EF +E L+H +
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS---------- 625
+V G + + +++ Y G L L + T ++S
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 626 ---VANALSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
+A + Y+ HH +VH+D++++NVL+ ++SD G+ + + +
Sbjct: 134 VAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY-AADYYK-- 185
Query: 681 VGTFGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHP------RDFISSISS 728
+ + APE + K + D++S+GV+ EV G P +D + I +
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
LP P + + +++ C NE P RP + L
Sbjct: 246 RQ-------------VLP-CPDDCPAWVYALMI---ECWNEFPSRRPRFKDIHSRL 284
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 54/155 (34%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGS 140
LDL L +F LT L + L N L ++ V +L L L L+ NQL+ S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 141 IPPTL-GNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL-GNLS 197
+P + +L+ L L+L GN L S+PS + L L L L++NQL SIP L+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 198 NLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTN 231
NL L L N L S+P L L + L N
Sbjct: 156 NLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 49/160 (30%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGN 159
+ + L L+ L L L+L NQL ++ +L+ L L L N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 160 SLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL-GNLSNLVVLHLFENSLFGSIPS-I 216
L+ S+P + +L L L+L NQL S+P + L+ L L L N L SIP+
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGA 150
Query: 217 LGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256
L L L LSTN L V + L L + L+ NQ
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 54/159 (33%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGV 236
L L S L+ + L+ L L+L N L ++ + + +L L LGL+ N L+ +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 237 IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIG---KLSSLNYLVLNGNQLYGNLPR-ALGS 292
+L L LYL NQL + G +L+ L L LN NQL ++P A
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKS----LPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDK 153
Query: 293 LTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQF 330
LT L+ L LSTN+L S+P L KL + L NQF
Sbjct: 154 LTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 53/148 (35%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
L L+ L+L N+L ++ F +LT L + L N L AS+P V +L L L L
Sbjct: 57 GLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYL 114
Query: 133 SENQLSGSIPPTL-GNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIP 190
NQL S+P + L+ L L L N L SIP+ L +L L LS+NQL S+P
Sbjct: 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVP 171
Query: 191 I-SLGNLSNLVVLHLFENSLFGSIPSIL 217
+ L L + LF N S IL
Sbjct: 172 HGAFDRLGKLQTITLFGNQFDCSRCEIL 199
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 51/156 (32%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGS 188
LDL L+ T L+ L L+L N L ++ + + +L L L L++NQL+ S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 189 IPISL-GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN 246
+P+ + +L+ L L+L N L S+PS + L L L L+TN L + + L N
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156
Query: 247 LIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQ 281
L L L NQL +P +L L + L GNQ
Sbjct: 157 LQTLSLSTNQLQ--SVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 6/132 (4%)
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKG 333
L L L LT+L +L+L N+L ++ +L +L L L+NNQ
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS- 97
Query: 334 FPVEL-EKLIQLSELDLSLNILEGKIPCEIC-NMESLEKLNLSHNNFSGLIPSCFEGMHG 391
P+ + + L QL +L L N L+ +P + + L++L L+ N + F+ +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156
Query: 392 LSCIDVSYNELR 403
L + +S N+L+
Sbjct: 157 LQTLSLSTNQLQ 168
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 55/311 (17%), Positives = 95/311 (30%), Gaps = 58/311 (18%)
Query: 127 LYHLDLSENQLSG----SIPPTLGNLSNLAVLHLYGNSLSG----SIPSIIGNLKSLFYL 178
+ L + ++ S+ L ++ + L GN++ + I + K L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 179 HLSSNQLS----------GSIPISLGNLSNLVVLHLFENSL----FGSIPSILGNLKMLL 224
S + +L L + L +N+ + L L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 225 HLGLSTNHLS--GVIPLS-----------IGNLNNLIGLYLYDNQL---SVGEIPIEIGK 268
HL L N L ++ N L + N+L S+ E
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 269 LSSLNYLVLNGNQLY-----GNLPRALGSLTELEYLDLSTNKLGN----SIPETLGNLLK 319
L+ + + N + L L EL+ LDL N + ++ L +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 320 LHYLNLSNNQFR-KGFPVELEKL-----IQLSELDLSLNILEGKIPCEIC-----NMESL 368
L L L++ +G ++ I L L L N +E + M L
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 369 EKLNLSHNNFS 379
L L+ N FS
Sbjct: 306 LFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 57/350 (16%), Positives = 97/350 (27%), Gaps = 68/350 (19%)
Query: 77 KSLSTLDLSKNKLNG----SIPFSFGNLTNLAIMYLYRNSLS----ASIPPVIGNLKFLY 128
S+ L + + S+ ++ + L N++ + I + K L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLS-- 186
+ S+ L L + L + LS N
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLL--------------QALLKCPKLHTVRLSDNAFGPT 109
Query: 187 GSIPIS--LGNLSNLVVLHLFENSL-------------FGSIPSILGNLKMLLHLGLSTN 231
P+ L + L L+L N L ++ N L + N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169
Query: 232 HLS--GVIPLS--IGNLNNLIGLYLYDNQLSVGEIPIEIGKL----SSLNYLVLNGNQLY 283
L + + + L + + N + I + + L L L N
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF- 228
Query: 284 GN-----LPRALGSLTELEYLDLSTNKLGN----SIPETLGNL--LKLHYLNLSNNQFRK 332
+ L AL S L L L+ L ++ + L + L L L N+
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 333 GFPVEL-----EKLIQLSELDLSLNIL--EGKIPCEICNMESLEKLNLSH 375
L EK+ L L+L+ N E + EI E
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIR--EVFSTRGRGE 336
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 53/319 (16%), Positives = 101/319 (31%), Gaps = 61/319 (19%)
Query: 71 GLKGNLKSLSTLDLSKNKLN--GSIPFSFG-----NLTNLAIMYLYRNSLSASIPPVIGN 123
L + S+ + LS N + + S +L ++ + IP +
Sbjct: 27 VLLED-DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL 85
Query: 124 L-------KFLYHLDLSENQLSG----SIPPTLGNLSNLAVLHLYGNSLS---------- 162
L L+ + LS+N + L + L L+L+ N L
Sbjct: 86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA 145
Query: 163 ---GSIPSIIGNLKSLFYLHLSSNQLS--GSIPIS--LGNLSNLVVLHLFENSLF----- 210
++ N L + N+L + + L + + +N +
Sbjct: 146 LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE 205
Query: 211 GSIPSILGNLKMLLHLGLSTNHLS--GVIPLS--IGNLNNLIGLYLYDNQLS-VGEIPI- 264
+ L + L L L N + G L+ + + NL L L D LS G +
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265
Query: 265 ---EIGKLSSLNYLVLNGNQLYGN----LPRALGS-LTELEYLDLSTNKLGN------SI 310
+ L L L N++ + L + + +L +L+L+ N+ I
Sbjct: 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEI 325
Query: 311 PETLGNLLKLHYLNLSNNQ 329
E + L + +
Sbjct: 326 REVFSTRGRGELDELDDME 344
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 32/229 (13%), Positives = 60/229 (26%), Gaps = 44/229 (19%)
Query: 217 LGNLKMLLHLGLSTNHLS--GVIPLS--IGNLNNLIGLYLYDNQLSVG---EIPIEIGKL 269
+ + L + ++ + + +++ + L N + + I
Sbjct: 1 MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 270 SSLNYLVLNGNQL----------YGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK 319
L + L +AL +L + LS N G + E L + L
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 320 ----LHYLNLSNNQF-------------RKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362
L +L L NN + + L + N LE E
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 363 CNM----ESLEKLNLSHNNF-----SGLIPSCFEGMHGLSCIDVSYNEL 402
L + + N L+ L +D+ N
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 29/168 (17%), Positives = 58/168 (34%), Gaps = 24/168 (14%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKL--NGSIPFS--FGNLTNLAIMYLYRNSL-----SAS 116
L+ N L ++ +N+L ++ F + L + + +N +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207
Query: 117 IPPVIGNLKFLYHLDLSENQLSG----SIPPTLGNLSNLAVLHLYGNSLSGS-IPSIIGN 171
+ + + L LDL +N + ++ L + NL L L LS +++
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267
Query: 172 LK-----SLFYLHLSSNQLSGSIPISLG-----NLSNLVVLHLFENSL 209
L L L N++ +L + +L+ L L N
Sbjct: 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 72/272 (26%), Positives = 114/272 (41%), Gaps = 41/272 (15%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELR 572
F++ IG G G V KL + ++ A+K L EM+ + E F E L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKI---LNKWEMLKRAETACFREERDVLVNGD 132
Query: 573 HRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIR----SV 626
+ I Y F N +LV +Y G L T+LS + + E + R +
Sbjct: 133 SKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPE-------EMARFYLAEM 184
Query: 627 ANALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFLKPDSSNCTE-LVG 682
A+ +H VHRDI N+L +D R++DFG L D + + VG
Sbjct: 185 VIAIDSVHQLH----YVHRDIKPDNIL--MDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 683 TFGYIAPELVYTMKVTEK-----CDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISL 737
T YI+PE++ M+ + CD +S GV E++ G+ P F + S + I +
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYAE-SLVETYGKI-M 294
Query: 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNE 769
N + PT +V + ++ +C E
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIR-RLICSRE 325
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 64/281 (22%), Positives = 113/281 (40%), Gaps = 58/281 (20%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKT----L 568
F++ IG G G V K + ++ A+K K + + V + +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-------QKCVERNEVRNVFKELQIM 69
Query: 569 TELRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR--- 624
L H +V +Y F + F+V + L G L L + +E ++
Sbjct: 70 QGLEHPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHLQQNVHFKE-------ETVKLFI 121
Query: 625 -SVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFLKPDSSNCTEL 680
+ AL Y+ I+HRD+ N+LL D ++DF IA L ++ T +
Sbjct: 122 CELVMALDYLQNQR----IIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRETQITT-M 174
Query: 681 VGTFGYIAPELV-------YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR 733
GT Y+APE+ Y+ V D +S GV A E+++G P + SS++
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP--Y---HIRSSTSS 225
Query: 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
++ + P E++S+++ L +P+ R
Sbjct: 226 KEIVHTFETTVVTYPS-AWSQEMVSLLK---KLLEPNPDQR 262
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 38/203 (18%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK-----KFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
IG G V A+ + +G +A+K + + + E++ + L H +I
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS------LQKLFREVRIMKILNHPNI 76
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE------FNWTVRMNVIRSVANAL 630
VK + + +L+ EY G + L G ++E F R + +A+
Sbjct: 77 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---------RQIVSAV 127
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
Y H IVHRD+ ++N+LL D +++DFG + G Y APE
Sbjct: 128 QYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPE 183
Query: 691 LV----YTMKVTEKCDVYSFGVL 709
L Y + DV+S GV+
Sbjct: 184 LFQGKKYDGP---EVDVWSLGVI 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 34/199 (17%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELRHRSIV 577
IG G G VYKA+ GE A+KK + + E + EI L EL+H +IV
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA----NALSYM 633
K Y + LV+E+L++ L + ++ + +S N ++Y
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKL------LDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL-- 691
H ++HRD+ +N+L+ + E +++DFG+A+ T + T Y AP++
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 692 ---VYTMKVTEKCDVYSFG 707
Y+ + D++S G
Sbjct: 174 GSKKYSTTI----DIWSVG 188
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPE---FVNEIKTLTELR 572
++V IG G G V + ++ ++ A+K L EM+ + + F E +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL---LSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 573 HRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
+V+ FY F R ++V EY+ G L ++SN E+ R V AL
Sbjct: 128 SPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARF-YTAEVVLALD 182
Query: 632 YMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE-LVGTFGYIAP 689
+H +HRD+ N+LL +++DFG + + + VGT YI+P
Sbjct: 183 AIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 690 ELVYTMKVTEK----CDVYSFGVLALEVIKGDHP 719
E++ + CD +S GV E++ GD P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVP--QPEFVN-EIKTLTELR 572
F +G G +V A+ + A+K L ++ + +V E ++ L
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIK---ILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVAN 628
H VK Y + Y + G L + G+ +E R + +
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-------TCTRFYTAEIVS 141
Query: 629 ALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE--LVGTFG 685
AL Y+H I+HRD+ +N+LL D +++DFG AK L P+S VGT
Sbjct: 142 ALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
Y++PEL+ + D+++ G + +++ G P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 58/294 (19%)
Query: 523 IGIGGQGSVYKAKLT-----SGEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTEL-RHR 574
+G G G V +A + AVK L + ++E+K ++ L +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATIL-SNDGAIEEFNWTVRMNVIRS-------- 625
+IV G C+H ++ EY G L L +E N S
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 626 --VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGT 683
VA ++++ +HRD++++NVLL + A++ DFG+A+ + DS +V
Sbjct: 171 SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIVKG 224
Query: 684 FGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHP-------RDFISSISSSS 730
+ APE ++ T + DV+S+G+L E+ G +P F +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 731 SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ P + SI++ C P RP +C L
Sbjct: 285 -------------QMA-QPAFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFL 321
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 37/206 (17%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK-----KFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G V+ A + + VK K E + EI L+ + H +I
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTV---RMN------VIRSVA 627
+K + LV E G ++ F + R++ + R +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-----------LDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
+A+ Y+ I+HRDI +N+++ D+ ++ DFG A +L+ T GT Y
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYC 196
Query: 688 APELV----YTMKVTEKCDVYSFGVL 709
APE++ Y + +++S GV
Sbjct: 197 APEVLMGNPYRGP---ELEMWSLGVT 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 34/199 (17%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELRHRSIV 577
+G G G VYKAK + G I+A+K+ + + E + EI L EL H +IV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 578 KFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA----NALSYM 633
R LV+E++E+ L +L + ++ + I+ +++
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG------LQDSQIKIYLYQLLRGVAHC 135
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL-- 691
H I+HRD+ +N+L+ D +++DFG+A+ + T V T Y AP++
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 692 ---VYTMKVTEKCDVYSFG 707
Y+ V D++S G
Sbjct: 193 GSKKYSTSV----DIWSIG 207
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 46/210 (21%), Positives = 77/210 (36%), Gaps = 25/210 (11%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVN---------EIKTLTELRH 573
I G G+V + G +A+K+ + + EI+ L H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI-LSDSFLCKRVLREIRLLNHFHH 88
Query: 574 RSIVKFYG-FCSHPRNSF----LVYEYLERGSLATILSNDGAIEEFNWTVRM-NVIRSVA 627
+I+ F + LV E + I I + M +++
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILL--- 145
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
L +H +VHRD+ N+LL + + + DF +A+ D +N T V Y
Sbjct: 146 -GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYR 200
Query: 688 APELVYT-MKVTEKCDVYSFGVLALEVIKG 716
APELV T+ D++S G + E+
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 41/205 (20%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELRHRSI 576
+G G G VYKA + E +A+K+ + + E V E+ L EL+HR+I
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----VANALSY 632
++ H L++EY E L + + + M VI+S + N +++
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS-------MRVIKSFLYQLINGVNF 147
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEAR-----VSDFGIAKFLKPDSSNCTELVGTFGYI 687
H +HRD+ +N+LL + + + DFG+A+ T + T Y
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204
Query: 688 APEL-----VYTMKVTEKCDVYSFG 707
PE+ Y+ V D++S
Sbjct: 205 PPEILLGSRHYSTSV----DIWSIA 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 57/291 (19%), Positives = 109/291 (37%), Gaps = 49/291 (16%)
Query: 523 IGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVP-QPEFVNEIKTLTEL-RHR 574
+G G G V +A + +AVK L ++E+K L + H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 575 SIVKFYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS-------- 625
++V G C+ P ++ E+ + G+L+T L + ++ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 626 -----VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
VA + ++ +HRD++++N+LL ++ DFG+A+ + D +
Sbjct: 152 CYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYV 205
Query: 681 VGTFGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRN 734
+ APE ++ T + DV+SFGVL E+ G P + +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------KIDEE 259
Query: 735 ISLNEILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + R+ P E+ + C + P RP + + L
Sbjct: 260 F-CRRLKEGTRMR-APDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 305
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 28/122 (22%), Positives = 54/122 (44%), Gaps = 6/122 (4%)
Query: 67 LSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLK 125
L G+ L L ++ S NK+ +F + + + L N L ++ + L+
Sbjct: 47 LEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLE 105
Query: 126 FLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIP-SIIGNLKSLFYLHLSSN 183
L L L N+++ + + LS++ +L LY N ++ ++ L SL L+L +N
Sbjct: 106 SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
Query: 184 QL 185
Sbjct: 164 PF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 8/138 (5%)
Query: 197 SNLVVLHLFENSLFGSIPS--ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
L L N + + I L L + S N ++ + + + + + L
Sbjct: 32 QYTAELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 255 NQLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE- 312
N+L + ++ L SL L+L N++ + L+ + L L N++ ++
Sbjct: 91 NRLE--NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI-TTVAPG 147
Query: 313 TLGNLLKLHYLNLSNNQF 330
L L LNL N F
Sbjct: 148 AFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 30/137 (21%), Positives = 57/137 (41%), Gaps = 11/137 (8%)
Query: 101 TNLAIMYLYRNSLSASIPP--VIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLY 157
A + L N + + + L L ++ S N+++ I S + + L
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT 89
Query: 158 GNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI-SLGNLSNLVVLHLFENSLFGSIP- 214
N L ++ + L+SL L L SN+++ + S LS++ +L L++N + ++
Sbjct: 90 SNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAP 146
Query: 215 SILGNLKMLLHLGLSTN 231
L L L L N
Sbjct: 147 GAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 28/152 (18%), Positives = 58/152 (38%), Gaps = 26/152 (17%)
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNS 309
L L +N+ +V E KL L + + N++ A + + + L++N+L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-EN 95
Query: 310 IPE-TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESL 368
+ L L L L +N+ ++ + + S+
Sbjct: 96 VQHKMFKGLESLKTLMLRSNR--------------ITCVGNDS----------FIGLSSV 131
Query: 369 EKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
L+L N + + P F+ +H LS +++ N
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 28/131 (21%), Positives = 54/131 (41%), Gaps = 9/131 (6%)
Query: 294 TELEYLDLSTNKLGNSIPET--LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSL 351
L L+ N+ + T L +L +N SNN+ E ++E+ L+
Sbjct: 32 QYTAELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 352 NILEGKIPCEIC-NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSR 410
N LE + ++ +ESL+ L L N + + F G+ + + + N++ +
Sbjct: 91 NRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG- 147
Query: 411 IFQYDPMEALQ 421
F D + +L
Sbjct: 148 AF--DTLHSLS 156
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 61/275 (22%), Positives = 101/275 (36%), Gaps = 45/275 (16%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVN-EIKTLTELR----H 573
+G GG G+V+ LT +A+K + + + + E+ L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGS-LATILSNDGAIEEFNWTVRMNVIRSVANALSY 632
+++ + LV E L ++ G + E R V A+ +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--PSR-CFFGQVVAAIQH 154
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
H +VHRDI +N+L+ L A++ DFG L T+ GT Y PE
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEW 209
Query: 692 VYTMKVT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP- 749
+ + V+S G+L +++ GD P + EIL+ L P
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFE--------------RDQEILEAELHFPAH 255
Query: 750 --QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ LI CL P SRP + +
Sbjct: 256 VSPDCCA-LIR------RCLAPKPSSRPSLEEILL 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 61/303 (20%), Positives = 116/303 (38%), Gaps = 68/303 (22%)
Query: 523 IGIGGQGSVYKAKLT-----SGEIL-AVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
IG G G V++A+ + AVK Q +F E + E + +I
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEFDNPNI 112
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----------- 625
VK G C+ + L++EY+ G L L + + + R+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 626 ----------VANALSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673
VA ++Y+ VHRD++++N L+ + +++DFG+++ +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 674 SSNCTELVGTFGYI-----APE-LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSI 726
I PE + Y + T + DV+++GV+ E+ G P
Sbjct: 228 D---YYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY------ 277
Query: 727 SSSSSNRNISLNEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781
++ E++ L P+N EL +++ LC ++ P RP ++
Sbjct: 278 ------YGMAHEEVIYYVRDGNILA-CPENCPLELYNLMR---LCWSKLPADRPSFCSIH 327
Query: 782 QLL 784
++L
Sbjct: 328 RIL 330
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 59/296 (19%)
Query: 523 IGIGGQGSVYKAKLTSGEIL--------AVKKFHSLWPCEMVPQP-EFVNEIKTLTEL-R 572
+G G G V A+ + AVK L + V+E++ + + +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS------- 625
H++I+ G C+ +++ EY +G+L L V
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 626 ------VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
+A + Y+ +HRD++++NVL+ + +++DFG+A+ +
Sbjct: 160 VSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNID---YY 213
Query: 680 LVGTFGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNR 733
T G + APE ++ T + DV+SFGVL E+ G P
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY------------P 261
Query: 734 NISLNEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
I + E+ R+ P N +EL ++ C + P RP + + L
Sbjct: 262 GIPVEELFKLLKEGHRMD-KPANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 67/270 (24%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVN-EIKTLTELRHRSIVKFY 580
IG G G VY+AKL SGE++A+KK ++ F N E++ + +L H +IV+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 581 GFCSHPRNSF------LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----VANAL 630
F LV +Y+ ++ + + T+ + ++ + +L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH---YSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 631 SYMH-HDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
+Y+H I HRDI +N+LL D ++ DFG AK L N + + Y A
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRA 224
Query: 689 PELV-----YTMKVTEKCDVYSFG-VLA------------------LEVIK--GDHPRDF 722
PEL+ YT + DV+S G VLA +E+IK G R+
Sbjct: 225 PELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 723 ISSISSSSSNRN------ISLNEILDPRLP 746
I ++ + + ++ PR P
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTP 310
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 61/297 (20%)
Query: 523 IGIGGQGSVYKAKLTSGEIL--------AVKKFHSLWPCEMVPQP-EFVNEIKTLTEL-R 572
+G G G V A+ + AVK L + ++E++ + + +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS------- 625
H++I+ G C+ +++ EY +G+L L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 626 ------VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
VA + Y+ +HRD++++NVL+ D +++DFG+A+ +
Sbjct: 194 VSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YY 247
Query: 680 LVGTFGYI-----APE-LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSN 732
T G + APE L T + DV+SFGVL E+ G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPY------------ 294
Query: 733 RNISLNEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + E+ R+ P N +EL ++ C + P RP + + L
Sbjct: 295 PGVPVEELFKLLKEGHRMD-KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 347
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 19/194 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G+G G V + +G +AVK + + ++V + + EI+ L RH I+K
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
Y S P + F+V EY+ G L + G +EE + + + +A+ Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE---MEARRLFQQILSAVDYCHRHM-- 131
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS---SNCTELVGTFGYIAPELVYTMK 696
+VHRD+ +NVLL A+++DFG++ + ++C G+ Y APE++
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVISGRL 186
Query: 697 VT-EKCDVYSFGVL 709
+ D++S GV+
Sbjct: 187 YAGPEVDIWSCGVI 200
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 70/363 (19%), Positives = 134/363 (36%), Gaps = 78/363 (21%)
Query: 473 FILRRREGPSSENRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKY---------CI 523
LRR+ S+E+ + +N L+ I T ++ + +++ +
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKL 83
Query: 524 GIG---GQGS---VYKAKLTSGEIL--------AVKKFHSLWPCEMVPQP-EFVNEIKTL 568
+G G+G V A+ + AVK L + V+E++ +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMM 140
Query: 569 TEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS-- 625
+ +H++I+ G C+ +++ EY +G+L L V
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 626 -----------VANALSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672
+A + Y+ +HRD++++NVL+ + +++DFG+A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 673 DSSNCTELVGTFGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSI 726
T G + APE ++ T + DV+SFGVL E+ G P
Sbjct: 256 ID---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY------ 306
Query: 727 SSSSSNRNISLNEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781
I + E+ R+ P N +EL ++ C + P RP +
Sbjct: 307 ------PGIPVEELFKLLKEGHRMD-KPANCTNELYMMMR---DCWHAVPSQRPTFKQLV 356
Query: 782 QLL 784
+ L
Sbjct: 357 EDL 359
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 39/208 (18%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELRHRSI 576
IG G G V+KA+ +G+ +A+KK M + E EIK L L+H ++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 78
Query: 577 VKFYG--------FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
V + + +LV+++ E LA +LSN +F + V++ + N
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLN 135
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF----LKPDSSNCTELVGTF 684
L Y+H + I+HRD+ + NVL+ D +++DFG+A+ + T V T
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 685 GYIAPEL-----VYTMKVTEKCDVYSFG 707
Y PEL Y + D++ G
Sbjct: 193 WYRPPELLLGERDYGPPI----DLWGAG 216
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 62/293 (21%), Positives = 116/293 (39%), Gaps = 52/293 (17%)
Query: 523 IGIGGQGSVYKAKLT-----SGEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTEL-RHR 574
+G G G V +A + AVK L P + + ++E+K L+ L H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS--------- 625
+IV G C+ + ++ EY G L L + T +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 626 ------VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE 679
VA ++++ +HRD++++N+LL ++ DFG+A+ +K DS
Sbjct: 148 LSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDS---NY 201
Query: 680 LVGTFGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNR 733
+V + APE ++ T + DV+S+G+ E+ G P +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-------- 253
Query: 734 NISLNEILDP--RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ +++ R+ P++ E+ I++ C + P RP + QL+
Sbjct: 254 DSKFYKMIKEGFRML-SPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLI 302
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 3e-14
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 35/200 (17%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELRHRSI 576
IG G G+V+KAK + EI+A+K+ + E V EI L EL+H++I
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNI 63
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA----NALSY 632
V+ + + LV+E+ ++ L + + +++S L +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGF 116
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL- 691
H ++HRD+ +N+L+ + E ++++FG+A+ + V T Y P++
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 692 ----VYTMKVTEKCDVYSFG 707
+Y+ + D++S G
Sbjct: 174 FGAKLYSTSI----DMWSAG 189
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 44/218 (20%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQ-PEFVN----EIKTLTELRHRSI 576
G G G+V K +G +A+KK V Q P F N ++ L L H +I
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKK---------VIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 577 VK-FYGFCSHPRNSF------LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS---- 625
V+ F + +V EY+ +L N + +I+
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV---APPPILIKVFLFQ 137
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLL-CLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
+ ++ +H + HRDI NVL+ D ++ DFG AK L P N + +
Sbjct: 138 LIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSR 195
Query: 685 GYIAPELV-----YTMKVTEKCDVYSFG-VLALEVIKG 716
Y APEL+ YT V D++S G + A E++ G
Sbjct: 196 YYRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLG 228
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 36/215 (16%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK-----KFHSLWPCEMVPQPEFVN------------- 563
IG G G V A A+K K P P
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 564 -----EIKTLTELRHRSIVKFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNW 616
EI L +L H ++VK P ++V+E + +G + + + E+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--- 137
Query: 617 TVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN 676
R + + + Y+H+ I+HRDI N+L+ D +++DFG++ K +
Sbjct: 138 QAR-FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 677 CTELVGTFGYIAPELVYTMKVT---EKCDVYSFGV 708
+ VGT ++APE + + + DV++ GV
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 47/240 (19%)
Query: 502 EGKILYEEIVRATNGF--DVKYC----IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEM 555
K++ G ++ Y IG G G V++AKL + +A+KK +
Sbjct: 21 PNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK--------V 72
Query: 556 VPQPEFVN-EIKTLTELRHRSIVKFYGFCSHPRNS------FLVYEYLERGSLATILSND 608
+ F N E++ + ++H ++V F + LV EY+ ++ +
Sbjct: 73 LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRH- 130
Query: 609 GAIEEFNWTVRMNVIRS----VANALSYMH-HDCFPPIVHRDISSKNVLLCLD-YEARVS 662
+ T+ M +I+ + +L+Y+H I HRDI +N+LL ++
Sbjct: 131 --YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLI 184
Query: 663 DFGIAKFLKPDSSNCTELVGTFGYIAPELV-----YTMKVTEKCDVYSFG-VLALEVIKG 716
DFG AK L N + + Y APEL+ YT + D++S G V+A E+++G
Sbjct: 185 DFGSAKILIAGEPN-VSYICSRYYRAPELIFGATNYTTNI----DIWSTGCVMA-ELMQG 238
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 41/272 (15%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK--KFHSLWPCEMVPQPEFVN-EIKTLTELRHRS--I 576
+G GG GSVY ++ +A+K + + +P V E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 577 VKFYGFCSHPRNSFLVYEYLE-RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
++ + P + L+ E E L ++ GA++E + + V A+ + H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCHN 167
Query: 636 DCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
++HRDI +N+L+ L+ E ++ DFG LK + T+ GT Y PE +
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRY 222
Query: 695 MKVT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP---Q 750
+ V+S G+L +++ GD P + EI+ ++
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVFFRQRVSS 268
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
Q LI CL P RP +
Sbjct: 269 ECQH-LIR------WCLALRPSDRPTFEEIQN 293
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 43/128 (33%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGS 140
L L N++ P F +L NL +YL N L ++P V +L L LDL NQL+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 141 IPPTL-GNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL 199
+P + L +L L + N L+ +P I L L +L L NQL + LS+L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 200 VVLHLFEN 207
+LF N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 41/131 (31%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 201 VLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260
+L+L +N + P + +L L L L +N L + +L L L L NQL+V
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV- 102
Query: 261 EIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLL 318
+P + +L L L + N+L LPR + LT L +L L N+L SIP L
Sbjct: 103 -LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLS 159
Query: 319 KLHYLNLSNNQ 329
L + L N
Sbjct: 160 SLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTL-GNLSNLAVLHLYGN 159
TN I+YL+ N ++ P V +L L L L NQL ++P + +L+ L VL L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 160 SLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS-IL 217
L+ +PS + L L L + N+L+ +P + L++L L L +N L SIP
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPHGAF 155
Query: 218 GNLKMLLHLGLSTN 231
L L H L N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 4/107 (3%)
Query: 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKLSSLNYLVLNGNQLYG 284
L L N ++ + P +L NL LYL NQL +P+ + L+ L L L NQL
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--LPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 285 NLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR 331
L L+ L + NKL +P + L L +L L NQ +
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK 148
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 39/129 (30%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGS 188
L L +NQ++ P +L NL L+L N L ++P + +L L L L +NQL+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 189 IPISL-GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247
+P ++ L +L L + N L +P + L L HL L N L + + L++L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 248 IGLYLYDNQ 256
YL+ N
Sbjct: 162 THAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 45/130 (34%), Positives = 62/130 (47%), Gaps = 7/130 (5%)
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL-GSLTELEYLDLSTNKLGN 308
LYL+DNQ++ E P L +L L L NQL G LP + SLT+L LDL TN+L
Sbjct: 45 LYLHDNQITKLE-PGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL-T 101
Query: 309 SIPETL-GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMES 367
+P + L+ L L + N+ P +E+L L+ L L N L+ + S
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 368 LEKLNLSHNN 377
L L N
Sbjct: 161 LTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 41/129 (31%), Positives = 64/129 (49%), Gaps = 4/129 (3%)
Query: 177 YLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSG 235
L+L NQ++ P +L NL L+L N L G++P + +L L L L TN L+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTE 295
+ L +L L++ N+L+ E+P I +L+ L +L L+ NQL A L+
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 296 LEYLDLSTN 304
L + L N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 32/86 (37%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 76 LKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L L+ LDL N+L +P + F L +L +++ N L+ +P I L L HL L +
Sbjct: 87 LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144
Query: 135 NQLSGSIPP-TLGNLSNLAVLHLYGN 159
NQL SIP LS+L +L+GN
Sbjct: 145 NQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL-GNLLKL 320
+P I ++ L L+ NQ+ P SL L+ L L +N+L ++P + +L +L
Sbjct: 34 VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQL 90
Query: 321 HYLNLSNNQFRKGFPVEL-EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHN 376
L+L NQ P + ++L+ L EL + N L ++P I + L L L N
Sbjct: 91 TVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 64/304 (21%), Positives = 116/304 (38%), Gaps = 70/304 (23%)
Query: 523 IGIGGQGSVYKAKLT-----SGEIL-AVKKFHSLWPCEMVPQP-EFVNEIKTLTELRHRS 575
+G G G V KA +G AVK L + + ++E L ++ H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS---------- 625
++K YG CS L+ EY + GSL L + + S
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 626 -----------VANALSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672
++ + Y+ +VHRD++++N+L+ + ++SDFG+++ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 673 DSSNCTELVGTFGYI-----APE-LVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISS 725
+ + + + G I A E L T + DV+SFGVL E++ G +P
Sbjct: 203 ED---SYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPY----- 253
Query: 726 ISSSSSNRNISLNEILDP-----RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
I + + R+ P N +E+ ++ C + P+ RP +
Sbjct: 254 -------PGIPPERLFNLLKTGHRME-RPDNCSEEMYRLML---QCWKQEPDKRPVFADI 302
Query: 781 CQLL 784
+ L
Sbjct: 303 SKDL 306
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 46/195 (23%), Positives = 90/195 (46%), Gaps = 21/195 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G +VYK T+G +A+K+ L E P + EI + EL+H +IV+ Y
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTP-STAIREISLMKELKHENIVRLYD 70
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA----NALSYMHHDC 637
LV+E+++ L + + + + +N+++ L++ H +
Sbjct: 71 VIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL-----V 692
I+HRD+ +N+L+ + ++ DFG+A+ + + V T Y AP++
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 693 YTMKVTEKCDVYSFG 707
Y+ + D++S G
Sbjct: 186 YSTSI----DIWSCG 196
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-14
Identities = 61/267 (22%), Positives = 104/267 (38%), Gaps = 30/267 (11%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFV----NEIKTLTEL 571
F +G GG G V ++ +G++ A KK + + + + NE + L ++
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK----KRIKKRKGEAMALNEKQILEKV 241
Query: 572 RHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
R +V Y + + LV + G L + + G F + + L
Sbjct: 242 NSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGL 299
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
+H + IV+RD+ +N+LL R+SD G+A + + VGT GY+APE
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPE 355
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP-- 748
+V + T D ++ G L E+I G P F + I E+ P
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSP--F------QQRKKKIKREEVERLVKEVPEE 407
Query: 749 -PQNVQDELISIVEVAFLCLNESPESR 774
+ + S+ L + P R
Sbjct: 408 YSERFSPQARSLCS---QLLCKDPAER 431
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 38/203 (18%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN--------EIKTLTELRH 573
+G G +VYKA+ + +I+A+KK + + E + EIK L EL H
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINRTALREIKLLQELSH 71
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----VANA 629
+I+ H N LV++++E L I+ ++ + + + I++
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV------LTPSHIKAYMLMTLQG 124
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
L Y+H I+HRD+ N+LL + +++DFG+AK + T V T Y AP
Sbjct: 125 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181
Query: 690 EL-----VYTMKVTEKCDVYSFG 707
EL +Y + V D+++ G
Sbjct: 182 ELLFGARMYGVGV----DMWAVG 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 26/197 (13%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G G V A + E +AVK ++ + + EI L H ++VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIK--KEICINKMLNHENVVK 69
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
FYG +L EY G L + D + E + + + Y+H
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQ-RFFHQLMAGVVYLHGIG- 125
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN------CTELVGTFGYIAPELV 692
I HRDI +N+LL ++SDFG+A + ++ C GT Y+APEL+
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELL 179
Query: 693 YTMKVT-EKCDVYSFGV 708
+ E DV+S G+
Sbjct: 180 KRREFHAEPVDVWSCGI 196
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 47/195 (24%), Positives = 91/195 (46%), Gaps = 26/195 (13%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G +VYK K + ++A+K+ L E P + E+ L +L+H +IV +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAP-CTAIREVSLLKDLKHANIVTLHD 67
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----VANALSYMHHDC 637
++ LV+EYL++ L L + G I + M+ ++ + L+Y H
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNI------INMHNVKLFLFQLLRGLAYCHRQK 120
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL-----V 692
++HRD+ +N+L+ E +++DFG+A+ + V T Y P++
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 693 YTMKVTEKCDVYSFG 707
Y+ ++ D++ G
Sbjct: 178 YSTQI----DMWGVG 188
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 59/299 (19%)
Query: 523 IGIGGQGSVYKAKLTSGE------ILAVKKFHSLWPCEMVPQP-EFVNEIKTLTEL-RHR 574
+G G G V A +AVK L + ++E+K +T+L H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS--------- 625
+IV G C+ +L++EY G L L + + N R
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 626 -----------VANALSYM--HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672
VA + ++ VHRD++++NVL+ ++ DFG+A+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 673 DSSNCTELVGTFGYI-----APELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSI 726
DS +V + APE ++ T K DV+S+G+L E+ G +P I
Sbjct: 225 DS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI--- 278
Query: 727 SSSSSNRNISLNEILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ N I + ++ P +E+ I++ C RP + L
Sbjct: 279 ---PVDANF-YKLIQNGFKMD-QPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 329
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 55/201 (27%), Positives = 80/201 (39%), Gaps = 37/201 (18%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELRHRSI 576
IG G G + + E++AVK + + ++ EI LRH +I
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK---------YIERGAAIDENVQREIINHRSLRHPNI 78
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
V+F P + ++ EY G L + N G E + + + +SY H
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE---DEARFFFQQLLSGVSYCHSM 135
Query: 637 CFPPIVHRDISSKNVLLCLDYEAR--VSDFGIAKFLKPDS---SNCTELVGTFGYIAPEL 691
I HRD+ +N LL R + DFG +K S S GT YIAPE+
Sbjct: 136 Q---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEV 188
Query: 692 V----YTMKVTEKCDVYSFGV 708
+ Y K DV+S GV
Sbjct: 189 LLRQEYDGK---IADVWSCGV 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 5e-13
Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 45/224 (20%)
Query: 517 FDVKYCIGIGGQGSVYKA-KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIK-TLTE---- 570
F V IG GG G VY K +G++ A+K + + L E
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK----KRIKMK---QGETLALNERIML 243
Query: 571 -----LRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR 624
IV Y F + P + + + G L LS G E +R
Sbjct: 244 SLVSTGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSE-------ADMR 295
Query: 625 ----SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTEL 680
+ L +MH+ +V+RD+ N+LL R+SD G+A +
Sbjct: 296 FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--S 350
Query: 681 VGTFGYIAPELV-----YTMKVTEKCDVYSFGVLALEVIKGDHP 719
VGT GY+APE++ Y D +S G + ++++G P
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 19/194 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G+G G V K +G +AVK + + ++V + EI+ L RH I+K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
Y S P + F+V EY+ G L + +G ++E + + + + + Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRLFQQILSGVDYCHRHM-- 136
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS---SNCTELVGTFGYIAPELVYTMK 696
+VHRD+ +NVLL A+++DFG++ + ++C G+ Y APE++
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVISGRL 191
Query: 697 VT-EKCDVYSFGVL 709
+ D++S GV+
Sbjct: 192 YAGPEVDIWSSGVI 205
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 47/130 (36%), Positives = 62/130 (47%), Gaps = 8/130 (6%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGS 140
LDL N L F LT+L +YL N L S+P V L L +L+LS NQL S
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 141 IPPTL-GNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI-SLGNLS 197
+P + L+ L L L N L S+P + L L L L NQL S+P L+
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 198 NLVVLHLFEN 207
+L + L +N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 44/133 (33%), Positives = 59/133 (44%), Gaps = 7/133 (5%)
Query: 201 VLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260
L L NSL + L L L L N L + L +L L L NQL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-- 89
Query: 261 EIPIEI-GKLSSLNYLVLNGNQLYGNLP-RALGSLTELEYLDLSTNKLGNSIPE-TLGNL 317
+P + KL+ L L LN NQL +LP LT+L+ L L N+L S+P+ L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRL 147
Query: 318 LKLHYLNLSNNQF 330
L Y+ L +N +
Sbjct: 148 TSLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 44/129 (34%), Positives = 59/129 (45%), Gaps = 4/129 (3%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
LDL N L L++L L+L GN L + L SL YL+LS+NQL S+
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91
Query: 190 PISL-GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247
P + L+ L L L N L S+P + L L L L N L V L +L
Sbjct: 92 PNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 150
Query: 248 IGLYLYDNQ 256
++L+DN
Sbjct: 151 QYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGN-LSNLAVLHLYGN 159
+ L NSL + V L L L L N+L S+P + N L++L L+L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 160 SLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPISL-GNLSNLVVLHLFENSLFGSIPS-I 216
L S+P+ + L L L L++NQL S+P + L+ L L L++N L S+P +
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGV 143
Query: 217 LGNLKMLLHLGLSTN 231
L L ++ L N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 34/93 (36%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 70 VGLKGNLKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFL 127
G+ L SL+ L+LS N+L S+P F LT L + L N L S+P V L L
Sbjct: 69 NGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQL 126
Query: 128 YHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGN 159
L L +NQL S+P L++L + L+ N
Sbjct: 127 KDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 41/117 (35%), Positives = 54/117 (46%), Gaps = 6/117 (5%)
Query: 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL-KL 320
+P I + YL L N L LT L L L NKL S+P + N L L
Sbjct: 22 VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSL 78
Query: 321 HYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICN-MESLEKLNLSHN 376
YLNLS NQ + +KL QL EL L+ N L+ +P + + + L+ L L N
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 7/107 (6%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGS 140
L L N+ +P N +L ++ L N +S ++ N+ L L LS N+L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 141 IPP-TLGNLSNLAVLHLYGNSLSGSIP-SIIGNLKSLFYLHLSSNQL 185
IPP T L +L +L L+GN +S +P +L +L +L + +N L
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 31/87 (35%), Positives = 43/87 (49%), Gaps = 4/87 (4%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
N K L+ +DLS N+++ SF N+T L + L N L IPP LK L L L
Sbjct: 52 NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLH 110
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGN 159
N +S +P +LS L+ L + N
Sbjct: 111 GNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 3/106 (2%)
Query: 153 VLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGS 212
L+L GN + +P + N K L + LS+N++S S N++ L+ L L N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RC 92
Query: 213 IPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL 257
IP LK L L L N +S V + +L+ L L + N L
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 6/106 (5%)
Query: 201 VLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260
L+L N +P L N K L + LS N +S + S N+ L+ L L N+L
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-- 91
Query: 261 EIPIEI-GKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTN 304
IP L SL L L+GN + +P A L+ L +L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF 334
L L+GNQ +P+ L + L +DLS N++ ++ N+ +L L LS N+ +
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCI 93
Query: 335 PVEL-EKLIQLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHN 376
P + L L L L N + +P ++ +L L + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 26/197 (13%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G G V A + E +AVK ++ + + EI L H ++VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIK--KEICINKMLNHENVVK 69
Query: 579 FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCF 638
FYG +L EY G L + D + E + + + Y+H
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQ-RFFHQLMAGVVYLHGIG- 125
Query: 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN------CTELVGTFGYIAPELV 692
I HRDI +N+LL ++SDFG+A + ++ C GT Y+APEL+
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELL 179
Query: 693 YTMKVT-EKCDVYSFGV 708
+ E DV+S G+
Sbjct: 180 KRREFHAEPVDVWSCGI 196
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 63/273 (23%), Positives = 105/273 (38%), Gaps = 39/273 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFV----NEIKTLTEL 571
F +G GG G V+ ++ +G++ A KK + + + + + E K L ++
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK----KRLKKRKGYQGAMVEKKILAKV 242
Query: 572 RHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS----- 625
R IV Y F + + LV + G + + N R+
Sbjct: 243 HSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNP-----GFQEPRAIFYTA 296
Query: 626 -VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF 684
+ + L ++H I++RD+ +NVLL D R+SD G+A LK + GT
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 685 GYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744
G++APEL+ + D ++ GV E+I P F + + E+
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP--F------RARGEKVENKELKQRV 405
Query: 745 LPTP---PQNVQDELISIVEVAFLCLNESPESR 774
L P E A L + PE R
Sbjct: 406 LEQAVTYPDKFSPASKDFCE-ALLQKD--PEKR 435
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 61/339 (17%), Positives = 112/339 (33%), Gaps = 55/339 (16%)
Query: 72 LKGNLKSLSTLDLSKNKL--NGSIPFSFG---NLTNLAIMYLYRNSLSASIPPVIG---- 122
+++LDLS N L ++ ++ + L NSL +
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 123 -NLKFLYHLDLSENQLSGSIPPTLGNL-----SNLAVLHLYGNSLSGS-----IPSIIGN 171
+ L+LS N LS L + VL L N S +
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 172 LKSLFYLHLSSNQLS--GSIPISLG---NLSNLVVLHLFENSL----FGSIPSILGNL-K 221
S+ L+L N L S + +N+ L+L N+L + L ++
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 222 MLLHLGLSTNHL--SGVIPLSIG---NLNNLIGLYLYDNQLS---VGEIPIEIGKLSSLN 273
+ L LS N L L+ N+++ L L N L + + + L L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 274 YLVLNGNQLYG-------NLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK-----LH 321
+ L+ + + L A ++ ++ +D + ++ S + NL++
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316
Query: 322 YLNLSNN-----QFRKGFPVELEKLIQLSELDLSLNILE 355
+L N Q + +L +L E + L
Sbjct: 317 VPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 56/282 (19%), Positives = 96/282 (34%), Gaps = 49/282 (17%)
Query: 145 LGNLSNLAVLHLYGNSLSGSIPSIIG-----NLKSLFYLHLSSNQLS--GSIPIS---LG 194
+ L L N+L + S+ L+LS N L S +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 195 NLSNLVVLHLFENSL----FGSIPSILGNLK-MLLHLGLSTNHLS--GVIPLS--IGNLN 245
+N+ L+L N L + L + + L L N S NL
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 246 -NLIGLYLYDNQLSVGEIPIEIGKL-----SSLNYLVLNGNQLYGN-----LPRALGSL- 293
++ L L N L + E+ ++ +++N L L GN L + L + L S+
Sbjct: 138 ASITSLNLRGNDLGIKSS-DELIQILAAIPANVNSLNLRGNNL-ASKNCAELAKFLASIP 195
Query: 294 TELEYLDLSTNKLGNSIPETLGNLLK-----LHYLNLSNNQFR----KGFPVELEKLIQL 344
+ LDLS N LG L + + LNL N + + + L L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 345 SELDLSLNIL--EGKIPCE-----ICNMESLEKLNLSHNNFS 379
+ L +I+ K C+ N++ + ++ +
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 56/301 (18%), Positives = 93/301 (30%), Gaps = 52/301 (17%)
Query: 127 LYHLDLSENQLSGSIPPTLG-----NLSNLAVLHLYGNSLSGS-----IPSIIGNLKSLF 176
+ LDLS N L L +++ L+L GNSL + + ++
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 177 YLHLSSNQLSGSIPISLGNL-----SNLVVLHLFENSLFGS-----IPSILGNLKMLLHL 226
L+LS N LS L + VL L N + + L
Sbjct: 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143
Query: 227 GLSTNHLS--GVIPLS--IGNLN-NLIGLYLYDNQLSVGEIPIEIGKL-----SSLNYLV 276
L N L L + + N+ L L N L+ E+ K +S+ L
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC-AELAKFLASIPASVTSLD 202
Query: 277 LNGNQLYGNLPRALGSL-----TELEYLDLSTNKLGNSIPETLGNLLK----LHYLNLSN 327
L+ N L L + + L+L N L E L L L + L
Sbjct: 203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262
Query: 328 NQFRKGFPVELEKLIQ-------LSELDLSLNILEGKIPCEICNM-----ESLEKLNLSH 375
+ + + + L + +D + + I N+ + +L +
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
Query: 376 N 376
Sbjct: 323 Q 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 57/295 (19%), Positives = 95/295 (32%), Gaps = 47/295 (15%)
Query: 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG-----NLSNLVVLHLFENS 208
L + S + + L LS N L + L +++ L+L NS
Sbjct: 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62
Query: 209 L----FGSIPSIL-GNLKMLLHLGLSTNHLS--GVIPLS---IGNLNNLIGLYLYDNQLS 258
L + IL + L LS N LS L + L L N S
Sbjct: 63 LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 259 VGEIPIEIGKL-----SSLNYLVLNGNQLYGNLPRALGSL-----TELEYLDLSTNKLGN 308
E + +S+ L L GN L L + + L+L N L +
Sbjct: 123 SKSS-SEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181
Query: 309 SIPETLGNLLK-----LHYLNLSNNQFRKGFPVELEKLIQ-----LSELDLSLNILEGKI 358
L L + L+LS N EL + + L+L LN L G
Sbjct: 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241
Query: 359 PCEICNME----SLEKLNLSHNNFSGL-------IPSCFEGMHGLSCIDVSYNEL 402
+ ++ L+ + L ++ + + + F + + +D + E+
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 41/209 (19%), Positives = 76/209 (36%), Gaps = 31/209 (14%)
Query: 224 LHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKL-----SSLNYLVLN 278
++ L+ + S + + + L L N L +E+ + +S+ L L+
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSIST-VELIQAFANTPASVTSLNLS 59
Query: 279 GNQLYGNLPRALGSL-----TELEYLDLSTNKLGNSIPETLGNLLK-----LHYLNLSNN 328
GN L L + + L+LS N L + L L + L+L N
Sbjct: 60 GNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN 119
Query: 329 QFRKGFPVELEKLIQ-----LSELDLSLNILEGKIPCEICNM-----ESLEKLNLSHNNF 378
F E ++ ++ L+L N L K E+ + ++ LNL NN
Sbjct: 120 DFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179
Query: 379 S----GLIPSCFEGMH-GLSCIDVSYNEL 402
+ + + ++ +D+S N L
Sbjct: 180 ASKNCAELAKFLASIPASVTSLDLSANLL 208
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 38/218 (17%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEF---VNEIKTLTELR 572
FD +G G G V K SG A+K L ++V + +NE + L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVAN 628
+VK N ++V EY+ G + + L G E R +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-------PHARFYAAQIVL 152
Query: 629 ALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFLKPDSSNCTELVGTFG 685
Y+H D +++RD+ +N+L +D + +V+DFG AK +K L GT
Sbjct: 153 TFEYLHSLD----LIYRDLKPENLL--IDQQGYIQVTDFGFAKRVK---GRTWTLCGTPE 203
Query: 686 YIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHP 719
+APE++ Y V D ++ GVL E+ G P
Sbjct: 204 ALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 46/210 (21%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN---------EIKTLTELR 572
IG G QG V A +A+KK + +P F N E+ + +
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKK---------LSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 573 HRSIVKFYG-FCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSV 626
H++I+ F +LV E ++ +L ++ + E ++ ++ +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQM 173
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY 686
+ ++H I+HRD+ N+++ D ++ DFG+A+ T V T Y
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYY 229
Query: 687 IAPELVYTMKVTEKCDVYSFGVLALEVIKG 716
APE++ M E D++S G + E+++
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 20/194 (10%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK--KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G G V A + + +A+K L +M + E EI L LRH I+K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
Y + P + +V EY G L + + E + + A+ Y H
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE---DEGRRFFQQIICAIEYCHRHK-- 128
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS---SNCTELVGTFGYIAPELVYTMK 696
IVHRD+ +N+LL + +++DFG++ + + ++C G+ Y APE++
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKL 183
Query: 697 VT-EKCDVYSFGVL 709
+ DV+S G++
Sbjct: 184 YAGPEVDVWSCGIV 197
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 52/241 (21%), Positives = 85/241 (35%), Gaps = 64/241 (26%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVN-EIKTLTELRHRSIVK-F 579
+G G G V + SG+ A+KK P + N E+ + L H +I+K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM------------------N 621
F + + + + +N + V
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 622 VIRSVAN-------------------ALSYMHHDCFPPIVHRDISSKNVLL-CLDYEARV 661
V++S A+ ++H I HRDI +N+L+ D ++
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183
Query: 662 SDFGIAKFLKPDSSNCTELVGTFGYIAPELV-----YTMKVTEKCDVYSFG-VLALEVIK 715
DFG AK L P + + + Y APEL+ YT + D++S G V E+I
Sbjct: 184 CDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSI----DLWSIGCVFG-ELIL 237
Query: 716 G 716
G
Sbjct: 238 G 238
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVN---------EIKTLTELR 572
IG G QG V A +A+KK + +P F N E+ + +
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKK---------LSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 573 HRSIVKFYG-FCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSV 626
H++I+ F ++V E ++ +L ++ + E ++ ++ +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQM 136
Query: 627 ANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGY 686
+ ++H I+HRD+ N+++ D ++ DFG+A+ T V T Y
Sbjct: 137 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYY 192
Query: 687 IAPELVYTMKVTEKCDVYSFGVLALEVIKG 716
APE++ M E D++S G + E+IKG
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 44/208 (21%), Positives = 76/208 (36%), Gaps = 41/208 (19%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
+G G G V + + AVK K + EI+ L LRH+++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK--KEIQLLRRLRHKNVIQ 70
Query: 579 FYGFCSH--PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA--------N 628
+ + ++V EY G E + A +
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQ----------EMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN------CTELVG 682
L Y+H IVH+DI N+LL ++S G+A+ L P +++ G
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ----G 173
Query: 683 TFGYIAPELVYTMKVTE--KCDVYSFGV 708
+ + PE+ + K D++S GV
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGV 201
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 82 LDLSKNKLNGSIPFS--FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLS 138
L L+ N+L I FG L +L + L RN L+ I P + L L EN++
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 139 GSIPP-TLGNLSNLAVLHLYGNSLSGSIP-SIIGNLKSLFYLHLSSN 183
I L L L+LY N +S + +L SL L+L+SN
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 30/111 (27%), Positives = 52/111 (46%), Gaps = 12/111 (10%)
Query: 226 LGLSTNHLSGVIPLSI-GNLNNLIGLYLYDNQLSVGEIPIEIG---KLSSLNYLVLNGNQ 281
L L+ N L + + G L +L+ L L NQL+ IE S + L L N+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG----IEPNAFEGASHIQELQLGENK 89
Query: 282 LYGNLP-RALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQF 330
+ + + L +L+ L+L N++ + + + +L L LNL++N F
Sbjct: 90 I-KEISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNL 124
+S+ GL G L L L+L +N+L G P +F +++ + L N + I + L
Sbjct: 43 RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGL 101
Query: 125 KFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGN 159
L L+L +NQ+S + P + +L++L L+L N
Sbjct: 102 HQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 7/106 (6%)
Query: 130 LDLSENQLSGSIPPT--LGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG 187
L L++N+L I G L +L L L N L+G P+ + L L N++
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 188 SIPISL-GNLSNLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTN 231
I + L L L+L++N + + +L L L L++N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 201 VLHLFENSLFGSIPS--ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258
L L +N L G I S + G L L+ L L N L+G+ P + +++ L L +N++
Sbjct: 33 ELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 259 VGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
EI ++ L L L L NQ+ +P + L L L+L++N
Sbjct: 92 --EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 65/267 (24%), Positives = 105/267 (39%), Gaps = 34/267 (12%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVK---KFHSLWPCEMVPQPEFVNEIKT----L 568
F+ +G G G V K +G A+K K E++ + V T L
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-------EVIVAKDEVAHTLTENRVL 202
Query: 569 TELRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA 627
RH + Y F +H R V EY G L LS + E R +
Sbjct: 203 QNSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFSE--DRARF-YGAEIV 258
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYI 687
+AL Y+H + +V+RD+ +N++L D +++DFG+ K D + GT Y+
Sbjct: 259 SALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 688 APELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747
APE++ D + GV+ E++ G P F + + IL +
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--F------YNQDHEKLFELILMEEIRF 368
Query: 748 PPQNVQDELISIVEVAFLCLNESPESR 774
P + E S++ L + P+ R
Sbjct: 369 PR-TLGPEAKSLLS---GLLKKDPKQR 391
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 42/213 (19%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFY 580
+G G V++A +T+ E + VK V + + EIK L LR +I+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGPNIITLA 97
Query: 581 GFCSHPRNSF---LVYEYLERGSLATILS--NDGAIEEFNWTVRMNVIRSVANALSYMH- 634
S LV+E++ + D I + + + AL Y H
Sbjct: 98 D-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--------MYEILKALDYCHS 148
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEA---RVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
I+HRD+ NV+ +D+E R+ D+G+A+F P V + + PEL
Sbjct: 149 MG----IMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPEL 201
Query: 692 V-----YTMKVTEKCDVYSFGVLALEVIKGDHP 719
+ Y + D++S G + +I P
Sbjct: 202 LVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 60/243 (24%), Positives = 95/243 (39%), Gaps = 61/243 (25%)
Query: 507 YEEIVRATNGFDV--KY----CIGIGGQGSVYKAKLT-SGEILAVKK---FHSLWPCEMV 556
E+VR FDV +Y IG G G V A + +A+KK F C+
Sbjct: 14 GPEMVRGQV-FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT 72
Query: 557 PQPEFVNEIKTLTELRHRSIVKFYG-FCSHPRNSF----LVYEYLERGSLATILSNDGAI 611
+ EIK L RH +I+ + +V + +E T L
Sbjct: 73 -----LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLY----- 117
Query: 612 EEFNWTVRMNVIRSVANALSYMHHDCF-------------PPIVHRDISSKNVLLCLDYE 658
++++ LS H F ++HRD+ N+LL +
Sbjct: 118 ---------KLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
Query: 659 ARVSDFGIAKFLKPDSSNC---TELVGTFGYIAPELVYT-MKVTEKCDVYSFG-VLALEV 713
++ DFG+A+ PD + TE V T Y APE++ T+ D++S G +LA E+
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA-EM 225
Query: 714 IKG 716
+
Sbjct: 226 LSN 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN--------EIKTLTELR- 572
IG+G G+VYKA+ SG +A+K + E+ L L
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVR------VPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 573 --HRSIVKFYGFCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS 625
H ++V+ C+ R LV+E++++ L T L + I+
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-----GLPAETIKD 124
Query: 626 VA----NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTEL 680
+ L ++H +C IVHRD+ +N+L+ +++DFG+A+ + T +
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPV 179
Query: 681 VGTFGYIAPELV----YTMKVTEKCDVYSFG 707
V T Y APE++ Y V D++S G
Sbjct: 180 VVTLWYRAPEVLLQSTYATPV----DMWSVG 206
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKK----FHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G GSV A SGE +A+KK F S + E+ L ++H +++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-----YRELLLLKHMQHENVI 86
Query: 578 KFYGFCSHPRNS------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
+ + +LV +++ L I+ + E+ + ++ + L
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-----LVYQMLKGLK 140
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
Y+H +VHRD+ N+ + D E ++ DFG+A+ + T V T Y APE+
Sbjct: 141 YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEV 194
Query: 692 VYT-MKVTEKCDVYSFGVLALEVIKG 716
+ + M + D++S G + E++ G
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 37/106 (34%), Positives = 48/106 (45%), Gaps = 6/106 (5%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGS 140
L+L NKL F LT L + L +N + S+P V L L L L EN+L S
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 141 IPP-TLGNLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSNQ 184
+P L+ L L L N L S+P I L SL + L +N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 6/110 (5%)
Query: 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTL-GNLSNLAVLHLYGN 159
++ + L N L + V L L L LS+NQ+ S+P + L+ L +L+L+ N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 160 SLSGSIPS-IIGNLKSLFYLHLSSNQLSGSIPI-SLGNLSNLVVLHLFEN 207
L S+P+ + L L L L +NQL S+P L++L + L N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 4/106 (3%)
Query: 153 VLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL-GNLSNLVVLHLFENSLFG 211
L L N L + L L L LS NQ+ S+P + L+ L +L+L EN L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL-Q 89
Query: 212 SIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256
S+P+ + L L L L TN L V L +L ++L+ N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 76 LKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLS 133
L L+ L LS+N++ S+P F LT L I+YL+ N L S+P V L L L L
Sbjct: 51 LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108
Query: 134 ENQLSGSIPP-TLGNLSNLAVLHLYGN 159
NQL S+P L++L + L+ N
Sbjct: 109 TNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 4/105 (3%)
Query: 274 YLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL-GNLLKLHYLNLSNNQFRK 332
L L N+L LT+L L LS N++ S+P+ + L KL L L N+ +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKL-Q 89
Query: 333 GFPVEL-EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHN 376
P + +KL QL EL L N L+ + SL+K+ L N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 32/105 (30%), Positives = 44/105 (41%), Gaps = 3/105 (2%)
Query: 201 VLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260
L L N L + L L L LS N + + L L LYL++N+L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-- 89
Query: 261 EIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304
+P + KL+ L L L+ NQL LT L+ + L TN
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKK----FHSLWPCEMVPQPEFVNEIKTLTELRHRSIV 577
+G G G+V A +G +A+KK F S + E++ L +RH +++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-----YRELRLLKHMRHENVI 87
Query: 578 KFYGFCSHPRNS------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
+ +LV ++ L ++ ++ E+ + +++ L
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK----GLR 142
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
Y+H I+HRD+ N+ + D E ++ DFG+A + S T V T Y APE+
Sbjct: 143 YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYRAPEV 196
Query: 692 VYT-MKVTEKCDVYSFGVLALEVIKG 716
+ M+ T+ D++S G + E+I G
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 1e-10
Identities = 79/494 (15%), Positives = 145/494 (29%), Gaps = 164/494 (33%)
Query: 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNL---LKLHY 322
GK + + V ++ + ++ +L+L ++ E L L + ++
Sbjct: 161 SGK-TWVALDVCLSYKVQCKMDF------KIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 323 LNLSNNQFRKGFPVE-----LEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS--- 374
+ S++ + L +L++ + L +L + N ++ NLS
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-----NVQNAKAWNAFNLSCKI 268
Query: 375 -----------------------HNNFSGLIPSCFEGMHGLS-CIDVSYNELRGPIPNSR 410
++ L P E L +D +L
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD--EVKSLLLKYLDCRPQDL-------- 318
Query: 411 IFQYDPMEALQGNKGLCGDI-KGFQSCNATFTPHKQISKRKWFIIVFPLLGALSLSVLAM 469
P E L N I + + AT+ K ++ K I+ SL+VL
Sbjct: 319 -----PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII-----ESSLNVLEP 368
Query: 470 GT-------FFILRRREGPSSENRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKYC 522
+ + + + LLS++ F+ +++ N
Sbjct: 369 AEYRKMFDRLSVFP-------PS-AH-IPTI-LLSLIWFDVI--KSDVMVVVNKLHKYSL 416
Query: 523 IGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFY-- 580
+ + S S+ E +++ L HRSIV Y
Sbjct: 417 VEKQPKESTIS-------------IPSI-------YLELKVKLENEYAL-HRSIVDHYNI 455
Query: 581 --GFCSH----PRN-----SFLVY-----EYLERGSLATILSNDGAIEEFNW---TVR-- 619
F S P S + + E+ ER +L ++ D F + +R
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----FRFLEQKIRHD 510
Query: 620 ---MNVIRSVANALS----YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672
N S+ N L Y + C N YE V+ I FL
Sbjct: 511 STAWNASGSILNTLQQLKFYKPYIC-----------DN---DPKYERLVNA--ILDFLPK 554
Query: 673 DSSNC-----TELV 681
N T+L+
Sbjct: 555 IEENLICSKYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 1e-08
Identities = 50/380 (13%), Positives = 108/380 (28%), Gaps = 99/380 (26%)
Query: 474 ILRRRE------GPSSENRVNCVTNQGLLSILTFEGKILYEEIVRATNGFDVKY------ 521
IL + E + + L L + + + ++ V + K+
Sbjct: 45 ILSKEEIDHIIMSKDAVSGT-----LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK 99
Query: 522 --CIGIGGQGSVYKAKL----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKT-LTELRHR 574
+Y + ++ A K++ V + + +++ L ELR
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFA--KYN-------VSRLQPYLKLRQALLELRPA 150
Query: 575 SIVKFYGF------------CS----HPRNSFLVY-----EYLERGSLATILSNDGAIEE 613
V G C + F ++ ++ +L +
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210
Query: 614 FNWTVRMN-------VIRSVANALSY-----MHHDCFPPIVHRDISSKNVLLCLDYEARV 661
NWT R + I S+ L + +C +V ++ + + ++
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKI 268
Query: 662 ----SDFGIAKFLKPDSSNCTELVG-TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG 716
+ FL ++ L + E + K L EV+
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCRPQDLPREVLTT 325
Query: 717 DHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNES------ 770
+PR +S I+ S + + + D+L +I+E + L +
Sbjct: 326 -NPR-RLSIIAESIRDGLATWDNWKHVNC--------DKLTTIIESSLNVLEPAEYRKMF 375
Query: 771 ------PESRP-PMHTVCQL 783
P S P + +
Sbjct: 376 DRLSVFPPSAHIPTILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 61/365 (16%), Positives = 109/365 (29%), Gaps = 100/365 (27%)
Query: 51 WFGI-QCNPAKRVISI--NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGN----LTNL 103
W + CN + V+ + L + N S S D S N I + L L
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQ-IDPNWTSRS--DHSSN-----IKLRIHSIQAELRRL 237
Query: 104 AIMYLYRNSL--------------------------SASIPPVIGNLKFLYHLDLSENQL 137
Y N L + + H+ L + +
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT-THISLDHHSM 296
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLS----GSIP---SIIGNLKSLF------YLHLSSNQ 184
+ + L L L + P SII + H++ ++
Sbjct: 297 TLTPDEVKSLLLK--YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 185 LSGSIPISLGNLSNLVVLHLFEN-SLFGS---IPSILGNLKML------LHLGLSTNHLS 234
L+ I SL L +F+ S+F IP+IL L ++ + + N L
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL--LSLIWFDVIKSDVMVVVNKLH 412
Query: 235 GVIPLSIGNLNNLIGLY-LYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSL 293
S+ + L E+ +++ +L+ +++ Y N+P+
Sbjct: 413 K---YSLVEKQPKESTISIPSIYL---ELKVKLENEYALHRSIVDH---Y-NIPKT---- 458
Query: 294 TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNI 353
+ DL L +G H+L + E++ + L
Sbjct: 459 --FDSDDLIPPYLDQYFYSHIG-----HHLKNIEHP---------ERMTLFRMVFLDFRF 502
Query: 354 LEGKI 358
LE KI
Sbjct: 503 LEQKI 507
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 37/205 (18%)
Query: 523 IGIGGQGSVYKAK--LTSGEILAVKKFHSLWPCEMVPQPEFVN-----EIKTLTELR--- 572
IG G G V+KA+ G +A+K+ + E + E+ L L
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 573 HRSIVKFYGFCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA 627
H ++V+ + C+ R LV+E++++ L T L V I+ +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-----VPTETIKDMM 126
Query: 628 ----NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVG 682
L ++H +VHRD+ +N+L+ + +++DFG+A+ + T +V
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV 181
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFG 707
T Y APE++ D++S G
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 53/242 (21%), Positives = 92/242 (38%), Gaps = 67/242 (27%)
Query: 516 GFDV--KY----CIGIGGQGSVYKAK-LTSGEILAVKK--FHSLWPCEMVPQPEFVNEIK 566
GFD+ +Y +G GG G V+ A + +A+KK + + EIK
Sbjct: 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-----LREIK 60
Query: 567 TLTELRHRSIVKFY----------GFCSHPRNSF----LVYEYLERGSLATILSNDGAIE 612
+ L H +IVK + +V EY+E T L+
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLA------ 109
Query: 613 EFNWTVRMNVIRSVANALSYMHHDCF-------------PPIVHRDISSKNVLL-CLDYE 658
NV+ L H F ++HRD+ N+ + D
Sbjct: 110 --------NVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159
Query: 659 ARVSDFGIAKFLKPDSSNC---TELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVI 714
++ DFG+A+ + P S+ +E + T Y +P L+ + T+ D+++ G + E++
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 715 KG 716
G
Sbjct: 220 TG 221
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 2e-10
Identities = 21/100 (21%), Positives = 31/100 (31%), Gaps = 2/100 (2%)
Query: 111 NSLSASIPPVIGNLKFLYHLDLSENQLSGSIPP-TLGNLSNLAVLHLYGNSLSGSIPSII 169
+ + + L L + Q + L L L L + + L P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 170 GNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSL 209
L L+LS N L S+ +L L L N L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 21/101 (20%), Positives = 34/101 (33%), Gaps = 4/101 (3%)
Query: 87 NKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGSIPP-T 144
NL +Y+ + + L L +L + ++ L + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 145 LGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L+ L+L N+L + L SL L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 4/89 (4%)
Query: 75 NLKSLSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDL 132
++L+ L + + + L L + + ++ L + P L L+L
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNL 87
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSL 161
S N L S+ +L L L GN L
Sbjct: 88 SFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 29/135 (21%), Positives = 45/135 (33%), Gaps = 7/135 (5%)
Query: 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTNKLGNSIPETLGNLLK 319
+ + +L L + Q +L L L EL L + + L P+ +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 320 LHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFS 379
L LNLS N + + + L EL LS N L C C + L++
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH----CS-CALRWLQRWEEEGLGGV 135
Query: 380 GLIPSCFEGMHGLSC 394
G L+
Sbjct: 136 PEQKLQCHGQGPLAH 150
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 24/102 (23%), Positives = 37/102 (36%), Gaps = 3/102 (2%)
Query: 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTNHLSGVIPLS 240
+ + L NL L++ + L L L +L + + L V P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 241 IGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL 282
L L L N L + + + SL LVL+GN L
Sbjct: 76 FHFTPRLSRLNLSFNALES--LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 24/102 (23%), Positives = 35/102 (34%), Gaps = 2/102 (1%)
Query: 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELDLSLNILEGKIPCE 361
T L L L + N Q + + L L +L L + + L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 362 ICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L +LNLS N L +G+ L + +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 517 FDV--KY----CIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVN------ 563
++V +Y +G G GSV A T +G +AVKK + +P F +
Sbjct: 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---------LSRP-FQSIIHAKR 74
Query: 564 ---EIKTLTELRHRSIVKFYGFCSHPRNS------FLVYEYLERGSLATILSNDGAIEEF 614
E++ L ++H +++ + R+ +LV + + +
Sbjct: 75 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 134
Query: 615 NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674
+ +I + L Y+H I+HRD+ N+ + D E ++ DFG+A + +
Sbjct: 135 QF-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTA 183
Query: 675 SNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKG 716
T V T Y APE++ M + D++S G + E++ G
Sbjct: 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 27/162 (16%)
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTF--GYIAPE 690
M +HRD++++N+LL ++ DFG+A+ + D + ++APE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIK-GDHP-------RDFISSISSSSSNRNISLNEILD 742
++ T + DV+SFGVL E+ G P +F + +
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT------------ 313
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
R+ P E+ + C + P RP + + L
Sbjct: 314 -RMR-APDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 350
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKK---FHSLWPCEMVPQPEFVNEIKTLTELR 572
F +K +G G G V A +GEI+A+KK F + EIK L +
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-----LREIKILKHFK 67
Query: 573 HRSIVKFYG-FCSHPRNSF----LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA 627
H +I+ + +F ++ E ++ L ++S ++ +R
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLR--- 123
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC---------- 677
A+ +H ++HRD+ N+L+ + + +V DFG+A+ + +++
Sbjct: 124 -AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 678 TELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKG 716
E V T Y APE++ T K + DV+S G + E+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 6e-10
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEF---VNEIKTLTELR 572
F + +G G G V+ + +G A+K L +V + +E L+ +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMK---VLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR----SVAN 628
H I++ +G + F++ +Y+E G L ++L V + V
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-------PVAKFYAAEVCL 117
Query: 629 ALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFLKPDSSNCTELVGTFG 685
AL Y+H D I++RD+ +N+L LD +++DFG AK++ PD + T L GT
Sbjct: 118 ALEYLHSKD----IIYRDLKPENIL--LDKNGHIKITDFGFAKYV-PDVTY-T-LCGTPD 168
Query: 686 YIAPELV----YTMKVTEKCDVYSFGVLALEVIKG 716
YIAPE+V Y + D +SFG+L E++ G
Sbjct: 169 YIAPEVVSTKPYNKSI----DWWSFGILIYEMLAG 199
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 10/114 (8%)
Query: 292 SLTELEYLDL--STNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELD 348
TE E ++L + + TL L +L LS N K + L + L L
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK---ISSLSGMENLRILS 76
Query: 349 LSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
L N+++ KI ++LE+L +S+N + L S E + L + +S N++
Sbjct: 77 LGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKI 127
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 10/119 (8%)
Query: 285 NLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQ 343
+ L +L ++L LSTN + I +L + L L+L N +K +E L+ +
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK---IENLDAVAD 93
Query: 344 -LSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIP-SCFEGMHGLSCIDVSYN 400
L EL +S N + + I + +L L +S+N + + L + ++ N
Sbjct: 94 TLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 46/171 (26%), Positives = 70/171 (40%), Gaps = 23/171 (13%)
Query: 195 NLSNLVVLHLFENSLFGSIPSI------LGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLI 248
++V + L G IP I L LK HL LSTN++ + LS + NL
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLS--GMENLR 73
Query: 249 GLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN 308
L L N + +I +L L ++ NQ+ +L + L L L +S NK+ N
Sbjct: 74 ILSLGRNLIK--KIENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSNNKITN 129
Query: 309 -SIPETLGNLLKLHYLNLSNNQFRKGFPVE----------LEKLIQLSELD 348
+ L L KL L L+ N + +++L L +LD
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 29/132 (21%), Positives = 53/132 (40%), Gaps = 10/132 (7%)
Query: 247 LIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL 306
+ L+ + ++ + L + +L L+ N + + +L + L L L N +
Sbjct: 27 KVELHGMIPPIE--KMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLI 82
Query: 307 GNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELDLSLN-ILEGKIPCEICN 364
I L L +S NQ + +EKL+ L L +S N I ++
Sbjct: 83 -KKIENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRVLYMSNNKITNWGEIDKLAA 138
Query: 365 MESLEKLNLSHN 376
++ LE L L+ N
Sbjct: 139 LDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 37/184 (20%), Positives = 63/184 (34%), Gaps = 44/184 (23%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSI--IGNLKSLFYLHLSSNQLS 186
L + + TL L L L N+ I I + +++L L L N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLIK 83
Query: 187 GSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN 246
+ NL + L L +S N ++ + + L N
Sbjct: 84 -----KIENLDAV--------------------ADTLEELWISYNQIASLSGIE--KLVN 116
Query: 247 LIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL----------PRALGSLTEL 296
L LY+ +N+++ ++ L L L+L GN LY + + L L
Sbjct: 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176
Query: 297 EYLD 300
+ LD
Sbjct: 177 KKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 34/114 (29%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
LK+ L LS N + I S + NL I+ L RN + I + L L +S
Sbjct: 46 TLKACKHLALSTNNI-EKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISY 102
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSI--IGNLKSLFYLHLSSNQLS 186
NQ++ S+ + L NL VL++ N ++ + I + L L L L+ N L
Sbjct: 103 NQIA-SLSG-IEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 34/117 (29%), Positives = 53/117 (45%), Gaps = 8/117 (6%)
Query: 117 IPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLF 176
+ + LK HL LS N + I L + NL +L L N + I ++ +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 177 YLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSI--LGNLKMLLHLGLSTN 231
L +S NQ++ S+ + L NL VL++ N + + I L L L L L+ N
Sbjct: 97 ELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKI-TNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 16/117 (13%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133
+++L L L +N + I L +++ N ++ S+ I L L L +S
Sbjct: 67 SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMS 123
Query: 134 ENQLS--GSIPPTLGNLSNLAVLHLYGNSLSGSIPS----------IIGNLKSLFYL 178
N+++ G I L L L L L GN L ++ L +L L
Sbjct: 124 NNKITNWGEIDK-LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 64/254 (25%), Positives = 110/254 (43%), Gaps = 53/254 (20%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFV---NEIKTLT 569
F++ +G G G V+ K + ++ A+K V + + + ++T
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMK----------VLKKATLKVRDRVRTKM 75
Query: 570 E------LRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
E + H IVK Y F + + +L+ ++L G L T LS + E
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE-------ED 127
Query: 623 IR----SVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFLKPDSS 675
++ +A AL ++H I++RD+ +N+LL D E +++DFG++K
Sbjct: 128 VKFYLAELALALDHLHSLG----IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK 181
Query: 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735
GT Y+APE+V T+ D +SFGVL E++ G P F +R
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--F------QGKDRKE 233
Query: 736 SLNEILDPRLPTPP 749
++ IL +L P
Sbjct: 234 TMTMILKAKLGMPQ 247
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 41/199 (20%), Positives = 75/199 (37%), Gaps = 49/199 (24%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFV-NEIKTLTEL-RHRSIVKF 579
+G+G G V + + E A+K M+ E++ + IV+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRASQCPHIVRI 76
Query: 580 YGFC----SHPRNSFLVYEYLERGSL-ATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+ + +V E L+ G L + I + F +++S+ A+ Y+H
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH 134
Query: 635 -HDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
+ I HRD+ +N+L + +++DFG AK E G Y
Sbjct: 135 SIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----------ETTGE-KY---- 175
Query: 691 LVYTMKVTEKCDVYSFGVL 709
+ CD++S GV+
Sbjct: 176 -------DKSCDMWSLGVI 187
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 7/117 (5%)
Query: 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSE 346
R + EL LD S + G + +L +L+ N + L KL +L +
Sbjct: 14 RTPSDVKEL-VLDNSRSNEG-KLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKK 68
Query: 347 LDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGL-IPSCFEGMHGLSCIDVSYNEL 402
L+LS N + G + +L LNLS N L + + L +D+ E+
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 28/113 (24%), Positives = 45/113 (39%), Gaps = 5/113 (4%)
Query: 96 SFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLH 155
+ ++ L + S + + + L L L+ SI L L+ L L
Sbjct: 15 TPSDVKELVL--DNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLE 70
Query: 156 LYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG-SIPISLGNLSNLVVLHLFEN 207
L N +SG + + +L +L+LS N++ S L L NL L LF
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 29/112 (25%), Positives = 43/112 (38%), Gaps = 6/112 (5%)
Query: 71 GLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHL 130
GL + L L L SI + L L + L N +S + + L HL
Sbjct: 36 GLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93
Query: 131 DLSENQLSG-SIPPTLGNLSNLAVLHLYGNSLSGSI---PSIIGNLKSLFYL 178
+LS N++ S L L NL L L+ ++ ++ L L YL
Sbjct: 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 29/110 (26%), Positives = 41/110 (37%), Gaps = 4/110 (3%)
Query: 171 NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230
++K L + SN G + L L L SI + L L L L LS
Sbjct: 18 DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLELSD 73
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN 280
N +SG + + NL L L N++ + KL +L L L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-07
Identities = 28/112 (25%), Positives = 44/112 (39%), Gaps = 5/112 (4%)
Query: 219 NLKMLLHLGLSTNHLS-GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVL 277
+ L L + + G + L L + L+ + KL+ L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN---LPKLNKLKKLEL 71
Query: 278 NGNQLYGNLPRALGSLTELEYLDLSTNKLGN-SIPETLGNLLKLHYLNLSNN 328
+ N++ G L L +L+LS NK+ + S E L L L L+L N
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 27/112 (24%), Positives = 43/112 (38%), Gaps = 6/112 (5%)
Query: 123 NLKFLYHLDLSENQLS-GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181
+ L L ++ + G + L L L+ SI + + L L L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 182 SNQLSGSIPISLGNLSNLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTN 231
N++SG + + NL L+L N + +I L L+ L L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 290 LGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELD 348
+ LDL K+ I L + ++ S+N+ RK ++ L +L L
Sbjct: 15 YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRK---LDGFPLLRRLKTLL 70
Query: 349 LSLNILEGKIPCEICNMESLEKLNLSHNNFSGL 381
++ N + + L +L L++N+ L
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 24/114 (21%), Positives = 42/114 (36%), Gaps = 7/114 (6%)
Query: 217 LGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE-IGKLSSLNYL 275
N L L + + L L+ + DN++ ++ L L L
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGA-TLDQFDAIDFSDNEIR----KLDGFPLLRRLKTL 69
Query: 276 VLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN-SIPETLGNLLKLHYLNLSNN 328
++N N++ +L +L L L+ N L + L +L L YL + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 23/127 (18%), Positives = 44/127 (34%), Gaps = 6/127 (4%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSI 141
+ L+ + + + N + L + I + L +D S+N++ +
Sbjct: 2 VKLTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 142 PPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG-SIPISLGNLSNLV 200
L L L + N + + L L L L++N L L +L +L
Sbjct: 58 D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 201 VLHLFEN 207
L + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 25/130 (19%), Positives = 45/130 (34%), Gaps = 12/130 (9%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
+ L+ + + N L L G + I ++ L + S N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--- 55
Query: 190 PIS-LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNH---LSGVIPLSIGNLN 245
+ L L L + N + + L L L L+ N L + PL+ +L
Sbjct: 56 KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA--SLK 113
Query: 246 NLIGLYLYDN 255
+L L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 24/113 (21%), Positives = 41/113 (36%), Gaps = 8/113 (7%)
Query: 71 GLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHL 130
L L +D S N++ + F L L + + N + + L L L
Sbjct: 36 NLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93
Query: 131 DLSENQLS--GSIPPTLGNLSNLAVLHLYGN---SLSGSIPSIIGNLKSLFYL 178
L+ N L G + P L +L +L L + N + +I + + L
Sbjct: 94 ILTNNSLVELGDLDP-LASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 17/107 (15%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 299 LDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE--LEKLIQLSELDLSLNILEG 356
+ L+ + + N ++ L+L + +E L Q +D S N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPV---IENLGATLDQFDAIDFSDNEIR- 55
Query: 357 KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
K+ + L+ L +++N + + + L+ + ++ N L
Sbjct: 56 KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 27/113 (23%), Positives = 42/113 (37%), Gaps = 10/113 (8%)
Query: 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIG--NLKSLFYLHL 180
N LDL ++ I L + N I + G L+ L L +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IRKLDGFPLLRRLKTLLV 71
Query: 181 SSNQLSGSIPISLGNLSNLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTN 231
++N++ L +L L L NSL G + L +LK L +L + N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 57/375 (15%), Positives = 119/375 (31%), Gaps = 42/375 (11%)
Query: 66 NLSTVGLK---GNLKSLSTLDLSKNKLNG-------SIPFSFGNLTNLAIMYLYRNSLSA 115
ST GL ++L LDL ++ ++ P ++ +L +L I L +
Sbjct: 142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFS 201
Query: 116 SIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSG------SIPSII 169
++ ++ L L L+ + L L L G + + +
Sbjct: 202 ALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVAL 261
Query: 170 GNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFG-SIPSILGNLKMLLHLGL 228
K L L + + +P S L L+L ++ + +L L L +
Sbjct: 262 SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV 321
Query: 229 STN-HLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIG---------KLSSLNYLVLN 278
+G+ L+ +L L ++ ++ V E + + L ++
Sbjct: 322 LDYIEDAGLEVLA-STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYF 380
Query: 279 GNQ--------LYGNLPR----ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLS 326
Q + N P L + L+ L + + L L+LS
Sbjct: 381 CRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS 440
Query: 327 NNQFRKGFPVELEKLIQLSELDLSL-NILEGKIPCEICNMESLEKLNLSHNNFSGL-IPS 384
K F ++ L ++ + + + +SL KL + F + +
Sbjct: 441 GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLA 500
Query: 385 CFEGMHGLSCIDVSY 399
+ + + +S
Sbjct: 501 NASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 53/333 (15%), Positives = 105/333 (31%), Gaps = 32/333 (9%)
Query: 89 LNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNL 148
++ F + ++ + + +P G + + +S +
Sbjct: 57 SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSS------------Y 104
Query: 149 SNLAVLHLYGNSLS-GSIPSIIGNLKSLFYLHLSS-NQLS-GSIPISLGNLSNLVVLHLF 205
+ L + L ++ + I + K+ L LSS S + NL L L
Sbjct: 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLR 164
Query: 206 ENSLFG----SIPSILGNLKMLLHLGLSTNHL----SGVIPLSIGNLNNLIGLYLYDNQL 257
E+ + + L+ L +S S + L NL L L +
Sbjct: 165 ESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV-TRCPNLKSLKLNRA-V 222
Query: 258 SVGEIPIEIGKLSSLNYLVLNG------NQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311
+ ++ + + L L G +Y L AL EL L + + +P
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282
Query: 312 ETLGNLLKLHYLNLSNNQFR-KGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEK 370
+L LNLS + L + +L L + I + + + L +
Sbjct: 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRE 342
Query: 371 LNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L + + + P+ GL + + +L
Sbjct: 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-09
Identities = 69/279 (24%), Positives = 110/279 (39%), Gaps = 59/279 (21%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVK---KFHSLWPCEMVPQPEFVNEIKT----L 568
FD +G G G V + +G A+K K E++ + V T L
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-------EVIIAKDEVAHTVTESRVL 59
Query: 569 TELRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRS-- 625
RH + Y F +H R V EY G L LS + E R+
Sbjct: 60 QNTRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTE---------ERARF 109
Query: 626 ----VANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTE 679
+ +AL Y+H D +V+RDI +N++L D +++DFG+ K + ++ T
Sbjct: 110 YGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 680 LVGTFGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735
GT Y+APE++ Y V D + GV+ E++ G P F + +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP--F------YNQDHER 212
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
IL + P + E S++ L + P+ R
Sbjct: 213 LFELILMEEIRFPR-TLSPEAKSLLA---GLLKKDPKQR 247
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 7/117 (5%)
Query: 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSE 346
R ++ EL LD + G I + L +L+L N V L KL +L +
Sbjct: 21 RTPAAVRELV-LDNCKSNDG-KIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKK 75
Query: 347 LDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGL-IPSCFEGMHGLSCIDVSYNEL 402
L+LS N + G + + +L LNLS N + + + L +D+ E+
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 7/117 (5%)
Query: 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLY--GNLPRALGSLTEL 296
L + L L + + + G+I + +L +L L L NLP+ L +L
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKL 73
Query: 297 EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVE-LEKLIQLSELDLSLN 352
+ L+LS N++ + L L +LNLS N+ + +E L+KL L LDL
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-08
Identities = 31/131 (23%), Positives = 46/131 (35%), Gaps = 5/131 (3%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
S +D+ + + + L + S I + L L L L
Sbjct: 4 GSSGMDMKRRIHLELRNRTPAAVRELVL--DNCKSNDGKIEGLTAEFVNLEFLSLINVGL 61
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG-SIPISLGNL 196
S+ L L L L L N + G + + L +L +L+LS N+L S L L
Sbjct: 62 I-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKL 119
Query: 197 SNLVVLHLFEN 207
L L LF
Sbjct: 120 ECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 8/113 (7%)
Query: 71 GLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHL 130
GL +L L L L S+ + L L + L N + + + L L HL
Sbjct: 43 GLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100
Query: 131 DLSENQLS--GSIPPTLGNLSNLAVLHLYGN---SLSGSIPSIIGNLKSLFYL 178
+LS N+L ++ P L L L L L+ +L+ S+ L L YL
Sbjct: 101 NLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 37/134 (27%), Positives = 49/134 (36%), Gaps = 6/134 (4%)
Query: 171 NLKSLFYLHLSSNQLS-GSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS 229
++ L L + + + G I NL L L L S+ S L L L L LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISV-SNLPKLPKLKKLELS 79
Query: 230 TNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN---QLYGNL 286
N + G + + L NL L L N+L + KL L L L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYR 139
Query: 287 PRALGSLTELEYLD 300
L +L YLD
Sbjct: 140 ESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 30/104 (28%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
LD ++ G I NL L L L S+ S + L L L LS N++ G +
Sbjct: 31 LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGL 87
Query: 190 PISLGNLSNLVVLHLFENSL--FGSIPSILGNLKMLLHLGLSTN 231
+ L NL L+L N L ++ L L+ L L L
Sbjct: 88 DMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (136), Expect = 1e-08
Identities = 26/170 (15%), Positives = 57/170 (33%), Gaps = 23/170 (13%)
Query: 228 LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP 287
+S + P+ + + L L + + I +L L + L ++
Sbjct: 156 ISWIEQVDLSPV-LDAMPLLNNLKIKGTN----NLSIGKKPRPNLKSLEIISGGLPDSVV 210
Query: 288 RALGS--LTELEYLDL---STNKLGNSIPETLGNLL------KLHYLNLSNNQFRKGFPV 336
+ L LE L L + + L L +L + + + +
Sbjct: 211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270
Query: 337 EL---EKLIQLSELDLSLNILEGKIPCEIC----NMESLEKLNLSHNNFS 379
+ L QL +D+S +L + + ++ L+ +N+ +N S
Sbjct: 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 3e-08
Identities = 39/222 (17%), Positives = 76/222 (34%), Gaps = 43/222 (19%)
Query: 126 FLYHLDLSENQLS----GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181
F +D E ++S + P L + L L + G + NLKSL +
Sbjct: 145 FWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EII 201
Query: 182 SNQLSGSIPISLG--NLSNLVVLHLF---ENSLFGSIPSIL------GNLKMLLHLGLST 230
S L S+ + +L NL L L+ E+ F ++ L LG+
Sbjct: 202 SGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261
Query: 231 NHLSGVIPLSIGN---LNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP 287
V+ L L + + L ++ L
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVL---------------------TDEGARLLL 300
Query: 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQ 329
+ + L+++++ N L + + + L L + +++S++Q
Sbjct: 301 DHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK-IDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 5e-04
Identities = 18/107 (16%), Positives = 35/107 (32%), Gaps = 16/107 (14%)
Query: 72 LKGNLKSLSTLDLSKNKLNGSIP---------FSFGNLTNLAIMYLYRNSLSASIPPVIG 122
L +L +L L L + FS NL + + + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 123 N---LKFLYHLDLSENQLSGS----IPPTLGNLSNLAVLHLYGNSLS 162
L L +D+S L+ + + + +L +++ N LS
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 62/249 (24%), Positives = 112/249 (44%), Gaps = 41/249 (16%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKT----L 568
F++ +G GG G V++ + +G+I A+K L +V + K L
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK---VLKKAMIVRNAKDTAHTKAERNIL 75
Query: 569 TELRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR--- 624
E++H IV Y F + + +L+ EYL G L L +G E +
Sbjct: 76 EEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-------DTACFYL 127
Query: 625 -SVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFLKPDSSNCTEL 680
++ AL ++H I++RD+ +N++L +++ +++DFG+ K D +
Sbjct: 128 AEISMALGHLHQKG----IIYRDLKPENIML--NHQGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 681 VGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740
GT Y+APE++ D +S G L +++ G P F + NR ++++I
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--F------TGENRKKTIDKI 233
Query: 741 LDPRLPTPP 749
L +L PP
Sbjct: 234 LKCKLNLPP 242
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 42/303 (13%), Positives = 78/303 (25%), Gaps = 70/303 (23%)
Query: 124 LKFLYHLDLSENQLSGSIPPTLG-----NLSNLAVLHLYGNSLSG-SIPSIIGNLKSLFY 177
L L L+L+ +++ + L ++L L + +++
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 178 LHLSSNQLS--GSIPIS---LGNLSNLVVLHLFENSL----FGSIPSILGNLKMLLHLGL 228
L L N L + L + + L L N L + L + HL L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 229 STNHLS--GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGN- 285
L G+ L+ N L L + N
Sbjct: 191 LHTGLGDEGLELLAAQLDRN-----------------------RQLQELNVAYNGAGDTA 227
Query: 286 ---LPRALGSLTELEYLDLSTNKLGNS----IPETLG---NLLKLHYLNLSNNQFRKG-- 333
L RA LE L L N+L + + + G ++ +
Sbjct: 228 ALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWS 287
Query: 334 -------------FPVELEKLIQLSELDLSLNILEGKIPCEICNM----ESLEKLNLSHN 376
+++ ++L DL + P + + L
Sbjct: 288 VILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLG 347
Query: 377 NFS 379
+
Sbjct: 348 SSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 51/277 (18%), Positives = 83/277 (29%), Gaps = 49/277 (17%)
Query: 126 FLYHLDLSENQ-LSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKS--LFYLHLSS 182
L L + N+ + + + NL L L ++ + + H
Sbjct: 2 LLVGLLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF 61
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILG-----NLKMLLHLGLSTNHLS--G 235
S LS+L L+L + +++ L + L++ L G
Sbjct: 62 QNQR----FSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAG 117
Query: 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKL-----SSLNYLVLNGNQLYGN----L 286
+ L L L L N L ++ L + L L+ N L L
Sbjct: 118 LRTLLPVFLR-ARKLGLQLNSLGPEAC-KDLRDLLLHDQCQITTLRLSNNPLTAAGVAVL 175
Query: 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSE 346
L T + +L L LG+ E L L + QL E
Sbjct: 176 MEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN--------------------RQLQE 215
Query: 347 LDLSLNILEGKIPCEICNM----ESLEKLNLSHNNFS 379
L+++ N + SLE L+L N S
Sbjct: 216 LNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 46/288 (15%), Positives = 74/288 (25%), Gaps = 61/288 (21%)
Query: 71 GLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHL 130
L +L ++L+ L + L PV + L
Sbjct: 95 VLGSGRHALDEVNLASC-----------QLDPAGLRTLL---------PVFLRAR---KL 131
Query: 131 DLSENQLSGSIPPTLG-----NLSNLAVLHLYGNSLSGS----IPSIIGNLKSLFYLHLS 181
L N L L + + L L N L+ + + + S+ +L L
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLL 191
Query: 182 SNQLS--GSIPIS--LGNLSNLVVLHLFENSL----FGSIPSILGNLKMLLHLGLSTNHL 233
L G ++ L L L++ N ++ L L L N L
Sbjct: 192 HTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
Query: 234 S--GVIPLSIG-----NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286
S G L ++ +S I +LN Q
Sbjct: 252 SSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQ----- 306
Query: 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLK----LHYLNLSNNQF 330
EL DL ++ P LL+ + L
Sbjct: 307 -----RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 59/253 (23%), Positives = 106/253 (41%), Gaps = 41/253 (16%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKT----L 568
F++ +G G G V+ + +G++ A+K L +V + + +T L
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK---VLKKATIVQKAKTTEHTRTERQVL 112
Query: 569 TELRHRS-IVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR-- 624
+R +V Y F + L+ +Y+ G L T LS E + ++
Sbjct: 113 EHIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFTHLSQRERFTE-------HEVQIY 164
Query: 625 --SVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAK-FLKPDSSNCT 678
+ AL ++H I++RDI +N+L LD ++DFG++K F+ ++
Sbjct: 165 VGEIVLALEHLHKLG----IIYRDIKLENIL--LDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 679 ELVGTFGYIAPELVYTMKV--TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNIS 736
+ GT Y+AP++V + D +S GVL E++ G P F +++
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTV--DGEKNSQAEI 274
Query: 737 LNEILDPRLPTPP 749
IL P P
Sbjct: 275 SRRILKSEPPYPQ 287
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 250 LYLYDNQLSVGEIPIEIG---KLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL 306
L+L +NQ++ +E G L +L L N N+L LT+L LDL+ N L
Sbjct: 38 LWLNNNQIT----KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93
Query: 307 GNSIPE-TLGNLLKLHYLNLSNN 328
SIP NL L ++ L NN
Sbjct: 94 -KSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 30/80 (37%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGS 140
L L+ N++ P F +L NL +Y N L+ +IP V L L LDL++N L S
Sbjct: 38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-S 95
Query: 141 IPP-TLGNLSNLAVLHLYGN 159
IP NL +L ++LY N
Sbjct: 96 IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
+ ++ +L S+P G T+ ++L N ++ + P V +L L L + N+
Sbjct: 13 DQTLVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNK 68
Query: 137 LSGSIPPTLG---NLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSN 183
L+ +IP G L+ L L L N L SIP NLKSL +++L +N
Sbjct: 69 LT-AIPT--GVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 22/71 (30%), Positives = 33/71 (46%), Gaps = 8/71 (11%)
Query: 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLG---NLL 318
+P I + L LN NQ+ P L L+ L ++NKL +IP G L
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPT--GVFDKLT 81
Query: 319 KLHYLNLSNNQ 329
+L L+L++N
Sbjct: 82 QLTQLDLNDNH 92
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
++ +L+ S+P G ++ L L N ++ P + +L +L L+ +SN+L+ +I
Sbjct: 17 VNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AI 72
Query: 190 PISL-GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTN 231
P + L+ L L L +N L SIP NLK L H+ L N
Sbjct: 73 PTGVFDKLTQLTQLDLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 212 SIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKL 269
S+P+ I + + L L+ N ++ + P +L NL LY N+L+ IP + KL
Sbjct: 26 SVPAGIPTDKQ---RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT--AIPTGVFDKL 80
Query: 270 SSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTN 304
+ L L LN N L ++PR A +L L ++ L N
Sbjct: 81 TQLTQLDLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 41/193 (21%), Positives = 75/193 (38%), Gaps = 35/193 (18%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVK---------KFHSLWPCEM-----VPQPEFVNEIKTL 568
IG GG G +Y A + S E + + E+ +PE + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 569 TELRHRSIVKFYGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNW-TVRMNVI 623
+L++ + K++G H +N F++ + L I + + F+ TV +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANA--KRFSRKTVLQLSL 159
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSN----- 676
R + + L Y+H + VH DI + N+LL +V D+G+A P+ +
Sbjct: 160 RIL-DILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 677 --CTELVGTFGYI 687
GT +
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 50/230 (21%), Positives = 83/230 (36%), Gaps = 52/230 (22%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+++++ IG G G V +A ++A+KK ++ + + EI L L H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDH 113
Query: 576 IVKFYG-FCSHPRNSF----LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
+VK F +V E + + E T+ N++ +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV----GV 169
Query: 631 SYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC------------ 677
Y+H I+HRD+ N L+ D +V DFG+A+ + +
Sbjct: 170 KYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 678 ---------------TELVGTFGYIAPELV-----YTMKVTEKCDVYSFG 707
T V T Y APEL+ YT + DV+S G
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIG 271
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 47/271 (17%), Positives = 91/271 (33%), Gaps = 81/271 (29%)
Query: 517 FDVKYCI----GIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL 571
F+ +Y + G G +V+ + + + +A+K S ++EI+ L +
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSV 90
Query: 572 RHRSIV-KFYGFCSHPRNSF-----------LVYEYLERGSLATIL--SNDGAIEEFNWT 617
R+ + F +V+E L L + SN +
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPL--PC 147
Query: 618 VRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD--------------------- 656
V+ +I+ V L Y+H C I+H DI +N+LL ++
Sbjct: 148 VKK-IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 657 ----------------------------YEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
+ +++D G A ++ TE + T Y +
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRS 261
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
E++ D++S +A E+ GD+
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 49/279 (17%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVK---KFHSLWPCEMVPQPEFVNEIKT----- 567
FD+ IG G V +L + I A+K K E+V E ++ ++T
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK-------ELVNDDEDIDWVQTEKHVF 63
Query: 568 LTELRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE----FNWTVRMNV 622
H +V F + R F V EY+ G L + + E F
Sbjct: 64 EQASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARF-------Y 115
Query: 623 IRSVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTEL 680
++ AL+Y+H I++RD+ NVLL + +++D+G+ K L+P + T
Sbjct: 116 SAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-F 170
Query: 681 VGTFGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHP-RDFISSISSSSSNRNI 735
GT YIAPE++ Y V D ++ GVL E++ G P SS + + +
Sbjct: 171 CGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
IL+ ++ P ++ + S+++ LN+ P+ R
Sbjct: 227 LFQVILEKQIRIPR-SLSVKAASVLK---SFLNKDPKER 261
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 46/224 (20%), Positives = 82/224 (36%), Gaps = 45/224 (20%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G +V+ AK + + +A+K E EIK L + K
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAED--EIKLLQRVNDADNTKEDS 82
Query: 582 ----FCSHPRNSF-----------LVYEYLERGSLATIL--SNDGAIEEFNWTVRMNVIR 624
+ F +V+E L +L ++ I + ++
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIP-------LIYVK 134
Query: 625 SVA----NALSYMHHDCFPPIVHRDISSKNVLLCL------DYEARVSDFGIAKFLKPDS 674
++ L YMH C I+H DI +NVL+ + + +++D G A +
Sbjct: 135 QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YD 189
Query: 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDH 718
+ T + T Y +PE++ D++S L E+I GD
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 49/235 (20%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKK----FHSLWPCEMVPQPEFVNEIKTLTEL 571
+ +K+ IG G G VY A + + +A+KK F L C+ + + EI L L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI-----LREITILNRL 82
Query: 572 RHRSIVKFYG-FCSHPRNSF----LVYEYLERGSLATILSNDGAIEEFNWTVRM-NVIRS 625
+ I++ Y F +V E + L + + E + + N++
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL- 140
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC-------- 677
+++H I+HRD+ N LL D +V DFG+A+ + +
Sbjct: 141 ---GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 678 --------------TELVGTFGYIAPELVYT-MKVTEKCDVYSFG-VLALEVIKG 716
T V T Y APEL+ T+ D++S G + A E++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNM 248
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 55/282 (19%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIK----TLTE- 570
FD+ IG G V +L + I A++ V + E VN+ + TE
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMR----------VVKKELVNDDEDIDWVQTEK 103
Query: 571 ------LRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE----FNWTVR 619
H +V F + R F V EY+ G L + + E F
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARF----- 157
Query: 620 MNVIRSVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNC 677
++ AL+Y+H I++RD+ NVLL + +++D+G+ K L+P +
Sbjct: 158 --YSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 211
Query: 678 TELVGTFGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHP-RDFISSISSSSSN 732
T GT YIAPE++ Y V D ++ GVL E++ G P SS + +
Sbjct: 212 T-FCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
Query: 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
+ IL+ ++ P ++ + S+++ LN+ P+ R
Sbjct: 267 EDYLFQVILEKQIRIPR-SLSVKAASVLK---SFLNKDPKER 304
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 4/84 (4%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQ 136
+ L L N++ P F LT L + L N L+ +P V L L L L++NQ
Sbjct: 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQ 89
Query: 137 LSGSIPP-TLGNLSNLAVLHLYGN 159
L SIP NL +L + L N
Sbjct: 90 LK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 40/108 (37%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSG 139
T+D S L S+P G T ++YLY N ++ + P V L L LDL NQL+
Sbjct: 13 TVDCSGKSLA-SVPT--GIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT- 67
Query: 140 SIPPTLG---NLSNLAVLHLYGNSLSGSIPS-IIGNLKSLFYLHLSSN 183
+P G L+ L L L N L SIP NLKSL ++ L +N
Sbjct: 68 VLPA--GVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 23/73 (31%), Positives = 35/73 (47%), Gaps = 8/73 (10%)
Query: 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLG---NLL 318
+P I ++ L L NQ+ P LT+L LDL N+L +P G L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPA--GVFDKLT 78
Query: 319 KLHYLNLSNNQFR 331
+L L+L++NQ +
Sbjct: 79 QLTQLSLNDNQLK 91
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
+D S L+ S+P G + VL+LY N ++ P + L L L L +NQL+ +
Sbjct: 14 VDCSGKSLA-SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VL 69
Query: 190 PISL-GNLSNLVVLHLFENSLFGSIPS-ILGNLKMLLHLGLSTN 231
P + L+ L L L +N L SIP NLK L H+ L N
Sbjct: 70 PAGVFDKLTQLTQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 212 SIPS-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI-GKL 269
S+P+ I + L L N ++ + P L L L L +NQL+ +P + KL
Sbjct: 23 SVPTGIPTTTQ---VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT--VLPAGVFDKL 77
Query: 270 SSLNYLVLNGNQLYGNLPR-ALGSLTELEYLDLSTN 304
+ L L LN NQL ++PR A +L L ++ L N
Sbjct: 78 TQLTQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 62/279 (22%), Positives = 106/279 (37%), Gaps = 58/279 (20%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFV---NEIK-TLTE- 570
F + +G G G V+ A+ + + A+K + + V ++++ T+ E
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIK----------ALKKDVVLMDDDVECTMVEK 68
Query: 571 ------LRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
H + F F + N F V EYL G L + + + +
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDL-------SRA 120
Query: 624 R----SVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAK-FLKPDSS 675
+ L ++H IV+RD+ N+LL D + +++DFG+ K + D+
Sbjct: 121 TFYAAEIILGLQFLHSKG----IVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDAK 174
Query: 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735
T GT YIAPE++ K D +SFGVL E++ G P F +
Sbjct: 175 TNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--F------HGQDEEE 225
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
+ I P ++ E ++ PE R
Sbjct: 226 LFHSIRMDNPFYPR-WLEKEAKDLLVK---LFVREPEKR 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/280 (20%), Positives = 112/280 (40%), Gaps = 60/280 (21%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFV---NEIK-TLTE- 570
F+ +G G G V ++ + E+ AVK + + + V ++++ T+ E
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVK----------ILKKDVVIQDDDVECTMVEK 392
Query: 571 ------LRHRSIVKFYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
+ + + + C + + V EY+ G L + G +E
Sbjct: 393 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE-------PHA 444
Query: 624 R----SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCT 678
+A L ++ I++RD+ NV+L + +++DFG+ K + + T
Sbjct: 445 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
Query: 679 ELVGTFGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRN 734
GT YIAPE++ Y V D ++FGVL E++ G P F + +
Sbjct: 502 -FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP--F------EGEDED 548
Query: 735 ISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
I++ + P ++ E ++I + + + P R
Sbjct: 549 ELFQSIMEHNVAYPK-SMSKEAVAICK-GL--MTKHPGKR 584
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 27/173 (15%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVK------KFHSLWPCEM-----VPQPEFVNEIKTLTE 570
IG GG G +Y A E A + + E+ V + + + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 571 LRHRSIVKFYGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNW-TVRMNVIRS 625
L + I FYG F+V E L L I +G F TV IR
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT---FKKSTVLQLGIRM 160
Query: 626 VANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSN 676
+ + L Y+H + + VH DI + N+LL +V +D+G++ P+ ++
Sbjct: 161 L-DVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 58/279 (20%)
Query: 517 FDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFV---NEIK-TLTE- 570
F IG G G V A+ AVK V Q + + E K ++E
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVK----------VLQKKAILKKKEEKHIMSER 89
Query: 571 ------LRHRSIVK-FYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
++H +V + F + + V +Y+ G L L + E
Sbjct: 90 NVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRERCFLE-------PRA 141
Query: 624 R----SVANALSYMH-HDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAK-FLKPDSS 675
R +A+AL Y+H + IV+RD+ +N+L LD + ++DFG+ K ++ +S+
Sbjct: 142 RFYAAEIASALGYLHSLN----IVYRDLKPENIL--LDSQGHIVLTDFGLCKENIEHNST 195
Query: 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735
T GT Y+APE+++ D + G + E++ G P F S N
Sbjct: 196 TST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--F------YSRNTAE 246
Query: 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
+ IL+ L P N+ + ++E L + R
Sbjct: 247 MYDNILNKPLQLKP-NITNSARHLLE---GLLQKDRTKR 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 39/231 (16%), Positives = 79/231 (34%), Gaps = 10/231 (4%)
Query: 106 MYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSI 165
+ L +L + + + + + + + + ++
Sbjct: 52 LDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110
Query: 166 PSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLF--GSIPSILGNLKML 223
I+ L L L +LS I +L SNLV L+L S F ++ ++L + L
Sbjct: 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 170
Query: 224 LHLGLS-TNHLS--GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIE--IGKLSSLNYLVLN 278
L LS + V + L L + ++ + + + + +L +L L+
Sbjct: 171 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 230
Query: 279 G-NQLYGNLPRALGSLTELEYLDLS-TNKLGNSIPETLGNLLKLHYLNLSN 327
L + + L L++L LS + LG + L L +
Sbjct: 231 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 35/171 (20%), Positives = 68/171 (39%), Gaps = 26/171 (15%)
Query: 523 IGIGGQGSVYKAK---------LTSGEILAVK-------KFHSLWPCEMVPQPEFVNEIK 566
QG +Y+A + ++K F+ + +P VN+ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 567 TLTELRHRSIVKFYGFCSH-PRNSFLVYEYLERGSLATILSNDGAIEEFNW-TVRMNVIR 624
L +I GF H + FLV L R SL + L + +V R
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPK-HVLSERSVLQVACR 167
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPD 673
+ +AL ++H + + VH +++++N+ + + +++V + +G A P
Sbjct: 168 LL-DALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 5e-07
Identities = 38/252 (15%), Positives = 69/252 (27%), Gaps = 54/252 (21%)
Query: 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWP-----CEMVPQPEFVNEIKT 567
T IG G G V++ +A+K P E + EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 568 LTEL---------RHRSIVKFYGFC----SHPRNSFLVYEYL--ERGSLATILSNDGA-- 610
EL R + S+P +++ +GS
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 611 ---IEEF---------------NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVL 652
+ EF + +++ + +L+ HRD+ NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194
Query: 653 LCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEK--CDVYSFGVLA 710
L ++ K + + G + YT+ E+ V+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST---------IPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 711 LEVIKGDHPRDF 722
++ GD F
Sbjct: 246 EDLFTGDGDYQF 257
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 27/155 (17%)
Query: 626 VANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGT 683
+ +AL ++H I++RD+ NVLL + +++DFG+ K + + T GT
Sbjct: 133 IISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGT 187
Query: 684 FGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739
YIAPE++ Y V D ++ GVL E++ G P F + N +
Sbjct: 188 PDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP--F------EAENEDDLFEA 235
Query: 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
IL+ + P + ++ I++ + ++P R
Sbjct: 236 ILNDEVVYPT-WLHEDATGILKS---FMTKNPTMR 266
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 44/328 (13%), Positives = 88/328 (26%), Gaps = 47/328 (14%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLS--ASIPPVIGN 123
L VG +L + +P + NL + S +P +
Sbjct: 232 ILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF 291
Query: 124 LKFLYHLDLSENQLSG-SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182
+ LDL L + NL VL + + K L L +
Sbjct: 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
+ G +S ++ L + + L ++ + + ++
Sbjct: 352 GADEQGMEDEEGLVSQRGLIALAQ------------GCQELEYMAVYVSDIT-------- 391
Query: 243 NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALG------SLTEL 296
S+ I + L ++L+ + +LP G +L
Sbjct: 392 -------------NESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438
Query: 297 EYLDLSTN--KLGNSIPETLGNLLK-LHYLNLSNNQFR-KGFPVELEKLIQLSELDLS-L 351
L + +G + ++ L +G L +L++
Sbjct: 439 RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC 498
Query: 352 NILEGKIPCEICNMESLEKLNLSHNNFS 379
E I + + SL L + S
Sbjct: 499 CFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 35/166 (21%), Positives = 60/166 (36%), Gaps = 32/166 (19%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ V IG G G +++ L + + +A+K P+ +E +T L +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 576 -IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA------- 627
I Y F ++ LV + L SL + + R +++VA
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGP-SLEDL---------LDLCGRKFSVKTVAMAAKQML 116
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR-----VSDFGIAK 668
+ +H V+RDI N L+ V DFG+ K
Sbjct: 117 ARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 30/164 (18%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ + IG G G +Y + +GE +A+K C P+ E K ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTKHPQLHIESKIYKMMQGGV 65
Query: 576 -IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA------- 627
I + + +V E L SL + FN+ R +++V
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGP-SLEDL---------FNFCSRKFSLKTVLLLADQMI 115
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEA---RVSDFGIAK 668
+ + Y+H F +HRD+ N L+ L + + DFG+AK
Sbjct: 116 SRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 39/222 (17%)
Query: 514 TNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVK------KFHSLWPCEMVPQPEFVNEIK 566
+ +++ IG G G V KA E +A+K F + Q + E++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--------QAQ--IEVR 102
Query: 567 TLTELRHR------SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRM 620
L + IV + LV+E L +L +L N F V +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN----FR-GVSL 156
Query: 621 NVIRSVA----NALSYMHHDCFPPIVHRDISSKNVLLCLDYEA--RVSDFGIAKFLKPDS 674
N+ R A AL ++ I+H D+ +N+LLC + ++ DFG +
Sbjct: 157 NLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LG 212
Query: 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG 716
+ + + Y +PE++ M D++S G + +E+ G
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 35/166 (21%), Positives = 60/166 (36%), Gaps = 32/166 (19%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F V IG G G + K L + E +A+K P+ E + +L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 576 -IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA------- 627
I + Y F + + +V E L SL + F+ R +++V
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGP-SLEDL---------FDLCDRTFSLKTVLMIAIQLI 115
Query: 628 NALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVS-----DFGIAK 668
+ + Y+H ++RD+ +N L+ DF +AK
Sbjct: 116 SRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 37/155 (23%), Positives = 69/155 (44%), Gaps = 27/155 (17%)
Query: 626 VANALSYMH-HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK-FLKPDSSNCTELVGT 683
+A L ++ I++RD+ NV+L + +++DFG+ K + + T GT
Sbjct: 130 IAIGLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGT 184
Query: 684 FGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739
YIAPE++ Y V D ++FGVL E++ G P F + +
Sbjct: 185 PDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP--F------EGEDEDELFQS 232
Query: 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
I++ + P ++ E ++I + + + P R
Sbjct: 233 IMEHNVAYPK-SMSKEAVAICK-GLMTKH--PGKR 263
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 56/243 (23%), Positives = 90/243 (37%), Gaps = 87/243 (35%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVN---------EIK 566
+++ +G G G V+K+ +GE++AVKK + F N EI
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKK---------IFDA-FQNSTDAQRTFREIM 60
Query: 567 TLTELR-HRSIVKFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
LTEL H +IV + +LV++Y+E T L VI
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-----TDLHA--------------VI 101
Query: 624 RSVANALSYMHHDCF-------------PPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670
R+ N L +H ++HRD+ N+LL + +V+DFG+++
Sbjct: 102 RA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 671 KPDSSNC---------------------TELVGTFGYIAPELV-----YTMKVTEKCDVY 704
T+ V T Y APE++ YT + D++
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMW 215
Query: 705 SFG 707
S G
Sbjct: 216 SLG 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 30/166 (18%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH 573
N F + IG G G +Y + + E +A+K P+ + E K L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKIYRILQG 61
Query: 574 RS-IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVA----- 627
+ I F + LV + L SL + FN+ R +++V
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDL---------FNFCSRKLSLKTVLMLADQ 111
Query: 628 --NALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR---VSDFGIAK 668
N + ++H F +HRDI N L+ L A + DFG+AK
Sbjct: 112 MINRVEFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 56/218 (25%)
Query: 527 GQGS---VYKAK-LTSGEILAVK------KFHSLWPCEMVPQPEFVNEIKTLTELRHR-- 574
G+GS V KA + +A+K +FH + EI+ L LR +
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR----------QAAEEIRILEHLRKQDK 155
Query: 575 ----SIVKFYG---FCSHPRNSFLVYEYLERGSLATIL---SNDGAIEEFNWTVRMNVIR 624
+++ F +H + +E L +L ++ G + ++R
Sbjct: 156 DNTMNVIHMLENFTFRNHI---CMTFELLSM-NLYELIKKNKFQG--------FSLPLVR 203
Query: 625 SVA----NALSYMHHDCFPPIVHRDISSKNVLLC--LDYEARVSDFGIAKFLKPDSSNCT 678
A L +H I+H D+ +N+LL +V DFG + + T
Sbjct: 204 KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYT 258
Query: 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG 716
+ F Y APE++ + D++S G + E++ G
Sbjct: 259 YIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 25/130 (19%), Positives = 42/130 (32%), Gaps = 19/130 (14%)
Query: 270 SSLNYLVLNGNQLYGN-----LPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK----L 320
L + LN AL + T ++ + + + + L +LK L
Sbjct: 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTL 95
Query: 321 HYLNLSNNQFRKGFPVELEKLIQ----LSELDLSLN--ILEGKIPCEICNM----ESLEK 370
LN+ +N + L + +Q L EL + L + EI NM +L K
Sbjct: 96 KSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLK 155
Query: 371 LNLSHNNFSG 380
Sbjct: 156 FGYHFTQQGP 165
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 25/148 (16%), Positives = 52/148 (35%), Gaps = 27/148 (18%)
Query: 254 DNQLSVGEIPIEIGKL----SSLNYLVLNGNQLYG-----NLPRALGSLTELEYLDLSTN 304
DN V I +L + L + +N + +L A + +E L+
Sbjct: 24 DNDTDVESC---INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANT 80
Query: 305 KLGNSIPETLGNLLK----LHYLNLSNNQFRKGFPVELEKLIQ----LSELDLS---LNI 353
+ +S L L++ L LN+ +N L + + E ++
Sbjct: 81 AISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSV 140
Query: 354 LEGKIPCEICNM----ESLEKLNLSHNN 377
L ++ ++ ESL ++ +S +
Sbjct: 141 LGNQVEMDMMMAIEENESLLRVGISFAS 168
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 784 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.98 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.37 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.04 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.07 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.51 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.09 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.37 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.12 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.77 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.36 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.31 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.96 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 83.8 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.68 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=529.18 Aligned_cols=337 Identities=38% Similarity=0.558 Sum_probs=264.0
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcC-ccCCCcCcEEeecCCCccc----------------
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPT-LGNLSNLAVLHLYGNSLSG---------------- 163 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~---------------- 163 (784)
++|++|+|++|.+++.+|..|+.+++|++|+|++|.+++.+|.. +..+++|++|+|++|.+++
T Consensus 294 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L 373 (768)
T 3rgz_A 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373 (768)
T ss_dssp TTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEE
T ss_pred CcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEE
Confidence 55666666666666677777777777777777777776555543 5555555555554444443
Q ss_pred -----------------------------------ccCCccccccccceeeccccccCCCccccccCccCCceeeccccc
Q 042086 164 -----------------------------------SIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENS 208 (784)
Q Consensus 164 -----------------------------------~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 208 (784)
.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|++++|.
T Consensus 374 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~ 453 (768)
T 3rgz_A 374 DLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453 (768)
T ss_dssp ECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred EccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCc
Confidence 344445555566666666666666666666666666666666666
Q ss_pred cCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCc
Q 042086 209 LFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR 288 (784)
Q Consensus 209 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~ 288 (784)
+++.+|..+..+++|++|++++|++++.+|..+..+++|++|+|++|+++ +.+|.++..+++|++|++++|++++.+|.
T Consensus 454 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 532 (768)
T 3rgz_A 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT-GEIPKWIGRLENLAILKLSNNSFSGNIPA 532 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCC-SCCCGGGGGCTTCCEEECCSSCCEEECCG
T ss_pred ccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccC-CcCChHHhcCCCCCEEECCCCcccCcCCH
Confidence 66667777777777777777777777777777777777888888887776 56777788888888888888888888888
Q ss_pred cccCCCccceeecccCccCCCCcccc------------------------------------------------------
Q 042086 289 ALGSLTELEYLDLSTNKLGNSIPETL------------------------------------------------------ 314 (784)
Q Consensus 289 ~l~~l~~L~~L~Ls~n~l~~~~~~~l------------------------------------------------------ 314 (784)
.+..+++|+.|++++|.+++.+|..+
T Consensus 533 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (768)
T 3rgz_A 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612 (768)
T ss_dssp GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCC
T ss_pred HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccc
Confidence 88888888888888888877666543
Q ss_pred ----------------cccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCcc
Q 042086 315 ----------------GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNF 378 (784)
Q Consensus 315 ----------------~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 378 (784)
..+++|+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|||++|++
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l 692 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc
Confidence 2356788999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccccCcccceEEEcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCCCCCCCCCCCC
Q 042086 379 SGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATF 440 (784)
Q Consensus 379 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~c~~~~ 440 (784)
+|.+|..+..+++|++||+++|+++|.+|....|..++..++.||+++||.|.. .|....
T Consensus 693 ~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~--~C~~~~ 752 (768)
T 3rgz_A 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP--RCDPSN 752 (768)
T ss_dssp EECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC--CCCSCC
T ss_pred cCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc--CCCCCc
Confidence 999999999999999999999999999999999999999999999999999853 786443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-53 Score=441.05 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=207.9
Q ss_pred cCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
..+++.+.||+|+||+||+|++. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 35677899999999999999863 57899999997542 33456789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 589 SFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
.++|||||++|+|.++++.... ...++|..+.+|+.|||+||+|||++ +||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 9999999999999999965421 23589999999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCC--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042086 656 DYEARVSDFGIAKFLKPDS--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSN 732 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~ 732 (784)
++.+||+|||+|+.+.... .......||++|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------ 254 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------ 254 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------
Confidence 9999999999998764332 22345679999999999999999999999999999999998 89999743321
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+......+..++ .++.+++.+||+.||++||||+||++.|
T Consensus 255 --~~~~~i~~~~~~~~p~~~~---~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 255 --DVVEMIRNRQVLPCPDDCP---AWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp --HHHHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHcCCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111222222222223333 3578899999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=441.62 Aligned_cols=253 Identities=25% Similarity=0.451 Sum_probs=206.8
Q ss_pred cCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
++|.+.+.||+|+||+||+|++. +++.||||+++.. +....++|.+|++++++++|||||+++|+|.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 46888999999999999999864 4788999999753 23346789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc
Q 042086 589 SFLVYEYLERGSLATILSNDG----------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE 658 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 658 (784)
.++|||||++|+|.++++..+ ....++|..+.+|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997643 234699999999999999999999999 9999999999999999999
Q ss_pred eEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 042086 659 ARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNI 735 (784)
Q Consensus 659 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 735 (784)
+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--------~ 238 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------E 238 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------H
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence 999999999876543322 233568999999999999999999999999999999999 89999743321 1
Q ss_pred ccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 736 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+...+ .++.+++.+||+.||++||||+||++.|
T Consensus 239 ~~~~i~~~~~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 239 VIECITQGRVLQRPRTCP---QEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp HHHHHHHTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111222222222223333 3578899999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=442.33 Aligned_cols=252 Identities=25% Similarity=0.455 Sum_probs=200.9
Q ss_pred cCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
++|.+.+.||+|+||+||+|+++ +++.||||+++.. +....++|.+|++++++++|||||+++|+|.+++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45778899999999999999864 4789999999753 23346789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC
Q 042086 589 SFLVYEYLERGSLATILSNDGA------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 656 (784)
.++|||||++|+|.++++.... ...++|..+.+|+.|||+||+|||++ +||||||||+|||++++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999976432 23589999999999999999999999 99999999999999999
Q ss_pred CceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 042086 657 YEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNR 733 (784)
Q Consensus 657 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~ 733 (784)
+.+||+|||+|+.+..... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------ 268 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------ 268 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999987654322 2345679999999999999999999999999999999999 899997433211
Q ss_pred ccccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 734 NISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 734 ~~~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+... ++..+ ...+ .++.+++.+||+.||++||||+||++.|
T Consensus 269 --~~~~i~~g~~~~~p-~~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 269 --AIDCITQGRELERP-RACP---PEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp --HHHHHHHTCCCCCC-TTCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred --HHHHHHcCCCCCCc-cccc---HHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 11112121 22222 2233 3578899999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=431.51 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=199.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.+++++.+.||+|+||+||+|++++ .||||+++.... +....++|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 4578899999999999999998753 699999875422 22345789999999999999999999999865 5689999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|||++|+|.++++... ..++|..+.+|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999997643 3689999999999999999999999 9999999999999999999999999999876532
Q ss_pred C--Cccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 674 S--SNCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 674 ~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
. ......+||+.|||||++.+ .+++.++|||||||++|||+||+.||........ ...........+.+...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVGRGYASPDLSKL 262 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHTTCCCCCSTTS
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCCcccc
Confidence 2 22345689999999999863 4689999999999999999999999974332110 00000011122222222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+... ..++.+++.+||+.||++||||+||++.|
T Consensus 263 ~~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 263 YKNC---PKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp CTTS---CHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred cccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2222 34678899999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=441.09 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=204.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ....+.|.+|++++++++|||||++++++.+++..|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999875 7999999999764322 223567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+. ..+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999975432 3578889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+.....+..+...
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~~~~~~- 249 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGSFPPVSLHY- 249 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCCCTTS-
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCCccC-
Confidence 3334556899999999999999999999999999999999999999974321 1112222332322222222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..++.+|+.+||+.||++|||++|+++
T Consensus 250 --s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 250 --SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 335788999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=434.97 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=210.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
..|++.+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+.+++.++|||||++++++.+++..||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG---GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46999999999999999999976 7999999999754 2334667899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++.. .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999999753 488999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||....... ....+.+.. ........
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~-~~~~~~~~ 294 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNL-PPRLKNLH 294 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSS-CCCCSCGG
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCC-CCCCCccc
Confidence 556677899999999999999999999999999999999999999996432211 011111111 11111122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....++.+|+.+||+.||++|||++|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23446889999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=426.88 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=209.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.........+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999875 79999999997543333445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997654 588899999999999999999999 9999999999999999999999999999987543
Q ss_pred C--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 S--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
. ......+||+.|||||++.+..++.++||||+||++|||+||+.||..... ......+.......+. .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~p~-~ 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLEYDFPE-K 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCT-T
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCc-c
Confidence 3 234567899999999999999999999999999999999999999963221 1111222222222221 2
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTV 780 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~v 780 (784)
. ..++.+|+.+||+.||++|||++|+
T Consensus 257 ~---s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 257 F---FPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp C---CHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred c---CHHHHHHHHHHccCCHhHCcChHHH
Confidence 2 2357889999999999999999885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=414.53 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=192.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.........+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999875 79999999997755444555678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+ +|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 679999997654 588899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||+.... ......+.......+ ...
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~~~p-~~~ 235 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVYTLP-KFL 235 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCC-TTS
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCC-CCC
Confidence 33455789999999999998876 5799999999999999999999973221 111112222222222 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.++.+++.+||+.||++|||++|+++
T Consensus 236 ---s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 ---SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 235778999999999999999999986
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=462.78 Aligned_cols=379 Identities=22% Similarity=0.282 Sum_probs=291.2
Q ss_pred hHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCccc---ceeEEcCCCCeEEEEeCCCcccC-----
Q 042086 3 GKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAW---FGIQCNPAKRVISINLSTVGLKG----- 74 (784)
Q Consensus 3 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C~w---~gv~C~~~~~v~~l~l~~~~~~~----- 74 (784)
.+|++||.+|++++..++ |.... +.+.....|. .+.|||.| .||+|+..+||+.+++.+.++.|
T Consensus 29 ~~d~~aL~~~~~~~~~~~------w~~~~-~~~~~~~~W~-~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~ 100 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKN------WSQQG-FGTQPGANWN-FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA 100 (636)
T ss_dssp HHHHHHHHHHHHHTTGGG------CCCCC-------CCCC-CSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGG
T ss_pred HHHHHHHHHHHHHcCCCC------cccCC-cCCccCCCCC-CCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChH
Confidence 369999999999996542 43110 0011111222 24789999 99999988999999999987754
Q ss_pred --CCCcccEEeCCCC-----------------------------------------------------------------
Q 042086 75 --NLKSLSTLDLSKN----------------------------------------------------------------- 87 (784)
Q Consensus 75 --~l~~l~~L~L~~n----------------------------------------------------------------- 87 (784)
+|++|++|+|++|
T Consensus 101 l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~ 180 (636)
T 4eco_A 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180 (636)
T ss_dssp GGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred HhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence 7899999999988
Q ss_pred -------------cccccCCCCcCCCCCCCEEEccCCccccc-----------------CCCCCC--CCCCCCEEEccCC
Q 042086 88 -------------KLNGSIPFSFGNLTNLAIMYLYRNSLSAS-----------------IPPVIG--NLKFLYHLDLSEN 135 (784)
Q Consensus 88 -------------~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~L~~n 135 (784)
+++| +|..|+++++|++|+|++|.+++. +|+.++ ++++|++|+|++|
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred cchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 4456 889999999999999999999986 999999 9999999999999
Q ss_pred ccCCCCCcCccCCCcCcEEeecCCC-ccc-ccCCccccc------cccceeeccccccCCCccc--cccCccCCceeecc
Q 042086 136 QLSGSIPPTLGNLSNLAVLHLYGNS-LSG-SIPSIIGNL------KSLFYLHLSSNQLSGSIPI--SLGNLSNLVVLHLF 205 (784)
Q Consensus 136 ~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~~~~l~~l------~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~ 205 (784)
.+.+.+|..++++++|++|+|++|+ +++ .+|..++++ ++|++|+|++|+++ .+|. .++++++|++|+++
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~ 338 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECL 338 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECC
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCc
Confidence 9999999999999999999999998 998 899888887 99999999999999 8888 89999999999999
Q ss_pred ccccCCccchhhhcccccceeccCCCccccccCCCCcCCCC-cceEEecCCCCCCCCccccccccc--ccceEeccCccc
Q 042086 206 ENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN-LIGLYLYDNQLSVGEIPIEIGKLS--SLNYLVLNGNQL 282 (784)
Q Consensus 206 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~n~l~~~~~~~~l~~l~--~L~~L~l~~n~l 282 (784)
+|++++.+| .+.++++|+.|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|++|++++|.+
T Consensus 339 ~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~--~lp~~~~~~~l~~L~~L~Ls~N~l 414 (636)
T 4eco_A 339 YNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK--YIPNIFDAKSVSVMSAIDFSYNEI 414 (636)
T ss_dssp SCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS--SCCSCCCTTCSSCEEEEECCSSCT
T ss_pred CCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc--ccchhhhhcccCccCEEECcCCcC
Confidence 999998888 8999999999999999999 78888999998 999999999987 6777766544 788888888888
Q ss_pred cCCCCcccc-------CCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcc-------cccCeec
Q 042086 283 YGNLPRALG-------SLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKL-------IQLSELD 348 (784)
Q Consensus 283 ~~~~~~~l~-------~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l-------~~L~~L~ 348 (784)
++..|..+. .+++|++|+|++|.++...+..+..+++|++|+|++|+++...+..+... ++|+.|+
T Consensus 415 ~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~ 494 (636)
T 4eco_A 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID 494 (636)
T ss_dssp TTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEE
T ss_pred CCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEE
Confidence 887777776 66677777777777774333334445666666666666653222222211 1555555
Q ss_pred cCCcccccccccccc--ccccccEEecCCCccCCCCcccccCcccceEEEc
Q 042086 349 LSLNILEGKIPCEIC--NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDV 397 (784)
Q Consensus 349 Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 397 (784)
|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 495 Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 495 LRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp CCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 5555555 4554444 55555555555555554 4555555555555555
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=435.78 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=210.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|+.++|||||+++++|.+++..||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST---TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 56999999999999999999976 7999999999754 2334677999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|||++|+|.++++.. .+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999999753 488899999999999999999999 9999999999999999999999999999988766
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... .......+.+... .
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-----~i~~~~~~~~~~~----~ 371 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-----MIRDNLPPRLKNL----H 371 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSCCCCCSCT----T
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-----HHHcCCCCCCccc----c
Confidence 566677899999999999999999999999999999999999999996432211000 0011111122211 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....++.+|+.+||+.||++|||++|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22335788999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=428.23 Aligned_cols=246 Identities=25% Similarity=0.266 Sum_probs=199.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|++.++||+|+||+||+|+.+ +|+.||||+++... .+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888899999999999999976 79999999997531 1247999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEeccccccccCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKFLKP 672 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~ 672 (784)
||+++|+|.++++..+ .+++..+..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+..
T Consensus 130 Ey~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999998654 588999999999999999999999 999999999999999997 699999999998754
Q ss_pred CCCc-----ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 673 DSSN-----CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 673 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
+... ....+||+.|||||++.+..++.++|||||||++|||+||+.||....... ....+.....+.
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~ 275 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LCLKIASEPPPI 275 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------CHHHHHHSCCGG
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHcCCCCc
Confidence 3221 234579999999999999999999999999999999999999997432211 111111111100
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+.....+.+++.+||+.||++|||+.|+++.
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00111223357889999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=415.20 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=196.8
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec----CCceEE
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH----PRNSFL 591 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 591 (784)
|++.+.||+|+||+||+|++. +++.||+|++..... .....+.|.+|++++++++|||||++++++.+ +...++
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 367788999999999999876 689999999875422 22235679999999999999999999999864 345799
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CCceEEecccccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKFL 670 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~ 670 (784)
|||||++|+|.++++..+ .+++..+..++.||+.||+|||++. ++||||||||+|||++. ++.+||+|||+|+..
T Consensus 107 vmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999997643 5888999999999999999999981 13999999999999984 799999999999864
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
.. ......+||+.|||||++.+ .++.++|||||||++|||+||+.||....... .....+.....+. .
T Consensus 183 ~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~~~~~~~--~ 250 (290)
T 3fpq_A 183 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKPA--S 250 (290)
T ss_dssp CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCCG--G
T ss_pred CC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHHcCCCCC--C
Confidence 32 33456789999999998865 69999999999999999999999996322110 0001111111110 0
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111235788999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=419.51 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=199.3
Q ss_pred cCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||+||+|+.. +++.||||+++..... ......+.+|++++++++|||||++++++.+++..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46999999999999999999863 5789999998754321 122446889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999998654 588899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
..........+||+.|||||++.+..++.++||||+||++|||+||+.||..... ......+.......+ .
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~p-~ 247 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILKAKLGMP-Q 247 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC-T
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHcCCCCCC-C
Confidence 5555555677899999999999999999999999999999999999999974221 111122222233222 2
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
.. +.++.+++.+||+.||++||| ++|+++
T Consensus 248 ~~---s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 248 FL---SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred cC---CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 22 235788999999999999998 467764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=418.18 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=196.5
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhH--HHHHHHHhccCCCceeeEEeEEecCC----c
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEF--VNEIKTLTELRHRSIVKFYGFCSHPR----N 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~~E~~~l~~l~h~niv~l~~~~~~~~----~ 588 (784)
.+|.+.+.||+|+||+||+|+++ |+.||||++... ..+++ ..|+..+.+++|||||+++|++.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 35778899999999999999984 899999998653 12333 44566667889999999999997654 5
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEeCCCCCCeeecCCCceEEec
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC-----FPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
.++|||||++|+|.++++.. .++|..+.+++.|+|+||+|||+++ .++||||||||+|||++.++.+||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 79999999999999999764 4899999999999999999999862 45899999999999999999999999
Q ss_pred cccccccCCCCCc----ccccccccccccccccccC------CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc----
Q 042086 664 FGIAKFLKPDSSN----CTELVGTFGYIAPELVYTM------KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---- 729 (784)
Q Consensus 664 fG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---- 729 (784)
||+|+........ ....+||+.|||||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 9999876543322 2345799999999999754 4678999999999999999998887543221100
Q ss_pred ---cccccccc----ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 730 ---SSNRNISL----NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 730 ---~~~~~~~~----~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+... ....++.++... ...+....+.+++.+||+.||++||||.||++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred ccccchHHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 00000011 111222222111 1224556788999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=428.11 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=209.5
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC-CceeeEE
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH-RSIVKFY 580 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~ 580 (784)
.+++...++|++.+.||+|+||+||+|++. .++.||||++.... .....++|.+|++++++++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 445556688999999999999999999864 24689999987642 22235679999999999965 8999999
Q ss_pred eEEecC-CceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC
Q 042086 581 GFCSHP-RNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDI 646 (784)
Q Consensus 581 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 646 (784)
|+|.++ +..++|||||++|+|.++++.... ...++|..+..++.|||+||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999764 568999999999999999975321 23589999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 042086 647 SSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFI 723 (784)
Q Consensus 647 k~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~ 723 (784)
||+|||+++++.+||+|||+|+.+..+... .....||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999976544332 345679999999999999999999999999999999998 99999743
Q ss_pred ccccccccccccccccccC-CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 724 SSISSSSSNRNISLNEILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.... .....+.+ .++..+ ...+ .++.+++.+||+.||++||||+||++.|
T Consensus 292 ~~~~-------~~~~~i~~g~~~~~p-~~~~---~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 292 KIDE-------EFCRRLKEGTRMRAP-DYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp CCSH-------HHHHHHHHTCCCCCC-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHH-------HHHHHHHcCCCCCCC-ccCC---HHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 2211 00111111 122222 2232 3578899999999999999999999864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=457.58 Aligned_cols=379 Identities=22% Similarity=0.293 Sum_probs=286.2
Q ss_pred hHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCC--ccc------------ceeEEcCCCCeEEEEeC
Q 042086 3 GKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISP--CAW------------FGIQCNPAKRVISINLS 68 (784)
Q Consensus 3 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~--C~w------------~gv~C~~~~~v~~l~l~ 68 (784)
.+|+.||++||+++. +| +|+... .| ...+| |.| .||+|+..+||+.++|.
T Consensus 268 ~~d~~ALl~~k~~l~-~~-----~W~~~~--------~~--~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls 331 (876)
T 4ecn_A 268 IKDYKALKAIWEALD-GK-----NWRYYS--------GT--INNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLA 331 (876)
T ss_dssp HHHHHHHHHHHHHTT-GG-----GCCCCC--------SS--CSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECT
T ss_pred hHHHHHHHHHHHHcC-CC-----CCCcCC--------Cc--ccccCCccccccccccccccCcCceEecCCCCEEEEECc
Confidence 479999999999995 44 796421 01 12345 999 99999988999999999
Q ss_pred CCccc-------CCCCcccEEeC-CCCccccc------------------------------------------------
Q 042086 69 TVGLK-------GNLKSLSTLDL-SKNKLNGS------------------------------------------------ 92 (784)
Q Consensus 69 ~~~~~-------~~l~~l~~L~L-~~n~i~~~------------------------------------------------ 92 (784)
+.++. ++|++|+.|+| ++|.++|.
T Consensus 332 ~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~ 411 (876)
T 4ecn_A 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN 411 (876)
T ss_dssp TTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTC
T ss_pred cCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhC
Confidence 98775 47889999999 77766554
Q ss_pred ----------------------------CCCCcCCCCCCCEEEccCCcccc-----------------cCCCCCC--CCC
Q 042086 93 ----------------------------IPFSFGNLTNLAIMYLYRNSLSA-----------------SIPPVIG--NLK 125 (784)
Q Consensus 93 ----------------------------~~~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~l~--~l~ 125 (784)
+|..|+++++|++|+|++|.|++ .+|+.++ +++
T Consensus 412 ~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~ 491 (876)
T 4ecn_A 412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLK 491 (876)
T ss_dssp TTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCT
T ss_pred ccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCC
Confidence 78889999999999999999998 4999988 999
Q ss_pred CCCEEEccCCccCCCCCcCccCCCcCcEEeecCCC-ccc-ccCCcccccc-------ccceeeccccccCCCccc--ccc
Q 042086 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS-LSG-SIPSIIGNLK-------SLFYLHLSSNQLSGSIPI--SLG 194 (784)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~~~~l~~l~-------~L~~L~L~~n~l~~~~~~--~~~ 194 (784)
+|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|.++ .+|. .++
T Consensus 492 ~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~ 570 (876)
T 4ecn_A 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQ 570 (876)
T ss_dssp TCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHT
T ss_pred CCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhh
Confidence 99999999999999999999999999999999998 998 7888777766 9999999999999 8888 899
Q ss_pred CccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCC-cceEEecCCCCCCCCcccccccccc--
Q 042086 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN-LIGLYLYDNQLSVGEIPIEIGKLSS-- 271 (784)
Q Consensus 195 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~n~l~~~~~~~~l~~l~~-- 271 (784)
++++|+.|+|++|+++ .+| .|+++++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..++.
T Consensus 571 ~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~--~lp~~~~~~~~~~ 645 (876)
T 4ecn_A 571 KMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK--YIPNIFNAKSVYV 645 (876)
T ss_dssp TCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC--SCCSCCCTTCSSC
T ss_pred cCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC--cCchhhhccccCC
Confidence 9999999999999998 777 8999999999999999999 78888999998 999999999987 67777666543
Q ss_pred cceEeccCccccCCCCccc---c--CCCccceeecccCccCCCCcccc-cccccceEEecccccccCCCchhhhc-----
Q 042086 272 LNYLVLNGNQLYGNLPRAL---G--SLTELEYLDLSTNKLGNSIPETL-GNLLKLHYLNLSNNQFRKGFPVELEK----- 340 (784)
Q Consensus 272 L~~L~l~~n~l~~~~~~~l---~--~l~~L~~L~Ls~n~l~~~~~~~l-~~l~~L~~L~ls~N~l~~~~~~~~~~----- 340 (784)
|+.|++++|++.+.+|... . .+++|+.|+|++|.++ .+|..+ ..+++|+.|+|++|+++. +|..+..
T Consensus 646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~-ip~~~~~~~~~~ 723 (876)
T 4ecn_A 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGN 723 (876)
T ss_dssp EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSC-CCTTSSSCTTSC
T ss_pred CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCc-cChHHhcccccc
Confidence 8888888888876554322 1 2235666666666665 333332 355555555555555553 3322211
Q ss_pred ---ccccCeeccCCcccccccccccc--ccccccEEecCCCccCCCCcccccCcccceEEEcCC------CCCcccCC
Q 042086 341 ---LIQLSELDLSLNILEGKIPCEIC--NMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSY------NELRGPIP 407 (784)
Q Consensus 341 ---l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~------N~l~~~~p 407 (784)
+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|
T Consensus 724 l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip 799 (876)
T 4ecn_A 724 YKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799 (876)
T ss_dssp CTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCC
T ss_pred ccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccCh
Confidence 225555555555555 4555554 55555555555555555 355555555555555544 44444444
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=410.34 Aligned_cols=250 Identities=23% Similarity=0.418 Sum_probs=193.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC------
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR------ 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 587 (784)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 35899999999999999999976 79999999986532 2223567999999999999999999999986544
Q ss_pred ------ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 588 ------NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 588 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
..|+||||+++|+|.++++......+.++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 3689999999999999998877666777888899999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCc------------ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 042086 662 SDFGIAKFLKPDSSN------------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS 729 (784)
Q Consensus 662 ~DfG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~ 729 (784)
+|||+|+.+...... .+..+||+.|||||++.+..++.++|||||||++|||++ ||.....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---- 232 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---- 232 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence 999999877543221 234579999999999999999999999999999999996 7652111
Q ss_pred ccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.+...+ ....+......+++.+||+.||++|||+.|+++
T Consensus 233 ---~~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 ---RVRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111111111211 112233345678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=399.90 Aligned_cols=260 Identities=20% Similarity=0.314 Sum_probs=199.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec------CC
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH------PR 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 587 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999975 7999999999764321 2234578899999999999999999998753 35
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 68999997653 588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC----CCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc
Q 042086 668 KFLKPD----SSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNI 735 (784)
Q Consensus 668 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~ 735 (784)
+.+... .......+||+.|||||++.+.. ++.++||||+||++|||++|+.||......... ......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876432 22345678999999999988754 689999999999999999999999643211000 000000
Q ss_pred --------ccccccCCCCCCCCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 --------SLNEILDPRLPTPPQNV----QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 --------~~~~~~d~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.......+... +....++.+|+.+||+.||++|||++|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000000000 011235789999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=386.30 Aligned_cols=198 Identities=25% Similarity=0.327 Sum_probs=171.4
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
+....+.|++.+.||+|+||+||+|+.+ +++.||+|++... ....++.+|+++++.+ +|||||++++++.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 3345678999999999999999999753 4789999998653 2356788999999998 6999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEec
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSD 663 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~D 663 (784)
+.+..++||||+++|+|.++++ .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 9999999999999999999984 378899999999999999999999 99999999999999877 7999999
Q ss_pred cccccccCCCCC----------------------------cccccccccccccccccccCC-cCcchhHHHHHHHHHHHH
Q 042086 664 FGIAKFLKPDSS----------------------------NCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVI 714 (784)
Q Consensus 664 fG~a~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~ell 714 (784)
||+|+....... .....+||+.|+|||++.+.. ++.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999986543211 123457999999999998764 889999999999999999
Q ss_pred hCCCCCC
Q 042086 715 KGDHPRD 721 (784)
Q Consensus 715 tg~~p~~ 721 (784)
||+.||.
T Consensus 242 ~G~~Pf~ 248 (361)
T 4f9c_A 242 SGRYPFY 248 (361)
T ss_dssp HTCSSSS
T ss_pred HCCCCCC
Confidence 9999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=411.14 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=207.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|+.+|+.++|||||++++++.+++..++||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999876 79999999986532 223567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC--CceEEeccccccccC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD--YEARVSDFGIAKFLK 671 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfG~a~~~~ 671 (784)
|||++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 234 E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 234 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp ECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred eecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999996542 3588999999999999999999999 99999999999999865 899999999999876
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
.. ......+||+.|||||++.+..++.++||||+||++|||++|+.||...... .....+.......+...
T Consensus 309 ~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~ 379 (573)
T 3uto_A 309 PK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWNMDDSA 379 (573)
T ss_dssp TT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCCCCCSGG
T ss_pred CC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCCCCCCccc
Confidence 43 3345678999999999999999999999999999999999999999743221 11112222221111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......++.+|+.+||+.||++|||++|+++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346788999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=409.81 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=200.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHH---HHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNE---IKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+...........+.+| +.+++.++|||||+++++|++++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56999999999999999999876 799999999865322222233344444 56677789999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||++||+|.+++...+ .+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999998654 588899999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||....... .......+.......+
T Consensus 343 ~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~~~~~~p- 414 (689)
T 3v5w_A 343 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVELP- 414 (689)
T ss_dssp SSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHHCCCCCC-
T ss_pred CCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcCCCCCCC-
Confidence 5432 345689999999999974 579999999999999999999999996322110 0011111222222222
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
.. .+.++.+|+.+||+.||++|++ ++||.+
T Consensus 415 ~~---~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TT---SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cc---CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 22 2335788999999999999998 677754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=422.56 Aligned_cols=281 Identities=39% Similarity=0.572 Sum_probs=206.8
Q ss_pred CCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCC-CCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNL-KFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 76 l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
+++|++|+|++|++++.+|.. .+++|++|+|++|.+++.+|..+..+ ++|++|+|++|.+++.+|..|+.+++|++|
T Consensus 246 l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 323 (768)
T 3rgz_A 246 CTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323 (768)
T ss_dssp CSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEE
Confidence 467999999999999988876 89999999999999999999998875 999999999999999999999999999999
Q ss_pred eecCCCcccccCCc-cccccccceeeccccccCCCccccccC---------------------------ccCCceeeccc
Q 042086 155 HLYGNSLSGSIPSI-IGNLKSLFYLHLSSNQLSGSIPISLGN---------------------------LSNLVVLHLFE 206 (784)
Q Consensus 155 ~L~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~---------------------------l~~L~~L~L~~ 206 (784)
+|++|.+++.+|.. +.++++|++|+|++|.+++.+|..+.. +++|+.|++++
T Consensus 324 ~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~ 403 (768)
T 3rgz_A 324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403 (768)
T ss_dssp ECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCS
T ss_pred ECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCC
Confidence 99999999888865 788888888888888777665554432 33455555566
Q ss_pred cccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCC
Q 042086 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286 (784)
Q Consensus 207 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 286 (784)
|++++.+|..+.++++|+.|+|++|++++.+|..+..+++|+.|++++|+++ +.+|..+..+++|++|++++|++++.+
T Consensus 404 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~ 482 (768)
T 3rgz_A 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE-GEIPQELMYVKTLETLILDFNDLTGEI 482 (768)
T ss_dssp SEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCC-SCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred CccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCccc-CcCCHHHcCCCCceEEEecCCcccCcC
Confidence 6665566777777777777777777777666766777777777777776665 455555666666666666666666666
Q ss_pred CccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccc
Q 042086 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP 359 (784)
Q Consensus 287 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 359 (784)
|..+..+++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|
T Consensus 483 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip 555 (768)
T 3rgz_A 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred CHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence 6666666666666666666666666666666666666666666665555555555555555555555544444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=373.58 Aligned_cols=278 Identities=33% Similarity=0.606 Sum_probs=228.6
Q ss_pred ccccHHHHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeE
Q 042086 503 GKILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582 (784)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 582 (784)
..+.+.++....++|++.+.||+|+||.||+|+..+++.||||++..... ......+.+|+++++.++||||++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34567889999999999999999999999999988899999999876432 2234479999999999999999999999
Q ss_pred EecCCceEEEEecccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 583 CSHPRNSFLVYEYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 583 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
+.+++..++||||+++|+|.++++.... ...+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999986543 345899999999999999999999987779999999999999999999999
Q ss_pred eccccccccCCCCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------cc
Q 042086 662 SDFGIAKFLKPDSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---------SS 731 (784)
Q Consensus 662 ~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---------~~ 731 (784)
+|||+++........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||+........ ..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999876543322 34456999999999999889999999999999999999999999632211100 11
Q ss_pred ccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 732 NRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 732 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
........+.+..... ....+....+.+++.+||+.||++|||++||++.|
T Consensus 256 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 256 LKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp TSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 1222233344444332 34467778899999999999999999999999875
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=388.51 Aligned_cols=333 Identities=24% Similarity=0.226 Sum_probs=285.7
Q ss_pred CCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccC-CCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASI-PPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 76 l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
.++|++|+|++|+|++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|.+++..|..|+++++|++|
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence 368999999999999998999999999999999999997554 5689999999999999999998889999999999999
Q ss_pred eecCCCcccccCCc--cccccccceeeccccccCCCcccc-ccCccCCceeeccccccCCccchhhhcc--cccceeccC
Q 042086 155 HLYGNSLSGSIPSI--IGNLKSLFYLHLSSNQLSGSIPIS-LGNLSNLVVLHLFENSLFGSIPSILGNL--KMLLHLGLS 229 (784)
Q Consensus 155 ~L~~n~l~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~ 229 (784)
+|++|.+++..+.. |.++++|++|+|++|.+++..|.. +.++++|++|++++|++++..+..+..+ .+|+.|+++
T Consensus 109 ~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~ 188 (455)
T 3v47_A 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188 (455)
T ss_dssp ECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECT
T ss_pred eCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccc
Confidence 99999998755544 889999999999999999877776 8899999999999999998888888776 567777777
Q ss_pred CCccccccCCC--------CcCCCCcceEEecCCCCCCCCccccc-----------------------------------
Q 042086 230 TNHLSGVIPLS--------IGNLNNLIGLYLYDNQLSVGEIPIEI----------------------------------- 266 (784)
Q Consensus 230 ~n~l~~~~~~~--------l~~l~~L~~L~L~~n~l~~~~~~~~l----------------------------------- 266 (784)
+|.+.+..+.. +..+++|++|++++|+++ +..|..+
T Consensus 189 ~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~ 267 (455)
T 3v47_A 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267 (455)
T ss_dssp TCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCC-HHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTT
T ss_pred cCcccccchhhccccccccccccceeeeEecCCCccc-ccchhhhhccccccceeeEeeccccccccccchhhhccCccc
Confidence 77777554433 234567777777777664 1111111
Q ss_pred --c--cccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhccc
Q 042086 267 --G--KLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLI 342 (784)
Q Consensus 267 --~--~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~ 342 (784)
. ..++|+.|++++|.+++..|..+..+++|++|++++|.+++..|..|.++++|++|+|++|++++..+..+..++
T Consensus 268 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (455)
T 3v47_A 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347 (455)
T ss_dssp TTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT
T ss_pred ccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc
Confidence 1 125899999999999988899999999999999999999988888999999999999999999988889999999
Q ss_pred ccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC
Q 042086 343 QLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409 (784)
Q Consensus 343 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 409 (784)
+|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|+++|.+|..
T Consensus 348 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred cCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 9999999999999888999999999999999999999988888899999999999999999999853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.33 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=208.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG---GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc---cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 468999999999999999999864 7999999998654 233467799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999999764 478899999999999999999999 999999999999999999999999999988776
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ......+.... .
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~----~ 239 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-----IATNGTPELQN----P 239 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHHCSCCCSC----G
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhCCCCCCCC----c
Confidence 55555667899999999999999999999999999999999999999964322110000 00000111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 122345788999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=369.47 Aligned_cols=268 Identities=35% Similarity=0.532 Sum_probs=219.7
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
++...+++|++.+.||+|+||.||+|+.++++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 344467899999999999999999999888999999988754 23346789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
.++||||+++|+|.+++..... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999875432 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccccc
Q 042086 668 KFLKPDS--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNISLN 738 (784)
Q Consensus 668 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~~~ 738 (784)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ........
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8754322 22344568999999999998899999999999999999999999986432211000 00112223
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.++++.... ....+....+.+++.+||+.||++|||++||++.|
T Consensus 267 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 267 QIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 344444332 23457778899999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.90 Aligned_cols=258 Identities=31% Similarity=0.469 Sum_probs=199.9
Q ss_pred HHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
...++|++.+.||+|+||+||+|+. +|+.||||++..... .....++|.+|++++++++||||+++++++.+.+..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3456899999999999999999987 488999999876422 22234678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP--IVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
||||+++|+|.+++...+....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999998765444589999999999999999999998 8 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
............||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ......+...+
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~- 261 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA------VGFKCKRLEIP- 261 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------HHHSCCCCCCC-
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcCCCCCCC-
Confidence 65444444567899999999999999999999999999999999999999974322110000 00011111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
... ...+.+++.+||+.||++|||++++++.|
T Consensus 262 ~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 262 RNL---NPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 122 23578899999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.48 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=213.9
Q ss_pred ccccHHHHHHHhcC----------CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc
Q 042086 503 GKILYEEIVRATNG----------FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL 571 (784)
Q Consensus 503 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l 571 (784)
+.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR---KQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT---TCCSHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc---chhHHHHHHHHHHHHHhC
Confidence 45667777776654 777889999999999999987 7999999998753 233467899999999999
Q ss_pred CCCceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 572 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+||||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 9999999999999999999999999999999998643 588999999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSS 731 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~ 731 (784)
+++.++.+||+|||++..............||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-- 250 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-- 250 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 999999999999999988765544456678999999999999999999999999999999999999998643221100
Q ss_pred ccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 732 NRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 732 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+.... .......+.+++.+||+.||++|||++|+++
T Consensus 251 ---~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 ---KRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000111111111 1122345788999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=366.21 Aligned_cols=250 Identities=23% Similarity=0.271 Sum_probs=208.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999876 79999999987543223345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999997643 578899999999999999999999 9999999999999999999999999999875544
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+ ...
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p-~~~- 228 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFP-RTL- 228 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC-TTS-
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCC-CCC-
Confidence 4555667899999999999999999999999999999999999999863221 111111222222222 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
..++.+++.+||+.||++|| +++|+++
T Consensus 229 --s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 229 --SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 23578899999999999999 8999875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=395.99 Aligned_cols=368 Identities=25% Similarity=0.198 Sum_probs=267.3
Q ss_pred CCeEEEEeCCCcc-------cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEc
Q 042086 60 KRVISINLSTVGL-------KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132 (784)
Q Consensus 60 ~~v~~l~l~~~~~-------~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 132 (784)
.+++.+++....+ .+++++|++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 3577777777543 346778888888888888888888888888888888888888877888888888888888
Q ss_pred cCCccCCCCCcCccCCCcCcEEeecCCCccc-ccCCccccccccceeeccccccCCCccccccCccCCc----eeecccc
Q 042086 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSG-SIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLV----VLHLFEN 207 (784)
Q Consensus 133 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~n 207 (784)
++|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|+|++|.+++..|..++.+.+|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 8888887776778888888888888888875 4677888888888888888887765554443333222 2222222
Q ss_pred ccCCccch------------------------------------------------------------------------
Q 042086 208 SLFGSIPS------------------------------------------------------------------------ 215 (784)
Q Consensus 208 ~l~~~~~~------------------------------------------------------------------------ 215 (784)
.+++..+.
T Consensus 192 ~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 271 (606)
T 3vq2_A 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271 (606)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCC
T ss_pred CcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccc
Confidence 22211111
Q ss_pred -------------------------------------------------------------------------hhhcccc
Q 042086 216 -------------------------------------------------------------------------ILGNLKM 222 (784)
Q Consensus 216 -------------------------------------------------------------------------~l~~l~~ 222 (784)
.+..+++
T Consensus 272 ~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~ 351 (606)
T 3vq2_A 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPS 351 (606)
T ss_dssp TTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTT
T ss_pred ccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCC
Confidence 1122334
Q ss_pred cceeccCCCccccc--cCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCC-ccccCCCcccee
Q 042086 223 LLHLGLSTNHLSGV--IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP-RALGSLTELEYL 299 (784)
Q Consensus 223 L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L 299 (784)
|++|++++|++++. .+..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++.+..| ..+..+++|++|
T Consensus 352 L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 429 (606)
T 3vq2_A 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI--IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429 (606)
T ss_dssp CCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE--EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred CCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc--cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence 44455555555433 2445555666666666666654 455667777888888888888877766 577888888888
Q ss_pred ecccCccCCCCcccccccccceEEecccccccC-CCchhhhcccccCeeccCCccccccccccccccccccEEecCCCcc
Q 042086 300 DLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRK-GFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNF 378 (784)
Q Consensus 300 ~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 378 (784)
++++|.+++..|..+.++++|++|++++|++++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++
T Consensus 430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 509 (606)
T 3vq2_A 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509 (606)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence 888888888888888888888888888888887 4677888888888888888888888888888888889999999988
Q ss_pred CCCCcccccCcccceEEEcCCCCCcccCCCC-CCCc-CCCcccccCCCCCCCCC
Q 042086 379 SGLIPSCFEGMHGLSCIDVSYNELRGPIPNS-RIFQ-YDPMEALQGNKGLCGDI 430 (784)
Q Consensus 379 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~-~~~~~~~~~n~~~c~~~ 430 (784)
++.+|..+..+++|+.|++++|+++. +|.. ..+. ......+.+|++.|+-+
T Consensus 510 ~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 510 LFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp SCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCc
Confidence 88888888888889999999988884 5553 1121 23445678888887643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=365.10 Aligned_cols=293 Identities=32% Similarity=0.482 Sum_probs=220.2
Q ss_pred chHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCcc--cceeEEcCCCCeEEEEeCCCcccCCCCcc
Q 042086 2 AGKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCA--WFGIQCNPAKRVISINLSTVGLKGNLKSL 79 (784)
Q Consensus 2 ~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C~--w~gv~C~~~~~v~~l~l~~~~~~~~l~~l 79 (784)
.++|+.||++||+++. +|. .+++|.. +.|||. |.||+|+... ...++
T Consensus 4 ~~~~~~aL~~~k~~~~-~~~-~l~~W~~---------------~~~~C~~~w~gv~C~~~~--------------~~~~l 52 (313)
T 1ogq_A 4 NPQDKQALLQIKKDLG-NPT-TLSSWLP---------------TTDCCNRTWLGVLCDTDT--------------QTYRV 52 (313)
T ss_dssp CHHHHHHHHHHHHHTT-CCG-GGTTCCT---------------TSCTTTTCSTTEEECCSS--------------SCCCE
T ss_pred CHHHHHHHHHHHHhcC-Ccc-cccCCCC---------------CCCCCcCCCcceEeCCCC--------------CCceE
Confidence 3689999999999995 564 7999963 357998 9999998531 01245
Q ss_pred cEEeCCCCcccc--cCCCCcCCCCCCCEEEccC-CcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 80 STLDLSKNKLNG--SIPFSFGNLTNLAIMYLYR-NSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 80 ~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
+.|+|++|++++ .+|..|.++++|++|+|++ |.+++.+|..|+++++|++|+|++|.+++.+|..+..+++|++|+|
T Consensus 53 ~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 132 (313)
T 1ogq_A 53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132 (313)
T ss_dssp EEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEEC
T ss_pred EEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeC
Confidence 667788888888 7888888888888888884 8888888888888888888888888888888888888888888888
Q ss_pred cCCCcccccCCccccccccceeeccccccCCCccccccCcc-CCceeeccccccCCccchhhhcccccceeccCCCcccc
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLS-NLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG 235 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 235 (784)
++|.+++.+|..|.++++|++|+|++|.+++.+|..+..++ +|++|+|++|++++.+|..+..++ |+.|++++|++++
T Consensus 133 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~ 211 (313)
T 1ogq_A 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211 (313)
T ss_dssp CSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE
T ss_pred CCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC
Confidence 88888888888888888888888888888877787777776 788888888887777777777776 7777777777776
Q ss_pred ccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccccc
Q 042086 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLG 315 (784)
Q Consensus 236 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~ 315 (784)
..|..|..+++|+.|+|++ |.+++..|. +..+++|++|+|++|.+++.+|..+.
T Consensus 212 ~~~~~~~~l~~L~~L~L~~-------------------------N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~ 265 (313)
T 1ogq_A 212 DASVLFGSDKNTQKIHLAK-------------------------NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp CCGGGCCTTSCCSEEECCS-------------------------SEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred cCCHHHhcCCCCCEEECCC-------------------------CceeeecCc-ccccCCCCEEECcCCcccCcCChHHh
Confidence 6665555555555555544 444443333 55566677777777777666677777
Q ss_pred ccccceEEecccccccCCCchhhhcccccCeeccCCcc
Q 042086 316 NLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNI 353 (784)
Q Consensus 316 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 353 (784)
.+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 266 ~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 266 QLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 7777777777777777666654 667777777777776
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=364.96 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=206.3
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 35799999999999999999997 4899999999875422 222356788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997653 478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccccccccCCcC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
. ......+||+.|+|||.+.+..++ .++||||+||++|||++|+.||+..... .....+.......+. .
T Consensus 167 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~p~-~ 236 (328)
T 3fe3_A 167 G-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERVLRGKYRIPF-Y 236 (328)
T ss_dssp S-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT-T
T ss_pred C-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC-C
Confidence 3 334567899999999999888775 7899999999999999999999743211 111122222222221 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ...+.+++.+||+.||++|||++|+++
T Consensus 237 ~---s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 237 M---STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp S---CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred C---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 235778999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=367.71 Aligned_cols=254 Identities=19% Similarity=0.267 Sum_probs=207.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC---CChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM---VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+.|++.+.||+|+||.||+|+.. +|+.||+|.+........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 699999999876433221 2357899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC----ceEEeccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY----EARVSDFG 665 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG 665 (784)
++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999997543 588999999999999999999999 999999999999998877 79999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
++..+... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||..... ......+.....
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITAVSY 235 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCC
T ss_pred CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC
Confidence 99876543 233556799999999999998999999999999999999999999963221 111111222221
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+..........+.+++.+||..||++|||+.|+++
T Consensus 236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111101112345789999999999999999999986
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=404.60 Aligned_cols=374 Identities=26% Similarity=0.261 Sum_probs=200.0
Q ss_pred cccceeEEcCCCCeEEEEeCCCcc-------cCCCCcccEEeCCCCcccccC-CCCcCCCCCCCEEEccCCcccccCCCC
Q 042086 49 CAWFGIQCNPAKRVISINLSTVGL-------KGNLKSLSTLDLSKNKLNGSI-PFSFGNLTNLAIMYLYRNSLSASIPPV 120 (784)
Q Consensus 49 C~w~gv~C~~~~~v~~l~l~~~~~-------~~~l~~l~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p~~ 120 (784)
|.|..|.+ -..+++.++++...+ .+++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|+.
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 55666665 334566666665432 235566666666666544444 556666666666666666666666666
Q ss_pred CCCCCCCCEEEccCCccCCCCCcC--ccCCCcCcEEeecCCCcccccC-CccccccccceeeccccccCCCccccccCc-
Q 042086 121 IGNLKFLYHLDLSENQLSGSIPPT--LGNLSNLAVLHLYGNSLSGSIP-SIIGNLKSLFYLHLSSNQLSGSIPISLGNL- 196 (784)
Q Consensus 121 l~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l- 196 (784)
|+++++|++|+|++|.+++.+|.. +.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 666666666666666666554443 6666666666666666665443 356666666666666666554433332221
Q ss_pred -------------------------cC------Cceeecccc--------------------------------------
Q 042086 197 -------------------------SN------LVVLHLFEN-------------------------------------- 207 (784)
Q Consensus 197 -------------------------~~------L~~L~L~~n-------------------------------------- 207 (784)
++ |+.|++++|
T Consensus 173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence 11 444444444
Q ss_pred ------------------------ccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcc
Q 042086 208 ------------------------SLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIP 263 (784)
Q Consensus 208 ------------------------~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 263 (784)
.+.+..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|+++ ...+
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~ 331 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYS 331 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCS-CCCS
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCC-ccCH
Confidence 333333334444445555555555555444445555555555555555544 2223
Q ss_pred cccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCC------------------c--------------
Q 042086 264 IEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI------------------P-------------- 311 (784)
Q Consensus 264 ~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~------------------~-------------- 311 (784)
..+..+++|+.|++++|.+.+..+..|..+++|+.|+|++|.+++.. |
T Consensus 332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N 411 (844)
T 3j0a_A 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSEN 411 (844)
T ss_dssp CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSC
T ss_pred HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccC
Confidence 44555555555555555555444444555555555555555444210 0
Q ss_pred --------ccccccccceEEecccccccCCC------------------------------chhhhcccccCeeccCCcc
Q 042086 312 --------ETLGNLLKLHYLNLSNNQFRKGF------------------------------PVELEKLIQLSELDLSLNI 353 (784)
Q Consensus 312 --------~~l~~l~~L~~L~ls~N~l~~~~------------------------------~~~~~~l~~L~~L~Ls~N~ 353 (784)
..+.++++|+.|+|++|++++.. +..+..+++|+.|+|++|+
T Consensus 412 ~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 491 (844)
T 3j0a_A 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491 (844)
T ss_dssp CCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHH
T ss_pred ccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCc
Confidence 00123344444444444443211 1224444555555555555
Q ss_pred ccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCCCCCcCCCcccccCCCCCCC
Q 042086 354 LEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCG 428 (784)
Q Consensus 354 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 428 (784)
+++..|..|..+++|+.|+|++|++++.+|..+. ++|+.|+|++|++++..|. .+.......+.+||+.|.
T Consensus 492 l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 492 LNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICE 562 (844)
T ss_dssp HTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCS
T ss_pred ccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcccc
Confidence 5555555555555555555555555555544444 4555555555555555553 244556667889999994
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=360.44 Aligned_cols=253 Identities=25% Similarity=0.461 Sum_probs=204.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.|.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 57899999999999999999976 6899999988543 2334678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp ECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999998643 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcc--------------cccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 674 SSNC--------------TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 674 ~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
.... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+......... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---~~~~~~~ 238 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---FGLNVRG 238 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---SSBCHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---Hhhhhhc
Confidence 2211 1457999999999999999999999999999999999999998643221100 0001111
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 740 ~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+...+. .. ...+.+++.+||+.||++|||+.++++.|
T Consensus 239 ~~~~~~~~---~~---~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 239 FLDRYCPP---NC---PPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp HHHHTCCT---TC---CTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccccCCC---CC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11111111 11 12477899999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=370.85 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=207.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++.........+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999999999999976 6889999999875444444566789999999887 89999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999997643 588899999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-ccccccccccCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSS-NRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~d~~~~~~~~ 750 (784)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||+.......... ........+.......+..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 444556677899999999999999999999999999999999999999964322111000 0111112222233322222
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPM------HTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~~vl~ 782 (784)
...++.+++.+||+.||++||++ +|+++
T Consensus 285 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 285 ----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 22357889999999999999985 56654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=365.73 Aligned_cols=251 Identities=21% Similarity=0.258 Sum_probs=206.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 468999999999999999999876 6899999998642 22356789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC--CCceEEecccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL--DYEARVSDFGIAKFL 670 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~ 670 (784)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++.+
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999997543 3588999999999999999999999 9999999999999987 789999999999887
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
... .......||+.|+|||.+.+..++.++|||||||++|||++|..||..... ......+.......+..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~ 225 (321)
T 1tki_A 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHH
T ss_pred CCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCCCChh
Confidence 543 334556799999999999988899999999999999999999999963221 11111222222211111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......++.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122346889999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.07 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=206.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
.++|++.+.||+|+||.||+|+.. ++..||||+++... .....+++.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 467999999999999999999852 45679999987542 222356799999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+.+..++||||+++|+|.+++..... ...+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 99999999999999999999976432 23578999999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++.+..... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-- 312 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 312 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 999999999999999987654332 2234467889999999999999999999999999999999 99998743211
Q ss_pred cccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+........+... ..++.+++.+||+.||++|||+.|+++.|
T Consensus 313 ------~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 313 ------ELFKLLKEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp ------GHHHHHHTTCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------HHHHHHhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111111111111111222 23588899999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.35 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=203.8
Q ss_pred cCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999997 478999999986532222334567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+ +|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 679999887543 588899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
......+||+.|+|||.+.+..+ ++++|||||||++|||++|+.||+..... .....+.......+ ...
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~~~~~p-~~~ 231 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP--------NLFKKVNSCVYVMP-DFL 231 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST--------TCBCCCCSSCCCCC-TTS
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCc-ccC
Confidence 23345679999999999988776 67999999999999999999999742211 11111111111111 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+||+.||++|||++|+++
T Consensus 232 ---s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 232 ---SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 235778999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=369.13 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=202.9
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 590 (784)
..++|++.+.||+|+||.||+|+.+ +++.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999876 6899999998754222333466788999999988 7999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999997643 588899999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~ 246 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEVVYPTW 246 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence 5444555667899999999999988899999999999999999999999964321 11122222233322221
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPM------HTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~~vl~ 782 (784)
. ...+.+++.+|++.||++||++ +|+++
T Consensus 247 -~---~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 -L---HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -S---CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -C---CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 2 2357789999999999999998 67764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=353.41 Aligned_cols=274 Identities=31% Similarity=0.519 Sum_probs=222.3
Q ss_pred ccccHHHHHHHhcCCCCc------eeEecccceEEEEEEEcCCCEEEEEEcCCCCCC-CCCChhhHHHHHHHHhccCCCc
Q 042086 503 GKILYEEIVRATNGFDVK------YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPC-EMVPQPEFVNEIKTLTELRHRS 575 (784)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 575 (784)
..+.+.++..+++.|... +.||+|+||.||+|.. +++.||||++...... .....+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 456788999999998877 8999999999999987 5889999998764322 2234567999999999999999
Q ss_pred eeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 576 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
|+++++++.+.+..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997554445689999999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc---
Q 042086 656 DYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--- 730 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--- 730 (784)
++.+||+|||++......... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||+.........
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543222 234578999999998865 47899999999999999999999997533211000
Q ss_pred ---cccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 731 ---SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 731 ---~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
........+.+++.+. .........+.+++.+||+.||++|||+++|++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN---DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS---CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHhhhhhhhhhhhcccccc---ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0011112233333332 23456677899999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.74 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=206.7
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|+..+++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT----SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc----ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3578999999999999999999988999999999763 234578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999997643 3588999999999999999999999 9999999999999999999999999999876432
Q ss_pred C-CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 S-SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||+...... ....+........+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 231 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPRL 231 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCTT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhcCccCCCCCc
Confidence 2 11233456788999999998999999999999999999999 999987432211 1111111111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ...+.+++.+||+.||++|||++++++.|
T Consensus 232 ~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 232 A---STHVYQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C---CHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 2 23578899999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=375.73 Aligned_cols=255 Identities=17% Similarity=0.229 Sum_probs=207.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||+||+|... +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 4567999999999999999999865 789999999876422 12234678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec---CCCceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG~a~ 668 (784)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999997654 488899999999999999999999 999999999999998 45789999999998
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
.............||+.|+|||++.+..++.++||||+||++|+|++|..||...... .....+.......+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~ 233 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--------RLYQQIKAGAYDFP 233 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCCC
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhCCCCCC
Confidence 8766555556678999999999999999999999999999999999999998632211 11111111111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111122346789999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.75 Aligned_cols=251 Identities=25% Similarity=0.449 Sum_probs=206.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|+.+++..||+|++... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG----SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT----TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC----CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 4679999999999999999999998889999998763 224578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++...+ ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999997643 2588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+...... ....+........+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 229 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQGHRLYRPHL 229 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCCTT
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HHHHHHcCCCCCCCCc
Confidence 221 233456778999999999899999999999999999999 999987433211 0111111111111122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+ ..+.+++..||+.||++|||++++++.|
T Consensus 230 ~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 230 AS---DTIYQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp SC---HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred Ch---HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22 3578899999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=359.86 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=201.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357999999999999999999875 7899999998654333333456799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997653 588899999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC-CC
Q 042086 673 DSS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP-PQ 750 (784)
Q Consensus 673 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~ 750 (784)
... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||+....... ....+....+.. ..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--------AIKHIQDSVPNVTTD 235 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--------HHHHHSSCCCCHHHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhhccCCCcchh
Confidence 322 23446799999999999999999999999999999999999999974322110 000111111100 00
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHh
Q 042086 751 NVQDELISIVEVAFLCLNESPESRP-PMHTVCQL 783 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RP-s~~~vl~~ 783 (784)
...+....+.+++.+|++.||++|| +++++.+.
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHH
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHH
Confidence 0111234688899999999999999 78777654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=357.25 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=202.5
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||+||+|+..+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 467999999999999999999998899999999875422 2223467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 8888887543 3588899999999999999999999 9999999999999999999999999999987655
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------c--ccccccc---c
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--------S--NRNISLN---E 739 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--------~--~~~~~~~---~ 739 (784)
........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......... . ....... .
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 555566688999999999876 568999999999999999999999996433211000 0 0000000 0
Q ss_pred ccCCCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPPQN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+......... .+....++.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000000 0111236789999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.72 Aligned_cols=254 Identities=19% Similarity=0.291 Sum_probs=206.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC---CChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM---VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+.|++.+.||+|+||.||+|+.. +|+.||+|.+........ ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999976 689999999876433221 2357899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC----ceEEeccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY----EARVSDFG 665 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG 665 (784)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999754 3588999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
+++.+.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNY 234 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHTCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHhcCC
Confidence 998775432 3345679999999999998999999999999999999999999986322110 0011111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+..........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110000112335788999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.94 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=202.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||.||+|+.. .+..||||++.... .....+.|.+|+.+++.++||||+++++++.+.+..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 357889999999999999999875 35569999987532 222356799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999997543 3689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-R 744 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~ 744 (784)
+...... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+... +
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~ 272 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--------VISSVEEGYR 272 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCC
Confidence 7543222 223345778999999998999999999999999999999 999986432211 01111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.+ .. ....+.+++..||+.||++|||+.+|++.|
T Consensus 273 ~~~~-~~---~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 273 LPAP-MG---CPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CCCC-TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC-CC---cCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1111 12 223578899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=368.82 Aligned_cols=257 Identities=21% Similarity=0.274 Sum_probs=206.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCC--CCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLW--PCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
.+.|++.+.||+|+||+||+|+.. +++.||||++.... .......+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999875 79999999985421 112234678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc---eEEecccc
Q 042086 591 LVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE---ARVSDFGI 666 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~ 666 (784)
+||||+++|+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998875432 223578899999999999999999999 9999999999999987654 99999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
+..............||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHHTCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHcCCCC
Confidence 98876554445567899999999999999999999999999999999999999964211 011111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+.........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111000112346889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=376.12 Aligned_cols=331 Identities=22% Similarity=0.192 Sum_probs=262.6
Q ss_pred CCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEe
Q 042086 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLH 155 (784)
Q Consensus 76 l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 155 (784)
.+++++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|.++++|++|+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence 35789999999999998899999999999999999999988899999999999999999999977677789999999999
Q ss_pred ecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccc
Q 042086 156 LYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG 235 (784)
Q Consensus 156 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 235 (784)
|++|.+++..+..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+++
T Consensus 111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~ 190 (477)
T 2id5_A 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA 190 (477)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence 99999998888899999999999999999998888889999999999999999988877888889999999999998887
Q ss_pred ccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccccc
Q 042086 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLG 315 (784)
Q Consensus 236 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~ 315 (784)
..+..|..+++|+.|++++|... +.+|.......+|+.|++++|.++...+..+.
T Consensus 191 ~~~~~~~~l~~L~~L~l~~~~~~-------------------------~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 245 (477)
T 2id5_A 191 IRDYSFKRLYRLKVLEISHWPYL-------------------------DTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245 (477)
T ss_dssp ECTTCSCSCTTCCEEEEECCTTC-------------------------CEECTTTTTTCCCSEEEEESSCCCSCCHHHHT
T ss_pred eChhhcccCcccceeeCCCCccc-------------------------cccCcccccCccccEEECcCCcccccCHHHhc
Confidence 76666666666666666665543 33333333444667777777777654445667
Q ss_pred ccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEE
Q 042086 316 NLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCI 395 (784)
Q Consensus 316 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l 395 (784)
.+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 325 (477)
T 2id5_A 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325 (477)
T ss_dssp TCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEE
T ss_pred CccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEE
Confidence 77777777777777777666677777777777777777777777778888888888888888888777778888888888
Q ss_pred EcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCCC
Q 042086 396 DVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIK 431 (784)
Q Consensus 396 ~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~ 431 (784)
++++|+|.|.++..+.+.......+.++...|..|.
T Consensus 326 ~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 326 ILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp ECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred EccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 888888888776544433333344566777777654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=362.43 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=207.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 592 (784)
++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999976 6899999999765333333455688999999988 899999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997643 588899999999999999999999 999999999999999999999999999987544
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-cccccccccccCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-SNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~d~~~~~~~~~ 751 (784)
........+||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .........+.......+. .
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-S 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT-T
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC-C
Confidence 4445566789999999999999999999999999999999999999996432211000 0001111122222222221 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPM------HTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~------~~vl~ 782 (784)
....+.+++.+||+.||++||++ +|+++
T Consensus 242 ---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 242 ---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ---CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 22357889999999999999995 66654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=355.34 Aligned_cols=263 Identities=20% Similarity=0.293 Sum_probs=210.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC--ceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR--NSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 591 (784)
++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++.... ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 57999999999999999999976 58999999987532 2234678899999999999999999999997655 7799
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee----cCCCceEEeccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL----CLDYEARVSDFGIA 667 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfG~a 667 (784)
||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999998755444589999999999999999999999 99999999999999 77888999999999
Q ss_pred cccCCCCCcccccccccccccccccc--------cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVY--------TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---------- 729 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---------- 729 (784)
+...... ......||+.|+|||.+. +..++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 8775443 334567999999999986 567899999999999999999999998632221100
Q ss_pred cc-c------cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 730 SS-N------RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 730 ~~-~------~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+ . ........+.+..+............+.+++.+||+.||++|||++|+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 00 0 000000001122333334456667789999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.22 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=207.2
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCce
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 589 (784)
...++|++.+.||+|+||.||+|+.+ +|+.||+|+++..........+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45678999999999999999999976 6899999998764222233466788999999887 999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999997643 588899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
...........+||+.|+|||.+.+..++.++|+|||||++|||++|+.||...... .....+.......+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPFYP- 238 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCC-
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCCCCC-
Confidence 544444456678999999999999999999999999999999999999999632211 11111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMH-TVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-~vl~ 782 (784)
... ..++.+++.+||+.||++||++. ++.+
T Consensus 239 ~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccc---CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112 23578899999999999999997 6653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=355.62 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=206.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999876 79999999987543223345677889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999998653 578899999999999999999999 999999999999999999999999999987543
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....+||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ......+.......+.. .
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~p~~-~- 226 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAELRFPPF-F- 226 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCCCCCTT-S-
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC-C-
Confidence 23456799999999999999999999999999999999999999963221 11112222222222221 2
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
..++.+++.+|++.||++|| +++|+++
T Consensus 227 --~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 23577899999999999999 8888875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=364.69 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=206.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3467999999999999999999876 689999999875422 12234678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC---ceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY---EARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG~a~ 668 (784)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999997543 578899999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+
T Consensus 180 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~~~~~~ 250 (362)
T 2bdw_A 180 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGAYDYP 250 (362)
T ss_dssp CCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCC
T ss_pred EecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCC
Confidence 76533 3334568999999999999989999999999999999999999998632211 01111111111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........++.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112223346889999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=348.54 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=185.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357999999999999999999874 7999999998653322233457899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999997643 3688999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||+..... .....+.......+ ..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-~~- 234 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--------NTLNKVVLADYEMP-SF- 234 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCC-TT-
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--------HHHHHHhhcccCCc-cc-
Confidence 444444567899999999999888999999999999999999999998743211 11111111111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...++.+++.+||+.||++|||++++++
T Consensus 235 --~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 235 --LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2235788999999999999999999986
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=380.71 Aligned_cols=326 Identities=25% Similarity=0.222 Sum_probs=176.9
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
++++|+|++|+|++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 46666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccc--eeccCCCcccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLL--HLGLSTNHLSG 235 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~--~L~L~~n~l~~ 235 (784)
+|.+++..+..+.++++|++|+|++|.+++..+..+..+++|++|++++|.+++..+..|+.+++|+ .|++++|++++
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence 6666655555666666666666666666653333333466666666666666655566666666665 55666665555
Q ss_pred ccCCCCcCC---------------------------------------------------CCcceEEecCCCCCCCCccc
Q 042086 236 VIPLSIGNL---------------------------------------------------NNLIGLYLYDNQLSVGEIPI 264 (784)
Q Consensus 236 ~~~~~l~~l---------------------------------------------------~~L~~L~L~~n~l~~~~~~~ 264 (784)
..|..+... .+|+.|++++|.++ ...+.
T Consensus 194 ~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~-~~~~~ 272 (606)
T 3t6q_A 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF-NISSN 272 (606)
T ss_dssp ECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCS-SCCTT
T ss_pred cChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccC-ccCHH
Confidence 444333211 03444444444443 11122
Q ss_pred ccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCch-hhhcccc
Q 042086 265 EIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPV-ELEKLIQ 343 (784)
Q Consensus 265 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~ 343 (784)
.+..+++|++|++++|+++ .+|..+..+++|++|++++|.+++..|..+..+++|++|++++|.+.+.++. .+..+++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 2444455555555555544 3444444555555555555555444444444555555555555544432322 2444455
Q ss_pred cCeeccCCccccccc--cccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCccc
Q 042086 344 LSELDLSLNILEGKI--PCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGP 405 (784)
Q Consensus 344 L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 405 (784)
|+.|++++|.+.+.. +..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++.+.
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 415 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECC
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCc
Confidence 555555555444433 34444445555555555554444444444455555555555544443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=369.69 Aligned_cols=252 Identities=23% Similarity=0.410 Sum_probs=204.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||||.++... .....++|.+|++++++++||||+++++++.+.+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 457899999999999999999986 78999999987532 122345788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++..+ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999997543 3588899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCC
Q 042086 673 DSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRLPTP 748 (784)
Q Consensus 673 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~ 748 (784)
.... .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||........ ...+.. .+++.+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--------~~~~~~~~~~~~~ 337 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--------REFVEKGGRLPCP 337 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--------HHHHHTTCCCCCC
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCCCC
Confidence 2111 112345778999999998899999999999999999998 9999874332110 000111 122222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+ ..+.+++.+||+.||++|||++++++.|
T Consensus 338 -~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 338 -ELCP---DAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp -TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 2222 3577899999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=360.13 Aligned_cols=252 Identities=21% Similarity=0.389 Sum_probs=204.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 457999999999999999999987 89999999987532 2334678999999999999999999999986543
Q ss_pred ----------------------------------------------------ceEEEEecccCCCHHHHHhcCCCCCCCC
Q 042086 588 ----------------------------------------------------NSFLVYEYLERGSLATILSNDGAIEEFN 615 (784)
Q Consensus 588 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~ 615 (784)
..++||||+++|+|.++++........+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 2789999999999999998877666778
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC------------cccccccc
Q 042086 616 WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS------------NCTELVGT 683 (784)
Q Consensus 616 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~gt 683 (784)
+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 888999999999999999999 999999999999999999999999999988765421 22345799
Q ss_pred cccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHH
Q 042086 684 FGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVA 763 (784)
Q Consensus 684 ~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li 763 (784)
+.|+|||.+.+..++.++|||||||++|||++|..|+...... .........+ .........+.+++
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~----------~~~~~~~~~~---~~~~~~~~~~~~li 306 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI----------ITDVRNLKFP---LLFTQKYPQEHMMV 306 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH----------HHHHHTTCCC---HHHHHHCHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH----------HHHhhccCCC---cccccCChhHHHHH
Confidence 9999999999999999999999999999999998875321110 0111111111 11223345678999
Q ss_pred HhcccCCCCCCCCHHHHHHh
Q 042086 764 FLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 764 ~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+||+.||++|||++|+++.
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=361.01 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=208.1
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 590 (784)
..++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999986 5889999998764322334567789999999988 8999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999997643 488899999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~- 242 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK- 242 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT-
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCC-
Confidence 4444455667899999999999999999999999999999999999999963221 1111222222222221
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
. ...++.+++.+||+.||++||+ ++++++
T Consensus 243 ~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 S---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp T---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 2235788999999999999995 577764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.66 Aligned_cols=252 Identities=23% Similarity=0.470 Sum_probs=193.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||.||+|+.. ++..||||+++... .....++|.+|+.++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 357999999999999999999865 57789999987532 223456799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.++++..+ ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999997653 3689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-R 744 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~ 744 (784)
....... .....+++.|+|||.+.+..++.++|||||||++||+++ |+.||....... ....+... +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------~~~~i~~~~~ 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEGYR 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------HHHHHHTTEE
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence 6543221 122345778999999999999999999999999999998 999986432110 00011111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.+ . .....+.+++.+||+.||++||++.+|++.|
T Consensus 269 ~~~~-~---~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 269 LPPP-M---DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp CCCC-T---TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC-c---cccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 1111 1 1223588899999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=359.27 Aligned_cols=247 Identities=22% Similarity=0.269 Sum_probs=206.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999976 79999999986543323345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999997643 478899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+. ..
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~-~~- 261 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPS-HF- 261 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT-TC-
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCC-CC-
Confidence 3456899999999999999999999999999999999999999963221 1111122222222221 12
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
...+.+++.+||+.||++||+ ++|+++
T Consensus 262 --~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 --SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 235788999999999999998 888875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.73 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=200.5
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||+||+|+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 47899999999999999999998899999999875432 22335678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9986 9999987543 3588899999999999999999999 99999999999999999999999999998765444
Q ss_pred CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------------cccccccccccc
Q 042086 675 SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------------SSNRNISLNEIL 741 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------------~~~~~~~~~~~~ 741 (784)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ............
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 444556789999999999764 5899999999999999999999999643221000 000000000001
Q ss_pred CCCCCCCC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 DPRLPTPP-----QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 d~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
++...... ........++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111000 000112345789999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.10 Aligned_cols=251 Identities=23% Similarity=0.427 Sum_probs=203.7
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|+..+++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT----SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC----CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 4579999999999999999999998999999999763 224578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999997632 3588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 SS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
.. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+........+..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 245 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRPHL 245 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCCTT
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--------HHHHHhcccCCCCCCc
Confidence 11 1233456788999999998899999999999999999998 999987433211 1111111111111122
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ...+.+++.+||+.||++|||++++++.|
T Consensus 246 ~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 246 A---SEKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp C---CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 2 23578899999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.51 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=197.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC-----------------------CCChhhHHHHHHHHh
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE-----------------------MVPQPEFVNEIKTLT 569 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 569 (784)
.++|++.+.||+|+||.||+|+.. +++.||||++....... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999875 68999999986543211 112467899999999
Q ss_pred ccCCCceeeEEeEEec--CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCC
Q 042086 570 ELRHRSIVKFYGFCSH--PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDIS 647 (784)
Q Consensus 570 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 647 (784)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999986 5678999999999999876532 3688999999999999999999999 99999999
Q ss_pred CCCeeecCCCceEEeccccccccCCCCCcccccccccccccccccccCC---cCcchhHHHHHHHHHHHHhCCCCCCccc
Q 042086 648 SKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK---VTEKCDVYSFGVLALEVIKGDHPRDFIS 724 (784)
Q Consensus 648 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~elltg~~p~~~~~ 724 (784)
|+||+++.++.+||+|||+++.+...........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999988765544455678999999999998665 4778999999999999999999986432
Q ss_pred cccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 725 SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.... ...+.......+. .......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~--------~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCL--------HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHH--------HHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHH--------HHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1100 0011111111110 0112235788999999999999999999975
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=386.41 Aligned_cols=338 Identities=22% Similarity=0.312 Sum_probs=302.4
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCC---------------------------------------------
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRN--------------------------------------------- 111 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n--------------------------------------------- 111 (784)
.+++.|+|++|+++|.+|.+|++|++|++|+|++|
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 47899999999999999999999999999999988
Q ss_pred ---------------------------------cccccCCCCCCCCCCCCEEEccCCccCCC-----------------C
Q 042086 112 ---------------------------------SLSASIPPVIGNLKFLYHLDLSENQLSGS-----------------I 141 (784)
Q Consensus 112 ---------------------------------~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----------------~ 141 (784)
++++ +|..|+++++|++|+|++|.+++. +
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i 239 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence 4445 889999999999999999999986 9
Q ss_pred CcCcc--CCCcCcEEeecCCCcccccCCccccccccceeeccccc-cCC-CccccccCc------cCCceeeccccccCC
Q 042086 142 PPTLG--NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQ-LSG-SIPISLGNL------SNLVVLHLFENSLFG 211 (784)
Q Consensus 142 p~~l~--~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~n~l~~ 211 (784)
|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~- 318 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK- 318 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-
T ss_pred chhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-
Confidence 99999 99999999999999999999999999999999999998 998 899988876 99999999999999
Q ss_pred ccch--hhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccc-cceEeccCccccCCCCc
Q 042086 212 SIPS--ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS-LNYLVLNGNQLYGNLPR 288 (784)
Q Consensus 212 ~~~~--~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~-L~~L~l~~n~l~~~~~~ 288 (784)
.+|. .++++++|+.|++++|+++|.+| .|..+++|+.|++++|+++ .+|..+..+++ |++|++++|+++ .+|.
T Consensus 319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~--~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~ 394 (636)
T 4eco_A 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT--EIPANFCGFTEQVENLSFAHNKLK-YIPN 394 (636)
T ss_dssp SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE--ECCTTSEEECTTCCEEECCSSCCS-SCCS
T ss_pred ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc--cccHhhhhhcccCcEEEccCCcCc-ccch
Confidence 7887 89999999999999999999999 9999999999999999998 88989999999 999999999999 7888
Q ss_pred cccCCC--ccceeecccCccCCCCccccc-------ccccceEEecccccccCCCchhhhcccccCeeccCCcccccccc
Q 042086 289 ALGSLT--ELEYLDLSTNKLGNSIPETLG-------NLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP 359 (784)
Q Consensus 289 ~l~~l~--~L~~L~Ls~n~l~~~~~~~l~-------~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 359 (784)
.+..++ +|+.|++++|.+++.+|..+. .+++|++|+|++|+++...+..+..+++|+.|+|++|+++ .+|
T Consensus 395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~ 473 (636)
T 4eco_A 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIP 473 (636)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCC
T ss_pred hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcC
Confidence 887765 999999999999999999998 8889999999999999755555667999999999999999 666
Q ss_pred ccccc-c-------ccccEEecCCCccCCCCccccc--CcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCC
Q 042086 360 CEICN-M-------ESLEKLNLSHNNFSGLIPSCFE--GMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGN 423 (784)
Q Consensus 360 ~~~~~-l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n 423 (784)
..+.. . ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|.. ..........+.+|
T Consensus 474 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N 546 (636)
T 4eco_A 474 KNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546 (636)
T ss_dssp SSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred HHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence 55443 2 29999999999999 6777776 99999999999999998 7753 22333334445443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=363.41 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=205.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999876 78999999986532 12345789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC--CCceEEecccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL--DYEARVSDFGIAKFL 670 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~ 670 (784)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||+++.+
T Consensus 127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999997543 3588999999999999999999999 9999999999999974 467999999999887
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..........
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------~~~i~~~~~~~~~~ 272 (387)
T 1kob_A 202 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--------LQNVKRCDWEFDED 272 (387)
T ss_dssp CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------HHHHHHCCCCCCSS
T ss_pred CCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCCCCCcc
Confidence 5432 33455799999999999999999999999999999999999999974322110 01111111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......++.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11122346789999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=364.42 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=205.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999876 68999999986543333445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999998643 588899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .......+.......+ .
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~p-~ 241 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTFETTVVTYP-S 241 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHHHHCCCCCC-T
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhhcccCCC-C
Confidence 33456789999999999974 458899999999999999999999996322111 0000111111111111 1
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPP-MHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs-~~~vl~ 782 (784)
. ....+.+++.+||+.||++||+ ++++.+
T Consensus 242 ~---~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 A---WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp T---SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c---CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 2 2235788999999999999998 777754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=372.94 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=207.0
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
+....++|++.+.||+|+||.||+|+.+ +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678999999999999999999976 689999999865332233345678999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999999753 478899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-cccccccccccccccccccCC----cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042086 669 FLKPDSS-NCTELVGTFGYIAPELVYTMK----VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 669 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
.+..... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .....++..
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~ 288 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNH 288 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hHHHHHHhc
Confidence 7654332 234568999999999997655 788999999999999999999999632211 111122211
Q ss_pred ----CCCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 042086 744 ----RLPTPPQNVQDELISIVEVAFLCLNESPES--RPPMHTVCQ 782 (784)
Q Consensus 744 ----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~vl~ 782 (784)
..+... ....++.+++.+|++.+|++ ||+++||++
T Consensus 289 ~~~~~~p~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 289 KNSLTFPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHCCCCTTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccccCCCcc----cccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111111 12235778999999999998 999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=353.31 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=196.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhc--cCCCceeeEEeEEec----CC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE--LRHRSIVKFYGFCSH----PR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~ 587 (784)
.++|++.+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+ ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 46799999999999999999988 5899999998642 34566777777766 799999999998644 34
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEeCCCCCCeeecCCCce
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH--------HDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
..++||||+++|+|.++++.. .+++..+.+++.|++.||+||| +. +|+||||||+||+++.++.+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 578999999999999999643 5889999999999999999999 76 99999999999999999999
Q ss_pred EEeccccccccCCCCCc----ccccccccccccccccccC------CcCcchhHHHHHHHHHHHHhC----------CCC
Q 042086 660 RVSDFGIAKFLKPDSSN----CTELVGTFGYIAPELVYTM------KVTEKCDVYSFGVLALEVIKG----------DHP 719 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~elltg----------~~p 719 (784)
||+|||+++........ .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999999876543322 2334799999999999876 456799999999999999999 666
Q ss_pred CCccccccccccccccccccc--cCCCCCCCCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 720 RDFISSISSSSSNRNISLNEI--LDPRLPTPPQ--NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~--~d~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
|......... ....... .+...+..+. ........+.+++.+||+.||++|||+++|++.|
T Consensus 233 f~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 233 FYDVVPNDPS----FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp TTTTSCSSCC----HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccCCCCcc----hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 6432111100 0000010 1111111111 1234566899999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=358.75 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=202.1
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC----ce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----NS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 589 (784)
.++|++.+.||+|+||+||+|+.. ++.||||++... ......+..|+.++++++||||+++++++.+.. ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 467999999999999999999886 799999998653 223445677899999999999999999997754 36
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeEEeCCCCCCeeecCCCceEEe
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC-------FPPIVHRDISSKNVLLCLDYEARVS 662 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------~~~ivH~Dlk~~Nill~~~~~~kl~ 662 (784)
++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999999764 4889999999999999999999861 2389999999999999999999999
Q ss_pred ccccccccCCCCC--ccccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-----
Q 042086 663 DFGIAKFLKPDSS--NCTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS----- 730 (784)
Q Consensus 663 DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~----- 730 (784)
|||+++.+..... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654332 2334679999999999986 356678999999999999999999987432211000
Q ss_pred ---cccccccccccCCCCCCC-CC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 731 ---SNRNISLNEILDPRLPTP-PQ--NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 731 ---~~~~~~~~~~~d~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.........+........ .. .......++.+++.+||+.||++|||++||++.|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 000000000111111111 00 1123455689999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.98 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=195.2
Q ss_pred hcCCCCceeEecccceEEEEEEE----cCCCEEEEEEcCCCCCC-CCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL----TSGEILAVKKFHSLWPC-EMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45799999999999999999987 47999999999764321 22335568899999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997643 478889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
.............||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKCKLNLP 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 655444444566899999999999999999999999999999999999999974221 111112222222222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
.. . ...+.+++.+||+.||++|| ++.|+++
T Consensus 242 ~~-~---~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 242 PY-L---TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TT-S---CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC-C---CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 1 23578899999999999999 7778875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.71 Aligned_cols=261 Identities=20% Similarity=0.279 Sum_probs=202.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 47999999999999999999976 689999999976432 2233467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ ++.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99986 6666665432 3588999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----------cccccccccccc
Q 042086 674 SSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-----------SSNRNISLNEIL 741 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-----------~~~~~~~~~~~~ 741 (784)
........||+.|+|||.+.+.. ++.++|||||||++|||++|..|+......... ............
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 55556678899999999998766 799999999999999999998885321110000 000000000000
Q ss_pred CC-------CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 DP-------RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 d~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+. ...............+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 000000111123346789999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=362.56 Aligned_cols=247 Identities=22% Similarity=0.267 Sum_probs=195.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHH-HhccCCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKT-LTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.........+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999976 688999999976544333445567778777 577899999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997643 478889999999999999999999 99999999999999999999999999998755
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
.........+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......++......+..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~- 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPLQLKPN- 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSCCCCCSS-
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcccCCCCC-
Confidence 444555677899999999999999999999999999999999999999963221 11112222222222221
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMH 778 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 778 (784)
. ...+.+++.+||+.||++||++.
T Consensus 262 ~---~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 262 I---TNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSTTTT
T ss_pred C---CHHHHHHHHHHcccCHHhCCCCC
Confidence 2 23577899999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.51 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=189.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467999999999999999999986 68899999987532 345788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG~a~~ 669 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999997643 488899999999999999999999 9999999999999975 88999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......+.........
T Consensus 201 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~~~~ 272 (349)
T 2w4o_A 201 VEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYYFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCCCCT
T ss_pred cCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCccCC
Confidence 6432 2234567899999999999999999999999999999999999998632211 0011112222211111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111223346889999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=372.30 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=208.8
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
.++....++|++.+.||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|+.++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344445678999999999999999999977 5889999998653222233455689999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999997642 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042086 667 AKFLKPDSSN-CTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 667 a~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
++........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--------~~~~~i 293 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKI 293 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--------HHHHhh
Confidence 9876544332 34468999999999997 567899999999999999999999999642211 111111
Q ss_pred cC----CCCCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 042086 741 LD----PRLPTPPQNVQDELISIVEVAFLCLNESPES--RPPMHTVCQ 782 (784)
Q Consensus 741 ~d----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~vl~ 782 (784)
+. ...+.... .....+.+++.+|+..+|++ ||+++|+++
T Consensus 294 ~~~~~~~~~p~~~~---~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKERFQFPTQVT---DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHHHCCCCSSCC---CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhccccccCCcccc---cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11 11111111 12335778999999998888 999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=373.59 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=197.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||||++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 7999999998754322333456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997643 58889999999999999999998 7 99999999999999999999999999998755
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+. .
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~-~ 371 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPR-T 371 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT-T
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCCCCc-c
Confidence 5545556678999999999999999999999999999999999999999632211 111111112222221 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
. ..++.+++.+||+.||++|| +++|+++
T Consensus 372 ~---~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 L---GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp S---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C---CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2 23578899999999999999 9999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=360.15 Aligned_cols=256 Identities=22% Similarity=0.419 Sum_probs=206.8
Q ss_pred HhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||.||+|+.. +++.||||+++... .....+.|.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 4578999999999999999999875 34899999987532 222356799999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeC
Q 042086 587 RNSFLVYEYLERGSLATILSNDGA---------------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRD 645 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 645 (784)
+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||++ +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 999999999999999999976421 14689999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEeccccccccCCCC--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCc
Q 042086 646 ISSKNVLLCLDYEARVSDFGIAKFLKPDS--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDF 722 (784)
Q Consensus 646 lk~~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~ 722 (784)
|||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999998654322 12234567899999999998899999999999999999999 9999864
Q ss_pred cccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 723 ISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.... .....+.+......+...+ ..+.+++.+||+.||++|||+.++++.|
T Consensus 280 ~~~~--------~~~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 280 MAHE--------EVIYYVRDGNILACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp SCHH--------HHHHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CChH--------HHHHHHhCCCcCCCCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 3211 1111122222222222222 3578899999999999999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=376.85 Aligned_cols=363 Identities=21% Similarity=0.177 Sum_probs=313.7
Q ss_pred CCeEEEEeCCCcc-------cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEc
Q 042086 60 KRVISINLSTVGL-------KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132 (784)
Q Consensus 60 ~~v~~l~l~~~~~-------~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 132 (784)
..++.++++...+ .+.+++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 3678888887643 357889999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCc--eeeccccccC
Q 042086 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLV--VLHLFENSLF 210 (784)
Q Consensus 133 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~ 210 (784)
++|++++..|..++.+++|++|+|++|.+++.....+..+++|++|+|++|.+++..|..++.+++|+ .|++++|.++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 99999987788899999999999999999975545556699999999999999988888899999999 8999999998
Q ss_pred Cccchhhhcc-------------------------------------------------c--ccceeccCCCccccccCC
Q 042086 211 GSIPSILGNL-------------------------------------------------K--MLLHLGLSTNHLSGVIPL 239 (784)
Q Consensus 211 ~~~~~~l~~l-------------------------------------------------~--~L~~L~L~~n~l~~~~~~ 239 (784)
+..+..+... . +|+.|++++|.+++..+.
T Consensus 193 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp EECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred ccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 7776554321 1 688899999999988888
Q ss_pred CCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcc-cccccc
Q 042086 240 SIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLL 318 (784)
Q Consensus 240 ~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~-~l~~l~ 318 (784)
.|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|++|++++|.+.+.+|. .+..++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~--~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS--ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS--CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HhccccCCCEEeccCCccC--CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 8999999999999999987 7888899999999999999999988888899999999999999998866654 488899
Q ss_pred cceEEecccccccCCC--chhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCccc-ccCcccceEE
Q 042086 319 KLHYLNLSNNQFRKGF--PVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC-FEGMHGLSCI 395 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l 395 (784)
+|++|++++|.+++.. +..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|.. +..+++|+.|
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 9999999999998765 778899999999999999999888888999999999999999998887654 8889999999
Q ss_pred EcCCCCCcccCCCC-CCCcCCCcccccCCC
Q 042086 396 DVSYNELRGPIPNS-RIFQYDPMEALQGNK 424 (784)
Q Consensus 396 ~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~ 424 (784)
++++|.+.+..|.. ..........+.+|+
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 460 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNH 460 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCB
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCC
Confidence 99999998876653 223344444555654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=368.65 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=207.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999976 79999999986543223334668999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999997543 588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
......+||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+.... ......+.+.....+ ...
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~p-~~~ 239 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDGIFYTP-QYL 239 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTTCCCCC-TTC
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCcCCC-ccC
Confidence 33345689999999999988775 6799999999999999999999974221 111122222222222 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+||+.||++|||++|+++
T Consensus 240 ---s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 ---NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 235788999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.63 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=201.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 368999999999999999999876 799999999865322 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999986543 588999999999999999999999 999999999999999999999999999986543
Q ss_pred CC--CcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 673 DS--SNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 673 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.. .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+....... ............
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~-- 228 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYL-- 228 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-------HHHHHHTTCTTS--
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHhcccccC--
Confidence 22 22345679999999999987775 7789999999999999999999974332110 000111111110
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011122345778999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.20 Aligned_cols=254 Identities=18% Similarity=0.269 Sum_probs=206.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC---CChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM---VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+.|++.+.||+|+||.||+|+.. +|+.||+|.+........ ...+++.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999976 689999999876433221 2357799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC----ceEEeccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY----EARVSDFG 665 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG 665 (784)
++||||+++++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 578899999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 165 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSVSY 235 (321)
T ss_dssp TCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC
T ss_pred cceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhccc
Confidence 99876543 2334567999999999999999999999999999999999999998632211 01111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+..........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1110000112235789999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.57 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=206.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
.++|.+.+.||+|+||.||+|+.. .++.||||++.... .....+++.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 467999999999999999999853 34689999987642 222346799999999999 9999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+++..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999976532 23589999999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCC--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDS--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999998765432 22334567889999999999999999999999999999999 999986432111
Q ss_pred cccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+... ..++.+++.+||+.||++|||++||++.|
T Consensus 302 -------~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 302 -------LFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp -------HHHHHHTTCCCCCCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------HHHHHHcCCCCCCCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 01111111111111222 23578899999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.13 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=195.7
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN---- 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 588 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++...........+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999997 4789999999976543333334578999999999999999999999876543
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++|+|.++++..+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 399999999999999997643 588899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 669 FLKPDSS---NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 669 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
.+..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~~ 236 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--------AYQHVREDP 236 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhcCCC
Confidence 7654322 22345689999999999999999999999999999999999999964322110 000111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+..........+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1000000112335788999999999999998888765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.03 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=196.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.++|++.+.||+|+||+||+|++. +++ +||+|.+.... .....++|.+|+.++++++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 357999999999999999999864 444 35888876432 3345678999999999999999999999998754
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 789999999999999997654 3588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 042086 669 FLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-- 743 (784)
Q Consensus 669 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-- 743 (784)
.+...... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||+...... ....+..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------~~~~~~~~~ 236 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE 236 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------HHHHHHcCC
Confidence 76543322 233456889999999999999999999999999999999 999997432211 1111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+...+. .....+.+++.+||+.||++|||+.++++.|
T Consensus 237 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 237 RLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp CCCCCT----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred CCCCCc----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 111111 1233578899999999999999999999754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=379.02 Aligned_cols=366 Identities=23% Similarity=0.234 Sum_probs=220.4
Q ss_pred CeEEEEeCCCcc-------cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEcc
Q 042086 61 RVISINLSTVGL-------KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLS 133 (784)
Q Consensus 61 ~v~~l~l~~~~~-------~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 133 (784)
++..+++....+ ...+++|++|+|++|+|++..+..|+++++|++|+|++|++++..|..|+++++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 566777766543 2467788888888888888878888888888888888888887777888888888888888
Q ss_pred CCccCCCCCcCccCCCcCcEEeecCCCccc-ccCCccccccccceeeccccccCCCccccccCccCC----ceeeccccc
Q 042086 134 ENQLSGSIPPTLGNLSNLAVLHLYGNSLSG-SIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL----VVLHLFENS 208 (784)
Q Consensus 134 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~n~ 208 (784)
+|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|.+++..+..++.+++| +.|++++|.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 888886665568888888888888888876 357788888888888888887776555555555544 445554444
Q ss_pred cCCccc--------------------------------------------------------------------------
Q 042086 209 LFGSIP-------------------------------------------------------------------------- 214 (784)
Q Consensus 209 l~~~~~-------------------------------------------------------------------------- 214 (784)
+.+..+
T Consensus 189 l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~ 268 (570)
T 2z63_A 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268 (570)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETT
T ss_pred ceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcch
Confidence 332221
Q ss_pred -------hhhhcccccceeccCCCccccccCCCC------------------------------------------cCCC
Q 042086 215 -------SILGNLKMLLHLGLSTNHLSGVIPLSI------------------------------------------GNLN 245 (784)
Q Consensus 215 -------~~l~~l~~L~~L~L~~n~l~~~~~~~l------------------------------------------~~l~ 245 (784)
..+..+++|+.|++++|.+++ +|..+ ..++
T Consensus 269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 347 (570)
T 2z63_A 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 347 (570)
T ss_dssp EEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCT
T ss_pred hhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCC
Confidence 222333444444444444331 12111 3456
Q ss_pred CcceEEecCCCCCCCC-cccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCc-ccccccccceEE
Q 042086 246 NLIGLYLYDNQLSVGE-IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP-ETLGNLLKLHYL 323 (784)
Q Consensus 246 ~L~~L~L~~n~l~~~~-~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~l~~l~~L~~L 323 (784)
+|++|++++|+++... .+..+..+++|++|++++|.+++..+. +..+++|+.|++++|.+++..+ ..+.++++|++|
T Consensus 348 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 426 (570)
T 2z63_A 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426 (570)
T ss_dssp TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred CCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence 6666666666665211 133455556666666666665543322 5555555555555555554433 345555555555
Q ss_pred ecccccccCCCchhhhcccccCeeccCCcccc-ccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCC
Q 042086 324 NLSNNQFRKGFPVELEKLIQLSELDLSLNILE-GKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402 (784)
Q Consensus 324 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l 402 (784)
++++|.+.+..|..+..+++|+.|++++|.+. +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++
T Consensus 427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence 55555555555555555555555555555554 34555555555555555555555555555555555555555555555
Q ss_pred cccCCCC-CCCcCCCcccccCCCCCCC
Q 042086 403 RGPIPNS-RIFQYDPMEALQGNKGLCG 428 (784)
Q Consensus 403 ~~~~p~~-~~~~~~~~~~~~~n~~~c~ 428 (784)
++..|.. ..+.......+.+|+..|.
T Consensus 507 ~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 507 KSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCHHHhhcccCCcEEEecCCcccCC
Confidence 5543321 1222333334455555544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=356.21 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=182.1
Q ss_pred ceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEEEEeccc
Q 042086 520 KYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 478999999999999976 6899999998642 3567889999999996 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC---ceEEeccccccccCCCC
Q 042086 598 RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY---EARVSDFGIAKFLKPDS 674 (784)
Q Consensus 598 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG~a~~~~~~~ 674 (784)
+|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++......
T Consensus 90 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 90 GGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp SCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999998753 588899999999999999999999 999999999999998765 89999999998776555
Q ss_pred CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHH
Q 042086 675 SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 754 (784)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .........+..............
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCCCCcccccC
Confidence 5556678899999999999999999999999999999999999999743221000 000111122222222222111122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 755 ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 755 ~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...++.+++.+||+.||++|||++|+++
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 3456889999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=373.57 Aligned_cols=251 Identities=22% Similarity=0.432 Sum_probs=204.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..++|++.+.||+|+||.||+|..++++.||||+++.. ....++|.+|+.+++.++||||+++++++. .+..++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT----SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC----CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 34678999999999999999999988999999999763 234788999999999999999999999986 5678999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999975321 2478889999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCC
Q 042086 673 DSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRLPTPP 749 (784)
Q Consensus 673 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~ 749 (784)
.... .....+++.|+|||.+....++.++|||||||++|||+| |+.||....... ....+.. .+++.+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~~- 407 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYRMPRP- 407 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHHTCCCCCC-
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC-
Confidence 2111 123346788999999998999999999999999999999 999997432211 0001111 122222
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
... ...+.+++.+||+.||++|||+++|++.|
T Consensus 408 ~~~---~~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 408 ENC---PEELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC---CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 222 23578899999999999999999998764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=379.40 Aligned_cols=181 Identities=28% Similarity=0.321 Sum_probs=93.2
Q ss_pred CcccceeEEcCCC-CeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCC
Q 042086 48 PCAWFGIQCNPAK-RVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKF 126 (784)
Q Consensus 48 ~C~w~gv~C~~~~-~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 126 (784)
.|.|.|+ |+..+ .++.+ + .+-.++|++|+|++|+|++..|..|.++++|++|+|++|++++..|.+|+.+++
T Consensus 3 ~C~~~~~-c~~~~~~l~~i--p----~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSI--P----SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECTTSE-EECTTSCCSSC--C----SCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCce-EECCCCccccc--c----ccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 4999998 87532 12111 0 011234555555555555555555555555555555555555555555555555
Q ss_pred CCEEEccCCccCCCCCcCccCCCcCcEEeecCCCccc-ccCCccccccccceeeccccccCCCcc-ccccCccCCceeec
Q 042086 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSG-SIPSIIGNLKSLFYLHLSSNQLSGSIP-ISLGNLSNLVVLHL 204 (784)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L 204 (784)
|++|+|++|++++..|..|+++++|++|+|++|.+++ ..|..+.++++|++|++++|.+.+.+| ..|.++++|++|++
T Consensus 76 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L 155 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155 (549)
T ss_dssp CCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEE
T ss_pred CCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeec
Confidence 5555555555554444445555555555555555543 233445555555555555554222222 34555555555555
Q ss_pred cccccCCccchhh------------------------hcccccceeccCCCcccc
Q 042086 205 FENSLFGSIPSIL------------------------GNLKMLLHLGLSTNHLSG 235 (784)
Q Consensus 205 ~~n~l~~~~~~~l------------------------~~l~~L~~L~L~~n~l~~ 235 (784)
++|++++..|..+ ..+++|++|++++|++++
T Consensus 156 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp EETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred cCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccc
Confidence 5555544444443 346667777777777665
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=366.40 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=200.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-ceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR-NSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv 592 (784)
.++|++.+.||+|+||.||+|..+ |+.||||+++... ..++|.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 467889999999999999999986 7899999987532 4678999999999999999999999987655 78999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++..+. ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999986432 3468899999999999999999999 999999999999999999999999999986432
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQ 750 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~ 750 (784)
. .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+... ++..+ .
T Consensus 342 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~p-~ 409 (450)
T 1k9a_A 342 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAP-D 409 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTTCCCCCC-T
T ss_pred c---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC-C
Confidence 2 223367889999999999999999999999999999998 999987432211 01111111 22222 2
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.. ...+.+++.+||+.||++|||+.++++.|
T Consensus 410 ~~---~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 410 GC---PPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cC---CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22 23578899999999999999999998764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=378.29 Aligned_cols=330 Identities=25% Similarity=0.260 Sum_probs=239.4
Q ss_pred CCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEe
Q 042086 76 LKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLH 155 (784)
Q Consensus 76 l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 155 (784)
.++|++|+|++|++++..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 36899999999999999999999999999999999999999999999999999999999999988899999999999999
Q ss_pred ecCCCcccccCCccccccccceeeccccccCC-CccccccCccCCceeeccccccCCccchhhhcccccc----eeccCC
Q 042086 156 LYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG-SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLL----HLGLST 230 (784)
Q Consensus 156 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~----~L~L~~ 230 (784)
|++|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..++.+++|+ +|++++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 99999998887899999999999999999986 5799999999999999999999988888888777654 566666
Q ss_pred CccccccCCCCc--------------------------------------------------------------------
Q 042086 231 NHLSGVIPLSIG-------------------------------------------------------------------- 242 (784)
Q Consensus 231 n~l~~~~~~~l~-------------------------------------------------------------------- 242 (784)
|++++..+..+.
T Consensus 191 n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 666543332221
Q ss_pred ----------------------------------CCCCcceEEecCCCCCCCCcc--------------------ccccc
Q 042086 243 ----------------------------------NLNNLIGLYLYDNQLSVGEIP--------------------IEIGK 268 (784)
Q Consensus 243 ----------------------------------~l~~L~~L~L~~n~l~~~~~~--------------------~~l~~ 268 (784)
.+++|++|++++|++. .+| ..+..
T Consensus 271 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~--~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK--QFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS--SCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc--ccccCCCCccceeeccCCcCccchhhcc
Confidence 1122223333332221 111 01223
Q ss_pred ccccceEeccCccccCC-------------------------CCccccCCCccceeecccCccCCCCc-ccccccccceE
Q 042086 269 LSSLNYLVLNGNQLYGN-------------------------LPRALGSLTELEYLDLSTNKLGNSIP-ETLGNLLKLHY 322 (784)
Q Consensus 269 l~~L~~L~l~~n~l~~~-------------------------~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~l~~l~~L~~ 322 (784)
+++|++|++++|++++. +|..+..+++|+.|++++|.+++..| ..+..+++|++
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 34444444444444432 33455555666666666666665555 45666666666
Q ss_pred EecccccccCCCchhhhcccccCeeccCCccccc-cccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCC
Q 042086 323 LNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG-KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNE 401 (784)
Q Consensus 323 L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 401 (784)
|++++|++++..|..+..+++|+.|++++|.+.+ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 508 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence 6666666666666666666666666666666665 356666666666666666666666666666666666666666666
Q ss_pred CcccCC
Q 042086 402 LRGPIP 407 (784)
Q Consensus 402 l~~~~p 407 (784)
+++..|
T Consensus 509 l~~~~~ 514 (606)
T 3vq2_A 509 LLFLDS 514 (606)
T ss_dssp CSCEEG
T ss_pred CCCcCH
Confidence 666544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.36 Aligned_cols=263 Identities=20% Similarity=0.316 Sum_probs=191.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 457999999999999999999875 68999999987543 233457889999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDG---AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
|||++ |+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 59999986432 223588999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cc---ccccccc
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SS---NRNISLN 738 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~---~~~~~~~ 738 (784)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... .. .......
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 76544445566889999999999764 5899999999999999999999999643221000 00 0000000
Q ss_pred c--ccCCCCCC-CCCCCH---------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 E--ILDPRLPT-PPQNVQ---------DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~--~~d~~~~~-~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ...+.... .+.... ....++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00001100 000000 11236889999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=362.87 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=203.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......++.+|+.++++++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 357999999999999999999843 56789999986532 2223457899999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC---ceE
Q 042086 588 NSFLVYEYLERGSLATILSNDGA----IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY---EAR 660 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~k 660 (784)
..++||||+++|+|.++++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999975432 23589999999999999999999999 999999999999999555 599
Q ss_pred EeccccccccCCCC--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccc
Q 042086 661 VSDFGIAKFLKPDS--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISL 737 (784)
Q Consensus 661 l~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 737 (784)
|+|||+++.+.... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~ 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVL 296 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence 99999998653221 22344567899999999999999999999999999999998 99998743221 111
Q ss_pred ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+........+... ...+.+++.+||+.||++|||+.+|++.|
T Consensus 297 ~~i~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 297 EFVTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp HHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCCCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 111111111112222 23578899999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=373.54 Aligned_cols=251 Identities=23% Similarity=0.407 Sum_probs=206.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..+|++.+.||+|+||.||+|++. +++.||||.++.. ....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc----ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 456889999999999999999987 4889999998763 23477899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 295 ~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999976432 4588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCC
Q 042086 673 DSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRLPTPP 749 (784)
Q Consensus 673 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~ 749 (784)
.... .....+++.|+|||.+....++.++|||||||++|||+| |+.||....... ....+.. .+...+
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~- 441 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRMERP- 441 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCCCC-
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC-
Confidence 3221 223456788999999999999999999999999999999 999987433211 0000111 112221
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
... ...+.+++.+||+.||++|||+.+|++.|
T Consensus 442 ~~~---~~~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 442 EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC---CHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 222 23578899999999999999999998864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.67 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=208.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357999999999999999999976 6889999998764333333456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++...+ .+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999987543 578899999999999999999999 999999999999999999999999999988765
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||+...... ....+.......+ ...
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~~ 238 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEYSIP-KHI 238 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCC-TTS
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhccCCCc-ccc
Confidence 5445556779999999999999889999999999999999999999997432110 0111111122111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+||+.||++|||++|+++
T Consensus 239 ---~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 239 ---NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 235778999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.86 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=205.8
Q ss_pred hcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++.++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 46799999999999999999986 245899999987532 2233567899999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC
Q 042086 588 NSFLVYEYLERGSLATILSNDGA---------------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDI 646 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 646 (784)
..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||++ +|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999976542 12488999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 042086 647 SSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFI 723 (784)
Q Consensus 647 k~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~ 723 (784)
||+||+++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 233456788999999999889999999999999999999 99998643
Q ss_pred ccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 724 SSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.... ....+........+.. ....+.+++.+||+.||++|||+.++++.|
T Consensus 257 ~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 257 PPER--------LFNLLKTGHRMERPDN---CSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp CGGG--------HHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHH--------HHHHhhcCCcCCCCcc---CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2211 0111111111111112 223578899999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.24 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=205.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ...+++.+|+++++.++||||+++++++.+++..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 35789999999999999999999889999999997632 23578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999997653 3578899999999999999999999 9999999999999999999999999999876432
Q ss_pred C-CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 S-SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
. .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+........+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~~ 229 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYKPRL 229 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCTT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--------HHHHHhcCCcCCCCcc
Confidence 1 11233456788999999998889999999999999999999 899987432111 0111111111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ...+.+++.+||+.||++|||++++++.|
T Consensus 230 ~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 230 A---STHVYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C---cHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2 23578899999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.96 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=202.6
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 590 (784)
..++|++.+.||+|+||.||+|+.+ +++.||+|++.... ..+.+|++++.++ +||||+++++++.+++..+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3567999999999999999999876 68999999987532 2345788888888 7999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC----CceEEecccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD----YEARVSDFGI 666 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~ 666 (784)
+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||++.++ +.+||+|||+
T Consensus 93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999997653 588899999999999999999999 99999999999998543 3599999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
++.............||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......+......
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGKFS 241 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCCCC
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCCcc
Confidence 9987655555566789999999999988889999999999999999999999996321110 00111111111221
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...........++.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111223346788999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=351.75 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=199.4
Q ss_pred hcCCCCceeEecccceEEEEEEE-----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--P 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 586 (784)
.++|++.+.||+|+||+||+|++ .+++.||||++... .....+.|.+|++++++++||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46799999999999999999984 26899999998753 22234679999999999999999999999854 3
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 56899999999999999997653 2588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccc----ccccccc----c
Q 042086 667 AKFLKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS----SSSSNRN----I 735 (784)
Q Consensus 667 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~----~~~~~~~----~ 735 (784)
++........ .....++..|+|||.+.+..++.++||||||+++|||+||..|+....... ....... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9876543221 233457778999999999999999999999999999999999986422110 0000000 0
Q ss_pred ccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 736 SLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 736 ~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+... +.+.+ ... ..++.+++.+||+.||++|||++|+++.|
T Consensus 241 ~~~~~~~~~~~~~~-~~~---~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 241 LIELLKNNGRLPRP-DGC---PDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHHTTCCCCCC-TTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhccCcCCCC-cCc---CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 00011111 12221 222 23588899999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.53 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=192.3
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCC-CCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCE-MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. ++.||||++....... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357999999999999999999986 8899999987643322 23357899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC--------CCceEEecc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL--------DYEARVSDF 664 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~Df 664 (784)
|||+++++|.++++. ..+++..+..++.|+++|++|||++...+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999864 25888999999999999999999992222999999999999986 678999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
|++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+....
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--------~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA--------YGVAMNK 230 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--------HHHHTSC
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------HhhhcCC
Confidence 9998765332 23457899999999999999999999999999999999999999743321100 0011111
Q ss_pred C-CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 L-PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ...+... ...+.+++.+||+.||++|||+.|+++.|
T Consensus 231 ~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 231 LALPIPSTC---PEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp CCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCccc---CHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 1 1111112 23588899999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=361.56 Aligned_cols=246 Identities=25% Similarity=0.302 Sum_probs=195.7
Q ss_pred ceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEecccC
Q 042086 520 KYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 578999999999999875 79999999987532 22456899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee--cCCCceEEeccccccccCCCCCc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL--CLDYEARVSDFGIAKFLKPDSSN 676 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~~~ 676 (784)
|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+.... .
T Consensus 171 ~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~ 244 (373)
T 2x4f_A 171 GELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-K 244 (373)
T ss_dssp CEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-B
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-c
Confidence 99999886543 3588899999999999999999999 99999999999999 567899999999998775432 3
Q ss_pred ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHH
Q 042086 677 CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDEL 756 (784)
Q Consensus 677 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 756 (784)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+........
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~~ 316 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILACRWDLEDEEFQDIS 316 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCSCSGGGTTSC
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccCCCChhhhccCC
Confidence 34457999999999999889999999999999999999999999643221 1111122111111111111223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 757 ISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 757 ~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.++.+++.+||+.||++|||+.|+++
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 46889999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=362.94 Aligned_cols=263 Identities=21% Similarity=0.345 Sum_probs=207.0
Q ss_pred HHHHHHHhcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeE
Q 042086 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKF 579 (784)
Q Consensus 507 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 579 (784)
..++....++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|+++++++ +||||+++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 345555678899999999999999999974 256899999997532 222346799999999999 79999999
Q ss_pred EeEEecCCc-eEEEEecccCCCHHHHHhcCCC------------------------------------------------
Q 042086 580 YGFCSHPRN-SFLVYEYLERGSLATILSNDGA------------------------------------------------ 610 (784)
Q Consensus 580 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 610 (784)
++++.+.+. .++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 8999999999999999976432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 611 ---------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 611 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 11288999999999999999999999 999999999999999999999999999987644322
Q ss_pred --cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 676 --NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 676 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .....+........+...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 321 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRAPDYT 321 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHHTCCCCCCTTC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------HHHHHHHcCCCCCCCCCC
Confidence 2345678899999999999999999999999999999998 999986432111 000001111111111112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..++.+++.+||+.||++|||+.|+++.|
T Consensus 322 ---~~~l~~li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 322 ---TPEMYQTMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 23578899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=373.88 Aligned_cols=258 Identities=22% Similarity=0.273 Sum_probs=210.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 357899999999999999999986 6999999998654333334567899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||+++|+|.+++..... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976432 34689999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.......+ ..
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~----~~~~~~~~i~~~~~~~p-~~ 415 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRVLEQAVTYP-DK 415 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----CHHHHHHHHHHCCCCCC-TT
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch----hHHHHHHHHhhcccCCC-cc
Confidence 55444455689999999999999999999999999999999999999997432110 00111112222222222 11
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPM-----HTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~~vl~ 782 (784)
....+.+++.+||+.||++||++ +++++
T Consensus 416 ---~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 416 ---FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 23357789999999999999975 56653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=350.03 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=205.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC-----CChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM-----VPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||.||+|+.. +++.||||++........ ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999865 789999999976543221 1345788999999999999999999999999
Q ss_pred CceEEEEecccCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 587 RNSFLVYEYLERG-SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 587 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999997654 488899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
+++...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||..... .....
T Consensus 176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~~ 240 (335)
T 3dls_A 176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEAA 240 (335)
T ss_dssp TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTTC
T ss_pred cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhhc
Confidence 998775433 3345679999999999988876 7899999999999999999999864221 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
...+ ... ..++.+++.+||+.||++|||++++++.
T Consensus 241 ~~~~-~~~---~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 IHPP-YLV---SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCS-SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cCCC-ccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 111 2357889999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.03 Aligned_cols=262 Identities=24% Similarity=0.280 Sum_probs=202.6
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCC--CCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWP--CEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
+....++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456678999999999999999999875 788999999864321 1233467899999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 042086 587 RNSFLVYEYLERGSLATILSNDGA-------------------------------------IEEFNWTVRMNVIRSVANA 629 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~ 629 (784)
+..++||||+++|+|.+++..... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852100 1123567788899999999
Q ss_pred HHHHhhCCCCCeEEeCCCCCCeeecCCC--ceEEeccccccccCCCCC----ccccccccccccccccccc--CCcCcch
Q 042086 630 LSYMHHDCFPPIVHRDISSKNVLLCLDY--EARVSDFGIAKFLKPDSS----NCTELVGTFGYIAPELVYT--MKVTEKC 701 (784)
Q Consensus 630 l~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~s 701 (784)
|+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999986543221 2345679999999999975 6788999
Q ss_pred hHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 702 DVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 702 DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
|||||||++|||++|+.||...... .....+..................+.+++.+||+.||++|||+.+++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9999999999999999999643321 11112222222111111112234688999999999999999999998
Q ss_pred H
Q 042086 782 Q 782 (784)
Q Consensus 782 ~ 782 (784)
+
T Consensus 330 ~ 330 (345)
T 3hko_A 330 Q 330 (345)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=344.50 Aligned_cols=253 Identities=19% Similarity=0.277 Sum_probs=204.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 468999999999999999999876 689999999865422 222346788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc---eEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE---ARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~a~~ 669 (784)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999887643 478899999999999999999999 9999999999999987655 99999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.......+.
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 158 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDYPS 228 (284)
T ss_dssp CCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCT
T ss_pred cccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--------HHHHHHhccccCCc
Confidence 6533 33345679999999999999999999999999999999999999986432211 00111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111122335788999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.75 Aligned_cols=252 Identities=21% Similarity=0.363 Sum_probs=191.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||.||+|+.. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 467999999999999999999874 35679999986532 2223567999999999999999999999985 4678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999997653 2588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 042086 670 LKPDSS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 670 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ....+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~~~ 237 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLP 237 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCCCC
Confidence 654322 2233456789999999998899999999999999999997 999987432211 111111111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+... ...+.+++.+||+.||++|||+.++++.|
T Consensus 238 ~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 238 MPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11222 23578899999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=367.48 Aligned_cols=258 Identities=25% Similarity=0.300 Sum_probs=206.0
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
.+.....++|++.+.||+|+||.||+|+.+ +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344445678999999999999999999976 7999999998653211222345689999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
+..++||||+++|+|.+++...+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999999997643 2588899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccccccccccc-------cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 667 AKFLKPDSSN-CTELVGTFGYIAPELVY-------TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 667 a~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
++.+...... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...... ....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~ 280 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--------ETYG 280 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--------HHHH
Confidence 9877554332 23468999999999997 456899999999999999999999999642211 1111
Q ss_pred cccC----CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 042086 739 EILD----PRLPTPPQNVQDELISIVEVAFLCLNESPESR---PPMHTVCQ 782 (784)
Q Consensus 739 ~~~d----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~~vl~ 782 (784)
.++. ...+..... ...++.+++.+||+ +|++| |+++|+++
T Consensus 281 ~i~~~~~~~~~p~~~~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 KIVHYKEHLSLPLVDEG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHTHHHHCCCC----C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhcccCcCCCccccC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111 011111111 22357889999999 99998 68999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=355.30 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=194.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG----AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS----TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC----ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 468999999999999999999976 7999999998753 22356789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc--eEEecccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKFL 670 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfG~a~~~ 670 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999997543 588899999999999999999999 9999999999999987765 999999999754
Q ss_pred CCCCCcccccccccccccccccccCCcCcc-hhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEK-CDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
... .......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||........ .......+.......+.
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVKYSIPD 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTCCCCCT
T ss_pred ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCCCCCCC
Confidence 322 22345679999999999988887665 8999999999999999999974332110 01111112222221111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 D--IRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp T--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred c--CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1 011235788999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=357.69 Aligned_cols=254 Identities=18% Similarity=0.227 Sum_probs=203.5
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 35799999999999999999996 478999999986532 245789999999999 99999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc-----eEEecccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE-----ARVSDFGI 666 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfG~ 666 (784)
||||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 899999998642 3689999999999999999999999 9999999999999998887 99999999
Q ss_pred ccccCCCCCc-------ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 667 AKFLKPDSSN-------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 667 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
++.+...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ......
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-----~~~~~~ 231 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-----KERYQK 231 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-----HHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-----HHHHHH
Confidence 9876543321 2456799999999999999999999999999999999999999974321100 000011
Q ss_pred ccCCCCCCCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 740 ILDPRLPTPPQN-VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 740 ~~d~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.......+... ..... ++.+++..||+.||++||++++|.+.|
T Consensus 232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 111111100000 00012 688999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.13 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=201.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999876 6789999998653222233456799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999997643 478899999999999999999999 999999999999999999999999999865433
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.......+ ...
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~~ 230 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFP-DFV 230 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCCC-TTS
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--------HHHHHHhCCCCCC-CcC
Confidence 2 2345678999999999999999999999999999999999999987432111 1111111111111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+||+.||++|||++|+++
T Consensus 231 ---~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 231 ---TEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 235778999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=343.46 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=203.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 457999999999999999999876 57899999987642 23467899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee---cCCCceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~ 669 (784)
|||+++++|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 85 MELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999987643 478899999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
+.... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... .....+.......+.
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 159 FKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTFTFPE 228 (277)
T ss_dssp CCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCH
T ss_pred ccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCCc
Confidence 65433 33456799999999998654 899999999999999999999999743221 111111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+|++.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000012346889999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=374.52 Aligned_cols=256 Identities=23% Similarity=0.268 Sum_probs=207.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457999999999999999999876 7999999998654322334466789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++...+. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999976542 3589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.......+ .
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~~~~~p-~-- 410 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVPEEYS-E-- 410 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHCCCCCC-T--
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcccccCC-c--
Confidence 32 3345689999999999999899999999999999999999999997432110 00000011111111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
....++.+++.+||+.||++|| +++||++
T Consensus 411 -~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 411 -RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1233578899999999999999 7888875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.55 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=208.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|.+.+.||+|+||.||+++.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999976 5889999998764333333456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999987543 588899999999999999999999 999999999999999999999999999988765
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||+...... ....+.......+ ...
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~-~~~ 264 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEYSIP-KHI 264 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCCC-TTS
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHhcCCCCCC-ccC
Confidence 5445556789999999999999899999999999999999999999997432110 0011111111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+||+.||++|||++|+++
T Consensus 265 ---~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 265 ---NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 235778999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=380.54 Aligned_cols=337 Identities=21% Similarity=0.186 Sum_probs=299.1
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
.+.+++.|++++|.++...+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46789999999999998777778999999999999999999999999999999999999999999888899999999999
Q ss_pred eecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccc
Q 042086 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 155 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (784)
+|++|.+++..+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.. +..+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999776677899999999999999999988989999999999999999998653 667889999999999998
Q ss_pred cccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccc
Q 042086 235 GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314 (784)
Q Consensus 235 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l 314 (784)
+. ...++|+.|++++|.++ .++..+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|
T Consensus 206 ~l-----~~~~~L~~L~ls~n~l~--~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 274 (597)
T 3oja_B 206 TL-----AIPIAVEELDASHNSIN--VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 274 (597)
T ss_dssp EE-----ECCTTCSEEECCSSCCC--EEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred cc-----cCCchhheeeccCCccc--cccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHh
Confidence 53 34468999999999987 344333 3689999999999996 4679999999999999999999999999
Q ss_pred cccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceE
Q 042086 315 GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSC 394 (784)
Q Consensus 315 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 394 (784)
..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|++++.. +..+++|+.
T Consensus 275 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~ 349 (597)
T 3oja_B 275 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKN 349 (597)
T ss_dssp TTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSE
T ss_pred cCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCE
Confidence 999999999999999998 6777888999999999999999 78888999999999999999999774 667889999
Q ss_pred EEcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCCC
Q 042086 395 IDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIK 431 (784)
Q Consensus 395 l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~ 431 (784)
|++++|+|.|.++.. .+.......+.+++..|+.+.
T Consensus 350 L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 350 LTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp EECCSSCEEHHHHHH-HTTTCCTTTBCCCCCCCCTTC
T ss_pred EEeeCCCCCChhHHH-HHHHHhhhccccccccCCcch
Confidence 999999999875432 344455556778889998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=358.76 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=191.6
Q ss_pred cCCCCc-eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhc-cCCCceeeEEeEEec----CC
Q 042086 515 NGFDVK-YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE-LRHRSIVKFYGFCSH----PR 587 (784)
Q Consensus 515 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~ 587 (784)
++|.+. +.||+|+||+||+|+.. +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 456666 78999999999999876 789999999853 3467889998754 489999999999865 56
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEecc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSDF 664 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 664 (784)
..++||||+++|+|.+++...+. ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence 78999999999999999986432 3589999999999999999999999 9999999999999997 788999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
|+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+....
T Consensus 209 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~i~~~~ 283 (400)
T 1nxk_A 209 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQ 283 (400)
T ss_dssp TTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC----CSHHHHHHHTC
T ss_pred ccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc----HHHHHHHHcCc
Confidence 999876532 2334567899999999999999999999999999999999999999643321100 00001111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.........++.+++.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111123346889999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.59 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=204.3
Q ss_pred HhcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH 585 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 585 (784)
..++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 457899999999999999999986 246689999997532 233467899999999999 89999999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeC
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAI--------------------EEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRD 645 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 645 (784)
.+..++||||+++|+|.+++...... ..+++..+..++.|++.||+|||++ +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999764321 2478999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCc
Q 042086 646 ISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDF 722 (784)
Q Consensus 646 lk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~ 722 (784)
|||+||+++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876543322 234567889999999999999999999999999999998 9999874
Q ss_pred cccccccccccccccccccCCCC-CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 723 ISSISSSSSNRNISLNEILDPRL-PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..... .....+.... ...+... ...+.+++.+||+.||++|||+.++++.|
T Consensus 278 ~~~~~--------~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDA--------NFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCSH--------HHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHH--------HHHHHHhcCCCCCCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 32211 0011111111 1111112 23578899999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=347.58 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=194.8
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 56889999999999999999886 788999998642 346789999999999999999999998864 5799999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc-eEEeccccccccCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE-ARVSDFGIAKFLKPD 673 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~DfG~a~~~~~~ 673 (784)
|+++|+|.++++.......+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999987665556888999999999999999999932229999999999999998886 799999999865432
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||+....... .....+.....+.....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~-- 228 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIMWAVHNGTRPPLIKN-- 228 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------HHHHHHHTTCCCCCBTT--
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------HHHHHHhcCCCCCcccc--
Confidence 2344689999999999999999999999999999999999999974321100 00000111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+.+++.+||+.||++|||++++++.|
T Consensus 229 -~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 229 -LPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -cCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 223578899999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.46 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=207.7
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 4567999999999999999999976 5889999998752 3346789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999976433 4588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 672 PDSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 672 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+........+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~ 234 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YELLEKDYRMERP 234 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------HHHHHTTCCCCCC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHhccCCCCCC
Confidence 43322 234457889999999998999999999999999999999 9999874322110 0011111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
... ...+.+++.+|++.||++|||++++++.|
T Consensus 235 ~~~---~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 235 EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC---CHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 122 23578899999999999999999998864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=368.55 Aligned_cols=250 Identities=24% Similarity=0.443 Sum_probs=199.1
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|..+++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 46789999999999999999999888889999987632 246789999999999999999999999976 6789999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999996421 12478899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCC
Q 042086 674 SSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRLPTPPQ 750 (784)
Q Consensus 674 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~ 750 (784)
... .....+++.|+|||.+....++.++|||||||++|||++ |+.||....... ....+.. .+++.+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~~~- 404 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMPCPP- 404 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCCT-
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCC-
Confidence 221 233456789999999999999999999999999999999 999986432211 0111111 1222222
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.. ...+.+++.+||+.||++|||++++++.|
T Consensus 405 ~~---~~~l~~li~~cl~~dP~~Rpt~~~l~~~L 435 (452)
T 1fmk_A 405 EC---PESLHDLMCQCWRKEPEERPTFEYLQAFL 435 (452)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 22 23578899999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=344.01 Aligned_cols=252 Identities=31% Similarity=0.487 Sum_probs=199.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC----CChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM----VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++........ ...+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367999999999999999999875 789999999876432221 11267999999999999999999999997654
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeeecCCCc-----eEE
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP--IVHRDISSKNVLLCLDYE-----ARV 661 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl 661 (784)
++||||+++|+|.+++.... ..+++..+..++.|++.|++|||++ + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999887543 3689999999999999999999998 7 999999999999988776 999
Q ss_pred eccccccccCCCCCcccccccccccccccccc--cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 662 SDFGIAKFLKPDSSNCTELVGTFGYIAPELVY--TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 662 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
+|||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||+........ ....
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK------FINM 241 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH------HHHH
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH------HHHH
Confidence 99999985432 344567899999999984 556788999999999999999999999743221100 0000
Q ss_pred ccCCCC-CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 740 ILDPRL-PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 740 ~~d~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+..... ...+. .....+.+++.+||+.||++|||++|+++.|
T Consensus 242 ~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 242 IREEGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp HHHSCCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhccCCCCCCCc---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 000111 11111 2233588999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=351.56 Aligned_cols=257 Identities=21% Similarity=0.352 Sum_probs=189.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEcC-C---CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTS-G---EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
..++|++.+.||+|+||.||+|+... + ..||||++..... .....+++.+|++++++++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34679999999999999999998653 3 3899999875422 22335789999999999999999999999987665
Q ss_pred e------EEEEecccCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 589 S------FLVYEYLERGSLATILSNDG---AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 589 ~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
. ++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999996432 122588999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNIS 736 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 736 (784)
||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... .
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~ 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------I 248 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------H
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--------H
Confidence 9999999987644322 1233456788999999999999999999999999999999 999987433211 1
Q ss_pred cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+........+.. ....+.+++.+||+.||++|||+.++++.|
T Consensus 249 ~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 249 YNYLIGGNRLKQPPE---CMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp HHHHHTTCCCCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcCCCCCCCCc---cCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111111111111112 223588999999999999999999988753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=358.65 Aligned_cols=264 Identities=19% Similarity=0.269 Sum_probs=203.0
Q ss_pred hcCCCCceeEecc--cceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 514 TNGFDVKYCIGIG--GQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 514 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
.++|++.+.||+| +||.||+|+.. +|+.||||++..... .....+.+.+|+.+++.++|||||++++++.+.+..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4679999999999 99999999986 799999999976422 1223467888999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999976432 3588999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCC-------Cccccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042086 671 KPDS-------SNCTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 671 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...................+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 3211 11233478999999999987 57899999999999999999999999643321100000000000000
Q ss_pred CCC---------------------------CCC-------CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 DPR---------------------------LPT-------PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 d~~---------------------------~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.. ... ...........+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 000 00011122346889999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=348.93 Aligned_cols=246 Identities=21% Similarity=0.246 Sum_probs=193.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 592 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++....... ....++..|+..+.++ +||||+++++++.+.+..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999987 79999999986543221 2234455666666555 899999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+ +++|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 669999887643 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
. .......||++|+|||++.+ .++.++|||||||++|||++|..|+....... .+.....+. ...
T Consensus 210 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~~~--~~~ 274 (311)
T 3p1a_A 210 A-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-----------QLRQGYLPP--EFT 274 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-----------HHTTTCCCH--HHH
T ss_pred C-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------HHhccCCCc--ccc
Confidence 3 23345579999999999876 78999999999999999999977654222110 111111100 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....++.+++.+||+.||++|||++|+++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112346889999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.26 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=199.8
Q ss_pred cCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|+..+.||+|+||.||+|+. .+++.||||++...........+++.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999986 479999999987543322233467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++ |+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 58888886432 3588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC-CCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP-RLPTPP 749 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~ 749 (784)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||........ ...+... ......
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPALQS 275 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHSCCCCCCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHHhcCCCCCCC
Confidence 3457899999999984 56789999999999999999999999864322110 0001111 111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... ...+.+++.+||+.||++|||++++++
T Consensus 276 ~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 276 GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 122 235778999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.22 Aligned_cols=253 Identities=19% Similarity=0.312 Sum_probs=202.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC---CChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM---VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||.||+|+.. +++.||+|.+........ ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999987 799999999876432221 23678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC----ceEEecccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY----EARVSDFGI 666 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~ 666 (784)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997543 588899999999999999999999 999999999999998877 799999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+......
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~ 229 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--------TLTNISAVNYD 229 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCC
T ss_pred ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--------HHHHhHhcccC
Confidence 98765432 2345578999999999999999999999999999999999999986432110 01111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
............+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 110000111335789999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=350.71 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=197.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCE----EEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEI----LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
++|++.+.||+|+||.||+|+.. +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++. .+..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 57999999999999999999865 4443 7888775432 2234567889999999999999999999986 4668
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 89999999999999997642 3678899999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 042086 670 LKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RL 745 (784)
Q Consensus 670 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~ 745 (784)
+..... ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||........ ...+... +.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--------PDLLEKGERL 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--------HHHHHTTCBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--------HHHHHcCCCC
Confidence 754432 2345567889999999999999999999999999999999 9999974322110 0001111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+ ... ...+.+++.+||+.||++|||++++++.|
T Consensus 237 ~~~-~~~---~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 237 AQP-QIC---TIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp CCC-TTB---CTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred CCC-CcC---cHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111 111 12467899999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=344.11 Aligned_cols=255 Identities=19% Similarity=0.261 Sum_probs=203.8
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.+++.+ +|+|++++++++.+....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-----CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 45799999999999999999986 47999999998643 2345788999999999 79999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc-----eEEecccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE-----ARVSDFGI 666 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfG~ 666 (784)
||||+ +++|.+++...+ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 84 v~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 899999998653 2588999999999999999999999 9999999999999987776 99999999
Q ss_pred ccccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 667 AKFLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 667 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~ 232 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYER 232 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----HHHHH
Confidence 987754322 134567999999999999999999999999999999999999999753221100 00000
Q ss_pred ccCCCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 740 ILDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 740 ~~d~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.......+ ..........+.+++.+||+.||++|||+++|++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 000000000 000001123688999999999999999999998764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.29 Aligned_cols=336 Identities=21% Similarity=0.182 Sum_probs=294.0
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
.+.+++.|++++|.++...+..|..+++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..++.+++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46889999999999997766668999999999999999998888899999999999999999998888999999999999
Q ss_pred eecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccc
Q 042086 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 155 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (784)
+|++|.++...+..|.++++|++|+|++|.+++..+..+..+++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999966556679999999999999999988888899999999999999999865 3677899999999999998
Q ss_pred cccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccc
Q 042086 235 GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETL 314 (784)
Q Consensus 235 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l 314 (784)
+. ...++|++|++++|++. .++.. ..++|+.|++++|.+++. ..+..+++|++|++++|.+++..|..+
T Consensus 200 ~~-----~~~~~L~~L~l~~n~l~--~~~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 268 (390)
T 3o6n_A 200 TL-----AIPIAVEELDASHNSIN--VVRGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPF 268 (390)
T ss_dssp EE-----ECCSSCSEEECCSSCCC--EEECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred cc-----CCCCcceEEECCCCeee--ecccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHc
Confidence 53 33468999999999997 33433 347999999999999864 578999999999999999999889999
Q ss_pred cccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceE
Q 042086 315 GNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSC 394 (784)
Q Consensus 315 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 394 (784)
..+++|++|+|++|++++ ++..+..+++|+.|+|++|++. .+|..+..+++|+.|+|++|+++... +..+++|+.
T Consensus 269 ~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~ 343 (390)
T 3o6n_A 269 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKN 343 (390)
T ss_dssp TTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSE
T ss_pred cccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCE
Confidence 999999999999999998 5667788999999999999999 67878899999999999999999763 677899999
Q ss_pred EEcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCC
Q 042086 395 IDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI 430 (784)
Q Consensus 395 l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 430 (784)
|++++|++.|.... ..+.......+.+++..|..+
T Consensus 344 L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 344 LTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp EECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred EEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 99999999986433 233344445566777778764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=370.18 Aligned_cols=345 Identities=25% Similarity=0.251 Sum_probs=299.4
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
+++++|+|++|+|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|.++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 57999999999999999999999999999999999999988999999999999999999999888899999999999999
Q ss_pred cCCCcccccCCccccccccceeeccccccCC-CccccccCccCCceeeccccccCCccchhhhccccc----ceeccCCC
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG-SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKML----LHLGLSTN 231 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L----~~L~L~~n 231 (784)
++|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..++.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999997766689999999999999999987 479999999999999999999998888899998888 78888888
Q ss_pred ccccccCC------------------------------------------------------------------------
Q 042086 232 HLSGVIPL------------------------------------------------------------------------ 239 (784)
Q Consensus 232 ~l~~~~~~------------------------------------------------------------------------ 239 (784)
.+++..+.
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred CceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence 77654443
Q ss_pred ---------CCcCCCCcceEEecCCCCCCCCccccc------------------------------------------cc
Q 042086 240 ---------SIGNLNNLIGLYLYDNQLSVGEIPIEI------------------------------------------GK 268 (784)
Q Consensus 240 ---------~l~~l~~L~~L~L~~n~l~~~~~~~~l------------------------------------------~~ 268 (784)
.+..+++|+.|++++|.++ .+|..+ ..
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~--~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE--RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEEC--SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred hhhhhhchhhhcCcCcccEEEecCccch--hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 3444567777777777665 333222 45
Q ss_pred ccccceEeccCccccCCC--CccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCc-hhhhcccccC
Q 042086 269 LSSLNYLVLNGNQLYGNL--PRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFP-VELEKLIQLS 345 (784)
Q Consensus 269 l~~L~~L~l~~n~l~~~~--~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~ 345 (784)
+++|++|++++|++++.. +..+..+++|++|++++|.+++..+ .+..+++|++|++++|.+.+..+ ..+..+++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 688999999999998654 6788899999999999999996544 49999999999999999998765 5789999999
Q ss_pred eeccCCccccccccccccccccccEEecCCCccC-CCCcccccCcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCC
Q 042086 346 ELDLSLNILEGKIPCEICNMESLEKLNLSHNNFS-GLIPSCFEGMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGN 423 (784)
Q Consensus 346 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n 423 (784)
.|++++|.+.+..|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++|++++..|.. ..........+.+|
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 504 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence 9999999999999999999999999999999998 678999999999999999999999977753 22334444455666
Q ss_pred C
Q 042086 424 K 424 (784)
Q Consensus 424 ~ 424 (784)
.
T Consensus 505 ~ 505 (570)
T 2z63_A 505 Q 505 (570)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.69 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=204.6
Q ss_pred HHhcCCCCceeEecccceEEEEEEEcC------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLTS------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
...++|++.+.||+|+||.||+|.... ++.||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345789999999999999999998652 3489999987642 122356799999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-----------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL 653 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 653 (784)
+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999964321 23578899999999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccc
Q 042086 654 CLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSS 730 (784)
Q Consensus 654 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~ 730 (784)
+.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||.......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--- 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---
Confidence 99999999999999876443222 234567889999999999899999999999999999998 999986432110
Q ss_pred cccccccccccCCCC-CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 731 SNRNISLNEILDPRL-PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 731 ~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.... ...+... ...+.+++.+||+.||++|||+.+|++.|
T Consensus 275 -----~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 275 -----KFYKLVKDGYQMAQPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp -----HHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----HHHHHHhcCCCCCCCCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 0001111110 0111112 23578899999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=348.13 Aligned_cols=255 Identities=22% Similarity=0.406 Sum_probs=206.2
Q ss_pred hcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 46799999999999999999985 257899999987542 122357799999999999 999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 587 RNSFLVYEYLERGSLATILSNDGA---------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999976432 12489999999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 9999999999999999877544322 234557889999999999999999999999999999999 999986432211
Q ss_pred cccccccccccccCCCCC-CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLP-TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+..... ..+.. ....+.+++.+||+.||++|||+.|+++.|
T Consensus 256 -------~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 256 -------KFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp -------HHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------HHHHHhccCCCCCCccc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 00011111110 11111 223578899999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=350.08 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=203.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 468999999999999999999863 57789999987532 222356789999999999 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 99999999999999999999976542 13488999999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 9999999999999999876543321 233456789999999998889999999999999999999 999986432110
Q ss_pred cccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+........+... ...+.+++.+||+.||++|||+.|+++.|
T Consensus 268 -------~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 268 -------LFKLLKEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp -------HHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------HHHHHhcCCCCCCCccC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00011111111111112 23578899999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.71 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=205.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999876 6889999998653222233457899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++...+ .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997643 478899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||+...... ....+.......+. ..
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~-~~ 235 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVDLKFPP-FL 235 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCT-TS
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccccCCCC-cC
Confidence 2 2345678999999999999999999999999999999999999997432211 11112222222221 12
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+|++.||++|||++++++
T Consensus 236 ---~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 236 ---SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 235778999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.56 Aligned_cols=252 Identities=21% Similarity=0.411 Sum_probs=203.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..++|++.+.||+|+||.||+|+..+++.||+|.+... ....+.+.+|+++++.++||||+++++++.+ +..++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC----cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 34679999999999999999999988889999998753 2346789999999999999999999999864 568999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999996432 12588899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 673 DSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 673 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+........+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~ 233 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYRMVRPD 233 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCCT
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--------HHHHHhcccCCCCcc
Confidence 3221 233456788999999998889999999999999999999 999986432110 001111111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.. ...+.+++.+|++.||++|||++++++.|
T Consensus 234 ~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 234 NC---PEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cc---cHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 22 23578899999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.44 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=207.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 356999999999999999999865 78999999987643 233467899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999864 3588999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+............
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~ 243 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--------FLIPKNNPPTLEGNY 243 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--------HHHHHSCCCCCCSSC
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH--------HHhhcCCCCCCcccc
Confidence 444445667899999999999999999999999999999999999998743221100 000001111111112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+||+.||++|||+.++++
T Consensus 244 ---~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 244 ---SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp ---CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 235788999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.13 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=200.9
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCC--CCCChhhHHHHHHHHhccC---CCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPC--EMVPQPEFVNEIKTLTELR---HRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||+||+|+.. +++.||+|++...... .......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999964 7899999998643321 2223457788888887774 99999999999765
Q ss_pred C-----ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 587 R-----NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 587 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
. ..++||||+. |+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 599999976543 3489999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------ccc
Q 042086 662 SDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--------SNR 733 (784)
Q Consensus 662 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--------~~~ 733 (784)
+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ...
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999999876533 33456688999999999999999999999999999999999999996432211000 000
Q ss_pred ccc-----c-ccccCCCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 734 NIS-----L-NEILDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 734 ~~~-----~-~~~~d~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
... . ...+.+..+.+ ....++....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 0 00000000000 00001123467899999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=369.20 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=208.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999976 7999999999765444455678899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee---cCCCceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~ 669 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999997653 588899999999999999999999 99999999999999 5678999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
+... .......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||....... ....+.........
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 179 FEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILKKVEKGKYTFEL 248 (484)
T ss_dssp BCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCS
T ss_pred cccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCCC
Confidence 7543 33455679999999999876 68999999999999999999999997432211 11111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 111223446889999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=358.25 Aligned_cols=263 Identities=20% Similarity=0.288 Sum_probs=208.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC--ceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR--NSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 591 (784)
++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 57999999999999999999976 59999999987532 2234678899999999999999999999998755 6799
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee----cCCCceEEeccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL----CLDYEARVSDFGIA 667 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfG~a 667 (784)
||||+++|+|.++++.......+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999997654444589999999999999999999999 99999999999999 77788999999999
Q ss_pred cccCCCCCccccccccccccccccccc--------CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYT--------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS---------- 729 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~---------- 729 (784)
+..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 876543 23345679999999999865 56788999999999999999999998632211100
Q ss_pred cc-cc------ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 730 SS-NR------NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 730 ~~-~~------~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+ .. .......+....+............+.+++.+||+.||++||+++++++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 00 00 00000011122233333446667789999999999999999999999865
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=359.97 Aligned_cols=330 Identities=22% Similarity=0.192 Sum_probs=290.1
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCC-CcCccCCCcCcEEeecCCCcccccCCccccccccceee
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSI-PPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH 179 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 179 (784)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 78999999999999999999999999999999999998655 67899999999999999999988899999999999999
Q ss_pred ccccccCCCcccc--ccCccCCceeeccccccCCccchh-hhcccccceeccCCCccccccCCCCcCC--CCcceEEecC
Q 042086 180 LSSNQLSGSIPIS--LGNLSNLVVLHLFENSLFGSIPSI-LGNLKMLLHLGLSTNHLSGVIPLSIGNL--NNLIGLYLYD 254 (784)
Q Consensus 180 L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~ 254 (784)
|++|.+++..+.. +..+++|++|+|++|.+++..|.. +.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999999866555 999999999999999999887776 8999999999999999999989888877 7999999999
Q ss_pred CCCCCCCcc-------cccccccccceEeccCccccCCCCccccC-----------------------------------
Q 042086 255 NQLSVGEIP-------IEIGKLSSLNYLVLNGNQLYGNLPRALGS----------------------------------- 292 (784)
Q Consensus 255 n~l~~~~~~-------~~l~~l~~L~~L~l~~n~l~~~~~~~l~~----------------------------------- 292 (784)
|.+...... ..+..+++|++|++++|++++..|..+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 998722110 12345689999999999987655443321
Q ss_pred ----CCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccc
Q 042086 293 ----LTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESL 368 (784)
Q Consensus 293 ----l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 368 (784)
.++|+.|++++|.+++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|.+++..|..+..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 2689999999999999999999999999999999999999889999999999999999999998889999999999
Q ss_pred cEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCCCCCCCCC
Q 042086 369 EKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGNKGLCGDI 430 (784)
Q Consensus 369 ~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~ 430 (784)
+.|+|++|++++..|..|..+++|++|++++|++++..+.. ..........+.+|+..|.-+
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999999999999999999999999999999999844432 234455566788898887754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=347.29 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=197.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 57999999999999999999976 699999999865422 1222466889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999999887543 478899999999999999999999 9999999999999999999999999999887655
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc------------cccccc
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRN------------ISLNEI 740 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~------------~~~~~~ 740 (784)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 544556689999999999976 5679999999999999999999999964332110000000 000000
Q ss_pred -cCCCCCCCCCC------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 -LDPRLPTPPQN------VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 -~d~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.+... .+.....+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00011111000 0112335789999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=355.39 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=189.9
Q ss_pred CCCCceeEecccceEEEEEEEc--CC--CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-CCceE
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT--SG--EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-PRNSF 590 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 590 (784)
.|++.+.||+|+||.||+|+.. ++ ..||||.+.... .....++|.+|+.++++++||||+++++++.+ ++..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4677899999999999999864 22 468999886532 23345789999999999999999999998754 56789
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.++++... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999997643 3578899999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC----cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042086 671 KPDSS----NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 671 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
..... ......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||....... ....+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~ 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCC
Confidence 43221 1233457789999999999999999999999999999999 677776432211 0111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+...+ ..+.+++.+||+.||++|||++|+++.|
T Consensus 315 ~~~p~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 315 LLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11122222 3578899999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=339.34 Aligned_cols=249 Identities=19% Similarity=0.315 Sum_probs=200.6
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--CceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 591 (784)
.++|++.+.||+|+||.||+|+.+ ++.||||++..... .....+.|.+|+.++++++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 357999999999999999999986 88999999876422 222346799999999999999999999999877 78899
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP--IVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
||||+++|+|.++++.... ..+++..+..++.|++.||+|||+. + |+||||||+||+++.++.++++|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999986432 3589999999999999999999998 7 99999999999999999999999998765
Q ss_pred cCCCCCcccccccccccccccccccCCcCc---chhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-CCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTE---KCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL-DPRL 745 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-d~~~ 745 (784)
... ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||........ ...+. ....
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~ 229 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--------GMKVALEGLR 229 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--------HHHHHHSCCC
T ss_pred ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--------HHHHHhcCCC
Confidence 332 3346899999999998765554 79999999999999999999974332110 00010 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+... ...+.+++.+||+.||++|||++++++.|
T Consensus 230 ~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 230 PTIPPGI---SPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111122 23578899999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=351.26 Aligned_cols=260 Identities=19% Similarity=0.256 Sum_probs=193.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 57999999999999999999976 789999999875432 122334568999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++ +|.+++...+. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp ECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ccccc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 99985 99999876543 588899999999999999999999 9999999999999999999999999999876554
Q ss_pred CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccccccccc----
Q 042086 674 SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNISLNEIL---- 741 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~---- 741 (784)
........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... ............
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 444556678999999999876 56899999999999999999999999643211000 000000000000
Q ss_pred --CCCCCCCC-C----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 --DPRLPTPP-Q----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 --d~~~~~~~-~----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+... . ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 0 00111235789999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=347.67 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=194.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|... +|+.||+|++...........+++.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999874 7999999998764333333456799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986421 123578899999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......+.....+...
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~-- 259 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPLP-- 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHHHHHTTCSCCCC--
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHHHhhcccCCCCc--
Confidence 54444455678999999999999999999999999999999999999986321100 0000111111111110
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......++.+++.+||+.||++|||+++|++.|
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 011223578899999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.46 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=202.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe--cCCceE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS--HPRNSF 590 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 590 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 357999999999999999999876 789999999875422 2223567999999999999999999999874 456789
Q ss_pred EEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEEeCCCCCCeeecCCCceEEecc
Q 042086 591 LVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPP-----IVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
+||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999997532 123589999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
|+++.............|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~ 232 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGK 232 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--------HHHHHhhcc
Confidence 999876544333345678999999999999899999999999999999999999987432210 011111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+... ..++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 233 FRRIPYRY---SDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCccc---CHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11111122 2357889999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.05 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=202.3
Q ss_pred cCCCCceeEecccceEEEEEEE-----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--C
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--R 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 587 (784)
..|++.+.||+|+||.||+|++ .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4589999999999999999983 368999999997643 334567899999999999999999999999876 6
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 6899999999999999996543 3588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccc-------cccccccccc
Q 042086 668 KFLKPDSS---NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS-------SSSSNRNISL 737 (784)
Q Consensus 668 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~-------~~~~~~~~~~ 737 (784)
..+..... ......+|..|+|||.+.+..++.++||||||+++|||++|..|+....... ..........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 88765432 2234567888999999999999999999999999999999999864321100 0000000000
Q ss_pred ccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+... +...+ . .....+.+++.+||+.||++|||++++++.|
T Consensus 254 ~~~~~~~~~~~~-~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 254 NTLKEGKRLPCP-P---NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHTTCCCCCC-T---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHhccCCCCCC-C---CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 111111 11111 1 2223688999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=351.34 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=196.1
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC--CceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH--RSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 591 (784)
.+.|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.+++.++| |||+++++++.++...++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 356999999999999999999998999999999875422 22234678999999999976 999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||| +.+|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 56779999998653 578899999999999999999999 999999999999997 6789999999998765
Q ss_pred CCCC--ccccccccccccccccccc-----------CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 672 PDSS--NCTELVGTFGYIAPELVYT-----------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 672 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~ 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHHHH
Confidence 4332 2345679999999999865 67889999999999999999999999642210 01112
Q ss_pred cccCCCCCC-CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EILDPRLPT-PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~d~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.++++.... .+... ...+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 232 AIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcCCcccCCcccC---CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 222222111 11111 235778999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.43 Aligned_cols=260 Identities=21% Similarity=0.382 Sum_probs=207.6
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeE
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGF 582 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 582 (784)
++....++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......++.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 33445678999999999999999999764 47889999987532 22234578999999999999999999999
Q ss_pred EecCCceEEEEecccCCCHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 583 CSHPRNSFLVYEYLERGSLATILSNDG-------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 583 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
+.+.+..++||||+++|+|.++++... ....+++..+.+++.|++.||+|||++ +|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 999999999999999999999996422 224578899999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042086 656 DYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSN 732 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~ 732 (784)
++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 247 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------ 247 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------
Confidence 999999999999865433221 233456889999999999899999999999999999999 89998643221
Q ss_pred cccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 733 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+........+... ...+.+++.+||+.||++|||+.|+++.|
T Consensus 248 --~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 248 --QVLRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp --HHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHcCCcCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111111122222112222 23578899999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.52 Aligned_cols=251 Identities=22% Similarity=0.383 Sum_probs=195.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCE----EEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEI----LAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
.++|++.+.||+|+||.||+|+.. +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 357999999999999999999865 4543 5777775432 3345678999999999999999999999998754
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 789999999999999997653 3588899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042086 669 FLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-R 744 (784)
Q Consensus 669 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~ 744 (784)
.+...... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||+...... ....+... .
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~ 237 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER 237 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence 76543222 233456788999999999999999999999999999999 999997432211 00111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.+ .. ....+.+++.+||+.||++|||+.|+++.|
T Consensus 238 ~~~~-~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 238 LPQP-PI---CTIDVYMIMRKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp CCCC-TT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCC-cc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111 11 223578899999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.16 Aligned_cols=266 Identities=21% Similarity=0.259 Sum_probs=198.9
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC--CCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE--MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
...++|++.+.||+|+||.||+|+.. +|+.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999976 68999999987543221 1123578899999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999987 8999887543 3577888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccccc--ccc
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRN--ISL 737 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~--~~~ 737 (784)
.+...........||+.|+|||.+.+. .++.++|||||||++|||++|..||......... ..... ...
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 876555555667899999999999764 4788999999999999999999998643221100 00000 000
Q ss_pred ccccCCC-CCCCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 738 NEILDPR-LPTPPQNV-----QDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 738 ~~~~d~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
....+.. ....+... ......+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 00000000 1123468899999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=348.33 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=195.6
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++++++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999976 789999999876433222234679999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999997643 588899999999999999999999 99999999999999999999999999998765
Q ss_pred CCC-CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 672 PDS-SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 672 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+......+..
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---------MGAHINQAIPRPST 256 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---------HHHHHHSCCCCGGG
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---------HHHHhccCCCCccc
Confidence 432 22345578999999999999999999999999999999999999997432110 00000011110000
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRP-PMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RP-s~~~vl~~L 784 (784)
........+.+++.+||+.||++|| +++++++.|
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 0111223578899999999999999 999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=361.00 Aligned_cols=256 Identities=22% Similarity=0.300 Sum_probs=193.2
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCC-----CCCChhhHHHHHHHHhccCCCceeeEEeEEec
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPC-----EMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH 585 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 585 (784)
...++|.+.+.||+|+||.||+|... +++.||||++...... .......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999876 6899999998653211 12233468999999999999999999999865
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEe
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVS 662 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~ 662 (784)
+..++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 55789999999999999886543 588999999999999999999999 99999999999999754 459999
Q ss_pred ccccccccCCCCCccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 663 DFGIAKFLKPDSSNCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 663 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-------~~~~~ 356 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------SLKDQ 356 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-------CHHHH
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-------HHHHH
Confidence 99999876532 33345689999999999863 567889999999999999999999996322110 00011
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+........+.........+.+++.+||+.||++|||++|+++
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111111111111112346889999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.69 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=197.2
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC--CCceeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR--HRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 592 (784)
..|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45999999999999999999988899999999875422 2223567999999999996 59999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|| +.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56789999998654 578889999999999999999999 999999999999995 68999999999987654
Q ss_pred CCC--ccccccccccccccccccc-----------CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 673 DSS--NCTELVGTFGYIAPELVYT-----------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 673 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~~ 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHA 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHHH
Confidence 332 2345679999999999865 3688899999999999999999999963221 0111222
Q ss_pred ccCCCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
++++..... +... ...+.+++.+||+.||++|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 280 IIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 333222111 1111 235788999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.06 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=197.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 357999999999999999999875 68999999987643 233467899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee---cCCCceEEecccccc
Q 042086 593 YEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAK 668 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~ 668 (784)
|||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999885421 123588899999999999999999999 99999999999999 455789999999998
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
.+... .......||+.|+|||.+. ..++.++||||||+++|||++|+.||.......... . .....+.....
T Consensus 176 ~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~---~---~~~~~~~~~~~ 247 (285)
T 3is5_A 176 LFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ---K---ATYKEPNYAVE 247 (285)
T ss_dssp C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H---HHHCCCCCCC-
T ss_pred ecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh---h---hccCCcccccc
Confidence 76543 2334567899999999885 468899999999999999999999997432111000 0 00001111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CRP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 1235778999999999999999999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=367.72 Aligned_cols=354 Identities=21% Similarity=0.171 Sum_probs=267.9
Q ss_pred EEEEeCCCcccC----CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccC
Q 042086 63 ISINLSTVGLKG----NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLS 138 (784)
Q Consensus 63 ~~l~l~~~~~~~----~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 138 (784)
..+++.+.++.. -.++|++|+|++|+|++..|..|.++++|++|+|++|++++..|.+|+++++|++|+|++|+++
T Consensus 34 ~~l~ls~~~L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (562)
T 3a79_B 34 SMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113 (562)
T ss_dssp CEEECTTSCCCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred cEEEcCCCCCccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC
Confidence 445555554432 2367999999999999888889999999999999999999988999999999999999999998
Q ss_pred CCCCcCccCCCcCcEEeecCCCcccc-cCCccccccccceeeccccccCCCccccccCccCC--ceeecccccc--CCcc
Q 042086 139 GSIPPTLGNLSNLAVLHLYGNSLSGS-IPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL--VVLHLFENSL--FGSI 213 (784)
Q Consensus 139 ~~~p~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~ 213 (784)
.+|.. .+++|++|+|++|++++. +|..|+++++|++|+|++|.+++. .+..+++| +.|++++|.+ ++..
T Consensus 114 -~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~ 187 (562)
T 3a79_B 114 -NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGE 187 (562)
T ss_dssp -EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSS
T ss_pred -ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccC
Confidence 56665 799999999999999863 467899999999999999998853 34555555 9999999888 6655
Q ss_pred chhhhccc------------------------------------------------------------------------
Q 042086 214 PSILGNLK------------------------------------------------------------------------ 221 (784)
Q Consensus 214 ~~~l~~l~------------------------------------------------------------------------ 221 (784)
|..+..+.
T Consensus 188 ~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~ 267 (562)
T 3a79_B 188 TESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267 (562)
T ss_dssp CCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHH
T ss_pred cccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHH
Confidence 55554422
Q ss_pred ---------ccceeccCCCccccccCCCC-----cCCC--------------------------CcceEEecCCCCCCCC
Q 042086 222 ---------MLLHLGLSTNHLSGVIPLSI-----GNLN--------------------------NLIGLYLYDNQLSVGE 261 (784)
Q Consensus 222 ---------~L~~L~L~~n~l~~~~~~~l-----~~l~--------------------------~L~~L~L~~n~l~~~~ 261 (784)
+|++|++++|.+++.+|..+ ..++ +|+.|++++|.+....
T Consensus 268 ~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~ 347 (562)
T 3a79_B 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347 (562)
T ss_dssp HHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC
T ss_pred HHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc
Confidence 67777777777777777655 3332 3555555555543111
Q ss_pred cccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCC--CcccccccccceEEecccccccCCCc-hhh
Q 042086 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNS--IPETLGNLLKLHYLNLSNNQFRKGFP-VEL 338 (784)
Q Consensus 262 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~--~~~~l~~l~~L~~L~ls~N~l~~~~~-~~~ 338 (784)
....+++|++|++++|++++..|..+..+++|+.|++++|++++. +|..+.++++|++|++++|++++.+| ..+
T Consensus 348 ---~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 424 (562)
T 3a79_B 348 ---CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC 424 (562)
T ss_dssp ---CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCC
T ss_pred ---CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhh
Confidence 115678888888888888887888888888888888888888863 34668888888888888888887444 457
Q ss_pred hcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC--CCCcCCC
Q 042086 339 EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS--RIFQYDP 416 (784)
Q Consensus 339 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~~~~ 416 (784)
..+++|+.|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++ +|.. ..+....
T Consensus 425 ~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~ 500 (562)
T 3a79_B 425 AWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQ 500 (562)
T ss_dssp CCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCC
T ss_pred cCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCC
Confidence 7888888888888888877776554 68888888888888 456655688888888888888884 5553 2334444
Q ss_pred cccccCCCCCCCC
Q 042086 417 MEALQGNKGLCGD 429 (784)
Q Consensus 417 ~~~~~~n~~~c~~ 429 (784)
...+.+|++.|.-
T Consensus 501 ~L~l~~N~~~c~c 513 (562)
T 3a79_B 501 YIWLHDNPWDCTC 513 (562)
T ss_dssp CEECCSCCBCCCH
T ss_pred EEEecCCCcCCCc
Confidence 5567788877753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.49 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=201.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 457999999999999999999976 79999999987542 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee---cCCCceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~ 669 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 85 MQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp ECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999987543 478899999999999999999999 99999999999999 7789999999999976
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.......+.
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~ 228 (304)
T 2jam_A 159 EQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--------LFEKIKEGYYEFES 228 (304)
T ss_dssp CCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHCCCCCCT
T ss_pred cCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCCc
Confidence 432 22344578999999999999999999999999999999999999986422110 00111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122346889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=359.83 Aligned_cols=245 Identities=15% Similarity=0.133 Sum_probs=192.3
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHH---HHHhccCCCceeeEE-------eE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEI---KTLTELRHRSIVKFY-------GF 582 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 582 (784)
.++|++.+.||+|+||.||+|+. .+|+.||||++...........+.|.+|+ ++++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35788999999999999999996 47999999999765444444567899999 555566899999998 66
Q ss_pred EecCC-----------------ceEEEEecccCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 042086 583 CSHPR-----------------NSFLVYEYLERGSLATILSNDGA----IEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641 (784)
Q Consensus 583 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 641 (784)
+.+++ ..++||||+ +|+|.+++...+. ...+++..+..++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 278999999 6799999975321 12345688889999999999999999 99
Q ss_pred EEeCCCCCCeeecCCCceEEeccccccccCCCCCcccccccccccccccccccC-----------CcCcchhHHHHHHHH
Q 042086 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM-----------KVTEKCDVYSFGVLA 710 (784)
Q Consensus 642 vH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslGv~l 710 (784)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999998643 23345567 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 711 LEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 711 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
|||++|+.||....... ....+.. .. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~--------~~~~~~~-~~----~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALG--------GSEWIFR-SC----KNI---PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------C--------CSGGGGS-SC----CCC---CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCccccccc--------chhhhhh-hc----cCC---CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999986432211 1111111 11 111 235788999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=338.56 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=201.0
Q ss_pred cCCCCce-eEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKY-CIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|.+.+ .||+|+||.||+|... +++.||||++.... .....+++.+|+++++.++||||+++++++. .+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcE
Confidence 4566666 8999999999999854 67889999987642 2234567999999999999999999999994 56789
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999996543 3588999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 042086 671 KPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 671 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~i~~~~~~ 232 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRM 232 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHhcCCcC
Confidence 543322 223456889999999998889999999999999999998 999987432211 00111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+.. ....+.+++..||+.||++||++.++++.|
T Consensus 233 ~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 233 ECPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCC---cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11112 233688899999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=342.50 Aligned_cols=246 Identities=21% Similarity=0.390 Sum_probs=197.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CC-------CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SG-------EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 585 (784)
.++|++.+.||+|+||.||+|+.. ++ +.||+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 357899999999999999999865 33 57999998653 23346789999999999999999999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc-------
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE------- 658 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~------- 658 (784)
++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999997653 2488899999999999999999999 9999999999999998887
Q ss_pred -eEEeccccccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCC-CCCcccccccccccccc
Q 042086 659 -ARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDH-PRDFISSISSSSSNRNI 735 (784)
Q Consensus 659 -~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~-p~~~~~~~~~~~~~~~~ 735 (784)
+||+|||++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.. |+.......
T Consensus 159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------- 226 (289)
T 4fvq_A 159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------- 226 (289)
T ss_dssp EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------
T ss_pred eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--------
Confidence 99999999975432 234568899999999987 678999999999999999999554 443221110
Q ss_pred ccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 736 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...........+... ..++.+++.+||+.||++|||++++++.|
T Consensus 227 -~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 227 -KLQFYEDRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp -HHHHHHTTCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred -HHHHhhccCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 000000111111111 12477899999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.22 Aligned_cols=198 Identities=24% Similarity=0.298 Sum_probs=175.0
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-----CCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-----HRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+..|+.+++.++ ||||+++++++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 4578999999999999999999975 7899999998642 223466888999999986 99999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-----------
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL----------- 655 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----------- 655 (784)
+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchh
Confidence 9999999999 8899999976542 3588999999999999999999999 9999999999999975
Q ss_pred --------------CCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCC
Q 042086 656 --------------DYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRD 721 (784)
Q Consensus 656 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~ 721 (784)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 788999999999865432 245678999999999999999999999999999999999999996
Q ss_pred c
Q 042086 722 F 722 (784)
Q Consensus 722 ~ 722 (784)
.
T Consensus 261 ~ 261 (360)
T 3llt_A 261 T 261 (360)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=339.57 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=198.9
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
+|.....||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 4555669999999999999975 6899999998754 23345789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-CCceEEeccccccccCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~ 673 (784)
|+++++|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999998754444567888999999999999999999 9999999999999987 899999999999877544
Q ss_pred CCcccccccccccccccccccCC--cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMK--VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
........|++.|+|||.+.+.. ++.++||||||+++|||++|+.||.......... ... ......+.. +..
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~-~~~~~~~~~---~~~ 250 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM--FKV-GMFKVHPEI---PES 250 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--HHH-HHHCCCCCC---CTT
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--Hhh-ccccccccc---ccc
Confidence 43445567899999999997653 7889999999999999999999986432111000 000 000011111 111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...++.+++.+||+.||++|||+.++++
T Consensus 251 ---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 ---MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2235788999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=376.80 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=210.6
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 590 (784)
..++|++.+.||+|+||.||+|+.. +++.||||++...........+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999876 6889999998754322334567788999999988 7999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998653 588899999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......++......+..
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~ 564 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPKS 564 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSCCCCCTT
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCcc
Confidence 5455556677899999999999999999999999999999999999999974221 12222333333333222
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPM-----HTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~~vl~ 782 (784)
...++.+++.+||+.||++||++ +||++
T Consensus 565 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 565 ----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 23357889999999999999997 77764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.02 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=193.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999865 789999999975432 22234567899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-----CCCceEEecccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC-----LDYEARVSDFGI 666 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-----~~~~~kl~DfG~ 666 (784)
||||+++ +|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 9999997654 478899999999999999999999 999999999999994 455699999999
Q ss_pred ccccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------cc--ccc
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--------SN--RNI 735 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--------~~--~~~ 735 (784)
++.............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .. ...
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 98876554555666789999999999875 48999999999999999999999996432211000 00 000
Q ss_pred cccc--ccCCCCCCCCCCCHH------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 SLNE--ILDPRLPTPPQNVQD------ELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 ~~~~--~~d~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.... ......+........ ...++.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 000001100000001 1246789999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.69 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=197.1
Q ss_pred HHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc--CCCceeeEEeEEecC--
Q 042086 511 VRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL--RHRSIVKFYGFCSHP-- 586 (784)
Q Consensus 511 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-- 586 (784)
....++|++.+.||+|+||.||+|+.+ ++.||||++... ....+..|.+++... +||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 344578999999999999999999986 899999998542 244566676666655 899999999999876
Q ss_pred --CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEeCCCCCCeeecCCCce
Q 042086 587 --RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC-----FPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 587 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
...++||||+++|+|.++++.. .+++..+..++.|++.||+|||++. .++|+||||||+||+++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6789999999999999999754 4888999999999999999999762 3489999999999999999999
Q ss_pred EEeccccccccCCCCCc----ccccccccccccccccccCCcCcc------hhHHHHHHHHHHHHhCCC----------C
Q 042086 660 RVSDFGIAKFLKPDSSN----CTELVGTFGYIAPELVYTMKVTEK------CDVYSFGVLALEVIKGDH----------P 719 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslGv~l~elltg~~----------p 719 (784)
||+|||+++.+...... .....||+.|+|||.+.+...+.+ +|||||||++|||+||.. |
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999876543322 124579999999999987766654 999999999999999944 4
Q ss_pred CCccccccccccccccccccccC-CCCCC-CCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 720 RDFISSISSSSSNRNISLNEILD-PRLPT-PPQ--NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~d-~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
|........ ......+.+. ..... .+. ...+...++.+++.+||+.||++|||+.+|++.|
T Consensus 262 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 262 YHDLVPSDP----SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp TTTTSCSSC----CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HhhhcCCCC----chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 432111100 0000011111 11111 111 1125567799999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.06 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=196.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +|+.||||.+...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999999999986 79999999986543223345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999997643 478899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||+...... ....+.......+ ...
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~~ 234 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------LFKKIRGGVFYIP-EYL 234 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCC-TTS
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcCcccCc-hhc
Confidence 22345578999999999987765 579999999999999999999986422110 0111111111111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+++.+|++.||++|||+.|+++
T Consensus 235 ---~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 235 ---NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 235778999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=345.80 Aligned_cols=251 Identities=27% Similarity=0.475 Sum_probs=196.2
Q ss_pred cCCCCceeEecccceEEEEEEEcC-----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTS-----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+|++.+.||+|+||.||+|+... +..||||.+.... ......++.+|+.+++.++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 467888999999999999998652 3469999987532 222355789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999997643 3688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-R 744 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~ 744 (784)
....... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+.+. +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCCc
Confidence 6543221 223346788999999999999999999999999999999 99998643211 011111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.+ .. ....+.+++.+||+.||++||++.++++.|
T Consensus 269 ~~~~-~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 269 LPTP-MD---CPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp CCCC-TT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCc-cc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111 12 223578899999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.99 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=207.0
Q ss_pred HHHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC-----CChhhHHHHHHHHhcc-CCCceeeE
Q 042086 507 YEEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM-----VPQPEFVNEIKTLTEL-RHRSIVKF 579 (784)
Q Consensus 507 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l 579 (784)
+.......++|++.+.||+|+||.||+|+.. +|+.||||++........ ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444555678999999999999999999986 799999999875421110 1135688999999999 89999999
Q ss_pred EeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 580 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
++++......++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999754 3588899999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCccccccccccccccccccc------CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR 733 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 733 (784)
||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 240 kl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------ 312 (365)
T 2y7j_A 240 RLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------ 312 (365)
T ss_dssp EECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred EEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------
Confidence 99999999877643 23355689999999999863 357889999999999999999999986322110
Q ss_pred ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+..................+.+++.+||+.||++|||+.++++
T Consensus 313 --~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 --MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111111111100000011235889999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.27 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=190.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||.||+|+... .||+|++..... .....+.|.+|+.+++.++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 5689999999999999999998653 599999875432 222346799999999999999999999976 456789999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999996543 3688999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 674 --SSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 674 --~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......... ..........+.....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IEMVGRGSLSPDLSKV 250 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH---HHHHHHTSCCCCTTSS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH---HHHhcccccCcchhhc
Confidence 22234467899999999986 667888999999999999999999999743221100 0000000111111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ......+.+++.+||+.||++|||++++++.|
T Consensus 251 ~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 251 R---SNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred c---ccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1 12234688999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=370.83 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=197.0
Q ss_pred CCCCce-eEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 516 GFDVKY-CIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 516 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
.+.+.+ .||+|+||.||+|.+. ++..||||+++... .....++|.+|++++++++|||||++++++.. +..++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 344444 7999999999999864 46789999997642 33456889999999999999999999999976 56899
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 413 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999997543 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCC
Q 042086 672 PDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLP 746 (784)
Q Consensus 672 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~ 746 (784)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+... ++.
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~~ 559 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRME 559 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------HHHHHHTTCCCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence 43221 122345689999999999999999999999999999998 999997433211 11111111 122
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+ ... ..++.+++..||+.||++||++.+|++.|
T Consensus 560 ~p-~~~---~~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 560 CP-PEC---PPELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp CC-TTC---CHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred CC-CcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22 222 23578899999999999999999998764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=377.36 Aligned_cols=339 Identities=21% Similarity=0.273 Sum_probs=294.1
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEc-cCCccccc---------------------------------------
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYL-YRNSLSAS--------------------------------------- 116 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L-~~n~l~~~--------------------------------------- 116 (784)
..++.|+|++|+++|.+|+.|++|++|++|+| ++|.++|.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 47999999999999999999999999999999 77765544
Q ss_pred -------------------------------------CCCCCCCCCCCCEEEccCCccCC-----------------CCC
Q 042086 117 -------------------------------------IPPVIGNLKFLYHLDLSENQLSG-----------------SIP 142 (784)
Q Consensus 117 -------------------------------------~p~~l~~l~~L~~L~L~~n~l~~-----------------~~p 142 (784)
+|..|+++++|++|+|++|++++ .+|
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 78889999999999999999998 389
Q ss_pred cCcc--CCCcCcEEeecCCCcccccCCccccccccceeeccccc-cCC-CccccccCcc-------CCceeeccccccCC
Q 042086 143 PTLG--NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQ-LSG-SIPISLGNLS-------NLVVLHLFENSLFG 211 (784)
Q Consensus 143 ~~l~--~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~n~l~~ 211 (784)
+.++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++.++ +|+.|+|++|+++
T Consensus 483 ~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~- 561 (876)
T 4ecn_A 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE- 561 (876)
T ss_dssp SCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-
T ss_pred hhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-
Confidence 9988 99999999999999999999999999999999999998 998 7888776665 9999999999999
Q ss_pred ccch--hhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccc-cceEeccCccccCCCCc
Q 042086 212 SIPS--ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS-LNYLVLNGNQLYGNLPR 288 (784)
Q Consensus 212 ~~~~--~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~-L~~L~l~~n~l~~~~~~ 288 (784)
.+|. .++++++|+.|+|++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|.
T Consensus 562 ~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~--~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE--EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS--CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc--cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 7787 8999999999999999999 778 8999999999999999998 88989999999 999999999999 7888
Q ss_pred cccCCCc--cceeecccCccCCCCccc---cc--ccccceEEecccccccCCCchhhhcccccCeeccCCcccccccccc
Q 042086 289 ALGSLTE--LEYLDLSTNKLGNSIPET---LG--NLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCE 361 (784)
Q Consensus 289 ~l~~l~~--L~~L~Ls~n~l~~~~~~~---l~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 361 (784)
.+..++. |+.|+|++|.+++.+|.. +. .+++|+.|+|++|+++...+..+..+++|+.|+|++|+++ .+|..
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~ 715 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN 715 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChH
Confidence 8877754 999999999999876643 22 3458999999999999644444568999999999999999 77765
Q ss_pred cccc--------ccccEEecCCCccCCCCccccc--CcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCCC
Q 042086 362 ICNM--------ESLEKLNLSHNNFSGLIPSCFE--GMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGNK 424 (784)
Q Consensus 362 ~~~l--------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~ 424 (784)
+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|.. ..+.......+..|+
T Consensus 716 ~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~ 787 (876)
T 4ecn_A 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR 787 (876)
T ss_dssp SSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB
T ss_pred HhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC
Confidence 5443 39999999999999 6788876 99999999999999998 6642 223334444455543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=339.50 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=197.5
Q ss_pred hcCCCCceeEecccceEEEEEEEcC----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe-cCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS-HPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 588 (784)
...|++.+.||+|+||.||+|+..+ +..||+|.+.... .....+.+.+|+.++++++||||+++++++. .++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 3468889999999999999998642 3368999887532 2223567999999999999999999999864 5567
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 899999999999999997643 3578899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC----CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 042086 669 FLKPDS----SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 669 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
.+.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... ....+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~ 248 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQG 248 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHHHTT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhcC
Confidence 764322 12234567889999999999999999999999999999999 555654322111 11111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+...+ ..+.+++.+||+.||++|||++|+++.|
T Consensus 249 ~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 249 RRLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111122222 3578899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.97 Aligned_cols=259 Identities=18% Similarity=0.263 Sum_probs=203.5
Q ss_pred HHHHhcCCCCc-eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 510 IVRATNGFDVK-YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 510 ~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.....+.|.+. +.||+|+||.||+|+.. +++.||+|++..... ......++.+|+.+++.+ +||||+++++++.+.
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 34456678877 89999999999999876 699999999876432 223467899999999999 579999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEec
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSD 663 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~D 663 (784)
+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999986432 24689999999999999999999999 9999999999999987 78999999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+...
T Consensus 178 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~ 248 (327)
T 3lm5_A 178 FGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------TYLNISQV 248 (327)
T ss_dssp GGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred CccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------HHHHHHhc
Confidence 99998765332 2345679999999999999999999999999999999999999996432211 00011111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+..........+.+++.+||+.||++|||++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111111122345788999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.43 Aligned_cols=251 Identities=21% Similarity=0.363 Sum_probs=198.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcC----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||.||+|+... +..||+|.+.... .....+.|.+|+.+++.++||||+++++++.+ +..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 4679999999999999999998642 3469999987642 22245779999999999999999999999875 456
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 89999999999999997543 2578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCC
Q 042086 670 LKPDSS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLP 746 (784)
Q Consensus 670 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~ 746 (784)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--------~~~~~~~~~~~ 234 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--------IGVLEKGDRLP 234 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--------HHHHHHTCCCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--------HHHHhcCCCCC
Confidence 654322 2234457889999999998899999999999999999998 9999863322110 0011111 111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+ ... ...+.+++.+||+.||++|||+.|+++.|
T Consensus 235 ~~-~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 235 KP-DLC---PPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp CC-TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CC-CCC---CHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 11 122 23578899999999999999999999764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.23 Aligned_cols=355 Identities=23% Similarity=0.226 Sum_probs=250.0
Q ss_pred CCeEEEEeCCCccc-------CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEc
Q 042086 60 KRVISINLSTVGLK-------GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132 (784)
Q Consensus 60 ~~v~~l~l~~~~~~-------~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 132 (784)
.+++.+++....+. +.+++|++|+|++|+|++..|..|+++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 35666666665432 35677777777777777777777777777777777777777 45544 6777777777
Q ss_pred cCCccCC-CCCcCccCCCcCcEEeecCCCcccccCCcccccccc--ceeecccccc--CCCccccccC------------
Q 042086 133 SENQLSG-SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSL--FYLHLSSNQL--SGSIPISLGN------------ 195 (784)
Q Consensus 133 ~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L--~~L~L~~n~l--~~~~~~~~~~------------ 195 (784)
++|.+++ .+|..|+.+++|++|+|++|.+++ ..+..+++| ++|+|++|.+ .+..|..+..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 7777776 356777777777777777777765 345566666 7777777777 5555554443
Q ss_pred --------------ccCCceeeccccc-------cCCccchhhhc---------------------------ccccceec
Q 042086 196 --------------LSNLVVLHLFENS-------LFGSIPSILGN---------------------------LKMLLHLG 227 (784)
Q Consensus 196 --------------l~~L~~L~L~~n~-------l~~~~~~~l~~---------------------------l~~L~~L~ 227 (784)
+++|+.|++++|. +.+.++ .++. .++|++|+
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~ 253 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred Ccchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence 3444555554443 111111 1111 23677777
Q ss_pred cCCCccccccCCCC-----cCCCCcceEEecCCCCCCCCccc-------------------------c-cccccccceEe
Q 042086 228 LSTNHLSGVIPLSI-----GNLNNLIGLYLYDNQLSVGEIPI-------------------------E-IGKLSSLNYLV 276 (784)
Q Consensus 228 L~~n~l~~~~~~~l-----~~l~~L~~L~L~~n~l~~~~~~~-------------------------~-l~~l~~L~~L~ 276 (784)
+++|++++.+|..+ ..+++|+.+++++|.+ .+|. . ...+++|++|+
T Consensus 254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~---~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~ 330 (520)
T 2z7x_B 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF---GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330 (520)
T ss_dssp EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC---CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEE
T ss_pred eecccccCccccchhhcccccCceeEeccccccce---ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEE
Confidence 77777777777776 6666666666665554 1220 0 15678889999
Q ss_pred ccCccccCCCCccccCCCccceeecccCccCC--CCcccccccccceEEecccccccCCCch-hhhcccccCeeccCCcc
Q 042086 277 LNGNQLYGNLPRALGSLTELEYLDLSTNKLGN--SIPETLGNLLKLHYLNLSNNQFRKGFPV-ELEKLIQLSELDLSLNI 353 (784)
Q Consensus 277 l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~--~~~~~l~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~ 353 (784)
+++|++++..|..+..+++|++|++++|++++ .+|..+..+++|++|++++|++++.+|. .+..+++|+.|++++|+
T Consensus 331 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~ 410 (520)
T 2z7x_B 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410 (520)
T ss_dssp CCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred eECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence 99999988888888889999999999999886 4567788889999999999998885554 47888899999999999
Q ss_pred ccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC--CCCcCCCcccccCCCCCCC
Q 042086 354 LEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS--RIFQYDPMEALQGNKGLCG 428 (784)
Q Consensus 354 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~ 428 (784)
+++.+|..+. ++|+.|+|++|+++ .+|..+..+++|++|++++|++++ +|.. ..+.......+.+|+..|.
T Consensus 411 l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 411 LTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence 8887776664 78999999999988 567767788999999999999885 6653 2233444456677776665
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.93 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=196.6
Q ss_pred cCCCCc-eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 515 NGFDVK-YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 515 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
+.|++. +.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC---SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC---cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 567774 78999999999999865 7999999998754 233567899999999985 79999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc---eEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE---ARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~a~ 668 (784)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999997643 578899999999999999999999 9999999999999998776 9999999998
Q ss_pred ccCCCCC-------ccccccccccccccccccc-----CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc---
Q 042086 669 FLKPDSS-------NCTELVGTFGYIAPELVYT-----MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR--- 733 (784)
Q Consensus 669 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~--- 733 (784)
....... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6543211 1223468999999999875 558899999999999999999999997432211000000
Q ss_pred ----ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 ----NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 ----~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.......+..........+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0001111111111110000112346889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=364.05 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=199.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||+||+|+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356999999999999999999976 7899999998764322 23467899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~~ 669 (784)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887543 478899999999999999999999 99999999999999764 5599999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
+... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....+.........
T Consensus 189 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 189 FENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGKYTFDS 258 (494)
T ss_dssp CBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCCS
T ss_pred CCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCc
Confidence 7543 2335567999999999986 46899999999999999999999999743221 111111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111122346789999999999999999999985
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=366.62 Aligned_cols=352 Identities=27% Similarity=0.269 Sum_probs=271.4
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
+++++|||++|+|++..+.+|.++++|++|+|++|+|+++.|.+|+++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999999888889999999999999999999888888999999999999999998777778899999999999
Q ss_pred cCCCcccccCCccccccccceeeccccccCC-CccccccCccCCceeeccccccCCccchhhhccccc------------
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG-SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKML------------ 223 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L------------ 223 (784)
++|++++..+..|+++++|++|+|++|.+++ ..|..++.+++|++|+|++|++++..+..|..+.++
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999997777788999999999999999875 357788889999999999998876665554433322
Q ss_pred --------------------------------------------------------------------------------
Q 042086 224 -------------------------------------------------------------------------------- 223 (784)
Q Consensus 224 -------------------------------------------------------------------------------- 223 (784)
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence
Q ss_pred ---------------------------------------ceeccCCCccccccC-------------------CCCcCCC
Q 042086 224 ---------------------------------------LHLGLSTNHLSGVIP-------------------LSIGNLN 245 (784)
Q Consensus 224 ---------------------------------------~~L~L~~n~l~~~~~-------------------~~l~~l~ 245 (784)
+.|++.+|.+.+..+ .....++
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~ 371 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 371 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT
T ss_pred cccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc
Confidence 222222222211110 0112356
Q ss_pred CcceEEecCCCCCCC------------------------CcccccccccccceEeccCccccCCCC-ccccCCCccceee
Q 042086 246 NLIGLYLYDNQLSVG------------------------EIPIEIGKLSSLNYLVLNGNQLYGNLP-RALGSLTELEYLD 300 (784)
Q Consensus 246 ~L~~L~L~~n~l~~~------------------------~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~ 300 (784)
+|+.|++++|.+... ..+..+..+++|+.+++..|......+ ..+..+++++.++
T Consensus 372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred ccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 777777777766411 122345567788888888877765443 4677888888999
Q ss_pred cccCccCCCCcccccccccceEEeccccccc-CCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccC
Q 042086 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFR-KGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFS 379 (784)
Q Consensus 301 Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 379 (784)
++.|.+.+..+..+..+++|+.|++++|.+. +..|..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|+
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~ 531 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 531 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence 9999888888888888888999999888744 456778888888999999999888888888888889999999999988
Q ss_pred CCCcccccCcccceEEEcCCCCCcccCCCCC-CC-cCCCcccccCCCCCCC
Q 042086 380 GLIPSCFEGMHGLSCIDVSYNELRGPIPNSR-IF-QYDPMEALQGNKGLCG 428 (784)
Q Consensus 380 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-~~-~~~~~~~~~~n~~~c~ 428 (784)
+..|..|..+++|++|||++|++++..|..- .+ .......+.+||+.|+
T Consensus 532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 8888888888889999999998888776532 11 3344556788888885
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.86 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=199.0
Q ss_pred hcCCCCce-eEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKY-CIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+ .||+|+||.||+|.+. +++.||||++..... .....+++.+|+.+++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 45788888 9999999999999643 478999999876421 222356899999999999999999999999 55678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999998653 478899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~ 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGER 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC
Confidence 7544322 122346788999999998889999999999999999999 999987432211 0001111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+.. ....+.+++.+||+.||++|||+.++++.|
T Consensus 239 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 239 MGCPAG---CPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp CCCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111112 233588899999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=364.96 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=201.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC----------CCChhhHHHHHHHHhccCCCceeeEEeE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE----------MVPQPEFVNEIKTLTELRHRSIVKFYGF 582 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 582 (784)
.++|++.+.||+|+||+||+|+.. +++.||+|++....... ....+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 568999999999999999999976 68999999987643221 1345679999999999999999999999
Q ss_pred EecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC---ce
Q 042086 583 CSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY---EA 659 (784)
Q Consensus 583 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~ 659 (784)
+.+....++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999987643 588999999999999999999999 999999999999998776 69
Q ss_pred EEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
||+|||++..+... .......||+.|+|||.+. ..++.++||||+||++|+|++|+.||...... .....
T Consensus 189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIKK 258 (504)
T ss_dssp EECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred EEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 99999999877543 3345567999999999987 46899999999999999999999999743211 11111
Q ss_pred ccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.......+.........++.+++.+||+.||++|||++|+++
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111110000112346889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=363.97 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=203.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 457999999999999999999976 799999999865322 223467899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec---CCCceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG~a~~ 669 (784)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887543 588899999999999999999999 999999999999995 456799999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
+... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+.........
T Consensus 174 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 174 FQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGKYAFDL 243 (486)
T ss_dssp BCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCSCS
T ss_pred CCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC
Confidence 6543 23345679999999999876 5899999999999999999999998642211 111111111111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111223346889999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=342.31 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=193.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR- 587 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 587 (784)
..++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 4567999999999999999999764 355899999875422 1223467999999999999999999999997655
Q ss_pred ----ceEEEEecccCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceE
Q 042086 588 ----NSFLVYEYLERGSLATILSND---GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEAR 660 (784)
Q Consensus 588 ----~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 660 (784)
..++||||+++|+|.+++... .....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 349999999999999998532 2234689999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccc
Q 042086 661 VSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISL 737 (784)
Q Consensus 661 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 737 (784)
|+|||+++.+..... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~ 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------MY 259 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HH
Confidence 999999987654321 2234457889999999999999999999999999999999 889986432211 11
Q ss_pred ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+........+. .....+.+++.+||+.||++|||+.++++.|
T Consensus 260 ~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 260 DYLLHGHRLKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp HHHHTTCCCCCBT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCCCc---cccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111111111111 1223588899999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=340.92 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=201.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..+.|++.+.||+|+||.||+|... +|+.||+|.+... ...+++.+|+.+++.++||||+++++++.+.+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4568999999999999999999876 6999999998753 235789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999986432 3588899999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .......+....
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~---- 247 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-----MIPTNPPPTFRK---- 247 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSCCCCCSS----
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhcCCCcccCC----
Confidence 54444455678999999999999999999999999999999999999997433211000 000000011111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112346889999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=343.40 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=199.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEE--EEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEIL--AVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||.||+|+.. +++.+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 57999999999999999999865 56644 899886532 233456799999999999 8999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 591 LVYEYLERGSLATILSNDG-------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997653 224689999999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042086 658 EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNIS 736 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 736 (784)
.+||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... .
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~ 250 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------L 250 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------H
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------H
Confidence 9999999999754321 12233456889999999998889999999999999999998 999986432211 0
Q ss_pred cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+........+... ...+.+++.+||+.||++|||++++++.|
T Consensus 251 ~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 251 YEKLPQGYRLEKPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp HHHGGGTCCCCCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhhcCCCCCCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0111111111111112 23578899999999999999999999764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.76 Aligned_cols=251 Identities=24% Similarity=0.430 Sum_probs=203.8
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..++|++.+.||+|+||.||+|++.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 346789999999999999999999888899999997632 246789999999999999999999999976 678999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999996421 12478899999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCC
Q 042086 673 DSS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRLPTPP 749 (784)
Q Consensus 673 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~ 749 (784)
... ......++..|+|||.+....++.++|||||||++|||++ |+.||....... ....+.. .++..+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~~- 486 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMPCP- 486 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--------HHHHHHTTCCCCCC-
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC-
Confidence 211 1123456788999999999999999999999999999999 999986432211 0011111 122222
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
... ...+.+++.+||+.||++|||+++|++.|
T Consensus 487 ~~~---~~~l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 487 PEC---PESLHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 122 23578899999999999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=336.78 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=200.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 467999999999999999999986 7999999998764322 22356788999999999 99999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC--------------
Q 042086 592 VYEYLERGSLATILSNDGA-IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-------------- 656 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-------------- 656 (784)
||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975321 13588999999999999999999999 99999999999999844
Q ss_pred -----CceEEeccccccccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 042086 657 -----YEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS 730 (784)
Q Consensus 657 -----~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~ 730 (784)
..+||+|||.+...... ....||+.|+|||.+.+. .++.++|||||||++|||++|..|+......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---- 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---- 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----
T ss_pred ccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----
Confidence 47999999999876543 234589999999999866 5668999999999999999999876422111
Q ss_pred cccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 731 SNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 731 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
..+.....+..+.... ..+.+++.+||+.||++|||+.|+++.
T Consensus 238 -------~~~~~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 -------HEIRQGRLPRIPQVLS---QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHTTCCCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHcCCCCCCCcccC---HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111222222222222 357889999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.35 Aligned_cols=262 Identities=21% Similarity=0.345 Sum_probs=206.6
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEE
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFY 580 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 580 (784)
.++....++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|+.+++++ +||||++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34444567899999999999999999974 357899999987642 222345789999999999 799999999
Q ss_pred eEEecCC-ceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC
Q 042086 581 GFCSHPR-NSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDI 646 (784)
Q Consensus 581 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 646 (784)
+++...+ ..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9987654 58999999999999999976543 12278899999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 042086 647 SSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFI 723 (784)
Q Consensus 647 k~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~ 723 (784)
||+||+++.++.+||+|||+++.+...... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999876543322 234567889999999999999999999999999999998 99998643
Q ss_pred ccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 724 SSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.... .....+........+... ...+.+++.+||+.||++|||+.++++.|
T Consensus 255 ~~~~-------~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 255 KIDE-------EFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp CCSH-------HHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhH-------HHHHHhccCccCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2110 000001111111111111 23578899999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=337.86 Aligned_cols=256 Identities=19% Similarity=0.285 Sum_probs=197.4
Q ss_pred HhcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEE-ecCCceE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFC-SHPRNSF 590 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~ 590 (784)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.+++.++|++++..++++ .+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 457899999999999999999997 478999999865432 234688999999999888777666655 6677889
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee---cCCCceEEeccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIA 667 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a 667 (784)
+||||+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 889999997543 2589999999999999999999999 99999999999999 78899999999999
Q ss_pred cccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042086 668 KFLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 668 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~ 230 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERI 230 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----HHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-----hhhhh
Confidence 87654332 2235678999999999999999999999999999999999999997433211100 00011
Q ss_pred cCCCCCCCCC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 741 LDPRLPTPPQ-NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 741 ~d~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.......+.. ........+.+++..||+.||++|||+++|++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 1101100000 0001123688999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=357.84 Aligned_cols=258 Identities=19% Similarity=0.268 Sum_probs=194.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------ 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 586 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++..... .....+++.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 467999999999999999999866 689999999875421 222356788999999999999999999999654
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 356999999987 57776643 378899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cc------c
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SS------N 732 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~------~ 732 (784)
|+..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......... .. .
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9876533 2345578999999999999999999999999999999999999999743211000 00 0
Q ss_pred cccccccccCCCC----------------CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 RNISLNEILDPRL----------------PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 ~~~~~~~~~d~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+.... +...........++.+|+.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000011000 0000001112457889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.77 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=203.5
Q ss_pred hcCCCCceeEecccceEEEEEEE-----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe--cC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS--HP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~ 586 (784)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 35799999999999999999984 36889999998753 2223567999999999999999999999986 45
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 66889999999999999997532 2588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc------cccccccc
Q 042086 667 AKFLKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------SSNRNISL 737 (784)
Q Consensus 667 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------~~~~~~~~ 737 (784)
++........ .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9877543321 23346788899999999988999999999999999999999998632211000 00000000
Q ss_pred cccc-CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEIL-DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~-d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.+ .......+. .....+.+++.+||+.||++|||++++++.|
T Consensus 254 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 254 LELLEEGQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhhcccCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0111 111111111 2233588999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.94 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=197.4
Q ss_pred CCCCceeEecccceEEEEEEEc-C---CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce-E
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-S---GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS-F 590 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~ 590 (784)
.|+..+.||+|+||+||+|+.. + +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4666799999999999999854 2 2379999987532 222356789999999999999999999999776655 9
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+|+||+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999997643 3678899999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC----CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCC-CCccccccccccccccccccccCCCC
Q 042086 671 KPDS----SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP-RDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 671 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
.... .......+++.|+|||.+.+..++.++||||||+++|||++|..| |....... ....+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~ 246 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--------LTHFLAQGRR 246 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--------HHHHHHTTCC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--------HHHHhhcCCC
Confidence 4321 223345678899999999999999999999999999999996555 43221110 0011111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+... ...+.+++.+||+.||++|||++++++.|
T Consensus 247 ~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 247 LPQPEYC---PDSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCccc---hHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1111222 23578899999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=353.03 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=201.4
Q ss_pred cCCCCceeEecccceEEEEEEE----cCCCEEEEEEcCCCCC-CCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKL----TSGEILAVKKFHSLWP-CEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 588 (784)
++|++.+.||+|+||.||+|+. .+++.||||++..... ......+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 3789999999875321 1123456678899999999 69999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999997643 578899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-Cccccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 669 FLKPDS-SNCTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 669 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
.+.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .......+.....
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~~ 283 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSEP 283 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhccCC
Confidence 764322 22345679999999999985 3478899999999999999999999963221100 0000111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHh
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRP-----PMHTVCQL 783 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~~ 783 (784)
..+ . .....+.+++.+||+.||++|| +++|+++.
T Consensus 284 ~~~-~---~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 284 PYP-Q---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CCC-T---TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCC-c---ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 111 1 2223577899999999999999 99999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.69 Aligned_cols=244 Identities=17% Similarity=0.139 Sum_probs=197.6
Q ss_pred hcCCCCceeEecccceEEEEEE------EcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC---CCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAK------LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR---HRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 584 (784)
.++|++.+.||+|+||+||+|. ..+++.||||++... ...++..|+.+++.++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4679999999999999999994 447899999998653 3567889999998887 999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-------
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDG--AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL------- 655 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~------- 655 (784)
..+..++||||+++|+|.++++... ....+++..++.++.||++||+|||++ +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999997421 234689999999999999999999998 9999999999999998
Q ss_pred ----CCceEEeccccccccCC--CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 042086 656 ----DYEARVSDFGIAKFLKP--DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS 729 (784)
Q Consensus 656 ----~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~ 729 (784)
++.+||+|||+|+.+.. ........+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 89999999999976542 223345667999999999999999999999999999999999999998532110
Q ss_pred ccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHH
Q 042086 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRP-PMHTVCQ 782 (784)
Q Consensus 730 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~~vl~ 782 (784)
.. .+.......+ . ...+.+++..|++.+|.+|+ +++++.+
T Consensus 292 ----~~----~~~~~~~~~~--~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 292 ----EC----KPEGLFRRLP--H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ----EE----EECSCCTTCS--S---HHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ----ce----eechhccccC--c---HHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00 0111111111 1 23566788899999999985 6666554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=341.97 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=200.5
Q ss_pred CCCceeEecccceEEEEEEEc-----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC--Cce
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP--RNS 589 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 589 (784)
|++.+.||+|+||.||++.+. +++.||||++.... .....+.+.+|++++++++||||+++++++.+. ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 489999999999999998643 68899999987642 222356799999999999999999999999874 578
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 8999999999999999764 378899999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccc------cccccccccccc
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISS------SSSNRNISLNEI 740 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~------~~~~~~~~~~~~ 740 (784)
....... .....+|+.|+|||.+.+..++.++||||||+++|||+||+.||........ ..........+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 7644321 2344678889999999998999999999999999999999999864221000 000000001111
Q ss_pred cCCC-CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 741 LDPR-LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 741 ~d~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+... ....+. .....+.+++.+||+.||++|||++|+++.|
T Consensus 264 ~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 264 LERGERLPRPD---KCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhcccCCCCCc---cccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1111 111111 2234688999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=336.29 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=200.1
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEE-ecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFC-SHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.+++.++|++++..++++ .+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46899999999999999999997 579999999886532 245799999999999988776666655 56677899
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee---cCCCceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~ 668 (784)
||||+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 99999 889999997443 3589999999999999999999999 99999999999999 478899999999998
Q ss_pred ccCCCCCc-------ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042086 669 FLKPDSSN-------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 669 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~ 231 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----QKYERIS 231 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-----SHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-----hhhhhhc
Confidence 76544321 24567999999999999999999999999999999999999999743321100 0001111
Q ss_pred CCCCCCCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 742 DPRLPTPP-QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 742 d~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
......+. ........++.+++.+||+.||++|||+++|++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred ccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 10100000 00001123588899999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.90 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=193.0
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-CceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-RNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.+ |+.||||.+... ...+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 467999999999999999999875 889999998753 2457899999999999999999999997554 478999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.+++...+. ..+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999975321 2378889999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+........+..
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 238 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAPDG 238 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCCTT
T ss_pred c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCccc
Confidence 2 223467889999999999899999999999999999998 999987432211 0011111111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+.+++.+||+.||++|||+.++++.|
T Consensus 239 ---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 239 ---CPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---CCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 223578899999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=345.28 Aligned_cols=261 Identities=24% Similarity=0.318 Sum_probs=199.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--------
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-------- 585 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 585 (784)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 57999999999999999999974 799999999876532 23345678899999999999999999999976
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
.+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999986 8888776543 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC----Cccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----------
Q 042086 666 IAKFLKPDS----SNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS----------- 729 (784)
Q Consensus 666 ~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~----------- 729 (784)
+++.+.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998765322 22345678999999999876 45799999999999999999999998743211000
Q ss_pred -ccccccccccccCC-CC-CCCCCCCHHH------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 -SSNRNISLNEILDP-RL-PTPPQNVQDE------LISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 -~~~~~~~~~~~~d~-~~-~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+..+. .. ........+. ...+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000000000000 00 0000111111 234789999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=341.69 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=195.2
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec-----
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH----- 585 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 585 (784)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC----cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 4678999999999999999999975 7899999998653 23457899999999999 89999999999976
Q ss_pred -CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 586 -PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 586 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence 467899999999999999997643 23588899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
|++..............|++.|+|||.+. +..++.++|||||||++|||++|+.||......... ..
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~ 245 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------FL 245 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--------HH
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--------HH
Confidence 99987654433445567899999999987 566889999999999999999999998643321100 00
Q ss_pred cc-CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 740 IL-DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 740 ~~-d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+. .+......... ...+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSCCCCCSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCccccCCcccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000001111 235788999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=333.24 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=203.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 457999999999999999999976 78999999986532 223457899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+..+..
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999998654 3588899999999999999999999 999999999999999999999999999986543
Q ss_pred CC--CcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 673 DS--SNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 673 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.. .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||+....... ....+.......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~-- 228 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYL-- 228 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-------HHHHHHTTCTTS--
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHhhhccccc--
Confidence 22 22345678999999999987765 6789999999999999999999974322100 000111111000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011122345788999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=343.32 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=196.7
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCC-----CCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWP-----CEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||.||+|+.. +++.||||.+..... ........+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999876 689999999875422 1122345689999999999999999999999765
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc---eEEec
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE---ARVSD 663 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~D 663 (784)
. .++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999987543 588899999999999999999999 9999999999999987654 99999
Q ss_pred cccccccCCCCCcccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
||+++..... .......||+.|+|||.+. ...++.++|||||||++|||++|+.||....... .....+
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~ 232 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------SLKDQI 232 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-------CHHHHH
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-------HHHHHH
Confidence 9999876432 2234457899999999974 5668899999999999999999999986322110 000011
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+.........+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111111111000112346889999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.13 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=202.6
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhc--cCCCceeeEEeEEecCC
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE--LRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 587 (784)
.....++|++.+.||+|+||.||+|+.. ++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3445678999999999999999999985 899999998642 35678899999887 78999999999998775
Q ss_pred ----ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEeCCCCCCeeecC
Q 042086 588 ----NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH--------HDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 588 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlk~~Nill~~ 655 (784)
..++||||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+||+++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 789999999999999999753 4889999999999999999999 66 9999999999999999
Q ss_pred CCceEEeccccccccCCCCCc----ccccccccccccccccccC------CcCcchhHHHHHHHHHHHHhC---------
Q 042086 656 DYEARVSDFGIAKFLKPDSSN----CTELVGTFGYIAPELVYTM------KVTEKCDVYSFGVLALEVIKG--------- 716 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~elltg--------- 716 (784)
++.+||+|||++......... .....||+.|+|||.+.+. .++.++|||||||++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876544322 2445789999999999765 344689999999999999999
Q ss_pred -CCCCCccccccccccccccccccccCCCCCCC-CC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 717 -DHPRDFISSISSSSSNRNISLNEILDPRLPTP-PQ--NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 717 -~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.||........ ........+........ +. ...+....+.+++.+||+.||++|||+.+|++.|
T Consensus 263 ~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 263 YQLPYYDLVPSDP---SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCTTTTTSCSSC---CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccCccccCcCcc---cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 666653221100 00000111111111111 11 1225566799999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=344.38 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=199.8
Q ss_pred hcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 587 (784)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ......++.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 46799999999999999999983 257899999986432 2233567899999999999999999999999999
Q ss_pred ceEEEEecccCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceE
Q 042086 588 NSFLVYEYLERGSLATILSNDGA----IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEAR 660 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~k 660 (784)
..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999976532 13588999999999999999999999 9999999999999984 44699
Q ss_pred EeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccc
Q 042086 661 VSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISL 737 (784)
Q Consensus 661 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 737 (784)
|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVL 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HHH
Confidence 999999986543221 2234567899999999998899999999999999999998 99998643211 001
Q ss_pred ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 738 ~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+........+... ...+.+++.+||+.||++|||+.++++.|
T Consensus 256 ~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp HHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCCCCCCCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111111111111222 23578899999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.33 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=197.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 467999999999999999999986 6899999998754 334567899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999986532 2588999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
.........||+.|+|||.+. ...++.++||||||+++|||++|+.||........ ...+.....+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~ 241 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--------LLKIAKSDPPT 241 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHSCCCC
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--------HHHHhccCCcc
Confidence 212223457899999999983 66788999999999999999999999874332110 00000000000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. .........+.+++.+||+.||++|||+.++++
T Consensus 242 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 L-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c-CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 011122346889999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=345.35 Aligned_cols=260 Identities=26% Similarity=0.361 Sum_probs=194.4
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHH--hccCCCceeeEEeEEec-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTL--TELRHRSIVKFYGFCSH-----P 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~-----~ 586 (784)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++. ..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46899999999999999999977 5899999998642 244555555554 45899999999986532 2
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEeCCCCCCeeecCCCceE
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC------FPPIVHRDISSKNVLLCLDYEAR 660 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~k 660 (784)
...++||||+++|+|.++++.. ..++..+..++.|+++||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 3568999999999999999764 3478889999999999999999873 23899999999999999999999
Q ss_pred EeccccccccCCCC--------Cccccccccccccccccccc-------CCcCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 042086 661 VSDFGIAKFLKPDS--------SNCTELVGTFGYIAPELVYT-------MKVTEKCDVYSFGVLALEVIKGDHPRDFISS 725 (784)
Q Consensus 661 l~DfG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~elltg~~p~~~~~~ 725 (784)
|+|||+++.+.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765321 11234579999999999986 4567799999999999999999877642221
Q ss_pred ccccccc---------ccc-----ccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 726 ISSSSSN---------RNI-----SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 726 ~~~~~~~---------~~~-----~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....... ... .......+.++............+.+++.+||+.||++|||++|+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 1100000 000 0001111222222222334566799999999999999999999998864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=349.81 Aligned_cols=256 Identities=11% Similarity=0.023 Sum_probs=182.0
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc--CCCceeeEE-------eEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL--RHRSIVKFY-------GFCS 584 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 584 (784)
..|++.+.||+|+||.||+|++. +|+.||||++...........+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999976 7899999999875433333456678885544444 699988755 4443
Q ss_pred cC-----------------CceEEEEecccCCCHHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCe
Q 042086 585 HP-----------------RNSFLVYEYLERGSLATILSNDGAIEEFNWTVR------MNVIRSVANALSYMHHDCFPPI 641 (784)
Q Consensus 585 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i 641 (784)
.+ ...++||||++ |+|.++++..+. .+.+..+ ..++.||+.||+|||++ +|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 33 23799999999 799999975422 2344455 67889999999999999 99
Q ss_pred EEeCCCCCCeeecCCCceEEeccccccccCCCCCccccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCC
Q 042086 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHP 719 (784)
Q Consensus 642 vH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p 719 (784)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987542 2224567799999999987 6789999999999999999999999
Q ss_pred CCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 720 RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
|........... ...............+ ........+.+++.+||+.||++|||+.++++
T Consensus 293 f~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSW-KRPSLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCC-CBCCTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccch-hhhhhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 975422110000 0000001111111111 01122346888999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.82 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=195.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcC------CCEEEEEEcCCCCCCC--------CCChhhHHHHHHHHhccCCCceeeE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS------GEILAVKKFHSLWPCE--------MVPQPEFVNEIKTLTELRHRSIVKF 579 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l 579 (784)
.++|++.+.||+|+||.||+|.+.+ ++.||||++....... ......+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998764 4789999986532100 0011224445556677789999999
Q ss_pred EeEEecC----CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-
Q 042086 580 YGFCSHP----RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC- 654 (784)
Q Consensus 580 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~- 654 (784)
++++.+. ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 9998764 4579999999 999999997643 3689999999999999999999999 999999999999999
Q ss_pred -CCCceEEeccccccccCCCCCc-------ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 042086 655 -LDYEARVSDFGIAKFLKPDSSN-------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI 726 (784)
Q Consensus 655 -~~~~~kl~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~ 726 (784)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||+.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876533211 13445999999999999999999999999999999999999999742211
Q ss_pred ccc----ccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 727 SSS----SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 727 ~~~----~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
... .........+++++.+.. ... ..++.+++..||+.||++||++++|++.|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPA--ANA---PGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCT--TCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhccc--ccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 000 000001111222222111 111 23578899999999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.32 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=205.1
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC------CChhhHHHHHHHHhccC-CCceeeEEeEEe
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM------VPQPEFVNEIKTLTELR-HRSIVKFYGFCS 584 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 584 (784)
..++|++.+.||+|+||.||+|+.. +|+.||||++........ ...+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999976 689999999875432111 12356889999999995 999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
+.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999997643 578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccccccc------cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVY------TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
|++..+.... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ...
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLR 239 (298)
T ss_dssp TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH
T ss_pred cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--------HHH
Confidence 9998765432 334567899999999985 4567889999999999999999999986432110 011
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+.......+..........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111111111112233446889999999999999999999975
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=367.20 Aligned_cols=350 Identities=25% Similarity=0.247 Sum_probs=269.6
Q ss_pred ccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCC-----CCCc----CccCCC
Q 042086 79 LSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSG-----SIPP----TLGNLS 149 (784)
Q Consensus 79 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----~~p~----~l~~l~ 149 (784)
|++|+|++|++++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|++++|...+ .+|. .|..++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 7777777777777777777777777777777777777777777777777777777765443 2222 566777
Q ss_pred cCcEEeecCCCcccccCCccccccccceeeccccccCCCc--cccccCc--cCCceeeccccccCCccchhhhcccccce
Q 042086 150 NLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI--PISLGNL--SNLVVLHLFENSLFGSIPSILGNLKMLLH 225 (784)
Q Consensus 150 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~~~~~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 225 (784)
+|++|++++|.+++..+..|.++++|++|++++|.+.... ...|..+ ++|+.|++++|++++..+..|..+++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 7888888888887777777777788888888777654321 2223322 47788888888888777888888888888
Q ss_pred eccCCCccccccC-CCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCcccc--CCCCccccCCCccceeecc
Q 042086 226 LGLSTNHLSGVIP-LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLY--GNLPRALGSLTELEYLDLS 302 (784)
Q Consensus 226 L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~--~~~~~~l~~l~~L~~L~Ls 302 (784)
|++++|++++.+| ..|.++++|++|++++|++. ...+..+..+++|+.|++++|.+. +..|..+..+++|+.|+++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls 488 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL-QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEE-ECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcc-eeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence 8888888876655 57788888888888888876 334556778888888888888876 5678888899999999999
Q ss_pred cCccCCCCcccccccccceEEecccccccCCCc--------hhhhcccccCeeccCCccccccccccccccccccEEecC
Q 042086 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFP--------VELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374 (784)
Q Consensus 303 ~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 374 (784)
+|++++..+..|..+++|++|++++|++++..+ ..+..+++|+.|+|++|+++...+..|.++++|+.|+|+
T Consensus 489 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 568 (680)
T 1ziw_A 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECC
Confidence 999998777888899999999999999886422 237888999999999999994444568899999999999
Q ss_pred CCccCCCCcccccCcccceEEEcCCCCCcccCCCCC--CCcCCCcccccCCCCCCCC
Q 042086 375 HNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSR--IFQYDPMEALQGNKGLCGD 429 (784)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~ 429 (784)
+|++++..+..|..+++|+.|++++|++++..|... .+.......+.+||+.|+-
T Consensus 569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 999998888888899999999999999988655321 2445556678899999874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=365.77 Aligned_cols=163 Identities=24% Similarity=0.190 Sum_probs=135.2
Q ss_pred cccceeEEcCC---CCeEEEEeCCCcc-------cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCC
Q 042086 49 CAWFGIQCNPA---KRVISINLSTVGL-------KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIP 118 (784)
Q Consensus 49 C~w~gv~C~~~---~~v~~l~l~~~~~-------~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 118 (784)
|.+.+++.-|. ..++.+++.+..+ .+.+++|++|+|++|+|++..|..|+++++|++|+|++|++++..|
T Consensus 12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 91 (549)
T 2z81_A 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS 91 (549)
T ss_dssp CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence 45566665543 4688888887643 3578899999999999999999999999999999999999998888
Q ss_pred CCCCCCCCCCEEEccCCccCCC-CCcCccCCCcCcEEeecCCCcccccC-CccccccccceeeccccccCCCccccccC-
Q 042086 119 PVIGNLKFLYHLDLSENQLSGS-IPPTLGNLSNLAVLHLYGNSLSGSIP-SIIGNLKSLFYLHLSSNQLSGSIPISLGN- 195 (784)
Q Consensus 119 ~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~- 195 (784)
..|+++++|++|+|++|.+++. .|..++++++|++|++++|.+.+.+| ..|.++++|++|++++|.+++..|..+..
T Consensus 92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 171 (549)
T 2z81_A 92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171 (549)
T ss_dssp HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence 8899999999999999999873 57789999999999999998444454 68999999999999999999877777654
Q ss_pred -----------------------ccCCceeeccccccCC
Q 042086 196 -----------------------LSNLVVLHLFENSLFG 211 (784)
Q Consensus 196 -----------------------l~~L~~L~L~~n~l~~ 211 (784)
+++|++|++++|++++
T Consensus 172 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp SEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred ccCceEecccCcccccchhhHhhcccccEEEccCCcccc
Confidence 5677777777887765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.20 Aligned_cols=202 Identities=26% Similarity=0.432 Sum_probs=163.6
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCC--
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPR-- 587 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-- 587 (784)
...++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34678999999999999999999875 799999999865322 2223567889999999997 999999999997544
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||++ |+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 6899999998 5999998753 578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC---------------------CCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 668 KFLKPD---------------------SSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 668 ~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
+.+... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 875431 112344679999999999986 6789999999999999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.04 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=198.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 357999999999999999999976 589999999865421 122245688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.++....+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999998876543 488899999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccccc----------------cccc
Q 042086 673 DSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSS----------------NRNI 735 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~----------------~~~~ 735 (784)
.........||+.|+|||.+.+. .++.++|||||||++|||++|+.||........... ....
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 54445566799999999999875 688999999999999999999999964332110000 0000
Q ss_pred ccccccCCCCCCCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 SLNEILDPRLPTPPQ---NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 ~~~~~~d~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+....... ..+.....+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000011100000 00112346889999999999999999999986
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=364.42 Aligned_cols=343 Identities=26% Similarity=0.242 Sum_probs=222.1
Q ss_pred CCeEEEEeCCCccc-------CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEc
Q 042086 60 KRVISINLSTVGLK-------GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDL 132 (784)
Q Consensus 60 ~~v~~l~l~~~~~~-------~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 132 (784)
.+++.+++....+. +++++|++|+|++|++++..|..|+++++|++|+|++|++++..+.+|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 36777887765432 45677888888888888888888888888888888888888655567888888888888
Q ss_pred cCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCcccccc--CccCCceeeccccccC
Q 042086 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG--NLSNLVVLHLFENSLF 210 (784)
Q Consensus 133 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~ 210 (784)
++|++++..|..|+++++|++|+|++|.+++..|..+.++++|++|++++|.+++..+..+. .+++|++|++++|.++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 88888876677788888888888888888877777777788888888887777765554433 3355666666666555
Q ss_pred Cccch---------------------------------------------------hhhcccc--cceeccCCCcccccc
Q 042086 211 GSIPS---------------------------------------------------ILGNLKM--LLHLGLSTNHLSGVI 237 (784)
Q Consensus 211 ~~~~~---------------------------------------------------~l~~l~~--L~~L~L~~n~l~~~~ 237 (784)
+..+. .|.+++. |+.|++++|++++..
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 44443 3333332 666666666666555
Q ss_pred CCCCcCCCCcceEEecCCCCCCCCccccc---------------------------------ccccccceEeccCccccC
Q 042086 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEI---------------------------------GKLSSLNYLVLNGNQLYG 284 (784)
Q Consensus 238 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~l---------------------------------~~l~~L~~L~l~~n~l~~ 284 (784)
+..|..+++|++|++++|+++ ...|..+ ..+++|++|++++|.+++
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQ-HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBS-EECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred cccccCcccccEeeCCCCccC-ccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 566666666666666666554 1222223 333444444444444444
Q ss_pred CCCccccCCCccceeecccCccCCCC--ccccccc--ccceEEecccccccCCCchhhhcccccCeeccCCcccccccc-
Q 042086 285 NLPRALGSLTELEYLDLSTNKLGNSI--PETLGNL--LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP- 359 (784)
Q Consensus 285 ~~~~~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~l--~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~- 359 (784)
..+..|..+++|++|++++|.++... ...+..+ ++|+.|++++|++++..|..+..+++|+.|+|++|.+.+.+|
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 423 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS
T ss_pred CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc
Confidence 44444444444444444444322110 0111111 244445555566666667777788888888888888877665
Q ss_pred ccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCc
Q 042086 360 CEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403 (784)
Q Consensus 360 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 403 (784)
..+.++++|+.|++++|++.+..+..|..+++|+.|++++|.+.
T Consensus 424 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 467 (680)
T 1ziw_A 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467 (680)
T ss_dssp GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCB
T ss_pred ccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccc
Confidence 56777788888888888877777777777777777777777665
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=335.27 Aligned_cols=244 Identities=23% Similarity=0.405 Sum_probs=201.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec------
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH------ 585 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 585 (784)
...+|++.+.||+|+||.||+|+.. +++.||+|++... .+.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3467999999999999999999986 7999999998653 2467899999999999999999998854
Q ss_pred ----------CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC
Q 042086 586 ----------PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL 655 (784)
Q Consensus 586 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 655 (784)
....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 345789999999999999997532 23588999999999999999999999 9999999999999999
Q ss_pred CCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 042086 656 DYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~ 735 (784)
++.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+......
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------- 227 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF--------- 227 (284)
T ss_dssp TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH---------
T ss_pred CCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH---------
Confidence 9999999999998775432 234557899999999999999999999999999999999999987422111
Q ss_pred ccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 736 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+.+...+ ... ...+.+++.+||+.||++|||+.|+++.|
T Consensus 228 -~~~~~~~~~~---~~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 228 -FTDLRDGIIS---DIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp -HHHHHTTCCC---TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHhhccccc---ccC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0111111111 111 22477899999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.14 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=194.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCC--------CCChhhHHHHHHHHhccCCCceeeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCE--------MVPQPEFVNEIKTLTELRHRSIVKFYG 581 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~ 581 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... ......+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999975 57899999987532110 012234778888999999999999999
Q ss_pred EEec----CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 582 FCSH----PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 582 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
++.+ ....++||||+ +++|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9977 67889999999 999999997643 689999999999999999999999 999999999999999887
Q ss_pred --ceEEeccccccccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 042086 658 --EARVSDFGIAKFLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISS 728 (784)
Q Consensus 658 --~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~ 728 (784)
.+||+|||+++.+..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||+.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643211 12445799999999999999999999999999999999999999953211000
Q ss_pred cccccccccccccCCCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPP---QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.. . ..........+... ........++.+++..||+.||++|||+++|++.|
T Consensus 269 ~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 269 AV---Q-TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp HH---H-HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HH---H-HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 00 0 00000000000000 00001123688899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.42 Aligned_cols=200 Identities=24% Similarity=0.382 Sum_probs=168.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----R 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 587 (784)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|+++++.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 468999999999999999999876 688999999975422 222356789999999999999999999999765 5
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||+++ +|.++++... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCCc-CHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 68999999874 9999997643 588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----------------------ccccccccccccccccc-ccCCcCcchhHHHHHHHHHHHHhCCCCCC
Q 042086 668 KFLKPDSS----------------------NCTELVGTFGYIAPELV-YTMKVTEKCDVYSFGVLALEVIKGDHPRD 721 (784)
Q Consensus 668 ~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~elltg~~p~~ 721 (784)
+....... .....+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87654321 13566899999999986 56669999999999999999999766654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=368.36 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=194.0
Q ss_pred eeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEeccc
Q 042086 521 YCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
+.||+|+||.||+|.+. +++.||||+++.... .....++|.+|++++++++|||||++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999653 568899999876422 22345789999999999999999999999975 56889999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc-
Q 042086 598 RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN- 676 (784)
Q Consensus 598 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 676 (784)
+|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999997643 588899999999999999999999 9999999999999999999999999999877543321
Q ss_pred --ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 677 --CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 677 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+........+...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~~~p~~~- 597 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMGCPAGC- 597 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCCTTC-
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCCCC-
Confidence 233456789999999999999999999999999999998 999997432211 01111111111111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..++.+++..||+.||++||++++|++.|
T Consensus 598 --~~~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 598 --PREMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp --CHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred --CHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 23578899999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=338.74 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=192.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc--CCC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT--SGE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||.||+|++. +++ .||||+++..........+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999853 333 68999987653333344678999999999999999999999998754 8
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997542 3588899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-- 743 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-- 743 (784)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGE 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHccCC
Confidence 7544322 223457788999999998889999999999999999999 999987432211 01111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+.+ . .....+.+++.+||+.||++|||+.++++.|
T Consensus 243 ~~~~~-~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 243 RLPRP-E---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp CCCCC-T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCC-c---CcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 11111 1 2234688899999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=346.02 Aligned_cols=255 Identities=20% Similarity=0.330 Sum_probs=203.3
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCCh--------------hhHHHHHHHHhccCCCceeeE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQ--------------PEFVNEIKTLTELRHRSIVKF 579 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--------------~~~~~E~~~l~~l~h~niv~l 579 (784)
.++|++.+.||+|+||.||+|+. +++.||+|.+........... +.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 899999999865422211111 789999999999999999999
Q ss_pred EeEEecCCceEEEEecccCCCHHHH------HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCee
Q 042086 580 YGFCSHPRNSFLVYEYLERGSLATI------LSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVL 652 (784)
Q Consensus 580 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nil 652 (784)
++++.+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ . +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 5432 13468999999999999999999999 8 9999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcccccccccccccccccccC-CcCc-chhHHHHHHHHHHHHhCCCCCCccccccccc
Q 042086 653 LCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTE-KCDVYSFGVLALEVIKGDHPRDFISSISSSS 730 (784)
Q Consensus 653 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslGv~l~elltg~~p~~~~~~~~~~~ 730 (784)
++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence 999999999999999876433 34556789999999999877 6666 9999999999999999999997433210
Q ss_pred cccccccccccCCCCCCCC---------------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 731 SNRNISLNEILDPRLPTPP---------------QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 731 ~~~~~~~~~~~d~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.......+. .........+.+++.+||+.||++|||+.|+++
T Consensus 260 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000000000 000122346889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.25 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=197.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec----CCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH----PRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 589 (784)
..|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34788899999999999999875 688999999875422 22235679999999999999999999999865 3568
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeeec-CCCceEEecccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP--IVHRDISSKNVLLC-LDYEARVSDFGI 666 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfG~ 666 (784)
++||||+++|+|.+++...+ .+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999997643 478899999999999999999998 7 99999999999998 789999999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
+..... .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........ ....+.....+
T Consensus 179 ~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~ 248 (290)
T 1t4h_A 179 ATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKP 248 (290)
T ss_dssp GGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCC
T ss_pred cccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-------HHHHHhccCCc
Confidence 976543 23345679999999998864 589999999999999999999999964322110 00011111000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. .........+.+++.+||+.||++|||++|+++
T Consensus 249 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 A--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 000111235889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=339.63 Aligned_cols=263 Identities=23% Similarity=0.390 Sum_probs=185.3
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||.||+|+.. +++.||||.+..... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 3578999999999999999999865 789999998865422 2345678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhc-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 592 VYEYLERGSLATILSN-----DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
||||+++|+|.+++.. ......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999863 11234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-----ccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042086 667 AKFLKPDSS-----NCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 667 a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
+........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 987643221 1234578999999999875 5688999999999999999999999975332110000000000000
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..... ...........+.+++.+||+.||++|||+.++++
T Consensus 248 -~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 -ETGVQ-DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -TC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -ccccc-cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000 00001112235788999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.98 Aligned_cols=259 Identities=26% Similarity=0.407 Sum_probs=202.4
Q ss_pred hcCCCCceeEecccceEEEEEEE-----cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 587 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 35689999999999999999984 36899999998763 2334568999999999999999999999986644
Q ss_pred -ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 588 -NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 588 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 7899999999999999997653 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccc----ccccccc---cc
Q 042086 667 AKFLKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS----SSSSNRN---IS 736 (784)
Q Consensus 667 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~----~~~~~~~---~~ 736 (784)
+......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+....... ....... ..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9877544322 223456778999999998889999999999999999999999976321100 0000000 00
Q ss_pred cccccC--CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILD--PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+.+. .+.+.+ ... ..++.+++.+||+.||++|||+.|+++.|
T Consensus 272 ~~~~~~~~~~~~~~-~~~---~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 272 LIELLKNNGRLPRP-DGC---PDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HHHHHHTTCCCCCC-TTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHhhcCCCCCCC-Ccc---cHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 011111 111111 222 23588899999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.04 Aligned_cols=195 Identities=24% Similarity=0.384 Sum_probs=154.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-----CC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-----PR 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 587 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+.+|+++++.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 367999999999999999999876 789999999865322 22235678999999999999999999999843 35
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||+. |+|.++++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 6899999985 69999997643 588899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---------------------------Cccccccccccccccccc-ccCCcCcchhHHHHHHHHHHHHhC
Q 042086 668 KFLKPDS---------------------------SNCTELVGTFGYIAPELV-YTMKVTEKCDVYSFGVLALEVIKG 716 (784)
Q Consensus 668 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~elltg 716 (784)
+.+.... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 8764321 123445789999999986 466799999999999999999994
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=358.25 Aligned_cols=335 Identities=22% Similarity=0.292 Sum_probs=272.5
Q ss_pred CCeEEEEeCCCcc-------cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccc-cCCCCCCCCCCCCEEE
Q 042086 60 KRVISINLSTVGL-------KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSA-SIPPVIGNLKFLYHLD 131 (784)
Q Consensus 60 ~~v~~l~l~~~~~-------~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~ 131 (784)
.++..+++.+..+ .+.+++|++|+|++|+|+. +|.. .+++|++|+|++|.+++ .+|..|+++++|++|+
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 4677778776543 4578999999999999994 5655 89999999999999997 5789999999999999
Q ss_pred ccCCccCCCCCcCccCCCcC--cEEeecCCCc--ccccCCcccc--------------------------cc--------
Q 042086 132 LSENQLSGSIPPTLGNLSNL--AVLHLYGNSL--SGSIPSIIGN--------------------------LK-------- 173 (784)
Q Consensus 132 L~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l--~~~~~~~l~~--------------------------l~-------- 173 (784)
|++|.+++ ..+..+++| +.|+|++|.+ .+..|..+.. ++
T Consensus 122 L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 198 (520)
T 2z7x_B 122 LSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198 (520)
T ss_dssp EEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEE
T ss_pred ecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccc
Confidence 99999986 467788888 9999999999 6666666655 22
Q ss_pred -------------------------------------------------ccceeeccccccCCCccccc-----cCccCC
Q 042086 174 -------------------------------------------------SLFYLHLSSNQLSGSIPISL-----GNLSNL 199 (784)
Q Consensus 174 -------------------------------------------------~L~~L~L~~n~l~~~~~~~~-----~~l~~L 199 (784)
+|++|++++|.++|.+|..+ ..+++|
T Consensus 199 ~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L 278 (520)
T 2z7x_B 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278 (520)
T ss_dssp ECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEE
T ss_pred ccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCcee
Confidence 45555555555555555555 556666
Q ss_pred ceeeccccccCCccc-hhhhcc---cccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceE
Q 042086 200 VVLHLFENSLFGSIP-SILGNL---KMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYL 275 (784)
Q Consensus 200 ~~L~L~~n~l~~~~~-~~l~~l---~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L 275 (784)
+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|+++ +.+|..+..+++|++|
T Consensus 279 ~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L 353 (520)
T 2z7x_B 279 SIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETL 353 (520)
T ss_dssp EEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCC-TTTTTTCCCCSSCCEE
T ss_pred Eeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccC-hhhhhhhccCCCCCEE
Confidence 6666666665 233 334433 45777777777765322 1268899999999999998 4577889999999999
Q ss_pred eccCccccC--CCCccccCCCccceeecccCccCCCCccc-ccccccceEEecccccccCCCchhhhcccccCeeccCCc
Q 042086 276 VLNGNQLYG--NLPRALGSLTELEYLDLSTNKLGNSIPET-LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352 (784)
Q Consensus 276 ~l~~n~l~~--~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 352 (784)
++++|++++ .+|..+..+++|++|++++|.+++.+|.. +..+++|++|++++|++++..|..+. ++|+.|+|++|
T Consensus 354 ~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N 431 (520)
T 2z7x_B 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431 (520)
T ss_dssp ECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSS
T ss_pred EccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCC
Confidence 999999996 55678999999999999999999856654 88899999999999999987777664 79999999999
Q ss_pred cccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 353 ILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 353 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
+++ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++.|.++.
T Consensus 432 ~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 999 8898888999999999999999976555599999999999999999998874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=332.93 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=198.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCC-CCCChhhHHHHHHHHhccCCCceeeEEeEEe--cCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPC-EMVPQPEFVNEIKTLTELRHRSIVKFYGFCS--HPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 589 (784)
.++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 7899999998753211 1234578999999999999999999999984 45678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||++++ |.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999886 777776543 24688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CcccccccccccccccccccCC--cCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 670 LKPDS--SNCTELVGTFGYIAPELVYTMK--VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 670 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
..... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||+...... ....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--------LFENIGKGSY 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--------HHHHHhcCCC
Confidence 65322 2234557899999999997644 4779999999999999999999997432110 0111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+ ... ...+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~-~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 AIP-GDC---GPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCC-SSS---CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-Ccc---CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 112 235778999999999999999999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=356.94 Aligned_cols=336 Identities=23% Similarity=0.197 Sum_probs=266.6
Q ss_pred ccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecC
Q 042086 79 LSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYG 158 (784)
Q Consensus 79 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 158 (784)
.+++|+++|++++ +|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 4899999999996 676664 8999999999999988889999999999999999999998899999999999999999
Q ss_pred CCcccccCCccccccccceeeccccccCCC-ccccccCccCCceeeccccccCCccchhhhccccc--ceeccCCCcc--
Q 042086 159 NSLSGSIPSIIGNLKSLFYLHLSSNQLSGS-IPISLGNLSNLVVLHLFENSLFGSIPSILGNLKML--LHLGLSTNHL-- 233 (784)
Q Consensus 159 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L--~~L~L~~n~l-- 233 (784)
|.++ .+|.. .+++|++|+|++|.+++. +|..|+++++|++|+|++|++++. .+..+++| +.|++++|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9999 56666 899999999999999963 468999999999999999999763 45556666 9999999999
Q ss_pred ccccCCCCcCC--------------------------CCcceEEecCCCCCCCCccc---c-------------------
Q 042086 234 SGVIPLSIGNL--------------------------NNLIGLYLYDNQLSVGEIPI---E------------------- 265 (784)
Q Consensus 234 ~~~~~~~l~~l--------------------------~~L~~L~L~~n~l~~~~~~~---~------------------- 265 (784)
++..|..+..+ ++|+.|++++|+.....++. .
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence 76666666543 34555555554210000000 0
Q ss_pred --------cccccccceEeccCccccCCCCccc-----------------------------------------------
Q 042086 266 --------IGKLSSLNYLVLNGNQLYGNLPRAL----------------------------------------------- 290 (784)
Q Consensus 266 --------l~~l~~L~~L~l~~n~l~~~~~~~l----------------------------------------------- 290 (784)
....++|++|++++|.++|.+|..+
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~ 343 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCc
Confidence 0001245555555555554444433
Q ss_pred ------cCCCccceeecccCccCCCCcccccccccceEEecccccccCC--CchhhhcccccCeeccCCccccccccc-c
Q 042086 291 ------GSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKG--FPVELEKLIQLSELDLSLNILEGKIPC-E 361 (784)
Q Consensus 291 ------~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~ 361 (784)
..+++|++|++++|.+++.+|..+.++++|++|++++|++++. +|..+..+++|+.|++++|++++.+|. .
T Consensus 344 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 423 (562)
T 3a79_B 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423 (562)
T ss_dssp CCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCC
T ss_pred ccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhh
Confidence 6789999999999999999999999999999999999999983 356789999999999999999985665 4
Q ss_pred ccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCCCCC
Q 042086 362 ICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGNKGL 426 (784)
Q Consensus 362 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~ 426 (784)
+..+++|+.|+|++|++++.+|..+. ++|+.|++++|+++. +|.. ..........+.+|...
T Consensus 424 ~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 424 CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp CCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCC
T ss_pred hcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCC
Confidence 78899999999999999988887665 789999999999984 6653 23344444556666433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.77 Aligned_cols=270 Identities=21% Similarity=0.252 Sum_probs=199.1
Q ss_pred cHHHHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCC--------hhhHHHHHHHHhccCCCcee
Q 042086 506 LYEEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVP--------QPEFVNEIKTLTELRHRSIV 577 (784)
Q Consensus 506 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv 577 (784)
...++....++|++.+.||+|+||.||+|...+|+.||||++.......... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3456777889999999999999999999998889999999987643322211 26799999999999999999
Q ss_pred eEEeEEec-----CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCee
Q 042086 578 KFYGFCSH-----PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVL 652 (784)
Q Consensus 578 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil 652 (784)
++++++.. ....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 99999843 335799999998 58988887543 3688999999999999999999999 9999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-
Q 042086 653 LCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS- 730 (784)
Q Consensus 653 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~- 730 (784)
++.++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999865432 23345678999999999876 678999999999999999999999997432110000
Q ss_pred -------cc-------cccccccccCCCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 731 -------SN-------RNISLNEILDPRLPTPPQN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 731 -------~~-------~~~~~~~~~d~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.. ......+.+.......+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00 0000000000111100000 0111235889999999999999999999986
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=371.18 Aligned_cols=305 Identities=27% Similarity=0.263 Sum_probs=253.5
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccC-CCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASI-PPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV 153 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 153 (784)
.+++|++|||++|.|++..|..|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|.+.+..|..|.++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 5578999999999999999999999999999999999766555 889999999999999999999999999999999999
Q ss_pred EeecCCCcccccCCc--cccccccceeeccccccCCCcc-ccccCccCCceeeccccccCCccchhhhcc--cccceecc
Q 042086 154 LHLYGNSLSGSIPSI--IGNLKSLFYLHLSSNQLSGSIP-ISLGNLSNLVVLHLFENSLFGSIPSILGNL--KMLLHLGL 228 (784)
Q Consensus 154 L~L~~n~l~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L 228 (784)
|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|++
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 999999999876665 9999999999999999997755 579999999999999999999999999887 78999999
Q ss_pred CCCccccccCCCCcCCCC------cceEEecCCCCCCCCcccccc-----------------------------------
Q 042086 229 STNHLSGVIPLSIGNLNN------LIGLYLYDNQLSVGEIPIEIG----------------------------------- 267 (784)
Q Consensus 229 ~~n~l~~~~~~~l~~l~~------L~~L~L~~n~l~~~~~~~~l~----------------------------------- 267 (784)
++|.+.+..|..++.+++ |+.|++++|.++ +..+..+.
T Consensus 182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f 260 (844)
T 3j0a_A 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT-VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260 (844)
T ss_dssp CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSS-TTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTT
T ss_pred CCCccccccccchhhcCCccccCceeEEecCCCcCc-hhHHHHHHhhcCcccccceecccccccccccccccCCCChhhh
Confidence 999988877777666655 888888888665 12222111
Q ss_pred -c--ccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhccccc
Q 042086 268 -K--LSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQL 344 (784)
Q Consensus 268 -~--l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 344 (784)
. .++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|
T Consensus 261 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 340 (844)
T 3j0a_A 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340 (844)
T ss_dssp TTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTC
T ss_pred hccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCC
Confidence 1 2567778888888777777777777888888888888877777777777888888888888877777777778888
Q ss_pred CeeccCCccccccccccccccccccEEecCCCccCC
Q 042086 345 SELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380 (784)
Q Consensus 345 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 380 (784)
+.|++++|.+.+..+..|..+++|+.|+|++|.+++
T Consensus 341 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp CEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred CEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 888888887776666677777777777777777765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=345.89 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=201.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 457999999999999999999976 78999999987642 222356789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++..+ .+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999997643 4788999999999999999999831 799999999999999999999999999976532
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------------cc-------
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------------SN------- 732 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------------~~------- 732 (784)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 2234578999999999999999999999999999999999999996432110000 00
Q ss_pred ----------c----ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 ----------R----NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 ----------~----~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ......+.....+..+. .....++.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCT--TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCc--ccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 00000000011111000 112336889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.58 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=204.3
Q ss_pred HHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 511 VRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 511 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
....++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 345678999999999999999999976 789999999865432 233567899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC---CceEEecccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD---YEARVSDFGI 666 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~ 666 (784)
++|+||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999999886543 578899999999999999999999 99999999999999754 4699999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
+....... ......+++.|+|||.+.+. ++.++||||||+++|+|++|+.||....... ....+......
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYA 240 (287)
T ss_dssp GGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCC
T ss_pred ceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence 98765432 23445689999999998764 8899999999999999999999986432211 00111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...........++.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 111111122346789999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.09 Aligned_cols=253 Identities=18% Similarity=0.209 Sum_probs=198.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcC---------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceee------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS---------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK------ 578 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 578 (784)
.++|++.+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3679999999999999999998763 889999998642 47889999999999999988
Q ss_pred ---------EEeEEec-CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 042086 579 ---------FYGFCSH-PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISS 648 (784)
Q Consensus 579 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 648 (784)
+++++.. ....++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 6777765 67889999999 999999998642 24689999999999999999999999 999999999
Q ss_pred CCeeecCCC--ceEEeccccccccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 042086 649 KNVLLCLDY--EARVSDFGIAKFLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719 (784)
Q Consensus 649 ~Nill~~~~--~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p 719 (784)
+||+++.++ .+||+|||+++.+..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 899999999987653221 12345799999999999999999999999999999999999999
Q ss_pred CCcccccccccccc----ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 720 RDFISSISSSSSNR----NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 720 ~~~~~~~~~~~~~~----~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
|............. ........+... .......++.+++.+||+.||++|||+++|++.|
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCG-----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTS-----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhcc-----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 97532110000000 000000110000 0001123688899999999999999999998864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.82 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=193.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 467999999999999999999875 799999999865322 2223467889999999999999999999997653
Q ss_pred -ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 588 -NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 588 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
..++||||+ +++|.++++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 77999999753 478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccccc-
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNISL- 737 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~~- 737 (784)
++..... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......... ........
T Consensus 175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9875432 345678999999999887 67899999999999999999999999743321100 00000000
Q ss_pred --------------ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 738 --------------NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 738 --------------~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.. ........+.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFAS---ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGG---TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHH---HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 01112335789999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.17 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=182.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEe-------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCS------- 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~------- 584 (784)
..+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 357999999999999999999975 7899999988543 2233567899999999995 999999999984
Q ss_pred -cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeeecCCCceEE
Q 042086 585 -HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP--IVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 585 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl 661 (784)
.....++||||+. |+|.+++........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3345789999996 69999987533334689999999999999999999998 7 999999999999999999999
Q ss_pred eccccccccCCCCCc------------cccccccccccccccc---ccCCcCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 042086 662 SDFGIAKFLKPDSSN------------CTELVGTFGYIAPELV---YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI 726 (784)
Q Consensus 662 ~DfG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~ 726 (784)
+|||+++........ .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||+.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876543221 1134589999999998 5667889999999999999999999998642221
Q ss_pred cccccccccccccccCCCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 727 SSSSSNRNISLNEILDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 727 ~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+.......+ .... ...+.+++.+||+.||++|||+.|+++.|
T Consensus 260 ------------~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 260 ------------RIVNGKYSIPPHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ------------------CCCCTTCCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ------------HhhcCcccCCccccc---chHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1111111111 1111 12477899999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.85 Aligned_cols=256 Identities=19% Similarity=0.293 Sum_probs=197.9
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe----cCCc
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS----HPRN 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~ 588 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 35799999999999999999997 47999999988653 2234567999999999999999999999986 3347
Q ss_pred eEEEEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 589 SFLVYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 789999999999999987521 124688999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCc---------ccccccccccccccccccCC---cCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 042086 668 KFLKPDSSN---------CTELVGTFGYIAPELVYTMK---VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNI 735 (784)
Q Consensus 668 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~ 735 (784)
......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||+........ ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~ 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VAL 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhH
Confidence 765321111 12345799999999987554 688999999999999999999998642211000 000
Q ss_pred ccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 736 SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 736 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.... ....+... .....+.+++.+||+.||++|||++++++.|
T Consensus 259 ~~~~--~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 259 AVQN--QLSIPQSP----RHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHC--C--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred Hhhc--cCCCCccc----cCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 0000 01111111 1233688999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.46 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=191.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH------- 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 585 (784)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 467999999999999999999975 7999999998642 2235678999999999999999999998854
Q ss_pred ------CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 586 ------PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 586 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 356789999999999999997643 3567888999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCC--------------CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccc
Q 042086 660 RVSDFGIAKFLKPDS--------------SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFIS 724 (784)
Q Consensus 660 kl~DfG~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~ 724 (784)
||+|||++....... .......|++.|+|||.+.+. .++.++|||||||++|||++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 999999998764321 122345689999999999764 68999999999999999998 443111
Q ss_pred cccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 725 SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.. ......+.......++.........+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ER-------VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH-------HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hH-------HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 00001111111111111222333457889999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=345.42 Aligned_cols=197 Identities=20% Similarity=0.293 Sum_probs=172.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc------CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL------RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~ 586 (784)
..+|++.+.||+|+||.||+|+.. +++.||||++... ....+++.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 457999999999999999999876 6899999998752 22345778888888877 577999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc--eEEecc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE--ARVSDF 664 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Df 664 (784)
+..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999996 599999876542 3589999999999999999999999 9999999999999999987 999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 999765432 3446789999999999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=333.89 Aligned_cols=252 Identities=20% Similarity=0.265 Sum_probs=197.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEec--CCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSH--PRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~ 590 (784)
++|++.+.||+|+||.||+|+.. +++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 57999999999999999999864 7899999998642 3678999999999997 9999999999987 56789
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEeccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKF 669 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~ 669 (784)
+||||+++++|.++++ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.
T Consensus 110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999999985 377889999999999999999999 999999999999999776 899999999987
Q ss_pred cCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------------------
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------------------- 729 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------------------- 729 (784)
..... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 181 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 181 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 65433 3345678999999999987 66899999999999999999999998422110000
Q ss_pred -ccccccccccccCCCCC------CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 -SSNRNISLNEILDPRLP------TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 -~~~~~~~~~~~~d~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.........+....... ...........++.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000000 000011112346889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=342.14 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=191.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357999999999999999999875 689999999875321 2223467889999999999999999999997654
Q ss_pred -ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 588 -NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 588 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999975 88888863 478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc-------------
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR------------- 733 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~------------- 733 (784)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9876432 22345678999999999999999999999999999999999999997433211000000
Q ss_pred -c---------------cccccccCCC-CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 -N---------------ISLNEILDPR-LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 -~---------------~~~~~~~d~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
. ......+... .+............+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0000000000 00000011122557899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.45 Aligned_cols=263 Identities=20% Similarity=0.296 Sum_probs=200.8
Q ss_pred HhcCCCCceeEecccceEEEEEEE--cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc---CCCceeeEEeEEe---
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKL--TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL---RHRSIVKFYGFCS--- 584 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 584 (784)
..++|++.+.||+|+||.||+|+. .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 457899999999999999999997 36889999998754322 22345677888888776 8999999999987
Q ss_pred --cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEe
Q 042086 585 --HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVS 662 (784)
Q Consensus 585 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 662 (784)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 599999976432 3488999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccccc
Q 042086 663 DFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRN 734 (784)
Q Consensus 663 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~ 734 (784)
|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....
T Consensus 163 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 163 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99999865432 2234567899999999999999999999999999999999999999743221100 00000
Q ss_pred cc------cccccCCC-CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 IS------LNEILDPR-LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 ~~------~~~~~d~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.. ....+... ..............+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000000 00000011122345788999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.79 Aligned_cols=266 Identities=21% Similarity=0.228 Sum_probs=189.0
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
++.....++|++.+.||+|+||.||+|+.. +|+.||||++... ......+.+|++.++.++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC----TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC----ccccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 345667789999999999999999999975 7899999988653 22345677889999999999999999998653
Q ss_pred Cc-------eEEEEecccCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEEeCCCCCCeeecC-
Q 042086 587 RN-------SFLVYEYLERGSLATILSN-DGAIEEFNWTVRMNVIRSVANALSYMH--HDCFPPIVHRDISSKNVLLCL- 655 (784)
Q Consensus 587 ~~-------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlk~~Nill~~- 655 (784)
+. .++||||+++ +|.+.+.. ......+++..+..++.|++.|+.||| +. +|+||||||+||+++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 33 7899999987 55544432 122346788999999999999999999 77 9999999999999997
Q ss_pred CCceEEeccccccccCCCCCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccccc---
Q 042086 656 DYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSS--- 731 (784)
Q Consensus 656 ~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~--- 731 (784)
++.+||+|||+++.+.... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp TTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 8999999999998765433 334567899999999987654 89999999999999999999999974322100000
Q ss_pred ----cccc---------ccccccCCC-CC---CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 732 ----NRNI---------SLNEILDPR-LP---TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 732 ----~~~~---------~~~~~~d~~-~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.... ......+.. .. ............+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000000000 00 000011123456889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.10 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=185.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...... ....+.+..+...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 467999999999999999999975 7899999998754211 11223344555568888999999999999999999999
Q ss_pred EecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||+++ +|.+++... .....+++..+..++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999985 888877531 11236899999999999999999999852 89999999999999999999999999998765
Q ss_pred CCCCccccccccccccccccc----ccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC-CCC
Q 042086 672 PDSSNCTELVGTFGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP-RLP 746 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~ 746 (784)
... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||+...... ......+.. ...
T Consensus 162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 233 (290)
T 3fme_A 162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEPSPQ 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------HHHHHHHHSCCCC
T ss_pred ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------HHHHHHhccCCCC
Confidence 432 23445789999999996 56678899999999999999999999997422110 001111111 111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.+... ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 LPADK---FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCTTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccccc---CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111 2335788999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=341.75 Aligned_cols=257 Identities=21% Similarity=0.249 Sum_probs=191.4
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC------c
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR------N 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 588 (784)
.+|++.+.||+|+||+||+|+...+..||+|++.... +...+|+++++.++||||+++++++.... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4699999999999999999999877779999886532 12237999999999999999999985433 2
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-CCCceEEeccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC-LDYEARVSDFGIA 667 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~a 667 (784)
.++||||++++.+............+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 789999998854433332222234688899999999999999999999 999999999999999 7899999999999
Q ss_pred cccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccccc---c
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRN---I 735 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~---~ 735 (784)
+.+.... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ....+ .
T Consensus 190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8765433 23456789999999998765 5899999999999999999999999743321000 00000 0
Q ss_pred ccccccCCCCCCCCCC------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 SLNEILDPRLPTPPQN------VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 ~~~~~~d~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..........+..... ......++.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000001111110000 0012236889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=349.23 Aligned_cols=255 Identities=19% Similarity=0.284 Sum_probs=200.2
Q ss_pred hcCCCCceeEecccceEEEEEEE-cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC-CceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH-RSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++..|+++++.++| +++..+..++.+.+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 46899999999999999999986 479999999876532 23468899999999976 566667777778888999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee---cCCCceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL---CLDYEARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~ 668 (784)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 81 vme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99999 889999997543 3689999999999999999999999 99999999999999 688999999999998
Q ss_pred ccCCCCCc-------ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042086 669 FLKPDSSN-------CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 669 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
.+...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-----~~~~i~ 229 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-----KYEKIS 229 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-----HHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH-----HHHHHh
Confidence 77644322 225679999999999999999999999999999999999999997533211000 000000
Q ss_pred CCCCCCCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 742 DPRLPTPP-QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 742 d~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
........ ........++.+++..||+.||++||++++|++.|
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 00000000 00001123688999999999999999999998764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=334.59 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=172.8
Q ss_pred hcCCCCce-eEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHH-HHHhccCCCceeeEEeEEec----C
Q 042086 514 TNGFDVKY-CIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEI-KTLTELRHRSIVKFYGFCSH----P 586 (784)
Q Consensus 514 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~ 586 (784)
.++|.+.+ .||+|+||.||+|+.. +++.||||++... . ...+|+ ..++.++||||+++++++.. .
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------P-KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------H-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------H-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 56788854 6999999999999977 7999999998642 2 233333 34566799999999999865 4
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEec
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSD 663 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~D 663 (784)
...++||||+++|+|.+++...+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 458999999999999999986542 4689999999999999999999999 9999999999999976 45599999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP 743 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~ 743 (784)
||+++..... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .....+...
T Consensus 175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~ 248 (336)
T 3fhr_A 175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIRLG 248 (336)
T ss_dssp CTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhhcc
Confidence 9999876432 2345678999999999988889999999999999999999999986432211000 000111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+..........+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111223346889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=340.80 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=198.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----R 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 587 (784)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 468999999999999999999876 78899999987532 222346789999999999999999999999654 3
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||+++ +|.++++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 68999999975 999998753 488899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc
Q 042086 668 KFLKPDSSN---CTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNIS 736 (784)
Q Consensus 668 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~ 736 (784)
+........ .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 876533221 244589999999998764 458999999999999999999999996433211000 000000
Q ss_pred cccccC-------CCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 LNEILD-------PRLPTPPQN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ~~~~~d-------~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.+ ...+..... ......++.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000000 0111245789999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.81 Aligned_cols=253 Identities=18% Similarity=0.328 Sum_probs=196.5
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
..++|++.+.||+|+||.||+|+..+ .||+|++..... .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35789999999999999999998864 489999876432 233456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++++|.+++...+ ..+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999997643 3578899999999999999999999 999999999999998 68999999999876532
Q ss_pred C-----CCccccccccccccccccccc---------CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 673 D-----SSNCTELVGTFGYIAPELVYT---------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 673 ~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
. ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.......... ...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~ 256 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-----QMG 256 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-----HHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----Hhc
Confidence 1 122334568999999999864 357889999999999999999999997432210000 000
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+.... .. ...++.+++.+||+.||++|||++++++.|
T Consensus 257 ~~~~~~~~~--~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 257 TGMKPNLSQ--IG---MGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp TTCCCCCCC--SS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred cCCCCCCCc--CC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 001111110 01 112477899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.15 Aligned_cols=260 Identities=22% Similarity=0.239 Sum_probs=192.9
Q ss_pred HHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec----
Q 042086 511 VRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH---- 585 (784)
Q Consensus 511 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 585 (784)
....++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 345678999999999999999999874 79999999986532 223479999999999999999999843
Q ss_pred ----------------------------------CCceEEEEecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHH
Q 042086 586 ----------------------------------PRNSFLVYEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANAL 630 (784)
Q Consensus 586 ----------------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l 630 (784)
....++||||+++ +|.+.+... .....+++..+..++.|+++||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 2347899999985 887777531 1123688999999999999999
Q ss_pred HHHhhCCCCCeEEeCCCCCCeeec-CCCceEEeccccccccCCCCCcccccccccccccccccccCC-cCcchhHHHHHH
Q 042086 631 SYMHHDCFPPIVHRDISSKNVLLC-LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGV 708 (784)
Q Consensus 631 ~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv 708 (784)
+|||+. +|+||||||+||+++ .++.+||+|||+++.+.... ......+|+.|+|||.+.+.. ++.++||||+||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999 999999999999998 68899999999998765433 334567899999999988654 899999999999
Q ss_pred HHHHHHhCCCCCCccccccccc--------cccc------cccccccCCCCCCCC---CCCHHHHHHHHHHHHhcccCCC
Q 042086 709 LALEVIKGDHPRDFISSISSSS--------SNRN------ISLNEILDPRLPTPP---QNVQDELISIVEVAFLCLNESP 771 (784)
Q Consensus 709 ~l~elltg~~p~~~~~~~~~~~--------~~~~------~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~cl~~dP 771 (784)
++|||++|+.||.......... ...+ ....+..-+...... .........+.+++.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999997433211000 0000 000000000000000 0000122357899999999999
Q ss_pred CCCCCHHHHHH
Q 042086 772 ESRPPMHTVCQ 782 (784)
Q Consensus 772 ~~RPs~~~vl~ 782 (784)
++|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=343.74 Aligned_cols=258 Identities=20% Similarity=0.284 Sum_probs=199.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC--------CCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR--------HRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~ 584 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 367999999999999999999865 6899999998742 223567889999999985 788999999987
Q ss_pred ----cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC---
Q 042086 585 ----HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY--- 657 (784)
Q Consensus 585 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~--- 657 (784)
+....++||||+ ++++.+++.... ...+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 556789999999 557777665432 235889999999999999999999963 899999999999999775
Q ss_pred ----------------------------------------------ceEEeccccccccCCCCCcccccccccccccccc
Q 042086 658 ----------------------------------------------EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691 (784)
Q Consensus 658 ----------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~ 691 (784)
.+||+|||+++..... .....||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999876532 344578999999999
Q ss_pred cccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------------c----------------ccccccccccC
Q 042086 692 VYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------------S----------------NRNISLNEILD 742 (784)
Q Consensus 692 ~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------------~----------------~~~~~~~~~~d 742 (784)
+.+..++.++|||||||++|||++|+.||+......... . ........+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997432110000 0 00000000000
Q ss_pred CCC-------CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 PRL-------PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 ~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... ........+....+.+|+.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 0001123455678999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.89 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=201.0
Q ss_pred hcCCCCceeEecccceEEEEEEE-c-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCc------eeeEEeEEec
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL-T-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS------IVKFYGFCSH 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~ 585 (784)
.++|++.+.||+|+||.||+|.. . +++.||||++... ....+.+.+|+.+++.++|++ ++++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 35899999999999999999987 3 6899999998642 223567889999999887654 9999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC----------
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---------- 655 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---------- 655 (784)
.+..++||||+ +++|.+++...+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999 8899999976542 3578899999999999999999999 9999999999999987
Q ss_pred ---------CCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 042086 656 ---------DYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI 726 (784)
Q Consensus 656 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~ 726 (784)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999875432 34567899999999999999999999999999999999999999643221
Q ss_pred cccc-------cccc-----ccccccc-C-------------------CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCC
Q 042086 727 SSSS-------SNRN-----ISLNEIL-D-------------------PRLPTPPQNVQDELISIVEVAFLCLNESPESR 774 (784)
Q Consensus 727 ~~~~-------~~~~-----~~~~~~~-d-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 774 (784)
.... .... ....... . ................+.+++.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 0000 0000 0000000 0 00000001122445678999999999999999
Q ss_pred CCHHHHHH
Q 042086 775 PPMHTVCQ 782 (784)
Q Consensus 775 Ps~~~vl~ 782 (784)
||++|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.11 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=194.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC--CCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR--HRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 467999999999999999999998899999999865322 2223567899999999997 5999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||| +.+++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++ ++.+||+|||+++.+.
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999 56789999998653 578899999999999999999999 999999999999996 5899999999998765
Q ss_pred CCCCc--cccccccccccccccccc-----------CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 672 PDSSN--CTELVGTFGYIAPELVYT-----------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 672 ~~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
..... .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~~ 250 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 250 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHHHH
Confidence 43221 234578999999999875 46888999999999999999999998642211 01111
Q ss_pred cccCCCCCC-CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 739 EILDPRLPT-PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 739 ~~~d~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.++++.... .+... ...+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 251 AIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 222222111 11111 235788999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.24 Aligned_cols=256 Identities=25% Similarity=0.300 Sum_probs=190.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------C
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------R 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 587 (784)
..|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+|+++++.++||||+++++++... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 46899999999999999999986 69999999986532 2234799999999999999999998432 2
Q ss_pred ceEEEEecccCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEeccc
Q 042086 588 NSFLVYEYLERGSLATILSND-GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFG 665 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG 665 (784)
..++||||+++ ++.+.+... .....+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999987 676665421 1224688999999999999999999999 99999999999999965 578999999
Q ss_pred cccccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------ccc---
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--------SNR--- 733 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--------~~~--- 733 (784)
+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ...
T Consensus 203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998765433 23456789999999999765 68999999999999999999999997433211000 000
Q ss_pred ---ccccccccCCCCCCCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 ---NISLNEILDPRLPTPPQ---NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 ---~~~~~~~~d~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+...+.....+- .......++.+|+.+||+.||++|||+.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000011100000 00111246889999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=347.44 Aligned_cols=200 Identities=23% Similarity=0.381 Sum_probs=155.5
Q ss_pred hcCCCC-ceeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe--cCC
Q 042086 514 TNGFDV-KYCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS--HPR 587 (784)
Q Consensus 514 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~ 587 (784)
.+.|++ .++||+|+||+||+|+.. +++.||||++... ...+.+.+|+.+++.++||||+++++++. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 344665 568999999999999965 5789999998653 22457889999999999999999999994 467
Q ss_pred ceEEEEecccCCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee----cCCC
Q 042086 588 NSFLVYEYLERGSLATILSNDG------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL----CLDY 657 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~ 657 (784)
..++||||+++ +|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 88999999975 8888875321 122488999999999999999999999 99999999999999 6778
Q ss_pred ceEEeccccccccCCCC---CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 658 EARVSDFGIAKFLKPDS---SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
.+||+|||+++.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999998765332 223456789999999999874 589999999999999999999999963
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=339.01 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=181.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------ 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 586 (784)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 468999999999999999999865 789999999875321 222356788999999999999999999998654
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
...++|+||+ +++|.++++. ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 6799998864 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc--
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNIS-- 736 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~~-- 736 (784)
++..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......... .......
T Consensus 179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9875432 345678999999999987 67899999999999999999999999743321100 0000000
Q ss_pred ------cccccCCCCCCCCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 ------LNEILDPRLPTPPQNV----QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ------~~~~~d~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+......+.... ......+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000000000000 011235789999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=361.54 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=198.9
Q ss_pred HhcCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN 588 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 588 (784)
..++|++.+.||+|+||.||+|... .+..||+|.+.... .....+.|.+|+.++++++||||+++++++.+ +.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 3467899999999999999999874 35679999886532 22234679999999999999999999999854 66
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++|+|.++++..+ ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 899999999999999997643 2588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 042086 669 FLKPDSS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RL 745 (784)
Q Consensus 669 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~ 745 (784)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... ....+... +.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~ 611 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERL 611 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHHTCCC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence 7654322 2233456789999999998899999999999999999997 999987432211 01111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+.+ ... ...+.+++.+||+.||++|||+.++++.|
T Consensus 612 ~~~-~~~---~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 612 PMP-PNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp CCC-TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC-ccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111 122 23578899999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.58 Aligned_cols=199 Identities=22% Similarity=0.308 Sum_probs=170.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CC-----ceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HR-----SIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 586 (784)
.++|++.+.||+|+||+||+|+.. +++.||||++... ....+++..|+.+++.++ |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 468999999999999999999876 6889999998742 223456788999988884 54 499999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec--CCCceEEecc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC--LDYEARVSDF 664 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Df 664 (784)
+..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 999999999965 99999976532 3588999999999999999999952 12899999999999995 4678999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999876432 3456789999999999999999999999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.48 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=200.8
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC---CCChhhHHHHHHHHhccC--CCceeeEEeEEec
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE---MVPQPEFVNEIKTLTELR--HRSIVKFYGFCSH 585 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 585 (784)
...++|++.+.||+|+||.||+|+.. +++.||||++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34578999999999999999999865 78999999987643221 123356788999999996 5999999999999
Q ss_pred CCceEEEEecccC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-CCCceEEec
Q 042086 586 PRNSFLVYEYLER-GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC-LDYEARVSD 663 (784)
Q Consensus 586 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~D 663 (784)
++..++|+|++.+ ++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 89999997643 578899999999999999999999 999999999999999 779999999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d 742 (784)
||+++..... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+...... .
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~ 257 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------R 257 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------H
T ss_pred Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------c
Confidence 9999876532 2345678999999999987766 678999999999999999999997432211 0
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+ ... ..++.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~-~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQVFFR-QRV---SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCCCS-SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccccc-ccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 111 235788999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.38 Aligned_cols=256 Identities=20% Similarity=0.305 Sum_probs=194.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce---
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS--- 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 589 (784)
.++|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457999999999999999999876 789999999876422 222346788999999999999999999999876654
Q ss_pred ---EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 590 ---FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 590 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 589888743 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc--
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNIS-- 736 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~-- 736 (784)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9865432 345678999999999987 678999999999999999999999997432111000 000000
Q ss_pred ------cccccCCCCCCCCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 737 ------LNEILDPRLPTPPQN----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 737 ------~~~~~d~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...........+... .......+.+++.+||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000000000000 0112346889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=341.81 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=187.4
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 345567889999999998777778999999998642 245688999999887 8999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCC----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-------------
Q 042086 594 EYLERGSLATILSNDGAIEE----FNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD------------- 656 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~----l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~------------- 656 (784)
||+. |+|.+++........ .++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 599999976543211 12334578999999999999999 99999999999999754
Q ss_pred CceEEeccccccccCCCCCc----cccccccccccccccccc-------CCcCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 042086 657 YEARVSDFGIAKFLKPDSSN----CTELVGTFGYIAPELVYT-------MKVTEKCDVYSFGVLALEVIK-GDHPRDFIS 724 (784)
Q Consensus 657 ~~~kl~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~ellt-g~~p~~~~~ 724 (784)
+.+||+|||+++.+...... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||+...
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999987643322 234579999999999975 668899999999999999999 999986322
Q ss_pred cccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 725 SISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 725 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.... ............ ..........++.+++.+||+.||++|||+.+|++
T Consensus 245 ~~~~------~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRES------NIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHH------HHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHH------HHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1100 000001110000 11122345667899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=332.77 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=190.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEe--------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCS-------- 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-------- 584 (784)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 367999999999999999999987 5899999988653 2234567899999999999999999999873
Q ss_pred ------cCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-CCC
Q 042086 585 ------HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC-LDY 657 (784)
Q Consensus 585 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~ 657 (784)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++ +++
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 3467899999998 599999864 2578899999999999999999999 999999999999997 567
Q ss_pred ceEEeccccccccCCCC---Cccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc---
Q 042086 658 EARVSDFGIAKFLKPDS---SNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--- 730 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--- 730 (784)
.+||+|||+++...... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..........
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998765322 12334567899999998865 678999999999999999999999997433211000
Q ss_pred ----ccccccccccc-------CCCCCCCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 731 ----SNRNISLNEIL-------DPRLPTPPQ----NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 731 ----~~~~~~~~~~~-------d~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........++. ......+.. .......++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000000 000000000 00112346889999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.48 Aligned_cols=248 Identities=22% Similarity=0.302 Sum_probs=193.0
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC---CChhhHHHHHHHHhcc----CCCceeeEEe
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM---VPQPEFVNEIKTLTEL----RHRSIVKFYG 581 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~~ 581 (784)
.....++|++.+.||+|+||.||+|+.. +++.||||++........ .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999865 789999999976432211 2234567899999988 8999999999
Q ss_pred EEecCCceEEEEec-ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec-CCCce
Q 042086 582 FCSHPRNSFLVYEY-LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC-LDYEA 659 (784)
Q Consensus 582 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~ 659 (784)
++.+.+..++|+|| +.+++|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 99998999999999 78999999997643 488999999999999999999999 999999999999999 88999
Q ss_pred EEeccccccccCCCCCcccccccccccccccccccCCcC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVT-EKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 738 (784)
||+|||+++..... ......|++.|+|||.+.+..+. .++||||||+++|||++|+.||+.....
T Consensus 180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------ 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------------ 245 (312)
T ss_dssp EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------------
Confidence 99999999876543 23456789999999999877664 4899999999999999999998743211
Q ss_pred cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 739 EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 739 ~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.......+. . ....+.+++.+||+.||++|||++|+++.
T Consensus 246 --~~~~~~~~~-~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 --LEAELHFPA-H---VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HHTCCCCCT-T---SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hhhccCCcc-c---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111 1 12357789999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.40 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=178.0
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHH-HHhccCCCceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIK-TLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....++..|+. +++.++||||+++++++.+++..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 367999999999999999999975 789999999875421 122345666666 6777899999999999999999999
Q ss_pred EEecccCCCHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 592 VYEYLERGSLATILSND--GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
||||+++ +|.+++... .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999986 888877531 11246888999999999999999999852 899999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccc----ccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELV----YTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
..... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||....... .....+.....
T Consensus 176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~ 247 (327)
T 3aln_A 176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHHHhcCCC
Confidence 65332 23344789999999998 45668899999999999999999999997432210 01111111111
Q ss_pred CCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+.. ..........+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 110 0011122336889999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.44 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=196.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----R 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 587 (784)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 467999999999999999999976 78999999986431 222345788999999999999999999998654 6
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..++||||++ |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 7899999997 5999998753 588899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc----------cccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------
Q 042086 668 KFLKPDSSN----------CTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS------- 729 (784)
Q Consensus 668 ~~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~------- 729 (784)
+.+...... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 876532211 223578999999998764 67899999999999999999999999743211000
Q ss_pred -ccccccc--------cccccCCCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 -SSNRNIS--------LNEILDPRLPTPPQN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 -~~~~~~~--------~~~~~d~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....... ..+.+. ..+..+.. ......++.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHH-TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhh-cccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 000000 00000000 0112346789999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=354.16 Aligned_cols=262 Identities=26% Similarity=0.315 Sum_probs=201.5
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec------C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH------P 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~ 586 (784)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 368999999999999999999875 68999999987532 22335679999999999999999999999755 6
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCc---eEEec
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYE---ARVSD 663 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~D 663 (784)
+..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 67899999999999999998765545688899999999999999999999 9999999999999997764 99999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccc-cc-----cccccccc
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS-SS-----SSNRNISL 737 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~-~~-----~~~~~~~~ 737 (784)
||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. ........
T Consensus 168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 99998765432 3355689999999999999999999999999999999999999986321100 00 00000000
Q ss_pred c------cccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 738 N------EILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 738 ~------~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
. ..+....+.+..........+.+++..||+.||++|||+.+++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0 0111222222233444566789999999999999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=339.11 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=186.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 592 (784)
..+|++.+.||+|+||+||.....+++.||||++... ..+.+.+|+.+++.+ +|||||++++++.+....++|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE------CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT------TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3468889999999999977655667999999998652 234567899999999 899999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---C--CceEEeccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---D--YEARVSDFGIA 667 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~DfG~a 667 (784)
|||+. |+|.+++..... ...+..+..++.||+.||+|||+. +|+||||||+||+++. + ..+||+|||++
T Consensus 97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99997 599999976542 233345678999999999999999 9999999999999953 2 35889999999
Q ss_pred cccCCCC---Ccccccccccccccccccc---cCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042086 668 KFLKPDS---SNCTELVGTFGYIAPELVY---TMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 668 ~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
+...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||........ ...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---------~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---------NIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---------HHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---------HHH
Confidence 8765432 2234567999999999997 4567889999999999999999 9999853211100 000
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..................+.+++.+||+.||++|||++||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 100000001111234456789999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.46 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=193.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc-----
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN----- 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 588 (784)
++|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 57999999999999999999875 799999999876321 22234678899999999999999999999977654
Q ss_pred -eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 589 -SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 589 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
.++||||++ |+|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 588887642 488899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc--
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS-------SNRNISL-- 737 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~-------~~~~~~~-- 737 (784)
+..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .......
T Consensus 174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 865432 344578999999999876 678899999999999999999999997433210000 0000000
Q ss_pred ----------ccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 738 ----------NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 738 ----------~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+-.................+.+++.+|++.||++|||++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000111122346889999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=329.85 Aligned_cols=257 Identities=18% Similarity=0.264 Sum_probs=198.7
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CC-CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCc------eeeEEeEEec
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SG-EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS------IVKFYGFCSH 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~ 585 (784)
.++|++.+.||+|+||.||+|+.. ++ +.||+|++... ....+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 368999999999999999999875 44 78999998642 223567889999999997766 9999999999
Q ss_pred CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee------------
Q 042086 586 PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL------------ 653 (784)
Q Consensus 586 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill------------ 653 (784)
.+..++||||+ ++++.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 5678777765432 3588999999999999999999999 99999999999999
Q ss_pred -------cCCCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 042086 654 -------CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSI 726 (784)
Q Consensus 654 -------~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~ 726 (784)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999875432 24567899999999999999999999999999999999999999743221
Q ss_pred ccc-------ccccc------cccccccCCC-------------------CCCCCCCCHHHHHHHHHHHHhcccCCCCCC
Q 042086 727 SSS-------SSNRN------ISLNEILDPR-------------------LPTPPQNVQDELISIVEVAFLCLNESPESR 774 (784)
Q Consensus 727 ~~~-------~~~~~------~~~~~~~d~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 774 (784)
... ..... .......... ..............+.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 000 00000 0000000000 000001122345578899999999999999
Q ss_pred CCHHHHHH
Q 042086 775 PPMHTVCQ 782 (784)
Q Consensus 775 Ps~~~vl~ 782 (784)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=338.35 Aligned_cols=321 Identities=21% Similarity=0.216 Sum_probs=229.6
Q ss_pred cEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCC
Q 042086 80 STLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGN 159 (784)
Q Consensus 80 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (784)
+.++.++++++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 45667776666 3344332 35556666666655555555555555555555555555555555555555555555555
Q ss_pred CcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCC
Q 042086 160 SLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPL 239 (784)
Q Consensus 160 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 239 (784)
.+++..+..|.++++|++|+|++|.+. +..+..|.++++|+.|+|++|.+++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 146 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIV------------------------ILLDYMFQDLYNLKSLEVGDNDLVYISHR 146 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCC------------------------EECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred cCCccCcccccCCCCCCEEECCCCccc------------------------cCChhHccccccCCEEECCCCccceeChh
Confidence 555433344444555555555555444 44444555555555555555555555555
Q ss_pred CCcCCCCcceEEecCCCCCCCCcc-cccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccc
Q 042086 240 SIGNLNNLIGLYLYDNQLSVGEIP-IEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL 318 (784)
Q Consensus 240 ~l~~l~~L~~L~L~~n~l~~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~ 318 (784)
.|.++++|++|+|++|+++ .++ ..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.+|..+....
T Consensus 147 ~~~~l~~L~~L~l~~n~l~--~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~ 224 (477)
T 2id5_A 147 AFSGLNSLEQLTLEKCNLT--SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224 (477)
T ss_dssp SSTTCTTCCEEEEESCCCS--SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTC
T ss_pred hccCCCCCCEEECCCCcCc--ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCc
Confidence 6666666666666666665 233 3467788888888888888887788899999999999999998888888877778
Q ss_pred cceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcC
Q 042086 319 KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 398 (784)
+|++|+|++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|+
T Consensus 225 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 99999999999998766789999999999999999998888889999999999999999999999999999999999999
Q ss_pred CCCCcccCCCC-CCCcCCCcccccCCCCCCCC
Q 042086 399 YNELRGPIPNS-RIFQYDPMEALQGNKGLCGD 429 (784)
Q Consensus 399 ~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~ 429 (784)
+|++++..+.. ..+.......+.+|++.|.-
T Consensus 305 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 305 GNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp SSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 99999844432 22344555677889888763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.14 Aligned_cols=258 Identities=22% Similarity=0.269 Sum_probs=197.6
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-----------CCceeeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-----------HRSIVKFYG 581 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~ 581 (784)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 357999999999999999999874 7899999998742 223567889999999886 899999999
Q ss_pred EEecCC----ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec---
Q 042086 582 FCSHPR----NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC--- 654 (784)
Q Consensus 582 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--- 654 (784)
++...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 997644 688999999 8899999976432 35888999999999999999999953 899999999999995
Q ss_pred ---CCCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 042086 655 ---LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSS 731 (784)
Q Consensus 655 ---~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~ 731 (784)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||+..........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3447999999999876432 2345789999999999999999999999999999999999999974321100000
Q ss_pred -----------------------------ccccccccccCCCC-------CCCCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 042086 732 -----------------------------NRNISLNEILDPRL-------PTPPQNVQDELISIVEVAFLCLNESPESRP 775 (784)
Q Consensus 732 -----------------------------~~~~~~~~~~d~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 775 (784)
........+..... ............++.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00000000000000 000112345667899999999999999999
Q ss_pred CHHHHHH
Q 042086 776 PMHTVCQ 782 (784)
Q Consensus 776 s~~~vl~ 782 (784)
|++|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=330.21 Aligned_cols=336 Identities=29% Similarity=0.413 Sum_probs=260.6
Q ss_pred CeEEEEeCCCcc-----cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCC
Q 042086 61 RVISINLSTVGL-----KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135 (784)
Q Consensus 61 ~v~~l~l~~~~~-----~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 135 (784)
+++.+++.+.++ ...+++|++|+|++|.+++..+ +.++++|++|+|++|.+++..+ ++++++|++|+|++|
T Consensus 47 ~l~~L~l~~~~i~~l~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n 122 (466)
T 1o6v_A 47 QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122 (466)
T ss_dssp TCCEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred cccEEecCCCCCccCcchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCC
Confidence 445555554433 2467889999999999987655 8999999999999999986655 899999999999999
Q ss_pred ccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccch
Q 042086 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS 215 (784)
Q Consensus 136 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 215 (784)
.+++..+ +..+++|++|++++|.+++. + .+..+++|++|+++ |.+.+.. .+.++++|+.|++++|.+... .
T Consensus 123 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~ 193 (466)
T 1o6v_A 123 QITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--S 193 (466)
T ss_dssp CCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--G
T ss_pred CCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--h
Confidence 9986533 88999999999999998853 3 47888888888886 4555333 378888889999988888654 3
Q ss_pred hhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCc
Q 042086 216 ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTE 295 (784)
Q Consensus 216 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 295 (784)
.+..+++|++|++++|.+++..+ ++.+++|++|++++|+++ .++ .+..+++|+.|++++|.+++..+ +..+++
T Consensus 194 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~--~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 266 (466)
T 1o6v_A 194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK--DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTK 266 (466)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC--CCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc--cch-hhhcCCCCCEEECCCCccccchh--hhcCCC
Confidence 47888888888888888886655 677888888888888886 333 57788888888888888886544 778888
Q ss_pred cceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCC
Q 042086 296 LEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSH 375 (784)
Q Consensus 296 L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 375 (784)
|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|++++
T Consensus 267 L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 340 (466)
T 1o6v_A 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340 (466)
T ss_dssp CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred CCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCC
Confidence 8888888888886544 7788888888888888887443 7888888888888888887665 67888888888888
Q ss_pred CccCCCCcccccCcccceEEEcCCCCCcccCCCCCCCcCCCcccccCCCC
Q 042086 376 NNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKG 425 (784)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 425 (784)
|++++. ..+..+++|+.|++++|++++..| ...+.......+.+|+.
T Consensus 341 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 341 NKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAW 387 (466)
T ss_dssp SCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEE
T ss_pred CccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcc
Confidence 888876 467888888888888888888766 33333333344444443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=326.16 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=178.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ....+.+..+..+++.++||||+++++++.+.+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 357899999999999999999986 7999999998754211 11123344555678888999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||+ ++.+..+..... ..+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||++..+.
T Consensus 103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 556666554322 357889999999999999999998 5 89999999999999999999999999998665
Q ss_pred CCCCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
... ......+++.|+|||.+. ...++.++|||||||++|||++|+.||....... .....+......
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~ 248 (318)
T 2dyl_A 177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-------EVLTKVLQEEPP 248 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHHHHHHHSCCC
T ss_pred CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-------HHHHHHhccCCC
Confidence 332 234457899999999994 4568889999999999999999999997422110 001111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+. .......+.+++.+||+.||++|||++++++
T Consensus 249 ~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPG-HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCc-cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1100 0012235788999999999999999999975
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.27 Aligned_cols=306 Identities=27% Similarity=0.418 Sum_probs=268.8
Q ss_pred CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcE
Q 042086 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV 153 (784)
Q Consensus 74 ~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 153 (784)
..+++|++|++++|+++.. + .+..+++|++|+|++|++++..+ +..+++|++|++++|.+++. +.+..+++|++
T Consensus 41 ~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~ 114 (347)
T 4fmz_A 41 EELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRE 114 (347)
T ss_dssp HHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred hhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCE
Confidence 3578899999999999854 3 58999999999999999986543 99999999999999999853 46999999999
Q ss_pred EeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcc
Q 042086 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233 (784)
Q Consensus 154 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 233 (784)
|+|++|.+++..+ +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.+
T Consensus 115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred EECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence 9999999996533 8899999999999997664444 48999999999999999986554 88999999999999999
Q ss_pred ccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccc
Q 042086 234 SGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313 (784)
Q Consensus 234 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 313 (784)
++..+ +..+++|+.|++++|.+. .++. +..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..
T Consensus 190 ~~~~~--~~~l~~L~~L~l~~n~l~--~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~ 260 (347)
T 4fmz_A 190 EDISP--LASLTSLHYFTAYVNQIT--DITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260 (347)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCC--CCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred ccccc--ccCCCccceeecccCCCC--CCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence 86544 889999999999999987 3332 8889999999999999986544 88999999999999999864 57
Q ss_pred ccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccce
Q 042086 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLS 393 (784)
Q Consensus 314 l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 393 (784)
+..+++|++|++++|++++. ..+..+++|+.|++++|++.+..|..+..+++|+.|+|++|++++..| +..+++|+
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 336 (347)
T 4fmz_A 261 VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCS
T ss_pred HhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccc
Confidence 89999999999999999984 568999999999999999999999999999999999999999999877 88999999
Q ss_pred EEEcCCCCCc
Q 042086 394 CIDVSYNELR 403 (784)
Q Consensus 394 ~l~l~~N~l~ 403 (784)
.|++++|+++
T Consensus 337 ~L~l~~N~i~ 346 (347)
T 4fmz_A 337 SADFANQVIK 346 (347)
T ss_dssp EESSSCC---
T ss_pred eeehhhhccc
Confidence 9999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.36 Aligned_cols=229 Identities=13% Similarity=0.076 Sum_probs=180.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.. +++.||||++...........+.|.+|+.+++.++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999976 58999999998654333333478999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++++|.++++.. .....+.+++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999542 24456788999999999999999 99999999999999999999998543
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
|++| ++.++|||||||++|||+||+.||.......... .....+......+.....
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 230 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----PAERDTAGQPIEPADIDR 230 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----ECCBCTTSCBCCHHHHCT
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----HHHHHhccCCCChhhccc
Confidence 3333 6789999999999999999999997433211000 000111111111000011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....++.+++.+||+.||++| |+.|+++.|
T Consensus 231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 231 DIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred CCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 123358899999999999999 999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.95 Aligned_cols=230 Identities=21% Similarity=0.318 Sum_probs=178.9
Q ss_pred cCCCCc-eeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHH-hccCCCceeeEEeEEec----CC
Q 042086 515 NGFDVK-YCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTL-TELRHRSIVKFYGFCSH----PR 587 (784)
Q Consensus 515 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~ 587 (784)
++|.+. +.||+|+||.||+|... +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 567776 78999999999999875 789999999853 35678999988 55599999999999876 66
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEecc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSDF 664 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 664 (784)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 78999999999999999986532 3589999999999999999999999 9999999999999998 788999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
|++.... +..++.++|||||||++|||++|+.||......... ......+....
T Consensus 165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----~~~~~~~~~~~ 218 (299)
T 3m2w_A 165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQ 218 (299)
T ss_dssp TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------CCSCCSSCTTC
T ss_pred ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----HHHHHHHhhcc
Confidence 9987543 134678999999999999999999999643221100 00001111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.........++.+++.+||+.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11110000112346889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.79 Aligned_cols=244 Identities=14% Similarity=0.096 Sum_probs=181.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC-Ccee---------e-----
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH-RSIV---------K----- 578 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv---------~----- 578 (784)
..|...+.||+|+||+||+|++. +|+.||||++...........+.|.+|+.+++.++| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35778899999999999999965 799999999885544444557889999999999977 2211 1
Q ss_pred -------EEeEEec-----CCceEEEEecccCCCHHHHHhc----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 042086 579 -------FYGFCSH-----PRNSFLVYEYLERGSLATILSN----DGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642 (784)
Q Consensus 579 -------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 642 (784)
+..++.. ....+++|+++ +++|.++++. ......+++..+..++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1111111 12356777765 5799998841 12234578889999999999999999999 999
Q ss_pred EeCCCCCCeeecCCCceEEeccccccccCCCCCccccccccccccccccc----------ccCCcCcchhHHHHHHHHHH
Q 042086 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELV----------YTMKVTEKCDVYSFGVLALE 712 (784)
Q Consensus 643 H~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslGv~l~e 712 (784)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999865432 344567 999999999 55568889999999999999
Q ss_pred HHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 713 VIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 713 lltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
|++|+.||...... .....++.... . . ...+.+++.+||+.||++||++.++++
T Consensus 310 lltg~~Pf~~~~~~--------~~~~~~~~~~~----~-~---~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAAL--------GGSEWIFRSCK----N-I---PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGG--------SCSGGGGSSCC----C-C---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchh--------hhHHHHHhhcc----c-C---CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999743221 11111221111 1 1 135888999999999999999988864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=319.56 Aligned_cols=313 Identities=20% Similarity=0.157 Sum_probs=275.3
Q ss_pred CCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCcccccccccee
Q 042086 99 NLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYL 178 (784)
Q Consensus 99 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 178 (784)
.+.+|++|++++|.++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46899999999999997666668999999999999999998888899999999999999999998888999999999999
Q ss_pred eccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCC
Q 042086 179 HLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258 (784)
Q Consensus 179 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 258 (784)
+|++|.++...+..|.++++|++|++++|++++..+..+.++++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999965555679999999999999999988889999999999999999999865 3677899999999999987
Q ss_pred CCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhh
Q 042086 259 VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL 338 (784)
Q Consensus 259 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 338 (784)
.+...++|++|++++|.+... |.. ..++|+.|++++|.+++. ..+..+++|++|++++|.+++..|..+
T Consensus 200 ------~~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 268 (390)
T 3o6n_A 200 ------TLAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPF 268 (390)
T ss_dssp ------EEECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred ------ccCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHc
Confidence 344557899999999999854 433 357999999999999864 688999999999999999999889999
Q ss_pred hcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCCCCCcCCCcc
Q 042086 339 EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPME 418 (784)
Q Consensus 339 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~ 418 (784)
..+++|+.|+|++|++++ +|..+..+++|+.|+|++|++++ +|..+..+++|+.|++++|+++.. | ...+......
T Consensus 269 ~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~-~~~~~~L~~L 344 (390)
T 3o6n_A 269 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K-LSTHHTLKNL 344 (390)
T ss_dssp TTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C-CCTTCCCSEE
T ss_pred cccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcccee-C-chhhccCCEE
Confidence 999999999999999994 67777889999999999999995 566788899999999999999864 3 3345556666
Q ss_pred cccCCCCCCCC
Q 042086 419 ALQGNKGLCGD 429 (784)
Q Consensus 419 ~~~~n~~~c~~ 429 (784)
.+.+|++.|..
T Consensus 345 ~l~~N~~~~~~ 355 (390)
T 3o6n_A 345 TLSHNDWDCNS 355 (390)
T ss_dssp ECCSSCEEHHH
T ss_pred EcCCCCccchh
Confidence 77888877753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=348.15 Aligned_cols=233 Identities=25% Similarity=0.335 Sum_probs=188.9
Q ss_pred cCCCCceeEecccceEEEEEEEc--CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCc----
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT--SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRN---- 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 588 (784)
++|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 68999999999999999999975 68999999986532 22234678999999999999999999999987655
Q ss_pred -eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 589 -SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 589 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
.++||||+++++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987753 588999999999999999999999 99999999999999875 8999999999
Q ss_pred cccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
+..... ....||++|+|||++.+.. +.++|||||||++|||++|..||..... + .++.
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------~-~~~~ 286 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------------D-GLPE 286 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC----------------S-SCCT
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc----------------c-cccc
Confidence 876543 4457999999999987654 8899999999999999999988752110 0 0000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
..........+.+++.+||+.||++||+..+.+
T Consensus 287 -~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 319 (681)
T 2pzi_A 287 -DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319 (681)
T ss_dssp -TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred -cccccccCHHHHHHHhhhccCChhhCCCHHHHH
Confidence 011112235688999999999999999755544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=321.42 Aligned_cols=317 Identities=30% Similarity=0.418 Sum_probs=278.0
Q ss_pred CCeEEEEeCCCcc-----cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccC
Q 042086 60 KRVISINLSTVGL-----KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134 (784)
Q Consensus 60 ~~v~~l~l~~~~~-----~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 134 (784)
.++..+++.+..+ .+.+++|++|+|++|.+++..+ ++++++|++|+|++|.+++..+ ++.+++|++|++++
T Consensus 68 ~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 143 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSS 143 (466)
T ss_dssp TTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEE
T ss_pred cCCCEEECCCCccCCchhhhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCC
Confidence 3567777776544 4578999999999999997765 9999999999999999986543 99999999999999
Q ss_pred CccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccc
Q 042086 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP 214 (784)
Q Consensus 135 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 214 (784)
|.+.+. + .+..+++|+.|+++ |.+.+.. .+.++++|++|++++|.+++. ..+..+++|++|++++|.+.+..+
T Consensus 144 n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 216 (466)
T 1o6v_A 144 NTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP 216 (466)
T ss_dssp EEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc
Confidence 999863 3 58999999999997 5565443 388999999999999999854 348899999999999999987765
Q ss_pred hhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCC
Q 042086 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT 294 (784)
Q Consensus 215 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 294 (784)
++.+++|+.|++++|++++. ..+..+++|+.|++++|+++ .++ .+..+++|+.|++++|.+++..+ +..++
T Consensus 217 --~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~--~~~-~~~~l~~L~~L~l~~n~l~~~~~--~~~l~ 287 (466)
T 1o6v_A 217 --LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS--NLA-PLSGLTKLTELKLGANQISNISP--LAGLT 287 (466)
T ss_dssp --GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC--CCG-GGTTCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred --ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccc--cch-hhhcCCCCCEEECCCCccCcccc--ccCCC
Confidence 78899999999999999864 46889999999999999997 333 38899999999999999996544 88999
Q ss_pred ccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecC
Q 042086 295 ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374 (784)
Q Consensus 295 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 374 (784)
+|+.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|+++
T Consensus 288 ~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~ 361 (466)
T 1o6v_A 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAG 361 (466)
T ss_dssp TCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred ccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCC
Confidence 99999999999997554 8899999999999999998665 88999999999999999965 478999999999999
Q ss_pred CCccCCCCcccccCcccceEEEcCCCCCcc
Q 042086 375 HNNFSGLIPSCFEGMHGLSCIDVSYNELRG 404 (784)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 404 (784)
+|++++..| +..+++|+.|++++|++++
T Consensus 362 ~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 362 HNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp SSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCccCccch--hhcCCCCCEEeccCCcccC
Confidence 999999887 8999999999999999998
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=333.39 Aligned_cols=332 Identities=23% Similarity=0.234 Sum_probs=266.5
Q ss_pred CCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccc
Q 042086 93 IPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNL 172 (784)
Q Consensus 93 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l 172 (784)
+|..+- +++++|+|++|+|++..+.+|+++++|++|+|++|+|++..|.+|.++++|++|+|++|+|++..+..|.++
T Consensus 46 vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L 123 (635)
T 4g8a_A 46 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 123 (635)
T ss_dssp CCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTC
T ss_pred cCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCC
Confidence 555442 479999999999998888999999999999999999998888899999999999999999998777889999
Q ss_pred cccceeeccccccCCCccccccCccCCceeeccccccCCc-cchhhhcccccceeccCCCccccccCCCCcCCC------
Q 042086 173 KSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGS-IPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN------ 245 (784)
Q Consensus 173 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~------ 245 (784)
++|++|+|++|++++..+..|+++++|++|+|++|.++.. .|..++.+++|++|+|++|++++..+..|..+.
T Consensus 124 ~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~ 203 (635)
T 4g8a_A 124 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 203 (635)
T ss_dssp TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred CCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhh
Confidence 9999999999999987777899999999999999999764 678899999999999999998765544332221
Q ss_pred --------------------------------------------------------------------------------
Q 042086 246 -------------------------------------------------------------------------------- 245 (784)
Q Consensus 246 -------------------------------------------------------------------------------- 245 (784)
T Consensus 204 ~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~ 283 (635)
T 4g8a_A 204 LSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 283 (635)
T ss_dssp CEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEE
T ss_pred hhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhh
Confidence
Q ss_pred ---------------------------------------------CcceEEecCCCCCCC------------------Cc
Q 042086 246 ---------------------------------------------NLIGLYLYDNQLSVG------------------EI 262 (784)
Q Consensus 246 ---------------------------------------------~L~~L~L~~n~l~~~------------------~~ 262 (784)
+|+.|++.+|.+... ..
T Consensus 284 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~ 363 (635)
T 4g8a_A 284 EEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 363 (635)
T ss_dssp EEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCC
T ss_pred hhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCC
Confidence 122222222222100 00
Q ss_pred ccccccccccceEeccCccccCC-------------------------CCccccCCCccceeecccCccCCCCc-ccccc
Q 042086 263 PIEIGKLSSLNYLVLNGNQLYGN-------------------------LPRALGSLTELEYLDLSTNKLGNSIP-ETLGN 316 (784)
Q Consensus 263 ~~~l~~l~~L~~L~l~~n~l~~~-------------------------~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~l~~ 316 (784)
+.....+++|+.|++++|.+... .+..+..+++|+.++++.|+.....+ ..+..
T Consensus 364 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~ 443 (635)
T 4g8a_A 364 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 443 (635)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTT
T ss_pred Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccc
Confidence 00112356788888888776421 23456678999999999988776544 56789
Q ss_pred cccceEEecccccccCCCchhhhcccccCeeccCCcccc-ccccccccccccccEEecCCCccCCCCcccccCcccceEE
Q 042086 317 LLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILE-GKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCI 395 (784)
Q Consensus 317 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l 395 (784)
+++++.++++.|.+.+..+..+..++.|+.|+|++|.+. +..|..|..+++|+.|+|++|++++.+|..|.++++|+.|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 999999999999999999999999999999999999754 4678899999999999999999999999999999999999
Q ss_pred EcCCCCCcccCCCC-CCCcCCCcccccCCCCC
Q 042086 396 DVSYNELRGPIPNS-RIFQYDPMEALQGNKGL 426 (784)
Q Consensus 396 ~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~ 426 (784)
+|++|++++..|.. ..........+.+|...
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 555 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 555 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCC
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCC
Confidence 99999999866542 22334444556666443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=318.27 Aligned_cols=302 Identities=21% Similarity=0.256 Sum_probs=257.4
Q ss_pred CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcE
Q 042086 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV 153 (784)
Q Consensus 74 ~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 153 (784)
+++++|++|+|++|+|++. | .|+.+++|++|+|++|++++. | ++.+++|++|+|++|.+++. + ++.+++|++
T Consensus 39 ~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~ 110 (457)
T 3bz5_A 39 EQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTY 110 (457)
T ss_dssp HHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCE
T ss_pred hHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCE
Confidence 4678899999999999975 5 799999999999999999974 4 89999999999999999975 3 889999999
Q ss_pred EeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcc
Q 042086 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233 (784)
Q Consensus 154 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 233 (784)
|+|++|.+++ ++ ++++++|++|++++|++++. + ++.+++|+.|++++|+..+.+ .+..+++|+.|++++|++
T Consensus 111 L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 111 LNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp EECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcc
Confidence 9999999996 44 88999999999999999964 3 888999999999999655555 478899999999999999
Q ss_pred ccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccc
Q 042086 234 SGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313 (784)
Q Consensus 234 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 313 (784)
++. | +..+++|+.|++++|+++. + .+..+++|+.|++++|++++ +| +..+++|+.|++++|++++..+..
T Consensus 183 ~~l-~--l~~l~~L~~L~l~~N~l~~--~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~ 252 (457)
T 3bz5_A 183 TEL-D--VSQNKLLNRLNCDTNNITK--L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVST 252 (457)
T ss_dssp CCC-C--CTTCTTCCEEECCSSCCSC--C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTT
T ss_pred cee-c--cccCCCCCEEECcCCcCCe--e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHH
Confidence 974 4 8889999999999999983 3 47888999999999999997 55 888999999999999999876666
Q ss_pred ccccc-------cceEEecccccccCCCchhhhcccccCeeccCCccccccccc--------cccccccccEEecCCCcc
Q 042086 314 LGNLL-------KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPC--------EICNMESLEKLNLSHNNF 378 (784)
Q Consensus 314 l~~l~-------~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l 378 (784)
+.++. +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. .+..+++|+.|++++|++
T Consensus 253 l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l 330 (457)
T 3bz5_A 253 LSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTEL 330 (457)
T ss_dssp CTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCC
T ss_pred CCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcc
Confidence 66554 56677777777766565 57789999999999988777764 255668999999999999
Q ss_pred CCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 379 SGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 379 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
++. + +..+++|+.|++++|++++ +|
T Consensus 331 ~~l-~--l~~l~~L~~L~l~~N~l~~-l~ 355 (457)
T 3bz5_A 331 TEL-D--VSHNTKLKSLSCVNAHIQD-FS 355 (457)
T ss_dssp SCC-C--CTTCTTCSEEECCSSCCCB-CT
T ss_pred ccc-c--cccCCcCcEEECCCCCCCC-cc
Confidence 995 3 8899999999999999998 44
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.57 Aligned_cols=281 Identities=21% Similarity=0.233 Sum_probs=191.7
Q ss_pred hHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCcccceeEEcCCCCeEEEEeCCCcccCCCCcccEE
Q 042086 3 GKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTL 82 (784)
Q Consensus 3 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~~L 82 (784)
.+|+.||++||+++..|+++.+++|.... ....++|.|.|++|+..... + .......++.|
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~~-----------~~~~~~~~~~g~~~~~~~~~----l----~~~~~~~l~~L 86 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQAN-----------SNNPQIETRTGRALKATADL----L----EDATQPGRVAL 86 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHHT-----------TTCTTSCCSHHHHHHHHHHH----H----HHHTSTTCCEE
T ss_pred chHHHHHHHHHHhccCCchhhhhhhcccc-----------cccccccccCCcchhhhHHH----H----hcccccceeEE
Confidence 47899999999999889988888994211 12457899999999631100 0 01124567888
Q ss_pred eCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcc
Q 042086 83 DLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLS 162 (784)
Q Consensus 83 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 162 (784)
+|++|+++ .+|..+.++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..+..+++|++|+|++|++.
T Consensus 87 ~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~ 163 (328)
T 4fcg_A 87 ELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163 (328)
T ss_dssp EEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred EccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence 88888888 67777888888888888888888 77888888888888888888888 77888888888888888888777
Q ss_pred cccCCcccc---------ccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcc
Q 042086 163 GSIPSIIGN---------LKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233 (784)
Q Consensus 163 ~~~~~~l~~---------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 233 (784)
+.+|..+.. +++|++|+|++|.++ .+|..+..+++|++|+|++|++++ +|..+..+++|++|+|++|.+
T Consensus 164 ~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~ 241 (328)
T 4fcg_A 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241 (328)
T ss_dssp CCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT
T ss_pred cccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc
Confidence 777776654 555666666666555 455555555555555555555553 333455555555555555555
Q ss_pred ccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccc
Q 042086 234 SGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313 (784)
Q Consensus 234 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 313 (784)
.+.+|. .+..+++|++|++++|.+.+.+|..+..+++|++|+|++|++.+.+|..
T Consensus 242 ~~~~p~-------------------------~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~ 296 (328)
T 4fcg_A 242 LRNYPP-------------------------IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296 (328)
T ss_dssp CCBCCC-------------------------CTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGG
T ss_pred hhhhHH-------------------------HhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHH
Confidence 544444 4555555666666666655666666666666666666666666666666
Q ss_pred ccccccceEEecccccccC
Q 042086 314 LGNLLKLHYLNLSNNQFRK 332 (784)
Q Consensus 314 l~~l~~L~~L~ls~N~l~~ 332 (784)
++++++|+.+++..|.+..
T Consensus 297 l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 297 IAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp GGGSCTTCEEECCGGGSCC
T ss_pred HhhccCceEEeCCHHHHHH
Confidence 6666677776666655543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=335.02 Aligned_cols=313 Identities=20% Similarity=0.155 Sum_probs=278.8
Q ss_pred CCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCcccccccccee
Q 042086 99 NLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYL 178 (784)
Q Consensus 99 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 178 (784)
.+.+++.|++++|.++...+..|+.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 36789999999999997777778999999999999999998888899999999999999999999888899999999999
Q ss_pred eccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCC
Q 042086 179 HLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258 (784)
Q Consensus 179 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 258 (784)
+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|+.|+|++|.+++. .+..+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccc
Confidence 9999999976666789999999999999999999999999999999999999999965 3667899999999999987
Q ss_pred CCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhh
Q 042086 259 VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL 338 (784)
Q Consensus 259 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 338 (784)
.+...++|+.|++++|.+....+. + .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..+
T Consensus 206 ------~l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 274 (597)
T 3oja_B 206 ------TLAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 274 (597)
T ss_dssp ------EEECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred ------cccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHh
Confidence 445567899999999999854332 3 3689999999999986 4789999999999999999999999999
Q ss_pred hcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCCCCCcCCCcc
Q 042086 339 EKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPME 418 (784)
Q Consensus 339 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~ 418 (784)
+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|++.+. | ...+......
T Consensus 275 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~~~L~~L 350 (597)
T 3oja_B 275 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K-LSTHHTLKNL 350 (597)
T ss_dssp TTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C-CCTTCCCSEE
T ss_pred cCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCc-C-hhhcCCCCEE
Confidence 999999999999999995 67778889999999999999994 677789999999999999999874 3 2345556666
Q ss_pred cccCCCCCCCC
Q 042086 419 ALQGNKGLCGD 429 (784)
Q Consensus 419 ~~~~n~~~c~~ 429 (784)
.+.+|++.|..
T Consensus 351 ~l~~N~~~~~~ 361 (597)
T 3oja_B 351 TLSHNDWDCNS 361 (597)
T ss_dssp ECCSSCEEHHH
T ss_pred EeeCCCCCChh
Confidence 78899888864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=316.59 Aligned_cols=318 Identities=19% Similarity=0.168 Sum_probs=262.9
Q ss_pred CeEEEEeCCCccc-----CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCC
Q 042086 61 RVISINLSTVGLK-----GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135 (784)
Q Consensus 61 ~v~~l~l~~~~~~-----~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 135 (784)
++..+++.+..+. +.+++|++|+|++|+|++. | ++.+++|++|+|++|.+++. + ++.+++|++|++++|
T Consensus 43 ~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N 116 (457)
T 3bz5_A 43 TLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTN 116 (457)
T ss_dssp TCCEEECCSSCCCCCTTGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSS
T ss_pred CCCEEEccCCCcccChhhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCC
Confidence 4556666654433 4678999999999999985 3 99999999999999999975 3 899999999999999
Q ss_pred ccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccch
Q 042086 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS 215 (784)
Q Consensus 136 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 215 (784)
++++. | ++.+++|++|++++|.+++. + ++++++|++|++++|...+.+ .+..+++|+.|++++|++++. |
T Consensus 117 ~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~- 186 (457)
T 3bz5_A 117 KLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D- 186 (457)
T ss_dssp CCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C-
T ss_pred cCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c-
Confidence 99974 4 89999999999999999974 3 889999999999999666555 488899999999999999874 4
Q ss_pred hhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCC-
Q 042086 216 ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT- 294 (784)
Q Consensus 216 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~- 294 (784)
++.+++|+.|++++|++++. .++.+++|+.|++++|+++ .+| +..+++|+.|++++|++++..+..+..++
T Consensus 187 -l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~--~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~ 258 (457)
T 3bz5_A 187 -VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT--EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTT 258 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCS--CCC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCE
T ss_pred -cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccc--ccC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCE
Confidence 88899999999999999975 4889999999999999998 355 88899999999999999987665565554
Q ss_pred ------ccceeecccCccCCCCcccccccccceEEecccccccCCCch--------hhhcccccCeeccCCccccccccc
Q 042086 295 ------ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPV--------ELEKLIQLSELDLSLNILEGKIPC 360 (784)
Q Consensus 295 ------~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~--------~~~~l~~L~~L~Ls~N~l~~~~~~ 360 (784)
+|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. .++.+++|+.|++++|++++. +
T Consensus 259 L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~- 334 (457)
T 3bz5_A 259 LHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D- 334 (457)
T ss_dssp EECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C-
T ss_pred EeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c-
Confidence 56777777777766665 56789999999999987665553 356778999999999999974 3
Q ss_pred cccccccccEEecCCCccCCCCccccc-------------CcccceEEEcCCCCCcccCCCC
Q 042086 361 EICNMESLEKLNLSHNNFSGLIPSCFE-------------GMHGLSCIDVSYNELRGPIPNS 409 (784)
Q Consensus 361 ~~~~l~~L~~L~L~~N~l~~~~p~~~~-------------~l~~L~~l~l~~N~l~~~~p~~ 409 (784)
++.+++|+.|++++|++++. + .+. .+..|..+++++|+++|.+|..
T Consensus 335 -l~~l~~L~~L~l~~N~l~~l-~-~L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 335 -VSHNTKLKSLSCVNAHIQDF-S-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp -CTTCTTCSEEECCSSCCCBC-T-TGGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCTT
T ss_pred -cccCCcCcEEECCCCCCCCc-c-ccccccccCCcEEecceeeecCccccccCcEEEEcChh
Confidence 88999999999999999974 2 111 2245677888888888888864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=304.90 Aligned_cols=287 Identities=24% Similarity=0.282 Sum_probs=184.1
Q ss_pred CCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccc
Q 042086 103 LAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182 (784)
Q Consensus 103 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 182 (784)
|+.++++++.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 444444444443 3333332 3444455555544444444444455555555555555444444455555555555555
Q ss_pred cccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccc--cccCCCCcCCCCcceEEecCCCCCCC
Q 042086 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS--GVIPLSIGNLNNLIGLYLYDNQLSVG 260 (784)
Q Consensus 183 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~ 260 (784)
|.++ .+|..+. ++|++|++++|+++...+..|.++++|+.|++++|.++ +..+..+..+ +|+.|++++|+++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-- 185 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-- 185 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS--
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC--
Confidence 5554 3333332 45555555555555444445555555555555555554 2445555555 6666666666665
Q ss_pred CcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhc
Q 042086 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEK 340 (784)
Q Consensus 261 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~ 340 (784)
.+|..+. ++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|+++. +|..+..
T Consensus 186 ~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~l~~ 262 (332)
T 2ft3_A 186 GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPD 262 (332)
T ss_dssp SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCB-CCTTGGG
T ss_pred ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCee-cChhhhc
Confidence 3444443 678888888888887777888888888888888888888777788888888888888888884 7777888
Q ss_pred ccccCeeccCCccccccccccccc------cccccEEecCCCccC--CCCcccccCcccceEEEcCCCC
Q 042086 341 LIQLSELDLSLNILEGKIPCEICN------MESLEKLNLSHNNFS--GLIPSCFEGMHGLSCIDVSYNE 401 (784)
Q Consensus 341 l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~l~~N~ 401 (784)
+++|+.|++++|++++..+..|.. .++|+.|++++|++. +..|..|..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 888999999999888766666654 367899999999987 6778889999999999998884
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.14 Aligned_cols=291 Identities=24% Similarity=0.281 Sum_probs=172.6
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
+++.+++++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4666677666665 2343332 455666666666665555556666666666666666665555555556666666666
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (784)
+|.++ .+|..+. ++|++|++++|.+++..+..|.++++|+.|++++|.+.. .+..
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~ 163 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIE 163 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBC
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc----------------------cCcC
Confidence 65555 2333332 445555555555554444444444455555554444431 1133
Q ss_pred CCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccccccc
Q 042086 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNL 317 (784)
Q Consensus 238 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l 317 (784)
+..+.++++|+.|++++|+++ .+|..+. ++|++|++++|++++..+..+..+++|+.|++++|.+++..+..+..+
T Consensus 164 ~~~~~~l~~L~~L~l~~n~l~--~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 239 (330)
T 1xku_A 164 NGAFQGMKKLSYIRIADTNIT--TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239 (330)
T ss_dssp TTGGGGCTTCCEEECCSSCCC--SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred hhhccCCCCcCEEECCCCccc--cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC
Confidence 444455555555555555544 3333332 566667777777666666667777777777777777776666667777
Q ss_pred ccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccc------cccccEEecCCCccCC--CCcccccCc
Q 042086 318 LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICN------MESLEKLNLSHNNFSG--LIPSCFEGM 389 (784)
Q Consensus 318 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~p~~~~~l 389 (784)
++|++|+|++|+++. +|..+..+++|+.|++++|++++..+..|+. .+.|+.|++++|++.. ..|..|..+
T Consensus 240 ~~L~~L~L~~N~l~~-lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~ 318 (330)
T 1xku_A 240 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318 (330)
T ss_dssp TTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred CCCCEEECCCCcCcc-CChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccc
Confidence 777777777777763 5666777777777777777777655555543 3677888888888753 566778888
Q ss_pred ccceEEEcCCCC
Q 042086 390 HGLSCIDVSYNE 401 (784)
Q Consensus 390 ~~L~~l~l~~N~ 401 (784)
++++.++|++|+
T Consensus 319 ~~l~~l~L~~N~ 330 (330)
T 1xku_A 319 YVRAAVQLGNYK 330 (330)
T ss_dssp CCGGGEEC----
T ss_pred cceeEEEecccC
Confidence 888888888874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=307.82 Aligned_cols=255 Identities=31% Similarity=0.506 Sum_probs=163.4
Q ss_pred CcCcEEeecCCCccc--ccCCccccccccceeeccc-cccCCCccccccCccCCceeeccccccCCccchhhhcccccce
Q 042086 149 SNLAVLHLYGNSLSG--SIPSIIGNLKSLFYLHLSS-NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLH 225 (784)
Q Consensus 149 ~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 225 (784)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 578888888888887 7888888888888888884 8888888888888888888888888888788888888888888
Q ss_pred eccCCCccccccCCCCcCCCCcceEEecCCCCCCCCccccccccc-ccceEeccCccccCCCCccccCCCccceeecccC
Q 042086 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLS-SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304 (784)
Q Consensus 226 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n 304 (784)
|+|++|++++.+|..+..+++|++|++++|+++ +.+|..+..++ +|++|++++|++++.+|..+..++ |+.|++++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRIS-GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCE-EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCccc-CcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 888888888777776666666666666666654 34455555554 555555555555555555555554 555555555
Q ss_pred ccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcc
Q 042086 305 KLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPS 384 (784)
Q Consensus 305 ~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 384 (784)
.+++..|..+..+++|+.|+|++|++++ .+|. +..+++|+.|+|++|++++.+|.
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------------------~~~~-~~~l~~L~~L~Ls~N~l~~~~p~ 262 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAF------------------------DLGK-VGLSKNLNGLDLRNNRIYGTLPQ 262 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECC------------------------BGGG-CCCCTTCCEEECCSSCCEECCCG
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceee------------------------ecCc-ccccCCCCEEECcCCcccCcCCh
Confidence 5555555555555555555555555544 3332 44444555555555555544555
Q ss_pred cccCcccceEEEcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCC
Q 042086 385 CFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI 430 (784)
Q Consensus 385 ~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 430 (784)
.+..+++|+.|++++|+++|.+|....+.......+.+|+++||.|
T Consensus 263 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred HHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 5555555555555555555555544444444444555566666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=300.67 Aligned_cols=297 Identities=25% Similarity=0.396 Sum_probs=256.6
Q ss_pred CeEEEEeCCCcc-----cCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCC
Q 042086 61 RVISINLSTVGL-----KGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN 135 (784)
Q Consensus 61 ~v~~l~l~~~~~-----~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 135 (784)
.+..+++.+..+ .+.+++|++|+|++|++++..+ +..+++|++|+|++|.+++. +.+..+++|++|++++|
T Consensus 45 ~L~~L~l~~~~i~~~~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n 120 (347)
T 4fmz_A 45 SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNED 120 (347)
T ss_dssp TCSEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTS
T ss_pred cccEEEEeCCccccchhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCC
Confidence 445555554432 3468899999999999997544 99999999999999999863 46999999999999999
Q ss_pred ccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccch
Q 042086 136 QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPS 215 (784)
Q Consensus 136 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 215 (784)
.+.+. +. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+..+
T Consensus 121 ~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~- 194 (347)
T 4fmz_A 121 NISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP- 194 (347)
T ss_dssp CCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG-
T ss_pred cccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc-
Confidence 99954 33 8999999999999997664444 48999999999999999985544 8899999999999999986544
Q ss_pred hhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCc
Q 042086 216 ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTE 295 (784)
Q Consensus 216 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 295 (784)
+..+++|+.|++++|.+++..+ +..+++|++|++++|+++ .++. +..+++|++|++++|.+++. ..+..+++
T Consensus 195 -~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~--~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~ 266 (347)
T 4fmz_A 195 -LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT--DLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTK 266 (347)
T ss_dssp -GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC--CCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred -ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC--CCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCC
Confidence 8899999999999999996654 889999999999999997 4443 88999999999999999864 56889999
Q ss_pred cceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCC
Q 042086 296 LEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSH 375 (784)
Q Consensus 296 L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 375 (784)
|++|++++|.+++. ..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++..| +..+++|+.|++++
T Consensus 267 L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 342 (347)
T 4fmz_A 267 LKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342 (347)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSC
T ss_pred cCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhh
Confidence 99999999999864 468999999999999999999899999999999999999999997766 88999999999999
Q ss_pred CccC
Q 042086 376 NNFS 379 (784)
Q Consensus 376 N~l~ 379 (784)
|+|+
T Consensus 343 N~i~ 346 (347)
T 4fmz_A 343 QVIK 346 (347)
T ss_dssp C---
T ss_pred hccc
Confidence 9986
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=295.29 Aligned_cols=296 Identities=23% Similarity=0.243 Sum_probs=211.8
Q ss_pred cccceeEEcCCCCeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCC
Q 042086 49 CAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLY 128 (784)
Q Consensus 49 C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 128 (784)
|.|..+.|...+ ++.+ + ..-.+.+++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|+.+++|+
T Consensus 31 c~l~~l~~~~~~-l~~l--p----~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (330)
T 1xku_A 31 CHLRVVQCSDLG-LEKV--P----KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103 (330)
T ss_dssp EETTEEECTTSC-CCSC--C----CSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CCCeEEEecCCC-cccc--C----ccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCC
Confidence 788888886432 1111 1 11236899999999999998888999999999999999999999999999999999
Q ss_pred EEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCC--CccccccCccCCceeeccc
Q 042086 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG--SIPISLGNLSNLVVLHLFE 206 (784)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~ 206 (784)
+|+|++|.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+.. ..+..+.++++|++|++++
T Consensus 104 ~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~ 180 (330)
T 1xku_A 104 RLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180 (330)
T ss_dssp EEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred EEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCC
Confidence 9999999999 5666655 799999999999998877889999999999999999964 6677888899999999999
Q ss_pred cccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCC
Q 042086 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286 (784)
Q Consensus 207 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 286 (784)
|+++.. |..+. ++|++|++++|++++..+..|..+++|++|++++|+++ ...+..+..+++|++|++++|+++ .+
T Consensus 181 n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 181 TNITTI-PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp SCCCSC-CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-EECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred CccccC-Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc-eeChhhccCCCCCCEEECCCCcCc-cC
Confidence 998753 43332 67888888888888777777777777777777777765 222335666666666666666666 55
Q ss_pred CccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccc--cccccccc
Q 042086 287 PRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG--KIPCEICN 364 (784)
Q Consensus 287 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~ 364 (784)
|..+..+++|++|++++|++++..+..|.... .....+.|+.|++++|.+.. ..|..|..
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred ChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccceEeecCcccccccCcccccc
Confidence 55666666666666666666654444443220 00012344445555554432 33445555
Q ss_pred cccccEEecCCCc
Q 042086 365 MESLEKLNLSHNN 377 (784)
Q Consensus 365 l~~L~~L~L~~N~ 377 (784)
+..|+.++|++|+
T Consensus 318 ~~~l~~l~L~~N~ 330 (330)
T 1xku_A 318 VYVRAAVQLGNYK 330 (330)
T ss_dssp CCCGGGEEC----
T ss_pred ccceeEEEecccC
Confidence 5556666665553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.19 Aligned_cols=245 Identities=16% Similarity=0.117 Sum_probs=185.3
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCC-----CCCChhhHHHHHHHHhccC---------CCceeeE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPC-----EMVPQPEFVNEIKTLTELR---------HRSIVKF 579 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~niv~l 579 (784)
.++|++.+.||+|+||+||+|+. +|+.||||++...... .....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35689999999999999999998 6899999999765321 2223478999999999886 6666666
Q ss_pred EeEE-----------------ec-------------CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 042086 580 YGFC-----------------SH-------------PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANA 629 (784)
Q Consensus 580 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 629 (784)
.+.+ .+ .+..++||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 6553 32 6789999999999977666643 357889999999999999
Q ss_pred HHHHh-hCCCCCeEEeCCCCCCeeecCCC--------------------ceEEeccccccccCCCCCccccccccccccc
Q 042086 630 LSYMH-HDCFPPIVHRDISSKNVLLCLDY--------------------EARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688 (784)
Q Consensus 630 l~~LH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~a 688 (784)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccC
Confidence 99999 88 999999999999999887 899999999987653 23479999999
Q ss_pred ccccccCCcCcchhHHHHHHH-HHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcc
Q 042086 689 PELVYTMKVTEKCDVYSFGVL-ALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCL 767 (784)
Q Consensus 689 PE~~~~~~~~~~sDvwslGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl 767 (784)
||++.+.. +.++||||+|++ .+++++|..||....+... ......... ................++.+++.+||
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY---LTDKMLKQM-TFKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH---HHHHHHHTC-CCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH---HHHhhhhhh-ccCcccchhhhhhcCHHHHHHHHHHh
Confidence 99998776 889999998777 7788899999853211000 000000000 00111111122345678999999999
Q ss_pred cCCCCCCCCHHHHH
Q 042086 768 NESPESRPPMHTVC 781 (784)
Q Consensus 768 ~~dP~~RPs~~~vl 781 (784)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 999998
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=297.04 Aligned_cols=267 Identities=24% Similarity=0.240 Sum_probs=135.5
Q ss_pred CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeecc
Q 042086 102 NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181 (784)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 181 (784)
+|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++|.++ .+|..+. ++|++|+++
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECC
Confidence 4444444444444444444444444444444444444444444444444444444444444 2232222 344444444
Q ss_pred ccccCCCccccccCccCCceeeccccccC--CccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCC
Q 042086 182 SNQLSGSIPISLGNLSNLVVLHLFENSLF--GSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSV 259 (784)
Q Consensus 182 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 259 (784)
+|.+++..+..|..+++|+.|++++|.++ +..+..+..+ +|++|++++|++++ +|..+. ++|++|++++|+++
T Consensus 132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~- 206 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ- 206 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCC-
T ss_pred CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCC-
Confidence 44444333334444444444444444443 2334444444 45555555555543 232222 45555555555554
Q ss_pred CCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhh
Q 042086 260 GEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELE 339 (784)
Q Consensus 260 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~ 339 (784)
...+..+..+++|++|++++|++++..+..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++++..+..+.
T Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 122234555556666666666665555555666666666666666665 4555566666666666666666655444444
Q ss_pred c------ccccCeeccCCcccc--ccccccccccccccEEecCCCc
Q 042086 340 K------LIQLSELDLSLNILE--GKIPCEICNMESLEKLNLSHNN 377 (784)
Q Consensus 340 ~------l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 377 (784)
. ...|+.|++++|++. +..|..|..+++|+.|++++|+
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 3 245667777777665 4556666677777777777764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-32 Score=300.61 Aligned_cols=304 Identities=30% Similarity=0.396 Sum_probs=173.5
Q ss_pred eEEEEeCCCcccC---CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccC
Q 042086 62 VISINLSTVGLKG---NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLS 138 (784)
Q Consensus 62 v~~l~l~~~~~~~---~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 138 (784)
++.+++.+.++.+ ..++|++|+|++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|+++
T Consensus 73 l~~L~l~~~~l~~lp~~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 73 AHELELNNLGLSSLPELPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp CSEEECTTSCCSCCCSCCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS
T ss_pred CCEEEecCCccccCCCCcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC
Confidence 4566666655443 34578888888888876 5543 3677777777777764 2221 157777777777777
Q ss_pred CCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhh
Q 042086 139 GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILG 218 (784)
Q Consensus 139 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 218 (784)
+ +| .++.+++|++|++++|++++ +|..+ ++|++|++++|.+++ +| .++++++|+.|++++|++++ +|...
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 5 55 47777777777777777774 45433 467777777777775 45 57777777777777777764 23222
Q ss_pred cccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccce
Q 042086 219 NLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY 298 (784)
Q Consensus 219 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 298 (784)
++|++|++++|+++ .+| .++.+++|++|++++|+++ .+|.. +++|+.|++++|++++ +|.. +++|+.
T Consensus 215 --~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~--~l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~ 281 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK--TLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTF 281 (454)
T ss_dssp --TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS--SCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCE
T ss_pred --CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCC--ccccc---ccccCEEECCCCcccc-cCcc---cCcCCE
Confidence 46777777777777 455 3677777777777777776 34432 3567777777777764 3432 256667
Q ss_pred eecccCccCC--CCccc-------------cccc-ccceEEecccccccCCCchhhhcccccCeeccCCccccccccccc
Q 042086 299 LDLSTNKLGN--SIPET-------------LGNL-LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362 (784)
Q Consensus 299 L~Ls~n~l~~--~~~~~-------------l~~l-~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 362 (784)
|++++|.+++ .+|.. +..+ ++|++|++++|++++ +|.. +++|+.|++++|+++ .+|.
T Consensus 282 L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~-- 354 (454)
T 1jl5_A 282 LDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE-- 354 (454)
T ss_dssp EECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC--
T ss_pred EECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc--
Confidence 7777776664 22210 1111 244555555555444 2222 344555555555554 2333
Q ss_pred cccccccEEecCCCccCC--CCcccccCc-------------ccceEEEcCCCCCcc
Q 042086 363 CNMESLEKLNLSHNNFSG--LIPSCFEGM-------------HGLSCIDVSYNELRG 404 (784)
Q Consensus 363 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l-------------~~L~~l~l~~N~l~~ 404 (784)
.+++|+.|++++|++++ .+|..+..+ ++|+.|++++|++++
T Consensus 355 -~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 355 -LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp -CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred -hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 23455555555555555 444444444 445555555555554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-32 Score=298.92 Aligned_cols=309 Identities=28% Similarity=0.371 Sum_probs=183.3
Q ss_pred CCCCcccEEeCCCCcccccCCCCcCCCCCC-------------CEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCC
Q 042086 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNL-------------AIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGS 140 (784)
Q Consensus 74 ~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 140 (784)
+++++|++|+|++|+++|.+|..++.+.+| ++|++++|.+++ +|.. .++|++|++++|.+++
T Consensus 31 ~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~- 105 (454)
T 1jl5_A 31 ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE- 105 (454)
T ss_dssp ---CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-
T ss_pred hcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-
Confidence 456667777777777777777777776653 777777777764 3332 3567777777777775
Q ss_pred CCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcc
Q 042086 141 IPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNL 220 (784)
Q Consensus 141 ~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 220 (784)
+|.. +++|++|++++|.+++ ++.. .++|++|++++|++++ +| .++++++|++|++++|++++ +|..+
T Consensus 106 lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~--- 172 (454)
T 1jl5_A 106 LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP--- 172 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---
T ss_pred cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---
Confidence 5543 3567777777776664 2221 1567777777777774 55 47777777777777777764 33322
Q ss_pred cccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceee
Q 042086 221 KMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300 (784)
Q Consensus 221 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 300 (784)
++|++|++++|++++ +| .++++++|+.|++++|+++ .+|... ++|++|++++|.++ .+| .+..+++|++|+
T Consensus 173 ~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~--~l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~ 243 (454)
T 1jl5_A 173 PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK--KLPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIY 243 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS--SCCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEE
T ss_pred ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCC--cCCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEE
Confidence 467777777777775 44 4677777777777777765 333222 46777777777776 455 366677777777
Q ss_pred cccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccc--cccccc-------------ccc
Q 042086 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG--KIPCEI-------------CNM 365 (784)
Q Consensus 301 Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~-------------~~l 365 (784)
+++|++++ +|.. +++|++|++++|++++ +|.. .++|+.|++++|++++ .+|..+ ..+
T Consensus 244 l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~ 315 (454)
T 1jl5_A 244 ADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL 315 (454)
T ss_dssp CCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCC
T ss_pred CCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCC
Confidence 77777764 3332 2566666666666665 3322 2455566666665554 222111 112
Q ss_pred -ccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCCCCCcCCCcccccCCC
Q 042086 366 -ESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNK 424 (784)
Q Consensus 366 -~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 424 (784)
++|+.|++++|++++ +|.. +++|+.|++++|.+++ +|. .........+.+|+
T Consensus 316 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~~N~ 368 (454)
T 1jl5_A 316 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNP 368 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSC
T ss_pred cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc--hhhhccEEECCCCC
Confidence 356666666666665 3332 3556666666666663 444 23333333444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=279.35 Aligned_cols=261 Identities=24% Similarity=0.224 Sum_probs=131.0
Q ss_pred CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCC--CCcCccCCCcCcEEeecCCCcccccCCccccccccceee
Q 042086 102 NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGS--IPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH 179 (784)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 179 (784)
+|++|+|++|+++...+..|+++++|++|+|++|.++.. .|..+..+++|++|+|++|.++ .+|..+..+++|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence 444444444444433333344555555555555554421 1334444555555555555554 2344445555555555
Q ss_pred ccccccCCCcc-ccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccc-ccCCCCcCCCCcceEEecCCCC
Q 042086 180 LSSNQLSGSIP-ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG-VIPLSIGNLNNLIGLYLYDNQL 257 (784)
Q Consensus 180 L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l 257 (784)
+++|.+++..+ ..+..+++|++|++++|.+.+..+..+.++++|++|++++|.+++ ..|..+..+++|++|++++|++
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 187 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence 55555553332 344555555555555555554445555555555555555555543 3445555555555555555554
Q ss_pred CCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccc-cceEEecccccccCCCc-
Q 042086 258 SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL-KLHYLNLSNNQFRKGFP- 335 (784)
Q Consensus 258 ~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~-~L~~L~ls~N~l~~~~~- 335 (784)
+ ...|..+..+++|++|++++|++++..+..+..+++|+.|++++|.+++..|..+..++ +|++|+|++|++++...
T Consensus 188 ~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 188 E-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp C-EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred C-CcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 4 12233445555555555555555554444556666666666666666666666666653 66666666666654211
Q ss_pred -hhhhcccccCeeccCCccccccccccccc
Q 042086 336 -VELEKLIQLSELDLSLNILEGKIPCEICN 364 (784)
Q Consensus 336 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 364 (784)
.....+..++.+....+.+....|..+.+
T Consensus 267 ~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 267 QSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp HHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred HHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 11222333444444445555444544433
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-34 Score=324.79 Aligned_cols=344 Identities=23% Similarity=0.197 Sum_probs=271.7
Q ss_pred CeEEEEeCCCcc--------cCCCCcccEEeCCCCcccc----cCCCCcCCCCCCCEEEccCCcccccCCCCC-CCCC--
Q 042086 61 RVISINLSTVGL--------KGNLKSLSTLDLSKNKLNG----SIPFSFGNLTNLAIMYLYRNSLSASIPPVI-GNLK-- 125 (784)
Q Consensus 61 ~v~~l~l~~~~~--------~~~l~~l~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~-- 125 (784)
+++.+++....+ ...+++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 356666665543 2357889999999999985 356778889999999999999976444332 2344
Q ss_pred --CCCEEEccCCccCC----CCCcCccCCCcCcEEeecCCCcccccCCccc-----cccccceeeccccccCCCc----c
Q 042086 126 --FLYHLDLSENQLSG----SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIG-----NLKSLFYLHLSSNQLSGSI----P 190 (784)
Q Consensus 126 --~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~-----~l~~L~~L~L~~n~l~~~~----~ 190 (784)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|.+++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 79999999999985 4578889999999999999999865444433 2567999999999998643 5
Q ss_pred ccccCccCCceeeccccccCCccchhhhc-----ccccceeccCCCccccc----cCCCCcCCCCcceEEecCCCCCCCC
Q 042086 191 ISLGNLSNLVVLHLFENSLFGSIPSILGN-----LKMLLHLGLSTNHLSGV----IPLSIGNLNNLIGLYLYDNQLSVGE 261 (784)
Q Consensus 191 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~-----l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~ 261 (784)
..+..+++|++|++++|.++...+..+.. .++|++|++++|.+++. ++..+..+++|++|++++|+++...
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 56677899999999999987655554433 56899999999999864 4667778899999999999886322
Q ss_pred c----ccccccccccceEeccCccccCC----CCccccCCCccceeecccCccCCCCccccccc-----ccceEEecccc
Q 042086 262 I----PIEIGKLSSLNYLVLNGNQLYGN----LPRALGSLTELEYLDLSTNKLGNSIPETLGNL-----LKLHYLNLSNN 328 (784)
Q Consensus 262 ~----~~~l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l-----~~L~~L~ls~N 328 (784)
+ +..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+... ++|++|++++|
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 323 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCC
Confidence 1 11223578999999999999864 56677789999999999999986655555443 69999999999
Q ss_pred cccCC----CchhhhcccccCeeccCCccccccccccccc-----cccccEEecCCCccCC----CCcccccCcccceEE
Q 042086 329 QFRKG----FPVELEKLIQLSELDLSLNILEGKIPCEICN-----MESLEKLNLSHNNFSG----LIPSCFEGMHGLSCI 395 (784)
Q Consensus 329 ~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~l 395 (784)
.+++. ++..+..+++|+.|+|++|.+++..+..+.. .++|+.|+|++|++++ .+|..+..+++|++|
T Consensus 324 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L 403 (461)
T 1z7x_W 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403 (461)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred CCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEE
Confidence 99875 4666778899999999999998776666654 6799999999999986 778888889999999
Q ss_pred EcCCCCCcc
Q 042086 396 DVSYNELRG 404 (784)
Q Consensus 396 ~l~~N~l~~ 404 (784)
++++|++++
T Consensus 404 ~l~~N~i~~ 412 (461)
T 1z7x_W 404 DLSNNCLGD 412 (461)
T ss_dssp ECCSSSCCH
T ss_pred ECCCCCCCH
Confidence 999999875
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=286.16 Aligned_cols=280 Identities=20% Similarity=0.167 Sum_probs=167.6
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeec
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 180 (784)
+.....++++|.++ .+|..+. ++|++|+|++|++++..+..+.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 33344555555555 3344332 35555555555555444445555555555555555555444444555555555555
Q ss_pred cccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccC-CCCcCCCCcceEEecCCC-CC
Q 042086 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP-LSIGNLNNLIGLYLYDNQ-LS 258 (784)
Q Consensus 181 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~-l~ 258 (784)
++|.++ +..+..|.++++|++|++++|++++..+ ..+..+++|++|++++|+ +.
T Consensus 108 s~n~l~------------------------~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~ 163 (353)
T 2z80_A 108 SYNYLS------------------------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163 (353)
T ss_dssp CSSCCS------------------------SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC
T ss_pred CCCcCC------------------------cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc
Confidence 555554 3333334445555555555555543222 245555555555555553 22
Q ss_pred CCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhh
Q 042086 259 VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL 338 (784)
Q Consensus 259 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 338 (784)
...+..+..+++|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|+.|++++|++++..+..+
T Consensus 164 -~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l 242 (353)
T 2z80_A 164 -KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242 (353)
T ss_dssp -EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--
T ss_pred -ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccc
Confidence 1223345566666667777777666666777777777777777777753333334456777777777777776544433
Q ss_pred h---cccccCeeccCCccccc----cccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 339 E---KLIQLSELDLSLNILEG----KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 339 ~---~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
. ....++.++|++|.+.+ .+|..+..+++|+.|+|++|+++...+..|..+++|+.|++++|++.|.+|.
T Consensus 243 ~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 2 34556666777766665 4777888899999999999999965555578999999999999999998873
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=286.08 Aligned_cols=258 Identities=21% Similarity=0.174 Sum_probs=141.3
Q ss_pred CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeecc
Q 042086 102 NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181 (784)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 181 (784)
+|++|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 45555555555544444445555555555555555554444445555555555555555553333334555555555555
Q ss_pred ccccCCCcc-ccccCccCCceeecccc-ccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCC
Q 042086 182 SNQLSGSIP-ISLGNLSNLVVLHLFEN-SLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSV 259 (784)
Q Consensus 182 ~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 259 (784)
+|++++..+ ..+..+++|++|++++| .+....+..|.++++|++|++++|++++..|..+..+++|++|++++|+++
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~- 211 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI- 211 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-
Confidence 555553222 24555555555555555 344444555666666666666666666666666666666666666666654
Q ss_pred CCcccc-cccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccC----CC
Q 042086 260 GEIPIE-IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRK----GF 334 (784)
Q Consensus 260 ~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~----~~ 334 (784)
.++.. +..+++|+.|++++|.+++..+..+... .....++.++++++.+++ .+
T Consensus 212 -~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~---------------------~~~~~l~~l~L~~~~l~~~~l~~l 269 (353)
T 2z80_A 212 -LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG---------------------ETNSLIKKFTFRNVKITDESLFQV 269 (353)
T ss_dssp -THHHHHHHHTTTEEEEEEESCBCTTCCCC---------------------------CCCCCCEEEEESCBCCHHHHHHH
T ss_pred -cchhhhhhhcccccEEECCCCccccccccccccc---------------------cccchhhccccccccccCcchhhh
Confidence 33332 2345666677777766665433322210 112233334444444333 24
Q ss_pred chhhhcccccCeeccCCcccccccccc-ccccccccEEecCCCccCCCCc
Q 042086 335 PVELEKLIQLSELDLSLNILEGKIPCE-ICNMESLEKLNLSHNNFSGLIP 383 (784)
Q Consensus 335 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p 383 (784)
|..+..+++|+.|+|++|+++ .+|.. +..+++|++|+|++|++.+..|
T Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 270 MKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 566777777777777777777 45544 4777888888888888776543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.41 Aligned_cols=276 Identities=26% Similarity=0.250 Sum_probs=170.6
Q ss_pred EEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccc--cCCccccccccceeeccc
Q 042086 105 IMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGS--IPSIIGNLKSLFYLHLSS 182 (784)
Q Consensus 105 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~ 182 (784)
.++.+++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++.. .+..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 4455555554 4555443 6788999999998855555678888999999999888733 356666788888888888
Q ss_pred cccCCCccccccCccCCceeeccccccCCccc-hhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCC
Q 042086 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGE 261 (784)
Q Consensus 183 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 261 (784)
|.++ .+|..+..+++|++|++++|++++..+ ..+.++++|++|++++|.+++..+..+..+++|++|++++|.++...
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 8887 466667788888888888888876554 56777778888888888777666666666666666666666655223
Q ss_pred cccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcc
Q 042086 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKL 341 (784)
Q Consensus 262 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l 341 (784)
+|..+..+++|++|++++|++++..|..+..++ +|++|+|++|++++..+..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~------------------------~L~~L~L~~N~l~~~~~~~~~~l 222 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS------------------------SLQVLNMSHNNFFSLDTFPYKCL 222 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT------------------------TCCEEECTTSCCSBCCSGGGTTC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC------------------------CCCEEECCCCccCccChhhccCc
Confidence 444445555555555555555444444444444 45555555554444444444555
Q ss_pred cccCeeccCCccccccccccccccc-cccEEecCCCccCCCCc--ccccCcccceEEEcCCCCCcccCCC
Q 042086 342 IQLSELDLSLNILEGKIPCEICNME-SLEKLNLSHNNFSGLIP--SCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 342 ~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
++|+.|+|++|++++..|..+..++ +|+.|+|++|++++.-+ .....+...+.+.+..+.+.|..|.
T Consensus 223 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 5555555555555555555555553 55566666665554321 1112233344445555666665553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-33 Score=316.00 Aligned_cols=329 Identities=19% Similarity=0.122 Sum_probs=268.7
Q ss_pred CCcccEEeCCCCcccccCCCC-cCCCCCCCEEEccCCcccc----cCCCCCCCCCCCCEEEccCCccCCCCCcCcc-CCC
Q 042086 76 LKSLSTLDLSKNKLNGSIPFS-FGNLTNLAIMYLYRNSLSA----SIPPVIGNLKFLYHLDLSENQLSGSIPPTLG-NLS 149 (784)
Q Consensus 76 l~~l~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~ 149 (784)
+++|++|||++|+++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+.+..+..+. .++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 457899999999998665444 7889999999999999985 4577788899999999999999865444433 355
Q ss_pred ----cCcEEeecCCCccc----ccCCccccccccceeeccccccCCCcccccc-----CccCCceeeccccccCCcc---
Q 042086 150 ----NLAVLHLYGNSLSG----SIPSIIGNLKSLFYLHLSSNQLSGSIPISLG-----NLSNLVVLHLFENSLFGSI--- 213 (784)
Q Consensus 150 ----~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~--- 213 (784)
+|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|++++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 79999999999994 5688899999999999999999865444332 3568999999999998644
Q ss_pred -chhhhcccccceeccCCCccccccCCCCc-----CCCCcceEEecCCCCCCCC---cccccccccccceEeccCccccC
Q 042086 214 -PSILGNLKMLLHLGLSTNHLSGVIPLSIG-----NLNNLIGLYLYDNQLSVGE---IPIEIGKLSSLNYLVLNGNQLYG 284 (784)
Q Consensus 214 -~~~l~~l~~L~~L~L~~n~l~~~~~~~l~-----~l~~L~~L~L~~n~l~~~~---~~~~l~~l~~L~~L~l~~n~l~~ 284 (784)
+..+..+++|++|++++|.+++..+..+. ..++|++|++++|.++... ++..+..+++|++|++++|.+++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 66677889999999999999865554443 3679999999999998432 56677889999999999999975
Q ss_pred CC-----CccccCCCccceeecccCccCCC----CcccccccccceEEecccccccCCCchhhhcc-----cccCeeccC
Q 042086 285 NL-----PRALGSLTELEYLDLSTNKLGNS----IPETLGNLLKLHYLNLSNNQFRKGFPVELEKL-----IQLSELDLS 350 (784)
Q Consensus 285 ~~-----~~~l~~l~~L~~L~Ls~n~l~~~----~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l-----~~L~~L~Ls 350 (784)
.. +..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+... ++|+.|+|+
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 43 22334689999999999999864 56778889999999999999987655555543 699999999
Q ss_pred Ccccccc----ccccccccccccEEecCCCccCCCCcccccC-----cccceEEEcCCCCCcc
Q 042086 351 LNILEGK----IPCEICNMESLEKLNLSHNNFSGLIPSCFEG-----MHGLSCIDVSYNELRG 404 (784)
Q Consensus 351 ~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~ 404 (784)
+|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|+.|++++|++++
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 9999976 5667778899999999999999876665553 6799999999999985
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=278.53 Aligned_cols=252 Identities=24% Similarity=0.237 Sum_probs=155.7
Q ss_pred CEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeecccc
Q 042086 128 YHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFEN 207 (784)
Q Consensus 128 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 207 (784)
..++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 44555555555 3444332 45566666666665555555666666666666666665555555555666666666666
Q ss_pred ccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCC
Q 042086 208 SLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP 287 (784)
Q Consensus 208 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 287 (784)
+++...+..|.++++|++|+|++|+++...+..|..+++|+.|++++|.. +....+
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~------------------------l~~i~~ 189 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK------------------------LEYISE 189 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTT------------------------CCEECT
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCC------------------------ccccCh
Confidence 66555555566666666666666666654445555555555555554321 111122
Q ss_pred ccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccccccccccc
Q 042086 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMES 367 (784)
Q Consensus 288 ~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 367 (784)
..|..+++|++|+|++|++++. | .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++
T Consensus 190 ~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 267 (452)
T 3zyi_A 190 GAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267 (452)
T ss_dssp TTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence 2344555555555555555532 2 3556666777777777776666667777777777777777777777777777778
Q ss_pred ccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 368 LEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 368 L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
|+.|+|++|++++..+..+..+++|+.|+|++|+|.|.+.-
T Consensus 268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 88888888888877777777788888888888888877653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=266.75 Aligned_cols=232 Identities=23% Similarity=0.266 Sum_probs=133.5
Q ss_pred CCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceee
Q 042086 100 LTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH 179 (784)
Q Consensus 100 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 179 (784)
.++++.|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 467777777777777 66777777777777777777777 67777777777777777777777 5676777777777777
Q ss_pred ccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCC
Q 042086 180 LSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSV 259 (784)
Q Consensus 180 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 259 (784)
|++|++.+.+|..+... ..+..|.++++|++|+|++|+++ .+|..+..+++|++|+|++|+++
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~- 219 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS- 219 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-
Confidence 77776666666554320 01122444555555555555555 44444444555555555555444
Q ss_pred CCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhh
Q 042086 260 GEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELE 339 (784)
Q Consensus 260 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~ 339 (784)
.+|..+..+++|++|++++|.+.+.+|..+..+++|++|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..++
T Consensus 220 -~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 220 -ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp -CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred -cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 3343444445555555555555545555555555555555555444444444444444444444444444444444444
Q ss_pred cccccCeeccCCc
Q 042086 340 KLIQLSELDLSLN 352 (784)
Q Consensus 340 ~l~~L~~L~Ls~N 352 (784)
.+++|+.+++..|
T Consensus 299 ~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 299 QLPANCIILVPPH 311 (328)
T ss_dssp GSCTTCEEECCGG
T ss_pred hccCceEEeCCHH
Confidence 4444444444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=261.06 Aligned_cols=254 Identities=25% Similarity=0.240 Sum_probs=157.8
Q ss_pred cEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCC
Q 042086 80 STLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGN 159 (784)
Q Consensus 80 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (784)
++++.++++++. +|..+ .++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 577888888773 34433 457777777777777766677777777777777777777666777777777777777777
Q ss_pred C-cccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccC
Q 042086 160 S-LSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP 238 (784)
Q Consensus 160 ~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 238 (784)
. ++...|..|..+++|++|+|++|.+++..|..+..+++|++|++++|++++..+..|+++++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 5 665556666777777777777777766556666666666666666666665555555556666666666665554333
Q ss_pred CCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccc
Q 042086 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL 318 (784)
Q Consensus 239 ~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~ 318 (784)
.. +..+++|++|++++|.+++..|..+..+++|+.|++++|.+++..+..+..++
T Consensus 171 ~~-------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 171 RA-------------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TT-------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HH-------------------------hcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 33 34445555555555555555566666666666666666666655555566666
Q ss_pred cceEEecccccccCCCchhhhcccccCeeccCCccccccccccc
Q 042086 319 KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 362 (784)
+|++|++++|++....+. ..-...++.+..+.+.+....|..+
T Consensus 226 ~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp TCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred ccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHh
Confidence 666666666666542221 1112233444455555555555444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=275.78 Aligned_cols=254 Identities=25% Similarity=0.280 Sum_probs=187.4
Q ss_pred CCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeecc
Q 042086 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLF 205 (784)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 205 (784)
....++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4567888888887 5666554 678888888888887777778888888888888888776666777777777777777
Q ss_pred ccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCC
Q 042086 206 ENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGN 285 (784)
Q Consensus 206 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~ 285 (784)
+|+++...+..|.++++|++|+|++|+++...+..|..+++|++|+|++|. .+...
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~------------------------~l~~i 176 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK------------------------RLSYI 176 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT------------------------TCCEE
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC------------------------Cccee
Confidence 777776666667777777777777777776555556666666666655532 22222
Q ss_pred CCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccccccccc
Q 042086 286 LPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365 (784)
Q Consensus 286 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 365 (784)
.+..|..+++|++|+|++|+++. +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+
T Consensus 177 ~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 177 SEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp CTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred CcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 23356666666777777776663 33 36677778888888888877777788888888888888888887778888888
Q ss_pred ccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 366 ESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 366 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
++|+.|+|++|++++..+..|..+++|+.|+|++|+|.|.+.-
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 8888888888888888888888888899999999998887754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=260.49 Aligned_cols=208 Identities=30% Similarity=0.380 Sum_probs=184.2
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCc-cCCCCCcCccCCCcCcE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ-LSGSIPPTLGNLSNLAV 153 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~ 153 (784)
..++|++|+|++|+|++..+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|. +....|..+..+++|++
T Consensus 30 ~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~ 109 (285)
T 1ozn_A 30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109 (285)
T ss_dssp CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCE
Confidence 45689999999999999988999999999999999999999999999999999999999997 88777899999999999
Q ss_pred EeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcc
Q 042086 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233 (784)
Q Consensus 154 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 233 (784)
|+|++|.+++..|..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|.++++|+.|++++|++
T Consensus 110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 189 (285)
T 1ozn_A 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189 (285)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcc
Confidence 99999999988899999999999999999999977777899999999999999999988778899999999999999999
Q ss_pred ccccCCCCcCCCCcceEEecCCCCCCCCcc-cccccccccceEeccCccccC
Q 042086 234 SGVIPLSIGNLNNLIGLYLYDNQLSVGEIP-IEIGKLSSLNYLVLNGNQLYG 284 (784)
Q Consensus 234 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~l~~l~~L~~L~l~~n~l~~ 284 (784)
++..|..|..+++|+.|++++|+++ .++ ..+..+++|+.|++++|++..
T Consensus 190 ~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 190 AHVHPHAFRDLGRLMTLYLFANNLS--ALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCS--CCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred cccCHhHccCcccccEeeCCCCcCC--cCCHHHcccCcccCEEeccCCCccC
Confidence 9888888888888888888777776 233 335666666666666666653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=276.49 Aligned_cols=246 Identities=25% Similarity=0.211 Sum_probs=126.1
Q ss_pred CEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeecccc
Q 042086 104 AIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN 183 (784)
Q Consensus 104 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 183 (784)
..++.+++.++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 33444444443 2333332 34555555555555444555555555555555555555444455555555555555555
Q ss_pred ccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCC-CccccccCCCCcCCCCcceEEecCCCCCCCCc
Q 042086 184 QLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST-NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEI 262 (784)
Q Consensus 184 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 262 (784)
.+++..+..|..+++|++|+|++|+++...+..|.++++|+.|++++ |.+....+..|.++++|+.|+|++|+++ .+
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~--~~ 211 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK--DM 211 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS--SC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc--cc
Confidence 55544444455555555555555555544445555556666666655 3333333334555555555555555554 22
Q ss_pred ccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhccc
Q 042086 263 PIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLI 342 (784)
Q Consensus 263 ~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~ 342 (784)
| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 2 344455555555555555555555555555555555555555554455555555555555555555544444444444
Q ss_pred ccCeeccCCcccc
Q 042086 343 QLSELDLSLNILE 355 (784)
Q Consensus 343 ~L~~L~Ls~N~l~ 355 (784)
+|+.|+|++|.+.
T Consensus 291 ~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 291 YLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEccCCCcC
Confidence 4555555444443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-29 Score=275.03 Aligned_cols=248 Identities=25% Similarity=0.248 Sum_probs=136.6
Q ss_pred ccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecC
Q 042086 79 LSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYG 158 (784)
Q Consensus 79 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 158 (784)
.+.++.++++++ .+|..+. ++++.|+|++|+|++..+..|+++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 456677777666 3454443 4566666666666666666666666666666666666655555666666666666666
Q ss_pred CCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccC
Q 042086 159 NSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP 238 (784)
Q Consensus 159 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 238 (784)
|+++...+..|.++++|++|+|++|.++...+..|..+++|+.|+|++|. .+....+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~-----------------------~l~~i~~ 178 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK-----------------------RLSYISE 178 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT-----------------------TCCEECT
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC-----------------------CcceeCc
Confidence 66665444455666666666666666554444455555555555555422 2222223
Q ss_pred CCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccc
Q 042086 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL 318 (784)
Q Consensus 239 ~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~ 318 (784)
..|.++++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|.+++
T Consensus 179 ~~~~~l~~L~~L~L~~n~l~--~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 255 (440)
T 3zyj_A 179 GAFEGLSNLRYLNLAMCNLR--EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255 (440)
T ss_dssp TTTTTCSSCCEEECTTSCCS--SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT
T ss_pred chhhcccccCeecCCCCcCc--ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC
Confidence 34444444555555544443 233 244455555555555555555555555555555555555555555555555555
Q ss_pred cceEEecccccccCCCchhhhcccccCeeccCCcccc
Q 042086 319 KLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILE 355 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 355 (784)
+|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus 256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 5555555555555544444455555555555555443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-31 Score=278.05 Aligned_cols=250 Identities=24% Similarity=0.245 Sum_probs=160.7
Q ss_pred CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcc-cccCCCCCC-------CCCCCCEEEccCCccCCCCCcCc
Q 042086 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSL-SASIPPVIG-------NLKFLYHLDLSENQLSGSIPPTL 145 (784)
Q Consensus 74 ~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l-~~~~p~~l~-------~l~~L~~L~L~~n~l~~~~p~~l 145 (784)
+...+|+.|++++|++ .+|..+... |+.|+|++|.+ ...+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3456778888888888 667666544 78888888888 345666555 67888888888888887777766
Q ss_pred --cCCCcCcEEeecCCCcccccCCccccc-----cccceeeccccccCCCccccccCccCCceeeccccccCCc--cchh
Q 042086 146 --GNLSNLAVLHLYGNSLSGSIPSIIGNL-----KSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGS--IPSI 216 (784)
Q Consensus 146 --~~l~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~ 216 (784)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .+..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 7788888888888888866 7777766 7777888887777766667777777777777777776543 2223
Q ss_pred h--hcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcc-cccccccccceEeccCccccCCCC-ccccC
Q 042086 217 L--GNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIP-IEIGKLSSLNYLVLNGNQLYGNLP-RALGS 292 (784)
Q Consensus 217 l--~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~-~~l~~ 292 (784)
+ .++++|++|+|++|++++.. .++ ..+..+++|++|++++|++++..| ..+..
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~-----------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPS-----------------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHH-----------------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred HHhccCCCCCEEECCCCcCcchH-----------------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 3 55666666666666665211 011 112334555555555555554443 23444
Q ss_pred CCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccc
Q 042086 293 LTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356 (784)
Q Consensus 293 l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 356 (784)
+++|++|+|++|.++ .+|..+. ++|++|+|++|++++. |. +..+++|+.|+|++|++++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 556666666666665 4455444 5666666666666653 33 5666666666666666553
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=274.08 Aligned_cols=258 Identities=20% Similarity=0.136 Sum_probs=167.5
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
.++.++++.+.+.......+..+++|++|+|++|++++..|..|+.+++|++|+|++|.+++..+ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45667777777776666666777788888888888887777778888888888888888876544 7778888888888
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (784)
+|.+++.. ..++|++|++++|.+++..+.. +++|+.|++++|++++..+..+..+++|++|+|++|++++..
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 88877433 2367888888888887554433 466777888888777766767777777777777777777665
Q ss_pred CCCCc-CCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccc
Q 042086 238 PLSIG-NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGN 316 (784)
Q Consensus 238 ~~~l~-~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~ 316 (784)
+..+. .+++|++|+|++|+++ .++ ....+++|++|++++|++++ +|..+..+++|+.|+|++|.++ .+|..+..
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~--~~~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~ 235 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIY--DVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCC--EEE-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCC
T ss_pred HHHHhhccCcCCEEECCCCcCc--ccc-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhc
Confidence 55543 5666666666666665 222 22235555555555555553 2333555555555555555555 34444555
Q ss_pred cccceEEeccccccc-CCCchhhhcccccCeeccC
Q 042086 317 LLKLHYLNLSNNQFR-KGFPVELEKLIQLSELDLS 350 (784)
Q Consensus 317 l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~Ls 350 (784)
+++|+.|++++|++. +.++..+..+++|+.|+++
T Consensus 236 l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 555555555555554 3344444444555555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-28 Score=275.53 Aligned_cols=268 Identities=26% Similarity=0.336 Sum_probs=193.5
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
.++.|++++|+|+ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 4788999999998 6777665 89999999999998 4555 5789999999999988 4555 67899999999
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (784)
+|.+++ +|. .+++|+.|+|++|++++ +|.. +++|++|+|++|++++. |. .+++|+.|++++|.+++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-C
Confidence 999885 444 56789999999999884 5543 47888888888888753 32 34678888888888885 4
Q ss_pred CCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccccccc
Q 042086 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNL 317 (784)
Q Consensus 238 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l 317 (784)
| ..+++|+.|++++|+++ .+|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|.+++ +| ..+
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~--~l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l 240 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLA--SLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLP 240 (622)
T ss_dssp C---CCCTTCCEEECCSSCCS--CCCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCC
T ss_pred c---ccCCCCcEEECCCCCCC--CCCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCC
Confidence 4 34577888888888776 34432 367777777777777 34432 3667777777777774 44 344
Q ss_pred ccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcc
Q 042086 318 LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMH 390 (784)
Q Consensus 318 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 390 (784)
++|+.|+|++|+|+. +|. .+++|+.|+|++|+++ .+|..+.++++|+.|+|++|++++.+|..+..++
T Consensus 241 ~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 241 SELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 667777777777765 333 4566777777777776 5666677777777777777777766666555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-30 Score=272.75 Aligned_cols=266 Identities=22% Similarity=0.200 Sum_probs=163.6
Q ss_pred CCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccc
Q 042086 103 LAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182 (784)
Q Consensus 103 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 182 (784)
++.++++.+.+.......+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+ +..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4455677777765555556667788888888888887777778888888888888888876554 77788888888888
Q ss_pred cccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCc
Q 042086 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEI 262 (784)
Q Consensus 183 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 262 (784)
|.+++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..+..+++|+.|++++|+++
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---- 157 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID---- 157 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC----
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC----
Confidence 8877332 2367777777777776554433 455667777777766655555555555555555555554
Q ss_pred ccccccccccceEeccCccccCCCCccc-cCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcc
Q 042086 263 PIEIGKLSSLNYLVLNGNQLYGNLPRAL-GSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKL 341 (784)
Q Consensus 263 ~~~l~~l~~L~~L~l~~n~l~~~~~~~l-~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l 341 (784)
+..+..+ ..+++|++|+|++|.+++. + ....+++|++|+|++|++++ +|..+..+
T Consensus 158 ---------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 213 (317)
T 3o53_A 158 ---------------------TVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSA 213 (317)
T ss_dssp ---------------------EEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGG
T ss_pred ---------------------cccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhccc
Confidence 3333333 2344455555555554432 1 12224555555555555554 23335555
Q ss_pred cccCeeccCCccccccccccccccccccEEecCCCccC-CCCcccccCcccceEEEcCC-CCCcccCC
Q 042086 342 IQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFS-GLIPSCFEGMHGLSCIDVSY-NELRGPIP 407 (784)
Q Consensus 342 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~l~~-N~l~~~~p 407 (784)
++|+.|+|++|+++ .+|..+..+++|+.|+|++|++. +.+|..+..+++|+.+++++ +.++|..|
T Consensus 214 ~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp TTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 66666666666665 35555666666666666666666 55556666666666666663 34444433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=272.28 Aligned_cols=263 Identities=27% Similarity=0.368 Sum_probs=223.8
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeec
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 180 (784)
.+++.|++++|.++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35899999999999 7787776 89999999999999 5565 57999999999999984 565 6799999999
Q ss_pred cccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCC
Q 042086 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260 (784)
Q Consensus 181 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 260 (784)
++|.+++ +|. .+++|+.|++++|+++.. |.. +++|++|+|++|++++ +|. .+++|+.|++++|+++
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-- 174 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLT-- 174 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCC--
Confidence 9999995 454 568999999999999864 433 4899999999999985 343 3578999999999998
Q ss_pred CcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhc
Q 042086 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEK 340 (784)
Q Consensus 261 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~ 340 (784)
.+| ..+++|+.|++++|.+++ +|.. +++|+.|++++|.++. +|.. +++|++|+|++|++++ +| ..
T Consensus 175 ~l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~ 239 (622)
T 3g06_A 175 SLP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VL 239 (622)
T ss_dssp CCC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CC
T ss_pred CCc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CC
Confidence 466 456899999999999985 4543 4799999999999984 5543 4789999999999998 55 56
Q ss_pred ccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 341 LIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 341 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
+++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++.+|.
T Consensus 240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 689999999999999 5665 6789999999999999 6688899999999999999999987764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-30 Score=270.44 Aligned_cols=253 Identities=21% Similarity=0.195 Sum_probs=176.8
Q ss_pred CCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcc-cccCCccc-------cccccceeeccccccCCCccc
Q 042086 120 VIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLS-GSIPSIIG-------NLKSLFYLHLSSNQLSGSIPI 191 (784)
Q Consensus 120 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~~~~l~-------~l~~L~~L~L~~n~l~~~~~~ 191 (784)
.++..++|++|++++|.+ .+|..+... |+.|+|++|.++ ..+|..+. ++++|++|+|++|.+++.+|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 345567889999999998 677766644 889999999884 45565554 688999999999999988888
Q ss_pred cc--cCccCCceeeccccccCCccchhhhcc-----cccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCC-Ccc
Q 042086 192 SL--GNLSNLVVLHLFENSLFGSIPSILGNL-----KMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG-EIP 263 (784)
Q Consensus 192 ~~--~~l~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~ 263 (784)
.+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..+..|+.+++|++|+|++|++... .++
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8889999999999999877 7778777 7888888888888877777777777777777777765410 011
Q ss_pred cccccccccceEeccCccccCCCCccccCCCccceeecccCccCC--CCc-ccccccccceEEecccccccCCCc-hhhh
Q 042086 264 IEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN--SIP-ETLGNLLKLHYLNLSNNQFRKGFP-VELE 339 (784)
Q Consensus 264 ~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~--~~~-~~l~~l~~L~~L~ls~N~l~~~~~-~~~~ 339 (784)
..+ .+..+++|++|+|++|++++ .++ ..+..+++|++|++++|++++..| ..+.
T Consensus 193 ~~~----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 193 SAL----------------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp HHS----------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred HHH----------------------HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 122 11344455555555555542 111 223345566666666666665443 3444
Q ss_pred cccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcc
Q 042086 340 KLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRG 404 (784)
Q Consensus 340 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 404 (784)
.+++|+.|+|++|+++ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|++++|++++
T Consensus 251 ~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5667777777777776 5666555 7788888888888876 55 7788888888888888775
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=277.01 Aligned_cols=236 Identities=24% Similarity=0.217 Sum_probs=127.1
Q ss_pred CCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceee
Q 042086 124 LKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLH 203 (784)
Q Consensus 124 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 203 (784)
+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.+++..+ .++|++|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 3355555555555555545555555555555555555554433 5555555555555555553211 14555555
Q ss_pred ccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCcccc
Q 042086 204 LFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLY 283 (784)
Q Consensus 204 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~ 283 (784)
+++|.+++..+.. +++|+.|+|++|.+++..|..++ .+++|+.|+|++|.++
T Consensus 106 L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~-------------------------~l~~L~~L~Ls~N~l~ 157 (487)
T 3oja_A 106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEG-------------------------CRSRVQYLDLKLNEID 157 (487)
T ss_dssp CCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGG-------------------------GGSSEEEEECTTSCCC
T ss_pred CcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhc-------------------------CCCCCCEEECCCCCCC
Confidence 5555554433321 23445555555555444443333 3344444444444444
Q ss_pred CCCCcccc-CCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccc
Q 042086 284 GNLPRALG-SLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEI 362 (784)
Q Consensus 284 ~~~~~~l~-~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 362 (784)
+..|..+. .+++|+.|+|++|.+++. | .+..+++|++|+|++|.+++ +|..+..+++|+.|+|++|.+++ +|..+
T Consensus 158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 158 TVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred CcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhh
Confidence 44444443 445555555555555533 1 12235566666666666665 33346666666666666666663 56566
Q ss_pred cccccccEEecCCCccC-CCCcccccCcccceEEEcC
Q 042086 363 CNMESLEKLNLSHNNFS-GLIPSCFEGMHGLSCIDVS 398 (784)
Q Consensus 363 ~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~l~ 398 (784)
..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 66777777777777776 5566667777777777665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-29 Score=282.10 Aligned_cols=186 Identities=22% Similarity=0.159 Sum_probs=132.6
Q ss_pred EecccceEEEEEE-EcCCCEEEEEEcCCCCCCCC-------CChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceEEEE
Q 042086 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEM-------VPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 523 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.+.|++|.+..++ .-.|+.|++|.+........ ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777666654 33589999999876432221 1235699999999999 7999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||++|++|.+++...+. ++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+....+
T Consensus 322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999987653 4433 5899999999999999 9999999999999999999999999999987666
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDH 718 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~ 718 (784)
.......+||++|||||++.+. +..++|+||+|++++++.++..
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 5556678899999999999764 5678999999999887765543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=273.31 Aligned_cols=238 Identities=21% Similarity=0.137 Sum_probs=154.2
Q ss_pred CCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccce
Q 042086 98 GNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY 177 (784)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 177 (784)
..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|++
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 344467777777777776666677777777777777777765544 6677777777777777764332 267777
Q ss_pred eeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCc-CCCCcceEEecCCC
Q 042086 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG-NLNNLIGLYLYDNQ 256 (784)
Q Consensus 178 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~n~ 256 (784)
|+|++|.+++..+. .+++|+.|+|++|.+++..|..++++++|+.|+|++|.+++..|..+. .+++|+.|+|++|.
T Consensus 104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 77777777755443 346777777887777777777777778888888888888776666654 56667777777766
Q ss_pred CCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEeccccccc-CCCc
Q 042086 257 LSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR-KGFP 335 (784)
Q Consensus 257 l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~-~~~~ 335 (784)
++ .++ ....+++|+.|+|++|.+++. |..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+|
T Consensus 181 l~--~~~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 181 IY--DVK-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp CC--EEE-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred cc--ccc-ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchH
Confidence 65 222 233456666666666666643 3336666666666666666663 4555666666666666666665 3344
Q ss_pred hhhhcccccCeeccC
Q 042086 336 VELEKLIQLSELDLS 350 (784)
Q Consensus 336 ~~~~~l~~L~~L~Ls 350 (784)
..+..++.|+.|+++
T Consensus 256 ~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 256 DFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHTTCHHHHHHHHH
T ss_pred HHHHhCCCCcEEecc
Confidence 555555555555554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=240.28 Aligned_cols=216 Identities=27% Similarity=0.286 Sum_probs=148.8
Q ss_pred CCcccceeEEcCCCCeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCC
Q 042086 47 SPCAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKF 126 (784)
Q Consensus 47 ~~C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 126 (784)
++|.|.|+.|..... ++.+++++++++. +|..+. ++|++|+|++|++++..+..|+++++
T Consensus 3 ~~C~~~~~~C~c~~~-----------------~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~ 62 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNN-----------------KNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTK 62 (270)
T ss_dssp CCBGGGTCSBEEETT-----------------TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTT
T ss_pred ccCCCCCCCCEeCCC-----------------CCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCC
Confidence 689999999874332 3456666666663 454443 56777777777777666666777777
Q ss_pred CCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccc
Q 042086 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206 (784)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 206 (784)
|++|+|++|.++...+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus 63 L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 142 (270)
T 2o6q_A 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGY 142 (270)
T ss_dssp CCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCC
Confidence 77777777777755555566677777777777777765556667777777777777777766666677777777777777
Q ss_pred cccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCccc-ccccccccceEeccCccccC
Q 042086 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPI-EIGKLSSLNYLVLNGNQLYG 284 (784)
Q Consensus 207 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~-~l~~l~~L~~L~l~~n~l~~ 284 (784)
|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++ .++. .+..+++|+.|++++|.+..
T Consensus 143 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 143 NELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK--RVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS--CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC--cCCHHHhccccCCCEEEecCCCeeC
Confidence 7777666666777777777777777777666666777777777777777776 3333 46667777777777777764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-26 Score=235.65 Aligned_cols=210 Identities=25% Similarity=0.236 Sum_probs=145.8
Q ss_pred CCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEec
Q 042086 198 NLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVL 277 (784)
Q Consensus 198 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l 277 (784)
+|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|+++ ...+..+..+++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC-ccChhhhcCCccccEEEC
Confidence 3444444444444333334444444444444444444444444444445555555555443 112234555666666666
Q ss_pred cCccccCCCCccccCCCccceeecccCccCCC-CcccccccccceEEecccccccCCCchhhhcccccC----eeccCCc
Q 042086 278 NGNQLYGNLPRALGSLTELEYLDLSTNKLGNS-IPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS----ELDLSLN 352 (784)
Q Consensus 278 ~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N 352 (784)
++|.+.+..+..+..+++|++|++++|.+++. +|..+.++++|++|++++|++++..+..+..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 66666665555677888888888888888763 578888888899999999988887777888888887 8999999
Q ss_pred cccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC
Q 042086 353 ILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409 (784)
Q Consensus 353 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 409 (784)
.+++..+..+ ...+|+.|+|++|++++..+..+..+++|+.|++++|++.|.+|..
T Consensus 188 ~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 188 PMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred cccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 9996555444 4458999999999999988888999999999999999999988854
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=234.03 Aligned_cols=205 Identities=23% Similarity=0.210 Sum_probs=93.0
Q ss_pred cCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccC
Q 042086 150 NLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS 229 (784)
Q Consensus 150 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 229 (784)
+|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34444444444443333344444444444444444443333344444444444444444444444444555555555555
Q ss_pred CCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccc----eeecccCc
Q 042086 230 TNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELE----YLDLSTNK 305 (784)
Q Consensus 230 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~----~L~Ls~n~ 305 (784)
+|++++..+..+..+++|++|++++|+++...+|..+..+++|++|++++|++++..+..+..+++|+ .|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 55555444444455555555555555554323444455555555555555555544444444444444 44455555
Q ss_pred cCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccc
Q 042086 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILE 355 (784)
Q Consensus 306 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 355 (784)
+++..+..+. ..+|+.|++++|++++..+..+..+++|+.|+|++|++.
T Consensus 189 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 189 MNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp CCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred ccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 4433222222 224444444444444433333333334444444433333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-28 Score=282.64 Aligned_cols=323 Identities=12% Similarity=0.055 Sum_probs=174.5
Q ss_pred ccEEeCCCCc-ccc-cCCCCcCCCCCCCEEEccCCccccc----CCCCCCCCCCCCEEEccCCccCCC----CCcCccCC
Q 042086 79 LSTLDLSKNK-LNG-SIPFSFGNLTNLAIMYLYRNSLSAS----IPPVIGNLKFLYHLDLSENQLSGS----IPPTLGNL 148 (784)
Q Consensus 79 l~~L~L~~n~-i~~-~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l 148 (784)
|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 6666666554 211 1112223556666666666655443 222334455666666666655422 22233445
Q ss_pred CcCcEEeecCCCcccccCCccccccccceeecc---------------------------ccccCCCccccccCccCCce
Q 042086 149 SNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS---------------------------SNQLSGSIPISLGNLSNLVV 201 (784)
Q Consensus 149 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~---------------------------~n~l~~~~~~~~~~l~~L~~ 201 (784)
++|++|+|++|.+.+ ++..+.++++|++|+++ ++... .+|..+..+++|++
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRK 297 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCE
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcE
Confidence 566666666655553 33444445555555554 43222 34555555666666
Q ss_pred eeccccccCCccc-hhhhcccccceeccCCCccc-cccCCCCcCCCCcceEEec-----------CCCCCCCCccccccc
Q 042086 202 LHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLS-GVIPLSIGNLNNLIGLYLY-----------DNQLSVGEIPIEIGK 268 (784)
Q Consensus 202 L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~-----------~n~l~~~~~~~~l~~ 268 (784)
|+|++|.+++... ..+.++++|+.|+++ +.+. +.++..+..+++|++|+++ .|.++...++.....
T Consensus 298 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~ 376 (592)
T 3ogk_B 298 LDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376 (592)
T ss_dssp EEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred EecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence 6666666543322 334556666666666 3332 2223333455666677766 244442223322344
Q ss_pred ccccceEeccCccccCCCCccccC-CCccceeecc----cCccCCC-----CcccccccccceEEecccc--cccCCCch
Q 042086 269 LSSLNYLVLNGNQLYGNLPRALGS-LTELEYLDLS----TNKLGNS-----IPETLGNLLKLHYLNLSNN--QFRKGFPV 336 (784)
Q Consensus 269 l~~L~~L~l~~n~l~~~~~~~l~~-l~~L~~L~Ls----~n~l~~~-----~~~~l~~l~~L~~L~ls~N--~l~~~~~~ 336 (784)
+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|++|++++| .+++..+.
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~ 456 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence 667777777666666555555544 6677777775 5556543 2333555677777777643 25544444
Q ss_pred hhhc-ccccCeeccCCccccc-cccccccccccccEEecCCCccCCCC-cccccCcccceEEEcCCCCCcc
Q 042086 337 ELEK-LIQLSELDLSLNILEG-KIPCEICNMESLEKLNLSHNNFSGLI-PSCFEGMHGLSCIDVSYNELRG 404 (784)
Q Consensus 337 ~~~~-l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~ 404 (784)
.+.. +++|+.|+|++|++++ .++..+..+++|+.|+|++|++++.. +..+..+++|+.|++++|+++.
T Consensus 457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 4433 6677777777777765 33444466677777777777765442 3334456777777777777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=226.52 Aligned_cols=210 Identities=27% Similarity=0.296 Sum_probs=108.0
Q ss_pred CCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccce
Q 042086 98 GNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY 177 (784)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 177 (784)
..+++|+.|++++|.++. .+.++.+++|++|+|++|.+++. +.+..+++|++|+|++|.+++..+..|.++++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 344445555555554442 12344455555555555555431 24445555555555555555444444455555555
Q ss_pred eeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCC
Q 042086 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQL 257 (784)
Q Consensus 178 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 257 (784)
|+|++|++++..+..|..+++|++|+|++|++++..+..+.++++|+.|++++|++++..+..|..+++|+.|++++|++
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 55555555544444445555555555555555544444455555555555555555544444455555555555555555
Q ss_pred CCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccccccccc
Q 042086 258 SVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK 319 (784)
Q Consensus 258 ~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~ 319 (784)
+ +..+..+..+++|+.|++++|.+.+. +++|+.|+++.|.++|.+|.+++.++.
T Consensus 194 ~-~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 194 K-SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp S-CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred C-ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 4 22222345556666666666655532 335666666666666666666665543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-24 Score=222.34 Aligned_cols=205 Identities=24% Similarity=0.259 Sum_probs=129.9
Q ss_pred cceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecC
Q 042086 175 LFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254 (784)
Q Consensus 175 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 254 (784)
++.++++++.++ .+|..+. ++|+.|+|++|+++...+..|.++++|++|+|++|+++...+..|
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~------------- 81 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF------------- 81 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTT-------------
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhh-------------
Confidence 445555555555 3343332 344555555555444444444445555555555555443333333
Q ss_pred CCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCC
Q 042086 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF 334 (784)
Q Consensus 255 n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~ 334 (784)
..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|.+++..
T Consensus 82 ------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 82 ------------KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp ------------SSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ------------cCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 34445555555555555444455566666666666666666666666667777777777777777655
Q ss_pred chhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 335 PVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 335 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+|.+.++
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 5667777777777777777776666667778888888888888888777778888888999999998888765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=221.27 Aligned_cols=190 Identities=26% Similarity=0.275 Sum_probs=150.3
Q ss_pred CCcccceeEEcCCCCeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCC
Q 042086 47 SPCAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKF 126 (784)
Q Consensus 47 ~~C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 126 (784)
+||.|.|++|.. ..+++++++++++ .+|..+. ++|+.|+|++|.+++..+..|+++++
T Consensus 3 ~Cp~~~gC~C~~-------------------~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~ 60 (251)
T 3m19_A 3 TCETVTGCTCNE-------------------GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTK 60 (251)
T ss_dssp -CHHHHSSEEEG-------------------GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred cCCCCCceEcCC-------------------CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCccc
Confidence 588999999963 2456777777777 4555554 57888888888888887888888888
Q ss_pred CCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccc
Q 042086 127 LYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206 (784)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 206 (784)
|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++
T Consensus 61 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 140 (251)
T 3m19_A 61 LTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140 (251)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcC
Confidence 88888888888877777788888888888888888877777788888888888888888866666677888888888888
Q ss_pred cccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCC
Q 042086 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258 (784)
Q Consensus 207 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 258 (784)
|+|++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 141 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 141 NQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 8888777777888888888888888888766667777777777777777765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=230.05 Aligned_cols=209 Identities=26% Similarity=0.269 Sum_probs=123.9
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
.+++|+.|++++|.++. ...+..+++|++|+|++|.+++. +.++.+++|++|+|++|.+++..+..+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 44556666666666552 22455666666666666666542 355666666666666666665555555666666666
Q ss_pred eecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccc
Q 042086 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 155 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (784)
+|++|++++..+..|.++++|++|+|++|.+++..+..+..+++|+.|++++|++++..+..+.++++|+.|++++|+++
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 66666666555555566666666666666666555555566666666666666666555555566666666666666666
Q ss_pred cccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCc
Q 042086 235 GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTE 295 (784)
Q Consensus 235 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 295 (784)
+..+..+..+++|+.|++++|.+. +.+++|+.|+++.|.++|.+|..++.++.
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~--------~~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWD--------CTCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBC--------CCTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred ccCHHHHhCCcCCCEEEccCCCcc--------ccCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 555555666666666666666543 22345666666666666666665554433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-26 Score=256.32 Aligned_cols=186 Identities=12% Similarity=0.173 Sum_probs=146.0
Q ss_pred CCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCC-----CChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 518 DVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEM-----VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 518 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
...+.||+|+||.||+|.. .++.+++|+......... ...+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 478889998654321111 0134589999999999999999766666677788999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999865 457899999999999999 9999999999999998 999999999998754
Q ss_pred CCCc-------cccccccccccccccccc--CCcCcchhHHHHHHHHHHHHhCCCCC
Q 042086 673 DSSN-------CTELVGTFGYIAPELVYT--MKVTEKCDVYSFGVLALEVIKGDHPR 720 (784)
Q Consensus 673 ~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~elltg~~p~ 720 (784)
.... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 135689999999999976 56788899999999999888887765
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=249.82 Aligned_cols=258 Identities=19% Similarity=0.136 Sum_probs=143.7
Q ss_pred EeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCC----CCCCCCC-CCCEEEccCCccCCCCCcCccCC-----CcC
Q 042086 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIP----PVIGNLK-FLYHLDLSENQLSGSIPPTLGNL-----SNL 151 (784)
Q Consensus 82 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~L 151 (784)
++|+.|+++|.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5677777777777666666667777777777776555 5666676 77777777777776666666554 777
Q ss_pred cEEeecCCCcccccCCccccc-----cccceeeccccccCCCcccccc----C-ccCCceeeccccccCCccc----hhh
Q 042086 152 AVLHLYGNSLSGSIPSIIGNL-----KSLFYLHLSSNQLSGSIPISLG----N-LSNLVVLHLFENSLFGSIP----SIL 217 (784)
Q Consensus 152 ~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~~~----~-l~~L~~L~L~~n~l~~~~~----~~l 217 (784)
++|+|++|.+++..+..+... ++|++|+|++|.+++..+..+. . .++|++|+|++|+++.... ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 777777777776555443332 6777777777777655444332 2 2467777777776654332 233
Q ss_pred hccc-ccceeccCCCccccccCCCCc----CC-CCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCcccc
Q 042086 218 GNLK-MLLHLGLSTNHLSGVIPLSIG----NL-NNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALG 291 (784)
Q Consensus 218 ~~l~-~L~~L~L~~n~l~~~~~~~l~----~l-~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~ 291 (784)
..++ +|++|+|++|++++..+..++ .+ ++|++|+|++|+++.... . .++..+.
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~-~--------------------~l~~~l~ 221 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY-A--------------------ELAYIFS 221 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH-H--------------------HHHHHHH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHH-H--------------------HHHHHHh
Confidence 3343 666666666666654443222 22 355555555555441110 0 0222222
Q ss_pred C-CCccceeecccCccCCCCcc----cccccccceEEecccccccCCC-------chhhhcccccCeeccCCcccccccc
Q 042086 292 S-LTELEYLDLSTNKLGNSIPE----TLGNLLKLHYLNLSNNQFRKGF-------PVELEKLIQLSELDLSLNILEGKIP 359 (784)
Q Consensus 292 ~-l~~L~~L~Ls~n~l~~~~~~----~l~~l~~L~~L~ls~N~l~~~~-------~~~~~~l~~L~~L~Ls~N~l~~~~~ 359 (784)
. .++|++|+|++|.+++..+. .+..+++|+.|+|++|.+.+.. +..+..+++|+.||+++|++.+..+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 2 22455555555555443321 2233445555555555533322 2234455556666666666655444
Q ss_pred c
Q 042086 360 C 360 (784)
Q Consensus 360 ~ 360 (784)
.
T Consensus 302 ~ 302 (362)
T 3goz_A 302 I 302 (362)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-24 Score=223.44 Aligned_cols=206 Identities=28% Similarity=0.273 Sum_probs=106.1
Q ss_pred cccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcc
Q 042086 169 IGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLI 248 (784)
Q Consensus 169 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 248 (784)
+.++++|+++++++|.++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.+++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 344555556666665555 3444332 4556666666666555555666666666666666666543222 4445555
Q ss_pred eEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccc
Q 042086 249 GLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNN 328 (784)
Q Consensus 249 ~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N 328 (784)
+|+|++|+++ .+|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC--cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 5555555554 34444444455555555555555444444555555555555555554444444444444444444444
Q ss_pred cccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccC
Q 042086 329 QFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPI 406 (784)
Q Consensus 329 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 406 (784)
++++..+ ..+..+++|+.|+|++|+++ .+|..+..+.+|+.++|++|+|.|.+
T Consensus 159 ~l~~l~~------------------------~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 159 NLTELPA------------------------GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSCCCT------------------------TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cCCccCH------------------------HHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 4444333 33444555555555555555 23444444555666666666665543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=223.72 Aligned_cols=204 Identities=28% Similarity=0.266 Sum_probs=142.5
Q ss_pred ccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCccccccccccc
Q 042086 193 LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSL 272 (784)
Q Consensus 193 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L 272 (784)
+.++++++.+++++|+++.. |..+. ++|+.|+|++|.+++..+..|.++ ++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l-------------------------~~L 57 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPY-------------------------TRL 57 (290)
T ss_dssp EECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTC-------------------------TTC
T ss_pred ccccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcC-------------------------CCC
Confidence 44555666666666666532 22221 355556666666555444444444 455
Q ss_pred ceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCc
Q 042086 273 NYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352 (784)
Q Consensus 273 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 352 (784)
++|++++|.+++..+ ...+++|++|++++|.++ .+|..+..+++|++|++++|++++..+..|..+++|+.|+|++|
T Consensus 58 ~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 58 TQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp CEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred CEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 555555555543222 145667777777777776 56667777778888888888888766777888888888888888
Q ss_pred cccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCC-CCCcCCCcccccCCCCCCC
Q 042086 353 ILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS-RIFQYDPMEALQGNKGLCG 428 (784)
Q Consensus 353 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~ 428 (784)
++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++. +|.. ..........+.+||+.|.
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCccCc
Confidence 8887767778889999999999999998888889999999999999999995 5543 2233445557789999886
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-26 Score=252.79 Aligned_cols=189 Identities=24% Similarity=0.205 Sum_probs=97.5
Q ss_pred cCccCCceeeccccccCC----ccchhhhcccccceeccCCCccccccCCCCc----CC---------CCcceEEecCCC
Q 042086 194 GNLSNLVVLHLFENSLFG----SIPSILGNLKMLLHLGLSTNHLSGVIPLSIG----NL---------NNLIGLYLYDNQ 256 (784)
Q Consensus 194 ~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~----~l---------~~L~~L~L~~n~ 256 (784)
..+++|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 344555555555555544 2444455555555555555555433222222 11 556666666665
Q ss_pred CCCCCcc---cccccccccceEeccCccccC-----CCCccccCCCccceeecccCccC----CCCcccccccccceEEe
Q 042086 257 LSVGEIP---IEIGKLSSLNYLVLNGNQLYG-----NLPRALGSLTELEYLDLSTNKLG----NSIPETLGNLLKLHYLN 324 (784)
Q Consensus 257 l~~~~~~---~~l~~l~~L~~L~l~~n~l~~-----~~~~~l~~l~~L~~L~Ls~n~l~----~~~~~~l~~l~~L~~L~ 324 (784)
++...++ ..+..+++|++|++++|+++. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|++|+
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 5433333 244455666666666666652 23335556666666666666664 34455555666666666
Q ss_pred cccccccCC----Cchhhhc--ccccCeeccCCccccc----cccccc-cccccccEEecCCCccCCCC
Q 042086 325 LSNNQFRKG----FPVELEK--LIQLSELDLSLNILEG----KIPCEI-CNMESLEKLNLSHNNFSGLI 382 (784)
Q Consensus 325 ls~N~l~~~----~~~~~~~--l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~~~ 382 (784)
|++|++++. ++..+.. +++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 666666543 2333322 5555555555555554 244444 33455555555555555443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-26 Score=246.97 Aligned_cols=256 Identities=22% Similarity=0.168 Sum_probs=141.7
Q ss_pred EEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCC----cCccCCC-cCcEEeecCCCcccccCCccccc-----cc
Q 042086 105 IMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIP----PTLGNLS-NLAVLHLYGNSLSGSIPSIIGNL-----KS 174 (784)
Q Consensus 105 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l-----~~ 174 (784)
++.|+.|.+++.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35667777777777666666667777777777776555 5556666 67777777777666555555554 56
Q ss_pred cceeeccccccCCCccccccC----c-cCCceeeccccccCCccchhhhc-----ccccceeccCCCccccccCCCCcCC
Q 042086 175 LFYLHLSSNQLSGSIPISLGN----L-SNLVVLHLFENSLFGSIPSILGN-----LKMLLHLGLSTNHLSGVIPLSIGNL 244 (784)
Q Consensus 175 L~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~L~~n~l~~~~~~~l~~-----l~~L~~L~L~~n~l~~~~~~~l~~l 244 (784)
|++|+|++|.+++..+..+.. + ++|++|+|++|+++...+..+.. .++|++|+|++|++++....
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~----- 156 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD----- 156 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH-----
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH-----
Confidence 666666666666544443222 2 45555555555554444433322 13444444444444422111
Q ss_pred CCcceEEecCCCCCCCCccccccccc-ccceEeccCccccCCCCcccc----CC-CccceeecccCccCCC----Ccccc
Q 042086 245 NNLIGLYLYDNQLSVGEIPIEIGKLS-SLNYLVLNGNQLYGNLPRALG----SL-TELEYLDLSTNKLGNS----IPETL 314 (784)
Q Consensus 245 ~~L~~L~L~~n~l~~~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~l~----~l-~~L~~L~Ls~n~l~~~----~~~~l 314 (784)
.++..+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|.+++. ++..+
T Consensus 157 ----------------~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l 220 (362)
T 3goz_A 157 ----------------ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIF 220 (362)
T ss_dssp ----------------HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred ----------------HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHH
Confidence 1222333333 666777777766655443333 33 4777777777777653 23334
Q ss_pred cc-cccceEEecccccccCCCchh----hhcccccCeeccCCccccccc-------cccccccccccEEecCCCccCCC
Q 042086 315 GN-LLKLHYLNLSNNQFRKGFPVE----LEKLIQLSELDLSLNILEGKI-------PCEICNMESLEKLNLSHNNFSGL 381 (784)
Q Consensus 315 ~~-l~~L~~L~ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~~-------~~~~~~l~~L~~L~L~~N~l~~~ 381 (784)
.. .++|++|+|++|++++..+.. +..+++|+.|+|++|.+.+.. +..+..+++|+.|++++|++...
T Consensus 221 ~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred hcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 44 247777777777776644422 344566666666666643222 22344445555555555555444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=216.57 Aligned_cols=178 Identities=20% Similarity=0.245 Sum_probs=95.9
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCc-ccccCCCCCCCCCCCCEEEccC-CccCCCCCcCccCCCcCcEEe
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNS-LSASIPPVIGNLKFLYHLDLSE-NQLSGSIPPTLGNLSNLAVLH 155 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~ 155 (784)
+|++|+|++|+|++..+..|.++++|++|+|++|+ ++...+..|.++++|++|+|++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 55666666666665555556666666666666664 5544445555666666666665 555544445555556666666
Q ss_pred ecCCCcccccCCccccccccc---eeecccc-ccCCCccccccCccCCc-eeeccccccCCccchhhhcccccceeccCC
Q 042086 156 LYGNSLSGSIPSIIGNLKSLF---YLHLSSN-QLSGSIPISLGNLSNLV-VLHLFENSLFGSIPSILGNLKMLLHLGLST 230 (784)
Q Consensus 156 L~~n~l~~~~~~~l~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 230 (784)
|++|.+++ +|. |..+++|+ +|++++| .+++..+..|.++++|+ .|++++|+++...+..|.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 66665553 343 55555555 5555555 55544444455555555 5555555555333333333 4555555555
Q ss_pred Cc-cccccCCCCcCC-CCcceEEecCCCCC
Q 042086 231 NH-LSGVIPLSIGNL-NNLIGLYLYDNQLS 258 (784)
Q Consensus 231 n~-l~~~~~~~l~~l-~~L~~L~L~~n~l~ 258 (784)
|+ +++..+..|.++ ++|+.|++++|+++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 53 554444444444 44444444444443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-26 Score=241.43 Aligned_cols=237 Identities=21% Similarity=0.235 Sum_probs=123.6
Q ss_pred CCcccceeEEcCCCCeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCC--CCCCEEEccCCcccccCCCCCCCC
Q 042086 47 SPCAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNL--TNLAIMYLYRNSLSASIPPVIGNL 124 (784)
Q Consensus 47 ~~C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~l~~l 124 (784)
-|..|.++.|++ ..++.||+++|++. +..+..+ ++++.|++++|.+++..+. +..+
T Consensus 35 vc~~W~~~~~~~------------------~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~ 92 (336)
T 2ast_B 35 VCKRWYRLASDE------------------SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSP 92 (336)
T ss_dssp SCHHHHHHHTCS------------------TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCC
T ss_pred HHHHHHHHhcCc------------------hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccC
Confidence 355788877653 23678888888776 3445555 6677777777766655444 3456
Q ss_pred CCCCEEEccCCccCCC-CCcCccCCCcCcEEeecCCCcccccCCccccccccceeecccc-ccCCCccccccCccCCcee
Q 042086 125 KFLYHLDLSENQLSGS-IPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN-QLSGSIPISLGNLSNLVVL 202 (784)
Q Consensus 125 ~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L 202 (784)
++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++.
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~-------------- 158 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF-------------- 158 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH--------------
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHH--------------
Confidence 6666666666665543 4445555555555555555555444444445555555555555 33321
Q ss_pred eccccccCCccchhhhcccccceeccCCC-ccccc-cCCCCcCCC-CcceEEecCC--CCCCCCcccccccccccceEec
Q 042086 203 HLFENSLFGSIPSILGNLKMLLHLGLSTN-HLSGV-IPLSIGNLN-NLIGLYLYDN--QLSVGEIPIEIGKLSSLNYLVL 277 (784)
Q Consensus 203 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~-~L~~L~L~~n--~l~~~~~~~~l~~l~~L~~L~l 277 (784)
.++..+.++++|++|++++| .+++. ++..+..++ +|++|++++| .++...++..+..+++|++|++
T Consensus 159 ---------~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l 229 (336)
T 2ast_B 159 ---------ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 229 (336)
T ss_dssp ---------HHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred ---------HHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeC
Confidence 13333444445555555554 44432 233333444 4444444444 2222233434445555666666
Q ss_pred cCcc-ccCCCCccccCCCccceeecccCc-cCCCCcccccccccceEEecccc
Q 042086 278 NGNQ-LYGNLPRALGSLTELEYLDLSTNK-LGNSIPETLGNLLKLHYLNLSNN 328 (784)
Q Consensus 278 ~~n~-l~~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~l~~l~~L~~L~ls~N 328 (784)
++|. +++..+..+..+++|++|++++|. +.......+.++++|+.|++++|
T Consensus 230 ~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 6555 444444555555666666666653 22111123445555555555555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=240.66 Aligned_cols=252 Identities=18% Similarity=0.181 Sum_probs=133.2
Q ss_pred CCEEEccCCccCCCCCcCccCC--CcCcEEeecCCCcccccCCccccccccceeeccccccCCC-ccccccCccCCceee
Q 042086 127 LYHLDLSENQLSGSIPPTLGNL--SNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS-IPISLGNLSNLVVLH 203 (784)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~ 203 (784)
++.|++++|.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 556666666554 3344444 5666666666666654443 34566666666666666544 555566666666666
Q ss_pred ccccccCCccchhhhcccccceeccCCC-ccccc-cCCCCcCCCCcceEEecCC-CCCCCCccccccccc-ccceEeccC
Q 042086 204 LFENSLFGSIPSILGNLKMLLHLGLSTN-HLSGV-IPLSIGNLNNLIGLYLYDN-QLSVGEIPIEIGKLS-SLNYLVLNG 279 (784)
Q Consensus 204 L~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~l~~l~-~L~~L~l~~ 279 (784)
|++|.+++..+..++.+++|++|++++| .+++. ++..+..+++|++|++++| .++...++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 6666666555666666666666666666 45532 3444455555555555555 554222333444445 555555555
Q ss_pred ccccCCCCccccCCCccceeecccCccC-CCCcccccccccceEEeccccc-ccCCCchhhhcccccCeeccCCcc-ccc
Q 042086 280 NQLYGNLPRALGSLTELEYLDLSTNKLG-NSIPETLGNLLKLHYLNLSNNQ-FRKGFPVELEKLIQLSELDLSLNI-LEG 356 (784)
Q Consensus 280 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~-~~~~~~l~~l~~L~~L~ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~ 356 (784)
|.+ .++ +.++..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +..
T Consensus 205 ~~~----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~ 262 (336)
T 2ast_B 205 YRK----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 262 (336)
T ss_dssp CGG----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred Ccc----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCH
Confidence 521 222 2233344445555555555555 444444455555555555555552 222
Q ss_pred cccccccccccccEEecCCCccCCCCcccccCc-ccceEEEcCCCCCcccCCC
Q 042086 357 KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGM-HGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 357 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p~ 408 (784)
.....+..+++|+.|++++| ++ ...+..+ ..|..|++++|++++..|.
T Consensus 263 ~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 263 ETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp GGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred HHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCC
Confidence 22224555666666666666 22 1223333 2355555666666665554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-26 Score=263.74 Aligned_cols=323 Identities=14% Similarity=0.081 Sum_probs=234.9
Q ss_pred CCCcccEEeCCCCccccc----CCCCcCCCCCCCEEEccCCccc----ccCCCCCCCCCCCCEEEccCCccCCCCCcCcc
Q 042086 75 NLKSLSTLDLSKNKLNGS----IPFSFGNLTNLAIMYLYRNSLS----ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLG 146 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 146 (784)
.+++|++|+|++|.+++. ++..+..+++|++|+|++|.++ +.++..+.++++|++|+|++|.+.+ +|..+.
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~ 240 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK 240 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence 578889999999888765 3334567788888888888876 3344455677888888888887664 334444
Q ss_pred CCCc---------------------------CcEEeecCCCcccccCCccccccccceeeccccccCCCcc-ccccCccC
Q 042086 147 NLSN---------------------------LAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIP-ISLGNLSN 198 (784)
Q Consensus 147 ~l~~---------------------------L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~ 198 (784)
.+++ |+.|+++++. ...+|..+..+++|++|+|++|.+++... ..+..+++
T Consensus 241 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~ 319 (592)
T 3ogk_B 241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319 (592)
T ss_dssp HCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred hhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence 4444 4444444432 23566777889999999999999875443 44688999
Q ss_pred CceeeccccccCCccchhhhcccccceeccC-----------CCccccccC-CCCcCCCCcceEEecCCCCCCCCccccc
Q 042086 199 LVVLHLFENSLFGSIPSILGNLKMLLHLGLS-----------TNHLSGVIP-LSIGNLNNLIGLYLYDNQLSVGEIPIEI 266 (784)
Q Consensus 199 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~-----------~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~l 266 (784)
|++|+++++.....++..+..+++|++|+++ .|.+++... ..+..+++|++|+++.|+++. ..+..+
T Consensus 320 L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~-~~~~~l 398 (592)
T 3ogk_B 320 LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITN-ESLESI 398 (592)
T ss_dssp CCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCH-HHHHHH
T ss_pred CCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccH-HHHHHH
Confidence 9999999443334455566788999999999 367764432 224568999999999998873 333345
Q ss_pred cc-ccccceEecc----CccccCC-----CCccccCCCccceeecccCc--cCCCCcccccc-cccceEEecccccccC-
Q 042086 267 GK-LSSLNYLVLN----GNQLYGN-----LPRALGSLTELEYLDLSTNK--LGNSIPETLGN-LLKLHYLNLSNNQFRK- 332 (784)
Q Consensus 267 ~~-l~~L~~L~l~----~n~l~~~-----~~~~l~~l~~L~~L~Ls~n~--l~~~~~~~l~~-l~~L~~L~ls~N~l~~- 332 (784)
.. +++|+.|+++ .|.+++. ++..+..+++|++|++++|. +++..+..+.. +++|++|+|++|++++
T Consensus 399 ~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 478 (592)
T 3ogk_B 399 GTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE 478 (592)
T ss_dssp HHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHH
T ss_pred HhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHH
Confidence 44 8899999996 6777753 33346678999999998544 66655555554 8899999999999986
Q ss_pred CCchhhhcccccCeeccCCcccccc-ccccccccccccEEecCCCccCCCCccccc-CcccceEEEcCCC
Q 042086 333 GFPVELEKLIQLSELDLSLNILEGK-IPCEICNMESLEKLNLSHNNFSGLIPSCFE-GMHGLSCIDVSYN 400 (784)
Q Consensus 333 ~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~l~l~~N 400 (784)
.++..+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++.....+. .++.+....+..+
T Consensus 479 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 479 GLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 3455668899999999999998765 344456789999999999999877554443 5677776666554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-26 Score=247.79 Aligned_cols=245 Identities=20% Similarity=0.197 Sum_probs=133.1
Q ss_pred CCCCcCCCCCCCEEEccCCccccc----CCCCCCCCCCCCEEEccCC---ccCCCCCcCc-------cCCCcCcEEeecC
Q 042086 93 IPFSFGNLTNLAIMYLYRNSLSAS----IPPVIGNLKFLYHLDLSEN---QLSGSIPPTL-------GNLSNLAVLHLYG 158 (784)
Q Consensus 93 ~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~L~~ 158 (784)
++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++| ++.+.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 455566677777777777777654 3344667777777777775 3444445444 4566666677766
Q ss_pred CCccc----ccCCccccccccceeeccccccCCCcccccc----Cc---------cCCceeeccccccC-Cccc---hhh
Q 042086 159 NSLSG----SIPSIIGNLKSLFYLHLSSNQLSGSIPISLG----NL---------SNLVVLHLFENSLF-GSIP---SIL 217 (784)
Q Consensus 159 n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~----~l---------~~L~~L~L~~n~l~-~~~~---~~l 217 (784)
|.+++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ ..++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 66665 3555566666666666666666533332222 22 56666666666654 2223 344
Q ss_pred hcccccceeccCCCcccc-----ccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccC
Q 042086 218 GNLKMLLHLGLSTNHLSG-----VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGS 292 (784)
Q Consensus 218 ~~l~~L~~L~L~~n~l~~-----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~ 292 (784)
..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++... .+.+|..+..
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g---------------------~~~l~~~l~~ 242 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG---------------------SSALAIALKS 242 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH---------------------HHHHHHHGGG
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH---------------------HHHHHHHHcc
Confidence 455556666666665551 22224444444444444444442100 0234444555
Q ss_pred CCccceeecccCccCCC----Cccccc--ccccceEEecccccccC----CCchhh-hcccccCeeccCCccccccc
Q 042086 293 LTELEYLDLSTNKLGNS----IPETLG--NLLKLHYLNLSNNQFRK----GFPVEL-EKLIQLSELDLSLNILEGKI 358 (784)
Q Consensus 293 l~~L~~L~Ls~n~l~~~----~~~~l~--~l~~L~~L~ls~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~~ 358 (784)
+++|++|+|++|.+++. ++..+. .+++|++|+|++|.+++ .+|..+ .++++|+.|+|++|++++..
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 55555555555555443 233332 25556666666666555 344444 44566666666666666544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=227.28 Aligned_cols=205 Identities=22% Similarity=0.203 Sum_probs=107.0
Q ss_pred CCCCEEEccCCcccccCCCCC--CCCCCCCEEEccCCccCCCCC----cCccCCCcCcEEeecCCCcccccCCccccccc
Q 042086 101 TNLAIMYLYRNSLSASIPPVI--GNLKFLYHLDLSENQLSGSIP----PTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKS 174 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 174 (784)
++|++|+|++|.+++..|..+ +.+++|++|+|++|.+++..+ ..+..+++|++|+|++|.+++..+..|.++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 445566666665555555555 555556666666665554433 22334555555566555555555555555555
Q ss_pred cceeeccccccCCC--c--cccccCccCCceeeccccccCCccc--h-hhhcccccceeccCCCccccccCCCCcCCCCc
Q 042086 175 LFYLHLSSNQLSGS--I--PISLGNLSNLVVLHLFENSLFGSIP--S-ILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247 (784)
Q Consensus 175 L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~n~l~~~~~--~-~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 247 (784)
|++|+|++|++.+. + +..+..+++|++|+|++|+++.... . .++++++|++|+|++|++++..|..+..+.
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-- 248 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM-- 248 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC--
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc--
Confidence 55555555555431 1 1122455555555555555542111 1 234455555555555555554444433331
Q ss_pred ceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEeccc
Q 042086 248 IGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSN 327 (784)
Q Consensus 248 ~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~ 327 (784)
.+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|+|++
T Consensus 249 --------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 249 --------------------WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDG 303 (310)
T ss_dssp --------------------CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSS
T ss_pred --------------------CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcC
Confidence 1145555555555555 3444442 5666666666666642 22 45556666666666
Q ss_pred ccccC
Q 042086 328 NQFRK 332 (784)
Q Consensus 328 N~l~~ 332 (784)
|+++.
T Consensus 304 N~l~~ 308 (310)
T 4glp_A 304 NPFLV 308 (310)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 66653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=224.14 Aligned_cols=108 Identities=18% Similarity=0.112 Sum_probs=53.3
Q ss_pred CCCEEEccCCccCCCCCc---CccCCCcCcEEeecCCCcccccCCcc--ccccccceeeccccccCCCcc----ccccCc
Q 042086 126 FLYHLDLSENQLSGSIPP---TLGNLSNLAVLHLYGNSLSGSIPSII--GNLKSLFYLHLSSNQLSGSIP----ISLGNL 196 (784)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~---~l~~l~~L~~L~L~~n~l~~~~~~~l--~~l~~L~~L~L~~n~l~~~~~----~~~~~l 196 (784)
.++.|.++++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 456666666655421100 11123456666666666666655555 556666666666666654332 122334
Q ss_pred cCCceeeccccccCCccchhhhcccccceeccCCCcc
Q 042086 197 SNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233 (784)
Q Consensus 197 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 233 (784)
++|++|+|++|++.+..+..|+++++|++|+|++|++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 181 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPG 181 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCC
Confidence 4444444444444444444444444444444444443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=209.59 Aligned_cols=197 Identities=20% Similarity=0.189 Sum_probs=126.6
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCc-cCCCCCcCccCCCcCcEEeecC-CCcccccCCcccccccccee
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ-LSGSIPPTLGNLSNLAVLHLYG-NSLSGSIPSIIGNLKSLFYL 178 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L 178 (784)
++|++|+|++|++++..+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |.+++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 378888888888887777788888888888888886 7766666778888888888887 78876666777778888888
Q ss_pred eccccccCCCccccccCccCCc---eeecccc-ccCCccchhhhcccccc-eeccCCCccccccCCCCcCCCCcceEEec
Q 042086 179 HLSSNQLSGSIPISLGNLSNLV---VLHLFEN-SLFGSIPSILGNLKMLL-HLGLSTNHLSGVIPLSIGNLNNLIGLYLY 253 (784)
Q Consensus 179 ~L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 253 (784)
++++|.+++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++...+..|
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~------------ 176 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF------------ 176 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTT------------
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhc------------
Confidence 888888774 454 66666666 6666666 56555555555555555 55555555552222222
Q ss_pred CCCCCCCCcccccccccccceEeccCcc-ccCCCCccccCC-CccceeecccCccCCCCcccccccccceEEecccc
Q 042086 254 DNQLSVGEIPIEIGKLSSLNYLVLNGNQ-LYGNLPRALGSL-TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNN 328 (784)
Q Consensus 254 ~n~l~~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~l~~l-~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N 328 (784)
..++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 177 --------------~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 177 --------------NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp --------------TTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred --------------CCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 22455555555553 554444555555 6666666666666532 222 3445555555544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=5.1e-23 Score=216.75 Aligned_cols=107 Identities=31% Similarity=0.450 Sum_probs=49.7
Q ss_pred cccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccC
Q 042086 266 IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS 345 (784)
Q Consensus 266 l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~ 345 (784)
+..+++|++|++++|++++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+
T Consensus 125 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~ 198 (308)
T 1h6u_A 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLI 198 (308)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCC
T ss_pred hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCC
Confidence 3444444444444444443221 4444555555555555543222 4445555555555555544222 44455555
Q ss_pred eeccCCccccccccccccccccccEEecCCCccCC
Q 042086 346 ELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380 (784)
Q Consensus 346 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 380 (784)
.|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 199 ~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 199 EVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp EEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred EEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 55555555543321 4445555555555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-23 Score=216.37 Aligned_cols=213 Identities=23% Similarity=0.377 Sum_probs=165.8
Q ss_pred cccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEe
Q 042086 173 KSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYL 252 (784)
Q Consensus 173 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 252 (784)
.++..+.+..+.+.+.+ .+..+++|++|++++|.+... + .+..+++|++|+|++|++++..+ +..+++|++|+|
T Consensus 19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L 92 (308)
T 1h6u_A 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (308)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEc
Confidence 33444455555554322 234556666667766666532 2 46667777777777777765443 677777777777
Q ss_pred cCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccC
Q 042086 253 YDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRK 332 (784)
Q Consensus 253 ~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~ 332 (784)
++|+++ .++ .+..+++|++|++++|++++. + .+..+++|++|++++|.+++..+ +..+++|+.|++++|++++
T Consensus 93 ~~n~l~--~~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 93 SGNPLK--NVS-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CSCCCS--CCG-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred cCCcCC--Cch-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 777776 333 577888999999999999864 3 38999999999999999996544 8999999999999999998
Q ss_pred CCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcc
Q 042086 333 GFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRG 404 (784)
Q Consensus 333 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 404 (784)
..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++
T Consensus 166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 444 9999999999999999996544 8899999999999999998764 8899999999999999986
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.7e-26 Score=260.98 Aligned_cols=326 Identities=17% Similarity=0.152 Sum_probs=180.6
Q ss_pred CCCcccEEeCCCCcccccCCCCcC-CCCCCCEEEccCC-ccccc-CCCCCCCCCCCCEEEccCCccCCCCCcCcc----C
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFG-NLTNLAIMYLYRN-SLSAS-IPPVIGNLKFLYHLDLSENQLSGSIPPTLG----N 147 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~----~ 147 (784)
.+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 345666777777666655555553 4666777777666 44332 333334566677777776666654433333 4
Q ss_pred CCcCcEEeecCCC--cccc-cCCccccccccceeecccc-ccCCCccccccCccCCceeeccccc---------------
Q 042086 148 LSNLAVLHLYGNS--LSGS-IPSIIGNLKSLFYLHLSSN-QLSGSIPISLGNLSNLVVLHLFENS--------------- 208 (784)
Q Consensus 148 l~~L~~L~L~~n~--l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~--------------- 208 (784)
+++|++|+|++|. ++.. ++..+.++++|++|+|++| .+. .++..+..+++|+.|+++.+.
T Consensus 183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l 261 (594)
T 2p1m_B 183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVAL 261 (594)
T ss_dssp CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHH
T ss_pred CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHH
Confidence 4566677766665 2211 1112234466666666666 233 244445555555555543321
Q ss_pred -----------c----CCccchhhhcccccceeccCCCccccccC-CCCcCCCCcceEEecCCCCCCCCccccccccccc
Q 042086 209 -----------L----FGSIPSILGNLKMLLHLGLSTNHLSGVIP-LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSL 272 (784)
Q Consensus 209 -----------l----~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L 272 (784)
+ ...++..+..+++|++|+|++|.+++... ..+..+++|++|++++| +....++.....+++|
T Consensus 262 ~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L 340 (594)
T 2p1m_B 262 SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDL 340 (594)
T ss_dssp HTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTC
T ss_pred hcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCC
Confidence 1 11233334456677777777777654322 22446677777777766 3322223223346677
Q ss_pred ceEeccC---------ccccCCCCcccc-CCCccceeecccCccCCCCccccc-ccccceEEecc--c----ccccCC--
Q 042086 273 NYLVLNG---------NQLYGNLPRALG-SLTELEYLDLSTNKLGNSIPETLG-NLLKLHYLNLS--N----NQFRKG-- 333 (784)
Q Consensus 273 ~~L~l~~---------n~l~~~~~~~l~-~l~~L~~L~Ls~n~l~~~~~~~l~-~l~~L~~L~ls--~----N~l~~~-- 333 (784)
++|++.+ +.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+++ + |.++..
T Consensus 341 ~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~ 420 (594)
T 2p1m_B 341 RELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL 420 (594)
T ss_dssp CEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCT
T ss_pred CEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCch
Confidence 7777632 334322222222 366777777777777655444444 46777777777 3 445421
Q ss_pred ---CchhhhcccccCeeccCCccccccccccccc-cccccEEecCCCccCCCCcccc-cCcccceEEEcCCCCCc
Q 042086 334 ---FPVELEKLIQLSELDLSLNILEGKIPCEICN-MESLEKLNLSHNNFSGLIPSCF-EGMHGLSCIDVSYNELR 403 (784)
Q Consensus 334 ---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~ 403 (784)
++..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|+++
T Consensus 421 ~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 421 DIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred hhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 122255667777777766 555555555554 6777777777777765554444 45677777777777764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-25 Score=256.13 Aligned_cols=341 Identities=14% Similarity=0.083 Sum_probs=245.8
Q ss_pred CCeEEEEeCCCcccC--------CCCcccEEeCCCC-ccccc-CCCCcCCCCCCCEEEccCCcccccCCCCC----CCCC
Q 042086 60 KRVISINLSTVGLKG--------NLKSLSTLDLSKN-KLNGS-IPFSFGNLTNLAIMYLYRNSLSASIPPVI----GNLK 125 (784)
Q Consensus 60 ~~v~~l~l~~~~~~~--------~l~~l~~L~L~~n-~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p~~l----~~l~ 125 (784)
.++..+++....+.+ .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 356778877654332 5789999999999 66643 44445689999999999999876554433 4778
Q ss_pred CCCEEEccCCc--cCCC-CCcCccCCCcCcEEeecCC-CcccccCCccccccccceeeccccc-----------------
Q 042086 126 FLYHLDLSENQ--LSGS-IPPTLGNLSNLAVLHLYGN-SLSGSIPSIIGNLKSLFYLHLSSNQ----------------- 184 (784)
Q Consensus 126 ~L~~L~L~~n~--l~~~-~p~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n~----------------- 184 (784)
+|++|+|++|. +... ++..+..+++|++|+|++| .+. .++..+.++++|++|+++.+.
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 99999999997 2211 1112244699999999998 444 377777788888888865542
Q ss_pred ---------cCC----CccccccCccCCceeeccccccCCcc-chhhhcccccceeccCCCcccccc-CCCCcCCCCcce
Q 042086 185 ---------LSG----SIPISLGNLSNLVVLHLFENSLFGSI-PSILGNLKMLLHLGLSTNHLSGVI-PLSIGNLNNLIG 249 (784)
Q Consensus 185 ---------l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~ 249 (784)
+.. .++..+..+++|++|+|++|.++... ...+.++++|+.|++++| ++... +.....+++|++
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 111 23333346789999999999976443 334668899999999998 54322 222345899999
Q ss_pred EEecC---------CCCCCCCcccccccccccceEeccCccccCCCCcccc-CCCccceeecc--c----CccCCCC---
Q 042086 250 LYLYD---------NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALG-SLTELEYLDLS--T----NKLGNSI--- 310 (784)
Q Consensus 250 L~L~~---------n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~-~l~~L~~L~Ls--~----n~l~~~~--- 310 (784)
|++.+ +.++...+......+++|+.|.+..|.+++.....+. .+++|+.|+++ + |.+++..
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~ 422 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence 99943 4554322222223588999999999999876555565 58999999999 4 5666321
Q ss_pred --cccccccccceEEecccccccCCCchhhhc-ccccCeeccCCccccccccccc-cccccccEEecCCCccCCCCcc-c
Q 042086 311 --PETLGNLLKLHYLNLSNNQFRKGFPVELEK-LIQLSELDLSLNILEGKIPCEI-CNMESLEKLNLSHNNFSGLIPS-C 385 (784)
Q Consensus 311 --~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~-~ 385 (784)
+..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. .
T Consensus 423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~ 501 (594)
T 2p1m_B 423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN 501 (594)
T ss_dssp HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHT
T ss_pred HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHH
Confidence 22366789999999987 677656666665 8999999999999987666665 6789999999999999655544 4
Q ss_pred ccCcccceEEEcCCCCCc
Q 042086 386 FEGMHGLSCIDVSYNELR 403 (784)
Q Consensus 386 ~~~l~~L~~l~l~~N~l~ 403 (784)
+..+++|+.|++++|+++
T Consensus 502 ~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 502 ASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp GGGGGGSSEEEEESSCCB
T ss_pred HHhCCCCCEEeeeCCCCC
Confidence 456899999999999874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=199.53 Aligned_cols=184 Identities=27% Similarity=0.268 Sum_probs=151.8
Q ss_pred cccceeEEcCCCCeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCC
Q 042086 49 CAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLY 128 (784)
Q Consensus 49 C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 128 (784)
|.|.+|.|...+ .+.+ ..+..++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|+.+++|+
T Consensus 7 C~~~~v~c~~~~-l~~~------p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 79 (208)
T 2o6s_A 7 CSGTTVECYSQG-RTSV------PTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79 (208)
T ss_dssp EETTEEECCSSC-CSSC------CSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred ECCCEEEecCCC-ccCC------CCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcC
Confidence 899999998542 1111 122346789999999999987777889999999999999999977777789999999
Q ss_pred EEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccc
Q 042086 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENS 208 (784)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 208 (784)
+|+|++|++++..+..+..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..+..+++|++|++++|.
T Consensus 80 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 159 (208)
T 2o6s_A 80 YLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 159 (208)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred EEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCC
Confidence 99999999997777778899999999999999997777778899999999999999997767678889999999999998
Q ss_pred cCCccchhhhcccccceeccCCCccccccCCCCcCCCC
Q 042086 209 LFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN 246 (784)
Q Consensus 209 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 246 (784)
+.+ .+++|++|+++.|+++|.+|..++.++.
T Consensus 160 ~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 160 WDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp BCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred eec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 754 3457888889999999888887765543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.1e-22 Score=202.16 Aligned_cols=181 Identities=24% Similarity=0.252 Sum_probs=128.9
Q ss_pred cceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecc
Q 042086 223 LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302 (784)
Q Consensus 223 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 302 (784)
.+.++++++.++ .+|..+. ++|+.|+|++|+++ ...+..+..+++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcC-ccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 445555555555 3333332 35556666666555 2223346666677777777777776666677777778888888
Q ss_pred cCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCC
Q 042086 303 TNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLI 382 (784)
Q Consensus 303 ~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 382 (784)
+|.+++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 88777666677777788888888888887766666777888888888888888666667788888888888888888887
Q ss_pred cccccCcccceEEEcCCCCCcccCC
Q 042086 383 PSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 383 p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
+..+..+++|+.|++++|+|.|..+
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTST
T ss_pred HHHHhCCCCCCEEEeeCCceeCCcc
Confidence 7788888888888888888887633
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-22 Score=214.00 Aligned_cols=221 Identities=20% Similarity=0.168 Sum_probs=116.4
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCC-cCccCCCcCcE-EeecCCCcccccCCcccccccccee
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIP-PTLGNLSNLAV-LHLYGNSLSGSIPSIIGNLKSLFYL 178 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~-L~L~~n~l~~~~~~~l~~l~~L~~L 178 (784)
+++++|+|++|+|+.+.+.+|+++++|++|+|++|++.+.+| .+|.++++|+. +.+++|+++...|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 456666666666665444566666666666666666654443 34566666554 4455566665556666666666666
Q ss_pred eccccccCCCccccccCccCCceeeccc-cccCCccchhhhccc-ccceeccCCCccccccCCCCcCCCCcceEEecC-C
Q 042086 179 HLSSNQLSGSIPISLGNLSNLVVLHLFE-NSLFGSIPSILGNLK-MLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD-N 255 (784)
Q Consensus 179 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-n 255 (784)
++++|++....+..+....++..|++.+ +++....+..|..+. .++.|+|++|+|+.+.+..| ...+|++|++.+ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCC
Confidence 6666666655444555555566666643 445444444455443 35566666666663333322 334555555543 3
Q ss_pred CCCCCCccc-ccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccc
Q 042086 256 QLSVGEIPI-EIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNN 328 (784)
Q Consensus 256 ~l~~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N 328 (784)
.++ .+|. .|..+++|++|+|++|+|+...+..+.++++|+.+++ +.++ .+| .+.++++|+.++++++
T Consensus 189 ~l~--~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 189 NLE--ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp TCC--CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred ccc--CCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence 333 3332 3455555555555555555333333333333333222 1222 333 2455555555555543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=5e-22 Score=213.36 Aligned_cols=239 Identities=20% Similarity=0.176 Sum_probs=170.7
Q ss_pred EEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccC-Cccccccccce-eeccc
Q 042086 105 IMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIP-SIIGNLKSLFY-LHLSS 182 (784)
Q Consensus 105 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~-L~L~~ 182 (784)
.++.++++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| .+|.++++|++ +.+++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4555666666 566655 3679999999999996666788999999999999999876555 56788888775 66677
Q ss_pred cccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCC-CccccccCCCCcCCC-CcceEEecCCCCCCC
Q 042086 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST-NHLSGVIPLSIGNLN-NLIGLYLYDNQLSVG 260 (784)
Q Consensus 183 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~ 260 (784)
|+++...|..|..+++|++|++++|++....+..+....++..|++.+ |++....+..|..+. .++.|+|++|+++
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-- 167 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-- 167 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC--
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc--
Confidence 889877788889999999999999999877777777777788888855 677766666677664 5778888888876
Q ss_pred CcccccccccccceEeccC-ccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhh
Q 042086 261 EIPIEIGKLSSLNYLVLNG-NQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELE 339 (784)
Q Consensus 261 ~~~~~l~~l~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~ 339 (784)
.++.......+|++|++.+ |.++...+..|..+++|+.|+|++|+|+...+..+.++++|+.+++ +.++ .+| .+.
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~ 243 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLE 243 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTT
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cch
Confidence 5666655667788888764 5565444456777788888888888887544444544444443332 2233 344 366
Q ss_pred cccccCeeccCCc
Q 042086 340 KLIQLSELDLSLN 352 (784)
Q Consensus 340 ~l~~L~~L~Ls~N 352 (784)
.+++|+.++++++
T Consensus 244 ~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 244 KLVALMEASLTYP 256 (350)
T ss_dssp TCCSCCEEECSCH
T ss_pred hCcChhhCcCCCC
Confidence 6777777777654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-23 Score=211.90 Aligned_cols=166 Identities=17% Similarity=0.133 Sum_probs=128.0
Q ss_pred HHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCC---------------CChhhHHHHHHHHhccCC
Q 042086 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEM---------------VPQPEFVNEIKTLTELRH 573 (784)
Q Consensus 509 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h 573 (784)
.+......|.+.+.||+|+||.||+|+..+|+.||+|.++....... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 44445667788899999999999999998899999999865322111 02456899999999999
Q ss_pred CceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee
Q 042086 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL 653 (784)
Q Consensus 574 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 653 (784)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.|++|||+. +|+||||||+|||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 4 566665543 56799999999999988 522 12346999999999999999 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCCccccccccccccccccccc----------CCcCcchhHHH
Q 042086 654 CLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT----------MKVTEKCDVYS 705 (784)
Q Consensus 654 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvws 705 (784)
+ ++.+||+|||+|+. +..|+|||++.. .++...+|+|.
T Consensus 227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE-------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp E-TTEEEECCCTTCEE-------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred E-CCcEEEEECCCCeE-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9 99999999999974 334788998743 34445556654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=227.96 Aligned_cols=209 Identities=26% Similarity=0.325 Sum_probs=137.9
Q ss_pred CCCCc-----cccee-EEcCCCCeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCC
Q 042086 45 KISPC-----AWFGI-QCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIP 118 (784)
Q Consensus 45 ~~~~C-----~w~gv-~C~~~~~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 118 (784)
+.+|| .|.|+ .|.. .+|+.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+|
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~------------------~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip 96 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLI------------------NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP 96 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHH------------------TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC
T ss_pred cCCccccccchhhhcccccc------------------CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc
Confidence 34677 79998 7752 257889999999987 67655 378999999999988 566
Q ss_pred CCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccC
Q 042086 119 PVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSN 198 (784)
Q Consensus 119 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 198 (784)
..+++|++|+|++|+|++ +|. +.. +|++|+|++|.|++ +|. .+++|++|+|++|.+++ +|. .+++
T Consensus 97 ---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~ 161 (571)
T 3cvr_A 97 ---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTS 161 (571)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTT
T ss_pred ---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCC
Confidence 457888899999888886 666 654 88888888888886 555 56788888888888885 554 4677
Q ss_pred CceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEecc
Q 042086 199 LVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLN 278 (784)
Q Consensus 199 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~ 278 (784)
|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| ....+.|+.|+|+
T Consensus 162 L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L------------------~~~~~~L~~L~Ls 215 (571)
T 3cvr_A 162 LEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN------------------HHSEETEIFFRCR 215 (571)
T ss_dssp CCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------------------------CCEEEECC
T ss_pred cCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh------------------hcccccceEEecC
Confidence 8888888887775 444 44 67777777777777 4444 332 33 0001122555555
Q ss_pred CccccCCCCccccCCCccceeecccCccCCCCccccccc
Q 042086 279 GNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNL 317 (784)
Q Consensus 279 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l 317 (784)
+|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..+
T Consensus 216 ~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp SSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred CCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 55554 344444445555555555555555555544443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.5e-21 Score=189.77 Aligned_cols=161 Identities=29% Similarity=0.291 Sum_probs=82.4
Q ss_pred CCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeecc
Q 042086 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLF 205 (784)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 205 (784)
+|++|+|++|++++..+..+..+++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444443333334444444444444444443333344445555555555555554333444555555555555
Q ss_pred ccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCC
Q 042086 206 ENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGN 285 (784)
Q Consensus 206 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~ 285 (784)
+|++++..+..|.++++|+.|++++|++++..+..|..+++|+.|++++|.+. ..+++|++|+++.|+++|.
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~--------~~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD--------CTCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC--------CCTTTTHHHHHHHHHCTTT
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee--------cCCCCHHHHHHHHHhCCce
Confidence 55555444444555566666666666665544444555555555555555433 2234555666666666666
Q ss_pred CCccccCCC
Q 042086 286 LPRALGSLT 294 (784)
Q Consensus 286 ~~~~l~~l~ 294 (784)
+|..++.++
T Consensus 181 ip~~~~~l~ 189 (208)
T 2o6s_A 181 VRNSAGSVA 189 (208)
T ss_dssp BBCTTSSBC
T ss_pred eeccCcccc
Confidence 665555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.8e-21 Score=213.83 Aligned_cols=191 Identities=25% Similarity=0.290 Sum_probs=126.7
Q ss_pred CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeecc
Q 042086 102 NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181 (784)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 181 (784)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|.|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 77777777777775 565543 67777777777777 455 345677777777777775 555 444 67777777
Q ss_pred ccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCC
Q 042086 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGE 261 (784)
Q Consensus 182 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 261 (784)
+|.+++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|++++
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-------------------------- 174 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-------------------------- 174 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC--------------------------
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC--------------------------
Confidence 777664 444 45566666666666554 232 34455555555555553
Q ss_pred cccccccccccceEeccCccccCCCCccccC-----CCccceeecccCccCCCCcccccccccceEEecccccccCCCch
Q 042086 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGS-----LTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPV 336 (784)
Q Consensus 262 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~-----l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~ 336 (784)
+|. +. ++|+.|+|++|+|+ .+|. +.. .+.|+.|+|++|.|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus 175 lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 175 LPE-LP--ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred cch-hh--CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 333 32 45556666666655 3444 333 123399999999999 6888888899999999999999999999
Q ss_pred hhhcccc
Q 042086 337 ELEKLIQ 343 (784)
Q Consensus 337 ~~~~l~~ 343 (784)
.+..+..
T Consensus 249 ~l~~l~~ 255 (571)
T 3cvr_A 249 SLSQQTA 255 (571)
T ss_dssp HHHHHHH
T ss_pred HHHHhhc
Confidence 8888765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=6e-21 Score=190.35 Aligned_cols=157 Identities=19% Similarity=0.204 Sum_probs=124.1
Q ss_pred eEEecCCCCCCCCcccccccccccceEeccCccccCCCC-ccccCCCccceeecccCccCCCCcccccccccceEEeccc
Q 042086 249 GLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP-RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSN 327 (784)
Q Consensus 249 ~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~ 327 (784)
.+++++|.++ .+|..+. ..+++|+|++|++++..+ ..|..+++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus 15 ~l~~s~n~l~--~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN--KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS--SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc--cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4455555544 3444332 345677777777776544 4577888888888888888877777888888888888888
Q ss_pred ccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 328 NQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 328 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|+|.|.++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88888777788888888888888888888888888899999999999999999889999999999999999999998877
Q ss_pred CC
Q 042086 408 NS 409 (784)
Q Consensus 408 ~~ 409 (784)
-.
T Consensus 171 l~ 172 (220)
T 2v70_A 171 LA 172 (220)
T ss_dssp GH
T ss_pred hH
Confidence 43
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=8.8e-21 Score=189.14 Aligned_cols=157 Identities=20% Similarity=0.232 Sum_probs=129.5
Q ss_pred ceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEeccc
Q 042086 248 IGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSN 327 (784)
Q Consensus 248 ~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~ 327 (784)
+.++++++.++ .+|..+. ++|+.|++++|++++..+..|..+++|+.|+|++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~--~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT--EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS--SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC--cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 34555555554 4454443 5788888888888877777888888888888888888887788888888899999999
Q ss_pred ccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 328 NQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 328 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
|+|+...+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|.++
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 98888767778888999999999999998888888999999999999999999888889999999999999999988766
Q ss_pred C
Q 042086 408 N 408 (784)
Q Consensus 408 ~ 408 (784)
-
T Consensus 170 l 170 (220)
T 2v9t_B 170 L 170 (220)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.6e-20 Score=184.06 Aligned_cols=160 Identities=29% Similarity=0.309 Sum_probs=122.3
Q ss_pred CCCcccceeEEcCCCCeEEEEeCCCcccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCC
Q 042086 46 ISPCAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125 (784)
Q Consensus 46 ~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 125 (784)
.+.|+|.+|.|... +++.+ ..+-.++|++|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..++
T Consensus 16 ~~~Cs~~~v~c~~~-~l~~i------p~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 88 (229)
T 3e6j_A 16 QCSCSGTTVDCRSK-RHASV------PAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT 88 (229)
T ss_dssp TCEEETTEEECTTS-CCSSC------CSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCEEeCCEeEccCC-CcCcc------CCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCC
Confidence 46799999999743 22211 112236788888888888888888888888888888888888766666778888
Q ss_pred CCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeecc
Q 042086 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLF 205 (784)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 205 (784)
+|++|+|++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|+
T Consensus 89 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 167 (229)
T 3e6j_A 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167 (229)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 8888888888888766667788888888888888888 667777888888888888888886666667778888888888
Q ss_pred ccccCCcc
Q 042086 206 ENSLFGSI 213 (784)
Q Consensus 206 ~n~l~~~~ 213 (784)
+|.+....
T Consensus 168 ~N~~~c~c 175 (229)
T 3e6j_A 168 GNPWDCEC 175 (229)
T ss_dssp TSCBCTTB
T ss_pred CCCccCCc
Confidence 88776543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.8e-20 Score=211.44 Aligned_cols=190 Identities=28% Similarity=0.341 Sum_probs=101.7
Q ss_pred CcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCC
Q 042086 151 LAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230 (784)
Q Consensus 151 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 230 (784)
+..+.+..+.+.+..+ +..+++|+.|+|++|.+.. ++ .+..+++|+.|+|++|++++..+ +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 3344444444443222 3344555555555555542 22 34455555555555555544333 55555555555555
Q ss_pred CccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCC
Q 042086 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSI 310 (784)
Q Consensus 231 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 310 (784)
|.+++ ++ .+..+++|+.|+|++|+++ .++ .+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++..
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~--~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGIS--DIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCC--CCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCC--CCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 55553 12 4555555666666555554 222 455556666666666666543 44556666666666666666544
Q ss_pred cccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccc
Q 042086 311 PETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK 357 (784)
Q Consensus 311 ~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 357 (784)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+.
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 4 56666666666666666652 3456666666666666666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-21 Score=225.52 Aligned_cols=219 Identities=24% Similarity=0.214 Sum_probs=113.8
Q ss_pred chHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCcccceeEEcCCCCeEEEEeCCCcccC-CCCccc
Q 042086 2 AGKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVISINLSTVGLKG-NLKSLS 80 (784)
Q Consensus 2 ~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~-~l~~l~ 80 (784)
...++.||+++..+........-..|. ......+.|.++++.. .+++.+++...+... ....++
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~~~l~ 194 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPT--------------GDSTPSGTATNSAVST-PLTPKIELFANGKDEANQALLQ 194 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCc--------------CCCCccccCCCceecC-CccceEEeeCCCCCcchhhHhh
Confidence 456788999998887543333333442 2334567899888875 567777765544332 223355
Q ss_pred EEeCCCCcccc---------cCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcC
Q 042086 81 TLDLSKNKLNG---------SIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNL 151 (784)
Q Consensus 81 ~L~L~~n~i~~---------~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 151 (784)
.++|+.|.|.+ ..+..|..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+.+++|
T Consensus 195 ~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L 272 (727)
T 4b8c_D 195 HKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNL 272 (727)
T ss_dssp ---------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTC
T ss_pred cCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCC
Confidence 56666665554 23666777777777777777777 56666667777777777777777 677777777777
Q ss_pred cEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccc-cceeccCC
Q 042086 152 AVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKM-LLHLGLST 230 (784)
Q Consensus 152 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~ 230 (784)
++|+|++|.|+ .+|..|+++++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++
T Consensus 273 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~ 350 (727)
T 4b8c_D 273 RVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRD 350 (727)
T ss_dssp CEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhcc
Confidence 77777777777 56777777777777777777776 66667777777777777777777777777665432 23466777
Q ss_pred CccccccCC
Q 042086 231 NHLSGVIPL 239 (784)
Q Consensus 231 n~l~~~~~~ 239 (784)
|.+++.+|.
T Consensus 351 N~l~~~~p~ 359 (727)
T 4b8c_D 351 NRPEIPLPH 359 (727)
T ss_dssp CCCCCCCCC
T ss_pred CcccCcCcc
Confidence 777766654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-20 Score=194.65 Aligned_cols=171 Identities=27% Similarity=0.353 Sum_probs=82.8
Q ss_pred ccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceE
Q 042086 196 LSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYL 275 (784)
Q Consensus 196 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L 275 (784)
+++|+.|++++|.+... ..+..+++|++|++++|++++..+ +..+++|+.|++++|+++ .++ .+..+++|++|
T Consensus 45 l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~--~~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--DLS-SLKDLKKLKSL 117 (291)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC--CGG-GGTTCTTCCEE
T ss_pred cCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC--CCh-hhccCCCCCEE
Confidence 34444444444444322 124444444444444444443222 444444444444444443 122 24444555555
Q ss_pred eccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccc
Q 042086 276 VLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILE 355 (784)
Q Consensus 276 ~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 355 (784)
++++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555555432 2344555555555555555533 345555555555555555555332 555555555555555555
Q ss_pred ccccccccccccccEEecCCCccCCC
Q 042086 356 GKIPCEICNMESLEKLNLSHNNFSGL 381 (784)
Q Consensus 356 ~~~~~~~~~l~~L~~L~L~~N~l~~~ 381 (784)
+ ++ .+..+++|+.|++++|+++..
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred C-Ch-hhccCCCCCEEECcCCcccCC
Confidence 3 22 255555666666666665543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.5e-20 Score=196.78 Aligned_cols=157 Identities=29% Similarity=0.208 Sum_probs=95.1
Q ss_pred cccEEeCCCCcccccCCCCcC-CCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 78 SLSTLDLSKNKLNGSIPFSFG-NLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
.++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 119 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence 456666666666666666665 6666666666666666666666666666666666666666555556666666666666
Q ss_pred cCCCcccccCCccccccccceeeccccccCCCccccc---cCccCCceeeccccccCCccchhhhcccc--cceeccCCC
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISL---GNLSNLVVLHLFENSLFGSIPSILGNLKM--LLHLGLSTN 231 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~~~~~l~~l~~--L~~L~L~~n 231 (784)
++|.|++..|..|.++++|++|+|++|.|++..+..| ..+++|+.|+|++|+|+...+..+..++. |+.|+|++|
T Consensus 120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N 199 (361)
T 2xot_A 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence 6666666556666666666666666666664333333 34566666666666665555455555554 244555555
Q ss_pred ccc
Q 042086 232 HLS 234 (784)
Q Consensus 232 ~l~ 234 (784)
.+.
T Consensus 200 ~~~ 202 (361)
T 2xot_A 200 PLE 202 (361)
T ss_dssp CEE
T ss_pred Ccc
Confidence 544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-20 Score=195.58 Aligned_cols=188 Identities=27% Similarity=0.360 Sum_probs=103.9
Q ss_pred ccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecC
Q 042086 79 LSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYG 158 (784)
Q Consensus 79 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 158 (784)
+..+.+..+.+++.. .+..+++|++|++++|.++.. +.+..+++|++|+|++|++++..+ +..+++|++|+|++
T Consensus 26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 344455555555332 234566666666666666533 236666666666666666664333 66666666666666
Q ss_pred CCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccC
Q 042086 159 NSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP 238 (784)
Q Consensus 159 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 238 (784)
|.+++ ++ .+..+++|++|+|++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 66664 22 356666666666666666642 3455566666666666666543 345556666666666666654333
Q ss_pred CCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCcccc
Q 042086 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLY 283 (784)
Q Consensus 239 ~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~ 283 (784)
+..+++|+.|++++|+++ .++ .+..+++|+.|++++|+++
T Consensus 174 --l~~l~~L~~L~L~~N~i~--~l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHIS--DLR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp --GTTCTTCCEEECCSSCCC--BCG-GGTTCTTCSEEEEEEEEEE
T ss_pred --hcCCCccCEEECCCCcCC--CCh-hhccCCCCCEEECcCCccc
Confidence 445555555555555544 222 2444444444444444444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.3e-20 Score=209.65 Aligned_cols=205 Identities=23% Similarity=0.279 Sum_probs=164.7
Q ss_pred cccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceE
Q 042086 171 NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250 (784)
Q Consensus 171 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 250 (784)
.+..+..+.++.+.+.+..+ +..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..+ +..+++|+.|
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 45667778888888875443 56788999999999998754 3 58889999999999999987655 8889999999
Q ss_pred EecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccc
Q 042086 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF 330 (784)
Q Consensus 251 ~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l 330 (784)
+|++|+++ .++ .+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+
T Consensus 93 ~Ls~N~l~--~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l 165 (605)
T 1m9s_A 93 FLDENKIK--DLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 165 (605)
T ss_dssp ECCSSCCC--CCT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCC
T ss_pred ECcCCCCC--CCh-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcC
Confidence 99999887 344 688888999999999998853 4588889999999999998865 6788889999999999999
Q ss_pred cCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccc
Q 042086 331 RKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGL 392 (784)
Q Consensus 331 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 392 (784)
++..| +..+++|+.|+|++|++++. | .+..+++|+.|+|++|++.+.....+..+..+
T Consensus 166 ~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~ 223 (605)
T 1m9s_A 166 SDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPINHQSNLVVP 223 (605)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECCCCCCCSSCEEE
T ss_pred CCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCCcccccccEEec
Confidence 88655 88889999999999988853 3 68888899999999999887655555444333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-19 Score=178.19 Aligned_cols=133 Identities=22% Similarity=0.275 Sum_probs=72.4
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+++...+..|..+++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 34555555555555555555555555555555555555555555555555555555555555444444455555555555
Q ss_pred cCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeecccccc
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSL 209 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 209 (784)
++|.|++..|..|.++++|++|+|++|.+++..+..|..+++|+.|+|++|.+
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 55555555455555555555555555555544444455555555555555544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=179.66 Aligned_cols=156 Identities=23% Similarity=0.285 Sum_probs=135.3
Q ss_pred cceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecc
Q 042086 247 LIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLS 326 (784)
Q Consensus 247 L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls 326 (784)
.+.+++++++++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|+++...+..|..+++|++|+|+
T Consensus 21 ~~~v~c~~~~l~--~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 21 GTTVDCRSKRHA--SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp TTEEECTTSCCS--SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEeEccCCCcC--ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 345666666654 5554443 788999999999998888889999999999999999987666778899999999999
Q ss_pred cccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccC
Q 042086 327 NNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPI 406 (784)
Q Consensus 327 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 406 (784)
+|+|++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.|.+
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 99999877778899999999999999999 78889999999999999999999888888999999999999999999877
Q ss_pred C
Q 042086 407 P 407 (784)
Q Consensus 407 p 407 (784)
+
T Consensus 176 ~ 176 (229)
T 3e6j_A 176 R 176 (229)
T ss_dssp G
T ss_pred c
Confidence 6
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-21 Score=222.44 Aligned_cols=216 Identities=22% Similarity=0.168 Sum_probs=121.6
Q ss_pred CCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhccccccee
Q 042086 147 NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHL 226 (784)
Q Consensus 147 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 226 (784)
.+++|+.|+|++|.++ .+|..++++++|++|++++|......|.. +..+.+.+..|..++++++|+.|
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~L 414 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKAV 414 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHHH
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhcccC
Confidence 4555666666666665 45666666666666666544311011100 01111344556666666667666
Q ss_pred c-cCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCc
Q 042086 227 G-LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305 (784)
Q Consensus 227 ~-L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 305 (784)
+ ++.|.+. +|+.+.+++|.++ .++. ..|+.|+|++|.+++ +|. +..+++|+.|+|++|.
T Consensus 415 ~~l~~n~~~-----------~L~~l~l~~n~i~--~l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 415 DPMRAAYLD-----------DLRSKFLLENSVL--KMEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp CGGGHHHHH-----------HHHHHHHHHHHHH--HHHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred cchhhcccc-----------hhhhhhhhccccc--ccCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 6 5555432 2333444444443 1111 236666666666664 444 6666666666666666
Q ss_pred cCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccc-cccccccccccEEecCCCccCCCCcc
Q 042086 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKI-PCEICNMESLEKLNLSHNNFSGLIPS 384 (784)
Q Consensus 306 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~ 384 (784)
|+ .+|..++++++|+.|+|++|+|++ +| .++.+++|+.|+|++|++++.. |..++.+++|+.|+|++|++++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 66 556666666666666666666666 44 5666666666666666666554 66666666777777777766665442
Q ss_pred c---ccCcccceEEEc
Q 042086 385 C---FEGMHGLSCIDV 397 (784)
Q Consensus 385 ~---~~~l~~L~~l~l 397 (784)
. +..+++|+.||+
T Consensus 552 ~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 552 QERLAEMLPSVSSILT 567 (567)
T ss_dssp TTHHHHHCTTCSEEEC
T ss_pred HHHHHHHCcccCccCC
Confidence 2 223566666653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=195.16 Aligned_cols=174 Identities=27% Similarity=0.260 Sum_probs=127.1
Q ss_pred EEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCC-CCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCC
Q 042086 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIG-NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGN 159 (784)
Q Consensus 81 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (784)
.+++++++++. +|..+. ..++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45666676663 565543 4588899999999888888787 8889999999999888777778888888888888888
Q ss_pred CcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhh---hcccccceeccCCCccccc
Q 042086 160 SLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSIL---GNLKMLLHLGLSTNHLSGV 236 (784)
Q Consensus 160 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l---~~l~~L~~L~L~~n~l~~~ 236 (784)
+|+...+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|+...+..| ..+++|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 8887777778888888888888888887777788888888888888888876555555 4566777777777777644
Q ss_pred cCCCCcCCCC--cceEEecCCCC
Q 042086 237 IPLSIGNLNN--LIGLYLYDNQL 257 (784)
Q Consensus 237 ~~~~l~~l~~--L~~L~L~~n~l 257 (784)
.+..+..++. |+.|+|++|.+
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCE
T ss_pred CHHHhhhccHhhcceEEecCCCc
Confidence 4344444443 24444444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-21 Score=221.20 Aligned_cols=217 Identities=22% Similarity=0.142 Sum_probs=152.8
Q ss_pred CCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCce
Q 042086 122 GNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVV 201 (784)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 201 (784)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|......|. .+..+.+.+..|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 67899999999999998 8899999999999999977642111110 11122334456667777777777
Q ss_pred ee-ccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCc
Q 042086 202 LH-LFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN 280 (784)
Q Consensus 202 L~-L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n 280 (784)
|+ ++.|.+ .+|+.+.+++|.++...+. .|+.|+|++|+++ .+|. +..+++|+.|+|++|
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~--~lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLT--VLCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCS--SCCC-GGGGTTCCEEECCSS
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCC--CCcC-ccccccCcEeecCcc
Confidence 77 555543 3455566666666643322 3677777777776 4564 777777888888888
Q ss_pred cccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCC-chhhhcccccCeeccCCcccccccc
Q 042086 281 QLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF-PVELEKLIQLSELDLSLNILEGKIP 359 (784)
Q Consensus 281 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~ 359 (784)
+++ .+|..++.+++|+.|+|++|.|++ +| .++.+++|+.|+|++|+|++.. |..++.+++|+.|+|++|++++..|
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 777 667777788888888888888875 55 7777888888888888888765 7788888888888888888876544
Q ss_pred cc---ccccccccEEec
Q 042086 360 CE---ICNMESLEKLNL 373 (784)
Q Consensus 360 ~~---~~~l~~L~~L~L 373 (784)
.. +..+++|+.|++
T Consensus 551 ~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 551 IQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTHHHHHCTTCSEEEC
T ss_pred HHHHHHHHCcccCccCC
Confidence 22 234677887764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=177.48 Aligned_cols=131 Identities=21% Similarity=0.214 Sum_probs=59.6
Q ss_pred ccEEeCCCCcccccCC-CCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 79 LSTLDLSKNKLNGSIP-FSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 79 l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|+.+++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 3444444444444432 224444444444444444444444444444444444444444444444444444444444444
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeecccccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSL 209 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 209 (784)
+|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 4444444444444444444444444444444344444444444444444444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-19 Score=211.61 Aligned_cols=184 Identities=25% Similarity=0.261 Sum_probs=74.1
Q ss_pred CccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccc
Q 042086 188 SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIG 267 (784)
Q Consensus 188 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~ 267 (784)
..+..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|.. +.
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~-------------------------~~ 267 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAE-------------------------IK 267 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGG-------------------------GG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChh-------------------------hh
Confidence 34445555555555555555554 33333445555555555555555 44444 44
Q ss_pred cccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccc-cCe
Q 042086 268 KLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQ-LSE 346 (784)
Q Consensus 268 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~-L~~ 346 (784)
.+++|++|+|++|.|+ .+|..|..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|++.+|..+..+.. +..
T Consensus 268 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~ 345 (727)
T 4b8c_D 268 NLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLI 345 (727)
T ss_dssp GGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHH
T ss_pred CCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhH
Confidence 4445555555555554 34555555555555555555554 44444555555555555555555555554443321 223
Q ss_pred eccCCccccccccccccccccccEEecCCC--------ccCCCCcccccCcccceEEEcCCCCCcccC
Q 042086 347 LDLSLNILEGKIPCEICNMESLEKLNLSHN--------NFSGLIPSCFEGMHGLSCIDVSYNELRGPI 406 (784)
Q Consensus 347 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N--------~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 406 (784)
|+|++|.+++.+|.. |+.|++++| .+.+..+..+..+..+....+++|-+.+..
T Consensus 346 l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~ 407 (727)
T 4b8c_D 346 FYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHY 407 (727)
T ss_dssp HHHHHCCCCCCCCCC-----------------------------------------------CCCGGG
T ss_pred HhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeecccccccc
Confidence 556666666555532 344445544 444444555556666777777888766433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.8e-19 Score=182.40 Aligned_cols=80 Identities=31% Similarity=0.376 Sum_probs=37.0
Q ss_pred cccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeecc
Q 042086 270 SSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDL 349 (784)
Q Consensus 270 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L 349 (784)
++|+.|++++|++++. ..+..+++|+.|++++|++++. + .+..+++|+.|++++|++++. ..+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 4444444444444432 1344444555555555554432 1 344444555555555555443 33444444444455
Q ss_pred CCcccc
Q 042086 350 SLNILE 355 (784)
Q Consensus 350 s~N~l~ 355 (784)
++|.+.
T Consensus 180 ~~N~~~ 185 (263)
T 1xeu_A 180 TGQKCV 185 (263)
T ss_dssp EEEEEE
T ss_pred CCCccc
Confidence 444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-19 Score=182.00 Aligned_cols=169 Identities=26% Similarity=0.337 Sum_probs=84.4
Q ss_pred CCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceee
Q 042086 124 LKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLH 203 (784)
Q Consensus 124 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 203 (784)
+.++..+++++|.+++.. .+..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 344445555555555321 34455555555555555552 23 44555555555555555553322 44555555555
Q ss_pred ccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCcccc
Q 042086 204 LFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLY 283 (784)
Q Consensus 204 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~ 283 (784)
|++|++++. +. +.. ++|+.|+|++|+++ .++ .+..+++|+.|++++|+++
T Consensus 92 L~~N~l~~l-------------------------~~-~~~-~~L~~L~L~~N~l~--~~~-~l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 92 VNRNRLKNL-------------------------NG-IPS-ACLSRLFLDNNELR--DTD-SLIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp CCSSCCSCC-------------------------TT-CCC-SSCCEEECCSSCCS--BSG-GGTTCTTCCEEECTTSCCC
T ss_pred CCCCccCCc-------------------------Cc-ccc-CcccEEEccCCccC--CCh-hhcCcccccEEECCCCcCC
Confidence 555555432 11 111 44555555555444 222 3455555555555555555
Q ss_pred CCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccC
Q 042086 284 GNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRK 332 (784)
Q Consensus 284 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~ 332 (784)
+. + .+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++
T Consensus 142 ~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 142 SI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp BC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred CC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 32 2 455555566666666655543 445555666666666666554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=170.97 Aligned_cols=153 Identities=19% Similarity=0.260 Sum_probs=113.9
Q ss_pred CCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccce
Q 042086 98 GNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY 177 (784)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 177 (784)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.+. .+..+..+++|++|+|++|.+++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 55677777777777777 444 5777778888888888665 2346777888888888888888777777888888888
Q ss_pred eeccccccCCCccccccCccCCceeeccccc-cCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCC
Q 042086 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENS-LFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256 (784)
Q Consensus 178 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 256 (784)
|+|++|.+++..|..++.+++|++|+|++|. ++ .++ .+.++++|+.|++++|++++. + .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 8888888887677778888888888888887 54 444 577888888888888888753 3 67788888888888887
Q ss_pred CC
Q 042086 257 LS 258 (784)
Q Consensus 257 l~ 258 (784)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 65
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=167.82 Aligned_cols=153 Identities=17% Similarity=0.202 Sum_probs=102.6
Q ss_pred CCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCce
Q 042086 122 GNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVV 201 (784)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 201 (784)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|.+++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45667777777777776 444 56777777777777775542 235666777777777777777666667777777777
Q ss_pred eeccccccCCccchhhhcccccceeccCCCc-cccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCc
Q 042086 202 LHLFENSLFGSIPSILGNLKMLLHLGLSTNH-LSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGN 280 (784)
Q Consensus 202 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n 280 (784)
|+|++|++++..+..++.+++|++|++++|+ ++. ++ .+..+++|+.|++++|+++ .++ .+..+++|+.|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~--~~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVH--DYR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCC--CCT-TGGGCSSCCEEEECBC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCc--ChH-HhccCCCCCEEEeeCc
Confidence 7777777776666677777777777777776 543 33 4667777777777777766 333 5666777777777777
Q ss_pred ccc
Q 042086 281 QLY 283 (784)
Q Consensus 281 ~l~ 283 (784)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-18 Score=175.88 Aligned_cols=140 Identities=17% Similarity=0.174 Sum_probs=107.8
Q ss_pred CCCCceeEecccceEEEEEEE-cCCCE--EEEEEcCCCCCCCCC---------------------ChhhHHHHHHHHhcc
Q 042086 516 GFDVKYCIGIGGQGSVYKAKL-TSGEI--LAVKKFHSLWPCEMV---------------------PQPEFVNEIKTLTEL 571 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~~---------------------~~~~~~~E~~~l~~l 571 (784)
-|++.+.||+|+||.||+|.. .+|+. ||||+++.....-.. ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 68989 999987543211000 013688999999999
Q ss_pred CCCce--eeEEeEEecCCceEEEEecccC-C----CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEE
Q 042086 572 RHRSI--VKFYGFCSHPRNSFLVYEYLER-G----SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-HDCFPPIVH 643 (784)
Q Consensus 572 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH 643 (784)
.|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.|+.||| +. +|+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 88764 344432 357899999942 4 77776532 123456789999999999999 88 9999
Q ss_pred eCCCCCCeeecCCCceEEecccccccc
Q 042086 644 RDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 644 ~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=169.92 Aligned_cols=156 Identities=24% Similarity=0.332 Sum_probs=100.1
Q ss_pred ceEeccCccccCCCCccccCCCccceeecccCccCCCCcc-cccccccceEEecccccccCCCchhhhcccccCeeccCC
Q 042086 273 NYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE-TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSL 351 (784)
Q Consensus 273 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~-~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 351 (784)
+.|++++|.++ .+|..+.. +|++|++++|.+++..+. .+..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 55666666664 44544432 666777777777654443 366677777777777777776667777777777777777
Q ss_pred ccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCCC
Q 042086 352 NILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIK 431 (784)
Q Consensus 352 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~ 431 (784)
|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|.|.++..+.........+.++...|+.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 77776666667777777777777777777777777777777777777777777666432221111122334455566553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-19 Score=189.60 Aligned_cols=260 Identities=14% Similarity=0.085 Sum_probs=153.8
Q ss_pred CCCCCEEEccCCccC--CCCCcCccCCCcCcEEeecCCCcccccCCcccc--------ccccceeeccccccCCCccccc
Q 042086 124 LKFLYHLDLSENQLS--GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGN--------LKSLFYLHLSSNQLSGSIPISL 193 (784)
Q Consensus 124 l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~--------l~~L~~L~L~~n~l~~~~~~~~ 193 (784)
+++|+.|||++|++. ...+. .++.++.+.+..|.| .+.+|.+ +++|++|+|.+ .++...+..|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 555666666666555 11111 122234444444422 2244444 66666666666 5554445556
Q ss_pred cCccCCceeeccccccCCccchhhhcccccceeccCCCcc----ccccCCCCcCCCCcc-eEEecCCCCCCCCccccc--
Q 042086 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL----SGVIPLSIGNLNNLI-GLYLYDNQLSVGEIPIEI-- 266 (784)
Q Consensus 194 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l----~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~~l-- 266 (784)
.++++|+.|++++|.+..+.+.+|.++.++..+.+..+.. ......+|.++..|+ .+.+.... .++..+
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~----~l~~~~~~ 196 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG----KLEDEIMK 196 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC----CHHHHHHH
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC----cHHHHHhh
Confidence 6666666666666666655566666665565555544221 222334455555555 44443221 122111
Q ss_pred --ccccccceEeccCccccCCCCccc-cCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccc
Q 042086 267 --GKLSSLNYLVLNGNQLYGNLPRAL-GSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQ 343 (784)
Q Consensus 267 --~~l~~L~~L~l~~n~l~~~~~~~l-~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 343 (784)
....++..+.+.++-.. .....+ ..+++|+.|+|++|+++...+..|.++++|+.|+|++| ++.+.+.+|.++++
T Consensus 197 ~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~ 274 (329)
T 3sb4_A 197 AGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGR 274 (329)
T ss_dssp TTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred cccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChh
Confidence 12345555555544221 111111 13677888888888777666667788888888888877 77767777888888
Q ss_pred cC-eeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEc
Q 042086 344 LS-ELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDV 397 (784)
Q Consensus 344 L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 397 (784)
|+ .|++.+ .++...+.+|.++++|+.|++++|+++...+..|.++++|+.++.
T Consensus 275 L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 275 LAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 88 888887 666566678888888888888888888887788888888887753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=5.2e-17 Score=158.04 Aligned_cols=129 Identities=27% Similarity=0.331 Sum_probs=85.8
Q ss_pred EeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCC-CCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCC
Q 042086 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPP-VIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS 160 (784)
Q Consensus 82 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 160 (784)
|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|+.+++|++|+|++|++++..|..|..+++|++|+|++|+
T Consensus 13 l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 89 (192)
T 1w8a_A 13 VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence 444455553 34444432 667777777777655554 36677777777777777776666777777777777777777
Q ss_pred cccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCcc
Q 042086 161 LSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSI 213 (784)
Q Consensus 161 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 213 (784)
|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+.+..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 77666666777777777777777777666777777777777777777776543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2e-17 Score=160.90 Aligned_cols=132 Identities=25% Similarity=0.297 Sum_probs=112.0
Q ss_pred ceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCc
Q 042086 273 NYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352 (784)
Q Consensus 273 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 352 (784)
+.+++++|.++ .+|..+. ++|++|+|++|.++ .+|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 56777788777 4565443 57888888888887 66788888889999999999998887888889999999999999
Q ss_pred cccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 353 ILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 353 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|.+.-
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 99988888899999999999999999988888899999999999999999987764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.3e-17 Score=152.74 Aligned_cols=132 Identities=23% Similarity=0.186 Sum_probs=69.4
Q ss_pred CCCCEEEccCCccc-ccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceee
Q 042086 101 TNLAIMYLYRNSLS-ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH 179 (784)
Q Consensus 101 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 179 (784)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44444444444444 34444445555555555555555433 4455555555555555555544444444455555555
Q ss_pred ccccccCCCc-cccccCccCCceeeccccccCCccc---hhhhcccccceeccCCCccc
Q 042086 180 LSSNQLSGSI-PISLGNLSNLVVLHLFENSLFGSIP---SILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 180 L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~---~~l~~l~~L~~L~L~~n~l~ 234 (784)
|++|.+++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555555321 1455555566666666665554433 35556666666666666655
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=6.7e-17 Score=153.73 Aligned_cols=135 Identities=24% Similarity=0.239 Sum_probs=122.4
Q ss_pred CCCcccEEeCCCCccc-ccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcE
Q 042086 75 NLKSLSTLDLSKNKLN-GSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV 153 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 153 (784)
.+++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 4578999999999998 88899999999999999999999976 88999999999999999999888888888999999
Q ss_pred EeecCCCccccc-CCccccccccceeeccccccCCCcc---ccccCccCCceeeccccccCC
Q 042086 154 LHLYGNSLSGSI-PSIIGNLKSLFYLHLSSNQLSGSIP---ISLGNLSNLVVLHLFENSLFG 211 (784)
Q Consensus 154 L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~n~l~~ 211 (784)
|+|++|.+++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+..
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 999999999643 2788999999999999999996555 488999999999999999863
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-16 Score=151.58 Aligned_cols=113 Identities=26% Similarity=0.239 Sum_probs=59.5
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeec
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 180 (784)
++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 34455555555554444444455555555555555555444444455555555555555555444444555555555555
Q ss_pred cccccCCCccccccCccCCceeeccccccCCcc
Q 042086 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSI 213 (784)
Q Consensus 181 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 213 (784)
++|.+++..+..+..+++|++|+|++|.+.+..
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 555555444444455556666666666555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=170.24 Aligned_cols=259 Identities=14% Similarity=0.102 Sum_probs=149.7
Q ss_pred CCCcccEEeCCCCccc--ccCCCCcCCCCCCCEEEccCCcccccCCCCCCC--------CCCCCEEEccCCccCCCCCcC
Q 042086 75 NLKSLSTLDLSKNKLN--GSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGN--------LKFLYHLDLSENQLSGSIPPT 144 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~--------l~~L~~L~L~~n~l~~~~p~~ 144 (784)
.+++|++|||++|+|. ...+..+ +.+..+.+..|.| .+.+|.+ |++|++|+|.+ .++...+.+
T Consensus 47 ~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~a 119 (329)
T 3sb4_A 47 EFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAA 119 (329)
T ss_dssp SCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTT
T ss_pred hhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHH
Confidence 3788999999999998 3333223 2245566666643 2356666 88888888888 777666778
Q ss_pred ccCCCcCcEEeecCCCcccccCCccccccccceeecccccc----CCCccccccCccCCc-eeeccccccCCccchhhh-
Q 042086 145 LGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL----SGSIPISLGNLSNLV-VLHLFENSLFGSIPSILG- 218 (784)
Q Consensus 145 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l----~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~l~- 218 (784)
|.++++|+.|+++.|.+....+.+|.++.++..+.+..+.. .......|.++.+|+ .+.+.... .++..+.
T Consensus 120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~ 196 (329)
T 3sb4_A 120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMK 196 (329)
T ss_dssp TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHH
T ss_pred hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhh
Confidence 88888888888888888877778888887777777766332 222233455555555 33332211 1111111
Q ss_pred ---cccccceeccCCCccccccCCCC-cCCCCcceEEecCCCCCCCCccc-ccccccccceEeccCccccCCCCccccCC
Q 042086 219 ---NLKMLLHLGLSTNHLSGVIPLSI-GNLNNLIGLYLYDNQLSVGEIPI-EIGKLSSLNYLVLNGNQLYGNLPRALGSL 293 (784)
Q Consensus 219 ---~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l 293 (784)
...+++.+.+.++-.. .....+ ..+++|+.|+|++|+++ .++. .|..+++|+.|++.+| ++...+.+|.++
T Consensus 197 ~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~--~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~ 272 (329)
T 3sb4_A 197 AGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNAT--TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNC 272 (329)
T ss_dssp TTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCC--EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred cccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcc--eecHhhhhCCCCCCEEECCcc-cceehHHHhhCC
Confidence 1233333433332111 100111 12445555555555544 3322 3555555666666555 444455566666
Q ss_pred Cccc-eeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeec
Q 042086 294 TELE-YLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELD 348 (784)
Q Consensus 294 ~~L~-~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 348 (784)
++|+ .+++.+ .++...+..|.++++|+.|++++|.++.+.+.+|.++++|+.|+
T Consensus 273 ~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 273 GRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred hhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 6666 666665 55545556666666666666666666666666666666666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=7.1e-17 Score=150.18 Aligned_cols=128 Identities=23% Similarity=0.262 Sum_probs=65.9
Q ss_pred CcccEEeCCCCccc-ccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEe
Q 042086 77 KSLSTLDLSKNKLN-GSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLH 155 (784)
Q Consensus 77 ~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 155 (784)
++|++|++++|+++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45556666666655 45555555555555555555555543 4455555555555555555544444444444555555
Q ss_pred ecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccc---hhhhcccccceeccC
Q 042086 156 LYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP---SILGNLKMLLHLGLS 229 (784)
Q Consensus 156 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~---~~l~~l~~L~~L~L~ 229 (784)
+++|.+++.. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~-----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLS-----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHH-----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChH-----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5555444321 22444555555555555555544433 345555666666554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=148.83 Aligned_cols=129 Identities=22% Similarity=0.204 Sum_probs=104.5
Q ss_pred CCCCCEEEccCCccC-CCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCcee
Q 042086 124 LKFLYHLDLSENQLS-GSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVL 202 (784)
Q Consensus 124 l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 202 (784)
.++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+.++++|++|+|++|.+++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356777777777776 56677777777777777777777754 667788888888888888887678777788999999
Q ss_pred eccccccCCc-cchhhhcccccceeccCCCccccccC---CCCcCCCCcceEEecC
Q 042086 203 HLFENSLFGS-IPSILGNLKMLLHLGLSTNHLSGVIP---LSIGNLNNLIGLYLYD 254 (784)
Q Consensus 203 ~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~---~~l~~l~~L~~L~L~~ 254 (784)
++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999864 34789999999999999999997665 5788999999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.4e-15 Score=163.30 Aligned_cols=240 Identities=13% Similarity=0.055 Sum_probs=123.2
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeec
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 180 (784)
..++.+.+.+ .++.+-..+|.++ +|+.++|.++ ++.....+|.+ .+|+.+.|.. .++...+.+|.++++|+.++|
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4555555544 3444445556554 5666666554 44444455555 3566666664 455455566666666666666
Q ss_pred cccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCC
Q 042086 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVG 260 (784)
Q Consensus 181 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 260 (784)
++|.++......|. +.+|+.+.|..+ +..+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+..+ ++
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~~-i~-- 260 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPNG-VT-- 260 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEETT-CC--
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCCC-cc--
Confidence 66666643333444 466666666633 55555666677777777777654 44445555655 56666666322 22
Q ss_pred Cc-ccccccccccceEeccCcccc-----CCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCC
Q 042086 261 EI-PIEIGKLSSLNYLVLNGNQLY-----GNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGF 334 (784)
Q Consensus 261 ~~-~~~l~~l~~L~~L~l~~n~l~-----~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~ 334 (784)
.+ ...|..+++|+.+.+.+|.+. ...+.+|..+++|+.++|. +.++......|.++++|+.+.|..| ++.+.
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 22 223445555555555554443 2333445555555555554 2244333344444444444444332 33333
Q ss_pred chhhhcccccCeeccCCcccc
Q 042086 335 PVELEKLIQLSELDLSLNILE 355 (784)
Q Consensus 335 ~~~~~~l~~L~~L~Ls~N~l~ 355 (784)
..+|.++ +|+.|++++|.+.
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSCC
T ss_pred HHhCCCC-CCCEEEEcCCCCc
Confidence 3334443 4444444444333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.4e-16 Score=148.27 Aligned_cols=135 Identities=24% Similarity=0.245 Sum_probs=103.0
Q ss_pred ccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccC
Q 042086 271 SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS 350 (784)
Q Consensus 271 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls 350 (784)
+.+.+++++|.++ .+|..+ .++|+.|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+.|+|+
T Consensus 8 ~~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 3456677777766 344333 2577788888888776666667777888888888888877666667888888888888
Q ss_pred CccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCCC
Q 042086 351 LNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 351 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
+|++++..+..+..+++|+.|+|++|++++..+..+..+++|++|++++|++.|.+|.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 8888866666678888888888888888877777778888889999999988887763
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5e-15 Score=160.80 Aligned_cols=264 Identities=15% Similarity=0.065 Sum_probs=192.1
Q ss_pred CCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCcee
Q 042086 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVL 202 (784)
Q Consensus 123 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 202 (784)
.+..++.+.+.+ .++.....+|.+. +|+.+.|..+ ++.+...+|.+. +|+.+.+.+ .++...+..|.++++|+.+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence 346777888765 4554556677774 7888888776 666667778774 688888886 6665666788888999999
Q ss_pred eccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCccc-ccccccccceEeccCcc
Q 042086 203 HLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPI-EIGKLSSLNYLVLNGNQ 281 (784)
Q Consensus 203 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~-~l~~l~~L~~L~l~~n~ 281 (784)
+|.+|+++.+....|. ..+|+.+.|.++ ++.+...+|.++++|+.+.+..| ++ .++. .|.+ .+|+.+.+. +.
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~--~I~~~aF~~-~~L~~i~lp-~~ 258 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS--TIGQEAFRE-SGITTVKLP-NG 258 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC--EECTTTTTT-CCCSEEEEE-TT
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc--Ccccccccc-CCccEEEeC-CC
Confidence 9988888877777777 578888888754 76677778888888888888775 32 3333 3444 688888884 45
Q ss_pred ccCCCCccccCCCccceeecccCccC-----CCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccc
Q 042086 282 LYGNLPRALGSLTELEYLDLSTNKLG-----NSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356 (784)
Q Consensus 282 l~~~~~~~l~~l~~L~~L~Ls~n~l~-----~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 356 (784)
++.....+|..+++|+.+++.+|.+. ...+..|.++++|+.++|. +.++.+...+|.++++|+.++|..| ++.
T Consensus 259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~ 336 (401)
T 4fdw_A 259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQ 336 (401)
T ss_dssp CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCE
T ss_pred ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccE
Confidence 66566778888888888888887765 3445667788888888887 4477666777888888888888554 665
Q ss_pred cccccccccccccEEecCCCccCCCCcccccCcc-cceEEEcCCCC
Q 042086 357 KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMH-GLSCIDVSYNE 401 (784)
Q Consensus 357 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~l~~N~ 401 (784)
..+.+|.++ +|+.|++++|.+....+..|..++ .++.|++..|.
T Consensus 337 I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 337 INFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp ECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred EcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 556677777 788888888877776667676663 56667666554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-15 Score=147.98 Aligned_cols=127 Identities=28% Similarity=0.362 Sum_probs=83.6
Q ss_pred cEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCC
Q 042086 80 STLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGN 159 (784)
Q Consensus 80 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (784)
+.+++++|+++ .+|..+. ++|++|+|++|.|+ .+|..|..+++|++|+|++|.|++..+..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46778887777 3454432 46777777777776 55566667777777777777777666666666777777777777
Q ss_pred CcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccC
Q 042086 160 SLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLF 210 (784)
Q Consensus 160 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 210 (784)
+|++..+..|.++++|++|+|++|.++...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 766666666666666666666666666544445666666666666666654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=169.50 Aligned_cols=144 Identities=10% Similarity=0.107 Sum_probs=101.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCC--CC---------CChhh--------HHHHHHHHhccCC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPC--EM---------VPQPE--------FVNEIKTLTELRH 573 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~---------~~~~~--------~~~E~~~l~~l~h 573 (784)
...-|++.+.||+|++|.||+|...+|+.||||+++..... .. ..... ..+|...+.++.+
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 33458999999999999999999999999999987643111 00 00111 1245555555544
Q ss_pred CceeeEEeEEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeee
Q 042086 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLL 653 (784)
Q Consensus 574 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 653 (784)
.++....-+.. ...++||||+++++|.++... .....++.|++.++.|||+. |||||||||.|||+
T Consensus 173 ~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl 238 (397)
T 4gyi_A 173 EGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILI 238 (397)
T ss_dssp TTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred cCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence 43322111111 234799999999888664321 12346789999999999998 99999999999999
Q ss_pred cCCC----------ceEEecccccccc
Q 042086 654 CLDY----------EARVSDFGIAKFL 670 (784)
Q Consensus 654 ~~~~----------~~kl~DfG~a~~~ 670 (784)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8876 3899999987653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-13 Score=150.57 Aligned_cols=311 Identities=12% Similarity=0.033 Sum_probs=214.9
Q ss_pred ccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcC
Q 042086 72 LKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNL 151 (784)
Q Consensus 72 ~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 151 (784)
.+.++.+|+.+.|.. +++.....+|.++++|+.++|.++ ++.+-..+|.++++|+.+.+..+ +......+|.+...+
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~ 142 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK 142 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence 445677788888864 477666778888888888888754 55555677888888888777654 333445566665544
Q ss_pred cEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCC
Q 042086 152 AVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTN 231 (784)
Q Consensus 152 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 231 (784)
........ ......+|.++++|+.+.+.++... .....|.++.+|+.+.+..+ +..+....|.++..|+.+.+.++
T Consensus 143 ~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 143 EITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp EEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTT
T ss_pred ccccCccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCC
Confidence 43333322 2234567888888888888765433 45567888888888888766 55566677888888888887766
Q ss_pred ccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCc
Q 042086 232 HLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311 (784)
Q Consensus 232 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~ 311 (784)
... +...+....+|+.+.+..+.-. --...+..+..|+.+.+..+... .....|..+..++.+....+.+. .
T Consensus 219 ~~~--i~~~~~~~~~l~~i~ip~~~~~--i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~ 290 (394)
T 4fs7_A 219 LYY--LGDFALSKTGVKNIIIPDSFTE--LGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---E 290 (394)
T ss_dssp CCE--ECTTTTTTCCCCEEEECTTCCE--ECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---T
T ss_pred ceE--eehhhcccCCCceEEECCCcee--cccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---c
Confidence 543 2333444567888877654321 11234667788888888776554 55667888888888877766543 2
Q ss_pred ccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCccc
Q 042086 312 ETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHG 391 (784)
Q Consensus 312 ~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 391 (784)
..|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|..+ ++..-..+|.++.+|+.+++..| ++.....+|.++.+
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 367 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN 367 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence 45777788888888765 66666778888888999888754 66555678888889999988776 66666788888888
Q ss_pred ceEEEcCCC
Q 042086 392 LSCIDVSYN 400 (784)
Q Consensus 392 L~~l~l~~N 400 (784)
|+.+++..+
T Consensus 368 L~~i~lp~~ 376 (394)
T 4fs7_A 368 LKKVELPKR 376 (394)
T ss_dssp CCEEEEEGG
T ss_pred CCEEEECCC
Confidence 888888644
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=2.7e-15 Score=143.70 Aligned_cols=132 Identities=18% Similarity=0.203 Sum_probs=77.6
Q ss_pred cCCCCCCCEEEccCCcccccCCCCCCCCC-CCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCcccccccc
Q 042086 97 FGNLTNLAIMYLYRNSLSASIPPVIGNLK-FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSL 175 (784)
Q Consensus 97 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 175 (784)
+.++.+|++|+|++|+++. +|. +..+. +|++|+|++|.+++. ..+..+++|++|+|++|.+++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4455556666666666553 233 33333 666666666666643 456666666666666666664433444666666
Q ss_pred ceeeccccccCCCccc--cccCccCCceeeccccccCCccch----hhhcccccceeccCCCccc
Q 042086 176 FYLHLSSNQLSGSIPI--SLGNLSNLVVLHLFENSLFGSIPS----ILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 176 ~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~----~l~~l~~L~~L~L~~n~l~ 234 (784)
++|+|++|.++ .+|. .+..+++|+.|++++|.++.. |. .+..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 66666666665 3443 566666666666666666533 33 3666677777777766654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3.1e-17 Score=160.65 Aligned_cols=132 Identities=28% Similarity=0.314 Sum_probs=66.9
Q ss_pred CCCCEEEccCCcccccCCC------CCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccc
Q 042086 101 TNLAIMYLYRNSLSASIPP------VIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKS 174 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~------~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 174 (784)
..++.++++.+.+++.+|. .++.+++|++|+|++|.+++ +| .+..+++|++|+|++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3344444444444444433 45555555555555555553 33 5555555555555555555 34444445555
Q ss_pred cceeeccccccCCCccccccCccCCceeeccccccCCccc-hhhhcccccceeccCCCcccccc
Q 042086 175 LFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLSGVI 237 (784)
Q Consensus 175 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~ 237 (784)
|++|+|++|++++ +| .+..+++|++|++++|+++...+ ..+..+++|++|++++|++++..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 5555555555553 23 34555555555555555543222 34555555555555555555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-16 Score=156.35 Aligned_cols=161 Identities=21% Similarity=0.246 Sum_probs=90.0
Q ss_pred hhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCcc
Q 042086 217 LGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTEL 296 (784)
Q Consensus 217 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 296 (784)
+.....++.++++.+.+++..|. + ..+|..+..+++|++|++++|.+++ +| .+..+++|
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l--~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L 72 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPP-----------------I--EKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENL 72 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTT-----------------C--CCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTC
T ss_pred HHhcccccCcchheeEeccccCc-----------------H--hhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCC
Confidence 44555666777777777665443 0 1233345555555555555555553 34 55555566
Q ss_pred ceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccc-ccccccccccEEecCC
Q 042086 297 EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP-CEICNMESLEKLNLSH 375 (784)
Q Consensus 297 ~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~ 375 (784)
++|++++|.++ .+|..+..+++|++|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 73 ~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~ 149 (198)
T 1ds9_A 73 RILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149 (198)
T ss_dssp CEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECS
T ss_pred CEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecC
Confidence 66666666555 345555555566666666666655 23 45566666666666666653222 3455666666666666
Q ss_pred CccCCCCccc----------ccCcccceEEEcCCCCCc
Q 042086 376 NNFSGLIPSC----------FEGMHGLSCIDVSYNELR 403 (784)
Q Consensus 376 N~l~~~~p~~----------~~~l~~L~~l~l~~N~l~ 403 (784)
|++++.+|.. +..+++|+.|| +|+++
T Consensus 150 N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 150 NPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp CHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 6665554442 55566666665 44443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=5.7e-15 Score=141.43 Aligned_cols=131 Identities=21% Similarity=0.166 Sum_probs=113.3
Q ss_pred CCCCcccEEeCCCCcccccCCCCcCCCC-CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCc
Q 042086 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLT-NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLA 152 (784)
Q Consensus 74 ~~l~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 152 (784)
.++.+|++|+|++|+|+.. |. +..+. +|++|+|++|.|++. +.|+.+++|++|+|++|++++..+..+..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 3567899999999999954 54 55554 999999999999976 7899999999999999999966555569999999
Q ss_pred EEeecCCCcccccCC--ccccccccceeeccccccCCCcccc----ccCccCCceeeccccccC
Q 042086 153 VLHLYGNSLSGSIPS--IIGNLKSLFYLHLSSNQLSGSIPIS----LGNLSNLVVLHLFENSLF 210 (784)
Q Consensus 153 ~L~L~~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~n~l~ 210 (784)
+|+|++|.++ .+|. .+..+++|++|++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999997 4565 7899999999999999998 55664 889999999999999875
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=4.3e-14 Score=134.30 Aligned_cols=108 Identities=25% Similarity=0.294 Sum_probs=67.4
Q ss_pred ceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCC
Q 042086 297 EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHN 376 (784)
Q Consensus 297 ~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 376 (784)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 44555555554 2343332 45556666666666555555666666666666666666555555666677777777777
Q ss_pred ccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 377 NFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 377 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
+|++..+..|..+++|+.|+|++|+|.|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 7776666667777777777777777776655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=2.7e-13 Score=128.78 Aligned_cols=103 Identities=32% Similarity=0.412 Sum_probs=63.6
Q ss_pred EEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCC
Q 042086 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS 160 (784)
Q Consensus 81 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 160 (784)
+|++++|+++. +|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45566666663 444442 566666666666666666666666666666666666665555555666666666666666
Q ss_pred cccccCCccccccccceeeccccccC
Q 042086 161 LSGSIPSIIGNLKSLFYLHLSSNQLS 186 (784)
Q Consensus 161 l~~~~~~~l~~l~~L~~L~L~~n~l~ 186 (784)
|++..+..|.++++|++|+|++|.+.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 66554555666666666666666655
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-12 Score=139.93 Aligned_cols=316 Identities=11% Similarity=0.040 Sum_probs=234.3
Q ss_pred CeEEEEeCCC------cccCCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccC
Q 042086 61 RVISINLSTV------GLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134 (784)
Q Consensus 61 ~v~~l~l~~~------~~~~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 134 (784)
.++.++++.. ..+.++++|+.++|..+ ++.....+|.++.+|+.+.+..+ +......+|.++..+.......
T Consensus 72 ~L~~i~lp~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~ 149 (394)
T 4fs7_A 72 KVTEIKIPSTVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEG 149 (394)
T ss_dssp TEEEEECCTTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTT
T ss_pred CceEEEeCCCccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCcc
Confidence 4666666532 23457889999999865 66677788999999999888765 5556667888886555444433
Q ss_pred CccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccc
Q 042086 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP 214 (784)
Q Consensus 135 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 214 (784)
... ....+|.++++|+.+.+..+. ......+|.++.+|+.+++..| ++......|.++..|+.+.+..+... +.
T Consensus 150 ~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~ 223 (394)
T 4fs7_A 150 VTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LG 223 (394)
T ss_dssp CCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--EC
T ss_pred ccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--ee
Confidence 322 345688999999999998764 4366678999999999999877 55455677889999999988776542 23
Q ss_pred hhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCC
Q 042086 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT 294 (784)
Q Consensus 215 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 294 (784)
.......+|+.+.+..+ ++......|.++.+|+.+.+..+... -....+..+..++.+....+.+. ...|..+.
T Consensus 224 ~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~--i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~ 297 (394)
T 4fs7_A 224 DFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR--IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCS 297 (394)
T ss_dssp TTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE--ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCT
T ss_pred hhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce--eeccccccccccceeccCceeec---cccccccc
Confidence 34445578888888654 34456678889999999999887654 22345778888888888776543 35788889
Q ss_pred ccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecC
Q 042086 295 ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374 (784)
Q Consensus 295 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 374 (784)
+|+.+.+..+ ++......|.++.+|+.++|.++ ++.+...+|.++.+|+.++|..| ++.....+|.++.+|+.+++.
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 9999999765 66566678889999999999754 77767788999999999999877 775667789999999999997
Q ss_pred CCccCCCCcccccCcccceEE
Q 042086 375 HNNFSGLIPSCFEGMHGLSCI 395 (784)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~l 395 (784)
.+ +. .+...|.+.++|+.+
T Consensus 375 ~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 375 KR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp GG-GG-GGGGGBCTTCEEEEE
T ss_pred CC-CE-EhhheecCCCCCcEE
Confidence 65 22 234567777777764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.4e-13 Score=131.27 Aligned_cols=107 Identities=21% Similarity=0.285 Sum_probs=57.3
Q ss_pred eeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCc
Q 042086 298 YLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNN 377 (784)
Q Consensus 298 ~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 377 (784)
.+++++|.++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4444444443 3333332 345555555555555445555555555555555555554333344556666666666666
Q ss_pred cCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 378 FSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 378 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
|++..+..|..+++|++|+|++|+|.+.++
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred cceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 665555556666666666666666665443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=5.6e-13 Score=126.98 Aligned_cols=104 Identities=25% Similarity=0.313 Sum_probs=67.3
Q ss_pred cEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCC
Q 042086 80 STLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGN 159 (784)
Q Consensus 80 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (784)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 35677777775 4555443 66777777777777666666777777777777777776554455566666666666666
Q ss_pred CcccccCCccccccccceeeccccccC
Q 042086 160 SLSGSIPSIIGNLKSLFYLHLSSNQLS 186 (784)
Q Consensus 160 ~l~~~~~~~l~~l~~L~~L~L~~n~l~ 186 (784)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666544445666666666666666655
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-11 Score=134.02 Aligned_cols=297 Identities=10% Similarity=0.049 Sum_probs=152.1
Q ss_pred cCCCCcCCCC-CCCEEEccCCcccccCCCCCCCCCCCCEEEccCCc---cCCCCCcCccCCCcCcEEeecCCCcccccCC
Q 042086 92 SIPFSFGNLT-NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ---LSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS 167 (784)
Q Consensus 92 ~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~ 167 (784)
+...+|.++. .|+.+.+..+ ++.+-..+|.+|++|+.+.++.|. ++.....+|..+.+|+.+.+..+ ++.....
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 3444555553 4666666543 554555566666666666665543 44334455666666666655544 3334445
Q ss_pred ccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCc
Q 042086 168 IIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247 (784)
Q Consensus 168 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 247 (784)
+|.++.+|+.+.+..+- .......|..+.+|+.+.+..+ +..+...+|.+ .+|+.+.+..+-.. ....+|.++.++
T Consensus 132 aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l 207 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFAL 207 (394)
T ss_dssp TTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTC
T ss_pred hhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccc
Confidence 56666666666665432 2233445566666666666543 33333444443 45666665543322 444555566666
Q ss_pred ceEEecCCCCCCCCcccc--------------cccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccc
Q 042086 248 IGLYLYDNQLSVGEIPIE--------------IGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPET 313 (784)
Q Consensus 248 ~~L~L~~n~l~~~~~~~~--------------l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 313 (784)
+......+.... +... +.....+..+.+.+ .++.....+|..+.+|+.+.+..+..+ .....
T Consensus 208 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~a 283 (394)
T 4gt6_A 208 STITSDSESYPA--IDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGA 283 (394)
T ss_dssp CEEEECCSSSCB--SSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTT
T ss_pred ceeccccccccc--ccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcc
Confidence 655554433221 0000 01111222233221 222233445666666666666544332 33445
Q ss_pred ccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccce
Q 042086 314 LGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLS 393 (784)
Q Consensus 314 l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 393 (784)
|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.....+|.++.+|+.+.|..+ ++.....+|.++.+|+
T Consensus 284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~ 360 (394)
T 4gt6_A 284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALN 360 (394)
T ss_dssp TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCC
T ss_pred cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCC
Confidence 5566666666664 3444444555666666666666543 44334455666666666666433 5545555666666666
Q ss_pred EEEcCCCC
Q 042086 394 CIDVSYNE 401 (784)
Q Consensus 394 ~l~l~~N~ 401 (784)
.+++.+|.
T Consensus 361 ~i~~~~~~ 368 (394)
T 4gt6_A 361 NIEYSGSR 368 (394)
T ss_dssp EEEESSCH
T ss_pred EEEECCce
Confidence 66666553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.4e-15 Score=157.87 Aligned_cols=166 Identities=20% Similarity=0.175 Sum_probs=84.1
Q ss_pred cCCceeeccccccCCccchhhhcc-----cccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccc
Q 042086 197 SNLVVLHLFENSLFGSIPSILGNL-----KMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS 271 (784)
Q Consensus 197 ~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~ 271 (784)
+.|+.|+|++|.++......+... ++|+.|+|++|.++......+ ...+++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l------------------------~~~L~~ 127 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL------------------------LPVFLR 127 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHT------------------------HHHHHT
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHH------------------------HHHHHh
Confidence 456666666666654433333332 355555555555543222111 223344
Q ss_pred cceEeccCccccCCCCccc-----cCCCccceeecccCccCCC----CcccccccccceEEecccccccCC----Cchhh
Q 042086 272 LNYLVLNGNQLYGNLPRAL-----GSLTELEYLDLSTNKLGNS----IPETLGNLLKLHYLNLSNNQFRKG----FPVEL 338 (784)
Q Consensus 272 L~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~Ls~n~l~~~----~~~~l~~l~~L~~L~ls~N~l~~~----~~~~~ 338 (784)
|+.|+|++|.++......+ ...++|++|+|++|.++.. ++..+..+++|++|+|++|.|+.. ++..+
T Consensus 128 L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L 207 (372)
T 3un9_A 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL 207 (372)
T ss_dssp EEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHG
T ss_pred ccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHH
Confidence 5555555555543222222 1235566666666665532 222334556666666666666542 23444
Q ss_pred hcccccCeeccCCcccccc----ccccccccccccEEecCCCccCCCCcccc
Q 042086 339 EKLIQLSELDLSLNILEGK----IPCEICNMESLEKLNLSHNNFSGLIPSCF 386 (784)
Q Consensus 339 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 386 (784)
...++|+.|+|++|.|++. ++..+...++|+.|+|++|.|+......+
T Consensus 208 ~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 208 DRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp GGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 5556666666666666543 22333345667777777777665444433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-12 Score=138.65 Aligned_cols=96 Identities=23% Similarity=0.197 Sum_probs=67.1
Q ss_pred cccccCCCCcCCCCCCCEEEccC-CcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccC
Q 042086 88 KLNGSIPFSFGNLTNLAIMYLYR-NSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIP 166 (784)
Q Consensus 88 ~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~ 166 (784)
+|+. +|. |..+++|++|+|++ |.|++..+..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+
T Consensus 20 ~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 97 (347)
T 2ifg_A 20 ALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSW 97 (347)
T ss_dssp CCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCS
T ss_pred CCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCH
Confidence 4442 566 77777777777775 77777666777777777777777777777777777777777777777777775555
Q ss_pred CccccccccceeeccccccC
Q 042086 167 SIIGNLKSLFYLHLSSNQLS 186 (784)
Q Consensus 167 ~~l~~l~~L~~L~L~~n~l~ 186 (784)
..|..++ |+.|+|.+|.+.
T Consensus 98 ~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 98 KTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TTTCSCC-CCEEECCSSCCC
T ss_pred HHcccCC-ceEEEeeCCCcc
Confidence 5555554 777777777665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.4e-11 Score=130.13 Aligned_cols=311 Identities=9% Similarity=0.067 Sum_probs=210.3
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCc---ccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcE
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNS---LSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV 153 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 153 (784)
..|+.+.|-.+ ++.....+|.++++|+.+.+..|. ++.+-..+|..+.+|+.+.+..+ ++.....+|..+.+|+.
T Consensus 64 ~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~ 141 (394)
T 4gt6_A 64 YVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDT 141 (394)
T ss_dssp SCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCE
T ss_pred CcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccc
Confidence 35888888754 777788899999999999998874 66666788999999999988765 45456678899999999
Q ss_pred EeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcc
Q 042086 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHL 233 (784)
Q Consensus 154 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 233 (784)
+.+..+ +......+|.++.+|+.+.+..+ ++......|. ..+|+.+.+..+- .......|.++.+|+......+..
T Consensus 142 i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~-~~i~~~af~~c~~l~~~~~~~~~~ 217 (394)
T 4gt6_A 142 VTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKV-TRIGTNAFSECFALSTITSDSESY 217 (394)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTC-CEECTTTTTTCTTCCEEEECCSSS
T ss_pred ccccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcc-cccccchhhhccccceeccccccc
Confidence 999765 44466778899999999999866 4423344554 4678888886543 335566788888887776655544
Q ss_pred ccccCCCC-------------cCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceee
Q 042086 234 SGVIPLSI-------------GNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300 (784)
Q Consensus 234 ~~~~~~~l-------------~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 300 (784)
.......+ .....+..+.+..+ ++ .--...|..+..|+.+.+.++... ....+|.++++|+.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~-v~-~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~ 294 (394)
T 4gt6_A 218 PAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNG-VA-RIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIE 294 (394)
T ss_dssp CBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTT-EE-EECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEE
T ss_pred ccccceeecccccccccccccccccccceEEcCCc-ce-EcccceeeecccccEEecccccce-ecCccccccccccccc
Confidence 31111111 11122333333221 11 011225677788888888766543 5567788888888888
Q ss_pred cccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCC
Q 042086 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380 (784)
Q Consensus 301 Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 380 (784)
+. +.++......|.++.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ ++..-..+|.++++|+.+++.+|....
T Consensus 295 l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~ 371 (394)
T 4gt6_A 295 FS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW 371 (394)
T ss_dssp CC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH
T ss_pred CC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh
Confidence 86 4555455667888888999988764 66666778888889999988655 664556788888999999998886542
Q ss_pred CCcccccCcccceEEEcCCCCC
Q 042086 381 LIPSCFEGMHGLSCIDVSYNEL 402 (784)
Q Consensus 381 ~~p~~~~~l~~L~~l~l~~N~l 402 (784)
..+....+|+.+.+..|.+
T Consensus 372 ---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 372 ---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp ---HTCBCCCCC----------
T ss_pred ---hhhhccCCCCEEEeCCCCE
Confidence 4566677788887766543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.2e-14 Score=154.12 Aligned_cols=187 Identities=17% Similarity=0.071 Sum_probs=82.3
Q ss_pred cccceeeccccccCCCccccccC-----ccCCceeeccccccCCccchhh-hcccccceeccCCCccccccCCCC-----
Q 042086 173 KSLFYLHLSSNQLSGSIPISLGN-----LSNLVVLHLFENSLFGSIPSIL-GNLKMLLHLGLSTNHLSGVIPLSI----- 241 (784)
Q Consensus 173 ~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~~~l----- 241 (784)
++|++|+|++|.++......+.. .++|++|+|++|.++......+ ..+++|+.|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 34555555555555332222221 2466666666666643322222 335566677777776654332222
Q ss_pred cCCCCcceEEecCCCCCCC---CcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccc
Q 042086 242 GNLNNLIGLYLYDNQLSVG---EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLL 318 (784)
Q Consensus 242 ~~l~~L~~L~L~~n~l~~~---~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~ 318 (784)
...++|++|+|++|.++.. .++..+..+++|++|+|++|.+++.... .++..+...+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------~L~~~L~~~~ 211 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------LLAAQLDRNR 211 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------HHHHHGGGCS
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------HHHHHHhcCC
Confidence 1234445555555544311 1112223334444444444444321100 1122334444
Q ss_pred cceEEecccccccCC----CchhhhcccccCeeccCCccccccccccccccc-----cccEEe--cCCCccC
Q 042086 319 KLHYLNLSNNQFRKG----FPVELEKLIQLSELDLSLNILEGKIPCEICNME-----SLEKLN--LSHNNFS 379 (784)
Q Consensus 319 ~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~L~--L~~N~l~ 379 (784)
+|++|+|++|.|+.. ++..+...++|+.|||++|.|++.....+..+. .|+.+. +..|.+.
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 555555555555432 223334455666666666666554444443321 155565 5555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=9.2e-12 Score=133.10 Aligned_cols=106 Identities=25% Similarity=0.165 Sum_probs=92.7
Q ss_pred CEEEccCC-cccccCCCCCCCCCCCCEEEccC-CccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeecc
Q 042086 104 AIMYLYRN-SLSASIPPVIGNLKFLYHLDLSE-NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181 (784)
Q Consensus 104 ~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 181 (784)
..++++++ +++ .+|. |..+++|++|+|++ |.|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35688887 888 4788 99999999999996 99998888899999999999999999999888999999999999999
Q ss_pred ccccCCCccccccCccCCceeeccccccCCc
Q 042086 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGS 212 (784)
Q Consensus 182 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 212 (784)
+|+|++..+..|..++ |+.|+|.+|.+...
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 9999976666676666 99999999998744
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=5.9e-11 Score=121.36 Aligned_cols=148 Identities=15% Similarity=0.069 Sum_probs=115.8
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCc
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRN 588 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 588 (784)
+....+.|++...++.|+.+.||++... ++.+++|....... .....+.+|+.+++.+. +..+.++++++.+.+.
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 3445568988899999999999999765 68999999865321 22346899999999984 6778899999988889
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC------------------------------- 637 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 637 (784)
.++||||++|.+|.+.+... .....++.+++++++.||+..
T Consensus 85 ~~lv~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred eEEEEEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 99999999999998763211 123467889999999999810
Q ss_pred -------------------------CCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 638 -------------------------FPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 638 -------------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
.+.++|||+++.||+++++..+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998765567999997753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.10 E-value=5.1e-09 Score=113.13 Aligned_cols=284 Identities=12% Similarity=0.022 Sum_probs=139.9
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
.+|+.+.+.. +++.+...+|.+|.+|+.+.|..+ ++.+-..+|.++ +|+.+.+..+ +......+|.. .+|+.+.+
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~l 120 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEF 120 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEEC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccC
Confidence 4566666643 466566677888888888888644 665556677776 5777766543 44233344444 46777777
Q ss_pred cCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCc------------cchhhhcccccc
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGS------------IPSILGNLKMLL 224 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------------~~~~l~~l~~L~ 224 (784)
..+ +......+|.+. +|+.+.+..+ ++......|..+.+++.+.+..+..... ....+.....+.
T Consensus 121 p~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (379)
T 4h09_A 121 PGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGT 197 (379)
T ss_dssp CTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCS
T ss_pred CCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccc
Confidence 655 332334455443 4555555443 3323445566666666666554432111 111122222333
Q ss_pred eeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccC
Q 042086 225 HLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304 (784)
Q Consensus 225 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n 304 (784)
.+.+..+. .......+....+|+.+.+..+--. -....+..+..|+.+.+..+ ++.....+|..+.+|+.+.+..+
T Consensus 198 ~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~~~~--i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~ 273 (379)
T 4h09_A 198 EFTIPSTV-KTVTAYGFSYGKNLKKITITSGVTT--LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK 273 (379)
T ss_dssp EEECCTTC-CEECTTTTTTCSSCSEEECCTTCCE--ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC
T ss_pred ccccccce-eEEeecccccccccceeeeccceeE--EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc
Confidence 33332221 1123334445555555555433211 11123444555555555443 33333445555555555555432
Q ss_pred ccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecC
Q 042086 305 KLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS 374 (784)
Q Consensus 305 ~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 374 (784)
++......|.++++|+.+.+.++.++.+...+|.++.+|+.++|..+ ++..-..+|.++.+|+.+.+.
T Consensus 274 -i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 274 -VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp -CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred -ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 33233334555555555555555555444455555555555555433 332333445555555555543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=2.6e-10 Score=116.37 Aligned_cols=138 Identities=16% Similarity=0.113 Sum_probs=102.0
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCc--eeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS--IVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv 592 (784)
..+.+....+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 345544333456679999998777888999986542 2356889999999985444 55688988887889999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC----------------------------------- 637 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 637 (784)
|||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998874 211 11 2256778888888888742
Q ss_pred --------------------CCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 638 --------------------FPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 638 --------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
.+.++|||++|.||++++++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11289999999999998776677999998764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.9e-11 Score=128.65 Aligned_cols=85 Identities=16% Similarity=0.260 Sum_probs=51.3
Q ss_pred CCCccceeecccCccCCCCccccc---ccccceEEecccccccCC----CchhhhcccccCeeccCCccccccccccccc
Q 042086 292 SLTELEYLDLSTNKLGNSIPETLG---NLLKLHYLNLSNNQFRKG----FPVELEKLIQLSELDLSLNILEGKIPCEICN 364 (784)
Q Consensus 292 ~l~~L~~L~Ls~n~l~~~~~~~l~---~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 364 (784)
.+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 356677777777666543333332 466777777777777653 2333456677888888877777554444433
Q ss_pred cccccEEecCCCc
Q 042086 365 MESLEKLNLSHNN 377 (784)
Q Consensus 365 l~~L~~L~L~~N~ 377 (784)
.- ...+++++|+
T Consensus 330 al-g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL-PMKIDVSDSQ 341 (362)
T ss_dssp HC-CSEEECCSBC
T ss_pred Hc-CCEEEecCCc
Confidence 11 3557777776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.2e-10 Score=124.03 Aligned_cols=84 Identities=19% Similarity=0.244 Sum_probs=62.9
Q ss_pred ccccceEEecccccccCCCchhhh---cccccCeeccCCcccccc----ccccccccccccEEecCCCccCCCCcccccC
Q 042086 316 NLLKLHYLNLSNNQFRKGFPVELE---KLIQLSELDLSLNILEGK----IPCEICNMESLEKLNLSHNNFSGLIPSCFEG 388 (784)
Q Consensus 316 ~l~~L~~L~ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 388 (784)
.+++|++|+|++|.+....+..+. .+++|+.|+|+.|.+.+. ++..+..+++|+.|+|++|.++...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 478999999999998764444443 488999999999999874 3444456799999999999887654444443
Q ss_pred -cccceEEEcCCCC
Q 042086 389 -MHGLSCIDVSYNE 401 (784)
Q Consensus 389 -l~~L~~l~l~~N~ 401 (784)
+ ...++++.|+
T Consensus 330 al--g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL--PMKIDVSDSQ 341 (362)
T ss_dssp HC--CSEEECCSBC
T ss_pred Hc--CCEEEecCCc
Confidence 2 3568898886
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-08 Score=110.52 Aligned_cols=291 Identities=9% Similarity=0.014 Sum_probs=204.5
Q ss_pred CcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCcccccccc
Q 042086 96 SFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSL 175 (784)
Q Consensus 96 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 175 (784)
.+....+|+.+.+.. .++.+-..+|.+|.+|+.++|..+ ++.....+|.+. +|+.+.+..+ +......+|.+. +|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 355667899998875 467667789999999999999754 665666778776 7888888755 554555667664 79
Q ss_pred ceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccc------------ccCCCCcC
Q 042086 176 FYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG------------VIPLSIGN 243 (784)
Q Consensus 176 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~------------~~~~~l~~ 243 (784)
+.+.+..+-.. .....|.+. +|+.+.+..+ ++.+....|.++..++.+.+..+.... .....+..
T Consensus 116 ~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (379)
T 4h09_A 116 DDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA 192 (379)
T ss_dssp SEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred ccccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence 99999876332 334445543 5666665543 444556678888888887776544321 11223344
Q ss_pred CCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEE
Q 042086 244 LNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYL 323 (784)
Q Consensus 244 l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L 323 (784)
..++..+.+..+.-. .....+..+.+|+.+.+..+ +......++..+.+|+.+.+..+ ++......|.++.+|+.+
T Consensus 193 ~~~~~~~~~~~~~~~--i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i 268 (379)
T 4h09_A 193 AKTGTEFTIPSTVKT--VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTL 268 (379)
T ss_dssp TCCCSEEECCTTCCE--ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEE
T ss_pred cccccccccccceeE--Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccc
Confidence 455555555443322 12234566778888888665 34355678888999999999776 555566778888999999
Q ss_pred ecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCC
Q 042086 324 NLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400 (784)
Q Consensus 324 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N 400 (784)
.+..+ +..+....|.++.+|+.+++.++.++......|.++.+|+.+.|..+ ++.....+|.++.+|+.+.+..+
T Consensus 269 ~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 269 NFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp EECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 98654 66556678899999999999998888666778899999999999755 66666778999999998887543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-09 Score=115.85 Aligned_cols=143 Identities=14% Similarity=0.220 Sum_probs=106.8
Q ss_pred CceeEecccceEEEEEEEcCCCEEEEEEcC--CCCCCCCCChhhHHHHHHHHhccC--CCceeeEEeEEecC---CceEE
Q 042086 519 VKYCIGIGGQGSVYKAKLTSGEILAVKKFH--SLWPCEMVPQPEFVNEIKTLTELR--HRSIVKFYGFCSHP---RNSFL 591 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~l 591 (784)
..+.++.|.++.||+....+ ..+++|+.. ... .......+.+|+.+++.+. +..+.++++++.+. +..++
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~--~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK--LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC--CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 45779999999999998764 678888765 321 1122457889999999996 45688999988766 45899
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC---------------------------------- 637 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 637 (784)
||||++|..+.+. ....++...+..++.+++++|+.||+..
T Consensus 119 vme~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999999776431 1224667888899999999999999731
Q ss_pred ---------------------CCCeEEeCCCCCCeeecCCCc--eEEeccccccc
Q 042086 638 ---------------------FPPIVHRDISSKNVLLCLDYE--ARVSDFGIAKF 669 (784)
Q Consensus 638 ---------------------~~~ivH~Dlk~~Nill~~~~~--~kl~DfG~a~~ 669 (784)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997753 68999998874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.1e-10 Score=117.61 Aligned_cols=63 Identities=32% Similarity=0.442 Sum_probs=30.7
Q ss_pred CCCCCCEEEccCCccCC--CCCcCccCCCcCcEEeecCCCcccccCCcccccc--ccceeeccccccCC
Q 042086 123 NLKFLYHLDLSENQLSG--SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLK--SLFYLHLSSNQLSG 187 (784)
Q Consensus 123 ~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~L~~n~l~~ 187 (784)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+.+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 45556666666666654 2334444555555555555555532 1222222 44444444444443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=1.6e-09 Score=113.30 Aligned_cols=185 Identities=18% Similarity=0.202 Sum_probs=121.7
Q ss_pred ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCc--eeeEEeEEecCC---ceEEEE
Q 042086 520 KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRS--IVKFYGFCSHPR---NSFLVY 593 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~ 593 (784)
.+.++.|....||+.. +.+++|+.... .....+.+|+.+++.+ .+.. +.+++.+..... ..++||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999863 46888875431 2346789999999888 3333 345555543333 347899
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------------------------------------
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD------------------------------------- 636 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------- 636 (784)
|+++|.++.+... ..++...+..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 96 TKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp ECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 9999988765332 1355667778888888888888861
Q ss_pred ------------------CCCCeEEeCCCCCCeeecC--CCceEEeccccccccCCCCCcccc--------------ccc
Q 042086 637 ------------------CFPPIVHRDISSKNVLLCL--DYEARVSDFGIAKFLKPDSSNCTE--------------LVG 682 (784)
Q Consensus 637 ------------------~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~--------------~~g 682 (784)
..+.++|+|++|.||++++ +..+.|+||+.+..-.+...-... ...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 1135799999999999998 456789999998754321100000 000
Q ss_pred cccccc-ccccccCCcCcchhHHHHHHHHHHHHhCCCCC
Q 042086 683 TFGYIA-PELVYTMKVTEKCDVYSFGVLALEVIKGDHPR 720 (784)
Q Consensus 683 t~~y~a-PE~~~~~~~~~~sDvwslGv~l~elltg~~p~ 720 (784)
..++.. |+.... .....+.|++|.++|++.+|+.+|
T Consensus 251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111122 222111 123468999999999999999886
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=1.3e-08 Score=97.64 Aligned_cols=92 Identities=18% Similarity=0.135 Sum_probs=46.9
Q ss_pred ccccccccceEeccCc-cccCC----CCccccCCCccceeecccCccCCCC----cccccccccceEEecccccccCC--
Q 042086 265 EIGKLSSLNYLVLNGN-QLYGN----LPRALGSLTELEYLDLSTNKLGNSI----PETLGNLLKLHYLNLSNNQFRKG-- 333 (784)
Q Consensus 265 ~l~~l~~L~~L~l~~n-~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----~~~l~~l~~L~~L~ls~N~l~~~-- 333 (784)
.+...++|++|+|++| .+... +...+...++|++|+|++|.++... ...+...++|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3445566777777776 66532 2233444566666666666665422 22233335555666666555532
Q ss_pred --CchhhhcccccCeecc--CCccccc
Q 042086 334 --FPVELEKLIQLSELDL--SLNILEG 356 (784)
Q Consensus 334 --~~~~~~~l~~L~~L~L--s~N~l~~ 356 (784)
+...+...++|++|+| ++|.++.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 2333344445555555 4455443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=1.4e-08 Score=97.38 Aligned_cols=115 Identities=17% Similarity=0.160 Sum_probs=57.4
Q ss_pred CcCCCCcceEEecCC-CCCCC---CcccccccccccceEeccCccccCC----CCccccCCCccceeecccCccCCC---
Q 042086 241 IGNLNNLIGLYLYDN-QLSVG---EIPIEIGKLSSLNYLVLNGNQLYGN----LPRALGSLTELEYLDLSTNKLGNS--- 309 (784)
Q Consensus 241 l~~l~~L~~L~L~~n-~l~~~---~~~~~l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~--- 309 (784)
+...++|++|+|++| .+... .+...+...++|++|+|++|.+... +...+...++|++|+|++|.|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 444556666666666 55421 1222334445666666666666432 122333445566666666666542
Q ss_pred -CcccccccccceEEec--ccccccCC----CchhhhcccccCeeccCCcccc
Q 042086 310 -IPETLGNLLKLHYLNL--SNNQFRKG----FPVELEKLIQLSELDLSLNILE 355 (784)
Q Consensus 310 -~~~~l~~l~~L~~L~l--s~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 355 (784)
+...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2334444556666666 55666542 2223333345555555555443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=2.7e-08 Score=100.16 Aligned_cols=79 Identities=30% Similarity=0.339 Sum_probs=38.7
Q ss_pred ccccceEEecccccccC--CCchhhhcccccCeeccCCccccccccccccccc--cccEEecCCCccCCCCcc-------
Q 042086 316 NLLKLHYLNLSNNQFRK--GFPVELEKLIQLSELDLSLNILEGKIPCEICNME--SLEKLNLSHNNFSGLIPS------- 384 (784)
Q Consensus 316 ~l~~L~~L~ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~------- 384 (784)
++++|+.|+|++|+|++ .++..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++++..|+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 34455555555555554 2234444555555555555555533 1222222 556666666666554432
Q ss_pred cccCcccceEEE
Q 042086 385 CFEGMHGLSCID 396 (784)
Q Consensus 385 ~~~~l~~L~~l~ 396 (784)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 244455555554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.4e-06 Score=87.31 Aligned_cols=142 Identities=16% Similarity=0.178 Sum_probs=101.0
Q ss_pred hcCCCCceeEecccce-EEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceE
Q 042086 514 TNGFDVKYCIGIGGQG-SVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 590 (784)
...|+. +.+..|..| .||+.... ++..+++|+-... ...++.+|+..++.+. +--+.++++++.+++..+
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 344543 456666665 68988765 5678899975432 3557889999998884 334678899999889999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD---------------------------------- 636 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 636 (784)
+|||++++.++.+...... .....+..++++.++.||+.
T Consensus 97 lvme~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEEECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 9999999988877653221 12334556666666766642
Q ss_pred ---------------------CCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 637 ---------------------CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 637 ---------------------~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 011378999999999999877777999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=5.7e-06 Score=86.03 Aligned_cols=138 Identities=17% Similarity=0.130 Sum_probs=94.4
Q ss_pred CceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCC---ceeeEEeEEe-cCCceEEEEe
Q 042086 519 VKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHR---SIVKFYGFCS-HPRNSFLVYE 594 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e 594 (784)
-.+.++.|....||+. |+.+++|+-.. ......+.+|+.+++.+.+. .+.+++.+.. ..+..++|||
T Consensus 23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp CEEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 3467889999999988 56788887432 12346789999999999642 3567777774 4556789999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD-------------------------------------- 636 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------- 636 (784)
|++|.++.+.... .++...+..++.++++.++.||+.
T Consensus 94 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999887653211 123334444455555555555432
Q ss_pred -------------------CCCCeEEeCCCCCCeeecC---CCc-eEEecccccccc
Q 042086 637 -------------------CFPPIVHRDISSKNVLLCL---DYE-ARVSDFGIAKFL 670 (784)
Q Consensus 637 -------------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~DfG~a~~~ 670 (784)
..+.++|+|+++.||+++. ++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235699999999999987 455 489999988754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=4.7e-06 Score=88.86 Aligned_cols=83 Identities=7% Similarity=0.061 Sum_probs=57.1
Q ss_pred ceeE-ecccceEEEEEEEc-------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-C--CceeeEEeEEecC--
Q 042086 520 KYCI-GIGGQGSVYKAKLT-------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-H--RSIVKFYGFCSHP-- 586 (784)
Q Consensus 520 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 586 (784)
.+.| +.|....+|+.... +++.+++|...............+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998754 26788999765421000111356889999998884 3 3567788887655
Q ss_pred -CceEEEEecccCCCHH
Q 042086 587 -RNSFLVYEYLERGSLA 602 (784)
Q Consensus 587 -~~~~lv~e~~~~gsL~ 602 (784)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999986654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.07 E-value=6.9e-07 Score=83.30 Aligned_cols=83 Identities=16% Similarity=0.163 Sum_probs=44.9
Q ss_pred CCCEEEccCCccCCCCCcCccCCCcCcEEeecCCC-cccccCCccccc----cccceeeccccc-cCCCccccccCccCC
Q 042086 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS-LSGSIPSIIGNL----KSLFYLHLSSNQ-LSGSIPISLGNLSNL 199 (784)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~L 199 (784)
+|++|||++|.++...-..+..+++|++|+|++|. |++..-..++.+ ++|++|+|++|. ++...-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555554444445555556666666553 443332333332 356666666653 554444455566677
Q ss_pred ceeeccccc
Q 042086 200 VVLHLFENS 208 (784)
Q Consensus 200 ~~L~L~~n~ 208 (784)
++|+|++|.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777776664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.4e-06 Score=81.27 Aligned_cols=83 Identities=14% Similarity=0.144 Sum_probs=43.4
Q ss_pred ccceeecccCccCCCCcccccccccceEEeccccc-ccCCCchhhhcc----cccCeeccCCcc-ccccccccccccccc
Q 042086 295 ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQ-FRKGFPVELEKL----IQLSELDLSLNI-LEGKIPCEICNMESL 368 (784)
Q Consensus 295 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L 368 (784)
+|+.||+++|.++......+..+++|++|+|++|. ++...-..++.+ ++|++|+|++|. +++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555554444445555555555555553 444333334432 245666666552 554444445556666
Q ss_pred cEEecCCCc
Q 042086 369 EKLNLSHNN 377 (784)
Q Consensus 369 ~~L~L~~N~ 377 (784)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-05 Score=83.54 Aligned_cols=78 Identities=15% Similarity=0.028 Sum_probs=51.3
Q ss_pred ceeEecccceEEEEEEEc-CCCEEEEEEcCCCCC----CCCCChhhHHHHHHHHhccC-C-C-ceeeEEeEEecCCceEE
Q 042086 520 KYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWP----CEMVPQPEFVNEIKTLTELR-H-R-SIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~l 591 (784)
.+.+|.|..+.||++... +++.|+||....... ......+.+..|+++++.+. + | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999764 578899998654321 00123456788999998773 2 3 34455544 3455689
Q ss_pred EEecccCC
Q 042086 592 VYEYLERG 599 (784)
Q Consensus 592 v~e~~~~g 599 (784)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.81 E-value=8.3e-05 Score=78.53 Aligned_cols=141 Identities=19% Similarity=0.260 Sum_probs=81.1
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC--CceeeEEe------EEecCCceEEE
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH--RSIVKFYG------FCSHPRNSFLV 592 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv 592 (784)
+.|+.|..+.||+....+| .+++|+... ...++..|+.+++.+.. -.+.+++. +....+..++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-------~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-------PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-------CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-------CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 4466677899999987655 488998764 13445556666665531 12333332 12345678899
Q ss_pred EecccCCCHH--------------HHHhc--CCC--C-------CCCCHHHH----------------------------
Q 042086 593 YEYLERGSLA--------------TILSN--DGA--I-------EEFNWTVR---------------------------- 619 (784)
Q Consensus 593 ~e~~~~gsL~--------------~~l~~--~~~--~-------~~l~~~~~---------------------------- 619 (784)
|||++|.++. ..+|. ... . ..-.|...
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986432 11111 100 0 01123211
Q ss_pred ---HHHHHHHHHHHHHHhh----------CCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 620 ---MNVIRSVANALSYMHH----------DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 620 ---~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
..+...+.+++++|+. ...+.++|||+++.||+++.++.+.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111224456667763 0234899999999999998888899999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00036 Score=75.90 Aligned_cols=76 Identities=13% Similarity=0.118 Sum_probs=47.6
Q ss_pred CCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccccccc--ccccccccccccC---CcCcchhHHHHHHHHHHH
Q 042086 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG--TFGYIAPELVYTM---KVTEKCDVYSFGVLALEV 713 (784)
Q Consensus 639 ~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDvwslGv~l~el 713 (784)
+.++|||+++.||+++.++ ++++||+.+..-.+...- ..... ...|++|+..... +.....++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3789999999999998776 999999988753221100 00111 1346666655321 122345566777788877
Q ss_pred HhC
Q 042086 714 IKG 716 (784)
Q Consensus 714 ltg 716 (784)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=74.32 Aligned_cols=139 Identities=17% Similarity=0.154 Sum_probs=93.1
Q ss_pred CceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC---CCceeeEEeEEecCCceEEEEec
Q 042086 519 VKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR---HRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
-.+.|+.|....+|+... +++.+++|+.... ....|..|+..++.+. ...+.+++++....+..++||||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 346799999999999986 4678889986532 2567899999998883 36788899998888889999999
Q ss_pred ccCCCHH--------H---HHhcCCCCC-------------------CCCHHHHH---HHHH----------------HH
Q 042086 596 LERGSLA--------T---ILSNDGAIE-------------------EFNWTVRM---NVIR----------------SV 626 (784)
Q Consensus 596 ~~~gsL~--------~---~l~~~~~~~-------------------~l~~~~~~---~i~~----------------~i 626 (784)
+++..+. + .+|...... .-+|.... ++.. .+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 9987541 1 122221100 12454321 1111 11
Q ss_pred H-HHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEeccc
Q 042086 627 A-NALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFG 665 (784)
Q Consensus 627 ~-~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 665 (784)
+ +....|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 11223432 2245789999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00037 Score=71.55 Aligned_cols=79 Identities=18% Similarity=0.160 Sum_probs=57.6
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-C--CceeeEEeEEecCCceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-H--RSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 591 (784)
.+..-++.+|.|..+.||+.+..+|+.|++|+..... ......|..|+..|+.+. . --+.+++++. ..++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 3456678899999999999999999999999865432 223446889999998884 2 1344555543 3478
Q ss_pred EEecccCCC
Q 042086 592 VYEYLERGS 600 (784)
Q Consensus 592 v~e~~~~gs 600 (784)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.51 E-value=1.7e-05 Score=75.43 Aligned_cols=14 Identities=14% Similarity=0.387 Sum_probs=5.9
Q ss_pred CccceeecccCccC
Q 042086 294 TELEYLDLSTNKLG 307 (784)
Q Consensus 294 ~~L~~L~Ls~n~l~ 307 (784)
+.|+.|+|++|.|.
T Consensus 70 ~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 70 KHIEKFSLANTAIS 83 (197)
T ss_dssp SCCCEEECTTSCCB
T ss_pred CCcCEEEccCCCCC
Confidence 34444444444443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.51 E-value=2e-05 Score=74.87 Aligned_cols=114 Identities=14% Similarity=0.193 Sum_probs=80.7
Q ss_pred cccCCCccceeecccC-ccCCC----CcccccccccceEEecccccccC----CCchhhhcccccCeeccCCcccccccc
Q 042086 289 ALGSLTELEYLDLSTN-KLGNS----IPETLGNLLKLHYLNLSNNQFRK----GFPVELEKLIQLSELDLSLNILEGKIP 359 (784)
Q Consensus 289 ~l~~l~~L~~L~Ls~n-~l~~~----~~~~l~~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 359 (784)
.+..-+.|++|+|++| .|... +.+.+..-+.|+.|+|++|.|.. .+...+...+.|+.|+|++|.|....-
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3445567888888875 66542 33456667899999999999985 455666778899999999999987544
Q ss_pred ----ccccccccccEEecCCCcc---CCC----CcccccCcccceEEEcCCCCC
Q 042086 360 ----CEICNMESLEKLNLSHNNF---SGL----IPSCFEGMHGLSCIDVSYNEL 402 (784)
Q Consensus 360 ----~~~~~l~~L~~L~L~~N~l---~~~----~p~~~~~l~~L~~l~l~~N~l 402 (784)
+.+..-+.|+.|+|++|.. ... +.+.+..-+.|+.|++++|..
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 3444557799999987633 322 334455567888888887643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0016 Score=67.77 Aligned_cols=159 Identities=16% Similarity=0.134 Sum_probs=89.9
Q ss_pred ccHHHHHHHhcCCCC-----ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCc--ee
Q 042086 505 ILYEEIVRATNGFDV-----KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS--IV 577 (784)
Q Consensus 505 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 577 (784)
++.+++......|.+ .+.|+.|....+|+....+| .+++|..... ...+++..|+.+++.+.... +.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 445566666666765 24466788899999987666 5788987652 12346677888887774222 23
Q ss_pred eEEeE------EecCCceEEEEecccCCCHHH--------------HHhcC----CCC-----CCCCHHHHHH-------
Q 042086 578 KFYGF------CSHPRNSFLVYEYLERGSLAT--------------ILSND----GAI-----EEFNWTVRMN------- 621 (784)
Q Consensus 578 ~l~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~-----~~l~~~~~~~------- 621 (784)
+++.. ....+..+++++|++|..+.. .+|.. ... ....|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 33321 122356789999999854310 01111 100 0012322110
Q ss_pred -----HHHHHHHHHHHHhhC----CCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 622 -----VIRSVANALSYMHHD----CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 622 -----i~~~i~~~l~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
+...+.+.+++++.. ..++++|+|+.+.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455565532 123789999999999998876668999998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0012 Score=69.29 Aligned_cols=142 Identities=15% Similarity=0.121 Sum_probs=74.8
Q ss_pred eeEecccceE-EEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-C-CceeeEEeEEecCCceEEEEeccc
Q 042086 521 YCIGIGGQGS-VYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-H-RSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 521 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
+.|+.|.... +|+....+|+.+++|...... ..++..|+.+++.+. + -.+.+++.+..+.+ +++||++.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 3465555444 667765447778887644321 134556777777663 2 23556666643332 78999998
Q ss_pred CCCHHHHHhcC---------------------C--CCCCCCHHHHH--------HH------------HHHHHHHHHHHh
Q 042086 598 RGSLATILSND---------------------G--AIEEFNWTVRM--------NV------------IRSVANALSYMH 634 (784)
Q Consensus 598 ~gsL~~~l~~~---------------------~--~~~~l~~~~~~--------~i------------~~~i~~~l~~LH 634 (784)
+..+.+++... . ....++..... .+ ...+.+.++.+.
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 76765544211 0 01112211100 00 011122223331
Q ss_pred h---CCCCCeEEeCCCCCCeeecCC----CceEEecccccccc
Q 042086 635 H---DCFPPIVHRDISSKNVLLCLD----YEARVSDFGIAKFL 670 (784)
Q Consensus 635 ~---~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~a~~~ 670 (784)
. ...+.++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1 123478999999999999875 67899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0013 Score=67.96 Aligned_cols=139 Identities=15% Similarity=0.095 Sum_probs=76.2
Q ss_pred ceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce-eeEEeEEecCCceEEEEecc-c
Q 042086 520 KYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI-VKFYGFCSHPRNSFLVYEYL-E 597 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~ 597 (784)
.+.|+.|....+|+. +.+++|+...... ...+...|+.+++.+....+ .+++++. ++.-++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 678999999999999 5688888764211 11234578888877742223 4555543 34457899999 5
Q ss_pred CCCHHH------------------HHhcCCC-C-CCCCH-HHHHHHHH--------------HHHHHH----HHHhh-CC
Q 042086 598 RGSLAT------------------ILSNDGA-I-EEFNW-TVRMNVIR--------------SVANAL----SYMHH-DC 637 (784)
Q Consensus 598 ~gsL~~------------------~l~~~~~-~-~~l~~-~~~~~i~~--------------~i~~~l----~~LH~-~~ 637 (784)
+.++.. .+|.... . ..++. .....+.. .+.+.+ +.+.. ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 543321 0111111 0 01111 11111100 011111 11211 11
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 638 ~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
.+.++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 235799999999999 56677899999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0031 Score=65.81 Aligned_cols=142 Identities=12% Similarity=0.122 Sum_probs=82.8
Q ss_pred eeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCC--ceeeEEeE-----EecCCceEEEE
Q 042086 521 YCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHR--SIVKFYGF-----CSHPRNSFLVY 593 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~ 593 (784)
+.++ |....||+....+|+.+++|...... ...+.+..|+.+++.+... .+.+++.. ....+..++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4576 88889999887778789999986421 1356777888888877422 23444443 12245567899
Q ss_pred ecccCCCHH-----HH---------Hhc----CCC--CCCCCHHHH----HHH---------------HHHHHHHHHHHh
Q 042086 594 EYLERGSLA-----TI---------LSN----DGA--IEEFNWTVR----MNV---------------IRSVANALSYMH 634 (784)
Q Consensus 594 e~~~~gsL~-----~~---------l~~----~~~--~~~l~~~~~----~~i---------------~~~i~~~l~~LH 634 (784)
||++|..+. .. +|. ... ....++... ..+ ...+.+.++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999875321 11 111 110 112222211 001 111112233332
Q ss_pred hC----CCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 635 HD----CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 635 ~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
.. ..+.++|||+++.||+++ + .+.++||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 223578999999999999 4 899999988764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00056 Score=60.60 Aligned_cols=60 Identities=20% Similarity=0.253 Sum_probs=46.3
Q ss_pred eeccCCcccc-ccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 346 ELDLSLNILE-GKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 346 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|+|.+.+-
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 5666666665 34554332 468899999999998888889999999999999999988655
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0024 Score=69.42 Aligned_cols=71 Identities=20% Similarity=0.220 Sum_probs=49.8
Q ss_pred ceeEecccceEEEEEEEcC--------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCc-eeeEEeEEecCCceE
Q 042086 520 KYCIGIGGQGSVYKAKLTS--------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS-IVKFYGFCSHPRNSF 590 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~ 590 (784)
.+.|+.|....+|++...+ ++.+++|+.... ...+.+..|..+++.+...+ ..++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3568889899999998753 578999987431 11256778999998884333 3567766542 3
Q ss_pred EEEecccCC
Q 042086 591 LVYEYLERG 599 (784)
Q Consensus 591 lv~e~~~~g 599 (784)
+|+||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0033 Score=66.70 Aligned_cols=141 Identities=14% Similarity=0.219 Sum_probs=83.1
Q ss_pred eeEecccceEEEEEEEc--------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceEE
Q 042086 521 YCIGIGGQGSVYKAKLT--------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 591 (784)
+.+..|....+|+.... +++.|++|+.... ......+.+|..+++.+. +.-..++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 56777888999999864 3578999986331 223566779999998884 3333566766643 28
Q ss_pred EEecccCCCHHH--------------H---HhcCCC--CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 042086 592 VYEYLERGSLAT--------------I---LSNDGA--IEEFN--WTVRMNVIRSVAN-------------------ALS 631 (784)
Q Consensus 592 v~e~~~~gsL~~--------------~---l~~~~~--~~~l~--~~~~~~i~~~i~~-------------------~l~ 631 (784)
|+||++|.++.. . +|.... ..... |....++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999854421 1 121111 11122 3444444433321 223
Q ss_pred H----HhhC-CCCCeEEeCCCCCCeeecCC----CceEEeccccccc
Q 042086 632 Y----MHHD-CFPPIVHRDISSKNVLLCLD----YEARVSDFGIAKF 669 (784)
Q Consensus 632 ~----LH~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~a~~ 669 (784)
. |... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3 3221 12357899999999999877 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0068 Score=66.15 Aligned_cols=73 Identities=18% Similarity=0.066 Sum_probs=47.7
Q ss_pred ceeEecccceEEEEEEEcC-CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce-eeEEeEEecCCceEEEEeccc
Q 042086 520 KYCIGIGGQGSVYKAKLTS-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI-VKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 597 (784)
.+.|+.|-...+|+....+ ++.+++|+..... ...-+-.+|..+++.+...++ .++++++. + .+|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C----CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 4578889999999998775 5788899875421 111123588999988854444 56777663 2 35999998
Q ss_pred CCC
Q 042086 598 RGS 600 (784)
Q Consensus 598 ~gs 600 (784)
+.+
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.38 E-value=0.012 Score=55.93 Aligned_cols=103 Identities=18% Similarity=0.128 Sum_probs=66.8
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCccc
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT 678 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 678 (784)
-+|.+.|+..+. ++++++++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 389999986653 79999999999999999887622111 1 1222346889999999888764 1110
Q ss_pred ccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCC
Q 042086 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719 (784)
Q Consensus 679 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p 719 (784)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122467888764 3456788999999999999965444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0035 Score=66.70 Aligned_cols=73 Identities=8% Similarity=0.031 Sum_probs=44.1
Q ss_pred ceeEecccceEEEEEEEcC---------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCc-eeeEEeEEecCCce
Q 042086 520 KYCIGIGGQGSVYKAKLTS---------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS-IVKFYGFCSHPRNS 589 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~ 589 (784)
.+.++.|....+|+....+ ++.+++|+...... ...+...|..+++.+...+ +.++++.. . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 3567788888999998654 26888888654211 1113467888888774333 34666554 2 3
Q ss_pred EEEEecccCCC
Q 042086 590 FLVYEYLERGS 600 (784)
Q Consensus 590 ~lv~e~~~~gs 600 (784)
++||||++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0049 Score=54.44 Aligned_cols=7 Identities=29% Similarity=0.055 Sum_probs=2.5
Q ss_pred EccCCcc
Q 042086 107 YLYRNSL 113 (784)
Q Consensus 107 ~L~~n~l 113 (784)
+.+++.+
T Consensus 14 ~Cs~~~L 20 (130)
T 3rfe_A 14 DCGRRGL 20 (130)
T ss_dssp ECCSSCC
T ss_pred EeCCCCC
Confidence 3333333
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.014 Score=61.05 Aligned_cols=31 Identities=23% Similarity=0.278 Sum_probs=27.6
Q ss_pred CCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 639 PPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 639 ~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
..++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.77 E-value=0.12 Score=55.39 Aligned_cols=73 Identities=7% Similarity=-0.031 Sum_probs=48.3
Q ss_pred ceeEecccceEEEEEEEcC--------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceE
Q 042086 520 KYCIGIGGQGSVYKAKLTS--------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 590 (784)
.+.+..|-...+|+....+ ++.|++|+..... ...-+-.+|..+++.+. +.-..++++.+. -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3567778889999998763 6789999864421 11223457888888874 333445565432 37
Q ss_pred EEEecccCCC
Q 042086 591 LVYEYLERGS 600 (784)
Q Consensus 591 lv~e~~~~gs 600 (784)
.|+||++|.+
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999999865
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.36 E-value=0.13 Score=34.83 Aligned_cols=29 Identities=31% Similarity=0.246 Sum_probs=17.2
Q ss_pred eeehhHHHHHHHHHHHHhhhchhhhccCC
Q 042086 453 IIVFPLLGALSLSVLAMGTFFILRRREGP 481 (784)
Q Consensus 453 ~~~~~~~~~~~l~~~~~~~~~~~rrr~~~ 481 (784)
|++.++.|++++++++++.++++|||+.+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 45555666666666666666666665543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.76 E-value=0.12 Score=35.04 Aligned_cols=29 Identities=17% Similarity=0.166 Sum_probs=16.7
Q ss_pred eeehhHHHHHHHHHHHHhhhchhhhccCC
Q 042086 453 IIVFPLLGALSLSVLAMGTFFILRRREGP 481 (784)
Q Consensus 453 ~~~~~~~~~~~l~~~~~~~~~~~rrr~~~ 481 (784)
++..++.|++++++++...++++|||+.+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 45555555666666665656666655543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.31 E-value=0.73 Score=49.14 Aligned_cols=29 Identities=24% Similarity=0.415 Sum_probs=24.6
Q ss_pred eEEeCCCCCCeee------cCCCceEEeccccccc
Q 042086 641 IVHRDISSKNVLL------CLDYEARVSDFGIAKF 669 (784)
Q Consensus 641 ivH~Dlk~~Nill------~~~~~~kl~DfG~a~~ 669 (784)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 4799999999999 4456799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.96 E-value=0.86 Score=43.30 Aligned_cols=116 Identities=9% Similarity=0.115 Sum_probs=82.5
Q ss_pred CCCceeeEEeEEecCCceEEEEecccCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCC
Q 042086 572 RHRSIVKFYGFCSHPRNSFLVYEYLERG-SLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKN 650 (784)
Q Consensus 572 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 650 (784)
.||+.+.. .+-.+.+.+.+.|+.-+.+ ++.. ....+...+++++.+|+....+++.. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888866 5666667766777654422 2222 23467789999999999988777766 899999999
Q ss_pred eeecCCCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 651 VLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 651 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
++++.++.+++.=.|+-..+ +|. ..+...=.-.+=+++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999877754332 222 122233345677889999999998863
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=83.80 E-value=0.68 Score=31.26 Aligned_cols=27 Identities=26% Similarity=0.432 Sum_probs=12.8
Q ss_pred eehhHHHHHHHHHHHHhhhchhhhccC
Q 042086 454 IVFPLLGALSLSVLAMGTFFILRRREG 480 (784)
Q Consensus 454 ~~~~~~~~~~l~~~~~~~~~~~rrr~~ 480 (784)
++..++|++++++++++.+++.|||+.
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 444555544444444444445555443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.68 E-value=3.9 Score=38.96 Aligned_cols=115 Identities=10% Similarity=0.066 Sum_probs=80.6
Q ss_pred CCCceeeEEeEEecCCceEEEEecccCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEEeCCCCC
Q 042086 572 RHRSIVKFYGFCSHPRNSFLVYEYLERG-SLATILSNDGAIEEFNWTVRMNVIRSVANALS-YMHHDCFPPIVHRDISSK 649 (784)
Q Consensus 572 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~Dlk~~ 649 (784)
.||++ -..+-.+++.+.+.|+.-+++ ++.. ++ ..+...+++++.+|+.... +++.. +|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 67887 445556777888888766443 4443 32 3567889999999998877 66665 88899999
Q ss_pred CeeecCCCceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCc
Q 042086 650 NVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDF 722 (784)
Q Consensus 650 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~ 722 (784)
|++++.++.+++.=.|+-.. ++|.. .+..-=.-++=+++..++.++..|+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-----------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-----------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-----------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCccc-----------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999987775433 23322 12122244677788888988888763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 784 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-29 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-28 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-15 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 6e-58
Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 20/273 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
V IG G G+VYK K +AVK + P Q F NE+ L + RH +I
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVNI 66
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
+ F G+ + P +V ++ E SL L +F +++ R A + Y+H
Sbjct: 67 LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHA- 122
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYT 694
I+HRD+ S N+ L D ++ DFG+A S + +L G+ ++APE++
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 695 MK---VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751
+ + DVY+FG++ E++ G P S+I++ + L P L N
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ ++ CL + + RP + +
Sbjct: 238 CPKAMKRLMA---ECLKKKRDERPLFPQILASI 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-57
Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 19/277 (6%)
Query: 512 RATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE 570
RA + ++V Y IG G G K + + G+IL K+ E Q V+E+ L E
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRE 59
Query: 571 LRHRSIVKFYGFCSHPRNS--FLVYEYLERGSLATILSNDGAIEE-FNWTVRMNVIRSVA 627
L+H +IV++Y N+ ++V EY E G LA++++ + + + V+ +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 628 NALSYMH--HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFG 685
AL H D ++HRD+ NV L ++ DFG+A+ L D+S VGT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY 179
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745
Y++PE + M EK D++S G L E+ P + ++ +I + +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREGKF 231
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
P DEL I+ LN RP + + +
Sbjct: 232 RRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 55/269 (20%), Positives = 107/269 (39%), Gaps = 20/269 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+ +G G G V+ +AVK + F+ E + +L+H+ +
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQHQRL 70
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
V+ Y + +++ EY+E GSL L I+ +++ +A ++++
Sbjct: 71 VRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER 128
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN-CTELVGTFGYIAPELVYTM 695
+HRD+ + N+L+ +++DFG+A+ ++ + + APE +
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
T K DV+SFG+L E++ + + P N +E
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPY-------PGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
L ++ LC E PE RP + +L
Sbjct: 239 LYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 58/269 (21%), Positives = 110/269 (40%), Gaps = 20/269 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
IG G G V+ + + +A+K + + +F+ E + + +L H +
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
V+ YG C LV+E++E G L+ L + F + + V + +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM---AYL 117
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE-LVGTFGYIAPELVYTM 695
++HRD++++N L+ + +VSDFG+ +F+ D + + +PE+
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
+ + K DV+SFGVL EV + + + + +I P+
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-------PYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ I+ C E PE RP + + L
Sbjct: 231 VYQIMN---HCWKERPEDRPAFSRLLRQL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 46/305 (15%)
Query: 513 ATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVP--QPEFVNEIKTLT 569
+ F+ +G G G V+K SG ++A K H E+ P + + + E++ L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLH 59
Query: 570 ELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANA 629
E IV FYG + E+++ GSL +L G + V +V
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKG 116
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
L+Y+ I+HRD+ N+L+ E ++ DFG++ L S VGT Y++P
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 172
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVIKGDHP------------------------------ 719
E + + + D++S G+ +E+ G +P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 720 RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFL--CLNESPESRPPM 777
S S +++ E+LD + PP + + S+ F+ CL ++P R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 778 HTVCQ 782
+
Sbjct: 293 KQLMV 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-51
Identities = 58/270 (21%), Positives = 110/270 (40%), Gaps = 22/270 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+G G G V K +A+K + + EF+ E K + L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLSHEKL 61
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
V+ YG C+ R F++ EY+ G L L F + + + V A+ Y+
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES- 118
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD-SSNCTELVGTFGYIAPELVYTM 695
+HRD++++N L+ +VSDFG+++++ D ++ + PE++
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 696 KVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754
K + K D+++FGVL E+ G P + + + I P +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYE--------RFTNSETAEHIAQGLRLYRPHLASE 228
Query: 755 ELISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ +I+ C +E + RP + +
Sbjct: 229 KVYTIMY---SCWHEKADERPTFKILLSNI 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-51
Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 21/267 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F++ +G G G+VY A+ S ILA+K + + + E++ + LRH +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
I++ YG+ +L+ EY G++ L +F+ I +ANALSY H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS 124
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
++HRDI +N+LL E +++DFG + SS T L GT Y+ PE++
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGR 179
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
EK D++S GVL E + G P + ++ + I T P V +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVE-FTFPDFVTEG 230
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQ 782
++ L +P RP + V +
Sbjct: 231 ARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-50
Identities = 63/269 (23%), Positives = 107/269 (39%), Gaps = 24/269 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+ IG G G V G +AVK + + Q F+ E +T+LRH ++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN----DATAQ-AFLAEASVMTQLRHSNL 62
Query: 577 VKFYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
V+ G + ++V EY+ +GSL L + G + V A+ Y+
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
VHRD++++NVL+ D A+VSDFG+ K SS + APE +
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREK 175
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
K + K DV+SFG+L E+ +++ + + P
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV------PYPRIPLKDV-VPRVEKGYKMDAPDGCPPA 228
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ +++ C + RP + + L
Sbjct: 229 VYEVMK---NCWHLDAAMRPSFLQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 1e-49
Identities = 62/310 (20%), Positives = 128/310 (41%), Gaps = 46/310 (14%)
Query: 504 KILYEEIVRATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVP 557
K+L E R N + IG G G V++A+ ++AVK +M
Sbjct: 4 KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-- 59
Query: 558 QPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDG-------- 609
Q +F E + E + +IVK G C+ + L++EY+ G L L +
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 610 -------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD 656
+ ++ + R VA ++Y+ VHRD++++N L+ +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176
Query: 657 YEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI 714
+++DFG+++ + ++ PE ++ + T + DV+++GV+ E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 715 KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESR 774
+ ++ + + + D + P+N EL +++ LC ++ P R
Sbjct: 237 SYGLQPYY------GMAHEEV-IYYVRDGNILACPENCPLELYNLMR---LCWSKLPADR 286
Query: 775 PPMHTVCQLL 784
P ++ ++L
Sbjct: 287 PSFCSIHRIL 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 57/269 (21%), Positives = 111/269 (41%), Gaps = 20/269 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
++ +G G G V+ +A+K + F+ E + + +LRH +
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
V+ Y S ++V EY+ +GSL L + + +++ +A+ ++Y+
Sbjct: 75 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM 132
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD-SSNCTELVGTFGYIAPELVYTM 695
VHRD+ + N+L+ + +V+DFG+A+ ++ + + + APE
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
+ T K DV+SFG+L E+ NR + L+++ P +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV------PYPGMVNREV-LDQVERGYRMPCPPECPES 242
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
L ++ C + PE RP + L
Sbjct: 243 LHDLMC---QCWRKEPEERPTFEYLQAFL 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 1e-49
Identities = 65/297 (21%), Positives = 127/297 (42%), Gaps = 37/297 (12%)
Query: 507 YEEIVRATNGFD---------VKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPC 553
+E+ A F ++ IG G G V L +A+K S +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 554 EMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE 613
+ +F++E + + H +++ G + ++ E++E GSL + L + +
Sbjct: 69 KQRR--DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQ 124
Query: 614 FNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673
F + ++R +A + Y+ VHRD++++N+L+ + +VSDFG+++FL+ D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 674 SSNCTE-----LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSIS 727
+S+ T + APE + K T DV+S+G++ EV+ G+ P
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW------ 235
Query: 728 SSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+N+++ +N I PP + L ++ C + RP + L
Sbjct: 236 -DMTNQDV-INAIEQDYRLPPPMDCPSALHQLML---DCWQKDRNHRPKFGQIVNTL 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 40/293 (13%)
Query: 522 CIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G V++ K GE +AVK F S EI LRH +I+ F
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIA 64
Query: 582 FCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
+ + +LV +Y E GSL L+ + + S A+ L+++H +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEI 120
Query: 638 F-----PPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN----CTELVGTFGYIA 688
P I HRD+ SKN+L+ + ++D G+A + VGT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 689 PELVYTM------KVTEKCDVYSFGVLALEVIKGDHP-----------RDFISSISSSSS 731
PE++ + ++ D+Y+ G++ E+ + D + S S
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 732 NRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
R + + L P +P Q+ + L + ++ C + +R + + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-49
Identities = 65/269 (24%), Positives = 104/269 (38%), Gaps = 26/269 (9%)
Query: 523 IGIGGQGSVYKAKL---TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G GSV + +A+K E + E + + +L + IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRL 74
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
G C LV E G L L EE + ++ V+ + Y+
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---K 128
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE---LVGTFGYIAPELVYTMK 696
VHRD++++NVLL + A++SDFG++K L D S T + APE + K
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 697 VTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
+ + DV+S+GV E + G P + + I + P E
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYK-------KMKGPEV-MAFIEQGKRMECPPECPPE 240
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
L +++ C E RP TV Q +
Sbjct: 241 LYALMS---DCWIYKWEDRPDFLTVEQRM 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-49
Identities = 62/287 (21%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 507 YEEIVRATNG---FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFV 562
YE + R N +++ +G G G VYKA+ + + A K + E+ +++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYM 57
Query: 563 NEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
EI L H +IVK + N +++ E+ G++ ++ + V
Sbjct: 58 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVV 115
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
+ +AL+Y+H I+HRD+ + N+L LD + +++DFG++ +G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172
Query: 683 TFGYIAPELVYTM-----KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISL 737
T ++APE+V K DV+S G+ +E+ + + P N L
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH--------ELNPMRVL 224
Query: 738 NEIL--DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+I +P P ++ CL ++ ++R + Q
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 5e-49
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
FD++ IG G +VYK T + +A + + Q F E + L L+H +
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQHPN 69
Query: 576 IVKFYGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
IV+FY LV E + G+L T L V + R + L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQ 126
Query: 632 YMHHDCFPPIVHRDISSKNVLLC-LDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
++H PPI+HRD+ N+ + ++ D G+A +S ++GT ++APE
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPE 183
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750
+Y K E DVY+FG+ LE+ ++P + +++ R + + + +
Sbjct: 184 -MYEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRV----TSGVKPASFDK 236
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
E+ I+E C+ ++ + R + +
Sbjct: 237 VAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 3e-48
Identities = 57/270 (21%), Positives = 112/270 (41%), Gaps = 24/270 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F IG G G+VY A+ + + E++A+KK + + E++ L +LRH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
+++ G ++LV EY + + + V L+Y+H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 133
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
++HRD+ + N+LL ++ DFG A + P +S GT ++APE++ M
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAPEVILAM 186
Query: 696 ---KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752
+ K DV+S G+ +E+ + P + + + + + +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNESPALQSGHW 239
Query: 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ + V+ CL + P+ RP + +
Sbjct: 240 SEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-48
Identities = 65/269 (24%), Positives = 105/269 (39%), Gaps = 26/269 (9%)
Query: 523 IGIGGQGSVYKAKL---TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKF 579
+G G G+V K + +AVK + + E + E + +L + IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPYIVRM 73
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
G C + LV E E G L L + + ++ V+ + Y+
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC---TELVGTFGYIAPELVYTMK 696
VHRD++++NVLL + A++SDFG++K L+ D + T + APE + K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 697 VTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
+ K DV+SFGVL E G P + + P E
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYR--------GMKGSEVTAMLEKGERMGCPAGCPRE 238
Query: 756 LISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ ++ LC E+RP V L
Sbjct: 239 MYDLMN---LCWTYDVENRPGFAAVELRL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 65/261 (24%), Positives = 121/261 (46%), Gaps = 20/261 (7%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
IG G G+VY A + +G+ +A+++ + + + +NEI + E ++ +IV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPI 641
++V EYL GSL +++ + V R AL ++H + +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ---V 137
Query: 642 VHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKC 701
+HRDI S N+LL +D +++DFG + P+ S + +VGT ++APE+V K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 702 DVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVE 761
D++S G++A+E+I+G+ P + + R + L P+ + +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 762 VAFLCLNESPESRPPMHTVCQ 782
CL+ E R + Q
Sbjct: 252 ---RCLDMDVEKRGSAKELLQ 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 6e-48
Identities = 55/271 (20%), Positives = 117/271 (43%), Gaps = 22/271 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+K+ +G G G VY+ +AVK + + EF+ E + E++H +
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPN 74
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
+V+ G C+ +++ E++ G+L L +E + V + + +++A+ Y+
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK 133
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN-CTELVGTFGYIAPELVYT 694
+HRD++++N L+ ++ +V+DFG+++ + D+ + APE +
Sbjct: 134 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL-PTPPQNVQ 753
K + K DV++FGVL E+ + E+L+ P+
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPY--------PGIDLSQVYELLEKDYRMERPEGCP 242
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+++ ++ C +P RP + Q
Sbjct: 243 EKVYELMR---ACWQWNPSDRPSFAEIHQAF 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-47
Identities = 61/270 (22%), Positives = 106/270 (39%), Gaps = 21/270 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+D+ +G G G V A + E +AVK + EI L H +
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHEN 64
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
+VKFYG +L EY G L + D + + Y+H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVY 693
I HRDI +N+LL ++SDFG+A + ++ ++ GT Y+APEL+
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 694 TMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752
+ E DV+S G++ ++ G+ P D S + + P + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 753 QDELISIVEVAFLCLNESPESRPPMHTVCQ 782
++++ L E+P +R + + +
Sbjct: 233 DSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 62/271 (22%), Positives = 102/271 (37%), Gaps = 26/271 (9%)
Query: 523 IGIGGQGSVYKAKL----TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVK 578
IG G G VY L AVK + + V Q F+ E + + H +++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPNVLS 92
Query: 579 FYGFCSHPRNS-FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC 637
G C S +V Y++ G L + N+ + + + M
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147
Query: 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS----SNCTELVGTFGYIAPELVY 693
VHRD++++N +L + +V+DFG+A+ + N T ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
T K T K DV+SFGVL E++ P N +L R P+
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPY-------PDVNTFDITVYLLQGRRLLQPEYCP 260
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQLL 784
D L ++ C + E RP + +
Sbjct: 261 DPLYEVML---KCWHPKAEMRPSFSELVSRI 288
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-46
Identities = 59/265 (22%), Positives = 101/265 (38%), Gaps = 21/265 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F +G G +V A+ L + A+K + P E ++ L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
VK Y + Y + G L + G+ F+ T + +AL Y+H
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG 126
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVY 693
I+HRD+ +N+LL D +++DFG AK L P+S VGT Y++PEL+
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
+ D+++ G + +++ G P + N + +I+ P+
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEYLIFQKIIKLE-YDFPEKFF 234
Query: 754 DELISIVEVAFLCLNESPESRPPMH 778
+ +VE L R
Sbjct: 235 PKARDLVE---KLLVLDATKRLGCE 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-45
Identities = 59/276 (21%), Positives = 117/276 (42%), Gaps = 25/276 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGE-----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL 571
+ IG G G VYK L + +A+K + + + + +F+ E + +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQF 66
Query: 572 RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALS 631
H +I++ G S + ++ EY+E G+L L EF+ + ++R +A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMK 124
Query: 632 YMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC---TELVGTFGYIA 688
Y+ + VHRD++++N+L+ + +VSDFG+++ L+ D + + A
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748
PE + K T DV+SFG++ EV+ + + + + I D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKAINDGFRLPT 234
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P + + ++ C + RP + +L
Sbjct: 235 PMDCPSAIYQLMM---QCWQQERARRPKFADIVSIL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-45
Identities = 55/287 (19%), Positives = 110/287 (38%), Gaps = 40/287 (13%)
Query: 523 IGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRS 575
+G G G V +A + +AVK + + ++E+K L+ L H +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP--SAHLTEREALMSELKVLSYLGNHMN 88
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE---------------FNWTVRM 620
IV G C+ + ++ EY G L L + +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 621 NVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CT 678
+ VA ++++ +HRD++++N+LL ++ DFG+A+ +K DS+
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 679 ELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLN 738
++APE ++ T + DV+S+G+ E+ +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVDSKFY 258
Query: 739 EILDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+++ P++ E+ I++ C + P RP + QL+
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLI 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 33/287 (11%)
Query: 515 NGFDVKYCIGIGGQGSVYKAKLTSG---EILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL 571
N + IG G G V KA++ A+K+ + +F E++ L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67
Query: 572 -RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEE-------------FNWT 617
H +I+ G C H +L EY G+L L +E +
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 618 VRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNC 677
++ VA + Y+ +HRD++++N+L+ +Y A+++DFG+++ +
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 678 TELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISL 737
++A E + T DV+S+GVL E++
Sbjct: 185 M-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------PYCGMTCAELY 236
Query: 738 NEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ P N DE+ ++ C E P RP + L
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 161 bits (408), Expect = 2e-44
Identities = 53/274 (19%), Positives = 105/274 (38%), Gaps = 26/274 (9%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH 573
+ +D+ +G G G V++ +G A K + + EI+T++ LRH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRH 82
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
++V + ++YE++ G L ++++ + + + +R V L +M
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHM 140
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSNCTELVGTFGYIAPEL 691
H + VH D+ +N++ + DFG+ L P S GT + APE+
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEV 196
Query: 692 VYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ- 750
V D++S GVL+ ++ G P N + +L +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG--------GENDDETLRNVKSCDWNMDDSA 248
Query: 751 --NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ ++ + L P +R +H +
Sbjct: 249 FSGISEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-44
Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 43/297 (14%)
Query: 517 FDVKYCIGIGGQGSVYKA------KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE 570
+ +G G G V A K +AVK + + ++E+K +T+
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMMTQ 96
Query: 571 L-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSN--------------------DG 609
L H +IV G C+ +L++EY G L L + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 610 AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669
+ + + VA + ++ VHRD++++NVL+ ++ DFG+A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 670 LKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS 727
+ DS+ ++APE ++ T K DV+S+G+L E+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PY 267
Query: 728 SSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
I + P +E+ I++ C RP + L
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 321
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 159 bits (402), Expect = 2e-43
Identities = 56/272 (20%), Positives = 104/272 (38%), Gaps = 26/272 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+D+ +G G G V++ +G + K ++ +P + + NEI + +L H
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPK 87
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
++ + L+ E+L G L ++ + + + +N +R L +MH
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE 145
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
IVH DI +N++ + V DFG+A L PD T + APE+V
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVD 201
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ--- 750
V D+++ GVL ++ G P + +L +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFA--------GEDDLETLQNVKRCDWEFDEDAFS 253
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+V E ++ L + P R +H +
Sbjct: 254 SVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 1e-42
Identities = 61/273 (22%), Positives = 111/273 (40%), Gaps = 21/273 (7%)
Query: 514 TNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR 572
+ +D + +G G V A+ + +++A+K + NEI L +++
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK--KALEGKEGSMENEIAVLHKIK 65
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSY 632
H +IV + +L+ + + G L + G + +I V +A+ Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKY 122
Query: 633 MHHDCFPPIVHRDISSKNVLLCL---DYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
+H IVHRD+ +N+L D + +SDFG++K P S T GT GY+AP
Sbjct: 123 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 178
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749
E++ ++ D +S GV+A ++ G P + + I L + P
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQI-LKAEYEFDSPYWD 234
Query: 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
++ D + + + PE R Q
Sbjct: 235 -DISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 53/275 (19%), Positives = 98/275 (35%), Gaps = 22/275 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR 572
+ +G G G V + + + +AVK + +F+ E+ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSY 632
HR++++ YG P +V E GSL L F VA + Y
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGY 126
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN---CTELVGTFGYIAP 689
+ +HRD++++N+LL ++ DFG+ + L + + F + AP
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749
E + T + D + FGV E+ + I + P
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE------PWIGLNGSQILHKIDKEGERLPRP 237
Query: 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
++ ++ +++ C PE RP + L
Sbjct: 238 EDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 60/282 (21%), Positives = 114/282 (40%), Gaps = 27/282 (9%)
Query: 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVPQPEFVNE 564
EI R ++ CIG G G V++ S +A+K + + + +F+ E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQE 58
Query: 565 IKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIR 624
T+ + H IVK G + +++ E G L + L + +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAY 115
Query: 625 SVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS-NCTELVGT 683
++ AL+Y+ VHRDI+++NVL+ + ++ DFG++++++ + ++
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 684 FGYIAPELVYTMKVTEKCDVYSFGVLALEVI-KGDHPRDFISSISSSSSNRNISLNEILD 742
++APE + + T DV+ FGV E++ G P + + + I +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIEN 224
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P N L S++ C P RP + L
Sbjct: 225 GERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 55/283 (19%), Positives = 117/283 (41%), Gaps = 30/283 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE 570
+ +G G G VY+ +A+K + M + EF+NE + E
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE--AASMRERIEFLNEASVMKE 79
Query: 571 LRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATIL-------SNDGAIEEFNWTVRMNVI 623
+V+ G S + + ++ E + RG L + L +N+ + + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS--NCTELV 681
+A+ ++Y++ VHRD++++N ++ D+ ++ DFG+ + + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741
+++PE + T DV+SFGV+ E+ SN + L ++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQV-LRFVM 249
Query: 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ L P N D L ++ +C +P+ RP + +
Sbjct: 250 EGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSI 289
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 58/264 (21%), Positives = 99/264 (37%), Gaps = 20/264 (7%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLT-ELRHR 574
F + +G G G V+ A+ + + A+K + E + L+ H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 575 SIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
+ + N F V EYL G L + + +F+ + + L ++H
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH 120
Query: 635 HDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYT 694
IV+RD+ N+LL D +++DFG+ K + GT YIAPE++
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQD 754
K D +SFGVL E++ G P + + I P P+ ++
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFH--------GQDEEELFHSIRMDN-PFYPRWLEK 228
Query: 755 ELISIVEVAFLCLNESPESRPPMH 778
E ++ PE R +
Sbjct: 229 EAKDLLV---KLFVREPEKRLGVR 249
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-41
Identities = 50/283 (17%), Positives = 102/283 (36%), Gaps = 26/283 (9%)
Query: 509 EIVRATNGFDVKYCIGIGGQGSVYKAKLTS-----GEILAVKKFHSLWPCEMVPQPEFVN 563
I++ T F +G G G+VYK +A+K+ + E ++
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60
Query: 564 EIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVI 623
E + + + + + G C L+ + + G L + + +N
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 117
Query: 624 RSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS--NCTELV 681
+A ++Y+ +VHRD++++NVL+ +++DFG+AK L + +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 682 GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741
++A E + T + DV+S+GV E++ I + +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------PYDGIPASEI-SSILE 227
Query: 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P ++ I+ C +SRP +
Sbjct: 228 KGERLPQPPICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 9e-41
Identities = 51/272 (18%), Positives = 100/272 (36%), Gaps = 27/272 (9%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ + +G G G V++ +S + K + Q EI L RHR+
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRN 62
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
I+ + +++E++ + ++ E N ++ + V AL ++H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS 120
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARV--SDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
I H DI +N++ + + +FG A+ LKP + L Y APE+
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQ 176
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ--- 750
V+ D++S G L ++ G +P + + I++ +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFL--------AETNQQIIENIMNAEYTFDEEAFK 228
Query: 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ E + V+ L + +SR Q
Sbjct: 229 EISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 55/292 (18%), Positives = 111/292 (38%), Gaps = 39/292 (13%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTS--------GEILAVKKFHSLWPCEMVPQPEFVNEIKTL 568
+ +G G G V A+ +AVK S + + + ++E++ +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEMM 72
Query: 569 TEL-RHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAI-------------EEF 614
+ +H++I+ G C+ +++ EY +G+L L E+
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 615 NWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674
+ ++ VA + Y+ +HRD++++NVL+ D +++DFG+A+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 675 SNCTELV--GTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSN 732
++APE ++ T + DV+SFGVL E+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-------PGVP 242
Query: 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + P N +EL ++ C + P RP + + L
Sbjct: 243 VEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (372), Expect = 3e-40
Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 26/273 (9%)
Query: 514 TNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR 572
++ +++ +G GG V+ A+ L +AVK + + F E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 573 HRSIVKFYGFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
H +IV Y + ++V EY++ +L I+ +G + VI
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTE---LVGTFG 685
AL++ H I+HRD+ N+++ +V DFGIA+ + ++ T+ ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745
Y++PE V + DVYS G + EV+ G+ P S +++ + + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-------GDSPVSVAYQHVREDPI 232
Query: 746 PTPP--QNVQDELISIVEVAFLCLNESPESRPP 776
P + + +L ++V L ++PE+R
Sbjct: 233 PPSARHEGLSADLDAVVL---KALAKNPENRYQ 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (367), Expect = 1e-39
Identities = 54/283 (19%), Positives = 109/283 (38%), Gaps = 35/283 (12%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQP------EFVNEIKTLT 569
++ K +G G V + + + AVK + + E+ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 570 ELR-HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
++ H +I++ FLV++ +++G L L+ + ++R++
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLE 121
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
+ +H IVHRD+ +N+LL D +++DFG + L P E+ GT Y+A
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLA 177
Query: 689 PELVYTM------KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL- 741
PE++ ++ D++S GV+ ++ G P + + L I+
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW--------HRKQMLMLRMIMS 229
Query: 742 -DPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ + +P + D + +V L P+ R
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 1e-39
Identities = 56/261 (21%), Positives = 105/261 (40%), Gaps = 22/261 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F + +G G G V+ + +G A+K + +E L+ + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
I++ +G + F++ +Y+E G L ++L + + +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEY 119
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
I++RD+ +N+LL + +++DFG AK++ L GT YIAPE+V T
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTK 176
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDE 755
+ D +SFG+L E++ G P SN + +IL+ L PP ++
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPP-FFNED 227
Query: 756 LISIVEVAFLCLNESPESRPP 776
+ ++ + R
Sbjct: 228 VKDLLS---RLITRDLSQRLG 245
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 2e-39
Identities = 50/285 (17%), Positives = 105/285 (36%), Gaps = 25/285 (8%)
Query: 511 VRATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLT 569
+R N + + IG G G +Y + +GE +A+K C P+ E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-----CVKTKHPQLHIESKIYK 57
Query: 570 ELRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANA 629
++ + +C + ++ L SL + + +F+ + + + +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISR 115
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSDFGIAKFLKPDSSN-------CTE 679
+ Y+H +HRD+ N L+ L + DFG+AK + ++
Sbjct: 116 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 680 LVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739
L GT Y + ++ + + D+ S G + + G P + + + IS +
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ P + + E + + C + + +P + QL
Sbjct: 233 MSTP-IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 49/274 (17%), Positives = 103/274 (37%), Gaps = 23/274 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVK---KFHSLWPCEMVPQPEFVNEIKTLTELR 572
+D +G G V K + ++G A K K + V + + E+ L E++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 573 HRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSY 632
H +++ + + + L+ E + G L L+ ++ E + L+
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE------EEATEFLKQILNG 125
Query: 633 MHHDCFPPIVHRDISSKNVLLCLDYEAR----VSDFGIAKFLKPDSSNCTELVGTFGYIA 688
+++ I H D+ +N++L + + DFG+A + + + GT ++A
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVA 184
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748
PE+V + + D++S GV+ ++ G P + + N+S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFL---GDTKQETLANVSAVNYEFE--DEY 239
Query: 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
N + L + P+ R + Q
Sbjct: 240 FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (360), Expect = 1e-38
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 25/284 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI 576
+ IG G G VYKA+ GE A+KK E +P + EI L EL+H +I
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-TTIREISILKELKHSNI 62
Query: 577 VKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
VK Y + LV+E+L++ + +G + + + N ++Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD- 118
Query: 637 CFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE-LVYTM 695
++HRD+ +N+L+ + E +++DFG+A+ T + T Y AP+ L+ +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 696 KVTEKCDVYSFGVLALEVIKGDHPRDFISSIS------------SSSSNRNISLNEILDP 743
K + D++S G + E++ G +S +S + N++ DP
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 744 RLPTPPQNVQDELISIVEVAFL-----CLNESPESRPPMHTVCQ 782
+ + ++ + + L P R +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (365), Expect = 2e-38
Identities = 58/266 (21%), Positives = 98/266 (36%), Gaps = 22/266 (8%)
Query: 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNE---IKTLTE 570
N F V IG GG G VY + +G++ A+K + +NE + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 571 LRHRSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
IV P + + + G L LS G F+ + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
+MH+ +V+RD+ N+LL R+SD G+A + + GT GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 691 -LVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749
L + D +S G + ++++G P + ++ + P
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVELP 229
Query: 750 QNVQDELISIVEVAFLCLNESPESRP 775
+ EL S++E L R
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRL 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 6e-38
Identities = 47/282 (16%), Positives = 97/282 (34%), Gaps = 29/282 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ V IG G G +++ L + + +A+K P+ +E +T L +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 61
Query: 576 -IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH 634
I Y F ++ LV + L + +F+ + + + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 118
Query: 635 HDCFPPIVHRDISSKNVLL-----CLDYEARVSDFGIAKFLKPDSSN-------CTELVG 682
+V+RDI N L+ V DFG+ KF + + L G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILD 742
T Y++ + + + D+ + G + + ++G P + + ++ I +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 743 PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
P L +E + N + ++ P + L
Sbjct: 236 P-LRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 59/273 (21%), Positives = 98/273 (35%), Gaps = 21/273 (7%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH 573
N FD +G G G V + +G A+K V E + L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+ V EY G L LS + F + +AL Y+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYL 121
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H +V+RDI +N++L D +++DFG+ K D + GT Y+APE++
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
D + GV+ E++ G P + + IL + P+ +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY--------NQDHERLFELILMEEIR-FPRTLS 229
Query: 754 DELISIVEVAFLCLNESPESRPPMH--TVCQLL 784
E S++ L + P+ R +++
Sbjct: 230 PEAKSLLA---GLLKKDPKQRLGGGPSDAKEVM 259
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-36
Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 26/269 (9%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFY 580
+G+G G V + + E A+K P+ E++ + IV+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQCPHIVRIV 71
Query: 581 GFCSHPRNS----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHD 636
+ +V E L+ G L + + + G + F +++S+ A+ Y+H
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI 130
Query: 637 CFPPIVHRDISSKNVLLCLDYE---ARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
I HRD+ +N+L +++DFG AK +S T T Y+APE++
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVLG 186
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
K + CD++S GV+ ++ G P ++ S + + P V
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS-EVS 245
Query: 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782
+E+ ++ L P R +
Sbjct: 246 EEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 37/291 (12%)
Query: 517 FDVKYCIGIGGQGSVYKA------KLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTE 570
+ +G G G V +A K + +AVK ++E+K L
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIH 72
Query: 571 LRHRS-IVKFYGFCSHPRNS-FLVYEYLERGSLATILSN-------------DGAIEEFN 615
+ H +V G C+ P ++ E+ + G+L+T L + D +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 616 WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675
+ VA + ++ +HRD++++N+LL ++ DFG+A+ + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 676 N--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNR 733
+ ++APE ++ T + DV+SFGVL E+
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVKID 243
Query: 734 NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
+ + P E+ + C + P RP + + L
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 291
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 9e-36
Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 32/283 (11%)
Query: 523 IGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPE--FVNEIKTLTELRHRSIVKF 579
+G G +VYKA+ + +I+A+KK E + EIK L EL H +I+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 580 YGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFP 639
H N LV++++E I N + + L Y+H
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 640 PIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKV-T 698
I+HRD+ N+LL + +++DFG+AK + T V T Y APEL++ ++
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 699 EKCDVYSFGVLALEVI------KGDHPRDFISSI-------------SSSSSNRNISLNE 739
D+++ G + E++ GD D ++ I S ++
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 740 ILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
L D+L+ +++ +P +R +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-35
Identities = 60/288 (20%), Positives = 109/288 (37%), Gaps = 31/288 (10%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
F IG G G VYKA+ +GE++A+KK E VP + EI L EL H +
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNHPN 62
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
IVK +LV+E+L + + ++ + + + + L++ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY-T 694
++HRD+ +N+L+ + +++DFG+A+ T V T Y APE++
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 695 MKVTEKCDVYSFGVLALEVIKGDHPRDFISSIS--------------------SSSSNRN 734
+ D++S G + E++ S I +S +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 735 ISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
S + + ++ S++ L+ P R
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-35
Identities = 59/275 (21%), Positives = 106/275 (38%), Gaps = 35/275 (12%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHS---LWPCEMVPQPEFVNEIKTLTELR 572
+ V +G GG GSVY ++ +A+K E+ E+ L ++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 573 --HRSIVKFYGFCSHPRNSFLVYEYLE-RGSLATILSNDGAIEEFNWTVRMNVIRSVANA 629
+++ + P + L+ E E L ++ GA + + V A
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEA 122
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
+ + H+ ++HRDI +N+L+ L+ E ++ DFG LK + T+ GT Y
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSP 177
Query: 689 PELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT 747
PE + + V+S G+L +++ GD P + EI+ ++
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVF- 222
Query: 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
Q V E ++ CL P RP +
Sbjct: 223 FRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 57/295 (19%), Positives = 111/295 (37%), Gaps = 30/295 (10%)
Query: 512 RATNGFDVKYCIGIGGQGSVYKAK--LTSGEILAVKKFHSLWPCEMVPQPEF--VNEIKT 567
RA ++ IG G G V+KA+ G +A+K+ E +P V ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 568 LTELRHRSIVKFYGFCSHPRNS-----FLVYEYLERGSLATILSNDGAIEEFNWTVRMNV 622
L H ++V+ + C+ R LV+E++++ + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDM 121
Query: 623 IRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVG 682
+ + L ++H +VHRD+ +N+L+ + +++DFG+A+ + T +V
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV 177
Query: 683 TFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP-------------RDFISSISSS 729
T Y APE++ D++S G + E+ + D I
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 730 SSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFL--CLNESPESRPPMHTVCQ 782
R+++L P I + L CL +P R ++
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 9e-33
Identities = 57/300 (19%), Positives = 100/300 (33%), Gaps = 43/300 (14%)
Query: 514 TNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR 572
+ IG G G V A + +A+KK + + EIK L R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFR 64
Query: 573 HRSIVKFYGFCSHP----RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
H +I+ P + +L L +L + + +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILR 120
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN---CTELVGTFG 685
L Y+H ++HRD+ N+LL + ++ DFG+A+ PD + TE V T
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 686 YIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHP----------------------RDF 722
Y APE++ T+ D++S G + E++ D
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 723 ISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
I+ + N +SL N + + +++ L +P R +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 9e-33
Identities = 55/263 (20%), Positives = 98/263 (37%), Gaps = 22/263 (8%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH 573
+ FD +G G G V K SG A+K ++ +NE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 574 RSIVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYM 633
+VK N ++V EY+ G + + L G F+ + Y+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157
Query: 634 HHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVY 693
H +++RD+ +N+L+ +V+DFG AK L GT +APE++
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIIL 211
Query: 694 TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753
+ + D ++ GVL E+ G P +++ I + E + P +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFF---------ADQPIQIYEKIVSGKVRFPSHFS 262
Query: 754 DELISIVEVAFLCLNESPESRPP 776
+L ++ L R
Sbjct: 263 SDLKDLLR---NLLQVDLTKRFG 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-32
Identities = 61/291 (20%), Positives = 101/291 (34%), Gaps = 35/291 (12%)
Query: 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ IG G G VY+AKL SGE++A+KK + E++ + +L H +
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHCN 74
Query: 576 IVKFYGFCSHPRNS------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANA 629
IV+ F LV +Y+ A + + + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKPDSSNCTELVGTFGYIA 688
L+Y+H I HRDI +N+LL D ++ DFG AK L N + + +
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 689 PELVYTMKVTEKCDVYSFGVLALEVIKGDHP--------------RDFISSISSSSSNRN 734
+ T DV+S G + E++ G + + N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 735 ISLNEILDPRLPTPP-QNVQDELISIVEVAFL--CLNESPESRPPMHTVCQ 782
+ E P++ P V +A L +P +R C
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 55/290 (18%), Positives = 112/290 (38%), Gaps = 35/290 (12%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
++ IG G G+V+KAK + EI+A+K+ E VP + EI L EL+H++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-SALREICLLKELKHKN 62
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
IV+ + + LV+E+ ++ S +G V + L +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGF 116
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTM 695
++HRD+ +N+L+ + E ++++FG+A+ + V T Y P++++
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 696 KV-TEKCDVYSFGVLALEVIKGDHP----------------------RDFISSISSSSSN 732
K+ + D++S G + E+ P + S++
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 733 RNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782
+ + + P + +++ L +P R Q
Sbjct: 237 KPYPMYPATTSLVNVVP-KLNATGRDLLQ---NLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 58/306 (18%), Positives = 113/306 (36%), Gaps = 41/306 (13%)
Query: 511 VRATNGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLT 569
+ ++ IG G G V+KA+ +G+ +A+KK E P + EIK L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI-TALREIKILQ 64
Query: 570 ELRHRSIVKFYGFCSHPRNS--------FLVYEYLERGSLATILSNDGAIEEFNWTVRMN 621
L+H ++V C + +LV+++ E + + +F +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR 121
Query: 622 VIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS----NC 677
V++ + N L Y+H I+HRD+ + NVL+ D +++DFG+A+ +
Sbjct: 122 VMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 678 TELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHP------RDFISSIS--- 727
T V T Y PEL+ + D++ G + E+ + ++ IS
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 728 ---------SSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFL--CLNESPESRPP 776
+ + E++ + ++ + + + L P R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 777 MHTVCQ 782
Sbjct: 299 SDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 55/270 (20%), Positives = 103/270 (38%), Gaps = 23/270 (8%)
Query: 515 NGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWPCEMVPQPE-FVNEIKTLT 569
F++ +G G G V+ + +G++ A+K + E E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 570 ELRHRS-IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
+R +V + L+ +Y+ G L T LS E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCT-ELVGTFGYI 687
+ + H I++RDI +N+LL + ++DFG++K D + + GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 688 APELVYTMK--VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745
AP++V + D +S GVL E++ G P N ++ +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-----VDGEKNSQAEISRRILKSE 252
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRP 775
P PQ + +++ L + P+ R
Sbjct: 253 PPYPQEMSALAKDLIQ---RLLMKDPKKRL 279
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-29
Identities = 52/309 (16%), Positives = 107/309 (34%), Gaps = 47/309 (15%)
Query: 507 YEEIVRATNGFDVKY----CIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEF 561
+E+ + Y +G G G+V A +G +A+KK + + E+ +
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RA 64
Query: 562 VNEIKTLTELRHRSIVKFYGFCSHPRNS------FLVYEYLERGSLATILSNDGAIEEFN 615
E++ L +RH +++ + +LV ++ + +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----KLG 119
Query: 616 WTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675
++ + L Y+H HRD+ N+ + D E ++ DFG+A+ DS
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ--ADSE 174
Query: 676 NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHP---------------- 719
+V + ++ M+ T+ D++S G + E+I G
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 720 -----RDFISSISSSSS-NRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPES 773
+F+ + S + N L E+ + N ++++E L E
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQ 291
Query: 774 RPPMHTVCQ 782
R
Sbjct: 292 RVTAGEALA 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (286), Expect = 1e-28
Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 16/290 (5%)
Query: 115 ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKS 174
+P + LDL N+++ NL NL L L N +S P L
Sbjct: 23 EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 175 LFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234
L L+LS NQL L L V + S+ + L N +++ LG + S
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSS 139
Query: 235 GVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLT 294
G+ + + L + + D ++ I G SL L L+GN++ +L L
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITT----IPQGLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 295 ELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNIL 354
L L LS N + +L N L L+L+NN+ K P L + + L N +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI 254
Query: 355 EG------KIPCEICNMESLEKLNLSHN--NFSGLIPSCFEGMHGLSCID 396
P S ++L N + + PS F ++ + +
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (250), Expect = 6e-24
Identities = 58/281 (20%), Positives = 96/281 (34%), Gaps = 14/281 (4%)
Query: 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ 136
+ LDL NK+ F NL NL + L N +S P L L L LS+NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 137 LSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNL 196
L L L V + S+ + + N + L + + SG + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 197 SNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQ 256
L + + + ++ + +L L L N ++ V S+ LNNL L
Sbjct: 150 KKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLG-LSFN 205
Query: 257 LSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN------SI 310
+ L L LN N+L P L ++ + L N +
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 311 PETLGNLLKLHYLNLSNN--QFRKGFPVELEKLIQLSELDL 349
P ++L +N Q+ + P + + + L
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.3 bits (181), Expect = 6e-15
Identities = 45/226 (19%), Positives = 84/226 (37%), Gaps = 7/226 (3%)
Query: 212 SIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS 271
+P L L L N ++ + NL NL L L +N++ P L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVK 80
Query: 272 LNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR 331
L L L+ NQL + +L EL + K+ S+ L ++ + L + +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSS 139
Query: 332 KGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHG 391
+ + +LS + ++ + IP + SL +L+L N + + + +G++
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNN 196
Query: 392 LSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCN 437
L+ + +S+N + S E N L G
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (281), Expect = 9e-28
Identities = 59/300 (19%), Positives = 104/300 (34%), Gaps = 48/300 (16%)
Query: 515 NGFDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR- 572
+ + + +G G V++A +T+ E + VK V + + EIK L LR
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88
Query: 573 HRSIVKFYGFCSHP--RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
+I+ P R LV+E++ + + + + AL
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL------YQTLTDYDIRFYMYEILKAL 142
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
Y H I+HRD+ NV++ + + R+ D+G+A+F P V + + P
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 198
Query: 690 ELVYTMK-VTEKCDVYSFGVLALEVIKGDHP-----------------------RDFISS 725
EL+ + D++S G + +I P D+I
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 726 ISSSSSNR-NISLNEILDPRLPTPPQNVQDELISIVEVAFL--CLNESPESRPPMHTVCQ 782
+ R N L R + L+S + FL L +SR +
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 110 bits (275), Expect = 3e-27
Identities = 93/334 (27%), Positives = 140/334 (41%), Gaps = 35/334 (10%)
Query: 5 EAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVIS 64
+ ALL+ K L N + LSSW T+ W G+ C+ +
Sbjct: 7 DKQALLQIKKDL--GNPTTLSSW-----LPTTDCC--------NRTWLGVLCDTDTQTYR 51
Query: 65 INLSTVGLKGNLKSLSTLDLSKNKLNG--SIPFSFGNLTNLAIMYLYRN-SLSASIPPVI 121
+N LDLS L IP S NL L +Y+ +L IPP I
Sbjct: 52 VN--------------NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97
Query: 122 GNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLS 181
L L++L ++ +SG+IP L + L L N+LSG++P I +L +L +
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 182 SNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSI 241
N++SG+IP S G+ S L + L + LS N L G +
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLF 217
Query: 242 GNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDL 301
G+ N ++L N L+ + + K + L N++YG LP+ L L L L++
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 302 STNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFP 335
S N L IP+ GNL + +NN+ G P
Sbjct: 276 SFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.3 bits (191), Expect = 3e-16
Identities = 67/263 (25%), Positives = 109/263 (41%), Gaps = 7/263 (2%)
Query: 170 GNLKSLFYLHLSSNQLSGSIPI--SLGNLSNLVVLHLFEN-SLFGSIPSILGNLKMLLHL 226
+ L LS L PI SL NL L L++ +L G IP + L L +L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 227 GLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286
++ ++SG IP + + L+ L N G +P I L +L + +GN++ G +
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNA-LSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 287 PRALGSLTELEYLDLST-NKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS 345
P + GS ++L + N+L IP T N + +G L + +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFAN--LNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 346 ELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGP 405
+ ++ ++L L+L +N G +P + L ++VS+N L G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 406 IPNSRIFQYDPMEALQGNKGLCG 428
IP Q + A NK LCG
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.7 bits (161), Expect = 2e-12
Identities = 22/68 (32%), Positives = 34/68 (50%), Gaps = 1/68 (1%)
Query: 125 KFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQ 184
K L LDL N++ G++P L L L L++ N+L G IP GNL+ ++N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302
Query: 185 LSGSIPIS 192
P+
Sbjct: 303 CLCGSPLP 310
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-26
Identities = 42/210 (20%), Positives = 83/210 (39%), Gaps = 18/210 (8%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ IG G QG V A +A+KK + + + E+ + + H++
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVNHKN 77
Query: 576 IVKFYGFCSHPRNS------FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANA 629
I+ + + +LV E ++ I E + ++ +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCG 131
Query: 630 LSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAP 689
+ ++H +HRD+ N+++ D ++ DFG+A+ S T V T Y AP
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAP 187
Query: 690 ELVYTMKVTEKCDVYSFGVLALEVIKGDHP 719
E++ M E D++S G + E+++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-24
Identities = 51/296 (17%), Positives = 96/296 (32%), Gaps = 44/296 (14%)
Query: 517 FDVKYCIGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+ +G G GSV A +G +AVKK + + + E++ L ++H +
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKHMKHEN 78
Query: 576 IVKFYGFCSHPR-----NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANAL 630
++ + R N + +L L I+ +I + L
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGL 134
Query: 631 SYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSNCTELVGTFGYIAPE 690
Y+H HRD+ N+ + D E ++ DFG+A+ D + +
Sbjct: 135 KYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEI 189
Query: 691 LVYTMKVTEKCDVYSFGVLALEVIKGDHP----------------------RDFISSISS 728
++ M + D++S G + E++ G S
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784
S+ N SL ++ + ++E L + R T Q L
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRI---TAAQAL 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.3 bits (233), Expect = 2e-21
Identities = 54/275 (19%), Positives = 91/275 (33%), Gaps = 23/275 (8%)
Query: 523 IGIGGQGSVYKAK-LTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYG 581
+G G +V+ AK + + +A+K + V +EIK L + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 582 FCS-------------HPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVAN 628
+ P +V + G L + + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 629 ALSYMHHDCFPPIVHRDISSKNVLLCL-DYEARVSDFGIAKFLKPDSS--NCTELVGTFG 685
L YMH C I+H DI +NVL+ + D + IA + T + T
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 686 YIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745
Y +PE++ D++S L E+I GD + S + + +I+ L L
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTV 780
P+ + L N S P+ V
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.1 bits (230), Expect = 7e-21
Identities = 75/366 (20%), Positives = 131/366 (35%), Gaps = 50/366 (13%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L L K + ++ + +L + + R + SI + L L ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFY------LHLSSNQLSGS 188
NQL+ P L NL+ L + + N ++ P + + + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 189 IPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLS-------I 241
+ + + + + S + L L T I + +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 242 GNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDL 301
L NL L +NQ+S +G L++L+ L LNGNQL L SLT L LDL
Sbjct: 194 AKLTNLESLIATNNQISD---ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 302 STNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPV--------------------ELEKL 341
+ N++ N P L L KL L L NQ P+ + L
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 342 IQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNE 401
L+ L L N + P + ++ L++L ++N S S + ++ + +N+
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 402 LRGPIP 407
+ P
Sbjct: 363 ISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.6 bits (226), Expect = 2e-20
Identities = 83/370 (22%), Positives = 134/370 (36%), Gaps = 54/370 (14%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
N++ + +L ++TL + + SI L NL + N L+ P + NL
Sbjct: 33 NVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLT 88
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSI---------------IG 170
L + ++ NQ++ P L + + ++ I
Sbjct: 89 KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS 148
Query: 171 NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230
L L L S + L NL+ L L + N S S+L L L L +
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDISVLAKLTNLESLIATN 206
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRAL 290
N +S + P +G L NL L L NQL + L++L L L NQ+ P L
Sbjct: 207 NQISDITP--LGILTNLDELSLNGNQLK---DIGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 291 GSLTELEYLDLSTNKLGNSIP--------------------ETLGNLLKLHYLNLSNNQF 330
LT+L L L N++ N P + NL L YL L N
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 331 RKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMH 390
P + L +L L + N + + N+ ++ L+ HN S L P +
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLT 373
Query: 391 GLSCIDVSYN 400
++ + ++
Sbjct: 374 RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.4 bits (223), Expect = 6e-20
Identities = 61/207 (29%), Positives = 86/207 (41%), Gaps = 14/207 (6%)
Query: 49 CAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYL 108
+ + + +S + G L +L L L+ N+L + +LTNL + L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 109 YRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSI 168
N +S P + L L L L NQ+S P L L+ L L L N S
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISP 302
Query: 169 IGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGL 228
I NLK+L YL L N +S P+ +L+ L L N + S S L NL + L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKV--SDVSSLANLTNINWLSA 358
Query: 229 STNHLSGVIPLSIGNLNNLIGLYLYDN 255
N +S + PL NL + L L D
Sbjct: 359 GHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (220), Expect = 3e-20
Identities = 67/278 (24%), Positives = 107/278 (38%), Gaps = 11/278 (3%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
+ L ++P + + + L+GN +S + ++L L L SN L+
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 189 IPISLGNLSNLVVLHLFENSLFGSI-PSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247
+ L+ L L L +N+ S+ P+ L L L L L + P L L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 248 IGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLG 307
LYL DN L L +L +L L+GN++ RA L L+ L L N++
Sbjct: 132 QYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 308 NSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICN-ME 366
+ P +L +L L L N L L L L L+ N C
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC--DCRARPLWA 248
Query: 367 SLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRG 404
L+K S + +P + + G ++ N+L+G
Sbjct: 249 WLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (216), Expect = 1e-19
Identities = 56/253 (22%), Positives = 92/253 (36%), Gaps = 29/253 (11%)
Query: 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNS------------------------ 112
+ + L N+++ SF NL I++L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 113 -LSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGN 171
L + P L L+ L L L P L+ L L+L N+L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 172 LKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTN 231
L +L +L L N++S + L +L L L +N + P +L L+ L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 232 HLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALG 291
+LS + ++ L L L L DN + + L + +++ +LP+ L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWV-CDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 292 --SLTELEYLDLS 302
L L DL
Sbjct: 270 GRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (196), Expect = 4e-17
Identities = 58/258 (22%), Positives = 88/258 (34%), Gaps = 6/258 (2%)
Query: 153 VLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGS 212
L ++P I + + L N++S S NL +L L N L
Sbjct: 15 TTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 213 IPSILGNLKMLLHLGLSTNHLSGVI-PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSS 271
+ L +L L LS N + P + L L L+L D P L++
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL-DRCGLQELGPGLFRGLAA 130
Query: 272 LNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFR 331
L YL L N L L L +L L N++ + L L L L N+
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 332 KGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHG 391
P L +L L L N L + + +L+ L L+ N + +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAW 249
Query: 392 LSCIDVSYNELRGPIPNS 409
L S +E+ +P
Sbjct: 250 LQKFRGSSSEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 5e-14
Identities = 48/244 (19%), Positives = 76/244 (31%), Gaps = 4/244 (1%)
Query: 15 SLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPCAWFGIQCNPAKRVISINLSTVGLKG 74
+ + + + + + ++ +
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L L TL L + L P F L L +YL N+L A +L L HL L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
N++S L +L L L+ N ++ P +L L L+L +N LS +L
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
L L L L +N L S++ + +P L L
Sbjct: 223 PLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAA 278
Query: 255 NQLS 258
N L
Sbjct: 279 NDLQ 282
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 28/173 (16%), Positives = 51/173 (29%), Gaps = 26/173 (15%)
Query: 523 IGIGGQGSVYKAKLTSGEILAVKK-------FHSLWPCEMVPQPEFVNEIKTLTELRHRS 575
+G G + +V+ VK F + F R+
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 576 IVKFYGFCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH 635
+ K G Y + E ++ L + + V+ + ++ +H
Sbjct: 68 LQKLQGLAVPKV-----YAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 636 DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK---------FLKPDSSNCTE 679
IVH D+S NVL+ + + DF + L+ D N
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.4 bits (163), Expect = 7e-13
Identities = 46/211 (21%), Positives = 75/211 (35%), Gaps = 8/211 (3%)
Query: 121 IGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180
+ + ++ + L+ ++PP L + +LHL N L + + L L+L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLS 240
+L+ L L L L N L + + +S N L+ + +
Sbjct: 63 DRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGA 119
Query: 241 IGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLD 300
+ L L LYL N+L P + L L L N L L L L+ L
Sbjct: 120 LRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFR 331
L N +IP+ L + L N +
Sbjct: 179 LQENS-LYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 54/210 (25%), Positives = 76/210 (36%), Gaps = 8/210 (3%)
Query: 169 IGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGL 228
+ + S ++ L+ ++P L + +LHL EN L+ + L L L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 229 STNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPR 288
G L L L L NQL + + L ++ N+L
Sbjct: 63 D--RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL--TVLDVSFNRLTSLPLG 118
Query: 289 ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELD 348
AL L EL+ L L N+L P L KL L+L+NN + L L L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 349 LSLNILEGKIPCEICNMESLEKLNLSHNNF 378
L N L IP L L N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (135), Expect = 3e-09
Identities = 54/207 (26%), Positives = 75/207 (36%), Gaps = 8/207 (3%)
Query: 55 QCNPAKRVISINLSTVGLK----GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYR 110
+ + + +N L K + L LS+N L + T L L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRL--TQLNL 62
Query: 111 NSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIG 170
+ + V G L L LDLS NQ S+P L L VL + N L+ +
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 171 NLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230
L L L+L N+L P L L L L N+L +L L+ L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 231 NHLSGVIPLSIGNLNNLIGLYLYDNQL 257
N L IP + L +L+ N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 1e-06
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 8/212 (3%)
Query: 192 SLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLY 251
+ +++ + ++ + +L ++P L K L LS N L ++ L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 252 LYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIP 311
L +L+ ++ + L +L+ L L LD+S N+L +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL----PALTVLDVSFNRLTSLPL 117
Query: 312 ETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKL 371
L L +L L L N+ + P L +L +L L+ N L + +E+L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 372 NLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
L N+ IP F G H L + N
Sbjct: 178 LLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.5 bits (158), Expect = 3e-12
Identities = 46/261 (17%), Positives = 91/261 (34%), Gaps = 18/261 (6%)
Query: 81 TLDLSKNKLNGSIPFSFGNLT--NLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLS 138
TLDL+ L+ + G L + R+ + + + + H+DLS + +
Sbjct: 4 TLDLTGKNLHPDVT---GRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59
Query: 139 G-SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSL--------FYLHLSSNQLSGSI 189
++ L S L L L G LS I + + +L + Q S
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 190 PISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIG 249
L L+ E + ++ + + L G N + + NL+
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNG-NQLYGNLPRALGSLTELEYLDLSTNKLGN 308
L L D+ + + E +L+ L +L L+ + LG + L+ L +
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 309 SIPETLGNL--LKLHYLNLSN 327
++ L L+++ + +
Sbjct: 240 TLQLLKEALPHLQINCSHFTT 260
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 4e-08
Identities = 36/266 (13%), Positives = 75/266 (28%), Gaps = 20/266 (7%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG- 187
LDL+ L + L + + + + + + + ++ LS++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 188 SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247
++ L S L L L L I + L L+ L LS L ++
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-SSC 120
Query: 248 IGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLG 307
L + + + + L G +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK---------------NLQKS 165
Query: 308 NSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS-LNILEGKIPCEICNME 366
+ +H + + E +L L L LS + + E+ +
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225
Query: 367 SLEKLNLSHNNFSGLIPSCFEGMHGL 392
+L+ L + G + E + L
Sbjct: 226 TLKTLQVFGIVPDGTLQLLKEALPHL 251
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 25/175 (14%), Positives = 53/175 (30%), Gaps = 5/175 (2%)
Query: 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQF-RKG 333
L L G L+ ++ L S + + + + E + ++ +++LSN+
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 334 FPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLS--HNNFSGLIPSCFEGMHG 391
L + +L L L L I + +L +LNLS + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 392 LSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQI 446
L +++S+ + Q N + +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 7e-04
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 162 SGSIPSIIGNLKSLFYLHLSS-NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNL 220
L L +L LS + + LG + L L +F G++ + L
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL 248
Query: 221 KMLLHLGLSTNHLSGVIPLSIGNLNNL 247
HL ++ +H + + +IGN N
Sbjct: 249 P---HLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 8e-04
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 4/87 (4%)
Query: 114 SASIPPVIGNLKFLYHLDLSE-NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNL 172
L +L HL LS + LG + L L ++G G++ + L
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL 248
Query: 173 KSLFYLHLSSNQLSGSIPISLGNLSNL 199
L ++ + + ++GN N
Sbjct: 249 PH---LQINCSHFTTIARPTIGNKKNQ 272
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 58.9 bits (141), Expect = 3e-10
Identities = 37/218 (16%), Positives = 75/218 (34%), Gaps = 21/218 (9%)
Query: 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182
L + ++ ++ ++ T +L + L +G ++ +I + L +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGV-QYLNNLIGLELKD 72
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
NQ++ P+ + L +I + + L T+ ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 243 NLNNLIGLYLYDNQLSVG-------------EIPIEIGKLSSLNYLVLNGNQLYGNLPRA 289
L + + L+ + LS L L + N++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 290 LGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSN 327
L SL L + L N++ + P L N L + L+N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 33/228 (14%), Positives = 74/228 (32%), Gaps = 19/228 (8%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L + + K+ + ++ + +L + + + ++ +I + L L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
NQ++ P L +I + ++ + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
L + + L G ++ + NL+ L L D
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVS----------DLTPLANLSKLTTLKADD 182
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302
N++S + L +L + L NQ+ P L + + L + L+
Sbjct: 183 NKISD---ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 8e-07
Identities = 38/229 (16%), Positives = 77/229 (33%), Gaps = 19/229 (8%)
Query: 147 NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206
L+N + ++++ ++ +L + L ++ +I + L+NL+ L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI 266
N + + + K+ + + ++ L ++ +
Sbjct: 73 NQIT-DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 267 GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLS 326
L + N + L G LS S L NL KL L
Sbjct: 132 QVLYLDLNQITNISPLAGLTN----------LQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 327 NNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSH 375
+N+ P L L L E+ L N + P + N +L + L++
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 5/79 (6%)
Query: 106 MYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSI 165
YL + S + NL L L +N++S P L +L NL +HL N +S
Sbjct: 154 QYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS 211
Query: 166 PSIIGNLKSLFYLHLSSNQ 184
P + N +LF + L +NQ
Sbjct: 212 P--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 41/205 (20%), Positives = 69/205 (33%), Gaps = 21/205 (10%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
N++ + +L ++TL + +I L NL + L N ++ P
Sbjct: 30 NVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKI 87
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNL------------- 172
L + + +I + + + S + L
Sbjct: 88 TELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPL 147
Query: 173 -KSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTN 231
+LS S L NLS L L +N + P L +L L+ + L N
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNN 205
Query: 232 HLSGVIPLSIGNLNNLIGLYLYDNQ 256
+S V PL+ N +NL + L NQ
Sbjct: 206 QISDVSPLA--NTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 27/203 (13%), Positives = 63/203 (31%), Gaps = 21/203 (10%)
Query: 219 NLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLN 278
L + + ++++ + + +L+ + L + ++ E + L++L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIE---GVQYLNNLIGLELK 71
Query: 279 GNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL 338
NQ+ P + L + K ++I + L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 339 EKLIQLSELDLSLNILEGKIPCE--------------ICNMESLEKLNLSHNNFSGLIPS 384
+ L +++ L G + + N+ L L N S + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 385 CFEGMHGLSCIDVSYNELRGPIP 407
+ L + + N++ P
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP 212
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.8 bits (143), Expect = 5e-10
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 9/94 (9%)
Query: 106 MYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSI 165
Y N+ S I + L L++S N+L +P L L N L+ +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EV 319
Query: 166 PSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL 199
P + NLK LH+ N L P ++ +L
Sbjct: 320 PELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 22/103 (21%), Positives = 36/103 (34%), Gaps = 9/103 (8%)
Query: 49 CAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYL 108
+ + + + L SL L++S NKL +P L L
Sbjct: 256 FSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IA 311
Query: 109 YRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNL 151
N L+ +P + NLK L + N L P ++ +L
Sbjct: 312 SFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 7e-08
Identities = 25/96 (26%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 129 HLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS 188
N S I +L L++ N L +P++ L+ L S N L+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-E 318
Query: 189 IPISLGNLSNLVVLHLFENSL--FGSIPSILGNLKM 222
+P NL LH+ N L F IP + +L+M
Sbjct: 319 VPELPQNLK---QLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 25/93 (26%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIP 214
Y N+ S I S+ SL L++S+N+L +P L L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVP 320
Query: 215 SILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNL 247
+ NLK L + N L P ++ +L
Sbjct: 321 ELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 7e-07
Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 11/97 (11%)
Query: 228 LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP 287
N S I +L L + +N+L E+P +L L + N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI--ELPALPPRLERLI---ASFNHL-AEVP 320
Query: 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLN 324
+L + L + N L P+ ++ L +N
Sbjct: 321 ELPQNLKQ---LHVEYNPL-REFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 6e-06
Identities = 24/76 (31%), Positives = 32/76 (42%), Gaps = 9/76 (11%)
Query: 269 LSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNN 328
SL L ++ N+L LP LE L S N L +PE N L L++ N
Sbjct: 283 PPSLEELNVSNNKL-IELP---ALPPRLERLIASFNHL-AEVPELPQN---LKQLHVEYN 334
Query: 329 QFRKGFPVELEKLIQL 344
R+ FP E + L
Sbjct: 335 PLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 6e-06
Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPC 360
N N I L LN+SNN+ + P + L L S N L ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 321
Query: 361 EICNMESLEKLNLSHNNFSGLIPSCFEGMHGL 392
N L++L++ +N P E + L
Sbjct: 322 LPQN---LKQLHVEYNPLREF-PDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 8e-06
Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 12/97 (12%)
Query: 277 LNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPV 336
N + LE L++S NKL +P L L S N
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHLA----- 317
Query: 337 ELEKLIQ-LSELDLSLNILEGKIPCEICNMESLEKLN 372
E+ +L Q L +L + N L + P ++E L ++N
Sbjct: 318 EVPELPQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 18/68 (26%), Positives = 30/68 (44%), Gaps = 5/68 (7%)
Query: 149 SNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENS 208
L L LS S+P + +L+S L S N L+ +P +L +L+V + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 209 LFGSIPSI 216
L P +
Sbjct: 93 LSDLPPLL 100
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 14/57 (24%), Positives = 21/57 (36%), Gaps = 5/57 (8%)
Query: 72 LKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLY 128
L L L S N L +P NL L ++ N L P + +++ L
Sbjct: 299 LPALPPRLERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 17/66 (25%), Positives = 30/66 (45%), Gaps = 5/66 (7%)
Query: 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQ 136
+ L+L+ L+ S+P +L +L NSL+ +P + +LK L + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 137 LSGSIP 142
LS P
Sbjct: 93 LSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 19/79 (24%), Positives = 31/79 (39%), Gaps = 5/79 (6%)
Query: 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS 160
+ L LS S+P + +L+ L S N L+ +P +L +L V + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 161 LSGSIPSIIGNLKSLFYLH 179
LS P + S L
Sbjct: 93 LSDLPPLLEYLGVSNNQLE 111
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 1e-09
Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 5/112 (4%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
+L+ + L ++ LDLS N+L P + L L ++ N+ + NL
Sbjct: 9 DLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVDGVANLP 65
Query: 126 FLYHLDLSENQL-SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLF 176
L L L N+L + L + L +L+L GNSL I L +
Sbjct: 66 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 7e-08
Identities = 30/126 (23%), Positives = 46/126 (36%), Gaps = 11/126 (8%)
Query: 177 YLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV 236
LHL+ L+ + L L + L L N L P++ L+ L L + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVL--QASDNALE 56
Query: 237 IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYG------NLPRAL 290
+ NL L L L +N+L + L L L GN L L L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 291 GSLTEL 296
S++ +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 26/108 (24%), Positives = 40/108 (37%), Gaps = 6/108 (5%)
Query: 298 YLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK 357
L L+ L ++ L LL + +L+LS+N+ R P L L L L S N LE
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 358 IPCEICNMESLEKLNLSHNNFSGL-IPSCFEGMHGLSCIDVSYNELRG 404
++L L +N L +++ N L
Sbjct: 59 DGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 5e-07
Identities = 26/108 (24%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGS 140
L L+ L ++ L + + L N L ++PP + L+ L L S+N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA--LE 56
Query: 141 IPPTLGNLSNLAVLHLYGNSL-SGSIPSIIGNLKSLFYLHLSSNQLSG 187
+ NL L L L N L + + + L L+L N L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 6e-07
Identities = 27/109 (24%), Positives = 41/109 (37%), Gaps = 6/109 (5%)
Query: 274 YLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKG 333
L L L + L L + +LDLS N+L ++P L L L L +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQ--ASDNALE 56
Query: 334 FPVELEKLIQLSELDLSLN-ILEGKIPCEICNMESLEKLNLSHNNFSGL 381
+ L +L EL L N + + + + L LNL N+
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 3e-09
Identities = 41/220 (18%), Positives = 77/220 (35%), Gaps = 23/220 (10%)
Query: 114 SASIPPVIG------NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS 167
+ ++P I +L + ++ ++ T L+++ + + +
Sbjct: 7 TITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG- 63
Query: 168 IIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLG 227
I L ++ L L+ N+L+ P++ NL L L
Sbjct: 64 -IQYLPNVTKLFLNGNKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117
Query: 228 LSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP 287
++ I L +L L + + +L+ L+ L L NQ+ +P
Sbjct: 118 SLEHN----GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP 173
Query: 288 RALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSN 327
L LT+L+ L LS N + S L L L L L +
Sbjct: 174 --LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 35/223 (15%), Positives = 74/223 (33%), Gaps = 21/223 (9%)
Query: 180 LSSNQLSGSIPIS----LGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSG 235
L S ++ PI + + +L + S+ ++ L + + + + +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS 60
Query: 236 VIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTE 295
V + L N+ L+L N+L+ +I L++L L + +
Sbjct: 61 VQGIQ--YLPNVTKLFLNGNKLT------DIKPLANLKNLGWLFLDENKVKDLSSLKDLK 112
Query: 296 LEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILE 355
+ + I + +N L KL LS D ++ +
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV 172
Query: 356 GKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398
+ + L+ L LS N+ S L G+ L +++
Sbjct: 173 -----PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 39/204 (19%), Positives = 63/204 (30%), Gaps = 17/204 (8%)
Query: 147 NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206
+ +L S++ ++ L S+ + +++ + I L N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI 266
N L P L NLK L L L N + + L + L G + +
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 267 GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLS 326
+ L + + L + E + L L KL L LS
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS---------DIVPLAGLTKLQNLYLS 186
Query: 327 NNQFRKGFPVELEKLIQLSELDLS 350
N L L L L+L
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 36/205 (17%), Positives = 71/205 (34%), Gaps = 17/205 (8%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
+L K + ++ + L ++ + + + + I L + L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
N+L+ L+NL L + + I G
Sbjct: 78 NKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN---G 129
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
+ + L+ + + ++L L L L L N +S ++PL+ L L LYL
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSK 187
Query: 255 NQLSVGEIPIEIGKLSSLNYLVLNG 279
N +S ++ + L +L+ L L
Sbjct: 188 NHIS--DLR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 42/191 (21%), Positives = 71/191 (37%), Gaps = 15/191 (7%)
Query: 66 NLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLK 125
+++ + L S+ + + + + L N+ ++L N L + + NLK
Sbjct: 35 SVTDAVTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKL--TDIKPLANLK 90
Query: 126 FLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQL 185
L L L EN++ + I I G + L
Sbjct: 91 NLGWLFLDENKVKDLSSLKDLK------KLKSLSLEHNGISDINGLVHLPQLESLYLGNN 144
Query: 186 SGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245
+ L L+ L L L +N + +P L L L +L LS NH+S + L+ L
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLK 200
Query: 246 NLIGLYLYDNQ 256
NL L L+ +Q
Sbjct: 201 NLDVLELF-SQ 210
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 1e-08
Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 246 NLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL----YGNLPRALGSLTELEYLDL 301
++ L + +LS + L + L+ L ++ AL L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 302 STNKLGNSIPETLGNLL-----KLHYLNLSNNQF 330
+N+LG+ + L K+ L+L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 9/83 (10%)
Query: 270 SSLNYLVLNGNQL----YGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK-----L 320
S L L L + +L L + L LDLS N LG++ L ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 321 HYLNLSNNQFRKGFPVELEKLIQ 343
L L + + + L+ L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 4e-07
Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 10/88 (11%)
Query: 127 LYHLDLSENQLSGS-IPPTLGNLSNLAVLHLYGNSLSG----SIPSIIGNLKSLFYLHLS 181
+ LD+ +LS + L L V+ L L+ I S + +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 182 SNQLSGSIPISLG-----NLSNLVVLHL 204
SN+L + + L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 5/91 (5%)
Query: 150 NLAVLHLYGNSLSGS-IPSIIGNLKSLFYLHLSSNQLSG----SIPISLGNLSNLVVLHL 204
++ L + LS + ++ L+ + L L+ I +L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 205 FENSLFGSIPSILGNLKMLLHLGLSTNHLSG 235
N L + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 78 SLSTLDLSKNKLNGS-IPFSFGNLTNLAIMYLYRNSLS----ASIPPVIGNLKFLYHLDL 132
+ +LD+ +L+ + L ++ L L+ I + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 133 SENQLSGSIPPTLGNLSNLAVLHLYGNSLSG 163
N+L + + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 20/84 (23%), Positives = 31/84 (36%), Gaps = 9/84 (10%)
Query: 147 NLSNLAVLHLYGNSLSG----SIPSIIGNLKSLFYLHLSSNQLSGSIPISLG-----NLS 197
S L VL L +S S+ + + SL L LS+N L + + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 198 NLVVLHLFENSLFGSIPSILGNLK 221
L L L++ + L L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 18/86 (20%), Positives = 30/86 (34%), Gaps = 9/86 (10%)
Query: 97 FGNLTNLAIMYLYRNSLS----ASIPPVIGNLKFLYHLDLSENQLSGSIPPTLG-----N 147
+ L +++L +S +S+ + L LDLS N L + L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 148 LSNLAVLHLYGNSLSGSIPSIIGNLK 173
L L LY S + + L+
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 17/80 (21%), Positives = 26/80 (32%), Gaps = 9/80 (11%)
Query: 319 KLHYLNLSNNQFR----KGFPVELEKLIQLSELDLSLNILEGKIPCEIC-----NMESLE 369
L L L++ L L ELDLS N L ++ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 370 KLNLSHNNFSGLIPSCFEGM 389
+L L +S + + +
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 14/100 (14%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 271 SLNYLVLNGNQLYGN-LPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK----LHYLNL 325
+ L + +L L L + + + L L + + + + L+ L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 326 SNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNM 365
+N+ + + +Q + L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 6e-05
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 12/86 (13%)
Query: 296 LEYLDLSTNKLGN----SIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQ-----LSE 346
L L L+ + + S+ TL L L+LSNN ++L + ++ L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 347 LDLSLNILEGKIPCEICNMESLEKLN 372
L L ++ + ++LEK
Sbjct: 431 LVLYDIYWSEEMEDRL---QALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 14/74 (18%), Positives = 24/74 (32%), Gaps = 5/74 (6%)
Query: 318 LKLHYLNLSNNQFR-KGFPVELEKLIQLSELDLSLNILEGKIPCEIC----NMESLEKLN 372
L + L++ + + L L Q + L L +I +L +LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 373 LSHNNFSGLIPSCF 386
L N + C
Sbjct: 62 LRSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 9/83 (10%)
Query: 171 NLKSLFYLHLSSNQLSG----SIPISLGNLSNLVVLHLFENSLFGSIPSILG-----NLK 221
L L L+ +S S+ +L +L L L N L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 222 MLLHLGLSTNHLSGVIPLSIGNL 244
+L L L + S + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.8 bits (117), Expect = 2e-07
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 12/186 (6%)
Query: 49 CAWFGIQCNPAKRVISINLSTVGLKGNLKSLSTLDLSKNKLNGSIPFSF-GNLTNLAIMY 107
C + C L + + + L L+ N+L G L +L +
Sbjct: 8 CEGTTVDCT------GRGLKEIP-RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60
Query: 108 LYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPS 167
L RN L+ P + L L EN++ L L L+LY N +S +P
Sbjct: 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120
Query: 168 IIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLG 227
+L SL L+L+SN + + ++ L L + PS + ++++
Sbjct: 121 SFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQI---KD 176
Query: 228 LSTNHL 233
L +
Sbjct: 177 LPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 4e-04
Identities = 38/178 (21%), Positives = 61/178 (34%), Gaps = 9/178 (5%)
Query: 106 MYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTL-GNLSNLAVLHLYGNSLSGS 164
+ L IP I L L++N+L L G L +L L L N L+G
Sbjct: 13 VDCTGRGLK-EIPRDIPLH--TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 165 IPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLL 224
P+ + L L N++ L L L+L++N + +P +L L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 225 HLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL 282
L L++N + L L L G K+ + L ++
Sbjct: 130 SLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS----KVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 0.002
Identities = 46/173 (26%), Positives = 68/173 (39%), Gaps = 6/173 (3%)
Query: 237 IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTEL 296
IP I + L L DN+L G+L L L L NQL G P A + +
Sbjct: 23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 297 EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEG 356
+ L L NK+ + L +L LNL +NQ P E L L+ L+L+ +
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA-SNPFN 139
Query: 357 KIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNS 409
E L K +L+ PS + + D+ ++E + NS
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENS 189
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 8e-07
Identities = 23/138 (16%), Positives = 40/138 (28%), Gaps = 5/138 (3%)
Query: 285 NLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQL 344
L + + L L + L LN ++ + E + +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPEL 67
Query: 345 SELDLSLNILEGK--IPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNEL 402
L+LS N L + + +L+ LNLS N L + + N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 403 RGPIPNSRIFQYDPMEAL 420
+ + E
Sbjct: 128 SDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 3e-06
Identities = 26/128 (20%), Positives = 50/128 (39%), Gaps = 5/128 (3%)
Query: 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKL 320
++ + + K + L+ L L + L+ + + ++ N+ +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67
Query: 321 HYLNLSNNQFRK--GFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNF 378
LNLSNN+ + ++K L L+LS N L+ + + LE+L L N+
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 379 SGLIPSCF 386
S
Sbjct: 128 SDTFRDQS 135
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 4e-05
Identities = 29/179 (16%), Positives = 56/179 (31%), Gaps = 27/179 (15%)
Query: 179 HLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIP 238
L Q+ + + + + L L L + + L + ++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 239 LSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEY 298
+ N+ L+ L L +N+L ++ + L+
Sbjct: 59 IIEENIPELLSLNLSNNRLYR-----------------------LDDMSSIVQKAPNLKI 95
Query: 299 LDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGK 357
L+LS N+L + LKL L L N F + + + E L L+G
Sbjct: 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 4e-05
Identities = 29/125 (23%), Positives = 49/125 (39%), Gaps = 7/125 (5%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
S LDL + + + + L R+S++A++ + N+ L L+LS N+L
Sbjct: 23 SQQALDLKGLRSDPDL-VAQNIDVVLNR----RSSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 138 SG--SIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
+ + NL +L+L GN L L L L N LS +
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 196 LSNLV 200
+S +
Sbjct: 138 ISAIR 142
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 21/119 (17%), Positives = 45/119 (37%), Gaps = 4/119 (3%)
Query: 64 SINLSTVGLKGNLKSLSTLDL--SKNKLNGSIPFSFGNLTNLAIMYLYRNSLS--ASIPP 119
+++L + +L + + + ++ + ++ N+ L + L N L +
Sbjct: 26 ALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSS 85
Query: 120 VIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYL 178
++ L L+LS N+L L L L GNSLS + + ++
Sbjct: 86 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (106), Expect = 4e-06
Identities = 20/129 (15%), Positives = 41/129 (31%), Gaps = 3/129 (2%)
Query: 293 LTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLN 352
LDL K+ I L + ++ S+N+ RK L +L L ++ N
Sbjct: 17 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTLLVNNN 73
Query: 353 ILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIPNSRIF 412
+ + L +L L++N+ L + R++
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 413 QYDPMEALQ 421
+ ++
Sbjct: 134 VIYKVPQVR 142
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 1e-05
Identities = 22/135 (16%), Positives = 44/135 (32%), Gaps = 7/135 (5%)
Query: 96 SFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLH 155
+ N + L + I + L +D S+N++ L L L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 156 LYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPIS----LGNLSNLVVLHLFENSLFG 211
+ N + + L L L L++N L + L +L+ L +L +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 212 SIPSILGNLKMLLHL 226
++ + + L
Sbjct: 130 YRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 2e-04
Identities = 27/132 (20%), Positives = 42/132 (31%), Gaps = 7/132 (5%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
N LDL K+ I L + N + L+ L L ++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSG-SIPSIIGNLKSLFYLHLSS---NQLSGSIP 190
N++ L +L L L NSL + +LKSL YL +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 191 ISLGNLSNLVVL 202
+ + + VL
Sbjct: 133 YVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 3e-04
Identities = 15/103 (14%), Positives = 36/103 (34%), Gaps = 5/103 (4%)
Query: 301 LSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPC 360
L+ + + N ++ L+L + L Q +D S N +
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 361 EICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELR 403
+ L+ L +++N + + + L+ + ++ N L
Sbjct: 60 P--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 17/114 (14%), Positives = 33/114 (28%), Gaps = 3/114 (2%)
Query: 341 LIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400
++ ELDL + I ++ + ++ S N L F + L + V+ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNN 73
Query: 401 ELRGPIPNSRIFQYDPMEALQGNKGLCGDIKGFQSCNATFTPHKQISKRKWFII 454
+ D E + N L + + I +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 17/134 (12%), Positives = 40/134 (29%), Gaps = 5/134 (3%)
Query: 271 SLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGN----SIPETLGNLLKLHYLNLS 326
SL + ++ L ++ + LS N +G + E + + L S
Sbjct: 9 SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 327 NNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCF 386
+ + E L L + L L + + ++ + + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 387 EGMHGLSCIDVSYN 400
+GL +
Sbjct: 128 LHNNGLGPQAGAKI 141
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 40/302 (13%), Positives = 79/302 (26%), Gaps = 30/302 (9%)
Query: 116 SIPPVIGNLKFLYHLDLSENQLSG----SIPPTLGNLSNLAVLHLYGNS---LSGSIPSI 168
S+ V+ + + LS N + + + + +L + + IP
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 169 IGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGL 228
+ L + + S ++ L +++ + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 229 STNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLN---------- 278
+ + N L + N+L G + S L
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 279 --GNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRK---- 332
+ L L + T+ +++ L + L L L++
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 333 --GFPVELEKLIQLSELDLSLNILEGKIPCEIC-----NMESLEKLNLSHNNFSGLIPSC 385
+ I L L L N +E + M L L L+ N FS
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 321
Query: 386 FE 387
E
Sbjct: 322 DE 323
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 12/82 (14%)
Query: 106 MYLYRNSLSASIPPVIGN------LKFLYHLDLSENQLSGSIPPTL-----GNLSNLAVL 154
+ L LSA + + L L L N++ TL + +L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 155 HLYGNSLSGSIPSIIGNLKSLF 176
L GN ++ ++ +F
Sbjct: 308 ELNGNRF-SEEDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 39/311 (12%), Positives = 78/311 (25%), Gaps = 31/311 (9%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFG-------NLTNLAIMYLYRNSLSASIPPVIGNLKFL 127
S+ + LS N + +L ++ + IP + L
Sbjct: 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 88
Query: 128 YHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSG 187
+ + S + L ++ + L ++
Sbjct: 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 148
Query: 188 SIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPL-------- 239
++ N L + N L L + + I
Sbjct: 149 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 208
Query: 240 ----SIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALG---- 291
L L L + I + +L L LN L A+
Sbjct: 209 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 268
Query: 292 --SLTELEYLDLSTNKLGNSIPETL-----GNLLKLHYLNLSNNQFRKGFPVELEKLIQL 344
L+ L L N++ TL + L +L L+ N+F ++++ ++
Sbjct: 269 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
Query: 345 SELDLSLNILE 355
+ E
Sbjct: 328 FSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 42/308 (13%), Positives = 88/308 (28%), Gaps = 31/308 (10%)
Query: 125 KFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSG----SIPSIIGNLKSLFYLHL 180
K L ++ S+ L ++ + L GN++ + I + K L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 181 SSNQ---LSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237
S + IP +L L ++ +++ S + + L LS + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSL------NYLVLNGNQLYGNLPRALG 291
L L G + + N L + + ++
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 292 SLTEL------EYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLS 345
L + + + L + + N + + L+ L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 346 ELDLSLNILEGKIPCEICNM------ESLEKLNLSHNNFSG-----LIPSCFEGMHGLSC 394
EL L+ +L + + + L+ L L +N L E M L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 395 IDVSYNEL 402
++++ N
Sbjct: 307 LELNGNRF 314
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 6e-05
Identities = 30/228 (13%), Positives = 71/228 (31%), Gaps = 6/228 (2%)
Query: 105 IMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGS 164
+ + ++ IP + + L +L +L + + N +
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 165 IPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENS--LFGSIPSILGNLKM 222
I + + + + + + + +L ++ + +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 223 LLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQL 282
+ L + N I + + + L+ N+ + EI + L+ L L+ N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 283 YGNLPR-ALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQ 329
LP + LD+S ++ + L NL KL + N +
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 33/224 (14%), Positives = 60/224 (26%), Gaps = 6/224 (2%)
Query: 130 LDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI 189
E++++ IP L N L L L + +S N + I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 190 PISLGNLSNLVVLHLF---ENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNN 246
+ + + N L+ + + + L +T I +L
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 247 LIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKL 306
++ + + E +G L LN N + A E N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 307 GNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLS 350
+ L++S + LE L +L
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 17/87 (19%), Positives = 28/87 (32%), Gaps = 3/87 (3%)
Query: 82 LDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSI 141
L L+KN + +F + N+L V LD+S ++
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 142 PPTLGNLSNLAVLHLYGNSLSGSIPSI 168
L NL L Y +P++
Sbjct: 218 SYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 5e-04
Identities = 7/52 (13%), Positives = 15/52 (28%), Gaps = 3/52 (5%)
Query: 165 IPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSI 216
+ L +S ++ L NL L + +P++
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 31/231 (13%), Positives = 70/231 (30%), Gaps = 6/231 (2%)
Query: 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137
S ++K+ IP N + L L +++S+N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSI--PSIIGNLKSLFYLHLSSNQLSGSIPISLGN 195
I + + + + P NL +L YL +S+ + + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 196 LSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDN 255
V+L + +N +I + L N + + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 256 QLSVGEIPIEI-GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305
++ E+P ++ S L ++ +++ L +L +L K
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 30/224 (13%), Positives = 58/224 (25%), Gaps = 6/224 (2%)
Query: 178 LHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237
++++ IP L N + L L L + +S N + VI
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELE 297
+ + + + ++ I E + +L N +LP + +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 298 YLDLSTNKLGNSIPETLGNLLKLHY---LNLSNNQFRKGFPVELEKLIQLSELDLSLNIL 354
L + + E + L L+ N ++ N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 355 EGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398
E L++S L E + L
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 8/47 (17%), Positives = 16/47 (34%), Gaps = 3/47 (6%)
Query: 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPV 120
LD+S+ +++ + NL L Y +P +
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 44/201 (21%), Positives = 73/201 (36%), Gaps = 17/201 (8%)
Query: 123 NLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182
L L + ++ ++ + +L + L + SI + L +L ++ S+
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242
NQL+ P+ + I I + GL+ + +
Sbjct: 72 NQLTDITPLKNLT------KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 243 NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302
NL NL L L N +S + L LN+ L + L +LT LE LD+S
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-----KPLANLTTLERLDIS 180
Query: 303 TNKLGNSIPETLGNLLKLHYL 323
+NK+ S L L L L
Sbjct: 181 SNKV--SDISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 17/201 (8%)
Query: 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSE 134
L L K + ++ + +L + + R + SI + L L ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 135 NQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLG 194
NQL+ L NL+ L + + N ++ P + L + L
Sbjct: 72 NQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DIDPLK 125
Query: 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYD 254
NL+NL L L N++ S L L L L S+N ++ + PL NL L L +
Sbjct: 126 NLTNLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDLKPL--ANLTTLERLDISS 181
Query: 255 NQLSVGEIPIEIGKLSSLNYL 275
N++S +I + KL++L L
Sbjct: 182 NKVS--DIS-VLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 17/201 (8%)
Query: 147 NLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206
L+ L +++ ++ +L + L + SI + L+NL ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEI 266
N L L + L L +I
Sbjct: 72 NQLTD---------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 267 GKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLS 326
+ N L + + AL LT L+ L+ S+N++ + P L NL L L++S
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 327 NNQFRKGFPVELEKLIQLSEL 347
+N+ L KL L L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 24/155 (15%), Positives = 44/155 (28%), Gaps = 3/155 (1%)
Query: 143 PTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIP-ISLGNLSNLVV 201
P + L + + ++L L++ + Q + L L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 202 LHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGE 261
L + ++ L P L L LS N L + +L L L N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 262 IPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTEL 296
+ + + +L + L +
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.3 bits (90), Expect = 6e-04
Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 24/180 (13%)
Query: 140 SIPPTLGNLS---NLAVLHLYGNSLSGSIPSI------IGNLKSLFYLHLSSNQLSGSIP 190
+I + ++ L G IP I + LK+ +L LS+N + I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64
Query: 191 ISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGL 250
SL + NL +L L N + + L ++ I L NL L
Sbjct: 65 -SLSGMENLRILSLGRNLIKKIENL---DAVADTLEELWISYNQIASLSGIEKLVNLRVL 120
Query: 251 YLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLP----------RALGSLTELEYLD 300
Y+ +N+++ ++ L L L+L GN LY + + L L+ LD
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 784 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.7 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.65 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.64 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.58 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.46 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.87 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.59 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.3 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.99 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=411.50 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=208.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+....+....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999986 78999999986543333445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999997643 588899999999999999999999 9999999999999999999999999999876533
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
......||+.|||||++.+..++.++|||||||++|||++|+.||+.... ......+.......+ ...
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p-~~~- 227 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEFTFP-DFV- 227 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCC-TTS-
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCC-ccC-
Confidence 33556899999999999999999999999999999999999999974221 111122222222222 222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..++.+++.+||+.||++|||++|+++
T Consensus 228 --s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 --TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 235778999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=412.28 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=196.3
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|++.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 468899999999999999999998999999998753 3346789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++.... ..+++..+..++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999987653 3688999999999999999999999 99999999999999999999999999998765433
Q ss_pred Cc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 675 SN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKG-DHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 675 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.. .....||+.|+|||.+.+..++.++|||||||++|||+|+ ++||+..... .....+........+...
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--------~~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKPRLA 227 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--------HHHHHHHHTCCCCCCTTS
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHhcCCCCCcccc
Confidence 22 3346789999999999999999999999999999999995 5555422110 001111111111111222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+ .++.+++.+||+.||++||||+||++.|
T Consensus 228 ~---~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 228 S---THVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp C---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C---HHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 2 3578899999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=412.36 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=208.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG---GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc---cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 47999999999999999999875 7999999998754 2334678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999999988653 488899999999999999999999 9999999999999999999999999999988766
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc---CCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL---DPRLPTPPQ 750 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---d~~~~~~~~ 750 (784)
.......+||+.|+|||++.+..++.++||||+||++|||+||+.||........ ...+. .+.+..
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--------~~~~~~~~~~~~~~--- 238 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--------LYLIATNGTPELQN--- 238 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHHCSCCCSS---
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--------HHHHHhCCCCCCCC---
Confidence 6566677899999999999999999999999999999999999999964322110 00111 011111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.+++.+||+.||++|||++|+++
T Consensus 239 -~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 -PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346888999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=413.56 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=195.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec--CCceEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH--PRNSFL 591 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 591 (784)
++|++.+.||+|+||+||+|+.+ +|+.||||.+..... +....+.|.+|++++++++|||||++++++.+ .+..++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 57999999999999999999875 799999999876432 22235679999999999999999999999865 456899
Q ss_pred EEecccCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDG-AIEEFNWTVRMNVIRSVANALSYMHHDC--FPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986432 1246899999999999999999999862 1149999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
.+...........||+.|||||++.+..++.++|||||||++|||+||+.||...... .....+........
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~~~~~~~ 234 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREGKFRRI 234 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCCC
Confidence 8766555556778999999999999999999999999999999999999999743221 11112222222222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+...+ .++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~s---~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 PYRYS---DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccC---HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 22222 35788999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=403.65 Aligned_cols=250 Identities=23% Similarity=0.431 Sum_probs=209.9
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||+||+|+.++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~----~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS----SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC----cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 579999999999999999999998999999998763 3346789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.+++.... ..+++..+.+++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999976543 3678899999999999999999999 99999999999999999999999999998765443
Q ss_pred C-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 675 S-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 675 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+.....+ ....+........+...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCCCCCCTTC
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--------HHHHHHhCCCCCCcccc
Confidence 3 2334678999999999999999999999999999999998 899997543211 11112222111222223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+ .++.+++.+||+.||++|||++++++.|
T Consensus 227 ~---~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 227 S---EKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp C---HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred c---HHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 3 3578999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=409.64 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=199.4
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||+||+|+.+ ..||||+++.... +....++|.+|+.++++++|||||++++++.+ ...++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 467999999999999999999865 3699999876432 33456789999999999999999999998865 5689999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.++++... ..+++..+..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999997543 3589999999999999999999999 9999999999999999999999999999876533
Q ss_pred C--Cccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 674 S--SNCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 674 ~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||+........ ..........+.....
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~---~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IFMVGRGYLSPDLSKV 234 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHHTSCCCCGGGS
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH---HHHHhcCCCCCcchhc
Confidence 2 23345689999999999864 35789999999999999999999999743321100 0000011111111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+... ..++.+++.+||+.||++||||+||++.|
T Consensus 235 ~~~~---~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 235 RSNC---PKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1222 23578899999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=408.63 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=202.7
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 56999999999999999999975 799999999875432 223467999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999997543 588999999999999999999999 9999999999999999999999999999876533
Q ss_pred C--CcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 674 S--SNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 674 ~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||+...... ..............
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~~~~~~~~~~~-- 227 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYLN-- 227 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-------HHHHHHHTTCTTST--
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCCCCC--
Confidence 2 22455789999999999988876 568999999999999999999997432211 00011111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122345778999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=409.03 Aligned_cols=252 Identities=21% Similarity=0.382 Sum_probs=203.8
Q ss_pred hcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
.++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC----cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 4678999999999999999999998899999998753 3346789999999999999999999998865 5679999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++..... ..+++..+.+|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 87 Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999998764322 3589999999999999999999999 9999999999999999999999999999987543
Q ss_pred CC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 674 SS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 674 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||..|+...... ......+........+...
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCTTC
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCcccC
Confidence 32 234567899999999999999999999999999999999966554321110 0111111111111112222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+ .++.+++.+||+.||++||||++|++.|
T Consensus 236 ~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L 264 (272)
T d1qpca_ 236 P---EELYQLMRLCWKERPEDRPTFDYLRSVL 264 (272)
T ss_dssp C---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred h---HHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 2 3578899999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=412.15 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=205.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|++.+.||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++|||||++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46899999999999999999975 7899999998754 2334678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999999976533 2588999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccc-----cCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVY-----TMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
........||+.|+|||++. ...++.++|||||||++|||+||+.||....... ....+.....+..
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~~~~~ 235 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPTL 235 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSCCCCC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence 23334568999999999984 4568899999999999999999999997432211 1111111111110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........++.+++.+||+.||++|||++|+++
T Consensus 236 -~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222346889999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-50 Score=414.47 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=207.4
Q ss_pred HhcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEE
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 591 (784)
..++|++.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++|||||++++++.+++..++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3467899999999999999999976 6889999998753 3356789999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
||||+++|+|.+++..... ..+++..+..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 9999999999999975432 4689999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCc-ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--CCCCC
Q 042086 672 PDSSN-CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP--RLPTP 748 (784)
Q Consensus 672 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~ 748 (784)
..... .....|++.|+|||.+.+..++.++|||||||++|||++|..|+...... ....+.+.. +...
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--------~~~~~~i~~~~~~~~- 237 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKDYRMER- 237 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHTTCCCCC-
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--------HHHHHHHhcCCCCCC-
Confidence 44332 33456889999999999999999999999999999999977765421111 001111111 1222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+... ..++.+++.+||+.||++|||++||++.|
T Consensus 238 ~~~~---~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 238 PEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred Cccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1222 23578999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=411.56 Aligned_cols=251 Identities=25% Similarity=0.483 Sum_probs=193.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CC---CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SG---EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
+.|++.+.||+|+||+||+|+++ ++ ..||||.+.... .....++|.+|++++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45778899999999999999875 33 368899886532 2234567999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++.... ..++|..+.+++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999987643 3689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc-----ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-C
Q 042086 671 KPDSSN-----CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-P 743 (784)
Q Consensus 671 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~ 743 (784)
...... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||....... ....+.. .
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCC
Confidence 543222 123457899999999999999999999999999999998 899986432211 1111111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 744 RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 744 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+++.+ ... ..++.+++.+||+.||++||||+||++.|
T Consensus 251 ~~~~~-~~~---~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 251 RLPPP-MDC---PSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp CCCCC-TTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCC-ccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 22222 222 33578899999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=409.20 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=205.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++...........+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999975 79999999987543223445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987654 588899999999999999999999 9999999999999999999999999999987543
Q ss_pred C--CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 674 S--SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 674 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
. ......+||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.......+. .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~-~ 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------LIFQKIIKLEYDFPE-K 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTCCCCCT-T
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--------HHHHHHHcCCCCCCc-c
Confidence 2 2234568999999999999999999999999999999999999999742211 111222222222221 2
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVC 781 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl 781 (784)
. ..++.+++.+||+.||++|||++|++
T Consensus 233 ~---s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 233 F---FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp C---CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred C---CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 2 23578899999999999999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=404.40 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=202.3
Q ss_pred cCCCCcee-EecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYC-IGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... .....++|.+|++++++++|||||+++|++.+ +..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 45667774 999999999999764 45679999987542 22345789999999999999999999999975 5688
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++.... ..+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999986543 3689999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 042086 671 KPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 671 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------~~~~i~~~~~~ 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRM 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence 543322 234568999999999999999999999999999999998 999997433211 11111121111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+...+ .++.+++.+||+.||++||||.+|++.|
T Consensus 232 ~~p~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L 266 (285)
T d1u59a_ 232 ECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRM 266 (285)
T ss_dssp CCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1122232 3578899999999999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-49 Score=408.50 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=191.1
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.+.|++.+.||+|+||+||+|+.+ +|+.||||++...... ...+.+.+|++++++++|||||++++++.+++..++|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999976 7899999998764322 2345688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec---CCCceEEeccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC---LDYEARVSDFGIAKF 669 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG~a~~ 669 (784)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999997653 588999999999999999999999 999999999999995 578999999999987
Q ss_pred cCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
.... ......+||+.|||||++.+..++.++||||+||++|||++|+.||...... .....+.......+.
T Consensus 160 ~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 160 EDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEYEFDS 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCCCCCT
T ss_pred ccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCCCCCC
Confidence 6533 2334568999999999999999999999999999999999999999642211 111112222221111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+.++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111223346889999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=399.72 Aligned_cols=244 Identities=27% Similarity=0.395 Sum_probs=194.9
Q ss_pred eeEecccceEEEEEEEc---CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEeccc
Q 042086 521 YCIGIGGQGSVYKAKLT---SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEYLE 597 (784)
Q Consensus 521 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 597 (784)
+.||+|+||+||+|.++ .++.||||+++.... +....++|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 46999999999999864 356899999875422 23335689999999999999999999999965 46789999999
Q ss_pred CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCCc-
Q 042086 598 RGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSSN- 676 (784)
Q Consensus 598 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 676 (784)
+|+|.++++... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+.+......
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999998654 588999999999999999999999 9999999999999999999999999999877544332
Q ss_pred --ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCCCC
Q 042086 677 --CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQNV 752 (784)
Q Consensus 677 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~ 752 (784)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+... ++..+ ...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~~~p-~~~ 235 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMGCP-AGC 235 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCC-TTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC-ccc
Confidence 234568999999999999999999999999999999998 899997432211 01111111 22222 223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
+ .++.+++.+||+.||++|||+++|++.|
T Consensus 236 ~---~~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 236 P---REMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp C---HHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred C---HHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 3 3577899999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=409.72 Aligned_cols=254 Identities=23% Similarity=0.400 Sum_probs=204.2
Q ss_pred hcCCCCceeEecccceEEEEEEEcC------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.++|++.+.||+|+||+||+|+... ...||||.+.... .......|.+|+.++.++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3679999999999999999998652 2369999987543 233466899999999998 899999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC
Q 042086 587 RNSFLVYEYLERGSLATILSNDGA--------------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDI 646 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 646 (784)
+..++||||+++|+|.++++.... ...+++..++.++.||++||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975432 13588999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 042086 647 SSKNVLLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFI 723 (784)
Q Consensus 647 k~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~ 723 (784)
||+||+++.++.+||+|||+|+........ .....||+.|||||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 235568999999999999999999999999999999998 89998743
Q ss_pred ccccccccccccccccccCC--CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 724 SSISSSSSNRNISLNEILDP--RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.... ...+++.. ++..+ ...+ .++.+|+.+||+.||++|||++||++.|
T Consensus 271 ~~~~--------~~~~~~~~~~~~~~p-~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 271 PVDA--------NFYKLIQNGFKMDQP-FYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCSH--------HHHHHHHTTCCCCCC-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHH--------HHHHHHhcCCCCCCC-CcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 2211 11111111 22222 2222 3588999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=407.64 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=202.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
..|+..+.||+|+||+||+|+.. +|+.||||++......+....+.|.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999875 78999999987654333334467999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|..++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987766543 588999999999999999999999 999999999999999999999999999987543
Q ss_pred CCccccccccccccccccccc---CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC-CC
Q 042086 674 SSNCTELVGTFGYIAPELVYT---MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPT-PP 749 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~ 749 (784)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||....... ....+.....+. ..
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~ 236 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPALQS 236 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCCSC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCCCC
Confidence 234579999999999864 458999999999999999999999986432211 011111111111 11
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
... +..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112 235788999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=399.74 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=196.3
Q ss_pred cCCCCceeEecccceEEEEEEEcCC-----CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSG-----EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+|+..+.||+|+||+||+|.+++. ..||||++.... ......+|.+|++++++++|||||+++|++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4688899999999999999987632 479999987532 222355799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+.+|++.+++.... ..+++..+.+++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999887553 3689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042086 670 LKPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLP 746 (784)
Q Consensus 670 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~ 746 (784)
+...... .....||+.|+|||.+.+..++.++|||||||++|||++|..|+..... .......+.+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRL 232 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHHHHHhccCCC
Confidence 6543222 2345689999999999999999999999999999999997666432111 11111122222111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 747 TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 747 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..+... ..++.+++.+||+.||++||||+||++.|
T Consensus 233 ~~~~~~---~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 233 PTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp CCCTTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCchhh---HHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 222222 23578899999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=401.54 Aligned_cols=254 Identities=19% Similarity=0.279 Sum_probs=207.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC---CCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE---MVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||+||+|+.+ +|+.||||++....... ....+.|.+|+.++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999975 79999999986543322 22457899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC----ceEEeccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY----EARVSDFG 665 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG 665 (784)
++||||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997653 588999999999999999999999 999999999999998776 49999999
Q ss_pred cccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 666 IAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 666 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....
T Consensus 163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAVNY 233 (293)
T ss_dssp TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTCC
T ss_pred hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCC
Confidence 99877543 3345567899999999999999999999999999999999999999743211 11111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+.......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111101112346789999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-48 Score=410.35 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=207.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999975 79999999987542 223567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC--CCceEEeccccccccC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL--DYEARVSDFGIAKFLK 671 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~~ 671 (784)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 103 E~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 103 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999996543 3589999999999999999999999 9999999999999964 5789999999999875
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
.. .......||+.|||||++.+..++.++||||+||++|||++|+.||...... .....+.......+...
T Consensus 178 ~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~ 248 (350)
T d1koaa2 178 PK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWNMDDSA 248 (350)
T ss_dssp TT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCSCCGG
T ss_pred cc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCccc
Confidence 43 3345678999999999999999999999999999999999999999632211 11112222222111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223346889999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=395.42 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=196.2
Q ss_pred CCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec----CCceEE
Q 042086 517 FDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH----PRNSFL 591 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 591 (784)
|++.+.||+|+||+||+|++. +++.||+|++..... .....+.|.+|++++++++|||||++++++.+ +...++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 367778999999999999976 688999999875422 22235679999999999999999999999864 345789
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeeec-CCCceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPP--IVHRDISSKNVLLC-LDYEARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfG~a~ 668 (784)
||||+++|+|.++++... .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999997643 588899999999999999999998 6 99999999999996 57899999999998
Q ss_pred ccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042086 669 FLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTP 748 (784)
Q Consensus 669 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 748 (784)
.... ......+||+.|||||++.+ .++.++|||||||++|||++|+.||....... .....+.....+.
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~~~- 232 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKPA- 232 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCCG-
T ss_pred eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHHcCCCCc-
Confidence 6543 33456789999999999865 59999999999999999999999996322111 0001111111100
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 749 PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 749 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........++.+++.+||+.||++|||++|+++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 001112235788999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=410.05 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=203.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... .....+.+.+|+.++++++|||||+++++|.+++..++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999975 78999999987542 233456899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEeccccccccC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLK 671 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 671 (784)
|||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999997653 58889999999999999999997 5 89999999999999999999999999998764
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccc------cc--
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNR------NI-- 735 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~------~~-- 735 (784)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......... .... ..
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 32 234568999999999999999999999999999999999999999643211000 0000 00
Q ss_pred ------------------ccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 ------------------SLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 ------------------~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....+.....+..+ ....+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000000000 0112346888999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=403.34 Aligned_cols=250 Identities=23% Similarity=0.266 Sum_probs=210.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++++.||+|+||+||+|+.+ +|+.||||++.+.........+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56999999999999999999975 79999999987543333445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999998654 478889999999999999999999 9999999999999999999999999999977655
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....+..+. ..
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~~~~p~-~~- 228 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPR-TL- 228 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT-TS-
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCCCCCCc-cC-
Confidence 5556678999999999999999999999999999999999999999974321 1111222222222222 22
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
+.++.+|+.+||+.||++||+ ++|+++
T Consensus 229 --s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 --SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 235778999999999999995 788775
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-47 Score=407.95 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=207.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
+.|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999975 79999999987532 223567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeec--CCCceEEeccccccccC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLC--LDYEARVSDFGIAKFLK 671 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfG~a~~~~ 671 (784)
||+++|+|.+++...+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999999876543 3589999999999999999999999 999999999999998 56899999999999876
Q ss_pred CCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCC
Q 042086 672 PDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQN 751 (784)
Q Consensus 672 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 751 (784)
.. .......||+.|+|||++.+..++.++||||+||++|||+||+.||....... ....+.......+...
T Consensus 181 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 181 PD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDEDA 251 (352)
T ss_dssp TT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCCCCSST
T ss_pred CC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCccc
Confidence 53 33455689999999999999999999999999999999999999997432211 1111111111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......++.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223346789999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=395.98 Aligned_cols=250 Identities=23% Similarity=0.407 Sum_probs=197.2
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc----cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 579999999999999999999998889999998753 2346789999999999999999999999855 56789999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|..++.... ...++|..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred ecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999886532 13589999999999999999999999 99999999999999999999999999998765433
Q ss_pred -CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC-CCCCCCCCC
Q 042086 675 -SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDP-RLPTPPQNV 752 (784)
Q Consensus 675 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~ 752 (784)
.......||+.|+|||++....++.++|||||||++|||+||..|+...... ......+... +.+.+ ...
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~-~~~ 239 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCP-PEC 239 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCC-TTS
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCC-ccc
Confidence 2234467899999999999999999999999999999999976665321111 0011111111 12222 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..++.+++.+||+.||++||||++|+++|
T Consensus 240 ---~~~l~~li~~cl~~dP~~Rps~~~i~~~L 268 (285)
T d1fmka3 240 ---PESLHDLMCQCWRKEPEERPTFEYLQAFL 268 (285)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---CHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 23578899999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-47 Score=396.32 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=206.9
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.+ +|+.||||+++..........+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999975 79999999987543333445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999987654 467788889999999999999999 9999999999999999999999999999886532
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
....+||+.|||||++.+..++.++||||+||++|||+||+.||...... .....+.......++. .
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~~~p~~-~- 224 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAELRFPPF-F- 224 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCCCCCTT-S-
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcCCCCCCCC-C-
Confidence 34568999999999999999999999999999999999999999742211 1112222222222222 2
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
..++.+++.+|++.||++|| |++++++
T Consensus 225 --s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 23577899999999999996 8999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=399.98 Aligned_cols=259 Identities=22% Similarity=0.402 Sum_probs=207.9
Q ss_pred HHHHhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEE
Q 042086 510 IVRATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFC 583 (784)
Q Consensus 510 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 583 (784)
++...++|++.+.||+|+||+||+|+.+ +++.||||+++... .....++|.+|+.++++++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3334578999999999999999999864 46789999987532 222356799999999999999999999999
Q ss_pred ecCCceEEEEecccCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 042086 584 SHPRNSFLVYEYLERGSLATILSNDGA---------------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIV 642 (784)
Q Consensus 584 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 642 (784)
.+.+..++||||+++|+|.++++.... ...+++..+..|+.|++.||+|||++ +||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 999999999999999999999964321 23488999999999999999999999 999
Q ss_pred EeCCCCCCeeecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCC-CC
Q 042086 643 HRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGD-HP 719 (784)
Q Consensus 643 H~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~-~p 719 (784)
||||||+|||++.++.+||+|||+|+.+..... ......|++.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999987644322 234567889999999999999999999999999999999986 56
Q ss_pred CCccccccccccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 720 RDFISSISSSSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
|...... .....+.+...+..+...+ .++.+|+.+||+.||++||||.||+++|
T Consensus 243 ~~~~~~~--------e~~~~v~~~~~~~~p~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 243 YYGMAHE--------EVIYYVRDGNILACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp TTTSCHH--------HHHHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCHH--------HHHHHHHcCCCCCCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6533221 1112223333222222222 3578999999999999999999998864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.5e-47 Score=387.68 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=207.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCC------hhhHHHHHHHHhccC-CCceeeEEeEEecC
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVP------QPEFVNEIKTLTELR-HRSIVKFYGFCSHP 586 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 586 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++.......... .+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999999999999875 79999999997654332221 235889999999996 99999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
+..++||||+++|+|.++++..+ .+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997654 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccc------CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYT------MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEI 740 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 740 (784)
++.+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--------~~~~~i 227 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LMLRMI 227 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--------HHHHHH
Confidence 99876533 3456789999999999853 34678999999999999999999999743211 111122
Q ss_pred cCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 741 LDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 741 ~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......+.......+.++.+++.+||+.||++|||++||++
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222222111122233446889999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=386.83 Aligned_cols=245 Identities=27% Similarity=0.410 Sum_probs=193.0
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-CCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-PRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 593 (784)
++|++.+.||+|+||.||+|+.+ |+.||||+++.. ...++|.+|++++++++|||||+++|++.+ .+..++||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 46888999999999999999985 789999998652 245789999999999999999999999855 45689999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+++|+|.+++...+ ...++|..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred eccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999999996532 13589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCCC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRLPTPPQN 751 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~ 751 (784)
.....+++.|+|||++.+..+++++|||||||++|||+| |+.||+...... ....+.. .+...+ ..
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--------~~~~i~~~~~~~~~-~~ 224 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAP-DG 224 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCC-TT
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCCCC-cc
Confidence 234567899999999999999999999999999999998 688876432211 1111111 122222 22
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 752 VQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 752 ~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ..++.+++.+||+.||++||||.++++.|
T Consensus 225 ~---~~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 225 C---PPAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C---CHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 2 23578899999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-47 Score=392.43 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=198.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC----c
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----N 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 588 (784)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.....+....+.|.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999875 79999999998754433334567999999999999999999999987644 3
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.++++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999987654 588899999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCC---CcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 669 FLKPDS---SNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 669 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
...... ......+||+.|+|||++.+..++.++||||+||++|||+||+.||....... ....++....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~~~~~~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVREDP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--------HHHHHHhcCC
Confidence 654322 22345679999999999999999999999999999999999999997432211 0011111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHh
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRP-PMHTVCQL 783 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~~vl~~ 783 (784)
..+.......+.++.+++.+|++.||++|| |++++.+.
T Consensus 232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~ 270 (277)
T d1o6ya_ 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270 (277)
T ss_dssp CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHH
Confidence 111011112234688899999999999999 88888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=388.22 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=192.9
Q ss_pred hcCCCCceeEecccceEEEEEEEcC----CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS----GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.++|++.+.||+|+||.||+|++.. +..||||.++... .....+.|.+|+.++++++|||||+++|++.+ +..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 3579999999999999999998642 4578999886532 22335679999999999999999999999964 678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++||||+++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999999876543 3689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 042086 670 LKPDSS-NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDPRLPT 747 (784)
Q Consensus 670 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 747 (784)
+..... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||....... ....+.......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLP 229 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence 654322 2345578999999999999999999999999999999998 899987433211 111122221111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 748 PPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 748 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.+...+ .++.+++.+||+.||++|||++||++.|
T Consensus 230 ~~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 230 MPPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 122222 3578899999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=394.52 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=197.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCC----EEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCce
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGE----ILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNS 589 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 589 (784)
.+|++.+.||+|+||+||+|++. +|+ +||+|+++... +....++|.+|++++++++|||||+++|++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 46999999999999999999865 444 68999886532 334577899999999999999999999999874 56
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 590 FLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 590 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
++++||+.+|+|.+++.... ..+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 78889999999999887653 3689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCC
Q 042086 670 LKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILD-PRL 745 (784)
Q Consensus 670 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d-~~~ 745 (784)
+...... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||+...... ....+.. .++
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~ 232 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERL 232 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence 7554332 234568999999999999999999999999999999998 788987432211 0111111 122
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+.+ ...+ .++.+++.+||+.||++|||++||++.
T Consensus 233 ~~p-~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 PQP-PICT---IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CCC-TTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-cccC---HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 222 2222 357889999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=390.84 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=193.3
Q ss_pred cCCCCceeEecccceEEEEEEEc--CC--CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT--SG--EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||.||+|+.. ++ ..||||++......+....++|.+|++++++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46999999999999999999864 23 3789999876544444445789999999999999999999999976 4678
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|++.+++.... ..+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999999886543 3689999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCc---ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--C
Q 042086 671 KPDSSN---CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISSSSSNRNISLNEILDP--R 744 (784)
Q Consensus 671 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~--~ 744 (784)
...... .....|++.|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+... +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~i~~~~~~ 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGER 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------HHHHHHhCCCC
Confidence 554332 233467889999999999999999999999999999998 899986432211 11111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
++.+ ... +..+.+++.+||+.||++||||+||.+.|
T Consensus 234 ~~~~-~~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 234 LPRP-EDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp CCCC-TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCc-ccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111 122 23588999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=394.99 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=206.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 592 (784)
.++|++.+.||+|+||+||+|+.. +|+.||||.++.. ......+.+|+++++.++|||||++++++.+++..|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 367999999999999999999876 7899999999763 22345688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC--CceEEecccccccc
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD--YEARVSDFGIAKFL 670 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfG~a~~~ 670 (784)
|||+++|+|.+++...+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999997653 2588999999999999999999999 99999999999999854 57999999999876
Q ss_pred CCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
... .......+|+.|+|||...+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHH
T ss_pred ccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCChh
Confidence 543 334556789999999999999999999999999999999999999963221 11112222222221111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.......++.+++.+|+..||++|||++|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112345789999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=394.91 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=206.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHh-ccCCCceeeEEeEEecCCceEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLT-ELRHRSIVKFYGFCSHPRNSFLV 592 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 592 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++++.........+.+..|+.++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999876 79999999997533223344567778887765 68999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCC
Q 042086 593 YEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKP 672 (784)
Q Consensus 593 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 672 (784)
|||+++|+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997654 478899999999999999999999 999999999999999999999999999997766
Q ss_pred CCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCC
Q 042086 673 DSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNV 752 (784)
Q Consensus 673 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 752 (784)
.........||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.......+ ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~~p-~~~ 226 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPFYP-RWL 226 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCC-TTS
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCC-ccC
Confidence 556666778999999999999999999999999999999999999999742211 11111111222221 222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 042086 753 QDELISIVEVAFLCLNESPESRPPMH-TVCQ 782 (784)
Q Consensus 753 ~~~~~~l~~li~~cl~~dP~~RPs~~-~vl~ 782 (784)
..++.+++.+||+.||++|||+. ++++
T Consensus 227 ---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 ---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 23578999999999999999985 6653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-46 Score=396.72 Aligned_cols=247 Identities=22% Similarity=0.279 Sum_probs=207.5
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++++.||+|+||+||+|+.+ +|+.||||++...........+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999975 79999999986543333445678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+.+|+|.+++...+ .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997654 488899999999999999999999 9999999999999999999999999999987532
Q ss_pred CCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCCCCH
Q 042086 674 SSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQNVQ 753 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 753 (784)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...... .....+.......+. ..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~~~p~-~~- 261 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSGKVRFPS-HF- 261 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT-TC-
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--------HHHHHHhcCCCCCCc-cC-
Confidence 34568999999999999999999999999999999999999999642211 111122222222222 22
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 042086 754 DELISIVEVAFLCLNESPESRP-----PMHTVCQ 782 (784)
Q Consensus 754 ~~~~~l~~li~~cl~~dP~~RP-----s~~~vl~ 782 (784)
..++.+++.+||+.||++|+ |++|+++
T Consensus 262 --s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 --SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 23578899999999999994 8999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=391.17 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=200.3
Q ss_pred cCCCCce-eEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEec----CC
Q 042086 515 NGFDVKY-CIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSH----PR 587 (784)
Q Consensus 515 ~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 587 (784)
++|++.. .||+|+||+||+|+.. +++.||||+++. .+.+.+|+.++.++ +|||||+++++|.+ ..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 5788764 6999999999999874 799999999864 35688999987655 89999999999865 35
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEecc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSDF 664 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 664 (784)
..++||||+++|+|.+++...+. ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 68999999999999999986532 4689999999999999999999999 9999999999999985 467999999
Q ss_pred ccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042086 665 GIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPR 744 (784)
Q Consensus 665 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~ 744 (784)
|+|+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .......+....
T Consensus 159 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~----~~~~~~~i~~~~ 233 (335)
T d2ozaa1 159 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKTRIRMGQ 233 (335)
T ss_dssp TTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS
T ss_pred ceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----HHHHHHHHhcCC
Confidence 9998776433 34567899999999999999999999999999999999999999964322110 001111122222
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 745 LPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 745 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+.......+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22221222233557889999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-46 Score=397.77 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=199.3
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHH---HHHHhccCCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNE---IKTLTELRHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||.||+|+.. +|+.||||++.+...........+.+| +.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999976 799999999864322122223344454 66777788999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFL 670 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 670 (784)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999997653 477899999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042086 671 KPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPP 749 (784)
Q Consensus 671 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 749 (784)
... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||........ ..............+
T Consensus 158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~- 229 (364)
T d1omwa3 158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVELP- 229 (364)
T ss_dssp SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHSSSCCCCCC-
T ss_pred CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcccCCCCCC-
Confidence 543 2345689999999999975 5689999999999999999999999974221100 000111111122211
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 750 QNVQDELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 750 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
... ..++.+++.+||+.||++||| ++|+++
T Consensus 230 ~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 222 235788999999999999999 688765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=385.18 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=197.0
Q ss_pred ceeEecccceEEEEEEEcCC----CEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-CCceEEEEe
Q 042086 520 KYCIGIGGQGSVYKAKLTSG----EILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH-PRNSFLVYE 594 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 594 (784)
.++||+|+||+||+|++.+. ..||||+++... .....++|.+|++++++++|||||+++|++.+ +...++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 57899999999999987532 368999987532 33345789999999999999999999999865 567899999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+++|+|.++++... ...++..+.+++.|+|+||.|+|+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999987654 3577888999999999999999999 99999999999999999999999999998765432
Q ss_pred Cc----ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCC
Q 042086 675 SN----CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRLPTPPQ 750 (784)
Q Consensus 675 ~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 750 (784)
.. .....||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ......+.....+..+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~~~~i~~g~~~~~p~ 257 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYLLQGRRLLQPE 257 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCCT
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHcCCCCCCcc
Confidence 22 23457899999999999999999999999999999999988887532211 01111112211111222
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 751 NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 751 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
..++ ++.+++.+||+.||++||||.||++.|
T Consensus 258 ~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 258 YCPD---PLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2333 578899999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=387.65 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=199.2
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCC--EEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecCCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGE--ILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 590 (784)
++|++.+.||+|+||+||+|+++ +|. .||||++.... .....++|.+|+++++++ +|||||+++|++.+.+..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 57899999999999999999876 444 47788875432 233466899999999999 7999999999999999999
Q ss_pred EEEecccCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC
Q 042086 591 LVYEYLERGSLATILSND-------------GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY 657 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 657 (784)
+||||+++|+|.++++.. .....+++..+.+++.|||+|+.|+|++ +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 999999999999999754 2235789999999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCC-CCCccccccccccccccc
Q 042086 658 EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDH-PRDFISSISSSSSNRNIS 736 (784)
Q Consensus 658 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~-p~~~~~~~~~~~~~~~~~ 736 (784)
.+||+|||+|+..... .......||+.|+|||.+.+..++.++|||||||++|||++|.. ||...... ..
T Consensus 165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--------~~ 235 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------EL 235 (309)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HH
T ss_pred ceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--------HH
Confidence 9999999999865432 22234568999999999999999999999999999999999765 56532211 11
Q ss_pred cccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+... ++.. +...+ .++.+++.+||+.||++||||+||++.|
T Consensus 236 ~~~i~~~~~~~~-~~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 236 YEKLPQGYRLEK-PLNCD---DEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp HHHGGGTCCCCC-CTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCCC-CccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111111 2222 22222 3578899999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=387.71 Aligned_cols=257 Identities=21% Similarity=0.359 Sum_probs=194.2
Q ss_pred HHhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 512 RATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 512 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
...++|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+..|+.++.++ +|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 34568999999999999999999854 35689999987532 222356788888888887 6899999999986
Q ss_pred cC-CceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCC
Q 042086 585 HP-RNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKN 650 (784)
Q Consensus 585 ~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 650 (784)
++ ...++||||+++|+|.++++.... ...+++..+..++.||++||+|||++ +||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 64 468999999999999999975321 23588999999999999999999999 99999999999
Q ss_pred eeecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCC-CCCCcccccc
Q 042086 651 VLLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGD-HPRDFISSIS 727 (784)
Q Consensus 651 ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~-~p~~~~~~~~ 727 (784)
||++.++.+||+|||+|+....... ......||+.|+|||.+.+..++.++|||||||++|||+||. .||.......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654332 234567999999999999999999999999999999999974 5775332211
Q ss_pred ccccccccccccccCC-CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 728 SSSSNRNISLNEILDP-RLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 728 ~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
. ....+.+. ++.. +... ..++.+++.+||+.||++|||++||++.|
T Consensus 245 ~-------~~~~~~~~~~~~~-~~~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 245 E-------FCRRLKEGTRMRA-PDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp H-------HHHHHHHTCCCCC-CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-------HHHHHhcCCCCCC-CccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 0 00011111 1111 1222 23578999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=388.54 Aligned_cols=256 Identities=21% Similarity=0.387 Sum_probs=208.0
Q ss_pred HhcCCCCceeEecccceEEEEEEEc------CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC
Q 042086 513 ATNGFDVKYCIGIGGQGSVYKAKLT------SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP 586 (784)
Q Consensus 513 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 586 (784)
..++|++.+.||+|+||+||+|.+. +++.||||+++... .......|.+|+.++++++|||||+++|++..+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3578999999999999999999764 36789999987532 222345699999999999999999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCce
Q 042086 587 RNSFLVYEYLERGSLATILSND-------GAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEA 659 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 659 (784)
+..++||||+++|+|.+++... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 9999999999999999998632 2334578999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCC-CCCCccccccccccccccc
Q 042086 660 RVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGD-HPRDFISSISSSSSNRNIS 736 (784)
Q Consensus 660 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~-~p~~~~~~~~~~~~~~~~~ 736 (784)
||+|||+|+.+...... .....||+.|+|||.+.+..++.++|||||||++|||+||. .||..... ...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999999876543322 23446899999999999999999999999999999999985 67653221 111
Q ss_pred cccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 737 LNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 737 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
...+.+......+...+ ..+.+++.+||+.||++||||++|++.|
T Consensus 245 ~~~i~~~~~~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 245 LRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp HHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22233333322223333 3588899999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=378.62 Aligned_cols=258 Identities=22% Similarity=0.230 Sum_probs=195.9
Q ss_pred CceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCC--CChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEec
Q 042086 519 VKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEM--VPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYEY 595 (784)
Q Consensus 519 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 595 (784)
..+.||+|+||+||+|+.+ +|+.||||++........ ...+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 799999999875432211 1245799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCCC
Q 042086 596 LERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDSS 675 (784)
Q Consensus 596 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 675 (784)
++++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998777665433 3577788999999999999999999 999999999999999999999999999988766555
Q ss_pred cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccccc--cccccc-cCC
Q 042086 676 NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRN--ISLNEI-LDP 743 (784)
Q Consensus 676 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~--~~~~~~-~d~ 743 (784)
.....+||+.|+|||.+... .++.++||||+||++|||+||+.||......... ....+ ...... ...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 55667899999999998754 5799999999999999999999998643221100 00000 000000 000
Q ss_pred CCCCCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 744 RLPTPPQNV-----QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 744 ~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+... .....++.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000 111346889999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=383.25 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=195.2
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHH--HHHHhccCCCceeeEEeEEecCC----c
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNE--IKTLTELRHRSIVKFYGFCSHPR----N 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~----~ 588 (784)
.+|.+.+.||+|+||.||+|+. +|+.||||+++.. ..+++..| +..+..++|||||++++++.+++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 4577889999999999999997 4889999998642 23344444 45556789999999999997643 5
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEeCCCCCCeeecCCCceEEec
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC-----FPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
.++||||+++|+|.++++.. .++|..+.+++.|+|.|++|+|+.. .++|+||||||+|||++.++.+||+|
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 78999999999999999864 4899999999999999999999731 24999999999999999999999999
Q ss_pred cccccccCCCCC----cccccccccccccccccccCC------cCcchhHHHHHHHHHHHHhCCCCCCccccccccc---
Q 042086 664 FGIAKFLKPDSS----NCTELVGTFGYIAPELVYTMK------VTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--- 730 (784)
Q Consensus 664 fG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--- 730 (784)
||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+..........
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 999987754332 234567999999999987542 6779999999999999999998875433211110
Q ss_pred ----cccccccccccCCCCCCC-CC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 731 ----SNRNISLNEILDPRLPTP-PQ--NVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 731 ----~~~~~~~~~~~d~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.........+.+...... +. ...+....+.+++.+||+.||++||||.||++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 000000111122222111 11 1224456789999999999999999999998864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=382.26 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=201.6
Q ss_pred hcCCCCceeEecccceEEEEEEEcC--------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEe
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLTS--------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCS 584 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 584 (784)
.++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|+..+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 4679999999999999999998532 3479999987642 223357789999999888 8999999999999
Q ss_pred cCCceEEEEecccCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 585 HPRNSFLVYEYLERGSLATILSNDGA-------------IEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 585 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+++..++||||+++|+|.+++..... ...+++..+++++.||+.||+|||++ +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975432 24589999999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCC--cccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSS--NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
|++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 999999999999999987654322 2344678999999999999999999999999999999998 68888633221
Q ss_pred cccccccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
.....+.+......+... ...+.+++.+||+.||++|||+.||++.|
T Consensus 245 ------~~~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 245 ------ELFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp ------HHHHHHHTTCCCCCCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------HHHHHHHcCCCCCCCccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 111111121111112222 23588999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=384.80 Aligned_cols=255 Identities=22% Similarity=0.401 Sum_probs=205.3
Q ss_pred hcCCCCceeEecccceEEEEEEE------cCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc-CCCceeeEEeEEecC
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKL------TSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL-RHRSIVKFYGFCSHP 586 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 586 (784)
.++|++.+.||+|+||.||+|++ .+++.||||+++... ......+|.+|+.+++++ +|||||++++++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 46889999999999999999975 256799999997643 223456799999999999 699999999999999
Q ss_pred CceEEEEecccCCCHHHHHhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 042086 587 RNSFLVYEYLERGSLATILSNDG---------------AIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNV 651 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 651 (784)
+..++||||+++|+|.++++... ....+++..+.+++.||++|++|||++ +||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999997543 123588999999999999999999999 999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCc--ccccccccccccccccccCCcCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 042086 652 LLCLDYEARVSDFGIAKFLKPDSSN--CTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIK-GDHPRDFISSISS 728 (784)
Q Consensus 652 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ellt-g~~p~~~~~~~~~ 728 (784)
+++.++.+|++|||.++........ .....||+.|+|||.+.+..++.++|||||||++|||+| |++||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999999977643332 344678999999999999999999999999999999999 55555432211
Q ss_pred cccccccccccccCCCCC-CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHhC
Q 042086 729 SSSNRNISLNEILDPRLP-TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQLL 784 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~L 784 (784)
....+++..... ..+... ...+.+|+.+||+.||++||||++|+++|
T Consensus 255 ------~~~~~~i~~~~~~~~~~~~---~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 255 ------SKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp ------HHHHHHHHHTCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCCcccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111122211111 111222 23588999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=379.27 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=201.1
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 57999999999999999999975 799999999975432 2334678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
||+.+ ++.+++.... ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 81 e~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99976 4544443322 23689999999999999999999999 9999999999999999999999999999987666
Q ss_pred CCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc---ccccccC
Q 042086 674 SSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNRNI---SLNEILD 742 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~~~---~~~~~~d 742 (784)
........||+.|+|||.+.... ++.++||||+||++|||++|+.||......... ....+. ......+
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 55666778999999999987665 578999999999999999999999643211000 000000 0000000
Q ss_pred --CCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 743 --PRLPTPPQN-----VQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 743 --~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
...+..... ......++.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000000 0111246788999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-44 Score=373.78 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=200.7
Q ss_pred cCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEEe
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVYE 594 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 594 (784)
++|++.+.||+|+||+||+|+.++|+.||||++..... .....+.+.+|+.++++++|||||++++++.+++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57999999999999999999999999999999976533 23346789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCCC
Q 042086 595 YLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPDS 674 (784)
Q Consensus 595 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 674 (784)
|+.++.+..+.+.. ..+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.|.......
T Consensus 81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99887777666544 3588899999999999999999999 99999999999999999999999999999876555
Q ss_pred CcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCccccccc------------ccccccccccccc
Q 042086 675 SNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISS------------SSSNRNISLNEIL 741 (784)
Q Consensus 675 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~------------~~~~~~~~~~~~~ 741 (784)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||........ .............
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 555666789999999998754 568999999999999999999999964321100 0000000000000
Q ss_pred CCCC----CCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 DPRL----PTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 d~~~----~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+... ..+ ..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000 0001112236789999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=374.29 Aligned_cols=242 Identities=22% Similarity=0.358 Sum_probs=198.4
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCC---CCChhhHHHHHHHHhccC--CCceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCE---MVPQPEFVNEIKTLTELR--HRSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 588 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++....... .....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 79999999987543221 122345789999999996 8999999999999999
Q ss_pred eEEEEecccC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCC-CceEEecccc
Q 042086 589 SFLVYEYLER-GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLD-YEARVSDFGI 666 (784)
Q Consensus 589 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~ 666 (784)
.++||||+.+ +++.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 68888887543 588899999999999999999999 99999999999999855 7999999999
Q ss_pred ccccCCCCCcccccccccccccccccccCCc-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTMKV-TEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
|+.... .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||+..... .....
T Consensus 158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------------~~~~~ 221 (273)
T d1xwsa_ 158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------IRGQV 221 (273)
T ss_dssp CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------------HHCCC
T ss_pred ceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------------hhccc
Confidence 987543 23456789999999999987776 56789999999999999999999743211 11111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
..+. .. +.++.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~-~~---s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 FFRQ-RV---SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSS-CC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-CC---CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111 11 235788999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=370.57 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=196.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-C-CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhcc---CCCceeeEEeEEec---
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-S-GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTEL---RHRSIVKFYGFCSH--- 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 585 (784)
.++|++.+.||+|+||+||+|++. + ++.||||+++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 468999999999999999999974 4 677999998754322 22344677888887766 79999999999853
Q ss_pred --CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEec
Q 042086 586 --PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSD 663 (784)
Q Consensus 586 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 663 (784)
....+++|||+++|++........ ..+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346789999999877765544332 3678899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------------
Q 042086 664 FGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------------- 729 (784)
Q Consensus 664 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------------- 729 (784)
||+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 160 fg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 999986543 23345678999999999999999999999999999999999999999743211000
Q ss_pred ccccccccccccCCCCC-CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 730 SSNRNISLNEILDPRLP-TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 730 ~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
................. ............+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000000000 000011112235778999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=355.16 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=205.6
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCCceEEEE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPRNSFLVY 593 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 593 (784)
++|++.+.||+|+||+||+|++. +++.||||+++.... .....+++.+|+.+++.++||||+++++++.+....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 57999999999999999999975 789999999965432 3334678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccccccCCC
Q 042086 594 EYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAKFLKPD 673 (784)
Q Consensus 594 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 673 (784)
|++.++++..+++..+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999988887553 577899999999999999999999 9999999999999999999999999999987765
Q ss_pred CCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cc---cccccccccc
Q 042086 674 SSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SS---NRNISLNEIL 741 (784)
Q Consensus 674 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~---~~~~~~~~~~ 741 (784)
........+++.|+|||.+.... ++.++||||+||++|||++|+.||......... .. ..........
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 55556667888999999987665 688999999999999999999997422111000 00 0000000000
Q ss_pred C-------CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 742 D-------PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 742 d-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
+ ................+.+|+.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000111111222345778999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=361.97 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=194.4
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec-------
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH------- 585 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 585 (784)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 368999999999999999999975 799999999876533 23356789999999999999999999999855
Q ss_pred -CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecc
Q 042086 586 -PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDF 664 (784)
Q Consensus 586 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 664 (784)
.+..++||||++++.+..+.... ..++...++.++.|++.||+|||++ +|+||||||+|||++.++.+|++||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 34578999999887666554332 3578889999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC----cccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccc
Q 042086 665 GIAKFLKPDSS----NCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSN 732 (784)
Q Consensus 665 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~ 732 (784)
|+++.+..... .....+||+.|+|||.+.+. .++.++||||+||++|||++|+.||+........ ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99987654322 22345799999999998765 5889999999999999999999999643221100 000
Q ss_pred ccccccc----ccCCC---CCCCCCCCHHH------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 733 RNISLNE----ILDPR---LPTPPQNVQDE------LISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 733 ~~~~~~~----~~d~~---~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
....... ..... .........+. ...+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000 00000 00000111111 235678999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-42 Score=364.04 Aligned_cols=256 Identities=24% Similarity=0.272 Sum_probs=190.7
Q ss_pred CCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC------Cc
Q 042086 516 GFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP------RN 588 (784)
Q Consensus 516 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 588 (784)
+|+..++||+|+||+||+|++. +|+.||||++.... ..+.+|++++++++||||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 5888999999999999999976 79999999986532 1234799999999999999999998532 34
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEeccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIA 667 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a 667 (784)
.++||||+++|.+....+.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 689999998764444433222234689999999999999999999999 999999999999999775 8999999999
Q ss_pred cccCCCCCccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccc---cc
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNR---NI 735 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~---~~ 735 (784)
+.+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......... .... ..
T Consensus 171 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 171 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp EECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 8775433 3345689999999998875 56899999999999999999999999643221000 0000 00
Q ss_pred ccccccCCCCCCCC------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 736 SLNEILDPRLPTPP------QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 736 ~~~~~~d~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
......+...+... ........++.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000100000 001112235788999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=365.23 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=200.7
Q ss_pred cCCCCceeEecccceEEEEEEEc----CCCEEEEEEcCCCCC-CCCCChhhHHHHHHHHhccCC-CceeeEEeEEecCCc
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT----SGEILAVKKFHSLWP-CEMVPQPEFVNEIKTLTELRH-RSIVKFYGFCSHPRN 588 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 588 (784)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .+....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 589999999875422 122345678899999999966 899999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.++||||+.+|+|.+++...+ .++......++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999997654 356688889999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CcccccccccccccccccccC--CcCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042086 669 FLKPDS-SNCTELVGTFGYIAPELVYTM--KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEILDPRL 745 (784)
Q Consensus 669 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~~ 745 (784)
.+.... .......|++.|+|||.+.+. .++.++||||+||++|||+||+.||......... ............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSEP 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcccCCC
Confidence 764332 234456799999999999754 4678999999999999999999999743321110 000111112222
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 042086 746 PTPPQNVQDELISIVEVAFLCLNESPESRPP-----MHTVCQ 782 (784)
Q Consensus 746 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~vl~ 782 (784)
+.+. ....++.+++.+||+.||++||| ++|+++
T Consensus 254 ~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2221 22346888999999999999994 788875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-41 Score=356.00 Aligned_cols=255 Identities=19% Similarity=0.251 Sum_probs=192.2
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce-eeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI-VKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ..+++..|+++++.++|+++ +.+.+++.+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 357999999999999999999875 78999999876532 23468899999999987665 555566677888899
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC---CCceEEecccccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL---DYEARVSDFGIAK 668 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG~a~ 668 (784)
||||+. |++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||+|+
T Consensus 81 vme~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999995 57777665433 3688999999999999999999999 9999999999999863 4579999999999
Q ss_pred ccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042086 669 FLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNEIL 741 (784)
Q Consensus 669 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 741 (784)
.+..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....................-
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 8754332 123557999999999999999999999999999999999999999743321111000000000000
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 742 DPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 742 d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
.+ .+..... .+.++.+++..||+.||++||+++++.+.
T Consensus 235 ~~-~~~~~~~---~p~~~~~li~~cl~~~p~~RP~~~~i~~~ 272 (299)
T d1ckia_ 235 TP-IEVLCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQL 272 (299)
T ss_dssp SC-HHHHTTT---SCHHHHHHHHHHHHSCTTCCCCHHHHHHH
T ss_pred CC-hhHhccC---CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00 0000011 12357889999999999999999988664
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=364.91 Aligned_cols=260 Identities=21% Similarity=0.269 Sum_probs=193.3
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC----c
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----N 588 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 588 (784)
+.+|++++.||+|+||+||+|+.. +|+.||||++.... .....+.+.+|+.+|++++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 357999999999999999999875 89999999987532 2223467899999999999999999999996543 2
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 589 SFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 589 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
.+++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 34555667799999999753 588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---ccccccccccccccccccc-CCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccccc--
Q 042086 669 FLKPDSS---NCTELVGTFGYIAPELVYT-MKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------SSNRN-- 734 (784)
Q Consensus 669 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~-- 734 (784)
....... .....+||+.|+|||.+.. ..++.++||||+||++|||++|+.||......... .....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 7644322 2345679999999999854 45788999999999999999999999643211000 00000
Q ss_pred -------cccccccCCCCCCCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 735 -------ISLNEILDPRLPTPP--QNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 735 -------~~~~~~~d~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........+.....+ ........++.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000 000011235789999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=363.98 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=191.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecCC-----
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHPR----- 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 587 (784)
.++|++++.||+|+||+||+|.+. +|+.||||+++.... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 467999999999999999999975 799999999975422 2223567899999999999999999999997654
Q ss_pred -ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEecccc
Q 042086 588 -NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGI 666 (784)
Q Consensus 588 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 666 (784)
..++||||+ +++|..+.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 55888877643 588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccC-CcCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccc-----
Q 042086 667 AKFLKPDSSNCTELVGTFGYIAPELVYTM-KVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SSNR----- 733 (784)
Q Consensus 667 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~~~----- 733 (784)
|+.... ..+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ....
T Consensus 168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 987643 23456899999999998764 5688999999999999999999999643221100 0000
Q ss_pred ----------ccccccccCCCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 ----------NISLNEILDPRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 ----------~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.....+.....+... .......+.+|+.+||..||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASI---LTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGT---CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhcchhhhhhhccCCcccccchHHh---ccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000 0111235778999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-41 Score=350.67 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=198.8
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC-CceeeEEeEEecCCceEE
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH-RSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 591 (784)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++.+....++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 367999999999999999999976 78999999875432 23467889999999965 899999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecC-----CCceEEecccc
Q 042086 592 VYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCL-----DYEARVSDFGI 666 (784)
Q Consensus 592 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfG~ 666 (784)
||||+ +++|.++++..+. .+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 79 vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 99998 6799999876543 588899999999999999999999 9999999999999974 57899999999
Q ss_pred ccccCCCCC-------cccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042086 667 AKFLKPDSS-------NCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSSSNRNISLNE 739 (784)
Q Consensus 667 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 739 (784)
|+.+..... ......||+.|||||.+.+..++.++|||||||++|||+||+.||.......... ....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-----~~~~ 227 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYER 227 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-----HHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-----HHHH
Confidence 987654321 2334679999999999999999999999999999999999999997433211100 0000
Q ss_pred ccCCCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 042086 740 ILDPRLPTP-PQNVQDELISIVEVAFLCLNESPESRPPMHTVCQL 783 (784)
Q Consensus 740 ~~d~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~~ 783 (784)
+.+.+...+ .+.....+.++.+++..|++.+|++||+++.+.+.
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 000000000 00000112357889999999999999998887654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.4e-41 Score=353.59 Aligned_cols=252 Identities=20% Similarity=0.269 Sum_probs=195.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEec--CCceE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSH--PRNSF 590 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~ 590 (784)
++|++++.||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+.+++.++ ||||+++++++.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 57999999999999999999975 7999999998642 3578999999999995 9999999999974 35689
Q ss_pred EEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCC-ceEEeccccccc
Q 042086 591 LVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDY-EARVSDFGIAKF 669 (784)
Q Consensus 591 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~ 669 (784)
+||||+++|+|.++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 999999999997754 2578899999999999999999999 999999999999998655 699999999987
Q ss_pred cCCCCCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCccccccc--------------------
Q 042086 670 LKPDSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISS-------------------- 728 (784)
Q Consensus 670 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~-------------------- 728 (784)
..... ......+|+.|+|||.+.+.. ++.++||||+||++||+++|+.||........
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred ccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 65433 345667899999999987654 78999999999999999999999864321100
Q ss_pred cccccccccccccCCCCC------CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 729 SSSNRNISLNEILDPRLP------TPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 729 ~~~~~~~~~~~~~d~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.................. ...........++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000000 000111122346789999999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.2e-41 Score=356.57 Aligned_cols=292 Identities=32% Similarity=0.484 Sum_probs=205.1
Q ss_pred hHHHHHHHHHHHhccCCCccccCCCCCCCCCCCccccccCCCCCCCc--ccceeEEcCCCCeEEEEeCCCcccCCCCccc
Q 042086 3 GKEAYALLKWKTSLQKHNRSLLSSWTFYPVNNATNVSFYSKIKISPC--AWFGIQCNPAKRVISINLSTVGLKGNLKSLS 80 (784)
Q Consensus 3 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~~~~~~~~~~~~~~~C--~w~gv~C~~~~~v~~l~l~~~~~~~~l~~l~ 80 (784)
++||+|||+||+++.+ | ..++||.. +.||| .|.||+|++.+++ .+++
T Consensus 5 ~~e~~aLl~~k~~~~~-~-~~l~sW~~---------------~~d~C~~~w~gv~C~~~~~~--------------~~v~ 53 (313)
T d1ogqa_ 5 PQDKQALLQIKKDLGN-P-TTLSSWLP---------------TTDCCNRTWLGVLCDTDTQT--------------YRVN 53 (313)
T ss_dssp HHHHHHHHHHHHHTTC-C-GGGTTCCT---------------TSCTTTTCSTTEEECCSSSC--------------CCEE
T ss_pred HHHHHHHHHHHHHCCC-C-CcCCCCCC---------------CCCCCCCcCCCeEEeCCCCc--------------EEEE
Confidence 6899999999999974 4 47999963 35899 5999999975422 1234
Q ss_pred EEeCCCCcccc--cCCCCcCCCCCCCEEEccC-CcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 81 TLDLSKNKLNG--SIPFSFGNLTNLAIMYLYR-NSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 81 ~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
.|||++|+++| .+|..+++|++|++|+|++ |+++|.+|++|+++++|++|+|++|++.+..+..+..+++|+.++++
T Consensus 54 ~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~ 133 (313)
T d1ogqa_ 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133 (313)
T ss_dssp EEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred EEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccc
Confidence 55666677766 4677788888888888875 67777777777777777777777777777777777777777777777
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCC-ceeeccccccCCccchhhhcccccceeccCCCccccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL-VVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV 236 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 236 (784)
+|.+.+.+|..+.++++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..+..+.++..+ .+++++|...+.
T Consensus 134 ~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~ 212 (313)
T d1ogqa_ 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGD 212 (313)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEEC
T ss_pred cccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccc
Confidence 777777777777777777777777777777777766666554 666667777766666666555433 466666666655
Q ss_pred cCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccc
Q 042086 237 IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGN 316 (784)
Q Consensus 237 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~ 316 (784)
+|.. +..+++|+.|++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..|++
T Consensus 213 ~~~~-------------------------~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~ 266 (313)
T d1ogqa_ 213 ASVL-------------------------FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266 (313)
T ss_dssp CGGG-------------------------CCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGG
T ss_pred cccc-------------------------cccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhC
Confidence 5544 4444555555555565554433 4556667777777777777677777777
Q ss_pred cccceEEecccccccCCCchhhhcccccCeeccCCcc
Q 042086 317 LLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNI 353 (784)
Q Consensus 317 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 353 (784)
+++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 267 L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 267 LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred CCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 77777777777777766653 5667777777777775
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=355.49 Aligned_cols=257 Identities=19% Similarity=0.260 Sum_probs=188.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEec------CC
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSH------PR 587 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 587 (784)
++|++.+.||+|+||+||+|++. +|+.||||++..... +....+++.+|+.++++++|||||++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 57999999999999999999976 799999999976432 22334578999999999999999999999954 35
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 789999999775 444443 2478899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------------cccc
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSS--------------SSNR 733 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~--------------~~~~ 733 (784)
+..... .......+|+.|+|||.+.+..+++++||||+||++|||++|+.||......... ....
T Consensus 167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 866532 3345667999999999999999999999999999999999999998532211000 0000
Q ss_pred cc---------------ccccccC-CCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 734 NI---------------SLNEILD-PRLPTPPQNVQDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 734 ~~---------------~~~~~~d-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
.. ....... ................+.+|+.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000000 0111111112334567899999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=353.23 Aligned_cols=257 Identities=21% Similarity=0.278 Sum_probs=192.9
Q ss_pred hcCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCceeeEEeEEecC-----C
Q 042086 514 TNGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSIVKFYGFCSHP-----R 587 (784)
Q Consensus 514 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 587 (784)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... +....+.+.+|++++++++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 457999999999999999999875 799999999976432 222345788999999999999999999998633 3
Q ss_pred ceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEEeccccc
Q 042086 588 NSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARVSDFGIA 667 (784)
Q Consensus 588 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 667 (784)
..+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 446667788899999998643 588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccccccCC-cCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cc--------
Q 042086 668 KFLKPDSSNCTELVGTFGYIAPELVYTMK-VTEKCDVYSFGVLALEVIKGDHPRDFISSISSS-------SS-------- 731 (784)
Q Consensus 668 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~-------~~-------- 731 (784)
.... .......|++.|+|||...+.. ++.++||||+||++|+|++|+.||......... ..
T Consensus 169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 7643 2334567899999999877654 678999999999999999999999643211000 00
Q ss_pred ccccccccccCCCCCCCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 042086 732 NRNISLNEILDPRLPTPPQNV-----QDELISIVEVAFLCLNESPESRPPMHTVCQ 782 (784)
Q Consensus 732 ~~~~~~~~~~d~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~~vl~ 782 (784)
........... .....+... ......+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhh-hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000000 000000000 011235788999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-36 Score=326.03 Aligned_cols=258 Identities=20% Similarity=0.232 Sum_probs=188.8
Q ss_pred cCCCCceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-----------CCceeeEEeE
Q 042086 515 NGFDVKYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-----------HRSIVKFYGF 582 (784)
Q Consensus 515 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~ 582 (784)
++|++++.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+++++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 35999999999999999999975 7999999998753 122467788999988875 5789999998
Q ss_pred Eec--CCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCC--
Q 042086 583 CSH--PRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDY-- 657 (784)
Q Consensus 583 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~-- 657 (784)
+.. ....+++++++..+..............+++..+..++.||+.|++|||+ . +|+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence 854 34556666666555433333222333567889999999999999999998 5 899999999999998665
Q ss_pred ----ceEEeccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHHHHHHhCCCCCCccccccccc---
Q 042086 658 ----EARVSDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLALEVIKGDHPRDFISSISSSS--- 730 (784)
Q Consensus 658 ----~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~elltg~~p~~~~~~~~~~~--- 730 (784)
.++++|||.+..... .....+||+.|+|||++....++.++|+||+||+++||++|+.||..........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 399999999986542 2345679999999999999999999999999999999999999986322110000
Q ss_pred ----------c-c-----cccccccccC-----CCCC------------CCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 042086 731 ----------S-N-----RNISLNEILD-----PRLP------------TPPQNVQDELISIVEVAFLCLNESPESRPPM 777 (784)
Q Consensus 731 ----------~-~-----~~~~~~~~~d-----~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 777 (784)
. . .........+ .... ...........++.+|+.+|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 0 0 0000000000 0000 0112234566789999999999999999999
Q ss_pred HHHHH
Q 042086 778 HTVCQ 782 (784)
Q Consensus 778 ~~vl~ 782 (784)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.7e-31 Score=280.53 Aligned_cols=255 Identities=31% Similarity=0.506 Sum_probs=157.4
Q ss_pred CcCcEEeecCCCccc--ccCCccccccccceeeccc-cccCCCccccccCccCCceeeccccccCCccchhhhcccccce
Q 042086 149 SNLAVLHLYGNSLSG--SIPSIIGNLKSLFYLHLSS-NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLH 225 (784)
Q Consensus 149 ~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 225 (784)
.+++.|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+..|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 368888888888876 4678888888888888876 7788888888888888888888888888777777888888888
Q ss_pred eccCCCccccccCCCCcCCCCcceEEecCCCCCCCCccccccccccc-ceEeccCccccCCCCccccCCCccceeecccC
Q 042086 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSL-NYLVLNGNQLYGNLPRALGSLTELEYLDLSTN 304 (784)
Q Consensus 226 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L-~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n 304 (784)
+++++|.+.+.+|..+.++++|+.+++++|.+. +.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~-~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRIS-GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCE-EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS
T ss_pred cccccccccccCchhhccCcccceeeccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 888888877777766666666666666666554 3445555444443 455555555555555444443322 3555555
Q ss_pred ccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcc
Q 042086 305 KLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPS 384 (784)
Q Consensus 305 ~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 384 (784)
...+.+|..+..+++|+.|++++|.+.+ .+| .++.+++|+.|+|++|+++|.+|+
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~------------------------~~~-~~~~~~~L~~L~Ls~N~l~g~iP~ 262 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAF------------------------DLG-KVGLSKNLNGLDLRNNRIYGTLPQ 262 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECC------------------------BGG-GCCCCTTCCEEECCSSCCEECCCG
T ss_pred cccccccccccccccccccccccccccc------------------------ccc-ccccccccccccCccCeecccCCh
Confidence 5555555555555555555555555544 332 344444455555555555544455
Q ss_pred cccCcccceEEEcCCCCCcccCCCCCCCcCCCcccccCCCCCCCCC
Q 042086 385 CFEGMHGLSCIDVSYNELRGPIPNSRIFQYDPMEALQGNKGLCGDI 430 (784)
Q Consensus 385 ~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 430 (784)
.|.++++|++|||++|+++|.+|....+..+....+.+|+.+||.|
T Consensus 263 ~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred HHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 5555555555555555555555544334444444555555566654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.5e-28 Score=265.60 Aligned_cols=301 Identities=29% Similarity=0.384 Sum_probs=192.2
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
++.+|++|++++|+|+.. +.+..+++|++|+|++|+|++.. .++++++|++|++++|++.+.. .++.+++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccc
Confidence 466789999999988853 46888999999999999998643 3888999999999999988543 37889999999
Q ss_pred eecCCCcccccCCccccccccceeeccccccCCC-----------------------------------------ccccc
Q 042086 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS-----------------------------------------IPISL 193 (784)
Q Consensus 155 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-----------------------------------------~~~~~ 193 (784)
++++|.+++..+ ......+..+....|.+... ....+
T Consensus 116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (384)
T d2omza2 116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGG
T ss_pred cccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 999988875433 22334455555544443321 12233
Q ss_pred cCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccc
Q 042086 194 GNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLN 273 (784)
Q Consensus 194 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~ 273 (784)
..+++++.+++++|.+++..+ +..+++|++|++++|+++.. ..+..+++|+.|++++|+++ .++ .+..+++|+
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~--~~~-~~~~~~~L~ 266 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS--NLA-PLSGLTKLT 266 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC--CCG-GGTTCTTCS
T ss_pred ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccC--CCC-cccccccCC
Confidence 445666666666666654433 34455666666666666532 24556666666666666665 222 355566666
Q ss_pred eEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcc
Q 042086 274 YLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNI 353 (784)
Q Consensus 274 ~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 353 (784)
+|++++|++++.. .+..++.++.++++.|.+++ ...+..+++++.|++++|++++.. .+..+++|+.|++++|+
T Consensus 267 ~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~ 340 (384)
T d2omza2 267 ELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNK 340 (384)
T ss_dssp EEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSC
T ss_pred EeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCC
Confidence 6666666665432 25556666666666666653 234556666666666666666532 25666666666666666
Q ss_pred ccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCC
Q 042086 354 LEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYN 400 (784)
Q Consensus 354 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N 400 (784)
+++ ++ .+.++++|++|+|++|++++..| +.++++|+.|+|++|
T Consensus 341 l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 341 VSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 663 33 46666666666666666665543 566666666666665
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.9e-26 Score=240.73 Aligned_cols=262 Identities=24% Similarity=0.258 Sum_probs=124.3
Q ss_pred CCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeec
Q 042086 101 TNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHL 180 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 180 (784)
+++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++|+++. +|..+ ...|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhc
Confidence 345555555555554444455555555555555555554445555555555555555555552 33222 134555555
Q ss_pred cccccCCCccccccCccCCceeeccccccC--CccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCC
Q 042086 181 SSNQLSGSIPISLGNLSNLVVLHLFENSLF--GSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258 (784)
Q Consensus 181 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 258 (784)
++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++. +|..+ ++
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~------------- 171 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PP------------- 171 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CT-------------
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CC-------------
Confidence 555555444434444445555555444321 2223344445555555555555442 22211 23
Q ss_pred CCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhh
Q 042086 259 VGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVEL 338 (784)
Q Consensus 259 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 338 (784)
+|+.|++++|.+++..+..+..++.++.|++++|.+++..+..+.++++|++|+|++|+|+. +|..+
T Consensus 172 ------------~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l 238 (305)
T d1xkua_ 172 ------------SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGL 238 (305)
T ss_dssp ------------TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTT
T ss_pred ------------ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-ccccc
Confidence 34444444444444444444444444444444444444444444444444444444444443 33444
Q ss_pred hcccccCeeccCCcccccccc------ccccccccccEEecCCCccC--CCCcccccCcccceE
Q 042086 339 EKLIQLSELDLSLNILEGKIP------CEICNMESLEKLNLSHNNFS--GLIPSCFEGMHGLSC 394 (784)
Q Consensus 339 ~~l~~L~~L~Ls~N~l~~~~~------~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~ 394 (784)
..+++|+.|+|++|+|+..-. .....+++|+.|+|++|++. ...|..|.-+.....
T Consensus 239 ~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~ 302 (305)
T d1xkua_ 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302 (305)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGG
T ss_pred ccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCcc
Confidence 444444444444444442211 12234566777777777654 344455554443333
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=8.7e-27 Score=251.66 Aligned_cols=302 Identities=27% Similarity=0.360 Sum_probs=244.0
Q ss_pred EEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCC
Q 042086 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS 160 (784)
Q Consensus 81 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 160 (784)
..+++.+++++.+. ...+.+|++|++++|.|+.. +.+..+++|++|+|++|+|++. | .++++++|++|++++|.
T Consensus 26 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccc
Confidence 34677777777654 35678999999999999853 5688999999999999999965 3 39999999999999999
Q ss_pred cccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccC------------------------------
Q 042086 161 LSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLF------------------------------ 210 (784)
Q Consensus 161 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~------------------------------ 210 (784)
+.+.. .++++++|+.|++++|.+++..+.. ....+..+....|.+.
T Consensus 100 i~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (384)
T d2omza2 100 IADIT--PLANLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175 (384)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCGGGT--TCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCT
T ss_pred ccccc--ccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence 98643 3889999999999999998654322 2334444433333321
Q ss_pred -----------CccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccC
Q 042086 211 -----------GSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNG 279 (784)
Q Consensus 211 -----------~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~ 279 (784)
......+..+++++.+++++|.+++..| +..+++|++|++++|+++ .++ .+..+++|+.|++++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~--~~~-~l~~l~~L~~L~l~~ 250 (384)
T d2omza2 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK--DIG-TLASLTNLTDLDLAN 250 (384)
T ss_dssp TCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC--CCG-GGGGCTTCSEEECCS
T ss_pred ccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCC--Ccc-hhhcccccchhcccc
Confidence 1123456778899999999999987654 466789999999999987 343 678899999999999
Q ss_pred ccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccc
Q 042086 280 NQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIP 359 (784)
Q Consensus 280 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 359 (784)
|.+++.. .+..+++|+.|++++|.+++.. .+..++.++.+.++.|.+++ ...+..+++++.|++++|++++..
T Consensus 251 n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~- 323 (384)
T d2omza2 251 NQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS- 323 (384)
T ss_dssp SCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-
T ss_pred CccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc-
Confidence 9998654 3788999999999999998643 47788999999999999987 346889999999999999999653
Q ss_pred ccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccCC
Q 042086 360 CEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPIP 407 (784)
Q Consensus 360 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 407 (784)
.+..+++|+.|++++|++++. + .+.++++|++|++++|++++..|
T Consensus 324 -~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 324 -PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp -GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred -ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh
Confidence 388999999999999999864 3 68999999999999999998544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.8e-26 Score=240.89 Aligned_cols=273 Identities=25% Similarity=0.286 Sum_probs=208.6
Q ss_pred CCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccc
Q 042086 103 LAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182 (784)
Q Consensus 103 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 182 (784)
++.++-++++++ .+|..+. ++|++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 444555555555 5566553 5788888888888855556788888888888888888877777788888888888888
Q ss_pred cccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCc
Q 042086 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEI 262 (784)
Q Consensus 183 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 262 (784)
|+++ .+|..+ ...+..|++.+|.+....+..+.....+..++...|..... ...
T Consensus 89 n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~-----------------------~~~ 142 (305)
T d1xkua_ 89 NQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-----------------------GIE 142 (305)
T ss_dssp SCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG-----------------------GBC
T ss_pred CccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccccc-----------------------CCC
Confidence 8887 444433 25677777777777766666666666666666666544311 112
Q ss_pred ccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhccc
Q 042086 263 PIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLI 342 (784)
Q Consensus 263 ~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~ 342 (784)
+..+..+++|+.+++++|.++ .+|..+ +++|+.|++++|..++..+..+.+++.++.|++++|.+.+..+..+..++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred ccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 234566677777888887776 344433 57899999999999999999999999999999999999998899999999
Q ss_pred ccCeeccCCccccccccccccccccccEEecCCCccCCCCcccc------cCcccceEEEcCCCCCc-ccCCC
Q 042086 343 QLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCF------EGMHGLSCIDVSYNELR-GPIPN 408 (784)
Q Consensus 343 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~------~~l~~L~~l~l~~N~l~-~~~p~ 408 (784)
+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+......| ..+.+|+.|++++|+|+ .+++.
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~ 291 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCH
Confidence 9999999999999 678899999999999999999998755444 45788999999999996 45554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.5e-25 Score=231.04 Aligned_cols=224 Identities=27% Similarity=0.265 Sum_probs=126.4
Q ss_pred EEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec-CC
Q 042086 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY-GN 159 (784)
Q Consensus 81 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~-~n 159 (784)
.++.++++++ .+|..+. +.+++|+|++|+|+...+.+|.++++|++|++++|++.+..+..+..++.++.+... .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4566666666 4454432 456666666666665555566666666666666666665555555666666665543 34
Q ss_pred CcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCC
Q 042086 160 SLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPL 239 (784)
Q Consensus 160 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 239 (784)
.++...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|.++++.+..|..+++|+.|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 45444455555556666666666555544444455555555555555555544444444444555555555554433333
Q ss_pred CCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCccccccccc
Q 042086 240 SIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLK 319 (784)
Q Consensus 240 ~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~ 319 (784)
.+..+++|++|++++|++++..|..|..+++|++|++++|.+.+..+..|..+++
T Consensus 172 -------------------------~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~ 226 (284)
T d1ozna_ 172 -------------------------AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (284)
T ss_dssp -------------------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred -------------------------hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence 3344445555555555555555566666666666666666666555556666666
Q ss_pred ceEEecccccccC
Q 042086 320 LHYLNLSNNQFRK 332 (784)
Q Consensus 320 L~~L~ls~N~l~~ 332 (784)
|++|+|++|++..
T Consensus 227 L~~L~l~~N~l~C 239 (284)
T d1ozna_ 227 LQYLRLNDNPWVC 239 (284)
T ss_dssp CCEEECCSSCEEC
T ss_pred cCEEEecCCCCCC
Confidence 6666666666654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.9e-26 Score=233.17 Aligned_cols=227 Identities=24% Similarity=0.229 Sum_probs=138.1
Q ss_pred EeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccC-CCc
Q 042086 154 LHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLS-TNH 232 (784)
Q Consensus 154 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~-~n~ 232 (784)
++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|++....+..+.+++.++.+... .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 445555555 3444332 345666666666654444455555556666655555555555555555555554432 334
Q ss_pred cccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcc
Q 042086 233 LSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPE 312 (784)
Q Consensus 233 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~ 312 (784)
++...+.. +.++++|++|++++|.+....+..+...++|+.+++++|.+++..+.
T Consensus 93 ~~~l~~~~-------------------------~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~ 147 (284)
T d1ozna_ 93 LRSVDPAT-------------------------FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147 (284)
T ss_dssp CCCCCTTT-------------------------TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cccccchh-------------------------hcccccCCEEecCCcccccccccccchhcccchhhhccccccccChh
Confidence 44333444 44555555555555555544455555566666666666666655555
Q ss_pred cccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccc
Q 042086 313 TLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGL 392 (784)
Q Consensus 313 ~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 392 (784)
.|..+++|++|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..|..|..+++|
T Consensus 148 ~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L 227 (284)
T d1ozna_ 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred HhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccccc
Confidence 66666666666666666666666666667777777777777776666777777777777777777777777777777777
Q ss_pred eEEEcCCCCCcccCCC
Q 042086 393 SCIDVSYNELRGPIPN 408 (784)
Q Consensus 393 ~~l~l~~N~l~~~~p~ 408 (784)
+.|++++|+|.|.++.
T Consensus 228 ~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 228 QYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CEEECCSSCEECSGGG
T ss_pred CEEEecCCCCCCCccc
Confidence 7777777777776653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.4e-23 Score=213.68 Aligned_cols=205 Identities=28% Similarity=0.269 Sum_probs=127.6
Q ss_pred ccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcce
Q 042086 170 GNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIG 249 (784)
Q Consensus 170 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 249 (784)
.+...+.+++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|+.
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 34456667788888887 5666554 4677777777777766666777777777777777777632 2 2344555555
Q ss_pred EEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEeccccc
Q 042086 250 LYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQ 329 (784)
Q Consensus 250 L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~ 329 (784)
|+|++|+++ . .+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.
T Consensus 82 L~Ls~N~l~--~------------------------~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 82 LDLSHNQLQ--S------------------------LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp EECCSSCCS--S------------------------CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred ccccccccc--c------------------------cccccccccccccccccccccceeeccccccccccccccccccc
Confidence 555555544 2 23344455555555555555554445555555556666666666
Q ss_pred ccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCcccccCcccceEEEcCCCCCcccC
Q 042086 330 FRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVSYNELRGPI 406 (784)
Q Consensus 330 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 406 (784)
++...+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|+|.|.+
T Consensus 136 l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 65555555555666666666666666555556666667777777777766 45555666777777777777777654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=4.7e-23 Score=209.80 Aligned_cols=202 Identities=28% Similarity=0.221 Sum_probs=134.5
Q ss_pred cCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccce
Q 042086 146 GNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLH 225 (784)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 225 (784)
.....+.+++.+++.++ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|+|+.. + .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 45667788899999999 5777664 5799999999999977778899999999999999999744 3 4678999999
Q ss_pred eccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCc
Q 042086 226 LGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNK 305 (784)
Q Consensus 226 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 305 (784)
|+|++|+++. .+..+.++++|+.|++++|.+.. ..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~-~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccccccccc-cccccccccccccccccccccce-eeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 9999999984 46667777777777777776651 112233444555555555555554444444444455555555555
Q ss_pred cCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccC
Q 042086 306 LGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFS 379 (784)
Q Consensus 306 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 379 (784)
++ +..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 160 l~------------------------~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 160 LT------------------------ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CS------------------------CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cc------------------------ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 44 444444444555555555555555 44545555555555555555544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.4e-22 Score=194.98 Aligned_cols=173 Identities=17% Similarity=0.131 Sum_probs=121.1
Q ss_pred CCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCC---------------ChhhHHHHHHHHhccCCCceeeEEe
Q 042086 517 FDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMV---------------PQPEFVNEIKTLTELRHRSIVKFYG 581 (784)
Q Consensus 517 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~~ 581 (784)
+.+.+.||+|+||+||+|+..+|+.||||+++........ ....+..|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3467899999999999999989999999987643211000 0123456888999999999999887
Q ss_pred EEecCCceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeeecCCCceEE
Q 042086 582 FCSHPRNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDCFPPIVHRDISSKNVLLCLDYEARV 661 (784)
Q Consensus 582 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 661 (784)
+.. .+++|||++++.+.+ ++.....+++.|++++++|||++ +|+||||||+|||++++ .++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 642 379999998865432 23344567999999999999999 99999999999999865 5899
Q ss_pred eccccccccCCCCCcccccccccccccccccccCCcCcchhHHHHHHHH
Q 042086 662 SDFGIAKFLKPDSSNCTELVGTFGYIAPELVYTMKVTEKCDVYSFGVLA 710 (784)
Q Consensus 662 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l 710 (784)
+|||.|.....+... .....+...+ .| +..++|..++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~-~~l~rd~~~~-~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR-EILERDVRNI-IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH-HHHHHHHHHH-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH-HHHHHHHHHH-HH-HHcCCCCCcccHHHHHHHH
Confidence 999999765422111 0000000000 11 1245678899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=9.1e-19 Score=185.44 Aligned_cols=286 Identities=28% Similarity=0.337 Sum_probs=180.0
Q ss_pred cccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeec
Q 042086 78 SLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLY 157 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (784)
++++|||++|+++ .+|+. .++|++|+|++|+|+ .+|.. +.+|++|++++|+++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5778888888887 46643 467888888888888 56765 357888888888887 33321 1458888888
Q ss_pred CCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCcccccc
Q 042086 158 GNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVI 237 (784)
Q Consensus 158 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (784)
+|.+. .+|. ++.+++|+.|++++|.+.. .+.. ...+..+.+..+... ....+..++.++.|++++|.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~- 177 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL- 177 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-
T ss_pred ccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccccc-
Confidence 88887 4453 5778888888888888773 3332 345566666555542 234466677777788877776532
Q ss_pred CCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccc-
Q 042086 238 PLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGN- 316 (784)
Q Consensus 238 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~- 316 (784)
+.. ....+.+...++.+. .++ .+..++.|+.+++++|.... .+. ...++..+.+.+|.+... +.....
T Consensus 178 ~~~---~~~~~~l~~~~~~~~--~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~~~~~l 246 (353)
T d1jl5a_ 178 PDL---PLSLESIVAGNNILE--ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PELPQSL 246 (353)
T ss_dssp CCC---CTTCCEEECCSSCCS--SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CCCCTTC
T ss_pred ccc---ccccccccccccccc--ccc-cccccccccccccccccccc-ccc---cccccccccccccccccc-ccccccc
Confidence 211 122344444444443 222 34556666666666666542 222 223455555555555421 111111
Q ss_pred ---------------c-ccceEEecccccccCCCchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCC
Q 042086 317 ---------------L-LKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSG 380 (784)
Q Consensus 317 ---------------l-~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 380 (784)
+ ......++..|.+.+ ....+++|++|+|++|+++ .+|.. +++|+.|+|++|+|+.
T Consensus 247 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~ 318 (353)
T d1jl5a_ 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE 318 (353)
T ss_dssp CEEECCSSCCSEESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC
T ss_pred cccccccccccccccccchhcccccccCcccc----ccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc
Confidence 1 122344444444443 2234678999999999998 67743 5789999999999985
Q ss_pred CCcccccCcccceEEEcCCCCCcccCCC
Q 042086 381 LIPSCFEGMHGLSCIDVSYNELRGPIPN 408 (784)
Q Consensus 381 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 408 (784)
+|.. +++|++|++++|+++. +|.
T Consensus 319 -l~~~---~~~L~~L~L~~N~L~~-lp~ 341 (353)
T d1jl5a_ 319 -VPEL---PQNLKQLHVEYNPLRE-FPD 341 (353)
T ss_dssp -CCCC---CTTCCEEECCSSCCSS-CCC
T ss_pred -cccc---cCCCCEEECcCCcCCC-CCc
Confidence 4543 4678999999999884 664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1.2e-19 Score=179.57 Aligned_cols=187 Identities=25% Similarity=0.389 Sum_probs=101.7
Q ss_pred CccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccce
Q 042086 195 NLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNY 274 (784)
Q Consensus 195 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~ 274 (784)
.+.+|+.|++.+|+|+.. ..+.++++|++|++++|++++..+ +..+++|+.+++++|.++ .++ .+..+++|+.
T Consensus 39 ~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~--~i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVS-AIAGLQSIKT 111 (227)
T ss_dssp HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS--CCG-GGTTCTTCCE
T ss_pred HcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc--ccc-cccccccccc
Confidence 344444444444444322 224444445555555554443221 444455555555555443 222 3445555566
Q ss_pred EeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccc
Q 042086 275 LVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNIL 354 (784)
Q Consensus 275 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 354 (784)
+++++|...+. ..+...+.++.+.++++.+... ..+..+++|+.|++++|.+... ..++++++|+.|+|++|++
T Consensus 112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185 (227)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence 66655555432 2244455666666666665532 2355566666666666666542 2366666777777777766
Q ss_pred cccccccccccccccEEecCCCccCCCCcccccCcccceEEEcC
Q 042086 355 EGKIPCEICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398 (784)
Q Consensus 355 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 398 (784)
++ ++ .++++++|++|+|++|++++..| +.++++|+.|+++
T Consensus 186 ~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 186 SD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 63 33 36667777777777777765432 6677777777765
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=1.4e-19 Score=179.22 Aligned_cols=207 Identities=27% Similarity=0.375 Sum_probs=115.4
Q ss_pred CcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEee
Q 042086 77 KSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHL 156 (784)
Q Consensus 77 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (784)
..+..++++.+++++.. .+..+.+|+.|++.+|+|+. + +.+..+++|++|++++|.+++.. .+..+++|++|++
T Consensus 19 ~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~ 92 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELEL 92 (227)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEEC
T ss_pred HHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--ccccccccccccc
Confidence 33445566666666543 34556677777777777764 3 34667777777777777776443 2666777777777
Q ss_pred cCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccc
Q 042086 157 YGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGV 236 (784)
Q Consensus 157 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 236 (784)
++|.++. + +.+.++++|+.+++++|...+. ..+...+.+..+.++++.+... ..+.++++|+.|++++|.+++.
T Consensus 93 ~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~ 166 (227)
T d1h6ua2 93 SGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL 166 (227)
T ss_dssp CSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC
T ss_pred ccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc
Confidence 7776663 2 2456666777777766665532 2244455666666666655432 2245555566666666555432
Q ss_pred cCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccc
Q 042086 237 IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGN 316 (784)
Q Consensus 237 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~ 316 (784)
. .+++++ +|+.|++++|++++. + .+..+++|++|+|++|++++.. .+.+
T Consensus 167 ~--~l~~l~-------------------------~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~ 215 (227)
T d1h6ua2 167 T--PLANLS-------------------------KLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLAN 215 (227)
T ss_dssp G--GGTTCT-------------------------TCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTT
T ss_pred h--hhcccc-------------------------cceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--cccc
Confidence 1 234444 444444444444422 1 2445555555555555555322 2455
Q ss_pred cccceEEecc
Q 042086 317 LLKLHYLNLS 326 (784)
Q Consensus 317 l~~L~~L~ls 326 (784)
+++|+.|+++
T Consensus 216 l~~L~~L~ls 225 (227)
T d1h6ua2 216 TSNLFIVTLT 225 (227)
T ss_dssp CTTCCEEEEE
T ss_pred CCCCCEEEee
Confidence 5555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=1.2e-17 Score=176.61 Aligned_cols=293 Identities=28% Similarity=0.317 Sum_probs=195.1
Q ss_pred CeEEEEeCCCccc---CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCcc
Q 042086 61 RVISINLSTVGLK---GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQL 137 (784)
Q Consensus 61 ~v~~l~l~~~~~~---~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 137 (784)
+...+|++..++. ..+++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. +++. .+.|++|++++|.+
T Consensus 39 ~l~~LdLs~~~L~~lp~~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~~n~l 110 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL 110 (353)
T ss_dssp TCSEEECTTSCCSCCCSCCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred CCCEEEeCCCCCCCCCCCCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccccccc
Confidence 4556777776653 34578999999999999 567654 589999999999873 3331 24699999999999
Q ss_pred CCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhh
Q 042086 138 SGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSIL 217 (784)
Q Consensus 138 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 217 (784)
. .+|. ++.+++|+.|++++|.+.. .+.. ...+..+.+..+... .+..+..++.++.|++++|.+..... .
T Consensus 111 ~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~-~- 180 (353)
T d1jl5a_ 111 E-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD-L- 180 (353)
T ss_dssp S-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCC-C-
T ss_pred c-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccccccc-c-
Confidence 8 5564 6889999999999998874 3333 355667777766654 34557778889999999888753321 1
Q ss_pred hcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCC----
Q 042086 218 GNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSL---- 293 (784)
Q Consensus 218 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l---- 293 (784)
....+.+...++.+. ..+ .+..++.|+.+++++|... .++. ...++..+.+.+|.+... +.....+
T Consensus 181 --~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~--~~~~---~~~~l~~~~~~~~~~~~~-~~~~~~l~~~~ 250 (353)
T d1jl5a_ 181 --PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK--TLPD---LPPSLEALNVRDNYLTDL-PELPQSLTFLD 250 (353)
T ss_dssp --CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS--SCCS---CCTTCCEEECCSSCCSCC-CCCCTTCCEEE
T ss_pred --ccccccccccccccc-ccc-ccccccccccccccccccc--cccc---cccccccccccccccccc-ccccccccccc
Confidence 122344555555554 222 3556777888888877664 2332 234566666666666522 2211111
Q ss_pred -------------CccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCccccccccc
Q 042086 294 -------------TELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPC 360 (784)
Q Consensus 294 -------------~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 360 (784)
......++..|.+. .....+++|++|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|.
T Consensus 251 ~~~~~~~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~ 321 (353)
T d1jl5a_ 251 VSENIFSGLSELPPNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPE 321 (353)
T ss_dssp CCSSCCSEESCCCTTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC
T ss_pred cccccccccccccchhcccccccCccc----cccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-cccc
Confidence 11223333333333 222345799999999999986 554 3678999999999998 6775
Q ss_pred cccccccccEEecCCCccCCCCcccccCcccceEEEc
Q 042086 361 EICNMESLEKLNLSHNNFSGLIPSCFEGMHGLSCIDV 397 (784)
Q Consensus 361 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l 397 (784)
. +++|+.|+|++|+++. +|+... +|+.|.+
T Consensus 322 ~---~~~L~~L~L~~N~L~~-lp~~~~---~L~~L~~ 351 (353)
T d1jl5a_ 322 L---PQNLKQLHVEYNPLRE-FPDIPE---SVEDLRM 351 (353)
T ss_dssp C---CTTCCEEECCSSCCSS-CCCCCT---TCCEEEC
T ss_pred c---cCCCCEEECcCCcCCC-CCcccc---ccCeeEC
Confidence 3 4689999999999984 565433 3455544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.3e-18 Score=173.95 Aligned_cols=104 Identities=20% Similarity=0.250 Sum_probs=64.5
Q ss_pred cEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCC-CcCccCCCcCcEEeecC
Q 042086 80 STLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSI-PPTLGNLSNLAVLHLYG 158 (784)
Q Consensus 80 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~ 158 (784)
+.++.++++++ .+|..+- +++++|+|++|.|+...+.+|.++++|++|+|++|.+...+ +..|..++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45666666666 4554432 46677777777776555556667777777777777665433 34566666666666543
Q ss_pred -CCcccccCCccccccccceeeccccccC
Q 042086 159 -NSLSGSIPSIIGNLKSLFYLHLSSNQLS 186 (784)
Q Consensus 159 -n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 186 (784)
|++....+..|.++++|++|++++|.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccchhhhc
Confidence 4555555566666666666666666665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=7.4e-19 Score=175.83 Aligned_cols=104 Identities=21% Similarity=0.204 Sum_probs=61.4
Q ss_pred CEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCc-cccccCccCCceeeccc
Q 042086 128 YHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSI-PISLGNLSNLVVLHLFE 206 (784)
Q Consensus 128 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~ 206 (784)
+.++.+++.++ .+|+.+. +++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56677776666 5555442 46777777777776544556667777777777777665433 33455566666665543
Q ss_pred -cccCCccchhhhcccccceeccCCCccc
Q 042086 207 -NSLFGSIPSILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 207 -n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (784)
|.+....+..|.++++|+.|++++|++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccchhhhc
Confidence 4444444455555555555555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.3e-21 Score=213.55 Aligned_cols=187 Identities=20% Similarity=0.122 Sum_probs=93.5
Q ss_pred hcccccceeccCCCccccc-----cCCCCcCCCCcceEEecCCCCCCCC---cccccccccccceEeccCccccCCCCcc
Q 042086 218 GNLKMLLHLGLSTNHLSGV-----IPLSIGNLNNLIGLYLYDNQLSVGE---IPIEIGKLSSLNYLVLNGNQLYGNLPRA 289 (784)
Q Consensus 218 ~~l~~L~~L~L~~n~l~~~-----~~~~l~~l~~L~~L~L~~n~l~~~~---~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 289 (784)
...+.++.+++.+|++... .........+++.+++++|.+.... ....+...+.++.+++++|.+++.....
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 3445566666666654321 1222334456666666666654211 1112344556666666666664321111
Q ss_pred c-----cCCCccceeecccCccCCCCcccc----cccccceEEecccccccCC----Cchhhh-cccccCeeccCCcccc
Q 042086 290 L-----GSLTELEYLDLSTNKLGNSIPETL----GNLLKLHYLNLSNNQFRKG----FPVELE-KLIQLSELDLSLNILE 355 (784)
Q Consensus 290 l-----~~l~~L~~L~Ls~n~l~~~~~~~l----~~l~~L~~L~ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~ 355 (784)
+ .....|+.+++++|.++......+ ...++|++|+|++|+++.. ++..+. ..+.|+.|+|++|.++
T Consensus 303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence 1 123456666666666654333323 2334566666666666542 122222 2445666666666665
Q ss_pred cc----ccccccccccccEEecCCCccCCCCcccc----c-CcccceEEEcCCCCCcc
Q 042086 356 GK----IPCEICNMESLEKLNLSHNNFSGLIPSCF----E-GMHGLSCIDVSYNELRG 404 (784)
Q Consensus 356 ~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~----~-~l~~L~~l~l~~N~l~~ 404 (784)
.. ++..+...++|++|+|++|+|+......+ . +...|+.|++.+|.+..
T Consensus 383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 42 23334455666666666666654322222 1 22346666666666543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.1e-18 Score=167.63 Aligned_cols=154 Identities=23% Similarity=0.221 Sum_probs=75.5
Q ss_pred CCCCEEEccCCcccccC-CCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceee
Q 042086 101 TNLAIMYLYRNSLSASI-PPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLH 179 (784)
Q Consensus 101 ~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 179 (784)
+++++|+|++|+|+..+ +..|+++++|++|+|++|.+....+..+..+++|++|+|++|+|+...+..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 34455555555554322 33445555555555555555555555555555555555555555544445555555555555
Q ss_pred ccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCC
Q 042086 180 LSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258 (784)
Q Consensus 180 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 258 (784)
|++|+|++..+..|..+++|++|+|++|.+...... ..-...++.+.+..|.++...|..+ ..++.++|+.|++.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCc
Confidence 555555544444555555555555555555432211 1111224444555555554444333 33444555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=3.2e-18 Score=164.26 Aligned_cols=173 Identities=26% Similarity=0.287 Sum_probs=98.7
Q ss_pred CEEEccCCccCCCCCcCccCCCcCcEEeecCCCccccc-CCccccccccceeeccccccCCCccccccCccCCceeeccc
Q 042086 128 YHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSI-PSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFE 206 (784)
Q Consensus 128 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 206 (784)
+.++.++++++ .+|..+. +++++|+|++|+|+..+ +..|.++++|++|+|++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34555555555 3444332 45555555555555322 34455566666666666666655555666666666666666
Q ss_pred cccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCC
Q 042086 207 NSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNL 286 (784)
Q Consensus 207 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 286 (784)
|+|+...+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+....-..++ ...++.+.+..+.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCeEeCC
Confidence 666655566666666666666666666666666666666777777776666521111111 123555566666666555
Q ss_pred CccccCCCccceeecccCccCC
Q 042086 287 PRALGSLTELEYLDLSTNKLGN 308 (784)
Q Consensus 287 ~~~l~~l~~L~~L~Ls~n~l~~ 308 (784)
|..+ ..++.++|+.|.+.-
T Consensus 166 p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp STTT---TTSBGGGSCTTTCCC
T ss_pred Chhh---cCCEeeecCHhhCcC
Confidence 5433 445566677766653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.2e-18 Score=165.91 Aligned_cols=179 Identities=30% Similarity=0.364 Sum_probs=82.1
Q ss_pred eCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcc
Q 042086 83 DLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLS 162 (784)
Q Consensus 83 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 162 (784)
++..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|+|++|.+++. + .++.+++|++|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccc
Confidence 4444544443321 23445555555555554321 244555555555555555532 1 2344555555555555554
Q ss_pred cccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCc
Q 042086 163 GSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIG 242 (784)
Q Consensus 163 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~ 242 (784)
+ ++ .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.++.. ..+.
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~------------------------ 153 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLS------------------------ 153 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGG------------------------
T ss_pred c-cc-cccccccccccccccccccc-c-cccccccccccccccccccccc--cccc------------------------
Confidence 2 22 24444555555555554431 1 2234444444444444444321 2233
Q ss_pred CCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCccceeecc
Q 042086 243 NLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLS 302 (784)
Q Consensus 243 ~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 302 (784)
.+++|+.+++++|+++ .++ .+.++++|++|++++|++++ ++ .+..+++|++|+|+
T Consensus 154 ~l~~L~~l~l~~n~l~--~i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQIS--DIV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GCTTCSEEECCSSCCC--CCG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccccccccccccccc--ccc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 3444444444444443 222 24455555555555555542 22 35555566666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=3.9e-18 Score=166.13 Aligned_cols=101 Identities=29% Similarity=0.428 Sum_probs=42.4
Q ss_pred ccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhcccccCeeccCCcccccccccccccccccc
Q 042086 290 LGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEKLIQLSELDLSLNILEGKIPCEICNMESLE 369 (784)
Q Consensus 290 l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 369 (784)
+..+++|+.|++++|.+.. ...+..+++|+.+++++|.+++ +..+..+++|+.+++++|++++ ++ .+.++++|+
T Consensus 108 l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~ 181 (210)
T d1h6ta2 108 LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQ 181 (210)
T ss_dssp GTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCC
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCC
Confidence 3334444444444444331 1223344444444444444433 2223344444444444444442 11 144444555
Q ss_pred EEecCCCccCCCCcccccCcccceEEEcC
Q 042086 370 KLNLSHNNFSGLIPSCFEGMHGLSCIDVS 398 (784)
Q Consensus 370 ~L~L~~N~l~~~~p~~~~~l~~L~~l~l~ 398 (784)
.|+|++|+++.. | .+.++++|++|+|+
T Consensus 182 ~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 182 NLYLSKNHISDL-R-ALAGLKNLDVLELF 208 (210)
T ss_dssp EEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred EEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence 555555554432 2 34445555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=3.6e-18 Score=164.95 Aligned_cols=163 Identities=26% Similarity=0.330 Sum_probs=81.8
Q ss_pred EEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCC
Q 042086 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS 160 (784)
Q Consensus 81 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 160 (784)
.+.++.+++++..+ ...+.+|++|++++|.++.. +.++.+++|++|+|++|++++.. .++++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcc--cccCCcccccccccccc
Confidence 34555555554432 23455666666666665532 23555666666666666665432 25556666666666665
Q ss_pred cccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCC
Q 042086 161 LSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLS 240 (784)
Q Consensus 161 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 240 (784)
+... + .+.++++|+.|++++|.+... ..+..+++|+.|++++|++... +.+..+++|+.|++++|++++.. .
T Consensus 96 ~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~ 167 (199)
T d2omxa2 96 IADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--P 167 (199)
T ss_dssp CCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--G
T ss_pred cccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--c
Confidence 5532 2 255555566666555555422 2244455555555555555321 23444555555555555554321 2
Q ss_pred CcCCCCcceEEecCCCC
Q 042086 241 IGNLNNLIGLYLYDNQL 257 (784)
Q Consensus 241 l~~l~~L~~L~L~~n~l 257 (784)
++++++|++|++++|++
T Consensus 168 l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 168 LANLTTLERLDISSNKV 184 (199)
T ss_dssp GTTCTTCCEEECCSSCC
T ss_pred ccCCCCCCEEECCCCCC
Confidence 34444444444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.7e-17 Score=158.66 Aligned_cols=162 Identities=31% Similarity=0.426 Sum_probs=137.9
Q ss_pred CCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEE
Q 042086 75 NLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVL 154 (784)
Q Consensus 75 ~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (784)
.+.++++|++++|+|+.. +.+..+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 467899999999999853 458899999999999999986543 8999999999999999884 33 58899999999
Q ss_pred eecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccc
Q 042086 155 HLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 155 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (784)
++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|+.|++.+|++++.. .++++++|++|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 9999998854 357889999999999999983 33 5888999999999999998653 4899999999999999998
Q ss_pred cccCCCCcCCCCcceE
Q 042086 235 GVIPLSIGNLNNLIGL 250 (784)
Q Consensus 235 ~~~~~~l~~l~~L~~L 250 (784)
+. + .++++++|++|
T Consensus 186 ~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 186 DI-S-VLAKLTNLESL 199 (199)
T ss_dssp CC-G-GGGGCTTCSEE
T ss_pred CC-c-cccCCCCCCcC
Confidence 53 3 47778888765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=4.7e-20 Score=202.92 Aligned_cols=327 Identities=22% Similarity=0.168 Sum_probs=220.6
Q ss_pred cccEEeCCCCcccccC-CCCcCCCCCCCEEEccCCcccc----cCCCCCCCCCCCCEEEccCCccCCC----CCcCcc-C
Q 042086 78 SLSTLDLSKNKLNGSI-PFSFGNLTNLAIMYLYRNSLSA----SIPPVIGNLKFLYHLDLSENQLSGS----IPPTLG-N 147 (784)
Q Consensus 78 ~l~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~-~ 147 (784)
+|++||++.|+|++.. ...+..+++++.|+|++|.|+. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5899999999998642 3345678999999999999974 4456678899999999999998642 222332 2
Q ss_pred CCcCcEEeecCCCcccc----cCCccccccccceeeccccccCCCccccc------------------------------
Q 042086 148 LSNLAVLHLYGNSLSGS----IPSIIGNLKSLFYLHLSSNQLSGSIPISL------------------------------ 193 (784)
Q Consensus 148 l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~------------------------------ 193 (784)
..+|++|+|++|++++. ++..+..+++|++|+|++|.++......+
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35799999999999854 45667888999999999998763211111
Q ss_pred ---cCccCCceeeccccccCCccc----hhhh-cccccceeccCCCccccc----cCCCCcCCCCcceEEecCCCCCCCC
Q 042086 194 ---GNLSNLVVLHLFENSLFGSIP----SILG-NLKMLLHLGLSTNHLSGV----IPLSIGNLNNLIGLYLYDNQLSVGE 261 (784)
Q Consensus 194 ---~~l~~L~~L~L~~n~l~~~~~----~~l~-~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~ 261 (784)
.....++.++++++.+..... ..+. .......+++..+.+... ....+...+.++.+++..|++....
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 112344555555444321100 1111 112344556665554421 1122345677888888888764221
Q ss_pred ----cccccccccccceEeccCccccCC----CCccccCCCccceeecccCccCCCCcccc-----cccccceEEecccc
Q 042086 262 ----IPIEIGKLSSLNYLVLNGNQLYGN----LPRALGSLTELEYLDLSTNKLGNSIPETL-----GNLLKLHYLNLSNN 328 (784)
Q Consensus 262 ----~~~~l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l-----~~l~~L~~L~ls~N 328 (784)
.........+++.|++++|.+... ....+...+.++.+++++|.+++.....+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 122234466899999999988633 22345567889999999999875333332 23468999999999
Q ss_pred cccCCCchhh----hcccccCeeccCCccccccc----ccccc-ccccccEEecCCCccCCC----CcccccCcccceEE
Q 042086 329 QFRKGFPVEL----EKLIQLSELDLSLNILEGKI----PCEIC-NMESLEKLNLSHNNFSGL----IPSCFEGMHGLSCI 395 (784)
Q Consensus 329 ~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~l 395 (784)
.++......+ ...++|++|+|++|++++.. +..+. ..+.|+.|+|++|+|+.. +++.+...++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 9887544444 44568999999999997643 33333 356799999999999854 34556677999999
Q ss_pred EcCCCCCcc
Q 042086 396 DVSYNELRG 404 (784)
Q Consensus 396 ~l~~N~l~~ 404 (784)
||++|+++.
T Consensus 403 ~Ls~N~i~~ 411 (460)
T d1z7xw1 403 DLSNNCLGD 411 (460)
T ss_dssp ECCSSSCCH
T ss_pred ECCCCcCCH
Confidence 999999864
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.6e-17 Score=169.77 Aligned_cols=159 Identities=21% Similarity=0.195 Sum_probs=68.1
Q ss_pred ccccccceeeccccccCCCccccccCccCCceeecccc-ccCCc-cchhhhcccccceeccCCC-ccccc-cCCCCc-CC
Q 042086 170 GNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFEN-SLFGS-IPSILGNLKMLLHLGLSTN-HLSGV-IPLSIG-NL 244 (784)
Q Consensus 170 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~l~-~l 244 (784)
.++++|++|+|++|.+++..+..++.+++|++|++++| .++.. +...+.++++|++|+++++ .++.. ....+. ..
T Consensus 68 ~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~ 147 (284)
T d2astb2 68 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 147 (284)
T ss_dssp TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC
T ss_pred HhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccc
Confidence 34444444444444444333444444444444444442 23211 1122334455555555543 22211 111111 12
Q ss_pred CCcceEEecCCC--CCCCCcccccccccccceEeccCc-cccCCCCccccCCCccceeecccC-ccCCCCcccccccccc
Q 042086 245 NNLIGLYLYDNQ--LSVGEIPIEIGKLSSLNYLVLNGN-QLYGNLPRALGSLTELEYLDLSTN-KLGNSIPETLGNLLKL 320 (784)
Q Consensus 245 ~~L~~L~L~~n~--l~~~~~~~~l~~l~~L~~L~l~~n-~l~~~~~~~l~~l~~L~~L~Ls~n-~l~~~~~~~l~~l~~L 320 (784)
++|+.|+++++. ++...+...+..+++|++|++++| .+++.....+..+++|++|++++| .+++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 345555554431 221122222334455555555554 244444445555555555555553 3444444445555555
Q ss_pred eEEecccc
Q 042086 321 HYLNLSNN 328 (784)
Q Consensus 321 ~~L~ls~N 328 (784)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 55555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.9e-17 Score=169.22 Aligned_cols=222 Identities=19% Similarity=0.164 Sum_probs=110.3
Q ss_pred EEEccCCccCCCCCcCccCC--CcCcEEeecCCCcccccCCccccccccceeeccccccCCC-ccccccCccCCceeecc
Q 042086 129 HLDLSENQLSGSIPPTLGNL--SNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGS-IPISLGNLSNLVVLHLF 205 (784)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~ 205 (784)
.|||+++.+.. +.++.+ ..+..+.++...+...... .....+|++|||++|.++.. ++..+..+++|++|+|+
T Consensus 4 ~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 4 TLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp EEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred EEECCCCCCCc---hHHHHHHhccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 56666655532 222211 1244555555544422222 23445677777777776633 33446667777777777
Q ss_pred ccccCCccchhhhcccccceeccCCC-cccccc-CCCCcCCCCcceEEecCC-CCCCCCccccccc-ccccceEeccCcc
Q 042086 206 ENSLFGSIPSILGNLKMLLHLGLSTN-HLSGVI-PLSIGNLNNLIGLYLYDN-QLSVGEIPIEIGK-LSSLNYLVLNGNQ 281 (784)
Q Consensus 206 ~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~-~~~l~~l~~L~~L~L~~n-~l~~~~~~~~l~~-l~~L~~L~l~~n~ 281 (784)
+|.++...+..++.+++|++|++++| .++... ...+.++++|++|++++| .++...+...+.. .++|+.|+++++.
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~ 159 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred ccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc
Confidence 77776666666777777777777764 444221 111234566666666654 2322122222222 2345555554431
Q ss_pred ccCCCCccccCCCccceeecccCccCCC-CcccccccccceEEecccc-cccCCCchhhhcccccCeeccCCc-cccccc
Q 042086 282 LYGNLPRALGSLTELEYLDLSTNKLGNS-IPETLGNLLKLHYLNLSNN-QFRKGFPVELEKLIQLSELDLSLN-ILEGKI 358 (784)
Q Consensus 282 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~ 358 (784)
. .++.. +...+.++++|++|++++| .+++.....+.++++|++|+|++| .+++..
T Consensus 160 ~----------------------~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~ 217 (284)
T d2astb2 160 K----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 217 (284)
T ss_dssp G----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGG
T ss_pred c----------------------ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHH
Confidence 1 12211 1111233445555555543 244444444555555555555553 444444
Q ss_pred cccccccccccEEecCCC
Q 042086 359 PCEICNMESLEKLNLSHN 376 (784)
Q Consensus 359 ~~~~~~l~~L~~L~L~~N 376 (784)
...++.+++|+.|+++++
T Consensus 218 l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 218 LLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGGGCTTCCEEECTTS
T ss_pred HHHHhcCCCCCEEeeeCC
Confidence 445555566666666655
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.58 E-value=8.8e-17 Score=169.51 Aligned_cols=252 Identities=20% Similarity=0.169 Sum_probs=113.0
Q ss_pred CCCCCCCCCCCCEEEccCCccCCC----CCcCccCCCcCcEEeecCCCcccc----------cCCccccccccceeeccc
Q 042086 117 IPPVIGNLKFLYHLDLSENQLSGS----IPPTLGNLSNLAVLHLYGNSLSGS----------IPSIIGNLKSLFYLHLSS 182 (784)
Q Consensus 117 ~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~----------~~~~l~~l~~L~~L~L~~ 182 (784)
+...+.....|++|+|++|.+... +...+...++|+.|+++++.+... +...+...++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 334455566677777777766532 223345556666666666543311 111223344555555555
Q ss_pred cccCCC----ccccccCccCCceeeccccccCCccchhhhcccccceeccCCCccccccCCCCcCCCCcceEEecCCCCC
Q 042086 183 NQLSGS----IPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLNNLIGLYLYDNQLS 258 (784)
Q Consensus 183 n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 258 (784)
|.++.. +...+..+++|++|++++|.+.......++. .|..+.. .......+.|+.+.+++|.++
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~---------~~~~~~~~~L~~l~l~~n~i~ 171 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAV---------NKKAKNAPPLRSIICGRNRLE 171 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHH---------HHHHHTCCCCCEEECCSSCCT
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccc--ccccccc---------ccccccCcccceeeccccccc
Confidence 554432 1122223344555555444442111111100 0000000 000112345555555555554
Q ss_pred CCC---cccccccccccceEeccCccccCC-----CCccccCCCccceeecccCccCCC----CcccccccccceEEecc
Q 042086 259 VGE---IPIEIGKLSSLNYLVLNGNQLYGN-----LPRALGSLTELEYLDLSTNKLGNS----IPETLGNLLKLHYLNLS 326 (784)
Q Consensus 259 ~~~---~~~~l~~l~~L~~L~l~~n~l~~~-----~~~~l~~l~~L~~L~Ls~n~l~~~----~~~~l~~l~~L~~L~ls 326 (784)
... +...+...++|+.|++++|+++.. +...+..+++|+.|+|++|.++.. +...+...++|++|+|+
T Consensus 172 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls 251 (344)
T d2ca6a1 172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251 (344)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred ccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhh
Confidence 221 112234455666666666665421 223345556666666666665432 22334455666666666
Q ss_pred cccccCCCchhh----hc--ccccCeeccCCcccccccc----cccc-ccccccEEecCCCccC
Q 042086 327 NNQFRKGFPVEL----EK--LIQLSELDLSLNILEGKIP----CEIC-NMESLEKLNLSHNNFS 379 (784)
Q Consensus 327 ~N~l~~~~~~~~----~~--l~~L~~L~Ls~N~l~~~~~----~~~~-~l~~L~~L~L~~N~l~ 379 (784)
+|.|++.....+ .. .+.|+.|+|++|+++.... ..+. +.++|+.|+|++|++.
T Consensus 252 ~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 666654322222 11 2345566666665543222 1121 2345555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.55 E-value=1.2e-16 Score=168.50 Aligned_cols=238 Identities=18% Similarity=0.139 Sum_probs=114.5
Q ss_pred cCCCCCCCEEEccCCcccc----cCCCCCCCCCCCCEEEccCCccCCC----------CCcCccCCCcCcEEeecCCCcc
Q 042086 97 FGNLTNLAIMYLYRNSLSA----SIPPVIGNLKFLYHLDLSENQLSGS----------IPPTLGNLSNLAVLHLYGNSLS 162 (784)
Q Consensus 97 ~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~L~~n~l~ 162 (784)
+.....|++|+|++|.|+. .+...+...++|+.|+++++..... +...+...++|+.|+|++|.++
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence 4445555556666555532 2233455556666666665543211 1122334566666666666665
Q ss_pred cc----cCCccccccccceeeccccccCCCcccc-------------ccCccCCceeeccccccCCc----cchhhhccc
Q 042086 163 GS----IPSIIGNLKSLFYLHLSSNQLSGSIPIS-------------LGNLSNLVVLHLFENSLFGS----IPSILGNLK 221 (784)
Q Consensus 163 ~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~ 221 (784)
.. +...+...++|++|++++|.+....... ....+.|+.|++++|.++.. +...+...+
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~ 186 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred cccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhh
Confidence 43 2223345566777777777654211111 12345666666666666422 223344556
Q ss_pred ccceeccCCCccccc-----cCCCCcCCCCcceEEecCCCCCCCCcccccccccccceEeccCccccCCCCccccCCCcc
Q 042086 222 MLLHLGLSTNHLSGV-----IPLSIGNLNNLIGLYLYDNQLSVGEIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTEL 296 (784)
Q Consensus 222 ~L~~L~L~~n~l~~~-----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 296 (784)
.|+.|+|++|+++.. +...+..+++|+.|+|++|.++..... .+...+..+++|
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~---------------------~L~~~l~~~~~L 245 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS---------------------ALAIALKSWPNL 245 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH---------------------HHHHHGGGCTTC
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccc---------------------cccccccccccc
Confidence 666666666666531 223344445555555555544311100 012233344445
Q ss_pred ceeecccCccCCCCcccc----c--ccccceEEecccccccCC----Cchhhh-cccccCeeccCCcccc
Q 042086 297 EYLDLSTNKLGNSIPETL----G--NLLKLHYLNLSNNQFRKG----FPVELE-KLIQLSELDLSLNILE 355 (784)
Q Consensus 297 ~~L~Ls~n~l~~~~~~~l----~--~l~~L~~L~ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~ 355 (784)
++|+|++|.+++.....+ . ..++|++|++++|.|+.. +...+. ++++|+.|+|++|++.
T Consensus 246 ~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 555555555443222221 1 123466666666665532 122222 3556666677666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.1e-15 Score=137.35 Aligned_cols=128 Identities=18% Similarity=0.163 Sum_probs=64.1
Q ss_pred cCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccc
Q 042086 97 FGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLF 176 (784)
Q Consensus 97 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 176 (784)
|.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|.|+. + +.+..+++|++|+|++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 3444455555555555542 24444445555555555555552 2 2355555555555555555543333344555555
Q ss_pred eeeccccccCCCcc-ccccCccCCceeeccccccCCcc---chhhhcccccceec
Q 042086 177 YLHLSSNQLSGSIP-ISLGNLSNLVVLHLFENSLFGSI---PSILGNLKMLLHLG 227 (784)
Q Consensus 177 ~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~---~~~l~~l~~L~~L~ 227 (784)
+|+|++|+++.... ..+..+++|++|++++|.++... +..++.+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 55555555552211 23455555555555555554221 12355555565555
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=8.2e-15 Score=135.29 Aligned_cols=128 Identities=21% Similarity=0.133 Sum_probs=107.4
Q ss_pred CCCCcccEEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcE
Q 042086 74 GNLKSLSTLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAV 153 (784)
Q Consensus 74 ~~l~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 153 (784)
.+...+++|||++|+|+.. +..+..+++|+.|+|++|+|+.. +.|..+++|++|++++|+++...+..+..+++|++
T Consensus 15 ~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 3567899999999999965 66778899999999999999854 45899999999999999999666666778999999
Q ss_pred EeecCCCcccccC-CccccccccceeeccccccCCCc---cccccCccCCceeec
Q 042086 154 LHLYGNSLSGSIP-SIIGNLKSLFYLHLSSNQLSGSI---PISLGNLSNLVVLHL 204 (784)
Q Consensus 154 L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~L 204 (784)
|+|++|+|+.... ..+..+++|++|++++|.++... +..+..+++|+.||-
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 9999999985322 46889999999999999998432 125778899999873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=2.7e-14 Score=125.24 Aligned_cols=77 Identities=29% Similarity=0.396 Sum_probs=34.0
Q ss_pred EEeCCCCcccccCCCCcCCCCCCCEEEccCCcccccCCCCCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCC
Q 042086 81 TLDLSKNKLNGSIPFSFGNLTNLAIMYLYRNSLSASIPPVIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNS 160 (784)
Q Consensus 81 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 160 (784)
+|||++|+|+.. + .++++++|++|++++|+|+ .+|+.|+.+++|++|++++|.|++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 455555555421 2 2444444444444444444 233344444444444444444442 12 24444444444444444
Q ss_pred cc
Q 042086 161 LS 162 (784)
Q Consensus 161 l~ 162 (784)
|+
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred cC
Confidence 44
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=2.5e-14 Score=125.45 Aligned_cols=87 Identities=31% Similarity=0.339 Sum_probs=36.9
Q ss_pred ccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCCceeeccccccCCcc-chhhhccccc
Q 042086 145 LGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNLVVLHLFENSLFGSI-PSILGNLKML 223 (784)
Q Consensus 145 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L 223 (784)
++.+++|++|++++|.|+ .+|..++.+++|+.|++++|.|++ +| .+..+++|++|++++|+|+... ...+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 344444444444444444 233334444444444444444442 22 2444444444444444443221 1234444444
Q ss_pred ceeccCCCccc
Q 042086 224 LHLGLSTNHLS 234 (784)
Q Consensus 224 ~~L~L~~n~l~ 234 (784)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 44444444444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=1.2e-14 Score=139.02 Aligned_cols=131 Identities=22% Similarity=0.237 Sum_probs=93.5
Q ss_pred CcccccccccccceEeccCccccCCCCccccCCCccceeecccCccCCCCcccccccccceEEecccccccCCCchhhhc
Q 042086 261 EIPIEIGKLSSLNYLVLNGNQLYGNLPRALGSLTELEYLDLSTNKLGNSIPETLGNLLKLHYLNLSNNQFRKGFPVELEK 340 (784)
Q Consensus 261 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~ 340 (784)
.++..+..+++|++|+|++|+|+. ++ .+..+++|+.|+|++|.++ .+|.....+++|+.|++++|+++.. ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 445567777788888888888874 33 4777788888888888887 4555555566788888888888762 45777
Q ss_pred ccccCeeccCCcccccccc-ccccccccccEEecCCCccCCCCccc----------ccCcccceEEE
Q 042086 341 LIQLSELDLSLNILEGKIP-CEICNMESLEKLNLSHNNFSGLIPSC----------FEGMHGLSCID 396 (784)
Q Consensus 341 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~l~ 396 (784)
+++|+.|++++|+++.... ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 8888888888888874322 45777888888888888876554433 45577777776
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=9.1e-15 Score=139.98 Aligned_cols=110 Identities=30% Similarity=0.326 Sum_probs=53.6
Q ss_pred CCCCCCCCCEEEccCCccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccccccCCCccccccCccCC
Q 042086 120 VIGNLKFLYHLDLSENQLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSNQLSGSIPISLGNLSNL 199 (784)
Q Consensus 120 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 199 (784)
.++.+++|++|+|++|+|+. ++ .+..+++|++|+|++|.|+ .+|..+..+++|++|++++|+++. + ..+..+++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence 34445555555555555542 22 3455555555555555554 233333344455555555555552 2 124445555
Q ss_pred ceeeccccccCCccc-hhhhcccccceeccCCCccc
Q 042086 200 VVLHLFENSLFGSIP-SILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 200 ~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~ 234 (784)
+.|+|++|+|+.... ..+..+++|+.|+|++|++.
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555543211 33455555555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.5e-12 Score=118.90 Aligned_cols=105 Identities=21% Similarity=0.132 Sum_probs=56.1
Q ss_pred cEEeecCCCcccccCCccccccccceeecccc-ccCCCccccccCccCCceeeccccccCCccchhhhcccccceeccCC
Q 042086 152 AVLHLYGNSLSGSIPSIIGNLKSLFYLHLSSN-QLSGSIPISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLST 230 (784)
Q Consensus 152 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 230 (784)
+.++++++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34444444444 23444445555555555443 35533444555556666666666666555555666666666666666
Q ss_pred CccccccCCCCcCCCCcceEEecCCCCC
Q 042086 231 NHLSGVIPLSIGNLNNLIGLYLYDNQLS 258 (784)
Q Consensus 231 n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 258 (784)
|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCcccChhhhccc-cccccccCCCccc
Confidence 66664333333332 4666666666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=4.2e-12 Score=115.96 Aligned_cols=140 Identities=18% Similarity=0.032 Sum_probs=69.7
Q ss_pred CEEEccCCcccccCCCCCCCCCCCCEEEccCC-ccCCCCCcCccCCCcCcEEeecCCCcccccCCccccccccceeeccc
Q 042086 104 AIMYLYRNSLSASIPPVIGNLKFLYHLDLSEN-QLSGSIPPTLGNLSNLAVLHLYGNSLSGSIPSIIGNLKSLFYLHLSS 182 (784)
Q Consensus 104 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 182 (784)
+.++.+++.+. ..|..+..+++|++|++++| .++...+.+|.++++|+.|+|++|+|+...+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34444444444 33444555555666666444 35544445556666666666666666655555566666666666666
Q ss_pred cccCCCccccccCccCCceeeccccccCCc-cchhhhcccccceeccCCCccccccCCCCcCCC
Q 042086 183 NQLSGSIPISLGNLSNLVVLHLFENSLFGS-IPSILGNLKMLLHLGLSTNHLSGVIPLSIGNLN 245 (784)
Q Consensus 183 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 245 (784)
|+|+...+..|. ..+|+.|+|++|.+.-. ....+..........+..++++...|..+.+++
T Consensus 90 N~l~~l~~~~~~-~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~p 152 (156)
T d2ifga3 90 NALESLSWKTVQ-GLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152 (156)
T ss_dssp SCCSCCCSTTTC-SCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCCC
T ss_pred CCCcccChhhhc-cccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcCC
Confidence 666633333333 23566666666665311 111222222223333344455544455444443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=3.7e-09 Score=96.66 Aligned_cols=84 Identities=29% Similarity=0.225 Sum_probs=50.1
Q ss_pred cccccccceEEecccccccCC--CchhhhcccccCeeccCCccccccccccccccccccEEecCCCccCCCCccc-----
Q 042086 313 TLGNLLKLHYLNLSNNQFRKG--FPVELEKLIQLSELDLSLNILEGKIPCEICNMESLEKLNLSHNNFSGLIPSC----- 385 (784)
Q Consensus 313 ~l~~l~~L~~L~ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~----- 385 (784)
....+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.++...+..+....+|+.|++++|+++......
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 334556666666666666653 2344566677777777777776433323334456777777777776554422
Q ss_pred --ccCcccceEEE
Q 042086 386 --FEGMHGLSCID 396 (784)
Q Consensus 386 --~~~l~~L~~l~ 396 (784)
+..+++|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 44567777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=6.8e-09 Score=94.85 Aligned_cols=64 Identities=30% Similarity=0.174 Sum_probs=25.4
Q ss_pred cccccceeeccccccCCCc--cccccCccCCceeeccccccCCccchhhhcccccceeccCCCccc
Q 042086 171 NLKSLFYLHLSSNQLSGSI--PISLGNLSNLVVLHLFENSLFGSIPSILGNLKMLLHLGLSTNHLS 234 (784)
Q Consensus 171 ~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (784)
.+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+-+...|+.|++++|++.
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3444444444444444221 122333444444444444443322212222233444444444443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=1e-06 Score=87.13 Aligned_cols=150 Identities=15% Similarity=0.071 Sum_probs=104.1
Q ss_pred HHHHHHhcCCCCceeEecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecC
Q 042086 508 EEIVRATNGFDVKYCIGIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHP 586 (784)
Q Consensus 508 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 586 (784)
.++...-+.|+.++..+.+..+.||+... +++.+++|+..... ......+.+|+.+++.+. +--+.+++++..++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~---~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY---KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG---TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc---ccchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 35666677888777655555678998864 46677888876532 223446788999888773 43466778888888
Q ss_pred CceEEEEecccCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 042086 587 RNSFLVYEYLERGSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMHHDC----------------------------- 637 (784)
Q Consensus 587 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 637 (784)
+..++||+++++.++.+...... ...+++.++++.++.||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 88999999999988866542211 12234555666666666420
Q ss_pred ---------------------------CCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 638 ---------------------------FPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 638 ---------------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999776667999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=6.5e-06 Score=80.62 Aligned_cols=131 Identities=16% Similarity=0.140 Sum_probs=86.2
Q ss_pred eEeccc-ceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCC--CceeeEEeEEecCCceEEEEecccC
Q 042086 522 CIGIGG-QGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRH--RSIVKFYGFCSHPRNSFLVYEYLER 598 (784)
Q Consensus 522 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 598 (784)
.+..|. .+.||+...+++..+++|..... ....+..|+..++.+.. -.+.+++++..+++..++||+|+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 445555 46799999888888999976542 23457888888887732 3356778888888889999999988
Q ss_pred CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 042086 599 GSLATILSNDGAIEEFNWTVRMNVIRSVANALSYMH-------------------------------------------- 634 (784)
Q Consensus 599 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-------------------------------------------- 634 (784)
.++.+.. .. ....+.++++.++-||
T Consensus 91 ~~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 91 QDLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp EETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 6542210 00 0111222233333333
Q ss_pred -------hCC----CCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 635 -------HDC----FPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 635 -------~~~----~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
... .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 12379999999999999876678999997753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.87 E-value=2.1e-06 Score=78.18 Aligned_cols=63 Identities=17% Similarity=0.198 Sum_probs=30.5
Q ss_pred hhcccccCeeccCCcccccccc----ccccccccccEEecCCCccCCC-------CcccccCcccceEEEcCCC
Q 042086 338 LEKLIQLSELDLSLNILEGKIP----CEICNMESLEKLNLSHNNFSGL-------IPSCFEGMHGLSCIDVSYN 400 (784)
Q Consensus 338 ~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~l~l~~N 400 (784)
+...+.|++|+|++|.++.... ..+...++|++|+|++|++... +...+..-++|+.|+++++
T Consensus 68 L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 68 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred hhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 3334445555555555443221 2233445566666666654432 2233334556666666655
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.84 E-value=2.1e-06 Score=78.16 Aligned_cols=36 Identities=22% Similarity=0.102 Sum_probs=15.5
Q ss_pred cccceeeccccccCCC----ccccccCccCCceeeccccc
Q 042086 173 KSLFYLHLSSNQLSGS----IPISLGNLSNLVVLHLFENS 208 (784)
Q Consensus 173 ~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~ 208 (784)
+.|++|+|++|.++.. +-..+...++|++|+|++|+
T Consensus 72 ~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~ 111 (167)
T d1pgva_ 72 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR 111 (167)
T ss_dssp SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred ccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCc
Confidence 4455555555544422 11123333445555554443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.59 E-value=0.00011 Score=76.52 Aligned_cols=79 Identities=15% Similarity=0.040 Sum_probs=50.1
Q ss_pred ceeEecccceEEEEEEEc-CCCEEEEEEcCCCCCC----CCCChhhHHHHHHHHhcc-CC--CceeeEEeEEecCCceEE
Q 042086 520 KYCIGIGGQGSVYKAKLT-SGEILAVKKFHSLWPC----EMVPQPEFVNEIKTLTEL-RH--RSIVKFYGFCSHPRNSFL 591 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l 591 (784)
.+.||.|....||+.... +++.|+||.-...... -....++...|++.++.+ .+ ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 356899999999999865 4678999965432110 112334566788888766 33 345566654 4456789
Q ss_pred EEecccCCC
Q 042086 592 VYEYLERGS 600 (784)
Q Consensus 592 v~e~~~~gs 600 (784)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.30 E-value=1.9e-05 Score=71.65 Aligned_cols=64 Identities=17% Similarity=0.116 Sum_probs=31.7
Q ss_pred cccccceEeccC-ccccCC----CCccccCCCccceeecccCccCCCCcc----cccccccceEEeccccccc
Q 042086 268 KLSSLNYLVLNG-NQLYGN----LPRALGSLTELEYLDLSTNKLGNSIPE----TLGNLLKLHYLNLSNNQFR 331 (784)
Q Consensus 268 ~l~~L~~L~l~~-n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~----~l~~l~~L~~L~ls~N~l~ 331 (784)
+.++|++|++++ +.++.. +-.++...++|++|++++|.++..... .+...++++.|++++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 446666666665 334321 122334555666666666665542222 2233445555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.23 E-value=2.6e-05 Score=70.67 Aligned_cols=40 Identities=15% Similarity=0.218 Sum_probs=17.0
Q ss_pred CCCcCcEEeecCCCcccc----cCCccccccccceeeccccccC
Q 042086 147 NLSNLAVLHLYGNSLSGS----IPSIIGNLKSLFYLHLSSNQLS 186 (784)
Q Consensus 147 ~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~ 186 (784)
..++|++|+|++|.++.. +...+...++|+.|++++|.++
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 344444444444444322 1122233344555555555444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.92 E-value=0.0014 Score=65.90 Aligned_cols=136 Identities=12% Similarity=0.124 Sum_probs=78.5
Q ss_pred ceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce--eeEEe-----EEecCCceEEEEecccCCC
Q 042086 528 QGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI--VKFYG-----FCSHPRNSFLVYEYLERGS 600 (784)
Q Consensus 528 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gs 600 (784)
--.||++...+|+.|++|+.+.. ....+++..|...+..+....+ +..+. .+...+..+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 45799999999999999998763 2246778899988888742222 11111 2234566788999987632
Q ss_pred H-----HHHH---------h----cCC--CCCCCCHH-------------------HHHHHHHHHHHHHHHHhh----CC
Q 042086 601 L-----ATIL---------S----NDG--AIEEFNWT-------------------VRMNVIRSVANALSYMHH----DC 637 (784)
Q Consensus 601 L-----~~~l---------~----~~~--~~~~l~~~-------------------~~~~i~~~i~~~l~~LH~----~~ 637 (784)
+ ..+- + ... .....++. .+..+...+.+.++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 1 1111 1 000 01111111 111122222233333322 22
Q ss_pred CCCeEEeCCCCCCeeecCCCceEEeccccccc
Q 042086 638 FPPIVHRDISSKNVLLCLDYEARVSDFGIAKF 669 (784)
Q Consensus 638 ~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 669 (784)
..++||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3468999999999999743 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.28 E-value=0.0079 Score=59.81 Aligned_cols=158 Identities=15% Similarity=0.081 Sum_probs=84.5
Q ss_pred ccHHHHHHHhcCCCCceeE-----ecccceEEEEEEEcCCCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccCCCce--e
Q 042086 505 ILYEEIVRATNGFDVKYCI-----GIGGQGSVYKAKLTSGEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELRHRSI--V 577 (784)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v 577 (784)
.+.+|+......|.+++.. ..|---+.|+.+.++|+ +++|++.... ..+++..|++++..+...++ .
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-----CHHHHHHHHHHHHhhhhcccccc
Confidence 4567788888889886554 35666778999877665 8899875421 23456677777777743222 1
Q ss_pred eEEe------EEecCCceEEEEecccCCCHH-----H---------HHhc----CCC--CCCC-----------------
Q 042086 578 KFYG------FCSHPRNSFLVYEYLERGSLA-----T---------ILSN----DGA--IEEF----------------- 614 (784)
Q Consensus 578 ~l~~------~~~~~~~~~lv~e~~~~gsL~-----~---------~l~~----~~~--~~~l----------------- 614 (784)
..+. +.........++.+..+.... . .++. ... ....
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 1111 112234456666666653211 0 0010 000 0000
Q ss_pred -CHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeeecCCCceEEecccccc
Q 042086 615 -NWTVRMNVIRSVANALSYMHH-DCFPPIVHRDISSKNVLLCLDYEARVSDFGIAK 668 (784)
Q Consensus 615 -~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 668 (784)
........+..+...+...+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 000111122222222222222 123479999999999999988777899999886
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.99 E-value=0.011 Score=60.74 Aligned_cols=72 Identities=18% Similarity=0.193 Sum_probs=49.6
Q ss_pred ceeEecccceEEEEEEEcC--------CCEEEEEEcCCCCCCCCCChhhHHHHHHHHhccC-CCceeeEEeEEecCCceE
Q 042086 520 KYCIGIGGQGSVYKAKLTS--------GEILAVKKFHSLWPCEMVPQPEFVNEIKTLTELR-HRSIVKFYGFCSHPRNSF 590 (784)
Q Consensus 520 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 590 (784)
++.|+.|-.-.+|++...+ .+.|++++.... .......+|..+++.+. +.-..++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3578889999999998654 356777765421 12345668999988884 4434577777743 6
Q ss_pred EEEecccCCC
Q 042086 591 LVYEYLERGS 600 (784)
Q Consensus 591 lv~e~~~~gs 600 (784)
+|+||+++.+
T Consensus 118 ~I~efi~g~~ 127 (395)
T d1nw1a_ 118 RLEEYIPSRP 127 (395)
T ss_dssp EEECCCCEEE
T ss_pred eEEEEecccc
Confidence 8999998743
|